PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	du Plessis, WJ; Kleynhans, L; du Plessis, N; Stanley, K; Malherbe, ST; Maasdorp, E; Ronacher, K; Chegou, NN; Walzl, G; Loxton, AG				du Plessis, Willem J.; Kleynhans, Leanie; du Plessis, Nelita; Stanley, Kim; Malherbe, Stephanus T.; Maasdorp, Elizna; Ronacher, Katharina; Chegou, Novel N.; Walzl, Gerhard; Loxton, Andre G.			The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; FLOW-CYTOMETRY; INNATE; AUTOIMMUNE; EXPRESSION; INFECTION; SUSCEPTIBILITY	Mycobacterium tuberculosis (M.tb) remains a successful pathogen, causing tuberculosis disease numbers to constantly increase. Although great progress has been made in delineating the disease, the host-pathogen interaction is incompletely described. B cells have shown to function as both effectors and regulators of immunity via non-humoral methods in both innate and adaptive immune settings. Here we assessed specific B cell functional interaction following stimulation with a broad range of antigens within the LTBI milieu. Our results indicate that B cells readily produce pro-and anti-inflammatory cytokines (including IL-1 beta, IL-10, IL-17, IL-21 and TNF-alpha) in response to stimulation. TLR4 and TLR9 based stimulations achieved the greatest secreted cytokine-production response and BCG stimulation displayed a clear preference for inducing IL-1 beta production. We also show that the cytokines produced by B cells are implicated strongly in cell-mediated communication and that plasma (memory) B cells (CD19(+)CD27(+)CD138(+)) is the subset with the greatest contribution to cytokine production. Collectively our data provides insight into B cell responses, where they are implicated in and quantifies responses from specific B cell phenotypes. These findings warrant further functional B cell research with a focus on specific B cell phenotypes under conditions of active TB disease to further our knowledge about the contribution of various cell subsets which could have implications for future vaccine development or refined B cell orientated treatment in the health setting.	[du Plessis, Willem J.; Kleynhans, Leanie; du Plessis, Nelita; Stanley, Kim; Malherbe, Stephanus T.; Maasdorp, Elizna; Ronacher, Katharina; Chegou, Novel N.; Walzl, Gerhard; Loxton, Andre G.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, SA MRC Ctr TB Res,DST NRF Ctr Excellence Biomed T, Cape Town, South Africa	Stellenbosch University	Loxton, AG (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, SA MRC Ctr TB Res,DST NRF Ctr Excellence Biomed T, Cape Town, South Africa.	GL2@sun.ac.za	Ronacher, Katharina/N-9603-2016; Walzl, Gerhard/N-6371-2016	Ronacher, Katharina/0000-0002-6371-1462; Maasdorp, Elizna/0000-0002-3402-169X; du Plessis, Jacques/0000-0002-8887-4938; Kleynhans, Leanie/0000-0003-1635-253X; Chegou, Novel N/0000-0002-8690-1699; Loxton, Andre/0000-0003-0659-9803; du Plessis, Nelita/0000-0001-7881-925X; Walzl, Gerhard/0000-0003-2487-125X	NRF	NRF	WJ du Plessis holds an NRF scholarship. GW holds the DST/NRF SA Research Chair Initiative (SARChI) for TB Biomarkers. The authors received no specific funding for this work.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Achkar JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018432; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; [Anonymous], 2015, GLOBAL TUBERCULOSIS; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Brighenti S, 2012, J INFECT DIS, V205, pS316, DOI 10.1093/infdis/jis043; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan J, 2014, SEMIN IMMUNOL, V26, P588, DOI 10.1016/j.smim.2014.10.005; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; de Wit J, 2015, J ALLERGY CLIN IMMUN, V135, P1053, DOI 10.1016/j.jaci.2014.08.012; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Fernando TR, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-7; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Gopalakrishnan A, 2016, CELL IMMUNOL, V302, P11, DOI 10.1016/j.cellimm.2015.12.009; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hoehlig K, 2008, ADV IMMUNOL, V98, P1, DOI 10.1016/S0065-2776(08)00401-X; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Kaufmann SHE, 2013, CURR OPIN IMMUNOL, V25, P441, DOI 10.1016/j.coi.2013.05.005; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Killick KE, 2013, CELL MICROBIOL, V15, P1484, DOI 10.1111/cmi.12161; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lebeis SL, 2009, CELL HOST MICROBE, V5, P114, DOI 10.1016/j.chom.2009.01.008; Lenaerts A, 2015, IMMUNOL REV, V264, P288, DOI 10.1111/imr.12252; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; McShane H, 2012, TUBERCULOSIS, V92, P283, DOI 10.1016/j.tube.2011.12.003; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Rangaka MX, 2015, LANCET, P6736; Rao M, 2015, CLIN INFECT DIS, V61, pS225, DOI 10.1093/cid/civ614; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Saiga H, 2015, J INFECT DIS, V211, P1831, DOI 10.1093/infdis/jiu675; Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schurz H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139711; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Wu LL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0166-1; Zhao LL, 2015, MED SCI MONITOR, V21, P1097, DOI 10.12659/MSM.893755; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	62	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152710	10.1371/journal.pone.0152710	http://dx.doi.org/10.1371/journal.pone.0152710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050308	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500049
J	Fischer, AW; Heinze, S; Putnam, DK; Li, B; Pino, JC; Xia, Y; Lopez, CF; Meiler, J				Fischer, Axel W.; Heinze, Sten; Putnam, Daniel K.; Li, Bian; Pino, James C.; Xia, Yan; Lopez, Carlos F.; Meiler, Jens			CASP11-An Evaluation of a Modular BCL:: Fold-Based Protein Structure Prediction Pipeline	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SECONDARY STRUCTURE; CONTACT ORDER; SOFTWARE; BINDING; SYSTEM; RATES; AMBER	In silico prediction of a protein's tertiary structure remains an unsolved problem. The community-wide Critical Assessment of Protein Structure Prediction (CASP) experiment provides a double-blind study to evaluate improvements in protein structure prediction algorithms. We developed a protein structure prediction pipeline employing a three-stage approach, consisting of low-resolution topology search, high-resolution refinement, and molecular dynamics simulation to predict the tertiary structure of proteins from the primary structure alone or including distance restraints either from predicted residue-residue contacts, nuclear magnetic resonance (NMR) nuclear overhauser effect (NOE) experiments, or mass spectroscopy (MS) cross-linking (XL) data. The protein structure prediction pipeline was evaluated in the CASP11 experiment on twenty regular protein targets as well as thirtythree 'assisted' protein targets, which also had distance restraints available. Although the low-resolution topology search module was able to sample models with a global distance test total score (GDT_TS) value greater than 30% for twelve out of twenty proteins, frequently it was not possible to select the most accurate models for refinement, resulting in a general decay of model quality over the course of the prediction pipeline. In this study, we provide a detailed overall analysis, study one target protein in more detail as it travels through the protein structure prediction pipeline, and evaluate the impact of limited experimental data.	[Fischer, Axel W.; Heinze, Sten; Li, Bian; Xia, Yan; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Fischer, Axel W.; Heinze, Sten; Li, Bian; Xia, Yan; Lopez, Carlos F.; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Putnam, Daniel K.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37232 USA; [Pino, James C.] Vanderbilt Univ, Chem & Phys Biol Grad Program, Nashville, TN 37232 USA; [Lopez, Carlos F.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Lopez, Carlos F.] Vanderbilt Univ, Ctr Quantitat Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.	jens@meilerlab.org	Putnam, Daniel/X-9760-2019; Li, Bian/AAM-4001-2020; Lopez, Carlos/P-7257-2019; Li, Bian/AAV-3933-2021	Putnam, Daniel/0000-0001-8080-775X; Li, Bian/0000-0002-8280-5018; Lopez, Carlos/0000-0003-3668-7468; Li, Bian/0000-0002-8280-5018; Fischer, Axel Walter/0000-0003-0237-7365	National Institutes of Health [R01 GM080403, R01 GM099842, R01 DK097376]; National Science Foundation [CHE 1305874, BIO 1411482]; U.S. National Library of Medicine [5T15LM007450-09]; Initiative for Maximizing Student Development [R25 GM 062459]; U.S. Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099842, R25GM062459, R01GM080403] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Initiative for Maximizing Student Development; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funded by National Institutes of Health, http://www.nih.gov R01 GM080403, R01 GM099842, R01 DK097376 (JM), National Science Foundation http://www.nsf.gov CHE 1305874, BIO 1411482 (JM CFL), U.S. National Library of Medicine-5T15LM007450-09 (DKP), Initiative for Maximizing Student Development-https://www.nigms.nih.gov/Training/IMSD/Pages/default.aspx-R25 GM 062459 (JCP), and U.S. Department of Energy-http://energy.gov/-DE-AC05-00OR22725 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneau R, 2002, PROTEIN SCI, V11, P1937, DOI 10.1110/ps.3790102; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Case D.A., 2022, AMBER; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9; Feig M, 2016, PROTEINS, V84, P282, DOI 10.1002/prot.24871; Fischer AW, 2014, BCL MP FOLD MEMBRANC, DOI 10.13140/2.1.4128.8004; Hanukoglu I, 2015, BIOCHEM MOL BIOL EDU, V43, P206, DOI 10.1002/bmb.20849; Hardin C, 2003, P NATL ACAD SCI USA, V100, P1679, DOI 10.1073/pnas.252753899; Hardin C, 2002, J COMPUT CHEM, V23, P138, DOI 10.1002/jcc.1162; Heinze S, 2015, PROTEINS, V83, P547, DOI 10.1002/prot.24733; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hofmann T, 2015, METHODS, V89, P79, DOI 10.1016/j.ymeth.2015.05.014; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karakas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049240; Kim H, 2016, PROTEINS, V84, P105, DOI 10.1002/prot.24920; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lindert S, 2015, J CHEM THEORY COMPUT, V11, P1337, DOI 10.1021/ct500995d; Lindert S, 2012, BIOPOLYMERS, V97, P669, DOI 10.1002/bip.22027; Lindert S, 2012, STRUCTURE, V20, P464, DOI 10.1016/j.str.2012.01.023; Lindert S, 2009, STRUCTURE, V17, P990, DOI 10.1016/j.str.2009.06.001; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Mendenhall J, 2014, SERMACS, DOI 10.13140/RG.2.1.2545.8724; MIYAMOTO S, 1992, J AM CHEM SOC, V114, P3668, DOI 10.1021/ja00036a015; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Ovchinnikov S, 2016, PROTEINS, V84, P67, DOI 10.1002/prot.24974; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Putnam DK, 2015, PROTEINS, V83, P1500, DOI 10.1002/prot.24838; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Weiner BE, 2014, PROTEINS, V82, P587, DOI 10.1002/prot.24427; Weiner BE, 2013, STRUCTURE, V21, P1107, DOI 10.1016/j.str.2013.04.022; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang WX, 2016, PROTEINS, V84, P76, DOI 10.1002/prot.24930	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152517	10.1371/journal.pone.0152517	http://dx.doi.org/10.1371/journal.pone.0152517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046050	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600022
J	Buenzli, PR				Buenzli, Pascal R.			Governing Equations of Tissue Modelling and Remodelling: A Unified Generalised Description of Surface and Bulk Balance	PLOS ONE			English	Article							HUMAN CORTICAL BONE; MATHEMATICAL-MODEL; OSTEOCYTE NETWORK; DYNAMICS; GROWTH; MINERALIZATION; TRANSPORT; FRAMEWORK; THEOREMS; POROSITY	Several biological tissues undergo changes in their geometry and in their bulk material properties by modelling and remodelling processes. Modelling synthesises tissue in some regions and removes tissue in others. Remodelling overwrites old tissue material properties with newly formed, immature tissue properties. As a result, tissues are made up of different "patches", i.e., adjacent tissue regions of different ages and different material properties, within evolving boundaries. In this paper, generalised equations governing the spatio-temporal evolution of such tissues are developed within the continuum model. These equations take into account nonconservative, discontinuous surface mass balance due to creation and destruction of material at moving interfaces, and bulk balance due to tissue maturation. These equations make it possible to model patchy tissue states and their evolution without explicitly maintaining a record of when/where resorption and formation processes occurred. The time evolution of spatially averaged tissue properties is derived systematically by integration. These spatially-averaged equations cannot be written in closed form as they retain traces that tissue destruction is localised at tissue boundaries. The formalism developed in this paper is applied to bone tissues, which exhibit strong material heterogeneities due to their slow mineralisation and remodelling processes. Evolution equations are proposed in particular for osteocyte density and bone mineral density. Effective average equations for bone mineral density (BMD) and tissue mineral density (TMD) are derived using a mean-field approximation. The error made by this approximation when remodelling patchy tissue is investigated. The specific signatures of the time evolution of BMD or TMD during remodelling events are exhibited. These signatures may provide a way to detect remodelling events at lower, unseen spatial resolutions from microCT scans.	[Buenzli, Pascal R.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia	Monash University	Buenzli, PR (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia.	pascal.buenzli@monash.edu		Buenzli, Pascal/0000-0003-3962-5393	Australian Research Council; Discovery Early Career Researcher Award [DE130101191]	Australian Research Council(Australian Research Council); Discovery Early Career Researcher Award(Australian Research Council)	This work was supported by Australian Research Council (www.arc.gov.au), Discovery Early Career Researcher Award, project number DE130101191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANO AM, 1979, PHYSICA A, V99, P293, DOI 10.1016/0378-4371(79)90136-5; Arhatari BD, 2011, PHYS MED BIOL, V56, P5265, DOI 10.1088/0031-9155/56/16/012; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bidan CM, 2012, ADV HEALTHCARE MAT; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Briggs AM, 2010, J CLIN DENSITOM, V13, P161, DOI 10.1016/j.jocd.2010.01.120; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buenzli PR, 2011, BONE, V48, P918, DOI 10.1016/j.bone.2010.12.009; Buenzli PR, 2015, BONE, V75, P144, DOI 10.1016/j.bone.2015.02.016; Buenzli PR, 2015, J THEOR BIOL, V364, P418, DOI 10.1016/j.jtbi.2014.09.028; Buenzli PR, 2014, BIOMECH MODEL MECHAN, V13, P185, DOI 10.1007/s10237-013-0495-y; Buenzli PR, 2013, INT J NUMER METH BIO, V29, P1307, DOI 10.1002/cnm.2567; Cantrell C. D., 2000, MODERN MATH METHODS; COHEN J, 1958, J BONE JOINT SURG AM, V40, P419, DOI 10.2106/00004623-195840020-00015; Cowin SC, 2012, MECH MATER, V44, P47, DOI 10.1016/j.mechmat.2011.07.005; Cumming BD, 2010, J R SOC INTERFACE, V7, P19, DOI 10.1098/rsif.2008.0536; Cushman JH, 1982, ADV WATER RESOUR, V5, P248, DOI 10.1016/0309-1708(82)90009-4; DEEMER AR, 1978, INT J MULTIPHAS FLOW, V4, P171, DOI 10.1016/0301-9322(78)90043-5; Evans DJ, 2008, STAT MECH NONEQUILIB; Giga Y., 2006, SURFACE EVOLUTION EQ; GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107; Gray W. G., 1977, International Journal of Multiphase Flow, V2, P333, DOI 10.1016/0301-9322(77)90013-1; GRAY WG, 1983, INT J MULTIPHAS FLOW, V9, P755, DOI 10.1016/0301-9322(83)90120-9; Guyot Y, 2015, BIOTECHNOL BIOENG, V112, P2591, DOI 10.1002/bit.25672; HUET C, 1990, J MECH PHYS SOLIDS, V38, P813, DOI 10.1016/0022-5096(90)90041-2; Irschik H, 2003, ACTA MECH, V162, P195, DOI 10.1007/s00707-002-0995-9; Jones D.S, 1982, THEORY GEN FUNCTIONS; Kerschnitzki M, 2013, J BONE MINER RES, V28, P1837, DOI 10.1002/jbmr.1927; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Landau L.D., 1959, FLUID MECH-SOV RES, DOI DOI 10.1016/C2013-0-03799-1; Lange RJ, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2012)032; Lasseux D, 2004, CHEM ENG SCI, V59, P1949, DOI 10.1016/j.ces.2004.02.003; Leigh SR, 2001, EVOL ANTHROPOL, V10, P223, DOI 10.1002/evan.20002; Lerebours C, 2015, BONE, V72, P109, DOI 10.1016/j.bone.2014.11.016; Lerebours C, 2015, BIOMECH MOD IN PRESS; Li Z., 2006, FRONT APP M; Lighthill M.J., 1958, INTRO FOURIER ANAL G; Liu D, 2013, BIOMECH MODEL MECHAN, V12, P19, DOI 10.1007/s10237-012-0378-7; Lowengrub JS, 2010, NONLINEARITY, V23, pR1, DOI 10.1088/0951-7715/23/1/R01; Lukas C, 2011, J STAT PHYS, V144, P316, DOI 10.1007/s10955-011-0209-8; Makarov B., 2013, REAL ANAL MEASURES I; MARTIN RB, 1972, J BIOMECH, V5, P447, DOI 10.1016/0021-9290(72)90003-6; MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179; Martin RB, 1998, SKELETAL TISSUE MECH; Osher S, 2006, LEVEL SET METHODS DY; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Parfitt AM., 1983, BONE HISTOMORPHOMETR, V1983, P143; Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025; Robling AG, 1999, CELLS TISSUES ORGANS, V164, P192, DOI 10.1159/000016659; RONIS D, 1978, PHYSICA A, V90, P487, DOI 10.1016/0378-4371(78)90005-5; Ryser MD, 2010, SIAM J APPL MATH, V70, P1899, DOI 10.1137/090746094; Ryser MD, 2009, J BONE MINER RES, V24, P860, DOI 10.1359/JBMR.081229; Sansalone V, 2012, BONE, V50, P876, DOI 10.1016/j.bone.2011.12.020; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Slattery J.C., 2007, INTERFACIAL TRANSPOR, V2nd ed.; Smith DW, 2013, WIRES SYST BIOL MED, V5, P523, DOI 10.1002/wsbm.1229; Stueckelberg ECG, 1974, THERMOCINETIQUE PHEN; TAO LN, 1986, SIAM J APPL MATH, V46, P254, DOI 10.1137/0146018; TAPPEN NC, 1977, AM J ANAT, V149, P301, DOI 10.1002/aja.1001490302; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009; WHITAKER S, 1973, CHEM ENG SCI, V28, P139, DOI 10.1016/0009-2509(73)85094-8; WHITAKER S, 1992, CHEM ENG SCI, V47, P1677, DOI 10.1016/0009-2509(92)85015-4	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152582	10.1371/journal.pone.0152582	http://dx.doi.org/10.1371/journal.pone.0152582			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043309	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100017
J	Fawzy, MS; Hussein, MH; Abdelaziz, EZ; Yamany, HA; Ismail, HM; Toraih, EA				Fawzy, Manal S.; Hussein, Mohammad H.; Abdelaziz, Eman Z.; Yamany, Hussain A.; Ismail, Hussein M.; Toraih, Eman A.			Association of MicroRNA-196a2 Variant with Response to Short-Acting beta 2-Agonist in COPD: An Egyptian Pilot Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CELL LUNG-CANCER; BREAST-CANCER; EXPRESSION; FIBROSIS; PATHOGENESIS; INFLAMMATION; FIBROBLASTS; GUIDELINES; NETWORKS	Chronic obstructive pulmonary disease (COPD) is a multifactorial chronic respiratory disease, characterized by an obstructive pattern. Understanding the genetic predisposition of COPD is essential to develop personalized treatment regimens. MicroRNAs (miRNAs) are small, endogenous, non-coding RNAs that modulate the expression levels of specific proteins based on sequence complementarity with their target mRNA molecules. Emerging evidences demonstrated the potential use of miRNAs as a disease biomarker. This pilot study aimed to investigate the association of the MIR-196a2 rs11614913 (C/T) polymorphism with COPD susceptibility, the clinical outcome and bronchodilator response to short-acting beta(2)-agonist. Genotyping of rs11614913 polymorphism was determined in 108 COPD male patients and 116 unrelated controls using real-time polymerase chain reaction technology. In silico target prediction and network core analysis were performed. COPD patients did not show significant differences in the genotype distribution (p = 0.415) and allele frequencies (p = 0.306) of the studied miRNA when compared with controls. There were also no associations with GOLD stage, dyspnea grade, disease exacerbations, COPD assessment test for estimating impact on health status score, or the frequency of intensive care unit admission. However, COPD patients with CC genotype corresponded to the smallest bronchodilator response after Salbutamol inhalation, the heterozygotes (CT) had an intermediate response, while those with the TT genotype showed the highest response (p < 0.001). In conclusion MIR-196a2 rs11614913 polymorphism is associated with the bronchodilator response of COPD in our sample of the Egyptian population, generating hypothesis of the potential use of MIR-196a2 variant as a pharmacogenetic marker for COPD.	[Fawzy, Manal S.] Suez Canal Univ, Fac Med, Dept Med Biochem, Ismailia, Egypt; [Hussein, Mohammad H.] Cairo Univ, Fac Med, Dept Chest Dis, Giza, Egypt; [Abdelaziz, Eman Z.] Suez Canal Univ, Fac Med, Dept Pharmacol, Ismailia, Egypt; [Yamany, Hussain A.; Ismail, Hussein M.] Taibah Univ, Coll Med, Dept Med, Almadinah Almunawwarah, Saudi Arabia; [Ismail, Hussein M.] Suez Canal Univ, Fac Med, Dept Cardiol, Ismailia, Egypt; [Toraih, Eman A.] Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Genet Unit, Ismailia, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Suez Canal University; Taibah University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University	Fawzy, MS (corresponding author), Suez Canal Univ, Fac Med, Dept Med Biochem, Ismailia, Egypt.; Toraih, EA (corresponding author), Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Genet Unit, Ismailia, Egypt.	manal2_khashana@ymail.com; emantoraih@gmail.com	Abdelaziz, Eman Z/ABG-6634-2020; Fawzy, Manal S./L-1516-2016; Ismail, Hussein/AAK-1325-2021; Toraih, Eman/I-3024-2019	Abdelaziz, Eman Z/0000-0002-6120-5048; Fawzy, Manal S./0000-0003-1252-8403; Ismail, Hussein/0000-0001-9377-0749; Toraih, Eman/0000-0001-9267-3787				Angulo M, 2012, ARCH BRONCONEUMOL, V48, P325, DOI 10.1016/j.arbres.2012.04.011; Baraldo S, 2012, RESPIRATION, V84, P89, DOI 10.1159/000341382; Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell JD, 2012, GENOME MED, V4, DOI 10.1186/gm367; Chen Zhi-Hua, 2008, Int J Chron Obstruct Pulmon Dis, V3, P359; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Chu R, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0045-y; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cui K, 2014, INTEGR BIOL-UK, V6, P1141, DOI 10.1039/c4ib00156g; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Francis SMS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-88; GOLD, 2011, GLOB STRAT DIAGN MAN; Graff JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044066; Hizawa N, 2007, CHEST, V132, P1485, DOI 10.1378/chest.07-1103; Hobbs BD, 2014, BIOCHEM BIOPH RES CO, V452, P276, DOI 10.1016/j.bbrc.2014.07.086; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hsu KY, 2013, SINGAP MED J, V54, P321, DOI 10.11622/smedj.2013125; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jiang XY, 2011, MOL CELL BIOCHEM, V353, P35, DOI 10.1007/s11010-011-0771-z; Jones PW, 2012, CHEST, V142, P134, DOI 10.1378/chest.11-0309; Kaneko Y, 2013, INT J CHRONIC OBSTR, V8, P65, DOI 10.2147/COPD.S39617; Khan JH, 2014, ANN THORAC MED, V9, P55, DOI 10.4103/1817-1737.128843; Kishore A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/259131; Li LJ, 2011, CLIN BIOCHEM, V44, P813, DOI 10.1016/j.clinbiochem.2011.04.021; Lin PY, 2010, BRIT J CANCER, V103, P1144, DOI 10.1038/sj.bjc.6605901; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu X, 2011, TRANSL RES, V157, P200, DOI 10.1016/j.trsl.2011.01.001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Oglesby IK, 2010, J IMMUNOL, V184, P1702, DOI 10.4049/jimmunol.0902669; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Soriano JB, 2013, CHEST, V143, P694, DOI 10.1378/chest.12-1053; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Toraih E, 2014, ADVANCES IN MOLECULA, V2014, DOI [10.1155/2014/471635, DOI 10.1155/2014/471635]; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Vaporidi K, 2012, AM J PHYSIOL-LUNG C, V303, pL199, DOI 10.1152/ajplung.00370.2011; Vermylen JH, 2013, TRANSL RES, V162, P203, DOI 10.1016/j.trsl.2013.07.008; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; Yin Y, 2012, INT J MOL SCI, V13, P12544, DOI 10.3390/ijms131012544; Yuan J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059885, 10.1371/journal.pone.0061047]; Zhang J, 2014, INT J CHRONIC OBSTR, V9, P57, DOI 10.2147/COPD.S52416; Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	54	24	26	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152834	10.1371/journal.pone.0152834	http://dx.doi.org/10.1371/journal.pone.0152834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043015	Green Submitted, gold, Green Published			2022-12-27	WOS:000373592100036
J	Pezier, AP; Jezzini, SH; Bacon, JP; Blagburn, JM				Pezier, Adeline P.; Jezzini, Sami H.; Bacon, Jonathan P.; Blagburn, Jonathan M.			Shaking B Mediates Synaptic Coupling between Auditory Sensory Neurons and the Giant Fiber of Drosophila melanogaster	PLOS ONE			English	Article							GAP-JUNCTION PROTEINS; TRANSGENIC RNAI; ELECTRICAL SYNAPSES; DISTINCT ROLES; EXPRESSION; SYSTEM; GENE; INNEXINS; REPRESENTATIONS; ACETYLCHOLINE	The Johnston's Organ neurons (JONs) form chemical and electrical synapses onto the giant fiber neuron (GF), as part of the neuronal circuit that mediates the GF escape response in Drosophila melanogaster. The purpose of this study was to identify which of the 8 Drosophila innexins (invertebrate gap junction proteins) mediates the electrical connection at this synapse. The GF is known to express Shaking B (ShakB), specifically the ShakB (N+16) isoform only, at its output synapses in the thorax. The shakB(2) mutation disrupts these GF outputs and also abolishes JON-GF synaptic transmission. However, the identity of the innexin that forms the presynaptic hemichannels in the JONs remains unknown. We used electrophysiology, immunocytochemistry and dye injection, along with presynaptically- driven RNA interference, to investigate this question. The amplitude of the compound action potential recorded in response to sound from the base of the antenna (sound-evoked potential, or SEP) was reduced by RNAi of the innexins Ogre, Inx3, Inx6 and, to a lesser extent Inx2, suggesting that they could be required in JONs for proper development, excitability, or synchronization of action potentials. The strength of the JON-GF connection itself was reduced to background levels only by RNAi of shakB, not of the other seven innexins. ShakB knockdown prevented Neurobiotin coupling between GF and JONs and removed the plaques of ShakB protein immunoreactivity that are present at the region of contact. Specific shakB RNAi lines that are predicted to target the ShakB(L) or ShakB(N) isoforms alone did not reduce the synaptic strength, implying that it is ShakB(N+ 16) that is required in the presynaptic neurons. Overexpression of ShakB(N+ 16) in JONs caused the formation of ectopic dye coupling, whereas ShakB(N) prevented it altogether, supporting this conclusion and also suggesting that gap junction proteins may have an instructive role in synaptic target choice.	[Pezier, Adeline P.; Jezzini, Sami H.; Blagburn, Jonathan M.] Univ Puerto Rico Med Sci Campus, Inst Neurobiol, San Juan, PR USA; [Bacon, Jonathan P.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Sussex	Blagburn, JM (corresponding author), Univ Puerto Rico Med Sci Campus, Inst Neurobiol, San Juan, PR USA.	jonathan.blagburn@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	NINDS [SC1NS081726]; NSF [DBI 0115825, DBI 1337284]; DoD [52680-RT-ISP]; NIMHD [G12 MD007600]; BBSRC [85/S15289]; Bloomington Drosophila Stock Center [NIH P40OD018537]; TRiP at Harvard Medical School (NIH/NIGMS) [R01-GM084947]; NIH [R01-GM09815101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098151, R01GM084947, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); DoD(United States Department of Defense); NIMHD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bloomington Drosophila Stock Center; TRiP at Harvard Medical School (NIH/NIGMS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors declare no competing financial interests. This work was supported by an NINDS grant SC1NS081726 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD G12 MD007600 (RCMI). Some of the antibodies and transgenic fly lines used in this study were made with the support of a grant from the BBSRC (85/S15289) to JPB. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. The authors thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks used in this study. The authors also acknowledge the Vienna Drosophila RNAi Center for the supply of fly lines. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and Analysis of Confocal Data as Applied to Zebrafish Research, R01-GM09815101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare no competing financial interests. This work was supported by an NINDS grant SC1NS081726 to JMB. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The Nikon confocal microscope was funded by NSF DBI 1337284. The Institute Drosophila resource center was supported by NIMHD G12 MD007600 (RCMI). Some of the antibodies and transgenic fly lines used in this study were made with the support of a grant from the BBSRC (85/S15289) to JPB. We thank Pauline Phelan, Andrea Brand and Michael Hoch for donating antibodies. We thank Pauline Phelan, Tanja Godenschwege, Liqun Luo and Bruno Marie for donating fly stocks. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) were used in this study. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing transgenic RNAi fly stocks used in this study. We also acknowledge the Vienna Drosophila RNAi Center for the supply of fly lines. This work was made possible in part by software funded by the NIH: Fluorender: An Imaging Tool for Visualization and	Allen M.J., 2010, COLD SPRING HARB PRO, V2010; Allen MJ, 2007, EUR J NEUROSCI, V26, P439, DOI 10.1111/j.1460-9568.2007.05686.x; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baker MW, 2014, FEBS LETT, V588, P1470, DOI 10.1016/j.febslet.2014.02.010; Baker MW, 2013, J NEUROSCI, V33, P16673, DOI 10.1523/JNEUROSCI.2387-13.2013; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Casso D, 1999, MECH DEVELOP, V88, P229, DOI 10.1016/S0925-4773(99)00174-4; Chang M, 1996, DEV BIOL, V175, P50, DOI 10.1006/dbio.1996.0094; CROMPTON D, 1995, DEV BIOL, V170, P142, DOI 10.1006/dbio.1995.1203; Curtin KD, 2002, J NEUROSCI, V22, P7088; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Eberl DF, 2011, COLD SPRING HARB PRO; Engel JE, 1996, J NEUROSCI, V16, P3486; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fiorini C, 2004, J CELL SCI, V117, P4665, DOI 10.1242/jcs.01335; Firme CP, 2012, J NEUROSCI, V32, P14265, DOI 10.1523/JNEUROSCI.2693-12.2012; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holcroft CE, 2013, J CELL SCI, V126, P3823, DOI 10.1242/jcs.117994; HOMYK T, 1980, MOL GEN GENET, V177, P553; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kamikouchi A, 2010, EUR J NEUROSCI, V31, P697, DOI 10.1111/j.1460-9568.2010.07099.x; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KRISHNAN SN, 1993, CELL, V73, P967, DOI 10.1016/0092-8674(93)90274-T; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lehmann C, 2006, MOL BIOL CELL, V17, P1676, DOI 10.1091/mbc.E05-11-1059; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Marks WD, 2014, J NEUROPHYSIOL, V111, P1383, DOI 10.1152/jn.00385.2013; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mu LY, 2014, J EXP BIOL, V217, P2121, DOI 10.1242/jeb.099135; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Orr BO, 2014, J NEUROSCI, V34, P5416, DOI 10.1523/JNEUROSCI.3183-13.2014; Ostrowski K, 2008, CELL COMMUN ADHES, V15, P155, DOI 10.1080/15419060802013976; Pereda AE, 2014, NAT REV NEUROSCI, V15, P250, DOI 10.1038/nrn3708; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pezier A, 2014, J NEUROSCI, V34, P11691, DOI 10.1523/JNEUROSCI.1939-14.2014; Pezier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071419; Phelan P, 1998, TRENDS GENET, V14, P348, DOI 10.1016/S0168-9525(98)01547-9; Phelan P, 1996, J NEUROSCI, V16, P1101; Phelan P, 2008, CURR BIOL, V18, P1955, DOI 10.1016/j.cub.2008.10.067; Rabinowitch I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5442; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; SARTHY PV, 1991, J NEUROCHEM, V57, P1757, DOI 10.1111/j.1471-4159.1991.tb06378.x; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Sivan-Loukianova E, 2005, J COMP NEUROL, V491, P46, DOI 10.1002/cne.20687; Speder P, 2014, DEV CELL, V30, P309, DOI 10.1016/j.devcel.2014.05.021; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; STRAUSFELD NJ, 1983, J NEUROCYTOL, V12, P971, DOI 10.1007/BF01153345; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; Tootoonian S, 2012, J NEUROSCI, V32, P787, DOI 10.1523/JNEUROSCI.5104-11.2012; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zhang Z, 1999, J NEUROBIOL, V40, P288, DOI 10.1002/(SICI)1097-4695(19990905)40:3<288::AID-NEU2>3.0.CO;2-O	60	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152211	10.1371/journal.pone.0152211	http://dx.doi.org/10.1371/journal.pone.0152211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043822	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000373592100009
J	Tkowska, EP; Kopec, A; Biezanowska-Kopec, R; Pysz, M; Kapusta-Duch, J; Koronowicz, AA; Smolen, S; Skoczylas, L; Ledwozyw-Smolen, I; Rakoczy, R; Maslak, E				Tkowska, Ewa Pi; Kopec, Aneta; Biezanowska-Kopec, Renata; Pysz, Miroslaw; Kapusta-Duch, Joanna; Koronowicz, Aneta Agnieszka; Smolen, Sylwester; Skoczylas, Lukasz; Ledwozyw-Smolen, Iwona; Rakoczy, Roksana; Maslak, Edyta			The Impact of Carrot Enriched in Iodine through Soil Fertilization on Iodine Concentration and Selected Biochemical Parameters in Wistar Rats	PLOS ONE			English	Article							DIFFERENT COOKING METHODS; HORMONE RECEPTOR-ALPHA; THYROID-HORMONE; VAPOR GENERATION; DEFICIENCY; METABOLISM; TISSUES; VEGETABLES; OXIDATION; BROMINE	Iodine is one of the trace elements which are essential for mammalian life. The major objective of iodine biofortification of plants is to obtain food rich in this trace element, which may increase its consumption by various populations. Additionally, it may reduce the risk of iodine deficiency diseases. In this research for the first time we have assessed the bioavailability of iodine from raw or cooked carrot biofortified with this trace element on iodine concentration in selected tissues and various biochemical parameters as well as mRNA expression of some genes involved in iodine metabolism in Wistar rats. Statistically, a significantly higher iodine level was determined in urine, faeces and selected tissues of rats fed a diet containing biofortified raw carrot as compared to a diet without iodine and a diet containing control cooked carrot. Biofortified raw carrot significantly increased triiodothyronine concentration as compared to animals from other experimental groups. The highest thyroid stimulating hormone level was determined in rats fed control cooked carrots. mRNA expression of selected genes was affected by different dietary treatment in rats' hearts. Biofortified raw and cooked carrot could be taken into account as a potential source of iodine in daily diets to prevent iodine deficiency in various populations.	[Tkowska, Ewa Pi; Kopec, Aneta; Biezanowska-Kopec, Renata; Pysz, Miroslaw; Kapusta-Duch, Joanna; Koronowicz, Aneta Agnieszka] Agr Univ Krakow, Fac Food Technol, Dept Human Nutr, Balicka 122, PL-30149 Krakow, Poland; [Smolen, Sylwester; Rakoczy, Roksana] Agr Univ Krakow, Fac Biotechnol & Hort, Inst Plant Biol & Biotechnol, Unit Plant Nutr, Al 29 Listopada 54, PL-31425 Krakow, Poland; [Skoczylas, Lukasz] Agr Univ Krakow, Fac Food Technol, Dept Fruit Vegetable & Mushroom Proc, Balicka 122, PL-30149 Krakow, Poland; [Ledwozyw-Smolen, Iwona] Agr Univ Krakow, Fac Biotechnol & Hort, Inst Plant Biol & Biotechnol, Biochem Unit, Al 29 Listopada 54, PL-31425 Krakow, Poland; [Maslak, Edyta] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut, Bobrzynskiego 14, PL-30060 Krakow, Poland	Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow; Agricultural University Krakow; Jagiellonian University	Tkowska, EP (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Human Nutr, Balicka 122, PL-30149 Krakow, Poland.	e.piatkowska@ur.krakow.pl	Smoleń, Sylwester/S-4081-2019; Kapusta-Duch, Joanna/AAF-9894-2019	Piatkowska, Ewa/0000-0003-3699-314X; Smolen, Sylwester/0000-0001-8093-3801; Ledwozyw-Smolen, Iwona/0000-0003-1419-1162; Skoczylas, Lukasz/0000-0002-8349-4477; Rakoczy-Lelek, Roksana/0000-0002-9782-3200	Polish National Science Center [DEC-2011/03/D/NZ9/05560]	Polish National Science Center	This work was financed by the 2012-2015 Polish National Science Center-grant no. DEC-2011/03/D/NZ9/05560 "I and Se biofortification of selected vegetables, including the influence of these microelements on yield quality as well as evaluation of iodine absorption and selected biochemical parameters in rats fed with vegetables biofortified with iodine".	Andersson M, 2010, BEST PRACT RES CL EN, V24, P1, DOI 10.1016/j.beem.2009.08.005; [Anonymous], 2008, USDA NATL DATABASE S; [Anonymous], 2007, ASS IOD DEF DIS MON; AOAC, 2006, AOAC OFF METH AN; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bochukova E, 2012, NEW ENGL J MED, V366, P243, DOI 10.1056/NEJMoa1110296; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Chantaro P, 2008, LWT-FOOD SCI TECHNOL, V41, P1987, DOI 10.1016/j.lwt.2007.11.013; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Comandini P, 2013, INT J FOOD SCI NUTR, V64, P857, DOI 10.3109/09637486.2013.798270; Dai JL, 2004, BIOL TRACE ELEM RES, V101, P265, DOI 10.1385/BTER:101:3:265; De Steur H, 2015, APPETITE, V92, P295, DOI 10.1016/j.appet.2015.05.038; Delange F, 2000, THYROID FUNDAMENTAL, P743; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-149; EBIHARA K, 1993, NUTR RES, V13, P1305, DOI 10.1016/S0271-5317(05)80815-2; El-Ghawi UM, 2006, BIOL TRACE ELEM RES, V111, P31, DOI 10.1385/BTER:111:1:31; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gawedzki J., 2010, HUMAN NUTR; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Haldimann M, 2005, J FOOD COMPOS ANAL, V18, P461, DOI 10.1016/j.jfca.2004.06.003; Hamza RG, 2011, ISOTOPE RAD RES, V43, P479; He ML, 2002, J ANIM PHYSIOL AN N, V86, P97, DOI 10.1046/j.1439-0396.2002.00363.x; Hefferon KL, 2015, INT J MOL SCI, V16, P3895, DOI 10.3390/ijms16023895; Hong CL, 2008, AGRON SUSTAIN DEV, V28, P575, DOI 10.1051/agro:2008033; Hou XL, 1997, BIOL TRACE ELEM RES, V56, P225, DOI 10.1007/BF02785395; Ibrahim HS, 2008, J MED FOOD, V11, P551, DOI 10.1089/jmf.2007.0517; Johansson C, 1998, AM J PHYSIOL-REG I, V275, pR640, DOI 10.1152/ajpregu.1998.275.2.R640; KHAMIS F, 1991, ARAB J SCI APPL, V24, P19; Kirchgessner M, 1999, J ANIM PHYSIOL AN N, V82, P238, DOI 10.1046/j.1439-0396.1999.00232.x; Kmiecik W, 1997, TECHNOLOGIA ZYWNOSCI, V9, P67; Komolka P, 2012, ZYWN-NAUK TECHNOL JA, V19, P68; Kopec A, 2015, J FUNCT FOODS, V14, P479, DOI 10.1016/j.jff.2015.02.027; Kuiper GGJM, 2005, THYROID, V15, P787, DOI 10.1089/thy.2005.15.787; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Lavado-Autric R, 2013, ENDOCRINOLOGY, V154, P529, DOI 10.1210/en.2012-1727; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Longvah T, 2012, FOOD CHEM, V130, P953, DOI 10.1016/j.foodchem.2011.08.024; Marounek M, 2007, PHYSIOL RES, V56, P433, DOI 10.33549/physiolres.930967; Nawirska A, 2005, FOOD CHEM, V91, P221, DOI 10.1016/j.foodchem.2003.10.005; OBA K, 1980, J NUTR SCI VITAMINOL, V26, P327, DOI 10.3177/jnsv.26.327; Patras A, 2011, LWT-FOOD SCI TECHNOL, V44, P299, DOI 10.1016/j.lwt.2010.06.019; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3421, DOI 10.1210/jc.2003-032002; Pesce L, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-8; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rana R, 2013, J FOOD SCI TECH MYS, V50, P1212, DOI 10.1007/s13197-011-0436-7; Reeves PG, 1997, J NUTR, V127, pS838; Robbins J., 2000, THYROID A FUNDAMENTA, V8th ed., P105; Sainmont J., 2014, STRATEGIES SUCCESS C; Smolen S, 2011, J ELEMENTOL, V16, P613, DOI 10.5601/jelem.2011.16.4.10; Tancevski I, 2009, J LIPID RES, V50, P938, DOI 10.1194/jlr.M800553-JLR200; Thomson BM, 2008, BRIT J NUTR, V99, P614, DOI 10.1017/S0007114507812001; Tonacchera M, 2013, J CLIN ENDOCR METAB, V98, pE694, DOI 10.1210/jc.2012-3509; Vtorushina EA, 2008, J ANAL CHEM+, V63, P643, DOI 10.1134/S1061934808070071; Vtorushina EA, 2009, J ANAL CHEM+, V64, P129, DOI 10.1134/S1061934809020063; Wachowicz I, 2004, ZYWNOSC NAUKA TECH S, V3, P204; Wang K, 2009, BIOL TRACE ELEM RES, V130, P72, DOI 10.1007/s12011-009-8315-z; Weiss RE, 1997, ENDOCRINOLOGY, V138, P3624, DOI 10.1210/en.138.9.3624; Wieczorek C., 2007, ZYWN-NAUK TECHNOL JA, V3, P159; Windisch W., 1999, J ANIMAL PHYSL ANIMA, V4, P205; Wolf G, 2002, NUTR REV, V60, P374, DOI 10.1301/00296640260385919; Yu XC, 1996, CARBOHYD RES, V292, P129; Yuan GF, 2009, J ZHEJIANG UNIV-SC B, V10, P580, DOI 10.1631/jzus.B0920051; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a	68	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152680	10.1371/journal.pone.0152680	http://dx.doi.org/10.1371/journal.pone.0152680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043135	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100026
J	Buurke, TJW; Lamoth, CJC; van der Woude, LHV; den Otter, AR				Buurke, Tom J. W.; Lamoth, Claud J. C.; van der Woude, Lucas H. V.; den Otter, A. Rob			Synergistic Structure in the Speed Dependent Modulation of Muscle Activity in Human Walking	PLOS ONE			English	Article							HUMAN LOCOMOTION; EMG PROFILES; ACTIVATION PATTERNS; SENSORY FEEDBACK; MOTOR MODULES; GAIT; PROGRESSION; COORDINATION; ADJUSTMENTS; STRATEGIES	Recently, a modular organisation has been proposed to simplify control of the large number of muscles involved in human walking. Although previous research indicates that a single set of modular activation patterns can account for muscle activity at different speeds, these studies only provide indirect evidence for the idea that speed regulation in human walking is under modular control. Here, a more direct approach was taken to assess the synergistic structure that underlies speed regulation, by isolating speed effects through the construction of gain functions that represent the linear relation between speed and amplitude for each point in the time-normalized gait cycle. The activity of 13 muscles in 13 participants was measured at 4 speeds (0.69, 1.00, 1.31, and 1.61 ms(-1)) during treadmill walking. Gain functions were constructed for each of the muscles, and gain functions and the activity patterns at 1.00 ms(-1) were both subjected to dimensionality reduction, to obtain modular gain functions and modular basis functions, respectively. The results showed that 4 components captured most of the variance in the gain functions (74.0% +/- 1.3%), suggesting that the neuromuscular regulation of speed is under modular control. Correlations between modular gain functions and modular basis functions (range 0.58-0.89) and the associated synergistic muscle weightings (range 0.6-0.95) were generally high, suggesting substantial overlap in the synergistic control of the basic phasing of muscle activity and its modulation through speed. Finally, the combined set of modular functions and associated weightings were well capable of predicting muscle activity patterns obtained at a speed (1.31 ms(-1)) that was not involved in the initial dimensionality reduction, confirming the robustness of the presently used approach. Taken together, these findings provide direct evidence of synergistic structure in speed regulation, and may inspire further work on flexibility in the modular control of gait.	[Buurke, Tom J. W.; Lamoth, Claud J. C.; van der Woude, Lucas H. V.; den Otter, A. Rob] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	den Otter, AR (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	a.r.den.otter@umcg.nl	van der Woude, Lucas H/E-7986-2018; Buurke, Tom J. W./T-9190-2019; Lamoth, Claudine JC/N-4325-2013	van der Woude, Lucas H/0000-0002-8472-334X; Buurke, Tom J. W./0000-0002-6441-7855; Lamoth, Claudine JC/0000-0002-6495-2823				Bernstein N, 1967, COORDINATION REGULAT; Bizzi E, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00051; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Cavagna GA, 2002, J EXP BIOL, V205, P3413; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; DAVIS BL, 1993, J ELECTROMYOGR KINES, V3, P51, DOI 10.1016/1050-6411(93)90023-P; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Duysens J, 2000, PHYSIOL REV, V80, P83, DOI 10.1152/physrev.2000.80.1.83; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; Gonzalez-Vargas J, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00114; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Hof AL, 2005, GAIT POSTURE, V21, P171, DOI 10.1016/j.gaitpost.2004.01.015; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Honeine JL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.229; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Latash ML, 2012, EXP BRAIN RES, V217, P1, DOI 10.1007/s00221-012-3000-4; MacLellan MJ, 2014, J NEUROPHYSIOL, V111, P1541, DOI 10.1152/jn.00437.2013; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Martino G, 2015, J NEUROPHYSIOL, V114, P2867, DOI 10.1152/jn.00029.2015; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; Nene A, 1999, GAIT POSTURE, V9, P1, DOI 10.1016/S0966-6362(98)00042-3; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Neptune RR, 2004, GAIT POSTURE, V19, P194, DOI 10.1016/S0966-6362(03)00062-6; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; NILSSON J, 1985, ACTA PHYSIOL SCAND, V123, P457, DOI 10.1111/j.1748-1716.1985.tb07612.x; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Perotto A, 2011, ANATOMICAL GUIDE ELE; Perry J., 1992, GAIT ANAL NORMAL PAT; Ranganathan R, 2012, J NEUROPHYSIOL, V108, P1537, DOI 10.1152/jn.01112.2011; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Safavynia Seyed A, 2011, Top Spinal Cord Inj Rehabil, V17, P16; Sartori M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00079; Shiavi R, 1987, J Rehabil Res Dev, V24, P13; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3; Zelik KE, 2014, J NEUROPHYSIOL, V111, P1686, DOI 10.1152/jn.00776.2013	45	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152784	10.1371/journal.pone.0152784	http://dx.doi.org/10.1371/journal.pone.0152784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035131	Green Published, gold			2022-12-27	WOS:000373201200039
J	Joly, S; Rhea, L; Volk, P; Moreland, JG; Dunnwald, M				Joly, Sophie; Rhea, Lindsey; Volk, Paige; Moreland, Jessica G.; Dunnwald, Martine			Interferon Regulatory Factor 6 Has a Protective Role in the Host Response to Endotoxic Shock	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; KERATINOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; ADAPTIVE IMMUNITY; WOUDE-SYNDROME; IRF6; EXPRESSION; MIGRATION; VAN; PHAGOCYTOSIS	Interferon Regulatory Factor (IRF) 6, a member of the IRF family, is essential for epidermal and orofacial embryonic development. Irf6 is strongly expressed in keratinocytes, in which it regulates epidermal proliferation, differentiation, and migration. A recent role for Irf6 in Tolllike receptor 2-dependent chemokine gene expression was also reported in an epithelial cell line. However, a function for Irf6 in innate immune cells was not previously reported. In the present study, we investigated the expression and function of Irf6 in bone marrow-derived neutrophils and macrophages. We show here, using a conditional knockout of Irf6 in lysosymeM expressing cells, that Irf6 is required for resistance to LPS-induced endotoxic shock. In addition, Irf6-deficient bone marrow-derived neutrophils exhibited increased chemotactic index and velocity compared with wild-type cells in vitro. TLR4-specific KC and IL6 secretions were upregulated in Irf6-deficient bone marrow-derived macrophages in vitro. These cells also exhibited an increased level of phosphorylated IkBa. Collectively, our findings suggest a role for Irf6 in the resistance to endotoxic shock due to NFk-B-mediated alteration of cytokine production.	[Joly, Sophie] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Rhea, Lindsey; Volk, Paige; Moreland, Jessica G.; Dunnwald, Martine] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rhea, Lindsey] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Boise, ID USA	University of Iowa; University of Iowa; United States Department of the Interior; United States Geological Survey	Dunnwald, M (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	martine-dunnwald@uiowa.edu			National Institutes of Health [AR0615086, AR067731]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067731, R03AR061586, R01AR067739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funds from the National Institutes of Health (AR0615086 and AR067731 to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Biggs LC, 2014, J CELL SCI, V127, P2840, DOI 10.1242/jcs.139246; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Kwa MQ, 2014, J BIOL CHEM, V289, P31077, DOI 10.1074/jbc.M114.589382; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Leslie EJ, 2015, AM J MED GENET A, V167, P545, DOI 10.1002/ajmg.a.36896; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lin Y, 2015, CELLULAR MOL NEUROBI; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Slattery ML, 2011, CARCINOGENESIS; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152385	10.1371/journal.pone.0152385	http://dx.doi.org/10.1371/journal.pone.0152385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035130	gold, Green Published			2022-12-27	WOS:000373201200015
J	Kosinova, L; Cahova, M; Fabryova, E; Tycova, I; Koblas, T; Leontovyc, I; Saudek, F; Kriz, J				Kosinova, Lucie; Cahova, Monika; Fabryova, Eva; Tycova, Irena; Koblas, Tomas; Leontovyc, Ivan; Saudek, Frantisek; Kriz, Jan			Unstable Expression of Commonly Used Reference Genes in Rat Pancreatic Islets Early after Isolation Affects Results of Gene Expression Studies	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME; HOUSEKEEPING GENES; RIBOSOMAL-RNA; RT-PCR; NORMALIZATION; VALIDATION; STRESS; TRANSPLANTATION; INAPPROPRIATE	The use of RT-qPCR provides a powerful tool for gene expression studies; however, the proper interpretation of the obtained data is crucially dependent on accurate normalization based on stable reference genes. Recently, strong evidence has been shown indicating that the expression of many commonly used reference genes may vary significantly due to diverse experimental conditions. The isolation of pancreatic islets is a complicated procedure which creates severe mechanical and metabolic stress leading possibly to cellular damage and alteration of gene expression. Despite of this, freshly isolated islets frequently serve as a control in various gene expression and intervention studies. The aim of our study was to determine expression of 16 candidate reference genes and one gene of interest (F3) in isolated rat pancreatic islets during short-term cultivation in order to find a suitable endogenous control for gene expression studies. We compared the expression stability of the most commonly used reference genes and evaluated the reliability of relative and absolute quantification using RT-qPCR during 0-120 hrs after isolation. In freshly isolated islets, the expression of all tested genes was markedly depressed and it increased several times throughout the first 48 hrs of cultivation. We observed significant variability among samples at 0 and 24 hrs but substantial stabilization from 48 hrs onwards. During the first 48 hrs, relative quantification failed to reflect the real changes in respective mRNA concentrations while in the interval 48-120 hrs, the relative expression generally paralleled the results determined by absolute quantification. Thus, our data call into question the suitability of relative quantification for gene expression analysis in pancreatic islets during the first 48 hrs of cultivation, as the results may be significantly affected by unstable expression of reference genes. However, this method could provide reliable information from 48 hrs onwards.	[Kosinova, Lucie; Fabryova, Eva; Koblas, Tomas; Leontovyc, Ivan; Saudek, Frantisek] Inst Clin & Expt Med, Ctr Med Expt, Lab Pancreat Islets, Prague, Czech Republic; [Kosinova, Lucie] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Cahova, Monika] Inst Clin & Expt Med, Ctr Med Expt, Dept Metab & Diabet, Prague, Czech Republic; [Tycova, Irena] Inst Clin & Expt Med, Transplant Lab, Ctr Med Expt, Prague, Czech Republic; [Saudek, Frantisek; Kriz, Jan] Inst Clin & Expt Med, Ctr Diabet, Dept Diabet, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Kosinova, L (corresponding author), Inst Clin & Expt Med, Ctr Med Expt, Lab Pancreat Islets, Prague, Czech Republic.; Kosinova, L (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.; Kriz, J (corresponding author), Inst Clin & Expt Med, Ctr Diabet, Dept Diabet, Prague, Czech Republic.	kosl@ikem.cz; jkri@ikem.cz	Kosinová, Lucie/AAW-8533-2021; Cahova, Monika/Z-1568-2018; Kriz, Jan/G-1067-2019; Saudek, František/E-1975-2018	Cahova, Monika/0000-0003-2640-5084; Kriz, Jan/0000-0001-7695-3885; Saudek, František/0000-0002-0448-4351; Kosinova, Lucie/0000-0001-5837-5508	Czech Science Foundation (CSF) [14-03305S]; Grant Agency of the Charles University in Prague [GA UK 108214]; Ministry of Health (MHCZ-IGA) [NT13099-4]; Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM) [IN 00023001]	Czech Science Foundation (CSF); Grant Agency of the Charles University in Prague; Ministry of Health (MHCZ-IGA); Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM)	J.K. was supported by the Czech Science Foundation (CSF #14-03305S), http://gacr.cz/; L.K. was supported by the Grant Agency of the Charles University in Prague (GA UK 108214), http://www.cuni.cz/UK-33.html; F.S. was supported by the Ministry of Health (MHCZ-IGA #NT13099-4), http://www.mzcr.cz/; M.C. was supported by Ministry of Health (MH CR-DRO Institute for Clinical and Experimental Medicine - IKEM, IN 00023001), http://www.mzcr.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ihm SH, 2009, TRANSPL INT, V22, P207, DOI 10.1111/j.1432-2277.2008.00769.x; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Karge W H 3rd, 1998, Methods Mol Biol, V110, P43; Kriz J, 2008, TRANSPL P, V40, P444, DOI 10.1016/j.transproceed.2008.02.018; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pileggi A, 2001, CLIN CHIM ACTA, V310, P3, DOI 10.1016/S0009-8981(01)00503-4; Planas R, 2010, CLIN EXP IMMUNOL, V159, P23, DOI 10.1111/j.1365-2249.2009.04053.x; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rodriguez-Mulero S, 2005, TRANSPLANTATION, V80, P650, DOI 10.1097/01.tp.0000173790.12227.7b; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153	31	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152664	10.1371/journal.pone.0152664	http://dx.doi.org/10.1371/journal.pone.0152664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035827	gold, Green Submitted, Green Published			2022-12-27	WOS:000373201200029
J	Oo, NN; Bancone, G; Maw, LZ; Chowwiwat, N; Bansil, P; Domingo, GJ; Htun, MM; Thant, KZ; Htut, Y; Nosten, F				Oo, Nwe Nwe; Bancone, Germana; Maw, Lwin Zar; Chowwiwat, Nongnud; Bansil, Pooja; Domingo, Gonzalo J.; Htun, Moh Moh; Thant, Kyaw Zin; Htut, Ye; Nosten, Francois			Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; DEHYDROGENASE-DEFICIENCY; BLOOD; POPULATION; MUTATIONS; VARIANT	Primaquine and other 8-amnoquinoline based anti-malarials can cause haemolysis in subjects with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Correct diagnosis of G6PD status in patients is crucial for safe treatment of both relapsing stages of Plasmodium vivax and transmitting forms of Plasmodium falciparum. Lack of suitable point-of-care tests has hampered a much needed wide use of primaquine for malaria elimination. In this study we have assessed the performances of two qualitative tests, the fluorescent spot test (FST) and the G6PD CareStart test (CST), against the gold standard quantitative spectrophotometric assay in a population of 1000 random adult healthy volunteers living in Yangon, Myanmar. The prevalence of G6PD deficiency in the Bamar, Karen and in the whole sample set was 6.6% (10.1% in males), 9.2% (21.0% in males) and 6.8% (11.1% in males) respectively. The FST and CST showed comparable performances with sensitivity over 95% and specificity over 90%, however for cases with severe G6PD activity the FTS had improved performance. If used with a conservative interpretation of the signal, the CareStart test has the potential to be used in the field and, by allowing a wider use of primaquine, to help malaria elimination.	[Oo, Nwe Nwe; Maw, Lwin Zar; Htun, Moh Moh; Thant, Kyaw Zin; Htut, Ye] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Bancone, Germana; Chowwiwat, Nongnud; Nosten, Francois] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [Bansil, Pooja; Domingo, Gonzalo J.] PATH, Diagnost Program, Seattle, WA USA; [Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Oo, NN (corresponding author), Dept Med Res Lower Myanmar, Yangon, Myanmar.; Bancone, G (corresponding author), Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand.	dr.dawnwenweoo@gmail.com; germana@tropmedres.ac	Nosten, Francois/AAC-5509-2019	Nosten, Francois/0000-0002-7951-0745; Domingo, Gonzalo/0000-0002-1004-4395; Bancone, Germana/0000-0003-4550-0431	Bill & Melinda Gates Foundation [OPP1034534]; UK Department for International Development (DFID) [204139]; Wellcome Trust	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK Department for International Development (DFID); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Bill & Melinda Gates Foundation, grant number OPP1034534; and the UK Department for International Development (DFID), grant number 204139. SMRU is part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme funded by the Wellcome Trust. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions of the Bill & Melinda Gates Foundation or DFID. The funders had in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyasi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125796; Alonso P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0787-z; [Anonymous], 1967, World Health Organ Tech Rep Ser, V366, P1; Baird JK, 2015, TRANSL RES, V165, P677, DOI 10.1016/j.trsl.2014.09.009; Bancone G, 2015, AM J TROP MED HYG, V92, P818, DOI 10.4269/ajtmh.14-0696; Bancone G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116063; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Espino FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148172; GIANAZZA E, 1983, J BIOCHEM BIOPH METH, V8, P109, DOI 10.1016/0165-022X(83)90039-8; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Kheng S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0441-1; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7; Nguyen TH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-152; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; Roca-Feltrer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116143; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; VANNOORDEN CJF, 1985, BRIT J HAEMATOL, V60, P57, DOI 10.1111/j.1365-2141.1985.tb07385.x; Yusoff Narazah Mohd, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P135	25	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152304	10.1371/journal.pone.0152304	http://dx.doi.org/10.1371/journal.pone.0152304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035821	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200013
J	Zhao, X; Liu, CM; Xu, MJ; Li, XL; Bi, KS; Jia, Y				Zhao, Xu; Liu, Chunmei; Xu, Mengjie; Li, Xiaolong; Bi, Kaishun; Jia, Ying			Total Lignans of Schisandra chinensis Ameliorates A beta(1-42)-Induced Neurodegeneration with Cognitive Impairment in Mice and Primary Mouse Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE BRAIN; BETA-PROTEIN; ANTIOXIDANT THERAPY; LIPID-PEROXIDATION; OXIDATIVE STRESS; RATS; NEUROPATHOLOGY; HYPOTHESIS; MICROGLIA	Lignan compounds extracted from Schisandra chinensis (Turcz.) Baill. have been reported to possess various biological activities, and have potential in the treatment of Alzheimer's disease. This study was designed to investigate the effects of total lignans of Schisandra chinensis (TLS) on cognitive function and neurodegeneration in the model of AD induced by A beta(1-42) in vivo and in vitro. It was found that intragastric infusion with TLS (50 and 200 mg/kg) to A beta(1-42)-induced mice significantly increased the number of avoidances in the shuttle-box test and swimming time in the target quadrant in the Morris water maze test. TLS at dose of 200 mg/kg significantly restored the activities of total antioxidant capacity (T-AOC), as well as the level of malondialdehyde (MDA) both in the hippocampus and cerebral cortex in mice. Results of histopathological examination indicated that TLS noticeably ameliorated the neurodegeneration in the hippocampus in mice. On the other hand, TLS (100 mu M) could protect the A beta(1-42)-induced primary mouse neuronal cells by blocking the decrease of mitochondrial membrane potential (MMP), change the expressions of Bcl-2 (important regulator in the mitochondria apoptosis pathway). Moreover, TLS also decreased the activity of beta-secretase 1 (BACE1), crucial protease contributes to the hydrolysis of amyloid precursor protein (APP), and inhibited the expression of JKN/p38, which involved in the MAPKs signaling pathways in both mice and primary mouse neuronal cells. In summary, TLS might protect against cognitive deficits and neurodegeneration by releasing the damage of oxidative stress, inhibiting the expression of BACE1 and the MAPKs inflammatory signaling pathways.	[Zhao, Xu; Liu, Chunmei; Xu, Mengjie; Li, Xiaolong; Jia, Ying] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Wenhua Rd 103, Shenyang 110016, Peoples R China; [Bi, Kaishun] Shenyang Pharmaceut Univ, Sch Pharm, Wenhua Rd 103, Shenyang 110016, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Jia, Y (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Wenhua Rd 103, Shenyang 110016, Peoples R China.	jiayingsyphu@126.com	Li, xiaolong/GRS-9148-2022					Ahmad M, 2005, J NEUROCHEM, V93, P94, DOI 10.1111/j.1471-4159.2005.03000.x; Ahmed T, 2010, NEUROSCIENCE, V169, P1296, DOI 10.1016/j.neuroscience.2010.05.078; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chauhan Ved, 2006, Pathophysiology, V13, P195, DOI 10.1016/j.pathophys.2006.05.004; Cho Jae-Young, 2005, Prog Neuropsychopharmacol Biol Psychiatry, V29, P901, DOI 10.1016/j.pnpbp.2005.04.022; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; dos Santos VV, 2013, BEHAV BRAIN RES, V244, P107, DOI 10.1016/j.bbr.2013.01.039; Ellis JM, 2005, J AM OSTEOPATH ASSOC, V105, P145; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hu D, 2014, PHYTOCHEMISTRY, V104, P72, DOI 10.1016/j.phytochem.2014.04.014; Jeong EJ, 2013, J ETHNOPHARMACOL, V146, P347, DOI 10.1016/j.jep.2013.01.003; Jin SL, 2012, FOOD CHEM TOXICOL, V50, P3814, DOI 10.1016/j.fct.2012.07.046; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee JK, 2013, IMMUNOLOGY, V140, P288, DOI 10.1111/imm.12133; Lee TH, 2012, FOOD CHEM TOXICOL, V50, P4239, DOI 10.1016/j.fct.2012.08.047; Li JE, 2013, INT IMMUNOPHARMACOL, V17, P267, DOI 10.1016/j.intimp.2013.05.033; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUGGE A, 1991, AM J PHYSIOL, V260, pC219, DOI 10.1152/ajpcell.1991.260.2.C219; Nagakannan P, 2012, J ETHNOPHARMACOL, V140, P247, DOI 10.1016/j.jep.2012.01.012; Ohno M, 2014, NEUROBIOL AGING, V35, P213, DOI 10.1016/j.neurobiolaging.2013.07.014; Park EJ, 2012, BIOCHEM PHARMACOL, V83, P378, DOI 10.1016/j.bcp.2011.11.002; Park SY, 2013, INT IMMUNOPHARMACOL, V17, P415, DOI 10.1016/j.intimp.2013.06.032; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; PRICE DL, 1994, ANNU REV MED, V45, P435; Ramin M, 2011, BEHAV BRAIN RES, V217, P424, DOI 10.1016/j.bbr.2010.11.017; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shah RS, 2008, BIOMED PHARMACOTHER, V62, P199, DOI 10.1016/j.biopha.2008.02.005; SLATER TF, 1984, METHOD ENZYMOL, V105, P283; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang CM, 2013, PHARMACOL BIOCHEM BE, V106, P57, DOI 10.1016/j.pbb.2013.03.010	42	24	25	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152772	10.1371/journal.pone.0152772	http://dx.doi.org/10.1371/journal.pone.0152772			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035824	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200037
J	Berman, Y; Ben-Jacob, E; Zhang, X; Shapira, Y				Berman, Yonatan; Ben-Jacob, Eshel; Zhang, Xin; Shapira, Yoash			Analyzing the Long Term Cohesive Effect of Sector Specific Driving Forces	PLOS ONE			English	Article							FINANCIAL-MARKETS; MEAN REVERSION; ASSET PRICES; DIVERSIFICATION; VOLATILITY; BEHAVIOR; EQUILIBRIUM; TRENDS; RISK	Financial markets are partially composed of sectors dominated by external driving forces, such as commodity prices, infrastructure and other indices. We characterize the statistical properties of such sectors and present a novel model for the coupling of the stock prices and their dominating driving forces, inspired by mean reverting stochastic processes. Using the model we were able to explain the market sectors' long term behavior and estimate the coupling strength between stocks in financial markets and the sector specific driving forces. Notably, the analysis was successfully applied to the shipping market, in which the Baltic dry index (BDI), an assessment of the price of transporting the major raw materials by sea, influences the shipping financial market. We also present the analysis of other sectors-the gold mining market and the food production market, for which the model was also successfully applied. The model can serve as a general tool for characterizing the coupling between external forces and affected financial variables and therefore for estimating the risk in sectors and their vulnerability to external stress.	[Berman, Yonatan; Ben-Jacob, Eshel; Shapira, Yoash] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Zhang, Xin] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China	Tel Aviv University; Shanghai Maritime University	Berman, Y; Shapira, Y (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	yonatanb@post.tau.ac.il; yoashshapia@gmail.com		Berman, Yonatan/0000-0001-6969-271X	Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University	Tauber Family Foundation; Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University	This research has been supported in part by the Tauber Family Foundation and the Maguy-Glass Chair in Physics of Complex System at the Tel-Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertijn S, 2011, J APPL CORP FINANC, V23, P70, DOI 10.1111/j.1745-6622.2011.00353.x; Allez R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025010; Beck T, 2000, WORLD BANK ECON REV, V14, P597, DOI 10.1093/wber/14.3.597; Benth F.E., 2008, STOCHASTIC MODELLING, V11; Benth FE, 2007, QUANT FINANC, V7, P553, DOI 10.1080/14697680601155334; Berman Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112427; Black F., 1990, FINANCIAL ANAL J, V46, P33, DOI DOI 10.2469/FAJ.V46.N1.33; Borghesi C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026104; Bourles R, 2000, REV ECON STAT, V95, P1750; Branch A., 2013, MARITIME EC; Campbell J. Y., 1997, ECONOMETRICS FINANCI, V2; Cecchetti SG, 1988, W2762 NBER; Cleveland W.S., 1981, T AM STAT, V35, P54, DOI DOI 10.2307/2683591; Cont R, 2000, MACROECON DYN, V4, P170; Cooke T.E., 1992, ACCOUNT BUS RES, V22, P229, DOI [https://doi.org/10.1080/00014788.1992.9729440, DOI 10.1080/00014788.1992.9729440]; COX JC, 1985, ECONOMETRICA, V53, P363, DOI 10.2307/1911241; De Bandt O, 2000, J BANK FINANC, V24, P1045, DOI 10.1016/S0378-4266(99)00117-X; Drobetz W., 2012, APPL FINANCIAL EC, V22, P1367, DOI DOI 10.1080/09603107.2012.657349; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; GINDLING TH, 1991, ECON DEV CULT CHANGE, V39, P585, DOI 10.1086/451892; Gopikrishnan P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.035106; Goswami B, 2012, PHYSICA A, V391, P4364, DOI 10.1016/j.physa.2012.04.018; Grammenos C.T., 2002, INT J MARIT EC, V4, P81, DOI DOI 10.1057/PALGRAVE.IJME.9100033; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Iacobucci D, 2005, SMALL BUS ECON, V25, P65, DOI 10.1007/s11187-005-4258-8; Imbs J, 2003, AM ECON REV, V93, P63, DOI 10.1257/000282803321455160; Kenett D. Y., 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019378, DOI 10.1371/JOURNAL.PONE.0019378]; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kinlaw W, 2012, J PORTFOLIO MANAGE, V38, P100, DOI 10.3905/jpm.2012.38.4.100; Krafft M, 2010, INT SHIPPING CRISIS; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Mantegna RN, 1997, J STAT PHYS, V89, P469, DOI 10.1007/BF02770777; Micciche S, 2003, PHYSICA A, V324, P66, DOI 10.1016/S0378-4371(03)00002-5; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Podobnik B, 2007, EUR PHYS J B, V56, P47, DOI 10.1140/epjb/e2007-00089-3; POTERBA JM, 1988, J FINANC ECON, V22, P27, DOI 10.1016/0304-405X(88)90021-9; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Samitas A.G., 2007, J FINANC SERV MANAG, V2, P327; Sandoval L, 2015, J RISK FINANC MANAG, V8, P227, DOI 10.3390/jrfm8020227; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; Shapira Y, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/053040; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Stanley HE, 2001, PHYSICA A, V299, P1, DOI 10.1016/S0378-4371(01)00351-X; Uechi L, 2015, PHYSICA A, V421, P488, DOI 10.1016/j.physa.2014.11.055; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wong HY, 2009, EUR J OPER RES, V197, P179, DOI 10.1016/j.ejor.2008.05.014; Wurgler J, 2000, J FINANC ECON, V58, P187, DOI 10.1016/S0304-405X(00)00070-2; Zapranis A., 2008, APPL MATH FINANCE, V15, P355, DOI [10.1080/13504860802006065, DOI 10.1080/13504860802006065]; Zhang X, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/58001; Zhang X, 2014, PHYSICA A, V415, P43, DOI 10.1016/j.physa.2014.07.068	54	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152487	10.1371/journal.pone.0152487	http://dx.doi.org/10.1371/journal.pone.0152487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031230	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800084
J	Jamal, WY; Albert, MJ; Rotimi, VO				Jamal, Wafaa Y.; Albert, M. John; Rotimi, Vincent O.			High Prevalence of New Delhi Metallo-beta-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; NDM-1-PRODUCING KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; GLOBAL SPREAD; EMERGENCE; SPECTRUM; OXA-48; ASSOCIATION; INFECTIONS	The aim of the study was to determine the prevalence of New Delhi metallo-beta lactamase-1 (NDM-1) producing Enterobacteriaceae in Kuwait over a one year period. Consecutive Enterobacteriaceae isolates with reduced susceptibility to carbapenems were collected from four government hospitals in Kuwait from January-December 2014. Their susceptibility to 18 antibiotics was performed by determining the minimum inhibitory concentration. Isolates resistant to carbapenems were tested by PCR for resistant genes. Finger printing of the positive isolates was done by DiversiLab (R). Clinical data of patients harboring NDM-1 positive isolates were analyzed. A total of 764 clinically significant Enterobacteriaceae isolates were studied. Of these, 61 (8%) were carbapenem-resistant. Twenty one out of these 61 (34.4%) were NDM-1-producers. All patients positive for NDM-1-carrying bacteria were hospitalized. About half were females (11/21 [52.3%]), average age was 53.3 years and the majority were Kuwaitis (14/21 [66.6%]). Six patients (28.5%) gave a history of travel or healthcare contact in an endemic area. Mortality rate was relatively high (28.6%). The predominant organism was Klebsiella pneumoniae (14 [66.6%]) followed by E. coli (4 [19%]). All NDM-1-positive isolates were resistant to meropenem, ertapenem, cefotaxime, cefoxitin and ampicillin, while 95.2% were resistant to imipenem, cefepime, and piperacillin-tazobactam. They were multidrug resistant including resistance to tigecycline, but 90% remained susceptible to colistin. About two-thirds of isolates (61.9%) co-produced-extended spectrum beta-lactamases. During the study period, an outbreak of NDM-1 positive K. pneumoniae occurred in one hospital involving 3 patients confirmed by DiversiLab (R) analysis. In conclusion, NDM-1-producing Enterobacteriaceae is a growing healthcare problem with increasing prevalence in Kuwait, especially in hospitalized patients, leaving few therapeutic options. A high prevalence of NDM-1 necessitates the implementation of strict infection control to prevent the spread of these organisms.	[Jamal, Wafaa Y.] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait; Mubarak Al Kabir Hosp, Microbiol Unit, Jabriya, Kuwait	Kuwait University; Mubarak Al-Kabeer Hospital	Jamal, WY (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	wjamal@hsc.edu.kw			Kuwait University Research grant [MI06/10]	Kuwait University Research grant	This work was supported by the Kuwait University Research grant number MI06/10. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Sweih N, 2005, MED PRIN PRACT, V14, P401, DOI 10.1159/000088113; Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010; Bathoorn E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.42.20610; Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Dortet L, 2015, ANTIMICROB AGENTS CH, V59, P7420, DOI 10.1128/AAC.01636-15; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Foxman B, 2014, INFECT DIS CLIN N AM, V28, P1, DOI 10.1016/j.idc.2013.09.003; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Gharout-Sait A, 2014, J MED MICROBIOL, V63, P1316, DOI 10.1099/jmm.0.073767-0; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Hidalgo L, 2013, J ANTIMICROB CHEMOTH, V68, P1543, DOI 10.1093/jac/dkt078; Jain A, 2014, J ANTIMICROB CHEMOTH, V69, P1777, DOI 10.1093/jac/dku084; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Jamal W, 2013, J MED MICROBIOL, V62, P1239, DOI 10.1099/jmm.0.059915-0; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lachish T, 2012, INT J ANTIMICROB AG, V40, P566, DOI 10.1016/j.ijantimicag.2012.07.011; Lukinmaa-Aberg S, 2013, FOODBORNE PATHOG DIS, V10, P632, DOI 10.1089/fpd.2012.1411; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Nordmann P, 2012, CLIN INFECT DIS, V54, P150, DOI 10.1093/cid/cir720; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Poirel L, 2014, ANTIMICROB AGENTS CH, V58, P2929, DOI 10.1128/AAC.02047-13; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Struelens M.J., 2010, EUROSURVEILLANCE, V15, P15; US Centers for Disease Control and Prevention (CDC), 2015, FAC GUID CONTR CARB; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zowawi HM, 2014, ANTIMICROB AGENTS CH, V58, P3085, DOI [10.1128/AAC.02050-13, 10.1128/AAC.]	35	57	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152638	10.1371/journal.pone.0152638	http://dx.doi.org/10.1371/journal.pone.0152638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031521	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800106
J	Klooster, J; Kamermans, M				Klooster, Jan; Kamermans, Maarten			An Ultrastructural and Immunohistochemical Analysis of the Outer Plexiform Layer of the Retina of the European Silver Eel (Anguilla anguilla L)	PLOS ONE			English	Article							CELL INPUT MECHANISMS; HORIZONTAL CELLS; BIPOLAR CELLS; RECEPTOR SUBUNITS; VISUAL PIGMENTS; AMPA RECEPTORS; CYPRINID FISH; GIANT DANIO; GLUTAMATE; EXPRESSION	Here we studied the ultrastructural organization of the outer retina of the European silver eel, a highly valued commercial fish species. The retina of the European eel has an organization very similar to most vertebrates. It contains both rod and cone photoreceptors. Rods are abundantly present and immunoreactive for rhodopsin. Cones are sparsely present and only show immunoreactivity for M-opsin and not for L-, S- or UV-cone opsins. As in all other vertebrate retinas, Muller cells span the width of the retina. OFF-bipolar cells express the ionotropic glutamate receptor GluR4 and ON-bipolar cells, as identified by their PKCa immunoreactivity, express the metabotropic receptor mGluR6. Both the ON- and the OFF-bipolar cell dendrites innervate the cone pedicle and rod spherule. Horizontal cells are surrounded by punctate Cx53.8 immunoreactivity indicating that the horizontal cells are strongly electrically coupled by gap-junctions. Connexin-hemichannels were found at the tips of the horizontal cell dendrites invaginating the photoreceptor synapse. Such hemichannels are implicated in the feedback pathway from horizontal cells to cones. Finally, horizontal cells are surrounded by tyrosine hydroxylase immunoreactivity, illustrating a strong dopaminergic input from interplexiform cells.	[Klooster, Jan; Kamermans, Maarten] Netherlands Inst Neurosci, Retinal Signal Proc Lab, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Kamermans, M (corresponding author), Netherlands Inst Neurosci, Retinal Signal Proc Lab, Amsterdam, Netherlands.; Kamermans, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl						Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; BALDRIDGE WH, 1987, J COMP NEUROL, V265, P428, DOI 10.1002/cne.902650310; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; BRAEKEVELT CR, 1988, ANAT ANZEIGER, V167, P1; Cheng CL, 2007, VISUAL NEUROSCI, V24, P269, DOI 10.1017/S0952523807070137; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Connaughton VP, 2000, J PHYSIOL-LONDON, V524, P135, DOI 10.1111/j.1469-7793.2000.t01-1-00135.x; Cottrill PB, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-71; Damjanovic I, 2005, ANN NY ACAD SCI, V1048, P69, DOI 10.1196/annals.1342.007; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DJAMGOZ MBA, 1988, PROC R SOC SER B-BIO, V235, P281, DOI 10.1098/rspb.1988.0076; DOWNING JEG, 1989, J COMP NEUROL, V289, P537, DOI 10.1002/cne.902890402; Endeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068540; GORDON J, 1978, J GEN PHYSIOL, V71, P123, DOI 10.1085/jgp.71.2.123; Grant GB, 1996, J NEUROPHYSIOL, V76, P3842, DOI 10.1152/jn.1996.76.6.3842; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Huang H, 2004, BRAIN RES, V1002, P86, DOI 10.1016/j.brainres.2003.12.019; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035256; Janssen-Bienhoid U, 2009, J COMP NEUROL, V513, P363, DOI 10.1002/cne.21965; Janssen-Bienhold U, 2001, Prog Brain Res, V131, P93; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1995, PROG RETIN EYE RES, V14, P313, DOI 10.1016/1350-9462(94)00003-2; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Klooster J, 2001, J COMP NEUROL, V441, P155, DOI 10.1002/cne.1404; Klooster J, 2011, INVEST OPHTH VIS SCI, V52, P8356, DOI 10.1167/iovs.11-7575; Klooster J, 2009, J CHEM NEUROANAT, V37, P254, DOI 10.1016/j.jchemneu.2009.02.004; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Li YN, 2009, J COMP NEUROL, V516, P442, DOI 10.1002/cne.22135; LYTHGOE JN, 1984, VISION RES, V24, P1539, DOI 10.1016/S0042-6989(84)80003-6; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rousseau K, 2009, METAMORPHOSIS FISH; Rousseau K, 2012, SPAWNING MIGRATION E, P39; Schultz K, 1997, J NEUROCYTOL, V26, P651, DOI 10.1023/A:1018597811439; Schultz K, 2001, J COMP NEUROL, V435, P433, DOI 10.1002/cne.1042; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; STELL WK, 1967, AM J ANAT, V121, P401, DOI 10.1002/aja.1001210213; SUZUKI S, 1990, VISUAL NEUROSCI, V5, P223, DOI 10.1017/S0952523800000298; Tesch F-W, 1977, EEL BIOL MANAGEMENT, P68; van Ginneken VJT, 2005, REV FISH BIOL FISHER, V15, P367, DOI 10.1007/s11160-006-0005-8; VANDENPOL AN, 1986, J COMP NEUROL, V252, P507, DOI 10.1002/cne.902520407; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vroman R, 2015, J PHYSIOL-LONDON, V593, P2927, DOI 10.1113/JP270158; Vroman R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00612; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong KY, 2005, J NEUROPHYSIOL, V93, P84, DOI 10.1152/jn.00259.2004; Wong KY, 2005, J NEUROPHYSIOL, V93, P94, DOI 10.1152/jn.00270.2004; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yazulla S, 1999, J NEUROCYTOL, V28, P63, DOI 10.1023/A:1007015801586	53	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152967	10.1371/journal.pone.0152967	http://dx.doi.org/10.1371/journal.pone.0152967			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032102	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800161
J	Nieuwenhuys, A; Papageorgiou, E; Pataky, T; De Laet, T; Molenaers, G; Desloovere, K				Nieuwenhuys, Angela; Papageorgiou, Eirini; Pataky, Todd; De Laet, Tinne; Molenaers, Guy; Desloovere, Kaat			Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral Palsy	PLOS ONE			English	Review							LOWER-LIMB SPASTICITY; A TREATMENT; MOTOR FUNCTION; SOLEUS MUSCLE; EQUINUS GAIT; CALF MUSCLES; INJECTIONS; GASTROCNEMIUS; MANAGEMENT; SURGERY	Aim This study aimed at comparing two statistical approaches to analyze the effect of Botulinum Toxin A (BTX-A) treatment on gait in children with a diagnosis of spastic cerebral palsy (CP), based on three-dimensional gait analysis (3DGA) data. Through a literature review, the available expert knowledge on gait changes after BTX-A treatment in children with CP is summarized. Methods Part 1-Intervention studies on BTX-A treatment in children with CP between 4-18 years that used 3DGA data as an outcome measure and were written in English, were identified through a broad systematic literature search. Reported kinematic and kinetic gait features were extracted from the identified studies. Part 2-A retrospective sample of 53 children with CP (6.1 +/- 2.3years, GMFCS I-III) received 3DGA before and after multilevel BTX-A injections. The effect of BTX-A on gait was interpreted by comparing the results of paired samples t-tests on the kinematic gait features that were identified from literature to the results of statistical parametric mapping analysis on the kinematic waveforms of the lower limb joints. Results Part 1-53 kinematic and 33 kinetic features were described in literature. Overall, there is no consensus on which features should be evaluated after BTX-A treatment as 49 features were reported only once or twice. Part 2-Post-BTX-A, both statistical approaches found increased ankle dorsiflexion throughout the gait cycle. Statistical parametric mapping analyses additionally found increased knee extension during terminal stance. In turn, feature analyses found increased outtoeing during stance after BTX-A. Conclusion This study confirms that BTX-A injections are a valuable treatment option to improve gait function in children with CP. However, different statistical approaches may lead to different interpretations of treatment outcome. We suggest that a clear, definite hypothesis should be stated a priori and a commensurate statistical approach should accompany this hypothesis.	[Nieuwenhuys, Angela; Papageorgiou, Eirini; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Nieuwenhuys, Angela; Papageorgiou, Eirini; Desloovere, Kaat] Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium; [Pataky, Todd] Shinshu Univ, Dept Bioengn, Ueda, Nagano, Japan; [De Laet, Tinne] Katholieke Univ Leuven, Fac Engn Sci, Leuven, Belgium; [Molenaers, Guy] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Molenaers, Guy] Univ Hosp Leuven, Dept Orthoped, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Shinshu University; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Nieuwenhuys, A (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.; Nieuwenhuys, A (corresponding author), Univ Hosp Leuven, Clin Mot Anal Lab, Leuven, Belgium.	Angela.nieuwenhuys@faber.kuleuven.be	Desloovere, Kaat/F-3240-2014	Desloovere, Kaat/0000-0002-8507-5276; De Laet, Tinne/0000-0003-0624-3305	'Onderzoekstoelage' (OT) of KU Leuven university [OT/12/100]; MD Paedigree project, a Model-Driven Paediatric European Digital Repository; European Commission under FP7 - ICT Programme [600932]	'Onderzoekstoelage' (OT) of KU Leuven university; MD Paedigree project, a Model-Driven Paediatric European Digital Repository; European Commission under FP7 - ICT Programme	AN is supported by an 'Onderzoekstoelage' (OT) of KU Leuven university (OT/12/100). EP is supported by the MD Paedigree project, a Model-Driven Paediatric European Digital Repository, partially funded by the European Commission under FP7 - ICT Programme (grant agreement no: 600932, http://www.md-paedigree.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JD, 2005, DEV MED CHILD NEUROL, V47, P620, DOI 10.1017/S0012162205001222; Adler R., 2007, RANDOM FIELDS GEOMET; [Anonymous], 2013, HOLM BONFERRONI SEQU; Baker R., MEASURING WALKING HD, V213AD, P216; Bang MS, 2002, AM J PHYS MED REHAB, V81, P760, DOI 10.1097/00002060-200210000-00007; Bottos M, 2003, DEV MED CHILD NEUROL, V45, P758, DOI 10.1017/S0012162203001403; Boyd RN, 2000, DEV MED CHILD NEUROL, V42, P32, DOI 10.1017/S0012162200000074; Boyd RN, 1999, EUR J NEUROL, V6, pS37, DOI 10.1111/j.1468-1331.1999.tb00033.x; Cook RE, 2003, J PEDIATR ORTHOPED, V23, P292, DOI 10.1097/00004694-200305000-00004; Corry IS, 1999, GAIT POSTURE, V10, P206, DOI 10.1016/S0966-6362(99)00037-5; Corry IS, 1998, J PEDIATR ORTHOPED, V18, P304, DOI 10.1097/00004694-199805000-00006; Desloovere K, 2001, EUR J NEUROL, V8, P75, DOI 10.1046/j.1468-1331.2001.00040.x; Desloovere K, 2007, DEV MED CHILD NEUROL, V49, P56, DOI 10.1017/S001216220700014X; Detrembleur C, 2002, MOVEMENT DISORD, V17, P162, DOI 10.1002/mds.1282; Dreher T, 2013, GAIT POSTURE, V37, P430, DOI 10.1016/j.gaitpost.2012.08.020; Galli M, 2001, FUNCT NEUROL, V16, P317; Galli M, 2007, DISABIL REHABIL, V29, P659, DOI 10.1080/09638280600948136; Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5; HOLM S, 1979, SCAND J STAT, V6, P65; Kay RM, 2004, J BONE JOINT SURG AM, V86A, P2377, DOI 10.2106/00004623-200411000-00003; Klotz MCM, 2013, CLIN ORTHOP RELAT R, V471, P2327, DOI 10.1007/s11999-013-2897-7; Knudson D, 2009, SPORT BIOMECH, V8, P96, DOI 10.1080/14763140802629966; Lee JH, 2009, J REHABIL MED, V41, P740, DOI 10.2340/16501977-0418; Lukban MB, 2009, J NEURAL TRANSM, V116, P319, DOI 10.1007/s00702-008-0175-8; Marconi V, 2014, GAIT POSTURE, V40, P633, DOI 10.1016/j.gaitpost.2014.07.014; McLaughlin MJ, 2014, PM&R, V6, P544, DOI 10.1016/j.pmrj.2014.04.006; Metaxiotis D, 2002, CLIN ORTHOP RELAT R, P177; Molenaers G, 2001, EUR J NEUROL, V8, P88, DOI 10.1046/j.1468-1331.2001.00041.x; Molenaers G, 1999, EUR J NEUROL, V6, pS51, DOI 10.1111/j.1468-1331.1999.tb00035.x; Molenaers G, 2013, J CHILD ORTHOP, V7, P383, DOI 10.1007/s11832-013-0511-x; Ostensjo S, 2004, DEV MED CHILD NEUROL, V46, P580; Papadonikolakis AS, 2003, ACTA ORTHOP SCAND, V74, P749, DOI 10.1080/00016470310018315; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Perry J., 1992, GAIT ANAL; Polak F, 2002, DEV MED CHILD NEUROL, V44, P551; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Rosenbaum Peter, 2004, Semin Pediatr Neurol, V11, P5, DOI 10.1016/j.spen.2004.01.002; Sutherland D.H., 1996, GAIT POSTURE, V4, P269, DOI 10.1016/0966-6362(95)01054-8; Sutherland DH, 1999, GAIT POSTURE, V10, P1, DOI 10.1016/S0966-6362(99)00012-0; Svehlik M, 2012, CESK SLOV NEUROL N, V75, P737; Thompson NS, 1998, DEV MED CHILD NEUROL, V40, P622; Wissel J, 1999, EUR J NEUROL, V6, pS63, DOI 10.1111/j.1468-1331.1999.tb00037.x; Wren TAL, 2011, GAIT POSTURE, V34, P364, DOI 10.1016/j.gaitpost.2011.06.002; Zurcher A W, 2001, Acta Orthop Belg, V67, P475; Zwick EB, 2009, CESK SLOV NEUROL N, V72, P553	47	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152697	10.1371/journal.pone.0152697	http://dx.doi.org/10.1371/journal.pone.0152697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030973	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800122
J	Ramadona, AL; Lazuardi, L; Hii, YL; Holmner, A; Kusnanto, H; Rocklov, J				Ramadona, Aditya Lia; Lazuardi, Lutfan; Hii, Yien Ling; Holmner, Asa; Kusnanto, Hari; Rocklov, Joacim			Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; TRANSMISSION; CLIMATE; BURDEN	Research is needed to create early warnings of dengue outbreaks to inform stakeholders and control the disease. This analysis composes of a comparative set of prediction models including only meteorological variables; only lag variables of disease surveillance; as well as combinations of meteorological and lag disease surveillance variables. Generalized linear regression models were used to fit relationships between the predictor variables and the dengue surveillance data as outcome variable on the basis of data from 2001 to 2010. Data from 2011 to 2013 were used for external validation purposed of prediction accuracy of the model. Model fit were evaluated based on prediction performance in terms of detecting epidemics, and for number of predicted cases according to RMSE and SRMSE, as well as AIC. An optimal combination of meteorology and autoregressive lag terms of dengue counts in the past were identified best in predicting dengue incidence and the occurrence of dengue epidemics. Past data on disease surveillance, as predictor alone, visually gave reasonably accurate results for outbreak periods, but not for non-outbreaks periods. A combination of surveillance and meteorological data including lag patterns up to a few years in the past showed most predictive of dengue incidence and occurrence in Yogyakarta, Indonesia. The external validation showed poorer results than the internal validation, but still showed skill in detecting outbreaks up to two months ahead. Prior studies support the fact that past meteorology and surveillance data can be predictive of dengue. However, to a less extent has prior research shown how the longer-term past disease incidence data, up to years, can play a role in predicting outbreaks in the coming years, possibly indicating cross-immunity status of the population.	[Ramadona, Aditya Lia; Hii, Yien Ling; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden; [Ramadona, Aditya Lia; Kusnanto, Hari] Univ Gadjah Mada, Ctr Environm Studies, Yogyakarta, Indonesia; [Lazuardi, Lutfan; Kusnanto, Hari] Univ Gadjah Mada, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Holmner, Asa] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Gadjah Mada University; Gadjah Mada University; Umea University	Ramadona, AL (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden.; Ramadona, AL (corresponding author), Univ Gadjah Mada, Ctr Environm Studies, Yogyakarta, Indonesia.	alramadona@ugm.ac.id	Lazuardi, Lutfan/K-6812-2019; Ramadona, Aditya L/M-2677-2013; Ramadona, Aditya Lia/N-1518-2019	Lazuardi, Lutfan/0000-0001-5146-8162; Ramadona, Aditya L/0000-0003-0968-988X; Ramadona, Aditya Lia/0000-0003-0968-988X; Rocklov, Joacim/0000-0003-4030-0449	Swedish Research Councils Swedish Research Links Program [348-2013-6692]; Umea Centre for Global Health Research from The Swedish Council for Working Life and Social Research [20061512]	Swedish Research Councils Swedish Research Links Program; Umea Centre for Global Health Research from The Swedish Council for Working Life and Social Research	The authors acknowledge the financial support from the Swedish Research Councils Swedish Research Links Program (grant no. 348-2013-6692), and the Umea Centre for Global Health Research with support from The Swedish Council for Working Life and Social Research (grant no. 20061512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SR, 1978, T I BRIT GEOGR, V3, P476, DOI 10.2307/622125; Anastuti RA, 2013, THESIS U GADJAH MADA; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Azad S, 2014, J VECTOR DIS, V51, P165; Badan Lingkungan Hidup, 2012, STAT LINGK HID DAER; Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Dieng Hamady, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P228, DOI 10.1016/S2221-1691(12)60047-1; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Handoko D, 2011, MODUL PENGENDALIAN D; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001848; Indriani C, 2011, BER KEDOKT MASY, V27, P41; IRI, 2014, EM EL NIN COND NOT G; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Juffrie M, 2009, BERKALA ILMU KEDOKTE, V41, P134; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; OhAinle M, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P229, DOI 10.1079/9781845939649.0229; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Perkins TA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P99, DOI 10.1079/9781845939649.0099; Promprou S, 2005, DENGUE B, V29; R Core Team, 2013, R LANG ENV STAT COMP; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Rodriguez-Roche R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/690835; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048; Suhail Jeelani, 2013, International Journal of Current Microbiology and Applied Sciences, V2, P313; Widiarti, 2011, BUL PENELIT KESEHAT, V39, P176; Wiwanitkit V., 2014, Asian Pacific Journal of Tropical Disease, V4, P67; Wongkoon S, 2013, TROP BIOMED, V30, P631; Wongkoon S, 2013, INDIAN J MED RES, V138, P347; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT	39	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152688	10.1371/journal.pone.0152688	http://dx.doi.org/10.1371/journal.pone.0152688			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031524	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800116
J	Choi, JI; Wang, CJ; Thomas, MJ; Pitt, GS				Choi, Jong-Il; Wang, Chaojian; Thomas, Matthew J.; Pitt, Geoffrey S.			alpha 1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium Current	PLOS ONE			English	Article							FACTOR HOMOLOGOUS FACTORS; SARCOLEMMAL CALCIUM-PUMP; NITRIC-OXIDE SYNTHASE; CARDIAC-ARRHYTHMIA; HEART-FAILURE; CHANNEL; MUTATION; COMPLEX; REPOLARIZATION; PROTEIN	Drug-induced long-QT syndrome (diLQTS) is often due to drug block of I-Kr, especially in genetically susceptible patients with subclinical mutations in the I-Kr-encoding KCHN2. Few variants in the cardiac Na(V)1.5 Na+ channel complex have been associated with diLQTS. We tested whether a novel SNTA1 (alpha 1-syntrophin) variant (p.E409Q) found in a patient with diLQTS increases late sodium current (INa-L), thereby providing a disease mechanism. Electrophysiological studies were performed in HEK293T cells co-expressing human Na(V)1.5/nNOS/PMCA4b with either wild type (WT) or SNTA1 variants (A390V-previously reported in congenital LQTS; and E409Q); and in adult rat ventricular cardiomyocytes infected with SNTA1 expressing adenoviruses (WT or one of the two SNTA1 variants). In HEK293T cells and in cardiomyocytes, there was no significant difference in the peak I-Na densities among the SNTA1 WT and variants. However, both variants increased INa-L (% of peak current) in HEK293T cells (0.58 +/- 0.10 in WT vs. 0.90 +/- 0.11 in A390V, p = 0.048; vs. 0.88 +/- 0.07 in E409Q, p = 0.023). In cardiomyocytes, INa-L was significantly increased by E409Q, but not by A390V compared to WT (0.49 +/- 0.14 in WT vs. 0.94 +/- 0.23 in A390V, p = 0.099; vs. 1.12 +/- 0.24 in E409Q, p = 0.019). We demonstrated that a novel SNTA1 variant is likely causative for diLQTS by augmenting INa-L. These data suggest that variants within the Na(V)1.5-interacting alpha 1-syntrophin are a potential mechanism for diLQTS, thereby expanding the concept that variants within congenital LQTS loci can cause diLQTS.	[Choi, Jong-Il; Wang, Chaojian; Pitt, Geoffrey S.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Choi, Jong-Il; Wang, Chaojian; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA; [Choi, Jong-Il] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea; [Choi, Jong-Il] Korea Univ, Med Ctr, Seoul, South Korea; [Thomas, Matthew J.] Univ Virginia Hlth Syst, Dept Pediat, Div Genet, Charlottesville, VA USA	Duke University; Duke University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Virginia	Choi, JI; Pitt, GS (corresponding author), Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA.; Choi, JI; Pitt, GS (corresponding author), Duke Univ, Med Ctr, Ion Channel Res Unit, Durham, NC USA.; Choi, JI (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea.; Choi, JI (corresponding author), Korea Univ, Med Ctr, Seoul, South Korea.	jongilchoi@korea.ac.kr; geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Choi, Jong-Il/0000-0001-6617-508X	National Institutes of Health [R01 HL112918]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2015R1D1A1A02061859]; Korea University Grant; Kim Sang-Hee Fellowship Fund Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122967, R01HL112918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Korea University Grant; Kim Sang-Hee Fellowship Fund Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health R01 HL112918 (GSP), the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education 2015R1D1A1A02061859 (J-IC), and the Korea University Grant and the Kim Sang-Hee Fellowship Fund Inc. (J-IC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahern GP, 2000, J BIOL CHEM, V275, P28810, DOI 10.1074/jbc.M003090200; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ballou LM, 2015, CIRC RES, V116, P127, DOI 10.1161/CIRCRESAHA.116.303975; Belardinelli L, 2015, HEART RHYTHM, V12, P440, DOI 10.1016/j.hrthm.2014.11.009; Bhat HF, 2013, CELL MOL LIFE SCI, V70, P2533, DOI 10.1007/s00018-012-1233-9; Cheng JD, 2009, CIRC-ARRHYTHMIA ELEC, V2, P667, DOI 10.1161/CIRCEP.109.891440; Cronk LB, 2007, HEART RHYTHM, V4, P161, DOI 10.1016/j.hrthm.2006.11.030; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Gee SH, 1998, J NEUROSCI, V18, P128; Hennessey JA, 2013, CIRC RES, V113, P381, DOI 10.1161/CIRCRESAHA.113.301215; Hund TJ, 2014, CIRCULATION, V130, P132, DOI 10.1161/CIRCULATIONAHA.114.010867; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lu Z, 2012, SCI TRANSL MED, V4, P131, DOI DOI 10.1126/SCITRANSLMED.3003623; Lu ZJ, 2013, DIABETES, V62, P4257, DOI 10.2337/db13-0420; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shryock JC, 2013, CARDIOVASC RES, V99, P600, DOI 10.1093/cvr/cvt145; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Sun AY, 2011, CIRC-CARDIOVASC GENE, V4, P163, DOI 10.1161/CIRCGENETICS.110.958652; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Vicente J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001615; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang C, 2011, CIRC RES, V109, P775, DOI 10.1161/CIRCRESAHA.111.247957; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Wu L, 2011, CIRCULATION, V123, P1713, DOI 10.1161/CIRCULATIONAHA.110.000661; Yang T, 2014, CIRCULATION, V130, P224, DOI 10.1161/CIRCULATIONAHA.113.007765; Zhao CM, 1999, J BIOL CHEM, V274, P19649, DOI 10.1074/jbc.274.28.19649; ZIPES DP, 1987, AM J CARDIOL, V59, pE26, DOI 10.1016/0002-9149(87)90198-6	42	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152355	10.1371/journal.pone.0152355	http://dx.doi.org/10.1371/journal.pone.0152355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028743	Green Submitted, Green Published, gold			2022-12-27	WOS:000373116500039
J	Paraje, G				Paraje, Guillermo			The Effect of Price and Socio-Economic Level on the Consumption of Sugar-Sweetened Beverages (SSB): The Case of Ecuador	PLOS ONE			English	Article							TAXES; ELASTICITIES; SUBSIDIES; QUALITY; HEALTH; FOOD	The objective of this article is to estimate the own-price, cross-price and income elasticities of demand for SSB in Ecuador, as an indispensable step for predicting a reduction in the consumption of said beverages caused by the potential implementation of taxes in Ecuador. In addition, the own-price, cross-price and income elasticities of sugar-free substitutes like mineral water and diet soft drinks and juices are also estimated. The data from the 20112012 ENIGHUR, which contains detailed information on household consumption and socioeconomic variables, was used. The estimates are done using Deaton's Almost Ideal Demand System (AIDS) which accounts for differences in the quality of goods purchased. This demand system is estimated for different socio-economic groups, according to total household expenditure. The results reveal own-price elasticities for SSB between -1.17 and -1.33 depending on the socio-economic group, in line with the existing evidence for developed countries. Own-price elasticity for non-SSB is between -1 and -1.24. Income elasticities reveal that both SSB and non-SSB are normal goods with elasticities decreasing for higher socio-economic groups. These results show that the consumption of SSB is sensitive to price changes, meaning that the implementation of taxes on said beverages could be effective in reducing their consumption. The fact that non-SSB are also sensitive to price changes would indicate that subsidies could be implemented for the production of some of them.	[Paraje, Guillermo] Univ Adolfo Ibanez, Sch Business, Santiago, Chile	Universidad Adolfo Ibanez	Paraje, G (corresponding author), Univ Adolfo Ibanez, Sch Business, Santiago, Chile.	guillermo.paraje@uai.cl		Paraje, Guillermo/0000-0002-7863-907X	Pan-American Health Organization; UNICEF	Pan-American Health Organization; UNICEF	This study was funded by the Pan-American Health Organization and UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Chaloupka FJ, 2000, TOBACCO CONTROL IN D; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; DEATON A, 1988, AM ECON REV, V78, P418; DEATON A, 1987, J ECONOMETRICS, V36, P7, DOI 10.1016/0304-4076(87)90041-8; DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7; Deaton A, 1997, THE ANALYSIS OF HOUS; Delipalla S, 2001, INT J IND ORGAN, V19, P885, DOI 10.1016/S0167-7187(99)00057-0; Department of Justice, 2010, HORIZONTAL MERGER GU; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Euromonitor International, 2015, CARBONATES IN ECUADO; Euromonitor International, 2015, SOFT DRINKS STAT 201; Freire WB., 2014, ENSA NUT ECU 2012; Grogger J., 2015, NATIONAL BUREAU OF E, DOI [10.3386/w21197, DOI 10.3386/W21197]; Guindon GE, 2011, NATIONAL BUREAU OF E, DOI [10.3386/w17580, DOI 10.3386/W17580]; Instituto Nacional de Estadistica y Censos, 2012, ENCUESTA NACL INGRES; Instituto Nacional de Estadisticas y Censos del Ecuador, 2014, REPORTE DE POBREZA P; McKelvey C, 2011, J DEV ECON, V95, P157, DOI 10.1016/j.jdeveco.2010.05.004; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Organizacion Panamericana de la Salud (PAHO), 2011, AGUA Y SANEAMIENTO E; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Rtveladze K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068785; Singh GM, 2015, CIRCULATION; The World Health Organization The World Bank, 2013, JOINT WHO WORLD BANK; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782	27	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152260	10.1371/journal.pone.0152260	http://dx.doi.org/10.1371/journal.pone.0152260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028608	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500038
J	Cheek, M; Challen, G; Lebbie, A; Banks, H; Barbera, P; Riina, R				Cheek, Martin; Challen, Gill; Lebbie, Aiah; Banks, Hannah; Barbera, Patricia; Riina, Ricarda			Discovering Karima (Euphorbiaceae), a New Crotonoid Genus from West Tropical Africa Long Hidden within Croton	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE	Croton scarciesii (Euphorbiaceae-Crotonoideae), a rheophytic shrub from West Africa, is shown to have been misplaced in Croton for 120 years, having none of the diagnostic characters of that genus, but rather a set of characters present in no known genus of the family. Pollen analysis shows that the new genus Karima belongs to the inaperturate crotonoid group. Analysis of a concatenated molecular dataset combining trnL-F and rbcL sequences positioned Karima as sister to Neoholstia from south eastern tropical Africa in a well-supported clade comprised of genera of subtribes Grosserineae and Neoboutonieae of the inaperturate crotonoid genera. Several morphological characters support the relationship of Karima with Neoholstia, yet separation is merited by numerous characters usually associated with generic rank in Euphorbiaceae. Quantitative ecological data and a conservation assessment supplement illustrations and descriptions of the taxon.	[Cheek, Martin; Challen, Gill; Banks, Hannah] Royal Bot Gardens, Dept Sci, Richmond, Surrey, England; [Lebbie, Aiah] Njala Univ, PMB, Dept Biol Sci, Natl Herbarium Sierra Leone, Freetown, Sierra Leone; [Barbera, Patricia; Riina, Ricarda] CSIC, RJB, Dept Biodivers & Conservat, Plaza Murillo, Madrid, Spain	Royal Botanic Gardens, Kew; Njala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Cheek, M (corresponding author), Royal Bot Gardens, Dept Sci, Richmond, Surrey, England.; Riina, R (corresponding author), CSIC, RJB, Dept Biodivers & Conservat, Plaza Murillo, Madrid, Spain.	m.cheek@kew.org; rgriina@gmail.com	Riina, Ricarda/J-1032-2014; Barbera, Patricia/ABC-1793-2020	Riina, Ricarda/0000-0002-7423-899X; LEBBIE, AIAH/0000-0001-8725-3593	Joule Engineering; EU program Synthesys [NL-TAF-3710]; Spanish Government [CGL2012-32934, CGL2014-52787-C3-1-P]	Joule Engineering; EU program Synthesys; Spanish Government(Spanish GovernmentEuropean Commission)	The fieldwork which produced the specimen which triggered this study was ultimately funded by Joule Engineering as part of baseline studies for a hydroelectric dam at Bumbuna-Yiben, Sierra Leone. The funder of the fieldwork had no role in study design, data-collection and analysis, decision to publish or preparation of the manuscript. RR visit to WAG was supported by the EU program Synthesys (NL-TAF-3710). PB was supported by the Spanish Government through projects: Flora de Guinea Ecuatorial (CGL2012-32934) and Flora Iberica (CGL2014-52787-C3-1-P).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ake-Assi L., 2001, BOISSIERA, V57, P1; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; BERHAUT J, 1975, FLORE ILLUSTREE SENE; Berhaut J., 1967, FLORE DU SENEGAL; BURKHILL HM, 1994, USEFUL PLANTS W TROP, V2; Chevalier A.J.B., 1920, EXPLORATION BOT AFRI; Davis PH, 1963, PRINCIPLES ANGIOSPER; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hoffmann P., 2007, FLOWERING PLANT FAMI, P144; Hutchinson J, 1928, FLORA W TROPICAL AFR, V1, P276; Hutchinson J, 1913, FLORA TROPICAL AFRIC, V6, P609; Irvine FR, 1961, WOODY PLANTS GHANA; Keay R. W. J, 1958, FLORA W TROPICAL AFR, V2, P364; Lisowski S., 2009, SCRIPTA BOT BELGICA; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; McNeill J, 2012, REGNUM VEG, V154, P1; Nylander J. A. A., 2004, MRMODELTEST V2; Radcliffe-Smith A., 1996, FLORA ZAMBESICA, V9, P1; Radcliffe-Smith A., 2001, GENERA EUPHORBIACEAR; Riina R, 2014, SYST BOT, V39, P227, DOI 10.1600/036364414X678170; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scott-Elliot GF, 1895, J LINN SOC, V30, P64; Simmons MP, 2004, MOL PHYLOGENET EVOL, V31, P874, DOI 10.1016/j.ympev.2003.10.008; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thiers B., INDEX HERBARIORUM GL; van der Burgt XM, 2014, BUMBUNA PHASE UNPUB; van Ee BW, 2011, TAXON, V60, P791, DOI 10.1002/tax.603013; WEBSTER GL, 1993, TAXON, V42, P793, DOI 10.2307/1223265; Webster GL., 2014, FAMILIES GENERA VASC, P51, DOI [10.1007/978-3-642-39417-1_10, DOI 10.1007/978-3-642-39417-1_10]; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	37	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152110	10.1371/journal.pone.0152110	http://dx.doi.org/10.1371/journal.pone.0152110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049519	gold, Green Submitted, Green Published			2022-12-27	WOS:000373603500025
J	Ferrario, A; Luna, M; Rucker, N; Wong, S; Lederman, A; Kim, J; Gomer, C				Ferrario, Angela; Luna, Marian; Rucker, Natalie; Wong, Sam; Lederman, Ariel; Kim, Jonathan; Gomer, Charles			Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors	PLOS ONE			English	Article							SEPANTRONIUM BROMIDE YM155; ANTITUMOR-ACTIVITY; CANCER CELL; LUNG-CANCER; THERAPEUTIC TARGET; BREAST-CANCER; PHASE I/II; SUPPRESSANT; APOPTOSIS; COMBINATION	Treatments for retinoblastoma (Rb) vary depending on the size and location of the intraocular lesions and include chemotherapy and radiation therapy. We examined whether agents used to treat Rb induce a pro-survival phenotype associated with increased expression of survivin, a member of the inhibitor of apoptosis family of proteins. We document that exposure to carboplatin, topotecan or radiation resulted in elevated expression of survivin in two human Rb cell lines but not in normal retinal pigmented epithelial (RPE) cells. Cellular levels of survivin were attenuated in Rb cells exposed to an imidazolium-based survivin suppressant, Sepantronium bromide (YM155). Protein expression patterns of survivin in RPE cells were not altered following treatment protocols involving exposure to YM155. Including YM155 with chemotherapy or radiation increased levels of apoptosis in Rb cells but not in RPE cells. Intraocular luciferase expressing Rb tumors were generated from the Rb cell lines and used to evaluate the effects of carboplatin and YM155 on in-vivo survivin expression and tumor growth. Carboplatin induced expression of survivin while carboplatin combined with YM155 reduced survivin expression in tumor bearing eyes. The combination protocol was also most effective in reducing the rate of tumor regrowth. These results indicate that targeted inhibition of the anti-apoptotic protein survivin provides a therapeutic advantage for Rb cells and tumors treated with chemotherapy.	[Ferrario, Angela; Luna, Marian; Rucker, Natalie; Wong, Sam; Lederman, Ariel; Kim, Jonathan; Gomer, Charles] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Kim, Jonathan] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90027 USA; [Gomer, Charles] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA; [Gomer, Charles] Univ So Calif, Keck Sch Med, Dept Radiat Oncol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of Southern California	Gomer, C (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA.; Gomer, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90027 USA.; Gomer, C (corresponding author), Univ So Calif, Keck Sch Med, Dept Radiat Oncol, Los Angeles, CA 90027 USA.	cgomer@chla.usc.edu			SC CTSI (NIH/NCRR/NCATS) [UL1TR000130]; ThinkCure; Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER	SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ThinkCure; Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported in part by SC CTSI (NIH/NCRR/NCATS) through grant UL1TR000130, a grant from ThinkCure, and from the Las Madrinas Endowment for Experimental Therapeutics in Ophthalmology.	Abramson DH, 2010, OPHTHALMOLOGY, V117, P1623, DOI 10.1016/j.ophtha.2009.12.030; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Berry JL, 2014, BRIT J OPHTHALMOL, V98, P1061, DOI 10.1136/bjophthalmol-2013-304411; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Buitrago E, 2013, EXP EYE RES, V108, P103, DOI 10.1016/j.exer.2013.01.002; Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050; Carew JS, 2015, MOL CANCER THER, V14, P1404, DOI 10.1158/1535-7163.MCT-14-1036; Chantada Guillermo L, 2004, Ophthalmic Genet, V25, P37, DOI 10.1076/opge.25.1.37.28996; Chen J, 2013, BLOOD, V121, P2029, DOI 10.1182/blood-2012-05-427773; Coumar MS, 2013, CANCER TREAT REV, V39, P802, DOI 10.1016/j.ctrv.2013.02.002; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Elison JR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1269, DOI 10.1001/archopht.124.9.1269; Ferrario A, 2007, CANCER RES, V67, P4989, DOI 10.1158/0008-5472.CAN-06-4785; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Houston Samuel K, 2011, Int Ophthalmol Clin, V51, P77, DOI 10.1097/IIO.0b013e3182010f29; Huang JC, 2015, AM J CANCER RES, V5, P20; Ikeguchi M, 2002, APOPTOSIS, V7, P23, DOI 10.1023/A:1013556727182; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Jehanne M, 2009, PEDIATR BLOOD CANCER, V52, P637, DOI 10.1002/pbc.21898; Jiang LB, 2008, HISTOL HISTOPATHOL, V23, P827, DOI 10.14670/HH-23.827; Kawano H, 2014, EUR J PHARM BIOPHARM, V88, P283, DOI 10.1016/j.ejpb.2014.06.015; Kelly RJ, 2013, ANN ONCOL, V24, P2601, DOI 10.1093/annonc/mdt249; Kennedy SM, 2003, BRIT J CANCER, V88, P1077, DOI 10.1038/sj.bjc.6600776; Konduri S, 2009, MOL CANCER THER, V8, P533, DOI 10.1158/1535-7163.MCT-08-0405; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Leng T, 2010, RETINA, V30, P66; Li FZ, 2014, AM J CANCER RES, V4, P304; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lin P, 2009, AM J OPHTHALMOL, V148, P192, DOI 10.1016/j.ajo.2009.04.004; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; Minematsu T, 2012, BIOPHARM DRUG DISPOS, V33, P160, DOI 10.1002/bdd.1781; Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Rodel F, 2005, CANCER RES, V65, P4881, DOI 10.1158/0008-5472.CAN-04-3028; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Shehata HH, 2010, CLIN BIOCHEM, V43, P362, DOI 10.1016/j.clinbiochem.2009.10.056; Shen JJ, 2009, ACTA BIOCH BIOPH SIN, V41, P223, DOI 10.1093/abbs/gmp005; Shields CL, 2013, EYE, V27, P253, DOI 10.1038/eye.2012.175; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018; Smith AM, 2015, LEUKEMIA RES, V39, P435, DOI 10.1016/j.leukres.2015.01.005; Sudhakar J, 2013, PEDIATR BLOOD CANCER, V60, P1598, DOI 10.1002/pbc.24599; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Tong CT, 2005, BRIT J OPHTHALMOL, V89, P1217, DOI 10.1136/bjo.2004.064915; Turaka K, 2012, PEDIATR BLOOD CANCER, V59, P121, DOI 10.1002/pbc.23278; Wang QW, 2011, CANCER LETT, V302, P29, DOI 10.1016/j.canlet.2010.12.007; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	58	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153011	10.1371/journal.pone.0153011	http://dx.doi.org/10.1371/journal.pone.0153011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050416	Green Published, gold			2022-12-27	WOS:000373603500084
J	Jiang, W; Luo, T; Li, S; Zhou, Y; Shen, XY; He, F; Xu, J; Wang, HQ				Jiang, Wei; Luo, Tao; Li, Sheng; Zhou, Yue; Shen, Xiu-Yin; He, Feng; Xu, Jie; Wang, Hua-Qiao			Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3 beta Signaling Pathways in HT22 Hippocampal Neurons	PLOS ONE			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; CELL-DEATH; LONG-TERM; TAU; INDUCTION; EXPRESSION; HYPERPHOSPHORYLATION; PHOSPHORYLATION	Increasing evidence shows that oxidative stress and the hyperphosphorylation of tau protein play essential roles in the progression of Alzheimer's disease (AD). Quercetin is a major flavonoid that has anti-oxidant, anti-cancer and anti-inflammatory properties. We investigated the neuroprotective effects of quercetin to HT22 cells (a cell line from mouse hippocampal neurons). We found that Okadaic acid (OA) induced the hyperphosphorylation of tau protein at Ser199, Ser396, Thr205, and Thr231 and produced oxidative stress to the HT22 cells. The oxidative stress suppressed the cell viability and decreased the levels of lactate dehydrogenase (LDH), superoxide dismutase (SOD), mitochondria membrane potential (MMP) and Glutathione peroxidase (GSH-Px). It up-regulated malondialdehyde (MDA) production and intracellular reactive oxygen species (ROS). In addition, phosphoinositide 3 kinase/protein kinase B/Glycogen synthase kinase3 beta (PI3K/Akt/GSK3 beta) and mitogen activated protein kinase (MAPK) were also involved in this process. We found that pretreatment with quercetin can inhibited OA-induced the hyperphosphorylation of tau protein and oxidative stress. Moreover, pre-treatment with quercetin not only inhibited OA-induced apoptosis via the reduction of Bax, and up-regulation of cleaved caspase 3, but also via the inhibition of PI3K/Akt/GSK3 beta, MAPKs and activation of NF-kappa B p65. Our findings suggest the therapeutic potential of quercetin to treat AD.	[Jiang, Wei; Luo, Tao; Li, Sheng; Zhou, Yue; Shen, Xiu-Yin; Xu, Jie; Wang, Hua-Qiao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou 510080, Guangdong, Peoples R China; [Jiang, Wei] Zhaoqing Med Coll, Dept Anat & Histoembryol, Zhaoqing 526020, Guangdong, Peoples R China; [He, Feng] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, HQ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat & Neurobiol, Guangzhou 510080, Guangdong, Peoples R China.; He, F (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	hefeng@mail.sysu.edu.cn; wanghq@mail.sysu.edu.cn			National Key Development Program for Basic Research of China [2006cb500700]; Science and Technology Innovation Project of Guangdong Education Department [2012KJCX0089]; Medical Scientific Research Foundation of Guangdong Province [A2010222, A2015032]; Fundamental Research Founds for the Central Universities of China [14ykpy03]; National Natural Science Foundation of China [81173577, 81501093]; Natural Science Foundation of Guangdong Province [2015A030313066, 2015A030310251]; Science and Technology Planning Project of Guangdong Province [2014A020212622]	National Key Development Program for Basic Research of China(National Basic Research Program of China); Science and Technology Innovation Project of Guangdong Education Department; Medical Scientific Research Foundation of Guangdong Province; Fundamental Research Founds for the Central Universities of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province	This work was supported by National Key Development Program for Basic Research of China (No. 2006cb500700), Science and Technology Innovation Project of Guangdong Education Department (No. 2012KJCX0089), Medical Scientific Research Foundation of Guangdong Province (No. A2010222, A2015032), Fundamental Research Founds for the Central Universities of China (No. 14ykpy03), National Natural Science Foundation of China (No. 81173577, 81501093), Natural Science Foundation of Guangdong Province (No. 2015A030313066, 2015A030310251), and Science and Technology Planning Project of Guangdong Province (No. 2014A020212622).	Meraz-Rios MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/375968; Chen LQ, 2005, ANAT REC PART A, V287A, P1236, DOI 10.1002/ar.a.20241; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Chung CW, 2003, NEUROBIOL DIS, V14, P557, DOI 10.1016/j.nbd.2003.08.017; Clausen A, 2012, J ALZHEIMERS DIS, V30, P183, DOI 10.3233/JAD-2012-111298; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Feng Y, 2013, J NEUROCHEM, V126, P234, DOI 10.1111/jnc.12285; Giridharan VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142483; Hanana H, 2012, BIOL OPEN, V1, P1192, DOI 10.1242/bio.20122170; Hu SQ, 2013, NEUROCHEM INT, V62, P468, DOI 10.1016/j.neuint.2013.01.022; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Islam MR, 2013, J YOUNG PHARM, V5, P173, DOI 10.1016/j.jyp.2013.11.005; Jiang W, 2015, CNS NEUROL DISORD-DR, V14, P1334, DOI 10.2174/1871527314666150821104455; Kamat PK, 2011, PHARMACOL BIOCHEM BE, V100, P311, DOI 10.1016/j.pbb.2011.08.019; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Luo T, 2012, CNS NEUROL DISORD-DR, V11, P1030; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Park SY, 2010, PLANTA MED, V76, P863, DOI 10.1055/s-0029-1240801; Post A, 2000, EUR J NEUROSCI, V12, P4331, DOI 10.1046/j.0953-816X.2000.01352.x; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Thal DR, 2013, EUR ARCH PSY CLIN N, V263, pS137, DOI 10.1007/s00406-013-0449-5; Valdiglesias V, 2011, TOXICON, V57, P882, DOI 10.1016/j.toxicon.2011.03.005; Wang DM, 2014, NEUROCHEM RES, V39, P1533, DOI 10.1007/s11064-014-1343-x; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Yan FG, 2012, ENVIRON TOXICOL PHAR, V33, P181, DOI 10.1016/j.etap.2011.12.006; Zeng KW, 2011, EUR J PHARMACOL, V672, P45, DOI 10.1016/j.ejphar.2011.09.177; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao RP, 2011, J ETHNOPHARMACOL, V133, P1109, DOI 10.1016/j.jep.2010.11.054; Zhou SS, 2013, NEUROTOXICOLOGY, V38, P136, DOI 10.1016/j.neuro.2013.07.007; Zimmer ER, 2012, CURR ALZHEIMER RES, V9, P1182	32	42	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152371	10.1371/journal.pone.0152371	http://dx.doi.org/10.1371/journal.pone.0152371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050422	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500034
J	Lapenta, F; Silva, AM; Brandimarti, R; Lanzi, M; Gratani, FL; Gonzalez, PV; Perticarari, S; Hochkoeppler, A				Lapenta, Fabio; Silva, Alejandro Monton; Brandimarti, Renato; Lanzi, Massimiliano; Gratani, Fabio Lino; Gonzalez, Perceval Vellosillo; Perticarari, Sofia; Hochkoeppler, Alejandro			Escherichia coli DnaE Polymerase Couples Pyrophosphatase Activity to DNA Replication	PLOS ONE			English	Article							FAMILY-II PYROPHOSPHATASES; INORGANIC PYROPHOSPHATASE; DEOXYRIBONUCLEIC-ACID; EXONUCLEASE ACTIVITY; BACILLUS-SUBTILIS; STREPTOCOCCUS-GORDONII; QUATERNARY STRUCTURE; ENZYMATIC SYNTHESIS; GAMMA-SUBUNIT; PHP DOMAIN	DNA Polymerases generate pyrophosphate every time they catalyze a step of DNA elongation. This elongation reaction is generally believed as thermodynamically favoured by the hydrolysis of pyrophosphate, catalyzed by inorganic pyrophosphatases. However, the specific action of inorganic pyrophosphatases coupled to DNA replication in vivo was never demonstrated. Here we show that the Polymerase-Histidinol-Phosphatase (PHP) domain of Escherichia coli DNA Polymerase III a subunit features pyrophosphatase activity. We also show that this activity is inhibited by fluoride, as commonly observed for inorganic pyrophosphatases, and we identified 3 amino acids of the PHP active site. Remarkably, E. coli cells expressing variants of these catalytic residues of a subunit feature aberrant phenotypes, poor viability, and are subject to high mutation frequencies. Our findings indicate that DNA Polymerases can couple DNA elongation and pyrophosphate hydrolysis, providing a mechanism for the control of DNA extension rate, and suggest a promising target for novel antibiotics.	[Lapenta, Fabio; Silva, Alejandro Monton; Brandimarti, Renato; Gratani, Fabio Lino; Gonzalez, Perceval Vellosillo; Perticarari, Sofia; Hochkoeppler, Alejandro] Univ Bologna, Dept Pharm & Biotechnol, Viale Risorgimento 4, I-40136 Bologna, Italy; [Lanzi, Massimiliano] Univ Bologna, Dept Ind Chem, Viale Risorgimento 4, I-40136 Bologna, Italy; [Hochkoeppler, Alejandro] Univ Florence, CSGI, Via Lastruccia 3, I-50019 Sesto Fiorentino, FI, Italy	University of Bologna; University of Bologna; University of Florence	Hochkoeppler, A (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Viale Risorgimento 4, I-40136 Bologna, Italy.; Hochkoeppler, A (corresponding author), Univ Florence, CSGI, Via Lastruccia 3, I-50019 Sesto Fiorentino, FI, Italy.	a.hochkoeppler@unibo.it	Hochkoeppler, Alejandro/HGA-5916-2022; Lapenta, Fabio/T-3825-2017; Lanzi, Massimiliano/F-3973-2016; Lanzi, Massimiliano/AAV-7432-2020	Lanzi, Massimiliano/0000-0002-2466-2813; Lanzi, Massimiliano/0000-0002-2466-2813; Lapenta, Fabio/0000-0003-1195-3758; Vellosillo, Perceval/0000-0002-5998-6316; BRANDIMARTI, RENATO/0000-0003-3078-9009				Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070; Ahsan MR, 2005, INDIAN J PURE AP PHY, V43, P89; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Barros T, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-8; Beckwith J, 1992, POWER BACTERIAL GENE, P4; BESSMAN MJ, 1958, J BIOL CHEM, V233, P171; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bressanin D, 2009, BBA-PROTEINS PROTEOM, V1794, P1606, DOI 10.1016/j.bbapap.2009.07.011; CAMPBELL JL, 1972, P NATL ACAD SCI USA, V69, P2090, DOI 10.1073/pnas.69.8.2090; Conte E, 2011, BIOTECHNOL LETT, V33, P1815, DOI 10.1007/s10529-011-0624-6; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0; DEMEIS L, 1984, J BIOL CHEM, V259, P6090; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fabrichniy IP, 2004, BIOCHEMISTRY-US, V43, P14403, DOI 10.1021/bi0484973; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; Grigorieva OV, 2001, RUSS J BIOORG CHEM+, V27, P27, DOI 10.1023/A:1009574901422; Suarez ASG, 2012, BIOTECHNIQUES, V53, P99, DOI 10.2144/000113905; Hamdan S, 2002, BIOCHEMISTRY-US, V41, P5266, DOI 10.1021/bi0159480; Heikinheimo P, 2001, P NATL ACAD SCI USA, V98, P3121, DOI 10.1073/pnas.061612498; JOYCE CM, 1984, J BACTERIOL, V158, P636, DOI 10.1128/JB.158.2.636-643.1984; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Knippers A., 1970, NATURE, V228, P1050; Kornberg A., 1992, DNA REPLICATION; KORNBERG T, 1972, J BIOL CHEM, V247, P5369; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Nakane S, 2009, NUCLEIC ACIDS RES, V37, P2037, DOI 10.1093/nar/gkp064; NUSSLEIN V, 1971, NATURE-NEW BIOL, V234, P285, DOI 10.1038/newbio234285a0; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Rock JM, 2015, NAT GENET, V47, P677, DOI 10.1038/ng.3269; Scheibe P., 1974, METHODEN ENZYMATISCH, P1999; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva AM, 2015, BIOCHEM BIOPH RES CO, V462, P14, DOI 10.1016/j.bbrc.2015.04.067; SKLYANKINA VA, 1990, EUR J BIOCHEM, V191, P195, DOI 10.1111/j.1432-1033.1990.tb19110.x; Standish AJ, 2013, BIOCHEM BIOPH RES CO, V430, P167, DOI 10.1016/j.bbrc.2012.11.049; Stano NM, 2006, NAT STRUCT MOL BIOL, V13, P458, DOI 10.1038/nsmb1078; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Young TW, 1998, MICROBIOL-SGM, V144, P2563, DOI 10.1099/00221287-144-9-2563	49	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152915	10.1371/journal.pone.0152915	http://dx.doi.org/10.1371/journal.pone.0152915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050298	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500066
J	Shi, XX; Yin, BS; Yang, P; Chen, H; Li, X; Su, LX; Fan, HG; Wang, HB				Shi, Xing-Xing; Yin, Bai-Shuang; Yang, Peng; Chen, Hao; Li, Xin; Su, Li-Xue; Fan, Hong-Gang; Wang, Hong-Bin			Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats	PLOS ONE			English	Article							AMP; ENERGY; PHOSPHORYLATION; RECEPTOR; PHARMACOKINETICS; INTOXICATION; DEPRIVATION; METABOLISM; UPSTREAM; KETAMINE	Xylazine is a potent analgesic extensively used in veterinary and animal experimentation. Evidence exists that the analgesic effect can be inhibited using adenosine 5'-monophosphate activated protein kinase (AMPK) inhibitors. Considering this idea, the aim of this study was to investigate whether the AMPK signaling pathway is involved in the central analgesic mechanism of xylazine in the rat. Xylazine was administrated via the intraperitoneal route. Sprague-Dawley rats were sacrificed and the cerebral cortex, cerebellum, hippocampus, thalamus and brainstem were collected for determination of liver kinase B1 (LKB1) and AMPK alpha mRNA expression using quantitative real-time polymerase chain reaction (qPCR), and phosphorylated LKB1 and AMPK alpha levels using western blot. The results of our study showed that compared with the control group, xylazine induced significant increases in AMPK activity in the cerebral cortex, hippocampus, thalamus and cerebellum after rats received xylazine (P < 0.01). Increased AMPK activities were accompanied with increased phosphorylation levels of LKB1 in corresponding regions of rats. The protein levels of phosphorylated LKB1 and AMPK alpha in these regions returned or tended to return to control group levels. However, in the brainstem, phosphorylated LKB1 and AMPK alpha protein levels were decreased by xylazine compared with the control (P < 0.05). In conclusion, our data indicates that xylazine alters the activities of LKB1 and AMPK in the central nervous system of rats, which suggests that xylazine affects the regulatory signaling pathway of the analgesic mechanism in the rat brain.	[Shi, Xing-Xing; Yang, Peng; Chen, Hao; Li, Xin; Su, Li-Xue; Fan, Hong-Gang; Wang, Hong-Bin] Northeast Agr Univ, Dept Vet Surg, Coll Vet Med, Harbin, Heilongjiang Pr, Peoples R China; [Yin, Bai-Shuang] Jilin Agr Sci & Technol Coll, Dept Vet Med, Jilin, Jilin Province, Peoples R China	Northeast Agricultural University - China	Wang, HB (corresponding author), Northeast Agr Univ, Dept Vet Surg, Coll Vet Med, Harbin, Heilongjiang Pr, Peoples R China.	hbwang1940@163.com			National Natural Science Foundation of China [31272617, 31472245, 31302150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China, grant numbers 31272617 and 31472245 (College of Veterinary Medicine, Northeast Agricultural University, HBW), and by the National Natural Science Foundation of China, grant number 31302150 (Department of Veterinary Medicine, Jilin Agriculture Science and Technology College, BSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bogdanov VB, 2015, BEHAV BRAIN RES, V281, P187, DOI 10.1016/j.bbr.2014.11.028; Cho KS, 2013, LIFE SCI, V92, P929, DOI 10.1016/j.lfs.2013.03.011; Daunt DA, 2002, VET CLIN N AM-EQUINE, V18, P39, DOI 10.1016/S0749-0739(02)00004-4; Delehant TM, 2003, VET THER, V4, P128; Doran GS, 2015, J CHROMATOGR B, V997, P81, DOI 10.1016/j.jchromb.2015.06.005; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Goodchild CS, 1996, BRIT J ANAESTH, V76, P544, DOI 10.1093/bja/76.4.544; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hoffmann U, 2001, J ANAL TOXICOL, V25, P245, DOI 10.1093/jat/25.4.245; Hu XY, 2016, COMP BIOCHEM PHYS B, V191, P146, DOI 10.1016/j.cbpb.2015.10.007; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim Sun Kwang, 2014, BMC Complement Altern Med, V14, P211, DOI 10.1186/1472-6882-14-211; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Liangpunsakul S, 2009, ARCH BIOCHEM BIOPHYS, V485, P10, DOI 10.1016/j.abb.2009.02.006; Romero TRL, 2013, BRAIN RES, V1506, P58, DOI 10.1016/j.brainres.2013.02.030; Romero TRL, 2009, EUR J PHARMACOL, V608, P23, DOI 10.1016/j.ejphar.2009.02.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JQ, 2015, EXP CELL RES, V334, P194, DOI 10.1016/j.yexcr.2015.04.006; Mackenzie RWA, 2014, DIABETES METAB SYNDR, V7, P55, DOI 10.2147/DMSO.S48260; Park HG, 2011, PROG NEURO-PSYCHOPH, V35, P1933, DOI 10.1016/j.pnpbp.2011.09.008; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Price TJ, 2013, NEUROSCI LETT, V557, P9, DOI 10.1016/j.neulet.2013.06.060; Ruiz-Colon K, 2014, FORENSIC SCI INT, V240, P1, DOI 10.1016/j.forsciint.2014.03.015; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; SCHMITT H, 1974, NEUROPHARMACOLOGY, V13, P295, DOI 10.1016/0028-3908(74)90113-0; Seo JP, 2011, J VET SCI, V12, P281, DOI 10.4142/jvs.2011.12.3.281; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stillwell ME, 2003, FORENSIC SCI INT, V134, P25, DOI 10.1016/S0379-0738(03)00083-5; Sunkin SM, 2006, TRENDS GENET, V22, P211, DOI 10.1016/j.tig.2006.02.006; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	41	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153169	10.1371/journal.pone.0153169	http://dx.doi.org/10.1371/journal.pone.0153169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049320	Green Published, gold			2022-12-27	WOS:000373603500109
J	Berwald, S; Roche, M; Adelman, S; Mukadam, N; Livingston, G				Berwald, Sharne; Roche, Moise; Adelman, Simon; Mukadam, Naaheed; Livingston, Gill			Black African and Caribbean British Communities' Perceptions of Memory Problems: "We Don't Do Dementia"	PLOS ONE			English	Article							MINORITY ETHNIC-COMMUNITIES; ADVANCED CANCER; CARE SERVICES; HEALTH; PEOPLE; IMPAIRMENT; PREVALENCE; AMERICAN; BARRIERS; MEANINGS	Objectives We aimed to identify and explore the barriers to help-seeking for memory problems, specifically within UK Black African and Caribbean communities. Method We purposively recruited participants from community groups and subsequent snowball sampling, to achieve a maximum variation sample and employed thematic analysis. Our qualitative semi-structured interviews used a vignette portraying a person with symptoms of dementia, and we asked what they or their family should do. We stopped recruiting when no new themes were arising. Results and significance We recruited 50 people from a range of age groups, country of origin, time in the UK, religion and socio-economic background. Some of the barriers to presentation with dementia have been reported before, but others were specific to this group and newly identified. Many people recognised forgetfulness but neither that it could be indicative of dementia, nor the concept of dementia as applying to them. Dementia was viewed as a white person's illness. Participants felt there was little point in consulting a doctor for forgetfulness. Many thought that seeing a GP was only for severe problems. Some said that their culture was secretive and highly valued privacy of personal affairs and therefore did not want to discuss what they regarded as a private and stigmatising problem with a GP. Participants did not appreciate their GP could refer to memory services who have more time and expertise. They were concerned about harm from medication and compulsory institutionalisation. Care should be from the family. Any intervention should emphasise the legitimacy of seeing a doctor early for memory concerns, that dementia is a physical illness which also occurs in the Black community, that help and time are available from memory services whose role is to prolong independence and support families in caring.	[Berwald, Sharne; Roche, Moise; Adelman, Simon; Mukadam, Naaheed; Livingston, Gill] Camden & Islington NHS Fdn Trust, London, England; [Berwald, Sharne; Mukadam, Naaheed; Livingston, Gill] UCL, Div Psychiat, London, England	University of London; University College London	Livingston, G (corresponding author), Camden & Islington NHS Fdn Trust, London, England.; Livingston, G (corresponding author), UCL, Div Psychiat, London, England.	g.livingston@ucl.ac.uk		Livingston, Gill/0000-0001-6741-5516	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust	The research was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Adelman S, 2011, BRIT J PSYCHIAT, V199, P119, DOI 10.1192/bjp.bp.110.086405; Adelman S, 2009, INT J GERIATR PSYCH, V24, P657, DOI 10.1002/gps.2186; Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; Arrey AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119653; Botsford J, 2012, J ADV NURS, V68, P2207, DOI 10.1111/j.1365-2648.2011.05905.x; Boyd AE, 2005, HIV MED, V6, P59, DOI 10.1111/j.1468-1293.2005.00267.x; Brooker D, 2014, INT J GERIATR PSYCH, V29, P682, DOI 10.1002/gps.4066; BURNS A, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3199; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Butt J., 2006, ARE WE THERE YET IDE; Cooper C, 2010, AM J GERIAT PSYCHIAT, V18, P193, DOI 10.1097/JGP.0b013e3181bf9caf; Daker-White G, 2002, AGING MENT HEALTH, V6, P101, DOI 10.1080/13607860220126835; Drummond PD, 2011, HEALTH CARE WOMEN IN, V32, P206, DOI 10.1080/07399332.2010.529216; Ehiwe E., 2012, ETHNICITY INEQUALITI, V5, P5, DOI 10.1108/17570981211286732; Giebel CM, 2015, INT J GERIATR PSYCH, V30, P345, DOI 10.1002/gps.4242; Jett KF, 2006, J AGING STUD, V20, P1, DOI 10.1016/j.jaging.2005.05.002; Jolley D., 2009, ETHNICITY INEQUALITI, V2, P5; Koffman J, 2008, PALLIATIVE MED, V22, P350, DOI 10.1177/0269216308090168; Koffman J, 2008, SOC SCI MED, V67, P780, DOI 10.1016/j.socscimed.2008.05.004; Lawrence V, 2008, BRIT J PSYCHIAT, V193, P240, DOI 10.1192/bjp.bp.107.045187; Lawrence V, 2011, GERONTOLOGIST, V51, P39, DOI 10.1093/geront/gnq073; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moriarty J., 2011, BLACK MINORITY ETHNI; Mukadam N, 2015, WHAT WOULD ENCOURAGE; Mukadam N, 2013, CURR OPIN PSYCHIATR, V26, P409, DOI 10.1097/YCO.0b013e32835ee668; Mukadam N, 2011, INT PSYCHOGERIATR, V23, P1070, DOI 10.1017/S1041610211000214; Mukadam N, 2011, INT J GERIATR PSYCH, V26, P12, DOI 10.1002/gps.2484; Rait G, 1999, BRIT MED J, V318, P305; Regan JL, 2013, MENT HEALTH RELIG CU, V16, P1, DOI 10.1080/13674676.2011.639751; Rugkasa J, 2011, QUAL HEALTH RES, V21, P132, DOI 10.1177/1049732310379115; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Smith W, 2014, MULT SCLER INT, V2014; Werner P, 2014, ALZ DIS ASSOC DIS, V28, P299, DOI 10.1097/WAD.0000000000000065; Werner P, 2012, GERONTOLOGIST, V52, P89, DOI 10.1093/geront/gnr117	34	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151878	10.1371/journal.pone.0151878	http://dx.doi.org/10.1371/journal.pone.0151878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045999	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600006
J	Nicholson, KL; Arthur, SM; Horne, JS; Garton, EO; Del Vecchio, PA				Nicholson, Kerry L.; Arthur, Stephen M.; Horne, Jon S.; Garton, Edward O.; Del Vecchio, Patricia A.			Modeling Caribou Movements: Seasonal Ranges and Migration Routes of the Central Arctic Herd	PLOS ONE			English	Article							PETROLEUM DEVELOPMENT; RANGIFER-TARANDUS; WOODLAND CARIBOU; CALVING CARIBOU; MULE DEER; DYNAMICS; ALASKA; OIL; LANDSCAPE; PRODUCTIVITY	Migration is an important component of the life history of many animals, but persistence of large-scale terrestrial migrations is being challenged by environmental changes that fragment habitats and create obstacles to animal movements. In northern Alaska, the Central Arctic herd (CAH) of barren-ground caribou (Rangifer tarandus granti) is known to migrate over large distances, but the herd's seasonal distributions and migratory movements are not well documented. From 2003-2007, we used GPS radio-collars to determine seasonal ranges and migration routes of 54 female caribou from the CAH. We calculated Brownian bridges to model fall and spring migrations for each year and used the mean of these over all 4 years to identify areas that were used repeatedly. Annual estimates of sizes of seasonal ranges determined by 90% fixed kernel utilization distributions were similar between summer and winter ((X) over bar = 27,929 SE = 1,064 and (X) over bar = 26,585 SE = 4912 km(2), respectively). Overlap between consecutive summer and winter ranges varied from 3.3-18.3%. Percent overlap between summer ranges used during consecutive years ((X) over bar = 62.4% SE = 3.7%) was higher than for winter ranges ((X) over bar = 42.8% SE = 5.9%). Caribou used multiple migration routes each year, but some areas were used by caribou during all years, suggesting that these areas should be managed to allow for continued utilization by caribou. Restoring migration routes after they have been disturbed or fragmented is challenging. However, prior knowledge of movements and threats may facilitate maintenance of migratory paths and seasonal ranges necessary for long-term persistence of migratory species.	[Nicholson, Kerry L.; Horne, Jon S.; Garton, Edward O.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Nicholson, Kerry L.; Arthur, Stephen M.; Del Vecchio, Patricia A.] Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA; [Arthur, Stephen M.] US Fish & Wildlife Serv, Arctic Natl Wildlife Refuge, Fairbanks, AK USA; [Horne, Jon S.] Idaho Dept Fish & Game, Lewiston, ID USA; [Del Vecchio, Patricia A.] 1580 Ivans Alley, Fairbanks, AK USA	Idaho; University of Idaho; Alaska Department of Fish & Game; United States Department of the Interior; US Fish & Wildlife Service	Nicholson, KL (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.; Nicholson, KL (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Fairbanks, AK USA.	kerry.nicholson@alaska.gov	Arthur, Stephen/AAP-1708-2021; Arthur, Stephen/GPX-2624-2022; Nicholson, Kerry/F-2077-2013	Nicholson, Kerry/0000-0001-9951-9897	U.S. Bureau of Land Management; Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects [3.46, 3.49]; National Institute of General Medical Sciences of the National Institutes of Health [P30 GM103324]; Bureau of Land Management ARRA [L10AC16256]; ConocoPhillips-Alaska, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103324] Funding Source: NIH RePORTER	U.S. Bureau of Land Management; Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bureau of Land Management ARRA; ConocoPhillips-Alaska, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the U.S. Bureau of Land Management, ConocoPhillips-Alaska, Inc., and the Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects 3.46 and 3.49. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30 GM103324. Radiocollars were purchased by the Bureau of Land Management and U.S. Fish and Wildlife Service, and the U.S. National Park Service provided logistical support for winter surveys and caribou captures. Support for JSH was provided by Bureau of Land Management ARRA agreement L10AC16256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study was provided by the U.S. Bureau of Land Management, ConocoPhillips-Alaska, Inc., and the Alaska Department of Fish and Game through Federal Aid in Wildlife Restoration Projects 3.46 and 3.49. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P30 GM103324. Radiocollars were purchased by the Bureau of Land Management and U.S. Fish and Wildlife Service, and the U.S. National Park Service provided logistical support for winter surveys and caribou captures. Support for JSH was provided by Bureau of Land Management ARRA agreement L10AC16256. C. Beddingfield and A. Everts of the Alaska State Troopers provided housing and aircraft facilities for field crews. We are especially grateful for the expertise of net gunners B. Miner, J. Lawler, and M. Kienzler and pilots R. Swisher, T. Cambier, A. Einer, M. Webb, S. Hamilton, P. Zaczkowski, L. Larrivee, and D. Miller. We thank L. Adams, S. Brainerd, L. Parrett, B. Taras, and K. Whitten for reviewing earlier drafts of the manuscript.	Alcock J., 2001, ANIMAL BEHAV EVOLUTI, V7th ed.; Anderson TA, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00010.1; Arthur S. M., 2009, W275 AL DEP FISH GAM; Arthur Stephen M., 1999, Ursus, V11, P139; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; BERGERUD AT, 1990, ANIM BEHAV, V39, P360, DOI 10.1016/S0003-3472(05)80882-6; BERGERUD AT, 1986, CAN J ZOOL, V64, P1515, DOI 10.1139/z86-226; Bergerud AT, 1974, IUCN PUBLICATIONS, V24; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Boertje RD, 2000, RANGIFER, V12, P17; Bolger DT, 2008, ECOL LETT, V11, P63; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Cameron R. D., 1995, Rangifer, V15, P3; Cameron R.D., 2002, ARCTIC REFUGE COASTA, P38; Cameron RD, 2005, ARCTIC, V58, P1; CAMERON RD, 1992, ARCTIC, V45, P338; CAMERON RD, 1979, CAN FIELD NAT, V93, P155; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; CARRUTHERS DR, 1987, CAN FIELD NAT, V101, P423; CARRUTHERS DR, 1987, WILDLIFE SOC B, V15, P414; Christianson D, 2009, OECOLOGIA, V158, P603, DOI 10.1007/s00442-008-1200-1; Cronin MA, 2000, WILDLIFE SOC B, V28, P919; DUQUETTE LS, 1988, ARCTIC, V41, P143; DUQUETTE LS, 1987, CAN J ZOOL, V65, P164, DOI 10.1139/z87-023; FANCY SG, 1989, CAN J ZOOL, V67, P644, DOI 10.1139/z89-093; Fancy Steven, 1986, THESIS U ALASKA FAIR; Ferguson MAD, 2000, J WILDLIFE MANAGE, V64, P168, DOI 10.2307/3802987; Ferguson SH, 2004, BASIC APPL ECOL, V5, P465, DOI 10.1016/j.baae.2004.04.011; Grovenburg TW, 2011, J MAMMAL, V92, P534, DOI 10.1644/09-MAMM-A-407.1; Gunn A, 1986, RANGIFER, V6, P151, DOI 10.7557/2.6.2.640; Haskell SP, 2006, ARCTIC, V59, P179; Hemming JE., 1971, ALASKA DEP FISH GAME; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; Kelsall J. P., 1968, MIGRATORY BARREN GRO; Lenart EA, 2009, CARIBOU MANAGEMENT R, P299; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Mahoney SP, 2002, J MAMMAL, V83, P957, DOI 10.1644/1545-1542(2002)083<0957:LTCIDA>2.0.CO;2; McCabe, 2002, ARCTIC REFUGE COASTA, P8; McKinley, 2000, ALCES, V36, P93, DOI DOI 10.7557/2.6.2.582; Mose VN, 2013, ECOL MODEL, V254, P43, DOI 10.1016/j.ecolmodel.2013.01.016; Nellemann C, 1998, CAN J ZOOL, V76, P1425, DOI 10.1139/cjz-76-8-1425; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Nielson R.M., 2011, BBMM BROWNIAN BRIDGE; OOSENBRUG SM, 1980, ARCTIC, V33, P59; Parker GR, 1972, CANADIAN WILDLIFE SE, V20; Person BT, 2007, ARCTIC, V60, P238; Pruitt WO., 1959, ARCTIC, V12, P158, DOI [10.14430/arctic3723, DOI 10.14430/ARCTIC3723]; PULLIAINEN E, 1974, Naturaliste Canadien (Quebec), V101, P379; Rankin MA, 1985, CONTRIBUTIONS MARINE, V27, P1; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Russell DE, 1992, CANADIAN WILDLIFE SE; Russell DE, 1993, RANGIFER, V8, P3; Saher D. J., 2005, THESIS U ALBERTA EDM; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinclair A.R.E., 1983, P240; Singh NJ, 2010, BIOL CONSERV, V143, P1770, DOI 10.1016/j.biocon.2010.04.026; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Skoog RO, 1968, THESIS U CALIFORNIA; Smith WT, 1994, ALASKA DEP FISH GAME, V12; Taillon J, 2012, BIOL CONSERV, V147, P163, DOI 10.1016/j.biocon.2011.12.027; Valkenburg P., 1983, Acta Zoologica Fennica, P125; WALKER DA, 1985, ARCTIC ALPINE RES, V17, P321, DOI 10.2307/1551021; WALKER MD, 1994, J VEG SCI, V5, P843, DOI 10.2307/3236198; WHITE R G, 1975, Biological Papers of the University of Alaska Special Report, V2, P151; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; Whitten K, 1980, P 2 INT REIND CAR S; WHITTEN KR, 1992, J WILDLIFE MANAGE, V56, P201, DOI 10.2307/3808814; WHITTEN KR, 1983, CAN FIELD NAT, V97, P143; Whitten KR, 1985, ARCTIC NATL WILDLIFE, P515; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wolfe SA., 2000, THESIS U ALASKA FAIR	80	42	43	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0150333	10.1371/journal.pone.0150333	http://dx.doi.org/10.1371/journal.pone.0150333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045587	Green Submitted, gold, Green Published			2022-12-27	WOS:000373599600001
J	Hanif, MU; Capareda, SC; Iqbal, H; Arazo, RO; Baig, MA				Hanif, Muhammad Usman; Capareda, Sergio C.; Iqbal, Hamid; Ortiz Arazo, Renato; Baig, Muhammad Anwar			Effects of Pyrolysis Temperature on Product Yields and Energy Recovery from Co-Feeding of Cotton Gin Trash, Cow Manure, and Microalgae: A Simulation Study	PLOS ONE			English	Article							RICE BRAN OIL; BIO-OIL; THERMOCHEMICAL CONVERSION; BIOMASS; LIQUID; BIOFUELS; ETHANOL; WASTE	The intensive search of new and cleaner energy catches interest in recent years due to huge consumption of fossil fuels coupled with the challenge of energy and environmental sustainability. Production of renewable and environmentally benign energy from locally available raw materials is coming in the frontline. In this work, conversion of the combined biomass (cotton gin trash, cow manure, and Microalgae [Nannochloropsis oculata]) through batch pyrolysis has been investigated. The effect of temperature to the production of energy fuels such as bio-oil, char, and biogas have been simulated considering the yield and energy content as responses. Result of the investigation generally revealed that the proportions of the different biomass did not significantly affect the product yield and energy recovery. Significant effect of temperature is evident in the simulation result of energy recovery whereby maximum conversion was achieved at 400 degrees C for char (91 wt%), 600 degrees C for syngas (22 wt%), and 551 degrees C for bio-oil (48 wt%). Overall energy conversion efficiency of 75.5% was obtained at 589 degrees C in which 15.6 MJ/kg of mixed biomass will be elevated to pyrolysis products.	[Hanif, Muhammad Usman; Capareda, Sergio C.; Ortiz Arazo, Renato] Texas A&M Univ, Biol & Agr Engn Dept, BETA Lab, College Stn, TX 77843 USA; [Hanif, Muhammad Usman; Iqbal, Hamid; Baig, Muhammad Anwar] Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Environm Sci & Engn, Sect H-12, Islamabad 46000, Pakistan; [Ortiz Arazo, Renato] Misamis Oriental State Coll Agr & Technol, Inst Engn & Technol, Northern Mindanao 9004, Philippines	Texas A&M University System; Texas A&M University College Station; National University of Sciences & Technology - Pakistan	Hanif, MU (corresponding author), Texas A&M Univ, Biol & Agr Engn Dept, BETA Lab, College Stn, TX 77843 USA.; Hanif, MU (corresponding author), Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Environm Sci & Engn, Sect H-12, Islamabad 46000, Pakistan.	usman_hanif90@live.com	Arazo, Renato Ortiz/F-9465-2018; Capareda, Sergio C/C-5843-2015; Iqbal, Hamid/AAV-5062-2021	Arazo, Renato Ortiz/0000-0003-2524-0900; Capareda, Sergio C/0000-0003-4720-8098; 				Agblevor FA, 2006, RESOUR CONSERV RECY, V46, P198, DOI 10.1016/j.resconrec.2005.07.002; Asadullah M, 2007, FUEL, V86, P2514, DOI 10.1016/j.fuel.2007.02.007; Ates F, 2012, FUEL, V102, P681, DOI 10.1016/j.fuel.2012.05.051; Ben HX, 2013, FUEL, V103, P1148, DOI 10.1016/j.fuel.2012.08.039; Bhaskar T, 2011, BIOMASS BIOF BIOCHEM, P51; Biradar CH, 2014, FUEL, V119, P81, DOI 10.1016/j.fuel.2013.11.035; Bridgwater AV, 2012, BIOMASS BIOENERG, V38, P68, DOI 10.1016/j.biombioe.2011.01.048; Cao YC, 2012, ENVIRON PROT ENG, V38, P77, DOI 10.5277/epe120207; Capareda S., 2013, INTRO BIOMASS ENERGY; Capunitan JA, 2012, FUEL, V95, P563, DOI 10.1016/j.fuel.2011.12.029; Chutia RS, 2014, BIORESOURCE TECHNOL, V165, P336, DOI 10.1016/j.biortech.2014.03.118; Fonts I, 2012, RENEW SUST ENERG REV, V16, P2781, DOI 10.1016/j.rser.2012.02.070; Froilan Ludana A., 2007, THESIS TEXAS A M U; Huang HJ, 2013, J ANAL APPL PYROL, V102, P60, DOI 10.1016/j.jaap.2013.04.002; Jahirul MI, 2012, ENERGIES, V5, P4952, DOI 10.3390/en5124952; Kim SW, 2013, FUEL PROCESS TECHNOL, V108, P118, DOI 10.1016/j.fuproc.2012.05.002; Lin L, 2009, APPL ENERG, V86, P681, DOI 10.1016/j.apenergy.2008.06.002; Lopez-Urionabarrenechea A, 2012, APPL ENERG, V98, P524, DOI 10.1016/j.apenergy.2012.04.021; Maguyon MCC, 2013, ENERG CONVERS MANAGE, V76, P764, DOI 10.1016/j.enconman.2013.08.033; Manara P, 2012, RENEW SUST ENERG REV, V16, P2566, DOI 10.1016/j.rser.2012.01.074; Montoya JI, 2015, J ANAL APPL PYROL, V112, P379, DOI 10.1016/j.jaap.2014.11.007; Park HJ, 2010, BIORESOURCE TECHNOL, V101, pS83, DOI 10.1016/j.biortech.2009.06.103; Placido J, 2013, BIORESOURCE TECHNOL, V139, P203, DOI 10.1016/j.biortech.2013.04.012; Sinha S, 2008, ENERG CONVERS MANAGE, V49, P1248, DOI 10.1016/j.enconman.2007.08.010; Ward J, 2014, PROCEDIA ENGINEER, V90, P669, DOI 10.1016/j.proeng.2014.11.791; Yoder J, 2011, BIOMASS BIOENERG, V35, P1851, DOI 10.1016/j.biombioe.2011.01.026; Yuan XZ, 2011, BIORESOURCE TECHNOL, V102, P4104, DOI 10.1016/j.biortech.2010.12.055; Zabaniotou AA, 2000, J ANAL APPL PYROL, V56, P47, DOI 10.1016/S0165-2370(00)00088-7	28	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152230	10.1371/journal.pone.0152230	http://dx.doi.org/10.1371/journal.pone.0152230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043929	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100010
J	Payette, MC; Belanger, C; Leveille, V; Grenier, S				Payette, Marie-Christine; Belanger, Claude; Leveille, Vanessa; Grenier, Sebastien			Fall-Related Psychological Concerns and Anxiety among Community-Dwelling Older Adults: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							QUALITY-OF-LIFE; BALANCE CONFIDENCE; ELDERLY-PEOPLE; ACTIVITY RESTRICTION; DETECTING ANXIETY; DEPRESSION SCALE; FEAR; EFFICACY; VALIDATION; RISK	Fear of falling and other fall-related psychological concerns (FRPCs), such as falls-efficacy and balance confidence, are highly prevalent among community-dwelling older adults. Anxiety and FRPCs have frequently, but inconsistently, been found to be associated in the literature. The purpose of this study is to clarify those inconsistencies with a systematic review and meta-analysis and to evaluate if the strength of this relationship varies based on the different FRPC constructs used (e.g., fear of falling, falls-efficacy or balance confidence). A systematic review was conducted through multiple databases (e.g., MEDLINE, PsycINFO) to include all articles published before June 10th 2015 that measured anxiety and FRPCs in community-dwelling older adults. Active researchers in the field were also contacted in an effort to include unpublished studies. The systematic review led to the inclusion of twenty relevant articles (n = 4738). A random-effect meta-analysis revealed that the mean effect size for fear of falling and anxiety is r = 0.32 (95% CI: 0.22-0.40), Z = 6.49, p < 0.001 and the mean effect size for falls-efficacy or balance confidence and anxiety is r = 0.31 (95% CI: 0.23-0.40), Z = 6.72, p < 0.001. A Q-test for heterogeneity revealed that the two effect sizes are not significantly different (Q(19) = 0.13, p = n.s.). This study is the first meta-analysis on the relationship between anxiety and FRPCs among community-dwelling older adults. It demonstrates the importance of considering anxiety when treating older adults with FRPCs.	[Payette, Marie-Christine; Belanger, Claude] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Payette, Marie-Christine; Leveille, Vanessa; Grenier, Sebastien] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada; [Payette, Marie-Christine; Leveille, Vanessa; Grenier, Sebastien] Lab Etud Anxi & Depress gERiatr LEADER, Montreal, PQ, Canada; [Belanger, Claude] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Leveille, Vanessa; Grenier, Sebastien] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; McGill University; Universite de Montreal	Grenier, S (corresponding author), Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada.; Grenier, S (corresponding author), Lab Etud Anxi & Depress gERiatr LEADER, Montreal, PQ, Canada.; Grenier, S (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	sebastien.grenier@umontreal.ca	Grenier, Sébastien/AAA-4573-2021		Fonds de recherche societe et culture Quebec; Fonds de recherche sante Quebec (FRQS)	Fonds de recherche societe et culture Quebec; Fonds de recherche sante Quebec (FRQS)	This work was supported by Fonds de recherche societe et culture	American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Beck J. G., 1999, J CLIN GEROPSYCHOLOG, V5, P281, DOI [10.1023/A:1022962907930, DOI 10.1023/A:1022962907930]; Bloch F, 2010, CLINICS, V65, P895, DOI 10.1590/S1807-59322010000900013; Borenstein M., 2009, INTRO METAANALYSIS; BURKER EJ, 1995, PSYCHOL AGING, V10, P104, DOI 10.1037/0882-7974.10.1.104; Carpino E, 2014, J PAIN, V15, P527, DOI 10.1016/j.jpain.2014.01.493; Cassidy K.-L., 2008, GERIATRICS AGING, V11, P150; Cohen J.E., 1988, STAT POWER ANAL BEHA; Delbaere Kim, 2010, BMJ, V341, pc4165, DOI 10.1136/bmj.; Delbaere K, 2010, AGE AGEING, V39, P210, DOI 10.1093/ageing/afp225; Denkinger MD, 2015, AM J GERIAT PSYCHIAT, V23, P72, DOI 10.1016/j.jagp.2014.03.002; Dennis RE, 2007, AGING MENT HEALTH, V11, P668, DOI 10.1080/13607860701529916; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DOWNTON JH, 1990, INT J GERIATR PSYCH, V5, P93, DOI 10.1002/gps.930050206; Drozdick L., 2001, J CLIN GEROPSYCHOLOG, V7, P1; Fortinsky RH, 2009, HEALTH RISK SOC, V11, P341, DOI 10.1080/13698570903015735; Fragkos KC, 2014, INT SCHOLARLY RES NO; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gagnon N, 2005, AM J GERIAT PSYCHIAT, V13, P7, DOI 10.1176/appi.ajgp.13.1.7; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Greenberg S. A., 2015, THESIS; Hadjistavropoulos T, 2011, J AGING HEALTH, V23, P3, DOI 10.1177/0898264310378039; Hamilton A, 1969, BRIT J PSYCHIAT, P76; He XY., 2010, SHANGHAI ARCH PSYCHI, V22, P200, DOI DOI 10.3969/J.ISSN.1002-0829.2010.04.002; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Hotchkiss A, 2004, AM J OCCUP THER, V58, P100, DOI 10.5014/ajot.58.1.100; Howland J, 1993, J Aging Health, V5, P229, DOI 10.1177/089826439300500205; Hughes CC, 2015, INT PSYCHOGERIATR, V27, P1071, DOI 10.1017/S1041610214002701; Jorstad EC, 2005, J AM GERIATR SOC, V53, P501; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kempen GIJM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-170; Kendrick D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009848.pub2; Kepes S, 2013, J BUS PSYCHOL, V28, P123, DOI 10.1007/s10869-013-9300-2; Koloski NA, 2008, AGE AGEING, V37, P464, DOI 10.1093/ageing/afn091; Kvaal K, 2005, INT J GERIATR PSYCH, V20, P629, DOI 10.1002/gps.1330; Lackman ME, 1998, J GERONTOL B-PSYCHOL, V3B, P43, DOI DOI 10.1093/GER0NB/53B.1.P43; Lawrence RH, 1998, J AGING HEALTH, V10, P267, DOI 10.1177/089826439801000301; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Liu JYW, 2015, J CLIN NURS, V24, P393, DOI 10.1111/jocn.12613; Loney P L, 1998, Chronic Dis Can, V19, P170; Lusardi M M, 1997, J Outcome Meas, V1, P34; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P1265, DOI 10.1017/S1041610211002110; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Moher D, 2009, PLOS MED, V6, P1; Moore DS, 2008, AGING MENT HEALTH, V12, P684, DOI 10.1080/13607860802148855; Murphy SL, 2002, J AM GERIATR SOC, V50, P516, DOI 10.1046/j.1532-5415.2002.50119.x; Naqvi A, 2012, J AM GERIATR SOC, V60, P2373, DOI 10.1111/jgs.12014; Oh-Park M, 2011, J AM GERIATR SOC, V59, P1225, DOI 10.1111/j.1532-5415.2011.03475.x; Pachana NA, 2007, INT PSYCHOGERIATR, V19, P103, DOI 10.1017/S1041610206003504; Painter JA, 2012, AM J OCCUP THER, V66, P169, DOI 10.5014/ajot.2012.002535; Parry SW, 2001, POSTGRAD MED J, V77, P103, DOI 10.1136/pmj.77.904.103; Perez-Jara J, 2010, REV CLIN GERONTOL, V20, P277, DOI 10.1017/S0959259810000237; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Ribeiro O, 2015, EDUC GERONTOL, V41, P69, DOI 10.1080/03601277.2014.924272; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Schmidt F, 2010, PERSPECT PSYCHOL SCI, V5, P233, DOI 10.1177/1745691610369339; Sharpe D, 1997, CLIN PSYCHOL REV, V17, P881, DOI 10.1016/S0272-7358(97)00056-1; Simpson JM, 1998, AGE AGEING S2, V27, P57, DOI DOI 10.1093/AGEING/27.SUPPL_2.57-B; Sinoff G, 1999, INT J GERIATR PSYCH, V14, P1062, DOI 10.1002/(SICI)1099-1166(199912)14:12<1062::AID-GPS67>3.0.CO;2-Q; Smith JC, 2010, AGEING RES, V1, P6; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stanley MA, 1996, BEHAV RES THER, V34, P827, DOI 10.1016/0005-7967(96)00064-2; Therrien Z, 2013, CLIN GERONTOLOGIST, V36, P171, DOI 10.1080/07317115.2013.767871; Therrien Z, 2012, AGING MENT HEALTH, V16, P1, DOI 10.1080/13607863.2011.602960; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Valentine JD, 2011, DISABIL REHABIL, V33, P352, DOI 10.3109/09638288.2010.491575; Velozo CA, 2001, AM J PHYS MED REHAB, V80, P662, DOI 10.1097/00002060-200109000-00006; Williams J, 2005, ANXIETY STRESS COPIN, V18, P53, DOI 10.1080/10615800420004184; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Yiu J, 2012, NEUROREHAB NEURAL RE, V26, P999, DOI 10.1177/1545968312437941; Zijlstra GAR, 2007, J AM GERIATR SOC, V55, P603, DOI 10.1111/j.1532-5415.2007.01148.x; Zijlstra GAR, 2013, GERONTOLOGIST, V53, P839, DOI 10.1093/geront/gns142; Zur O, 2015, DISABIL REHABIL, V37, P2197, DOI 10.3109/09638288.2014.1002577	81	58	62	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152848	10.1371/journal.pone.0152848	http://dx.doi.org/10.1371/journal.pone.0152848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043139	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100037
J	Moreno-Marin, F; Vergara, JJ; Perez-Llorens, JL; Pedersen, MF; Brun, FG				Moreno-Marin, Francisco; Vergara, Juan J.; Lucas Perez-Llorens, J.; Pedersen, Morten F.; Brun, Fernando G.			Interaction between Ammonium Toxicity and Green Tide Development Over Seagrass Meadows: A Laboratory Study	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; NITROGEN UPTAKE; MACROALGAL BLOOMS; NUTRIENT CONTROL; COASTAL WATERS; ULVA-RIGIDA; GROWTH; NOLTII; CANOPIES; ECOSYSTEM	Eutrophication affects seagrasses negatively by increasing light attenuation through stimulation of biomass of fast-growing, bloom-forming algae and because high concentrations of ammonium in the water can be toxic to higher plants. We hypothesized nevertheless, that moderate amounts of nitrophilic macroalgae that coexists with seagrasses under eutrophic conditions, can alleviate the harmful effects of eutrophication on seagrasses by reducing ammonium concentrations in the seawater to non-toxic levels because such algae have a very large capacity to take up inorganic nutrients. We studied therefore how combinations of different ammonium concentrations (0, 25 and 50 mu M) and different standing stocks of macroalgae (i.e. 0, 1 and 6 layers of Ulva sp.) affected survival, growth and net production of the seagrass Zostera noltei. In the absence of Ulva sp., increasing ammonium concentrations had a negative influence on the performance of Z. noltei. The presence of Ulva sp. without ammonium supply had a similar, but slightly smaller, negative effect on seagrass fitness due to light attenuation. When ammonium enrichment was combined with presence of Ulva sp., Ulva sp. ameliorated some of negative effects caused by high ammonium availability although Ulva sp. lowered the availability of light. Benthic microalgae, which increased in biomass during the experiment, seemed to play a similar role as Ulva sp.-they contributed to remove ammonium from the water, and thus, aided to keep the ammonium concentrations experienced by Z. noltei at relatively non-toxic levels. Our findings show that moderate amounts of drift macroalgae, eventually combined with increasing stocks of benthic microalgae, may aid seagrasses to alleviate toxic effects of ammonium under eutrophic conditions, which highlights the importance of high functional diversity for ecosystem resistance to anthropogenic disturbance.	[Moreno-Marin, Francisco; Vergara, Juan J.; Lucas Perez-Llorens, J.; Brun, Fernando G.] Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEIMAR, Puerto Real 11510, Cadiz, Spain; [Moreno-Marin, Francisco; Pedersen, Morten F.] Roskilde Univ, Dept Nat Sci & Environm, POB 2660, DK-4000 Roskilde, Denmark	Universidad de Cadiz; Roskilde University	Moreno-Marin, F (corresponding author), Univ Cadiz, Fac Marine & Environm Sci, Dept Biol, Campus Excelencia Int Mar CEIMAR, Puerto Real 11510, Cadiz, Spain.; Moreno-Marin, F (corresponding author), Roskilde Univ, Dept Nat Sci & Environm, POB 2660, DK-4000 Roskilde, Denmark.	francisco.moreno@uca.es	Perez-Llorens, Jose Lucas/B-9361-2009; Perez-Llorens, Jose Lucas/GQR-0711-2022; Brun, Fernando G. G/L-1346-2014; Vergara, Juan J/H-9808-2012; Perez-Llorens, Jose Lucas/AAD-7078-2020	Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Perez-Llorens, Jose Lucas/0000-0003-2813-1443; Brun, Fernando G. G/0000-0002-6313-9531; Vergara, Juan J/0000-0003-4479-4693; Perez-Llorens, Jose Lucas/0000-0003-2813-1443	Spanish Ministry of Science and Innovation [CTM2011-24482]; Junta de Andalucia Excellence Project PRODESCA [P12-RNM-03020]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Excellence Project PRODESCA(Junta de Andalucia)	This work was supported by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation and by the Junta de Andalucia Excellence Project PRODESCA (P12-RNM-03020). Francisco Moreno holds a contract financed by the Spanish Project Sea-Live (CTM2011-24482) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borum J, 2005, J ECOL, V93, P148, DOI 10.1111/j.1365-2745.2004.00943.x; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; BOWER CE, 1980, CAN J FISH AQUAT SCI, V37, P794, DOI 10.1139/f80-106; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2003, MAR ECOL PROG SER, V265, P85, DOI 10.3354/meps265085; Brun FG, 2003, FUNCT PLANT BIOL, V30, P551, DOI 10.1071/FP03010; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Costanza R, 1997, FRONTIERS ECOLOGICAL; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; DEBUSK TA, 1986, BOT MAR, V29, P381, DOI 10.1515/botm.1986.29.5.381; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; Gerendas J, 1997, Z PFLANZ BODENKUNDE, V160, P239, DOI 10.1002/jpln.19971600218; GOYAL SS, 1982, J AM SOC HORTIC SCI, V107, P125; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Hauxwell J, 2001, ECOLOGY, V82, P1007, DOI 10.2307/2679899; Holmer M, 2001, AQUAT BOT, V70, P29, DOI 10.1016/S0304-3770(00)00142-X; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; IIZUMI H, 1982, AQUAT BOT, V12, P245, DOI 10.1016/0304-3770(82)90020-1; Marschener H, 1995, MINERAL NUTR HIGHER; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; McGlathery KJ, 2001, J PHYCOL, V37, P453, DOI 10.1046/j.1529-8817.2001.037004453.x; McGlathery KJ, 1996, J PHYCOL, V32, P393, DOI 10.1111/j.0022-3646.1996.00393.x; Meyers L. S., 2006, APPL MULTIVARIATE RE; Pedersen MF, 1996, MAR ECOL PROG SER, V142, P261, DOI 10.3354/meps142261; Pedersen MF, 1997, AQUAT BOT, V56, P105, DOI 10.1016/S0304-3770(96)01100-X; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; Rasmussen JR, 2013, ESTUAR COAST SHELF S, V119, P167, DOI 10.1016/j.ecss.2013.01.006; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Santandreu M, 2012, THESIS U CADIZ; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; SHORT FT, 1984, BOT MAR, V27, P547, DOI 10.1515/botm.1984.27.12.547; Small C, 2003, J COASTAL RES, V19, P584; Stapel J, 1996, MAR ECOL PROG SER, V134, P195, DOI 10.3354/meps134195; THURSBY GB, 1982, MAR BIOL, V72, P109, DOI 10.1007/BF00396910; Touchette BW, 2000, J EXP MAR BIOL ECOL, V250, P133, DOI 10.1016/S0022-0981(00)00195-7; ULLRICH WR, 1984, PHYSIOL PLANTARUM, V61, P369, DOI 10.1111/j.1399-3054.1984.tb06342.x; Underwood AJ, 1997, THEIR LOGICAL DESIGN; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; Van Engeland T, 2013, MAR ECOL PROG SER, V478, P87, DOI 10.3354/meps10183; Van Engeland T, 2011, MAR ECOL PROG SER, V427, P71, DOI 10.3354/meps09054; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; Vergara JJ, 1998, MAR ECOL PROG SER, V165, P283, DOI 10.3354/meps165283; Vergara JJ, 2012, ESTUAR COAST SHELF S, V112, P255, DOI 10.1016/j.ecss.2012.07.031; Villazan B, 2016, MAR ECOL PROG SER, V545, P109, DOI 10.3354/meps11631; Villazan B, 2013, MAR ECOL PROG SER, V493, P141, DOI 10.3354/meps10517; Villazan B, 2013, MAR ECOL PROG SER, V488, P133, DOI 10.3354/meps10395; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zhang M, 2011, CHEMOSPHERE, V82, P329, DOI 10.1016/j.chemosphere.2010.10.038	57	24	25	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152971	10.1371/journal.pone.0152971	http://dx.doi.org/10.1371/journal.pone.0152971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035662	Green Published, gold			2022-12-27	WOS:000373201200051
J	Fu, XY; Yu, SF; Yang, BY; Lao, SH; Li, BQ; Wu, CY				Fu, Xiaoying; Yu, Sifei; Yang, Binyan; Lao, Suihua; Li, Baiqing; Wu, Changyou			Memory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis Antigens	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BACILLE CALMETTE-GUERIN; INNATE LYMPHOID-CELLS; ADAPTIVE IMMUNITY; EFFECTOR FUNCTION; TRAINED IMMUNITY; IFN-GAMMA; CD4(+); INFLAMMATION; INFECTION	Our previous result indicated that memory-like human natural killer (NK) cells from TB pleural fluid cells (PFCs) produced large amounts of IFN-gamma in response to Bacille Calmette Guerin (BCG). Furthermore, recent studies have shown that human lymphoid tissues harbored a unique NK cell subset that specialized in production of interleukin (IL)-22, a proinflammatory cytokine that mediates host defense against pathogens. Yet little information was available with regard to the properties of IL-22 production by memory-like human NK cells. In the present study, we found that cytokines IL-15 induced and IL-12 enhanced the levels of IL-22 by NK cells from TB PFCs. In addition, IL-22 but not IL-17 was produced by NK cells from PFCs in response to BCG and M. tb-related Ags. More importantly, the subset of specific IL-22-producing NK cells were distinct from IFN-gamma-producing NK cells in PFCs. CD45RO(+) or CD45RO(-) NK cells were sorted, co-cultured with autologous monocytes and stimulated with BCG for the production of IL-22. The result demonstrated that CD45RO(+) but not CD45RO(-) NK cells produced significantly higher level of IL-22. Anti-IL-12R beta 1 mAbs (2B10) partially inhibit the expression of IL-22 by NK cells under the culture with BCG. Consistently, BCG specific IL-22-producing NK cells from PFCs expressed CD45RO(high)NKG2D(high)granzyme B-high. In conclusion, our data demonstrated that memory-like antigen-specific CD45RO(+) NK cells might participate in the recall immune response for M. tb infection via producing IL-22, which display a critical role to fight against M. tb.	[Fu, Xiaoying; Yu, Sifei; Yang, Binyan; Wu, Changyou] Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China; [Li, Baiqing] Bengbu Med Coll, Dept Immunol, Immunol Res Ctr, Bengbu, Peoples R China	Sun Yat Sen University; Bengbu Medical College	Wu, CY (corresponding author), Sun Yat Sen Univ, Key Lab Trop Dis Control Res, Zhongshan Sch Med, Inst Immunol,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			National Basic Research Program of China [2013CB531500]; Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]	National Basic Research Program of China(National Basic Research Program of China); Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology	This study was funded by grants from the National Basic Research Program of China (no. 2013CB531500) and Guangdong Provinicial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (no. 2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2005, J INFECT DIS, V192, P399, DOI 10.1086/431680; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Cummings KJ, 2007, TUBERCULOSIS CONTROL, P683; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Esin S, 2004, IMMUNOLOGY, V112, P143, DOI 10.1111/j.1365-2567.2004.01858.x; Feng L, 2011, EUR J IMMUNOL, V41, P3261, DOI 10.1002/eji.201141625; Fu XY, 2013, CLIN IMMUNOL, V148, P113, DOI 10.1016/j.clim.2013.04.003; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Le Bert N, 2014, IMMUNOL CELL BIOL, V92, P230, DOI 10.1038/icb.2013.111; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082196; Li L, 2012, TUBERCULOSIS, V92, P63, DOI 10.1016/j.tube.2011.11.004; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023700; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Liu Y, 2011, IMMUNOLOGY, V132, P540, DOI 10.1111/j.1365-2567.2010.03399.x; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Mackay CR, 2001, SCIENCE, V291, P2323, DOI 10.1126/science.1059984; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Qiao D, 2011, INFECT IMMUN, V79, P3358, DOI 10.1128/IAI.00014-11; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schierloh P, 2007, INFECT IMMUN, V75, P5325, DOI 10.1128/IAI.00381-07; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smith-Garvin JE, 2013, NATURE, V497, P194, DOI 10.1038/497194b; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yonkers NL, 2009, CLIN IMMUNOL, V131, P288, DOI 10.1016/j.clim.2008.12.012; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151721	10.1371/journal.pone.0151721	http://dx.doi.org/10.1371/journal.pone.0151721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031950	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800020
J	Rolle, K; Piwecka, M; Belter, A; Wawrzyniak, D; Jeleniewicz, J; Barciszewska, MZ; Barciszewski, J				Rolle, Katarzyna; Piwecka, Monika; Belter, Agnieszka; Wawrzyniak, Dariusz; Jeleniewicz, Jaroslaw; Barciszewska, Miroslawa Z.; Barciszewski, Jan			The Sequence and Structure Determine the Function of Mature Human miRNAs	PLOS ONE			English	Article							MESSENGER-RNA DECAY; BINDING PROTEIN; MICRORNA; TRANSLATION; SPECIFICITY; BIOGENESIS; MECHANISMS; REPEATS; PATHWAY; GENOME	Micro RNAs (miRNAs) (19-25 nucleotides in length) belong to the group of non-coding RNAs are the most abundant group of posttranscriptional regulators in multicellular organisms. They affect a gene expression by binding of fully or partially complementary sequences to the 3'-UTR of target mRNA. Furthermore, miRNAs present a mechanism by which genes with diverse functions on multiple pathways can be simultaneously regulated at the post-transcriptional level. However, little is known about the specific pathways through which miRNAs with specific sequence or structural motifs regulate the cellular processes. In this paper we showed the broad and deep characteristics of mature miRNAs according to their sequence and structural motifs. We investigated a distinct group of miRNAs characterized by the presence of specific sequence motifs, such as UGUGU, GUrepeats and purine/pyrimidine contents. Using computational function and pathway analysis of their targeted genes, we were able to observe the relevance of sequence and the type of targeted mRNAs. As the consequence of the sequence analysis we finally provide the comprehensive description of pathways, biological processes and proteins associated with the distinct group of characterized miRNAs. Here, we found that the specific group of miRNAs with UGUGU can activate the targets associated to the interferon induction pathway or pathways prominently observed during carcinogenesis. GU-rich miRNAs are prone to regulate mostly processes in neurogenesis, whereas purine/pyrimidine rich miRNAs could be involved rather in transport and/or degradation of RNAs. Additionally, we have also analyzed the simple sequence repeats (SSRs). Their variation within mature miRNAs might be critical for normal miRNA regular activity. Expansion or contraction of SSRs in mature miRNA might directly affect its mRNA interaction or even change the function of that distinct miRNA. Our results prove that due to the specific sequence features, these molecules can also be involved in well-defined cellular processes depending on their sequence contents. The pathway mapping and theoretical gene target identification allowed us to create a biological framework to show the relevance of the specific miRNAs in regulation the distinct type of targets.	[Rolle, Katarzyna; Piwecka, Monika; Belter, Agnieszka; Wawrzyniak, Dariusz; Jeleniewicz, Jaroslaw; Barciszewska, Miroslawa Z.; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Rolle, K; Barciszewski, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	Katarzyna.Rolle@ibch.poznan.pl; Jan.Barciszewski@ibch.poznan.pl	Belter, Agnieszka/W-6074-2018; Barciszewski, Jan/N-9283-2019	Belter, Agnieszka/0000-0001-7082-4986; Barciszewski, Jan/0000-0001-7766-5594; Piwecka, Monika/0000-0003-4104-6577; Wawrzyniak, Dariusz/0000-0002-6128-5383; Rolle, Katarzyna/0000-0002-4175-2490	European Regional Development Fund within the Innovative Economy Programme [POIG.01.03.01-30-050/09]; National Science Centre [5955/B/P01/2010/38]; Ministry of Science and Higher Education of the Republic of Poland by KNOW program	European Regional Development Fund within the Innovative Economy Programme; National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education of the Republic of Poland by KNOW program	This work was supported by the European Regional Development Fund within the Innovative Economy Programme, action 1.3.1. (POIG.01.03.01-30-050/09), http://www.poig.2007-2013.gov.pl/Strony/default.aspx, the National Science Centre, grant 5955/B/P01/2010/38, https://www.ncn.gov.pl/?language=en, and the Ministry of Science and Higher Education of the Republic of Poland by KNOW program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2005, J HERED, V96, P644, DOI 10.1093/jhered/esi097; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belter A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113848; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Das A.K., 2011, INT J AGR SCI, V3, P62; Dereeper A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-465; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fang ZD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054215; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Fu Y, 2012, CHEMBIOCHEM, V13, P112, DOI 10.1002/cbic.201100487; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Halees AS, 2011, RNA BIOL, V8, P681, DOI 10.4161/rna.8.4.16283; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ito K, 2011, J AM CHEM SOC, V133, P19153, DOI 10.1021/ja206353c; Janas MM, 2012, EMBO J, V31, P2446, DOI 10.1038/emboj.2012.119; JUCKER FM, 1995, RNA, V1, P219; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kiliszek A, 2012, NUCLEIC ACIDS RES, V40, P8155, DOI 10.1093/nar/gks557; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maiti M, 2010, BIOCHEM BIOPH RES CO, V392, P572, DOI 10.1016/j.bbrc.2010.01.072; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Mishra AK, 2009, BIOINFORMATION, V4, P151, DOI 10.6026/97320630004151; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Stewart CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021552; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Taulli R, 2013, NAT STRUCT MOL BIOL, V20, P541, DOI 10.1038/nsmb.2580; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang B, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/951570; Yang H, 2012, INT J ONCOL, V41, P2213, DOI 10.3892/ijo.2012.1658; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024	70	32	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151246	10.1371/journal.pone.0151246	http://dx.doi.org/10.1371/journal.pone.0151246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031951	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800010
J	Romeiras, MM; Vieira, A; Silva, DN; Moura, M; Santos-Guerra, A; Batista, D; Duarte, MC; Paulo, OS				Romeiras, Maria M.; Vieira, Ana; Silva, Diogo N.; Moura, Monica; Santos-Guerra, Arnoldo; Batista, Dora; Duarte, Maria Cristina; Paulo, Octavio S.			Evolutionary and Biogeographic Insights on the Macaronesian Beta-Patellifolia Species (Amaranthaceae) from a Time-Scaled Molecular Phylogeny	PLOS ONE			English	Article							CERCOSPORA-BETICOLA; GENETIC-STRUCTURE; WILD RELATIVES; POLYMYXA-BETAE; VULGARIS; HYBRIDIZATION; RESISTANCE; PROCUMBENS; ADDITIONS; NETWORKS	The Western Mediterranean Region and Macaronesian Islands are one of the top biodiversity hotspots of Europe, containing a significant native genetic diversity of global value among the Crop Wild Relatives (CWR). Sugar beet is the primary crop of the genus Beta (subfamily Betoideae, Amaranthaceae) and despite the great economic importance of this genus, and of the close relative Patellifolia species, a reconstruction of their evolutionary history is still lacking. We analyzed nrDNA (ITS) and cpDNA gene (matK, trnH-psbA, trnL intron, rbcL) sequences to: (i) investigate the phylogenetic relationships within the Betoideae subfamily, and (ii) elucidate the historical biogeography of wild beet species in the Western Mediterranean Region, including the Macaronesian Islands. The results support the Betoideae as a monophyletic group (excluding the Acroglochin genus) and provide a detailed inference of relationships within this subfamily, revealing: (i) a deep genetic differentiation between Beta and Patellifolia species, which may have occurred in Late Oligocene; and (ii) the occurrence of a West-East genetic divergence within Beta, indicating that the Mediterranean species probably differentiated by the end of the Miocene. This was interpreted as a signature of species radiation induced by dramatic habitat changes during the Messinian Salinity Crisis (MSC, 5.96-5.33 Mya). Moreover, colonization events during the Pleistocene also played a role in shaping the current diversity patterns among and within the Macaronesian Islands. The origin and number of these events could not be revealed due to insufficient phylogenetic resolution, suggesting that the diversification was quite recent in these archipelagos, and unravelling potential complex biogeographic patterns with hybridization and gene flow playing an important role. Finally, three evolutionary lineages were identified corresponding to major gene pools of sugar beet wild relatives, which provide useful information for establishing in situ and ex situ conservation priorities in the hotspot area of the Macaronesian Islands.	[Romeiras, Maria M.] Univ Lisbon, Fac Ciencias, Biosyst & Integrat Sci Inst BioISI, Lisbon, Portugal; [Romeiras, Maria M.; Vieira, Ana; Silva, Diogo N.; Batista, Dora; Duarte, Maria Cristina; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, CE3C, Lisbon, Portugal; [Vieira, Ana; Silva, Diogo N.; Batista, Dora] Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal; [Moura, Monica] Univ Porto, Associate Lab CIBIO InBIO, Res Network Biodivers & Evolutionary Biol, Vairao, Portugal; [Moura, Monica] Univ Acores, Dept Biol, Ponta Delgada, Portugal; [Santos-Guerra, Arnoldo] Jardin Aclimatac La Orotava ICIA, Unidad Bot, Tenerife, Spain	BIOISI; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade do Porto; Universidade dos Acores	Romeiras, MM (corresponding author), Univ Lisbon, Fac Ciencias, Biosyst & Integrat Sci Inst BioISI, Lisbon, Portugal.; Romeiras, MM (corresponding author), Univ Lisbon, Fac Ciencias, CE3C, Lisbon, Portugal.	mromeiras@yahoo.co.uk	Duarte, Maria Cristina/L-7571-2013; Paulo, Octávio/D-9921-2011; Duarte, Maria Cristina/AAA-9211-2021; Romeiras, Maria M./J-4552-2013; Batista, Dora/N-7385-2013	Duarte, Maria Cristina/0000-0002-3823-4369; Paulo, Octávio/0000-0001-5408-5212; Duarte, Maria Cristina/0000-0002-3823-4369; Romeiras, Maria M./0000-0002-9373-6302; Batista, Dora/0000-0003-4031-8999; Vieira, Ana/0000-0003-4384-6746; Moura, Monica/0000-0001-5555-2388; Silva, Diogo/0000-0002-6827-2673	Portuguese Foundation for Science and Technology (FCT); European Social Fund through project [PTDC/BIA-BIC/4113/2012]; FCT [SFRH/BGCT/113708/2015, SFRH/BD/89397/2012, SFRH/BD/86736/2012, SFRH/BPD/104629/2014]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund through project; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Some of the authors were supported by FCT grants: MMR: SFRH/BGCT/113708/2015: AV: SFRH/BD/89397/2012; DS: SFRH/BD/86736/2012; DB: SFRH/BPD/104629/2014. This research was supported by the Portuguese Foundation for Science and Technology (FCT) and the European Social Fund through project PTDC/BIA-BIC/4113/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksidze G, 2009, REPORT WORKING GROUP, P38; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; Bateman RM, 2013, PEERJ, V1, DOI 10.7717/peerj.218; Bilz M., 2011, EUROPEAN RED LIST VA, DOI DOI 10.1007/s11258-005-2182-2; Boratynski A, 2014, BOT J LINN SOC, V174, P637, DOI 10.1111/boj.12147; Bramwell D., 2011, BIOL ISLAND FLORAS; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Casimiro-Soriguer R, 2010, MOL PHYLOGENET EVOL, V56, P441, DOI 10.1016/j.ympev.2010.02.025; Castro S, 2013, PLANT SCI, V207, P72, DOI 10.1016/j.plantsci.2013.02.012; Castroviejo S., 1990, FLORA IBERICA, VII, P476; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Davis PH, 1988, FLORA OF TURKEY AND, V10; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Food and Agriculture Organization of the United Nations, 2010, 2 REP STAT WORLDS PL; Ford-Lloyd BV, 2011, BIOSCIENCE, V61, P559, DOI 10.1525/bio.2011.61.7.10; Ford-Lloyd BV, 2005, GENETICS BREEDING SU, P25; Frese L., 2003, Schriften zu Genetischen Ressourcen, P170; Frese L, 2009, REPORT WORKING GROUP, P45; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Hohmann S, 2006, TAXON, V55, P67, DOI 10.2307/25065529; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jung B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.1, 10.1038/NPLANTS.2014.1]; Kadereit Gudrun, 2006, Willdenowia, V36, P9, DOI 10.3372/wi.36.36101; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kell S., 2007, BOCCONEA, V21, P413; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kuhn U, 1993, FAMILIES GENERA VASC, P253, DOI DOI 10.1007/978-3-662-02899-5_26; Leys M, 2014, ECOL EVOL, V4, P1828, DOI 10.1002/ece3.1061; Maxted N., 2008, P3, DOI 10.1079/9781845930998.0003; Maxted N., 2009, FAO COMM GENET RESOU, P1; McGrath JM, 2011, WILD CROP RELATIVES, P1, DOI 10.1007/978-3-642-21102-7_1; Mesbah M, 1997, EUPHYTICA, V97, P117, DOI 10.1023/A:1003088922086; Miller MA, 2014, CIPRES PORTALS; Monteiro F., 2013, American Journal of Plant Sciences, V4, P21; Muller K, 2005, ANN MO BOT GARD, V92, P66; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; PAUL H, 1992, PLANT BREEDING, V109, P265, DOI 10.1111/j.1439-0523.1992.tb00184.x; Pinheiro-de-Carvalho M, 2013, IUCN RED LIST THREAT; REAMONRAMOS SM, 1992, THEOR APPL GENET, V84, P411, DOI 10.1007/BF00229501; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Romeiras MM, 2016, BOT J LINN SOC, V180, P413, DOI 10.1111/boj.12370; Romeiras MM, 2011, TAXON, V60, P1375, DOI 10.1002/tax.605013; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos-Guerra A, 2013, IUCN RED LIST THREAT; SCOTT AJ, 1977, TAXON, V26, P284, DOI 10.2307/1220567; Silva DN, 2014, ELCONCATENERO, DOI [10.5281/zenodo.10588, DOI 10.5281/ZENODO.10588]; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Villain S, 2007, THESIS; Villain S, 2009, REPORT WORKING GROUP, P31; Vincent H, 2013, BIOL CONSERV, V167, P265, DOI 10.1016/j.biocon.2013.08.011; Volkens G., 1892, NATURL PFLANZ, V1a, P36; Weiland J, 2004, MOL PLANT PATHOL, V5, P157, DOI 10.1111/J.1364-3703.2004.00218.X; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152456	10.1371/journal.pone.0152456	http://dx.doi.org/10.1371/journal.pone.0152456			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031338	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800075
J	Thomas, S; Straathof, K; Himoudi, N; Anderson, J; Pule, M				Thomas, Simon; Straathof, Karin; Himoudi, Nourredine; Anderson, John; Pule, Martin			An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTORS; MODIFIED T-CELLS; ANTITUMOR-ACTIVITY; SPACER DOMAIN; DESIGN; PERSISTENCE; EXPRESSION; TARGET; IMMUNOTHERAPY; EXPANSION	Neuroblastoma is the commonest extra cranial solid cancer of childhood. Despite escalation of treatment regimens, a significant minority of patients die of their disease. Disialogan-glioside (GD2) is consistently expressed at high-levels in neuroblastoma tumors, which have been targeted with some success using therapeutic monoclonal antibodies. GD2 is also expressed in a range of other cancer but with the exception of some peripheral nerves is largely absent from non-transformed tissues. Chimeric Antigen Receptors (CARs) are artificial type I proteins which graft the specificity of a monoclonal antibody onto a T-cell. Clinical data with early CAR designs directed against GD2 have shown some promise in Neuroblastoma. Here, we describe a GD2-targeting CAR retroviral cassette, which has been optimized for CAR T-cell persistence, efficacy and safety.	[Thomas, Simon; Pule, Martin] UCL, Inst Canc, London, England; [Straathof, Karin; Himoudi, Nourredine; Anderson, John] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University College London	Pule, M (corresponding author), UCL, Inst Canc, London, England.; Anderson, J (corresponding author), UCL, Inst Child Hlth, London, England.	j.anderson@ucl.ac.uk; m.pule@ucl.ac.uk		Anderson, William/0000-0001-7509-3203; Straathof, Karin/0000-0001-9673-8568; Pule, Martin/0000-0002-8347-9867	Neuroblastoma UK; UK NIHR Biomedical Research Centre; Wellcome Trust; Great Ormond Street Hospital, Biomedical Research Centre; Great Ormond Street Hospital Children's Charity; Cancer Research UK [14779] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-011] Funding Source: researchfish; Wellcome Trust [102803/Z/13/Z] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1243, W1006] Funding Source: researchfish	Neuroblastoma UK; UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital, Biomedical Research Centre; Great Ormond Street Hospital Children's Charity; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Childrens Charity	The study was funded by neuroblastoma Society now re-labelled "Neuroblastoma UK". This small charity provided a grant of  pound 133,000 in 2005 for a project entitled "Genetic Engineering of T-cells for Adoptive Immunotherapy of Neuroblastoma". Martin Pule is supported by the UK NIHR Biomedical Research Centre and the Wellcome Trust. John Anderson is supported by the Great Ormond Street Hospital, Biomedical Research Centre and the Great Ormond Street Hospital Children's Charity. Karin Straathof is supported by the Great Ormond Street Hospital, Biomedical Research Centre and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasbak H, 2015, GENE THER, V22, P391, DOI 10.1038/gt.2015.4; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Finney HM, 1998, J IMMUNOL, V161, P2791; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guest RD, 2005, J IMMUNOTHER, V28, P203, DOI 10.1097/01.cji.0000161397.96582.59; Hombach A, 2010, GENE THER, V17, P1206, DOI 10.1038/gt.2010.91; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Jensen MC, 2014, IMMUNOL REV, V257, P127, DOI 10.1111/imr.12139; Jonnalagadda M, 2015, MOL THER, V23, P757, DOI 10.1038/mt.2014.208; Kurre P, 2003, BLOOD, V102, P3117, DOI 10.1182/blood-2003-03-0962; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; London WB, 2011, J CLIN ONCOL, V29, P3286, DOI 10.1200/JCO.2010.34.3392; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Moreno R, 2011, TISSUE ENG PART C-ME, V17, P275, DOI [10.1089/ten.tec.2010.0383, 10.1089/ten.TEC.2010.0383]; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Nakamura K, 2001, CANCER IMMUNOL IMMUN, V50, P275, DOI 10.1007/PL00006689; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Turatti F, 2005, J GENE MED, V7, P158, DOI 10.1002/jgm.647; Westwood JA, 2005, P NATL ACAD SCI USA, V102, P19051, DOI 10.1073/pnas.0504312102; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	38	36	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152196	10.1371/journal.pone.0152196	http://dx.doi.org/10.1371/journal.pone.0152196			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030986	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800042
J	Lewis, C; Hill, M; Chitty, LS				Lewis, Celine; Hill, Melissa; Chitty, Lyn S.			Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study	PLOS ONE			English	Article							CELL-FREE DNA; DOWN-SYNDROME; DIAGNOSIS; ATTITUDES; DECISION; ANXIETY; CHOICE; VIEWS	Non-invasive prenatal testing (NIPT) for aneuploidy is currently only available in the UK through the private sector outside of the research arena. As part of an implementation study in the UK National Health Service we conducted a mixed methods study to assess women's experience of being offered NIPT using validated measures of decisional conflict, decisional regret and anxiety. Clinical service preferences were also explored. Women with a Down syndrome screening risk >1: 1000 were invited to take part in the study and offered NIPT, NIPT and invasive testing (for women with a risk above 1: 150) or no further testing. A cross-sectional survey and semi-structured interviews were conducted at two time points; at the time of testing and one month following receipt of results (or equivalent for NIPT decliners). In total, 845 questionnaires and 81 interviews were analysed. The main motivation to accept NIPT was for reassurance (30.8%). Decisional conflict occurred in a minimal number of cases (3.8%), however, none of the participants experienced decisional regret. Around a third (29.9%) of women had elevated anxiety at the time of testing, including intermediate risk women who traditionally would not be offered further testing (54.4% high risk; 20.1% medium risk), a finding supported through the qualitative interviews where prolonged or additional anxiety was found to occur in some medium risk cases. Women were overwhelmingly positive about the opportunity to have a test that was procedurally safe, accurate, reduced the need for invasive testing and identified cases of Down syndrome that might otherwise have been missed. Reassurance was identified as the main motivator for accepting NIPT, particularly amongst medium risk women, with high risk women inclined to accept NIPT to inform decisions around invasive testing. The current turnaround time for test result was identified as a key limitation. All the women interviewed thought NIPT should be adopted as part of NHS clinical practice, with the majority favouring NIPT offered as a first-line test. Our study highlights the potential that NIPT has to positively impact women's experience of prenatal testing for aneuploidy.	[Lewis, Celine; Hill, Melissa; Chitty, Lyn S.] UCL Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England; [Lewis, Celine; Hill, Melissa; Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 1EH, England; [Hill, Melissa; Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Serv, London WC1N 3BH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Lewis, C (corresponding author), UCL Inst Child Hlth, Genet & Genom Med, London WC1N 1EH, England.; Lewis, C (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 1EH, England.	celine.lewis@ucl.ac.uk	Hill, Melissa/AIC-6192-2022	chitty, lyn/0000-0002-4857-7138	National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme [RP-PG-0707-10107]; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research [NF-SI-0513-10141, RP-PG-0707-10107] Funding Source: researchfish	National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme (RP-PG-0707-10107) (the 'RAPID' project). LSC is partially funded by the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SCREENING TESTS YOU; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Dormandy E, 2005, INT J EPIDEMIOL, V34, P346, DOI 10.1093/ije/dyi021; Fisher J, 2015, J REPROD INFANT PSYC, V33, P69, DOI 10.1080/02646838.2014.970149; Fisher J, 2015, J OBSTET GYNAECOL, V35, P168, DOI 10.3109/01443615.2014.940291; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P67, DOI 10.1002/uog.14683; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Hill M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-229; Hill M, 2012, GENET MED, V14, P905, DOI 10.1038/gim.2012.68; Hurford E, 2013, J GENET COUNS, V22, P587, DOI 10.1007/s10897-013-9590-6; Lewis C, 2014, BJOG-INT J OBSTET GY, V121, P582, DOI 10.1111/1471-0528.12579; Lewis C, 2013, PUBLIC HEALTH GENOM, V16, P223, DOI 10.1159/000353523; Lewis C, 2015, EUR J HUM G IN PRESS; Lewis C, 2016, EUR J HUM GENET, V24, P809, DOI 10.1038/ejhg.2015.207; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; O'Connor AM, 1993, USER MANUAL DECISION; Ohman SG, 2006, BIRTH-ISS PERINAT C, V33, P64; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; RCOG, 2010, TERM PREGN FET ABN E; Royal College Obstetricians and Gynaecologists, 2014, 15 RCOG; Sachs A, 2015, PRENATAL DIAG, V35, P968, DOI 10.1002/pd.4666; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Seror V, 2009, PRENATAL DIAG, V29, P120, DOI 10.1002/pd.2183; Silcock C, 2015, HEALTH EXPECT, V18, P1658, DOI 10.1111/hex.12159; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Taylor JB, 2014, J GENET COUNS, V23, P72, DOI 10.1007/s10897-013-9609-z; Yi HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081794	36	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153147	10.1371/journal.pone.0153147	http://dx.doi.org/10.1371/journal.pone.0153147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045195	Green Submitted, gold, Green Published			2022-12-27	WOS:000373599600072
J	Obsuth, I; Cope, A; Sutherland, A; Pilbeam, L; Murray, AL; Eisner, M				Obsuth, Ingrid; Cope, Aiden; Sutherland, Alex; Pilbeam, Liv; Murray, Aja Louise; Eisner, Manuel			London Education and Inclusion Project (LEIP): Exploring Negative and Null Effects of a Cluster-Randomised School-Intervention to Reduce School Exclusion-Findings from Protocol-Based Subgroup Analyses	PLOS ONE			English	Article							AGGRESSIVE-BEHAVIOR; CRIME-PREVENTION; SOCIAL-SKILLS; CHILD; PROGRAMS; ADOLESCENTS; ENVIRONMENT; FIDELITY; STUDENTS; CRITERIA	This paper presents subgroup analyses from the London Education and Inclusion Project (LEIP). LEIP was a cluster-randomised controlled trial of an intervention called Engage in Education-London (EiE-L) which aimed to reduce school exclusions in those at greatest risk of exclusion. Pupils in the control schools attended an hour-long employability seminar. Minimisation was used to randomly assign schools to treatment and control following baseline data collection. The study involved 36 schools (17 in treatment-373 pupils; 19 in control-369 pupils) with > 28% free school meal eligibility across London and utilised on pupil self-reports, teacher reports as well as official records to assess the effectiveness of EiE-L. Due to multiple data sources, sample sizes varied according to analysis. Analyses of pre-specified subgroups revealed null and negative effects on school exclusion following the intervention. Our findings suggest that the design and implementation of EiE-L may have contributed to the negative outcomes for pupils in the treatment schools when compared to those in the control schools. These findings call into question the effectiveness of bolt-on short-term interventions with pupils, particularly those at the highest risk of school exclusion and when they are faced with multiple problems. This is especially pertinent given the possibility of negative outcomes.	[Obsuth, Ingrid; Cope, Aiden; Sutherland, Alex; Pilbeam, Liv; Murray, Aja Louise; Eisner, Manuel] Univ Cambridge, Inst Criminol, Cambridge CB3 9DT, England	University of Cambridge	Obsuth, I (corresponding author), Univ Cambridge, Inst Criminol, Cambridge CB3 9DT, England.	io229@cam.ac.uk		Sutherland, Alex/0000-0003-0276-9705; Obsuth, Ingrid/0000-0003-1690-1092	European Commission Social Experimentation Grant [VS/2012/0345]; Education Endowment Foundation	European Commission Social Experimentation Grant; Education Endowment Foundation	Support was provided by a European Commission Social Experimentation Grant (VS/2012/0345) awarded to the Greater London Authority for collaboration on this project with Professor Manuel Eisner, Principal Investigator [http://ec.europa.eu/index_en.htm]. The Education Endowment Foundation provided financial support for the implementation of the Catch22 intervention; however, the foundation did not fund the evolution itself. [https://educationendowmentfoundation.org.uk].	Aldridge J, 2013, IMPROV SCH, V16, P47, DOI 10.1177/1365480212473680; Angrist JD, 2014, LABOUR ECON, V30, P98, DOI 10.1016/j.labeco.2014.05.008; [Anonymous], 2006, SOCIAL POLICY REPORT; [Anonymous], 2014, BMC PSYCHOL; Apsler R, 2009, ADOLESCENCE, V44, P1; Beelmann A, 2006, PSICOTHEMA, V18, P603; Bishop DC, 2014, EVAL HEALTH PROF, V37, P231, DOI 10.1177/0163278713476882; Bonell C, 2013, HEALTH PLACE, V21, P180, DOI 10.1016/j.healthplace.2012.12.001; Brookes S T, 2001, Health Technol Assess, V5, P1; Bruhn A, 2015, BEHAV DISORDERS, V40, P102, DOI 10.17988/BD-13-45.1; Chaney B, 2015, AM J EVAL, V36, P1; Chapman RL, 2014, INT J QUAL STUD EDUC, V27, P413, DOI 10.1080/09518398.2013.771225; Clarke A, 2012, PERMANENT FIXED PERI; Clegg J, 2009, CHILD LANG TEACH THE, V25, P123, DOI 10.1177/0265659008098664; Cotzias E, 2014, PERMANENT FIXED PERI; Dishion TJ, 2011, ANNU REV PSYCHOL, V62, P189, DOI 10.1146/annurev.psych.093008.100412; Domitrovich CE, 2015, PREV SCI, V16, P1064, DOI 10.1007/s11121-015-0557-8; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Durlak JA, 2010, AM J COMMUN PSYCHOL, V45, P294, DOI 10.1007/s10464-010-9300-6; Ellis P, 2013, FINAL EVALUATION ENG; Evans SW, 2014, SCHOOL PSYCHOL REV, V43, P185; Gardner F, 2010, J CLIN CHILD ADOLESC, V39, P568, DOI 10.1080/15374416.2010.486315; Gazeley L., 2013, REDUCING INEQUALITIE; Gordon K, 2011, J CONSULT CLIN PSYCH, V79, P447, DOI 10.1037/a0024379; Hart CO, 2013, PSYCHOL SCHOOLS, V50, P116, DOI 10.1002/pits.21662; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Karcher MJ, 2008, PREV SCI, V9, P99, DOI 10.1007/s11121-008-0083-z; Lanskey C, 2014, INT J INCLUSIVE EDUC, P1; Law J, 2012, CHILD LANG TEACH THE, V28, P7, DOI 10.1177/0265659011414214; Little R. J. A., 1987, STAT ANAL MISSING DA; Losel F, 2012, AM J PREV MED, V43, pS68, DOI 10.1016/j.amepre.2012.04.029; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Mahoney JL, 2005, CHILD DEV, V76, P811, DOI 10.1111/j.1467-8624.2005.00879.x; Mahoney JL, 2007, ELEM SCHOOL J, V107, P385, DOI 10.1086/516670; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Massey A, 2011, BEST BEHAV SCH DISCI; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Mowbray CT, 2003, AM J EVAL, V24, P315, DOI 10.1177/109821400302400303; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449; Obsuth I, J YOUTH ADO IN PRESS; Perry BL, 2014, AM SOCIOL REV, V79, P1067, DOI 10.1177/0003122414556308; Pomeroy E, 1999, BRIT J SOCIOL EDUC, V20, P465, DOI 10.1080/01425699995218; Rorie M, 2011, J ADOLESCENCE, V34, P105, DOI 10.1016/j.adolescence.2010.01.007; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Sorlie M., 2015, INT J SCH ED PSYCHOL, V3, P202, DOI [DOI 10.1080/21683603.2015.1060912, 10.1080/216836.03.2015.1060912, DOI 10.1080/216836.03.2015.1060912]; Sprott Jane B., 2005, YOUTH VIOLENCE JUV J, V3, P59, DOI DOI 10.1177/1541204004270943; Sugai G, 2002, CHILD FAM BEHAV THER, V24, P23, DOI 10.1300/J019v24n01_03; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Taves DR, 2010, CONTEMP CLIN TRIALS, V31, P180, DOI 10.1016/j.cct.2009.12.005; Treasure T, 1998, BRIT MED J, V317, P362; Troop-Gordon W, 2011, SOC DEV, V20, P536, DOI 10.1111/j.1467-9507.2011.00604.x; Weiss B, 2005, J CONSULT CLIN PSYCH, V73, P1036, DOI 10.1037/0022-006X.73.6.1036; Welsh BC, 2014, J EXP CRIMINOL, V10, P245, DOI 10.1007/s11292-014-9199-2; Wilson SJ, 2003, J CONSULT CLIN PSYCH, V71, P136, DOI 10.1037/0022-006X.71.1.136; Zane SN, 2015, BRIT J CRIMINOLOGY	58	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152423	10.1371/journal.pone.0152423	http://dx.doi.org/10.1371/journal.pone.0152423			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045953	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000373599600020
J	Resque, R; Gusmao, L; Geppert, M; Roewer, L; Palha, T; Alvarez, L; Ribeiro-dos-Santos, A; Santos, S				Resque, Rafael; Gusmao, Leonor; Geppert, Maria; Roewer, Lutz; Palha, Teresinha; Alvarez, Luis; Ribeiro-dos-Santos, Andrea; Santos, Sidney			Male Lineages in Brazil: Intercontinental Admixture and Stratification of the European Background	PLOS ONE			English	Article							Y-CHROMOSOME ANALYSIS; INTERETHNIC ADMIXTURE; PATERNAL LINEAGES; GENETIC-VARIATION; RECENT RADIATION; POPULATION; DIVERSITY; ANCESTRY; PROPORTIONS; ORIGIN	The non-recombining nature of the Y chromosome and the well-established phylogeny of Y-specific Single Nucleotide Polymorphisms (Y-SNPs) make them useful for defining haplogroups with high geographical specificity; therefore, they are more apt than the Y-STRs to detect population stratification in admixed populations from diverse continental origins. Different Y-SNP typing strategies have been described to address issues of population history and movements within geographic territories of interest. In this study, we investigated a set of 41 Y-SNPs in 1217 unrelated males from the five Brazilian geopolitical regions, aiming to disclose the genetic structure of male lineages in the country. A population comparison based on pairwise F-ST genetic distances did not reveal statistically significant differences in haplogroup frequency distributions among populations from the different regions. The genetic differences observed among regions were, however, consistent with the colonization history of the country. The sample from the Northern region presented the highest Native American ancestry (8.4%), whereas the more pronounced African contribution could be observed in the Northeastern population (15.1%). The Central-Western and Southern samples showed the higher European contributions (95.7% and 93.6%, respectively). The Southeastern region presented significant European (86.1%) and African (12.0%) contributions. The subtyping of the most frequent European lineage in Brazil (R1b1a-M269) allowed differences in the genetic European background of the five Brazilian regions to be investigated for the first time.	[Resque, Rafael; Ribeiro-dos-Santos, Andrea; Santos, Sidney] Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Gusmao, Leonor] State Univ Rio de Janeiro UERJ, Inst Biol, DNA Diagnost Lab LDD, Rio De Janeiro, Brazil; [Gusmao, Leonor; Alvarez, Luis] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Gusmao, Leonor; Alvarez, Luis] Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Geppert, Maria; Roewer, Lutz] Charite, Inst Legal Med & Forens Sci, Dept Forens Genet, D-13353 Berlin, Germany; [Resque, Rafael] Univ Fed Amapa, Dept Ciencias Saude & Biol, Lab Toxicol & Quim Farmaceut, Macapa, Brazil; [Palha, Teresinha] Ctr Pericias Cient Renato Chaves, Inst Criminalist, Lab Genet, Belem, Para, Brazil; [Ribeiro-dos-Santos, Andrea; Santos, Sidney] Fed Univ Para, Nucleo Pesquisas Oncol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade do Estado do Rio de Janeiro; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fundacao Universidade Federal do Amapa; Universidade Federal do Para	Gusmao, L (corresponding author), State Univ Rio de Janeiro UERJ, Inst Biol, DNA Diagnost Lab LDD, Rio De Janeiro, Brazil.; Gusmao, L (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.; Gusmao, L (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lgusmao@ipatimup.pt	Gusmao, Leonor/B-3122-2013; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Gusmão, Leonor/L-8931-2019; Alvarez, Luis/J-6022-2013	Gusmao, Leonor/0000-0003-0432-6481; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Gusmão, Leonor/0000-0003-0432-6481; Alvarez, Luis/0000-0003-1311-4536; Roewer, Lutz/0000-0001-9383-4941; Seidel, Maria/0000-0001-8466-3378	FAPERJ (Fundacao de Amparo a Pesquisa do Rio de Janeiro); Programa APQ1 [E-26/111.395/2013]; FCT; Portuguese Foundation for Science and Technology; FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE; National Funds through the FCT-Foundation for Science and Technology [PEst-C/SAU/LA0003/2013]	FAPERJ (Fundacao de Amparo a Pesquisa do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa APQ1; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE; National Funds through the FCT-Foundation for Science and Technology	This work was supported by FAPERJ (Fundacao de Amparo a Pesquisa do Rio de Janeiro), Programa APQ1 2013/01, no processo E-26/111.395/2013. IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT, the Portuguese Foundation for Science and Technology. This work is funded by FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE and National Funds through the FCT-Foundation for Science and Technology, under the project "PEst-C/SAU/LA0003/2013".	Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014; Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Alvarez L, 2014, AM J HUM BIOL, V26, P740, DOI 10.1002/ajhb.22602; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Palha TDBF, 2011, AM J PHYS ANTHROPOL, V144, P471, DOI 10.1002/ajpa.21436; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Carvalho BM, 2008, GENET MOL BIOL, V31, P12, DOI 10.1590/S1415-47572008000100002; Carvalho M, 2010, GENET MOL BIOL, V33, P422, DOI 10.1590/S1415-47572010005000067; Noguera MC, 2014, ANN HUM BIOL, V41, P453, DOI 10.3109/03014460.2013.852244; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; Curtin PD, 1969, ATLANTIC SLAVE TRACE; de Azevedo DA, 2009, FORENS SCI INT-GEN S, V2, P421, DOI 10.1016/j.fsigss.2009.08.166; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Geppert M, 2012, METHODS MOL BIOL, V830, P127, DOI 10.1007/978-1-61779-461-2_9; Geppert M, 2011, FORENSIC SCI INT-GEN, V5, P100, DOI 10.1016/j.fsigen.2010.08.016; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Goncalves R, 2005, ANN HUM GENET, V69, P443, DOI 10.1111/j.1529-8817.2005.00161.x; Gonzalez M, 2013, EUR J HUM GENET, V21, P324, DOI 10.1038/ejhg.2012.167; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; IBGE, 2012, BRAS 500 AN POV; Larmuseau MHD, 2014, ANN HUM GENET, V78, P92, DOI 10.1111/ahg.12050; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Moore LT, 2006, AM J HUM GENET, V78, P334, DOI 10.1086/500055; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nascimento E, 2009, FORENS SCI INT-GEN S, V2, P349, DOI 10.1016/j.fsigss.2009.07.010; Nei N, 1987, MOL EVOLUTIONARY GEN; Oliveira AM, 2014, FORENSIC SCI INT-GEN, V13, P264, DOI 10.1016/j.fsigen.2014.08.017; Palha T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040007; Rebala K, 2013, EUR J HUM GENET, V21, P415, DOI 10.1038/ejhg.2012.190; Resque RL, 2010, AM J HUM BIOL, V22, P849, DOI 10.1002/ajhb.21089; Ribeiro D., 1995, POVO BRASILEIRO FORM; Ribeiro-dos-Santos AKC, 2002, AM J HUM BIOL, V14, P440, DOI 10.1002/ajhb.10059; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Silva DA, 2006, AM J HUM BIOL, V18, P829, DOI 10.1002/ajhb.20567; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Sole-Morata N, 2014, ANN HUM GENET, V78, P253, DOI 10.1111/ahg.12066; Toscanini U, 2008, FORENSIC SCI INT-GEN, V2, P274, DOI 10.1016/j.fsigen.2008.03.001; Valverde L, 2016, EUR J HUM GENET, V24, P437, DOI 10.1038/ejhg.2015.114; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Xavier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120155; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020	55	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152573	10.1371/journal.pone.0152573	http://dx.doi.org/10.1371/journal.pone.0152573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046235	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600026
J	Gui, ZP; Yu, MZ; Yang, CW; Jiang, YF; Chen, SQ; Xia, JZ; Huang, QY; Liu, K; Li, ZL; Hassan, MA; Jin, BX				Gui, Zhipeng; Yu, Manzhu; Yang, Chaowei; Jiang, Yunfeng; Chen, Songqing; Xia, Jizhe; Huang, Qunying; Liu, Kai; Li, Zhenlong; Hassan, Mohammed Anowarul; Jin, Baoxuan			Developing Subdomain Allocation Algorithms Based on Spatial and Communicational Constraints to Accelerate Dust Storm Simulation	PLOS ONE			English	Article							PARALLEL; IMPLEMENTATION; SCHEME; MODEL	Dust storm has serious disastrous impacts on environment, human health, and assets. The developments and applications of dust storm models have contributed significantly to better understand and predict the distribution, intensity and structure of dust storms. However, dust storm simulation is a data and computing intensive process. To improve the computing performance, high performance computing has been widely adopted by dividing the entire study area into multiple subdomains and allocating each subdomain on different computing nodes in a parallel fashion. Inappropriate allocation may introduce imbalanced task loads and unnecessary communications among computing nodes. Therefore, allocation is a key factor that may impact the efficiency of parallel process. An allocation algorithm is expected to consider the computing cost and communication cost for each computing node to minimize total execution time and reduce overall communication cost for the entire simulation. This research introduces three algorithms to optimize the allocation by considering the spatial and communicational constraints: 1) an Integer Linear Programming (ILP) based algorithm from combinational optimization perspective; 2) a K-Means and Kernighan-Lin combined heuristic algorithm (K&K) integrating geometric and coordinate-free methods by merging local and global partitioning; 3) an automatic seeded region growing based geometric and local partitioning algorithm (ASRG). The performance and effectiveness of the three algorithms are compared based on different factors. Further, we adopt the K&K algorithm as the demonstrated algorithm for the experiment of dust model simulation with the non-hydrostatic mesoscale model (NMMdust) and compared the performance with the MPI default sequential allocation. The results demonstrate that K&K method significantly improves the simulation performance with better subdomain allocation. This method can also be adopted for other relevant atmospheric and numerical modeling.	[Gui, Zhipeng] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Hubei Province, Peoples R China; [Gui, Zhipeng; Yu, Manzhu; Yang, Chaowei; Jiang, Yunfeng; Xia, Jizhe; Huang, Qunying; Liu, Kai; Li, Zhenlong] George Mason Univ, Ctr Intelligent Spatial Comp, Fairfax, VA 22030 USA; [Chen, Songqing; Hassan, Mohammed Anowarul] George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA; [Huang, Qunying] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Jin, Baoxuan] Yunnan Prov Geomat Ctr, Kunming, Yunnan, Peoples R China	Wuhan University; George Mason University; George Mason University; University of Wisconsin System; University of Wisconsin Madison	Yang, CW (corresponding author), George Mason Univ, Ctr Intelligent Spatial Comp, Fairfax, VA 22030 USA.	cyang3@gmu.edu	Yu, Manzhu/J-6953-2019; Yang, Chaowei/A-9881-2017; Gui, Zhipeng/I-1068-2019; Li, Zhenlong/M-1065-2017	Yu, Manzhu/0000-0001-6769-7517; Yang, Chaowei/0000-0001-7768-4066; Gui, Zhipeng/0000-0001-9467-9680; Li, Zhenlong/0000-0002-8938-5466	Federal Geographic Data Committee [G13PG00091]; Microsoft Research; NSF Cyber Polar, Innovation Center; Computer Network System Programs [PLR-1349259, IIP-1338925, CNS-1117300, ICER-1343759]; NASA [NNG12PP37I]; EarthCube; Direct For Computer & Info Scie & Enginr [1117300] Funding Source: National Science Foundation; Directorate For Geosciences [1541039] Funding Source: National Science Foundation	Federal Geographic Data Committee; Microsoft Research(Microsoft); NSF Cyber Polar, Innovation Center; Computer Network System Programs; NASA(National Aeronautics & Space Administration (NASA)); EarthCube(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research is supported by Federal Geographic Data Committee (G13PG00091), Microsoft Research, NSF Cyber Polar, Innovation Center, EarthCube and Computer Network System Programs (PLR-1349259, IIP-1338925, CNS-1117300, ICER-1343759) and NASA (NNG12PP37I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All research was conducted at George Mason University.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; ALPERT CJ, 1995, INTEGRATION, V19, P1, DOI 10.1016/0167-9260(95)00008-4; Arifin SMN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-290; Baillie C, 1997, PARALLEL COMPUT, V23, P2135, DOI 10.1016/S0167-8191(97)00104-X; Baillie C, 1995, P 4 INT C APPL HIGH; Banerjee Prithviraj, 1994, PARALLEL ALGORITHMS; Banos R, 2004, J HEURISTICS, V10, P315, DOI 10.1023/B:HEUR.0000026898.11874.e7; Banos R, 2003, LECT NOTES COMPUT SC, V2611, P143; BARNARD ST, 1994, CONCURRENCY-PRACT EX, V6, P101, DOI 10.1002/cpe.4330060203; BERGER MJ, 1987, IEEE T COMPUT, V36, P570, DOI 10.1109/TC.1987.1676942; Bergman T.L., 2011, FUNDAMENTALS HEAT MA, Vsixth; BERMAN F, 1987, J PARALLEL DISTR COM, V4, P439, DOI 10.1016/0743-7315(87)90018-9; BISWAS R, 1994, APPL NUMER MATH, V13, P437, DOI 10.1016/0168-9274(94)90007-8; BOKHARI SH, 1981, IEEE T COMPUT, V30, P207, DOI 10.1109/TC.1981.1675756; Bollinger S. W., 1988, Proceedings of the 1988 International Conference on Parallel Processing, P1; Bui TN, 1996, IEEE T COMPUT, V45, P841, DOI 10.1109/12.508322; Bui TN, 2002, P 4 ANN C GEN EV COM, P43; Dhillon I.S., 2004, P 10 ACM SIGKDD INT, P551, DOI DOI 10.1145/1014052.1014118; Dinh Q, 1988, COUPLING VISCOUS INV, P350; Du Q, 1999, SIAM REV, V41, P637, DOI 10.1137/S0036144599352836; DUNLOP AE, 1985, IEEE T COMPUT AID D, V4, P92, DOI 10.1109/TCAD.1985.1270101; FEO TA, 1995, J GLOBAL OPTIM, V6, P109, DOI 10.1007/BF01096763; Fiduccia C. M., 1982, P 19 IEEE DES AUT C, V19, P175, DOI DOI 10.1109/DAC.1982.1585498; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; Garey M. R., 1974, P 6 ANN ACM S THEOR, P47, DOI DOI 10.1145/800119.803884; Gibbs N. E., 1976, ACM Transactions on Mathematical Software, V2, P322, DOI 10.1145/355705.355707; GILBERT JR, 1987, INT J PARALLEL PROG, V16, P427, DOI 10.1007/BF01388998; Gilbert JR, 1998, SIAM J SCI COMPUT, V19, P2091, DOI 10.1137/S1064827594275339; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Gong SL, 2008, ATMOS CHEM PHYS, V8, P2333, DOI 10.5194/acp-8-2333-2008; Gropp W., 1999, USING MPI PORTABLE P; Hammond SW, 1992, MAPPING UNSTRUCTURED; HANSEN JV, 1986, OPER RES LETT, V5, P137, DOI 10.1016/0167-6377(86)90086-6; Hongyuan Zha, 2001, Proceedings of the 2001 ACM CIKM. Tenth International Conference on Information and Knowledge Management, P25; Huang QY, 2013, INT J GEOGR INF SCI, V27, P765, DOI 10.1080/13658816.2012.715650; Huang S., 2006, J GRID COMPUT, V4, P71, DOI DOI 10.1007/S10723-005-9018-0; Jerrum M., 1993, Proceedings. 34th Annual Symposium on Foundations of Computer Science (Cat. No.93CH3368-8), P94, DOI 10.1109/SFCS.1993.366878; Kantorovich LV, 1940, DOKLADY AKAD SCI USS, V28, P211; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Karypis G, 1999, IEEE T VLSI SYST, V7, P69, DOI 10.1109/92.748202; Karypis G, 1999, SIAM REV, V41, P278, DOI 10.1137/S0036144598334138; Kernighan B.W., 1970, BELL SYST TECH J, V49, P291, DOI DOI 10.1002/J.1538-7305.1970.TB01770.X; Khandekar R, 2009, J ACM, V56, DOI 10.1145/1538902.1538903; Korosec P, 2003, INT J PURE APPL MATH, V5, P143; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Leighton T, 1999, J ACM, V46, P787, DOI 10.1145/331524.331526; Lisser A, 2003, MATH PROGRAM, V95, P91, DOI 10.1007/s10107-002-0342-x; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; MANDEL J, 1993, COMMUN NUMER METH EN, V9, P233, DOI 10.1002/cnm.1640090307; Miller G., 1993, IMA VOLUMES MATH ITS, V56, P57; Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2; MUNTEAN T, 1991, HIGH PERFORMANCE COMPUTING II, P71; Nickovic S, 2001, J GEOPHYS RES-ATMOS, V106, P18113, DOI 10.1029/2000JD900794; Nour-Omid B, 1987, PARALLEL COMPUT, P209; Ou CW, 1996, J SUPERCOMPUT, V10, P119, DOI 10.1007/BF00130706; Portugal D, 2011, IFIP ADV INF COMM TE, V349, P139; Raju MP, 2009, INT J COMPUTER SCI I, V5, P27; Ramanujam J., 1988, ICS 88. Third International Conference on Supercomputing. Proceedings, Supercomputing '88, P471; SADAYAPPAN P, 1990, PARALLEL COMPUT, V13, P1, DOI 10.1016/0167-8191(90)90115-P; Schloegel K, 2000, TR00018 ARM HIGH PER; Shan J, 2008, P 9 INT C COMP VIS P, P6; Shih FY, 2005, IMAGE VISION COMPUT, V23, P877, DOI 10.1016/j.imavis.2005.05.015; Smith B.F., 2004, DOMAIN DECOMPOSITION; Su X, 2014, AAAI WORKSH MULT INT, P7; TOSELLI A., 2005, DOMAIN DECOMPOSITION; Ucar B, 2006, J PARALLEL DISTR COM, V66, P32, DOI 10.1016/j.jpdc.2005.06.014; Van den Bout D E, 1990, IEEE Trans Neural Netw, V1, P192, DOI 10.1109/72.80231; WAGNER HM, 1959, J AM STAT ASSOC, V54, P206, DOI 10.2307/2282146; Walshaw C, 1995, LECT NOTES COMPUTER, P121; Xie JB, 2010, COMPUT ENVIRON URBAN, V34, P278, DOI 10.1016/j.compenvurbsys.2009.08.002; YAN JT, 1994, INFORM PROCESS LETT, V52, P259, DOI 10.1016/0020-0190(94)00148-0; Yang CW, 2011, P NATL ACAD SCI USA, V108, P5498, DOI 10.1073/pnas.0909315108	75	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152250	10.1371/journal.pone.0152250	http://dx.doi.org/10.1371/journal.pone.0152250			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044039	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100012
J	Katolikova, M; Khaitov, V; Vainola, R; Gantsevich, M; Strelkov, P				Katolikova, Marina; Khaitov, Vadim; Vainola, Risto; Gantsevich, Michael; Strelkov, Petr			Genetic, Ecological and Morphological Distinctness of the Blue Mussels Mytilus trossulus Gould and M-edulis L. in the White Sea	PLOS ONE			English	Article							HYBRID ZONE; REPRODUCTIVE ISOLATION; RECIPROCAL TRANSPLANTATIONS; PHENOTYPIC DIFFERENCES; FERTILIZATION SUCCESS; RELATIVE ABUNDANCE; NORTHWEST ATLANTIC; PATTERNS; POPULATION; GALLOPROVINCIALIS	Two blue mussel lineages of Pliocene origin, Mytilus edulis (ME) and M. trossulus (MT), co-occur and hybridize in several regions on the shores of the North Atlantic. The two species were distinguished from each other by molecular methods in the 1980s, and a large amount of comparative data on them has been accumulated since that time. However, while ME and MT are now routinely distinguished by various genetic markers, they tend to be overlooked in ecological studies since morphological characters for taxonomic identification have been lacking, and no consistent habitat differences between lineages have been reported. Surveying a recently discovered area of ME and MT co-occurrence in the White Sea and employing a set of allozyme markers for identification, we address the issue whether ME and MT are true biological species with distinct ecological characteristics or just virtual genetic entities with no matching morphological and ecological identities. We find that: (1) in the White Sea, the occurrence of MT is largely concentrated in harbors, in line with observations from other subarctic regions of Europe; (2) mixed populations of ME and MT are always dominated by purebred individuals, animals classified as hybrids constituting only ca. 18%; (3) in terms of shell morphology, 80% of MT bear a distinct uninterrupted dark prismatic strip under the ligament while 97% of ME lack this character; (4) at sites of sympatry MT is more common on algal substrates while ME mostly lives directly on the bottom. This segregation by the substrate may contribute to maintaining reproductive isolation and decreasing competition between taxa. We conclude that while ME and MT are not fully reproductively isolated, they do represent clearly distinguishable biological, ecological and morphological entities in the White Sea. It remains to be documented whether the observed morphological and ecological differences are of a local character, or whether they have simply been overlooked in other contact zones.	[Katolikova, Marina; Strelkov, Petr] St Petersburg State Univ, Dept Ichthyol & Hydrobiol, St Petersburg 199034, Russia; [Khaitov, Vadim] St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia; [Khaitov, Vadim] Kandalaksha State Nat Reserve, Kandalaksha, Murmansk Region, Russia; [Vainola, Risto] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Gantsevich, Michael] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Moscow, Russia	Saint Petersburg State University; Saint Petersburg State University; University of Helsinki; Lomonosov Moscow State University	Katolikova, M (corresponding author), St Petersburg State Univ, Dept Ichthyol & Hydrobiol, St Petersburg 199034, Russia.	m.katolikova@spbu.ru	Strelkov, Petr/D-1606-2013; Gantsevich, Mikhail/B-4792-2012	Strelkov, Petr/0000-0002-6030-7034; Gantsevich, Mikhail/0000-0002-4854-2787; Khaitov, Vadim/0000-0001-5567-8554	Russian Foundation for Basic Research [08-04-01315-, 13-04-00394-a, N 15-29-02601]; St. Petersburg State University [1.38.253.2014, 1.42.1493.2015]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); St. Petersburg State University	This work was supported by Russian Foundation for Basic Research, http://www.rfbr.ru, Grants Nos. 08-04-01315-., 13-04-00394-a for PS, MK, VK, MG and N 15-29-02601 for MG; St. Petersburg State University, spbu.ru, Grants Nos. 1.38.253.2014, 1.42.1493.2015 for PS, MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Eric C., 2009, V17, P25; Babkov A., 1982, P ZOOL I LENINGRAD, P316; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bates JA, 1995, MAR BIOL, V124, P417, DOI 10.1007/BF00363915; Bayer TL., 1980, T BBS MGU, P124; Beaumont AR, 2008, J EXP MAR BIOL ECOL, V367, P100, DOI 10.1016/j.jembe.2008.08.021; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Braby CE, 2006, MAR BIOL, V148, P1249, DOI 10.1007/s00227-005-0177-0; Brannock PM, 2009, MAR ECOL PROG SER, V383, P161, DOI 10.3354/meps07995; Comesana AS, 1999, MAR BIOL, V133, P213, DOI 10.1007/s002270050460; CURREY JD, 1974, J ZOOL, V173, P395; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dias PJ, 2009, AQUACULT INT, V17, P437, DOI 10.1007/s10499-008-9214-6; Dias PJ, 2009, AQUACULTURE, V295, P175, DOI 10.1016/j.aquaculture.2009.07.007; Fly EK, 2013, OECOLOGIA, V172, P35, DOI 10.1007/s00442-012-2486-6; Fox J., 2019, R COMPANION APPL REG, V.; Fraisse C, 2016, MOL ECOL, V25, P269, DOI 10.1111/mec.13299; Gardner JPA, 2009, BIOL J LINN SOC, V96, P875, DOI 10.1111/j.1095-8312.2008.01166.x; Gardner JPA, 1996, MAR BIOL, V125, P385, DOI 10.1007/BF00346319; Gardner JPA, 2001, J EXP MAR BIOL ECOL, V265, P119, DOI 10.1016/S0022-0981(01)00328-8; Gause GF, 1932, J EXP BIOL, V9, P389; Gilg MR, 2003, ECOLOGY, V84, P2989, DOI 10.1890/02-0498; Gosling E.M., 1992, Developments in Aquaculture and Fisheries Science, V25, P309; Harrison R.G., 1989, P111; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; Hayhurst S, 2009, J MOLLUS STUD, V75, P215, DOI 10.1093/mollus/eyp019; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; Ivanova MB, 1979, DVUSTVORCHATYE MOLLY, P58; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; JOHANNESSON K, 1990, MAR ECOL PROG SER, V59, P211, DOI 10.3354/meps059211; Kartavtsev YP, 2014, RUSS J MAR BIOL+, V40, P208, DOI 10.1134/S1063074014030055; KAUTSKY N, 1990, MAR ECOL PROG SER, V59, P203, DOI 10.3354/meps059203; KEPEL AA, 1992, ZOOL ZH, V71, P33; Khaitov VM, 2013, CHRONICLE NATURE K 1, P152; Klibansky LKJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108433; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KOEHN RK, 1984, MAR BIOL, V79, P117, DOI 10.1007/BF00951820; KOEHN RK, 1991, AQUACULTURE, V94, P125, DOI 10.1016/0044-8486(91)90114-M; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; Liu GX, 2011, MAR ECOL-EVOL PERSP, V32, P480, DOI 10.1111/j.1439-0485.2011.00446.x; Lowen JB, 2013, MAR ECOL PROG SER, V475, P135, DOI 10.3354/meps10106; Lukanin V.V., 1985, P45; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; MALLET AL, 1995, CAN J FISH AQUAT SCI, V52, P1873, DOI 10.1139/f95-780; Maloy AP, 2003, J SHELLFISH RES, V22, P119; Mayr E, 1996, PHILOS SCI, V63, P262, DOI 10.1086/289912; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; MCDONALD JH, 1991, MAR BIOL, V111, P323, DOI 10.1007/BF01319403; MCDONALD JH, 1988, MAR BIOL, V99, P111, DOI 10.1007/BF00644984; Miranda MBB, 2010, BIOL BULL-US, V218, P266, DOI 10.1086/BBLv218n3p266; Moreau V, 2005, J SHELLFISH RES, V24, P545; Nikula R, 2008, MOL ECOL, V17, P1505, DOI 10.1111/j.1365-294X.2007.03688.x; Penney RW, 2008, J SHELLFISH RES, V27, P827, DOI 10.2983/0730-8000(2008)27[827:GVISTA]2.0.CO;2; Penney RW, 2007, N AM J AQUACULT, V69, P281, DOI 10.1577/A06-044.1; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Pinheiro J, 2020, R PACKAGE VERSION 31; Pritchard JK, 2000, GENETICS, V155, P945; Qiu JW, 2002, MAR ECOL PROG SER, V228, P143, DOI 10.3354/meps228143; R Development Core Team, R LANG ENV STAT COMP; Rawson PD, 2009, MAR BIOL, V156, P1857, DOI 10.1007/s00227-009-1218-x; Rawson PD, 2003, MAR BIOL, V143, P317, DOI 10.1007/s00227-003-1084-x; Rawson PD, 2001, J SHELLFISH RES, V20, P31; Reimer O, 1997, MAR FRESHW BEHAV PHY, V30, P251, DOI 10.1080/10236249709379029; Riginos C, 2005, MOL ECOL, V14, P381, DOI 10.1111/j.1365-294X.2004.02379.x; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Saavedra C, 1996, GENETICS, V143, P1359; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; Slaughter C, 2008, BIOL BULL-US, V214, P57, DOI 10.2307/25066660; Smietanka B, 2013, MAR BIOL, V160, P1709, DOI 10.1007/s00227-013-2223-7; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Toro JE, 2006, AQUAC RES, V37, P1703, DOI 10.1111/j.1365-2109.2006.01610.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; VAINOLA R, 1991, BIOL J LINN SOC, V43, P127, DOI 10.1111/j.1095-8312.1991.tb00589.x; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; Vainola R, 2011, MAR BIOL, V158, P817, DOI 10.1007/s00227-010-1609-z; VARVIO SL, 1988, MAR BIOL, V98, P51, DOI 10.1007/BF00392658; Wenne R, 2016, POLAR BIOL, V39, P343, DOI 10.1007/s00300-015-1785-x; Zbawicka M, 2014, AQUAT BIOL, V21, P25, DOI 10.3354/ab00566; Zbawicka M, 2010, GENE, V456, P45, DOI 10.1016/j.gene.2010.02.009; Zolotarev V.N., 2002, Visnyk Zhytomyrskoho Pedahohichnoho Universytetu, V10, P5; Zolotarev V.N., 1997, Biologiya Morya (Vladivostok), V23, P26; Zuur Alain F., 2009, P1	87	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152963	10.1371/journal.pone.0152963	http://dx.doi.org/10.1371/journal.pone.0152963			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044013	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100055
J	Lan, DL; Xiong, XR; Huang, C; Mipam, TD; Li, J				Lan, Daoliang; Xiong, Xianrong; Huang, Cai; Mipam, Tserang Donko; Li, Jian			Toward Understanding the Genetic Basis of Yak Ovary Reproduction: A Characterization and Comparative Analyses of Estrus Ovary Transcriptiome in Yak and Cattle	PLOS ONE			English	Article							IN-VITRO MATURATION; MESSENGER-RNA; CYTOCHROME-P450 AROMATASE; HORMONAL-REGULATION; EXPRESSION; COMPLEMENT; RECEPTOR; OOCYTES; BOVINE; EVOLUTION	Background Yaks (Bos grunniens) are endemic species that can adapt well to thin air, cold temperatures, and high altitude. These species can survive in harsh plateau environments and are major source of animal production for local residents, being an important breed in the Qinghai-Tibet Plateau. However, compared with ordinary cattle that live in the plains, yaks generally have lower fertility. Investigating the basic physiological molecular features of yak ovary and identifying the biological events underlying the differences between the ovaries of yak and plain cattle is necessary to understand the specificity of yak reproduction. Therefore, RNA-seq technology was applied to analyze transcriptome data comparatively between the yak and plain cattle estrous ovaries. Results After deep sequencing, 3,653,032 clean reads with a total of 4,828,772,880 base pairs were obtained from yak ovary library. Alignment analysis showed that 16992 yak genes mapped to the yak genome, among which, 12,731 and 14,631 genes were assigned to Gene Ontology (GO) categories and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Furthermore, comparison of yak and cattle ovary transcriptome data revealed that 1307 genes were significantly and differentially expressed between the two libraries, wherein 661 genes were upregulated and 646 genes were downregulated in yak ovary. Functional analysis showed that the differentially expressed genes were involved in various Gene Ontology (GO) categories and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. GO annotations indicated that the genes related to "cell adhesion," "hormonal" biological processes, and "calcium ion binding," "cation transmembrane transport" molecular events were significantly active. KEGG pathway analysis showed that the "complement and coagulation cascade" pathway was the most enriched in yak ovary transcriptome data, followed by the "cytochrome P450" related and "ECM-receptor interaction" pathways. Moreover, several novel pathways, such as "circadian rhythm," were significantly enriched despite having no evident associations with the reproductive function. Conclusion Our findings provide a molecular resource for further investigation of the general molecular mechanism of yak ovary and offer new insights to understand comprehensively the specificity of yak reproduction.	[Lan, Daoliang; Xiong, Xianrong; Huang, Cai; Li, Jian] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China; [Lan, Daoliang; Mipam, Tserang Donko; Li, Jian] Southwest Univ Nationalities, Inst Qinghai Tibetan Plateau, Chengdu 610041, Peoples R China	Southwest Minzu University; Southwest Minzu University	Li, J (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu 610041, Peoples R China.; Li, J (corresponding author), Southwest Univ Nationalities, Inst Qinghai Tibetan Plateau, Chengdu 610041, Peoples R China.	lijian@swun.cn			Innovationteam project for conservation and utilization of yak genetic resources [13CXTD01]	Innovationteam project for conservation and utilization of yak genetic resources	This study was supported by Innovationteam project for conservation and utilization of yak genetic resources (13CXTD01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldinger S, 2006, DEUT TIERARZTL WOCH, V113, P151; Anchordoquy JM, 2014, REPROD DOMEST ANIM, V49, P865, DOI 10.1111/rda.12385; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Azuma T, 2002, REPRODUCTION, V124, P235, DOI 10.1530/reprod/124.2.235; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Binder AK, 2013, ENDOCRINOLOGY, V154, P2174, DOI 10.1210/en.2012-2256; Couse JF, 2001, ANN NY ACAD SCI, V948, P1; Cui Y, 1999, VET J, V157, P192, DOI 10.1053/tvjl.1998.0283; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Fradette C, 2003, BRIT J PHARMACOL, V140, P1146, DOI 10.1038/sj.bjp.0705543; Fu Mei, 2014, PLoS One, V9, pe113669, DOI 10.1371/journal.pone.0113669; Fu M, 2014, ASIAN AUSTRAL J ANIM, V27, P1684, DOI 10.5713/ajas.2014.14380; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Guo XS, 2014, CRIT REV FOOD SCI, V54, P292, DOI 10.1080/10408398.2011.584134; Harris CL, 2006, MOL IMMUNOL, V43, P57, DOI 10.1016/j.molimm.2005.06.026; HASTY LA, 1994, AM J OBSTET GYNECOL, V170, P168; Hediger MA, 1997, CURR OPIN CELL BIOL, V9, P543, DOI 10.1016/S0955-0674(97)80031-2; Hu QJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-600; Kandiel MMM, 2010, EXP ANIM TOKYO, V59, P605, DOI 10.1538/expanim.59.605; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Long RJ, 1999, PREV VET MED, V38, P195, DOI 10.1016/S0167-5877(98)00125-1; Makki M, 2012, IRAN J REPROD MED, V10, P343; Mamo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-151; MaStellos D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P125, DOI 10.2174/1568010053622993; Miao FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127275; Miao XY, 2013, REPRODUCTION, V145, P587, DOI 10.1530/REP-12-0507; Moiseyev G, 2013, J BIOMECH, V46, P26, DOI 10.1016/j.jbiomech.2012.09.019; Pan Linlin, 2014, Genomics Proteomics & Bioinformatics, V12, P239, DOI 10.1016/j.gpb.2014.08.002; Piggins HD, 2002, ANN MED, V34, P394, DOI 10.1080/078538902320772142; Prakash BS, 2008, REPROD DOMEST ANIM, V43, P217, DOI 10.1111/j.1439-0531.2008.01165.x; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Quan K, 2005, XU MU YU SHI LIAO KE, P30; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Rozinek J, 2006, ANIM REPROD SCI, V91, P123, DOI 10.1016/j.anireprosci.2005.03.010; Sahmi M, 2006, J ENDOCRINOL, V190, P107, DOI 10.1677/joe.1.06827; Shughure PJ, 1998, STEROIDS, V63, P498, DOI 10.1016/S0039-128X(98)00054-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sunyer JO, 2003, IMMUNOL RES, V27, P549, DOI 10.1385/IR:27:2-3:549; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Wang ZF, 2015, GENE, V572, P298, DOI 10.1016/j.gene.2015.08.024; Xiao X, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-30; Xiong XR, 2015, ANIM BIOTECHNOL, V26, P222, DOI 10.1080/10495398.2014.1002563; Zi XD, 2006, ANIM REPROD SCI, V92, P183, DOI 10.1016/j.anireprosci.2005.05.017	49	24	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152675	10.1371/journal.pone.0152675	http://dx.doi.org/10.1371/journal.pone.0152675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044040	Green Published, gold			2022-12-27	WOS:000373592100023
J	Zagzag, J; Malone, MK; Lopresti, MA; Ogilvie, JB; Patel, KN; Heller, KS				Zagzag, Jonathan; Malone, Michael K.; Lopresti, Melissa A.; Ogilvie, Jennifer B.; Patel, Kepal N.; Heller, Keith S.			Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients	PLOS ONE			English	Article							UNITED-STATES; SOCIOECONOMIC-STATUS; INCREASING INCIDENCE; POOLED ANALYSIS; PAPILLARY; TRENDS; RISK; METAANALYSIS	Background The incidence of well-differentiated thyroid cancer (WDTC) is increasing rapidly. Many authors feel that this increase is due to over-diagnosis and that one of the contributing factors is the increasing use of various imaging studies. The rate of obesity has also been increasing in the United States. It has been suggested that patients with an increased body mass index (BMI kg/m(2)) have a higher incidence of WDTC than patients with normal BMI. One might hypothesize that thyroid nodules are more difficult to palpate in obese patients and that as more cancers are detected by imaging the apparent rate of increase in WDTC in obese patients would appear to be greater than in non-obese patients. This study was undertaken to evaluate this hypothesis by determining if there is any difference in the way thyroid cancers are initially detected in obese and non-obese patients. Methods The medical records of all 519 patients with a postoperative diagnosis of WDTC who underwent thyroidectomy at NYU Langone Medical Center from January 1, 2007 through August 31, 2010 by the three members of NYU Endocrine Surgery Associates were reviewed. Patients were divided into Non-obese (BMI<30 kg/m(2)) and Obese (BMI >= 30 kg/m(2)) groups. Patients were also divided by the initial method of detection of their tumor into Palpation, Imaging, and Incidental groups. Results The final study group contained 270 patients, 181(67%) of whom were in the Non-obese Group and 89(33%) were in the Obese Group. In the Non-obese group, 81(45%) of tumors were found by palpation, 72(40%) were found by imaging, and 28(16%) were found incidentally. In the Obese group, 40(45%) were found by palpation, 38(43%) were found by imaging, and 11(12%) were found incidentally. These differences were not statistically significant (p-value 0.769). Conclusion We show that BMI does not play a role in the method of initial detection in patients with WDTC. This suggests that the prevalence of WDTC detected by imaging is not an artifact caused by an increasingly obese population and that any association of WDTC and obesity is not related to the way in which these tumors are detected.	[Zagzag, Jonathan; Malone, Michael K.; Lopresti, Melissa A.; Ogilvie, Jennifer B.; Patel, Kepal N.; Heller, Keith S.] NYU, Dept Surg, Langone Med Ctr, Div Endocrine Surg, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Patel, KN (corresponding author), NYU, Dept Surg, Langone Med Ctr, Div Endocrine Surg, New York, NY 10016 USA.	kepal.patel@nyumc.org		Ogilvie, Jennifer/0000-0001-6139-606X; patel, kepal/0000-0002-9088-4844; Heller, Keith/0000-0003-2836-3359				Albores-Saavedra J, 2007, ENDOCR PATHOL, V18, P1, DOI 10.1007/s12022-007-0002-z; Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P14; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2012, LARYNGOSCOPE, V122, P1181, DOI [10.1002/lary.22418, DOI 10.1002/LARY.22418]; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Kent WDT, 2007, CAN MED ASSOC J, V177, P1357, DOI 10.1503/cmaj.061730; Kitahara CM, 2012, CANCER EPIDEM BIOMAR, V21, P2268, DOI 10.1158/1055-9965.EPI-12-0790; Kitahara CM, 2011, CANCER EPIDEM BIOMAR, V20, P464, DOI 10.1158/1055-9965.EPI-10-1220; Li N, 2013, THYROID, V23, P103, DOI 10.1089/thy.2012.0392; Malone MK, 2014, THYROID, V24, P314, DOI 10.1089/thy.2012.0651; Mitchell I, 2007, SURGERY, V142, P823, DOI 10.1016/j.surg.2007.09.011; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Pappa T, 2014, THYROID, V24, P190, DOI 10.1089/thy.2013.0232; Reitzel LR, 2014, THYROID, V24, P556, DOI 10.1089/thy.2013.0284; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Udelsman R, 2014, THYROID, V24, P472, DOI 10.1089/thy.2013.0257; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; World Health Organization, 2000, WHO TECHN REP SER, V894; Xu L, 2014, THYROID, V24, P966, DOI 10.1089/thy.2013.0566; Zhao ZG, 2012, J INT MED RES, V40, P2041, DOI 10.1177/030006051204000601; Zhu CR, 2009, THYROID, V19, P1061, DOI 10.1089/thy.2008.0342	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152768	10.1371/journal.pone.0152768	http://dx.doi.org/10.1371/journal.pone.0152768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043928	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100032
J	Nawata, A; Noguchi, H; Mazaki, Y; Kurahashi, T; Izumi, H; Wang, KY; Guo, X; Uramoto, H; Kohno, K; Taniguchi, H; Tanaka, Y; Fujii, J; Sasaguri, Y; Tanimoto, A; Nakayama, T; Yamada, S				Nawata, Aya; Noguchi, Hirotsugu; Mazaki, Yuichi; Kurahashi, Toshihiro; Izumi, Hiroto; Wang, Ke-Yong; Guo, Xin; Uramoto, Hidetaka; Kohno, Kimitoshi; Taniguchi, Hatsumi; Tanaka, Yoshiya; Fujii, Junichi; Sasaguri, Yasuyuki; Tanimoto, Akihide; Nakayama, Toshiyuki; Yamada, Sohsuke			Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							METABOLIC SYNDROME; SIGNALING PATHWAY; GENE-EXPRESSION; LXR-ALPHA; STEATOHEPATITIS; MICE; CHOLESTEROL; APOPTOSIS; RECEPTOR; MECHANISMS	Background Accumulating evidence has shown that methionine- and choline-deficient high fat (MCD+HF) diet induces the development of nonalcoholic fatty liver disease (NAFLD), in which elevated reactive oxygen species play a crucial role. We have reported that peroxiredoxin 4 (PRDX4), a unique secretory member of the PRDX antioxidant family, protects against NAFLD progression. However, the detailed mechanism and potential effects on the intestinal function still remain unclear. Methods & Results Two weeks after feeding mice a MCD+HF diet, the livers of human PRDX4 transgenic (Tg) mice exhibited significant suppression in the development of NAFLD compared with wildtype (WT) mice. The serum thiobarbituric acid reactive substances levels were significantly lower in Tg mice. In contrast, the Tg small intestine with PRDX4 overexpression showed more suppressed shortening of total length and villi height, and more accumulation of lipid in the jejunum, along with lower levels of dihydroethidium binding. The enterocytes exhibited fewer apoptotic but more proliferating cells, and inflammation was reduced in the mucosa. Furthermore, the small intestine of Tg mice had significantly higher expression of cholesterol absorption-regulatory factors, including liver X receptor-alpha, but lower expression of microsomal triglyceride-transfer protein. Conclusion Our present data provide the first evidence of the beneficial effects of PRDX4 on intestinal function in the reduction of the severity of NAFLD, by ameliorating oxidative stress-induced local and systemic injury. We can suggest that both liver and intestine are spared, to some degree, by the antioxidant properties of PRDX4.	[Nawata, Aya; Noguchi, Hirotsugu; Wang, Ke-Yong; Guo, Xin; Sasaguri, Yasuyuki; Nakayama, Toshiyuki; Yamada, Sohsuke] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Nawata, Aya; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan; [Mazaki, Yuichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido 0608638, Japan; [Kurahashi, Toshihiro; Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Dept Biomol Funct, Yamagata 9909585, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Sch Med, Dept Occupat Pneumol, Kitakyushu, Fukuoka 8078555, Japan; [Wang, Ke-Yong] Univ Occupat & Environm Hlth, Sch Med, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Guo, Xin] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Kitakyushu, Fukuoka 8078555, Japan; [Uramoto, Hidetaka] Med Univ, Hebei Canc Inst, Hosp Hebei 4, Pathol Lab, Jiankang Rd 12, Shijiazhuang 050011, Hebei, Peoples R China; [Uramoto, Hidetaka] Saitama Canc Ctr, Dept Thorac Surg, 818 Komuro, Ina, Saitama 3620806, Japan; [Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, President Lab, Kitakyushu, Fukuoka 8078555, Japan; [Kohno, Kimitoshi] Asahi Matsumoto Hosp, Kitakyushu, Fukuoka 8000242, Japan; [Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 8078555, Japan; [Sasaguri, Yasuyuki] Fukuoka Wajiro Hosp, Pathol Lab, Fukuoka 8110213, Japan; [Tanimoto, Akihide; Yamada, Sohsuke] Kagoshima Univ, Dept Pathol, Field Oncol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Yamada, Sohsuke] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Yamada, Sohsuke] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Hokkaido University; Yamagata University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Kagoshima University; Medical University of Graz; University of Graz	Yamada, S (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan.; Yamada, S (corresponding author), Kagoshima Univ, Dept Pathol, Field Oncol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.; Yamada, S (corresponding author), Med Univ Graz, Inst Pathol, A-8010 Graz, Austria.; Yamada, S (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	sohsuke@m.kufm.kagoshima-u.ac.jp	Nawata, Aya/AHA-1272-2022	Mazaki, Yuichi/0000-0003-4192-0834; wang, ke-yong/0000-0001-8295-1229	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [24790394]; Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan	Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan	This work was supported in part by Grants-in-Aid for Scientific Research (24790394) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to S.Y.) and by the Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan (to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2012, EUR J INTERN MED, V23, P649, DOI 10.1016/j.ejim.2012.05.001; Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Cruz-Garcia L, 2014, J LIPID RES, V55, P1944, DOI 10.1194/jlr.M052845; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fujii J, 2015, FREE RADICAL BIO MED, V83, P373, DOI 10.1016/j.freeradbiomed.2015.01.025; Giguere P, 2007, FEBS LETT, V581, P3863, DOI 10.1016/j.febslet.2007.07.011; Guo X, 2012, ANTIOXID REDOX SIGN, V17, P1362, DOI 10.1089/ars.2012.4549; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Ito R, 2012, MOL MED REP, V6, P379, DOI 10.3892/mmr.2012.935; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Kurahashi T, 2012, FEBS LETT, V586, P4289, DOI 10.1016/j.febslet.2012.09.047; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Morotomi N, 2011, BIOL PHARM BULL, V34, P1011, DOI 10.1248/bpb.34.1011; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Syn WK, 2009, CLIN LIVER DIS, V13, P565, DOI 10.1016/j.cld.2009.07.003; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; Usui S, 2002, J LIPID RES, V43, P805; Vallejo SJH, 2009, AM J PHYSIOL-GASTR L, V296, pG782, DOI 10.1152/ajpgi.90324.2008; Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198; Wang N, 2013, EXP THER MED, V6, P635, DOI 10.3892/etm.2013.1214; Yamada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113509; Yamada Sohsuke, 2012, Journal of UOEH, V34, P27; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	44	24	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152549	10.1371/journal.pone.0152549	http://dx.doi.org/10.1371/journal.pone.0152549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035833	gold, Green Published			2022-12-27	WOS:000373201200021
J	Conboy, L; Gerke, T; Hsu, KY; St John, M; Goldstein, M; Schnyer, R				Conboy, Lisa; Gerke, Travis; Hsu, Kai-Yin; St John, Meredith; Goldstein, Marc; Schnyer, Rosa			The Effectiveness of Individualized Acupuncture Protocols in the Treatment of Gulf War Illness: A Pragmatic Randomized Clinical Trial	PLOS ONE			English	Article							UNITED-STATES; PAIN; QUALITY; VETERANS; COMPLEX	Background Gulf War Illness is a Complex Medical Illness characterized by multiple symptoms, including fatigue, sleep and mood disturbances, cognitive dysfunction, and musculoskeletal pain affecting veterans of the first Gulf War. No standard of care treatment exists. Methods This pragmatic Randomized Clinical Trial tested the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness were randomized to either six months of biweekly acupuncture treatments (group 1, n = 52) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n = 52). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P) and the secondary outcome is the McGill Pain scale. Results Of the 104 subjects who underwent randomization, 85 completed the protocol (82%). A clinically and statistically significant average improvement of 9.4 points (p = 0.03) in the SF-36P was observed for group 1 at month 6 compared to group 2, adjusting for baseline pain. The secondary outcome of McGill pain index produced similar results; at 6 months, group 1 was estimated to experience a reduction of approximately 3.6 points (p = 0.04) compared to group 2. Conclusions Individualized acupuncture treatment of sufficient dose appears to offer significant relief of physical disability and pain for veterans with Gulf War Illness. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Gulf War Illness Research Program under Award No. W81XWH-09-2-0064. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	[Conboy, Lisa; Hsu, Kai-Yin; St John, Meredith] New England Sch Acupuncture, Newton, MA USA; [Gerke, Travis] Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL USA; [Gerke, Travis] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Goldstein, Marc] Boston Vet Healthcare Syst, Jamaica Plain Campus, Boston, MA USA; [Schnyer, Rosa] Univ Texas Austin, Austin, TX 78712 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Austin	Conboy, L (corresponding author), New England Sch Acupuncture, Newton, MA USA.	Lisa_conboy@hms.harvard.edu	Conboy, Lisa/ABC-5173-2021	Conboy, Lisa/0000-0003-2218-7841	Office of the Assistant Secretary of Defense for Health Affairs through the Gulf War Illness Research Program [W81XWH-09-2-0064]	Office of the Assistant Secretary of Defense for Health Affairs through the Gulf War Illness Research Program	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Gulf War Illness Research Program under Award No. W81XWH-09-2-0064. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Allen JJB, 1998, PSYCHOL SCI, V9, P397, DOI 10.1111/1467-9280.00074; Allen JJB, 2006, J CLIN PSYCHIAT, V67, P1665, DOI 10.4088/JCP.v67n1101; Berman BM, 1999, J FAM PRACTICE, V48, P213; Blanchard MS, 2006, AM J EPIDEMIOL, V163, P66, DOI 10.1093/aje/kwj008; Bullock M L, 1997, J Altern Complement Med, V3, P31, DOI 10.1089/acm.1997.3.31; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Cassidy CM, 1998, J ALTERN COMPLEM MED, V4, P17, DOI 10.1089/acm.1998.4.1-17; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P443; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conboy L, 2012, CONTEMP CLIN TRIALS, V33, P557, DOI 10.1016/j.cct.2012.02.006; Duncan Barbara, 2007, Acupunct Med, V25, P137; Fireman Z, 2001, DIGESTION, V64, P100, DOI 10.1159/000048847; Goertz CMH, 2006, MIL MED, V171, P1010, DOI 10.7205/MILMED.171.10.1010; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hollifield M, 2007, J NERV MENT DIS, V195, P504, DOI 10.1097/NMD.0b013e31803044f8; Hull A, 2012, BMC COMPLEMENT AL S1, V12, P194; Jena S, 2008, CEPHALALGIA, V28, P969, DOI 10.1111/j.1468-2982.2008.01640.x; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kang HK, 2009, OCCUP ENVIRON MED, V51, P401, DOI DOI 10.1097/JOM.0B013E3181A2FEEB; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; KING G, 2000, AM J POLIT SCI, V0044; Lao L, 1996, J Altern Complement Med, V2, P27, DOI 10.1089/acm.1996.2.27; Manber R, 2004, J AFFECT DISORDERS, V83, P89, DOI 10.1016/j.jad.2004.05.009; Manheimer Eric, 2006, Acupunct Med, V24 Suppl, pS7; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Melchart D, 2004, ARCH INTERN MED, V164, P104, DOI 10.1001/archinte.164.1.104; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Napadow V, 2008, J ALTERN COMPLEM MED, V14, P861, DOI 10.1089/acm.2008.SAR-3; Niemtzow RC, 2006, J ALTERN COMPLEM MED, V12, P597, DOI 10.1089/acm.2006.597; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Paterson C, 2004, J ALTERN COMPLEM MED, V10, P791; Pilkington K.KirkwoodG, 2007, ACUPUNCT MED, V12, P1; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Tukmachi Emad, 2004, Acupunct Med, V22, P14; Vickers AJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Vickers AJ, 2014, JAMA-J AM MED ASSOC, V311, P955, DOI 10.1001/jama.2013.285478; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Witt CM, 2009, FORSCH KOMPLEMENTMED, V16, P91, DOI 10.1159/000209315; Wyrwich KW, 2005, HEALTH SERV RES, V40, P577, DOI 10.1111/j.1475-6773.2005.0l374.x; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006	41	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0149161	10.1371/journal.pone.0149161	http://dx.doi.org/10.1371/journal.pone.0149161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031099	Green Published, gold			2022-12-27	WOS:000373121800003
J	Enuameh, YAK; Okawa, S; Asante, KP; Kikuchi, K; Mahama, E; Ansah, E; Tawiah, C; Adjei, K; Shibanuma, A; Nanishi, K; Yeji, F; Agyekum, EO; Yasuoka, J; Gyapong, M; Oduro, AR; Asare, GQ; Hodgson, A; Jimba, M; Owusu-Agyei, S				Enuameh, Yeetey Akpe Kwesi; Okawa, Sumiyo; Asante, Kwaku Poku; Kikuchi, Kimiyo; Mahama, Emmanuel; Ansah, Evelyn; Tawiah, Charlotte; Adjei, Kwame; Shibanuma, Akira; Nanishi, Keiko; Yeji, Francis; Agyekum, Enoch Oti; Yasuoka, Junko; Gyapong, Margaret; Oduro, Abraham Rexford; Asare, Gloria Quansah; Hodgson, Abraham; Jimba, Masamine; Owusu-Agyei, Seth		Ghana EMBRACE Implementation Res P	Factors Influencing Health Facility Delivery in Predominantly Rural Communities across the Three Ecological Zones in Ghana: A Cross-Sectional Study	PLOS ONE			English	Article							INSTITUTIONAL DELIVERY; SERVICE UTILIZATION; SKILLED ATTENDANCE; NEONATAL-MORTALITY; CARE PROGRAM; HOME-VISITS; BIRTH; DISTRICT; MOTHERS; PROFILE	Background Maternal and neonatal mortality indicators remain high in Ghana and other sub-Saharan African countries. Both maternal and neonatal health outcomes improve when skilled personnel provide delivery services within health facilities. Determinants of delivery location are crucial to promoting health facility deliveries, but little research has been done on this issue in Ghana. This study explored factors influencing delivery location in predominantly rural communities in Ghana. Methods Data were collected from 1,500 women aged 15-49 years with live or stillbirths that occurred between January 2011 and April 2013. This was done within the three sites operating Health and Demographic Surveillance Systems, i.e., the Dodowa (Greater Accra Region), Kintampo (Brong Ahafo Region), and Navrongo (Upper-East Region) Health Research Centers in Ghana. Multivariable logistic regression was used to identify the determinants of delivery location, controlling for covariates that were statistically significant in univariable regression models. Results Of 1,497 women included in the analysis, 75.6% of them selected health facilities as their delivery location. After adjusting for confounders, the following factors were associated with health facility delivery across all three sites: healthcare provider's influence on deciding health facility delivery, (AOR = 13.47; 95% CI 5.96-30.48), place of residence (AOR = 4.49; 95% CI 1.14-17.68), possession of a valid health insurance card (AOR = 1.90; 95% CI 1.29-2.81), and socio-economic status measured by wealth quintiles (AOR = 2.83; 95% CI 1.43-5.60). Conclusion In addition to known factors such as place of residence, socio-economic status, and possession of valid health insurance, this study identified one more factor associated with health facility delivery: healthcare provider's influence. Ensuring care provider's counseling of clients could improve the uptake of health facility delivery in rural communities in Ghana.	[Enuameh, Yeetey Akpe Kwesi; Asante, Kwaku Poku; Mahama, Emmanuel; Tawiah, Charlotte; Adjei, Kwame; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo, Ghana; [Okawa, Sumiyo; Kikuchi, Kimiyo; Shibanuma, Akira; Nanishi, Keiko; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ansah, Evelyn; Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, POB MB 190, Accra, Ghana; [Yeji, Francis; Oduro, Abraham Rexford] Navrongo Hlth Res Ctr, POB 114, Navrongo, Upper East, Ghana; [Agyekum, Enoch Oti] Syst Sci Consultants, Tokyo, Japan; [Gyapong, Margaret] Dodowa Hlth Res Ctr, POB DD1, Dodowa, Greater Accra, Ghana; [Asare, Gloria Quansah] Ghana Hlth Serv Headquarters, Ministries, Accra, Ghana	Kintampo Health Research Centre; University of Tokyo; Ghana Health Service; Navrongo Health Research Center	Enuameh, YAK (corresponding author), Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo, Ghana.	yeetey@gmail.com	Jimba, Masamine/AAF-5630-2020; Enuameh, Yeetey/AAO-7304-2020; Shibanuma, Akira/C-7652-2016; Yasuoka, Junko/GVT-8950-2022	Enuameh, Yeetey/0000-0003-3772-7425; Shibanuma, Akira/0000-0003-2058-1722; Nanishi, Keiko/0000-0001-7067-8413; Ansah, Evelyn/0000-0003-0401-8606; Gyapong, Margaret/0000-0002-4818-3497; ODURO, ABRAHAM/0000-0002-4191-7419; Owusu-Agyei, Seth/0000-0002-0807-1781; Narh, Clement/0000-0002-4025-5433; Debpuur, Cornelius/0000-0003-0968-5280	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; Ghana Health Service	Japan International Cooperation Agency (JICA) Human Development Department; JICA Research Institute; Ghana Health Service	The study was funded by the Japan International Cooperation Agency (JICA) Human Development Department, The JICA Research Institute (http://www.jica.go.jp/english/index.html) and the Ghana Health Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeje G, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-22; Acquah S, 2006, PROVIDING DOORSTEP S; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; AMONOOLARTSON R, 1981, SOC SCI MED-MED SOC, V15, P735, DOI 10.1016/0271-7123(81)90096-1; AMPOFO DA, 1976, STUD FAMILY PLANN, V7, P266, DOI 10.2307/1966342; Anyait A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-132; Aryeetey Rno, 2015, Ghana Med J, V49, P44, DOI 10.4314/gmj.v49i1.8; BINKA FN, 1995, STUD FAMILY PLANN, V26, P121, DOI 10.2307/2137832; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Esena RK, 2013, INT J SCI TECHNOL RE, V2, P13; Friedrich Erbert Stiftung Ghana, 2010, GUID DISTR ASS GHAN; Fry K., 2014, MEASURING EQUITY NAT; Ghana Health Service, 2008, GHAN NAT SAF MOTH SE; Ghana Statistical Service, 2013, MILL DEV GOALS GHAN; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Ghana Statistical Service, 2011, 2011 GHAN MULT IND C; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; GHS, 2002, COMMUNITY BASED HLTH; Gyapong M, 2013, INT J EPIDEMIOL, V42, P1686, DOI 10.1093/ije/dyt197; Habte F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0716-8; Hagos S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-178; IBM Corporation, 2014, SPSS VERS 22; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kikuchi K, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0539-3; Kintampo Health Research Centre, 2015, 2013 POP IND COMM KI; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; LAMPTEY P, 1984, J TROP PEDIATRICS, V30, P252, DOI 10.1093/tropej/30.5.252; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mekonnen A, 2002, UTILIZATION MATERNAL; Ministry of Health Ghana Ghana Health service UNDP, 2011, GHAN MDG ACC FRAM CO; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Navrongo Health Research Centre, 2015, 2013 POP IND COMM NA; Neumann AK, 1976, SOC SCI MED C, V13c, P129; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Roro Meselech Assegid, 2014, BMC Res Notes, V7, P556, DOI 10.1186/1756-0500-7-556; Sakeah E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-344; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Smith ME, 2012, AFR J REPROD HLTH, V16; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; United Nations Population Fund, 2014, SETT STAND EM OBST N; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Witter S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-16; World Health Organization, 2014, LEV TRENDS CHILD MOR; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	54	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152235	10.1371/journal.pone.0152235	http://dx.doi.org/10.1371/journal.pone.0152235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031301	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800044
J	Hu, JJ; Zhang, CL; Yan, JQ; Wang, RK; Wang, Y; Xu, M				Hu, Jiajia; Zhang, Chengliang; Yan, Jianqin; Wang, Ruike; Wang, Ying; Xu, Mu			Sufentanil and Bupivacaine Combination versus Bupivacaine Alone for Spinal Anesthesia during Cesarean Delivery: A Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							LOW-DOSE BUPIVACAINE; INTRATHECAL MORPHINE; HYPERBARIC BUPIVACAINE; INDUCED PRURITUS; FENTANYL; SECTION; OPIOIDS; ANALGESIA; EFFICACY; SURGERY	Objective The addition of lipophilic opioids to local anesthetics for spinal anesthesia has become a widely used strategy for cesarean anesthesia. A meta-analysis to quantify the benefits and risks of combining sufentanil with bupivacaine for patients undergoing cesarean delivery was conducted. Methods A comprehensive literature search without language or date limitation was performed to identify clinical trials that compared the addition of sufentanil to bupivacaine with bupivacaine alone for spinal anesthesia in healthy parturients choosing cesarean delivery. The Q and I-2 tests were used to assess heterogeneity of the data. Data from each trial were combined using relative ratios (RRs) for dichotomous data or weighted mean differences (WMDs) for continuous data and corresponding 95% confidence intervals (95% CIs) for each trial. Sensitivity analysis was conducted by removing one study a time to assess the quality and consistency of the results. Begg's funnel plots and Egger's linear regression test were used to detect any publication bias. Results This study included 9 trials containing 578 patients in the final meta-analysis. Sufentanil addition provided a better analgesia quality with less breakthrough pain during surgery than bupivacaine alone (RR = 0.10, 95% CI 0.06 to 0.18, P < 0.001). Sensory block onset time was shorter and first analgesic request time was longer in sufentanil added group compared with the bupivacaine-alone group (WMD = -1.0 min, 95% CI -1.5 to -0.58, P < 0.001 and WMD = 133 min, 95% CI 75 to 213, P < 192, respectively). There was no significant difference in the risk of hypotension and vomiting between these two groups. But pruritus was more frequentely reported in the group with sufentanil added (RR = 7.63, 95% CI 3.85 to 15.12, P < 0.001). Conclusion Bupivacaine and sufentanil combination is superior to that of bupivacaine alone for spinal anesthesia for cesarean delivery in analgesia quality. Women receiving the combined two drugs had less breakthrough pain, shorter sensory block onset time, and longer first analgesic request time. However, the addition of sufentanil to bupivacaine increased the incidence of pruritus.	[Hu, Jiajia; Yan, Jianqin; Wang, Ruike; Xu, Mu] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Zhang, Chengliang] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Surg, Changsha, Hunan, Peoples R China; [Wang, Ying] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Anesthesiol, Fuzhou, Peoples R China	Central South University; Central South University; Fujian Medical University	Yan, JQ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	jqyan480@gmail.com			Xiangya Clinical Research Fund [2013L13]; National Natural Science Foundation of China [81400921]	Xiangya Clinical Research Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Xiangya Clinical Research Fund 2013L13 (JY), Internal to Xiangya hospital of Central South University; National Natural Science Foundation of China 81400921 (YW), External fund to our organisations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi BB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004350.pub3; Arzola C, 2011, BRIT J ANAESTH, V107, P308, DOI 10.1093/bja/aer200; Bang YS, 2012, KOREAN J ANESTHESIOL, V63, P321, DOI 10.4097/kjae.2012.63.4.321; Braga ADFD, 2003, EUR J ANAESTH, V20, P631; Braga AA, 2012, REV BRAS ANESTESIOL, V62, P775, DOI 10.1016/S0034-7094(12)70178-2; Chinachoti Thitima, 2013, Journal of the Medical Association of Thailand, V96, P589; Choi DH, 2000, REGION ANESTH PAIN M, V25, P240, DOI 10.1016/S1098-7339(00)90005-1; Dahl JB, 1999, ANESTHESIOLOGY, V91, P1919, DOI 10.1097/00000542-199912000-00045; Dahlgren G, 1997, ANESTH ANALG, V85, P1288, DOI 10.1097/00000539-199712000-00020; Davies SJ, 1997, ANESTH ANALG, V85, P607, DOI 10.1097/00000539-199709000-00022; Demiraran Yavuz, 2006, J Anesth, V20, P274, DOI 10.1007/s00540-006-0437-2; Ginosar Y, 2013, BR J ANAESTH; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; HUNT CO, 1989, ANESTHESIOLOGY, V71, P535, DOI 10.1097/00000542-198910000-00009; Knobloch K, 2011, J CRANIO MAXILL SURG, V39, P91, DOI 10.1016/j.jcms.2010.11.001; Krajnik M, 2001, J PAIN SYMPTOM MANAG, V21, P151, DOI 10.1016/S0885-3924(00)00256-6; Kumar Kamal, 2013, J Anaesthesiol Clin Pharmacol, V29, P303, DOI 10.4103/0970-9185.117045; LABELLA FS, 1978, LIFE SCI, V23, P1797, DOI 10.1016/0024-3205(78)90111-X; Lee JH, 2011, KOREAN J ANESTHESIOL, V60, P103, DOI 10.4097/kjae.2011.60.2.103; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Meylan N, 2009, BRIT J ANAESTH, V102, P156, DOI 10.1093/bja/aen368; Ngan Kee WD, 2010, CURR OPIN ANESTHESIO, V23, P304, DOI 10.1097/ACO.0b013e328337ffc6; Ngiam S. K. K., 1998, SMJ, V39, P290; Popping DM, 2012, PAIN, V153, P784, DOI 10.1016/j.pain.2011.11.028; Qiu MT, 2012, CNS NEUROSCI THER, V18, P426, DOI 10.1111/j.1755-5949.2012.00306.x; Raffaeli W, 2006, EUR J ANAESTH, V23, P605, DOI 10.1017/S026502150600038X; RANDALLS B, 1991, BRIT J ANAESTH, V66, P314, DOI 10.1093/bja/66.3.314; Schmelz M, 2009, ANAESTHESIST, V58, P61, DOI 10.1007/s00101-008-1478-8; Shah MK, 2000, ANAESTHESIA, V55, P1008, DOI 10.1046/j.1365-2044.2000.01618-2.x; Szarvas S, 2003, J CLIN ANESTH, V15, P234, DOI 10.1016/S0952-8180(02)00501-9; Veena A, 2010, ANAESTH PAIN INTENSI, V14, P99; Vyas Nitika, 2010, J Anaesthesiol Clin Pharmacol, V26, P488; Yeh HM, 2000, ANESTH ANALG, V91, P172, DOI 10.1097/00000539-200007000-00032	35	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152605	10.1371/journal.pone.0152605	http://dx.doi.org/10.1371/journal.pone.0152605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032092	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800101
J	Kim, DK; Koo, KC; Raheem, AA; Kim, KH; Chung, BH; Choi, YD; Rha, KH				Kim, Dae Keun; Koo, Kyo Chul; Raheem, Ali Abdel; Kim, Ki Hong; Chung, Byung Ha; Choi, Young Deuk; Rha, Koon Ho			Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence	PLOS ONE			English	Article							ASSISTED RADICAL PROSTATECTOMY; MEN; DISSECTION; OUTCOMES	Purpose/Objectives To investigate pN1 prostate cancer (PCa) patients treated surgically without immediate adjuvant treatment. Materials and Methods We analyzed the database of 2316 patients at our institution who underwent robot-assisted radical prostatectomy (RARP)/radical prostatectomy (RP) between July 2005 and November 2012. 87 patients with pN1 PCa and received no neoadjuvant and immediate adjuvant therapy were included in the study. Included pN1 PCa patients were followed up for median of 60 months. Biochemical recurrence (BCR)-free survival, metastasis-free survival (MFS), cancer specific survival (CSS), and overall survival (OS) rates were determined by using Kaplan-Meier analysis. Cox regression analysis was performed to investigate the impact of prostate-specific antigen (PSA) level, Gleason score, extraprostatic extension, seminal vesicle invasion, perineural invasion, lymphovascular invasion, positive surgical margin, tumor volume, early post-operative PSA(6 weeks), PSA nadir, lymph node yield, and number of pathologically positive lymph nodes on survival. Results The 5-year OS rate of patients was 86.1%, while the CSS rate was 89.6%. The metastasis-free and BCR-free survival rates were 71% and 19.1%, respectively, and each was significantly correlated with the number of positive lymph nodes on log rank tests (p = 0.004 and p = 0.039, respectively). The presence of 2 or more pathologically positive LNs (HR: 2.20; 95% CI 1.30-3.72; p = 0.003) and a Gleason score >= 8 (HR: 2.40; 95% CI: 1.32-4.38; p = 0.04) were significant negative predictors of BCR free survival on multivariable regression analysis. Furthermore, the presence of 2 or more positive lymph nodes (HR: 1.06; 95% CI 1.01-1.11; p = 0.029) were significant negative predictors of metastasis-free survival on multivariable regression analysis. Additionally, in the patients who had no BCR without adjuvant treatment 9 patients out of 10 (90%) had single positive LN and 5 patients out of 10 (50%) had Gleason score 7. Therefore, single positive LN, and Gleason scores <= 7 have significantly low risk of disease progression. Conclusions pN1 PCa patients have heterogenous clinical courses. Patients with single positive LN, and Gleason scores <= 7 have low risk of recurrence. Close observation with delayed adjuvant hormone therapy can be considered in these patients.	[Kim, Dae Keun] CHA Univ, CHA Seoul Stn, CHA Med Sch, Dept Urol,Med Ctr, Seoul, South Korea; [Kim, Dae Keun] Hanyang Univ, Grad Sch, Sch Med, Dept Urol, Seoul 133791, South Korea; [Koo, Kyo Chul; Raheem, Ali Abdel; Chung, Byung Ha; Choi, Young Deuk; Rha, Koon Ho] Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea; [Raheem, Ali Abdel] Tanta Univ, Dept Urol, Tanta, Egypt; [Kim, Ki Hong] Soonchunhyang Univ, Cheonan Hosp, Dept Urol, Cheonan, Chungcheongnam, South Korea	Pochon Cha University; Hanyang University; Yonsei University; Yonsei University Health System; Egyptian Knowledge Bank (EKB); Tanta University; Soonchunhyang University	Rha, KH (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Urol Sci Inst, Seoul, South Korea.	khrha@yuhs.ac	김, 대근/X-8040-2019	김, 대근/0000-0003-3237-6304; Choi, Young Deuk/0000-0002-8545-5797; Koo, Kyo Chul/0000-0001-7303-6256; Rha, Koon Ho/0000-0001-8588-7584; Chung, Byung Ha/0000-0001-9817-3660				Abdollah F, 2012, BJU INT, V109, P1177, DOI 10.1111/j.1464-410X.2011.10518.x; Boorjian SA, 2007, J UROLOGY, V178, P864, DOI 10.1016/j.juro.2007.05.048; Feifer AH, 2011, CANCER-AM CANCER SOC, V117, P3933, DOI 10.1002/cncr.25981; Gerber GS, 1997, EUR UROL, V32, P385, DOI 10.1159/000480794; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Kim KH, 2014, BJU INT, V113, P598, DOI 10.1111/bju.12280; Kim KH, 2013, BJU INT, V112, P216, DOI 10.1111/j.1464-410X.2012.11765.x; Koo KC, 2014, PROSTATE INT, V2, P127, DOI 10.12954/PI.14050; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686, DOI 10.6004/jnccn.2014.0072; Moschini M, 2015, EUR UROL; Nini A., 2015, EUR UROL; Palapattu GS, 2004, J UROLOGY, V172, P1860, DOI 10.1097/01.ju.0000139886.25848.4a; Pierorazio PM, 2013, PROSTATE, V73, P1673, DOI 10.1002/pros.22702; Seiler R, 2014, J UROLOGY, V191, P1280, DOI 10.1016/j.juro.2013.11.029; Spiess PE, 2007, BJU INT, V99, P321, DOI 10.1111/j.1464-410X.2006.06648.x; Touijer KA, 2014, EUR UROL, V65, P20, DOI 10.1016/j.eururo.2013.03.053; Zwergel U, 2004, J UROLOGY, V171, P1128, DOI 10.1097/01.ju.0000113202.37783.1f	18	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152391	10.1371/journal.pone.0152391	http://dx.doi.org/10.1371/journal.pone.0152391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031340	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800065
J	Kim, JH; Furrow, E; Ritt, MG; Utz, PJ; Robinson, WH; Yu, LP; Eckert, A; Stuebner, K; O'Brien, TD; Steinman, L; Modiano, JF				Kim, Jong-Hyuk; Furrow, Eva; Ritt, Michelle G.; Utz, Paul J.; Robinson, William H.; Yu, Liping; Eckert, Andrea; Stuebner, Kathleen; O'Brien, Timothy D.; Steinman, Lawrence; Modiano, Jaime F.			Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; SUSCEPTIBILITY GENES; MELLITUS; INSULIN; AUTOANTIBODIES; POLYMORPHISMS; ANTIBODIES; HUMANS	Diabetes mellitus occurs spontaneously in dogs. Although canine diabetes shares many features with human type-1 diabetes, there are differences that have cast doubt on the immunologic origin of the canine disease. In this study, we examined whether peripheral immune responses directed against islet antigens were present in dogs with diabetes. Routine diagnostics were used to confirm diabetic status, and serum samples from dogs with (N = 15) and without (N = 15) diabetes were analyzed for the presence of antibodies against islet antigens (insulin, glutamic acid decarboxylase, insulinoma-associated protein tyrosine phosphatase, and islet beta-cell zinc cation efflux transporter) using standard radioassays. Interferon-gamma production from peripheral blood T cells stimulated by porcine insulin and by human insulin was tested using Elispot assays. Anti-insulin antibodies were detectable in a subset of diabetic dogs receiving insulin therapy. Pre-activated T cells and incipient insulin-reactive T cells in response to porcine or human insulin were identified in non-diabetic dogs and in dogs with diabetes. The data show that humoral and cellular anti-insulin immune responses are detectable in dogs with diabetes. This in turn provides support for the potential to ethically use dogs with diabetes to study the therapeutic potential of antigen-specific tolerance.	[Kim, Jong-Hyuk; Furrow, Eva; Ritt, Michelle G.; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Kim, Jong-Hyuk; Stuebner, Kathleen; O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Anim Canc Care & Res Program, St Paul, MN 55108 USA; [Kim, Jong-Hyuk; O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, St Paul, MN 55108 USA; [Utz, Paul J.; Robinson, William H.] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; [Utz, Paul J.; Robinson, William H.; Steinman, Lawrence] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Yu, Liping] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Eckert, Andrea; Stuebner, Kathleen] Univ Minnesota, Coll Vet Med, Clin Invest Ctr, St Paul, MN 55108 USA; [O'Brien, Timothy D.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [O'Brien, Timothy D.; Modiano, Jaime F.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Steinman, Lawrence] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Modiano, Jaime F.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Modiano, JF (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Anim Canc Care & Res Program, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, St Paul, MN 55108 USA.; Modiano, JF (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA.; Modiano, JF (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN USA.	modiano@umn.edu	MODIANO, JAIME/K-3583-2019; Furrow, Eva/W-9963-2018; KIM, JONG HYUK/AAC-7433-2020	MODIANO, JAIME/0000-0001-6398-7648; KIM, JONG HYUK/0000-0002-1645-0036; O'Brien, Timothy/0000-0001-9742-0930; Steinman, Lawrence/0000-0002-2437-2250; Robinson, William/0000-0003-4385-704X; Furrow, Eva/0000-0002-7339-2354	Morris Animal Foundation grant [D12CA-031]; NIH ORIP K01 Mentored Research Scientist Development Award [1K01OD019912-01]; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; Animal Cancer Care and Research Program of the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Morris Animal Foundation grant; NIH ORIP K01 Mentored Research Scientist Development Award; Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; Animal Cancer Care and Research Program of the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by a Morris Animal Foundation grant (#D12CA-031) to EF. Partial funding for EF was provided by an NIH ORIP K01 Mentored Research Scientist Development Award (1K01OD019912-01). JFM was supported in part by the Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota. Donations to the Animal Cancer Care and Research Program of the University of Minnesota also helped support this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105473; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Arif S, 2011, DIABETES, V60, P2112, DOI 10.2337/db10-1643; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; Cook Audrey K, 2012, J Diabetes Sci Technol, V6, P491; Davison LJ, 2008, J VET INTERN MED, V22, P1317, DOI 10.1111/j.1939-1676.2008.0194.x; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2003, VET IMMUNOL IMMUNOP, V91, P53, DOI 10.1016/S0165-2427(02)00267-2; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; Eisenbarth GS, 2008, ARQ BRAS ENDOCRINOL, V52, P146, DOI 10.1590/S0004-27302008000200002; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; Haley PJ, 1997, IMMUNOPHARM IMMUNOT, V19, P459, DOI 10.3109/08923979709007668; Hess RS, 2000, J AM VET MED ASSOC, V216, P1414, DOI 10.2460/javma.2000.216.1414; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kronenberg D, 2012, DIABETES, V61, P1752, DOI 10.2337/db11-1520; Kumar P, 2014, VET WORLD, V7, P952, DOI 10.14202/vetworld.2014.952-959; KWOK SCM, 1983, J BIOL CHEM, V258, P2357; Nelson RW, 2014, J ENDOCRINOL, V222, pT1, DOI 10.1530/JOE-14-0202; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Roep BO, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006103; Shields EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129809; Short AD, 2010, TISSUE ANTIGENS, V75, P242, DOI 10.1111/j.1399-0039.2009.01434.x; Short AD, 2007, J HERED, V98, P518, DOI 10.1093/jhered/esm048; Short AD, 2009, VET IMMUNOL IMMUNOP, V128, P137, DOI 10.1016/j.vetimm.2008.10.301; SMITH LF, 1966, AM J MED, V40, P662, DOI 10.1016/0002-9343(66)90145-8; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697	30	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152397	10.1371/journal.pone.0152397	http://dx.doi.org/10.1371/journal.pone.0152397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031512	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800066
J	Milutinovic, S; Heynen-Genel, S; Chao, E; Dewing, A; Solano, R; Milan, L; Barron, N; He, M; Diaz, PW; Matsuzawa, S; Reed, JC; Hassig, CA				Milutinovic, Snezana; Heynen-Genel, Susanne; Chao, Elizabeth; Dewing, Antimone; Solano, Ricardo; Milan, Loribelle; Barron, Nikki; He, Min; Diaz, Paul W.; Matsuzawa, Shuichi; Reed, John C.; Hassig, Christian A.			Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)	PLOS ONE			English	Article							ARSENIC TRIOXIDE; CARDIOTONIC STEROIDS; APOPTOSIS; INHIBITION; ATPASE; MULTIPLE; CELL	Cardiac glycosides (CGs), inhibitors of Na+/K+-ATPase (NKA), used clinically to treat heart failure, have garnered recent attention as potential anti-cancer and anti-viral agents. A high-throughput phenotypic screen designed to identify modulators of promyelocytic leukemia protein (PML) nuclear body (NB) formation revealed the CG gitoxigenin as a potent activator of PML. We demonstrate that multiple structurally distinct CGs activate the formation of PML NBs and induce PML protein SUMOylation in an NKA-dependent fashion. CG effects on PML occur at the post-transcriptional level, mechanistically distinct from previously described PML activators and are mediated through signaling events downstream of NKA. Curiously, genomic deletion of PML in human cancer cells failed to abrogate the cytotoxic effects of CGs and other apoptotic stimuli such as ceramide and arsenic trioxide that were previously shown to function through PML in mice. These findings suggest that alternative pathways can compensate for PML loss to mediate apoptosis in response to CGs and other apoptotic stimuli.	[Milutinovic, Snezana; Heynen-Genel, Susanne; Chao, Elizabeth; Dewing, Antimone; Solano, Ricardo; Milan, Loribelle; Matsuzawa, Shuichi; Reed, John C.; Hassig, Christian A.] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Barron, Nikki] Bemer USA LLC, Carlsbad, CA USA; [He, Min] NCI, Bethesda, MD 20892 USA; [Diaz, Paul W.] P William Diaz Pharmaceut Consulting, Riverside, CA USA; [Reed, John C.] Roche, Grenzacherstr 124, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding	Hassig, CA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chassig@sbpdiscovery.org			National Cancer Institute NExT Program, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	National Cancer Institute NExT Program, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute NExT Program, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.; We are grateful to members of the Reed laboratory and the Conrad Prebys Center for Chemical Genomics for assistance with assay optimization and screening. This project was supported in part by federal funds from the National Cancer Institute NExT Program, National Institutes of Health, under contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	Akimova Olga A, 2005, Pathophysiology, V12, P125, DOI 10.1016/j.pathophys.2005.03.003; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Cheng Xiwen, 2012, Front Oncol, V2, P210, DOI 10.3389/fonc.2012.00210; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fasci D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3929; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Hands KJ, 2014, J CELL SCI, V127, P365, DOI 10.1242/jcs.132290; Hartley C, 2006, ARCH VIROL, V151, P2495, DOI 10.1007/s00705-006-0824-x; HOLLMAN A, 1985, BRIT HEART J, V54, P258; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Kapoor A, 2012, ANTIMICROB AGENTS CH, V56, P4891, DOI 10.1128/AAC.00898-12; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Komura N, 2007, EXP CELL RES, V313, P2753, DOI 10.1016/j.yexcr.2007.03.032; Li L, 2006, CANCER LETT, V236, P259, DOI 10.1016/j.canlet.2005.05.034; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Mathews V, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.056; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Rabellino A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00060; SCHONFELD W, 1986, BIOCHEM PHARMACOL, V35, P3221, DOI 10.1016/0006-2952(86)90416-8; Stadler M, 1995, ONCOGENE, V11, P2565; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; TOBIN T, 1975, EUR J PHARMACOL, V32, P133, DOI 10.1016/0014-2999(75)90276-9; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Xu ZX, 2004, J BIOL CHEM, V279, P1838, DOI 10.1074/jbc.M310987200; Yip KW, 2011, J BIOMOL SCREEN, V16, P251, DOI 10.1177/1087057110394181; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152692	10.1371/journal.pone.0152692	http://dx.doi.org/10.1371/journal.pone.0152692			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031987	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800120
J	Popoola, VO; Lau, BD; Shihab, HM; Farrow, NE; Shaffer, DL; Hobson, DB; Kulik, SV; Zaruba, PD; Shermock, KM; Kraus, PS; Pronovost, PJ; Streiff, MB; Haut, ER				Popoola, Victor O.; Lau, Brandyn D.; Shihab, Hasan M.; Farrow, Norma E.; Shaffer, Dauryne L.; Hobson, Deborah B.; Kulik, Susan V.; Zaruba, Paul D.; Shermock, Kenneth M.; Kraus, Peggy S.; Pronovost, Peter J.; Streiff, Michael B.; Haut, Elliott R.			Patient Preferences for Receiving Education on Venous Thromboembolism Prevention - A Survey of Stakeholder Organizations	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; RISK-FACTORS; THROMBOPROPHYLAXIS; METAANALYSIS; ADHERENCE; TRAUMA	Importance Venous thromboembolism (VTE) is a major cause of morbidity and mortality among hospitalized patients and is largely preventable. Strategies to decrease the burden of VTE have focused on improving clinicians' prescribing of prophylaxis with relatively less emphasis on patient education. Objective To develop a patient-centered approach to education of patients and their families on VTE: including importance, risk factors, and benefit/harm of VTE prophylaxis in hospital settings. Design, Setting and Participants The objective of this study was to develop a patient-centered approach to education of patients and their families on VTE: including importance, risk factors, and benefit/harm of VTE prophylaxis in hospital settings. We implemented a three-phase, web-based survey (SurveyMonkey) between March 2014 and September 2014 and analyzed survey data using descriptive statistics. Four hundred twenty one members of several national stakeholder organizations and a single local patient and family advisory board were invited to participate via email. We assessed participants' preferences for VTE education topics and methods of delivery. Participants wanted to learn about VTE symptoms, risk factors, prevention, and complications in a context that emphasized harm. Although participants were willing to learn using a variety of methods, most preferred to receive education in the context of a doctor-patient encounter. The next most common preferences were for video and paper educational materials. Conclusions Patients want to learn about the harm associated with VTE through a variety of methods. Efforts to improve VTE prophylaxis and decrease preventable harm from VTE should target the entire continuum of care and a variety of stakeholders including patients and their families.	[Popoola, Victor O.; Lau, Brandyn D.; Shihab, Hasan M.; Farrow, Norma E.; Shaffer, Dauryne L.; Hobson, Deborah B.; Zaruba, Paul D.; Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lau, Brandyn D.] Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Shaffer, Dauryne L.; Hobson, Deborah B.; Kulik, Susan V.] Johns Hopkins Univ Hosp, Dept Nursing, Baltimore, MD 21287 USA; [Shermock, Kenneth M.; Kraus, Peggy S.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Lau, Brandyn D.; Shermock, Kenneth M.; Pronovost, Peter J.; Streiff, Michael B.; Haut, Elliott R.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Lau, Brandyn D.; Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA.; Haut, ER (corresponding author), Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA.; Haut, ER (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.	ehaut1@jhmi.edu	Lau, Brandyn/H-4825-2018; Haut, Elliott R./J-3948-2019	Lau, Brandyn/0000-0003-3575-2440; Farrow, Norma/0000-0002-0404-214X; Haut, Elliott/0000-0001-7075-771X	Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology" [CE-12-11-4489]	Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology"(Patient-Centered Outcomes Research Institute - PCORI)	BDL, NEF, VOP, ERH, PJP, and MBS, are supported by a contract (CE-12-11-4489) from the Patient-Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKWELL B, 1992, PSYCHOTHER PSYCHOSOM, V58, P161, DOI 10.1159/000288624; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Elder S, 2014, J PATIENT SAFETY; Fanikos J, 2010, AM J MED, V123, P536, DOI 10.1016/j.amjmed.2009.11.017; Farrimond H, 2010, PSYCHOL HEALTH, V25, P289, DOI 10.1080/08870440802499382; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Geist MR, 2010, EVAL PROGRAM PLANN, V33, P147, DOI 10.1016/j.evalprogplan.2009.06.006; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Haut ER, 2013, COMP EFFECTIVENESS R, P211; Haut ER, 2015, JAMA SURG; Kucher N, 2005, THROMB HAEMOSTASIS, V93, P494, DOI 10.1160/TH04-09-0587; Lau BD, ANN SURG IN PRESS; Lau BD, 2014, BMJ QUAL SAF, V23, P187, DOI 10.1136/bmjqs-2012-001782; Lee MD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096431, 10.1371/journal.pone.0104744]; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Marden JI, 1995, ANAL MODELIG RANK DA; Maynard G, 2008, PREVENTING HOSP ACQU; Maynard GA, 2011, SOC HOSP MED ANN M; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Office of the Surgeon General (US); National Heart Lung and Blood Institute (US), 2008, SURG GEN CALL ACT PR; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Shekelle P G, 2013, Evid Rep Technol Assess (Full Rep), P1; Shekelle PG, 2013, ANN INTERN MED, V158, P365, DOI 10.7326/0003-4819-158-5-201303051-00001; Shermock KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066311; Streiff MB, 2012, HEMATOL-AM SOC HEMAT, P631, DOI 10.1182/asheducation-2012.1.631; Streiff MB, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3935; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; Wendelboe AM, 2015, J THROMB HAEMOST, V13, P1365, DOI 10.1111/jth.13031; Wong A, 2015, J HOSP MED, V10, P108, DOI 10.1002/jhm.2282	32	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152084	10.1371/journal.pone.0152084	http://dx.doi.org/10.1371/journal.pone.0152084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031330	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800035
J	Porteous, T; Ryan, M; Bond, C; Watson, M; Watson, V				Porteous, Terry; Ryan, Mandy; Bond, Christine; Watson, Margaret; Watson, Verity			Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment	PLOS ONE			English	Article							PRIMARY-CARE; ILLNESS; SATISFACTION; PERCEPTIONS; EXPERIENCES; MANAGEMENT; SERVICES; DELIVERY; VISITS; USERS	Background Demand for health services continues to rise. Greater use of community pharmacy services instead of medical services for minor ailments could help relieve pressure on healthcare providers in high-cost settings. Community pharmacies are recognised sources of treatment and advice for people wishing to manage these ailments. However, increasing the public's use of pharmacy services may depend on attributes of pharmacies and their staff. This study aimed to determine the general public's relative preferences for community pharmacy attributes using a discrete choice experiment (DCE). Method A UK-wide DCE survey of the general public was conducted using face-to-face computer-assisted personal interviews. Attributes and levels for the DCE were informed by a literature review and a cohort study of community pharmacy customers. The context for the experiment was a minor ailment scenario describing flu-like symptoms. The DCE choice sets described two hypothetical community pharmacy services; respondents were asked to choose which (if either) of the two pharmacies they would prefer to help them manage symptoms. Data from 1,049 interviews were analysed using an error components logit model. Willingness to pay (WTP), a monetary measure of benefit, was estimated for the different attribute levels. Results When seeking help or treatment for flu-like symptoms, respondents most valued a pharmacy service that would improve their understanding and management of symptoms (WTP = 6.28) pound, provided by staff who are trained (WTP (pharmacist) = 2.63 pound: WTP(trained assistant) = 3.22) pound, friendly and approachable (WTP = 3.38) pound. Waiting time, pharmacy location and availability of parking also contributed to respondents' preferences. WTP for a service comprising the best possible combination of attributes and levels was calculated as 55.43 pound. Conclusion Attributes of a community pharmacy and its staff may influence people's decisions about which pharmacy they would visit to access treatment and advice for minor ailments. In line with the public's preferences, offering community pharmacy services that help people to better understand and manage symptoms, are provided promptly by trained staff who are friendly and approachable, and in a local setting with easy access to parking, has the potential to increase uptake amongst those seeking help to manage minor ailments. In this way it may be possible to shift demand away from high-cost health services and make more efficient use of scarce public resources.	[Porteous, Terry; Watson, Margaret] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Serv Res Unit, Polwarth Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland; [Ryan, Mandy; Watson, Verity] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Polwarth Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland; [Bond, Christine] Univ Aberdeen, Inst Appl Hlth Sci, Acad Primary Care, Polwarth Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Watson, V (corresponding author), Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Polwarth Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland.	v.watson@abdn.ac.uk		Watson, Verity/0000-0002-3824-5076; , Margaret/0000-0002-8198-9273	Medical Research Council [MR/J004812/1]; Pharmacy Research UK [1076457]; Chief Scientist Office [HERU1, HSRU2] Funding Source: researchfish; MRC [MR/J004812/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pharmacy Research UK; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council MR/J004812/1 to VW (www.mrc.ac.uk), and Pharmacy Research UK 1076457 to MW (www.pharmacyresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Omar SM, 2000, INT J PHARM PRACT, V8, P135, DOI DOI 10.1111/J.2042-7174.2000.TB00998.X; Gastelurrutia MA, 2006, PHARM WORLD SCI, V28, P374, DOI 10.1007/s11096-006-9049-z; Arrow Kenneth., 1993, FED REGISTER, V58, P4601, DOI DOI 10.1002/QJ.49703213905; Bond C, 2003, DRUG SAFETY, V26, P1065, DOI 10.2165/00002018-200326150-00001; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Caldow J, 2007, HEALTH EXPECT, V10, P30, DOI 10.1111/j.1369-7625.2006.00422.x; Cavaco AM, 2005, PHARM WORLD SCI, V27, P54, DOI 10.1007/s11096-004-2129-z; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Entwistle V, 2012, J HEALTH SERV RES PO, V17, P70, DOI 10.1258/jhsrp.2011.011029; Ericsson K.A., 1993, PROTOCOL ANAL VERBAL; Fielding S, 2015, FAM PRACT, V32, P165, DOI 10.1093/fampra/cmv003; Gerard K, 2014, HLTH EXPECT; Gerard K, 2012, VALUE HEALTH, V15, P699, DOI 10.1016/j.jval.2012.02.006; Grindrod KA, 2010, ANN PHARMACOTHER, V44, P1554, DOI 10.1345/aph.1P228; Hammond T, 2004, FAM PRACT, V21, P146, DOI 10.1093/fampra/cmh207; Hassell K., 1999, INT J PHARM PRACT, V7, P51, DOI [10.1111/j.2042-7174.1999.tb00948.x, DOI 10.1111/J.2042-7174.1999.TB00948.X]; Hippisley-Cox JVY, 2009, TRENDS CONSULTATION; Horvat N, 2011, INT J CLIN PHARM-NET, V33, P985, DOI 10.1007/s11096-011-9572-4; Kuhfeld W.F., 2010, SAS; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; MARSH GN, 1995, BRIT MED J, V310, P778, DOI 10.1136/bmj.310.6982.778; Mitchell R.C., 1989, USING SURVEYS VALUE; Munro J, 2000, BRIT MED J, V321, P150, DOI 10.1136/bmj.321.7254.150; Naik-Panvelkar Pradnya, 2013, Int J Pharm Pract, V21, P3, DOI 10.1111/ijpp.12002; NHS England, 2013, TRANSF URG EM CAR SE; Paudyal V, 2013, BRIT J GEN PRACT, V63, pE472, DOI 10.3399/bjgp13X669194; Porteous T, 2005, FAM PRACT, V22, P78, DOI 10.1093/fampra/cmh719; Porteous T, 2006, BRIT J GEN PRACT, V56, P911; Proprietary Association of Great Britain, 2009, MAK CAS SELF CAR MIN; Raven MC, 2013, JAMA-J AM MED ASSOC, V309, P1145, DOI 10.1001/jama.2013.1948; Rennie L, 2012, VALUE HEALTH, V15, P1069, DOI 10.1016/j.jval.2012.06.013; Royal Pharmaceutical Society of Great Britain, 1996, COMM PHARM CHOIC IS; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Ryan M, 2014, SOC SCI MED, V106, P194, DOI 10.1016/j.socscimed.2014.01.013; Salisbury C, 2002, BRIT J GEN PRACT, V52, P554; Scott A, 2007, PHARMACOECONOMICS, V25, P783, DOI 10.2165/00019053-200725090-00006; Simoens S, 2009, PHARM WORLD SCI, V31, P450, DOI 10.1007/s11096-009-9293-0; Sinclair H, 2000, INT J PHARM PRACT, V8; SKOMO ML, 2008, INT J PHARM PRACT, V16, P357, DOI DOI 10.1211/ijpp.16.6.0004; Tinelli Michela, 2009, Int J Pharm Pract, V17, P275; Ubach C, 2002, INT J PHARM PRACT, V10, P191; Uscher-Pines L, 2013, AM J MANAG CARE, V19, P47; Watson MC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006261; Watson M.C., 2004, INT J PHARM PRACT, V12, P65; Watson MC, 2009, FAM PRACT, V26, P532, DOI 10.1093/fampra/cmp061; Welle-Nilsen LK, 2011, SCAND J PRIM HEALTH, V29, P39, DOI 10.3109/02813432.2010.545209; WHITTINGTON Z, 2001, PHARM J, V266, P425; Whitty JA, 2015, RES SOC ADMIN PHARM, V11, P197, DOI 10.1016/j.sapharm.2014.06.007	50	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152257	10.1371/journal.pone.0152257	http://dx.doi.org/10.1371/journal.pone.0152257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031588	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000373121800046
J	Sorensen, CE; Tritsaris, K; Reibel, J; Lauritzen, M; Mortensen, EL; Osler, M; Pedersen, AML				Sorensen, Christiane Elisabeth; Tritsaris, Katerina; Reibel, Jesper; Lauritzen, Martin; Mortensen, Erik Lykke; Osler, Merete; Pedersen, Anne Marie Lynge			Elevated p16ink4a Expression in Human Labial Salivary Glands as a Potential Correlate of Cognitive Aging in Late Midlife	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; IN-VIVO; CELLULAR SENESCENCE; P16(INK4A); CELLS; AGE; INHIBITION; BIOMARKER; REGENERATION; DECLINE	Background The cell-cycle inhibitor and tumor suppressor cyclin dependent kinase inhibitor, p16(ink4a), is one of the two gene products of the ink4a/ARF (cdkn2a) locus on chromosome 9q21. Upregulation of p16(ink4a) has been linked to cellular senescence, and findings from studies on different mammalian tissues suggest that p16(ink4a) may be a biomarker of organismal versus chronological age. Objective The aim of this study was to examine the immunolocalization pattern of p16(ink4a) in human labial salivary gland (LSG) tissue, and to analyze whether its expression level in LSGs is a peripheral correlate of cognitive decline in late midlife. Methods The present study was a part of a study of causes and predictors of cognitive decline in middle-aged men in a Danish birth cohort. It is based on data from 181 male participants from the Danish Metropolit birth cohort, born in 1953, who were examined for age-associated alterations in cognition, dental health, and morphological and autonomic innervation characteristics of the LSGs. The participants were allocated to two groups based on the relative change in cognitive performance from young adulthood to late midlife. LSG biopsies were analyzed by qRT-PCR for the expression level of p16(ink4a). Immunohistochemistry was performed on formalin-fixed, paraffin-embedded sections of LSGs. Results p16(ink4a) immunoreactivity was observed in LSG ductal, myoepithelial, and stromal cells, but not in acinar cells. The mean relative expression of p16(ink4a) in LSGs was higher in the group of participants with decline in cognitive performance. A logistic regression analysis revealed that the relative p16 expression was predictive of the participant's group assignment. A negative correlation was found between relative p16(ink4a) expression and the participant's standardized regression residuals from early adulthood to late midlife cognitive performance scores. Conclusions p16(ink4a) expression in human LSGs may constitute a potential peripheral correlate of cognitive decline. Human labial salivary glands seem suitable for studies on organismal as opposed to chronological age.	[Sorensen, Christiane Elisabeth; Reibel, Jesper; Pedersen, Anne Marie Lynge] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Oral Med Clin Oral Physiol Oral Pathol & Ana, Copenhagen, Denmark; [Tritsaris, Katerina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Sorensen, Christiane Elisabeth; Tritsaris, Katerina; Lauritzen, Martin; Mortensen, Erik Lykke; Pedersen, Anne Marie Lynge] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark; [Lauritzen, Martin] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Lauritzen, Martin] Rigshosp, Dept Clin Neurophysiol, Glostrup, Denmark; [Mortensen, Erik Lykke; Osler, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke; Osler, Merete] Univ Aarhus, Danish Aging Res Ctr, Southern Denmark, Denmark; [Mortensen, Erik Lykke; Osler, Merete] Univ Aarhus, Copenhagen, Denmark; [Mortensen, Erik Lykke; Osler, Merete] Univ Aarhus, Odense, Denmark; [Osler, Merete] Rigshosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Sorensen, Christiane Elisabeth] Univ Copenhagen, Sect Cell Biol & Physiol, Dept Biol, August Krogh Bldg, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen	Sorensen, CE; Pedersen, AML (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Oral Med Clin Oral Physiol Oral Pathol & Ana, Copenhagen, Denmark.; Sorensen, CE; Pedersen, AML (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark.; Sorensen, CE (corresponding author), Univ Copenhagen, Sect Cell Biol & Physiol, Dept Biol, August Krogh Bldg, Copenhagen, Denmark.	christiane.soerensen@bio.ku.dk; amlp@sund.ku.dk	Pedersen, Anne Marie Lynge/N-4899-2019; Osler, Merete/AAF-7885-2019; Tritsaris, Katerina/M-4095-2015	Pedersen, Anne Marie Lynge/0000-0002-6424-5803; Tritsaris, Katerina/0000-0002-9344-6460; Soerensen, Christiane/0000-0001-6814-1166; Lauritzen, Martin/0000-0002-1517-1131; Osler, Merete/0000-0002-6921-220X	Nordea Foundation; Danish Dental Association Research Foundation (KOF/FORSKU); Velux Foundation	Nordea Foundation; Danish Dental Association Research Foundation (KOF/FORSKU); Velux Foundation(Velux Fonden)	The Nordea Foundation funded this study. CES received funding for the study from the Danish Dental Association Research Foundation (KOF/FORSKU). The Velux Foundation funded the Copenhagen Aging and Midlife Biobank project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMTHAUER R, 2000, INTELLIGENZ STRUKTUR; Berkenkamp B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088071; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Carpenter GH, 2010, FRONT ORAL BIOL, V14, P107, DOI 10.1159/000313710; Chinta SJ, 2015, EXP GERONTOL, V68, P3, DOI 10.1016/j.exger.2014.09.018; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; DEWILDE PCM, 1986, J CLIN PATHOL, V39, P406, DOI 10.1136/jcp.39.4.406; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DRUMMOND JR, 1984, ARCH ORAL BIOL, V29, P151, DOI 10.1016/0003-9969(84)90120-1; Hansen NL, 2014, HUM BRAIN MAPP, V35, P4488, DOI 10.1002/hbm.22489; Ihrler S, 2002, VIRCHOWS ARCH, V440, P519, DOI 10.1007/s004280100537; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Mortensen EL, 2014, J AGING HEALTH, V26, P37, DOI 10.1177/0898264313508780; Nielsen GP, 1999, LAB INVEST, V79, P1137; Osler M, 2006, INT J EPIDEMIOL, V35, P541, DOI 10.1093/ije/dyi300; Osler M, 2013, EUR J PUBLIC HEALTH, V23, P974, DOI 10.1093/eurpub/cks140; Pedersen AM, 1999, J ORAL PATHOL MED, V28, P303, DOI 10.1111/j.1600-0714.1999.tb02045.x; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Schildhorn C, 2015, MECH AGEING DEV, V150, P65, DOI 10.1016/j.mad.2015.08.004; SCOTT J, 1980, J BIOL BUCCALE, V8, P187; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Shintani S, 2000, ANTICANCER RES, V20, P2169; Sorensen CE, 2014, EXP GERONTOL, V57, P211, DOI 10.1016/j.exger.2014.06.004; SYRJANEN S, 1984, AGE AGEING, V13, P159, DOI 10.1093/ageing/13.3.159; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Vered M, 2000, EXP GERONTOL, V35, P1075, DOI 10.1016/S0531-5565(00)00129-7; Yamakoshi K, 2015, AGING CELL, V14, P616, DOI 10.1111/acel.12337; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152612	10.1371/journal.pone.0152612	http://dx.doi.org/10.1371/journal.pone.0152612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27029014	gold, Green Published, Green Submitted			2022-12-27	WOS:000373116500057
J	Barsoumian, HB; Yolcu, ES; Shirwan, H				Barsoumian, Hampartsoum B.; Yolcu, Esma S.; Shirwan, Haval			4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4(+)CD25(+)FoxP3(+) T Regulatory Cell Suppression	PLOS ONE			English	Article							THERAPEUTIC CANCER VACCINES; MURINE DENDRITIC CELLS; GROWTH-FACTOR-BETA; IFN-GAMMA; MEDIATED APOPTOSIS; IMMUNE-RESPONSES; FOXP3 EXPRESSION; VIVO EXPANSION; CUTTING EDGE; COSTIMULATION	Costimulation with the recombinant SA-4-1BBL agonist of 4-1BB receptor on conventional CD4(+) T cells (Tconvs) overcomes the suppression mediated by naturally occurring CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs). The mechanistic basis of this observation has remained largely unknown. Herein we show that Tconvs, but not Tregs, are the direct target of SA-4-1BBL-mediated evasion of Treg suppression. IL-2 produced by Tconvs in response to 4-1BB signaling is both necessary and sufficient for overcoming Treg suppression. Supernatant from Tconvs stimulated with SA-4-1BBL contains high levels of IL-2 and overcomes Treg suppression in ex vivo Tconv: Treg cocultures. Removal of IL-2 from such supernatant restores Treg suppression and repletion of Tconv: Treg cocultures with exogenous recombinant IL-2 overcomes suppression. This study establishes 4-1BB signaling as a key circuit that regulates physical and functional equilibrium between Tregs and Tconvs with important implications for immunotherapy for indications where a fine balance between Tregs and Teffs plays a decisive role.	[Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Yolcu, ES; Shirwan, H (corresponding author), Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA.; Yolcu, ES; Shirwan, H (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	esma.yolcu@louisville.edu; haval.shirwan@louisville.edu			Commonwealth of Kentucky Research Challenge Trust Fund; Keck Foundation	Commonwealth of Kentucky Research Challenge Trust Fund; Keck Foundation(W.M. Keck Foundation)	This work was supported by the Commonwealth of Kentucky Research Challenge Trust Fund and the Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 2002, SEMIN ONCOL, V29, P12, DOI 10.1053/sonc.2002.33077; Chang JH, 2009, EUR J IMMUNOL, V39, P1241, DOI 10.1002/eji.200838913; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; Choi BK, 2004, J LEUKOCYTE BIOL, V75, P785, DOI 10.1189/jlb.1003491; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Eljaafari A, 2009, J IMMUNOL, V183, P2932, DOI 10.4049/jimmunol.0804352; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; Finney CAM, 2007, EUR J IMMUNOL, V37, P1874, DOI 10.1002/eji.200636751; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Hagness M, 2012, J IMMUNOL, V188, P5459, DOI 10.4049/jimmunol.1101367; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Kawamoto K, 2012, AUTOIMMUNITY, V45, P310, DOI 10.3109/08916934.2012.664667; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kim YJ, 2005, BLOOD, V105, P274, DOI 10.1182/blood-2003-12-4343; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kuang YL, 2012, ONCOL LETT, V3, P477, DOI 10.3892/ol.2011.506; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Madireddi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042459; McCoy KD, 1999, IMMUNOL CELL BIOL, V77, P1, DOI 10.1046/j.1440-1711.1999.00795.x; Menoret A, 2006, J IMMUNOL, V177, P6091, DOI 10.4049/jimmunol.177.9.6091; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schabowsky RH, 2007, CURR OPIN INVEST DR, V8, P1002; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2010, CANCER GENE THER, V17, P730, DOI 10.1038/cgt.2010.29; Sharma RK, 2014, EXPERT REV VACCINES, V13, P387, DOI 10.1586/14760584.2014.880340; Sharma RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073145; Sharma RK, 2010, CANCER RES, V70, P3945, DOI 10.1158/0008-5472.CAN-09-4480; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Sitrin J, 2013, J EXP MED, V210, P1153, DOI 10.1084/jem.20122248; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Srivastava AK, 2014, CANCER RES, V74, P6441, DOI 10.1158/0008-5472.CAN-14-1768-A; Srivastava AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048463; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Zhang P, 2007, SCAND J IMMUNOL, V66, P435, DOI 10.1111/j.1365-3083.2007.01994.x; Zheng GX, 2004, J IMMUNOL, V173, P2428, DOI 10.4049/jimmunol.173.4.2428; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153088	10.1371/journal.pone.0153088	http://dx.doi.org/10.1371/journal.pone.0153088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049955	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500097
J	Billard, MJ; Fitzhugh, DJ; Parker, JS; Brozowski, JM; McGinnis, MW; Timoshchenko, RG; Serafin, S; Lininger, R; Klauber-Demore, N; Sahagian, G; Truong, YK; Sassano, MF; Serody, JS; Tarrant, TK				Billard, Matthew J.; Fitzhugh, David J.; Parker, Joel S.; Brozowski, Jaime M.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Lininger, Ruth; Klauber-Demore, Nancy; Sahagian, Gary; Truong, Young K.; Sassano, Maria F.; Serody, Jonathan S.; Tarrant, Teresa K.			G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-LINES; BETA-ARRESTIN; CHEMOKINE RECEPTORS; DOWN-REGULATION; TUMOR NECROSIS; CXCR4; EXPRESSION; GROWTH; ACTIVATION	Triple negative breast cancer (TNBC) is a heterogeneous disease that has a poor prognosis and limited treatment options. Chemokine receptor interactions are important modulators of breast cancer metastasis; however, it is now recognized that quantitative surface expression of one important chemokine receptor, CXCR4, may not directly correlate with metastasis and that its functional activity in breast cancer may better inform tumor pathogenicity. G protein coupled receptor kinase 3 (GRK3) is a negative regulator of CXCR4 activity, and we show that GRK expression correlates with tumorigenicity, molecular subtype, and metastatic potential in human tumor microarray analysis. Using established human breast cancer cell lines and an immunocompetent in vivo mouse model, we further demonstrate that alterations in GRK3 expression levels in tumor cells directly affect migration and invasion in vitro and the establishment of distant metastasis in vivo. The effects of GRK3 modulation appear to be specific to chemokine-mediated migration behaviors without influencing tumor cell proliferation or survival. These data demonstrate that GRK3 dysregulation may play an important part in TNBC metastasis.	[Billard, Matthew J.; Fitzhugh, David J.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Tarrant, Teresa K.] Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA; [Billard, Matthew J.; Fitzhugh, David J.; McGinnis, Marcus W.; Timoshchenko, Roman G.; Serafin, Stephen; Tarrant, Teresa K.] Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.; Lininger, Ruth; Klauber-Demore, Nancy; Serody, Jonathan S.; Tarrant, Teresa K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Brozowski, Jaime M.; Tarrant, Teresa K.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lininger, Ruth] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Klauber-Demore, Nancy] Univ N Carolina, Dept Surg, Div Surg Oncol, Chapel Hill, NC 27599 USA; [Serody, Jonathan S.] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27599 USA; [Sahagian, Gary] Tufts Univ, Dept Dev Mol & Chem Biol, Medford, MA 02155 USA; [Truong, Young K.] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Sassano, Maria F.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarrant, TK (corresponding author), Univ N Carolina, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Dept Med, Div Rheumatol Allergy & Immunol, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Tarrant, TK (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	Tarra002@med.unc.edu	Parker, Joel/AAG-1108-2019; , UNC Flow Cytometry Core/AGU-9839-2022	Tarrant, Teresa/0000-0003-4067-5363	North Carolina University Cancer Research Funds (UCRF) [K01 AI091863, K08 AI070684, R03AR059286]; NHLBI [F31HL128029]; UNC Thurston Arthritis Research Center (TARC) Funds; NSF [DMS-1106962]; UNC Clinical Translation Science Award [TR000083-05]; Cancer Center Core Support Grant [P30 CA016086]; NATIONAL CANCER INSTITUTE [P50CA058223, P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL128029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091863, K08AI070684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059286] Funding Source: NIH RePORTER	North Carolina University Cancer Research Funds (UCRF); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UNC Thurston Arthritis Research Center (TARC) Funds; NSF(National Science Foundation (NSF)); UNC Clinical Translation Science Award; Cancer Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors wish to acknowledge the following funding sources in support of this research: North Carolina University Cancer Research Funds (UCRF) (TKT), K01 AI091863 (MJB), K08 AI070684 (TKT), R03AR059286 (TKT), NHLBI F31HL128029 (JMB), UNC Thurston Arthritis Research Center (TARC) Funds (TKT, MJB), NSF DMS-1106962 (YKT), and UNC Clinical Translation Science Award, Biostatistics Core TR000083-05 (YKT). The UNC Flow Cytometry Core Facility is supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; BONFIL RD, 1988, CLIN EXP METASTAS, V6, P121, DOI 10.1007/BF01784843; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Chen HW, 2013, CURR MOL MED, V13, P410; Chu QYD, 2010, J SURG RES, V159, P689, DOI 10.1016/j.jss.2008.09.020; Cleere DW., 2010, COMMUNITY ONCOLOGY, V7; Costantini S, 2013, CYTOKINE, V64, P316, DOI 10.1016/j.cyto.2013.05.024; Desai AN, 2006, J PHARMACOL EXP THER, V317, P1027, DOI 10.1124/jpet.105.098996; Diaz-Montero CM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-39; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Duffy MJ, 2012, INT J CANCER, V131, P2471, DOI 10.1002/ijc.27632; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; King DW, 2003, ENDOCRINE, V22, P135, DOI 10.1385/ENDO:22:2:135; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li F, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0180-8; Li J, 2004, ONCOGENE, V23, P9359, DOI 10.1038/sj.onc.1208039; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lipfert J, 2013, CELL MOL NEUROBIOL, V33, P111, DOI 10.1007/s10571-012-9876-5; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Martens K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-162; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mishan MA, 2015, IRAN J PUBLIC HEALTH, V44, P1353; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Norton KA, 2015, AM J CANCER RES, V5, P1295; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; Prat A, 2013, BREAST CANCER RES TR, V142, P237, DOI 10.1007/s10549-013-2743-3; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raghuwanshi SK, 2013, J IMMUNOL, V190, P5329, DOI 10.4049/jimmunol.1202058; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Salazar N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-198; Salim S, 2007, J PHARMACOL EXP THER, V321, P51, DOI 10.1124/jpet.106.116921; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Stacer AC, 2016, ONCOGENE, V35, P1716, DOI 10.1038/onc.2015.236; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tarrant TK, 2013, J LEUKOCYTE BIOL, V94, P1243, DOI 10.1189/jlb.0213097; Tutunea-Fatan E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0306-4; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; Wani NA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3665; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Woerner BM, 2012, MOL CANCER RES, V10, P156, DOI 10.1158/1541-7786.MCR-11-0411; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656; Yuan LP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-18; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhu GQ, 2015, ONCOTARGET, V6, P43408, DOI 10.18632/oncotarget.6125	70	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152856	10.1371/journal.pone.0152856	http://dx.doi.org/10.1371/journal.pone.0152856			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049755	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500061
J	Randhawa, IAS; Khatkar, MS; Thomson, PC; Raadsma, HW				Randhawa, Imtiaz A. S.; Khatkar, Mehar S.; Thomson, Peter C.; Raadsma, Herman W.			A Meta-Assembly of Selection Signatures in Cattle	PLOS ONE			English	Article							GENOME-WIDE SCAN; RECENT POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM PATTERNS; ADAPTIVE GENETIC-DIVERGENCE; ARTIFICIAL SELECTION; COMPLEX TRAITS; BOS-TAURUS; NATURAL-SELECTION; JAPANESE BLACK; CONTEMPORARY SELECTION	Since domestication, significant genetic improvement has been achieved for many traits of commercial importance in cattle, including adaptation, appearance and production. In response to such intense selection pressures, the bovine genome has undergone changes at the underlying regions of functional genetic variants, which are termed "selection signatures". This article reviews 64 recent (2009-2015) investigations testing genomic diversity for departure from neutrality in worldwide cattle populations. In particular, we constructed a meta-assembly of 16,158 selection signatures for individual breeds and their archetype groups (European, African, Zebu and composite) from 56 genome-wide scans representing 70,743 animals of 90 pure and crossbred cattle breeds. Meta-selection-scores (MSS) were computed by combining published results at every given locus, within a sliding window span. MSS were adjusted for common samples across studies and were weighted for significance thresholds across and within studies. Published selection signatures show extensive coverage across the bovine genome, however, the meta-assembly provides a consensus profile of 263 genomic regions of which 141 were unique (113 were breed-specific) and 122 were shared across cattle archetypes. The most prominent peaks of MSS represent regions under selection across multiple populations and harboured genes of known major effects (coat color, polledness and muscle hypertrophy) and genes known to influence polygenic traits (stature, adaptation, feed efficiency, immunity, behaviour, reproduction, beef and dairy production). As the first meta-assembly of selection signatures, it offers novel insights about the hotspots of selective sweeps in the bovine genome, and this method could equally be applied to other species.	[Randhawa, Imtiaz A. S.; Khatkar, Mehar S.; Thomson, Peter C.; Raadsma, Herman W.] Univ Sydney, Fac Vet Sci, Reprogen Anim Biosci Grp, 425 Werombi Rd, Camden, NSW 2570, Australia	University of Sydney	Randhawa, IAS (corresponding author), Univ Sydney, Fac Vet Sci, Reprogen Anim Biosci Grp, 425 Werombi Rd, Camden, NSW 2570, Australia.	imtiaz.randhawa@sydney.edu.au	Randhawa, Imtiaz/AAE-4535-2019; Thomson, Peter/V-7290-2019	Randhawa, Imtiaz/0000-0001-7224-191X; Thomson, Peter/0000-0003-4428-444X				Achat G, 2008, GENETICS, V179, P1409, DOI 10.1534/genetics.107.082198; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ayers KL, 2007, GENET EPIDEMIOL, V31, P672, DOI 10.1002/gepi.20232; Bahbahani H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11729; Banos G, 2008, J DAIRY SCI, V91, P3190, DOI 10.3168/jds.2007-0930; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bennett GL, 2013, J ANIM SCI, V91, P565, DOI 10.2527/jas.2012-5454; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boitard S, 2013, ANIM GENET, V44, P579, DOI 10.1111/age.12042; Boitard S, 2009, GENETICS, V181, P1567, DOI 10.1534/genetics.108.100032; Bollongino R, 2012, MOL BIOL EVOL, V29, P2101, DOI 10.1093/molbev/mss092; Bomba L, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0113-9; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Braunschweig MH, 2010, J APPL GENET, V51, P289, DOI 10.1007/BF03208858; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Burt David W., 2009, Journal of Biology (London), V8, P36, DOI 10.1186/jbiol137; Capuco Anthony V., 2009, Journal of Biology (London), V8, P37, DOI 10.1186/jbiol139; Chan EKF, 2010, ANIM GENET, V41, P467, DOI 10.1111/j.1365-2052.2010.02053.x; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Crisci JL, 2012, J HERED, V103, P287, DOI 10.1093/jhered/esr128; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Daetwyler HD, 2011, GENETICS, V189, P317, DOI 10.1534/genetics.111.128082; Dayo GK, 2009, MOL ECOL, V18, P1801, DOI 10.1111/j.1365-294X.2009.04141.x; Decker JE, 2009, P NATL ACAD SCI USA, V106, P18644, DOI 10.1073/pnas.0904691106; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Druet T, 2013, ANIM GENET, V44, P758, DOI 10.1111/age.12073; Edea Z, 2014, J ANIM BREED GENET, V131, P358, DOI 10.1111/jbg.12083; Edwards CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015922; Fadista J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-284; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Fan HZ, 2014, J APPL GENET, V55, P343, DOI 10.1007/s13353-014-0200-6; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Fay JC, 2000, GENETICS, V155, P1405; Flori L, 2014, MOL ECOL, V23, P3241, DOI 10.1111/mec.12816; Flori L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036133; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Freeman AR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-62; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Gautier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013038; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Georges Michel, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P240; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Glick G, 2012, ANIM GENET, V43, P45, DOI 10.1111/j.1365-2052.2012.02348.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Guastella AM, 2011, ANIM PROD SCI, V51, P1039, DOI 10.1071/AN11070; Gurgul A, 2016, J ANIM BREED GENET, V133, P264, DOI 10.1111/jbg.12196; Gurgul A, 2015, ANIM SCI J, V86, P17, DOI 10.1111/asj.12242; Gutierrez-Gil B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00167; Haase B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075071; Hancock AM, 2008, ANNU REV ANTHROPOL, V37, P197, DOI 10.1146/annurev.anthro.37.081407.085141; Hanna LLH, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-4; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Hauswirth R, 2013, ANIM GENET, V44, P763, DOI 10.1111/age.12057; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Heslot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074612; Hill WG, 2014, GENETICS, V196, P1, DOI 10.1534/genetics.112.147850; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Hoshiba H, 2013, ANIM SCI J, V84, P529, DOI 10.1111/asj.12033; Hosokawa D, 2012, ANIM SCI J, V83, P7, DOI 10.1111/j.1740-0929.2011.00927.x; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kasarda R., 2015, POTRAVIN SLOVAK J FO, V9, P268, DOI [10.5219/478, DOI 10.5219/478]; Kelley JL, 2008, ANNU REV GENOM HUM G, V9, P143, DOI 10.1146/annurev.genom.9.081307.164411; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kemper KE, 2012, HUM MOL GENET, V21, pR45, DOI 10.1093/hmg/dds332; Kemper KE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-246; Khatkar MS, 2014, LIVEST SCI, V166, P144, DOI 10.1016/j.livsci.2014.05.015; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Khatkar MS, 2004, GENET SEL EVOL, V36, P163, DOI 10.1051/gse:2003057; Kim ES, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1500-x; Kim ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119380; Kim ES, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00443; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lee HJ, 2014, GENOME BIOL EVOL, V6, P1366, DOI 10.1093/gbe/evu102; Lee T, 2013, BMB REP, V46, P346, DOI 10.5483/BMBRep.2013.46.7.211; Lemay DG, 2009, J NUTR, V139, P1271, DOI 10.3945/jn.109.107656; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Li MH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-32; Li Y, 2015, EVOL BIOINFORM, V11, DOI 10.4137/EBO.S24359; Liao XP, 2013, GENOME, V56, P592, DOI 10.1139/gen-2013-0082; Lillehammer M, 2008, GENETICS, V179, P1539, DOI 10.1534/genetics.107.084483; Lim D, 2013, ASIAN AUSTRAL J ANIM, V26, P603, DOI 10.5713/ajas.2012.12456; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Littlejohn MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6861; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu L, 2009, J GENET GENOMICS, V36, P661, DOI 10.1016/S1673-8527(08)60158-7; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-179; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; MacLeod IM, 2014, GENETICS, V198, P1671, DOI 10.1534/genetics.114.168344; Makina SO, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0173-x; Mancini G, 2014, MOL BIOL REP, V41, P957, DOI 10.1007/s11033-013-2940-5; Marchitelli C, 2003, MAMM GENOME, V14, P392, DOI 10.1007/s00335-002-2176-5; Mariasegaram M, 2012, ANIM GENET, V43, P683, DOI 10.1111/j.1365-2052.2012.02336.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Mueller JC, 2004, BIOINFORMATICS, V20, P786, DOI 10.1093/bioinformatics/btg481; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Nicholas FW, 2006, AUST J EXP AGR, V46, P155, DOI 10.1071/EA05228; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Nicolazzi EL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-123; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Nosil P, 2012, PHILOS T R SOC B, V367, P332, DOI 10.1098/rstb.2011.0263; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Noyes H, 2011, P NATL ACAD SCI USA, V108, P9304, DOI 10.1073/pnas.1013486108; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Olsen HG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-32; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pan DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060440; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pintus E, 2014, ANIM GENET, V45, P1, DOI 10.1111/age.12076; Porto-Neto LR, 2014, ANIM GENET, V45, P180, DOI 10.1111/age.12119; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Prasad A, 2008, ANIM GENET, V39, P597, DOI 10.1111/j.1365-2052.2008.01772.x; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2014, LIVEST SCI, V166, P133, DOI 10.1016/j.livsci.2014.05.003; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Ramey HR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-382; Randhawa IAS, 2015, G3-GENES GENOM GENET, V5, P1391, DOI 10.1534/g3.115.017772; Randhawa IAS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-34; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; Rischkowsky B., 2007, STATE WORLDS ANIMAL; Rocha D, 2014, J ANIM BREED GENET, V131, P483, DOI 10.1111/jbg.12095; Rothammer S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-908; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ryu J, 2014, ANIM GENET, V45, P765, DOI 10.1111/age.12209; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schmutz SM, 2013, ANIM GENET, V44, P9, DOI 10.1111/j.1365-2052.2012.02361.x; Schwarzenbacher H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-48; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Sheehy PA, 2009, ANIM GENET, V40, P492, DOI 10.1111/j.1365-2052.2009.01862.x; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Somavilla AL, 2014, ANIM GENET, V45, P771, DOI 10.1111/age.12210; Sorbolini S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0128-2; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Stinckens A, 2011, ANIM GENET, V42, P229, DOI 10.1111/j.1365-2052.2010.02144.x; Stock F, 2013, AFR ARCHAEOL REV, V30, P51, DOI 10.1007/s10437-013-9131-6; Taberlet P, 2011, CR BIOL, V334, P247, DOI 10.1016/j.crvi.2010.12.007; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Utsunomiya YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064280; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiener P, 2009, ANIM GENET, V40, P598, DOI 10.1111/j.1365-2052.2009.01886.x; Wiener P, 2011, P ROY SOC B-BIOL SCI, V278, P3161, DOI 10.1098/rspb.2011.1376; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wong AK, 2013, ANIM GENET, V44, P305, DOI 10.1111/age.12006; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3	196	50	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153013	10.1371/journal.pone.0153013	http://dx.doi.org/10.1371/journal.pone.0153013			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045296	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600058
J	Sansone, A; Tolika, E; Louka, M; Sunda, V; Deplano, S; Melchiorre, M; Anagnostopoulos, D; Chatgilialoglu, C; Formisano, C; Di Micco, R; Mennella, MRF; Ferreri, C				Sansone, Anna; Tolika, Evanthia; Louka, Maria; Sunda, Valentina; Deplano, Simone; Melchiorre, Michele; Anagnostopoulos, Dimitrios; Chatgilialoglu, Chryssostomos; Formisano, Cesare; Di Micco, Rosa; Mennella, Maria Rosaria Faraone; Ferreri, Carla			Hexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles	PLOS ONE			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ESTIMATED DESATURASE ACTIVITIES; PREPUBERTAL OBESE CHILDREN; STEAROYL-COA DESATURASE-1; HUMAN PLASMA; ADIPOSE-TISSUE; MASS-SPECTROMETRY; DOUBLE-BONDS; BIOMARKER; RISK	Monounsaturated fatty acids (MUFA) are emerging health biomarkers, and in particular the ratio between palmitoleic acid (9cis-16:1) and palmitic acid (16:0) affords the delta-9 desaturase index that is increased in obesity. Recently, other positional and geometrical MUFA isomers belonging to the hexadecenoic family (C16 MUFA) were found in circulating lipids, such as sapienic acid (6cis-16: 1), palmitelaidic acid (9trans-16:1) and 6trans-16:1. In this work we report: i) the identification of sapienic acid as component of human erythrocyte membrane phospholipids with significant increase in morbidly obese patients (n = 50) compared with age-matched lean controls (n = 50); and ii) the first comparison of erythrocyte membrane phospholipids (PL) and plasma cholesteryl esters (CE) in morbidly obese patients highlighting that some of their fatty acid levels have opposite trends: increases of both palmitic and sapienic acids with the decrease of linoleic acid (9cis, 12cis-18:2, omega-6) in red blood cell (RBC) membrane PL were reversed in plasma CE, whereas the increase of palmitoleic acid was similar in both lipid species. Consequentially, desaturase enzymatic indexes gave different results, depending on the lipid class used for the fatty acid content. The fatty acid profile of morbidly obese subjects also showed significant increases of stearic acid (C18:0) and C20 omega-6, as well as decreases of oleic acid (9cis-18:1) and docosahexaenoic acid (C22:6 omega-3) as compared with lean healthy controls. Trans monounsaturated and polyunsaturated fatty acids were also measured and found significantly increased in both lipid classes of morbidly obese subjects. These results highlight the C16 MUFA isomers as emerging metabolic marker provided that the assignment of the double bond position and geometry is correctly performed, thus identifying the corresponding lipidomic pathway. Since RBC membrane PL and plasma CE have different fatty acid trends, caution must also be used in the choice of lipid species for the interpretation of lipidomic profiles.	[Sansone, Anna; Tolika, Evanthia; Ferreri, Carla] CNR, ISOF, Bologna, Italy; [Louka, Maria; Sunda, Valentina; Deplano, Simone; Melchiorre, Michele] Lipinutragen Srl, Lipid Lab, Bologna, Italy; [Anagnostopoulos, Dimitrios; Chatgilialoglu, Chryssostomos] NCSR Demokritos, INN, Athens, Greece; [Formisano, Cesare; Di Micco, Rosa] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Mennella, Maria Rosaria Faraone] Univ Naples Federico II, Dept Biol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); National Centre of Scientific Research "Demokritos"; University of Naples Federico II; University of Naples Federico II	Ferreri, C (corresponding author), CNR, ISOF, Bologna, Italy.	carla.ferreri@isof.cnr.it	Chatgilialoglu, Chryssostomos/A-1190-2013; FERRERI, CARLA/G-6821-2013; Chatgilialoglu, Chryssostomos/AAG-6193-2021; Sansone, Anna/AAX-5478-2020; Di Micco, Rosa/AAC-3067-2019	Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; FERRERI, CARLA/0000-0002-1359-0869; Chatgilialoglu, Chryssostomos/0000-0003-2626-2925; Di Micco, Rosa/0000-0002-2575-8729; Louka, Maria/0000-0002-7008-2406; sansone, anna/0000-0003-0865-4861; faraone mennella, maria rosaria/0000-0003-1947-4700; FORMISANO, Cesare/0000-0002-6793-5631; Melchiorre, Michele/0000-0003-0536-907X	COST Action "Biomimetic Radical Chemistry" [1201]; Lipinutragen srl through the funding of Marie Sklodowska-Curie ITN project CLICKGENE [642023, MSCA-ITN-2014-ETN]	COST Action "Biomimetic Radical Chemistry"; Lipinutragen srl through the funding of Marie Sklodowska-Curie ITN project CLICKGENE	ET, DA and ML received grants for Short Term Scientific Mission from the COST Action 1201 "Biomimetic Radical Chemistry". ML received her salary from Lipinutragen srl through the funding of the MSCA-ITN-2014-ETN - Marie Sklodowska-Curie ITN project CLICKGENE (#642023) that supports research activity as part of her PhD training program. Lipinutragen srl provided support in the form of salaries for VS, SD and MM that were involved in data collection, membrane lipidomics and statistical analyses, but did not have any additional role in the study design, decision to publish, or writing of the manuscript. The specific roles of these authors are articulated in the "Author contributions" section. No other specific funding for this work has been received.	Abdelmagid SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116195; Burch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134206; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Chatgilialoglu C, 2014, CHEM REV, V114, P255, DOI 10.1021/cr4002287; Ferreri C, 2004, J AM CHEM SOC, V126, P1063, DOI 10.1021/ja038072o; Ferreri C, 2012, EXPERT REV MOL DIAGN, V12, P767, DOI [10.1586/erm.12.73, 10.1586/ERM.12.73]; Ghezzo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066418; Gil-Campos M, 2008, BRIT J NUTR, V99, P909, DOI 10.1017/S0007114507831722; Hauff S, 2009, J AGR FOOD CHEM, V57, P3423, DOI 10.1021/jf803665u; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Jove M, 2014, FASEB J, V28, P5163, DOI 10.1096/fj.14-253187; Karpe F, 2008, ARTERIOSCL THROM VAS, V28, pE152, DOI 10.1161/ATVBAHA.108.167718; Katan MB, 1997, J LIPID RES, V38, P2012; King IB, 2006, AM J CLIN NUTR, V83, P227; Klawitter J, 2014, ANAL BIOANAL CHEM, V406, P6399, DOI 10.1007/s00216-014-8020-4; Klem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033874; Kunnen S, 2012, J LIPID RES, V53, P1783, DOI 10.1194/jlr.R024513; Larque E, 2006, INT J OBESITY, V30, P1488, DOI 10.1038/sj.ijo.0803403; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Ma XX, 2016, P NATL ACAD SCI USA, V113, P2573, DOI 10.1073/pnas.1523356113; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Melchiorre M, 2011, J AM CHEM SOC, V133, P15184, DOI 10.1021/ja205903h; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; MOSS CW, 1989, J CLIN MICROBIOL, V27, P1467, DOI 10.1128/JCM.27.7.1467-1470.1989; Ng DS, 2012, BBA-MOL CELL BIOL L, V1821, P654, DOI 10.1016/j.bbalip.2011.12.012; Park HG, 2016, BBA-MOL CELL BIOL L, V1861, P91, DOI 10.1016/j.bbalip.2015.11.007; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Prouty S. M., 2015, LIPIDS SKIN HLTH, P139; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ruggles KV, 2013, ANNU REV NUTR, V33, P413, DOI 10.1146/annurev-nutr-071812-161254; Sansone A, 2013, CHEM RES TOXICOL, V26, P1703, DOI 10.1021/tx400287u; Sartore G, 2008, PROSTAG LEUKOTR ESS, V79, P55, DOI 10.1016/j.plefa.2008.07.001; Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565; Stamatikos AD, 2013, AM J PHYSIOL-ENDOC M, V305, pE767, DOI 10.1152/ajpendo.00268.2013; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Thompson AK, 2011, INT J OBESITY, V35, P315, DOI 10.1038/ijo.2010.141; Vinknes KJ, 2013, OBESITY, V21, pE512, DOI 10.1002/oby.20457; Wang LY, 2013, GENOME MED, V5, DOI 10.1186/gm443; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37	45	45	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152378	10.1371/journal.pone.0152378	http://dx.doi.org/10.1371/journal.pone.0152378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045677	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600017
J	Whitaker, LHR; Reid, J; Choa, A; McFee, S; Seretny, M; Wilson, J; Elton, RA; Vincent, K; Horne, AW				Whitaker, Lucy H. R.; Reid, Jen; Choa, Alex; McFee, Stuart; Seretny, Marta; Wilson, John; Elton, Rob A.; Vincent, Katy; Horne, Andrew W.			An Exploratory Study into Objective and Reported Characteristics of Neuropathic Pain in Women with Chronic Pelvic Pain	PLOS ONE			English	Article							QUESTIONNAIRE; ENDOMETRIOSIS; HYPERALGESIA	Chronic pelvic pain (CPP) affects 5.7-26.6% women worldwide. 55% have no obvious pathology and 40% have associated endometriosis. Neuropathic pain (NeP) is pain arising as a consequence of a lesion/disease affecting the somatosensory system. The prevalence of NeP in women with CPP is not known. The diagnosis of NeP is challenging because there is no gold-standard assessment. Questionnaires have been used in the clinical setting to diagnose NeP in other chronic pain conditions and quantitative sensory testing (QST) has been used in a research setting to identify abnormal sensory function. We aimed to determine if women with chronic pelvic pain (CPP) have a neuropathic pain (NeP) component to their painful symptoms and how this is best assessed. We performed an exploratory prospective cohort study of 72 pre-menopausal women with a diagnosis of CPP. They underwent a clinician completed questionnaire (DN4) and completed the S-LANSS and PainDETECT (TM) questionnaires. Additionally QST testing was performed by a clinician. They also completed a patient acceptability questionnaire. Clinical features of NeP were identified by both questionnaires and QST. Of the women who were NeP positive, 56%, 35% and 26% were identified by the S-LANSS, DN4 and PainDETECT (TM) respectively. When NeP was identified by questionnaire, the associated laparoscopy findings were similar irrespective of which questionnaire was used. No subject had entirely unchanged QST parameters. There were distinct loss and gain subgroups, as well as mixed alteration in function, but this was not necessarily clinically significant in all patients. 80% of patients were confident that questionnaires could diagnose NeP, and 90% found them easy to complete. Early identification of NeP in women with CPP with a simple questionnaire could facilitate targeted therapy with neuromodulators, which are cheap, readily available, and have good safety profiles. This approach could prevent unnecessary or fertility-compromising surgery and prolonged treatment with hormones.	[Whitaker, Lucy H. R.; Horne, Andrew W.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Reid, Jen; Choa, Alex; McFee, Stuart] Univ Edinburgh, Sch Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Seretny, Marta; Wilson, John] Royal Infirm Edinburgh NHS Trust, Dept Anaesthesia, 51 Little France Crescent, Edinburgh EH16 4SA, Midlothian, Scotland; [Elton, Rob A.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland; [Vincent, Katy] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Oxford	Horne, AW (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	andrew.horne@ed.ac.uk		Seretny, Marta/0000-0003-0615-1224; Whitaker, Lucy/0000-0002-7678-6551	MRC Centre for Reproductive Health MRC Centre Grant [G1002033]; MRC [G1002033, MR/N022556/1] Funding Source: UKRI; Medical Research Council [G1002033, MR/N022556/1] Funding Source: researchfish	MRC Centre for Reproductive Health MRC Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AH and LW: MRC Centre for Reproductive Health MRC Centre Grant (G1002033).	Ahangari A, 2014, PAIN PHYSICIAN, V17, pE141; Anaf V, 2002, HUM REPROD, V17, P1895, DOI 10.1093/humrep/17.7.1895; Asante A, 2011, ANNU REV PHYSIOL, V73, P163, DOI 10.1146/annurev-physiol-012110-142158; Aslam N, 2009, BJOG-INT J OBSTET GY, V116, P1551, DOI 10.1111/j.1471-0528.2009.02305.x; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Bennett MI, 2005, J PAIN, V6, P149, DOI 10.1016/j.jpain.2004.11.007; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Brawn J, 2014, HUM REPROD UPDATE, V20, P737, DOI 10.1093/humupd/dmu025; Breivik H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1229; Daniels J, 2009, JAMA-J AM MED ASSOC, V302, P955, DOI 10.1001/jama.2009.1268; Engeler D, 2012, GUIDELINES CHRONIC P; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Jarrell J., 2011, PAIN RES TREAT, V2011, DOI [10.1155/2011/692102, DOI 10.1155/2011/692102]; Jarrell J, 2008, J MUSCULOSKELET PAIN, V16, P21, DOI 10.1080/10582450801960131; Khan K., MEDAL MRI ESTABLISH; Kirkwood BR, 2003, ESSENTIAL MED STAT; Malykhina AP, 2007, NEUROSCIENCE, V149, P660, DOI 10.1016/j.neuroscience.2007.07.053; Moore SJ, 2012, 41 ROYAL COLL OBST G; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Reimer M, 2014, CURR OPIN SUPPORT PA, V8, P124, DOI 10.1097/SPC.0000000000000045; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Swank DJ, 2003, LANCET, V361, P1247, DOI 10.1016/S0140-6736(03)12979-0; Vincent KF., 2015, CONTRACT NO 46; Wang G, 2009, HUM REPROD, V1, P1	25	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151950	10.1371/journal.pone.0151950	http://dx.doi.org/10.1371/journal.pone.0151950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046128	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600008
J	Gao, JZ; Cui, W; Sheng, YJ; Ruan, JS; Kurgan, L				Gao, Jianzhao; Cui, Wei; Sheng, Yajun; Ruan, Jishou; Kurgan, Lukasz			PSIONplus: Accurate Sequence-Based Predictor of Ion Channels and Their Types	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; M2 PROTON CHANNELS; STRUCTURAL-CHANGES; BINDING PROTEINS; WEB-SERVER; POTASSIUM; DATABASE; INFORMATION; MEMBRANE; SURFACE	Ion channels are a class of membrane proteins that attracts a significant amount of basic research, also being potential drug targets. High-throughput identification of these channels is hampered by the low levels of availability of their structures and an observation that use of sequence similarity offers limited predictive quality. Consequently, several machine learning predictors of ion channels from protein sequences that do not rely on high sequence similarity were developed. However, only one of these methods offers a wide scope by predicting ion channels, their types and four major subtypes of the voltage-gated channels. Moreover, this and other existing predictors utilize relatively simple predictive models that limit their accuracy. We propose a novel and accurate predictor of ion channels, their types and the four subtypes of the voltage-gated channels called PSIONplus. Our method combines a support vector machine model and a sequence similarity search with BLAST. The originality of PSIONplus stems from the use of a more sophisticated machine learning model that for the first time in this area utilizes evolutionary profiles and predicted secondary structure, solvent accessibility and intrinsic disorder. We empirically demonstrate that the evolutionary profiles provide the strongest predictive input among new and previously used input types. We also show that all new types of inputs contribute to the prediction. Results on an independent test dataset reveal that PSIONplus obtains relatively good predictive performance and outperforms existing methods. It secures accuracies of 85.4% and 68.3% for the prediction of ion channels and their types, respectively, and the average accuracy of 96.4% for the discrimination of the four ion channel subtypes. Stand-alone version of PSIONplus is freely available from https://sourceforge.net/projects/psion/	[Gao, Jianzhao; Ruan, Jishou] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China; [Gao, Jianzhao; Ruan, Jishou] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Cui, Wei] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA; [Sheng, Yajun] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kurgan, Lukasz] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Kurgan, Lukasz] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	Nankai University; Nankai University; University of California System; University of California Riverside; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Nankai University; University of Alberta; Virginia Commonwealth University	Ruan, JS (corresponding author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.; Ruan, JS (corresponding author), Nankai Univ, LPMC, Tianjin 300071, Peoples R China.; Ruan, JS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.; Kurgan, L (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.; Kurgan, L (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA.	jsruan@nankai.edu.cn; lkurgan@vcu.edu	Kurgan, Lukasz/B-5721-2009	Kurgan, Lukasz/0000-0002-7749-0314; Gao, Jianzhao/0000-0002-9943-4786	National Science Foundation of China (NSFC) [31050110432, 31150110577, 11101226]; Discovery grant from National Science and Engineering Research Council (NSERC) Canada [298328]; International Development Research Center, Ottawa, Canada [104519-010]; Specialized Research Fund for Doctoral Program of Higher Education (SRFDP) [20130031120001]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Discovery grant from National Science and Engineering Research Council (NSERC) Canada; International Development Research Center, Ottawa, Canada; Specialized Research Fund for Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	LK and JR were supported by the National Science Foundation of China (NSFC) grants 31050110432 and 31150110577. LK was also supported by the Discovery grant 298328 from National Science and Engineering Research Council (NSERC) Canada. JR was also supported by the International Development Research Center, Ottawa, Canada grant 104519-010. JG was supported by Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) grant 20130031120001 and by the National Science Foundation of China (NSFC) grant 11101226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banghart MR, 2006, BIOCHEMISTRY-US, V45, P15129, DOI 10.1021/bi0618058; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Camerino DC, 2008, ADV GENET, V64, P81, DOI 10.1016/S0065-2660(08)00804-3; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S4; Chen W, 2012, COMPUT BIOL MED, V42, P504, DOI 10.1016/j.compbiomed.2012.01.003; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Chung SH, 2002, BBA-BIOMEMBRANES, V1565, P267, DOI 10.1016/S0005-2736(02)00574-6; Consortium TU, 2012, NUCL ACIDS RES, V40; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; Domene C, 2003, CURR OPIN DRUG DISC, V6, P611; Donizelli M, 2006, NUCLEIC ACIDS RES, V34, pD267, DOI 10.1093/nar/gkj104; Doyle DA, 2004, MOL MEMBR BIOL, V21, P221, DOI 10.1080/09687680410001716844; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Gabashvili IS, 2007, JARO-J ASSOC RES OTO, V8, P305, DOI 10.1007/s10162-007-0082-y; Gallin WJ, 2011, NUCLEIC ACIDS RES, V39, pD362, DOI 10.1093/nar/gkq1000; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; Ger MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012827; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Konijnenberg A, 2014, P NATL ACAD SCI USA, V111, P17170, DOI 10.1073/pnas.1413118111; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang Xin, 2010, Virologica Sinica, V25, P267, DOI 10.1007/s12250-010-3136-y; Lin H-T, 2007, MACH LEARN, V68, P10; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Liu LX, 2006, ACTA BIOCH BIOPH SIN, V38, P363, DOI 10.1111/j.1745-7270.2006.00177.x; Liu WX, 2014, INT J MOL SCI, V15, P12940, DOI 10.3390/ijms150712940; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Platt JC, 2000, ADV NEUR IN, P61; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P253, DOI 10.1016/S1672-0229(07)60006-0; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; TABASSUM N, 2011, J APPL PHARM SCI, V1, P6; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207; Wang J, 2013, P NATL ACAD SCI USA, V110, P1315, DOI 10.1073/pnas.1216526110; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu TF, 2004, J MACHINE LEARNING R, V5, P31; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Zhang H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-388; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zheng C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-430	65	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152964	10.1371/journal.pone.0152964	http://dx.doi.org/10.1371/journal.pone.0152964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044036	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100056
J	Pepin, E; Al-Mass, A; Attane, C; Zhang, KZ; Lamontagne, J; Lussier, R; Madiraju, SRM; Joly, E; Ruderman, NB; Sladek, R; Prentki, M; Peyot, ML				Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Zhang, Kezhuo; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Ruderman, Neil B.; Sladek, Robert; Prentki, Marc; Peyot, Marie-Line			Pancreatic beta-Cell Dysfunction in Diet-Induced Obese Mice: Roles of AMP-Kinase, Protein Kinase C epsilon, Mitochondrial and Cholesterol Metabolism, and Alterations in Gene Expression	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; INSULIN-SECRETION; MALONYL-COA; GLUCOSE; FUEL; GLUCOLIPOTOXICITY; PHOSPHORYLATION; ACCUMULATION; DISSOCIATION	Diet induced obese (DIO) mice can be stratified according to their weight gain in response to high fat diet as low responders (LDR) and high responders (HDR). This allows the study of beta-cell failure and the transitions to prediabetes (LDR) and early diabetes (HDR). C57BL/6N mice were fed for 8 weeks with a normal chow diet (ND) or a high fat diet and stratified as LDR and HDR. Freshly isolated islets from ND, LDR and HDR mice were studied ex-vivo for mitochondrial metabolism, AMPK activity and signalling, the expression and activity of key enzymes of energy metabolism, cholesterol synthesis, and mRNA profiling. Severely compromised glucose-induced insulin secretion in HDR islets, as compared to ND and LDR islets, was associated with suppressed AMP-kinase activity. HDR islets also showed reduced acetyl-CoA carboxylase activity and enhanced activity of 3-hydroxy-3-methylglutaryl-CoA reductase, which led respectively to elevated fatty acid oxidation and increased cholesterol biosynthesis. HDR islets also displayed mitochondrial membrane hyperpolarization and reduced ATP turnover in the presence of elevated glucose. Expression of protein kinase C epsilon, which reduces both lipolysis and production of signals for insulin secretion, was elevated in DIO islets. Genes whose expression increased or decreased by more than 1.2-fold were minor between LDR and ND islets (17 differentially expressed), but were prominent between HDR and ND islets (1508 differentially expressed). In HDR islets, particularly affected genes were related to cell cycle and proliferation, AMPK signaling, mitochondrial metabolism and cholesterol metabolism. In conclusion, chronically reduced AMPK activity, mitochondrial dysfunction, elevated cholesterol biosynthesis in islets, and substantial alterations in gene expression accompany beta-cell failure in HDR islets. The beta-cell compensation process in the prediabetic state (LDR) is largely independent of transcriptional adaptive changes, whereas the transition to early diabetes (HDR) is associated with major alterations in gene expression.	[Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc; Peyot, Marie-Line] CHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Pepin, Emilie; Al-Mass, Anfal; Attane, Camille; Lamontagne, Julien; Lussier, Roxane; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc; Peyot, Marie-Line] CHUM, Ctr Rech, Montreal, PQ, Canada; [Al-Mass, Anfal; Zhang, Kezhuo; Sladek, Robert] McGill Univ, Dept Med, Montreal, PQ, Canada; [Al-Mass, Anfal; Zhang, Kezhuo; Sladek, Robert] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Ruderman, Neil B.] Boston Med Ctr, Diabet Unit, Boston, MA USA	Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Boston University; Boston University; Boston Medical Center	Prentki, M; Peyot, ML (corresponding author), CHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada.; Prentki, M; Peyot, ML (corresponding author), CHUM, Ctr Rech, Montreal, PQ, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada.; Prentki, M (corresponding author), Univ Montreal, Fac Med, Dept Mol Med, Montreal, PQ H3C 3J7, Canada.	marc.prentki@umontreal.ca; marie-line.peyot@crchum.qc.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204	Canadian Institutes of Health Research; National Institute of Health [RO1-DK19514]; Kuweit University; Canadian Diabetes Association; Universite de Montreal; Diabete Quebec and Fonds de Recherche du Quebec-Sante; Fonds de Recherche du Quebec-Sante; Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kuweit University; Canadian Diabetes Association; Universite de Montreal; Diabete Quebec and Fonds de Recherche du Quebec-Sante; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Diabete Quebec; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the Canadian Institutes of Health Research to MP and SRMM, and by grant RO1-DK19514 from the National Institute of Health to NR and MP. MP holds the Canada Research Chair in Diabetes and Metabolism. AA is supported by a fellowship from Kuweit University. CA was supported by a fellowship from the Canadian Diabetes Association, EP by fellowships from Universite de Montreal and Diabete Quebec, JL by fellowships from Diabete Quebec and Fonds de Recherche du Quebec-Sante, and RS by Chercheur Boursier award from the Fonds de Recherche du Quebec-Sante and a New Investigator Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2010, MOL CELL ENDOCRINOL, V316, P140, DOI 10.1016/j.mce.2009.09.031; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brunham LR, 2010, CURR DIABETES REP, V10, P55, DOI 10.1007/s11892-009-0090-x; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Cenni V, 2002, BIOCHEM J, V545, P537; Cheng YS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005561; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Doliba NM, 2015, MOL METAB, V4, P926, DOI 10.1016/j.molmet.2015.09.010; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006; Fex M, 2009, DIABETOLOGIA, V52, P271, DOI 10.1007/s00125-008-1191-9; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; Garcia-Ruiz C, 2009, HISTOL HISTOPATHOL, V24, P117, DOI 10.14670/HH-24.117; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kowluru A, 2001, DIABETES, V50, P1580, DOI 10.2337/diabetes.50.7.1580; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Michelakis ED, 2008, CIRCULATION, V117, P2431, DOI 10.1161/CIRCULATIONAHA.108.775163; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Thomson DM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1572, DOI 10.1152/ajpendo.00371.2007; WENCEL HE, 1995, PHYSIOL BEHAV, V57, P1215, DOI 10.1016/0031-9384(95)00022-B; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wojtaszewski JFP, 2002, BIOCHEM BIOPH RES CO, V298, P309, DOI 10.1016/S0006-291X(02)02465-8; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; Zuniga-Hertz JP, 2015, J ENDOCRINOL, V224, P75, DOI 10.1530/JOE-14-0348	55	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153017	10.1371/journal.pone.0153017	http://dx.doi.org/10.1371/journal.pone.0153017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043434	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100062
J	Thangakani, AM; Nagarajan, R; Kumar, S; Sakthivel, R; Velmurugan, D; Gromiha, MM				Thangakani, A. Mary; Nagarajan, R.; Kumar, Sandeep; Sakthivel, R.; Velmurugan, D.; Gromiha, M. Michael			CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; SEQUENCE DETERMINANTS; AMYLOID FIBRIL; PROPENSITY; PREDICTION; INSIGHTS; FEATURES	Accurate distinction between peptide sequences that can form amyloid-fibrils or amorphous beta-aggregates, identification of potential aggregation prone regions in proteins, and prediction of change in aggregation rate of a protein upon mutation(s) are critical to research on protein misfolding diseases, such as Alzheimer's and Parkinson's, as well as biotechnological production of protein based therapeutics. We have developed a Curated Protein Aggregation Database (CPAD), which has collected results from experimental studies performed by scientific community aimed at understanding protein/peptide aggregation. CPAD contains more than 2300 experimentally observed aggregation rates upon mutations in known amyloidogenic proteins. Each entry includes numerical values for the following parameters: change in rate of aggregation as measured by fluorescence intensity or turbidity, name and source of the protein, Uniprot and Protein Data Bank codes, single point as well as multiple mutations, and literature citation. The data in CPAD has been supplemented with five different types of additional information: (i) Amyloid fibril forming hexa-peptides, (ii) Amorphous beta-aggregating hexa-peptides, (iii) Amyloid fibril forming peptides of different lengths, (iv) Amyloid fibril forming hexa-peptides whose crystal structures are available in the Protein Data Bank (PDB) and (v) Experimentally validated aggregation prone regions found in amyloidogenic proteins. Furthermore, CPAD is linked to other related databases and resources, such as Uniprot, Protein Data Bank, PUBMED, GAP, TANGO, WALTZ etc. We have set up a web interface with different search and display options so that users have the ability to get the data in multiple ways. CPAD is freely available at http://www.iitm.ac.in/bioinfo/CPAD/. The potential applications of CPAD have also been discussed.	[Thangakani, A. Mary; Velmurugan, D.] Univ Madras, Ctr Adv Studies Crystallog & Biophys & Bioinforma, Madras 600025, Tamil Nadu, India; [Nagarajan, R.; Sakthivel, R.; Gromiha, M. Michael] Indian Inst Technol, Bhupat & Jyoti Metha Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Kumar, Sandeep] Pfizer Inc, Biotherapeut Pharmaceut Sci, 700 Chesterfield Pkwy West, Chesterfield, MO 63017 USA	University of Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Pfizer	Gromiha, MM (corresponding author), Indian Inst Technol, Bhupat & Jyoti Metha Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gromiha@iitm.ac.in	Ramasamy, Sakthivel/AAU-7918-2020; Gromiha, Michael/H-8493-2019; Raju, Nagarajan/H-9157-2013	Raju, Nagarajan/0000-0003-3851-5520; Kumar, Sandeep/0000-0003-2840-6398; Michael, Gromiha/0000-0002-1776-4096	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sandeep Kumar is an employee of Pfizer, Inc. This funder provided support in the form of salaries for authors [SK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Prof. Fabrizio Chiti for providing experimental data on Acylphosphatase. We thank the Bioinformatics facility, Department of Biotechnology and IIT Madras for computational facilities. The work was partially supported by Department of Biotechnology, Government of India.	Agrawal NJ, 2011, J PHARM SCI-US, V100, P5081, DOI 10.1002/jps.22705; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beerten J, 2015, BIOINFORMATICS, V31, P1698, DOI 10.1093/bioinformatics/btv027; Buck PM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003291; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Cohen E, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10088; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kumar S, 2015, DEVELOPABILITY OF BI; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22258; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Porcari R, 2015, J BIOL CHEM, V290, P2395, DOI 10.1074/jbc.M114.610527; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Sarkar A, 2012, CURR BIOINFORM, V7, P87, DOI 10.2174/157489312799304495; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Swart C, 2014, EXP GERONTOL, V58, P279, DOI 10.1016/j.exger.2014.09.003; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Thangakani AM, 2014, BIOINFORMATICS, V30, P1983, DOI 10.1093/bioinformatics/btu167; Thangakani AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S8-S6; Thangakani AM, 2012, PROTEINS, V80, P1003, DOI 10.1002/prot.24002; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175	27	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152949	10.1371/journal.pone.0152949	http://dx.doi.org/10.1371/journal.pone.0152949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043825	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100053
J	Uppangala, S; Mathai, SE; Salian, SR; Kumar, D; Singh, VJ; D'Souza, F; Kalthur, G; Kamath, A; Adiga, SK				Uppangala, Shubhashree; Mathai, Sherine Eliza; Salian, Sujith Raj; Kumar, Dayanidhi; Singh, Vikram Jeet; D'Souza, Fiona; Kalthur, Guruprasad; Kamath, Asha; Adiga, Satish Kumar			Sperm Chromatin Immaturity Observed in Short Abstinence Ejaculates Affects DNA Integrity and Longevity In Vitro	PLOS ONE			English	Article							SEXUAL ABSTINENCE; SPERMATOZOA; DECREASES; DURATION; DAMAGE; ZINC; CRYOPRESERVATION; FRAGMENTATION; METHYLATION; QUALITY	Background The influence of ejaculatory abstinence (EA) on semen parameters and subsequent reproductive outcome is still debatable; hence understanding the impact of EA on sperm structural and functional integrity may provide a valuable information on predicting successful clinical outcome. Objective To understand the influence of EA on sperm chromatin maturity, integrity, longevity and global methylation status. Methods This experimental prospective study included 76 ejaculates from 19 healthy volunteers who provided ejaculates after observing 1, 3, 5 and 7 days of abstinence. Sperm chromatin maturity, DNA integrity and global methylation status were assessed in the neat ejaculate. Sperm motility, DNA integrity and longevity were assessed in the processed fraction of the fresh and frozen-thawed ejaculates to determine their association with the length of EA. Results Spermatozoa from 1 day ejaculatory abstinence (EA-1) displayed significantly higher level of sperm chromatin immaturity in comparison to EA-3 (P < 0.05) and EA-5 (P < 0.01) whereas; the number of 5-methyl cytosine immunostained spermatozoa did not vary significantly across groups. On the other hand, in vitro incubation of processed ejaculate from EA-1 resulted in approximately 20 and 40 fold increase in the DNA fragmented spermatozoa at the end of 6 and 24h respectively (P < 0.01-0.001). Conclusion Use of short-term EA for therapeutic fertilization would be a clinically valuable strategy to improve the DNA quality. However, use of such spermatozoa after prolonged incubation in vitro should be avoided as it can carry a substantial risk of transmitting DNA fragmentation to the oocytes.	[Uppangala, Shubhashree; Mathai, Sherine Eliza; Salian, Sujith Raj; Kumar, Dayanidhi; Singh, Vikram Jeet; D'Souza, Fiona; Kalthur, Guruprasad; Adiga, Satish Kumar] Manipal Univ, Kasturba Med Coll, Div Clin Embryol, Manipal 576104, Karnataka, India; [Kamath, Asha] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Adiga, SK (corresponding author), Manipal Univ, Kasturba Med Coll, Div Clin Embryol, Manipal 576104, Karnataka, India.	satish.adiga@manipal.edu	Adiga, Satish Kumar/AAU-4386-2020; Uppangala, Shubhashree/AAA-4965-2021	Adiga, Satish Kumar/0000-0002-2897-4697; Uppangala, Shubhashree/0000-0002-5633-3977; Kumar, Dayanidhi/0000-0003-2832-0121; Kamath, Asha/0000-0003-0727-8067				Aoki VW, 2006, FERTIL STERIL, V86, P1541, DOI 10.1016/j.fertnstert.2006.04.023; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Bjorndahl L, 2010, MOL HUM REPROD, V16, P23, DOI 10.1093/molehr/gap099; BLACKWELL JM, 1992, FERTIL STERIL, V58, P798; Boitrelle F, 2012, J ANDROL, V33, P1371, DOI 10.2164/jandrol.112.016980; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; De Jonge C, 2004, FERTIL STERIL, V82, P57, DOI 10.1016/j.fertnstert.2004.03.014; Elzanaty S, 2005, HUM REPROD, V20, P221, DOI 10.1093/humrep/deh586; Fernandez JL, 2003, J ANDROL, V24, P59; FREUND M, 1963, J REPROD FERTIL, V6, P269; Gosalvez J, 2011, MOL REPROD DEV, V78, P951, DOI 10.1002/mrd.21394; Gosalvez J, 2011, FERTIL STERIL, V96, P1083, DOI 10.1016/j.fertnstert.2011.08.027; Jurema MW, 2005, FERTIL STERIL, V84, P678, DOI 10.1016/j.fertnstert.2005.03.044; Kotdawala AP, 2012, J ASSIST REPROD GEN, V29, P1447, DOI 10.1007/s10815-012-9894-8; Kumar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069927; LELANNOU D, 1986, ARCH ANDROLOGY, V17, P35; Levitas E, 2005, FERTIL STERIL, V83, P1680, DOI 10.1016/j.fertnstert.2004.12.045; Marshbum PB, 2010, FERTIL STERIL, V93, P286, DOI 10.1016/j.fertnstert.2009.07.972; Montjean D, 2015, ANDROLOGY-US, V3, P235, DOI 10.1111/andr.12001; Pfeifer S, 2015, FERTIL STERIL, V103, pE44, DOI 10.1016/j.fertnstert.2015.03.019; Pons I, 2013, J ASSIST REPROD GEN, V30, P1211, DOI 10.1007/s10815-013-0089-8; Stoltenberg M, 1997, HISTOCHEM J, V29, P721, DOI 10.1023/A:1026413101443; Terquem A, 1993, THE SPERM CELL, P249; Tischner M., 1972, Acta Agraria et Silvestria, Zootechnica, V12, P77; Varshini J, 2012, ANDROLOGIA, V44, P642, DOI 10.1111/j.1439-0272.2011.01243.x; World Health Organization, 2010, WHO LAB MAN EX HUM S; Zhang XY, 2006, J ANDROL, V27, P414, DOI 10.2164/jandrol.05171	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152942	10.1371/journal.pone.0152942	http://dx.doi.org/10.1371/journal.pone.0152942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043437	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100051
J	Koher, A; Lentz, HHK; Hovel, P; Sokolov, IM				Koher, Andreas; Lentz, Hartmut H. K.; Hoevel, Philipp; Sokolov, Igor M.			Infections on Temporal Networks-A Matrix-Based Approach	PLOS ONE			English	Article							DISEASE; PERCOLATION; EVOLUTION; COMPLEX; SPREAD; MODEL	We extend the concept of accessibility in temporal networks to model infections with a finite infectious period such as the susceptible-infected-recovered (SIR) model. This approach is entirely based on elementary matrix operations and unifies the disease and network dynamics within one algebraic framework. We demonstrate the potential of this formalism for three examples of networks with high temporal resolution: networks of social contacts, sexual contacts, and livestock-trade. Our investigations provide a new methodological framework that can be used, for instance, to estimate the epidemic threshold, a quantity that determines disease parameters, for which a large-scale outbreak can be expected.	[Koher, Andreas; Hoevel, Philipp] Tech Univ Berlin, Inst Theoret Phys, Hardenbergstr 36, D-10623 Berlin, Germany; [Lentz, Hartmut H. K.] Friedrich Loeffler Inst, Inst Epidemiol, Sudufer 10, D-17493 Greifswald, Germany; [Hoevel, Philipp] Humboldt Univ, Bernstein Ctr Computat Neurosci Berlin, Philippstr 13, D-10115 Berlin, Germany; [Sokolov, Igor M.] Humboldt Univ, Inst Phys, Newtonstr 15, D-12489 Berlin, Germany	Technical University of Berlin; Friedrich Loeffler Institute; Humboldt University of Berlin; Humboldt University of Berlin	Koher, A (corresponding author), Tech Univ Berlin, Inst Theoret Phys, Hardenbergstr 36, D-10623 Berlin, Germany.	andreas.koher@tu-berlin.de	Sokolov, Igor M/D-1668-2009	Sokolov, Igor M/0000-0002-4688-9162; Hoevel, Philipp/0000-0002-1370-4272; Lentz, Hartmut/0000-0002-1713-9506; Koher, Andreas/0000-0001-7049-9538	Deutsche Forschungsgemeinschaft of the Collaborative Research Center [(SFB) 910]; Federal Ministry of Education and Research (BMBF), Germany [01GQ1001B]; Deutsche Forschungsgemeinschaft of the International Research Training Group (IRTG) [1740]	Deutsche Forschungsgemeinschaft of the Collaborative Research Center(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft of the International Research Training Group (IRTG)(German Research Foundation (DFG))	AK and PH acknowledge funding by the Deutsche Forschungsgemeinschaft in the framework of the Collaborative Research Center (SFB) 910. PH was partially supported by the Federal Ministry of Education and Research (BMBF), Germany (grant no. 01GQ1001B). IMS acknowledges support by the Deutsche Forschungsgemeinschaft in the framework of the International Research Training Group (IRTG) 1740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; BARTLETT MS, 1949, J R STAT SOC B, V11, P211; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Casteigts A, 2012, INT J PARALLEL EMERG, V27, P387, DOI [10.1080/17445760.2012.668546, 10.1007/978-3-642-22450-8_27]; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Gleeson JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026106; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Konschake M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055223; Lentz HHK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.118701; LUCE RD, 1952, P AM MATH SOC, V3, P382, DOI 10.2307/2031888; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Sander LM, 2003, PHYSICA A, V325, P1, DOI 10.1016/S0378-4371(03)00176-6; Sander LM, 2002, MATH BIOSCI, V180, P293, DOI 10.1016/S0025-5564(02)00117-7; STAUFFER D, 1994, INTRO PERCOLATION TH; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Valdano E, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021005; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Van Mieghem P, 2014, ARXIV14021731; Wang Y, 2003, SYM REL DIST SYST, P25	41	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151209	10.1371/journal.pone.0151209	http://dx.doi.org/10.1371/journal.pone.0151209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035128	gold, Green Published, Green Submitted			2022-12-27	WOS:000373201200007
J	Tran, A; Fortier, C; Giovannini-Chami, L; Demonchy, D; Caci, H; Desmontils, J; Montaudie-Dumas, I; Bensaid, R; Haas, H; Berard, E				Tran, Antoine; Fortier, Clara; Giovannini-Chami, Lisa; Demonchy, Diane; Caci, Herve; Desmontils, Jonathan; Montaudie-Dumas, Isabelle; Bensaid, Ronny; Haas, Herve; Berard, Etienne			Evaluation of the Bladder Stimulation Technique to Collect Midstream Urine in Infants in a Pediatric Emergency Department	PLOS ONE			English	Article							TRACT-INFECTION; YOUNG-CHILDREN; CLEAN-CATCH; PAIN SCALE; DIAGNOSIS; BAG; PREVALENCE; URINALYSIS; EVENDOL	Objective Midstream clean-catch urine is an accepted method to diagnose urinary tract infection but is impracticable in infants before potty training. We tested the bladder stimulation technique to obtain a clean-catch urine sample in infants. Materials and methods We included 142 infants under walking age who required a urine sample in a cross-sectional study carried out during a 3-months period, from September to November 2014, in the emergency department of the University Children's Hospital of Nice (France). A technique based on bladder stimulation and lumbar stimulation maneuvers, with at least two attempts, was tested by four trained physicians. The success rate and time to obtain urine sample within 3 minutes were evaluated. Discomfort (EVENDOL score >= 4/15) was measured. We estimated the risk factors in the failure of the technique. Chi-square test or Fisher's exact test were used to compare frequencies. T-test and Wilcoxon test were used to compare quantitative data according to the normality of the distribution. Risk factors for failure of the technique were evaluated using a multivariate logistic regression model. Results We obtained midstream clean-catch urine in 55.6% of infants with a median time of 52.0 s (10.0; 110.0). The success rate decreased with age from 88.9% (newborn) to 28.6% (>1 y) (p = 0.0001) and with weight, from 85.7% (<4kg) to 28.6% (>10kg) (p = 0.0004). The success rate was 60.8% for infants without discomfort (p<0.0001). Heavy weight and discomfort were associated with failure, with adjusted ORs of 1.47 [1.04-2.31] and 6.65 [2.85-15.54], respectively. Conclusion Bladder stimulation seems to be efficient in obtaining midstream urine with a moderate success rate in our study sample. This could be an alternative technique for infants before potty training but further randomized multicenter studies are needed to validate this procedure.	[Tran, Antoine; Fortier, Clara; Giovannini-Chami, Lisa; Demonchy, Diane; Caci, Herve; Desmontils, Jonathan; Montaudie-Dumas, Isabelle; Bensaid, Ronny; Haas, Herve] CHU Lenval, Hop Pediat Nice, Nice, France; [Berard, Etienne] CHU Nice, Serv Nephrol Pediat, Archet 2, F-06202 Nice, France	CHU Nice; CHU Nice	Tran, A (corresponding author), CHU Lenval, Hop Pediat Nice, Nice, France.	tran.a@pediatrie-chulenval-nice.fr						Al-Orifi F, 2000, J PEDIATR-US, V137, P221, DOI 10.1067/mpd.2000.107466; Altuntas N, 2015, EUR J PEDIATR, V174, P577, DOI 10.1007/s00431-014-2434-z; Bachur R, 2001, ARCH PEDIAT ADOL MED, V155, P60, DOI 10.1001/archpedi.155.1.60; Bagga Arvind, 2001, Indian Journal of Pediatrics, V68, pS40; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coulthard MG, 2014, ARCH DIS CHILD, V99, P342, DOI 10.1136/archdischild-2013-304428; Dai B, 2010, ARCH DIS CHILD, V95, P499, DOI 10.1136/adc.2009.173112; Etoubleau C, 2009, J PEDIATR-US, V154, P803, DOI 10.1016/j.jpeds.2009.01.008; Finnell SME, 2011, PEDIATRICS, V128, P749, DOI 10.1542/peds.2011-1332; Fournier-Charriere E, 2013, ANN FR ANESTH, V32, P447, DOI 10.1016/j.annfar.2013.05.001; Fournier-Charriere E, 2012, PAIN, V153, P1573, DOI 10.1016/j.pain.2012.02.024; HARDY JD, 1976, BRIT J UROL, V48, P279, DOI 10.1111/j.1464-410X.1976.tb03021.x; Hari Pankaj, 2003, Indian Journal of Pediatrics, V70, P235, DOI 10.1007/BF02725591; Hay AD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6316; Fernandez MLH, 2013, ARCH DIS CHILD, V98, P27, DOI 10.1136/archdischild-2012-301872; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Jansson UB, 2000, J UROLOGY, V164, P2050, DOI 10.1016/S0022-5347(05)66963-7; Karacan C, 2010, MED PRIN PRACT, V19, P188, DOI 10.1159/000273068; Lau AY, 2007, ACTA PAEDIATR, V96, P432, DOI 10.1111/j.1651-2227.2006.00146.x; McGillivray D, 2005, J PEDIATR-US, V147, P451, DOI 10.1016/j.jpeds.2005.05.007; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; NCC for W and CH, 2007, UR TRACT INF CHILR; Oswald J, 2002, J UROLOGY, V168, P2586, DOI 10.1016/S0022-5347(05)64222-X; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Saadeh SA, 2011, PEDIATR NEPHROL, V26, P1967, DOI 10.1007/s00467-011-1801-5; Schlager T A, 2001, Paediatr Drugs, V3, P219, DOI 10.2165/00128072-200103030-00004; Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16; Shim YH, 2009, PEDIATR NEPHROL, V24, P309, DOI 10.1007/s00467-008-1001-0; Sillen U, 2001, J UROLOGY, V166, P2376, DOI 10.1016/S0022-5347(05)65594-2; Tullus K, 2015, PEDIATR NEPHROL, V30, P1375, DOI 10.1007/s00467-015-3130-6; Tullus K, 2012, PEDIATR NEPHROL, V27, P509, DOI 10.1007/s00467-011-2077-5; Tullus K, 2011, PEDIATR NEPHROL, V26, P1923, DOI 10.1007/s00467-011-1966-y; Woock JP, 2011, AM J PHYSIOL-REG I, V300, pR398, DOI 10.1152/ajpregu.00154.2010	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152598	10.1371/journal.pone.0152598	http://dx.doi.org/10.1371/journal.pone.0152598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031953	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800100
J	Lopez-Antonanzas, R; Gutkin, V; Rabinovich, R; Calvo, R; Grossman, A				Lopez-Antonanzas, Raquel; Gutkin, Vitaly; Rabinovich, Rivka; Calvo, Ran; Grossman, Aryeh			A Transitional Gundi (Rodentia: Ctenodactylidae) from the Miocene of Israel	PLOS ONE			English	Article							HAZEVA FORMATION; FOSSIL RODENTS; STRATIGRAPHY; PAKISTAN; MAMMALIA; AFRICA	We describe a new species of gundi (Rodentia: Ctenodactylidae: Ctenodactylinae), Sayimys negevensis, on the basis of cheek teeth from the Early Miocene of the Rotem Basin, southern Israel. The Rotem ctenodactylid differs from all known ctenodactylid species, including Sayimys intermedius, which was first described from the Middle Miocene of Saudi Arabia. Instead, it most resembles Sayimys baskini from the Early Miocene of Pakistan in characters of the m1-2 (e.g., the mesoflexid shorter than the metaflexid, the obliquely orientated hypolophid, and the presence of a strong posterolabial ledge) and the upper molars (e.g., the paraflexus that is longer than the metaflexus). However, morphological (e.g., presence of a well-developed paraflexus on unworn upper molars) and dimensional (regarding, in particular, the DP4 and M1 or M2) differences between the Rotem gundi and Sayimys baskini distinguish them and testify to the novelty and endemicity of the former. In its dental morphology, Sayimys negevensis sp. nov. shows a combination of both the ultimate apparition of key-characters and incipient features that would be maintained and strengthened in latter ctenodactylines. Thus, it is a pivotal species that bridges the gap between an array of primitive ctenodactylines and the most derived, Early Miocene and later, gundis.	[Lopez-Antonanzas, Raquel] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Lopez-Antonanzas, Raquel] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Gutkin, Vitaly] Hebrew Univ Jerusalem, Harvey M Krueger Family Ctr Nanosci & Nanotechnol, Jerusalem, Israel; [Rabinovich, Rivka] Hebrew Univ Jerusalem, Inst Earth Sci, Natl Nat Hist Collect, IL-91904 Jerusalem, Israel; [Rabinovich, Rivka] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Calvo, Ran] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Grossman, Aryeh] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ USA; [Grossman, Aryeh] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Geological Survey Israel; Midwestern University; Arizona State University; Arizona State University-Tempe	Lopez-Antonanzas, R (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.; Lopez-Antonanzas, R (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	r.lopez-antonanzas@bristol.ac.uk	Grossman, Ari/T-4975-2017	Grossman, Ari/0000-0001-5978-9614; Lopez-Antonanzas, Raquel/0000-0003-3025-0476; Rabinovich, Rivka/0000-0002-1343-3134; Calvo, Ran/0000-0001-8381-7101	Alexander von Humboldt Foundation; SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program; European Union via a Marie Curie fellowship [PIEF-GA-2013-623352]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); SYNTHESYS Project - European Community Research Infrastructure Action under the FP7 "Capacities" Program; European Union via a Marie Curie fellowship	The sojourn in Berlin was funded by the Alexander von Humboldt Foundation through sponsorship of renewed research stay in Germany, whereas that in Paris was funded by the SYNTHESYS Project (http://www.synthesys.info/), which is financed by the European Community Research Infrastructure Action under the FP7 "Capacities" Program. RLA is supported by the European Union via a Marie Curie fellowship (PIEF-GA-2013-623352).	Antonanzas RL, 2004, PALAEONTOLOGY, V47, P1477, DOI 10.1111/j.0031-0239.2004.00424.x; Baskin J.A., 1996, Palaeovertebrata (Montpellier), V25, P1; BLACK C C, 1972, Palaeontology (Oxford), V15, P238; Blyth E., 1856, J ASIATIC SOC BENGAL, V24, P291; Bohlin B., 1946, PALAEONTOLOGIA SIN C, V8b, P1; Bowditch TE., 1821, ANAL NATURAL CLASSIF; De Bruijn H., 1974, P KON NED AKAD WET B, V77, P45; De Gregorio A., 1887, ATTI SOC TOSC SCI, V8, P3; DEBRUIJN H, 1989, P K NED AKAD B PHYS, V92, P191; Flynn L.J., 2013, FOSSIL MAMMALS ASIA, P353, DOI DOI 10.1130/0091-7613(1997)025<0019:OWFADO>2.3.CO;2; GEORGE W, 1985, MAMMALIA, V49, P53, DOI 10.1515/mamm.1985.49.1.53; GEORGE W, 1979, ZOOL J LINN SOC-LOND, V65, P261, DOI 10.1111/j.1096-3642.1979.tb01096.x; Gervais M. P., 1853, ANN SCI NAT ZOOL, V20, P238; GOLDSMITH NF, 1994, NEWSL STRATIGR, V31, P167; GOLDSMITH NF, 1988, NEWSL STRATIGR, V20, P73; GOLDSMITH NF, 1982, NATURE, V296, P645, DOI 10.1038/296645a0; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HINTON MARTIN A. C., 1933, ANN AND MAG NAT HIST, V12, P620; Jaeger JJ., 1971, NOTES SERV GEOL MARO, V31, P113; Lataste F., 1886, NATURALISTE, V36, P287; Lataste F., 1881, B SOC ZOOL FRANCE, V6, P214; Lavocat R., 1961, NOTES MEM SERV GEOL, V155, P29; Lopez Antonanzas Raquel, 2003, Eclogae Geologicae Helvetiae, V96, P521; Lopez-Antonanzas R, 2004, J VERTEBR PALEONTOL, V24, P676, DOI 10.1671/0272-4634(2004)024[0676:ANLCSF]2.0.CO;2; Lopez-Antonanzas R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12871; Lopez-Antonanzas R, 2011, J SYST PALAEONTOL, V9, P379, DOI 10.1080/14772019.2010.529175; LOPEZANTONANZAS R, 2014, J VERTEBR PALEONTO S, V34, P170; Matthew W. D., 1923, American Museum Novitates, VNo. 102, P1; Mein P, 2010, HIST BIOL, V22, P224, DOI 10.1080/08912961003644104; Munthe J, 1980, MILWAUKEE PUBLIC MUS, V34, P1; Neev D, 1960, B GEOL SURV ISR, V25, P1; Rothman G., 1776, NEUER BRIEFWECHSEL H, P326; Savage R.J.G., 1968, P GEOL SOC LONDON, P98; Savage RJG, 1990, EUROPEAN NEOGENE MAM, P587; Schaub S., 1958, TRAIT PAL ONTOLOGIE, VVol. 2, P659; Sen S., 1979, COMPTE RENDU SOMMAIR, V1, P34; STEHLIN HG, 1951, SCHWEIZ PALEONT ABH, V67, P1; Tchernov E., 1987, Journal of Vertebrate Paleontology, V7, P284; Thomas O., 1902, P ZOOL SOC LOND, V2, P2; VANCOUVERING JA, 1969, NATURE, V221, P628, DOI 10.1038/221628a0; Vianey-Liaud M, 2010, ZOOL J LINN SOC-LOND, V160, P531, DOI 10.1111/j.1096-3642.2010.00615.x; Wang BY, 1997, B AM MUS NAT HIST, P1; Wang Xiaoming, 2013, P274; WESSELS W, 1982, P K NED AKAD B PHYS, V85, P337; Wood AE, 1937, AM J SCI, V34, P64; Wood Albert E., 1998, Journal of Vertebrate Paleontology, V18, p87A	46	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151804	10.1371/journal.pone.0151804	http://dx.doi.org/10.1371/journal.pone.0151804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049960	gold, Green Published			2022-12-27	WOS:000373603500012
J	Asaf, S; Khan, AL; Khan, AR; Waqas, M; Kang, SM; Khan, MA; Shahzad, R; Seo, CW; Shin, JH; Lee, IJ				Asaf, Sajjad; Khan, Abdul Latif; Khan, Abdur Rahim; Waqas, Muhammad; Kang, Sang-Mo; Khan, Muhammad Aaqil; Shahzad, Raheem; Seo, Chang-Woo; Shin, Jae-Ho; Lee, In-Jung			Mitochondrial Genome Analysis of Wild Rice (Oryza minuta) and Its Comparison with Other Related Species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PHYLOGENETIC-RELATIONSHIPS; PHYSICAL STRUCTURE; NUCLEAR GENES; GENUS ORYZA; DNA; EVOLUTION; L.; REARRANGEMENT; SATIVA	Oryza minuta (Poaceae family) is a tetraploid wild relative of cultivated rice with a BBCC genome. O. minuta has the potential to resist against various pathogenic diseases such as bacterial blight (BB), white backed planthopper (WBPH) and brown plant hopper (BPH). Here, we sequenced and annotated the complete mitochondrial genome of O. minuta. The mtDNA genome is 515,022 bp, containing 60 protein coding genes, 31 tRNA genes and two rRNA genes. The mitochondrial genome organization and the gene content at the nucleotide level are highly similar (89%) to that of O. rufipogon. Comparison with other related species revealed that most of the genes with known function are conserved among the Poaceae members. Similarly, O. minuta mt genome shared 24 protein-coding genes, 15 tRNA genes and 1 ribosomal RNA gene with other rice species (indica and japonica). The evolutionary relationship and phylogenetic analysis revealed that O. minuta is more closely related to O. rufipogon than to any other related species. Such studies are essential to understand the evolutionary divergence among species and analyze common gene pools to combat risks in the current scenario of a changing environment.	[Asaf, Sajjad; Khan, Abdur Rahim; Waqas, Muhammad; Kang, Sang-Mo; Khan, Muhammad Aaqil; Shahzad, Raheem; Seo, Chang-Woo; Shin, Jae-Ho; Lee, In-Jung] Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea; [Khan, Abdul Latif] Univ Nizwa, Chair Omans Med Plants & Marine Nat Prod, Nizwa 616, Oman; [Waqas, Muhammad] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	Kyungpook National University; University of Nizwa	Lee, IJ (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea.	ijlee@knu.ac.kr	Asaf, Sajjad/ABA-3647-2021; Shahzad, Raheem/AAG-8370-2019; Lee, In-Jung/GLS-0432-2022; Khan, Abdur Rahim/N-5836-2015; Khan, Muhammad Aqil/ABB-9797-2021	Shahzad, Raheem/0000-0002-6594-8287; Lee, In-Jung/0000-0001-7154-4820; Khan, Abdur Rahim/0000-0001-5370-6216; Khan, Abdul Latif/0000-0001-9700-8903	research fund from Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311058-05-3-CG000]	research fund from Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea	This study was supported by a research fund (311058-05-3-CG000) from the Ministry for Food, Agriculture, Forestry, and Fisheries, Republic of Korea.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; AMANTEBORDEOS A, 1992, THEOR APPL GENET, V84, P345, DOI 10.1007/BF00229493; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017662; CHETRIT P, 1984, CURR GENET, V8, P413, DOI 10.1007/BF00433907; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cui P, 2009, J GENET, V88, P299, DOI 10.1007/s12041-009-0043-9; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darracq A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-233; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Matter F, 1988, PHILOS T R SOC LON B, V319; Michael TP, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0001in; Miyata S, 1998, CURR GENET, V34, P216, DOI 10.1007/s002940050389; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Rahman ML, 2009, THEOR APPL GENET, V119, P1237, DOI 10.1007/s00122-009-1125-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnell J, 2015, TRANSGENIC RES, V24, P1, DOI 10.1007/s11248-014-9843-7; SCHUSTER W, 1994, ANNU REV PLANT PHYS, V45, P61, DOI 10.1146/annurev.pp.45.060194.000425; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; STERN DB, 1986, NUCLEIC ACIDS RES, V14, P5651, DOI 10.1093/nar/14.14.5651; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vaughan DA, 1994, THE WILD RELATIVES O; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; Wu ZH, 2014, BIG DATA RES, V1, P1, DOI 10.1016/j.bdr.2014.08.0022214; Wu ZQ, 2016, MITOCHONDRIAL DNA A, V27, P4155, DOI 10.3109/19401736.2014.1003890; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu T, 2014, MOL PHYLOGENET EVOL, V70, P348, DOI 10.1016/j.ympev.2013.10.008	52	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152937	10.1371/journal.pone.0152937	http://dx.doi.org/10.1371/journal.pone.0152937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045847	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600049
J	Liu, YL; Zhou, JA; Qu, YL; Yang, XG; Shi, GJ; Wang, XH; Hong, YZ; Drlica, K; Zhao, XL				Liu, Yuanli; Zhou, Jinan; Qu, Yilin; Yang, Xinguang; Shi, Guojing; Wang, Xiuhong; Hong, Yuzhi; Drlica, Karl; Zhao, Xilin			Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants	PLOS ONE			English	Article							CELL-DEATH; ERYTHROMYCIN RESISTANCE; GENOTOXIC EVALUATION; ESCHERICHIA-COLI; ANTIBIOTICS; INVOLVEMENT; CONSUMPTION; BIOAVAILABILITY; CIPROFLOXACIN; PATHWAYS	Reactive oxygen species (ROS; superoxide, peroxide, and hydroxyl radical) are thought to contribute to the rapid bactericidal activity of diverse antimicrobial agents. The possibility has been raised that consumption of antioxidants in food may interfere with the lethal action of antimicrobials. Whether nutritional supplements containing antioxidant activity are also likely to interfere with antimicrobial lethality is unknown. To examine this possibility, resveratrol, a popular antioxidant dietary supplement, was added to cultures of Escherichia coli and Staphylococcus aureus that were then treated with antimicrobial and assayed for bacterial survival and the recovery of mutants resistant to an unrelated antimicrobial, rifampicin. Resveratrol, at concentrations likely to be present during human consumption, caused a 2- to 3-fold reduction in killing during a 2-hr treatment with moxifloxacin or kanamycin. At higher, but still subinhibitory concentrations, resveratrol reduced antimicrobial lethality by more than 3 orders of magnitude. Resveratrol also reduced the increase in reactive oxygen species (ROS) characteristic of treatment with quinolone (oxolinic acid). These data support the general idea that the lethal activity of some antimicrobials involves ROS. Surprisingly, subinhibitory concentrations of resveratrol promoted (2- to 6-fold) the recovery of rifampicinresistant mutants arising from the action of ciprofloxacin, kanamycin, or daptomycin. This result is consistent with resveratrol reducing ROS to sublethal levels that are still mutagenic, while the absence of resveratrol allows ROS levels to high enough to kill mutagenized cells. Suppression of antimicrobial lethality and promotion of mutant recovery by resveratrol suggests that the antioxidant may contribute to the emergence of resistance to several antimicrobials, especially if new derivatives and/or formulations of resveratrol markedly increase bioavailability.	[Liu, Yuanli; Zhou, Jinan; Qu, Yilin; Yang, Xinguang; Shi, Guojing; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team High, 194 Xuefu Rd, Harbin 150081, Heilongjiang Pr, Peoples R China; [Hong, Yuzhi; Drlica, Karl; Zhao, Xilin] Rutgers State Univ, Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA; [Hong, Yuzhi; Drlica, Karl; Zhao, Xilin] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA; [Zhao, Xilin] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, South Xiang An Rd, Xiamen 361102, Fujian Province, Peoples R China	Harbin Medical University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Xiamen University	Wang, XH (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team High, 194 Xuefu Rd, Harbin 150081, Heilongjiang Pr, Peoples R China.; Zhao, XL (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.; Zhao, XL (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.; Zhao, XL (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, South Xiang An Rd, Xiamen 361102, Fujian Province, Peoples R China.	wangxh700417@aliyun.com; zhaox5@njms.rutgers.edu		Zhao, Xilin/0000-0001-8375-8658; Hong, Yuzhi/0000-0003-4277-1834	National Institutes of Health [1DP2OD007423, 1R01AI073491, 1R21A03781, 1R01AI87671]; National Natural Science Foundation of China [30973596, 81473251]; Natural Science Foundation of Heilongjiang Province [QC2012C086]; Heilongjiang Postdoctoral Program [LBH-Z13147]; Research Project of Heilongjiang Department of Public Health [2012-756]; Natural Science Foundation of Fujian Province [2014J01139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073491, R21AI103781, R01AI087671] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Postdoctoral Program; Research Project of Heilongjiang Department of Public Health; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from the National Institutes of Health (1DP2OD007423, 1R01AI073491, 1R21A03781, and 1R01AI87671), National Natural Science Foundation of China (30973596 and 81473251), Natural Science Foundation of Heilongjiang Province (QC2012C086), Heilongjiang Postdoctoral Program (LBH-Z13147), Research Project of Heilongjiang Department of Public Health (2012-756), and Natural Science Foundation of Fujian Province (2014J01139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires V, 2015, CURR PHARM BIOTECHNO, V16, P219, DOI 10.2174/1389201016666150118132457; Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Arriaga-Alba M, 1998, ARCH MED RES, V29, P235; BASS DA, 1983, J IMMUNOL, V130, P1910; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Boyce A, 2004, J CHROMATOGR B, V802, P217, DOI 10.1016/j.jchromb.2003.10.057; BRANDT R, 1965, ANAL BIOCHEM, V11, P6, DOI 10.1016/0003-2697(65)90035-7; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dorsey-Oresto A, 2013, CELL REP, V3, P528, DOI 10.1016/j.celrep.2013.01.026; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Ferrandiz MJ, 2016, ANTIMICROB AGENTS CH, V60, P409, DOI 10.1128/AAC.02299-15; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Granzotto A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00095; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guo W, 2015, AM J INFECT CONTROL, V43, P358, DOI 10.1016/j.ajic.2014.12.010; Hoshino J, 2010, J MED CHEM, V53, P5033, DOI 10.1021/jm100274c; Hwang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10029; Isidori M, 2005, SCI TOTAL ENVIRON, V346, P87, DOI 10.1016/j.scitotenv.2004.11.017; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Li LP, 2014, MBIO, V5, DOI 10.1128/mBio.01708-14; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262; Long QX, 2015, ANTIMICROB AGENTS CH, V59, P1787, DOI 10.1128/AAC.04434-14; Malik M, 2014, J ANTIMICROB CHEMOTH, V69, P3227, DOI 10.1093/jac/dku285; Marathe SA, 2013, J ANTIMICROB CHEMOTH, V68, P139, DOI 10.1093/jac/dks375; Marshall DA, 2006, CAN J PUBLIC HEALTH, V97, P126, DOI 10.1007/BF03405330; Mosel M, 2013, ANTIMICROB AGENTS CH, V57, P5755, DOI 10.1128/AAC.00754-13; Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Sinha R, 2003, J Postgrad Med, V49, P222; Stivala L, 2001, J BIOL CHEM, V276; Su YL, 2014, MOLECULES, V19, P12630, DOI 10.3390/molecules190812630; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Yang X, 2014, ANTI-CANCER AGENT ME, V14, P806, DOI 10.2174/1871520614666140521121722; Zhao XL, 2015, J ANTIMICROB CHEMOTH, V70, P639, DOI 10.1093/jac/dku463; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008	48	28	31	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153023	10.1371/journal.pone.0153023	http://dx.doi.org/10.1371/journal.pone.0153023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045517	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600060
J	Makanya, AN; Dimova, I; Koller, T; Styp-Rekowska, B; Djonov, V				Makanya, Andrew Ndegwa; Dimova, Ivanka; Koller, Tobias; Styp-Rekowska, Beata; Djonov, Valentin			Dynamics of the Developing Chick Chorioallantoic Membrane Assessed by Stereology, Allometry, Immunohistochemistry and Molecular Analysis	PLOS ONE			English	Article							SHELL-LESS CULTURE; INTUSSUSCEPTIVE ANGIOGENESIS; CHORIONIC EPITHELIUM; VASCULAR NETWORK; EMBRYO; DIFFERENTIATION; ULTRASTRUCTURE; PROPAGATION; INCUBATION; EXPRESSION	The chick chorioallantoic membrane (CAM) is a widely used model for the study of angiogenesis, tumour growth, as well as drug efficacy. In spite of this, little is known about the developmental alteration from its appearance to the time of hatching. In the current study the CAM has been studied by classical stereology and allometry. Expression levels of selected angiogenesis-related molecules were estimated by RT-PCR and cell dynamics assessed by proliferation and apoptosis assays. Absolute CAM volume increased from a low of 0.47 +/- 0.11 cm(3) at embryonic day 8 (E8) to a high of 2.05 +/- 0.27 cm(3) at E18, and then decreased to 1.6 +/- 0.47 cm(3) at E20. On allometric analysis, three growth phases were identifiable. Between E8-13 (phase I), the CAM grew fastest; moderately in phase II (E13-18) but was regressing in phase III (E18-20). The chorion, the mesenchyme and the allantoic layers grew fastest in phase I, but moderately in phase II. The mesenchyme grew slowly in phase III while the chorion and allantois were regressing. Chorionic cell volume increased fastest in phase I and was regressing in phase III. Chorionic capillaries grew steadily in phase I and II but regressed in phase III. Both the chorion and the allantois grew by intrinsic cell proliferation as well as recruitment of cells from the mesenchyme. Cell proliferation was prominent in the allantois and chorion early during development, declined after E17 and apoptosis started mainly in the chorion from E14. VEGFR2 expression peaked at E11 and declined steadily towards E20, VEGF peaked at E13 and E20 while HIF 1 alpha had a peak at E11 and E20. Studies targeting CAM growth and angiogenesis need to take these growth phases into consideration	[Makanya, Andrew Ndegwa] Univ Nairobi, Dept Vet Anat & Physiol, Riverside Dr,Chiromo Campus,Box 30197, Nairobi 00100, Kenya; [Dimova, Ivanka] Med Univ Sofia, Dept Med Genet, Zdrave St 2, Sofia 1431, Bulgaria; [Koller, Tobias; Styp-Rekowska, Beata; Djonov, Valentin] Univ Bern, Inst Anat, Baltzerstr 2, CH-3000 Bern 9, Switzerland	University of Nairobi; Medical University Sofia; University of Bern	Makanya, AN (corresponding author), Univ Nairobi, Dept Vet Anat & Physiol, Riverside Dr,Chiromo Campus,Box 30197, Nairobi 00100, Kenya.	makanya@uonbi.ac.ke	Dimova, Ivanka/ABH-5382-2020; Makanya, Andrew N/F-4180-2012	Makanya, Andrew N/0000-0002-9983-785X; Djonov, Valentin/0000-0002-5062-1169	ERAfrica [RDS Control-NI-036]; Swiss National Science Foundation [31003A_135740]	ERAfrica; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by ERAfrica grant No. RDS Control-NI-036, http://www.erafrica.eu/, and Swiss National Science Foundation Grant No: 31003A_135740.	AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Baum O, 2010, MICROCIRCULATION, V17, P447, DOI 10.1111/j.1549-8719.2010.00043.x; Bellairs R., 2005, ATLAS CHICK DEV, DOI DOI 10.1016/C2010-0-65149-2; Cimpean AM, 2008, ANGIOGENESIS, V11, P311, DOI 10.1007/s10456-008-9117-1; COLEMAN JR, 1970, EXP CELL RES, V63, P216, DOI 10.1016/0014-4827(70)90356-3; Davies JA, 1996, ACTA ANAT, V156, P187; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; Dimitropoulou C, 1998, Angiogenesis, V2, P255, DOI 10.1023/A:1009210918738; Dimova I, 2013, ANGIOGENESIS, V16, P921, DOI 10.1007/s10456-013-9366-5; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; DUNN BE, 1979, DEV BIOL, V71, P216, DOI 10.1016/0012-1606(79)90165-9; FANCSI T, 1979, ZBL VET MED C, V8, P151, DOI 10.1111/j.1439-0264.1979.tb00687.x; Ferner K, 2011, RESP PHYSIOL NEUROBI, V178, P39, DOI 10.1016/j.resp.2011.03.029; Fitze-Gschwind VD., 1973, ENTWICKLUNG CHORIOAL; FRIED B, 1991, ADV PARASIT, V30, P107; Gabrielli MG, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/940741; Gabrielli MG, 2001, J ANAT, V198, P229, DOI 10.1046/j.1469-7580.2001.19820229.x; GANOTE CE, 1964, LAB INVEST, V13, P1575; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Guy James S., 2008, V454, P109, DOI 10.1007/978-1-59745-181-9_10; Hlushchuk R, 2011, ARTERIOSCL THROM VAS, V31, P2836, DOI 10.1161/ATVBAHA.111.231811; Konig MF, 1997, ADV EXP MED BIOL, V411, P353; LEESON TS, 1963, J ANAT, V97, P585; Little M, 2010, CURR TOP DEV BIOL, V90, P193, DOI 10.1016/S0070-2153(10)90005-7; Lusimbo WS, 2000, ANAT REC, V259, P25, DOI 10.1002/(SICI)1097-0185(20000501)259:1<25::AID-AR3>3.0.CO;2-Y; Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5; Maksimov VF, 2006, B EXP BIOL MED+, V142, P367, DOI 10.1007/s10517-006-0368-9; Marinaccio C, 2013, INT J DEV BIOL, V57, P907, DOI 10.1387/ijdb.130317dr; Matschke K, 2006, CELL TISSUE RES, V323, P395, DOI 10.1007/s00441-005-0112-1; Mortola JP, 2009, COMP BIOCHEM PHYS A, V153, P359, DOI 10.1016/j.cbpa.2009.02.041; NARBAITZ R, 1978, J EMBRYOL EXP MORPH, V45, P1; Reizis A, 2005, J EXP BIOL, V208, P2483, DOI 10.1242/jeb.01662; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Ribatti D, 2012, METHODS MOL BIOL, V843, P47, DOI 10.1007/978-1-61779-523-7_5; RIZZO V, 1993, TISSUE CELL, V25, P847, DOI 10.1016/0040-8166(93)90033-H; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; SCHERLE W, 1970, Mikroskopie, V26, P57; Schlatter P, 1997, MICROVASC RES, V54, P65, DOI 10.1006/mvre.1997.2022; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; TAZAWA H, 1977, RESP PHYSIOL, V31, P203, DOI 10.1016/0034-5687(77)90103-7; TUAN RS, 1987, J EXP ZOOL, P1; WANGENSTEEN D, 1982, RESP PHYSIOL, V47, P1, DOI 10.1016/0034-5687(82)90089-5; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6	45	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152821	10.1371/journal.pone.0152821	http://dx.doi.org/10.1371/journal.pone.0152821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046154	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600038
J	Manchope, MF; Calixto-Campos, C; Coelho-Silva, L; Zarpelon, AC; Pinho-Ribeiro, FA; Georgetti, SR; Baracat, MM; Casagrande, R; Verri, WA				Manchope, Marilia F.; Calixto-Campos, Cassia; Coelho-Silva, Leticia; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Georgetti, Sandra R.; Baracat, Marcela M.; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Naringenin Inhibits Superoxide Anion-Induced Inflammatory Pain: Role of Oxidative Stress, Cytokines, Nrf-2 and the NO-cGMP -PKG-K(ATP)Channel Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ENDOTHELIN RECEPTOR ANTAGONIST; DOWN-REGULATION; FLAVONOID NARINGENIN; TRANSCRIPTION FACTOR; NEUROPATHIC PAIN; REACTIVE OXYGEN; SPINAL-CORD; MICE	In the present study, the effect and mechanism of action of the flavonoid naringenin were evaluated in superoxide anion donor (KO2)-induced inflammatory pain in mice. Naringenin reduced KO2-induced overt-pain like behavior, mechanical hyperalgesia, and thermal hyperalgesia. The analgesic effect of naringenin depended on the activation of the NO-cGMP-PKG -ATP-sensitive potassium channel (K-ATP) signaling pathway. Naringenin also reduced KO2-induced neutrophil recruitment (myeloperoxidase activity), tissue oxidative stress, and cytokine production. Furthermore, naringenin downregulated KO2-induced mRNA expression of gp91phox, cyclooxygenase (COX)-2, and preproendothelin-1. Besides, naringenin upregulated KO2-reduced nuclear factor (erythroid-derived 2)-like 2 (Nrf2) mRNA expression coupled with enhanced heme oxygenase (HO-1) mRNA expression. In conclusion, the present study demonstrates that the use of naringenin represents a potential therapeutic approach reducing superoxide anion-driven inflammatory pain. The antinociceptive, antiinflammatory and antioxidant effects are mediated via activation of the NO-cGMP-PKG-KATP channel signaling involving the induction of Nrf2/HO-1 pathway.	[Manchope, Marilia F.; Calixto-Campos, Cassia; Coelho-Silva, Leticia; Zarpelon, Ana C.; Pinho-Ribeiro, Felipe A.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Brazil; [Georgetti, Sandra R.; Baracat, Marcela M.; Casagrande, Rubia] Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Brazil.	waverri@uel.br	Georgetti, Sandra/AAA-6576-2020; de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; Casagrande, Rubia/U-6019-2019; WA, Verri/I-1330-2013; Casagrande, Rubia/I-1377-2013	de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; Casagrande, Rubia/0000-0002-2296-1668; WA, Verri/0000-0003-2756-9283; Georgetti, Sandra Regina/0000-0003-2580-8762; Fernandes Manchope, Marilia/0000-0003-2882-6536	Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Ciencias Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI); Fundacao Araucaria; Fundacao Araucaria/CAPES (Brazil); Parana State Government	Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Ciencias Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fundacao Araucaria/CAPES (Brazil); Parana State Government	Regarding the authors' Funding Statement/Financial Disclosure, the authors inform that "Conselho Nacional de Desenvolvimento Cientifico e Teconologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Ciencias Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI), Fundacao Araucaria and Parana State Government grants supported this study (Brazil). A.C.Z. received a postdoctoral fellowship from Fundacao Araucaria/CAPES (Brazil)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Ciencias Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI), Fundacao Araucaria and Parana State Government grants supported this study (Brazil). A.C.Z. received a postdoctoral fellowship from Fundacao Araucaria/CAPES (Brazil).	Al-Rejaie SS, 2015, NEUROL RES, V37, P924, DOI 10.1179/1743132815Y.0000000079; Anderson G, 2014, CURR PHARM DESIGN, V20, P3812, DOI 10.2174/13816128113196660738; Anuja G I, 2014, ISRN Inflamm, V2014, P302089, DOI 10.1155/2014/302089; Borghi SM, 2015, EXP PHYSIOL, V100, P531, DOI 10.1113/EP085026; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189, DOI 10.1111/j.1476-5381.1993.tb13940.x; Calixto-Campos C, 2015, J NAT PROD, V78, P1799, DOI 10.1021/acs.jnatprod.5b00246; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Chao CL, 2010, NUTR RES, V30, P858, DOI 10.1016/j.nutres.2010.10.011; Chen FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143868; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Chtourou Y, 2015, CHEM-BIOL INTERACT, V239, P76, DOI 10.1016/j.cbi.2015.06.036; Closa D, 2004, IUBMB LIFE, V56, P185, DOI 10.1080/15216540410001701642; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Dean RT, 1997, BIOCH J, P324; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; DROYLEFAIX MT, 1991, FREE RADICAL RES COM, V12-3, P725, DOI 10.3109/10715769109145852; DUARTE IDG, 1992, EUR J PHARMACOL, V217, P225, DOI 10.1016/0014-2999(92)90881-4; Esmaeili MA, 2014, CLIN EXP PHARMACOL P, V41, P416, DOI 10.1111/1440-1681.12230; Fattori V, 2016, PHARMACOL RES, V112, P84, DOI 10.1016/j.phrs.2016.01.027; Fattori V, 2015, INFLAMM RES, V64, P993, DOI 10.1007/s00011-015-0885-y; Goto T, 2012, PEDIATR RES, V72, P600, DOI 10.1038/pr.2012.134; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Hasanein P, 2014, J PHYSIOL BIOCHEM, V70, P997, DOI 10.1007/s13105-014-0369-5; Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255; Karuppagounder V, 2015, INT IMMUNOPHARMACOL, V28, P154, DOI 10.1016/j.intimp.2015.05.050; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; Kaulaskar Shyam, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1482, DOI 10.3736/jcim20121223; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kim SW, 2013, FREE RADICAL BIO MED, V65, P468, DOI 10.1016/j.freeradbiomed.2013.07.028; Lavich TR, 2005, BRAZ J MED BIOL RES, V38, P445, DOI 10.1590/S0100-879X2005000300016; Lee C, 2001, HIGH CHOLESTEROL FED, V688, P681, DOI [10.1006/bbrc.2001.5001, DOI 10.1006/BBRC.2001.5001]; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Magro DAC, 2013, BRAZ J MED BIOL RES, V46, P601, DOI 10.1590/1414-431X20132894; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Martinez RM, 2015, J NAT PROD, V78, P1647, DOI 10.1021/acs.jnatprod.5b00198; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Navarro SA, 2013, PHARMACOL BIOCHEM BE, V105, P183, DOI 10.1016/j.pbb.2013.02.018; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Ramprasath T, 2014, J PHYSIOL BIOCHEM, V70, P407, DOI 10.1007/s13105-014-0318-3; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Serafim KGG, 2015, N-S ARCH PHARMACOL, V388, P1211, DOI 10.1007/s00210-015-1160-z; Shi Y, 2009, CAN J PHYSIOL PHARM, V87, P729, DOI [10.1139/y09-065, 10.1139/Y09-065]; So H, 2008, JARO-J ASSOC RES OTO, V9, P290, DOI 10.1007/s10162-008-0126-y; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; Tsai SJ, 2012, J AGR FOOD CHEM, V60, P514, DOI 10.1021/jf203259h; Ventura-Martinez R, 2004, EUR J PHARMACOL, V503, P43, DOI 10.1016/j.ejphar.2004.09.018; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Verri WA, 2007, BRAIN BEHAV IMMUN, V21, P535, DOI 10.1016/j.bbi.2006.11.005; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2006, P NATL ACAD SCI USA, V103, P9721, DOI 10.1073/pnas.0603286103; Wang HK, 2012, J AGR FOOD CHEM, V60, P2171, DOI 10.1021/jf204625y; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Yamacita-Borin FY, 2015, NEUROSCI LETT, V605, P53, DOI 10.1016/j.neulet.2015.08.015; Yang J, 2011, MOL CELL BIOCHEM, V351, P29, DOI 10.1007/s11010-010-0708-y; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zamudio-Cuevas Y, 2015, CLIN RHEUMATOL, V34, P1667, DOI 10.1007/s10067-015-2933-y; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146	73	86	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153015	10.1371/journal.pone.0153015	http://dx.doi.org/10.1371/journal.pone.0153015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045367	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600059
J	Robert, S; Gicquel, T; Bodin, A; Lagente, V; Boichot, E				Robert, Sacha; Gicquel, Thomas; Bodin, Aude; Lagente, Vincent; Boichot, Elisabeth			Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1 beta or TNF-alpha Release from Human Hepatic Stellate Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED LIVER-INJURY; ALCOHOLIC HEPATITIS; FACTOR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; CARBON-TETRACHLORIDE; DOUBLE-BLIND; TGF-BETA; FIBROSIS; MICE	Inflammation has an important role in the development of liver fibrosis in general and the activation of hepatic stellate cells (HSCs) in particular. It is known that HSCs are themselves able to produce cytokines and chemokines, and that this production may be a key event in the initiation of fibrogenesis. However, the direct involvement of cytokines and chemokines in HSC (self-)activation remains uncertain. In this study, the effects of pro-inflammatory cytokines IL-1 alpha and beta, TNF-alpha, and IL-8 on the activation state of HSCs were examined, in comparison to the pro-fibrogenic mediator TGF-beta 1. LX-2 cells were stimulated for 24 or 48 hours with recombinant human form of the pro-inflammatory cytokines IL-1 alpha and beta, TNF-alpha, and IL-8, and also the pro-fibrogenic mediator TGF-beta 1. Two drugs were also evaluated, the anti-TNF-alpha monoclonal antibody infliximab and the IL-1 receptor antagonist anakinra, regarding their inhibitory effects. In LX-2 human HSC, treatment with TGF-beta 1 are associated with downregulation of the metalloproteinase (MMP)-1 and MMP-3, with upregulation of tissue inhibitor of metalloproteinase (TIMP)-1, collagen type I alpha 1, collagen type IV alpha 1, alpha-SMA, endothelin-1 and PDGF-BB. Cytokines and chemokines expression were found to be downregulated, excepting IL-6. In contrast, we observed that LX-2 exposure to IL-1, TNF-alpha and IL-8 can reverse the phenotype of pro-fibrogenic activated cells. Indeed, MMP-1, MMP-3 and MMP-9 were found elevated, associated with downregulation of a-SMA and/or PDGF-BB, and a greater expression of IL-1 beta, IL-6, IL-8, CXCL1 and CCL2. Lastly, we found that infliximab and anakinra successfully inhibits effects of TNF-alpha and IL-1 respectively in LX-2 cells. Infliximab and anakinra may be of value in preclinical trials in chronic liver disease. Overall, our results suggest that (i) pro-inflammatory mediators exert complex effects in HSCs via an MMP/TIMP imbalance, and (ii) targeting IL-1 signaling may be a potentially valuable therapeutic strategy in chronic liver diseases.	[Robert, Sacha; Gicquel, Thomas; Bodin, Aude; Lagente, Vincent; Boichot, Elisabeth] Univ Rennes 1, INSERM, UMR991, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Robert, S (corresponding author), Univ Rennes 1, INSERM, UMR991, Rennes, France.	sacharobert35@gmail.com	Gicquel, Thomas/Q-1880-2019	Gicquel, Thomas/0000-0002-2354-1884; Lagente, Vincent/0000-0003-4920-009X; LORANT, Elisabeth/0000-0002-4914-0122				Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Cui QB, 2011, EUR J APPL PHYSIOL, V111, P1457, DOI 10.1007/s00421-010-1764-4; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Diehl Anna Mae, 2004, Clin Liver Dis, V8, P619, DOI 10.1016/j.cld.2004.04.012; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; Ghazwani M, 2014, PHYTOMEDICINE, V21, P254, DOI 10.1016/j.phymed.2013.09.014; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Hayashi H, 2011, AM J PHYSIOL-GASTR L, V300, pG729, DOI 10.1152/ajpgi.00013.2011; Hellerbrand C, 1998, AM J PHYSIOL-GASTR L, V275, pG269, DOI 10.1152/ajpgi.1998.275.2.G269; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Ishikawa M, 2010, ALCOHOL CLIN EXP RES, V34, pS25, DOI 10.1111/j.1530-0277.2008.00850.x; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Knittel T, 1997, J HEPATOL, V27, P1067, DOI 10.1016/S0168-8278(97)80151-1; Koca SS, 2008, INFLAMMATION, V31, P91, DOI 10.1007/s10753-007-9053-z; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; MANCINI R, 1994, VIRCHOWS ARCH, V424, P25; MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412; Mortensen C, 2012, EUR J GASTROEN HEPAT, V24, P619, DOI 10.1097/MEG.0b013e328351db6e; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; Neuman Manuela G., 1998, Clinical and Investigative Medicine, V21, P283; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Osawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065251; Patil PB, 2014, CYTOTHERAPY, V16, P990, DOI 10.1016/j.jcyt.2014.03.001; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Tarantino G, 2009, EUR J GASTROEN HEPAT, V21, P504, DOI 10.1097/MEG.0b013e3283229b40; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Varela-Rey M, 2007, CYTOKINE, V37, P212, DOI 10.1016/j.cyto.2007.03.013; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Yu Q, 2000, GENE DEV, V14, P163	50	99	111	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153118	10.1371/journal.pone.0153118	http://dx.doi.org/10.1371/journal.pone.0153118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046197	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600070
J	Tebbe, B; Wilde, B; Ye, Z; Wang, JY; Wang, XN; Jian, F; Dolff, S; Schedlowski, M; Hoyer, PF; Kribben, A; Witzke, O; Hoerning, A				Tebbe, Bastian; Wilde, Benjamin; Ye, Zeng; Wang, Junyu; Wang, Xinning; Jian, Fu; Dolff, Sebastian; Schedlowski, Manfred; Hoyer, Peter F.; Kribben, Andreas; Witzke, Oliver; Hoerning, Andre			Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19(+)CD24(hi)CD38(hi) Regulatory B-Lymphocytes	PLOS ONE			English	Article							KIDNEY ALLOGRAFT; CELL SUBSETS; B10 CELLS; TOLERANCE; HUMANS; AUTOIMMUNITY; EXPRESSION; PHENOTYPE; SIGNATURE; REJECTION	Background CD19(+)CD24(hi)CD38(hi) transitional immature B-lymphocytes have been demonstrated to play an important role in regulating the alloimmune response in transplant recipients. Here, we analyzed the effect of calcineurin inhibition on these peripherally circulating regulatory B-cells (Breg) in renal transplant recipients receiving cyclosporine A (CsA) or tacrolimus. Methods PBMCs from healthy subjects (HS) (n = 16) and renal transplant recipients (n = 46) were isolated. Flow cytometry was performed for CD19, CD24, CD38 and IL-10 either after isolation or after 72 hours of co-culture in presence of PMA/Ionomycin and TLR9-ligand in presence or absence of increasing concentrations of tacrolimus or CsA. Results The amount of CD19(+) B-cells among lymphocytes was similar to 9.1% in HS, similar to 3.6% in CsA (n = 11, p<0.05) and similar to 6.4% in TAC (n = 35, p<0.05) treated patients. Among B-cells, a distinct subset of Breg was found to be 4.7% in HS, 1.4% in tacrolimus treated patients and almost blunted in patients receiving CsA. Similarily, similar to 4% of B-cells in HS and even fewer in CsA or tacrolimus treated patients produced IL-10 (0.5% and 1.5%, p<0.05) and this was confirmed both in non-transplanted CsA-treated healthy subjects and in in vitro co-culture experiments. Among 29 patients with <1% of Breg, 9 cases (31%) displayed an allograft rejection in contrast to only one case of rejection (6%) among 17 patients with >1%. Conclusion Calcineurin inhibitors reduce number and IL-10 production of Bregs in the peripheral circulation of both renal transplant recipients and non-transplanted healthy subjects. CNI induced Breg reduction is not restricted to a solid organ transplant setting and is not mediated by co-medication with steroids or MPA. A low proportion of Breg cells is associated with an elevated frequency of allograft rejection events.	[Tebbe, Bastian; Wilde, Benjamin; Ye, Zeng; Wang, Junyu; Wang, Xinning; Jian, Fu; Dolff, Sebastian; Kribben, Andreas; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany; [Wang, Xinning; Hoyer, Peter F.; Hoerning, Andre] Univ Duisburg Essen, Childrens Hosp Essen, Dept Pediat Pediat Nephrol Gastroenterol Endocrin, Essen, Germany; [Schedlowski, Manfred] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Dolff, Sebastian; Witzke, Oliver] Univ Duisburg Essen, Univ Hosp Essen, Dept Infect Dis, Essen, Germany; [Hoerning, Andre] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Erlangen Nuremberg	Hoerning, A (corresponding author), Univ Duisburg Essen, Childrens Hosp Essen, Dept Pediat Pediat Nephrol Gastroenterol Endocrin, Essen, Germany.; Hoerning, A (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany.	andre.hoerning@uk-erlangen.de	wang, yixuan/GXW-2866-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; Wilde, Benjamin/H-9986-2012	Wilde, Benjamin/0000-0002-5115-6799; Dolff, Sebastian/0000-0001-5549-1706				Albring A, 2015, CLIN TRANSPLANT, V29, P294, DOI 10.1111/ctr.12504; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Braza F, 2014, ALLERGY, V69, P1454, DOI 10.1111/all.12490; Chesneau M, 2014, AM J TRANSPLANT, V14, P144, DOI 10.1111/ajt.12508; Chesneau M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00497; Chung BH, 2014, TRANSPL IMMUNOL, V30, P159, DOI 10.1016/j.trim.2014.03.003; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fillatreau S, 2013, ANN RHEUM DIS, V72, P80, DOI 10.1136/annrheumdis-2012-202253; Heidt S, 2008, TRANSPLANTATION, V86, P1292, DOI 10.1097/TP.0b013e3181874a36; Hoerning A, 2012, CLIN EXP IMMUNOL, V168, P251, DOI 10.1111/j.1365-2249.2012.04571.x; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Loupy A, 2012, NAT REV NEPHROL, V8, P348, DOI 10.1038/nrneph.2012.81; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Nouel A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00011; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Shabir S, 2015, AM J TRANSPLANT, V15, P1384, DOI 10.1111/ajt.13122; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Silva HM, 2012, MOL MED, V18, P733, DOI 10.2119/molmed.2011.00281; Traitanon O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129658; Wilde B, 2013, ANN RHEUM DIS, V72, P1416, DOI 10.1136/annrheumdis-2012-202986; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	30	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153170	10.1371/journal.pone.0153170	http://dx.doi.org/10.1371/journal.pone.0153170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045291	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600073
J	Solomon, GEA; Carley, S; Porter, AL				Solomon, Gregg E. A.; Carley, Stephen; Porter, Alan L.			How Multidisciplinary Are the Multidisciplinary Journals Science and Nature?	PLOS ONE			English	Article							INTERDISCIPLINARY RESEARCH; IMPACT; TECHNOLOGY; DIVERSITY; METRICS	Interest in cross-disciplinary research knowledge interchange runs high. Review processes at funding agencies, such as the U.S. National Science Foundation, consider plans to disseminate research across disciplinary bounds. Publication in the leading multidisciplinary journals, Nature and Science, may signify the epitome of successful interdisciplinary integration of research knowledge and cross-disciplinary dissemination of findings. But how interdisciplinary are they? The journals are multidisciplinary, but do the individual articles themselves draw upon multiple fields of knowledge and does their influence span disciplines? This research compares articles in three fields (Cell Biology, Physical Chemistry, and Cognitive Science) published in a leading disciplinary journal in each field to those published in Nature and Science. We find comparable degrees of interdisciplinary integration and only modest differences in cross-disciplinary diffusion. That said, though the rate of out-of-field diffusion might be comparable, the sheer reach of Nature and Science, indicated by their potent Journal Impact Factors, means that the diffusion of knowledge therein can far exceed that of leading disciplinary journals in some fields (such as Physical Chemistry and Cognitive Science in our samples).	[Solomon, Gregg E. A.] Natl Sci Fdn, Div Res Learning, 4201 Wilson Blvd, Arlington, VA 22230 USA; [Solomon, Gregg E. A.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Carley, Stephen] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Porter, Alan L.] Georgia Inst Technol, Technol Policy & Assessment Ctr, Atlanta, GA 30332 USA; [Porter, Alan L.] Search Technol Inc, Norcross, GA USA	National Science Foundation (NSF); Harvard University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Solomon, GEA (corresponding author), Natl Sci Fdn, Div Res Learning, 4201 Wilson Blvd, Arlington, VA 22230 USA.; Solomon, GEA (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gesolomo@nsf.gov	Carley, Stephen F/A-7068-2017; porter, alan l/A-7013-2009	Carley, Stephen F/0000-0003-3859-1857; porter, alan l/0000-0002-4520-6518	US National Science Foundation [DRL-1348765]; Search Technology, Inc.; Direct For Education and Human Resources [1348765] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Search Technology, Inc.; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by US National Science Foundation DRL-1348765 to AP (www.nsf.gov). Any opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect those of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alan L. Porter is employed by Search Technology, Inc. Search Technology, Inc. provided support in the form of salary for author ALP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alberts B, 2013, SCIENCE, V340, P787, DOI 10.1126/science.1240319; Bergmann T, 2017, COGNITIVE SCI, V41, P1412, DOI 10.1111/cogs.12352; Bornmann L, 2015, J INFORMETR, V9, P419, DOI 10.1016/j.joi.2015.03.001; Bornmann L, 2015, J INFORMETR, V9, P477, DOI 10.1016/j.joi.2015.04.001; Bornmann L, 2015, SCIENTOMETRICS, V103, P1123, DOI 10.1007/s11192-015-1565-y; Bornmann L, 2014, J INFORMETR, V8, P895, DOI 10.1016/j.joi.2014.09.005; Bornmann L, 2014, J DOC, V70, P52, DOI 10.1108/JD-10-2012-0136; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Carley S, 2012, SCIENTOMETRICS, V90, P407, DOI 10.1007/s11192-011-0528-1; Garner J, 2014, SCIENTOMETRICS, V100, P687, DOI 10.1007/s11192-014-1316-5; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hoffmann MHG, 2012, SYNTHESE ONLINE 1, DOI [10.1007/s11229-012-0214-8, DOI 10.1007/S11229-012-0214-8]; Karlovcec M, 2015, SCIENTOMETRICS, V102, P433, DOI 10.1007/s11192-014-1355-y; Kay L, 2014, J ASSOC INF SCI TECH, V65, P2432, DOI 10.1002/asi.23146; Koen F, 2005, J ENG TECHNOL MANAGE, V22, P9; Kuhn TS, 1979, ESSENTIAL TENSION SE; Lane J, 2009, SCIENCE, V324, P1273, DOI 10.1126/science.1175335; Leydesdorff L, 2010, USER FRIENDLY METHOD; Leydesdorff L, 2013, J AM SOC INF SCI TEC, V64, P2573, DOI 10.1002/asi.22946; Macilwain C, 2010, NATURE, V465, P682, DOI 10.1038/465682a; Marx W, 2015, SCIENTOMETRICS, V102, P1823, DOI 10.1007/s11192-014-1499-9; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; National Academies Committee on Science, 2005, FAC INT RES; National Academies of Science, 2009, NAT AC KECK FUT IN N; Ponomarev IV, 2014, SCIENTOMETRICS, V100, P755, DOI 10.1007/s11192-014-1320-9; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Porter AL, 2006, RES EVALUAT, V15, P187, DOI 10.3152/147154406781775841; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Porter AL, 2008, RES EVALUAT, V17, P273, DOI 10.3152/095820208X364553; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Rafols I, 2009, J AM SOC INF SCI TEC, V60, P1823, DOI 10.1002/asi.21086; Roessner D, 2013, SCIENTOMETRICS, V94, P439, DOI 10.1007/s11192-012-0872-9; Rogers JD, 2010, RES EVALUAT, V19, P281, DOI 10.3152/095820210X12827366906409; Rylance R, 2015, NATURE, V525, P313, DOI 10.1038/525313a; Schunn CD, 1998, COGNITIVE SCI, V22, P107, DOI 10.1016/S0364-0213(99)80036-6; Solomon GEA, 2014, ANN M SCI TEAM SCI A; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Van Noorden R, 2015, NATURE, V525, P306, DOI 10.1038/525306a; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095; Zhang L, 2016, J ASSOC INF SCI TECH, V67, P1257, DOI 10.1002/asi.23487	41	20	21	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152637	10.1371/journal.pone.0152637	http://dx.doi.org/10.1371/journal.pone.0152637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043924	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100021
J	Taylor, AD; Ohashi, K; Sheng, JY; Litvak, MK				Taylor, Andrew Douglas; Ohashi, Kyoko; Sheng, Jinyu; Litvak, Matthew Kenneth			Oceanic Distribution, Behaviour, and a Winter Aggregation Area of Adult Atlantic Sturgeon, Acipenser oxyrinchus oxyrinchus, in the Bay of Fundy, Canada	PLOS ONE			English	Article							CHOCTAWHATCHEE RIVER SYSTEM; SHORTNOSE STURGEON; HABITAT USE; MARINE DISTRIBUTION; GULF STURGEON; MINAS BASIN; MANAGEMENT; MIGRATION; ESTUARINE; PATTERNS	Seasonal distribution of adult Atlantic sturgeon was examined using pop-up satellite archival tags (PSATs) and ultrasonic transmitters deployed in the Saint John River, New Brunswick, Canada. Seven MK10 PSATs programmed for release in June 2012 and seven MiniPAT PSATs programmed for release in February and April 2013 were deployed in August 2011 and 2012, respectively. Eleven of 14 PSATs surfaced and transmitted depth and temperature data archived for the duration of their deployment (121-302 days). Among these eleven PSATs, five were recovered and 15-sec archival data was downloaded. Following exit from the Saint John River in the fall, tagged fish occupied a mean monthly depth of 76.3-81.6 m at temperatures as low as 4.9 degrees C throughout the winter before returning to shallower areas in the spring. The majority of ultrasonic detections occurred in the Bay of Fundy, but fish were detected as far as Riviere Saint-Jean, Quebec, approximately 1500 km from the Bay of Fundy (representing long-distance migratory rates of up to 44 km/day). All PSATs were first detected in the Bay of Fundy. Tags that released in February and April were found 5-21 km offshore of the Saint John Harbour, while tags that released in June were first detected in near shore areas throughout the Bay of Fundy. The substrate at winter tag release locations (estimated from backward numerical particle-tracking experiments) consisted primarily of moraines and postglacial mud substrate with low backscatter strength, indicative of soft or smooth seabed. Based on the proximity of winter tag release locations, the consistent depths observed between fish, and previous research, it is suspected that a winter aggregation exists in the Bay of Fundy. This study expands the understanding of the marine distribution and range of Atlantic sturgeon on the east coast of Canada.	[Taylor, Andrew Douglas; Litvak, Matthew Kenneth] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Ohashi, Kyoko; Sheng, Jinyu] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Mount Allison University; Dalhousie University	Taylor, AD (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	adtaylor@mta.ca			Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon); Natural Sciences and Engineering Research PGS-M; Ocean Tracking Network; New Brunswick Wildlife Trust Fund; Natural Sciences and Engineering Research grants	Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon); Natural Sciences and Engineering Research PGS-M; Ocean Tracking Network; New Brunswick Wildlife Trust Fund; Natural Sciences and Engineering Research grants	Natural Sciences and Engineering Research Council of Canada: Strategic Network Grant-Ocean Tracking Network (1.2.3 Atlantic Sturgeon), http://www.nserc-crsng.gc.ca/index_eng.; We would like to thank Kevin Isherwood, Thane Jones, Christine Adams, Sima Usvyatsov and all other field assistants for help with this project. We would like to thank Dr. D. Lieske and C. Tardif for help with ArcGIS mapping. We would also like to thank Canadian Hydrographic Service and Natural Resources Canada for providing habitat data. This study was supported by a Natural Sciences and Engineering Research PGS-M to ADT and Ocean Tracking Network, New Brunswick Wildlife Trust Fund, and Natural Sciences and Engineering Research grants to MKL.	APOSTLE R, 2013, J INT WILDLIFE LAW P, V16, P170, DOI DOI 10.1080/13880292.2013.805062; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Bain M., 2000, Boletin Instituto Espanol de Oceanografia, V16, P43; Balazik MT, 2013, T AM FISH SOC, V142, P1640, DOI 10.1080/00028487.2013.824924; Collins M. R., 1997, J FISH MANAG, V17, P995; COSEWIC, 2011, COSEWIC ASS STAT REP; Crossman JA, 2013, N AM J FISH MANAGE, V33, P549, DOI 10.1080/02755947.2013.785994; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Damon-Randall K, 2010, NMFSNE215 NOAA, P64; DFO (Fisheries and Oceans Canada), 2013, 2013022 DFO CAN SCI; Dunton KJ, 2012, J FISH BIOL, V80, P207, DOI 10.1111/j.1095-8649.2011.03151.x; Dunton KJ, 2015, MAR COAST FISH, V7, P18, DOI 10.1080/19425120.2014.986348; Edwards RE, 2007, AM FISH S S, V56, P183; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Erickson DL, 2007, AM FISH S S, V56, P197; Fox DA, 2000, T AM FISH SOC, V129, P811, DOI 10.1577/1548-8659(2000)129<0811:GSSMAH>2.3.CO;2; Fox DA, 2002, AM FISH S S, V28, P111; Kynard B, 2000, T AM FISH SOC, V129, P487, DOI 10.1577/1548-8659(2000)129<0487:HUBSSI>2.0.CO;2; Kynard B, 1997, ENVIRON BIOL FISH, V48, P319, DOI 10.1023/A:1007372913578; Laney RW, 2007, AM FISH S S, V56, P167; McLean MF, 2013, J APPL ICHTHYOL, V29, P503, DOI 10.1111/jai.12175; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5914; Savoy T, 2003, T AM FISH SOC, V132, P1, DOI 10.1577/1548-8659(2003)132<0001:MAIHOS>2.0.CO;2; Scott WB, 1988, CAN B FISH AQUAT SCI, P219; Secor DH, 2002, AM FISH S S, V28, P89; Shaw J., 2012, GEOLOGICAL SURVEY CA, DOI [10.4095/292047, DOI 10.4095/292047]; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Timoshkin V. P., 1968, J ICHTHYOL, V8, P598; Todd BJ, 2014, CONT SHELF RES, V83, P64, DOI 10.1016/j.csr.2013.11.017; U.S. Office of the Federal Register, 2012, FED REGISTER, V77, P5880; Vladykov VD, 1963, ORDER ACIPENSEROIDEI; Wirgin I, 2015, J FISH BIOL, V86, P1251, DOI 10.1111/jfb.12631; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899	35	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152470	10.1371/journal.pone.0152470	http://dx.doi.org/10.1371/journal.pone.0152470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043209	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100016
J	Zhang, D; Feng, ZS; Zhao, MC; Wang, H; Wang, L; Yang, S; Li, GX; Lu, L; Ma, XJ				Zhang, Dan; Feng, Zhishan; Zhao, Mengchuan; Wang, Hao; Wang, Le; Yang, Shuo; Li, Guixia; Lu, Li; Ma, Xuejun			Clinical Evaluation of a Single-Tube Multiple RT-PCR Assay for the Detection of 13 Common Virus Types/Subtypes Associated with Acute Respiratory Infection	PLOS ONE			English	Article							ARMORED RNA; SEEPLEX RV15; CHILDREN	Respiratory viruses are among the most important causes of human morbidity and mortality worldwide, especially for infants and young children. In the past years, a few commercial multiplex RT-PCR assays have been used to detect respiratory viruses in spite of the high cost. In the present study, an improved single-tube multiplex reverse transcription PCR assay for simultaneous detection of 13 respiratory viruses was evaluated and compared with a previously reported two-tube assay as the reference method using clinical nasopharyngeal aspirates samples. Of 310 prospectively tested respiratory specimens selected from children hospitalized with acute respiratory illness, 226 (72.90%, 226/310) and 214 (69.03%, 214/310) positive for one or more viruses were identified by the single-tube and the two-tube assays, respectively, with combined test results showing good concordance (Kappa value = 0.874). Individually, the single-tube assay for adenovirus (Adv), human metapneumovirus (HMPV), human rhinovirus (HRV), parainfluenza virus type 1 (PIV1), parainfluenza virus type 3 (PIV3) and parainfluenza virus type 4 (PIV4) showed the significantly superior sensitivities to those of the two-tube assay. No false positives were found. In conclusion, our results demonstrates the one-tube assay revealed significant improvements over the two-tube assay in terms of the better sensitivity, more accurate quality control, less nonspecific amplification, more cost-effective and shorter turn-around time and will be a valuable tool for routine surveillance of respiratory virus infection in China.	[Zhang, Dan; Lu, Li] Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Dan; Zhao, Mengchuan; Wang, Hao; Ma, Xuejun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Beijing, Peoples R China; [Feng, Zhishan; Zhao, Mengchuan; Wang, Le; Yang, Shuo; Li, Guixia] Hebei Med Univ, Childrens Hosp Hebei Prov, Pediat Res Inst, Shijiazhuang, Peoples R China; [Wang, Hao] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden	Guangzhou Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hebei Medical University; University of Gothenburg	Lu, L (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.; Ma, XJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Beijing, Peoples R China.	925295339@qq.com; maxj@ivdc.chinacdc.cn		Wang, Hao/0000-0001-9425-4666	China Mega-Project for Infectious Disease [2016ZX10004-101, 2016 ZX10004-215, 2013ZX10004804-007]; Beijing Municipal Science & Technology Commission project [D151100002115003]	China Mega-Project for Infectious Disease; Beijing Municipal Science & Technology Commission project(Beijing Municipal Science & Technology Commission)	This work was supported by grants from China Mega-Project for Infectious Disease (2016ZX10004-101, 2016 ZX10004-215, 2013ZX10004-202, and 2013ZX10004804-007) and Beijing Municipal Science & Technology Commission project (D151100002115003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby DF, 2011, J MED VIROL, V83, P1469, DOI 10.1002/jmv.22125; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cho CH, 2014, DIAGN MICR INFEC DIS, V79, P14, DOI 10.1016/j.diagmicrobio.2014.01.016; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; Feng LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099419; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016033; Huh HJ, 2014, DIAGN MICR INFEC DIS, V79, P419, DOI 10.1016/j.diagmicrobio.2014.01.025; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jung YJ, 2015, J VIROL METHODS, V224, P42, DOI 10.1016/j.jviromet.2015.08.003; Li J, 2013, MICRO NANO LETT, V8, P8, DOI 10.1049/mnl.2012.0578; Liu CY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1126-2; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998; Renaud C, 2012, DIAGN MICR INFEC DIS, V74, P379, DOI 10.1016/j.diagmicrobio.2012.08.003; Sakthivel SK, 2012, J VIROL METHODS, V185, P259, DOI 10.1016/j.jviromet.2012.07.010; Stevenson J, 2008, J VIROL METHODS, V150, P73, DOI 10.1016/j.jviromet.2008.02.007; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tran DN, 2016, EPIDEMIOL INFECT, V144, P346, DOI 10.1017/S0950268815000953; Vallieres E, 2013, DIAGN MICR INFEC DIS, V76, P255, DOI 10.1016/j.diagmicrobio.2013.03.008; Wang F, 2015, CHINESE MED J-PEKING, V128, P2726, DOI 10.4103/0366-6999.167297; Wei BJ, 2008, INTERVIROLOGY, V51, P144, DOI 10.1159/000141707; Xie Zheng-de, 2011, Zhonghua Er Ke Za Zhi, V49, P745; Zhan S, 2009, J CLIN MICROBIOL, V47, P2571, DOI 10.1128/JCM.00232-09; Zhao Lin-qing, 2007, Zhonghua Er Ke Za Zhi, V45, P91	25	8	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152702	10.1371/journal.pone.0152702	http://dx.doi.org/10.1371/journal.pone.0152702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043208	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100027
J	Li, JJ; Chen, K; Li, SN; Liu, T; Wang, F; Xia, YJ; Lu, J; Zhou, YQ; Guo, CY				Li, Jingjing; Chen, Kan; Li, Sainan; Liu, Tong; Wang, Fan; Xia, Yujing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong			Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; A-INDUCED HEPATITIS; KAPPA-B ACTIVATION; CONCANAVALIN-A; TNF-ALPHA; AUTOIMMUNE HEPATITIS; CYTOKINE EXPRESSION; MICE; AUTOPHAGY; PATHWAY	This study aimed to explore the effects of fucoidan from Fucus vesiculosus on concanavalin A (ConA)-induced acute liver injury in mice. Pretreatment with fucoidan protected liver function indicated by ALT, AST and histopathological changes by suppressing inflammatory cytokines, such as tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma). In addition, intrinsic and extrinsic apoptosis mediated by Bax, Bid, Bcl-2, Bcl-xL and Caspase 3, 8, and 9 were inhibited by fucoidan and the action was associated with the TRADD/TRAF2 and JAK2/STAT1 signal pathways. Our results demonstrated that fucoidan from Fucus vesiculosus alleviated ConA-induced acute liver injury via the inhibition of intrinsic and extrinsic apoptosis mediated by the TRADD/TRAF2 and JAK2/STAT1 pathways which were activated by TNF-alpha and IFN-gamma. These findings could provide a potential powerful therapy for T cell-related hepatitis.	[Li, Jingjing; Chen, Kan; Li, Sainan; Liu, Tong; Wang, Fan; Xia, Yujing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200072, Peoples R China	Tongji University	Zhou, YQ; Guo, CY (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200072, Peoples R China.	yqzh02@163.com; guochuanyong@hotmail.com		Li, Sainan/0000-0002-1880-6294; Guo, Chuanyong/0000-0002-6527-4673	Natural Science Foundation of China [81270515, 81500466]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant No. 81270515; 81500466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Baker SJ, 1996, ONCOGENE, V12, P1; Bird GM, 1931, BIOCHEM J, V25, P403, DOI 10.1042/bj0250403; Chen K, 2014, PPAR RES, V2014, DOI 10.1155/2014/215631; Cheng P, 2014, DRUG DES DEV THER, V8, P1277, DOI 10.2147/DDDT.S66573; Cui YQ, 2012, CNS NEUROSCI THER, V18, P827, DOI 10.1111/j.1755-5949.2012.00372.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Do H, 2010, J NUTR BIOCHEM, V21, P671, DOI 10.1016/j.jnutbio.2009.03.013; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Gambin Anna, 2013, JAKSTAT, V2, pe24672, DOI 10.4161/jkst.24672; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Garcia FAO, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-283; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Granert C, 1999, INFECT IMMUN, V67, P2071, DOI 10.1128/IAI.67.5.2071-2074.1999; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Kang GH, 2012, J NEUROL SCI, V318, P25, DOI 10.1016/j.jns.2012.04.013; Kawano N, 2007, J NUTR SCI VITAMINOL, V53, P315, DOI 10.3177/jnsv.53.315; Ksontini R, 1998, J IMMUNOL, V160, P4082; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kunstle G, 1999, HEPATOLOGY, V30, P1241, DOI 10.1002/hep.510300517; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Kylin H., 1913, Z PHYSL CHEM, V83, P3, DOI DOI 10.1515/bchm2.1913.83.3.171; Lee DH, 2015, EUR J PHARMACOL, V749, P39, DOI 10.1016/j.ejphar.2014.11.048; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Li JJ, 2015, MAR DRUGS, V13, P3368, DOI 10.3390/md13063368; Li JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120440; LOHSE AW, 1990, HEPATOLOGY, V11, P24, DOI 10.1002/hep.1840110106; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; NISHINO T, 1994, CARBOHYD RES, V255, P213, DOI 10.1016/S0008-6215(00)90980-7; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Park B, 2011, BIOCHEM PHARMACOL, V82, P1134, DOI 10.1016/j.bcp.2011.07.062; Park Mi Sun, 2014, Genes Cancer, V5, P470; PERCIVAL EGV, 1950, J CHEM SOC, P717, DOI 10.1039/jr9500000717; Thinh PD, 2013, MAR DRUGS, V11, P1456, DOI 10.3390/md11051456; Raghavendran HRB, 2011, INT IMMUNOPHARMACOL, V11, P157, DOI 10.1016/j.intimp.2010.11.002; Saito A, 2006, HEPATOL RES, V35, P190, DOI 10.1016/j.hepres.2006.03.012; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Senthilkumar K, 2013, INT J BIOL MACROMOL, V60, P366, DOI 10.1016/j.ijbiomac.2013.06.030; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Soares PAG, 2011, J CHROMATOGR B, V879, P457, DOI 10.1016/j.jchromb.2010.12.030; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Tao YY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-449; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; Ward J, 2015, EUR J TRAUMA EMERG S, V41, P229, DOI 10.1007/s00068-015-0521-0; Xue ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043483	51	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152570	10.1371/journal.pone.0152570	http://dx.doi.org/10.1371/journal.pone.0152570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035150	Green Submitted, Green Published, gold			2022-12-27	WOS:000373201200023
J	Ji, H; Zhu, YT; Zhang, YY; Li, ZH; Ge, J; Zhuo, YH				Ji, Hong; Zhu, Yingting; Zhang, Yingying; Li, Zuohong; Ge, Jian; Zhuo, Yehong			Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy	PLOS ONE			English	Article							OCULAR SURFACE DISEASE; MITOMYCIN-C; TEAR-FILM; WORKSHOP 2007; GLAUCOMA; PREVALENCE; TESTS; CLASSIFICATION; CORNEAL; SUBCOMMITTEE	Purpose The aim of this study was to analyze dry eye disease (DED) in patients with functioning filtering blebs and to explore the relationship between the morphology of filtering blebs and ocular surface instability. Methods This was a cross-sectional, case-comparison study. Seventy glaucomatous patients (70 eyes) with functioning blebs who had undergone trabeculectomy more than 6 months prior (study group) and 35 control subjects (35 eyes) (control group) were included. All subjects completed an ocular symptom questionnaire that referred to the Shihpai Eye Study. Evaluation of meibomian gland obstruction, a tear film break-up time test (TFBUT), fluorescein corneal staining and a Schirmer's tear test were then performed. Filtering bleb morphology was analyzed using Wuerzburg bleb classification scoring criteria in the study group. The presence of DED was defined as the concomitant presence of TFBUT <10 seconds and the presence of superficial punctate keratitis. Results The patients with functioning blebs presented higher corneal staining scores (P = 0.012) and lower TFBUT values (P = 0.043) than the control group. DED was present in 28/70 patients in the study group and 6/35 patients in the control group (P = 0.018). More patients in the study group complained of dryness (P = 0.001), a gritty or sandy sensation (P < 0.001) and redness (P = 0.048). In the study group, the patients with DED were significantly different from the patients without DED in both TFBUT (P < 0.001) and corneal staining (P < 0.001). More patients in the DED group were likely to report dryness (P = 0.013) and watery or teary eyes (P = 0.012). The differences in meibomian gland obstruction scores between the study and the control group, the DED and the non-DED group were not significant (P = 0.105 and P = 0.077, respectively). The values for microcysts and bleb heights were significantly higher in the DED group (P = 0.040 and P = 0.011, respectively). A Spearman's rank correlation showed that microcysts were positively correlated with corneal staining (r = 0.270, P = 0.024). Bleb height was negatively correlated with TFBUT (r = -0.299, P = 0.012) and positively correlated with corneal staining (r = 0.275, P = 0.021). The relationships between DED and microcysts and between DED and bleb height were significant (r = 0.247, P = 0.039 and r = 0.307, P = 0.010, respectively). Conclusion DED is relatively common in patients with functioning filtering blebs following trabeculectomy. In DED patients, dryness and watery are common symptoms. Microcysts and bleb height are related to ocular surface instability and DED.	[Ji, Hong; Zhu, Yingting; Zhang, Yingying; Li, Zuohong; Ge, Jian; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn			Guangdong Province National Natural Science Foundation [2014A030308016]	Guangdong Province National Natural Science Foundation	This work was supported by Guangdong Province National Natural Science Foundation (2014A030308016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albietz JM, 2004, J REFRACT SURG, V20, P62; Amar N, 2008, OPHTHALMOLOGY, V115, P1154, DOI 10.1016/j.ophtha.2007.10.024; Argueso P, 2001, EXP EYE RES, V73, P281, DOI 10.1006/exer.2001.1045; Baudouin C, 2014, BRIT J OPHTHALMOL, V98, P1168, DOI 10.1136/bjophthalmol-2013-304619; Baudouin C, 2012, DEV OPHTHALMOL, V50, P64, DOI 10.1159/000334791; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Budenz DL, 2001, AM J OPHTHALMOL, V131, P626, DOI 10.1016/S0002-9394(00)00901-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ghosh S, 2012, CLIN EXP OPHTHALMOL, V40, P675, DOI 10.1111/j.1442-9071.2012.02781.x; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Jie Y, 2009, EYE, V23, P688, DOI 10.1038/sj.eye.6703101; Johnston PR, 2013, CLIN OPHTHALMOL, V7, P253, DOI 10.2147/OPTH.S39104; Khanal S, 2008, OPHTHAL PHYSL OPT, V28, P127, DOI 10.1111/j.1475-1313.2008.00539.x; Klink T, 2008, OPHTHALMOLOGICA, V222, P408, DOI 10.1159/000161555; Korb DR, 2000, CORNEA, V19, P483, DOI 10.1097/00003226-200007000-00016; Lemp MA, 2007, OCUL SURF, V5, P75; Li J, 2001, Zhonghua Yan Ke Za Zhi, V37, P43; Liang SYW, 2009, CLIN EXP OPHTHALMOL, V37, P316, DOI 10.1111/j.1442-9071.2009.02023.x; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; MATHERS WD, 1991, CORNEA, V10, P277, DOI 10.1097/00003226-199107000-00001; Mohammadi SF, 2014, J CATARACT REFR SURG, V40, P937, DOI 10.1016/j.jcrs.2013.10.043; Nemeth J, 2012, BRIT J OPHTHALMOL, V96, P1380, DOI 10.1136/bjophthalmol-2012-301580; Mendes CRN, 2012, CURR EYE RES, V37, P309, DOI 10.3109/02713683.2011.635400; Nichols KK, 2000, CORNEA, V19, P477, DOI 10.1097/00003226-200007000-00015; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Picht G, 1998, OPHTHALMOLOGE, V95, P380, DOI 10.1007/s003470050285; Rossi GCM, 2013, EUR J OPHTHALMOL, V23, P296, DOI 10.5301/ejo.5000220; Sacu S, 2003, J GLAUCOMA, V12, P430, DOI 10.1097/00061198-200310000-00006; SHIELDS MB, 1993, AM J OPHTHALMOL, V116, P673, DOI 10.1016/S0002-9394(14)73465-8; Shigeeda T, 2006, J GLAUCOMA, V15, P195, DOI 10.1097/01.ijg.0000212202.57029.45; Stedman T.L., 2000, STEDMANS MED DICT, V27th ed.; Sullivan BD, 2012, CORNEA, V31, P1000, DOI 10.1097/ICO.0b013e318242fd60; XIN C, 2010, OPHTHALMOL CHINA, V19, P19	36	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152696	10.1371/journal.pone.0152696	http://dx.doi.org/10.1371/journal.pone.0152696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032098	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800121
J	Pessoa, R; Loureiro, P; Lopes, ME; Carneiro-Proietti, ABF; Sabino, EC; Busch, MP; Sanabani, SS				Pessoa, Rodrigo; Loureiro, Paula; Lopes, Maria Esther; Carneiro-Proietti, Anna B. F.; Sabino, Ester C.; Busch, Michael P.; Sanabani, Sabri S.			Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUAL INFECTION; DRUG-RESISTANCE; SAO-PAULO; SUBTYPE-C; RECOMBINANTS; TRANSMISSION; PREVALENCE; FREQUENCY; JANEIRO	Background Here, we aimed to gain a comprehensive picture of the HIV-1 diversity in the northeast and southeast part of Brazil. To this end, a high-throughput sequencing-by-synthesis protocol and instrument were used to characterize the near full length (NFLG) and partial HIV-1 proviral genome in 259 HIV-1 infected blood donors at four major blood centers in Brazil: Pro-Sangue foundation (Sao Paulo state (SP), n 51), Hemominas foundation (Minas Gerais state (MG), n 41), Hemope foundation (Recife state (PE), n 96) and Hemorio blood bank (Rio de Janeiro (RJ), n 70). Materials and Methods A total of 259 blood samples were obtained from 195 donors with long-standing infections and 64 donors with a lack of stage information. DNA was extracted from the peripheral blood mononuclear cells (PBMCs) to amplify the HIV-1 NFLGs from five overlapping fragments. The amplicons were molecularly bar-coded, pooled, and sequenced by Illumina paired-end protocol. Results Of the 259 samples studied, 208 (80%) NFLGs and 49 (18.8%) partial fragments were de novo assembled into contiguous sequences and successfully subtyped. Of these 257 samples, 183 (71.2%) were pure subtypes consisting of clade B (n = 167, 65%), C (n = 10, 3.9%), F1 (n = 4, 1.5%), and D (n = 2, 0.7%). Recombinant viruses were detected in 74 (28.8%) samples and consist of unique BF1 (n = 41, 15.9%), BC (n = 7, 2.7%), BCF1 (n = 4, 1.5%), CF1 and CDK (n = 1, 0.4%, each), CRF70_BF1 (n = 4, 1.5%), CRF71_BF1 (n = 12, 4.7%), and CRF72_BF1 (n = 4, 1.5%). Evidence of dual infection was detected in four patients coinfected with the same subtype (n = 3) and distinct subtype (n = 1). Conclusion Based on this work, subtype B appears to be the prevalent subtype followed by a high proportion of intersubtype recombinants that appeared to be arising continually in this country. Our study represents the largest analysis of the viral NFLG ever undertaken worldwide and provides insights into the understanding the genesis of the HIV-1 epidemic in this particular area of South America and informs vaccine design and clinical trials.	[Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Clin Lab, Dept Pathol,LIM 03,HC, Sao Paulo, Brazil; [Loureiro, Paula] Pernambuco State Ctr Hematol & Hemotherapy HEMOPE, Recife, PE, Brazil; [Lopes, Maria Esther] Hemorio, Rio De Janeiro, Brazil; [Carneiro-Proietti, Anna B. F.] Minas Gerais State Ctr Hematol & Hemotherapy HEMO, Belo Horizonte, MG, Brazil; [Sabino, Ester C.] Univ Sao Paulo, Inst Trop Med, Dept Infect Dis, Sao Paulo, Brazil; [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Vitalant; Vitalant Research Institute	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Clin Lab, Dept Pathol,LIM 03,HC, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Sabino, Ester C/F-7750-2010; Loureiro, Paula/A-2965-2013; Pessôa, Rodrigo/B-7206-2018; Sanabani, Sabri Saeed/F-5600-2012	Sabino, Ester C/0000-0003-2623-5126; Loureiro, Paula/0000-0003-1849-0047; Sanabani, Sabri Saeed/0000-0002-8876-8262	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/11090-5, 2011/12297-2, 2014/24596-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants 2011/11090-5, 2011/12297-2, and 2014/24596-2 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemelaar J, 2013, J INFECTION, V66, P391, DOI 10.1016/j.jinf.2012.10.026; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lau KA, 2013, INFECT DIS REP, V5, P15, DOI 10.4081/idr.2013.s1.e4; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Pessoa R, 2015, TRANSFUSION, V55, P980, DOI 10.1111/trf.12936; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093374; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	38	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152499	10.1371/journal.pone.0152499	http://dx.doi.org/10.1371/journal.pone.0152499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031505	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800086
J	MacDiarmid, JA; Langova, V; Bailey, D; Pattison, ST; Pattison, SL; Christensen, N; Armstrong, LR; Brahmbhatt, VN; Smolarczyk, K; Harrison, MT; Costa, M; Mugridge, NB; Sedliarou, I; Grimes, NA; Kiss, DL; Stillman, B; Hann, CL; Gallia, GL; Graham, RM; Brahmbhatt, H				MacDiarmid, Jennifer A.; Langova, Veronika; Bailey, Dale; Pattison, Scott T.; Pattison, Stacey L.; Christensen, Neil; Armstrong, Luke R.; Brahmbhatt, Vatsala N.; Smolarczyk, Katarzyna; Harrison, Matthew T.; Costa, Marylia; Mugridge, Nancy B.; Sedliarou, Ilya; Grimes, Nicholas A.; Kiss, Debra L.; Stillman, Bruce; Hann, Christine L.; Gallia, Gary L.; Graham, Robert M.; Brahmbhatt, Himanshu			Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model	PLOS ONE			English	Article							BLOOD-BRAIN; DRUG-DELIVERY; GLIOBLASTOMA-MULTIFORME; VASCULAR-PERMEABILITY; MALIGNANT GLIOMA; PET DOGS; CANCER; BARRIER; THERAPY; SYSTEMS	Background Cytotoxic chemotherapy can be very effective for the treatment of cancer but toxicity on normal tissues often limits patient tolerance and often causes long-term adverse effects. The objective of this study was to assist in the preclinical development of using modified, non-living bacterially-derived minicells to deliver the potent chemotherapeutic doxorubicin via epidermal growth factor receptor (EGFR) targeting. Specifically, this study sought to evaluate the safety and efficacy of EGFR targeted, doxorubicin loaded minicells (designated (EGFR)minicells(Dox)) to deliver doxorubicin to spontaneous brain tumors in 17 companion dogs; a comparative oncology model of human brain cancers. Methodology/Principle Findings (EGFR)minicells(Dox) were administered weekly via intravenous injection to 17 dogs with late-stage brain cancers. Biodistribution was assessed using single-photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI). Anti-tumor response was determined using MRI, and blood samples were subject to toxicology (hematology, biochemistry) and inflammatory marker analysis. Targeted, doxorubicin-loaded minicells rapidly localized to the core of brain tumors. Complete resolution or marked tumor regression (>90% reduction in tumor volume) were observed in 23.53% of the cohort, with lasting anti-tumor responses characterized by remission in three dogs for more than two years. The median overall survival was 264 days (range 49 to 973). No adverse clinical, hematological or biochemical effects were observed with repeated administration of (EGFR)minicells(Dox) (30 to 98 doses administered in 10 of the 17 dogs). Conclusions/Significance Targeted minicells loaded with doxorubicin were safely administered to dogs with late stage brain cancer and clinical activity was observed. These findings demonstrate the strong potential for clinical applications of targeted, doxorubicin-loaded minicells for the effective treatment of patients with brain cancer. On this basis, we have designed a Phase 1 clinical study of EGFR-targeted, doxorubicin-loaded minicells for effective treatment of human patients with recurrent glioblastoma.	[MacDiarmid, Jennifer A.; Pattison, Scott T.; Pattison, Stacey L.; Armstrong, Luke R.; Brahmbhatt, Vatsala N.; Smolarczyk, Katarzyna; Harrison, Matthew T.; Costa, Marylia; Mugridge, Nancy B.; Sedliarou, Ilya; Grimes, Nicholas A.; Kiss, Debra L.; Brahmbhatt, Himanshu] EnGeneIC Pty Ltd, Canc Therapeut, Sydney, NSW, Australia; [Langova, Veronika; Christensen, Neil] Small Anim Specialist Hosp, Sydney, NSW, Australia; [Bailey, Dale] Royal N Shore Hosp, Dept Nucl Med, Sydney, NSW, Australia; [Stillman, Bruce] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Hann, Christine L.; Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Gallia, Gary L.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Graham, Robert M.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Graham, Robert M.] Univ New S Wales, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney; Cold Spring Harbor Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Brahmbhatt, H (corresponding author), EnGeneIC Pty Ltd, Canc Therapeut, Sydney, NSW, Australia.	hbrahmbhatt@engeneic.com	Brahmbhatt, Himanshu/AAY-9997-2020; Bailey, Dale L/A-3359-2012	Sedliarou, Ilya/0000-0002-0001-2568; Christensen, Neil/0000-0003-3277-0344	EnGeneIC Pty Ltd; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	EnGeneIC Pty Ltd; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EnGeneIC Pty Ltd conceived, designed and funded this study. EnGeneIC Pty Ltd funded the salaries for authors JAM, STP, SLP, LRA, VNB, KS, MTH, MC, NBM, IS, NAG, DLK, HB. The specific role of these authors are articulated in the author contributions section.	ABE T, 1994, INT J CANCER, V58, P860; Afra D, 2002, LANCET, V359, P1011; Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; [Anonymous], NEUROSURG FOCUS; Berens Michael E., 1999, Neoplasia (New York), V1, P107, DOI 10.1038/sj.neo.7900020; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fokas E, 2013, BBA-REV CANCER, V1835, P61, DOI 10.1016/j.bbcan.2012.10.005; FOSTER ES, 1988, J VET INTERN MED, V2, P71, DOI 10.1111/j.1939-1676.1988.tb02796.x; Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769; Gaillard PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082331; Gieger TL, 2000, J VET INTERN MED, V14, P277, DOI 10.1892/0891-6640(2000)014&lt;0277:TFASHE&gt;2.3.CO;2; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; HEIDNER GL, 1991, J VET INTERN MED, V5, P219, DOI 10.1111/j.1939-1676.1991.tb00952.x; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Juillerat-Jeanneret L, 2008, DRUG DISCOV TODAY, V13, P1099, DOI 10.1016/j.drudis.2008.09.005; Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Koestner A., 2002, Tumors in domestic animals, P697, DOI 10.1002/9780470376928.ch14; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Liu Y, 2012, EXPERT OPIN DRUG DEL, V9, P671, DOI 10.1517/17425247.2012.682726; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; MacDiarmid JA, 2007, CANCER CELL, V11, P431, DOI 10.1016/j.ccr.2007.03.012; MacDiarmid JA, 2009, NAT BIOTECHNOL, V27, P643, DOI 10.1038/nbt.1547; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Muldoon LL, 2003, J NEURO-ONCOL, V65, P49, DOI 10.1023/A:1026234130830; Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Pluhar GE, 2010, VACCINE, V28, P3371, DOI 10.1016/j.vaccine.2010.02.082; Rainov NG, 2000, J NEUROPATH EXP NEUR, V59, P607, DOI 10.1093/jnen/59.7.607; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Roberts N.J., 2014, SCI TRANSL MED, V6, P249, DOI DOI 10.1126/SCITRANSLMED.3008982; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sarin H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-80; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Syakalima M, 1998, VET QUART, V20, P18, DOI 10.1080/01652176.1998.9694829; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Veterinary Co-operative Oncology Group (VCOG), 2004, Vet Comp Oncol, V2, P195, DOI 10.1111/j.1476-5810.2004.0053b.x; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yang Y, 2013, ACM T MULTIM COMPUT, V9, DOI 10.1145/2457450.2457456	54	49	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151832	10.1371/journal.pone.0151832	http://dx.doi.org/10.1371/journal.pone.0151832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050167	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000373603500014
J	Chen, H; Pu, JS; Liu, D; Yu, WS; Shao, YY; Yang, GW; Xiang, ZH; He, NJ				Chen, Hu; Pu, Junsong; Liu, Dan; Yu, Wansha; Shao, Yunying; Yang, Guangwei; Xiang, Zhonghuai; He, Ningjia			Anti-Inflammatory and Antinociceptive Properties of Flavonoids from the Fruits of Black Mulberry (Morus nigra L.)	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; CHEMICAL-COMPOSITION; ALBA L.; RUBRA; EXTRACT; WOGONIN	We analyzed the anti-inflammatory and antinociceptive activities of total flavonoids (TF) found in black mulberry fruits. The TF content was 20.9 mg/g (dry weight). Two anthocyanins, cyanidin-3-O-glucoside (8.3 mg/g) and cyanidin-3-O-rutinoside (2.9 mg/g), were identified in the fruits by UPLC. The TF of black mulberry fruits had significant reducing power and radical (OH-, O-2(-), DPPH and ABTS) scavenging activities that was demonstrated in a dose-response curve. The TF had inhibitory activities on xylene-induced ear edema and carrageenan-induced paw edema in mice. In addition, TF had antinociceptive activities in the two nociceptive phases of formalin test. We used ELISA to detect the pro-inflammatory cytokines IL-1 beta, TNF-alpha, IFN-gamma, and NO in the serum of mice. These cytokines were significantly inhibited or scavenged by TF (50 and 100 mg/kg). The results demonstrated that TF of black mulberry possess anti-inflammatory and analgesic effects that might correlate to its antioxidant activities and inhibition of pro-inflammatory cytokines.	[Chen, Hu; Pu, Junsong; Liu, Dan; Yu, Wansha; Shao, Yunying; Yang, Guangwei; Xiang, Zhonghuai; He, Ningjia] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Southwest University - China	He, NJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	hejia@swu.edu.cn			National Hi-Tech Research and Development Program of China [2013AA100605-3]; Special Fund for Agro-scientific Research in Public Interest of China [201403064]; Fundamental Research Funds for Central Universities [2362014xk05]; "111" Project [B12006]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in Public Interest of China; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); "111" Project(Ministry of Education, China - 111 Project)	This project was funded by the research grants from the National Hi-Tech Research and Development Program of China (No. 2013AA100605-3), Special Fund for Agro-scientific Research in the Public Interest of China (No. 201403064), the Fundamental Research Funds for the Central Universities (No. 2362014xk05), and the "111" Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈虎 Chen Hu], 2014, [食品科学, Food Science], V35, P7; Chen JM, 2009, CHINA BREWING, P153; Chi YS, 2003, BIOCHEM PHARMACOL, V66, P1271, DOI 10.1016/S0006-2952(03)00463-5; Chou TC, 2003, ANESTH ANALG, V97, P1724, DOI 10.1213/01.ANE.0000087066.71572.3F; de Queiroz GT, 2012, FOOD CHEM TOXICOL, V50, P816, DOI 10.1016/j.fct.2011.12.014; Ercisli S, 2008, SCI HORTIC-AMSTERDAM, V116, P41, DOI 10.1016/j.scienta.2007.10.021; Ercisli S, 2007, FOOD CHEM, V103, P1380, DOI 10.1016/j.foodchem.2006.10.054; Fazio A, 2013, FOOD CHEM, V140, P817, DOI 10.1016/j.foodchem.2012.11.010; FERNANDEZLOPEZ JA, 1992, J SCI FOOD AGR, V58, P153, DOI 10.1002/jsfa.2740580127; Fletcher D, 1996, ANESTHESIOLOGY, V84, P1129, DOI 10.1097/00000542-199605000-00015; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Gundogdu M, 2011, SCI HORTIC-AMSTERDAM, V132, P37, DOI 10.1016/j.scienta.2011.09.035; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Janisch KM, 2005, DEV OPHTHALMOL, V38, P59, DOI 10.1159/000082767; Jiang Y, 2015, FOOD CHEM, V174, P460, DOI 10.1016/j.foodchem.2014.11.083; Kowalski ML, 2015, J ALLERGY CLIN IMMUN, V136, P245, DOI 10.1016/j.jaci.2015.06.021; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Li X, 2014, FOOD CHEM, V152, P531, DOI 10.1016/j.foodchem.2013.12.010; Ma Y.P, 2002, XINJIANG J TRADIT CH, V20, P83; Man SL, 2013, FOOD CHEM, V136, P513, DOI 10.1016/j.foodchem.2012.08.010; Morales-Cano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114492; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Ozgen M, 2009, SCI HORTIC-AMSTERDAM, V119, P275, DOI 10.1016/j.scienta.2008.08.007; Gil ALAP, 2012, J ETHNOPHARMACOL, V144, P712, DOI 10.1016/j.jep.2012.10.018; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Riccioni G, 2005, EXPERT OPIN INV DRUG, V14, P1145, DOI 10.1517/13543784.14.9.1145; ROSA MD, 1971, J PHARM PHARMACOL, V23, P297, DOI 10.1111/j.2042-7158.1971.tb08661.x; Roth SH, 2012, DRUGS, V72, P873, DOI 10.2165/11633740-000000000-00000; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Sagnia B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103999; Sanchez-Salcedo EM, 2015, J FUNCT FOODS, V12, P399, DOI 10.1016/j.jff.2014.12.010; Santos BL, 2015, CHEM-BIOL INTERACT, V242, P123, DOI 10.1016/j.cbi.2015.07.014; Valkhoff VE, 2012, BEST PRACT RES CL GA, V26, P125, DOI 10.1016/j.bpg.2012.01.011; Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003; [王元成 WANG Yuancheng], 2011, [食品科学, Food Science], V32, P135; Wang ZJ, 2009, CHIN J PUBLIC HLTH, P181; [肖更生 XIAO GengSheng], 2011, [蚕业科学, Acta Sericologica Sinica], V37, P600; Yamanishi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093818; Yoon JH, 2005, YONSEI MED J, V46, P585, DOI 10.3349/ymj.2005.46.5.585; Zhao P, 2015, J CHROMATOGR B, V1007, P8, DOI 10.1016/j.jchromb.2015.10.019	41	44	50	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153080	10.1371/journal.pone.0153080	http://dx.doi.org/10.1371/journal.pone.0153080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046026	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600066
J	Li, FH; Wang, H; Liu, JF; Lin, JB; Zeng, AB; Ai, WM; Wang, XD; Dahlgren, RA; Wang, HL				Li, Fanghui; Wang, Hui; Liu, Jinfeng; Lin, Jiebo; Zeng, Aibing; Ai, Weiming; Wang, Xuedong; Dahlgren, Randy A.; Wang, Huili			Immunotoxicity of beta-Diketone Antibiotic Mixtures to Zebrafish (Danio rerio) by Transcriptome Analysis	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; EXPRESSION; TOXICITY; MICE; METASTASIS; PATHWAY; EMBRYO; GROWTH; CELLS; MODEL	Fluoroquinolones and tetracyclines are known as beta-diketone antibiotics (DKAs) because of bearing a diketone group in their molecular structure. DKAs are the most widely used antibiotics to prevent generation of disease in humans and animals and to suppress bacterial growth in aquaculture. In recent years, overuse of DKAs has caused serious environmental risk due to their pseudo-persistence in the environment, even though their half-lives are not long. So far, no reports were concerned with the joint immunotoxicity of DKAs. Herein, we reported on the immunotoxicity of DKAs on zebrafish after a 3-month DKAs exposure using transcriptomic techniques. According to transcriptome sequencing, 10 differentially expressed genes were screened out among the genes related to KEGG pathways with high enrichment. The identified 7 genes showed to be consistent between RNA-seq and qRT-PCR. Due to DKAs exposure, the content or activity for a series of immune-related biomarkers (Complement 3, lysozyme, IgM and AKP) showed the inconsistent changing trends as compared with the control group. Histopathological observations showed that the number of goblet cells increased sharply, the columnar epithelial cells swelled, the nucleus became slender in intestinal villi, and numerous brown metachromatic granules occurred in spleens of DKAs-exposed groups. Overall, both detection of biomarkers and histopathological observation corroborated that chronic DKAs exposure could result in abnormal expression of immune genes and enzymes, and variable levels of damage to immune-related organs. These complex effects of DKAs may lead to zebrafish dysfunction and occurrence of diseases related to the immune system.	[Li, Fanghui; Liu, Jinfeng; Lin, Jiebo; Zeng, Aibing; Ai, Weiming; Wang, Huili] Wenzhou Med Univ, Sch Life Sci, Wenzhou, Peoples R China; [Wang, Hui; Wang, Xuedong; Dahlgren, Randy A.] Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Wang, HL (corresponding author), Wenzhou Med Univ, Sch Life Sci, Wenzhou, Peoples R China.; Wang, XD (corresponding author), Wenzhou Med Univ, Key Lab Watershed Sci & Hlth Zhejiang Prov, Wenzhou, Peoples R China.	zjuwxd@163.com; whuili@163.com	Wang, Xuedong/B-3279-2018; Wang, Huili/AAA-4941-2020	Wang, Huili/0000-0002-1359-9484; Dahlgren, Randy/0000-0002-8961-875X	National Natural Science Foundation of China [31270548, 21377100]; Natural Science Foundation of Zhejiang Province [LY15C030004, LY15B070009]; Zhejiang Provincial Xinmiao Talent Project [2015R413078]; Public Beneficial Project of Wenzhou City Sci Technol Bureau [H20150005, Y20150096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Xinmiao Talent Project; Public Beneficial Project of Wenzhou City Sci Technol Bureau	This work is jointly supported by the National Natural Science Foundation of China (31270548, and 21377100), the Natural Science Foundation of Zhejiang Province (LY15C030004 and LY15B070009), the Zhejiang Provincial Xinmiao Talent Project (2015R413078) and the Public Beneficial Project of Wenzhou City Sci & Technol Bureau (H20150005 and Y20150096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfosso F, 2001, J BIOL CHEM, V276, P1564, DOI 10.1074/jbc.M007065200; Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Dagur PK, 2011, J AUTOIMMUN, V37, P319, DOI 10.1016/j.jaut.2011.09.003; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Driessen M, 2014, TOXICOL LETT, V230, P48, DOI 10.1016/j.toxlet.2014.06.844; Driessen M, 2013, ARCH TOXICOL, V87, P807, DOI 10.1007/s00204-013-1039-z; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lindberg R, 2004, CHEMOSPHERE, V57, P1479, DOI 10.1016/j.chemosphere.2004.09.015; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Melvin SD, 2014, J TOXICOL ENV HEAL A, V77, P337, DOI 10.1080/15287394.2013.865107; Mulgaonkar A, 2012, EXPERT OPIN DRUG MET, V8, P553, DOI 10.1517/17425255.2012.674512; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Paul T, 2007, ENVIRON SCI TECHNOL, V41, P4720, DOI 10.1021/es070097q; Schlagbauer-Wadl H, 1999, INT J CANCER, V81, P951, DOI 10.1002/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V; Segu L, 2008, NEUROBIOL AGING, V29, P231, DOI 10.1016/j.neurobiolaging.2006.10.014; Sheng ZG, 2013, TOXICOL APPL PHARM, V267, P74, DOI 10.1016/j.taap.2012.12.015; Shih IM, 1997, AM J PATHOL, V151, P745; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Suwa T, 2001, AM J RESP CRIT CARE, V163, P970, DOI 10.1164/ajrccm.163.4.2005132; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; Wang HL, 2016, ENVIRON TOXICOL, V31, P1357, DOI 10.1002/tox.22141; Wang HL, 2014, ENVIRON TOXICOL, V29, P1134, DOI 10.1002/tox.21843; Wang N, 2009, CHEMOSPHERE, V77, P1577, DOI 10.1016/j.chemosphere.2009.09.038; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P267; Wu GJ, 2004, GENE, V327, P201, DOI 10.1016/j.gene.2003.11.018; Xie SH, 1997, CANCER RES, V57, P2295; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078; Yin XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102731; Zhang HC, 2005, ENVIRON SCI TECHNOL, V39, P4474, DOI 10.1021/es048166d; Zhang Q, 2015, ECOTOXICOLOGY, V24, P707, DOI 10.1007/s10646-015-1417-9; [张澍 ZHANG Shu], 2009, [中国实用外科杂志, Chinese Journal of Practical Surgery], V29, P395; Zhang Y, 2009, J CHIN MISDIAGN, V9, P7549; Zhang YN, 2016, ENVIRON TOXICOL, V31, P736, DOI 10.1002/tox.22087	39	13	14	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152530	10.1371/journal.pone.0152530	http://dx.doi.org/10.1371/journal.pone.0152530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046191	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600024
J	Lin, C; Chu, CM; Su, SL				Lin, Chin; Chu, Chi-Ming; Su, Sui-Lung			Epistasis Test in Meta-Analysis: A Multi-Parameter Markov Chain Monte Carlo Model for Consistency of Evidence	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; INDIVIDUAL PATIENT DATA; MISSING HERITABILITY; META-REGRESSION; ANGIOTENSIN-I; GSTM1; POLYMORPHISMS; CYP1A1; GSTT1; ALDOSTERONE	Conventional genome-wide association studies (GWAS) have been proven to be a successful strategy for identifying genetic variants associated with complex human traits. However, there is still a large heritability gap between GWAS and transitional family studies. The "missing heritability" has been suggested to be due to lack of studies focused on epistasis, also called gene-gene interactions, because individual trials have often had insufficient sample size. Meta-analysis is a common method for increasing statistical power. However, sufficient detailed information is difficult to obtain. A previous study employed a meta-regression-based method to detect epistasis, but it faced the challenge of inconsistent estimates. Here, we describe a Markov chain Monte Carlo-based method, called "Epistasis Test in Meta-Analysis" (ETMA), which uses genotype summary data to obtain consistent estimates of epistasis effects in meta-analysis. We defined a series of conditions to generate simulation data and tested the power and type I error rates in ETMA, individual data analysis and conventional meta-regression-based method. ETMA not only successfully facilitated consistency of evidence but also yielded acceptable type I error and higher power than conventional meta-regression. We applied ETMA to three real meta-analysis data sets. We found significant gene-gene interactions in the renin-angiotensin system and the polycyclic aromatic hydrocarbon metabolism pathway, with strong supporting evidence. In addition, glutathione S-transferase (GST) mu 1 and theta 1 were confirmed to exert independent effects on cancer. We concluded that the application of ETMA to real meta-analysis data was successful. Finally, we developed an R package, etma, for the detection of epistasis in meta-analysis [etma is available via the Comprehensive R Archive Network (CRAN) at https://cran.r-project.org/web/packages/etma/index.html].	[Lin, Chin; Chu, Chi-Ming; Su, Sui-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Chi-Ming; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center	Chu, CM; Su, SL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chu, CM; Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	chuchiming@web.de; a131419@gmail.com	Lin, Chin/M-2832-2015	Lin, Chin/0000-0003-2337-2096; Su, Sui-Lung/0000-0003-3122-1116				Aros C, 2002, J HYPERTENS, V20, pS45; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bhattacharjee P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02704; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Caulfield M, 1996, HYPERTENSION, V28, P1123, DOI 10.1161/01.HYP.28.6.1123; Chen WJ, 2014, TOXICOL APPL PHARM, V279, P95, DOI 10.1016/j.taap.2014.05.011; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; DEJONG JL, 1991, BIOCHEM BIOPH RES CO, V180, P15, DOI 10.1016/S0006-291X(05)81248-3; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Doran H., 2007, J STAT SOFTW, V20, P1, DOI [10.18637/jss.v020.i02, DOI 10.18637/JSS.V020.I02]; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Fang JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078707; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Hung RJ, 2003, CARCINOGENESIS, V24, P875, DOI 10.1093/carcin/bgg026; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Lin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124967; Lin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087604; Liu HT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000895; Liu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102372; Lodovici M, 2004, CANCER EPIDEM BIOMAR, V13, P1342; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Mackay TFC, 2014, GENOME MED, V6, DOI 10.1186/gm561; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Palla L, 2010, AM J EPIDEMIOL, V171, P1225, DOI 10.1093/aje/kwq051; Pawlik M, 2014, J RENIN-ANGIO-ALDO S, V15, P553, DOI 10.1177/1470320313489588; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Shaikh R, 2014, J RENIN-ANGIO-ALDO S, V15, P124, DOI 10.1177/1470320313512390; Shen YH, 2014, TUMOR BIOL, V35, P4007, DOI 10.1007/s13277-013-1524-2; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Su SL, 2014, SCI WORLD J, DOI 10.1155/2014/169798; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Volk DE, 2003, BIOCHEMISTRY-US, V42, P1410, DOI 10.1021/bi026745u; Wei WH, 2014, NAT REV GENET, V15, P722, DOI 10.1038/nrg3747; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WOLF G, 1993, J AM SOC NEPHROL, V3, P1531; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhu HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106761; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152891	10.1371/journal.pone.0152891	http://dx.doi.org/10.1371/journal.pone.0152891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045371	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600044
J	Chu, ZJ; Wang, YJ; Ying, SH; Wang, XW; Feng, MG				Chu, Zhen-Jian; Wang, Yu-Jun; Ying, Sheng-Hua; Wang, Xiao-Wei; Feng, Ming-Guang			Genome-Wide Host-Pathogen Interaction Unveiled by Transcriptomic Response of Diamondback Moth to Fungal Infection	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; SCORPION NEUROTOXIN; SPODOPTERA-LITURA; GENE-EXPRESSION; VIRULENCE; PROTEASE; CUTICLE; INTEGRATION; MECHANISMS; MANAGEMENT	Genome-wide insight into insect pest response to the infection of Beauveria bassiana (fungal insect pathogen) is critical for genetic improvement of fungal insecticides but has been poorly explored. We constructed three pairs of transcriptomes of Plutella xylostella larvae at 24, 36 and 48 hours post treatment of infection (hpt(I)) and of control (hpt(C)) for insight into the host-pathogen interaction at genomic level. There were 2143, 3200 and 2967 host genes differentially expressed at 24, 36 and 48 hpt(I)/ hpt(C) respectively. These infection-responsive genes (similar to 15% of the host genome) were enriched in various immune processes, such as complement and coagulation cascades, protein digestion and absorption, and drug metabolism- cytochrome P450. Fungal penetration into cuticle and host defense reaction began at 24 hpt(I), followed by most intensive host immune response at 36 hpt(I) and attenuated immunity at 48 hpt(I). Contrastingly, 44% of fungal genes were differentially expressed in the infection course and enriched in several biological processes, such as antioxidant activity, peroxidase activity and proteolysis. There were 1636 fungal genes co-expressed during 24-48 hpt(I), including 116 encoding putative secretion proteins. Our results provide novel insights into the insect-pathogen interaction and help to probe molecular mechanisms involved in the fungal infection to the global pest.	[Chu, Zhen-Jian; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Yu-Jun; Wang, Xiao-Wei] Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Feng, MG (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, XW (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xwwang@zju.edu.cn; mgfeng@zju.edu.cn			National Natural Science Foundation of China [31270537, 31572054, 31321063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Natural Science Foundation of China (Grants 31270537, 31572054 and 31321063) at http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P911, DOI 10.1016/j.funbio.2010.08.007; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; Fan YH, 2007, APPL ENVIRON MICROB, V73, P295, DOI 10.1128/AEM.01974-06; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Fang WG, 2009, J INVERTEBR PATHOL, V102, P155, DOI 10.1016/j.jip.2009.07.013; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; GUPTA SC, 1994, J INVERTEBR PATHOL, V64, P13, DOI 10.1006/jipa.1994.1062; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Holder DJ, 2007, MICROBIOL-SGM, V153; Hou CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091189; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim JS, 2010, FUNGAL BIOL-UK, V114, P120, DOI 10.1016/j.mycres.2009.10.011; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Lewis MW, 2009, MICROBIOL-SGM, V155; Li F, 2015, FUNGAL GENET BIOL, V81, P160, DOI 10.1016/j.fgb.2014.09.006; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu YJ, 2013, APPL ENVIRON MICROB, V79, P6452, DOI 10.1128/AEM.01594-13; Lu DD, 2008, APPL MICROBIOL BIOT, V81, P515, DOI 10.1007/s00253-008-1695-8; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Montesinos-Matias R, 2011, WORLD J MICROB BIOT, V27; Pava-Ripoll M, 2008, J INVERTEBR PATHOL, V99, P220, DOI 10.1016/j.jip.2008.05.004; PENDLAND JC, 1993, J BACTERIOL, V175, P5962, DOI 10.1128/JB.175.18.5962-5969.1993; Qin Y, 2010, APPL ENVIRON MICROB, V76, P4611, DOI 10.1128/AEM.00302-10; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7; Shen DX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086436, 10.1371/journal.pone.0105709]; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wanchoo A, 2009, MICROBIOL-SGM, V155, P3121, DOI 10.1099/mic.0.029157-0; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; Wang CS, 2014, BIOL CONTROL, V68, P129, DOI 10.1016/j.biocontrol.2013.06.017; Wang Long-Jiang, 2010, Acta Entomologica Sinica, V53, P118; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x; Wang ZL, 2013, MICROB BIOTECHNOL, V6, P27, DOI 10.1111/j.1751-7915.2012.00351.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068185; Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483; Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhang L, 2014, BIOL CONTROL, V79, P8, DOI 10.1016/j.biocontrol.2014.08.001	57	26	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152908	10.1371/journal.pone.0152908	http://dx.doi.org/10.1371/journal.pone.0152908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043942	gold, Green Published			2022-12-27	WOS:000373592100043
J	Mateen, S; Moin, S; Khan, AQ; Zafar, A; Fatima, N				Mateen, Somaiya; Moin, Shagufta; Khan, Abdul Qayyum; Zafar, Atif; Fatima, Naureen			Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; PROTEIN CARBONYL GROUPS; LIPID-PEROXIDATION; DISEASE-ACTIVITY; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; DNA-DAMAGE; PLASMA; BLOOD; OXIDE	Background Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder. Highly reactive oxygen free radicals are believed to be involved in the pathogenesis of the disease. In this study, RA patients were sub-grouped depending upon the presence or absence of rheumatoid factor, disease activity score and disease duration. RA Patients (120) and healthy controls (53) were evaluated for the oxidant-antioxidant status by monitoring ROS production, biomarkers of lipid peroxidation, protein oxidation and DNA damage. The level of various enzymatic and non-enzymatic antioxidants was also monitored. Correlation analysis was also performed for analysing the association between ROS and various other parameters. Methods Intracellular ROS formation, lipid peroxidation (MDA level), protein oxidation (carbonyl level and thiol level) and DNA damage were detected in the blood of RA patients. Antioxidant status was evaluated by FRAP assay, DPPH reduction assay and enzymatic (SOD, catalase, GST, GR) and non-enzymatic (vitamin C and GSH) antioxidants. Results RA patients showed a higher ROS production, increased lipid peroxidation, protein oxidation and DNA damage. A significant decline in the ferric reducing ability, DPPH radical quenching ability and the levels of antioxidants has also been observed. Significant correlation has been found between ROS and various other parameters studied. Conclusion RA patients showed a marked increase in ROS formation, lipid peroxidation, protein oxidation, DNA damage and decrease in the activity of antioxidant defence system leading to oxidative stress which may contribute to tissue damage and hence to the chronicity of the disease.	[Mateen, Somaiya; Moin, Shagufta; Fatima, Naureen] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India; [Khan, Abdul Qayyum] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Orthoped Surg, Aligarh, Uttar Pradesh, India; [Zafar, Atif] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Mateen, S (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India.	smateen.amu@gmail.com	Fatima, Naureen/AFK-6203-2022; Fatima, Naureen/AAG-4508-2022	Fatima, Naureen/0000-0002-7839-8827; Fatima, Naureen/0000-0002-7839-8827				Aebi H, 1984, Methods Enzymol, V105, P121; Akyol O, 2001, JOINT BONE SPINE, V68, P311, DOI 10.1016/S1297-319X(01)00279-2; Ali AM, 2014, REV BRAS REUMATOL, P54; Altindag O, 2007, CLIN BIOCHEM, V40, P167, DOI 10.1016/j.clinbiochem.2006.10.006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BIEMOND P, 1984, ARTHRITIS RHEUM-US, V27, P760, DOI 10.1002/art.1780270706; Bracht A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1671-1; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Buege J A, 1978, Methods Enzymol, V52, P302; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Comar JF, 2013, FREE RADICAL BIO MED, V58, P144, DOI 10.1016/j.freeradbiomed.2012.12.003; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Demirbag R, 2005, CAN J CARDIOL, V21, P851; El-Barbary AM, 2011, EGYPT RHEUMATOL, V33, P179, DOI 10.1016/j.ejr.2011.07.002; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haris ED, 1989, TXB RHEUMATOLOGY, P905; Hassan MQ, 2001, J APPL TOXICOL, V21, P69, DOI 10.1002/jat.736; Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002; Janaszewska A, 2002, SCAND J CLIN LAB INV, V62, P231, DOI 10.1080/003655102317475498; Jaswal S, 2003, CLIN CHIM ACTA, V338, P123, DOI 10.1016/j.cccn.2003.08.011; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kalpakcioglu B, 2008, CLIN RHEUMATOL, V27, P141, DOI 10.1007/s10067-007-0746-3; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Keller A, 2004, FREE RADICAL RES, V38, P1257, DOI 10.1080/10715760400022145; KRANE SM, 1986, MED CLIN N AM, V70, P263, DOI 10.1016/S0025-7125(16)30953-1; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; KYAW A, 1978, CLIN CHIM ACTA, V86, P153, DOI 10.1016/0009-8981(78)90128-6; Leonaviciene L, 2008, BIOLOGIJA, V54, P290, DOI DOI 10.2478/V10054-008-0059-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahajan A, 2004, J INDIAN RHEUMATOL A, V12, P139; Maki-Petaja KM, 2008, INT J CARDIOL, V129, P399, DOI 10.1016/j.ijcard.2008.02.011; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mazzetti I, 1996, INT J CLIN LAB RES, V26, P245, DOI 10.1007/BF02602957; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mulherin DM, 1996, ANN RHEUM DIS, V55, P837, DOI 10.1136/ard.55.11.837; Wendt MMN, 2015, EXP MOL PATHOL, V98, P549, DOI 10.1016/j.yexmp.2015.04.002; OLIVIERI O, 1991, J RHEUMATOL, V18, P1263; Ozgocmen S, 2006, RHEUMATOL INT, V26, P585, DOI 10.1007/s00296-005-0078-z; Ozturk HS, 1999, RHEUMATOL INT, V19, P35, DOI 10.1007/s002960050097; Renke J, 2000, FREE RADICAL BIO MED, V29, P101, DOI 10.1016/S0891-5849(00)00288-4; Reznick AZ, 1991, METHOD ENZYMOL, V233, P357; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Ueki Y, 1996, J RHEUMATOL, V23, P230; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; Vasanthi P, 2004, J INDIAN RHEUMATOL A, V12, P40; Veselinovic M, 2014, MOL CELL BIOCHEM, V391, P225, DOI 10.1007/s11010-014-2006-6; Vijayakumar D, 2006, INDIAN J CLIN BIOCHE, V21, P104, DOI 10.1007/BF02913075	54	209	223	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152925	10.1371/journal.pone.0152925	http://dx.doi.org/10.1371/journal.pone.0152925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043143	gold, Green Submitted, Green Published			2022-12-27	WOS:000373592100048
J	Nullens, S; Staessens, M; Peleman, C; Plaeke, P; Malhotra-Kumar, S; Francque, S; De Man, JG; De Winter, BY				Nullens, Sara; Staessens, Michael; Peleman, Cedric; Plaeke, Philip; Malhotra-Kumar, Surbhi; Francque, Sven; De Man, Joris G.; De Winter, Benedicte Y.			Beneficial Effects of Anti-Interleukin-6 Antibodies on Impaired Gastrointestinal Motility, Inflammation and Increased Colonic Permeability in a Murine Model of Sepsis Are Most Pronounced When Administered in a Preventive Setup	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; INTERLEUKIN-6 IL-6; ANIMAL-MODELS; INTESTINAL PERMEABILITY; EPITHELIAL BARRIER; PROTEIN EXPRESSION; IMPROVES SURVIVAL; CECAL LIGATION; GUT; CYTOKINE	Background and Objectives During sepsis, gastrointestinal ileus, mucosal barrier dysfunction and bacterial translocation are accepted to be important triggers that can maintain or exacerbate the septic state. In the caecal ligation and puncture animal model of sepsis, we demonstrated that systemic and colonic interleukin-6 levels are significantly increased coinciding with an impaired colonic barrier function. We therefore aimed to study the effect of therapeutic or curative administration of anti-IL6 antibodies on overall GI motility, colonic permeability and translocation of intestinal bacteria in blood and mesenteric lymph nodes in the mouse caecal ligation and puncture model. Methods OF-1 mice were randomized to either the preventive or curative protocol, in which they received 1 mg/ kg of antibodies to interleukin-6, or its IgG isotype control solution. They subsequently underwent either the caecal ligation and puncture procedure, or sham-surgery. GI motility was assessed 48h following the procedure, as well as colonic permeability, serum and colon cytokines, colonic tight junction proteins at the mRNA level; cultures of blood and mesenteric lymph nodes were performed. Results Preventive administration of anti-interleukin-6 antibodies successfully counteracted the gastrointestinal motility disturbances and impaired colonic barrier function that could beobserved in vehicle-treated septic animals. Serum and colonic levels of proinflammatory cytokines were significantly lower when animals were preventively treated with anti-interleukin- 6 antibodies. A repetitive injection 24h later resulted in the most pronounced effects. Curative treatment significantly lowered systemic and colonic inflammation markers while the effects on transit and permeability were unfortunately no longer significant. Conclusions Caecal ligation and puncture resulted in septic ileus with an increased colonic permeability. Antibodies to interleukin-6 were able to ameliorate gastro-intestinal motility, suppress inflammation and normalize the permeability of the colonic wall, with the preventive administration combined with a repeat injection being far more efficacious than the sole preventive or curative one.	[Nullens, Sara; Staessens, Michael; Peleman, Cedric; Plaeke, Philip; Francque, Sven; De Man, Joris G.; De Winter, Benedicte Y.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Malhotra-Kumar, Surbhi] Univ Antwerp, Lab Med Microbiol, B-2020 Antwerp, Belgium; [Francque, Sven] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@uantwerpen.be	De Winter, Benedicte Y/G-2616-2011	De Winter, Benedicte Y/0000-0003-0327-6304	Fund for Scientific Research (FWO), Flanders [11G7415N]; FWO [G028615N]; University of Antwerp [GOA-2013]	Fund for Scientific Research (FWO), Flanders(FWO); FWO(FWO); University of Antwerp	S. Nullens is an aspirant of the Fund for Scientific Research (FWO), Flanders (11G7415N). This work was supported financially by the FWO (G028615N), and by a GOA-2013 funding of the University of Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Barkhausen T, 2011, CRIT CARE MED, V39, P1407, DOI 10.1097/CCM.0b013e318211ff56; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Costes LMM, 2014, AUTON NEUROSCI-BASIC, V185, P76, DOI 10.1016/j.autneu.2014.07.006; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Eadon MT, 2012, AM J PHYSIOL-RENAL, V303, pF821, DOI 10.1152/ajprenal.00023.2012; GENNARI R, 1994, ARCH SURG-CHICAGO, V129, P1191; GENNARI R, 1995, CRIT CARE MED, V23, P1945, DOI 10.1097/00003246-199512000-00002; Giannoudis PV, 2008, J TRAUMA, V65, P646, DOI 10.1097/TA.0b013e3181820d48; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Heylen M, 2013, INFLAMM BOWEL DIS; Kang SJ, 2015, INT IMMUNOL, V27, P21, DOI 10.1093/intimm/dxu081; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; LANGE S, 1994, SCAND J GASTROENTERO, V29, P38, DOI 10.3109/00365529409090435; Ledeganck KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057016; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; MATTHYS P, 1995, INFECT IMMUN, V63, P1158, DOI 10.1128/IAI.63.4.1158-1164.1995; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nullens S, 2015, SHOCK; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Pallua N, 2003, CRIT CARE MED, V31, P1495, DOI 10.1097/01.CCM.0000065725.80882.BD; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Pene F, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0050-3; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; SCHINDLER R, 1990, BLOOD, V75, P40; Seerden TC, 2007, NEUROGASTROENT MOTIL, V19, P856, DOI 10.1111/j.1365-2982.2007.00968.x; Stoffels B, 2013, GASTROENTEROLOGY, V22, P10; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tazuke Y, 2003, PEDIATR SURG INT, V19, P321, DOI 10.1007/s00383-003-1003-8; TILG H, 1994, BLOOD, V83, P113; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vyas D, 2005, AM J PHYSIOL-REG I, V289, pR1048, DOI 10.1152/ajpregu.00312.2005; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	56	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152914	10.1371/journal.pone.0152914	http://dx.doi.org/10.1371/journal.pone.0152914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044016	Green Published, gold			2022-12-27	WOS:000373592100044
J	Bahijri, SM; Jambi, HA; Al Raddadi, RM; Ferns, G; Tuomilehto, J				Bahijri, Suhad M.; Jambi, Hanan A.; Al Raddadi, Rajaa M.; Ferns, Gordon; Tuomilehto, Jaakko			The Prevalence of Diabetes and Prediabetes in the Adult Population of Jeddah, Saudi Arabia- A Community-Based Survey	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; UNITED-STATES; METABOLIC SYNDROME; RISK-FACTORS; LIFE-STYLE; OBESITY; PREVENTION	Background Type 2 (T2DM) is believed to be common in Saudi Arabia, but data are limited. In this population survey, we determined the prevalence of T2DM and prediabetes. Materials and Methods A representative sample among residents aged >= 18 years of the city of Jeddah was obtained comprising both Saudi and non-Saudi families (N = 1420). Data on dietary, clinical and sociodemographic characteristics were collected and anthropometric measurements taken. Fasting plasma glucose and glycated hemoglobin (HbA1c) were used to diagnose diabetes and prediabetes employing American Diabetes Association criteria. Multiple logistic regression analysis was used to identify factors associated with T2DM. Results Age and sex standardized prevalence of prediabetes was 9.0% (95% CI 7.5-10.5); 9.4% (7.1-11.8) in men and 8.6% (6.6-10.6) in women. For DM it was 12.1% (10.7-13.5); 12.9% (10.7-13.5) in men and 11.4% (9.5-13.3) in women. The prevalence based on World Population as standard was 18.3% for DM and 11.9% for prediabetes. The prevalence of DM and prediabetes increased with age. Of people aged >= 50 years 46% of men and 44% of women had DM. Prediabetes and DM were associated with various measures of adiposity. DM was also associated with and family history of dyslipidemia in women, cardiovascular disease in men, and with hypertension, dyslipidemia and family history of diabetes in both sexes. Discussion Age was the strongest predictor of DM and prediabetes followed by obesity. Of people aged 50 years or over almost half had DM and another 10-15% had prediabetes leaving only a small proportion of people in this age group with normoglycemia. Since we did not use an oral glucose tolerance test the true prevalence of DM and prediabetes is thus likely to be even higher than reported here. These results demonstrate the urgent need to develop primary prevention strategies for type 2 diabetes in Saudi Arabia.	[Bahijri, Suhad M.] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia; [Bahijri, Suhad M.; Jambi, Hanan A.; Al Raddadi, Rajaa M.; Ferns, Gordon; Tuomilehto, Jaakko] King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Group, Jeddah 21413, Saudi Arabia; [Jambi, Hanan A.] King Abdulaziz Univ, Dept Food & Nutr, Home Econ, Jeddah 21413, Saudi Arabia; [Al Raddadi, Rajaa M.] Minist Hlth, Publ Hlth Directorate, Jeddah, Saudi Arabia; [Ferns, Gordon] Brighton & Sussex Med Sch, Div Med Educ, Mayfield House, Brighton, E Sussex, England; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Ministry of Health - Saudi Arabia; University of Brighton; University of Sussex; Danube University Krems	Bahijri, SM (corresponding author), King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21413, Saudi Arabia.; Bahijri, SM (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Saudi Diabet Study Res Group, Jeddah 21413, Saudi Arabia.	sbahijri@gmail.com	Al-Raddadi, Rajaa/F-8337-2010; Bahijri, Suhad M/AAF-4141-2020; Ghayour-Mobarhan, Majid/AAY-5963-2020	Al-Raddadi, Rajaa/0000-0002-8921-9628; Bahijri, Suhad M/0000-0001-6674-5409; 	King Abdulaziz University Deanship of Scientific Research [01-33-RG]	King Abdulaziz University Deanship of Scientific Research	This study was funded by King Abdulaziz University Deanship of Scientific Research, grant number (01-33-RG), http://dsr.kau.edu.sa/Default.aspx?Site_ID=305&lng=AR.	Al-Kaabba A., 2012, OJEMD, V2, P89, DOI [10.4236/ojemd.2012.24014, DOI 10.4236/OJEMD.2012.24014]; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Al-Nozha MM, 2004, DIABETES MELLITUS SA; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alqurashi KA, 2011, ANN SAUDI MED, V31, P19, DOI 10.4103/0256-4947.75773; [Anonymous], 2003, WORLD POPULATION PRO; [Anonymous], 2000, WHO NCD RISK FACTORS; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Bahijri SM, 2013, THER ADV ENDOCRINOL, V4, P51, DOI 10.1177/2042018813483165; Balkau B, 2006, EUR J CLIN NUTR, V60, P295, DOI 10.1038/sj.ejcn.1602308; Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x; Bray GA, 2008, AM J CLIN NUTR, V87, P1212, DOI 10.1093/ajcn/87.5.1212; Cheng C, 2006, METABOLISM, V55, P434, DOI 10.1016/j.metabol.2005.10.003; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Elhadd TA, 2007, ANN SAUDI MED, V27, P241; Grais R.F., 2007, EMERG THEMES EPIDEMI, V4, P1; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; IDF, 2014, INT DIAB FED 2013; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karter AJ, 2005, DIABETES OBES METAB, V7, P230, DOI 10.1111/j.1463-1326.2004.00441.x; Kim KS, 2008, DIABETIC MED, V25, P997, DOI 10.1111/j.1464-5491.2008.02489.x; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; MACMAHON S, 1987, EUR HEART J, V8, P57, DOI 10.1093/eurheartj/8.suppl_B.57; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Okosun IS, 2001, OBES RES, V9, P1, DOI 10.1038/oby.2001.1; Patel P., 2010, DIABETES, V100, P13; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Ramachandran A, 2002, J Indian Med Assoc, V100, P425; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Satman I, 2013, EUR J EPIDEMIOL, V28, P169, DOI 10.1007/s10654-013-9771-5; Schwarz PEH, 2008, EXP CLIN ENDOCR DIAB, V116, P167, DOI 10.1055/s-2007-992115; Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1; Thabit H, 2013, DIABETES VASC DIS RE, V10, P337, DOI 10.1177/1479164113479808; Uusitupa MI, 2011, DIABETES CARE, V34, P418, DOI 10.2337/dc10-1013; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhao XL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-821; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zimmet PZ, 2005, MED J AUSTRALIA, V183, P175, DOI 10.5694/j.1326-5377.2005.tb06987.x	50	62	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152559	10.1371/journal.pone.0152559	http://dx.doi.org/10.1371/journal.pone.0152559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035920	Green Published, gold, Green Accepted			2022-12-27	WOS:000373201200022
J	Choo, SW; Dutta, A; Wong, GJ; Wee, WY; Ang, MY; Siow, CC				Choo, Siew Woh; Dutta, Avirup; Wong, Guat Jah; Wee, Wei Yee; Ang, Mia Yang; Siow, Cheuk Chuen			Comparative Genomic Analysis Reveals a Possible Novel Non-Tuberculous Mycobacterium Species with High Pathogenic Potential	PLOS ONE			English	Article							VIRULENCE FACTOR; NITRATE REDUCTASE; ELEMENT PSAM2; PPE PROTEINS; TUBERCULOSIS; BIOSYNTHESIS; GROWTH; IDENTIFICATION; DISRUPTION; GENES	Mycobacteria have been reported to cause a wide range of human diseases. We present the first whole-genome study of a Non-Tuberculous Mycobacterium, Mycobacterium sp. UM_CSW (referred to hereafter as UM_CSW), isolated from a patient diagnosed with bronchiectasis. Our data suggest that this clinical isolate is likely a novel mycobacterial species, supported by clear evidence from molecular phylogenetic, comparative genomic, ANI and AAI analyses. UM_CSW is closely related to the Mycobacterium avium complex. While it has characteristic features of an environmental bacterium, it also shows a high pathogenic potential with the presence of a wide variety of putative genes related to bacterial virulence and shares very similar pathogenomic profiles with the known pathogenic mycobacterial species. Thus, we conclude that this possible novel Mycobacterium species should be tightly monitored for its possible causative role in human infections.	[Choo, Siew Woh; Wee, Wei Yee] Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia; [Choo, Siew Woh; Dutta, Avirup; Wong, Guat Jah; Wee, Wei Yee; Ang, Mia Yang; Siow, Cheuk Chuen] Univ Malaya, Genome Informat Res Lab, High Impact Res HIR Bldg, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Fac Dent, Dept Oral Biol & Biomed Sci, Kuala Lumpur 50603, Malaysia.; Choo, SW (corresponding author), Univ Malaya, Genome Informat Res Lab, High Impact Res HIR Bldg, Kuala Lumpur 50603, Malaysia.	lchoo@um.edu.my		Dutta, Avirup/0000-0002-3595-6198	University of Malaya (UM) High Impact Research grant [UM-MOHE UM.C/HIR/MOHE/08]; University of Malaya Research Grant (UMRG) [RG541-13HTM]; UM High Impact Research grant from Ministry of Higher Education Malaysia [UM-MOHE UM.C/HIR/MOHE/08]; UMRG grant from the University of Malaya [RG541-13HTM]	University of Malaya (UM) High Impact Research grant; University of Malaya Research Grant (UMRG); UM High Impact Research grant from Ministry of Higher Education Malaysia; UMRG grant from the University of Malaya	This work was supported by University of Malaya (UM) High Impact Research grant (grant number: UM-MOHE UM.C/HIR/MOHE/08), and University of Malaya Research Grant (UMRG) grant (Project code: RG541-13HTM).; We would like to thank all members from the Genome Research Informatics Group for their IT or bioinformatics assistance and supports. Special thanks to Professor Dr. Ngeow Yun Fong from University of Malaya for her generosity in providing DNA material, valuable inputs and proofreading this manuscript. This research was funded by the UM High Impact Research grant (grant number: UM-MOHE UM.C/HIR/MOHE/08) from the Ministry of Higher Education Malaysia and the UMRG grant (Project code: RG541-13HTM) from the University of Malaya	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Cayrou C, 2010, MICROBIOL-SGM, V156, P687, DOI 10.1099/mic.0.033522-0; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cook JL, 2010, BRIT MED BULL, V96, P45, DOI 10.1093/bmb/ldq035; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Falkinham JO, 2013, SEMIN RESP CRIT CARE, V34, P95, DOI 10.1055/s-0033-1333568; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Fischer LJ, 1996, INFECT IMMUN, V64, P269, DOI 10.1128/IAI.64.1.269-276.1996; Garcia-Pelayo MC, 2004, TUBERCULOSIS, V84, P159, DOI 10.1016/j.tube.2003.12.002; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gaur RL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004376; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Giffin MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045459; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HAGEGE J, 1993, J BACTERIOL, V175, P5529; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Huet G, 2005, J BACTERIOL, V187, P6137, DOI 10.1128/JB.187.17.6137-6146.2005; Hutter B, 1999, FEMS MICROBIOL LETT, V178, P63, DOI 10.1016/S0378-1097(99)00348-1; KING CH, 1993, INFECT IMMUN, V61, P2708, DOI 10.1128/IAI.61.6.2708-2712.1993; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; Knoll BM, 2012, TRANSPL INFECT DIS, V14, P452, DOI 10.1111/j.1399-3062.2012.00753.x; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Li W, 2013, CELL PHYSIOL BIOCHEM, V31, P1, DOI 10.1159/000343343; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Park SJ, 2003, J BACTERIOL, V185, P5391, DOI 10.1128/JB.185.18.5391-5397.2003; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puri RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070514; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rindi L, 2002, MICROBIOL-SGM, V148, P3873, DOI 10.1099/00221287-148-12-3873; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sezonov G, 2000, J BACTERIOL, V182, P1243, DOI 10.1128/JB.182.5.1243-1250.2000; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shukla S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004471; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; UDOU T, 1994, CAN J MICROBIOL, V40, P318, DOI 10.1139/m94-052; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	67	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0150413	10.1371/journal.pone.0150413	http://dx.doi.org/10.1371/journal.pone.0150413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035710	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200004
J	Maatta, J; Roos, T				Maatta, Jussi; Roos, Teemu			Maximum Parsimony and the Skewness Test: A Simulation Study of the Limits of Applicability	PLOS ONE			English	Article							TREE; PERFORMANCE; LIKELIHOOD; INFORMATION; ALGORITHMS; SEQUENCES; EVOLUTION; LENGTHS; BRANCH; MODELS	The maximum parsimony (MP) method for inferring phylogenies is widely used, but little is known about its limitations in non-asymptotic situations. This study employs large-scale computations with simulated phylogenetic data to estimate the probability that MP succeeds in finding the true phylogeny for up to twelve taxa and 256 characters. The set of candidate phylogenies are taken to be unrooted binary trees; for each simulated data set, the tree lengths of all (2n - 5)!! candidates are computed to evaluate quantities related to the performance of MP, such as the probability of finding the true phylogeny, the probability that the tree with the shortest length is unique, the probability that the true phylogeny has the shortest tree length, and the expected inverse of the number of trees sharing the shortest length. The tree length distributions are also used to evaluate and extend the skewness test of Hillis for distinguishing between random and phylogenetic data. The results indicate, for example, that the critical point after which MP achieves a success probability of at least 0.9 is roughly around 128 characters. The skewness test is found to perform well on simulated data and the study extends its scope to up to twelve taxa.	[Maatta, Jussi; Roos, Teemu] Univ Helsinki, Dept Comp Sci, HIIT, Teollisuuskatu 23, SF-00510 Helsinki, Finland	Aalto University; University of Helsinki	Maatta, J (corresponding author), Univ Helsinki, Dept Comp Sci, HIIT, Teollisuuskatu 23, SF-00510 Helsinki, Finland.	jussi.maatta@helsinki.fi		Maatta, Jussi/0000-0003-2613-1204; Roos, Teemu/0000-0001-9470-3759	Academy of Finland (Finnish Centre of Excellence in Computational Inference Research COIN)	Academy of Finland (Finnish Centre of Excellence in Computational Inference Research COIN)	This work has been supported by the Academy of Finland (Finnish Centre of Excellence in Computational Inference Research COIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; CARPENTER JM, 1992, CLADISTICS, V8, P147, DOI 10.1111/j.1096-0031.1992.tb00059.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Erdos PL, 1997, LECT NOTES COMPUT SC, V1256, P827; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fischer M, 2014, MOL PHYLOGENET EVOL, V80, P165, DOI 10.1016/j.ympev.2014.07.010; FITCH WM, 1979, SYST ZOOL, V28, P375, DOI 10.2307/2412591; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FOULDS LR, 1982, ADV APPL MATH, V3, P43, DOI DOI 10.1016/S0196-8858(82)80004-3; GOLOBOFF PA, 1991, CLADISTICS, V7, P395, DOI 10.1111/j.1096-0031.1991.tb00046.x; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HENDY MD, 1982, MATH BIOSCI, V59, P277, DOI 10.1016/0025-5564(82)90027-X; Hillis D. M, 1991, ANAL DNA SEQUENCES, P278; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; HUELSENBECK JP, 1991, SYST ZOOL, V40, P257, DOI 10.2307/2992321; JUKES T H, 1969, P21; KALLERSJO M, 1992, CLADISTICS, V8, P275, DOI 10.1111/j.1096-0031.1992.tb00071.x; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lehmann EL, 1999, ELEMENTS OF LARGE SA; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P1; LEQUESNE WJ, 1989, CLADISTICS, V5, P395, DOI 10.1111/j.1096-0031.1989.tb00571.x; Rice K., 1997, Computing and Combinatorics. Third Annual International Conference COCOON '97 Proceedings, P124, DOI 10.1007/BFb0045079; ROHLF FJ, 1983, B MATH BIOL, V45, P33, DOI 10.1016/S0092-8240(83)80039-1; Schoniger M, 1995, SYST BIOL, V44, P533, DOI 10.2307/2413659; Slowinski JB, 1998, CLADISTICS, V14, P297, DOI 10.1111/j.1096-0031.1998.tb00340.x; Steel M, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P125; Steel M, 2001, SIAM J DISCRETE MATH, V14, P36, DOI 10.1137/S0895480198343571; Steel M.A., 2006, PARSIMONY PHYLOGENY, P163; Tehrani J.J., 2015, DIGITAL SCHOLARSHIP; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Zhu S, 2013, MATH BIOSCI, V243, P109, DOI 10.1016/j.mbs.2013.02.003	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152656	10.1371/journal.pone.0152656	http://dx.doi.org/10.1371/journal.pone.0152656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035667	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200027
J	Bolanca, I; Obhodas, J; Ljiljak, D; Matjacic, L; Kuna, K				Bolanca, Ivan; Obhodas, Jasmina; Ljiljak, Dejan; Matjacic, Lidija; Kuna, Krunoslav			Synergetic Effects of K, Ca, Cu and Zn in Human Semen in Relation to Parameters Indicative of Spontaneous Hyperactivation of Spermatozoa	PLOS ONE			English	Article							SPERM HYPERACTIVATION; CATSPER CHANNELS; MAMMALIAN SPERM; CALCIUM; ZINC; MAGNESIUM; PH	We have observed that sperm quality parameters indicative of spermatozoa hyperactivation such are lower "linearity" and "straightness", and as showed by this research "elongation", were more pronounced in patients with normal spermiogram compared to the group of men with reduced sperm motility who were undergoing routine in vitro fertilisation. The research encompassed 97 men diagnosed with normozoospermia (n = 20), asthenozoospermia (n = 54) and oligoasthenozoospermia (n = 23). The findings indicate that sperm quality of patients with normal spermiogram diagnosed according to WHO criteria, may be compromised by showing premature spontaneous hyperactivation which can decrease the chances of natural conception. We assessed synergistic effects of multiple chemical elements in ejaculated semen to find if premature spontaneous hyperactivation of spermatozoa can be a sign of imbalanced semen composition especially of elements K, Ca, Cu and Zn. Human semen samples showing low or high baseline status of chemical elements concentrations were found in samples from all three diagnostic groups. However, correlation of K/Ca and Cu/Zn ratios, taking into account samples from all three groups of men, were negative at statistical significance level p = 0.01. We tested if the negative correlation between K/Ca and Cu/Zn ratio works for greater number of semen samples. We found the negative correlation to be valid for 175 semen samples at statistical significance of p = 0.00002. The ratio of K/Ca and Cu/Zn, i.e. increased concentrations of K and Zn in comparison to concentrations of Ca and Cu, were associated with a decrease of "straightness" in the group of men with normal spermiogram and pronounced spontaneous hyperactivation of spermatozoa, implying that these elements act in synergy and that the balance of elements and not their absolute concentrations plays the major role in premature spermatozoa hyperactivation in ejaculated semen.	[Bolanca, Ivan; Ljiljak, Dejan; Kuna, Krunoslav] Univ Hosp Ctr Sestre Milosrdnice, Dept Obstet & Gynecol, Vinogradska C 29, Zagreb 10000, Croatia; [Obhodas, Jasmina; Matjacic, Lidija] Rudjer Boskovic Inst, Bijenicka C 54, Zagreb 10000, Croatia	Rudjer Boskovic Institute	Obhodas, J (corresponding author), Rudjer Boskovic Inst, Bijenicka C 54, Zagreb 10000, Croatia.	jobhodas@irb.hr		Matjacic, Lidija/0000-0003-4765-2877	Croatian Ministry of Science, Education and Sports project (MZOS) [098-0362975-2881]	Croatian Ministry of Science, Education and Sports project (MZOS)	This work was supported by the Croatian Ministry of Science, Education and Sports project (MZOS) grant No.098-0362975-2881 (http://zprojekti.mzos.hr/page.aspx?pid=96&lid=1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2015, ASIAN J ANDROL, V17, P633, DOI 10.4103/1008-682X.153850; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; Beltran C, 2014, DEV BIOL, V394, P15, DOI 10.1016/j.ydbio.2014.07.017; Bjorndahl L, 2010, MOL HUM REPROD, V16, P23, DOI 10.1093/molehr/gap099; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Coomes RK, 1968, SELECTIVE UPTAKE 90Y, P146; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; DELAMIRANDE E, 1993, FERTIL STERIL, V59, P1291; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Gavella M, 1998, DIABETOLOGIA CROATIC, P27; Horovitz CT, 2000, BIOCH ELEMENTS B, V13, P324; HUACUJA L, 1973, LIFE SCI, V13, P1383, DOI 10.1016/0024-3205(73)90159-8; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Kirichok Y, 2011, MOL HUM REPROD, V17, P478, DOI 10.1093/molehr/gar044; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Marzec-Wroblewska U, 2011, BIOL TRACE ELEM RES, V143, P167, DOI 10.1007/s12011-010-8868-x; Mortimer ST, 2015, ASIAN J ANDROL, V17, P545, DOI 10.4103/1008-682X.154312; Mortimer ST, 2000, J ANDROL, V21, P515; ORGEBINCRIST MC, 1971, ANN BIOL ANIM BIOCH, V11, P547, DOI 10.1051/rnd:19710403; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Perez-Cerezales S, 2015, ASIAN J ANDROL, V17, P628, DOI 10.4103/1008-682X.154308; QUINN PJ, 1968, J REPROD FERTIL, V17, P35, DOI 10.1530/jrf.0.0170035; Sasaki H, 2005, PHOTODERMATOL PHOTO, V21, P9, DOI 10.1111/j.1600-0781.2005.00117.x; Singh H. P., 1998, Indian Journal of Physiology and Pharmacology, V42, P311; Snell RS, 2000, STRUCTURES ANTERIOR, P153; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SUAREZ SS, 1987, J EXP ZOOL, V244, P331, DOI 10.1002/jez.1402440218; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; World Health Organization, 2010, LAB MAN EX PROC HUM; Wroblewski N, 2003, FERTIL STERIL, V79, P1584, DOI 10.1016/S0015-0282(03)00255-3	33	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152445	10.1371/journal.pone.0152445	http://dx.doi.org/10.1371/journal.pone.0152445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031102	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800073
J	de Vries, JD; van Hooff, MLM; Geurts, SAE; Kompier, MAJ				de Vries, Juriena D.; van Hooff, Madelon L. M.; Geurts, Sabine A. E.; Kompier, Michiel A. J.			Exercise as an Intervention to Reduce Study-Related Fatigue among University Students: A Two-Arm Parallel Randomized Controlled Trial	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXECUTIVE FUNCTIONS; LEISURE-TIME; BURNOUT; SLEEP; PERFORMANCE; HEALTH; ADULTS; METHODOLOGY; EXHAUSTION	Background Many university students experience high levels of study-related fatigue. This high prevalence, and the negative impact of fatigue on health and academic performance, call for prevention and reduction of these symptoms. The primary aim of the current study was to investigate to what extent an exercise intervention is effective in reducing three indicators of study-related fatigue (emotional exhaustion, overall fatigue, and need for recovery). Effects of exercise on secondary outcomes (sleep quality, self-efficacy, physical fitness, and cognitive functioning) were also investigated. Methods Participants were students with high levels of study-related fatigue, currently not exercising or receiving other psychological or pharmacological treatments, and with no medical cause of fatigue. They were randomly assigned to either a six-week exercise intervention (low-intensity running three times a week, n = 49) or wait list (no intervention, n = 48). All participants were measured before the intervention (T0), and immediately after the intervention (T1). Exercisers were also investigated 4 weeks (T2) and 12 weeks (T3) after the intervention. Results Participants in the exercise condition showed a larger decrease in two of the three indicators of study-related fatigue (i.e., overall fatigue and need for recovery) as compared to controls. Additionally, sleep quality and some indicators of cognitive functioning improved more among exercisers than among controls. No effects were found for self-efficacy, and physical fitness. The initial effects of the exercise intervention lasted at follow-up (T2 and T3). At 12-week follow up (T3), 80% of participants in the exercise condition still engaged in regular exercise, and further enhancements were seen for emotional exhaustion, overall fatigue, and sleep quality. Conclusions These results underline the value of low-intensity exercise for university students with high levels of study-related fatigue. The follow-up effects that were found in this study imply that the intervention has the potential to promote regular exercise and accompanying beneficial effects in the longer run.	[de Vries, Juriena D.; van Hooff, Madelon L. M.; Geurts, Sabine A. E.; Kompier, Michiel A. J.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	de Vries, JD (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	j.devries@psych.ru.nl	Geurts, Sabine/ABC-2479-2021	Geurts, Sabine/0000-0001-5125-5693				Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; Balogun JA, 1996, PERCEPT MOTOR SKILL, V83, P21, DOI 10.2466/pms.1996.83.1.21; Bernaards CM, 2006, OCCUP ENVIRON MED, V63, P10, DOI 10.1136/oem.2004.017541; Bodner ME, 2000, SPORTS MED, V30, P31, DOI 10.2165/00007256-200030010-00004; Bosquet L, 2002, SPORTS MED, V32, P675, DOI 10.2165/00007256-200232110-00002; Bosscher RJ, 1998, BEHAV RES THER, V36, P339, DOI 10.1016/S0005-7967(98)00025-4; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brooks Ka, 2013, J Nov Physiother, V3; Campos Juliana Alvares Duarte Bonini, 2012, Rev. bras. epidemiol., V15, P155, DOI 10.1590/S1415-790X2012000100014; Carson RL, 2010, J HEALTH PSYCHOL, V15, P905, DOI 10.1177/1359105309360697; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Conconi F, 1996, INT J SPORTS MED, V17, P509, DOI 10.1055/s-2007-972887; Craft LL, 2005, PSYCHOL SPORT EXERC, V6, P151, DOI 10.1016/j.psychsport.2003.11.003; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; De Vries J, 2004, BRIT J HEALTH PSYCH, V9, P279; Deligkaris P, 2014, WORK STRESS, V28, P107, DOI 10.1080/02678373.2014.909545; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Ekstedt M, 2006, SCAND J WORK ENV HEA, V32, P121, DOI 10.5271/sjweh.987; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gerber Markus, 2013, BMC Res Notes, V6, P78, DOI 10.1186/1756-0500-6-78; Geurts S., 2014, BRIDGING OCCUPATIONA, P193, DOI DOI 10.1007/978-94-007-5640-3_12; Geurts SAE, 2006, SCAND J WORK ENV HEA, V32, P482, DOI 10.5271/sjweh.1053; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hockey R., 2013, PSYCHOL FATIGUE WORK; Hreljac A, 2004, MED SCI SPORT EXER, V36, P845, DOI 10.1249/01.MSS.0000126803.66636.DD; IBM Corp, 2010, IBM SPSS STAT WIND V; Jackson EM, 2006, PSYCHOPHYSIOLOGY, V43, P57, DOI 10.1111/j.1469-8986.2006.00373.x; Jacobs S.R., 2003, J COLL STUDENT DEV, V44, P291, DOI [DOI 10.1353/CSD.2003.0028, 10.1353/csd.2003.0028]; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jonsdottir IH, 2010, PREV MED, V51, P373, DOI 10.1016/j.ypmed.2010.07.019; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Larun L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub3; Law DW, 2007, J AM COLL HEALTH, V55, P239, DOI 10.3200/JACH.55.4.239-245; Lindheimer JB, 2015, SPORTS MED, V45, P693, DOI 10.1007/s40279-015-0303-1; Lingard H., 2007, J ED BUILT ENV, V2, P90, DOI [10.11120/jebe.2007.02010090, DOI 10.11120/JEBE.2007.02010090]; Loy BD, 2013, FATIGUE, V1, P223, DOI 10.1080/21641846.2013.843266; Mailey EL, 2010, PSYCHOL HEALTH MED, V15, P646, DOI 10.1080/13548506.2010.498894; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C.J.S., 1997, MASLACH BURNOUT INVE, V3rd; McAuley E, 2013, ROUTLEDGE HDB PHYS A, P224; Meijman T.F., 1994, METEN PSYCHOSOCIALE; Meijman TF, 1992, HDB A O PSYCHOL; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Mohr DC, 2009, PSYCHOTHER PSYCHOSOM, V78, P275, DOI 10.1159/000228248; Oosterholt BG, 2015, J PSYCHOSOM RES, V78, P445, DOI 10.1016/j.jpsychores.2014.11.003; Oosterholt BG, 2014, STRESS, V17, P400, DOI 10.3109/10253890.2014.949668; Oosterholt BG, 2012, SCAND J WORK ENV HEA, V38, P358, DOI 10.5271/sjweh.3256; Otto M.W., 2011, EXERCISE MOOD ANXIET; Pagnin D, 2014, ACAD PSYCHIATR, V38, P438, DOI 10.1007/s40596-014-0093-z; Persinger R, 2004, MED SCI SPORT EXER, V36, P1632, DOI 10.1249/01.MSS.0000074690.03001.98; Poljac E, 2010, Q J EXP PSYCHOL, V63, P401, DOI 10.1080/17470210902990803; Puetz TW, 2008, PSYCHOTHER PSYCHOSOM, V77, P167, DOI 10.1159/000116610; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rook JW, 2006, EUR J WORK ORGAN PSY, V15, P218, DOI 10.1080/13594320500513962; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schaufeli W. B., 2001, PSYCHOLOOG, V36, P9, DOI DOI 10.1037/T05561-000; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schmidt E, 2015, PSYCHOL KLACHTEN OND; Shoji K, 2015, ANXIETY STRESS COPIN, V14, P1, DOI DOI 10.1080/10615806.2015.1058369; Sibbald B, 1998, BRIT MED J, V316, P201; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sonnentag S, 2012, CURR DIR PSYCHOL SCI, V21, P114, DOI 10.1177/0963721411434979; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; van Veldhoven M, 2003, OCCUP ENVIRON MED, V60, P3; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Vossensteyn Hans, 2013, INT EXPERIENCES STUD; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004	76	28	28	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152137	10.1371/journal.pone.0152137	http://dx.doi.org/10.1371/journal.pone.0152137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031610	Green Published, gold			2022-12-27	WOS:000373121800037
J	Goncalves, F; de Moraes, MS; Ferreira, LB; Carreira, ACO; Kossugue, PM; Boaro, LCC; Bentini, R; Garcia, CRD; Sogayar, MC; Arana-Chavez, VE; Catalani, LH				Goncalves, Flavia; de Moraes, Miriam Santos; Ferreira, Lorraine Braga; Oliveira Carreira, Ana Claudia; Kossugue, Patricia Mayumi; Cidreira Boaro, Leticia Cristina; Bentini, Ricardo; da Silva Garcia, Celia Regina; Sogayar, Mari Cleide; Arana-Chavez, Victor Elias; Catalani, Luiz Henrique			Combination of Bioactive Polymeric Membranes and Stem Cells for Periodontal Regeneration: In Vitro and In Vivo Analyses	PLOS ONE			English	Article							GUIDED TISSUE REGENERATION; BONE MORPHOGENETIC PROTEIN-7; OSTEOBLASTIC DIFFERENTIATION; MECHANICAL-PROPERTIES; BARRIER MEMBRANES; GENE-EXPRESSION; GROWTH-FACTOR; SCAFFOLDS; DEFECTS; INFILTRATION	Regeneration of periodontal tissues requires a concerted effort to obtain consistent and predictable results in vivo. The aim of the present study was to test a new family of bioactive polymeric membranes in combination with stem cell therapy for periodontal regeneration. In particular, the novel polyester poly(isosorbide succinate-co-L-lactide) (PisPLLA) was compared with poly(L-lactide) (PLLA). Both polymers were combined with collagen (COL), hydroxyapatite (HA) and the growth factor bone morphogenetic protein-7 (BMP7), and their osteoinductive capacity was evaluated via in vitro and in vivo experiments. Membranes composed of PLLA/COL/HA or PisPLLA/COL/HA were able to promote periodontal regeneration and new bone formation in fenestration defects in rat jaws. According to quantitative real-time polymerase chain reaction (qRT-PCR) and Alizarin Red assays, better osteoconductive capacity and increased extracellular mineralization were observed for PLLA/COL/HA, whereas better osteoinductive properties were associated with PisPLLA/COL/HA. We concluded that membranes composed of either PisPLLA/COL/HA or PLLA/COL/HA present promising results in vitro as well as in vivo and that these materials could be potentially applied in periodontal regeneration.	[Goncalves, Flavia; Bentini, Ricardo; Catalani, Luiz Henrique] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508000 Sao Paulo, SP, Brazil; [de Moraes, Miriam Santos; da Silva Garcia, Celia Regina] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508090 Sao Paulo, SP, Brazil; [Ferreira, Lorraine Braga; Cidreira Boaro, Leticia Cristina; Arana-Chavez, Victor Elias] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508000 Sao Paulo, SP, Brazil; [Oliveira Carreira, Ana Claudia; Kossugue, Patricia Mayumi; Sogayar, Mari Cleide] Univ Sao Paulo, Fac Med, NUCEL NETCEM Nucleo Terapia Celular & Mol, BR-05360130 Sao Paulo, SP, Brazil; [Sogayar, Mari Cleide] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Catalani, LH (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-05508000 Sao Paulo, SP, Brazil.	catalani@usp.br	Carreira, Ana Claudia Oliveira/B-7655-2012; Sogayar, Mari C/B-3980-2017; Gonçalves, Flavia/T-7159-2019; Boaro, Leticia CC/C-3167-2015; Goncalves, Flavia/ABJ-9410-2022; Catalani, Luiz Henrique/E-2841-2010; Goncalves, Flavia/L-6881-2015; Garcia, Celia R. S./A-4093-2011; Carreira, Ana Claudia Oliveira/AAR-4474-2021	Carreira, Ana Claudia Oliveira/0000-0002-9142-1155; Sogayar, Mari C/0000-0003-4805-4609; Gonçalves, Flavia/0000-0002-7202-7849; Boaro, Leticia CC/0000-0002-6687-585X; Catalani, Luiz Henrique/0000-0003-3689-1792; Goncalves, Flavia/0000-0002-7202-7849; Garcia, Celia R. S./0000-0003-2825-1701; Carreira, Ana Claudia Oliveira/0000-0002-9142-1155	CNPq; FAPESP [2010/17698-2, 2011/21442-6, 2011/51295-5]; BNDES; FAPESP; FINEP; MCTI; MS-DECIT	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); BNDES; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); MCTI; MS-DECIT	The authors FG, RB and LHC would like to thank CNPq and FAPESP (2010/17698-2 and 2011/21442-6) for funding. Additionally, MM and CRSG acknowledge funding from CNPq and FAPESP (2011/51295-5), and ACOC, PMK and MCS acknowledge funding from BNDES, CNPq, FAPESP, FINEP, MCTI and MS-DECIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI 10.1902/jop.2008.060521 ; Alfotawei R, 2014, J CRANIO MAXILL SURG, V42, P863, DOI 10.1016/j.jcms.2013.12.006; Alpar B, 2000, Clin Oral Investig, V4, P219, DOI 10.1007/s007840000079; Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; Behfarnia Parichehr, 2012, Dent Res J (Isfahan), V9, P574; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V231, P442, DOI 10.1006/bbrc.1997.6116; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022; Burrows MC, 2012, MACROMOL BIOSCI, V12, P1660, DOI 10.1002/mabi.201200154; Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0; Campos DM, 2014, BIORESEARCH OPEN ACC, V3, P117, DOI 10.1089/biores.2014.0015; Casarano R, 2009, POLYMER, V50, P6218, DOI 10.1016/j.polymer.2009.10.048; Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]; Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7; Costa PF, 2014, J CLIN PERIODONTOL, V41, P283, DOI 10.1111/jcpe.12214; Darby I, 2011, AUST DENT J, V56, P107, DOI 10.1111/j.1834-7819.2010.01301.x; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Goncalves F, 2015, MATERIALS, V8, P408, DOI 10.3390/ma8020408; Hong JK, 2011, TISSUE ENG PART B-RE, V17, P125, DOI [10.1089/ten.teb.2010.0552, 10.1089/ten.TEB.2010.0552]; Huang KK, 2005, J PERIODONTAL RES, V40, P1, DOI 10.1111/j.1600-0765.2004.00752.x; Hunter KT, 2013, J BIOMED MATER RES A, V101, P1016, DOI 10.1002/jbm.a.34396; Imbronito AV, 2002, BIOMATERIALS, V23, P4079, DOI 10.1016/S0142-9612(02)00145-X; Kim JH, 2014, J DENT RES; King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801; Lee CH, 2014, TISSUE ENG PT A, V20, P1342, DOI [10.1089/ten.tea.2013.0386, 10.1089/ten.TEA.2013.0386]; Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208; Li JH, 2011, CHINESE MED J-PEKING, V124, P4022, DOI 10.3760/cma.j.issn.0366-6999.2011.23.033; Liu TM, 2013, TISSUE ENG PART B-RE, V19, P254, DOI [10.1089/ten.TEB.2012.0527, 10.1089/ten.teb.2012.0527]; Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mitchell A, 2014, J BIOMED MATER RES A, V102, P655, DOI 10.1002/jbm.a.34728; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x; Needleman IG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001724.pub2; Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402; Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011; Ni PY, 2011, INT J NANOMED, V6, P3065, DOI 10.2147/IJN.S25297; Nygaard-Ostby P, 2010, J CLIN PERIODONTOL, V37, P366, DOI 10.1111/j.1600-051X.2010.01532.x; Piattelli A, 1996, BIOMATERIALS, V17, P791, DOI 10.1016/0142-9612(96)81416-5; Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007; Rakhmatia YD, 2013, J PROSTHODONT RES, V57, P3, DOI 10.1016/j.jpor.2012.12.001; Reis ECC, 2011, BIOMATERIALS, V32, P9244, DOI 10.1016/j.biomaterials.2011.08.040; Requicha JF, 2014, TISSUE ENG PT A, V20, P2483, DOI [10.1089/ten.tea.2013.0360, 10.1089/ten.TEA.2013.0360]; Sanz M, 2000, PERIODONTOL 2000, V22, P169, DOI 10.1034/j.1600-0757.2000.2220111.x; Schofer MD, 2009, THESCIENTIFICWORLDJO, V9, P118, DOI 10.1100/tsw.2009.13; Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Torricelli P, 2014, MAT SCI ENG C-MATER, V36, P130, DOI 10.1016/j.msec.2013.11.050; Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; Yang C, 2013, J PERIODONTAL IMPLAN, V43, P315, DOI 10.5051/jpis.2013.43.6.315; Zeng J, 2004, MACROMOL BIOSCI, V4, P1118, DOI 10.1002/mabi.200400092; Zohar R, 1997, J CELL PHYSIOL, V170, P88	55	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152412	10.1371/journal.pone.0152412	http://dx.doi.org/10.1371/journal.pone.0152412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031990	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800070
J	Janoff-Bulman, R; Carnes, NC				Janoff-Bulman, Ronnie; Carnes, Nate C.			Social Justice and Social Order: Binding Moralities across the Political Spectrum	PLOS ONE			English	Article							CONSERVATIVES; CONSEQUENCES; ORIENTATIONS; PERSONALITY; LIBERALISM; STRENGTH; CULTURES; MOTIVES	Two studies explored the relationship between political ideology and endorsement of a range of moral principles. Political liberals and conservatives did not differ on intrapersonal or interpersonal moralities, which require self-regulation. However differences emerged on collective moralities, which involve social regulation. Contrary to Moral Foundations Theory, both liberals and conservatives endorsed a group-focused binding morality, specifically Social Justice and Social Order respectively. Libertarians were the group without a binding morality. Although Social Justice and Social Order appear conflictual, analyses based on earlier cross-cultural work on societal tightness-looseness suggest that countries actually benefit in terms of economic success and societal well-being when these group-based moralities co-exist and serve as counterweights in social regulation.	[Janoff-Bulman, Ronnie; Carnes, Nate C.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Janoff-Bulman, R (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA.	janbul@psych.umass.edu			NSF [BCS-1053139, DGE-0907995]	NSF(National Science Foundation (NSF))	This research was supported by NSF Grant BCS-1053139 to Ronnie Janoff-Bulman and NSF Grant DGE-0907995 to Nate C. Carnes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Brickman P., 1981, JUSTICE MOTIVE SOCIA, P173, DOI DOI 10.1007/978-1-4899-0429-4_9; Carnes N, 2012, PSYCHOL INQ, V23, P137, DOI 10.1080/1047840X.2012.667768; Carnes NC, 2014, PERSONALITY SOCIAL P, V41, P351; Carnes NC, GROUP MORALITY UNPUB; Cohen R.L., 1987, SOC JUST RES, V1, P19, DOI [10.1007/BF01049382, DOI 10.1007/BF01049382]; DeWaal Frans B. M., 1996, GOOD NATURED ORIGINS; Fraley RC, 2012, PSYCHOL SCI, V23, P1425, DOI 10.1177/0956797612440102; Gelfand MJ, 2012, CURR DIR PSYCHOL SCI, V21, P420, DOI 10.1177/0963721412460048; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, PERS SOC PSYCHOL REV, V17, P237, DOI 10.1177/1088868313492020; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Haidt J., 2010, HDB SOCIAL PSYCHOL, P797, DOI DOI 10.1002/9780470561119.SOCPSY002022; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; HAIDT J, 2004, DAEDALUS         FAL, P55; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Haidt Jonathan., 2007, INNATE MIND, V3, P367, DOI DOI 10.1093/ACPROF:OSO/9780195332834.001.0001; Helliwell John, 2015, WORLD HAPPINESS REPO; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Hofmann W, 2014, SCIENCE, V345, P1340, DOI 10.1126/science.1251560; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Janoff-Bulman R., 2014, J SOCIAL POLITICAL P, V2, P43, DOI [10.5964/jspp.v2i1.243, DOI 10.5964/JSPP.V2I1.243]; Janoff-Bulman R, 2013, PERS SOC PSYCHOL REV, V17, P219, DOI 10.1177/1088868313480274; Janoff-Bulman R, 2013, PERS SOC PSYCHOL REV, V17, P242, DOI 10.1177/1088868313492021; Janoff-Bulman R, 2009, PSYCHOL INQ, V20, P120, DOI 10.1080/10478400903028581; Janoff-Bulman R, 2009, J PERS SOC PSYCHOL, V96, P521, DOI 10.1037/a0013779; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Kron Josh, 2012, ATLANTIC; Lavine H, 1999, PERS SOC PSYCHOL B, V25, P337, DOI 10.1177/0146167299025003006; Marsh HW, 1994, STRUCT EQU MODELING, V1, P5, DOI 10.1080/10705519409539960; McAdams DP, 2008, J PERS SOC PSYCHOL, V95, P978, DOI 10.1037/a0012650; McCrae RR, 1996, PSYCHOL BULL, V120, P323, DOI 10.1037/0033-2909.120.3.323; Neuberg SL, 2008, GROUP DYN-THEOR RES, V12, P63, DOI 10.1037/1089-2699.12.1.63; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Parker MT, 2013, SOC JUSTICE RES, V26, P81, DOI 10.1007/s11211-012-0175-6; Rai TS, 2011, PSYCHOL REV, V118, P57, DOI 10.1037/a0021867; Rock MS, 2010, SOC PSYCHOL PERS SCI, V1, P26, DOI 10.1177/1948550609347386; Sheikh S, 2013, J PERS SOC PSYCHOL, V105, P301, DOI 10.1037/a0032278; Shook NJ, 2009, J EXP SOC PSYCHOL, V45, P995, DOI 10.1016/j.jesp.2009.04.003; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; The World Bank, 2015, GDP PER CAP CURR US; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; Wenzel M., 2004, EUROPEAN REV SOCIAL, V15, P219, DOI [DOI 10.1080/10463280440000035, 10.1080/10463280440000035]; World Economic Forum, 2014, OV COMP RANK	52	21	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152479	10.1371/journal.pone.0152479	http://dx.doi.org/10.1371/journal.pone.0152479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031103	Green Published, gold			2022-12-27	WOS:000373121800083
J	Mahoney, S; Najera, M; Bai, Q; Burton, EA; Veser, G				Mahoney, Sharlee; Najera, Michelle; Bai, Qing; Burton, Edward A.; Veser, Goetz			The Developmental Toxicity of Complex Silica-Embedded Nickel Nanoparticles Is Determined by Their Physicochemical Properties	PLOS ONE			English	Article							DANIO-RERIO; SILVER NANOPARTICLES; LARVAL BEHAVIOR; IN-VITRO; ZEBRAFISH; EXPOSURE; CHLORPYRIFOS; CYTOTOXICITY; SIZE; COPPER	Complex engineered nanomaterials (CENs) are a rapidly developing class of structurally and compositionally complex materials that are expected to dominate the next generation of functional nanomaterials. The development of methods enabling rapid assessment of the toxicity risk associated with this type of nanomaterial is therefore critically important. We evaluated the toxicity of three differently structured nickel-silica nanomaterials as prototypical CENs: simple, surface-deposited Ni-SiO2 and hollow and non-hollow core-shell Ni@SiO2 materials (i.e., similar to 1-2 nm Ni nanoparticles embedded into porous silica shells with and without a central cavity, respectively). Zebrafish embryos were exposed to these CENs, and morphological (survival and malformations) and physiological (larval motility) endpoints were coupled with thorough characterization of physiochemical characteristics (including agglomeration, settling and nickel ion dissolution) to determine how toxicity differed between these CENs and equivalent quantities of Ni2+ salt (based on total Ni). Exposure to Ni2+ ions strongly compromised zebrafish larva viability, and surviving larvae showed severe malformations. In contrast, exposure to the equivalent amount of Ni CEN did not result in these abnormalities. Interestingly, exposure to Ni-SiO2 and hollow Ni@SiO2 provoked abnormalities of zebrafish larval motor function, indicating developmental toxicity, while non-hollow Ni@SiO2 showed no toxicity. Correlating these observations with physicochemical characterization of the CENs suggests that the toxicity of the Ni-SiO2 and hollow Ni@SiO2 material may result partly from an increased effective exposure at the bottom of the well due to rapid settling. Overall, our data suggest that embedding nickel NPs in a porous silica matrix may be a straightforward way to mitigate their toxicity without compromising their functional properties. At the same time, our results also indicate that it is critical to consider modification of the effective exposure when comparing different nanomaterial configurations, because effective exposure might influence NP toxicity more than specific "nano-chemistry" effects.	[Mahoney, Sharlee; Najera, Michelle; Veser, Goetz] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Najera, Michelle; Veser, Goetz] Univ Pittsburgh, Mascaro Ctr Sustainable Innovat, Pittsburgh, PA USA; [Bai, Qing; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Burton, Edward A.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Veser, G (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.; Veser, G (corresponding author), Univ Pittsburgh, Mascaro Ctr Sustainable Innovat, Pittsburgh, PA USA.	gveser@pitt.edu	Burton, Edward/AAO-9677-2021; Burton, Edward/ABB-1324-2021; Veser, Goetz/I-5727-2013	Burton, Edward/0000-0002-8072-4636; Veser, Goetz/0000-0002-2084-4636	National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award [1236258]; U.S. Department of Education Graduate Assistance in Areas of National Need fellowship [P200A060149]; National Science Foundation Integrative Graduate Education and Research Traineeship Program [DGE0504645]; Directorate For Engineering [1236258] Funding Source: National Science Foundation	National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award; U.S. Department of Education Graduate Assistance in Areas of National Need fellowship(US Department of Education); National Science Foundation Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by National Science Foundation-Chemical, Bioengineering, Environmental and Transport systems award #1236258 (EB, GV; http://www.nsf.gov/div/index.jsp?div=cbet), U.S. Department of Education Graduate Assistance in Areas of National Need fellowship (P200A060149) (GV; http://www2.ed.gov/programs/gaann/index.html), and National Science Foundation Integrative Graduate Education and Research Traineeship Program DGE0504645 (GV; https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada K, 2010, FOLIA HISTOCHEM CYTO, V48, P524, DOI 10.2478/v10042-010-0045-8; ALEXANDER GB, 1954, J PHYS CHEM-US, V58, P453, DOI 10.1021/j150516a002; Alsop D, 2014, COMP BIOCHEM PHYS C, V165, P67, DOI 10.1016/j.cbpc.2014.05.001; [Anonymous], 2000, D85900 ASTM; Association NPER, 2013, NAT TOX PROGR PROP L; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; Baganz D, 1998, WATER RES, V32, P948, DOI 10.1016/S0043-1354(97)00207-8; Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Bar-Ilan O, 2012, NANOTOXICOLOGY, V6, P670, DOI 10.3109/17435390.2011.604438; Bhavsar S, 2014, CATAL TODAY, V228, P96, DOI 10.1016/j.cattod.2013.12.025; Borgmann U, 2001, ENVIRON POLLUT, V111, P189, DOI 10.1016/S0269-7491(00)00076-2; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Boudjahem AG, 2004, J CATAL, V221, P325, DOI 10.1016/j.jcat.2003.08.002; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; Cao A, 2010, PHYS CHEM CHEM PHYS, V12, P13499, DOI 10.1039/c0cp00729c; Cario CL, 2011, J PHYSIOL-LONDON, V589, P3703, DOI 10.1113/jphysiol.2011.207308; Couto GG, 2007, J COLLOID INTERF SCI, V311, P461, DOI 10.1016/j.jcis.2007.03.045; Das KK, 2008, INDIAN J MED RES, V128, P412; DAVE G, 1991, ARCH ENVIRON CON TOX, V21, P126, DOI 10.1007/BF01055567; Deng XY, 2004, MATER LETT, V58, P276, DOI 10.1016/S0167-577X(03)00469-5; Duan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074606; Duan JC, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1700-8; Duan JC, 2013, BIOMATERIALS, V34, P5853, DOI 10.1016/j.biomaterials.2013.04.032; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Farrell TC, 2011, NEUROBIOL DIS, V44, P9, DOI 10.1016/j.nbd.2011.05.016; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Group TW, IMPORTANCE NICKEL CO; He MD, 2011, TOXICOL APPL PHARM, V253, P38, DOI 10.1016/j.taap.2011.03.008; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Ispas C, 2009, ENVIRON SCI TECHNOL, V43, P6349, DOI 10.1021/es9010543; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jin P, 2004, J PHYS CHEM B, V108, P6311, DOI 10.1021/jp049754g; Johnson A, 2007, AQUAT TOXICOL, V84, P431, DOI 10.1016/j.aquatox.2007.07.003; Kienle C, 2009, ECOTOX ENVIRON SAFE, V72, P1740, DOI 10.1016/j.ecoenv.2009.04.014; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirchhoff M, 2005, NANOTECHNOLOGY, V16, pS401, DOI 10.1088/0957-4484/16/7/014; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Leite ER, 2002, J NANOSCI NANOTECHNO, V2, P89, DOI 10.1166/jnn.2002.070; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P719, DOI 10.1016/j.ntt.2004.06.013; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t; Lin SJ, 2013, SMALL, V9, P1608, DOI 10.1002/smll.201202115; Lin SJ, 2011, ACS NANO, V5, P7284, DOI 10.1021/nn202116p; Metin O, 2010, J AM CHEM SOC, V132, P1468, DOI 10.1021/ja909243z; Napierska D, 2012, CHEM RES TOXICOL, V25, P828, DOI 10.1021/tx200361v; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Nusslein-Volhard C, 2002, ZEBRAFISH; Oberdorster C, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-8; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Orger MB, 2009, ESSENTIAL ZEBRAFISH, P113; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Park J, 2005, MONODISPERSE NANOPAR; PETERSON RE, 1993, CRIT REV TOXICOL, V23, P283, DOI 10.3109/10408449309105013; Powers CM, 2011, NEUROTOXICOL TERATOL, V33, P708, DOI 10.1016/j.ntt.2011.02.002; Powers CM, 2010, NEUROTOXICOL TERATOL, V32, P391, DOI 10.1016/j.ntt.2010.01.009; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P1888, DOI 10.1007/s12010-009-8726-5; Roco MC, 2011, SCI POL REP, V1, P1, DOI 10.1007/978-94-007-1168-6_1; Rostrup-Nielsen JR, 2002, ADV CATAL, V47, P65, DOI 10.1016/S0360-0564(02)47006-X; Scheil V, 2009, ARCH ENVIRON CON TOX, V56, P238, DOI 10.1007/s00244-008-9192-8; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Semisch A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-10; Shang Y, 2009, SCI CHINA SER B, V52, P1033, DOI 10.1007/s11426-009-0141-9; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165; Thomas JK, 2014, AQUAT TOXICOL, V152, P20, DOI 10.1016/j.aquatox.2014.03.022; Uzio D, 2010, CATAL REV, V52, P106, DOI 10.1080/01614940903510496; Warheit DB, 2008, TOXICOL SCI, V101, P183, DOI 10.1093/toxsci/kfm279; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xu SC, 2011, J PINEAL RES, V51, P426, DOI 10.1111/j.1600-079X.2011.00906.x; Yang SP, 2013, ENVIRON SCI TECHNOL, V47, P4718, DOI 10.1021/es3047334; Zhao JS, 2009, J ENVIRON PATHOL TOX, V28, P177, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i3.10; Zhou YZ, 2014, NAT PROTOC, V9, P1533, DOI 10.1038/nprot.2014.094; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu XF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/47/475303; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	84	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152010	10.1371/journal.pone.0152010	http://dx.doi.org/10.1371/journal.pone.0152010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031643	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000373121800027
J	McInroy, GR; Beraldi, D; Raiber, EA; Modrzynska, K; van Delft, P; Billker, O; Balasubramanian, S				McInroy, Gordon R.; Beraldi, Dario; Raiber, Eun-Ang; Modrzynska, Katarzyna; van Delft, Pieter; Billker, Oliver; Balasubramanian, Shankar			Enhanced Methylation Analysis by Recovery of Unsequenceable Fragments	PLOS ONE			English	Article							DNA-METHYLATION; PLASMODIUM-FALCIPARUM; SEQUENCING DATA; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; AMPLIFICATION; RESIDUES; DISPLAY; CANCER	Bisulfite sequencing is a valuable tool for mapping the position of 5-methylcytosine in the genome at single base resolution. However, the associated chemical treatment causes strand scission, which depletes the number of sequenceable DNA fragments in a library and thus necessitates PCR amplification. The AT-rich nature of the library generated from bisulfite treatment adversely affects this amplification, resulting in the introduction of major biases that can confound methylation analysis. Here, we report a method that enables more accurate methylation analysis, by rebuilding bisulfite-damaged components of a DNA library. This recovery after bisulfite treatment (ReBuilT) approach enables PCR-free bisulfite sequencing from low nanogram quantities of genomic DNA. We apply the ReBuilT method for the first whole methylome analysis of the highly AT-rich genome of Plasmodium berghei. Side-by-side comparison to a commercial protocol involving amplification demonstrates a substantial improvement in uniformity of coverage and reduction of sequence context bias. Our method will be widely applicable for quantitative methylation analysis, even for technically challenging genomes, and where limited sample DNA is available.	[McInroy, Gordon R.; Raiber, Eun-Ang; van Delft, Pieter; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, Cambs, England; [Beraldi, Dario; Balasubramanian, Shankar] Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, Cambs, England; [Modrzynska, Katarzyna; Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge, Cambs, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge, Cambs, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Wellcome Trust Sanger Institute; University of Cambridge	Balasubramanian, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, Cambs, England.; Balasubramanian, S (corresponding author), Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, Cambs, England.; Balasubramanian, S (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge, Cambs, England.	sb10031@cam.ac.uk	Balasubramanian, Shankar/C-1671-2009	Beraldi, Dario/0000-0003-1504-5212; Balasubramanian, Shankar/0000-0002-0281-5815; Billker, Oliver/0000-0003-1716-168X	Trinity College Cambridge; Wellcome Trust [099232/Z/12/Z]; Cancer Research UK; Cancer Research UK [19836] Funding Source: researchfish	Trinity College Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	GRM is supported by funding from Trinity College Cambridge and Herchel Smith. DB is supported by funding from the Wellcome Trust and Herchel Smith. EAR is a Herchel Smith Fellow. PVD is a Marie Curie Fellow of the European Union (FP7-PEOPLE-2013-IEF/624885). The Balasubramanian lab is supported by a Senior Investigator Award from the Wellcome Trust (099232/Z/12/Z to SB) and by core funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GRM is supported by funding from Trinity College Cambridge and Herchel Smith. DB is supported by funding from the Wellcome Trust and Herchel Smith. EAR is a Herchel Smith Fellow. PVD is a Marie Curie Fellow of the European Union (FP7-PEOPLE-2013-IEF/624885). The Balasubramanian lab is supported by a Senior Investigator Award from the Wellcome Trust (099232/Z/12/Z to S.B.) and by core funding from Cancer Research UK.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Doolan D. L., METHODS MOL MED, V72, P25; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Gupta AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003170; Hoeijmakers WAM, 2011, NAT PROTOC, V6, P1026, DOI 10.1038/nprot.2011.345; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ji LX, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00341; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Merrick CJ, 2010, EUKARYOT CELL, V9, P1150, DOI 10.1128/EC.00093-10; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Pedersen B. S., 2014, ARXIV14011129V2; Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; SANO H, 1982, P NATL ACAD SCI-BIOL, V79, P3584, DOI 10.1073/pnas.79.11.3584; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-59	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152322	10.1371/journal.pone.0152322	http://dx.doi.org/10.1371/journal.pone.0152322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031619	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000373121800057
J	Mynarova, A; Foitova, I; Kvac, M; Kvetonova, D; Rost, M; Morrogh-Bernard, H; Nurcahyo, W; Nguyen, C; Supriyadi, S; Sak, B				Mynarova, Anna; Foitova, Ivona; Kvac, Martin; Kvetonova, Dana; Rost, Michael; Morrogh-Bernard, Helen; Nurcahyo, Wisnu; Nguyen, Cathleen; Supriyadi, Supriyadi; Sak, Bohumil			Prevalence of Cryptosporidium spp., Enterocytozoon bieneusi, Encephalitozoon spp. and Giardia intestinalis in Wild, Semi-Wild and Captive Orangutans (Pongo abelii and Pongo pygmaeus) on Sumatra and Borneo, Indonesia	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA-BERINGEI; NONHUMAN-PRIMATES; INFECTED PATIENTS; GASTROINTESTINAL PARASITES; MOLECULAR CHARACTERIZATION; ZOONOTIC TRANSMISSION; RISK-FACTORS; DUODENALIS; IDENTIFICATION	Background Orangutans are critically endangered primarily due to loss and fragmentation of their natural habitat. This could bring them into closer contact with humans and increase the risk of zoonotic pathogen transmission. Aims To describe the prevalence and diversity of Cryptosporidium spp., microsporidia and Giardia intestinalis in orangutans at seven sites on Sumatra and Kalimantan, and to evaluate the impact of orangutans' habituation and location on the occurrence of these zoonotic protists. Result The overall prevalence of parasites in 298 examined animals was 11.1%. The most prevalent microsporidia was Encephalitozoon cuniculi genotype II, found in 21 animals (7.0%). Enterocytozoon bieneusi genotype D (n = 5) and novel genotype Pongo 2 were detected only in six individuals (2.0%). To the best of our knowledge, this is the first report of theseparasites in orangutans. Eight animals were positive for Cryptosporidium spp. (2.7%), including C. parvum (n = 2) and C. muris (n = 6). Giardia intestinalis assemblage B, subtype MB6, was identified in a single individual. While no significant differences between the different human contact level groups (p = 0.479-0.670) or between the different islands (p = 0.992) were reported in case of E. bieneusi or E. cuniculi, Cryptosporidium spp. was significantly less frequently detected in wild individuals (p < 2x10(-16)) and was significantly more prevalent in orangutans on Kalimantan than on Sumatra (p < 2x10(-16)). Conclusion Our results revealed that wild orangutans are significantly less frequently infected by Cryptosporidium spp. than captive and semi-wild animals. In addition, this parasite was more frequently detected at localities on Kalimantan. In contrast, we did not detect any significant difference in the prevalence of microsporidia between the studied groups of animals. The sources and transmission modes of infections were not determined, as this would require repeated sampling of individuals, examination of water sources, and sampling of humans and animals sharing the habitat with orangutans.	[Mynarova, Anna] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Mynarova, Anna; Kvac, Martin; Kvetonova, Dana; Sak, Bohumil] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Foitova, Ivona] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Kvac, Martin] Univ South Bohemia Ceske Budejovice, Fac Agr, Ceske Budejovice, Czech Republic; [Rost, Michael] Univ South Bohemia Ceske Budejovice, Fac Econ, Ceske Budejovice, Czech Republic; [Morrogh-Bernard, Helen] Outrop, Sabangau, Indonesia; [Nurcahyo, Wisnu] Gadjah Mada Univ, Fac Vet Med, Dept Parasitol, Yogyakarta, Indonesia; [Foitova, Ivona; Nguyen, Cathleen] UMI Saving Pongidae Fdn, Brno, Czech Republic; [Supriyadi, Supriyadi] Univ West Nusa Tenggara UNTB, Mataram, Indonesia	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Masaryk University Brno; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Gadjah Mada University	Sak, B (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.; Foitova, I (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic.; Foitova, I (corresponding author), UMI Saving Pongidae Fdn, Brno, Czech Republic.	foitova@sci.muni.cz; casio@paru.cas.cz	Kvac, Martin/G-7299-2014; Kvac, Martin/AAT-9533-2020; Supriadi, Supriadi/AAQ-5713-2020; Sak, Bohumil/G-9262-2014; Nurcahyo, Wisnu/R-6603-2019; Rost, Michael/Y-6857-2018	Kvac, Martin/0000-0003-0013-6090; Supriadi, Supriadi/0000-0002-0760-7871; Rost, Michael/0000-0002-4081-6392	Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan; Grant Agency of the Czech Republic [P505/11/1163]	Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	The study was financially supported by the Foundation "UMI - Saving of Pongidae" Parasites and Natural Antiparasitics in Orangutan, and by Grant Agency of the Czech Republic P505/11/1163.	AHMAD SR, 1995, WATER RES, V29, P1599, DOI 10.1016/0043-1354(94)00266-A; Al-Mekhlafi MSH, 2005, T ROY SOC TROP MED H, V99, P686, DOI 10.1016/j.trstmh.2005.02.006; Ananta SM, 2014, ASIAN PAC J TROP MED, V7, P197, DOI 10.1016/S1995-7645(14)60020-1; Anuar TS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071870, 10.1371/]; Asma L, 2011, TROP BIOMED, V28, P400; Boubli Jean Philippe, 2004, Ecotropica (Bonn), V10, P149; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Butel C, 2015, INT J PRIMATOL, V36, P227, DOI 10.1007/s10764-015-9820-x; Choy SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06909; da Silva AJ, 2003, VET PARASITOL, V111, P297, DOI 10.1016/S0304-4017(02)00384-9; Descovich KA, 2011, INT J PRIMATOL, V32, P616, DOI 10.1007/s10764-011-9491-1; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; Du SZ, 2015, KOREAN J PARASITOL, V53, P395, DOI 10.3347/kjp.2015.53.4.395; Farizawati S, 2005, Trop Biomed, V22, P89; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Foitova Ivona, 2009, P157; Galdikas BM, 2013, PRIMATES, V54, P61, DOI 10.1007/s10329-012-0331-5; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; GOMEZ MS, 1992, PARASITOL RES, V78, P619, DOI 10.1007/BF00936462; Gomez MS, 2000, PARASITOL RES, V86, P318, DOI 10.1007/s004360050049; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Hardus ME, 2012, BIOL CONSERV, V146, P177, DOI 10.1016/j.biocon.2011.12.014; Hasajova A, 2014, EUR J CLIN MICROBIOL, V33, P1401, DOI 10.1007/s10096-014-2082-2; HEUSCHELE WP, 1986, J WILDLIFE DIS, V22, P493, DOI 10.7589/0090-3558-22.4.493; Hope K, 2004, VET PARASITOL, V122, P165, DOI 10.1016/j.vetpar.2004.03.017; Husson Simon J., 2009, P77; ISEKI M, 1989, PARASITOL RES, V75, P218, DOI 10.1007/BF00931279; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Jones-Engel L, 2008, EMERG INFECT DIS, V14, P1200, DOI 10.3201/eid1408.071430; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Katsumata T, 1998, AM J TROP MED HYG, V59, P628, DOI 10.4269/ajtmh.1998.59.628; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Keita MB, 2014, MICROB PATHOGENESIS, V77, P149, DOI 10.1016/j.micpath.2014.09.003; Koehler AV, 2014, BIOTECHNOL ADV, V32, P280, DOI 10.1016/j.biotechadv.2013.10.009; Kurniawan A, 2013, ANN EPIDEMIOL, V23, P720, DOI 10.1016/j.annepidem.2013.07.019; Kvac M., 2014, CRYPTOSPORIDIUM PARA, P237, DOI DOI 10.1007/978-3-7091-1562-6_5; Labes EM, 2010, PARASITOLOGY, V137, P123, DOI 10.1017/S0031182009991120; Lai Karen P. F., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P578; Lalle M, 2005, J PARASITOL, V91, P203, DOI 10.1645/GE-293R; Langhout MV, 2010, J ZOO WILDLIFE MED, V41, P210, DOI 10.1638/2009-0051R1.1; Le Blancq SM, 1997, MOL BIOCHEM PARASIT, V90, P463, DOI 10.1016/S0166-6851(97)00181-3; Leelayoova S, 2006, J CLIN MICROBIOL, V44, P3001, DOI 10.1128/JCM.00945-06; Legesse M, 2004, ACTA TROP, V90, P231, DOI 10.1016/j.actatropica.2003.12.003; Lim YAL, 2008, VET PARASITOL, V157, P154, DOI 10.1016/j.vetpar.2008.07.015; Lim Y. A. L., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P801; Lim YAL, 2010, ADV PARASIT, V71, P1, DOI 10.1016/S0065-308X(10)71003-4; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Lono A, 2010, T ROY SOC TROP MED H, V104, P214, DOI 10.1016/j.trstmh.2009.07.006; Mahdy AKM, 2008, T ROY SOC TROP MED H, V102, P465, DOI 10.1016/j.trstmh.2008.02.004; MAJEWSKA AC, 1990, VET PARASITOL, V35, P169, DOI 10.1016/0304-4017(90)90127-W; Manduell KL, 2012, AM J PRIMATOL, V74, P1128, DOI 10.1002/ajp.22072; McEvoy JM, 2009, LETT APPL MICROBIOL, V48, P302, DOI 10.1111/j.1472-765X.2008.02516.x; Meamar AR, 2007, APPL ENVIRON MICROB, V73, P1033, DOI 10.1128/AEM.00964-06; Menon B. S., 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P319; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; MILLER RA, 1990, LAB ANIM SCI, V40, P42; MIRMANTO E, 2010, BIODIVERSITAS, V11, P82, DOI DOI 10.13057/biodiv/d110206; Mul IF, 2007, INT J PRIMATOL, V28, P407, DOI 10.1007/s10764-007-9119-7; Muriuki SMK, 1997, VET PARASITOL, V72, P141, DOI 10.1016/S0304-4017(97)00021-6; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Norhayati M, 2007, ANN TROP MED PARASIT, V101, P547, DOI 10.1179/136485907X193789; Pedraza-Diaz S, 2009, VET PARASITOL, V160, P204, DOI 10.1016/j.vetpar.2008.11.003; Raoult D, 2012, CLIN MICROBIOL INFEC, V18, P513, DOI 10.1111/j.1469-0691.2012.03810.x; RIJKSEN H D, 1978, Mededelingen Landbouwhogeschool Wageningen, V78, P1; RUSSELL RG, 1987, LAB ANIM SCI, V37, P309; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sak B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109751; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Soba B, 2006, CLIN MICROBIOL INFEC, V12, P918, DOI 10.1111/j.1469-0691.2006.01465.x; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; vanSchaik CP, 1995, NEGLECTED APE, P109; Meireles MV, 2007, VET PARASITOL, V147, P166, DOI 10.1016/j.vetpar.2007.03.034; Warren KS, 1998, J MED PRIMATOL, V27, P33, DOI 10.1111/j.1600-0684.1998.tb00066.x; Warren KS, 1999, J VIROL, V73, P7860, DOI 10.1128/JVI.73.9.7860-7865.1999; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wich SA, 2008, ORYX, V42, P620; Wilson HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102174; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	91	31	33	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152771	10.1371/journal.pone.0152771	http://dx.doi.org/10.1371/journal.pone.0152771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031241	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800134
J	Nah, G; Lee, M; Kim, DS; Rayburn, AL; Voigt, T; Lee, DK				Nah, Gyoungju; Lee, Moonsub; Kim, Do-Soon; Rayburn, A. Lane; Voigt, Thomas; Lee, D. K.			Transcriptome Analysis of Spartina pectinata in Response to Freezing Stress	PLOS ONE			English	Article							ABIOTIC STRESS; PRAIRIE CORDGRASS; ARABIDOPSIS-THALIANA; PHOSPHOLIPASE-C; COLD TOLERANCE; PLANT-RESPONSES; CIRCADIAN CLOCK; GENE-EXPRESSION; ORYZA-SATIVA; PROTEIN	Prairie cordgrass (Spartina pectinata), a perennial C-4 grass native to the North American prairie, has several distinctive characteristics that potentially make it a model crop for production in stressful environments. However, little is known about the transcriptome dynamics of prairie cordgrass despite its unique freezing stress tolerance. Therefore, the purpose of this work was to explore the transcriptome dynamics of prairie cordgrass in response to freezing stress at -5 degrees C for 5 min and 30 min. We used a RNA-sequencing method to assemble the S. pectinata leaf transcriptome and performed gene-expression profiling of the transcripts under freezing treatment. Six differentially expressed gene (DEG) groups were categorized from the profiling. In addition, two major consecutive orders of gene expression were observed in response to freezing; the first being the acute up-regulation of genes involved in plasma membrane modification, calcium-mediated signaling, proteasome-related proteins, and transcription regulators (e.g., MYB and WRKY). The follow-up and second response was of genes involved in encoding the putative anti-freezing protein and the previously known DNA and cell-damage-repair proteins. Moreover, we identified the genes involved in epigenetic regulation and circadian-clock expression. Our results indicate that freezing response in S. pectinata reflects dynamic changes in rapid-time duration, as well as in metabolic, transcriptional, post-translational, and epigenetic regulation.	[Nah, Gyoungju; Kim, Do-Soon; Lee, D. K.] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, 599 Gwanangno, Seoul 08826, South Korea; [Lee, Moonsub; Rayburn, A. Lane; Voigt, Thomas; Lee, D. K.] Univ Illinois, Dept Crop Sci, 1120 S Goodwin Ave, Urbana, IL 61801 USA	Seoul National University (SNU); University of Illinois System; University of Illinois Urbana-Champaign	Lee, DK (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Coll Agr & Life Sci, 599 Gwanangno, Seoul 08826, South Korea.; Lee, DK (corresponding author), Univ Illinois, Dept Crop Sci, 1120 S Goodwin Ave, Urbana, IL 61801 USA.	leedk@illinois.edu			Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST) [151S-4-3-1269]	Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST)	The work was supported by Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (KOFST), http://www.kofst.or.kr/main.bit?sys_type=000, Grant receiver: DKL, Grant Number: 151S-4-3-1269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Brain Pool Program through the Korean Federation of Science and Technology Societies of the Ministry of Science, ICT and Future Planning (151S-4-3-1269).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alves MS, 2011, PLANT SIGNAL BEHAV, V6, P1993, DOI 10.4161/psb.6.12.18268; Anderson E, 2013, WAT FOOD EN INN SUST; Arisz SA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00001; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Blum A, 1988, PLANT BREEDING STRES, P286; Boe A, 2009, GCB BIOENERGY, V1, P240, DOI 10.1111/j.1757-1707.2009.01018.x; Byun MY, 2015, PLANT SCI, V236, P61, DOI 10.1016/j.plantsci.2015.03.020; Castells E, 2010, PLANT SIGNAL BEHAV, V5, P409, DOI 10.4161/psb.5.4.11213; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cybulska I, 2010, ENERG FUEL, V24, P718, DOI 10.1021/ef9009179; Dametto A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1057369; Ding ZJ, 2015, PLANT J, V84, P56, DOI 10.1111/tpj.12958; Dudal R, 1976, INVENTORY MAJOR SOIL, P3; Dutilleul C, 2015, PLANT CELL ENVIRON, V38, P2688, DOI 10.1111/pce.12578; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Friesen PC, 2015, J EXP BOT, V66, P4403, DOI 10.1093/jxb/erv085; Gao Y, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/310402; Gedye K, 2010, PLANT GENOME-US, V3, P69, DOI 10.3835/plantgenome2010.06.0012; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Guo J, 2015, BIOENERG RES, V8, P1371, DOI 10.1007/s12155-015-9604-3; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Hichcock A., 1971, MANUAL GRASSES US; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Ishikawa T, 2013, METHOD ENZYMOL, V527, P239, DOI 10.1016/B978-0-12-405882-8.00013-1; Janmohammadi M, 2015, PHYTOCHEMISTRY, V117, P76, DOI 10.1016/j.phytochem.2015.06.003; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kim JM, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.00114, 10.3389/fpsyg.2015.00248]; Kim S, 2012, BIOENERG RES, V5, P225, DOI 10.1007/s12155-011-9145-3; Kim S, 2010, CROP SCI, V50, P2277, DOI 10.2135/cropsci2010.03.0140; Kim SM, 2015, BIORESOURCE TECHNOL, V183, P70, DOI 10.1016/j.biortech.2015.02.020; Kim YJ, 2004, FEBS LETT, V556, P127, DOI 10.1016/S0014-5793(03)01388-7; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mobberley D.G., 1953, TAXONOMY DISTRIBUTIO; Montemayor MB, 2008, ENVIRON EXP BOT, V62, P333, DOI 10.1016/j.envexpbot.2007.10.004; Msanne J, 2011, PLANTA, V234, P97, DOI 10.1007/s00425-011-1387-y; Nagarajan S, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9_1; Nah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134419; Nakagawa M, 2011, PLANT PHYSIOL, V155, P414, DOI 10.1104/pp.110.166082; Nakaminami K, 2014, MOL CELL PROTEOMICS, V13, P3602, DOI 10.1074/mcp.M114.039081; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Ren L, 2015, PLANT CELL REP, V34, P2161, DOI 10.1007/s00299-015-1859-9; Ruelland E, 2002, PLANT PHYSIOL, V130, P999, DOI 10.1104/pp.006080; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Seung D, 2012, PROTOPLASMA, V249, P445, DOI 10.1007/s00709-011-0304-3; Shimoni-Shor E, 2010, PLANT CELL ENVIRON, V33, P1029, DOI 10.1111/j.1365-3040.2010.02124.x; Shimosaka E, 2015, BREEDING SCI, V65, P363, DOI 10.1270/jsbbs.65.363; Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062494; Sinha S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00932; Skinner RH, 2009, J SOIL WATER CONSERV, V64, P413, DOI 10.2489/jswc.64.6.413; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Stubbendieck J., 1997, N AM RANGE PLANTS, V5th ed.; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Wang HH, 2015, PLANT MOL BIOL, V89, P157, DOI 10.1007/s11103-015-0360-8; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; Wang XT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00615; Wathugala DL, 2011, NEW PHYTOL, V191, P984, DOI 10.1111/j.1469-8137.2011.03759.x; Weaver JE., 1954, N AM PRAIRIE; Weis C, 2013, J EXP BOT, V64, P3855, DOI 10.1093/jxb/ert217; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Xu MY, 2011, PLANT CELL REP, V30, P1949, DOI 10.1007/s00299-011-1103-1; Yang YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131391; Zeng HQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00600; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	90	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152294	10.1371/journal.pone.0152294	http://dx.doi.org/10.1371/journal.pone.0152294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032112	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800051
J	Yim, K; Oh, G; Kim, S				Yim, Kyubin; Oh, Gabjin; Kim, Seunghwan			Understanding Financial Market States Using an Artificial Double Auction Market	PLOS ONE			English	Article							STATISTICAL PROPERTIES; LOSS AVERSION; LONG-MEMORY; ORDER BOOK; VOLATILITY; HETEROGENEITY; STRATEGIES; TRADERS; IMPACT; MODEL	The ultimate value of theories describing the fundamental mechanisms behind asset prices in financial systems is reflected in the capacity of such theories to understand these systems. Although the models that explain the various states of financial markets offer substantial evidence from the fields of finance, mathematics, and even physics, previous theories that attempt to address the complexities of financial markets in full have been inadequate. We propose an artificial double auction market as an agent-based model to study the origin of complex states in financial markets by characterizing important parameters with an investment strategy that can cover the dynamics of the financial market. The investment strategies of chartist traders in response to new market information should reduce market stability based on the price fluctuations of risky assets. However, fundamentalist traders strategically submit orders based on fundamental value and, thereby stabilize the market. We construct a continuous double auction market and find that the market is controlled by the proportion of chartists, P-c. We show that mimicking the real state of financial markets, which emerges in real financial systems, is given within the range P-c = 0.40 to P-c = 0.85; however, we show that mimicking the efficient market hypothesis state can be generated with values less than P-c = 0.40. In particular, we observe that mimicking a market collapse state is created with values greater than P-c = 0.85, at which point a liquidity shortage occurs, and the phase transition behavior is described at P-c = 0.85.	[Yim, Kyubin; Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Nonlinear & Complex Syst Lab, Pohang 790784, South Korea; [Oh, Gabjin] Chosun Univ, Div Business Adm, Kwangju 501759, South Korea	Pohang University of Science & Technology (POSTECH); Chosun University	Oh, G (corresponding author), Chosun Univ, Div Business Adm, Kwangju 501759, South Korea.	phecogjoh@gmail.com		KIM, Seunghwan/0000-0002-0563-3902	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2013017095, NRF- 4Q6 2014S1A3A2044643]; Chosun University, Korea	National Research Foundation of Korea (NRF) grant - Korea government (MEST); Chosun University, Korea	This work was supported by the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr) grant funded by the Korea government (MEST) (No. 2013017095) and by the research funds from Chosun University, Korea, 2015 (http://www2.chosun.ac.kr).; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013017095) and by the National Research Foundation of Korea Grant funded by the Korean Government (NRF- 4Q6 2014S1A3A2044643).	Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3; Antypas A, 2013, J EMPIR FINANC, V20, P102, DOI 10.1016/j.jempfin.2012.11.003; Barberis N, 2001, J FINANC, V56, P1247, DOI 10.1111/0022-1082.00367; Barberis N, 2001, Q J ECON, V116, P1, DOI 10.1162/003355301556310; Bartolozzi M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046112; Becker T, 2006, INT REV FINANC ANAL, V15, P434; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Boswijk HP, 2007, J ECON DYN CONTROL, V31, P1938, DOI 10.1016/j.jedc.2007.01.001; Bouchaud J.-P., 2002, Quantitative Finance, V2, P251, DOI 10.1088/1469-7688/2/4/301; Bouchaud JP, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228701; Carlson M., 1988, BRIEF HIST 1987 STOC; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Chen SH, 2001, J ECON DYN CONTROL, V25, P363, DOI 10.1016/S0165-1889(00)00030-0; Chen SH, 2001, J ECON BEHAV ORGAN, V46, P327, DOI 10.1016/S0167-2681(01)00181-0; Chiarella C., 2002, Quantitative Finance, V2, P346, DOI 10.1088/1469-7688/2/5/303; Chiarella C, 2009, J ECON DYN CONTROL, V33, P525, DOI 10.1016/j.jedc.2008.08.001; COHEN KJ, 1981, J POLIT ECON, V89, P287, DOI 10.1086/260966; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; COPELAND TE, 1983, J FINANC, V38, P1457, DOI 10.2307/2327580; Coval JD, 2005, J FINANC, V60, P1, DOI 10.1111/j.1540-6261.2005.00723.x; Daniel K, 1998, J FINANC, V53, P1839, DOI 10.1111/0022-1082.00077; DELONG JB, 1990, J FINANC, V45, P379, DOI 10.2307/2328662; DELONG JB, 1990, J POLIT ECON, V98, P703, DOI 10.1086/261703; Easley D, 1996, J FINANC, V51, P1405, DOI 10.2307/2329399; EASLEY D, 1987, J FINANC ECON, V19, P69, DOI 10.1016/0304-405X(87)90029-8; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Farmer JD, 2004, QUANT FINANC, V4, P383, DOI 10.1080/14697680400008627; Flannery MJ, 2013, J FINANC INTERMED, V22, P55, DOI 10.1016/j.jfi.2012.08.001; GARMAN MB, 1976, J FINANC ECON, V3, P257, DOI 10.1016/0304-405X(76)90006-4; Gillemot L, 2006, QUANT FINANC, V6, P371, DOI 10.1080/14697680600835688; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; HO TSY, 1983, J FINANC, V38, P1053, DOI 10.2307/2328011; Hommes C. H., 2001, Quantitative Finance, V1, P149, DOI 10.1088/1469-7688/1/1/311; Hommes C, 2008, J ECON BEHAV ORGAN, V67, P116, DOI 10.1016/j.jebo.2007.06.006; Iori G, 2002, J ECON BEHAV ORGAN, V49, P269, DOI 10.1016/S0167-2681(01)00164-0; KYLE AS, 1985, ECONOMETRICA, V53, P1315, DOI 10.2307/1913210; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Li W, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046112; Lillo F, 2005, FLUCT NOISE LETT, V5, pL209, DOI 10.1142/S0219477505002574; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; Liu YF, 2014, PHYSICA A, V407, P204, DOI 10.1016/j.physa.2014.04.004; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Maslov S, 2001, PHYSICA A, V1, P149; Plerou V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046131; Plerou V, 2000, PHYS REV E, V62, pR3023, DOI 10.1103/PhysRevE.62.R3023; Ponzi A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016112; Potters M, 2003, PHYSICA A, V324, P133, DOI 10.1016/S0378-4371(02)01896-4; Ross MM, 2008, J ECON BEHAV ORGAN, V68, P153, DOI [10.1016/j.jebo.2007.08.010, DOI 10.1016/J.JEBO.2007.08.010]; SHILLER RJ, 1984, BROOKINGS PAP ECO AC, P457; Stanley H.E., 1987, INTRO PHASE TRANSITI, pChapters 1 and 2; Treynor J, 1971, FINANC ANAL J, V22, P12, DOI 10.2469/faj.v27.n2.12; Weber P, 2005, QUANT FINANC, V5, P357, DOI 10.1080/14697680500244411; Xu HC, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/328498; Xu HC, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/563912; Yamamoto R, 2010, EUR PHYS J B, V73, P51, DOI 10.1140/epjb/e2009-00392-y; Yamamoto R, 2011, J ECON DYN CONTROL, V35, P1938, DOI 10.1016/j.jedc.2011.06.009; Zovko I., 2002, Quantitative Finance, V2, P387, DOI 10.1088/1469-7688/2/5/308	58	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152608	10.1371/journal.pone.0152608	http://dx.doi.org/10.1371/journal.pone.0152608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031110	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800103
J	Fukuyoshi, S; Kometani, M; Watanabe, Y; Hiratsuka, M; Yamaotsu, N; Hirono, S; Manabe, N; Takahashi, O; Oda, A				Fukuyoshi, Shuichi; Kometani, Masaharu; Watanabe, Yurie; Hiratsuka, Masahiro; Yamaotsu, Noriyuki; Hirono, Shuichi; Manabe, Noriyoshi; Takahashi, Ohgi; Oda, Akifumi			Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62	PLOS ONE			English	Article							CYP2D6 ALLELIC VARIANTS; FUNCTIONAL-CHARACTERIZATION; NATURAL VARIANT; WILD-TYPE; SUPERFAMILY; SEQUENCES; GENETICS; ENZYMES; DRUGS; P450S	Many natural mutants of the drug metabolizing enzyme cytochrome P450 (CYP) 2D6 have been reported. Because the enzymatic activities of many mutants are different from that of the wild type, the genetic polymorphism of CYP2D6 plays an important role in drug metabolism. In this study, the molecular dynamics simulations of the wild type and mutants of CYP2D6, CYP2D6.1, 2, 10, 14A, 51, and 62 were performed, and the predictions of static and dynamic structures within them were conducted. In the mutant CYP2D6.10, 14A, and 61, dynamic properties of the F-G loop, which is one of the components of the active site access channel of CYP2D6, were different from that of the wild type. The F-G loop acted as the "hatch" of the channel, which was closed in those mutants. The structure of CYP2D6.51 was not converged by the simulation, which indicated that the three-dimensional structure of CYP2D6.51 was largely different from that of the wild type. In addition, the intramolecular interaction network of CYP2D6.10, 14A, and 61 was different from that of the wild type, and it is considered that these structural changes are the reason for the decrease or loss of enzymatic activities. On the other hand, the static and dynamic properties of CYP2D6.2, whose activity was normal, were not considerably different from those of the wild type.	[Fukuyoshi, Shuichi; Kometani, Masaharu; Watanabe, Yurie; Oda, Akifumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan; [Manabe, Noriyoshi; Takahashi, Ohgi] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Oda, Akifumi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Kanazawa University; Tohoku University; Kitasato University; Tohoku Medical & Pharmaceutical University; Osaka University	Oda, A (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.; Oda, A (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	oda@p.kanazawa-u.ac.jp	Hiratsuka, Masahiro/AAO-8082-2020; Fukuyoshi, Shuichi/D-8388-2015; Yamaotsu, Noriyuki/AAW-2545-2020	Hiratsuka, Masahiro/0000-0002-3767-7686; Fukuyoshi, Shuichi/0000-0002-9015-0920; Yamaotsu, Noriyuki/0000-0002-4302-1085	Japan Society for the Promotion of Science [26460034, 15H01064]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research [26460034] and [15H01064] from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x; Case DA, 2012, AMBER 12; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Waal PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108607; GOTOH O, 1992, J BIOL CHEM, V267, P83; Handa K, 2014, DRUG METAB PHARMACOK, V29, P52, DOI 10.2133/dmpk.DMPK-13-RG-044; Ito Y, 2008, J MOL GRAPH MODEL, V26, P947, DOI 10.1016/j.jmgm.2007.07.004; Klein K, 2007, DRUG METAB DISPOS, V35, P1247, DOI 10.1124/dmd.107.015149; Kobayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096789; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Muroi Y, 2014, DRUG METAB PHARMACOK, V29, P360, DOI 10.2133/dmpk.DMPK-14-RG-014; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Niwa T, 2004, MOL BRAIN RES, V129, P117, DOI 10.1016/j.molbrainres.2004.06.030; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Oda A, 2004, PHARM RES, V21, P2270, DOI 10.1007/s11095-004-7680-8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; Shaik S., 2005, CYTOCHROME P450 STRU, P45, DOI DOI 10.1007/0-387-27447-2_2; Teh LK, 2012, DRUG METAB PHARMACOK, V27, P55, DOI 10.2133/dmpk.DMPK-11-RV-121; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wolkers J, 1998, AQUAT TOXICOL, V44, P103, DOI 10.1016/S0166-445X(98)00063-0	25	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152946	10.1371/journal.pone.0152946	http://dx.doi.org/10.1371/journal.pone.0152946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046024	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600051
J	Ji, JZ; Liu, JD; Liang, PP; Zhang, AD				Ji, Junzhong; Liu, Jinduo; Liang, Peipeng; Zhang, Aidong			Learning Effective Connectivity Network Structure from fMRI Data Based on Artificial Immune Algorithm	PLOS ONE			English	Article							BAYESIAN NETWORKS; CAUSAL DISCOVERY; BRAIN; MODEL	Many approaches have been designed to extract brain effective connectivity from functional magnetic resonance imaging (fMRI) data. However, few of them can effectively identify the connectivity network structure due to different defects. In this paper, a new algorithm is developed to infer the effective connectivity between different brain regions by combining artificial immune algorithm (AIA) with the Bayes net method, named as AIAEC. In the proposed algorithm, a brain effective connectivity network is mapped onto an antibody, and four immune operators are employed to perform the optimization process of antibodies, including clonal selection operator, crossover operator, mutation operator and suppression operator, and finally gets an antibody with the highest K2 score as the solution. AIAEC is then tested on Smith's simulated datasets, and the effect of the different factors on AIAEC is evaluated, including the node number, session length, as well as the other potential confounding factors of the blood oxygen level dependent (BOLD) signal. It was revealed that, as contrast to other existing methods, AIAEC got the best performance on the majority of the datasets. It was also found that AIAEC could attain a relative better solution under the influence of many factors, although AIAEC was differently affected by the aforementioned factors. AIAEC is thus demonstrated to be an effective method for detecting the brain effective connectivity.	[Ji, Junzhong; Liu, Jinduo] Beijing Univ Technol, Coll Comp Sci & Technol, Beijing Municipal Key Lab Multimedia & Intelligen, Beijing, Peoples R China; [Liang, Peipeng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China; [Zhang, Aidong] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 14260 USA	Beijing University of Technology; Capital Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liang, PP (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing Key Lab MRI & Brain Informat, Beijing, Peoples R China.	p.p.liang@163.com	Ji, Junzhong/GLU-8838-2022		NSFC Research Program [61375059, 61332016, 61473196]; National "973" Key Basic Research Program of China [2014CB744601]; Specialized Research Fund for the Doctoral Program of Higher Education [20121103110031]; Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B) [KZ201410005004]; Div Of Information & Intelligent Systems [1218393] Funding Source: National Science Foundation	NSFC Research Program(National Natural Science Foundation of China (NSFC)); National "973" Key Basic Research Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was partly supported by the NSFC Research Program (61375059, 61332016, 61473196), the National "973" Key Basic Research Program of China (2014CB744601), the Specialized Research Fund for the Doctoral Program of Higher Education (20121103110031), and the Beijing Municipal Education Research Plan key project (Beijing Municipal Fund Class B) (KZ201410005004).	Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Dasgupta D, 2003, IEEE C EVOL COMPUTAT, P123, DOI 10.1109/CEC.2003.1299565; Dasgupta D, 2011, APPL SOFT COMPUT, V11, P1574, DOI 10.1016/j.asoc.2010.08.024; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Heckerman D, 2008, STUD COMPUT INTELL, V156, P33; Hofmeyr SA, 2000, EVOL COMPUT, V8, P443, DOI 10.1162/106365600568257; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Ide JS, 2014, INT J APPROX REASON, V55, P23, DOI 10.1016/j.ijar.2013.03.013; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; McIntosh A.R., 1994, HUM BRAIN MAPP, V2, P2, DOI DOI 10.1002/HBM.460020104; Meek C., 1995, P 11 C UNC ART INT, P403; Mumford JA, 2014, NEUROIMAGE, V86, P573, DOI 10.1016/j.neuroimage.2013.10.020; Patel RS, 2006, HUM BRAIN MAPP, V27, P267, DOI 10.1002/hbm.20182; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rajapakse JC, 2007, NEUROIMAGE, V37, P749, DOI 10.1016/j.neuroimage.2007.06.003; Ramsey J, 2006, P 22 C UNC ART INT, P401; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Richardson TS, 1996, AUTOMATED DISCOVERY; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shimizu S, 2008, J STAT PLAN INFER, V138, P3483, DOI 10.1016/j.jspi.2006.01.017; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Wu X, 2014, NEURAL COMPUT APPL, V24, P91, DOI 10.1007/s00521-013-1465-0; Wu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134361; Xu LL, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00125; Zhang JJ, 2008, ARTIF INTELL, V172, P1873, DOI 10.1016/j.artint.2008.08.001; Zobay O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120123	34	10	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152600	10.1371/journal.pone.0152600	http://dx.doi.org/10.1371/journal.pone.0152600			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045295	gold, Green Published			2022-12-27	WOS:000373599600028
J	Hamaguchi-Hamada, K; Kurumata-Shigeto, M; Minobe, S; Fukuoka, N; Sato, M; Matsufuji, M; Koizumi, O; Hamada, S				Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami; Minobe, Sumiko; Fukuoka, Nozomi; Sato, Manami; Matsufuji, Miyuki; Koizumi, Osamu; Hamada, Shun			Thrombospondin Type-1 Repeat Domain-Containing Proteins Are Strongly Expressed in the Head Region of Hydra	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; METAZOAN HYDRA; GENE FAMILY; NERVE RING; HYPOSTOME; ORGANIZER; MOLECULES; SYSTEMS; ROLES; AXIS	The head region of Hydra, the hypostome, is a key body part for developmental control and the nervous system. We herein examined genes specifically expressed in the head region of Hydra oligactis using suppression subtractive hybridization (SSH) cloning. A total of 1414 subtracted clones were sequenced and found to be derived from at least 540 different genes by BLASTN analyses. Approximately 25% of the subtracted clones had sequences encoding thrombospondin type-1 repeat (TSR) domains, and were derived from 17 genes. We identified 11 TSR domain-containing genes among the top 36 genes that were the most frequently detected in our SSH library. Whole-mount in situ hybridization analyses confirmed that at least 13 out of 17 TSR domain-containing genes were expressed in the hypostome of Hydra oligactis. The prominent expression of TSR domain-containing genes suggests that these genes play significant roles in the hypostome of Hydra oligactis.	[Hamaguchi-Hamada, Kayoko; Kurumata-Shigeto, Mami; Matsufuji, Miyuki; Hamada, Shun] Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Food & Hlth Sci, Fukuoka, Japan; [Minobe, Sumiko; Fukuoka, Nozomi; Sato, Manami; Koizumi, Osamu] Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Environm Sci, Fukuoka, Japan		Hamada, S (corresponding author), Fukuoka Womens Univ, Int Coll Arts & Sci, Dept Food & Hlth Sci, Fukuoka, Japan.	hamada@fwu.ac.jp			KAKENHI [24570089]; Japan Society for the Promotion of Science; Japan Society for the Promotion of Science (JSPS; KAKENHI) [24570089]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS; KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by KAKENHI Grant Number 24570089, The Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/ index.html, to SH. The funder had roles in study design, decision to publish and preparation of the manuscript.; This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS; KAKENHI Grant Number 24570089).	Adams JC, 2000, DEV DYNAM, V218, P280; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; Bielen H, 2007, DEVELOPMENT, V134, P4187, DOI 10.1242/dev.010173; BODE H, 1973, ROUX ARCH DEV BIOL, V171, P269, DOI 10.1007/BF00577725; Bode HR, 2012, INT J DEV BIOL, V56, P473, DOI 10.1387/ijdb.113448hb; Bode HR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000463; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Broun M, 2002, DEVELOPMENT, V129, P875; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; DAVIS LE, 1968, J EXP ZOOL, V167, P295, DOI 10.1002/jez.1401670305; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Genikhovich G, 2006, DEV BIOL, V289, P466, DOI 10.1016/j.ydbio.2005.10.028; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; GRIMMELIKHUIJZEN CJP, 1985, CELL TISSUE RES, V241, P171, DOI 10.1007/BF00214639; Guder C, 2007, TSR CONTAINING PROTE; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; KINNAMON JC, 1981, J MORPHOL, V168, P321, DOI 10.1002/jmor.1051680308; KOIZUMI O, 1992, J COMP NEUROL, V326, P7, DOI 10.1002/cne.903260103; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Lopez JA, 2011, GENE, V473, P119, DOI 10.1016/j.gene.2010.11.013; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Meinhardt H, 2012, INT J DEV BIOL, V56, P447, DOI 10.1387/ijdb.113483hm; Milde S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r8; PASSANO LM, 1964, J EXP BIOL, V41, P643; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Schwarz RS, 2007, IMMUNOGENETICS, V59, P233, DOI 10.1007/s00251-006-0179-1; Siebert S, 2008, DEV BIOL, V313, P13, DOI 10.1016/j.ydbio.2007.09.007; Stout T, 2007, J BIOCHEM MOL BIOL, V40, P286; Swanson LW, 2012, FUNDAMENTAL NEUROSCI; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; YAO T, 1945, J EXP BIOL, V21, P147	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151823	10.1371/journal.pone.0151823	http://dx.doi.org/10.1371/journal.pone.0151823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043211	gold, Green Submitted, Green Published			2022-12-27	WOS:000373592100005
J	Hou, L; Zhang, MT; Han, W; Tang, Y; Xue, F; Liang, SH; Zhang, B; Wang, WZ; Asaiti, K; Wang, YH; Pang, HY; Wang, ZX; Wang, YY; Qiu, CC; Jiang, JM				Hou, Lei; Zhang, Mingtao; Han, Wei; Tang, Yong; Xue, Fang; Liang, Shaohua; Zhang, Biao; Wang, Weizhi; Asaiti, Kuliqian; Wang, Yanhong; Pang, Haiyu; Wang, Zixing; Wang, Yuyan; Qiu, Changchun; Jiang, Jingmei			Influence of Salt Intake on Association of Blood Uric Acid with Hypertension and Related Cardiovascular Risk	PLOS ONE			English	Article							INCIDENT HYPERTENSION; POTASSIUM EXCRETION; INSULIN SENSITIVITY; URINARY SODIUM; PRESSURE; DISEASE; LEVEL; PREVALENCE; MECHANISM; CHINA	Background A relationship of blood uric acid (UA) with hypertension and cardiovascular risk is under debate thus salt intake is hypothesized to contribute to such associations. Methods In this cross-sectional study, stratified cluster random sampling elicited a sample of 1805 Kazakhs with 92.4% compliance. Hypertension and moderate-or-high total cardiovascular risk (mTCR) were defined according to guidelines. Sodium intake was assessed by urinary sodium excretion. Prevalence ratios (PRs) were used to express associations of UA with hypertension and mTCR. Results In the highest tertile of sodium intake in women, the adjusted PRs (95% confidence intervals) of low to high quartiles compared with the lowest quartile of UA, were 1.22(0.78-1.91), 1.18(0.75-1.85), and 1.65(1.09-2.51) for hypertension and 1.19(0.74-1.90), 1.39(0.91-2.11), and 1.65(1.10-2.47) for mTCR (P for trend <0.05). However, these findings were not shown for other sodium intake levels. There were similar results in men. PRs markedly increased with a concomitant increase in UA and sodium intake and there was a significant interaction (P = 0.010) for mTCR with PRs of 1.69(1.10-2.60) for men and 3.70(2.09-6.52) for women in those with the highest compared with the lowest quartile of UA and tertile of sodium intake. Similar findings were shown for hypertension. Conclusions This study implied that a high salt intake may enhance the associations of UA with hypertension and cardiovascular risk.	[Hou, Lei; Han, Wei; Xue, Fang; Zhang, Biao; Wang, Yanhong; Pang, Haiyu; Wang, Zixing; Wang, Yuyan; Qiu, Changchun; Jiang, Jingmei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Mingtao; Tang, Yong; Liang, Shaohua; Wang, Weizhi] Peoples Hosp Altay Prefecture, Xinjiang, Peoples R China; [Asaiti, Kuliqian] Hong Dun Town Hosp, Xinjiang, Altay Prefectur, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Jiang, JM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	jingmeijiang@ibms.pumc.edu.cn	wang, yi/GVT-8516-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022; Wang, Yuyan/GQZ-8255-2022; wang, yan/GSE-6489-2022	Wang, Yuyan/0000-0003-3747-0762	National Natural Science Foundation of China [81273181]; government of Altay City and Hong Dun Town; Hong Dun Township Health Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); government of Altay City and Hong Dun Town; Hong Dun Township Health Center	The study design, data collection and analysis, decision to publish, or preparation of the manuscript were supported by the National Natural Science Foundation of China (grant number 81273181).; We thank the government of Altay City and Hong Dun Town and the Hong Dun Township Health Center who supported this project. Local village doctors and nurses, Kazakh college students from Xinjiang Medical University who participated in this survey, and all interviewees are acknowledged. P He, W Kang, L Jia, H Qin, H Yu, N Jumabieke, S Jiangtai provided administrative, technical, and material support.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Batis C, 2013, EPIDEMIOLOGY, V24, P410, DOI 10.1097/EDE.0b013e318289e047; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; Chamarthi B, 2010, J HYPERTENS, V28, P1020, DOI 10.1097/HJH.0b013e3283375974; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Houchens R, 2007, HIERARCHICAL MODELIN; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kobori H, 2010, J HYPERTENS, V28, P1422, DOI 10.1097/HJH.0b013e3283392673; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; Loeffler LF, 2012, HYPERTENSION, V59, P811, DOI 10.1161/HYPERTENSIONAHA.111.183244; Lu Z, 2009, J HUM HYPERTENS, V23, P113, DOI 10.1038/jhh.2008.104; Ma X. J., 2013, J HYPERTENS, V21, P1164; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Perlstein TS, 2004, KIDNEY INT, V66, P1465, DOI 10.1111/j.1523-1755.2004.00909.x; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P2222, DOI 10.1046/j.1523-1755.2001.00737.x; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; ter Maaten JC, 1999, EUR J CLIN INVEST, V29, P189; [王红梅 Wang Hongmei], 2010, [中华高血压杂志, Chinese Journal of Hypertension], V18, P960; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension, 2010, ZHONGHUA XIN XUE GUA, V39, P579, DOI DOI 10.3969/J.ISSN.1674-7372.2011.03.016; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891	32	13	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0150451	10.1371/journal.pone.0150451	http://dx.doi.org/10.1371/journal.pone.0150451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042828	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100002
J	Rousseau, A; Rozenberg, P; Perrodeau, E; Deneux-Tharaux, C; Ravaud, P				Rousseau, A.; Rozenberg, P.; Perrodeau, E.; Deneux-Tharaux, C.; Ravaud, P.			Variations in Postpartum Hemorrhage Management among Midwives: A National Vignette-Based Study	PLOS ONE			English	Article							CLINICAL VIGNETTES; QUALITY; PREVENTION; GUIDELINES; PHYSICIANS; MORTALITY; POLICIES; TRENDS; CARE	Objective To assess variations in adherence to guidelines for management of postpartum hemorrhage (PPH) among midwives. Methods A multicentre vignette-based study was e-mailed to a random sample of midwives from 145 maternity units in France. They were asked to describe how they would manage the PPH described in 2 case-vignettes. These previously validated case-vignettes described 2 different scenarios for severe PPH. Vignette 1 described a typical immediate, severe PPH and vignette 2 a less typical case of severe but gradual PPH. They were constructed in 3 successive steps and included multiple-choice questions proposing several types of clinical practice options at each step. An expert consensus defined 14 criteria for assessing adherence to guidelines issued by the French College of Obstetricians and Gynecologists in 2004 in the midwives' responses. We analyzed the number of errors among the 14 criteria to quantify the level of adherence. Results We obtained 450 complete responses from midwives from 87 maternity units. The rate of complete adherence (no error for any of the 14 criteria) was low: 25.1% in vignette 1 and 4.2% in vignette 2. The error rate was higher for pharmacological management, especially oxytocin use, than for non-pharmacological management and communication-monitoring-investigation. Adherence to guidelines varied substantially between and within maternity units, as well as between the vignettes for the same midwives. Conclusion Reponses to case-vignettes demonstrated substantial variations in PPH management and especially individual variations in adherence to guidelines. Midwives should participate in continuous and individualized training.	[Rousseau, A.; Rozenberg, P.] Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France; [Rousseau, A.; Perrodeau, E.; Ravaud, P.] Paris Descartes Sorbonne Paris Cite Univ, INSERM, U1153, METHODS Methodes Evaluat Therapeut Malad Chron Re, Paris, France; [Rozenberg, P.] Versailles St Quentin Univ, Res Unit EA 7285, St Quentin En Yvelines, France; [Perrodeau, E.; Ravaud, P.] Hop Hotel Dieu, AP HP, Ctr Epidemiol, F-75181 Paris, France; [Deneux-Tharaux, C.] Paris Descartes Sorbonne Paris Cite Univ, INSERM, U1153, EPOPe Epidemiol Obstet Perinatale & Pediat Res Un, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rousseau, A (corresponding author), Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France.; Rousseau, A (corresponding author), Paris Descartes Sorbonne Paris Cite Univ, INSERM, U1153, METHODS Methodes Evaluat Therapeut Malad Chron Re, Paris, France.	anne.rousseau@uvsq.fr	ravaud, philippe/C-1694-2009; deneux-tharaux, catherine/R-1111-2016	Ravaud, Philippe/0000-0001-8264-9206; deneux-tharaux, catherine/0000-0002-6561-3321	Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris [PHRC-AOR13212]	Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris	This trial was supported by a research grant from the Departement a la Recherche Clinique Ile-de-France, Assistance Publique-Hopitaux de Paris, which also sponsored the study (PHRC-AOR13212). The study sponsor did not participate in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors had full access to all the data and had final responsibility for the decision to submit for publication.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P1039; Audureau E, 2009, BJOG-INT J OBSTET GY, V116, P1325, DOI 10.1111/j.1471-0528.2009.02238.x; Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50; Berg CJ, 2009, OBSTET GYNECOL, V113, P1075, DOI 10.1097/AOG.0b013e3181a09fc0; Blondel B, 2012, J Gynecol Obstet Biol Reprod (Paris), V41, pe1, DOI 10.1016/j.jgyn.2012.04.014; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Bouvier-Colle MH, 2001, BRIT J OBSTET GYNAEC, V108, P898, DOI 10.1111/j.1471-0528.2001.00224.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Clark SL, 2008, AM J OBSTET GYNECOL, V199, P91, DOI 10.1016/j.ajog.2008.05.009; Clark SL, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.007; College National des Gynecologues et Obstetriciens Francais, 2004, J GYNECOLOGIE OBSTET, V33; Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564; Dahlke JD, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.023; Deneux-Tharaux C, 2008, J GYNECOL OBST BIO R, V37, P237, DOI 10.1016/j.jgyn.2008.01.007; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Driessen M, 2011, OBSTET GYNECOL, V117, P21, DOI 10.1097/AOG.0b013e318202c845; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Geller SE, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.046; Hofmeyr GJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006431.pub3; Kayem G, 2016, BJOG-INT J OBSTET GY, V123, P598, DOI 10.1111/1471-0528.13477; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Landon BE, 2001, MED CARE, V39, P889, DOI 10.1097/00005650-200108000-00014; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Mousa HA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub3; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128; Rousseau A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138663; Royal College of Obstetricians and Gynaecologists, 2009, PREV MAN POSTP HAEM; Saucedo M, 2013, J GYNECOL OBST BIO R, V42, P613, DOI 10.1016/j.jgyn.2013.06.011; Saucedo M, 2013, OBSTET GYNECOLOGY, V122, P752, DOI DOI 10.1097/A0G.0B013E31829FC38C; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Sentithes L, 2014, J GYNECOL OBST BIO R, V43, P1170, DOI 10.1016/j.jgyn.2014.10.009; Winter C, 2007, BJOG-INT J OBSTET GY, V114, P845, DOI 10.1111/j.1471-0528.2007.01377.x; Zhang WH, 2005, BJOG-INT J OBSTET GY, V112, P89, DOI 10.1111/j.1471-0528.2004.00303.x	39	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152863	10.1371/journal.pone.0152863	http://dx.doi.org/10.1371/journal.pone.0152863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043439	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100040
J	Sundberg, I; Ramklint, M; Stridsberg, M; Papadopoulos, FC; Ekselius, L; Cunningham, JL				Sundberg, Isak; Ramklint, Mia; Stridsberg, Mats; Papadopoulos, Fotios C.; Ekselius, Lisa; Cunningham, Janet L.			Salivary Melatonin in Relation to Depressive Symptom Severity in Young Adults	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MAJOR DEPRESSION; PLASMA MELATONIN; MOOD DISORDERS; CIRCADIAN MISALIGNMENT; NOCTURNAL MELATONIN; CORTISOL SECRETION; HEALTHY-SUBJECTS; SERUM MELATONIN; RATING-SCALE	Reduced levels of melatonin have been associated with severe depression. The aim was to investigate the correlation between salivary melatonin and dimensional measures of depressive symptom severity in young adult psychiatric patients. Levels of melatonin were analyzed in six saliva samples during waking hours from 119 young adult patients under outpatient psychiatric care. Melatonin levels were tested for association with the severity of depressive symptoms using the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS-S). Where possible, depressive symptoms were assessed again after 6 +/- 2 months of treatment. Response was defined as decrease in MADRS-S by >= 50% between baseline and follow-up. Patients with levels of melatonin in the lowest quartile at bedtime had an increased probability of a high MADRS-S score compared to those with the highest levels of melatonin (odds ratio 1.39, 95% CI 1.15-1.69, p<0.01). A post hoc regression analysis found that bedtime melatonin levels predicted response (odds ratio 4.4, 95% CI 1.06-18.43, p<0.05). A negative relationship between salivary melatonin and dimensional measures of depressive symptom severity was found in young patients under outpatient psychiatric care. Bedtime salivary melatonin levels may have prognostic implications.	[Sundberg, Isak; Ramklint, Mia; Papadopoulos, Fotios C.; Ekselius, Lisa; Cunningham, Janet L.] Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Biochem Endocrinol, Uppsala, Sweden	Uppsala University; Uppsala University	Cunningham, JL (corresponding author), Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden.	janet.cunningham@neuro.uu.se	Cunningham, Janet/C-4719-2013; Papadopoulos, Fotios/H-1319-2019	Cunningham, Janet/0000-0001-7876-7779; Papadopoulos, Fotios/0000-0002-8692-3652	Marta och Nicke Nasvells fund; Anna-Britta Gustafssons stiftelse; Stiftelsen Apotekare Hedbergs Fund; Erik. Karin and Gosta Selanders Stiftelse; Stiftelsen Soderstrom-Konigska sjukhemmet; Swedish Medical Association; Uppsala University Hospital	Marta och Nicke Nasvells fund; Anna-Britta Gustafssons stiftelse; Stiftelsen Apotekare Hedbergs Fund; Erik. Karin and Gosta Selanders Stiftelse; Stiftelsen Soderstrom-Konigska sjukhemmet; Swedish Medical Association; Uppsala University Hospital	This work was funded by grants from Marta och Nicke Nasvells fund (JC), Anna-Britta Gustafssons stiftelse (JC), Stiftelsen Apotekare Hedbergs Fund (JC), Erik. Karin and Gosta Selanders Stiftelse (JC), Stiftelsen Soderstrom-Konigska sjukhemmet (JC), Swedish Medical Association (JC) and Medical Training and Research Agreement (ALF) Funds from Uppsala University Hospital (IS, JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Bahr I, 2011, J PINEAL RES, V50, P336, DOI 10.1111/j.1600-079X.2010.00848.x; Bazwinsky-Wutschke I, 2012, J PINEAL RES, V53, P344, DOI 10.1111/j.1600-079X.2012.01004.x; BECKFRIIS J, 1984, PSYCHONEUROENDOCRINO, V9, P261, DOI 10.1016/0306-4530(84)90005-2; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; BRAMBILLA F, 1988, PSYCHIAT RES, V23, P267, DOI 10.1016/0165-1781(88)90017-0; BROWN R, 1985, AM J PSYCHIAT, V142, P811; BROWN RP, 1987, ACTA PSYCHIAT SCAND, V76, P272, DOI 10.1111/j.1600-0447.1987.tb02895.x; Carvalho LA, 2009, J PSYCHOPHARMACOL, V23, P315, DOI 10.1177/0269881108089871; Carvalho LA, 2006, PSYCHONEUROENDOCRINO, V31, P761, DOI 10.1016/j.psyneuen.2006.02.010; CLAUSTRAT B, 1984, BIOL PSYCHIAT, V19, P1215; Crasson M, 2004, PSYCHONEUROENDOCRINO, V29, P1, DOI 10.1016/S0306-4530(02)00123-3; Cunningham JL, 2011, J AFFECT DISORDERS, V135, P148, DOI 10.1016/j.jad.2011.07.005; Dahl J, 2015, PSYCHONEUROENDOCRINO, V56, P12, DOI 10.1016/j.psyneuen.2015.02.011; Emens J, 2009, PSYCHIAT RES, V168, P259, DOI 10.1016/j.psychres.2009.04.009; First M.B., 2014, STRUCTURED CLIN INTE; Hasler BP, 2010, PSYCHIAT RES, V178, P205, DOI 10.1016/j.psychres.2010.04.027; IGUCHI H, 1981, Fukuoka Acta Medica, V72, P423; Ito Y, 2013, INT J TRYPTOPHAN RES, P75, DOI 10.4137/IJTR.S11760; Karamitri A, 2013, MOL ENDOCRINOL, V27, P1217, DOI 10.1210/me.2013-1101; LAM RW, 1990, PSYCHIAT RES, V33, P129, DOI 10.1016/0165-1781(90)90066-E; Liu C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-59; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MattilaEvenden M, 1996, ACTA PSYCHIAT SCAND, V94, P386, DOI 10.1111/j.1600-0447.1996.tb09879.x; Meliska CJ, 2013, CHRONOBIOL INT, V30, P1160, DOI 10.3109/07420528.2013.808652; MENDLEWICZ J, 1980, COMMUN PSYCHOPHARMAC, V4, P49; Nordentoft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055176; Pacchierotti C, 2001, FRONT NEUROENDOCRIN, V22, P18, DOI 10.1006/frne.2000.0202; Paparrigopoulos T, 2002, ACTA PSYCHIAT SCAND, V106, P440, DOI 10.1034/j.1600-0447.2002.02342.x; Parry BL, 2001, NEUROPSYCHOPHARMACOL, V25, pS102, DOI 10.1016/S0893-133X(01)00340-2; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Ramirez A, 2009, PSYCHIAT SERV, V60, P1649, DOI 10.1176/ps.2009.60.12.1649; Robillard R, 2013, EUR PSYCHIAT, V28, P412, DOI 10.1016/j.eurpsy.2013.04.001; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P558; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV., 1983, ANXIETY DIS; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Soderquist F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120195; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Szymanska A, 2001, NEUROENDOCRINOL LETT, V22, P192; THOMPSON C, 1988, BRIT J PSYCHIAT, V152, P260, DOI 10.1192/bjp.152.2.260; Voderholzer U, 1997, PSYCHIAT RES, V71, P151, DOI 10.1016/S0165-1781(97)00048-6; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Wetterberg L, 1999, EUR ARCH PSY CLIN N, V249, P256, DOI 10.1007/s004060050095; WETTERBERG L, 1982, LANCET, V2, P100; WETTERBERG L, 1983, PSYCHONEUROENDOCRINO, V8, P75, DOI 10.1016/0306-4530(83)90042-2; Zawilska JB, 2009, PHARMACOL REP, V61, P383, DOI 10.1016/S1734-1140(09)70081-7	49	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152814	10.1371/journal.pone.0152814	http://dx.doi.org/10.1371/journal.pone.0152814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27042858	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100035
J	Urrutia-Cordero, P; Ekvall, MK; Hansson, LA				Urrutia-Cordero, Pablo; Ekvall, Mattias K.; Hansson, Lars-Anders			Controlling Harmful Cyanobacteria: Taxa-Specific Responses of Cyanobacteria to Grazing by Large-Bodied Daphnia in a Biomanipulation Scenario	PLOS ONE			English	Article							BODY-SIZE; PHYTOPLANKTON; ZOOPLANKTON; TOLERANCE; CLADOCERA; HISTORY; GRAZERS; BLOOMS; GROWTH	Lake restoration practices based on reducing fish predation and promoting the dominance of large-bodied Daphnia grazers (i.e., biomanipulation) have been the focus of much debate due to inconsistent success in suppressing harmful cyanobacterial blooms. While most studies have explored effects of large-bodied Daphnia on cyanobacterial growth at the community level and/or on few dominant species, predictions of such restoration practices demand further understanding on taxa-specific responses in diverse cyanobacterial communities. In order to address these questions, we conducted three grazing experiments during summer in a eutrophic lake where the natural phytoplankton community was exposed to an increasing gradient in biomass of the large-bodied Daphnia magna. This allowed evaluating taxa-specific responses of cyanobacteria to Daphnia grazing throughout the growing season in a desired biomanipulation scenario with limited fish predation. Total cyanobacterial and phytoplankton biomasses responded negatively to Daphnia grazing both in early and late summer, regardless of different cyanobacterial densities. Large-bodied Daphnia were capable of suppressing the abundance of Aphanizomenon, Dolichospermum, Microcystis and Planktothrix bloom-forming cyanobacteria. However, the growth of the filamentous Dolichospermum crassum was positively affected by grazing during a period when this cyanobacterium dominated the community. The eutrophic lake was subjected to biomanipulation since 2005 and nineteen years of lake monitoring data (1996-2014) revealed that reducing fish predation increased the mean abundance (50%) and body-size (20%) of Daphnia, as well as suppressed the total amount of nutrients and the growth of the dominant cyanobacterial taxa, Microcystis and Planktothrix. Altogether our results suggest that lake restoration practices solely based on grazer control by large-bodied Daphnia can be effective, but may not be sufficient to control the overgrowth of all cyanobacterial diversity. Although controlling harmful cyanobacterial blooms should preferably include other measures, such as nutrient reductions, our experimental assessment of taxa-specific cyanobacterial responses to large-bodied Daphnia and long-term monitoring data highlights the potential of such biomanipulations to enhance the ecological and societal value of eutrophic water bodies.	[Urrutia-Cordero, Pablo; Ekvall, Mattias K.; Hansson, Lars-Anders] Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden; [Urrutia-Cordero, Pablo] Lund Univ, Ctr Environm & Climate Res, Ecol Bldg, SE-22362 Lund, Sweden	Lund University; Lund University	Urrutia-Cordero, P (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, SE-22362 Lund, Sweden.; Urrutia-Cordero, P (corresponding author), Lund Univ, Ctr Environm & Climate Res, Ecol Bldg, SE-22362 Lund, Sweden.	pablo.urrutia_cordero@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317; Urrutia Cordero, Pablo/0000-0001-9560-8374	collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)'; Royal Physiographic Society of Lund; European Union Interreg IV A project 'Algae be gone!'; LIMNOTIP through the ERA-Net BiodivERsA	collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)'; Royal Physiographic Society of Lund; European Union Interreg IV A project 'Algae be gone!'; LIMNOTIP through the ERA-Net BiodivERsA	This research was funded by the collaborative strategic research area 'Biodiversity and Ecosystem Services in a Changing Climate (BECC)', The Royal Physiographic Society of Lund, the European Union Interreg IV A project 'Algae be gone!' and LIMNOTIP through the ERA-Net BiodivERsA, with the national funder Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, ACTA OECOL, V19, P331, DOI 10.1016/S1146-609X(98)80037-4; Bergman E, 1999, HYDROBIOLOGIA, V404, P145, DOI 10.1023/A:1003788900521; BERGQUIST AM, 1986, ECOLOGY, V67, P1351, DOI 10.2307/1938691; Bernes C, 2015, ENVIRON EVID, V4, DOI 10.1186/s13750-014-0030-3; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Carpenter SR, 2011, TROPHIC CASCADES, P55; Chislock MF, 2013, ECOLOGY, V94, P2375, DOI 10.1890/13-0320.1; Chislock MF, 2013, WATER RES, V47, P1961, DOI 10.1016/j.watres.2012.12.038; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Declerck S, 1997, HYDROBIOLOGIA, V360, P265, DOI 10.1023/A:1003175929208; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Ekvall MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112956; Ekvall MK, 2013, FRESHWATER BIOL, V58, P2414, DOI 10.1111/fwb.12220; Ger KA, 2014, FRESHWATER BIOL, V59, P1783, DOI 10.1111/fwb.12393; GLIWICZ ZM, 1990, HYDROBIOLOGIA, V200, P83, DOI 10.1007/BF02530331; Gustafsson S, 2005, ECOLOGY, V86, P2561, DOI 10.1890/04-1710; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; Hansson LA, 1999, HYDROBIOLOGIA, V404, P1, DOI 10.1023/A:1003793019176; Hansson LA, 1998, ECOSYSTEMS, V1, P558, DOI 10.1007/s100219900051; Hansson LA, 1996, LIMNOL OCEANOGR, V41, P1312, DOI 10.4319/lo.1996.41.6.1312; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Hudnell H.K., 2008, CYANOBACTERIAL HARMF; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Kasprzak P, 1999, J PLANKTON RES, V21, P2161, DOI 10.1093/plankt/21.11.2161; Kasprzak PH, 1997, J PLANKTON RES, V19, P1025, DOI 10.1093/plankt/19.8.1025; Lacerot G, 2013, FRESHWATER BIOL, V58, P494, DOI 10.1111/fwb.12075; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Sarnelle O, 2007, LIMNOL OCEANOGR, V52, P2120, DOI 10.4319/lo.2007.52.5.2120; Sarnelle O, 2010, J PLANKTON RES, V32, P471, DOI 10.1093/plankt/fbp151; Shapiro J., 1975, WATER QUALITY MANAGE, P85; Urrutia-Cordero P, 2015, FRESHWATER BIOL, V60, P960, DOI 10.1111/fwb.12555; Urrutia-Cordero P, 2013, AQUAT TOXICOL, V130, P9, DOI 10.1016/j.aquatox.2012.12.019; Verspagen JMH, 2005, FRESHWATER BIOL, V50, P854, DOI 10.1111/j.1365-2427.2005.01368.x; Via-Ordorika L, 2004, SYST APPL MICROBIOL, V27, P592, DOI 10.1078/0723202041748163; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Zillen L, 2010, BIOGEOSCIENCES, V7, P2567, DOI 10.5194/bg-7-2567-2010	46	35	35	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153032	10.1371/journal.pone.0153032	http://dx.doi.org/10.1371/journal.pone.0153032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043823	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100064
J	Horvath, G; Kiss, HJ				Horvath, Gergely; Kiss, Hubert Janos			Correlated Observations, the Law of Small Numbers and Bank Runs	PLOS ONE			English	Article							COORDINATION; DIFFUSION; EPIDEMICS; SPREAD	Empirical descriptions and studies suggest that generally depositors observe a sample of previous decisions before deciding if to keep their funds deposited or to withdraw them. These observed decisions may exhibit different degrees of correlation across depositors. In our model depositors decide sequentially and are assumed to follow the law of small numbers in the sense that they believe that a bank run is underway if the number of observed withdrawals in their sample is large. Theoretically, with highly correlated samples and infinite depositors runs occur with certainty, while with random samples it needs not be the case, as for many parameter settings the likelihood of bank runs is zero. We investigate the intermediate cases and find that i) decreasing the correlation and ii) increasing the sample size reduces the likelihood of bank runs, ceteris paribus. Interestingly, the multiplicity of equilibria, a feature of the canonical Diamond-Dybvig model that we use also, disappears almost completely in our setup. Our results have relevant policy implications.	[Horvath, Gergely] Univ Erlangen Nurnberg, Dept Econ Theory, Lange Gasse 20, D-90403 Nurnberg, Bavaria, Germany; [Kiss, Hubert Janos] Eotvos Lorand Univ, Dept Econ, Budapest, Hungary; [Kiss, Hubert Janos] MTA KRTK, Momentum LD Game Theory Res Grp 004 2010, Budapest, Hungary	University of Erlangen Nuremberg; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies	Horvath, G (corresponding author), Univ Erlangen Nurnberg, Dept Econ Theory, Lange Gasse 20, D-90403 Nurnberg, Bavaria, Germany.	horvathgergely@gmail.com	Kiss, Hubert János/C-6313-2016	Kiss, Hubert János/0000-0003-3666-9331	Emerging Field Initiative (EFI Taxation, Social Norms, and Compliance) of the University of Erlangen-Nuremberg; Spanish Ministry of Economics [ECO2014-52372]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Hungarian Scientific Research Fund (OTKA) [109354]; Pallas Athene Domus Scientiae Foundation	Emerging Field Initiative (EFI Taxation, Social Norms, and Compliance) of the University of Erlangen-Nuremberg; Spanish Ministry of Economics(Spanish Government); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Pallas Athene Domus Scientiae Foundation	Gergely Horvath acknowledges the financial support by the Emerging Field Initiative (EFI Taxation, Social Norms, and Compliance) of the University of Erlangen-Nuremberg. Hubert Janos Kiss is grateful for the financial support from the Spanish Ministry of Economics under research project ECO2014-52372, the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences and from the Hungarian Scientific Research Fund (OTKA) under the project 109354. This article was supported by the Pallas Athene Domus Scientiae Foundation. The content of this article expresses the views of the authors only; it cannot be therefore taken as the official standpoint of the Pallas Athene Domus Scientiae Foundation.	Arifovic J, 2013, J ECON DYN CONTROL, V37, P2446, DOI 10.1016/j.jedc.2013.06.016; Arthur WB, 1994, STRONG LAWS CLASS PA, P185; Axelrod R., 2006, EVOLUTION COOPERATIO; Barberis N., 2003, HDB EC FINANCE, P1053; Costain JS, 2007, BE J THEOR ECON, V7; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Davison LK, 2014, J MONETARY ECON, V66, P164, DOI 10.1016/j.jmoneco.2014.05.001; De Graeve F, 2014, J EUR ECON ASSOC, V12, P969, DOI 10.1111/jeea.12080; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; DIAMOND DW, 1983, J POLIT ECON, V91, P401, DOI 10.1086/261155; Ennis HM, 2009, AM ECON REV, V99, P1588, DOI 10.1257/aer.99.4.1588; Ennis HM, 2009, J ECON THEORY, V144, P1996, DOI 10.1016/j.jet.2009.05.001; Eyster E, 2014, Q J ECON; Gandelman N, 2014 FRB ST LOUIS; Garratt R, 2009, J ECON BEHAV ORGAN, V71, P300, DOI 10.1016/j.jebo.2009.03.009; Green EJ, 2003, J ECON THEORY, V109, P1, DOI 10.1016/S0022-0531(02)00017-0; Gu C, 2011, J ECON THEORY, V146, P163, DOI 10.1016/j.jet.2010.06.001; Hartley R, 2014, J APPL ECONOMET, V29, P861, DOI 10.1002/jae.2353; HILL BM, 1980, ANN PROBAB, V8, P214, DOI 10.1214/aop/1176994772; Iyer R, 2012, AM ECON REV, V102, P1414, DOI 10.1257/aer.102.4.1414; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Kelly M, 2000, AM ECON REV, V90, P1110, DOI 10.1257/aer.90.5.1110; Kinateder M, 2014, J FINANC STABIL, V15, P149, DOI 10.1016/j.jfs.2014.09.004; Kiss HJ, 2014, J ECON BEHAV ORGAN, V101, P87, DOI 10.1016/j.jebo.2014.01.019; Kleczkowski A, 1999, PHYSICA A, V274, P355, DOI 10.1016/S0378-4371(99)00393-3; Lopez-Pintado D, 2008, GAME ECON BEHAV, V62, P573, DOI 10.1016/j.geb.2007.08.001; Marlow C, 2010, MAINTAINED RELATIONS, V15; Montanari A, 2010, P NATL ACAD SCI USA, V107, P20196, DOI 10.1073/pnas.1004098107; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; Rabin M, 2002, Q J ECON, V117, P775, DOI 10.1162/003355302760193896; Schotter A, 2009, J FINANC INTERMED, V18, P217, DOI 10.1016/j.jfi.2008.06.002; Shiller RJ, 2015, IRRATIONAL EXUBERANC; Starr MA, 2007, SOUTH ECON J, V73, P1112, DOI 10.2307/20111944; Temzelides T, 1997, J MONETARY ECON, V40, P163, DOI 10.1016/S0304-3932(97)00033-0; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Tversky A., 1974, CONCEPT PROBABILITY, P25; Vega Redondo F, 2006, ECONOMETRIC IN PRESS; Wallace N., 1988, FEDERAL RESERVE BANK, V12; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Ziebarth NL, 2013, RADIO BANK DIS UNPUB	41	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0147268	10.1371/journal.pone.0147268	http://dx.doi.org/10.1371/journal.pone.0147268			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035435	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000373201200001
J	Humada, AM; Hojabri, M; Bin Sulaiman, MH; Hamada, HM; Ahmed, MN				Humada, Ali M.; Hojabri, Mojgan; Bin Sulaiman, Mohd Herwan; Hamada, Hussein M.; Ahmed, Mushtaq N.			Photovoltaic Grid-Connected Modeling and Characterization Based on Experimental Results	PLOS ONE			English	Article							EQUIVALENT-CIRCUIT MODELS; ELECTRIC VEHICLES; PARAMETER-IDENTIFICATION; DIFFERENTIAL EVOLUTION; GENETIC ALGORITHM; MODULES; ULTRACAPACITOR; OPTIMIZATION; EXTRACTION; BATTERY	A grid-connected photovoltaic (PV) system operates under fluctuated weather condition has been modeled and characterized based on specific test bed. A mathematical model of a small-scale PV system has been developed mainly for residential usage, and the potential results have been simulated. The proposed PV model based on three PV parameters, which are the photocurrent, I-L, the reverse diode saturation current, I-o, the ideality factor of diode, n. Accuracy of the proposed model and its parameters evaluated based on different benchmarks. The results showed that the proposed model fitting the experimental results with high accuracy compare to the other models, as well as the I-V characteristic curve. The results of this study can be considered valuable in terms of the installation of a grid-connected PV system in fluctuated climatic conditions.	[Humada, Ali M.; Hojabri, Mojgan; Bin Sulaiman, Mohd Herwan; Ahmed, Mushtaq N.] Univ Malaysia Pahang, Fac Elect & Elect Engn, Pekan, Malaysia; [Humada, Ali M.] Minist Elect, Elect Prod Directorate Salahaldeen, Baiji 34007, Iraq; [Hamada, Hussein M.] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Gambang 26300, Malaysia	Universiti Malaysia Pahang; Universiti Malaysia Pahang	Humada, AM (corresponding author), Univ Malaysia Pahang, Fac Elect & Elect Engn, Pekan, Malaysia.; Humada, AM (corresponding author), Minist Elect, Elect Prod Directorate Salahaldeen, Baiji 34007, Iraq.	alimhm82@yahoo.com	Ahmed, Mushtaq Najeeb/G-4196-2019; Sulaiman, Mohd Herwan/J-5606-2019; Humada, Ali M./X-8703-2019	Ahmed, Mushtaq Najeeb/0000-0002-3087-2390; Sulaiman, Mohd Herwan/0000-0003-2590-3807; 	University Malaysia Pahang [RDU1403133]	University Malaysia Pahang	The financial support was provided by the University Malaysia Pahang, grant no. RDU1403133, http://www.ump.edu.my/.	Akkaya R, 2004, APPL ENERG, V78, P419, DOI 10.1016/j.apenergy.2003.09.005; Amin N, 2009, RENEW ENERG, V34, P1939, DOI 10.1016/j.renene.2008.12.005; Cibira G, 2014, APPL SURFACE SCI; Dizqah AM, 2014, RENEW ENERG, V72, P212, DOI 10.1016/j.renene.2014.07.014; Dkhichi F, 2014, SOL ENERGY, V110, P781, DOI 10.1016/j.solener.2014.09.033; Gong WY, 2013, SOL ENERGY, V94, P209, DOI 10.1016/j.solener.2013.05.007; Hu XS, 2011, J ZHEJIANG UNIV-SC A, V12, P818, DOI 10.1631/jzus.A1100141; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Hu XS, 2012, J POWER SOURCES, V198, P359, DOI 10.1016/j.jpowsour.2011.10.013; Humada AM, 2014, POW EL MOT CONTR C E; Humada AM, 2014, PROPOSED METHOD PHOT; Hurnada AM, 2016, RENEW SUST ENERG REV, V56, P494, DOI 10.1016/j.rser.2015.11.051; Ishaque K, 2011, SOL ENERGY, V85, P2349, DOI 10.1016/j.solener.2011.06.025; Ismail MS, 2013, ENERG CONVERS MANAGE, V73, P10, DOI 10.1016/j.enconman.2013.03.033; Khezzar R, 2014, SOL ENERGY, V110, P452, DOI 10.1016/j.solener.2014.09.039; Laudani A, 2014, APPL ENERG, V111, P894; Micheli D, 2014, ENERG CONVERS MANAGE, V80, P436, DOI 10.1016/j.enconman.2014.01.053; Rajasekar N, 2013, SOL ENERGY, V97, P255, DOI 10.1016/j.solener.2013.08.019; Wolf P, 2013, SOL ENERGY, V93, P151, DOI 10.1016/j.solener.2013.03.018; Yuan XF, 2014, SOL ENERGY, V108, P238, DOI 10.1016/j.solener.2014.07.013; Zhang L, 2014, RESIDUAL CAPACITY ES; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204	25	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152766	10.1371/journal.pone.0152766	http://dx.doi.org/10.1371/journal.pone.0152766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035575	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200034
J	Amiri, FB; Mostafavi, E; Mirzazadeh, A				Amiri, Fahimeh Bagheri; Mostafavi, Ehsan; Mirzazadeh, Ali			HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; HEMOPHILIC PATIENTS; POSITIVE PATIENTS; VIRAL-HEPATITIS; INFECTION; TEHRAN; INMATES; HEALTH	Background worldwide, hepatitis C and B virus infections (HCV and HCV), are the two most common coinfections with human immunodeficiency virus (HIV) and has become a major threat to the survival of HIV-infected persons. The review aimed to estimate the prevalence of HIV, HBV, HCV, HIV/HCV and HIV/HBV and triple coinfections in different subpopulations in Iran. Method Following PRISMA guidelines, we conducted a systematic review and meta-analysis of reports on prevalence of HIV, HBV, HCV and HIV coinfections in different subpopulations in Iran. We systematically reviewed the literature to identify eligible studies from January 1996 to March 2012 in English or Persian/Farsi databases. We extracted the prevalence of HIV antibodies (diagnosed by Elisa confirmed with Western Blot test), HCV antibodies and HBsAg (with confirmatory laboratory test) as the main primary outcome. We reported the prevalence of the three infections and coinfections as point and 95% confidence intervals. Findings HIV prevalence varied from % 0.00 (95% CI: 0.00-0.003) in the general population to % 17.25 (95% CI: 2.94-31.57) in people who inject drugs (PWID). HBV prevalence ranged from % 0.00 (95% CI: 0.00-7.87) in health care workers to % 30.9 (95% CI: 27.88-33.92) in PWID. HCV prevalence ranged from % 0.19 (95% CI: 0.00-0.66) in health care workers to % 51.46 (95% CI: 34.30-68.62) in PWID. The coinfection of HIV/HBV and also HIV/HCV in the general population and in health care workers was zero, while the most common coinfections were HIV/HCV (10.95%), HIV/HBV (1.88%) and triple infections (1.25%) in PWID. Conclusions We found that PWID are severely and disproportionately affected by HIV and the other two infections, HCV and HBV. Screenings of such coinfections need to be reinforced to prevent new infections and also reduce further transmission in their community and to others.	[Amiri, Fahimeh Bagheri; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Amiri, Fahimeh Bagheri] Univ Tehran, Dept Epidemiol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Hamadan, Iran; [Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mostafavi, Ehsan; Mirzazadeh, Ali] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Mostafavi, Ehsan; Mirzazadeh, Ali] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of Tehran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; University of California System; University of California San Francisco; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization	Mostafavi, E (corresponding author), Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Hamadan, Iran.; Mirzazadeh, A (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Mostafavi, E; Mirzazadeh, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran.; Mostafavi, E; Mirzazadeh, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran.	mostafavi@pasteur.ac.ir; ali.mirzazadeh@ucsf.edu	Mirzazadeh, Ali/AAJ-5907-2021; Amiri, Fahimeh Bagheri/M-7724-2019; Mostafavi, Ehsan/A-7627-2011	Amiri, Fahimeh Bagheri/0000-0003-2943-2846; Mostafavi, Ehsan/0000-0002-1997-517X				Alavian S, 2002, KOWSAR MED J, V7, P1; Alavian S, 1994, J TONGJI MED U, V14, P178; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; [Anonymous], 2010, KOWSAR MADICAL J; Assarehzadegan MA, 2008, INT J INFECT DIS, V12, P387, DOI 10.1016/j.ijid.2007.09.015; Ataei B, 2010, SEROPREVALENCE HEPAT, P67; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Azarkar Z., 2007, J BIRJAND U MED SCI, V14, P9; Azarkar Z, 2010, HEPAT MON, V10, P26; Brundtland GH, 2002, JAMA-J AM MED ASSOC, V288, P1974, DOI 10.1001/jama.288.16.1974; Davoodian P, 2009, BRAZ J INFECT DIS, V13, P356, DOI 10.1590/S1413-86702009000500008; Esmaieli H, 2007, BUSHEHR IRANIAN J IN, V12, P85; Fauci AS, 2012, JAMA-J AM MED ASSOC, V308, P343, DOI 10.1001/jama.2012.8142; Ghafoorian-Broujerdnia M, 2006, SCI MED J, V5; Ghafouri M., 2011, BLOOD Q SCI J IRAN B, V7, P242; Ghafourian Boroujerdnia M, 2009, SCI MED J AJUMS, V7, pPe454; Ghafourian Boroujerdnia M, 2009, SCI MED J AJUMS, V7, pEn551; Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349; Hariri M, 2006, SCI J IRAN BLOOD TRA, V2, P201; Haydari E, 2011, INT C HIV AIDS WOM C; Hosseini M, 2010, ARCH IRAN MED, V13, P318, DOI 010134/AIM.0012; Javadi A, 2014, J RES MED SCI OFFICI, V19, pS17; Javadzadeh-Shashahani H, 2004, SCU J IRAN BLOOD TRA, V7, P315; Kalantari H, 2011, IRAN J CLIN INFECT D, V6; kazeminejad V., 2005, J GORGAN U MED SCI, V7, P84; Khajehkazemi R, 2013, HIV PREVALENCE RISK; Khani M, 2003, ARCH IRAN MED, V6, P1; Kheradpezhouh Maryam, 2007, Journal of Microbiology Immunology and Infection, V40, P106; KHORVASH F, 2009, JQUMS, V13, P23; Khumeisipour GR, 2001, IRANIAN S MED J, V3, P53; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Mahdaviani F, 2006, SCI J IRAN BLOOD TRA, V2, P343; Mahdaviani F, 2008, BLOOD SCI J IRAN, V4, P313; Mansouritorghabeh H., 2008, IRAN J BLOOD CANC, V1, P1; Mansouritorghabeh H, 2008, HEPAT MON, V8, P221; Mardani A, 2006, SCI J IRAN BLOOD TRA; Mardani A, 2010, IRANIAN J INFECT DIS, V49, P31; Masaeli Z, 2006, SCI J IRAN BLOOD TRA, V2, P301; Massoud A, 1996, TEHRAN U MED J TUMJ, V54, P3; Mirmomen Shahram, 2006, Arch Iran Med, V9, P319; Mohammadi M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-202; Mohebi Nobandegani Z, 2003, ARMAGHANE DANESH J, V8, P47; Nabavizadeh S, 2000, J GUILAN U MED SCI; Naini MM, 2007, HEPAT MON, V7, P59; Navadeh S, 2013, SEX TRANSM INFECT, V89, P33, DOI 10.1136/sextrans-2013-051295; Oshvandi K, 2009, SCI J HAMADAN NURSIN, V17, P57; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Pourahmad M, 2007, INFECT DIS CLIN PRAC, V15, P368, DOI 10.1097/IPC.0b013e318142ce16; Pourazar A., 2006, SJIBTO S, V2, P323; Rahimi-Movaghar A, 2011, INT J DRUG POLICY; Rahimi-Movaghar A, 2010, INT J INFECT DIS, V14, pE28, DOI 10.1016/j.ijid.2009.03.002; Razzaghi Emran M, 2006, Harm Reduct J, V3, P12; Sadeghi M, 2009, J DENT EDUC, V73, P740; Sahaf F., 2007, RES J MED SCI, V1, P138; Salehi AS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-19; Salehi H, 2011, J ISFAHAN MED SCH, V28; Sammak H, 2010, QOM U MED SCI J, V4, P17; Sanaei-Zadeh H, 2002, TEHRAN CAPITAL IRAN, P2; Sayad B, 2004, 13 C IR INF DIS TROP; Shamsian B, 2008, BLOOD TRANSFUSION ST; Sofian M, 2012, J ADDICT MED, V6, P292, DOI 10.1097/ADM.0b013e3182659928; Soleimani Z, 2007, ANTIHIV DENT KASH 20; Torabi S, 2005, BLOOD KHOON; UNAIDS, 2014, ISL REP IR AIDS PROG; UNPD, 2015, ENH NAT HIV RESP FOC; Vahdani Parviz, 2006, Arch Iran Med, V9, P153; Walusansa V, 2009, AFR HEALTH SCI, V9, P143; Ye SD, 2014, CURR HIV-AIDS REP, V11, P128, DOI 10.1007/s11904-014-0206-z; Zamani S, 2005, AIDS, V19, P709, DOI 10.1097/01.aids.0000166094.24069.72; Zamani S, 2007, INT J DRUG POLICY, V18, P359, DOI 10.1016/j.drugpo.2007.02.007; Zamani S, 2010, SEX TRANSM DIS, V37, P715, DOI 10.1097/OLQ.0b013e3181e2c73f; Ziaee M, 2007, HEPAT MON, V7, P11	73	57	58	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151946	10.1371/journal.pone.0151946	http://dx.doi.org/10.1371/journal.pone.0151946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031352	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800025
J	Shawwa, K; Kallas, R; Koujanian, S; Agarwal, A; Neumann, I; Alexander, P; Tikkinen, KAO; Guyatt, G; Akl, EA				Shawwa, Khaled; Kallas, Romy; Koujanian, Serge; Agarwal, Arnav; Neumann, Ignacio; Alexander, Paul; Tikkinen, Kari A. O.; Guyatt, Gordon; Akl, Elie A.			Requirements of Clinical Journals for Authors' Disclosure of Financial and Non-Financial Conflicts of Interest: A Cross Sectional Study	PLOS ONE			English	Article							INTEREST POLICIES; GUIDELINES	Importance It is unclear how medical journals address authors' financial and non-financial conflict of interest (COI). Objective To assess the policies of clinical journals for disclosure of financial and non-financial COI. Methods Cross sectional study that included both review of public documents as well as a simulation of a manuscript submission for the National Library of Medicine's "core clinical journals". The study did not involve human subjects. Investigators who abstracted the data, reviewed "instructions for authors" on the journal website and, in order to reflect the actual implementation of the COI disclosure policy, simulated the submission of a manuscript. Two individuals working in duplicate and independently to abstract information using a standardized data abstraction form, resolved disagreements by discussion or with the help of a third person. Results All but one of 117 core clinical journals had a COI policy. All journals required disclosure of financial COI pertaining to the authors and a minority (35%) asked for financial COI disclosure pertaining to the family members or authors' institution (29%). Over half required the disclosure of at least one form of non-financial COI (57%), out of which only two (3%) specifically referred to intellectual COI. Small minorities of journals (17% and 24% respectively) described a potential impact of disclosed COI and of non-disclosure of COI on the editorial process. Conclusion While financial COI disclosure was well defined by the majority of the journals, many did not have clear policies on disclosure of non-financial COI, disclosure of financial COI of family members and institutions of the authors, and effect of disclosed COI or non-disclosure of COI on editorial policies.	[Shawwa, Khaled] Amer Univ Beirut, Clin Res Inst, Beirut, Lebanon; [Kallas, Romy; Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Koujanian, Serge] Lebanese Amer Univ, Fac Med, Beirut, Lebanon; [Agarwal, Arnav; Neumann, Ignacio; Alexander, Paul; Tikkinen, Kari A. O.; Guyatt, Gordon; Akl, Elie A.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Dept Internal Med, Alameda 340, Santiago, Chile	American University of Beirut; American University of Beirut; Lebanese American University; McMaster University; Pontificia Universidad Catolica de Chile	Akl, EA (corresponding author), Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.; Akl, EA (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	ea32@aub.edu.lb	Agarwal, Arnav/J-1553-2014; Neumann, Ignacio/ABB-5013-2020; Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019; Shawwa, Khaled/AAC-4501-2019; Tikkinen, Kari/L-3632-2018	Agarwal, Arnav/0000-0002-0931-7851; Akl, Elie A/0000-0002-3444-8618; Shawwa, Khaled/0000-0001-8849-5244; Tikkinen, Kari/0000-0002-1389-8214	American University of Beirut Faculty of Medicine's Medical Practice Plan (MPP) funds	American University of Beirut Faculty of Medicine's Medical Practice Plan (MPP) funds	This project was partly funded by the American University of Beirut Faculty of Medicine's Medical Practice Plan (MPP) funds. There were no other funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoul H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035247; Baethge C, 2013, PEERJ, V1, DOI 10.7717/peerj.128; Barbour V, 2008, PLOS MED, V5, P1299, DOI 10.1371/journal.pmed.0050199; Bion J, 2009, CURR OPIN CRIT CARE, V15, P583, DOI 10.1097/MCC.0b013e328332f53a; Blum JA, 2009, JAMA-J AM MED ASSOC, V302, P2230, DOI 10.1001/jama.2009.1669; Bosch X, 2013, EUR J CLIN INVEST, V43, P660, DOI 10.1111/eci.12090; Boyd Elizabeth A, 2012, Proc Am Thorac Soc, V9, P234, DOI 10.1513/pats.201208-057ST; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; Drazen JM, 2010, NEW ENGL J MED, V363, P188, DOI 10.1056/NEJMe1006030; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Kesselheim AS, 2012, CANCER-AM CANCER SOC, V118, P188, DOI 10.1002/cncr.26237; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Lo B, 2009, CONFLICT INTEREST ME; Lo B, 2009, POLICIES CONFLICT IN; Luborsky L, 1999, CLIN PSYCHOL-SCI PR, V6, P95, DOI 10.1093/clipsy/6.1.95; Maharaj SVM, 2015, INT J OCCUP ENV HEAL, V21, P49, DOI 10.1179/2049396714Y.0000000097; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Panagiotou OA, 2012, J CLIN EPIDEMIOL, V65, P740, DOI 10.1016/j.jclinepi.2012.01.008; Probst P, 2015, SURGERY, V157, P627, DOI 10.1016/j.surg.2014.11.012; Rasmussen K, 2015, J ROY SOC MED, V108, P101, DOI 10.1177/0141076814557878; Schunemann HJ, 2009, AM J RESP CRIT CARE, V180, P564, DOI 10.1164/rccm.200901-0126ST	22	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152301	10.1371/journal.pone.0152301	http://dx.doi.org/10.1371/journal.pone.0152301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030966	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800052
J	Warwick-Evans, VC; Atkinson, PW; Robinson, LA; Green, JA				Warwick-Evans, Victoria C.; Atkinson, Philip W.; Robinson, Leonie A.; Green, Jonathan A.			Predictive Modelling to Identify Near-Shore, Fine-Scale Seabird Distributions during the Breeding Season	PLOS ONE			English	Article							SHAGS PHALACROCORAX-ARISTOTELIS; SPECIES DISTRIBUTION; HABITAT SELECTION; TOP PREDATOR; PREY; BEHAVIOR; PERFORMANCE; LOCATIONS; ECOLOGY; IMPACT	During the breeding season seabirds are constrained to coastal areas and are restricted in their movements, spending much of their time in near-shore waters either loafing or foraging. However, in using these areas they may be threatened by anthropogenic activities such as fishing, watersports and coastal developments including marine renewable energy installations. Although many studies describe large scale interactions between seabirds and the environment, the drivers behind near-shore, fine-scale distributions are not well understood. For example, Alderney is an important breeding ground for many species of seabird and has a diversity of human uses of the marine environment, thus providing an ideal location to investigate the near-shore fine-scale interactions between seabirds and the environment. We used vantage point observations of seabird distribution, collected during the 2013 breeding season in order to identify and quantify some of the environmental variables affecting the near-shore, fine-scale distribution of seabirds in Alderney's coastal waters. We validate the models with observation data collected in 2014 and show that water depth, distance to the intertidal zone, and distance to the nearest seabird nest are key predictors in the distribution of Alderney's seabirds. AUC values for each species suggest that these models perform well, although the model for shags performed better than those for auks and gulls. While further unexplained underlying localised variation in the environmental conditions will undoubtedly effect the fine-scale distribution of seabirds in near-shore waters we demonstrate the potential of this approach in marine planning and decision making.	[Warwick-Evans, Victoria C.; Robinson, Leonie A.; Green, Jonathan A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Atkinson, Philip W.] British Trust Ornithol, Thetford, Norfolk, England	University of Liverpool; British Trust for Ornithology	Warwick-Evans, VC (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	v.warwick-evans@liverpool.ac.uk	Green, Jonathan A/B-8799-2011; Atkinson, Philip/B-8975-2009	Green, Jonathan A/0000-0001-8692-0163; Atkinson, Philip/0000-0002-0838-557X	Natural Environment Research Council [NE/K500975/1]; Alderney Commission for Renewable Energy	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Alderney Commission for Renewable Energy	Funding was provided by Natural Environment Research Council PhD studentship to VWE NE/K500975/1; and Alderney Commission for Renewable Energy, http://www.acre.gov.gg/, to VWE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim P, 2009, ICES J MAR SCI, V66, P29, DOI 10.1093/icesjms/fsn175; [Anonymous], 2016, GADM DATABASE GLOBAL; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barrett RT, 1990, ORNIS SCAND, P179; Barton K., 2014, MUMIN MULTIMODEL INF; Bates D., 2013, LME4 LINEAR MIXED EF; Becker BH, 2003, MAR ECOL PROG SER, V256, P243, DOI 10.3354/meps256243; Benjamins S, 2015, OCEANOGR MAR BIOL, V53, P1; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Burger AE, 1997, COLON WATERBIRD, V20, P55, DOI 10.2307/1521764; Camphuysen C.J., 2004, STANDARDISED SEABIRD; Carney KM, 1999, WATERBIRDS, V22, P68, DOI 10.2307/1521995; Cox SL, 2013, MAR ECOL PROG SER, V479, P203, DOI 10.3354/meps10176; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Davoren GK, 2003, MAR ECOL PROG SER, V256, P229, DOI 10.3354/meps256229; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Embling CB, 2013, PROG OCEANOGR, V117, P106, DOI 10.1016/j.pocean.2013.06.013; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; Favero M, 2014, ANIM CONSERV, V17, P532, DOI 10.1111/acv.12180; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Furness RW, 2012, ICES J MAR SCI, V69, P1466, DOI 10.1093/icesjms/fss131; Gremillet D, 1998, IBIS, V140, P113, DOI 10.1111/j.1474-919X.1998.tb04547.x; Guinet C, 1998, P ROY SOC B-BIOL SCI, V265, P1001, DOI 10.1098/rspb.1998.0390; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris Michael P., 2012, Ringing & Migration, V27, P43; Hawkins P., 2004, MEM NATL I POLAR RES, V58, P58; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hope BK, 2006, ENVIRON INT, V32, P983, DOI 10.1016/j.envint.2006.06.005; Hunt G.L. Jr, 1987, P7; HUNT GL, 1999, P 22 INT ORN C DURB, P2040; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Knights AM, 2014, ENVIRON SCI POLICY, V39, P56, DOI 10.1016/j.envsci.2014.02.010; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martin E, 2014, ALDERNEY REGIONAL EN; Mehlum Fridtjof, 2001, Marine Ornithology, V29, P19; Morley T, 2014, ANN RAMSAR PROJECT R; Myers L, 2005, RENEW ENERG, V30, P1713, DOI 10.1016/j.renene.2005.02.008; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Oedekoven CS, 2001, MAR ECOL PROG SER, V212, P265, DOI 10.3354/meps212265; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rome MS, 2004, WATERBIRDS, V27, P200, DOI 10.1675/1524-4695(2004)027[0200:FEAIBH]2.0.CO;2; Scales KL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0679; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Scott BE, 2010, MAR ECOL PROG SER, V408, P207, DOI 10.3354/meps08552; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Soanes LM, 2013, MAR POLICY, V38, P507, DOI 10.1016/j.marpol.2012.08.006; Soanes LM, 2013, J APPL ECOL, V50, P671, DOI 10.1111/1365-2664.12069; Stevick PT, 2008, MAR ECOL PROG SER, V363, P15, DOI 10.3354/meps07475; STONE CJ, 1995, BIRD STUDY, V42, P50, DOI 10.1080/00063659509477148; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Thompson DR, 1999, TROPHIC RELATIONSHIP, P898; Waggitt JJ, 2014, INT J MAR ENERGY, V8, P36, DOI 10.1016/j.ijome.2014.10.004; Waggitt JJ, 2013, USING SPATIAL OVERLA; Wanless S, 1998, ICES J MAR SCI, V55, P1141, DOI 10.1006/jmsc.1998.0372; WANLESS S, 1991, IBIS, V133, P30, DOI 10.1111/j.1474-919X.1991.tb04806.x; WANLESS S, 1993, J ZOOL, V231, P11, DOI 10.1111/j.1469-7998.1993.tb05349.x; Warwick-Evans V, 2015, MAR ECOL PROG SER, V527, P233, DOI 10.3354/meps11262; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Wilson LJ, 2009, BIOL CONSERV, V142, P1808, DOI 10.1016/j.biocon.2009.03.019; Witt MJ, 2012, PHILOS T R SOC A, V370, P502, DOI 10.1098/rsta.2011.0265	66	17	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150592	10.1371/journal.pone.0150592	http://dx.doi.org/10.1371/journal.pone.0150592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031616	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800007
J	Pourzanjani, A; Quisel, T; Foschini, L				Pourzanjani, Arya; Quisel, Tom; Foschini, Luca			Adherent Use of Digital Health Trackers Is Associated with Weight Loss	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PROGRAMS; EXERCISE; PROGRESS; OBESITY	We study the association between weight fluctuation and activity tracking in an on-line population of thousands of individuals using digital health trackers (1,749 <= N <= 14,411, depending on the activity tracker considered) with millions of recorded activities (119,292 <= N <= 2,221,382) over the years 2013-2015. In a first between-subject analysis, we found a positive association between activity tracking frequency and weight loss. Users who log food with moderate frequency lost an additional 0.63% (CI [0.55, 0.72]; p < .001) of their body weight per month relative to low frequency loggers. Frequent workout loggers lost an additional 0.38%(CI [0.20, 0.56]; p < .001) and frequent weight loggers lost an additional 0.40% (CI [0.33, 0.47]; p < .001) as compared to infrequent loggers. In a subsequent within-subject analysis on a subset of the population (799 <= N <= 6,052) with sufficient longitudinal data, we used fixed effect models to explore the temporal relationship between a change in tracking adherence and weight change. We found that for the same individual, weight loss is significantly higher during periods of high adherence to tracking vs. periods of low adherence: +2.74% of body weight lost per month (CI [2.68, 2.81]; p < .001) during adherent weight tracking, +1.35% per month (CI [1.26, 1.43]; p < .001) during adherent food tracking, and +0.60% per month (CI [0.44, 0.76]; p < .001) during adherent workout tracking. The findings suggest that adherence to activity tracking can be utilized as a convenient real-time predictor of weight fluctuations, enabling large-scale, personalized intervention strategies.	[Pourzanjani, Arya; Quisel, Tom; Foschini, Luca] Evidat Hlth, Menlo Pk, CA USA		Pourzanjani, A (corresponding author), Evidat Hlth, Menlo Pk, CA USA.	lfoschini@evidation.com	Foschini, Luca/H-6876-2015	Foschini, Luca/0000-0001-9062-3647				[Anonymous], FUT BIOS WEAR; Bagchi R, 2011, J CONSUM RES, V37, P888, DOI 10.1086/656392; BAKER RC, 1993, BEHAV THER, V24, P377, DOI 10.1016/S0005-7894(05)80212-6; Baker RC, 1998, HEALTH PSYCHOL, V17, P367, DOI 10.1037/0278-6133.17.4.367; Boutelle KN, 1998, OBES RES, V6, P219, DOI 10.1002/j.1550-8528.1998.tb00340.x; Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Burke LE, 2008, CONTEMP CLIN TRIALS, V29, P182, DOI 10.1016/j.cct.2007.07.004; Burke LE, 2012, AM J PREV MED, V43, P20, DOI 10.1016/j.amepre.2012.03.016; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Burke LE, 2009, QUAL HEALTH RES, V19, P815, DOI 10.1177/1049732309335395; Carels RA, 2005, ANN BEHAV MED, V30, P182, DOI 10.1207/s15324796abm3003_2; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Croissant Y., 2008, J STAT SOFTWARE, V27; Dionne MM, 2005, J NUTR EDUC BEHAV, V37, P315, DOI 10.1016/S1499-4046(06)60162-0; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Gokee-LaRose J, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-10; Helander EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113164; Helsel DL, 2007, J AM DIET ASSOC, V107, P1807, DOI 10.1016/j.jada.2007.07.014; Illner AK, 2012, INT J EPIDEMIOL, V41, P1187, DOI 10.1093/ije/dys105; John LK, 2011, J GEN INTERN MED, V26, P621, DOI 10.1007/s11606-010-1628-y; Khan L. K., 2009, RECOMMENDED COMMUNIT; McCarthy J, 2014, US ADULT OBESITY RAT; McGuire S, 2012, ADV NUTR, V3, P708, DOI 10.3945/an.112.002733; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Plank W., FUTURE WEARABLES MAR; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; R Core Team, 2013, R LANG ENV STAT COMP; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; VanWormer JJ, 2012, INT J BEHAV MED, V19, P351, DOI 10.1007/s12529-011-9178-1; VanWormer JJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-54; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883	36	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152504	10.1371/journal.pone.0152504	http://dx.doi.org/10.1371/journal.pone.0152504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049859	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500045
J	Salkeld, G; Cunich, M; Dowie, J; Howard, K; Patel, MI; Mann, G; Lipworth, W				Salkeld, Glenn; Cunich, Michelle; Dowie, Jack; Howard, Kirsten; Patel, Manish I.; Mann, Graham; Lipworth, Wendy			The Role of Personalised Choice in Decision Support: A Randomized Controlled Trial of an Online Decision Aid for Prostate Cancer Screening	PLOS ONE			English	Article							HEALTH-CARE; MORTALITY; MEN	Importance Decision support tools can assist people to apply population-based evidence on benefits and harms to individual health decisions. A key question is whether "personalising" choice within decisions aids leads to better decision quality. Objective To assess the effect of personalising the content of a decision aid for prostate cancer screening using the Prostate Specific Antigen (PSA) test. Design Randomized controlled trial. Setting Australia. Participants 1,970 men aged 40-69 years were approached to participate in the trial. Intervention 1,447 men were randomly allocated to either a standard decision aid with a fixed set of five attributes or a personalised decision aid with choice over the inclusion of up to 10 attributes. Outcome Measures To determine whether there was a difference between the two groups in terms of: 1) the emergent opinion (generated by the decision aid) to have a PSA test or not; 2) self-rated decision quality after completing the online decision aid; 3) their intention to undergo screening in the next 12 months. We also wanted to determine whether men in the personalised choice group made use of the extra decision attributes. Results 5% of men in the fixed attribute group scored 'Have a PSA test' as the opinion generated by the aid, as compared to 62% of men in the personalised choice group (chi(2) = 569.38, 2df, p<0001). Those men who used the personalised decision aid had slightly higher decision quality (t = 2.157, df = 1444, p = 0.031). The men in the personalised choice group made extensive use of the additional decision attributes. There was no difference between the two groups in terms of their stated intention to undergo screening in the next 12 months. Conclusions Together, these findings suggest that personalised decision support systems could be an important development in shared decision-making and patient-centered care.	[Salkeld, Glenn] Univ Wollongong, Fac Social Sci, Wollongong, NSW, Australia; [Cunich, Michelle] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Cunich, Michelle] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Dowie, Jack] London Sch Hyg & Trop Med, London WC1, England; [Salkeld, Glenn; Howard, Kirsten] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Patel, Manish I.] Westmead Hosp, Westmead Clin Sch, Sydney, NSW, Australia; [Mann, Graham] Westmead Hosp, Westmead Inst Med Res, Sydney, NSW, Australia; [Lipworth, Wendy] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia	University of Wollongong; University of Sydney; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Salkeld, G (corresponding author), Univ Wollongong, Fac Social Sci, Wollongong, NSW, Australia.; Salkeld, G (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	gsalkeld@uow.edu.au	; Mann, Graham/G-4758-2014	Dowie, Jack/0000-0002-4572-9562; Cunich, Michelle/0000-0002-0163-3665; Mann, Graham/0000-0003-1301-405X; Lipworth, Wendy/0000-0002-0234-657X; Howard, Kirsten/0000-0002-0918-7540	National Health and Medical Research Council of Australia [6633003]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was undertaken as part of the Screening and Diagnostic Test Evaluation Program funded by the National Health and Medical Research Council of Australia under Program Grant number 6633003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, TEST PROST CANC 2010; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Australian Health Technology Advisory Committee, 1996, PROSTATE CANCER SCRE; Barton MK, 2014, CA-CANCER J CLIN, V64, P221, DOI 10.3322/caac.21229; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Cunich M, 2011, PATIENT, V4, P153, DOI 10.2165/11587070-000000000-00000; Dolan JG, 2010, PATIENT, V3, P229, DOI 10.2165/11539470-000000000-00000; Dolan JG, 2008, PATIENT EDUC COUNS, V73, P418, DOI 10.1016/j.pec.2008.07.032; Dorfman CS, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-12; Dowie J, 2015, HEALTH EXPECT, V18, P689, DOI 10.1111/hex.12111; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; Evans R, 2005, PATIENT EDUC COUNS, V58, P13, DOI 10.1016/j.pec.2004.06.009; Gaissmaier W, 2011, STRUNGMANN FORUM REP, P29; Gattellari M, 2003, J MED SCREEN, V10, P27, DOI 10.1258/096914103321610789; Gigerenzer G, 2011, STRUNGMANN FORUM REP, P3; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Hacking B, 2014, PSYCHO-ONCOLOGY, V23, P665, DOI 10.1002/pon.3466; Hacking B, 2013, PSYCHO-ONCOLOGY, V22, P1017, DOI 10.1002/pon.3093; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Kaltoft M, 2014, J HEALTH SERV RES PO, V19, P110, DOI 10.1177/1355819613511076; Krist AH, 2007, ANN FAM MED, V5, P112, DOI 10.1370/afm.623; Lim LS, 2008, AM J PREV MED, V34, P164, DOI 10.1016/j.amepre.2007.10.003; MacKenzie R, 2007, J ROY SOC MED, V100, P513, DOI 10.1258/jrsm.100.11.513; Marsh K, 2014, PHARMACOECONOMICS, V32, P345, DOI 10.1007/s40273-014-0135-0; Mayo Clinic, 2013, PROST CANC SCREEN SH; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Health Service, PSA PROST SPEC ANT T; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Option Grid Collaborative, 2015, PROST SPEC ANT PSA T; Schapira MM, 2000, J FAM PRACTICE, V49, P418; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U.S. Preventive Services Task Force, SHAR DEC SCREEN CHEM; UK National Screening Committee, UK SCREEN PORT PROGR; Urological Society of Australia and New Zealand, USANZ PSA TEST POL 2; Volk RJ, 2007, AM J PREV MED, V33, P428, DOI 10.1016/j.amepre.2007.07.030; Watson E, 2006, PATIENT EDUC COUNS, V63, P367, DOI 10.1016/j.pec.2006.05.005; Weber MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-429; Williams N, 2011, BJU INT, V108, P1402, DOI 10.1111/j.1464-410X.2011.10163.x; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	42	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152999	10.1371/journal.pone.0152999	http://dx.doi.org/10.1371/journal.pone.0152999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050101	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000373603500081
J	Soares, B; Rajao, R; Merry, F; Rodrigues, H; Davis, J; Lima, L; Macedo, M; Coe, M; Carneiro, A; Santiago, L				Soares-Filho, Britaldo; Rajao, Raoni; Merry, Frank; Rodrigues, Hermann; Davis, Juliana; Lima, Leticia; Macedo, Marcia; Coe, Michael; Carneiro, Arnaldo; Santiago, Leonardo			Brazil's Market for Trading Forest Certificates	PLOS ONE			English	Article							AMAZON; DEFORESTATION; BIOMASS; CARBON	Brazil faces an enormous challenge to implement its revised Forest Code. Despite big losses for the environment, the law introduces new mechanisms to facilitate compliance and foster payment for ecosystem services (PES). The most promising of these is a market for trading forest certificates (CRAs) that allows landowners to offset their restoration obligations by paying for maintaining native vegetation elsewhere. We analyzed the economic potential for the emerging CRA market in Brazil and its implications for PES programs. Results indicate a potential market for trading 4.2 Mha of CRAs with a gross value of US$9.2 +/- 2.4 billion, with main regional markets forming in the states of Mato Grosso and Sao Paulo. This would be the largest market for trading forests in the world. Overall, the potential supply of CRAs in Brazilian states exceeds demand, creating an opportunity for additional PES programs to use the CRA market. This expanded market could provide not only monetary incentives to conserve native vegetation, but also environmental co-benefits by fostering PES programs focused on biodiversity, water conservation, and climate regulation. Effective implementation of the Forest Code will be vital to the success of this market and this hurdle brings uncertainty into the market. Long-term commitment, both within Brazil and abroad, will be essential to overcome the many challenges ahead.	[Soares-Filho, Britaldo; Rodrigues, Hermann; Davis, Juliana; Lima, Leticia] Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil; [Rajao, Raoni; Santiago, Leonardo] Univ Fed Minas Gerais, Lab Gestao Serv Ambientais, Belo Horizonte, MG, Brazil; [Merry, Frank] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Lima, Leticia] Humboldt Univ, IRI THESys, Unter Linden 6, D-10099 Berlin, Germany; [Macedo, Marcia; Coe, Michael] Woods Hole Res Ctr, Falmouth, MA USA; [Carneiro, Arnaldo] Agroicone, Ave Gen Furtado do Nascimento, Sao Paulo, Brazil; [Santiago, Leonardo] Copenhagen Business Sch, Solbjerg Pl 3, Frederiksberg, Denmark	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Virginia Polytechnic Institute & State University; Humboldt University of Berlin; Woods Hole Research Center; Copenhagen Business School	Soares, B (corresponding author), Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Belo Horizonte, MG, Brazil.	britaldo@csr.ufmg.br	Santiago, Leonardo/G-3017-2011; Rajão, Raoni/GPX-3719-2022; Lima, Letícia Santos de/F-3694-2014; Macedo, Marcia N/N-3044-2017	Santiago, Leonardo/0000-0002-7041-7480; Rajão, Raoni/0000-0002-1133-4837; Lima, Letícia Santos de/0000-0002-0268-2055; Macedo, Marcia N/0000-0001-8102-5901	Climate and Land Use Alliance; Deutsche Gesellschaft fur Internationale Zusammenarbeit; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Servamb; Gordon and Betty Moore Foundation; AgroIcone	Climate and Land Use Alliance; Deutsche Gesellschaft fur Internationale Zusammenarbeit; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Servamb; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); AgroIcone	This work was supported by the Climate and Land Use Alliance, Deutsche Gesellschaft fur Internationale Zusammenarbeit, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Servamb, and the Gordon and Betty Moore Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AgroIcone provided support in the form of salary for one author [AC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], PROJ AGR BRAS 2013 2; Arrow Kenneth., 1993, FED REGISTER, V58, P4601, DOI DOI 10.1002/QJ.49703213905; Banco Nacional de Desenvolvimento Economico e Social do Brasil, 2015, IN BND MAT ATL; Bateman I., 2002, EC VALUATION STATED; Bernasconi P, 2013, THESIS U CAMPINAS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; Chomitz Kenneth M., 2005, Rev. Econ. Sociol. Rural, V43, P657, DOI 10.1590/S0103-20032005000400003; Costa TL, 2014, PLANT SOIL, V378, P113, DOI 10.1007/s11104-013-2009-1; Costa WLS, 2013, THESIS U FEDERAL MIN; Empresa de Pesquisa Energetica, 2014, NOT TECN DEA 13 14 D; Escobar H, 2015, SCIENCE, V347, P812, DOI 10.1126/science.347.6224.812; Fearnside PM, 2009, FOREST ECOL MANAG, V258, P1968, DOI 10.1016/j.foreco.2009.07.042; FNP, 2014, CONSULTORIA COMERCLO; Young CEF, 2014, NAT CONSERVACAO, V12, P71, DOI 10.4322/natcon.2014.013; Fundacao SOS Mata Atlantica, 2014, ATL REM FLOR MAT ATL; Gibbs HK, 2015, SCIENCE, V347, P377, DOI 10.1126/science.aaa0181; Gibbs HK, 2016, CONSERV LETT, V9, P32, DOI 10.1111/conl.12175; Gouvello C., 2010, BRAZIL LOW CARBON CO; Graca PMLDA, 1999, FOREST ECOL MANAG, V120, P179; Gupta A, 2012, CURR OPIN ENV SUST, V4, P726, DOI 10.1016/j.cosust.2012.10.004; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hissa LDV, 2014, T GIS, V18, P449, DOI 10.1111/tgis.12098; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; IBGE, 2012, MANUAL TECNICO DA VE; Industria Brasileira de Arvores, 2014, AN EST 2014; Instituto Brasileiro de Economia da Fundacao Getulio Vargas, IND PREC AGR RIO JAN; Instituto Brasileiro de Geografia e Estatistica, CENS DEM; Instituto Brasileiro de Geografia e Estatistica, PROD AGR MUN CULT TE; Instituto Brasileiro de Geografia e Estatistica, 2006, 01036157 I BRAS GEOG; Instituto Nacional de Pesquisas Espaciais, PROJ PRODES MON FLOR; Instituto Nacional de Pesquisas Espaciais, PROJ TERR; Instituto Nacional de Pesquisas Espaciais, SUG MON SAT IM; Laboratorio de Processamento de Imagens e Geoprocessamento, DAD VET AL DESM PER; Leite CC, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004133; Lima LS, 2012, P 17 C BRASILEIRO ME; Lopez-Gonzalez G., 2014, GLOBAL ECOL BIOGEOGR; Madsen B., 2011, UPDATE STATE BIODIVE; May P. H., 2015, CIFOR Occasional Paper; Millennium Ecosystem Assessment, 2005, 1597260401; Ministerio do Meio Ambiente, 2007, 9788577380763 MIN ME; Ministerio do Meio Ambiente, 2016, CADASTRO AMBIENTAL R; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Ottmar RD, 2001, STEREO PHOTO SERIES; Rajao R, 2015, SCIENCE, V350, P519, DOI 10.1126/science.350.6260.519-a; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Rosenfield MF, 2014, REV BIOL TROP, V62, P359, DOI 10.15517/rbt.v62i1.7923; Sampaio E.V.S.B., 2011, REV BRAS GEOGRAFIA F, V6, P1275, DOI DOI 10.26848/rbgf.v4i6.232783; SCHKADE DA, 1994, J ENVIRON ECON MANAG, V26, P88, DOI 10.1006/jeem.1994.1006; Schotter A, 2008, MICROECONOMICS MODEM; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2013, ENVIRON MODELL SOFTW, V43, P80, DOI 10.1016/j.envsoft.2013.01.010; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Soares-Filho BS, 2013, 9788561968045; Sonter LJ, 2014, CONSERV BIOL, V28, P1068, DOI 10.1111/cobi.12260; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Terra FS, 2014, PESQUI AGROPECU BRAS, V45, P384; Vibrans A. C., 2010, Pesquisa Florestal Brasileira, V30, P291, DOI 10.4336/2010.pfb.30.64.291	59	48	48	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152311	10.1371/journal.pone.0152311	http://dx.doi.org/10.1371/journal.pone.0152311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050309	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500032
J	Ballesteros, Y; Polidori, C; Tormos, J; Banos-Picon, L; Asis, JD				Ballesteros, Yolanda; Polidori, Carlo; Tormos, Jose; Banos-Picon, Laura; Asis, Josep D.			Falling Victim to Wasps in the Air: A Fate Driven by Prey Flight Morphology?	PLOS ONE			English	Article							CERCERIS-ARENARIA HYMENOPTERA; GOLDEN DIGGER WASP; NEOTROPICAL BUTTERFLIES; NESTING-BEHAVIOR; PREDATION RISK; BODY-SIZE; DIET PREFERENCE; BEMBIX-MERCETI; MUSCLE RATIO; PERFORMANCE	In prey-predator systems where the interacting individuals are both fliers, the flight performance of both participants heavily influences the probability of success of the predator (the prey is captured) and of the prey (the predator is avoided). While the flight morphology (an estimate of flight performance) of predatory wasps has rarely been addressed as a factor that may contribute to explain prey use, how the flight morphology of potential prey influences the output of predator-prey encounters has not been studied. Here, we hypothesized that flight morphology associated with flight ability (flight muscle mass to body mass ratio (FMR) and body mass to wing area ratio (wing loading, WL)) of Diptera affect their probability of being captured by specialized Diptera-hunting wasps (Bembix merceti and B. zonata), predicting a better manoeuvrability and acceleration capacity achieved by higher FMR and lower WL, and flight speed achieved by higher WL. In addition, wasp species with better flight morphology should be less limited by an advantageous Diptera flight morphology. Overall, the abundance of dipterans in the environment explained an important part of the observed variance in prey capture rate. However, it was not the only factor shaping prey capture. First, higher prey abundance was associated with greater capture rate for one species (B. merceti), although not for the other one. Second, the interaction observed between the environmental dipteran availability and dipteran WL for B. zonata suggests that greater dipteran WL (this probably meaning high cruising speed) decreased the probability of being captured, as long as fly abundance was high in the environment. Third, greater dipteran FMR (which likely means high manoeuvrability and acceleration capacity) helped to reduce predation by B. merceti if, again, dipterans were abundant in the environment. Wasp WL only varied with body mass but not between species, thereby hardly accounting for interspecific differences in the wasps' predatory patterns. However, the greater FMR of B. zonata, which implies better flight performance and greater load-lifting capacity, may explain why the capture rate in the two wasp species is affected by different factor interactions. In conclusion, although prey availability remains the primary factor shaping prey use, prey flight morphology seems to gain an additional role under conditions of abundant prey, when wasps can avoid flies with better flight ability.	[Ballesteros, Yolanda; Tormos, Jose; Banos-Picon, Laura; Asis, Josep D.] Univ Salamanca, Fac Biol, Area Zool, E-37008 Salamanca, Spain; [Polidori, Carlo] Univ Castilla La Mancha, Inst Ciencias Ambientales ICAM, Ave Carlos 3 S-N, E-45071 Toledo, Spain; [Polidori, Carlo] Univ Lisbon, Ctr Environm & Marine Studies CESAM, Dept Biol Anim, Fac Ciencias, C2-P3 Campo Grande, P-1749016 Lisbon, Portugal	University of Salamanca; Universidad de Castilla-La Mancha; Universidade de Lisboa	Ballesteros, Y (corresponding author), Univ Salamanca, Fac Biol, Area Zool, E-37008 Salamanca, Spain.	ballesteros.y@outlook.com	Polidori, Carlo/G-4382-2010; Asís, Josep D/K-5623-2014; Baños-Picón, Laura/A-7675-2017	Polidori, Carlo/0000-0003-4834-0752; Asís, Josep D/0000-0001-8134-1875; Baños-Picón, Laura/0000-0003-0500-8231	Junta de Castilla y Leon [SA094A09, SA010A06]; MICINN [CGL2010-16730]; Universidad de Salamanca-Santander Bank grant; Universidad de Castilla La Mancha; FSE; FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant [SFRH/BPD/100460/2014]	Junta de Castilla y Leon(Junta de Castilla y Leon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Universidad de Salamanca-Santander Bank grant; Universidad de Castilla La Mancha; FSE(European Social Fund (ESF)); FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant	This work was supported by the Projects SA094A09 and SA010A06 (Junta de Castilla y Leon) and CGL2010-16730 (MICINN). YB was funded by a Universidad de Salamanca-Santander Bank grant. CP was funded by a post-doctoral contract funded by Universidad de Castilla La Mancha and the FSE, and by a FCT (Fundacao para a Ciencia e a Tecnologia) post-doctoral grant (SFRH/BPD/100460/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman M, 2009, ECOL ENTOMOL, V34, P783, DOI 10.1111/j.1365-2311.2009.01126.x; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; ALDRIDGE HDJN, 1987, J EXP BIOL, V128, P419; ALEXANDER B, 1985, J NAT HIST, V19, P1139, DOI 10.1080/00222938500770711; Almbro M, 2009, BEHAV ECOL SOCIOBIOL, V63, P413, DOI 10.1007/s00265-008-0675-4; Almbro M, 2008, J EXP BIOL, V211, P24, DOI 10.1242/jeb.008219; Almbro M, 2012, J INSECT BEHAV, V25, P441, DOI 10.1007/s10905-011-9309-1; Asis JD, 2011, BEHAVIOUR, V148, P191, DOI 10.1163/000579510X551651; Asis JD, 2004, J NAT HIST, V38, P1799, DOI 10.1080/0022293031000156295; ASIS JD, 1992, DEUT ENTOMOL Z, V39, P221, DOI 10.1002/mmnd.19920390402; Asis JD, 2014, ETHOLOGY, V120, P340, DOI 10.1111/eth.12208; Ballesteros Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102325; Ballesteros Y, 2012, ANN SOC ENTOMOL FR, V48, P281, DOI 10.1080/00379271.2012.10697777; BEDNEKOFF PA, 1994, EVOL ECOL, V8, P36, DOI 10.1007/BF01237664; Bednekoff PA, 1996, P ROY SOC B-BIOL SCI, V263, P887, DOI 10.1098/rspb.1996.0131; Begon M., 2009, ECOLOGY INDIVIDUALS; BELWOOD JJ, 1976, CAN J ZOOL, V54, P1674, DOI 10.1139/z76-194; Bernard F., 1934, Bulletin de la Societe Entomologique de France Paris, V39, P247; Bernard F., 1935, Annales de la Societe Entomologique de France, V104, P31; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; BROCKMANN HJ, 1985, J KANSAS ENTOMOL SOC, V58, P631; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; CASEY TM, 1983, PHYSIOL ZOOL, V56, P160, DOI 10.1086/physzool.56.2.30156049; CHAI P, 1990, AM NAT, V135, P398; Coelho JR, 2008, J HYMENOPT RES, V17, P57; COELHO JR, 1995, FUNCT ECOL, V9, P171, DOI 10.2307/2390561; Coelho JR, 1999, ECOL ENTOMOL, V24, P480, DOI 10.1046/j.1365-2311.1999.00219.x; Coelho JR, UNPUB; Coello C., 2011, PREDATION HYMENOPTER, P23; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Domenici P, 2001, COMP BIOCHEM PHYS A, V131, P169, DOI 10.1016/S1095-6433(01)00465-2; DUDLEY R, 1994, J EXP BIOL, V191, P125; DUDLEY R, 1990, J EXP BIOL, V150, P37; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Evans HE., 2007, SAND WASPS NATURAL H; GRIFFITHS D, 1975, ECOLOGY, V56, P1209, DOI 10.2307/1936161; Gurevitz JM, 2007, J MED ENTOMOL, V44, P186, DOI 10.1603/0022-2585(2007)44[186:FMDAHI]2.0.CO;2; Hastings JM, 2008, FLA ENTOMOL, V91, P657; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Herzner G, 2005, ANIM BEHAV, V70, P1411, DOI 10.1016/j.anbehav.2005.03.032; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Kullberg C, 2000, AUK, V117, P1034, DOI 10.1642/0004-8038(2000)117[1034:HMFLIP]2.0.CO;2; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lind J, 1999, BEHAV ECOL SOCIOBIOL, V46, P65, DOI 10.1007/s002650050593; Linehan JE, 2001, J EXP MAR BIOL ECOL, V263, P25, DOI 10.1016/S0022-0981(01)00287-8; MARDEN JH, 1991, AM NAT, V138, P15, DOI 10.1086/285202; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; MARDEN JH, 1987, J EXP BIOL, V130, P235; Martin J, 2006, BEHAV ECOL SOCIOBIOL, V60, P778, DOI 10.1007/s00265-006-0221-1; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Norberg Ulla M., 1994, P205; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Polidori C, 2005, EUR J ENTOMOL, V102, P801, DOI 10.14411/eje.2005.111; Polidori C, 2009, J ZOOL, V279, P187, DOI 10.1111/j.1469-7998.2009.00605.x; Polidori C, 2011, PREDATION HYMENOPTER, P101; Polidori C, 2007, ZOOL STUD, V46, P83; Polidori C, 2015, CR BIOL, V338, P126, DOI 10.1016/j.crvi.2014.11.001; Polidori C, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-36; Polidori C, 2013, OIKOS, V122, P385, DOI 10.1111/j.1600-0706.2012.20387.x; Polidori C, 2010, BIOL J LINN SOC, V99, P544, DOI 10.1111/j.1095-8312.2009.01397.x; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; RYDELL J, 1986, HOLARCTIC ECOL, V9, P272; Spataro T, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00133.1; SRYGLEY RB, 1990, OECOLOGIA, V84, P491, DOI 10.1007/BF00328165; SRYGLEY RB, 1993, J EXP BIOL, V174, P155; STARMER WT, 1989, BIOL J LINN SOC, V37, P247, DOI 10.1111/j.1095-8312.1989.tb01903.x; STUBBLEFIELD JW, 1993, PHILOS T R SOC B, V339, P397, DOI 10.1098/rstb.1993.0039; SWIFT SM, 1985, J ANIM ECOL, V54, P217, DOI 10.2307/4632; Vogel S, 2008, INTEGR COMP BIOL, V48, P702, DOI 10.1093/icb/icn014; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x	77	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152256	10.1371/journal.pone.0152256	http://dx.doi.org/10.1371/journal.pone.0152256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046238	Green Submitted, gold, Green Published			2022-12-27	WOS:000373599600011
J	Kim, JI; Park, S; Lee, I; Park, KS; Kwak, EJ; Moon, KM; Lee, CK; Bae, JY; Park, MS; Song, KJ				Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Lee, Chang Kyu; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon			Genome-Wide Analysis of Human Metapneumovirus Evolution	PLOS ONE			English	Article							AVIAN METAPNEUMOVIRUS; GENETIC-VARIABILITY; YOUNG-CHILDREN; RNA VIRUSES; INFECTION; SEQUENCE; RECOMBINATION; CIRCULATION; PREVALENCE; DIVERSITY	Human metapneumovirus (HMPV) has been described as an important etiologic agent of upper and lower respiratory tract infections, especially in young children and the elderly. Most of school-aged children might be introduced to HMPVs, and exacerbation with other viral or bacterial super-infection is common. However, our understanding of the molecular evolution of HMPVs remains limited. To address the comprehensive evolutionary dynamics of HMPVs, we report a genome-wide analysis of the eight genes (N, P, M, F, M2, SH, G, and L) using 103 complete genome sequences. Phylogenetic reconstruction revealed that the eight genes from one HMPV strain grouped into the same genetic group among the five distinct lineages (A1, A2a, A2b, B1, and B2). A few exceptions of phylogenetic incongruence might suggest past recombination events, and we detected possible recombination breakpoints in the F, SH, and G coding regions. The five genetic lineages of HMPVs shared quite remote common ancestors ranging more than 220 to 470 years of age with the most recent origins for the A2b sublineage. Purifying selection was common, but most protein genes except the F and M2-2 coding regions also appeared to experience episodic diversifying selection. Taken together, these suggest that the five lineages of HMPVs maintain their individual evolutionary dynamics and that recombination and selection forces might work on shaping the genetic diversity of HMPVs.	[Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon] Korea Univ, Dept Microbiol, Inst Viral Dis, Seoul 136705, South Korea; [Kim, Jin Il; Park, Sehee; Lee, Ilseob; Park, Kwang Sook; Kwak, Eun Jung; Moon, Kwang Mee; Bae, Joon-Yong; Park, Man-Seong; Song, Ki-Joon] Korea Univ, Coll Med, Korea Bank Pathogen Viruses, Seoul 136705, South Korea; [Lee, Chang Kyu] Korea Univ, Coll Med, Dept Lab Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Song, KJ (corresponding author), Korea Univ, Dept Microbiol, Inst Viral Dis, Seoul 136705, South Korea.; Song, KJ (corresponding author), Korea Univ, Coll Med, Korea Bank Pathogen Viruses, Seoul 136705, South Korea.	songmicr@korea.ac.kr	Kim, Young-jin/GSD-3168-2022; Park, Man-Seong/AAF-1207-2020	Bae, Joon-Yong/0000-0002-2483-4208; Kim, Jin Il/0000-0001-8833-2138	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2010-0004691];  [PRJNA73051];  [PRJNA237298]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; ; 	This research was supported by the Bio & Medical Technology Development Program of the NRF (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi=sso-return2=none) funded by the Korean government, MSIP (NRF-2010-0004691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Mortimer Poncz (University of Pennsylvania, Department of Pediatrics and Children's Hospital of Philadelphia, PA, USA) for comments on the manuscript. We also would like to thank Dr. John V. Williams and his colleagues for their contribution to providing abundant amount of HMPV complete genome sequences through BioProject PRJNA73051 and to thank Dr. David E. Wentworth and his colleagues for their contribution through BioProject PRJNA237298.	[Anonymous], TRACER V1 6; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Buchholz U., 2012, NAMING CONVENTION HU; Buitendijk H, 2014, VIRUSES-BASEL, V6, P1442, DOI 10.3390/v6031442; Carneiro BM, 2009, J MED VIROL, V81, P1814, DOI 10.1002/jmv.21555; Chung JY, 2008, J MED VIROL, V80, P902, DOI 10.1002/jmv.21129; Collins PL, 2013, RESP SYNCYTIAL VIRUS; Cox RG, 2013, VIRUSES-BASEL, V5, P192, DOI 10.3390/v5010192; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Domingo E, 1998, ADV EXP MED BIOL, V440, P721; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Escobar C, 2009, J MED VIROL, V81, P340, DOI 10.1002/jmv.21399; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Gaunt E, 2015, J GEN VIROL, V96, P1067, DOI 10.1099/vir.0.000062; Govindarajan D, 2004, VIRUS RES, V105, P59, DOI 10.1016/j.virusres.2004.04.014; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; Holmes EC, 2013, FIELDS VIROLOGY; Huck B, 2006, J CLIN MICROBIOL, V44, P2300, DOI 10.1128/JCM.00152-06; Hughes AL, 2007, GENE, V404, P117, DOI 10.1016/j.gene.2007.09.013; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayali G, 2011, VECTOR-BORNE ZOONOT, V11, P1453, DOI 10.1089/vbz.2011.0637; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Kim HR, 2012, J MOL DIAGN, V14, P61, DOI 10.1016/j.jmoldx.2011.09.004; Kim JH, 2009, IEEE INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN ROBOTICS AND AUTOMATION, P159; Lamb RA, 2013, PARAMYXOVIRIDAE; Li JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034544; Lo Presti A, 2011, NEW MICROBIOL, V34, P337; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Lwamba HCM, 2005, VIRUS RES, V107, P83, DOI 10.1016/j.virusres.2004.07.002; Mackay IM, 2006, J INFECT DIS, V193, P1630, DOI 10.1086/504260; Melero JA, 2015, VIRUS RES, V209, P128, DOI 10.1016/j.virusres.2015.02.024; Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Neemuchwala A, 2015, J MED VIROL, V87, P269, DOI 10.1002/jmv.24024; Nei M., 2000, MOL EVOLUTION PHYLOG; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Opperdoes FR, 2009, PHYLOGENETIC HDB PRA; Padhi A, 2009, J VIROL, V83, P2015, DOI 10.1128/JVI.02047-08; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Papenburg J, 2013, J CLIN VIROL, V58, P541, DOI 10.1016/j.jcv.2013.08.029; Papenburg J, 2010, REV MED VIROL, V20, P245, DOI 10.1002/rmv.651; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Pizzorno A, 2010, J MED VIROL, V82, P861, DOI 10.1002/jmv.21752; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12288, DOI 10.1073/pnas.1402981111; Ren J, 2015, J GEN VIROL, V96, P1515, DOI 10.1099/vir.0.000083; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Salemi M, 2009, PHYLOGENETIC HDB PRA, Vxxvi; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Schuster JE, 2013, PEDIATR REV, V34, P558, DOI 10.1542/pir.34-12-558; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Slater OM, 2014, EMERG INFECT DIS, V20, P2115, DOI 10.3201/eid2012.140408; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Rueda AJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063070; Vrancken B, 2015, METHODS ECOL EVOL, V6, P67, DOI 10.1111/2041-210X.12293; Zappa A, 2011, J MED VIROL, V83, P156, DOI 10.1002/jmv.21940	67	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152962	10.1371/journal.pone.0152962	http://dx.doi.org/10.1371/journal.pone.0152962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046055	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600052
J	Matsushima-Nishiwaki, R; Toyoda, H; Nagasawa, T; Yasuda, E; Chiba, N; Okuda, S; Maeda, A; Kaneoka, Y; Kumada, T; Kozawa, O				Matsushima-Nishiwaki, Rie; Toyoda, Hidenori; Nagasawa, Tomoaki; Yasuda, Eisuke; Chiba, Naokazu; Okuda, Seiji; Maeda, Atsuyuki; Kaneoka, Yuji; Kumada, Takashi; Kozawa, Osamu			Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-alpha-Induced Migration and Invasion of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; EXPRESSION; HSP20; TRANSPLANTATION; PROGRESSION; METASTASIS; RECURRENCE; ACTIVATION; KINASES; SPREAD	Human hepatocellular carcinoma (HCC) is one of the major malignancies in the world. Small heat shock proteins (HSPs) are reported to play an important role in the regulation of a variety of cancer cell functions, and the functions of small HSPs are regulated by posttranslational modifications such as phosphorylation. We previously reported that protein levels of a small HSP, HSP20 (HSPB6), decrease in vascular invasion positive HCC compared with those in the negative vascular invasion. Therefore, in the present study, we investigated whether HSP20 is implicated in HCC cell migration and the invasion using human HCC-derived HuH7 cells. The transforming growth factor (TGF)-alpha-induced migration and invasion were suppressed in the wild-type-HSP20 overexpressed cells in which phosphorylated HSP20 was detected. Phospho-mimic-HSP20 overexpression reduced the migration and invasion compared with unphosphorylated HSP20 overexpression. Dibutyryl cAMP, which enhanced the phosphorylation of wild-type-HSP20, significantly reduced the TGF-alpha-induced cell migration of wild-type HSP20 overexpressed cells. The TGF-a-induced cell migration was inhibited by SP600125, a c-Jun N-terminal kinases (JNK) inhibitor. In phospho-mimic-HSP20 overexpressed HuH7 cells, TGF-alpha-stimulated JNK phosphorylation was suppressed compared with the unphosphorylated HSP20 overexpressed cells. Moreover, the level of phospho-HSP20 protein in human HCC tissues was significantly correlated with tumor invasion. Taken together, our findings strongly suggest that phosphorylated HSP20 inhibits TGF-a-induced HCC cell migration and invasion via suppression of the JNK signaling pathway.	[Matsushima-Nishiwaki, Rie; Nagasawa, Tomoaki; Chiba, Naokazu; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan; [Yasuda, Eisuke] Suzuka Univ, Med Sci, Dept Radiol Technol, Suzuka, Mie, Japan; [Okuda, Seiji] Ogaki Municipal Hosp, Dept Med Technol, Ogaki, Gifu, Japan; [Maeda, Atsuyuki; Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Ogaki, Gifu, Japan	Gifu University; Ogaki Municipal Hospital; Ogaki Municipal Hospital; Ogaki Municipal Hospital	Kozawa, O (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460989]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (25460989 to O.K.) from the Ministry of Education, Science, Sports and Culture of Japan. https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Yumiko Kurokawa for her skillful technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (25460989 to O.K.) from the Ministry of Education, Science, Sports and Culture of Japan.	Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; BOULIKAS T, 1995, CRIT REV EUKAR GENE, V5, P1; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Hou CH, 2014, BIOCHEM PHARMACOL, V89, P453, DOI 10.1016/j.bcp.2014.03.010; JASKIEWICZ K, 1995, ANTICANCER RES, V15, P559; JCMM, 2014, J CELL MOL MED, V18, P218, DOI DOI 10.1111/JCMM.12153; Kinoshita A, 2015, WORLD J HEPATOL, V7, P406, DOI 10.4254/wjh.v7.i3.406; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440; Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nagasawa T, 2015, ARCH BIOCHEM BIOPHYS, V565, P1, DOI 10.1016/j.abb.2014.10.010; Nagasawa T, 2014, ONCOL REP, V32, P1291, DOI 10.3892/or.2014.3278; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Niwa M, 2009, NEUROL RES, V31, P721, DOI 10.1179/174313209X380946; Noda T, 2007, ONCOL REP, V17, P1309; Poon RTP, 2007, ANN SURG, V245, P51, DOI 10.1097/01.sla.0000225255.01668.65; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; Sefton B M, 2001, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1401s00; Sneag DB, 2011, AM J ROENTGENOL, V197, pW658, DOI 10.2214/AJR.10.6402; Suzuki M, 2015, ARCH BIOCHEM BIOPHYS, V571, P40, DOI 10.1016/j.abb.2015.02.030; Toso C, 2011, AM J TRANSPLANT, V11, P2031, DOI 10.1111/j.1600-6143.2011.03689.x; Voll EA, 2014, ONCOTARGET, V5, P2648, DOI 10.18632/oncotarget.1917; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yeh CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079406, 10.1371/journal.pone.0056661]; YEH YC, 1987, CANCER RES, V47, P896; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032765; Zhang Y, 2014, WORLD J GASTROENTERO, V20, P142, DOI 10.3748/wjg.v20.i1.142	40	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151907	10.1371/journal.pone.0151907	http://dx.doi.org/10.1371/journal.pone.0151907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046040	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600007
J	Blanco-Perez, M; Perez-Canamas, M; Ruiz, L; Hernandez, C				Blanco-Perez, Marta; Perez-Canamas, Miryam; Ruiz, Leticia; Hernandez, Carmen			Efficient Translation of Pelargonium line pattern virus RNAs Relies on a TED-Like 3 '-Translational Enhancer that Communicates with the Corresponding 5 '-Region through a Long-Distance RNA-RNA Interaction	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; TOBACCO NECROSIS VIRUS; PLANT VIRAL RNAS; SATELLITE TOBACCO; MESSENGER-RNA; UNTRANSLATED REGIONS; FAMILY TOMBUSVIRIDAE; GENOME ORGANIZATION; LOOP INTERACTIONS; STEM-LOOP	Cap-independent translational enhancers (CITEs) have been identified at the 3'-terminal regions of distinct plant positive-strand RNA viruses belonging to families Tombusviridae and Luteoviridae. On the bases of their structural and/or functional requirements, at least six classes of CITEs have been defined whose distribution does not correlate with taxonomy. The so-called TED class has been relatively under-studied and its functionality only confirmed in the case of Satellite tobacco necrosis virus, a parasitic subviral agent. The 3' untranslated region of the monopartite genome of Pelargonium line pattern virus (PLPV), the recommended type member of a tentative new genus (Pelarspovirus) in the family Tombusviridae, was predicted to contain a TED-like CITE. Similar CITEs can be anticipated in some other related viruses though none has been experimentally verified. Here, in the first place, we have performed a reassessment of the structure of the putative PLPV-TED through in silico predictions and in vitro SHAPE analysis with the full-length PLPV genome, which has indicated that the presumed TED element is larger than previously proposed. The extended conformation of the TED is strongly supported by the pattern of natural sequence variation, thus providing comparative structural evidence in support of the structural data obtained by in silico and in vitro approaches. Next, we have obtained experimental evidence demonstrating the in vivo activity of the PLPV-TED in the genomic (g) RNA, and also in the subgenomic (sg) RNA that the virus produces to express 3'-proximal genes. Besides other structural features, the results have highlighted the key role of long-distance kissing-loop interactions between the 3'-CITE and 5'-proximal hairpins for gRNA and sgRNA translation. Bioassays of CITE mutants have confirmed the importance of the identified 5'-3' RNA communication for viral infectivity and, moreover, have underlined the strong evolutionary constraints that may operate on genome stretches with both regulatory and coding functions.	[Blanco-Perez, Marta; Perez-Canamas, Miryam; Ruiz, Leticia; Hernandez, Carmen] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain; [Ruiz, Leticia] IFAPA, Crop Protect, La Mojonera, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Hernandez, C (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46022 Valencia, Spain.	cahernan@ibmcp.upv.es	Hernandez, C./R-2047-2018; Garcia, Leticia Ruiz/AAE-4291-2021	Hernandez, C./0000-0003-1192-6223; Garcia, Leticia Ruiz/0000-0002-8612-966X; BLANCO-PEREZ, MARTA/0000-0001-5200-014X; Perez-Canamas, Miryam/0000-0002-0767-277X	Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain) [BFU2009-11699, BFU2012-36095]; Ministerio de Economia y Competitividad (MINECO, Spain); Generalitat Valenciana [ACOMP/2012/100]; predoctoral and postdoctoral (Juan de la Cierva program) from MICINN; predoctoral contract from MINECO	Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain); Ministerio de Economia y Competitividad (MINECO, Spain)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); predoctoral and postdoctoral (Juan de la Cierva program) from MICINN; predoctoral contract from MINECO	This work was supported by grants BFU2009-11699 and BFU2012-36095 from the Ministerio de Investigacion, Ciencia e Innovacion (MICINN, Spain, www.micinn.es) and the Ministerio de Economia y Competitividad (MINECO, Spain, http://www.mineco.gob.es), respectively, and ACOMP/2012/100 from the Generalitat Valenciana (http://www.gva.es) (to C.H.). MBP and LR were the recipients of a predoctoral and postdoctoral (Juan de la Cierva program) contract, respectively, from MICINN, and MPC was the recipient of a predoctoral contract from MINECO.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Batten JS, 2006, FEBS LETT, V580, P2591, DOI 10.1016/j.febslet.2006.04.006; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Castano A, 2007, ACTA VIROL, V51, P271; Castano A, 2005, ARCH VIROL, V150, P949, DOI 10.1007/s00705-004-0464-y; Castano A, 2011, VIRUS RES, V155, P274, DOI 10.1016/j.virusres.2010.10.022; Castano A, 2009, VIROLOGY, V386, P417, DOI 10.1016/j.virol.2009.01.017; Chattopadhyay M, 2014, VIROLOGY, V458, P43, DOI 10.1016/j.virol.2014.03.027; Chattopadhyay M, 2011, VIROLOGY, V417, P113, DOI 10.1016/j.virol.2011.05.007; DANTHINNE X, 1993, MOL CELL BIOL, V13, P3340, DOI 10.1128/MCB.13.6.3340; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gallie DR, 1996, PLANT MOL BIOL, V32, P145, DOI 10.1007/BF00039381; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Hermann T, 2000, STRUCTURE, V8, pR47, DOI 10.1016/S0969-2126(00)00110-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kinard GR, 2002, ACTA HORTIC, P17, DOI 10.17660/ActaHortic.2002.568.1; Komarova AV, 2009, ADV VIRUS RES, V73, P99, DOI 10.1016/S0065-3527(09)73003-9; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Liang XZ, 2002, J VIROL, V76, P12320, DOI 10.1128/JVI.76.23.12320-12324.2002; Lopez-Carrasco A, 2016, RNA BIOL, V13, P83, DOI 10.1080/15476286.2015.1119365; Martinez-Turino S, 2011, VIROLOGY, V413, P310, DOI 10.1016/j.virol.2011.03.001; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; Meulewaeter F, 1998, PLANT J, V14, P169, DOI 10.1046/j.1365-313X.1998.00104.x; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miras M, 2014, NEW PHYTOL, V202, P233, DOI 10.1111/nph.12650; Nicholson BL, 2013, J VIROL, V87, P1872, DOI 10.1128/JVI.02711-12; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; Nicholson BL, 2010, RNA, V16, P1402, DOI 10.1261/rna.2135210; Panavas T, 2002, VIROLOGY, V296, P263, DOI 10.1006/viro.2002.1423; Parsch J, 2000, GENETICS, V154, P909; Perez-Canamas M, 2015, J BIOL CHEM, V290, P3106, DOI 10.1074/jbc.M114.593707; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Rico P, 2006, J VIROL, V80, P8124, DOI 10.1128/JVI.00603-06; Rochon D, 2014, ICTV TAXONOMIC PROPO; Rochon D., 2012, 9 REPORT INT COMMITT, P1111, DOI DOI 10.1007/S00705-003-0258-7; Scheets K, 2015, ICTV TAXONOMIC PROPO; Scheets K, 2015, ARCH VIROL, V160, P2385, DOI 10.1007/s00705-015-2500-5; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; Stupina VA, 2011, J VIROL, V85, P4638, DOI 10.1128/JVI.00005-11; TIMMER RT, 1993, J BIOL CHEM, V268, P9504; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Van Lipzig R, 2002, RNA, V8, P229, DOI 10.1017/S1355838202018071; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wu BD, 1999, J VIROL, V73, P8982, DOI 10.1128/JVI.73.11.8982-8988.1999; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	11	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152593	10.1371/journal.pone.0152593	http://dx.doi.org/10.1371/journal.pone.0152593			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043436	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100018
J	Nguyen, C; Carlson, JM				Chantal Nguyen; Carlson, Jean M.			Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model	PLOS ONE			English	Article							FOOT	Real-time vaccination following an outbreak can effectively mitigate the damage caused by an infectious disease. However, in many cases, available resources are insufficient to vaccinate the entire at-risk population, logistics result in delayed vaccine deployment, and the interaction between members of different cities facilitates a wide spatial spread of infection. Limited vaccine, time delays, and interaction (or coupling) of cities lead to tradeoffs that impact the overall magnitude of the epidemic. These tradeoffs mandate investigation of optimal strategies that minimize the severity of the epidemic by prioritizing allocation of vaccine to specific subpopulations. We use an SIR model to describe the disease dynamics of an epidemic which breaks out in one city and spreads to another. We solve a master equation to determine the resulting probability distribution of the final epidemic size. We then identify tradeoffs between vaccine, time delay, and coupling, and we determine the optimal vaccination protocols resulting from these tradeoffs.	[Chantal Nguyen; Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Nguyen, C (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	cnguyen@physics.ucsb.edu		Nguyen, Chantal/0000-0001-7354-8147	David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies from U.S. Army Research Office [W911NF-09-D-0001]; David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies from U.S. Army Research Office [W911NF-09-D-0001]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies from U.S. Army Research Office; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies from U.S. Army Research Office	This work was supported by the David and Lucile Packard Foundation (https://www.packard.org/) and the Institute for Collaborative Biotechnologies (https://www.icb.ucsb.edu/) through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LJS, 1991, MATH BIOSCI, V105, P111, DOI 10.1016/0025-5564(91)90051-J; BAILEY NTJ, 1953, BIOMETRIKA, V40, P177, DOI 10.2307/2333107; Black AJ, 2015, J THEOR BIOL, V367, P159, DOI 10.1016/j.jtbi.2014.11.029; Black AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1019; Borse RH, 2013, EMERG INFECT DIS, V19, P439, DOI 10.3201/eid1903.120394; Centers for Disease Control, 2009, ALL DISTR Q A; Earn DJD, 1998, P ROY SOC B-BIOL SCI, V265, P7, DOI 10.1098/rspb.1998.0256; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Hethcote H.W., 1973, Mathematical Biosci, V18, P365, DOI 10.1016/0025-5564(73)90011-4; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; House T, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0436; Jenkinson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036160; Keeling MJ, 2012, EPIDEMICS-NETH, V4, P78, DOI 10.1016/j.epidem.2012.03.001; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Petrovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033285; Rhodes CJ, 1997, P ROY SOC B-BIOL SCI, V264, P1639, DOI 10.1098/rspb.1997.0228; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Yen C, 2015, LANCET INFECT DIS, V15, P340, DOI 10.1016/S1473-3099(14)70999-5; Yuan EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115826	25	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152950	10.1371/journal.pone.0152950	http://dx.doi.org/10.1371/journal.pone.0152950			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043931	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100054
J	Slatyer, RA; Schoville, SD				Slatyer, Rachel A.; Schoville, Sean D.			Physiological Limits along an Elevational Gradient in a Radiation of Montane Ground Beetles	PLOS ONE			English	Article							THERMAL TOLERANCE; WATER-LOSS; RANGE LIMITS; STRESS RESISTANCE; TEMPERATURE; COLEOPTERA; CARABIDAE; SURVIVAL; INSECTS; TRAITS	A central challenge in ecology and biogeography is to determine the extent to which physiological constraints govern the geographic ranges of species along environmental gradients. This study tests the hypothesis that temperature and desiccation tolerance are associated with the elevational ranges of 12 ground beetle species (genus Nebria) occurring on Mt. Rainier, Washington, U.S.A. Species from higher elevations did not have greater cold tolerance limits than lower-elevation species (all species ranged from -3.5 to -4.1 degrees C), despite a steep decline in minimum temperature with elevation. Although heat tolerance limits varied among species (from 32.0 to 37.0 degrees C), this variation was not generally associated with the relative elevational range of a species. Temperature gradients and acute thermal tolerance do not support the hypothesis that physiological constraints drive species turnover with elevation. Measurements of intraspecific variation in thermal tolerance limits were not significant for individuals taken at different elevations on Mt. Rainier, or from other mountains in Washington and Oregon. Desiccation resistance was also not associated with a species' elevational distribution. Our combined results contrast with previously-detected latitudinal gradients in acute physiological limits among insects and suggest that other processes such as chronic thermal stress or biotic interactions might be more important in constraining elevational distributions in this system.	[Slatyer, Rachel A.] Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia; [Slatyer, Rachel A.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Schoville, Sean D.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Melbourne; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison	Slatyer, RA (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic 3052, Australia.; Slatyer, RA (corresponding author), Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia.	rslatyer@gmail.com	Schoville, Sean D./J-8061-2012; Schoville, Sean D./AAY-5324-2020	Schoville, Sean D./0000-0001-7364-434X; Schoville, Sean D./0000-0001-7364-434X	National Geographic Young Explorer's Grant [9502-14]; Seattle City Light Wildlife Research Grant [2014-03]; University of Melbourne; University of Wisconsin	National Geographic Young Explorer's Grant(National Geographic Society); Seattle City Light Wildlife Research Grant; University of Melbourne(University of Melbourne); University of Wisconsin	Funding was provided by a National Geographic Young Explorer's Grant to RAS (#9502-14), a Seattle City Light Wildlife Research Grant to SDS (#2014-03), the University of Melbourne and the University of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; AHEARN GA, 1970, J EXP BIOL, V53, P573; Akaike H, 1973, 2 INT S INF THEOR, P276; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bird JM, 2005, ECOL ENTOMOL, V30, P510, DOI 10.1111/j.0307-6946.2005.00719.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; BRETT JR, 1956, Q REV BIOL, V31, P75, DOI 10.1086/401257; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cadena CD, 2007, ECOGRAPHY, V30, P491, DOI 10.1111/j.2007.0906-7590.05045.x; Cahill AE, 2014, J BIOGEOGR, V41, P429, DOI 10.1111/jbi.12231; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Crozier LG, 2004, OECOLOGIA, V141, P148, DOI 10.1007/s00442-004-1634-z; Cunningham HR, 2016, ECOGRAPHY, V39, P1, DOI 10.1111/ecog.01369; de lasVega G.J., 2015, ECOGRAPHY, V38, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1111/EC0G.01028; Drummond A., 2007, TRACER MCMC TRACE AN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endler J.A., 1977, Monographs in Population Biology, pi; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freckleton RP, 2009, J EVOLUTION BIOL, V22, P1367, DOI 10.1111/j.1420-9101.2009.01757.x; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gaston KJ, 1999, OIKOS, V86, P584, DOI 10.2307/3546663; Geiger R., 1995, CLIMATE NEAR GROUND; GEREBEN BA, 1995, ARCTIC ALPINE RES, V27, P371, DOI 10.2307/1552030; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Greene SE, 1985, SOIL AIR TEMPERATURE, P50; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; HADLEY NF, 1985, COMP BIOCHEM PHYS A, V80, P307, DOI 10.1016/0300-9629(85)90042-8; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hayward SAL, 2001, J INSECT PHYSIOL, V47, P11, DOI 10.1016/S0022-1910(00)00088-3; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; HUNTLEY B, 1989, J BIOGEOGR, V16, P551, DOI 10.2307/2845210; Hutchinson G.E., 1957, COLD SPRING HARBOR S; Jombart T., 2008, ADEPHYLO EXPLORATORY; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kamp J.W., 1973, BIOSYSTEMATICS GRYLL; Kavanaugh D.H., 1979, P369; Kavanaugh D.H., 1979, P35; Kavanaugh D.H, 1978, NEARCTIC SPECIES NEB; Kavanaugh D.H., 1985, TAXONOMY PHYLOGENY Z, P408; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Koivula MJ, 2011, ZOOKEYS, P287, DOI 10.3897/zookeys.100.1533; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Larsen TH, 2012, BIOTROPICA, V44, P82, DOI 10.1111/j.1744-7429.2011.00768.x; Lee JE, 2009, P ROY SOC B-BIOL SCI, V276, P1459, DOI 10.1098/rspb.2008.1240; MacArthur R.H., 1972, pvii; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; MacMillan HA, 2014, J EXP BIOL, V217, P2930, DOI 10.1242/jeb.107516; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Mani M. S., 1968, ECOLOGY BIOGEOGRAPHY, P71; MANN DH, 1980, ARCTIC ALPINE RES, V12, P359, DOI 10.2307/1550722; Mellanby K, 1939, PROC R SOC SER B-BIO, V127, P473, DOI 10.1098/rspb.1939.0035; MesoWest, 2014, MESOWEST DAT ARCH; Minder JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013493; Monasterio C, 2011, ECOGRAPHY, V34, P1030, DOI 10.1111/j.1600-0587.2010.06905.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Neargarder G, 2003, FUNCT ECOL, V17, P213, DOI 10.1046/j.1365-2435.2003.00722.x; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Nylander J.A.A., 2008, MRMODELTEST V2; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Rangel TF, 2015, EVOLUTION, V69, P1301, DOI 10.1111/evo.12644; Raso L, 2014, MOL ECOL, V23, P3744, DOI 10.1111/mec.12649; Renault D, 2011, ECOL ENTOMOL, V36, P36, DOI 10.1111/j.1365-2311.2010.01243.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Schoville SD, 2015, J INSECT PHYSIOL, V78, P55, DOI 10.1016/j.jinsphys.2015.04.014; Schoville SD, 2012, BIOL J LINN SOC, V107, P95, DOI 10.1111/j.1095-8312.2012.01911.x; Siefert A, 2015, GLOBAL ECOL BIOGEOGR, V24, P581, DOI 10.1111/geb.12287; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Slatyer RA, 2016, ECOGRAPHY, V39, P572, DOI 10.1111/ecog.01616; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Spence J.R., 1979, P525; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams JB, 2003, J EXP ZOOL PART A, V298A, P23, DOI 10.1002/jez.a.10264; Woods HA, 2015, J THERM BIOL, V54, P86, DOI 10.1016/j.jtherbio.2014.10.002; WORLAND MR, 1986, J INSECT PHYSIOL, V32, P579, DOI 10.1016/0022-1910(86)90075-2; Zalewski M, 2014, ANN ZOOL FENN, V51, P301, DOI 10.5735/086.051.0302	102	17	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151959	10.1371/journal.pone.0151959	http://dx.doi.org/10.1371/journal.pone.0151959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043311	gold, Green Submitted, Green Published			2022-12-27	WOS:000373592100006
J	Theuring, S; Jefferys, LF; Nchimbi, P; Mbezi, P; Sewangi, J				Theuring, Stefanie; Jefferys, Laura F.; Nchimbi, Philo; Mbezi, Paulina; Sewangi, Julius			Increasing Partner Attendance in Antenatal Care and HIV Testing Services: Comparable Outcomes Using Written versus Verbal Invitations in an Urban Facility-Based Controlled Intervention Trial in Mbeya, Tanzania	PLOS ONE			English	Article								In many Sub-Saharan African settings male partner involvement in antenatal care (ANC) remains low, although great benefits for maternal and infant health outcomes have been long recognised, in particular regarding the prevention of HIV transmission. Yet there is paucity on evidence regarding the effectiveness of strategies to increase male partner involvement. This controlled intervention trial in Ruanda Health Centre in Mbeya, Tanzania, assessed the effectiveness of invitation letters for male involvement in ANC. Pregnant women approaching ANC without partners received official letters inviting the partner to attend ANC. A control group was instructed to verbally invite partners. Partner attendance was recorded at two subsequent ANC visits. Rates for male partner return, couple voluntary counselling and testing (CVCT), and influencing factors were analysed. From 199 ANC clients in total, 97 were assigned to the invitation letter group; 30 of these (30.9%) returned with their male partners for ANC. In the control group of 102 women, 28 (27.5%) returned with their partner. In both groups CVCT rates among jointly returning couples were 100%. Partner return/CVCT rate was not statistically different in intervention and control group (OR 1.2, p = 0.59). Former partner attendance at ANC during a previous pregnancy was the only factor found to be significantly linked with partner return (p = 0.03). Our study demonstrates that rather simple measures to increase male partner attendance in ANC and CVCT can be effective, with written and verbal invitations having comparable outcomes. In terms of practicability in Sub-Saharan African settings, we recommend systematic coaching of ANC clients on how to verbally invite male partners in the first instance, followed by written invitation letters for partners in case of their non-attendance. Further studies covering both urban and rural settings will be more informative for effective translation into policy.	[Theuring, Stefanie; Jefferys, Laura F.] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Nchimbi, Philo; Mbezi, Paulina] Minist Hlth & Social Welf, PMTCT Program Mbeya Reg, Mbeya, Tanzania; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya, Mbeya, Tanzania	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Theuring, S (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	stefanie.theuring@charite.de			Gilead Sciences "HIV Clinical Cooperation Grant"	Gilead Sciences "HIV Clinical Cooperation Grant"	The study was funded by the Gilead Sciences "HIV Clinical Cooperation Grant." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Byamugisha R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-43; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Jefferys LF, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0084-x; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Matthews LT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-843; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Nyondo AL, PLOS ONE, V10, DOI [10.1371/journal.pone.0119273.17, DOI 10.1371/JOURNAL.PONE.0119273.17]; Nyondo AL, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22780; Osoti AO, 2014, AIDS, V28, P95, DOI 10.1097/QAD.0000000000000023; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; Tanzania Commission for AIDS, 2013, TANZ 3 NAT MULT SECT; The United Republic of Tanzania Ministry of Health and Social Welfare, TANZ EL MOTH CHILD T; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; WHO, 2012, MAL INV PREV MOTH TO	21	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152734	10.1371/journal.pone.0152734	http://dx.doi.org/10.1371/journal.pone.0152734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043707	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100030
J	Hopes, L; Grolez, G; Moreau, C; Lopes, R; Ryckewaert, G; Carriere, N; Auger, F; Laloux, C; Petrault, M; Devedjian, JC; Bordet, R; Defebvre, L; Jissendi, P; Delmaire, C; Devos, D				Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Lopes, Renaud; Ryckewaert, Gilles; Carriere, Nicolas; Auger, Florent; Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Defebvre, Luc; Jissendi, Patrice; Delmaire, Christine; Devos, David			Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BASAL GANGLIA; IRON CONTENT; BRAIN; DEMENTIA; DEGENERATION; SHAPE; AGE	Introduction Magnetic resonance imaging (MRI) can be used to identify biomarkers in Parkinson's disease (PD); R2* values reflect iron content related to high levels of oxidative stress, whereas volume and/or shape changes reflect neuronal death. We sought to assess iron overload in the nigrostriatal system and characterize its relationship with focal and overall atrophy of the striatum in the pivotal stages of PD. Methods Twenty controls and 70 PD patients at different disease stages (untreated de novo patients, treated early-stage patients and advanced-stage patients with L-dopa-related motor complications) were included in the study. We determined the R2* values in the substantia nigra, putamen and caudate nucleus, together with striatal volume and shape analysis. We also measured R2* in an acute MPTP mouse model and in a longitudinal follow-up two years later in the early-stage PD patients. Results The R2* values in the substantia nigra, putamen and caudate nucleus were significantly higher in de novo PD patients than in controls. Early-stage patients displayed significantly higher R2* values in the substantia nigra (with changes in striatal shape), relative to de novo patients. Measurements after a two-year follow-up in early-stage patients and characterization of the acute MPTP mouse model confirmed that R2* changed rapidly with disease progression. Advanced-stage patients displayed significant atrophy of striatum, relative to earlier disease stages. Conclusion Each pivotal stage in PD appears to be characterized by putative nigrostriatal MRI biomarkers: iron overload at the de novo stage, striatal shape changes at early-stage disease and generalized striatal atrophy at advanced disease.	[Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Ryckewaert, Gilles; Carriere, Nicolas; Defebvre, Luc; Devos, David] Lille Univ Hosp, Dept Movement Disorders & Neurol, Lille, France; [Hopes, Lucie; Grolez, Guillaume; Moreau, Caroline; Lopes, Renaud; Carriere, Nicolas; Auger, Florent; Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Defebvre, Luc; Jissendi, Patrice; Delmaire, Christine; Devos, David] Univ Lille, INSERM, U1171, Fac Med, Lille, France; [Lopes, Renaud; Jissendi, Patrice; Delmaire, Christine] Lille Univ Hosp, Dept Neuroradiol, Lille, France; [Auger, Florent] Univ Lille, Dept Small Anim Imaging Unit, Lille, France; [Laloux, Charlotte; Petrault, Maud; Devedjian, Jean-Christophe; Bordet, Regis; Devos, David] Univ Lille, Dept Med Pharmacol, Lille, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Hopes, L (corresponding author), Lille Univ Hosp, Dept Movement Disorders & Neurol, Lille, France.; Hopes, L (corresponding author), Univ Lille, INSERM, U1171, Fac Med, Lille, France.	lucie.hopes@hotmail.fr	; Devos, David/E-4059-2013	Lopes, Renaud/0000-0002-2425-2283; Devos, David/0000-0002-2417-799X; LALOUX, Charlotte/0000-0001-7039-9940	French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme [2008-006842-25]	French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme	The study was funded by the French Ministry of Health as part of the Projet Hospitalier Recherche Clinique (PHRC) programme (grant reference number: 2008-006842-25).	APA, 2000, DIAGN STAT MAN MENT; Apostolova LG, 2010, MOVEMENT DISORD, V25, P687, DOI 10.1002/mds.22799; Aquino D, 2014, NEUROL SCI, V35, P753, DOI 10.1007/s10072-013-1595-2; Bunzeck N, 2013, PARKINSONISM RELAT D, V19, P1136, DOI 10.1016/j.parkreldis.2013.08.011; Carriere N, 2014, MOVEMENT DISORD, V29, P897, DOI 10.1002/mds.25904; Daniel S E, 1993, J Neural Transm Suppl, V39, P165; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; DEXTER DT, 1987, LANCET, V2, P1219; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Geng DY, 2006, NEUROSURGERY, V58, P256, DOI 10.1227/01.NEU.0000194845.19462.7B; GRIFFITHS PD, 1993, DEMENTIA, V4, P61, DOI 10.1159/000107298; Haegelen C, 2012, INT J COMPUT ASSIST, V18; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Laloux C, 2012, PHARMACOL RES, V65, P514, DOI 10.1016/j.phrs.2012.02.008; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Minati L, 2007, AM J NEURORADIOL, V28, P309; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pitcher TL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-17; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Sterling NW, 2013, NEUROBIOL AGING, V34, P2510, DOI 10.1016/j.neurobiolaging.2013.05.017; Styner Martin, 2006, Insight J, P242; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071	30	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0147947	10.1371/journal.pone.0147947	http://dx.doi.org/10.1371/journal.pone.0147947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035571	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200002
J	Paulose, T; Montevil, M; Speroni, L; Cerruti, F; Sonnenschein, C; Soto, AM				Paulose, Tessie; Montevil, Mael; Speroni, Lucia; Cerruti, Florent; Sonnenschein, Carlos; Soto, Ana M.			SAMA: A Method for 3D Morphological Analysis	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; IMAGE-ANALYSIS; CULTURE MODEL; BREAST-CANCER; MAMMARY-GLAND; HORMONAL-REGULATION; SOFTWARE; MORPHOGENESIS; ORGANIZATION; MICROSCOPY	Three-dimensional (3D) culture models are critical tools for understanding tissue morphogenesis. A key requirement for their analysis is the ability to reconstruct the tissue into computational models that allow quantitative evaluation of the formed structures. Here, we present Software for Automated Morphological Analysis (SAMA), a method by which epithelial structures grown in 3D cultures can be imaged, reconstructed and analyzed with minimum human intervention. SAMA allows quantitative analysis of key features of epithelial morphogenesis such as ductal elongation, branching and lumen formation that distinguish different hormonal treatments. SAMA is a user-friendly set of customized macros operated via FIJI (http://fiji.sc/Fiji), an open-source image analysis platform in combination with a set of functions in R (http://www.r-project.org/), an open-source program for statistical analysis. SAMA enables a rapid, exhaustive and quantitative 3D analysis of the shape of a population of structures in a 3D image. SAMA is cross-platform, licensed under the GPLv3 and available at http://montevil.theobio.org/content/sama.	[Paulose, Tessie; Montevil, Mael; Speroni, Lucia; Cerruti, Florent; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	Tufts University	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA.	Ana.soto@tufts.edu	Montévil, Maël/S-2378-2017	Montévil, Maël/0000-0001-7177-5995; Speroni, Lucia/0000-0003-1567-8925	National Institute of Environmental Health Sciences of the National Institutes of Health [R01ES08314]; Avon Foundation for Women [02-2009-093, 02-2011-095]; Avon Grant [02-2009-093, 02-2011-095]; NIEHS/NIH [ES08314]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Avon Foundation for Women; Avon Grant; NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Award Number R01ES08314 from the National Institute of Environmental Health Sciences of the National Institutes of Health (https://www.niehs.nih.gov/) and Award numbers #02-2009-093 and #02-2011-095 from the Avon Foundation for Women (http://www.avonfoundation.org/) to AMS. The content does not necessarily represent the official views of the funding agencies and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the editorial assistance by Cheryl Schaeberle. This research was supported by Avon Grant #02-2009-093, and 02-2011-095. Additional support was provided by NIEHS/NIH ES08314. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Environmental Health Sciences or the National Institutes of Health.	Billeci L, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00002; Biot E, 2008, 5 IEEE INT S MIOM IM; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fessart D, 2013, EUR RESPIR J, V42, P1345, DOI 10.1183/09031936.00118812; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kohl P, 2000, PHILOS T R SOC A, V358, P579, DOI 10.1098/rsta.2000.0547; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Luisier F, 2010, SIGNAL PROCESS, V90, P415, DOI 10.1016/j.sigpro.2009.07.009; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Soto AM, 2013, J MAMMARY GLAND BIOL, V18, P199, DOI 10.1007/s10911-013-9293-5; Speroni L, 2014, TISSUE ENG PART C-ME, V20, P42, DOI [10.1089/ten.tec.2013.0054, 10.1089/ten.TEC.2013.0054]; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0153022	10.1371/journal.pone.0153022	http://dx.doi.org/10.1371/journal.pone.0153022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035711	gold, Green Submitted, Green Published			2022-12-27	WOS:000373201200052
J	Xiao, J; Zou, Y; Chen, X; Gao, Y; Xie, MX; Lu, XX; Li, W; He, BX; He, SY; You, SJ; Chen, Q				Xiao, Jian; Zou, Yong; Chen, Xi; Gao, Ying; Xie, Mingxuan; Lu, Xiaoxiao; Li, Wei; He, Bixiu; He, Shuya; You, Shaojin; Chen, Qiong			The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-CELL POLARITY; PEUTZ-JEGHERS-SYNDROME; KINASE B1 LKB1; CANCER PROGRESSION; GENE LKB1; SUPPRESSOR; EXPRESSION; METASTASIS; METABOLISM; MUTATIONS	Background Liver kinase B1 (LKB1) is a protein kinase that regulates the growth, integrity and polarity of mammalian cells. Recent studies have reported the prognostic value of decreased LKB1 expression in different tumors. However, the results of these studies remain controversial. Therefore, this meta-analysis was performed to more accurately estimate the role of decreased LKB1 in the prognostication of human solid tumors. Methods A systematic literature search in the electronic databases PubMed, Embase, Web of Science and CNKI (updated to October 15, 2015) was performed to identify eligible studies. The overall survival (OS), relapse-free survival (RFS), disease-free survival (DFS) and clinicopathological features data were collected from these studies. The hazard ratios (HRs), odds ratios (ORs) and 95% confidence intervals (CIs) were calculated and pooled with a random-effects models using Stata12.0 software. Results A total of 14 studies covering 1915 patients with solid tumors were included in this meta-analysis. Decreased LKB1 was associated with poorer OS in both the univariate (HR: 1.86, 95% CI: 1.42-2.42, P<0.001) and multivariate (HR: 1.55, 95% CI: 1.09-2.21, P = 0.015) analyses. A subgroup analysis revealed that the associations between decreased LKB1 and poor OS were significant within the Asian region (HR 2.18, 95% CI: 1.66-2.86, P<0.001) and obvious for lung cancer (HR: 2.16, 95% CI: 1.47-3.18, P<0.001). However, the articles that involved analyses of both RFS and DFS numbered only 3, and no statistically significant correlations of decreased LKB1 with RFS or DFS were observed in this study. Additionally, the pooled odds ratios (ORs) indicated that decreased LKB1 was associated with larger tumor size (OR: 1.60, 95% CI: 1.09-2.36, P = 0.017), lymph node metastasis (OR: 2.41, 95% CI: 1.53-3.78, P<0.001) and a higher TNM stage (OR: 3.35, 95% CI: 2.20-5.09, P<0.001). Conclusion These results suggest that decreased LKB1 expression in patients with solid tumors might be related to poor prognosis and serve as a potential predictive marker of poor clinicopathological prognostic factors. Additional studies are required to verify the clinical utility of decreased LKB1 in solid tumors.	[Xiao, Jian; Zou, Yong; Gao, Ying; Xie, Mingxuan; Lu, Xiaoxiao; Li, Wei; He, Bixiu; Chen, Qiong] Cent South Univ, Dept Geriatr, Resp Med, Xiangya Hosp, Changsha, Peoples R China; [Chen, Xi] Cent South Univ, Dept Resp Med, Xiangya Hosp, Changsha, Peoples R China; [He, Shuya] Univ South China, Dept Biol & Biochem, Hengyang, Peoples R China; [You, Shaojin] Atlanta VA Med Ctr, Lab Canc Expt Therapy, Atlanta Res & Educ Fdn 151F, Decatur, GA USA	Central South University; Central South University; University of South China; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Chen, Q (corresponding author), Cent South Univ, Dept Geriatr, Resp Med, Xiangya Hosp, Changsha, Peoples R China.	qiongch@163.com	Wei, Li/GPF-4910-2022		National Natural Science Foundation of China [81572284]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the National Natural Science Foundation of China (81572284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkemoun L, 2014, J CELL BIOL, V205, P447, DOI 10.1083/jcb.201312029; Bouchekioua-Bouzaghou K, 2014, INT J CANCER, V135, P1307, DOI 10.1002/ijc.28781; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Calles A, 2015, CLIN CANCER RES, V21, P2851, DOI 10.1158/1078-0432.CCR-14-3112; Ding XM, 2005, CHIN J CANC PREV TRE, P10; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Han K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068527; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; He TY, 2014, ANN SURG ONCOL, V21, pS703, DOI 10.1245/s10434-014-3824-1; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huang YH, 2013, ASIAN PAC J CANCER P, V14, P1985, DOI 10.7314/APJCP.2013.14.3.1985; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; JIANG L, 2014, BIORESOUR BIOPROCESS, V1, P1, DOI DOI 10.3892/0R.2014.3432; Kline ER, 2011, HEAD NECK-J SCI SPEC, V33, P1501, DOI 10.1002/hed.21638; Krawchuk D, 2015, J CELL SCI, V128, P1011, DOI 10.1242/jcs.162156; Krieg A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130192; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Li J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0070-0; Liang HJ, 2015, J NEUROSCI RES, V93, P253, DOI 10.1002/jnr.23486; Lin SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136374; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116683; Marignani PA, 2005, J CLIN PATHOL, V58, P15, DOI 10.1136/jcp.2003.015255; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Pena CG, 2015, J CLIN INVEST, V125, P4063, DOI 10.1172/JCI82152; Qin PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09500; Qiu W, 2006, ONCOGENE, V25, P2937, DOI 10.1038/sj.onc.1209325; Rhodes LV, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.27; Saigusa S, 2013, J CANCER RES CLIN, V139, P131, DOI 10.1007/s00432-012-1308-x; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsai LH, 2014, ONCOGENE, V33, P3851, DOI 10.1038/onc.2013.353; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wang JH, 2015, ONCOTARGET, V6, P18905, DOI 10.18632/oncotarget.4305; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131403; Yang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10575; Yang XW, 2012, CHIN ARCH GEN SURG E, P51; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09800	48	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152674	10.1371/journal.pone.0152674	http://dx.doi.org/10.1371/journal.pone.0152674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035914	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200030
J	Xu, TS; Le, TD; Liu, L; Wang, RJ; Sun, BY; Li, JY				Xu, Taosheng; Thuc Duy Le; Liu, Lin; Wang, Rujing; Sun, Bingyu; Li, Jiuyong			Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data	PLOS ONE			English	Article							CLINICALLY RELEVANT SUBTYPES; CLASS DISCOVERY; BREAST; CLASSIFICATION; CARCINOMAS; RESOURCE; MODEL	Background Identifying cancer subtypes is an important component of the personalised medicine framework. An increasing number of computational methods have been developed to identify cancer subtypes. However, existing methods rarely use information from gene regulatory networks to facilitate the subtype identification. It is widely accepted that gene regulatory networks play crucial roles in understanding the mechanisms of diseases. Different cancer subtypes are likely caused by different regulatory mechanisms. Therefore, there are great opportunities for developing methods that can utilise network information in identifying cancer subtypes. Results In this paper, we propose a method, weighted similarity network fusion (WSNF), to utilise the information in the complex miRNA-TF-mRNAregulatory network in identifying cancer subtypes. We firstly build the regulatory network where the nodes represent the features, i.e. the microRNAs (miRNAs), transcription factors (TFs) and messenger RNAs (mRNAs) and the edges indicate the interactions between the features. The interactions are retrieved from various interatomic databases. We then use the network information and the expression data of the miRNAs, TFs and mRNAs to calculate the weight of the features, representing the level of importance of the features. The feature weight is then integrated into a network fusion approach to cluster the samples (patients) and thus to identify cancer subtypes. We applied our method to the TCGA breast invasive carcinoma (BRCA) and glioblastoma multiforme (GBM) datasets. The experimental results show that WSNF performs better than the other commonly used computational methods, and the information from miRNA-TF-mRNA regulatory network contributes to the performance improvement. The WSNF method successfully identified five breast cancer subtypes and three GBM subtypes which show significantly different survival patterns. We observed that the expression patterns of the features in some miRNA-TF-mRNA sub-networks vary across different identified subtypes. In addition, pathway enrichment analyses show that the top pathways involving the most differentially expressed genes in each of the identified subtypes are different. The results would provide valuable information for understanding the mechanisms characterising different cancer subtypes and assist the design of treatment therapies. All datasets and the R scripts to reproduce the results are available online at the website:http://nugget.unisa.edu.au/Thuc/cancersubtypes/.	[Xu, Taosheng; Wang, Rujing; Sun, Bingyu] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Intelligent Machines, Hefei, Anhui, Peoples R China; [Xu, Taosheng] Univ Sci & Technol China, Dept Automat, Hefei 230026, Anhui, Peoples R China; [Thuc Duy Le; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of South Australia	Le, TD; Li, JY (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au	Liu, Lin/ABD-1224-2020; Le, Thuc Duy D/G-8444-2019; Li, Jiuyong/A-8134-2008; Li, Jiuyong/AAY-2706-2020	Liu, Lin/0000-0003-2843-5738; Le, Thuc Duy D/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878; Li, Jiuyong/0000-0002-9023-1878; Xu, Taosheng/0000-0001-8283-7274	Australian Research Council [DP130104090]; National Natural Science Foundation of China [31371340]	Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been partially supported by Australian Research Council (http://www.arc.gov.au/) Discovery Project DP130104090 (JL and LL), and the National Natural Science Foundation of China 31371340 (BS), http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Carlson M., 2013, GENOME WIDE ANNOTATI; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hastie T, 2012, IMPUTE IMPUTATION MI, V1; Higham DJ, 2003, I MATH ITS APPL IMA, V39, P192; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kamvar S. D., 2003, P 12 INT C WORLD WID, P261; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li J. -H., 2013, NUCLEIC ACIDS RES; Liu YY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-37; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morrison JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-233; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Page Lawrence, 1999, TECHNICAL REPORT; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Serra A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0680-3; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	46	40	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152792	10.1371/journal.pone.0152792	http://dx.doi.org/10.1371/journal.pone.0152792			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035433	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000373201200041
J	Yin, Q; Yang, CZ; Wu, JM; Lu, HY; Zheng, XH; Zhang, YY; Lv, ZZ; Zheng, XP; Li, ZJ				Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zheng, Xiaohui; Zhang, Youyi; Lv, Zhizhen; Zheng, Xiaopu; Li, Zijian			Downregulation of beta-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; RECEPTOR MESSENGER-RNA; LEFT-VENTRICULAR HYPERTROPHY; C6 GLIOMA-CELLS; BETA(2)-ADRENERGIC RECEPTOR; HEART-FAILURE; IN-VIVO; ARRIVE GUIDELINES; AGONIST; STABILIZATION	beta-adrenergic receptors (beta-ARs) play an important role in cardiac remodeling, which is the key pathological process in various heart diseases and leads to heart failure. However, the regulation of beta-AR expression in remodeling hearts is still unclear. This study aims to clarify the possible mechanisms underlying the regulation of beta(1)- and beta(2)-AR expression in cardiac remodeling. The rat model of cardiac remodeling was established by subcutaneous injection of isoproterenol(ISO) at the dose of 0.25 mg.kg(-1).d(-1) for 7days. We found that the expression of beta(1)-and beta(2)-ARs decreased in the remodeling heart. The mechanisms may include the inhibition of DNA transcription and the increase of mRNA degradation. cAMPresponse element binding protein(CREB) is a well-known transcription factor of beta-AR. However, the expression and activation of CREB was not changed in the remodeling heart. Further, human Antigen-R (HuR), a RNA binding protein, which binds to the 3'-untranslated region of the beta-AR mRNA and promotes RNA degradation, was increased in the remodeling model. And in vitro, HuR deficiency reversed the reduction of beta-AR mRNA induced by ISO. Therefore, the present findings indicate that HuR, but not CREB, is responsible for the reduction of beta-AR expression in ISO induced cardiac remodeling.	[Yin, Qian; Zheng, Xiaopu] Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Xian 71006, Peoples R China; [Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zhang, Youyi; Lv, Zhizhen; Li, Zijian] Peking Univ, Inst Vasc Med, Hosp 3,Minist Hlth, Beijing Key Lab Cardiovasc Receptors Res,Key Lab, Beijing 100191, Peoples R China; [Yin, Qian; Yang, Chengzhi; Wu, Jimin; Lu, Haiyan; Zhang, Youyi; Lv, Zhizhen; Li, Zijian] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Lu, Haiyan; Zheng, Xiaohui] NW Univ Xian, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Coll Life Sci, Xian 710069, Peoples R China; [Li, Zijian] Beijing Univ Chinese Med, Key Lab Chinese Internal Med MOE & Beijing, Dongzhimen Hosp, 5 Haiyuncang Lane, Beijing 100700, Peoples R China	Xi'an Jiaotong University; Peking University; Northwest University Xi'an; Beijing University of Chinese Medicine	Zheng, XP (corresponding author), Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Xian 71006, Peoples R China.; Li, ZJ (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3,Minist Hlth, Beijing Key Lab Cardiovasc Receptors Res,Key Lab, Beijing 100191, Peoples R China.; Li, ZJ (corresponding author), Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.; Li, ZJ (corresponding author), Beijing Univ Chinese Med, Key Lab Chinese Internal Med MOE & Beijing, Dongzhimen Hosp, 5 Haiyuncang Lane, Beijing 100700, Peoples R China.	zhengxp001@mail.xjtu.edu.cn; lizijian@bjmu.edu.cn	Wu, Jimin/A-3814-2013	Wu, Jimin/0000-0003-0749-2012	National Basic Research Program of China [2014CBA02000]; National Natural Science Foundation of China [81270157, 81471893, 91539123, 81070078]; National key Scientific Instrument and Equipment Development Project of China [2013YQ170525]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key Scientific Instrument and Equipment Development Project of China	This work was supported by grants from the National Basic Research Program of China (No. 2014CBA02000), the National Natural Science Foundation of China (Nos. 81270157, 81471893,91539123, and 81070078), and the National key Scientific Instrument and Equipment Development Project of China (2013YQ170525).	Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Bai Y, 2006, BBA-MOL CELL RES, V1763, P1076, DOI 10.1016/j.bbamcr.2006.08.009; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Cox B., 2000, IUPHAR COMPENDIUM RE, P321; Dangel V, 1996, BIOCHEM J, V317, P925, DOI 10.1042/bj3170925; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; GOLDSPINK PH, 1994, CIRC RES, V74, P1042, DOI 10.1161/01.RES.74.6.1042; HOSODA K, 1994, J NEUROCHEM, V63, P1635; Jiang BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059621; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kirigiti P, 2001, MOL PHARMACOL, V60, P1308, DOI 10.1124/mol.60.6.1308; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li H, 2014, CLIN EXP PHARMACOL P, V41, P58, DOI 10.1111/1440-1681.12176; Li Y, 2012, CELL SIGNAL, V24, P2297, DOI 10.1016/j.cellsig.2012.07.010; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084; Maurer F, 1999, NUCLEIC ACIDS RES, V27, P1664, DOI 10.1093/nar/27.7.1664; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Merlet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064711; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Mitchusson KD, 1998, BIOCHEM BIOPH RES CO, V252, P357, DOI 10.1006/bbrc.1998.9598; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Muller AL, 2012, HEART FAIL REV, V17, P395, DOI 10.1007/s10741-011-9269-8; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Ohte N, 2012, EUR J NUCL MED MOL I, V39, P1246, DOI 10.1007/s00259-012-2138-4; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pfeffer M, 1998, EUR J NEUROSCI, V10, P2896, DOI 10.1111/j.1460-9568.1998.00309.x; Renard M, 1990, B MEMOIRES ACAD ROYA, V146, P305; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Sato S, 2011, J TOXICOL SCI, V36, P479, DOI 10.2131/jts.36.479; Schlaich MP, 2003, CIRCULATION, V108, P560, DOI 10.1161/01.CIR.0000081775.72651.B6; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Simko F, 1996, CAN J CARDIOL, V12, P507; Subramaniam K, 2011, MOL CELL BIOCHEM, V352, P125, DOI 10.1007/s11010-011-0747-z; Sutton MS, 2003, CIRCULATION, V107, P2577, DOI 10.1161/01.CIR.0000070420.51787.A8; SYLVEN C, 1991, CARDIOVASC RES, V25, P737, DOI 10.1093/cvr/25.9.737; TEERLINK JR, 1994, CIRC RES, V75, P105, DOI 10.1161/01.RES.75.1.105; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Zhang JJ, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-4703; Zhou S, 2014, OXIDATIVE MED CELLUL, V2014	46	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152005	10.1371/journal.pone.0152005	http://dx.doi.org/10.1371/journal.pone.0152005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035432	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200009
J	Chandra, J; Miao, Y; Romoff, N; Frazer, IH				Chandra, Janin; Miao, Yan; Romoff, Natasha; Frazer, Ian H.			Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; HIGH-RISK; LANGERHANS CELLS; E-CADHERIN; IFN-GAMMA; T-CELLS; SUBSETS; INDUCE; RESPONSES; CANCER	Antigen presenting cells (APCs) in skin can promote either antigen-specific effector functions or antigen tolerance, and thus determine clearance or persistence of cutaneous viral infections. Human papillomavirus (HPV) infections can persist in squamous epithelium in immunocompetent individuals, and some persisting HPV infections, particularly with HPV16, promote malignant epithelial transformation. Here, we investigate whether local expression of the HPV16 protein most associated with malignant transformation, HPV16-E7, affects the phenotype and function of APC subsets in the skin. We demonstrate an expanded population of Langerhans cells in HPV16-E7 transgenic skin with distinct cell surface markers which express immune-modulatory enzymes and cytokines not expressed by cells from non transgenic skin. Furthermore, HPV16-E7 transgene expression in keratinocytes attracts new APC subsets to the epidermis. In vivo migration and transport of antigen to the draining lymph node by these APCs is markedly enhanced in HPV16-E7 expressing skin, whereas antigen-processing, as measured by proteolytic cleavage of DQ-OVA and activation of T cells in vivo by APCs, is significantly impaired. These data suggest that local expression of HPV16-E7 in keratinocytes can contribute to persisting infection with this oncogenic virus, by altering the phenotype and function of local APCs.	[Chandra, Janin; Miao, Yan; Romoff, Natasha; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia	University of Queensland	Frazer, IH (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld 4102, Australia.	i.frazer@uq.edu.au	Chandra, Janin/Y-2037-2019; Chandra, Janin/D-6580-2018; Frazer, Ian/A-1137-2007	Chandra, Janin/0000-0002-4456-9480; Chandra, Janin/0000-0002-4456-9480; Frazer, Ian/0000-0002-8002-4680	NIH [5U01CA141583]; ARC Discovery Scheme [DP130100996]; National Health and Medical Research Council of Australia [569938]; Queensland Government Premiers Fellowship; University of Queensland postdoctoral fellowship; NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Discovery Scheme(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Premiers Fellowship; University of Queensland postdoctoral fellowship(University of Queensland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to IHF from from the NIH (5U01CA141583), the ARC Discovery Scheme (Grant ID# DP130100996) and the National Health and Medical Research Council of Australia (Grant ID # 569938) IHF was recipient of Queensland Government Premiers Fellowship. JC is a recipient of University of Queensland postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Bergot AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004466; Caberg JHD, 2008, CARCINOGENESIS, V29, P1441, DOI 10.1093/carcin/bgn145; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; del Rio ML, 2007, J IMMUNOL, V178, P6861, DOI 10.4049/jimmunol.178.11.6861; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dunn LA, 1997, VIROLOGY, V235, P94, DOI 10.1006/viro.1997.8650; Frazer IH, 2011, CURR OPIN VIROL, V1, P268, DOI 10.1016/j.coviro.2011.07.007; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; Ginhoux F, 2010, IMMUNOL CELL BIOL, V88, P387, DOI 10.1038/icb.2010.38; Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201; Gosmann C, 2014, J IMMUNOL, V193, P2248, DOI 10.4049/jimmunol.1400216; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Iijima N, 2013, VIROLOGY, V444, P257, DOI 10.1016/j.virol.2013.06.020; Jaafar F, 2009, AM J PATHOL, V175, P1525, DOI 10.2353/ajpath.2009.090295; Kim HS, 2016, CANCER RES TREAT, V48, P527, DOI 10.4143/crt.2015.249; Tran LS, 2014, J INVEST DERMATOL, V134, P2438, DOI 10.1038/jid.2014.186; Lee BN, 2006, CANCER-AM CANCER SOC, V107, P999, DOI 10.1002/cncr.22092; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leong CM, 2010, BRIT J DERMATOL, V163, P1253, DOI 10.1111/j.1365-2133.2010.09968.x; Matsumoto K, 2004, JNCI-J NATL CANCER I, V96, P1611, DOI 10.1093/jnci/djh301; Mattarollo SR, 2010, J IMMUNOL, V184, P5663, DOI 10.4049/jimmunol.0903730; Mattarollo SR, 2010, J IMMUNOL, V184, P1242, DOI 10.4049/jimmunol.0902191; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; Mezache L, 2015, MODERN PATHOL, V28, P1594, DOI 10.1038/modpathol.2015.108; Mittal D, 2013, J INVEST DERMATOL, V133, P2686, DOI 10.1038/jid.2013.222; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; Monnier-Benoit S, 2006, GYNECOL ONCOL, V102, P22, DOI 10.1016/j.ygyno.2005.11.039; Nakayama Y, 2011, J DERMATOL SCI, V63, P173, DOI 10.1016/j.jdermsci.2011.05.006; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Warif NMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127155; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101; Zhang WB, 2009, AM J PATHOL, V175, P891, DOI 10.2353/ajpath.2009.081115; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	48	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152886	10.1371/journal.pone.0152886	http://dx.doi.org/10.1371/journal.pone.0152886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031095	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800153
J	Chu, HK; Hou, XH				Chu, Huikuan; Hou, Xiaohua			Understanding of Constipation Symptoms and the Diagnosis and Management of Constipation in Chinese Physicians	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; UNITED-STATES; TRANSIT-TIME; BIOFEEDBACK; POPULATION; EPIDEMIOLOGY; DEFINITION; MUSCLES; ASIA; AGE	Background and Aims Although a range of guidelines for the diagnosis and treatment of chronic constipation has been carried out, there was very little information about the understanding on constipation. The aim of the present study was to estimate the understanding of constipation symptoms and the diagnosis and management of constipation by clinical physicians in China. Methods Participants were physicians and researchers in the field of gastroenterology in China who were scheduled to attend the National Conference on gastrointestinal motility(Constipation). Based on the recommendation of the Rome Foundation Board, the self-reported questionnaire was constructed. Findings Although most of the opinions on symptoms of constipation were consistent, there were still some differences. Opinions on the Bristol stool form during constipation were discordant, 34% of the doctors thought that it was type 1 and type 2, while 46% of the doctors suggested that type 3 should also be considered constipation. There was no significant difference between them(P = 0.05); We investigated the interpretation on the duration of defecation prolonged, 27% of the doctors suggested it should be longer than 10 minutes, 22% of the doctors suggested it should be longer than 20 minutes, and other 22% of the doctors suggested it should be time of defecation became longer compared to previously bowel habits, there was no significant difference among them(P = 0.38). Only 36% of the doctors thought that psychotherapy was most important in the treatment of severe constipation, while 37% of the doctors thought that medication treatment was most important in the treatment of severe constipation, there was no significant difference between them(P = 0.895). Conclusion We were able to obtain valuable information about current views on symptoms of constipation and the diagnosis and treatment of constipation among Chinese doctors. Although most of the opinions were consistent there were still some differences. This study indicated that in practice in China there was a need for further study on the role of constipation symptoms and there may also be a need for better establishment of consensus guidelines for constipation.	[Chu, Huikuan; Hou, Xiaohua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, 1277 Jiefang Rd, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Hou, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, 1277 Jiefang Rd, Wuhan 430074, Peoples R China.	houxh@medmail.com.cn		Chu, Huikuan/0000-0001-5349-8429				American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; American Gastroenterology Association, 2010, CHRON CONST AGAGUIDE; [Anonymous], 2005, J FAM PRACTICE, V54, P932; [Anonymous], 2004, Chin J Dig Dis, V5, P134; [Anonymous], 2004, CHINESE J DIGESTIVE, V5, P134; BARNES PRH, 1988, INT J COLORECTAL DIS, V3, P207, DOI 10.1007/BF01660715; Bassotti G, 2004, WORLD J GASTROENTERO, V10, P713, DOI 10.3748/wjg.v10.i5.713; Bharucha AE, 2010, AM J GASTROENTEROL, V105, P786, DOI 10.1038/ajg.2010.70; Bytzer P, 2001, GUT, V49, P66, DOI 10.1136/gut.49.1.66; Chan YK, 2004, J GASTROEN HEPATOL, V19, P1270, DOI 10.1111/j.1440-1746.2004.03492.x; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Chu HK, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/532734; Corazziari E, 2004, BEST PRACT RES CL GA, V18, P613, DOI 10.1016/j.bpg.2004.04.012; Cottone C, 2014, UNITED EUR GASTROENT, V2, P232, DOI 10.1177/2050640614527283; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Ghoshal Uday C, 2008, Indian J Gastroenterol, V27, P22; Guo Xiao Feng, 2004, Chin J Dig Dis, V5, P98, DOI 10.1111/j.1443-9573.2004.00166.x; Gwee KA, 2012, NEUROGASTROENT MOTIL, V24, P114; Gwee KA, 2013, J NEUROGASTROENTEROL, V19, P149, DOI 10.5056/jnm.2013.19.2.149; Harris Lucinda A, 2005, Manag Care Interface, V18, P23; Hart SL, 2012, INT J COLORECTAL DIS, V27, P459, DOI 10.1007/s00384-011-1355-9; HEATON KW, 1993, DIGEST DIS SCI, V38, P1004, DOI 10.1007/BF01295713; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Ke M, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01983.x; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Ko CY, 1997, ARCH SURG-CHICAGO, V132, P829; Koch A, 1997, DIS COLON RECTUM, V40, P902, DOI 10.1007/BF02051196; Lindberg G, 2011, J CLIN GASTROENTEROL, V45, P483, DOI 10.1097/MCG.0b013e31820fb914; Liu BH, 2005, INT J COLORECTAL DIS, V20, P317, DOI 10.1007/s00384-004-0637-x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Cara MAL, 2006, REV ESP ENFERM DIG, V98, P449, DOI 10.4321/s1130-01082006000600006; Murakami K, 2006, EUR J CLIN NUTR, V60, P650, DOI 10.1038/sj.ejcn.1602365; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Park JM, 2011, J NEUROGASTROENTEROL, V17, P279, DOI 10.5056/jnm.2011.17.3.279; Patankar SK, 1997, DIS COLON RECTUM, V40, P827, DOI 10.1007/BF02055441; Prather Charlene M, 2004, Rev Gastroenterol Disord, V4 Suppl 2, pS11; Sakakibara R, 2003, J NEUROL NEUROSUR PS, V74, P268, DOI 10.1136/jnnp.74.2.268; SANDLER RS, 1990, AM J PUBLIC HEALTH, V80, P185, DOI 10.2105/AJPH.80.2.185; Shafik A, 2003, J SURG RES, V112, P162, DOI 10.1016/S0022-4804(03)00125-2; Shin YM, 2002, J PEDIATR SURG, V37, P1762, DOI 10.1053/jpsu.2002.36716; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Sun XB, 2009, J PEDIATR SURG, V44, P2384, DOI 10.1016/j.jpedsurg.2009.07.062; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059	45	3	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152801	10.1371/journal.pone.0152801	http://dx.doi.org/10.1371/journal.pone.0152801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031865	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800139
J	Hepp, J; Hilbig, BE; Kieslich, PJ; Herzog, J; Lis, S; Schmahl, C; Niedtfeld, I				Hepp, Johanna; Hilbig, Benjamin E.; Kieslich, Pascal J.; Herzog, Julia; Lis, Stefanie; Schmahl, Christian; Niedtfeld, Inga			Borderline Personality and the Detection of Angry Faces	PLOS ONE			English	Article							EMOTION RECOGNITION; FACIAL EXPRESSIONS; DISORDER; SENSITIVITY; INVENTORY; CROWD; ANGER	Background Many studies have assessed emotion recognition in patients with Borderline Personality Disorder and considerable evidence has been accumulated on patients' ability to categorize emotions. In contrast, their ability to detect emotions has been investigated sparsely. The only two studies that assessed emotion detection abilities found contradictory evidence on patients' ability to detect angry faces. Methods To clarify whether patients with Borderline Personality Disorder show enhanced detection of angry faces, we conducted three experiments: a laboratory study (n = 53) with a clinical sample and two highly powered web studies that measured Borderline features (n(1) = 342, n(2) = 220). Participants in all studies completed a visual search paradigm, and the reaction times for the detection of angry vs. happy faces were measured. Results Consistently, data spoke against enhanced detection of angry faces in the Borderline groups, indicated by non-significant group (Borderline vs. healthy control) x target (angry vs. happy) interactions, despite highly satisfactory statistical power to detect even small effects. Conclusions In contrast to emotion categorization, emotion detection appears to be intact in patients with Borderline Personality Disorder and individuals high in Borderline features. The importance of distinguishing between these two processes in future studies is discussed.	[Hepp, Johanna; Herzog, Julia; Lis, Stefanie; Schmahl, Christian; Niedtfeld, Inga] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychosomat Med, Mannheim, Germany; [Hilbig, Benjamin E.] Univ Koblenz Landau, Dept Psychol, Landau, Germany; [Kieslich, Pascal J.] Univ Mannheim, Dept Psychol, D-68131 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Koblenz & Landau; University of Mannheim	Hepp, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychosomat Med, Mannheim, Germany.	Johanna.Hepp@zi-mannheim.de	Niedtfeld, Inga/GLV-3573-2022; Schmahl, Christian/E-8760-2012	Niedtfeld, Inga/0000-0002-6118-1664; Hepp, Johanna/0000-0001-8453-6408; Schmahl, Christian/0000-0003-0141-0821; Kieslich, Pascal J./0000-0002-0853-9364	Baden-Wurttemberg Foundation, Germany; German Research Foundation [HI 1600/1-1]	Baden-Wurttemberg Foundation, Germany; German Research Foundation(German Research Foundation (DFG))	The research reported on was supported by grants to Prof. Benjamin E. Hilbig from the Baden-Wurttemberg Foundation, Germany (http://www.bwstiftung.de/forschung/) and from the German Research Foundation [HI 1600/1-1] (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BellPringle VJ, 1997, ASSESSMENT, V4, P131, DOI 10.1177/107319119700400203; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Chapman AL, 2008, J PERS DISORD, V22, P148, DOI 10.1521/pedi.2008.22.2.148; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daros AR, 2013, PSYCHOL MED, V43, P1953, DOI 10.1017/S0033291712002607; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Domes G, 2009, J PERS DISORD, V23, P6, DOI 10.1521/pedi.2009.23.1.6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Groves JA, 2007, J PERS ASSESS, V88, P49, DOI 10.1207/s15327752jpa8801_07; Hagenhoff M, 2013, J PERS DISORD, V27, P19, DOI 10.1521/pedi.2013.27.1.19; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hepp J, 2014, PERS INDIV DIFFER, V56, P19, DOI 10.1016/j.paid.2013.08.013; Jovev M, 2011, PSYCHIAT RES, V187, P234, DOI 10.1016/j.psychres.2010.12.019; Lazarus SA, 2014, CLIN PSYCHOL REV, V34, P193, DOI 10.1016/j.cpr.2014.01.007; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; Mitchell AE, 2014, NEUROPSYCHOL REV, V24, P166, DOI 10.1007/s11065-014-9254-9; Mombour W., 1996, INT PERSONALITY DISO; Morey L.C., 1991, PERSONALITY ASSESSME; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Purcell DG, 2010, ATTEN PERCEPT PSYCHO, V72, P2115, DOI 10.3758/APP.72.8.2115; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Robin M, 2012, PSYCHIAT RES, V200, P417, DOI 10.1016/j.psychres.2012.03.032; Schmahl C, 2014, BORDER PERS DIS EMOT, V1, DOI 10.1186/2051-6673-1-12; Schulze L, 2013, PSYCHOPATHOLOGY, V46, P217, DOI 10.1159/000341730; Snowden RJ, 2013, PERS INDIV DIFFER, V54, P158, DOI 10.1016/j.paid.2012.08.007; Stein MB, 2007, J PERS ASSESS, V88, P81, DOI 10.1207/s15327752jpa8801_11; Sweeny TD, 2013, EMOTION, V13, P76, DOI 10.1037/a0029193; The Inkscape Team, 2011, INKSC VERS 0 48 1 CO; Tomko RL, 2014, J PERS DISORD, V28, P734, DOI 10.1521/pedi_2012_26_093; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Veague HB, 2014, PSYCHIAT RES, V215, P687, DOI 10.1016/j.psychres.2013.12.045; Wittchen H.-U., 1997, SKID STRUKTURIERTES	33	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152947	10.1371/journal.pone.0152947	http://dx.doi.org/10.1371/journal.pone.0152947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031611	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800157
J	Lin, X; He, Y; Hou, X; Zhang, ZM; Wang, R; Wu, Q				Lin, Xiao; He, Yu; Hou, Xue; Zhang, Zhenming; Wang, Rui; Wu, Qiong			Endothelial Cells Can Regulate Smooth Muscle Cells in Contractile Phenotype through the miR-206/ARF6&NCX1/Exosome Axis	PLOS ONE			English	Article							EXOSOME BIOGENESIS; MEDIATED TRANSFER; ANGIOGENESIS; EXPRESSION; SECRETION; EXCHANGER; SYNTENIN; RELEASE; HEART; ARF6	Active interactions between endothelial cells and smooth muscle cells (SMCs) are critical to maintaining the SMC phenotype. Exosomes play an important role in intercellular communication. However, little is known about the mechanisms that regulate endothelial cells and SMCs crosstalk. We aimed to determine the mechanisms underlying the regulation of the SMC phenotype by human umbilical vein endothelial cells (HUVECs) through exosomes. We found that HUVECs overexpressing miR-206 upregulated contractile marker (alpha-SMA, Smoothelin and Calponin) mRNA expression in SMCs. We also found that the expression of miR-206 by HUVECs reduced exosome production by regulating ADP-Ribosylation Factor 6 (ARF6) and sodium/calcium exchanger 1 (NCX1). Using real-time PCR and western blot analysis, we showed that HUVEC-derived exosomes decreased the expression of contractile phenotype marker genes (alpha-SMA, Smoothelin and Calponin) in SMCs. Furthermore, a reduction of the miR-26a-containing exosomes secreted from HUVECs affects the SMC phenotype. We propose a novel mechanism in which miR-206 expression in HUVECs maintains the contractile phenotype of SMCs by suppressing exosome secretion from HUVECs, particularly miR-26a in exosomes, through targeting ARF6 and NCX1.	[Lin, Xiao; He, Yu; Zhang, Zhenming; Wang, Rui; Wu, Qiong] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Hou, Xue] Qinghai Univ, Coll Med, Dept Basic Med, Xining 810016, Peoples R China	Tsinghua University; Qinghai University	Wu, Q (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	wuqiong@mail.tsinghua.edu.cn	wu, qiong/GRY-4672-2022		National Natural Science Foundation of China [31170940, 31070095]; State Basic Science Foundation 973 [2012CB725204]; National High Technology Research and Development Program of China (863) [2012AA020503, 2011AA02A201, 2012AA02A700]; Tsinghua University Initiative Scientific Research Program [20131089199]; National Fund for Talent Training in Basic Science [J1310020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Basic Science Foundation 973(National Basic Research Program of China); National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); Tsinghua University Initiative Scientific Research Program; National Fund for Talent Training in Basic Science	This work was supported by the National Natural Science Foundation of China (Grant No. 31170940, No. 31070095); The State Basic Science Foundation 973 (Grant No. 2012CB725204); National High Technology Research and Development Program of China (863) (Grant No. 2012AA020503, No. 2011AA02A201, No. 2012AA02A700); Tsinghua University Initiative Scientific Research Program (Grant No. 20131089199) and National Fund for Talent Training in Basic Science (No. J1310020).	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Fedele C, 2015, J BIOL CHEM, V290, P4545, DOI 10.1074/jbc.C114.617662; Friand V, 2015, BIOL CELL, V107, P331, DOI 10.1111/boc.201500010; Ghossoub R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4477; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herrmann S, 2013, CARDIOVASC RES, V99, P780, DOI 10.1093/cvr/cvt154; Heydarkhan-Hagvall S, 2003, J CELL BIOCHEM, V89, P1250, DOI 10.1002/jcb.10583; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; KOK JW, 1990, EUR J CELL BIOL, V53, P173; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Roucourt B, 2015, CELL RES, V25, P412, DOI 10.1038/cr.2015.29; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sharma A, 2015, J VIS EXP; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; van Balkom BWM, 2013, BLOOD, V121, P3997, DOI 10.1182/blood-2013-02-478925; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Wanichawan P, 2014, J BIOL CHEM, V289, P33984, DOI 10.1074/jbc.M114.602581; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yin Y, 2014, CELL RES, V24, P1164, DOI 10.1038/cr.2014.121	35	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152959	10.1371/journal.pone.0152959	http://dx.doi.org/10.1371/journal.pone.0152959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031991	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800160
J	Shi, X; Walter, NAR; Harkness, JH; Neve, KA; Williams, RW; Lu, L; Belknap, JK; Eshleman, AJ; Phillips, TJ; Janowsky, A				Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Williams, Robert W.; Lu, Lu; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron			Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; PROTEIN-COUPLED RECEPTORS; METHAMPHETAMINE INTAKE; BETA-PHENYLETHYLAMINE; CELL-TYPE; TAAR1; AMPHETAMINE; AGONISTS; MICE; METABOLITES	Methamphetamine (MA) and neurotransmitter precursors and metabolites such as tyramine, octopamine, and beta-phenethylamine stimulate the G protein-coupled trace amine-associated receptor 1 (TAAR1). TAAR1 has been implicated in human conditions including obesity, schizophrenia, depression, fibromyalgia, migraine, and addiction. Additionally TAAR1 is expressed on lymphocytes and astrocytes involved in inflammation and response to infection. In brain, TAAR1 stimulation reduces synaptic dopamine availability and alters glutamatergic function. TAAR1 is also expressed at low levels in heart, and may regulate cardiovascular tone. Taar1 knockout mice orally self-administer more MA than wild type and are insensitive to its aversive effects. DBA/2J (D2) mice express a non-synonymous single nucleotide polymorphism (SNP) in Taar1 that does not respond to MA, and D2 mice are predisposed to high MA intake, compared to C57BL/6 (B6) mice. Here we demonstrate that endogenous agonists stimulate the recombinant B6 mouse TAAR1, but do not activate the D2 mouse receptor. Progeny of the B6XD2 (BxD) family of recombinant inbred (RI) strains have been used to characterize the genetic etiology of diseases, but contrary to expectations, BXDs derived 30-40 years ago express only the functional B6 Taar1 allele whereas some more recently derived BXD RI strains express the D2 allele. Data indicate that the D2 mutation arose subsequent to derivation of the original RIs. Finally, we demonstrate that SNPs in human TAAR1 alter its function, resulting in expressed, but functional, sub-functional and non-functional receptors. Our findings are important for identifying a predisposition to human diseases, as well as for developing personalized treatment options.	[Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Shi, Xiao; Neve, Kim A.; Belknap, John K.; Phillips, Tamara J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA; [Shi, Xiao; Walter, Nicole A. R.; Harkness, John H.; Neve, Kim A.; Belknap, John K.; Eshleman, Amy J.; Phillips, Tamara J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Williams, Robert W.; Lu, Lu] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; University of Tennessee System; University of Tennessee Health Science Center; Nantong University; Oregon Health & Science University	Janowsky, A (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Janowsky, A (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA.	janowsky@ohsu.edu	Harkness, John/AAE-6965-2020; Williams, Robert W./H-8789-2016	Harkness, John/0000-0002-4044-0647; Williams, Robert W./0000-0001-8924-4447; Walter, Nicole/0000-0003-0431-8078	NIH [T32 DA007262]; Methamphetamine Abuse Research Center [P50 DA018165]; Portland Alcohol Research Center [P60 AA010760]; VA Merit Review grants from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [I01 BX002106, I01 BX002758]; VA Research Career Scientist Program; NIAAA [U01 AA016662, U01 AA013499, U01 AA014425]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, P60AA010760, U01AA014425, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, T32DA007262] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002106, I01BX002758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Methamphetamine Abuse Research Center; Portland Alcohol Research Center; VA Merit Review grants from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service; VA Research Career Scientist Program; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	The authors have no personal or professional associations that could be considered conflicts of interest. This work was supported by NIH grant T32 DA007262, the Methamphetamine Abuse Research Center (P50 DA018165) the Portland Alcohol Research Center (P60 AA010760), and by a VA Merit Review grants (I01 BX002106 and I01 BX002758) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service, and the VA Research Career Scientist Program. Production of the new BXD strains was supported in part by NIAAA U01 AA016662, U01 AA013499, and U01 AA014425. The contents of this article may not necessarily represent the views of the U.S. Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Babusyte A, 2013, J LEUKOCYTE BIOL, V93, P387, DOI 10.1189/jlb.0912433; BAUD P, 1985, J PHARMACOL EXP THER, V235, P220; Belknap JK, 2013, MAMM GENOME, V24, P446, DOI 10.1007/s00335-013-9484-9; Berry MD, 2013, SYNAPSE, V67, P656, DOI 10.1002/syn.21670; Berry MD, 2004, J NEUROCHEM, V90, P257, DOI 10.1111/j.1471-4159.2004.02501.x; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Cichero E, 2013, CHEM BIOL DRUG DES, V81, P509, DOI 10.1111/cbdd.12018; Cisneros IE, 2014, NEUROPHARMACOLOGY, V85, P499, DOI 10.1016/j.neuropharm.2014.06.011; D'Andrea G, 2013, CEPHALALGIA, V33, P932, DOI 10.1177/0333102413480755; Deb I, 2010, J NEUROCHEM, V112, P486, DOI 10.1111/j.1471-4159.2009.06472.x; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Espinoza S, 2015, NEUROPSYCHOPHARMACOL, V40, P2217, DOI 10.1038/npp.2015.65; Espinoza S, 2015, NEUROPHARMACOLOGY, V93, P308, DOI 10.1016/j.neuropharm.2015.02.010; Espinoza S, 2011, MOL PHARMACOL, V80, P416, DOI 10.1124/mol.111.073304; Federici M, 2005, MOL PHARMACOL, V67, P1283, DOI 10.1124/mol.104.007427; Fortin JP, 2010, MOL PHARMACOL, V78, P837, DOI 10.1124/mol.110.064188; Galley G, 2012, BIOORG MED CHEM LETT, V22, P5244, DOI 10.1016/j.bmcl.2012.06.060; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Gulaboski R, 2007, ANAL BIOCHEM, V361, P236, DOI 10.1016/j.ab.2006.11.006; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Ishida K, 2005, BIOL PHARM BULL, V28, P1626, DOI 10.1248/bpb.28.1626; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; Liu XH, 2014, J PHARMACOL EXP THER, V350, P124, DOI 10.1124/jpet.114.213116; Lu H, 2011, INVEST OPHTH VIS SCI, V52, P4132, DOI 10.1167/iovs.10-6493; Lynch LJ, 2013, SUBST ABUS-RES TREAT, V7, P117, DOI 10.4137/SART.S12110; Panas MW, 2012, J NEUROIMMUNE PHARM, V7, P866, DOI 10.1007/s11481-011-9321-4; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pei Y, 2014, NEUROPSYCHOPHARMACOL, V39, P2299, DOI 10.1038/npp.2014.88; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Raab S, 2016, MOL METAB, V5, P47, DOI 10.1016/j.molmet.2015.09.015; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; Reese EA, 2014, J MED CHEM, V57, P378, DOI 10.1021/jm401316v; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Revel FG, 2013, MOL PSYCHIATR, V18, P543, DOI 10.1038/mp.2012.57; Revel FG, 2012, BIOL PSYCHIAT, V72, P934, DOI 10.1016/j.biopsych.2012.05.014; Revel FG, 2011, P NATL ACAD SCI USA, V108, P8485, DOI 10.1073/pnas.1103029108; Rickli A, 2015, BRIT J PHARMACOL, V172, P3412, DOI 10.1111/bph.13128; Shabani S, 2011, GENES BRAIN BEHAV, V10, P625, DOI 10.1111/j.1601-183X.2011.00700.x; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P2169, DOI 10.1016/j.neuropharm.2012.01.002; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P1134, DOI 10.1016/j.neuropharm.2011.11.005; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Snead AN, 2008, BIOORG MED CHEM LETT, V18, P5920, DOI 10.1016/j.bmcl.2008.08.013; Sotnikova TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013452; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Sotnikova Tatyana D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS99, DOI 10.1016/j.parkreldis.2008.04.006; Stalder H, 2011, BIOORG MED CHEM LETT, V21, P1227, DOI 10.1016/j.bmcl.2010.12.075; Sukhanov I, 2014, INT J NEUROPSYCHOPH, V17, P1683, DOI 10.1017/S1461145714000509; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Wang DX, 2001, J BIOL CHEM, V276, P34624, DOI 10.1074/jbc.M104083200; Watts VJ, 1998, J NEUROSCI, V18, P8692; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x; Wolinsky TD, 2007, GENES BRAIN BEHAV, V6, P628, DOI 10.1111/j.1601-183X.2006.00292.x; Xie ZH, 2007, J PHARMACOL EXP THER, V321, P128, DOI 10.1124/jpet.106.117382; Zhao WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133132	58	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152581	10.1371/journal.pone.0152581	http://dx.doi.org/10.1371/journal.pone.0152581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031617	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800097
J	Sui, YY; Ou, Y; Yan, BX; Xu, XH; Rousseau, AN; Zhang, Y				Sui, Yuanyuan; Ou, Yang; Yan, Baixing; Xu, Xiaohong; Rousseau, Alain N.; Zhang, Yu			Assessment of Micro-Basin Tillage as a Soil and Water Conservation Practice in the Black Soil Region of Northeast China	PLOS ONE			English	Article							RESERVOIR TILLAGE; FURROW DIKING; EROSION; CROP; PHOSPHORUS; RUNOFF; IMPACT	Micro-basin tillage is a soil and water conservation practice that requires building individual earth blocks along furrows. In this study, plot experiments were conducted to assess the efficiency of micro-basin tillage on sloping croplands between 2012 and 2013 (5 degrees and 7 degrees). The conceptual, optimal, block interval model was used to design micro-basins which are meant to capture the maximum amount of water per unit area. Results indicated that when compared to the up-down slope tillage, micro-basin tillage could increase soil water content and maize yield by about 45% and 17%, and reduce runoff, sediment and nutrients loads by about 63%, 96% and 86%, respectively. Meanwhile, micro-basin tillage could reduce the peak runoff rates and delay the initial runoff-yielding time. In addition, micro-basin tillage with the optimal block interval proved to be the best one among all treatments with different intervals. Compared with treatments of other block intervals, the optimal block interval treatments increased soil moisture by around 10% and reduced runoff rate by around 15%. In general, micro-basin tillage with optimal block interval represents an effective soil and water conservation practice for sloping farmland of the black soil region.	[Sui, Yuanyuan; Ou, Yang; Yan, Baixing] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun 130102, Peoples R China; [Sui, Yuanyuan] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Xu, Xiaohong; Zhang, Yu] Soil & Water Conservat Res Inst Jilin Prov, Changchun 130033, Peoples R China; [Rousseau, Alain N.] Inst Natl Rech Sci INRS ETE, Ctr Eau Terre Environm, 490 Couronne, Quebec City, PQ, Canada	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Quebec; Institut national de la recherche scientifique (INRS)	Ou, Y (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun 130102, Peoples R China.	ouyang@iga.ac.cn	Ou, Yang/AAE-4514-2020		National Key Technology R & D Program of China [2011BAD31B01]; Natural Science Foundation of China [41201534, 41571480]; Natural Science Foundation of Jilin Province [20130522072JH, 20150224046SF]	National Key Technology R & D Program of China(National Key Technology R&D Program); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was supported by the National Key Technology R & D Program of China (No. 2011BAD31B01), http://www.most.gov.cn/eng/organization/mission/index.htm; Natural Science Foundation of China (No. 41201534, 41571480), http://www.nsfc.gov.cn/publish/portal1/; and Natural Science Foundation of Jilin Province (No. 20130522072JH, 20150224046SF), http://kjt.jl.gov.cn/kjt/4/tindex.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brhane G, 2006, AGRON J, V98, P124, DOI 10.2134/agronj2005-0148; Campos H, 2006, MAYDICA, V51, P369; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Duan XW, 2011, CATENA, V87, P268, DOI 10.1016/j.catena.2011.06.012; [范昊明 Fan Haoming], 2005, [自然资源学报, Journal of Natural Resources], V20, P387; GERARD CJ, 1984, AGRON J, V76, P945, DOI 10.2134/agronj1984.00021962007600060019x; Gordon RJ, 2011, AGR WATER MANAGE, V98, P1782, DOI 10.1016/j.agwat.2011.07.007; Guzha AC, 2004, SOIL TILL RES, V76, P105, DOI 10.1016/j.still.2003.09.002; Hackwell S, 1991, T ASAE US; JONES OR, 1990, SOIL TILL RES, V18, P249, DOI 10.1016/0167-1987(90)90064-K; JONES OR, 1987, SOIL SCI SOC AM J, V51, P1307, DOI 10.2136/sssaj1987.03615995005100050039x; KRISHNA JH, 1989, AGR WATER MANAGE, V16, P87, DOI 10.1016/0378-3774(89)90043-7; Liu HH, 2013, ENVIRON EARTH SCI, V68, P1723, DOI 10.1007/s12665-012-1863-0; Liu XB, 2011, SOIL TILL RES, V117, P44, DOI 10.1016/j.still.2011.08.005; Ma Y-s, 2004, J SHENYANG AGR U, pZ1; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Nuti RC, 2009, AGR WATER MANAGE, V96, P1078, DOI 10.1016/j.agwat.2009.03.006; Organization WH, 2004, GUID DRINK WAT QUAL; Patrick C, 2007, SOIL USE MANAGE, V23, P185, DOI 10.1111/j.1475-2743.2006.00069.x; Pendke M. S., 2004, Journal of Maharashtra Agricultural Universities, V29, P319; Previati M, 2010, AGR WATER MANAGE, V97, P449, DOI 10.1016/j.agwat.2009.11.004; ROCHESTER EW, 1994, T ASAE, V37, P1183, DOI 10.13031/2013.28192; Salem HM, 2014, CATENA, V113, P353, DOI 10.1016/j.catena.2013.08.018; Sanders JH., 1996, EC AGR TECHNOLOGY SE; Sharpley A, 2003, J ENVIRON QUAL, V32, P2172, DOI 10.2134/jeq2003.2172; Sun T, 2014, J HYDROL, V519, P1141, DOI 10.1016/j.jhydrol.2014.08.048; Truman CC, 2010, AGR WATER MANAGE, V97, P835, DOI 10.1016/j.agwat.2010.01.004; Truman CC, 2009, AGR WATER MANAGE, V96, P1071, DOI 10.1016/j.agwat.2008.12.002; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; Wiyo KA, 2000, AGR WATER MANAGE, V45, P101, DOI 10.1016/S0378-3774(99)00103-1; Xiao B, 2012, SOIL TILL RES, V122, P22, DOI 10.1016/j.still.2012.02.006; Xu XZ, 2010, ENVIRON SCI POLICY, V13, P793, DOI 10.1016/j.envsci.2010.07.004; ZHANG X, 2006, SCI GEOGRAPHICA SINI, V26, P692; Zhao J, 2015, POTENTIAL YIELD IMPR, P2	34	14	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152313	10.1371/journal.pone.0152313	http://dx.doi.org/10.1371/journal.pone.0152313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031339	Green Published, gold, Green Accepted			2022-12-27	WOS:000373121800055
J	Wandeler, G; Musukuma, K; Zurcher, S; Vinikoor, MJ; Llenas-Garcia, J; Aly, MM; Mulenga, L; Chi, BH; Ehmer, J; Hobbins, MA; Bolton-Moore, C; Hoffmann, CJ; Egger, M				Wandeler, Gilles; Musukuma, Kalo; Zuercher, Samuel; Vinikoor, Michael J.; Llenas-Garcia, Jara; Aly, Mussa M.; Mulenga, Lloyd; Chi, Benjamin H.; Ehmer, Jochen; Hobbins, Michael A.; Bolton-Moore, Carolyn; Hoffmann, Christopher J.; Egger, Matthias		IeDEA-Southern Africa	Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia	PLOS ONE			English	Article							1ST-LINE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; COINFECTED PATIENTS; VIRUS INFECTION; TENOFOVIR; EPIDEMIOLOGY; PREVALENCE; VALIDATION; LAMIVUDINE; MUTATIONS	Background Few data on the virological determinants of hepatitis B virus (HBV) infection are available from southern Africa. Methods We enrolled consecutive HIV-infected adult patients initiating antiretroviral therapy (ART) at two urban clinics in Zambia and four rural clinics in Northern Mozambique between May 2013 and August 2014. HBsAg screening was performed using the Determine (R) rapid test. Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients. Risk factors for HBV infection were evaluated using Chi-square and Mann-Whitney tests and associations between baseline characteristics and high level HBV replication explored in multivariable logistic regression. Results Seventy-eight of 1,032 participants in Mozambique (7.6%, 95% confidence interval [CI]: 6.1-9.3) and 90 of 797 in Zambia (11.3%, 95% CI: 9.3-13.4) were HBsAg-positive. HBsAg-positive individuals were less likely to be female compared to HBsAg-negative ones (52.3% vs. 66.1%, p<0.001). Among 156 (92.9%) HBsAg-positive patients with an available measurement, median HBV viral load was 13,645 IU/mL (interquartile range: 192-8,617,488 IU/mL) and 77 (49.4%) had high values (>20,000 UI/mL). HBsAg-positive individuals had higher levels of ALT and AST compared to HBsAg-negative ones (both p<0.001). In multivariable analyses, male sex (adjusted odds ratio: 2.59, 95% CI: 1.22-5.53) and CD4 cell count below 200/mu l (2.58, 1.20-5.54) were associated with high HBV DNA. HBV genotypes A1 (58.8%) and E (38.2%) were most prevalent. Four patients had probable resistance to lamivudine and/or entecavir. Conclusion One half of HBsAg-positive patients demonstrated high HBV viremia, supporting the early initiation of tenofovir-containing ART in HIV/HBV-coinfected adults.	[Wandeler, Gilles] Univ Bern, Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Wandeler, Gilles; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Wandeler, Gilles] Univ Dakar, Dept Infect Dis, Dakar, Senegal; [Musukuma, Kalo; Vinikoor, Michael J.; Mulenga, Lloyd; Bolton-Moore, Carolyn] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Zuercher, Samuel] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Vinikoor, Michael J.; Bolton-Moore, Carolyn] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Llenas-Garcia, Jara] SolidarMed, Ancuabe, Mozambique; [Aly, Mussa M.] Nucleo Invest Operat Pemba, Pemba, Mozambique; [Chi, Benjamin H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ehmer, Jochen; Hobbins, Michael A.] SolidarMed, Luzern, Switzerland; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Cape Town	Wandeler, G (corresponding author), Univ Bern, Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland.; Wandeler, G (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Wandeler, G (corresponding author), Univ Dakar, Dept Infect Dis, Dakar, Senegal.	gilles.wandeler@ispm.unibe.ch	Wandeler, Gilles/ABB-2961-2020; Prozesky, Hans Walter/ABE-6956-2020	Prozesky, Hans Walter/0000-0001-9715-3449; Llenas-Garcia, Jara/0000-0001-9125-7706; Hoffmann, Christopher/0000-0002-9422-0519; Egger, Matthias/0000-0001-7462-5132; Bolton Moore, Carolyn/0000-0001-9103-7746	National Institute of Allergy and Infectious Diseases [5U01-AI069924-05]; Fogarty International Center of the National Institutes of Health [1K01TW009998]; Ambizione-PROSPER fellowship from the Swiss National Science Foundation [PZ00P3_154730]; FOGARTY INTERNATIONAL CENTER [K01TW009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, P30AI050410] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Ambizione-PROSPER fellowship from the Swiss National Science Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases (Grant number 5U01-AI069924-05) and Fogarty International Center (Grant number 1K01TW009998) of the National Institutes of Health. GW was supported by an Ambizione-PROSPER fellowship from the Swiss National Science Foundation (PZ00P3_154730). Support for Zambian laboratory capacity building came from the HIV Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants and staff of all participating sites. This study was supported by the National Institute of Allergy and Infectious Diseases (Grant number 5U01-AI069924-05) and Fogarty International Center (Grant number 1K01TW009998) of the National Institutes of Health. GW was supported by an Ambizione-PROSPER fellowship from the Swiss National Science Foundation (PZ00P3_154730). Support for Zambian laboratory capacity building came from the HIV Research Trust.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Aoudjane S, 2014, CLIN INFECT DIS, V59, P1618, DOI 10.1093/cid/ciu630; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Chadwick D, 2012, J ANTIMICROB CHEMOTH, V67, P2939, DOI 10.1093/jac/dks333; Childs K, 2013, AIDS, V27, P1443, DOI 10.1097/QAD.0b013e32836011c2; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; Day SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059346; Delaney WE, 2006, ANTIMICROB AGENTS CH, V50, P2471, DOI 10.1128/AAC.00138-06; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Hamers RL, 2013, JAIDS-J ACQ IMM DEF, V64, P174, DOI 10.1097/QAI.0b013e3182a60f7d; Hawkins C, 2013, AIDS, V27, P919, DOI 10.1097/QAD.0b013e32835cb9c8; Hill A, 2015, J VIRUS ERAD, V1, P103; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534; Lacombe K, 2005, AIDS, V19, P907, DOI 10.1097/01.aids.0000171404.07995.5c; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Mallory MA, 2011, J VIROL METHODS, V177, P31, DOI 10.1016/j.jviromet.2011.06.009; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Matthews PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134037; Schildgen O, 2006, NEW ENGL J MED, V354, P1807, DOI 10.1056/NEJMoa051214; Sheldon J, 2005, ANTIVIR THER, V10, P727; Stabinski L, 2015, JAIDS-J ACQ IMM DEF, V68, pS274, DOI 10.1097/QAI.0000000000000496; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Vinikoor MJ, 2015, J CLIN VIROL, V72, P20, DOI 10.1016/j.jcv.2015.08.019; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wandeler G, 2013, J INFECT DIS, V208, P1454, DOI 10.1093/infdis/jit351; WHO, 2015, WHO GUID PREV CAR TR	31	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152043	10.1371/journal.pone.0152043	http://dx.doi.org/10.1371/journal.pone.0152043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032097	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800031
J	Yuan, XP; Chen, JX; Zhao, YH; Liu, GQ; Ying, HP				Yuan, Xiao-Ping; Chen, Jiang-Xing; Zhao, Ye-Hua; Liu, Gui-Quan; Ying, He-Ping			Dynamics of Scroll Wave in a Three-Dimensional System with Changing Gradient	PLOS ONE			English	Article							EXCITABLE MEDIA; WINFREE TURBULENCE; INSTABILITY	The dynamics of a scroll wave in an excitable medium with gradient excitability is studied in detail. Three parameter regimes can be distinguished by the degree of gradient. For a small gradient, the system reaches a simple rotating synchronization. In this regime, the rigid rotating velocity of spiral waves is maximal in the layers with the highest filament twist. As the excitability gradient increases, the scroll wave evolutes into a meandering synchronous state. This transition is accompanied by a variation in twisting rate. Filament twisting may prevent the breakup of spiral waves in the bottom layers with a low excitability with which a spiral breaks in a 2D medium. When the gradient is large enough, the twisted filament breaks up, which results in a semi-turbulent state where the lower part is turbulent while the upper part contains a scroll wave with a low twisting filament.	[Yuan, Xiao-Ping] Hangzhou Dianzi Univ, Informat Engn Sch, Hangzhou 310018, Zhejiang, Peoples R China; [Chen, Jiang-Xing; Zhao, Ye-Hua] Hangzhou Dianzi Univ, Dept Phys, Hangzhou 310018, Zhejiang, Peoples R China; [Liu, Gui-Quan] China Jiliang Univ, Dept Phys, Hangzhou 310018, Zhejiang, Peoples R China; [Ying, He-Ping] Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China	Hangzhou Dianzi University; Hangzhou Dianzi University; China Jiliang University; Zhejiang University	Chen, JX (corresponding author), Hangzhou Dianzi Univ, Dept Phys, Hangzhou 310018, Zhejiang, Peoples R China.	jxchen@hdu.edu.cn	Chen, Jiang-Xing/B-4982-2018	Chen, Jiang-Xing/0000-0002-0820-2788	Science and Technology Project of Zhejiang Province [2014C33226]; National Natural Science Foundation of China [11274271]; National Natural Science Foundation of Zhejiang Province [LQ14A050003]	Science and Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Zhejiang Province	This work is supported by Science and Technology Project of Zhejiang Province (Nos. 2014C33226), National Natural Science Foundation of China (Nos. 11274271), and National Natural Science Foundation of Zhejiang Province (Nos. LQ14A050003).	Alonso S, 2003, SCIENCE, V299, P1722, DOI 10.1126/science.1080207; Alonso S, 2006, J PHYS CHEM A, V110, P12063, DOI 10.1021/jp064155q; Bansagi T, 2008, CHAOS, V18, DOI 10.1063/1.2896100; BAR M, 1993, PHYS REV E, V48, pR1635; Biktashev VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024388; Biton Y, 2011, PHYS LETT A, V375, P2333, DOI 10.1016/j.physleta.2011.05.007; Dahmlow P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062923; Gray RA, 2009, CHAOS, V19, DOI 10.1063/1.3204256; Jayaraman A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016209; Jimenez ZA, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036205; Jimenez ZA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.244101; Kupitz D, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066208; Kupitz D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056210; Luengviriya C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056214; Luengviriya C, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.015201; Madruga S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026210; Majumder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018052; Ouyang Q, 2000, PHYS REV LETT, V84, P1047, DOI 10.1103/PhysRevLett.84.1047; Qiao C, 2008, CHAOS, V18, DOI 10.1063/1.2927532; Verschelde H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168104; Vinson M, 1997, NATURE, V386, P477, DOI 10.1038/386477a0; WINFREE AT, 1973, SCIENCE, V181, P937, DOI 10.1126/science.181.4103.937; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Wu YB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036226; Yang Z, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056209	25	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152175	10.1371/journal.pone.0152175	http://dx.doi.org/10.1371/journal.pone.0152175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031956	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800040
J	Barreto, RR; de Farias, WKT; Andrade, H; Santana, FM; Lessa, R				Barreto, Rodrigo R.; de Farias, Wialla K. T.; Andrade, Humber; Santana, Francisco M.; Lessa, Rosangela			Age, Growth and Spatial Distribution of the Life Stages of the Shortfin Mako, Isurus oxyrinchus (Rafinesque, 1810) Caught in the Western and Central Atlantic	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; REPRODUCTIVE-BIOLOGY; PELAGIC SHARKS; VALIDATION; MATURITY; PACIFIC; COAST	The shortfin mako (Isurus oxyrinchus) is a highly migratory pelagic shark that preferentially inhabits oceanic regions in practically all oceans. The wide distribution range of this species renders it susceptible to coastal and oceanic fishing operations. The International Union for Conservation of Nature (IUCN) and the International Commission for the Conservation of Atlantic Tunas (ICCAT) consider this species to be highly vulnerable, especially due to its biological parameters, which are different from those of other sharks that occupy the same niche (e.g., Prionace glauca). Consequently, considerable declines in abundance have been detected over various parts of its range, most of which are linked to oceanic longline fishing. The species has conflicting life history parameters in studies conducted in the last 30 years, especially with regard to age and growth. The main discrepancies regard the interpretation of the periodicity of the deposition of band pairs (BPs) on vertebrae and the possibility of ontogenetic variations in growth. Shortfin mako sharks (n = 1325) were sampled by onboard observers of the Brazilian chartered pelagic longline fleet based in northeast Brazil from 2005 to 2011. Lengths were 79 to 250 and 73 to 296 cm (fork length, FL) for males and females, respectively, with a statistically significant difference in size between sexes and differences in the proportion of individuals in each size class. The onboard observers collected a subsample of vertebrae (n = 467), only 234 of which were suitable for analyses. Reliability between readings was satisfactory. However, it was not possible to validate periodicity in the formation of age bands in the sample. Thus, the von Bertalanffy growth function was used to calculate growth rates for the species through the interpretation of BPs in different scenarios: one BP per year (s1), two BPs per year (s2) and two BPs per year until five years of life (s3). Growth parameters varied for both females (Linf = 309.7[s3] to 441.6 [s1]; k = 0.04[s1] to 0.13[s3]; t0 = -7.08[s1] and -3.27[s3]) and males (Linf = 291.5[s3] to 340.2[s1]; k = 0.04[s1] to 0.13[s3]; t0 = -7.08[s1] and -3.27[s3]). To advance the understanding of the use of habitat, the first analysis of the spatial distribution of the life stages of the shortfin mako sharks caught by commercial longline fishing operations in the South Atlantic was performed. The findings indicate that the portion of the population exploited by the fleets is predominantly juvenile and future actions should take the following issues into account: improvements in the efficiency of data collection procedures, the reestablishment of the onboard observer program, emergency investments in studies that can contribute to a better understanding of habitat use and life history theory.	[Barreto, Rodrigo R.; de Farias, Wialla K. T.; Santana, Francisco M.; Lessa, Rosangela] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil; [Andrade, Humber] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Modelagem Estat MOE, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE)	Barreto, RR (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Lab Dinam Populacoes Marinhas DIMAR, Recife, PE, Brazil.	rodrigorpbarreto@gmail.com	Santana, Francisco/ABG-2693-2020; Barreto, Rodrigo/O-3089-2016; LESSA, ROSANGELA PAULA TEIXEIRA/D-5043-2013	Santana, Francisco/0000-0002-3225-8861; Barreto, Rodrigo/0000-0002-5737-9416; Lessa, Rosangela/0000-0002-9217-1215	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE; CNPq (National Counsel of Technological and Scientific Development)	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco-FACEPE (http://www.facepe.br/): Scholarship to R.B. This work was also supported in part by CNPq (National Counsel of Technological and Scientific Development): Productivity Grant to R.L.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Ardizzone D, 2006, ENVIRON BIOL FISH, V77, P355, DOI 10.1007/s10641-006-9106-4; Barreto R, 2016, CONSERV BIOL, V30, P792, DOI 10.1111/cobi.12663; BARTOO NW, 1983, FISH B-NOAA, V81, P91; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Bishop SDH, 2006, MAR FRESHWATER RES, V57, P143, DOI 10.1071/MF05077; Cailliet G.M., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P57; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2009, DATABASE IUCN RED LI; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; CAREY FG, 1981, PHYSIOL ZOOL, V54, P334, DOI 10.1086/physzool.54.3.30159948; Cerna F, 2009, MAR FRESHWATER RES, V60, P394, DOI 10.1071/MF08125; Clarke SC, 2013, CONSERV BIOL, V27, P197, DOI 10.1111/j.1523-1739.2012.01943.x; Cortes E., 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P2637; Cortes Enric, 2007, Gulf and Caribbean Research, V19, P37; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; Dono F, 2015, ENVIRON BIOL FISH, V98, P517, DOI 10.1007/s10641-014-0284-1; Ebert DA., 2013, SHARKS WORLD; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; French RP, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov044; Goldman KJ, 2012, CRC MAR BIOL SER, P423; Haddon M., 2001, MODELING QUANTITATIV; HAZIN FHV, 2008, SHARKS OPEN OCEAN BI, P213; Hsu H.-H., 2003, THESIS NATL TAIWAN O, P107; Isermann DA, 2005, N AM J FISH MANAGE, V25, P1153, DOI 10.1577/M04-130.1; Joung SJ, 2005, ZOOL STUD, V44, P487; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Maia A, 2007, J APPL ICHTHYOL, V23, P246, DOI 10.1111/j.1439-0426.2007.00849.x; Mejuto J, 2013, COLLECT VOL SCI PAP, V69, P1657; Mejuto J, 2010, COLLECT VOL SCI PAP, V65, P2006; Mollet HF, 2000, FISH B-NOAA, V98, P299; Mourato BL, 2008, COLLECT VOL SCI PAP, V62, P1542; Musick J.A, 2005, MANAGEMENT TECHNIQUE; Natanson LJ, 2006, ENVIRON BIOL FISH, V77, P367, DOI 10.1007/s10641-006-9127-z; NATANSON LJ, 1995, FISH B-NOAA, V93, P116; Ogle D. H., 2015, INTRO FISHERIES ANAL; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Pratt HL, 1983, P INT WORKSH AG DET, P175; Ribot-Carballal MC, 2005, FISH RES, V76, P14, DOI 10.1016/j.fishres.2005.05.004; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; Semba Y, 2011, MAR FRESHWATER RES, V62, P20, DOI 10.1071/MF10123; Semba Y, 2009, ENVIRON BIOL FISH, V84, P377, DOI 10.1007/s10641-009-9447-x; Smith Susan E., 2008, Fish and Aquatic Resources Series, V13, P288; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stevens J.D., 2008, SHARKS OPEN OCEAN BI, P87; STEVENS JD, 1983, COPEIA, P126, DOI 10.2307/1444706; Wells RJD, 2013, FISH B-NOAA, V111, P147, DOI 10.7755/FB.111.2.3; [No title captured]	51	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153062	10.1371/journal.pone.0153062	http://dx.doi.org/10.1371/journal.pone.0153062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049319	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500092
J	Marcotuli, I; Houston, K; Schwerdt, JG; Waugh, R; Fincher, GB; Burton, RA; Blanco, A; Gadaleta, A				Marcotuli, Ilaria; Houston, Kelly; Schwerdt, Julian G.; Waugh, Robbie; Fincher, Geoffrey B.; Burton, Rachel A.; Blanco, Antonio; Gadaleta, Agata			Genetic Diversity and Genome Wide Association Study of beta-Glucan Content in Tetraploid Wheat Grains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OAT AVENA-SATIVA; POPULATION-STRUCTURE; (1,3/1,4)-BETA-D-GLUCAN SYNTHESIS; AMYLOSE CONTENT; DIETARY FIBER; CELL-WALLS; BARLEY; STARCH; CEREAL	Non-starch polysaccharides (NSPs) have many health benefits, including immunomodulatory activity, lowering serum cholesterol, a faecal bulking effect, enhanced absorption of certain minerals, prebiotic effects and the amelioration of type II diabetes. The principal components of the NSP in cereal grains are (1,3; 1,4)-beta-glucans and arabinoxylans. Although (1,3; 1,4)-beta-glucan (hereafter called beta-glucan) is not the most representative component of wheat cell walls, it is one of the most important types of soluble fibre in terms of its proven beneficial effects on human health. In the present work we explored the genetic variability of beta-glucan content in grains from a tetraploid wheat collection that had been genotyped with a 90k-iSelect array, and combined this data to carry out an association analysis. The beta-glucan content, expressed as a percentage w/w of grain dry weight, ranged from 0.18% to 0.89% across the collection. Our analysis identified seven genomic regions associated with a-glucan, located on chromosomes 1A, 2A (two), 2B, 5B and 7A (two), confirming the quantitative nature of this trait. Analysis of marker trait associations (MTAs) in syntenic regions of several grass species revealed putative candidate genes that might influence A-glucan levels in the endosperm, possibly via their participation in carbon partitioning. These include the glycosyl hydrolases endo-beta-(1,4)-glucanase (cellulase), beta-amylase, (1,4)-beta-xylan endohydrolase, xylanase inhibitor protein I, isoamylase and the glycosyl transferase starch synthase II.	[Marcotuli, Ilaria; Blanco, Antonio] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Via G Amendola 165-A, I-70126 Bari, Italy; [Houston, Kelly; Waugh, Robbie] James Hutton Inst, Dundee DD2 5DA, Scotland; [Schwerdt, Julian G.; Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council Ctr Excellence Plant Cell, Waite Campus, Glen Osmond, SA 5064, Australia; [Gadaleta, Agata] Univ Bari Aldo Moro, Agr & Environm Sci, Via G Amendola 165-A, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; James Hutton Institute; University of Adelaide; Universita degli Studi di Bari Aldo Moro	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Agr & Environm Sci, Via G Amendola 165-A, I-70126 Bari, Italy.	agata.gadaleta@uniba.it	Burton, Rachel A/C-4441-2011; Gadaleta, Agata/H-2627-2012	Burton, Rachel A/0000-0002-0638-4709; Gadaleta, Agata/0000-0002-6312-249X; Marcotuli, Ilaria/0000-0002-0146-5286	Ministero dell'Istruzione, dell'Universita e della Ricerca [PON-01_01145 ISCOCEM]; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish; BBSRC [BB/J014869/1, BB/L026317/1] Funding Source: UKRI	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, project 'PON-01_01145 ISCOCEM'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, J AM DIET ASSOC, V95, P493; Asoro FG, 2013, CROP SCI, V53, P542, DOI 10.2135/cropsci2012.01.0039; BACIC A, 1980, CARBOHYD RES, V82, P372, DOI 10.1016/S0008-6215(00)85713-4; BERESFORD G, 1983, J CEREAL SCI, V1, P111, DOI 10.1016/S0733-5210(83)80028-9; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Christensen U, 2012, J CEREAL SCI, V55, P69, DOI 10.1016/j.jcs.2011.10.005; Clarke B, 2008, FUNCT INTEGR GENOMIC, V8, P211, DOI 10.1007/s10142-007-0070-7; Collins HM, 2010, CEREAL CHEM, V87, P272, DOI 10.1094/CCHEM-87-4-0272; Dabney A, 2010, QVALUE Q VALUE ESTIM; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferguson LR, 2003, LANCET, V361, P1487, DOI 10.1016/S0140-6736(03)13219-9; Fincher G.B., 2004, ENCY GRAIN SCI, P206, DOI [10.1016/B0-12-765490-9/00107-5, DOI 10.1016/B0-12-765490-9/00107-5]; Fincher GB, 2009, CURR OPIN PLANT BIOL, V12, P140, DOI 10.1016/j.pbi.2009.01.002; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; HAN F, 1995, THEOR APPL GENET, V91, P921, DOI 10.1007/BF00223901; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Islamovic E, 2013, MOL BREEDING, V31, P15, DOI 10.1007/s11032-012-9764-1; Kianian SF, 2000, THEOR APPL GENET, V101, P1039, DOI 10.1007/s001220051578; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Kim HongSik, 2011, Journal of Crop Science and Biotechnology, V14, P239, DOI 10.1007/s12892-011-0045-z; Kim SJ, 2015, PLANT J, V81, P537, DOI 10.1111/tpj.12748; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Kooiker M, 2013, J EXP BOT, V64, P3681, DOI 10.1093/jxb/ert205; Lafiandra D, 2014, J CEREAL SCI, V59, P312, DOI 10.1016/j.jcs.2014.01.001; Li JZ, 2008, J CEREAL SCI, V48, P647, DOI 10.1016/j.jcs.2008.02.004; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; MCCLEARY BV, 1991, J SCI FOOD AGR, V55, P303, DOI 10.1002/jsfa.2740550215; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Molina-Cano JL, 2007, MOL BREEDING, V19, P275, DOI 10.1007/s11032-006-9075-5; National Health and Medical Research Council, 2013, AUSTR DIET GUID; Newell MA, 2012, THEOR APPL GENET, V125, P1687, DOI 10.1007/s00122-012-1945-0; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; POWELL W, 1985, THEOR APPL GENET, V71, P461, DOI 10.1007/BF00251188; Pritchard JR, 2011, J SCI FOOD AGR, V91, P1298, DOI 10.1002/jsfa.4316; Pritchard JK, 2000, GENETICS, V155, P945; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RC, 2012, R LANG ENV STAT COMP; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Utsumi Y UC, 2011, PLANT PHYSL, V156; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; WENZL H, 1981, Z PFLANZENK PFLANZEN, V88, P584; Wilson SM, 2015, PLANT CELL, V27, P754, DOI 10.1105/tpc.114.135970; Woodward J., 1983, CARBOHYD POLYM, V3, P143	68	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152590	10.1371/journal.pone.0152590	http://dx.doi.org/10.1371/journal.pone.0152590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045166	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600027
J	Bradberry, LA				Bradberry, Leigh A.			The Effect of Religion on Candidate Preference in the 2008 and 2012 Republican Presidential Primaries	PLOS ONE			English	Article								Thanks to the work of politics and religion scholars, we now know a lot about the relationship between religion and voting in American presidential general elections. However, we know less about the influence of religion on individual vote choice in presidential primaries. This article fills that gap by exploring the relationship between religion and candidate preference in the 2008 and 2012 Republican primaries. Using pre-Super Tuesday surveys conducted by the Pew Research Center, I find that the Republican candidate who most explicitly appealed to religious voters (Mike Huckabee in 2008 and Rick Santorum in 2012) was the preferred candidate of Republican respondents who attended religious services at the highest levels, and that as attendance increased, so did the likelihood of preferring that candidate. I also find that identification as a born again Christian mattered to candidate preference. Specifically, born again Christians were more likely than non-born again Christians to prefer Huckabee to Mitt Romney, John McCain and Ron Paul in 2008, and Santorum to Romney in 2012. Although ideology was not the primary subject of this article, I find that ideology was also a statistically significant predictor of Republican candidate preference in both 2008 and 2012. This robust finding reinforces scholars' prior work on the importance of ideology in explaining presidential primary vote choice. The overall findings of the paper provide evidence that religion variables can add to our understanding of why voters prefer one candidate over another in presidential primaries.	[Bradberry, Leigh A.] Calif State Univ Los Angeles, Dept Polit Sci, Los Angeles, CA 90032 USA	California State University System; California State University Los Angeles	Bradberry, LA (corresponding author), Calif State Univ Los Angeles, Dept Polit Sci, Los Angeles, CA 90032 USA.	leigh.bradberry@csun.edu			College of Social and Behavioral Sciences at California State University, Northridge	College of Social and Behavioral Sciences at California State University, Northridge	The author received an internal research grant from the College of Social and Behavioral Sciences at California State University, Northridge to assist with the completion of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWITZ AI, 1987, POLITICAL BEHAVIOR, V0009; ALDRICH JH, 1994, POLITICAL BEHAV, V0016; Aldrich John H., 1980, CONVENTION STRATEGIE; Bartels LM., 1988, PRESIDENTIAL PRIMARI; Campbell DE, 2012, POLIT BEHAV, V34, P277, DOI 10.1007/s11109-012-9200-6; Cohen M., 2008, PARTY DECIDES PRESID; Djupe PA., 2014, GOD TALK EXPT RELIG, DOI 10.2307/j.ctvrf8960; GOPOIAN JD, 1982, AM J POLIT SCI, V26, P523, DOI 10.2307/2110941; Green J.C., 2007, FAITH FACTOR RELIG I; Green J. C., 2007, MATTER FAITH RELIG 2, P15; Guth JL, 2013, AM ELECTIONS 2012, P190; Kohut A., 2000, DIMINISHING DIVIDE R; Leege DavidC., 1993, REDISCOVERING RELIG; Norrander B., 1986, THE JOURNAL OF POLIT, V48, P156, DOI [10.2307/2130931, DOI 10.2307/2130931]; Pew Research Center, 2011, ROMN MORM FAITH LIK; Pew Research Center, 2007, PUBL PERC ROMN MORM; Popkin S., 1994, REASONING VOTER COMM, V2nd ed.; Putnam R. D., 2012, AM GRACE RELIG DIVID; Rickershauser J, 2007, ELECT STUD, V26, P371, DOI 10.1016/j.electstud.2006.09.003; STONE WJ, 1992, J POLIT, V54, P1074, DOI 10.2307/2132109; WATTIER MJ, 1983, J POLIT, V45, P1016, DOI 10.2307/2130423	21	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152037	10.1371/journal.pone.0152037	http://dx.doi.org/10.1371/journal.pone.0152037			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043438	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100007
J	Xiang, KL; Wu, SD; Yu, SX; Liu, Y; Jabbour, F; Erst, AS; Zhao, L; Wang, W; Chen, ZD				Xiang, Kun-Li; Wu, Sheng-Dan; Yu, Sheng-Xian; Liu, Yang; Jabbour, Florian; Erst, Andrey S.; Zhao, Liang; Wang, Wei; Chen, Zhi-Duan			The First Comprehensive Phylogeny of Coptis (Ranunculaceae) and Its Implications for Character Evolution and Classification	PLOS ONE			English	Article							RHIZOMA-COPTIDIS; RIBOSOMAL DNA; ALKALOIDS; SEQUENCES; INFERENCE; CHLOROPLAST; JAPONICA; UTILITY	Coptis (Ranunculaceae) contains 15 species and is one of the pharmaceutically most important plant genera in eastern Asia. Understanding of the evolution of morphological characters and phylogenetic relationships within the genus is very limited. Here, we present the first comprehensive phylogenetic analysis of the genus based on two plastid and one nuclear markers. The phylogeny was reconstructed using Bayesian inference, as well as maximum parsimony and maximum likelihood methods. The Swofford-Olsen-Waddell-Hillis and Bayesian tests were used to assess the strength of the conflicts between traditional taxonomic units and those suggested by the phylogenetic inferences. Evolution of morphological characters was inferred using Bayesian method to identify synapomorphies for the infrageneric lineages. Our data recognize two strongly supported clades within Coptis. The first clade contains subgenus Coptis and section Japonocoptis of subgenus Metacoptis, supported by morphological characters, such as traits of the central leaflet base, petal color, and petal shape. The second clade consists of section Japonocoptis of subgenus Metacoptis. Coptis morii is not united with C. quinquefolia, in contrast with the view that C. morii is a synonym of C. quinquefolia. Two varieties of C. chinensis do not cluster together. Coptis groenlandica and C. lutescens are reduced to C. trifolia and C. japonica, respectively. Central leaflet base, sepal shape, and petal blade carry a strong phylogenetic signal in Coptis, while leaf type, sepal and petal color, and petal shape exhibit relatively higher levels of evolutionary flexibility.	[Xiang, Kun-Li; Yu, Sheng-Xian; Wang, Wei; Chen, Zhi-Duan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Xiang, Kun-Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Sheng-Dan] Shanxi Normal Univ, Coll Life Sci, Linfen 041004, Peoples R China; [Liu, Yang] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Jabbour, Florian] Univ Paris 04, Museum Natl Hist Nat, Inst Systemat,EPHE, Evolut,Biodiversite,UMR 7205,ISYEB,MNHN,CNRS,UPMC, F-75005 Paris, France; [Erst, Andrey S.] Russian Acad Sci, Cent Siberian Bot Garden Siberian Branch, Zolotodolinskaya Str 101, Novosibirsk 630090, Russia; [Erst, Andrey S.] Natl Res Tomsk State Univ, Lab Systemat & Phylogeny Plants, Prospekt Lenina 36, Tomsk 634050, Russia; [Zhao, Liang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi Normal University; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Central Siberian Botanical Garden; Russian Academy of Sciences; Tomsk State University; Northwest A&F University - China	Wang, W (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	wangwei1127@ibcas.ac.cn	Erst, Andrey/M-3444-2016; Wu, Shengdan/ABE-3272-2020; Wu, Shengdan/L-7193-2019; Xiang, Kun-Li/X-1220-2018; Wu, Sheng-Dan/AAM-4003-2021	Wu, Shengdan/0000-0003-1481-4825; Xiang, Kun-Li/0000-0002-0800-6015; Liu, Yang/0000-0002-5942-839X	NSFC [31270269, 31590822, 31300158]; Youth Innovation Promotion Association Foundation of CAS; RFBR [16-54-53127]; PRF [7530.2016.4]; NSF [DEB-1240045]; Direct For Biological Sciences [1240045] Funding Source: National Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association Foundation of CAS; RFBR(Russian Foundation for Basic Research (RFBR)); PRF; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was partially funded by grants NSFC (31270269, 31590822, and 31300158), the Youth Innovation Promotion Association Foundation of CAS, RFBR (16-54-53127), PRF (7530.2016.4), and NSF (DEB-1240045).	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen JH, 2008, ELECTROPHORESIS, V29, P2135, DOI 10.1002/elps.200700797; Chen ZD, 2004, INT J PLANT SCI, V165, P325, DOI 10.1086/382795; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Doh EJ, 2014, GENES GENOM, V36, P345, DOI 10.1007/s13258-014-0172-2; FERNALD M. L., 1929, RHODORA, V31, P136; Ford BA, 1996, FLORA N AM, V3, P242; Fu DZ, 2001, FLORA CHINA, V6, P309; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayata B, 1913, COPTIS ICON PI FORMO, V3, P9; He Y, 2014, BIOCHEM SYST ECOL, V56, P88, DOI 10.1016/j.bse.2014.05.002; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hoot SB, 1995, PLANT SYST EVOL, P241; Hsiao PG, 1979, FLORA REIPUBLICAE PO, V27, P592; Hulten E, 1937, FLORA ALEUTIAN ISLAN, P397; Hulten E, 1944, FLORA ALASKA YUKON, V4; Jensen U, 1995, PLANT SYST EVOL, P273; Kadota Y, 2006, FLORA JAPAN A, VIIa, P323; Kadota Yuichi, 2004, Journal of Japanese Botany, V79, P311; Kamath Shreya, 2009, Chin Med, V4, P17, DOI 10.1186/1749-8546-4-17; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuang HX., 2017, CHEM TRADITIONAL CHI; Lee DU, 2003, LIFE SCI, V73, P1401, DOI 10.1016/S0024-3205(03)00435-1; Li CY, 2009, J PHARMACEUT BIOMED, V49, P1272, DOI 10.1016/j.jpba.2009.02.028; Li RQ, 2004, INT J PLANT SCI, V165, P311, DOI 10.1086/381920; Liu Y, 2012, MOL PHYLOGENET EVOL, V62, P130, DOI 10.1016/j.ympev.2011.09.010; Pagel M, 2014, BAYESTRAITS V 2 0 RE; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiao YL, 2009, J AOAC INT, V92, P663; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rambaut A., 2007, TRACER V1 4; Ro KE, 1997, MOL PHYLOGENET EVOL, V8, P117, DOI 10.1006/mpev.1997.0413; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SATAKE YOSISUKE, 1949, JOUR JAPANESE BOT, V24, P69; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAMURA M, 1981, BOT MAG TOKYO, V94, P165, DOI 10.1007/BF02488274; TAMURA M, 1968, Science Reports College of General Education Osaka University, V17, P41; Tamura M., 1995, NATURL PFLANZ, V17, P444; Tamura M, 1978, J GEOBOT, V26, P2; Tamura M, 1982, WILD FLOWERS JAPAN, V2, P86; TAMURA MICHIO, 1958, ACTA PHYTOTAX ET GEOBOT, V17, P114; Taylor RL, 1968, FLORA QUEEN CHARLO 2, P148; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; [辜天琪 Tianqi Gu], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P80; Torrey J, 1838, FLORA N AM, V1; Wang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/798093; Wang W, 2005, PLANT SYST EVOL, V255, P41, DOI 10.1007/s00606-005-0339-z; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang W, 2010, TAXON, V59, P1712, DOI 10.1002/tax.596006; Wu H, 2014, PHYTOMEDICINE, V21, P1373, DOI 10.1016/j.phymed.2014.05.002; Yang KC, 1996, FLORA TAIWAN, V2, P545; Yoshimatsu H, 1927, SUPPLEMENTA ICONUM P, V3, P25; Yu YF, 1999, PLANTS, V151, P3; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493	62	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153127	10.1371/journal.pone.0153127	http://dx.doi.org/10.1371/journal.pone.0153127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044035	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100067
J	Coupat-Goutaland, B; Regoudis, E; Besseyrias, M; Mularoni, A; Binet, M; Herbelin, P; Pelandakis, M				Coupat-Goutaland, Benedicte; Regoudis, Estelle; Besseyrias, Matthieu; Mularoni, Angelique; Binet, Marie; Herbelin, Pascaline; Pelandakis, Michel			Population Structure in Naegleria fowleri as Revealed by Microsatellite Markers	PLOS ONE			English	Article							FREE-LIVING AMEBA; INTERNAL TRANSCRIBED SPACERS; RIBOSOMAL-RNA GENE; TIME PCR ASSAY; WATER SAMPLES; IDENTIFICATION; DNA; EXPLORATION; ENVIRONMENT; ITALICA	Naegleria sp. is a free living amoeba belonging to the Heterolobosea class. Over 40 species of Naegleria were identified and recovered worldwide in different habitats such as swimming pools, freshwater lakes, soil or dust. Among them, N. fowleri, is a human pathogen responsible for primary amoeboic meningoencephalitis (PAM). Around 300 cases were reported in 40 years worldwide but PAM is a fatal disease of the central nervous system with only 5% survival of infected patients. Since both pathogenic and non pathogenic species were encountered in the environment, detection and dispersal mode are crucial points in the fight against this pathogenic agent. Previous studies on identification and genotyping of N. fowleri strains were focused on RAPD analysis and on ITS sequencing and identified 5 variants: euro-american, south pacific, widespread, cattenom and chooz. Microsatellites are powerful markers in population genetics with broad spectrum of applications (such as paternity test, fingerprinting, genetic mapping or genetic structure analysis). They are characterized by a high degree of length polymorphism. The aim of this study was to genotype N. fowleri strains using microsatellites markers in order to track this population and to better understand its evolution. Six microsatellite loci and 47 strains from different geographical origins were used for this analysis. The microsatellite markers revealed a level of discrimination higher than any other marker used until now, enabling the identification of seven genetic groups, included in the five main genetic groups based on the previous RAPD and ITS analyses. This analysis also allowed us to go further in identifying private alleles highlighting intra-group variability. A better identification of the N. fowleri isolates could be done with this type of analysis and could allow a better tracking of the clinical and environmental N. fowleri strains.	[Coupat-Goutaland, Benedicte; Regoudis, Estelle; Pelandakis, Michel] Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenesis 5240, F-69622 Villeurbanne, France; [Besseyrias, Matthieu] Univ Lyon 1, F-69622 Villeurbanne, France; [Mularoni, Angelique] Univ Lyon 1, ISPB EA Bioact Mol & Med Chem 4446, F-69365 Lyon, France; [Binet, Marie; Herbelin, Pascaline] EDF Res & Dev, Lab Natl Hydraul & Environm, Chatou, France	Centre National de la Recherche Scientifique (CNRS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Electricite de France (EDF)	Pelandakis, M (corresponding author), Univ Lyon 1, CNRS, UMR Microbiol Adaptat & Pathogenesis 5240, F-69622 Villeurbanne, France.	michel.pelandakis@univ-lyon1.fr	COUPAT, Bénédicte/G-5488-2019	COUPAT, Bénédicte/0000-0002-0614-9848; Mularoni, Angelique/0000-0002-3289-805X	EDF	EDF(Electricite de France (EDF))	The funder EDF played a role in the strains collection, the site access and agreement and decision to publish (insofar the confidentiality of the site is respected). The funder provided support in the form of salaries for authors ER and BCG but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	ADAMS M, 1989, INT J PARASITOL, V19, P823, DOI 10.1016/0020-7519(89)90107-0; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 1996, 5000 CNRS UMR; Behets J, 2007, WATER RES, V41, P118, DOI 10.1016/j.watres.2006.10.003; CARIOU ML, 1987, GENETICS, V115, P265; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; De Jonckheere JF, 2014, EXP PARASITOL, V145, pS2, DOI 10.1016/j.exppara.2014.07.011; De Jonckheere JF, 2011, INFECT GENET EVOL, V11, P1520, DOI 10.1016/j.meegid.2011.07.023; DEJONCKHEERE JF, 1988, BIOSYSTEMS, V21, P269, DOI 10.1016/0303-2647(88)90022-6; DEJONCKHEERE JF, 1984, J PROTOZOOL, V31, P324, DOI 10.1111/j.1550-7408.1984.tb02971.x; DEJONCKHEERE JF, 1987, MOL BIOCHEM PARASIT, V24, P55, DOI 10.1016/0166-6851(87)90115-0; Fritz-Laylin LK, 2011, RES MICROBIOL, V162, P607, DOI 10.1016/j.resmic.2011.03.003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gur-Arie R, 2000, GENOME RES, V10, P62; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Kebede N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-160; KILVINGTON S, 1995, APPL ENVIRON MICROB, V61, P3764, DOI 10.1128/AEM.61.10.3764-3767.1995; Madarova L, 2010, EXP PARASITOL, V126, P37, DOI 10.1016/j.exppara.2009.11.001; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Pelandakis M, 1997, FEMS MICROBIOL LETT, V151, P31, DOI 10.1016/S0378-1097(97)00129-8; Pelandakis M, 1998, APPL ENVIRON MICROB, V64, P2977; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Puzon GJ, 2009, ENVIRON SCI TECHNOL, V43, P6691, DOI 10.1021/es900432m; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reveiller FL, 2003, J EUKARYOT MICROBIOL, V50, P109, DOI 10.1111/j.1550-7408.2003.tb00244.x; Robinson BS, 2004, PARASITOL INT, V53, P23, DOI 10.1016/j.parint.2003.10.002; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Siddiqui R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003017; Tiewcharoen S, 2007, PARASITOL RES, V101, P139, DOI 10.1007/s00436-006-0442-2; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Visvesvara GS, 2007, TROPICAL INFECT DIS, P707; Zhou L, 2003, J EUKARYOT MICROBIOL, V50, P522, DOI 10.1111/j.1550-7408.2003.tb00617.x; Zysset-Burri DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-496	41	8	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152434	10.1371/journal.pone.0152434	http://dx.doi.org/10.1371/journal.pone.0152434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035434	gold, Green Published			2022-12-27	WOS:000373201200017
J	Dong, WJ; Gong, MC; Shi, ZR; Xiao, JJ; Zhang, JK; Peng, JW				Dong, Wenjing; Gong, Mancheng; Shi, Zhirong; Xiao, Jianjun; Zhang, Junkai; Peng, Jiewen			Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHINESE HAN POPULATION; GENE POLYMORPHISM; RHEUMATOID-ARTHRITIS; INHIBITORY MOLECULE; PD-1 POLYMORPHISMS; ESOPHAGEAL CANCER; BREAST-CANCER; LUNG-CANCER; ASSOCIATION	Programmed cell death-1 (PD-1) plays an important inhibitory role in anti-tumor responses, so it is considered as a powerful candidate gene for individual's genetic susceptibility to cancer. Recently, some epidemiological studies have evaluated the association between PD-1 polymorphisms and cancer risk. However, the results of the studies are conflicting. Therefore, a meta-analysis was performed. We identified all studies reporting the relationship between PD-1 polymorphisms and cancers by electronically searches. According to the inclusion criteria and the quality assessment of Newcastle-Ottawa Scale (NOS), only high quality studies were included. A total of twelve relevant studies involving 5,206 cases and 5,174 controls were recruited. For PD-1.5 (rs2227981) polymorphism, significantly decreased cancer risks were obtained among overall population, Asians subgroup and population- based subgroup both in TT vs. CC and TT vs. CT+CC genetic models. In addition, a similar result was also found in TT vs. C allele for overall population. However, there were no significant associations between either PD-1.9 (rs2227982) or PD-1 rs7421861 polymorphisms and cancer risks in all genetic models and alleles. For PD-1.3 (rs11568821) polymorphism, we found different cancer susceptibilities between GA vs. GG and AA vs. AG+GG genetic models, and no associations between AA vs. GG, AA+AG vs. GG genetic models or A vs. G allele and cancer risks. In general, our results firstly indicated that PD-1.5 (rs2227981) polymorphism is associated a strongly decreased risk of cancers. Additional epidemiological studies are needed to confirm our findings.	[Dong, Wenjing; Xiao, Jianjun; Zhang, Junkai; Peng, Jiewen] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Oncol, Zhongshan 528403, Guangdong, Peoples R China; [Gong, Mancheng] Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Urol, Zhongshan 528403, Guangdong, Peoples R China; [Shi, Zhirong] Second Peoples Hosp Zhuhai, Dept Pharm, Zhuhai 519020, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Peng, JW (corresponding author), Sun Yat Sen Univ, Zhongshan Affiliated Hosp, Dept Oncol, Zhongshan 528403, Guangdong, Peoples R China.	medicinegd@163.com						BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bayram S, 2012, GENE, V511, P308, DOI 10.1016/j.gene.2012.09.119; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cao Pingping, 2008, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V22, P1115; Dehaghani AS, 2009, J REPROD MED, V54, P25; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinesh RK, 2010, AUTOIMMUN REV, V9, P583, DOI 10.1016/j.autrev.2010.04.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flores S, 2010, REV MED CHILE, V138, P543, DOI /S0034-98872010000500003; Foureau DM, 2011, CANCER IMMUNOL IMMUN, V60, P1347, DOI 10.1007/s00262-011-1035-1; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Ge J, 2015, J CANCER RES CLIN, V141, P1533, DOI 10.1007/s00432-015-1915-4; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Haghshenas MR, 2011, MOL BIOL REP, V38, P4205, DOI 10.1007/s11033-010-0542-z; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hua Z, 2011, BREAST CANCER RES TR, V129, P195, DOI 10.1007/s10549-011-1440-3; Ivansson EL, 2010, GYNECOL ONCOL, V116, P544, DOI 10.1016/j.ygyno.2009.10.084; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee SH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2071; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Lv F, 2011, WORLD J HEPATOL, V3, P72, DOI 10.4254/wjh.v3.i3.72; Ma Y, 2015, INT J CLIN EXP MED, V8, P16585; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mamat U, 2015, INT J CLIN EXP MED, V8, P13282; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meng Qing, 2008, Zhonghua Zhongliu Zazhi, V30, P192; Mojtahedi Z, 2012, GENE, V508, P229, DOI 10.1016/j.gene.2012.07.059; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Qiu H, 2014, CLIN BIOCHEM, V47, P612, DOI 10.1016/j.clinbiochem.2013.12.023; Sasaki H, 2014, MOL CLIN ONCOL, V2, P1035, DOI 10.3892/mco.2014.358; Savabkar Sanaz, 2013, Gastroenterol Hepatol Bed Bench, V6, P178; Tang WF, 2015, INT J CLIN EXP MED, V8, P8086; Velazquez-Cruz R, 2007, EUR J HUM GENET, V15, P336, DOI 10.1038/sj.ejhg.5201767; Wells GA, 2015, NEWCASTLE OTTAWA SCA, DOI DOI 10.13105/WJMA.V5.I4.80; Yin L, 2014, INT J CLIN EXP MED, V7, P5832; Yousefi AR, 2013, LAB MED, V44, P23; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446	49	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152448	10.1371/journal.pone.0152448	http://dx.doi.org/10.1371/journal.pone.0152448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031235	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800074
J	Martin, PM; Palhiere, I; Ricard, A; Tosser-Klopp, G; Rupp, R				Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel			Genome Wide Association Study Identifies New Loci Associated with Undesired Coat Color Phenotypes in Saanen Goats	PLOS ONE			English	Article							AGOUTI SIGNALING PROTEIN; ASIP GENE; BLACK SHEEP; MISSENSE; BREEDS; MUTATIONS	This paper reports a quantitative genetics and genomic analysis of undesirable coat color patterns in goats. Two undesirable coat colors have routinely been recorded for the past 15 years in French Saanen goats. One fifth of Saanen females have been phenotyped "pink" (8.0%) or "pink neck" (11.5%) and consequently have not been included in the breeding program as elite animals. Heritability of the binary "pink" and "pink neck" phenotype, estimated from 103,443 females was 0.26 for "pink" and 0.21 for "pink neck". Genome wide association studies (using haplotypes or single SNPs) were implemented using a daughter design of 810 Saanen goats sired by 9 Artificial Insemination bucks genotyped with the goatSNP50 chip. A highly significant signal (-log10pvalue = 10.2) was associated with the "pink neck" phenotype on chromosome 11, suggesting the presence of a major gene. Highly significant signals for the "pink" phenotype were found on chromosomes 5 and 13 (-log10p values of 7.2 and, 7.7 respectively). The most significant SNP on chromosome 13 was in the ASIP gene region, well known for its association with coat color phenotypes. Nine significant signals were also found for both traits. The highest signal for each trait was detected by both single SNP and haplotype approaches, whereas the smaller signals were not consistently detected by the two methods. Altogether these results demonstrated a strong genetic control of the "pink" and "pink neck" phenotypes in French Saanen goats suggesting that SNP information could be used to identify and remove undesired colored animals from the breeding program.	[Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] INRA, UMR Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France; [Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENSAT, Castanet Tolosan, France; [Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel] Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENVT, Toulouse, France	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Martin, PM (corresponding author), INRA, UMR Genet Physiol & Syst Elevage 1388, F-31326 Castanet Tolosan, France.; Martin, PM (corresponding author), Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENSAT, Castanet Tolosan, France.; Martin, PM (corresponding author), Univ Toulouse, UMR Genet Physiol & Syst Elevage 1388, INPT ENVT, Toulouse, France.	pauline.martin@toulouse.inra.fr		Rupp, Rachel/0000-0003-3375-5816; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673	French organization through "Genomcap" (INRA); French organization through "Genomcap" (APIS-GENE); French organization through "Genomcap" (UNCEIA); French organization through "Genomcap" (CAPGENES); French organization through "Genomcap" (FCEL); EC (FP7) [245140]	French organization through "Genomcap" (INRA); French organization through "Genomcap" (APIS-GENE); French organization through "Genomcap" (UNCEIA); French organization through "Genomcap" (CAPGENES); French organization through "Genomcap" (FCEL); EC (FP7)	This work was supported by grants from French organizations through "Genomcap" (a research program including INRA, APIS-GENE, UNCEIA, CAPGENES and FCEL) and EC (FP7/2007-2013), grant no 245140, "3SR", Sustainable Solutions for Small Ruminants (http://www.3srbreeding.eu/). This Publication reflects only the authors' views and the EC is not liable for any use that may be made of the information contained herein.	Abitbol M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0112-x; ADALSTEINSSON S, 1994, J HERED, V85, P267, DOI 10.1093/oxfordjournals.jhered.a111454; Adefenwa MA, 2013, MOL BIOL REP, V40, P4447, DOI 10.1007/s11033-013-2535-1; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cuenot L., 1905, ARCH ZOOL EXP GEN, V3, P123; Davenport CB, 1905, SCIENCE, V22, P674, DOI 10.1126/science.22.569.674; Dong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1606-1; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Fontanesi L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-47; Gershony LC, 2014, ANIM GENET, V45, P893, DOI 10.1111/age.12206; Gilmour AR, 2009, ASREML USER GUIDE RE; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Jackson IJ, PIGMENT CELL RES, V7, P73; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Peters K.J., 1982, TROP ANIM HEALTH PRO, V7, P296; Searle A.G., 1968, COMP GENETICS COAT C; Sponenberg D. P., 1996, MENDELIAN INHERITANC, P15; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; Wilson BD, 1999, MOL MED TODAY, V5, P250, DOI 10.1016/S1357-4310(99)01471-9; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	27	24	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152426	10.1371/journal.pone.0152426	http://dx.doi.org/10.1371/journal.pone.0152426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030980	Green Published, gold			2022-12-27	WOS:000373121800072
J	Wee, WY; Tan, TK; Jakubovics, NS; Choo, SW				Wee, Wei Yee; Tan, Tze King; Jakubovics, Nicholas S.; Choo, Siew Woh			Whole-Genome Sequencing and Comparative Analysis of Mycobacterium brisbanense Reveals a Possible Soil Origin and Capability in Fertiliser Synthesis	PLOS ONE			English	Article							SP-NOV.; NONTUBERCULOUS MYCOBACTERIA; TISSUE INFECTION; TUBERCULOSIS; VIRULENCE; GENE; EVOLUTION; ISLANDS; VFDB; IDENTIFICATION	Mycobacterium brisbanense is a member of Mycobacterium fortuitum third biovariant complex, which includes rapidly growing Mycobacterium spp. that normally inhabit soil, dust and water, and can sometimes cause respiratory tract infections in humans. We present the first whole-genome analysis of M. brisbanense UM_WWY which was isolated from a 70-year-old Malaysian patient. Molecular phylogenetic analyses confirmed the identification of this strain as M. brisbanense and showed that it has an unusually large genome compared with related mycobacteria. The large genome size of M. brisbanense UM_WWY (similar to 7.7Mbp) is consistent with further findings that this strain has a highly variable genome structure that contains many putative horizontally transferred genomic islands and prophage. Comparative analysis showed that M. brisbanense UM_WWY is the only Mycobacterium species that possesses a complete set of genes encoding enzymes involved in the urea cycle, suggesting that this soil bacterium is able to synthesize urea for use as plant fertilizers. It is likely that M. brisbanense UM_WWY is adapted to live in soil as its primary habitat since the genome contains many genes associated with nitrogen metabolism. Nevertheless, a large number of predicted virulence genes were identified in M. brisbanense UM_WWY that are mostly shared with well-studied mycobacterial pathogens such as Mycobacterium tuberculosis and Mycobacterium abscessus. These findings are consistent with the role of M. brisbanense as an opportunistic pathogen of humans. The whole-genome study of UM_WWY has provided the basis for future work of M. brisbanense.	[Wee, Wei Yee; Tan, Tze King; Choo, Siew Woh] Univ Malaya, Genome Informat Res Lab, High Impact Res Bldg HIR Bldg, Kuala Lumpur 50603, Malaysia; [Wee, Wei Yee; Tan, Tze King; Choo, Siew Woh] Univ Malaya, Dept Oral Biol & Biomed Sci, Fac Dent, Kuala Lumpur 50603, Malaysia; [Jakubovics, Nicholas S.] Newcastle Univ, Sch Dent Sci, Ctr Oral Hlth Res, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jakubovics, Nicholas S.] Univ Malaya, Genome Solut Sdn Bhd, Innovat Incubator UM, Suite 8,Level 5,Res Management & Innovat Complex, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Newcastle University - UK; Universiti Malaya	Choo, SW (corresponding author), Univ Malaya, Genome Informat Res Lab, High Impact Res Bldg HIR Bldg, Kuala Lumpur 50603, Malaysia.; Choo, SW (corresponding author), Univ Malaya, Dept Oral Biol & Biomed Sci, Fac Dent, Kuala Lumpur 50603, Malaysia.	lchoo@um.edu.my	Jakubovics, Nicholas S/B-1938-2010	Jakubovics, Nicholas S/0000-0001-6667-0515; Tze King, Tan/0000-0003-1623-615X	Ministry of Education, Malaysia under the High Impact Research (HIR) [UM.C/625/HIR/MOHE/CHAN-08]; UMRG grant from University of Malaya and Ministry of Education, Malaysia [RG541-13HTM]; University of Malaya	Ministry of Education, Malaysia under the High Impact Research (HIR); UMRG grant from University of Malaya and Ministry of Education, Malaysia; University of Malaya(Universiti Malaya)	This project was supported by University of Malaya and Ministry of Education, Malaysia under the High Impact Research (HIR) grant UM.C/625/HIR/MOHE/CHAN-08 and UMRG grant (grant number: RG541-13HTM) from University of Malaya and Ministry of Education, Malaysia.	Amon J, 2009, J MOL MICROB BIOTECH, V17, P20, DOI 10.1159/000159195; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BASTOS MDD, 1988, EMBO J, V7, P2935, DOI 10.1002/j.1460-2075.1988.tb03152.x; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Choo SW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04061; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Rabello MCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029884; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; Goyer A, 2004, J BIOL CHEM, V279, P16947, DOI 10.1074/jbc.M400071200; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; KAMALA T, 1994, APPL ENVIRON MICROB, V60, P1021, DOI 10.1128/AEM.60.3.1021-1024.1994; Khurana JL, 2009, BIOCHEM J, V418, P431, DOI 10.1042/BJ20081488; KVALNESKRICK K, 1986, BIOCHEMISTRY-US, V25, P6061, DOI 10.1021/bi00368a034; Lamy B, 2008, INT J SYST EVOL MICR, V58, P486, DOI 10.1099/ijs.0.65222-0; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lin WW, 2012, INFECT IMMUN, V80, P2771, DOI 10.1128/IAI.06195-11; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Poh ME, 2014, CHEST, V145, P858, DOI 10.1378/chest.13-1952; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Rhodes MW, 2005, INT J SYST EVOL MICR, V55, P1139, DOI 10.1099/ijs.0.63343-0; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Schinsky MF, 2004, INT J SYST EVOL MICR, V54, P1653, DOI 10.1099/ijs.0.02743-0; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Talavlikar R, 2011, CAN J INFECT DIS MED, V22, P101, DOI 10.1155/2011/206532; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Viator Ryan J., 2008, BMC Biochemistry, V9, P15, DOI 10.1186/1471-2091-9-15; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951	47	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152682	10.1371/journal.pone.0152682	http://dx.doi.org/10.1371/journal.pone.0152682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031249	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800114
J	Yan, YF; Jiang, L; Zhang, MD; Li, XH; Nie, MX; Feng, TT; Zhao, X; Wang, LY; Zhao, QM				Yan, Yun-Feng; Jiang, Long; Zhang, Ming-Duo; Li, Xin-He; Nie, Mao-Xiao; Feng, Ting-Ting; Zhao, Xin; Wang, Lu-Ya; Zhao, Quan-Ming			Can Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized Individuals	PLOS ONE			English	Article							DESIGN; ALLOY	Objective In the era of bare metal stents (BMSs), alloys have been considered to be better materials for stent design than stainless steel. In the era of biodegradable polymer drug-eluting stents (BP-DESs), the safety and efficacy of BP-DESs with different metal platforms (stainless steel or alloys) have not yet been reported, although their polymers are eventually absorbed, and only the metal platforms remain in the body. This study sought to determine the clinical safety and efficacy of BP-DESs with different platforms compared with other stents (other DESs and BMSs). Methods PubMed, Embase and Clinical Trials.gov were searched for randomized controlled trials (RCTs) that compared BP-DESs with other stents. After performing pooled analysis of BPDESs and other stents, we performed a subgroup analysis using two classification methods: stent platform and follow-up time. The study characteristics, patient characteristics and clinical outcomes were abstracted. Results Forty RCTs (49 studies) comprising 34,850 patients were included. Biodegradable polymer stainless drug-eluting stents (BP-stainless DESs) were superior to the other stents [mainly stainless drug-eluting stents (DESs)] in terms of pooled definite/probable stent thrombosis (ST) (OR [95% CI] = 0.76[0.61-0.95], p = 0.02), long-term definite/probable ST (OR [95% CI] = 0.73[0.57-0.94], p = 0.01), very late definite/probable ST (OR [95% CI] = 0.56[0.33-0.93], p = 0.03) and long-term definite ST. BP-stainless DESs had lower rates of pooled, mid-term and long-term target vessel revascularization (TVR) and target lesion revascularization (TLR) than the other stainless DESs and BMSs. Furthermore, BP-stainless DESs were associated with lower rates of long-term death than other stainless DESs and lower rates of mid-term myocardial infarction than BMSs. However, only the mid-term and long-term TVR rates were superior in BP-alloy DESs compared with the other stents. Conclusion Our results indirectly suggest that BP-stainless DESs may offer more benefits than BP-alloy DESs in the era of BP-DESs. Further well-designed RCTs comparing BP-stainless with BP-alloy DESs are needed to confirm which platform is better.	[Yan, Yun-Feng; Zhang, Ming-Duo; Li, Xin-He; Nie, Mao-Xiao; Feng, Ting-Ting; Zhao, Xin] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodelling Related Cardiovasc Dis, Beijing Anzhen Hosp,Minist Educ,Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China; [Jiang, Long; Wang, Lu-Ya; Zhao, Quan-Ming] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodelling Related Cardiovasc Dis, Beijing Anzhen Hosp,Minist Educ,Dept Atherosclero, 2 Anzhen Rd, Beijing 100029, Peoples R China	Capital Medical University; Capital Medical University	Wang, LY; Zhao, QM (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodelling Related Cardiovasc Dis, Beijing Anzhen Hosp,Minist Educ,Dept Atherosclero, 2 Anzhen Rd, Beijing 100029, Peoples R China.	azyywly@163.com; zhaoquanming1@sina.com		Jiang, Long/0000-0002-1506-7385	National Natural Science Foundation of China [81370437, 81170810, 81471098]; Beijing Natural Science Foundation of China [7132078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (website? http://www.nsfc.gov.cn/) (No. 81370437, received by QMZ; 81170810, received by LYW and 81471098, received by LYW). Beijing Natural Science Foundation of China(http://www.bjkw.gov.cn/n244495/index.html) (No. 7132078, received by QMZ.)	Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Danzi GB, 2012, EUROINTERVENTION, V8, P109, DOI 10.4244/EIJV8I1A17; Foin N, 2014, INT J CARDIOL, V177, P800, DOI 10.1016/j.ijcard.2014.09.143; Hamon M, 2013, EUROINTERVENTION, V8, P1006, DOI 10.4244/EIJV8I9A155; Han YL, 2009, JACC-CARDIOVASC INTE, V2, P303, DOI 10.1016/j.jcin.2008.12.013; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009; Mehta Ashwin B, 2013, Indian Heart J, V65, P593, DOI 10.1016/j.ihj.2013.08.031; Menown IBA, 2010, ADV THER, V27, P129, DOI 10.1007/s12325-010-0022-9; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Milewski K, 2010, MED SCI MONITOR, V16, pBR40; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raungaard B, 2015, LANCET, V385, P1527, DOI 10.1016/S0140-6736(14)61794-3; Ribeiro EE, 2014, EUROINTERVENTION, V9, P1380, DOI 10.4244/EIJV9I12A234; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Xu B, 2014, CHINESE MED J-PEKING, V127, P1027, DOI 10.3760/cma.j.issn.0366-6999.20133222	26	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151259	10.1371/journal.pone.0151259	http://dx.doi.org/10.1371/journal.pone.0151259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032086	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800011
J	Zimmermann, MT; Oberg, AL; Grill, DE; Ovsyannikova, IG; Haralambieva, IH; Kennedy, RB; Poland, GA				Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.; Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.			System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination	PLOS ONE			English	Article							GENOME BROWSER; SEASONAL INFLUENZA; OLDER-ADULTS; B-CELLS; DATABASE; MEASLES; BIOLOGY; EPIGENETICS; DROSOPHILA; PROFILES	Failure to achieve a protected state after influenza vaccination is poorly understood but occurs commonly among aged populations experiencing greater immunosenescence. In order to better understand immune response in the elderly, we studied epigenetic and transcriptomic profiles and humoral immune response outcomes in 50-74 year old healthy participants. Associations between DNA methylation and gene expression reveal a systemwide regulation of immune-relevant functions, likely playing a role in regulating a participant's propensity to respond to vaccination. Our findings show that sites of methylation regulation associated with humoral response to vaccination impact known cellular differentiation signaling and antigen presentation pathways. We performed our analysis using per-site and regionally average methylation levels, in addition to continuous or dichotomized outcome measures. The genes and molecular functions implicated by each analysis were compared, highlighting different aspects of the biologic mechanisms of immune response affected by differential methylation. Both cis-acting (within the gene or promoter) and trans-acting (enhancers and transcription factor binding sites) sites show significant associations with measures of humoral immunity. Specifically, we identified a group of CpGs that, when coordinately hypo-methylated, are associated with lower humoral immune response, and methylated with higher response. Additionally, CpGs that individually predict humoral immune responses are enriched for polycomb-group and FOXP2 transcription factor binding sites. The most robust associations implicate differential methylation affecting gene expression levels of genes with known roles in immunity (e.g. HLA-B and HLA-DQB2) and immunosenescence. We believe our data and analysis strategy highlight new and interesting epigenetic trends affecting humoral response to vaccination against influenza; one of the most common and impactful viral pathogens.	[Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.; Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN USA.	poland.gregory@mayo.edu		Zimmermann, Michael/0000-0001-7073-0525; Kennedy, Rick/0000-0001-6164-4967	NIH [U01AI089859]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge support from NIH grant U01AI089859 for this work. This publication was supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Caromile LA, 2010, J BIOL CHEM, V285, P10487, DOI 10.1074/jbc.M109.066563; Chappell C, 2006, J IMMUNOL, V176, P4562, DOI 10.4049/jimmunol.176.8.4562; CREMER NE, 1985, J CLIN MICROBIOL, V21, P869, DOI 10.1128/JCM.21.6.869-874.1985; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dedeurwaerder S, 2014, BRIEF BIOINFORM, V15, P929, DOI 10.1093/bib/bbt054; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Haralambieva IH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122282; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jacobson RM, 2015, HUM VACC IMMUNOTHER, V11, P961, DOI 10.1080/21645515.2015.1011990; Jacoby M, 2012, EPIGENETICS-US, V7, P1421, DOI 10.4161/epi.22845; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jones MJ, 2015, AGING CELL; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Kennedy RB, 2015, VACCINE, V33, P3682, DOI 10.1016/j.vaccine.2015.06.031; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Lambert ND, 2012, EXPERT REV VACCINES, V11, P985, DOI [10.1586/erv.12.61, 10.1586/ERV.12.61]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledford H, 2008, NATURE, V455, P1023, DOI 10.1038/4551023a; Lu YT, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-12; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McCleary-Wheeler AL, 2013, CANCER LETT, V328, P212, DOI 10.1016/j.canlet.2012.10.005; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; O'Keefe DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-498; Oberg AL, 2015, VACCINE; Ovsyannikova IG, 2015, GENESET SIGNATURES A, P58; Ovsyannikova IG, 2014, VIRAL IMMUNOL, V27, P174, DOI 10.1089/vim.2013.0111; Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009; Painter SD, 2014, VIRAL IMMUNOL, V27, P32, DOI 10.1089/vim.2013.0099; Poland GA, 2014, CURR OPIN IMMUNOL, V29, P62, DOI 10.1016/j.coi.2014.04.005; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Reynolds LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6366; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salk HM, 2013, J IMMUNOL METHODS, V398, P44, DOI 10.1016/j.jim.2013.09.007; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Umlauf BJ, 2012, VIRAL IMMUNOL, V25, P29, DOI 10.1089/vim.2011.0051; Umlauf BJ, 2012, DETECTION VACCINIA V, P199, DOI 10.1007/978-1-61779-325-7_16; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang LG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku846; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Webster DE, 2002, J VIROL, V76, P7910, DOI 10.1128/JVI.76.15.7910-7912.2002; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Youngblood B, 2013, CURR OPIN VIROL, V3, P371, DOI 10.1016/j.coviro.2013.05.017; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025	88	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152034	10.1371/journal.pone.0152034	http://dx.doi.org/10.1371/journal.pone.0152034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031986	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800030
J	Vassal, F; Schneider, F; Boutet, C; Jean, B; Sontheimer, A; Lemaire, JJ				Vassal, Francois; Schneider, Fabien; Boutet, Claire; Jean, Betty; Sontheimer, Anna; Lemaire, Jean-Jacques			Combined DTI Tractography and Functional MRI Study of the Language Connectome in Healthy Volunteers: Extensive Mapping of White Matter Fascicles and Cortical Activations	PLOS ONE			English	Article							FMRI TIME-SERIES; TENSOR IMAGING TRACTOGRAPHY; HUMAN BRAIN; IN-VIVO; INTERSUBJECT VARIABILITY; LONGITUDINAL FASCICLE; PLANUM TEMPORALE; FIBER TRACKING; PATHWAYS; LATERALIZATION	Despite a better understanding of brain language organization into large-scale cortical networks, the underlying white matter (WM) connectivity is still not mastered. Here we combined diffusion tensor imaging (DTI) fiber tracking (FT) and language functional magnetic resonance imaging (fMRI) in twenty healthy subjects to gain new insights into the macroscopic structural connectivity of language. Eight putative WM fascicles for language were probed using a deterministic DTI-FT technique: the arcuate fascicle (AF), superior longitudinal fascicle (SLF), uncinate fascicle (UF), temporo-occipital fascicle, inferior fronto-occipital fascicle (IFOF), middle longitudinal fascicle (MdLF), frontal aslant fascicle and operculopre-motor fascicle. Specific measurements (i.e. volume, length, fractional anisotropy) and precise cortical terminations were derived for each WM fascicle within both hemispheres. Connections between these WM fascicles and fMRI activations were studied to determine which WM fascicles are related to language. WM fascicle volumes showed asymmetries: leftward for the AF, temporoparietal segment of SLF and UF, and rightward for the frontoparietal segment of the SLF. The lateralization of the AF, IFOF and MdLF extended to differences in patterns of anatomical connections, which may relate to specific hemispheric abilities. The leftward asymmetry of the AF was correlated to the leftward asymmetry of fMRI activations, suggesting that the lateralization of the AF is a structural substrate of hemispheric language dominance. We found consistent connections between fMRI activations and terminations of the eight WM fascicles, providing a detailed description of the language connectome. WM fascicle terminations were also observed beyond fMRI-confirmed language areas and reached numerous cortical areas involved in different functional brain networks. These findings suggest that the reported WM fascicles are not exclusively involved in language and might be related to other cognitive functions such as visual recognition, spatial attention, executive functions, memory, and processing of emotional and behavioral aspects.	[Vassal, Francois; Sontheimer, Anna; Lemaire, Jean-Jacques] Univ Auvergne, Unite Format & Rech Med, EA 7282, IGCNC, Clermont Ferrand, France; [Vassal, Francois] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Neurochirurg, St Etienne, France; [Schneider, Fabien; Boutet, Claire] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Unite Neuroradiol, St Etienne, France; [Jean, Betty] Hop Gabriel Montpied, Unite Neuroradiol, Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Sontheimer, Anna; Lemaire, Jean-Jacques] Hop Gabriel Montpied, Ctr Hosp Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU de St Etienne; CHU de St Etienne; CHU Clermont Ferrand; CHU Clermont Ferrand	Vassal, F; Lemaire, JJ (corresponding author), Univ Auvergne, Unite Format & Rech Med, EA 7282, IGCNC, Clermont Ferrand, France.; Vassal, F (corresponding author), Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Serv Neurochirurg, St Etienne, France.; Lemaire, JJ (corresponding author), Hop Gabriel Montpied, Ctr Hosp Univ Clermont Ferrand, Serv Neurochirurg, Clermont Ferrand, France.	francois.vassal@chu-st-etienne.fr; jjlemaire@chu-clermontferrand.fr						Amunts K, 2006, BRAIN LANG, V96, P147, DOI 10.1016/j.bandl.2005.06.004; [Anonymous], 2011, EPILEPTOLOGIE; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Binder JR, 1997, CLIN NEUROSCI, V4, P87; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; de Champfleur NM, 2013, EUR J RADIOL, V82, P151, DOI 10.1016/j.ejrad.2012.05.034; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; Duffau H, 2008, NEUROPSYCHOLOGIA, V46, P927, DOI 10.1016/j.neuropsychologia.2007.10.025; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Hagmann P, 2006, HUM BRAIN MAPP, V27, P828, DOI 10.1002/hbm.20224; Hirano Asao, 1995, P49; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lehericy S, 2000, NEUROLOGY, V54, P1625, DOI 10.1212/WNL.54.8.1625; Lemaire JJ, 2013, BRAIN TOPOGR, V26, P428, DOI 10.1007/s10548-012-0257-7; Lurito JT, 2001, NEUROIMAG CLIN N AM, V11, P355; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2013, BRAIN STRUCT FUNCT, V218, P951, DOI 10.1007/s00429-012-0441-2; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Ocklenburg S, 2014, NEUROSCI LETT, V580, P32, DOI 10.1016/j.neulet.2014.07.044; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Stieglitz LH, 2012, NEUROSURGERY, V70, P56, DOI 10.1227/NEU.0b013e31822cb882; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	51	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152614	10.1371/journal.pone.0152614	http://dx.doi.org/10.1371/journal.pone.0152614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029050	Green Published, gold, Green Submitted			2022-12-27	WOS:000373116500058
J	Guo, ZY; Xiao, D; Li, DL; Wang, XH; Wang, YY; Yan, TC; Wang, ZQ				Guo, Zuiyuan; Xiao, Dan; Li, Dongli; Wang, Xiuhong; Wang, Yayu; Yan, Tiecheng; Wang, Zhiqi			Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures	PLOS ONE			English	Article							MODEL; TRANSMISSION; SENSITIVITY; UNCERTAINTY; MALARIA	We constructed dynamic Ebola virus disease (EVD) transmission models to predict epidemic trends and evaluate intervention measure efficacy following the 2014 EVD epidemic in West Africa. We estimated the effective vaccination rate for the population, with basic reproduction number (R-0) as the intermediate variable. Periodic EVD fluctuation was analyzed by solving a Jacobian matrix of differential equations based on a SIR (susceptible, infective, and removed) model. A comprehensive compartment model was constructed to fit and predict EVD transmission patterns, and to evaluate the effects of control and prevention measures. Effective EVD vaccination rates were estimated to be 42% (31-50%), 45% (42-48%), and 51% (44-56%) among susceptible individuals in Guinea, Liberia and Sierra Leone, respectively. In the absence of control measures, there would be rapid mortality in these three countries, and an EVD epidemic would be likely recur in 2035, and then again 8 similar to 9 years later. Oscillation intervals would shorten and outbreak severity would decrease until the periodicity reached similar to 5.3 years. Measures that reduced the spread of EVD included: early diagnosis, treatment in isolation, isolating/monitoring close contacts, timely corpse removal, post-recovery condom use, and preventing or quarantining imported cases. EVD may re-emerge within two decades without control and prevention measures. Mass vaccination campaigns and control and prevention measures should be instituted to prevent future EVD epidemics.	[Guo, Zuiyuan; Li, Dongli; Wang, Xiuhong; Wang, Yayu; Yan, Tiecheng] Ctr Dis Control & Prevent Shenyang Mil Reg, Dept Dis Control, Shenyang, Liaoning Provin, Peoples R China; [Xiao, Dan] Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi Prov, Peoples R China; [Wang, Zhiqi] Shenyang Jianzhu Univ, Coll Municipal & Environm Engn, Shenyang, Liaoning Provin, Peoples R China	Air Force Military Medical University; Shenyang Jianzhu University	Li, DL (corresponding author), Ctr Dis Control & Prevent Shenyang Mil Reg, Dept Dis Control, Shenyang, Liaoning Provin, Peoples R China.; Xiao, D (corresponding author), Fourth Mil Med Univ, Dept Epidemiol, Xian 710032, Shaanxi Prov, Peoples R China.	danxiao@fmmu.edu.cn; syjqcdc@sina.cn			China Postdoctoral Science Fund [2014T07967]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation)	This work is supported by China Postdoctoral Science Fund (No. 2014T07967).	Althaus CL, 2015, PLOS CURR IN PRESS; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Breman JG, 2014, NEW ENGL J MED, V371, P1663, DOI 10.1056/NEJMp1410540; Busenderg S, 1990, J MATH BIOL, V28, P256; Carroll MW, 2015, NATURE IN PRESS; Cenciarelli O, 2015, INT J MICRO IN PRESS; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Chua AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003734; Deguen S, 2000, EUR J EPIDEMIOL, V16, P1177, DOI 10.1023/A:1010935317612; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Endo A, 2015, J THEOR BIOL, V380, P499, DOI 10.1016/j.jtbi.2015.06.024; Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471; Fast SM, 2015, PLOS CURR IN PRESS; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fisman D, 2015, PLOS CURR IN PRESS; Kerkhove MD Van, 2015, SCI DATA IN PRESS; Kouadio KI, 2015, PLOS CURR IN PRESS; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Luo ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126893; Luo T, 2011, EPIDEMIOL INFECT, V139, P257, DOI 10.1017/S0950268810001056; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Matua Gerald A, 2015, Sultan Qaboos Univ Med J, V15, pe171; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; McLeod RG, 2006, MATH BIOSCI ENG, V3, P527, DOI 10.3934/mbe.2006.3.527; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Seidu B, 2015, ACTA BIOTHEOR, V63, P151, DOI 10.1007/s10441-015-9255-y; Siettos C, 2015, PLOS CURR IN PRESS; Sinha S., 2014, AM J COMP APPL MATH, V4, P17; United Nations Department of Economic and Social Affairs, 2015, TOT POP BOTH SEX COM; United Nations Department of Economic and Social Affairs, 2015, RAT NAT INCR MAJ AR; United Nations Department of Economic and Social Affairs, 2015, CRUD DEATH RAT MAJ A; WHO, 2015, EB SIT REP; WHO, 2015, EB RESP ROADM, V7, P15; WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992	37	10	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152438	10.1371/journal.pone.0152438	http://dx.doi.org/10.1371/journal.pone.0152438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049322	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500041
J	Seto, E; Hua, J; Wu, L; Shia, V; Eom, S; Wang, M; Li, Y				Seto, Edmund; Hua, Jenna; Wu, Lemuel; Shia, Victor; Eom, Sue; Wang, May; Li, Yan			Models of Individual Dietary Behavior Based on Smartphone Data: The Influence of Routine, Physical Activity, Emotion, and Food Environment	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; PORTION SIZE ESTIMATION; CONCEPTUAL-FRAMEWORK; OBESITY EPIDEMIC; ASSOCIATION; CHRONOTYPE; TYPOLOGY; MOOD; PREVENTION; MANAGEMENT	Introduction Smartphone applications (apps) facilitate the collection of data on multiple aspects of behavior that are useful for characterizing baseline patterns and for monitoring progress in interventions aimed at promoting healthier lifestyles. Individual-based models can be used to examine whether behavior, such as diet, corresponds to certain typological patterns. The objectives of this paper are to demonstrate individual-based modeling methods relevant to a person's eating behavior, and the value of such approach compared to typical regression models. Method Using a mobile app, 2 weeks of physical activity and ecological momentary assessment (EMA) data, and 6 days of diet data were collected from 12 university students recruited from a university in Kunming, a rapidly developing city in southwest China. Phone GPS data were collected for the entire 2-week period, from which exposure to various food environments along each subject's activity space was determined. Physical activity was measured using phone accelerometry. Mobile phone EMA was used to assess self-reported emotion/feelings. The portion size of meals and food groups was determined from voice-annotated videos of meals. Individual-based regression models were used to characterize subjects as following one of 4 diet typologies: those with a routine portion sizes determined by time of day, those with portion sizes that balance physical activity (energy balance), those with portion sizes influenced Results Ample compliance with the phone-based behavioral assessment was observed for all participants. Across all individuals, 868 consumed food items were recorded, with fruits, grains and dairy foods dominating the portion sizes. On average, 218 hours of accelerometry and 35 EMA responses were recorded for each participant. For some subjects, the routine model was able to explain up to 47% of the variation in portion sizes, and the energy balance model was able to explain over 88% of the variation in portion sizes. Across all our subjects, the food environment was an important predictor of eating patterns. Generally, grouping all subjects into a pooled model performed worse than modeling each individual separately. Conclusion A typological modeling approach was useful in understanding individual dietary behaviors in our cohort. This approach may be applicable to the study of other human behaviors, particularly those that collect repeated measures on individuals, and those involving smartphone- based behavioral measurement.	[Seto, Edmund] Univ Washington, Sch Publ Hlth, Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Hua, Jenna] Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci, Berkeley, CA 94720 USA; [Wu, Lemuel; Shia, Victor] Univ Calif Berkeley, Sch Engn, Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Eom, Sue] Seoul Natl Univ, Sch Publ Hlth, Publ Hlth Nutr, Seoul, South Korea; [Wang, May] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Community Hlth Sci, Los Angeles, CA USA; [Li, Yan] Kunming Med Univ, Sch Publ Hlth, Maternal & Child Hlth, Kunming, Peoples R China	University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Seoul National University (SNU); University of California System; University of California Los Angeles; Kunming Medical University	Hua, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci, Berkeley, CA 94720 USA.	jenna_hua@berkeley.edu			Llewellyn Student Project Award - Center for Occupational and Environmental Health (COEH) at University of California Berkeley; Ruth L. Kirschstein National Research Service Award [F31, F31CA180477]; National Cancer Institute	Llewellyn Student Project Award - Center for Occupational and Environmental Health (COEH) at University of California Berkeley; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Llewellyn Student Project Award given by Center for Occupational and Environmental Health (COEH) at University of California Berkeley (http://coeh.berkeley.edu/students/studentaward.htm), and the Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31) and (F31CA180477) awarded by National Cancer Institute, (http://www.cancer.gov/grants-training/training/funding/f31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala GX, 2006, HEALTH EDUC RES, V21, P133, DOI 10.1093/her/cyh049; Barker RG, 1968, ECOLOGICAL PSYCHOL C, Vvi; BIRCH LL, 1987, LEARN MOTIV, V18, P301, DOI 10.1016/0023-9690(87)90017-8; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Buck HG, 2013, J CARDIOVASC NURS, V28, pE37, DOI 10.1097/JCN.0b013e31827fcc4c; Carter MC, 2013, BRIT J NUTR, V109, P539, DOI 10.1017/S0007114512001353; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; CHRISTENSEN L, 1993, INT J EAT DISORDER, V14, P171, DOI [10.1002/1098-108X(199309)14:2<171::AID-EAT2260140207>3.0.CO;2-U, 10.1002/1098-108X(199309)14:2&lt;171::AID-EAT2260140207&gt;3.0.CO;2-U]; Collins LM, 2004, PREV SCI, V5, P185, DOI 10.1023/B:PREV.0000037641.26017.00; Courvoisier DS, 2010, EMOTION, V10, P115, DOI 10.1037/a0017813; Donaire-Gonzalez D, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2470; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Fisher L, 2000, BEHAV MED, V26, P53, DOI 10.1080/08964280009595752; Fleig D, 2009, EAT BEHAV, V10, P115, DOI 10.1016/j.eatbeh.2009.03.002; Fletcher RR, 2011, PERV COMP TECHN HEAL; Friedman SL, 1999, MEASURING ENV LIFE S; Godwin SL, 2004, J AM DIET ASSOC, V104, P585, DOI 10.1016/j.jada.2004.01.006; Gruber R, 2010, SLEEP, V33, pA80; Hebden L, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2205; Hensel DJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-75; Hernandez T, 2006, J FOOD COMPOS ANAL, V19, pS14, DOI 10.1016/j.jfca.2006.02.010; Hughes Deonna C, 2010, J Diabetes Sci Technol, V4, P429; Jon Noronha EH, 2011, P 24 ANN ACM S US IN; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; Kong FY, 2012, PERVASIVE MOB COMPUT, V8, P147, DOI 10.1016/j.pmcj.2011.07.003; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lakerveld J, 2016, OBES REV, V17, P5, DOI 10.1111/obr.12384; Lakerveld J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-793; LEATHWOOD PD, 1983, J PSYCHIATR RES, V17, P147, DOI 10.1016/0022-3956(82)90016-4; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Lynch K., 1982, IMAGEN CITY; McSweeney FK, 2014, WILEY BLACKWELL HANDBOOK OF OPERANT AND CLASSICAL CONDITIONING, P1, DOI 10.1002/9781118468135; Montoliu R, 2010, P 9 INT C MOB UB MUL; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Newman O, 1972, DEFENSIBLE SPACE CRI, Vxvii; O'Reilly GA, 2013, AM J PREV MED, V45, P501, DOI 10.1016/j.amepre.2013.05.012; Qiu H, 2009, CHINESE PRIMARY HLTH, V4; Rivera-Pelayo V, 2012, MOBILE LEARNING; Schoggen P, 1989, BEHAV SETTINGS REVIS, Vxii; Schubert E, 2008, APPETITE, V51, P501, DOI 10.1016/j.appet.2008.03.018; Seto E, 2010, PETRAE C WORKSH LIGH; Shaw RJ, 2003, PEDIATR TRANSPLANT, V7, P489, DOI 10.1046/j.1397-3142.2003.00117.x; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Silk JS, 2011, J EXP CHILD PSYCHOL, V110, P241, DOI 10.1016/j.jecp.2010.10.007; Six BL, 2010, J AM DIET ASSOC, V110, P74, DOI 10.1016/j.jada.2009.10.010; Stone AA, 1999, WELL BEING FDN HEDON, P26; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; THOMPSON DA, 1988, MED SCI SPORT EXER, V20, P222, DOI 10.1249/00005768-198806000-00002; VERGER P, 1994, APPETITE, V22, P159, DOI 10.1006/appe.1994.1015; WHO, 2014, GLOB DAT BOD MASS IN; Williamson DA, 2003, J AM DIET ASSOC, V103, P1139, DOI 10.1016/S0002-8223(03)00974-X; Woo I, 2010, ELECT IMAGING SCI TE, V8, P1; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246; Zhu FQ, 2010, IEEE J-STSP, V4, P756, DOI 10.1109/JSTSP.2010.2051471; Zhu K, 2008, CHIN J CHILD HLTH CA, V16, P696	59	27	29	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153085	10.1371/journal.pone.0153085	http://dx.doi.org/10.1371/journal.pone.0153085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049852	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500096
J	van Horck, M; Alonso, A; Wesseling, G; de Winter-de Groot, K; van Aalderen, W; Hendriks, H; Winkens, B; Rijkers, G; Jobsis, Q; Dompeling, E				van Horck, Marieke; Alonso, Ariel; Wesseling, Geertjan; de Winter-de Groot, Karin; van Aalderen, Wim; Hendriks, Han; Winkens, Bjorn; Rijkers, Ger; Jobsis, Quirijn; Dompeling, Edward			Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study	PLOS ONE			English	Article							LUNG-DISEASE; INFLAMMATION; ASTHMA; SPUTUM; PH	Background Cystic Fibrosis (CF) is characterized by chronically inflamed airways, and inflammation even increases during pulmonary exacerbations. These adverse events have an important influence on the well-being, quality of life, and lung function of patients with CF. Prediction of exacerbations by inflammatory markers in exhaled breath condensate (EBC) combined with early treatment may prevent these pulmonary exacerbations and may improve the prognosis. Aim To investigate the diagnostic accuracy of a set of inflammatory markers in EBC to predict pulmonary exacerbations in children with CF. Methods In this one-year prospective observational study, 49 children with CF were included. During study visits with an interval of 2 months, a symptom questionnaire was completed, EBC was collected, and lung function measurements were performed. The acidity of EBC was measured directly after collection. Inflammatory markers interleukin (IL)-6, IL-8, tumor necrosis factor alpha (TNF-alpha), and macrophage migration inhibitory factor (MIF) were measured using high sensitivity bead based flow immunoassays. Pulmonary exacerbations were recorded during the study and were defined in two ways. The predictive power of inflammatory markers and the other covariates was assessed using conditionally specified models and a receiver operating characteristic curve (SAS version 9.2). In addition, k-nearest neighbors (KNN) algorithm was applied (SAS version 9.2). Results Sixty-five percent of the children had one or more exacerbations during the study. The conditionally specified models showed an overall correct prediction rate of 55%. The area under the curve (AUC) was equal to 0.62. The results obtained with the KNN algorithm were very similar. Conclusion Although there is some evidence indicating that the predictors outperform random guessing, the general diagnostic accuracy of EBC acidity and the EBC inflammatory markers IL-6, IL-8, TNF-alpha and MIF is low. At present it is not possible to predict pulmonary exacerbations in children with CF with the chosen biomarkers and the method of EBC analysis. The biochemical measurements of EBC markers should be improved and other techniques should be considered.	[van Horck, Marieke; Jobsis, Quirijn; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Hlth Care CAPHRI, Dept Pediat Pulmonol, Maastricht, Netherlands; [Alonso, Ariel] Katholieke Univ Leuven, Leuven Biostat & Stat Bioinformat Ctr, Leuven, Belgium; [Wesseling, Geertjan] MUMC, CAPHRI, Dept Pulmonol, Maastricht, Netherlands; [de Winter-de Groot, Karin] UMCU, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [van Aalderen, Wim] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Resp Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hendriks, Han] Viecuri Med Ctr, Dept Pediat, Venlo, Netherlands; [Winkens, Bjorn] MUMC, CAPHRI, Dept Methodol & Stat, Maastricht, Netherlands; [Rijkers, Ger] St Antonius Hosp, Lab Med Microbiol & Immunol, Nieuwegein, Netherlands; [Rijkers, Ger] Univ Coll Roosevelt, Dept Sci, Middelburg, Netherlands	Maastricht University; KU Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Emma Children's Hospital; University of Amsterdam; VieCuri Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); St. Antonius Hospital Utrecht	van Horck, M (corresponding author), MUMC, Sch Publ Hlth & Primary Hlth Care CAPHRI, Dept Pediat Pulmonol, Maastricht, Netherlands.	marieke.van.horck@mumc.nl	Rijkers, Ger/AAW-6143-2020; Alonso, Ariel/ABB-3765-2021; Rijkers, Ger/R-7236-2019	Rijkers, Ger/0000-0001-6948-6123; Winkens, Bjorn/0000-0002-6747-6228; Alonso Abad, Ariel/0000-0003-4966-1689	Dutch Cystic Fibrosis Foundation; Chiesi Pharmaceuticals	Dutch Cystic Fibrosis Foundation; Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc)	This work was supported by Dutch Cystic Fibrosis Foundation (http://www.ncfs.nl) and Chiesi Pharmaceuticals (http://www.chiesi.com/en/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodini A, 2007, INT J IMMUNOPATH PH, V20, P467, DOI 10.1177/039463200702000305; Bodini A, 2005, PEDIATR PULM, V40, P494, DOI 10.1002/ppul.20336; CBO, 2007, RICHTL DIAGN BEH CYS; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Colombo C, 2011, INT J IMMUNOPATH PH, V24, P423, DOI 10.1177/039463201102400215; Cooke G, 2009, BIOFACTORS, V35, P165, DOI 10.1002/biof.27; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Hastie T., 2003, ELEMENTS STAT LEARNI; Horak F, 2007, PEDIATR PULM, V42, P1198, DOI 10.1002/ppul.20719; Klijn Peter H, 2004, J Cyst Fibros, V3, P29; Liou TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042748; Melotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114274; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Molenberghs G., 2005, MODELS DISCRETE LONG; Nichols DP, 2015, PEDIATR PULM, V50, pS39, DOI 10.1002/ppul.23242; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ojoo JC, 2005, THORAX, V60, P22, DOI 10.1136/thx.2003.017327; Ratjen F, 2008, PAEDIATR RESPIR REV, V9, P144, DOI 10.1016/j.prrv.2008.01.004; Robroeks C, 2008, EUR RESP SOC C, p540s; Robroeks CMHHT, 2012, CLIN EXP ALLERGY, V42, P792, DOI 10.1111/j.1365-2222.2012.03992.x; Robroeks CMHHT, 2008, PEDIAT ALLERG IMM-UK, V19, P652, DOI 10.1111/j.1399-3038.2007.00693.x; Rosenfeld M, 2001, J PEDIATR-US, V139, P359, DOI 10.1067/mpd.2001.117288; Rosias PP, 2008, EUR RESPIR J, V31, P934, DOI 10.1183/09031936.00073207; Rosias PPR, 2010, PEDIAT ALLERG IMM-UK, V21, pE235, DOI 10.1111/j.1399-3038.2009.00909.x; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Smyth AR, 2014, J CYST FIBROS, V13, pS23, DOI 10.1016/j.jcf.2014.03.010; Treggiari MM, 2009, CONTEMP CLIN TRIALS, V30, P256, DOI 10.1016/j.cct.2009.01.003; van Mastrigt E, 2015, CLIN EXP ALLERGY, V45, P1170, DOI 10.1111/cea.12454; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119434; Zemanick ET, 2010, J CYST FIBROS, V9, P1, DOI 10.1016/j.jcf.2009.09.003	31	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152156	10.1371/journal.pone.0152156	http://dx.doi.org/10.1371/journal.pone.0152156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049850	Green Published, gold			2022-12-27	WOS:000373603500028
J	Esposito, S; Zampiero, A; Bianchini, S; Mori, A; Scala, A; Tagliabue, C; Sciarrabba, CS; Fossali, E; Piralla, A; Principi, N				Esposito, Susanna; Zampiero, Alberto; Bianchini, Sonia; Mori, Alessandro; Scala, Alessia; Tagliabue, Claudia; Sciarrabba, Calogero Sathya; Fossali, Emilio; Piralla, Antonio; Principi, Nicola			Epidemiology and Clinical Characteristics of Respiratory Infections Due to Adenovirus in Children Living in Milan, Italy, during 2013 and 2014	PLOS ONE			English	Article							REAL-TIME PCR; TRACT INFECTIONS; TYPE-7; PNEUMONIA; OUTBREAKS; FEATURES; DISEASE; TAIWAN	To evaluate the predominant human adenovirus (HAdV) species and types associated with pediatric respiratory infections, nasopharyngeal swabs were collected from otherwise healthy children attending an emergency room in Milan, Italy, due to a respiratory tract infection from January 1 to February 28 of two subsequent years, 2013 and 2014. The HAdVs were detected using a respiratory virus panel fast assay (xTAG RVP FAST v2) and with a HAdV-specific real-time polymerase chain reaction; their nucleotides were sequenced, and they were tested for positive selection. Among 307 nasopharyngeal samples, 61 (19.9%) tested positive for HAdV. HAdV was the only virus detected in 31/61 (50.8%) cases, whereas it was found in association with one other virus in 25 (41.0%) cases and with two or more viruses in 5 (8.2%) cases. Human Enterovirus/human rhinovirus and respiratory syncytial virus were the most common co-infecting viral agents and were found in 12 (19.7%) and 7 (11.5%) samples, respectively. Overall, the HAdV strain sequences analyzed were highly conserved. In comparison to HAdV-negative children, those infected with HAdV had a reduced frequency of lower respiratory tract involvement (36.1% vs 55.2%; p = 0.007), wheezing (0.0% vs 12.5%; p = 0.004), and hospitalization (27.9% vs 56.1%; p < 0.001). Antibiotic therapy and white blood cell counts were more frequently prescribed (91.9% vs 57.1%; p = 0.04) and higher (17,244 +/- 7,737 vs 9,565 +/- 3,211 cells/mu L; p = 0.04), respectively, in children infected by HAdV-C than among those infected by HAdV-B. On the contrary, those infected by HAdV-B had more frequently lower respiratory tract involvement (57.1% vs 29.7%) but difference did not reach statistical significant (p = 0.21). Children with high viral load were absent from child care attendance for a longer period of time (14.5 +/- 7.5 vs 5.5 +/- 3.2 days; p = 0.002) and had higher C reactive protein levels (41.3 +/- 78.5 vs 5.4 +/- 9.6 mu g/dL; p = 0.03). This study has shown that HAdV infections are diagnosed more commonly than usually thought and that HAdVs are stable infectious agents that do not frequently cause severe diseases. A trend toward more complex disease in cases due to HAdV species C and in those with higher viral load was demonstrated. However, further studies are needed to clarify factors contributing to disease severity to understand how to develop adequate preventive and therapeutic measures.	[Esposito, Susanna; Zampiero, Alberto; Bianchini, Sonia; Mori, Alessandro; Scala, Alessia; Tagliabue, Claudia; Sciarrabba, Calogero Sathya; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Fossali, Emilio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Emergency Unit, Milan, Italy; [Piralla, Antonio] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Fondazione San Matteo	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Fossali, Emilio/K-2200-2015; Tagliabue, Claudia/K-2706-2016; Esposito, Susanna/K-3475-2016; Piralla, Antonio/K-4756-2018	Fossali, Emilio/0000-0002-3197-062X; Tagliabue, Claudia/0000-0003-0293-933X; Esposito, Susanna/0000-0003-4103-2837; Piralla, Antonio/0000-0002-6062-2579	Italian Ministry of Health (Bando Giovani Ricercatori) [2009-1596786]	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy)	SE received a grant from the Italian Ministry of Health (Bando Giovani Ricercatori 2009-1596786) for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HL, 2004, J TROP PEDIATRICS, V50, P279, DOI 10.1093/tropej/50.5.279; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Ganzenmueller T, 2012, REV MED VIROL, V22, P194, DOI 10.1002/rmv.724; GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005; Grondahl B, 1999, J CLIN MICROBIOL, V37, P1; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; HERBERT FA, 1977, CAN MED ASSOC J, V116, P274; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Huang YC, 2013, J CLIN VIROL, V57, P300, DOI 10.1016/j.jcv.2013.03.017; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Knapp K.M., 2009, FEIGIN CHERRYS TXB P, P2741; La Rosa G, 2006, NEW MICROBIOL, V29, P177; LEWIS FA, 1973, J HYG-CAMBRIDGE, V71, P139, DOI 10.1017/S0022172400046301; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Lukashev AN, 2008, J GEN VIROL, V89, P380, DOI 10.1099/vir.0.83057-0; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Maitreyi RS, 2000, J CLIN VIROL, V16, P41, DOI 10.1016/S1386-6532(99)00075-X; MARTONE WJ, 1980, AM J EPIDEMIOL, V111, P229, DOI 10.1093/oxfordjournals.aje.a112890; Morfin F, 2009, ANTIVIR THER, V14, P55; Moura FEA, 2007, MEM I OSWALDO CRUZ, V102, P937, DOI 10.1590/S0074-02762007000800008; Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002; SUTTON RNP, 1976, LANCET, V2, P987; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; WADELL G, 1980, AM J EPIDEMIOL, V112, P619, DOI 10.1093/oxfordjournals.aje.a113034; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075208; Wo Y, 2015, ARCH VIROL, V160, P633, DOI 10.1007/s00705-014-2308-8; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136	34	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152375	10.1371/journal.pone.0152375	http://dx.doi.org/10.1371/journal.pone.0152375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045588	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600016
J	Qin, XX; Deng, YY; Wu, DD; Yu, LH; Huang, RZ				Qin, Xiaoxia; Deng, Yanye; Wu, Dandong; Yu, Lehua; Huang, Rongzhong			Does Enhanced External Counterpulsation (EECP) Significantly Affect Myocardial Perfusion?: A Systematic Review & Meta-Analysis	PLOS ONE			English	Review							ISCHEMIC-HEART-DISEASE; STABLE ANGINA; NITRIC-OXIDE; MULTICENTER; OUTCOMES; THERAPY; FLOW	Background Enhanced external counterpulsation (EECP) is currently applied for treating coronary artery disease (CAD) patients. However, the mechanism(s) by which EECP ameliorates angina pectoris and long-term left ventricular function remain largely unknown. The aim of this study will be to assess whether EECP significantly affects myocardial perfusion in CAD patients through a systematic review and meta-analysis of the available literature. Methods MEDLINE, EMBASE, and Cochrane CENTRAL databases were searched for prospective studies on CAD patients that underwent EECP and reported myocardial perfusion data pre-and post-EECP. The impact of EECP was assessed based on the weighted mean difference (WMD) in myocardial perfusion from pre-EECP to post-EECP. Statistical heterogeneity was assessed by the I-2 index. Publication bias was assessed through visual inspection of the funnel plot as well as Begg's and Egger's testing. Results Standard EECP therapy (i.e., 35-36 one-hour sessions within a seven-week period) significantly increased myocardial perfusion in CAD patients (pooled WMD: -0.19, 95% CI: -0.38 to 0.00, p = 0.049). A random effects analysis was applied on account of significant heterogeneity (I-2 = 89.1%, p = 0.000). There was no evidence of significant publication bias (Begg's p = 0.091; Egger's p = 0.282). Conclusions Standard EECP therapy significantly increases myocardial perfusion in CAD patients. This study's findings support the continued use of standard EECP therapy in CAD patients and provides one putative physiological mechanism to help explain the improvements in angina	[Qin, Xiaoxia; Deng, Yanye; Wu, Dandong; Yu, Lehua; Huang, Rongzhong] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China	Chongqing Medical University	Yu, LH; Huang, RZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China.	yulehuadoc@aliyun.com; rzhuang@live.com			National Natural Science Foundation of China [31300137, 81171859]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant nos. 31300137 and 81171859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant nos. 31300137 and 81171859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar M, 2006, AM J CARDIOL, V98, P28, DOI 10.1016/j.amjcard.2006.01.053; Arora Rohit R, 2007, Am J Ther, V14, P519, DOI 10.1097/01.mjt.0000249890.00290.30; Arora RR, 1999, J AM COLL CARDIOL, V33, P1833, DOI 10.1016/S0735-1097(99)00140-0; Bart BA, 2012, CORONARY ARTERY DIS, P53; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1918, DOI 10.1016/S0735-1097(03)00428-5; Braith RW, 2012, EXERC SPORT SCI REV, V40, P145, DOI 10.1097/JES.0b013e318253de5e; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fitzgerald CP, 2003, CARDIOLOGY, V100, P129, DOI 10.1159/000073930; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Lawson WE, 2006, CLIN CARDIOL, V29, P69, DOI 10.1002/clc.4960290207; LAWSON WE, 1992, AM J CARDIOL, V70, P859, DOI 10.1016/0002-9149(92)90727-G; Masuda D, 2001, EUR HEART J, V22, P1451, DOI 10.1053/euhj.2000.2545; Masuda D, 2001, CIRCULATION; Michaels AD, 2005, AM HEART J, V150, P1066, DOI 10.1016/j.ahj.2005.01.054; Michaels AD, 2002, CIRCULATION, V106, P1237, DOI 10.1161/01.CIR.0000028336.95629.B0; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Soran O, 2006, AM J CARDIOL, V97, P17, DOI 10.1016/j.amjcard.2005.07.122; Soran O, 2014, CARDIOL CLIN, V32, P429, DOI 10.1016/j.ccl.2014.04.009; Soran O, 2012, TURK KARDIYOL DERN A, V40, P323, DOI 10.5543/tkda.2012.59144; Tartaglia J, 2003, CLIN CARDIOL, V26, P287, DOI 10.1002/clc.4950260610; Wells G., 2014, S SYST REV BAS; Wu GF, 2006, AM J PHYSIOL-HEART C, V290, pH248, DOI 10.1152/ajpheart.01225.2004	24	18	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151822	10.1371/journal.pone.0151822	http://dx.doi.org/10.1371/journal.pone.0151822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045935	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600005
J	Zhao, CH; Lv, C; Li, H; Du, SJ; Liu, XL; Li, Z; Xin, WF; Zhang, WS				Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Liu, Xiaoli; Li, Zhi; Xin, Wenfeng; Zhang, Wensheng			Geniposide Protects Primary Cortical Neurons against Oligomeric A beta(1-42)-Induced Neurotoxicity through a Mitochondrial Pathway	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDES; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; A-BETA; ATTENUATES MITOCHONDRIAL; SYNAPTIC PLASTICITY; DNA FRAGMENTATION; INDUCED APOPTOSIS; OXIDATIVE DAMAGE; MEMORY DEFICITS	Mitochondrial dysfunction plays a key role in the progression of Alzheimer's disease (AD). The accumulation of amyloid-beta peptide (A beta) in the brains of AD patients is thought to be closely related to neuronal mitochondrial dysfunction and oxidative stress. Therefore, protecting mitochondria from A beta-induced neurotoxicity is an effective strategy for AD therapeutics. In a previous study, we found that geniposide, a pharmacologically active compound purified from gardenia fruit, has protective effects on oxidative stress and mitochondrial dysfunction in AD transgenic mouse models. However, whether geniposide has a protective effect on A beta-induced neuronal dysfunction remains unknown. In the present study, we demonstrate that geniposide protects cultured primary cortical neurons from A beta-mediated mitochondrial dysfunction by recovering ATP generation, mitochondrial membrane potential (MMP), and cytochrome c oxidase (CcO) and caspase 3/9 activity; by reducing ROS production and cytochrome c leakage; as well as by inhibiting apoptosis. These findings suggest that geniposide may attenuate A beta-induced neuronal injury by inhibiting mitochondrial dysfunction and oxidative stress.	[Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Zhang, Wensheng] Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China; [Lv, Cui] Shandong Acad Sci, Shandong Anal & Test Ctr, Lab Immunol Environm & Hlth, Jinan, Peoples R China; [Zhao, Chunhui; Lv, Cui; Li, Hang; Du, Shijing; Zhang, Wensheng] Beijing Normal Univ, Coll Resources Sci Technol, Beijing 100875, Peoples R China; [Zhao, Chunhui; Li, Hang; Du, Shijing; Liu, Xiaoli; Li, Zhi; Xin, Wenfeng; Zhang, Wensheng] Beijing Normal Univ, Engn Res Ctr Nat Med, Minist Educ, Beijing 100875, Peoples R China; [Liu, Xiaoli; Xin, Wenfeng; Zhang, Wensheng] Engn Res Ctr Sanqi Biotechnol & Pharmaceut, Kunming, Yun Nan Provinc, Peoples R China	Beijing Normal University; Qilu University of Technology; Beijing Normal University; Beijing Normal University	Zhang, WS (corresponding author), Beijing Normal Univ, Beijing Area Major Lab Protect & Utilizat Tradit, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Coll Resources Sci Technol, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Engn Res Ctr Nat Med, Minist Educ, Beijing 100875, Peoples R China.; Zhang, WS (corresponding author), Engn Res Ctr Sanqi Biotechnol & Pharmaceut, Kunming, Yun Nan Provinc, Peoples R China.	zws@bnu.edu.cn	Liu, Xiaoli/HGE-7614-2022		National Natural Science Foundation of China [81274118]; Key New Drug Creation and Development Program of China [2012ZX09103-201]; National Key Technology R D Program [2012BAI29B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Development Program of China; National Key Technology R D Program(National Key Technology R&D Program)	This work was supported by grants by the National Natural Science Foundation of China (No. 81274118, http://www.nsfc.gov.cn/,WZ); The Key New Drug Creation and Development Program of China (No. 2012ZX09103-201, http://www.nmp.gov.cn/,WZ); and The National Key Technology R & D Program (No. 2012BAI29B08, http://www.most.gov.cn/kjgh/lskjgh/,WZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Broe M, 2001, ACTA NEUROPATHOL, V101, P616; Candela P, 2010, J ALZHEIMERS DIS, V22, P849, DOI 10.3233/JAD-2010-100462; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cavallucci V, 2013, CURR PHARM DESIGN, V19, P6440, DOI 10.2174/1381612811319360005; Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357; Chen YH, 2012, ONCOL REP, V27, P1233, DOI 10.3892/or.2012.1632; Chin D, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0397-3; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Colurso GJ, 2003, LIFE SCI, V73, P1795, DOI 10.1016/S0024-3205(03)00512-5; Daffu G, 2013, INT J MOL SCI, V14, P19891, DOI 10.3390/ijms141019891; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forlenza OV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-89; Gao C, 2014, BRAIN PATHOL, V24, P261, DOI 10.1111/bpa.12116; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Han L, 2014, CELL REP, V7, P316, DOI 10.1016/j.celrep.2014.03.024; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kirkland RA, 2003, ANTIOXID REDOX SIGN, V5, P589, DOI 10.1089/152308603770310257; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Kunnumakkara AB, 2010, CANCER RES, V70, P8695, DOI 10.1158/0008-5472.CAN-10-2318; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0044670, 10.1371/journal.pone.0050296, 10.1186/1747-597X-7-11]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Z, 2015, CNS NEUROLOGICAL DIS; Liu JH, 2007, NEUROCHEM INT, V51, P361, DOI 10.1016/j.neuint.2007.04.021; Liu JH, 2013, ACTA BIOCH BIOPH SIN, V45, P787, DOI 10.1093/abbs/gmt069; Lv C, 2015, NEUROPHARMACOLOGY, V89, P175, DOI 10.1016/j.neuropharm.2014.09.019; Lv C, 2014, CURR ALZHEIMER RES, V11, P580, DOI 10.2174/1567205011666140618095925; Lv C, 2014, CURR ALZHEIMER RES, V11, P430, DOI 10.2174/1567205011666140514111204; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Peng CH, 2007, TOXICOLOGY, V238, P130, DOI 10.1016/j.tox.2007.05.029; Prezma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.316; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Robinson KS, 2011, ONCOGENE, V30, P2391, DOI 10.1038/onc.2010.636; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Silva DF, 2012, ADV PHARMACOL, V64, P83, DOI 10.1016/B978-0-12-394816-8.00003-9; Smilansky A, 2015, J BIOL CHEM, V290, P30670, DOI 10.1074/jbc.M115.691493; Spuch Carlos, 2012, J Aging Res, V2012, P324968, DOI 10.1155/2012/324968; Swerdlow RH, 2012, NEUROTOX RES, V22, P182, DOI 10.1007/s12640-011-9272-9; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Thinnes FP, 2009, MOL GENET METAB, V97, P241, DOI 10.1016/j.ymgme.2009.04.010; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yin F, 2011, NEUROCHEM INT, V58, P399, DOI 10.1016/j.neuint.2010.12.017	62	28	28	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152551	10.1371/journal.pone.0152551	http://dx.doi.org/10.1371/journal.pone.0152551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046221	Green Submitted, gold, Green Published			2022-12-27	WOS:000373599600025
J	Fontana, C; Lambert, A; Benaroudj, N; Gasparini, D; Gorgette, O; Cachet, N; Bomchil, N; Picardeau, M				Fontana, Celia; Lambert, Ambroise; Benaroudj, Nadia; Gasparini, David; Gorgette, Olivier; Cachet, Nathalie; Bomchil, Natalia; Picardeau, Mathieu			Analysis of a Spontaneous Non-Motile and Avirulent Mutant Shows That FliM Is Required for Full Endoflagella Assembly in Leptospira interrogans	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTOR; SWITCH PROTEIN; BORRELIA-BURGDORFERI; MOTILITY; VIRULENCE; INACTIVATION; EXPRESSION; COMPLEX; HOOK	Pathogenic Leptospira strains are responsible for leptospirosis, a worldwide emerging zoonotic disease. These spirochetes are unique amongst bacteria because of their corkscrew-like cell morphology and their periplasmic flagella. Motility is reported as an important virulence determinant, probably favoring entry and dissemination of pathogenic Leptospira in the host. However, proteins constituting the periplasmic flagella and their role in cell shape, motility and virulence remain poorly described. In this study, we characterized a spontaneous L. interrogans mutant strain lacking motility, correlated with the loss of the characteristic hook-shaped ends, and virulence in the animal model. Whole genome sequencing allowed the identification of one nucleotide deletion in the fliM gene resulting in a premature stop codon, thereby preventing the production of flagellar motor switch protein FliM. Genetic complementation restored cell morphology, motility and virulence comparable to those of wild type cells. Analyses of purified periplasmic flagella revealed a defect in flagella assembly, resulting in shortened flagella compared to the wild type strain. This also correlated with a lower amount of major filament proteins FlaA and FlaB. Altogether, these findings demonstrate that FliM is required for full and correct assembly of the flagella which is essential for motility and virulence.	[Fontana, Celia; Lambert, Ambroise; Benaroudj, Nadia; Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France; [Fontana, Celia; Cachet, Nathalie; Bomchil, Natalia] Lab Lyon Gerland, Lyon, France; [Gasparini, David] Ctr Rech Clin St Vulbas, Merial, St Vulbas, France; [Gorgette, Olivier] Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Merial SASU; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, Paris, France.; Bomchil, N (corresponding author), Lab Lyon Gerland, Lyon, France.	natalia.bomchil@merial.com; mathieu.picardeau@pasteur.fr	LAMBERT, AMBROISE/AAH-1384-2021; Lambert, Ambroise/P-3792-2016	Lambert, Ambroise/0000-0002-3909-2948; Benaroudj, Nadia/0000-0002-6475-0041	Institut Pasteur [FUI 14]; Fonds Unique Interministeriel "COVALEPT"; BPI France; Association Nationale de la Recherche et de la Technologie; Merial SAS France	Institut Pasteur(European Commission); Fonds Unique Interministeriel "COVALEPT"; BPI France; Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Merial SAS France	This work was funded by the Institut Pasteur (http://www.pasteur.fr), FUI 14 (Fonds Unique Interministeriel) "COVALEPT", BPI France (http://www.bpifrance.fr/), Association Nationale de la Recherche et de la Technologie (http://www.anrt.asso.fr/), and Merial SAS France (http://www.merial.com). The funder provided support in the form of salaries for authors [CF, DG, NC, N. Benaroudj, MP, N. Bomchil, OG, AL] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8_1; Ahn DR, 2013, INT J BIOL MACROMOL, V54, P76, DOI 10.1016/j.ijbiomac.2012.12.003; Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Eshghi A, 2009, J PROTEOME RES, V8, P4564, DOI 10.1021/pr9004597; FAINE S, 1964, J BACTERIOL, V88, P1493, DOI 10.1128/JB.88.5.1493-1496.1964; Guyard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072550; Huo LA, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-015-0394-x; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martinez-Garcia E, 2014, ENVIRON MICROBIOL, V16, P291, DOI 10.1111/1462-2920.12309; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Motaleb MA, 2000, P NATL ACAD SCI USA, P97; Murray GL, 2015, CURR TOP MICROBIOL, V387, P139, DOI 10.1007/978-3-662-45059-8_7; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Pappas CJ, 2015, APPL ENVIRON MICROBI; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Pinne M, 2011, JOVE-J VIS EXP, DOI 10.3791/2805; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; SIMPSON CF, 1964, J INFECT DIS, V114, P69, DOI 10.1093/infdis/114.1.69; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Toker AS, 1996, J BACTERIOL, V178, P7069, DOI 10.1128/jb.178.24.7069-7079.1996; Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46	42	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152916	10.1371/journal.pone.0152916	http://dx.doi.org/10.1371/journal.pone.0152916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044038	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100045
J	Alshamsi, A; Pianesi, F; Lepri, B; Pentland, A; Rahwan, I				Alshamsi, Aamena; Pianesi, Fabio; Lepri, Bruno; Pentland, Alex; Rahwan, Iyad			Network Diversity and Affect Dynamics: The Role of Personality Traits	PLOS ONE			English	Article							POSITIVE AFFECT; NEGATIVE AFFECT; EXPERIENCE; COMMUNICATION; VALIDATION	People divide their time unequally among their social contacts due to time constraints and varying strength of relationships. It was found that high diversity of social communication, dividing time more evenly among social contacts, is correlated with economic well-being both at macro and micro levels. Besides economic well-being, it is not clear how the diversity of social communication is also associated with the two components of individuals' subjective well-being, positive and negative affect. Specifically, positive affect and negative affect are two independent dimensions representing the experience (feeling) of emotions. In this paper, we investigate the relationship between the daily diversity of social communication and dynamic affect states that people experience in their daily lives. We collected two high-resolution datasets that capture affect scores via daily experience sampling surveys and social interaction through wearable sensing technologies: sociometric badges for face-to-face interaction and smart phones for mobile phone calls. We found that communication diversity correlates with desirable affect states-e.g. an increase in the positive affect state or a decrease in the negative affect state-for some personality types, but correlates with undesirable affect states for others. For example, diversity in phone calls is experienced as good by introverts, but bad by extroverts; diversity in face-to-face interaction is experienced as good by people who tend to be positive by nature (trait) but bad for people who tend to be not positive by nature. More broadly, the moderating effect of personality type on the relationship between diversity and affect was detected without any knowledge of the type of social tie or the content of communication. This provides further support for the power of unobtrusive sensing in understanding social dynamics, and in measuring the effect of potential interventions designed to improve well-being.	[Alshamsi, Aamena; Rahwan, Iyad] Masdar Inst Sci & Technol, Dept Elect Engn & Comp Sci, Abu Dhabi, U Arab Emirates; [Pianesi, Fabio; Lepri, Bruno] Fdn Bruno Kessler, Trento, Trento, Italy; [Lepri, Bruno; Pentland, Alex; Rahwan, Iyad] MIT, Media Lab, Cambridge, MA 02139 USA	Khalifa University of Science & Technology; Fondazione Bruno Kessler; Massachusetts Institute of Technology (MIT)	Rahwan, I (corresponding author), Masdar Inst Sci & Technol, Dept Elect Engn & Comp Sci, Abu Dhabi, U Arab Emirates.; Rahwan, I (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	irahwan@acm.org	Rahwan, Iyad/ABB-2422-2020	Rahwan, Iyad/0000-0002-1796-4303; Alshamsi, Aamena/0000-0001-6846-4627	European Union [PCOFUND-GA-2008 226070]	European Union(European Commission)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under the agreement no PCOFUND-GA-2008 226070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agneessens F, 2006, SOC NETWORKS, V28, P427, DOI 10.1016/j.socnet.2005.10.001; Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Alshamsi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135740; Barsade SG, 2000, ADMIN SCI QUART, V45, P802, DOI 10.2307/2667020; Barsade SG, 2007, ACAD MANAGE PERSPECT, V21, P36, DOI 10.5465/AMP.2007.24286163; Barsoukova SY, 2003, SOTSIOL ISSLED+, P3; BEISER M, 1974, J HEALTH SOC BEHAV, V15, P320, DOI 10.2307/2137092; BERNARD HR, 1982, SOC SCI RES, V11, P30, DOI 10.1016/0049-089X(82)90006-0; Bogomolov A, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P477, DOI 10.1145/2647868.2654933; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Centellegher S, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0064-6; Chittaranjan G, 2013, PERS UBIQUIT COMPUT, V17, P433, DOI 10.1007/s00779-011-0490-1; Clark L, 1986, M AM PSYCH ASS WASH; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Csikszentmihalyi M., 2014, THE J, P89, DOI [10.1007/978-94-017-9088-8_6, DOI 10.1023/A:1024409732742]; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; DIENER E, 1985, J PERS SOC PSYCHOL, V48, P1253, DOI 10.1037/0022-3514.48.5.1253; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Erez A, 2002, J APPL PSYCHOL, V87, P1055, DOI 10.1037//0021-9010.87.6.1055; Friedkin NE, 2010, SOC PSYCHOL QUART, V73, P196, DOI 10.1177/0190272510369661; Gini C, 1912, VARIABILITA MUTABILI, P1, DOI [10.2307/2340052, DOI 10.2307/2340052]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Lane ND, 2010, IEEE COMMUN MAG, V48, P140, DOI 10.1109/MCOM.2010.5560598; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lepri B, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P623, DOI 10.1109/SocialCom-PASSAT.2012.71; Likamwa R., 2013, P 11 ANN INT C MOB S, P389, DOI [DOI 10.1145/2462456.2464449, 10.1145/2462456.2464449]; Lucas RE, 2006, DOES EXISTENCE SOCIA; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Madan A, 2012, IEEE PERVAS COMPUT, V11, P36, DOI 10.1109/MPRV.2011.79; Madan A, 2010, UBICOMP 2010: PROCEEDINGS OF THE 2010 ACM CONFERENCE ON UBIQUITOUS COMPUTING, P291; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Perry-Smith JE, 2006, ACAD MANAGE J, V49, P85, DOI 10.2307/20159747; Perugini M., 2002, BIG 5 MARKER SCALES; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sandstrom GM, 2014, PERS SOC PSYCHOL B, V40, P910, DOI 10.1177/0146167214529799; Staiano J, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P321; Stehle J, 2011, HIGH RESOLUTION MEAS; Tellegen A, 1985, STRUCTURES MOOD PERS; Tellegen A., 2008, SAGE HDB PERSONALITY, P261, DOI [10.4135/9781849200479.n13, DOI 10.4135/9781849200479.N13]; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Vaquero LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01174; Villalpando O., 2002, NASPA J, V40, P124, DOI [DOI 10.2202/0027-6014.1194, 10.2202/1949-6605.1194]; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wei Pan, 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P200, DOI 10.1109/PASSAT/SocialCom.2011.163; YITZHAKI S, 1979, Q J ECON, V93, P321, DOI 10.2307/1883197; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	57	13	13	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152358	10.1371/journal.pone.0152358	http://dx.doi.org/10.1371/journal.pone.0152358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035904	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200014
J	Van Bogaert, P; Peremans, L; Diltour, N; Van Heusden, D; Dilles, T; Van Rompaey, B; Havens, DS				Van Bogaert, Peter; Peremans, Lieve; Diltour, Nadine; Van Heusden, Danny; Dilles, Tinne; Van Rompaey, Bart; Havens, Donna Sullivan			Staff Nurses' Perceptions and Experiences about Structural Empowerment: A Qualitative Phenomenological Study	PLOS ONE			English	Article							NURSING WORK ENVIRONMENTS; ORGANIZATIONAL COMMITMENT; WORKPLACE EMPOWERMENT; HOSPITAL-CARE; JOB-OUTCOMES; BURNOUT; IMPACT; MODEL; SATISFACTION	The aim of the study reported in this article was to investigate staff nurses' perceptions and experiences about structural empowerment and perceptions regarding the extent to which structural empowerment supports safe quality patient care. To address the complex needs of patients, staff nurse involvement in clinical and organizational decision-making processes within interdisciplinary care settings is crucial. A qualitative study was conducted using individual semi-structured interviews of 11 staff nurses assigned to medical or surgical units in a 600-bed university hospital in Belgium. During the study period, the hospital was going through an organizational transformation process to move from a classic hierarchical and departmental organizational structure to one that was flat and interdisciplinary. Staff nurses reported experiencing structural empowerment and they were willing to be involved in decision-making processes primarily about patient care within the context of their practice unit. However, participants were not always fully aware of the challenges and the effect of empowerment on their daily practice, the quality of care and patient safety. Ongoing hospital change initiatives supported staff nurses' involvement in decision-making processes for certain matters but for some decisions, a classic hierarchical and departmental process still remained. Nurses perceived relatively high work demands and at times viewed empowerment as presenting additional. Staff nurses recognized the opportunities structural empowerment provided within their daily practice. Nurse managers and unit climate were seen as crucial for success while lack of time and perceived work demands were viewed as barriers to empowerment.	[Van Bogaert, Peter; Peremans, Lieve; Diltour, Nadine; Van Heusden, Danny; Dilles, Tinne; Van Rompaey, Bart] Univ Antwerp, Nursing & Midwifery Sci, Ctr Res & Innovat Care, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Van Bogaert, Peter] Univ Antwerp Hosp, Dept Nursing, Antwerp, Belgium; [Havens, Donna Sullivan] Univ N Carolina, Sch Nursing, Chapel Hill, NC USA; [Peremans, Lieve] Univ Antwerp, Dept Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Peremans, Lieve] Vrije Univ Brussel, Mental Hlth & Wellbeing Res Grp, Brussels, Belgium; [Van Bogaert, Peter; Peremans, Lieve; Diltour, Nadine; Van Heusden, Danny; Dilles, Tinne; Van Rompaey, Bart] Univ Pl 1, B-2610 Antwerp, Belgium; [Havens, Donna Sullivan] Carrington Hall,Campus Box 7640, Chapel Hill, NC 27599 USA	University of Antwerp; University of Antwerp; University of North Carolina; University of North Carolina Chapel Hill; University of Antwerp; Vrije Universiteit Brussel	Van Bogaert, P (corresponding author), Univ Antwerp, Nursing & Midwifery Sci, Ctr Res & Innovat Care, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium.; Van Bogaert, P (corresponding author), Univ Antwerp Hosp, Dept Nursing, Antwerp, Belgium.; Van Bogaert, P (corresponding author), Univ Pl 1, B-2610 Antwerp, Belgium.	peter.vanbogaert@uantwerpen.be	Dilles, Tinne/F-3393-2013; Van heusden, Danny/L-2983-2018; peremans, lieve/N-4336-2015; Van Rompaey, Bart/T-9884-2018; Van Rompaey, Bart/AAM-3215-2021; Van Rompaey, Bart/B-1861-2017; Van Bogaert, Peter/R-8735-2016	Dilles, Tinne/0000-0003-2817-0944; Van heusden, Danny/0000-0001-8950-9302; peremans, lieve/0000-0001-6849-0040; Van Rompaey, Bart/0000-0001-7670-0300; Van Rompaey, Bart/0000-0001-7670-0300; Van Rompaey, Bart/0000-0001-7670-0300; Van Bogaert, Peter/0000-0001-6636-3793				Aiken LH, 2008, J NURS ADMIN, V38, P223, DOI 10.1097/01.NNA.0000312773.42352.d7; American Nurses Credentialing Center, 2005, MAGN REC PROGR REC E; American Nurses Credentialing Center, 2014, MAGN REC PROGR MOD; Bakker AB, 2008, J ORGAN BEHAV, V29, P147, DOI 10.1002/job.515; Castledine George, 2008, Br J Nurs, V17, P801; Choi JK, 2004, NURS RES, V53, P370, DOI 10.1097/00006199-200411000-00005; Davies A, 2011, J NURS MANAGE, V19, P632, DOI 10.1111/j.1365-2834.2011.01269.x; Eo YS, 2014, ASIAN NURS RES, V8, P42, DOI 10.1016/j.anr.2014.02.001; Estabrooks CA, 2002, RES NURS HEALTH, V25, P256, DOI 10.1002/nur.10043; Friese CR, 2008, HEALTH SERV RES, V43, P1145, DOI 10.1111/j.1475-6773.2007.00825.x; Gunnarsdottir S, 2007, INT J NURS STUD, V46, P920, DOI DOI 10.1016/J.IJNURSTU.2006.11.007; Halcomb EJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-26; Havens DS, 1999, J NURS ADMIN, V29, P14, DOI 10.1097/00005110-199902000-00006; Joint Commission International Accreditation, 2010, GETT START, P2; Kanter R., 1993, WOMEN MEN CORPORATIO, V2nd; Lachinger HK, 2014, INT J NURS STUD, DOI [10.1016/j.ijnurstu.2014.04.010, DOI 10.1016/J.IJNURSTU.2014.04.010]; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Laschinger HKS, 2009, J NURS MANAGE, V17, P636, DOI 10.1111/j.1365-2834.2008.00907.x; Laschinger HKS, 2004, J ORGAN BEHAV, V25, P527, DOI 10.1002/job.256; Li YF, 2007, RES NURS HEALTH, V30, P31, DOI 10.1002/nur.20172; Morrow E, 2012, INT J HEALTH CARE Q, V25, P237, DOI 10.1108/09526861211221464; Polit D., 2010, ESSENTIALS NURSING R, V7th; Rafferty AM, 2001, QUAL HEALTH CARE, V10, P32; Robert Glenn, 2011, Nurs Times, V107, P18; Schubert M, 2009, INT J NURS STUD, V46, P884, DOI 10.1016/j.ijnurstu.2008.10.008; Spreitzer GM, 1995, AM J COMMUN PSYCHOL, V23, P601, DOI 10.1007/BF02506984; Tourangeau Ann E, 2005, Nurs Leadersh (Tor Ont), V18, P54; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; Van Bogaert P, 2014, J NURS ADMIN, V44, P452, DOI 10.1097/NNA.0000000000000100; Van Bogaert P, 2013, INT J NURS STUD, V50, P1667, DOI 10.1016/j.ijnurstu.2013.05.010; Van Bogaert P, 2010, J CLIN NURS, V19, P1664, DOI 10.1111/j.1365-2702.2009.03128.x; Van Bogaert P, 2009, J ADV NURS, V65, P2175, DOI 10.1111/j.1365-2648.2009.05082.x; Van Bogaert P, 2009, INT J NURS STUD, V46, P55, DOI 10.1016/j.ijnurstu.2008.07.009; Wagner JIJ, 2013, CAN J NURS RES, V45, P108; Wang SS, 2015, J NURS MANAGE, V23, P287, DOI 10.1111/jonm.12124; White M., 2015, NURS TIMES, V111, P12; WOLF GA, 1994, J NURS ADMIN, V24, P38, DOI 10.1097/00005110-199405000-00009; WOLF GA, 1994, J NURS ADMIN, V24, P51, DOI 10.1097/00005110-199404000-00014; Wolf GA, 2006, J NURS ADMIN, V36, P458, DOI 10.1097/00005110-200610000-00006; Yang JH, 2013, INT J NURS PRACT, V19, P44, DOI 10.1111/ijn.12016	40	22	22	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152654	10.1371/journal.pone.0152654	http://dx.doi.org/10.1371/journal.pone.0152654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035457	Green Published, gold			2022-12-27	WOS:000373201200025
J	Hashimoto, A; Sato, T; Iyama, S; Yoshida, M; Ibata, S; Tatekoshi, A; Kamihara, Y; Horiguchi, H; Murase, K; Kawano, Y; Takada, K; Miyanishi, K; Kobune, M; Ichimiya, S; Kato, J				Hashimoto, Akari; Sato, Tsutomu; Iyama, Satoshi; Yoshida, Masahiro; Ibata, Soushi; Tatekoshi, Ayumi; Kamihara, Yusuke; Horiguchi, Hiroto; Murase, Kazuyuki; Kawano, Yutaka; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Ichimiya, Shingo; Kato, Junji			Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells	PLOS ONE			English	Article							STEROID-REFRACTORY ACUTE; PITUITARY-ADRENAL AXIS; EXTRACORPOREAL PHOTOPHERESIS; ACUTE GVHD; THERAPY; UVB; TRANSPLANTATION; PREDNISONE; ANTIGENS; SOCIETY	Narrowband ultraviolet B (NB-UVB) has been widely used in dermatological phototherapy. As for the application of NB-UVB phototherapy to graft-versus-host disease (GVHD), we previously reported that it was highly efficacious for cutaneous lesions of acute GVHD (aGVHD) and that expansion of regulatory T (Treg) cells induced by NB-UVB might be one of the mechanisms. In order to examine whether NB-UVB irradiation through expansion of Treg cells is effective for the treatment of not only cutaneous aGVHD but also aGVHD of inner organs such as the intestine or liver, we conducted experiments in which a murine lethal aGVHD model, characterized by severe involvement of the intestine, was irradiated with NB-UVB. We found that NB-UVB irradiation improved the clinical score and survival rate. The pathological score of aGVHD was improved in all affected organs: intestine, liver, and skin. In the serum of mice irradiated with NB-UVB, the levels of Treg cells-associated cytokines such as transforming growth factor beta (TGF beta) and interleukin-10 (IL-10) were elevated. The numbers of infiltrating Treg cells in inflamed tissue of the intestine and those in spleen were increased in mice treated with NB-UVB. This is the first report demonstrating that NB-UVB phototherapy has the ability to ameliorate intestinal aGVHD through the expansion of Treg cells.	[Hashimoto, Akari; Sato, Tsutomu; Iyama, Satoshi; Yoshida, Masahiro; Ibata, Soushi; Tatekoshi, Ayumi; Kamihara, Yusuke; Horiguchi, Hiroto; Murase, Kazuyuki; Kawano, Yutaka; Takada, Kohichi; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan; [Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Human Immunol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Kato, J (corresponding author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Horiguchi, Hiroto/ADC-8272-2022; Iyama, Satoshi/AAA-6237-2019	Horiguchi, Hiroto/0000-0001-6811-3042; Goto, Akari/0000-0003-2582-851X; Miyanishi, Koji/0000-0002-6466-3458	Japan Society for the Promotion of Science [25461429]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (C: 25461429 to Tsutomu Sato, Satoshi Iyama, and Yutaka Kawano) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dalle I, 2014, BIOL BLOOD MARROW TR, V20, P1677, DOI 10.1016/j.bbmt.2014.05.017; Akiyama T, 2012, WORLD J ORTHOP, V3, P142, DOI 10.5312/wjo.v3.i9.142; Brazzelli V, 2010, BRIT J DERMATOL, V162, P404, DOI 10.1111/j.1365-2133.2009.09503.x; Christensen ME, 2010, HAEMATOL-HEMATOL J, V95, P2102, DOI 10.3324/haematol.2010.028910; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Dawe RS, 1998, BRIT J DERMATOL, V138, P833; Dickinson AM, 2008, BEST PRACT RES CL HA, V21, P149, DOI 10.1016/j.beha.2008.03.004; Dignan FL, 2012, BRIT J HAEMATOL, V158, P30, DOI 10.1111/j.1365-2141.2012.09129.x; Feldstein JV, 2011, J AM ACAD DERMATOL, V65, P733, DOI 10.1016/j.jaad.2010.08.006; Flowers MED, 2008, BLOOD, V112, P2667, DOI 10.1182/blood-2008-03-141481; Girerd S, 2013, BONE MARROW TRANSPL, V48, P1243, DOI 10.1038/bmt.2013.16; Hannani D, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00349; HINGS IM, 1993, TRANSPLANTATION, V56, P577, DOI 10.1097/00007890-199309000-00016; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jagasia M, 2013, BIOL BLOOD MARROW TR, V19, P1129, DOI 10.1016/j.bbmt.2013.04.018; Kambham N, 2014, ADV ANAT PATHOL, V21, P301, DOI 10.1097/PAP.0000000000000032; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kunisada M, 2007, J INVEST DERMATOL, V127, P2865, DOI 10.1038/sj.jid.5701001; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; MARTIN PJ, 1990, BLOOD, V76, P1464, DOI 10.1182/blood.V76.8.1464.1464; Mielcarek M, 2009, BLOOD, V113, P2888, DOI 10.1182/blood-2008-07-168401; Miklos S, 2008, BIOL BLOOD MARROW TR, V14, P1004, DOI 10.1016/j.bbmt.2008.06.015; Panoskaltsis-Mortari A, 2011, AM J RESP CRIT CARE, V183, P1262, DOI 10.1164/rccm.2007-413ST; Reich A, 2013, INT J MOL SCI, V14, P8456, DOI 10.3390/ijms14048456; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Thompson JS, 2010, BONE MARROW TRANSPL, V45, P712, DOI 10.1038/bmt.2009.215; Treister N, 2015, PHOTODERMATOL PHOTO, V31, P75, DOI 10.1111/phpp.12141; van Leeuwen L, 2002, BONE MARROW TRANSPL, V29, P151, DOI 10.1038/sj.bmt.1703328; Van Lint MT, 1998, BLOOD, V92, P2288; vanLeeuwen L, 1997, TRANSPLANTATION, V64, P1097, DOI 10.1097/00007890-199710270-00002; Ward DM, 2011, J CLIN APHERESIS, V26, P276, DOI 10.1002/jca.20300; Wong YS, 2015, PEDIATR DERMATOL, V32, pE221, DOI 10.1111/pde.12632	47	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152823	10.1371/journal.pone.0152823	http://dx.doi.org/10.1371/journal.pone.0152823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031239	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800144
J	Hsiao, NY; Dunning, L; Kroon, M; Myer, L				Hsiao, Nei-yuan; Dunning, Lorna; Kroon, Max; Myer, Landon			Laboratory Evaluation of the Alere q Point-of-Care System for Early Infant HIV Diagnosis	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MORTALITY; INFECTION; PROGRAMS	Introduction Early infant diagnosis (EID) and prompt linkage to care are critical to minimise the high morbidity and mortality associated with infant HIV infection. Attrition in the "EID cascade" is common; however, point-of-care (POC) EID assays with same-day result could facilitate prompt linkage of HIV-infected infant to treatment. Despite a number of POC EID assays in development, few have been independently evaluated and data on new technologies are urgently needed to inform policy. Methods We compared Alere q 1/2 Detect POC system laboratory test characteristics with the local standard of care (SOC), Roche CAP/CTM HIV-1 qualitative PCR in an independent laboratory-based evaluation in Cape Town, South Africa. Routinely EID samples collected between November 2013 and September 2014 were each tested by both SOC and POC systems. Repeat testing was done to troubleshoot any discrepancy between POC and SOC results. Results Overall, 1098 children with a median age of 47 days (IQR, 42-117) were included. Birth PCR (age <7 days) comprised of 8% (n = 92) tests while 56% (n = 620) of children tested as part of routine EID (ages 6-14 weeks). In the overall direct comparison, Alere q Detect achieved sensitivity of 95.5%(95% CI, 91.7-97.9%) and a specificity of 99.8% (95% CI, 99.1-100%). Following repeat testing of discordant samples and exclusion of any inconclusive results, the POC assay sensitivity and specificity were 96.9% (95% CI 93.4-98.9%) and 100% (lower 95% CI 98%) respectively. Among birth PCR tests the POC assay had slightly lower sensitivity (93.3% vs 96.5% in routine EID) and higher assay error rate (10% vs 5% in samples of older children, p = 0.04). Conclusion Our results indicate this POC assay performs well for EID in the laboratory. The high specificity and thus high positive predictive value would suggest a positive POC result may be adequate for immediate infant ART initiation. While POC testing for EID may have particular utility for birth testing at delivery facilities, the lower sensitivity and error rate requires further attention, as does field implementation of POC EID technologies in other clinical care settings.	[Hsiao, Nei-yuan] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Dunning, Lorna; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, ZA-7925 Cape Town, South Africa; [Kroon, Max] Univ Cape Town, Dept Neonatal Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Hsiao, NY (corresponding author), Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa.	marvin.hsiao@uct.ac.za			Elizabeth Glaser Pediatric AIDS foundation [02294]	Elizabeth Glaser Pediatric AIDS foundation	LM was awarded a grant from Elizabeth Glaser Pediatric AIDS foundation (grant number 02294) [http://www.pedaids.org/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, 2014 PROGR REP GLOB; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Eley B, 2006, SAMJ S AFR MED J, V96, P988; Feucht U, 2012, SAMJ S AFR MED J, V102, P149, DOI 10.7196/SAMJ.4951; Hsiao NY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055308; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; King CC, 2015, AIDS, V29, P1953, DOI 10.1097/QAD.0000000000000794; Lilian RR, 2013, PEDIATR INFECT DIS J, V32, P1080, DOI 10.1097/INF.0b013e318290622e; Lilian RR, 2012, J CLIN MICROBIOL, V50, P2373, DOI 10.1128/JCM.00431-12; Maritz J, 2014, J MED VIROL, V86, P82, DOI 10.1002/jmv.23811; Motswere-Chirwa C, 2014, MMWR-MORBID MORTAL W, V63, P158; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Oladokun R, 2015, S Afr Med J, V105, P877; Stringer Jeffrey S A, 2013, PLoS Med, V10, pe1001424, DOI 10.1371/journal.pmed.1001424; Sutcliffe CG, 2015, PEDIATR INFECT DIS J, V34, P607, DOI 10.1097/INF.0000000000000684; UNITAID, 2014, HIV AIDS DIAGN TECHN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; [WHO] World Health Organization, 2014, CONS GUID US ANT DRU; World Health Organization, 2004, RAP HIV TESTS GUID U	22	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152672	10.1371/journal.pone.0152672	http://dx.doi.org/10.1371/journal.pone.0152672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032094	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800111
J	Richter, MJ; Milger, K; Haase, S; Sommer, N; Tello, K; Seeger, W; Mayer, E; Wiedenroth, CB; Grimminger, F; George, W; Ghofrani, HA; Guth, S; Gall, H				Richter, Manuel Jonas; Milger, Katrin; Haase, Sarah; Sommer, Natascha; Tello, Khodr; Seeger, Werner; Mayer, Eckhard; Wiedenroth, Christoph Benjamin; Grimminger, Friedrich; George, Wolfgang; Ghofrani, Hossein Ardeschir; Guth, Stefan; Gall, Henning			The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; INSULIN-RESISTANCE; ENDARTERECTOMY; DISEASE; HEART; ASSOCIATION; PREDICTORS; ADULTS	Background Glycosylated hemoglobin A1c (HbA1c) has been proposed as an independent predictor of long-term prognosis in pulmonary arterial hypertension. However, the clinical relevance of HbA1c in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) remains unknown. The aim of the present study was to investigate the clinical significance of HbA1c as a biomarker in CTEPH. Methods Prospectively, 102 patients underwent pulmonary endarterectomy (PEA) in our national referral center between March 2013 and March 2014, of which after exclusion 45 patients were analyzed. HbA1c- levels, hemodynamic and exercise parameters were analyzed prior and one-year post-PEA. Results 45 patients (BMI: 27.3 +/- 6.0 kg/m(2); age: 62.7 +/- 12.3 years) with a mean pulmonary arterial pressure (mPAP) of 43.6 +/- 9.4 mmHg, a pulmonary vascular resistance (PVR) of 712.1 +/- 520.4 dyn*s/cm(5), a cardiac index (CI) of 2.4 +/- 0.5 l/min/m(2) and a mean HbA1c-level of 39.8 +/- 5.6 mmol/mol were included. One-year post-PEA pulmonary hemodynamic and functional status significantly improved in our cohort. Baseline HbA1c-levels were significantly associated with CI, right atrial pressure, peak oxygen uptake and the change of 6-minute walking distance using linear regression analysis. However, using logistic regression analysis baseline HbA1c-levels were not significantly associated with residual post-PEA PH. Conclusions This is the first prospective study to describe an association of HbA1c-levels with pulmonary hemodynamics and exercise capacity in operable CTEPH patients. Our preliminary results indicate that in these patients impaired glucose metabolism as assessed by HbA1c is of clinical significance. However, HbA1c failed as a predictor of the hemodynamic outcome one-year post-PEA.	[Richter, Manuel Jonas; Grimminger, Friedrich; Ghofrani, Hossein Ardeschir] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany; [Richter, Manuel Jonas; Milger, Katrin; Haase, Sarah; Sommer, Natascha; Tello, Khodr; Seeger, Werner; Grimminger, Friedrich; Ghofrani, Hossein Ardeschir; Gall, Henning] Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany; [Milger, Katrin] Univ Munich, Comprehens Pneumol Ctr, Med Clin 5, Munich, Germany; [Mayer, Eckhard; Wiedenroth, Christoph Benjamin] Kerckhoff Heart Rheuma & Thorac Ctr, Dept Thorac Surg, Bad Nauheim, Germany; [George, Wolfgang; Guth, Stefan] THM Univ Appl Sci, TransMIT Project Div Hlth Serv Res & Consulting, Giessen, Germany	Kerckhoff Clinic; Justus Liebig University Giessen; University of Munich; Kerckhoff Clinic	Richter, MJ (corresponding author), Kerckhoff Heart Rheuma & Thorac Ctr, Dept Pneumol, Bad Nauheim, Germany.; Richter, MJ (corresponding author), Univ Giessen, Dept Internal Med, UGMLC, Giessen, Germany.	manuel.richter@innere.med.uni-giessen.de	Milger, Katrin/AFI-3881-2022; Sommer, Natascha/AAD-5406-2020; Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; George, Wolfgang/0000-0001-5462-7309; Sommer, Natascha/0000-0002-8915-7762; Milger, Katrin/0000-0003-2914-8773; Grimminger, Friedrich/0000-0001-8725-6276; Seeger, Werner/0000-0003-1946-0894				Abernethy AD, 2015, PULM CIRC, V5, P117, DOI 10.1086/679705; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Belly MJ, 2012, J HEART LUNG TRANSPL, V31, P1109, DOI 10.1016/j.healun.2012.08.014; Bresser Paul, 2006, Proc Am Thorac Soc, V3, P594, DOI 10.1513/pats.200605-115LR; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Freed DH, 2008, EUR J CARDIO-THORAC, V34, P525, DOI 10.1016/j.ejcts.2008.04.018; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Gopal DM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001597; Grignola JC, 2013, WORLD J CARDIOL, V5, P18, DOI 10.4330/wjc.v5.i3.18; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hernandez D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-151; Ishida K, 2012, J THORAC CARDIOV SUR, V144, P321, DOI 10.1016/j.jtcvs.2011.09.004; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kunihara T, 2011, EUR J CARDIO-THORAC, V40, P154, DOI 10.1016/j.ejcts.2010.10.043; Kunihara T, 2010, ANN THORAC SURG, V90, P957, DOI 10.1016/j.athoracsur.2010.05.008; Lang IM, 2013, THROMB HAEMOSTASIS, V110, P83, DOI 10.1160/TH13-02-0097; Lankeit M, 2008, EUR RESPIR J, V31, P1024, DOI 10.1183/09031936.00100407; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lopez-Lopez JG, 2008, AM J PHYSIOL-LUNG C, V295, pL727, DOI 10.1152/ajplung.90354.2008; Mauritz GJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-5; Mayer E, 2010, EUR RESPIR REV, V19, P64, DOI 10.1183/09059180.00007409; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Poms AD, 2013, CHEST, V144, P169, DOI 10.1378/chest.11-3241; Pugh ME, 2010, INT J CLIN PRACT, V64, P5, DOI 10.1111/j.1742-1241.2010.02523.x; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Rahnavardi M, 2011, ANN THORAC CARDIOVAS, V17, P435, DOI 10.5761/atcs.oa.10.01653; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Ross RVM, 2013, AM J PHYSIOL-HEART C, V305, pH259, DOI 10.1152/ajpheart.00128.2013; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sato Masato, 2013, Ann Vasc Dis, V6, P578, DOI 10.3400/avd.oa.13-00056; Taboada D, 2014, EUR RESPIR J, V44, P1635, DOI 10.1183/09031936.00050114; Task Force for D, 2009, EUROPEAN RESP J, V34, P1219, DOI [DOI 10.1183/09031936.00139009, 10.1183/09031936.00139009]; Thistlethwaite PA, 2002, J THORAC CARDIOV SUR, V124, P1203, DOI 10.1067/mtc.2002.127313; van der Plas MN, 2010, ANN THORAC SURG, V89, P347, DOI 10.1016/j.athoracsur.2009.08.001; von Haehling S, 2010, INT J CARDIOL, V144, P206, DOI 10.1016/j.ijcard.2009.04.019; West J, 2013, EUR RESPIR J, V41, P861, DOI 10.1183/09031936.00030312; Widya RL, 2013, DIABETES CARE, V36, P457, DOI 10.2337/dc12-0474; Zabini D, 2014, EUR RESPIR J, V44, P951, DOI 10.1183/09031936.00145013; Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152580	10.1371/journal.pone.0152580	http://dx.doi.org/10.1371/journal.pone.0152580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031508	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800096
J	Santos-Pontelli, TEG; Rimoli, BP; Favoretto, DB; Mazin, SC; Truong, DQ; Leite, JP; Pontes-Neto, OM; Babyar, SR; Reding, M; Bikson, M; Edwards, DJ				Santos-Pontelli, Taiza E. G.; Rimoli, Brunna P.; Favoretto, Diandra B.; Mazin, Suleimy C.; Truong, Dennis Q.; Leite, Joao P.; Pontes-Neto, Octavio M.; Babyar, Suzanne R.; Reding, Michael; Bikson, Marom; Edwards, Dylan J.			Polarity-Dependent Misperception of Subjective Visual Vertical during and after Transcranial Direct Current Stimulation (tDCS)	PLOS ONE			English	Article							GALVANIC-VESTIBULAR STIMULATION; NONINVASIVE BRAIN-STIMULATION; MOTOR CORTEX EXCITABILITY; RANDOMIZED-TRIALS; PERCEPTION; MODULATION; NEGLECT; STROKE; LATEROPULSION; RECOVERY	Pathologic tilt of subjective visual vertical (SVV) frequently has adverse functional consequences for patients with stroke and vestibular disorders. Repetitive transcranial magnetic stimulation (rTMS) of the supramarginal gyrus can produce a transitory tilt on SVV in healthy subjects. However, the effect of transcranial direct current stimulation (tDCS) on SVV has never been systematically studied. We investigated whether bilateral tDCS over the temporal-parietal region could result in both online and offline SVV misperception in healthy subjects. In a randomized, sham-controlled, single-blind crossover pilot study, thirteen healthy subjects performed tests of SVV before, during and after the tDCS applied over the temporal- parietal region in three conditions used on different days: right anode/left cathode; right cathode/left anode; and sham. Subjects were blind to the tDCS conditions. Montage-specific current flow patterns were investigated using computational models. SVV was significantly displaced towards the anode during both active stimulation conditions when compared to sham condition. Immediately after both active conditions, there were rebound effects. Longer lasting after-effects towards the anode occurred only in the right cathode/left anode condition. Current flow models predicted the stimulation of temporal-parietal regions under the electrodes and deep clusters in the posterior limb of the internal capsule. The present findings indicate that tDCS over the temporal-parietal region can significantly alter human SVV perception. This tDCS approach may be a potential clinical tool for the treatment of SVV misperception in neurological patients.	[Santos-Pontelli, Taiza E. G.; Rimoli, Brunna P.; Favoretto, Diandra B.; Mazin, Suleimy C.; Leite, Joao P.; Pontes-Neto, Octavio M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Truong, Dennis Q.; Bikson, Marom] CUNY City Coll, Neural Engn Lab, Dept Biomed Engn, New York, NY 10031 USA; [Babyar, Suzanne R.; Reding, Michael; Edwards, Dylan J.] Cornell Univ, Coll Med, Burke Med Res Inst, Noninvas Brain Stimulat & Human Motor Control Lab, White Plains, NY 10605 USA; [Babyar, Suzanne R.; Reding, Michael; Edwards, Dylan J.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA	Universidade de Sao Paulo; City University of New York (CUNY) System; City College of New York (CUNY); Cornell University; Cornell University	Santos-Pontelli, TEG (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Neurosci & Behav Sci, BR-14049 Ribeirao Preto, SP, Brazil.	taiza@fmrp.usp.br	Edwards, Taiza GS/F-9214-2012; Leite, Joao/B-9070-2012; Pontes-Neto, Octavio Marques/G-4294-2012	Edwards, Taiza GS/0000-0003-3033-2981; Leite, Joao/0000-0003-0558-3519; Pontes-Neto, Octavio Marques/0000-0003-0317-843X; Babyar, Suzanne/0000-0002-3367-3717; Edwards, Dylan/0000-0001-7346-3100; Favoretto, Diandra/0000-0001-6853-1914	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil; NICHD of the National Institutes of Health - USA [R01HD069776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069776] Funding Source: NIH RePORTER	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NICHD of the National Institutes of Health - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil. DJE was supported by NICHD of the National Institutes of Health - USA, under award number R01HD069776.; This work was supported by funds from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil. DJE was supported by NICHD of the National Institutes of Health-USA, under award number R01HD069776. The authors declare no competing financial interests.	Ahmad H, 2014, J VESTIBUL RES-EQUIL, V24, P453, DOI 10.3233/VES-140530; Arshad Q, 2014, BRAIN STIMUL, V7, P85, DOI 10.1016/j.brs.2013.07.002; Baier B, 2012, NEUROLOGY, V78, P728, DOI 10.1212/WNL.0b013e318248e544; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Batuecas-Caletrio A, 2013, ACTA OTO-LARYNGOL, V133, P475, DOI 10.3109/00016489.2012.757798; Bjasch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049311; Bonan IV, 2007, J NEUROL NEUROSUR PS, V78, P49, DOI 10.1136/jnnp.2006.087791; Brandt T, 2000, NEUROREHAB NEURAL RE, V14, P1, DOI 10.1177/154596830001400101; Bronstein AM, 1999, ANN NY ACAD SCI, V871, P324, DOI 10.1111/j.1749-6632.1999.tb09195.x; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Cocks K, 2013, J CLIN EPIDEMIOL, V66, P197, DOI 10.1016/j.jclinepi.2012.09.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; DIETERICH M, 1993, NEUROLOGY, V43, P1732, DOI 10.1212/WNL.43.9.1732; Donaldson PH, 2015, NEUROSCI BIOBEHAV R, V55, P547, DOI 10.1016/j.neubiorev.2015.05.017; Fertonani A, 2011, J NEUROSCI, V31, P15416, DOI 10.1523/JNEUROSCI.2002-11.2011; Giglia G, 2011, BRAIN STIMUL, V4, P294, DOI 10.1016/j.brs.2011.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd edn; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kerkhoff G, 1998, EXP BRAIN RES, V122, P108, DOI 10.1007/s002210050497; Kheradmand A, 2015, CEREB CORTEX, V25, P765, DOI 10.1093/cercor/bht267; Kyriakareli A, 2013, NEUROREPORT, V24, P808, DOI 10.1097/WNR.0b013e3283646e65; Laakso I, 2015, BRAIN STIMUL, V8, P906, DOI 10.1016/j.brs.2015.05.002; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Mars F, 2001, NEUROREPORT, V12, P2991, DOI 10.1097/00001756-200109170-00047; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Min KK, 2007, OTOL NEUROTOL, V28, P520, DOI 10.1097/01.mao.0000271674.41307.f2; Nasseri P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00054; Oppenlander K, 2015, NEUROPSYCHOLOGIA, V74, P178, DOI 10.1016/j.neuropsychologia.2015.03.004; Oppenlander K, 2015, NEUROPSYCHOLOGIA, V74, P170, DOI 10.1016/j.neuropsychologia.2014.10.039; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Pergolizzi D, 2015, NEUROPSYCHOLOGIA, V66, P88, DOI 10.1016/j.neuropsychologia.2014.11.012; Rohrmeier C, 2013, OTOL NEUROTOL, V34, P297, DOI 10.1097/MAO.0b013e31827d0901; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rousseaux M, 2013, NEUROLOGY, V81, P1291, DOI 10.1212/WNL.0b013e3182a823a7; Saj A, 2006, NEUROPSYCHOLOGIA, V44, P1509, DOI 10.1016/j.neuropsychologia.2005.11.018; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Shin YI, 2015, NEUROPSYCHOLOGIA, V69, P154, DOI 10.1016/j.neuropsychologia.2015.02.002; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stinear CM, 2015, BRAIN STIMUL, V8, P1183, DOI 10.1016/j.brs.2015.06.015; Sunwoo H, 2013, NEUROSCI LETT, V554, P94, DOI 10.1016/j.neulet.2013.08.064; Tazoe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114244; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Turkeltaub PE, 2012, BRAIN STIMUL, V5, P201, DOI 10.1016/j.brs.2011.04.002; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Volkening K, 2014, NEUROSCI LETT, V581, P75, DOI 10.1016/j.neulet.2014.08.028; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Yelnik AP, 2002, STROKE, V33, P2247, DOI 10.1161/01.STR.0000027212.26686.48; Zwergal A, 2009, NEUROLOGY, V72, P1689, DOI 10.1212/WNL.0b013e3181a55ecf	60	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152331	10.1371/journal.pone.0152331	http://dx.doi.org/10.1371/journal.pone.0152331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031726	Green Published, gold			2022-12-27	WOS:000373121800058
J	Sink, R; Kotnik, M; Zega, A; Barreteau, H; Gobec, S; Blanot, D; Dessen, A; Contreras-Martel, C				Sink, Roman; Kotnik, Miha; Zega, Anamarija; Barreteau, Helene; Gobec, Stanislav; Blanot, Didier; Dessen, Andrea; Contreras-Martel, Carlos			Crystallographic Study of Peptidoglycan Biosynthesis Enzyme MurD: Domain Movement Revisited	PLOS ONE			English	Article							GLUTAMIC-ACID-DERIVATIVES; ESCHERICHIA-COLI; ALANINE LIGASE; ADDING ENZYME; CONFORMATIONAL-CHANGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; KINETIC MECHANISM; CYTOPLASMIC STEPS; D-GLU	The biosynthetic pathway of peptidoglycan, an essential component of bacterial cell wall, is a well-recognized target for antibiotic development. Peptidoglycan precursors are synthesized in the bacterial cytosol by various enzymes including the ATP-hydrolyzing Mur ligases, which catalyze the stepwise addition of amino acids to a UDP-MurNAc precursor to yield UDP-MurNAc-pentapeptide. MurD catalyzes the addition of D-glutamic acid to UDP-MurNAc-L-Ala in the presence of ATP; structural and biochemical studies have suggested the binding of the substrates with an ordered kinetic mechanism in which ligand binding inevitably closes the active site. In this work, we challenge this assumption by reporting the crystal structures of intermediate forms of MurD either in the absence of ligands or in the presence of small molecules. A detailed analysis provides insight into the events that lead to the closure of MurD and reveals that minor structural modifications contribute to major overall conformation alterations. These novel insights will be instrumental in the development of new potential antibiotics designed to target the peptidoglycan biosynthetic pathway.	[Sink, Roman; Zega, Anamarija; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Askerceva 7, Ljubljana, Slovenia; [Kotnik, Miha] Lek Pharmaceut Dd, Verovskova 57, Ljubljana, Slovenia; [Barreteau, Helene; Blanot, Didier] Univ Paris 11, Inst Biol Integrat Cellule I2BC, Lab Enveloppes Bacteriennes & Antibiot, CEA,CNRS, Gif Sur Yvette, France; [Dessen, Andrea; Contreras-Martel, Carlos] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Dessen, Andrea; Contreras-Martel, Carlos] CNRS, IBS, Grenoble, France; [Dessen, Andrea; Contreras-Martel, Carlos] CEA, IBS, Grenoble, France; [Dessen, Andrea] Brazilian Natl Lab Biosci LNBio, CNPEM, Sao Paulo, Brazil	University of Ljubljana; Novartis; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Contreras-Martel, C (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.; Contreras-Martel, C (corresponding author), CNRS, IBS, Grenoble, France.; Contreras-Martel, C (corresponding author), CEA, IBS, Grenoble, France.	carlos.contreras-martel@ibs.fr	Contreras-Martel, Carlos/AAA-1212-2021	Dessen, Andrea/0000-0001-6487-4020; Gobec, Stanislav/0000-0002-9678-3083	European Union FP6 Integrated Project EURINTAFAR [LSHM-CT-2004-512138]; Slovenian Research Agency [L1-6745]; Proteus program [31185YL]; Institut Francais Charles Nodier; FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	European Union FP6 Integrated Project EURINTAFAR; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Proteus program; Institut Francais Charles Nodier; FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB)	This work was financially supported by the European Union FP6 Integrated Project EURINTAFAR (project no. LSHM-CT-2004-512138; http://www.eur-intafar.ulg.ac.be/usefulllinks/index.html); the Slovenian Research Agency (grant no. L1-6745; https://www.arrs.gov.si/en/novo.asp); the Proteus program (project 31185YL; http://www.campusfrance.org/fr/proteus) and the Institut Francais Charles Nodier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB)[Lek Pharmaceuticals d.d. http://www.lek.si]. The funder provided support in the form of salaries for MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 1996, BIOCHEMISTRY-US, V35, P16264, DOI 10.1021/bi961872+; [Anonymous], PYMOL MOL GRAPH SYST; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Barreteau H, 2012, BIOCHEM PHARMACOL, V84, P625, DOI 10.1016/j.bcp.2012.06.006; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Bertrand JA, 2000, J MOL BIOL, V301, P1257, DOI 10.1006/jmbi.2000.3994; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Best RB, 2006, P NATL ACAD SCI USA, V103, P10901, DOI 10.1073/pnas.0511156103; Bouhss A, 1997, BIOCHEMISTRY-US, V36, P11556, DOI 10.1021/bi970797f; Bouhss A, 2002, METHOD ENZYMOL, V354, P189; Bratkovic T, 2008, J BASIC MICROB, V48, P202, DOI 10.1002/jobm.200700133; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; Buszek KR, 2007, ORG LETT, V9, P4135, DOI 10.1021/ol701595n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chopra I, 2013, J ANTIMICROB CHEMOTH, V68, P496, DOI 10.1093/jac/dks436; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Dementin S, 2001, EUR J BIOCHEM, V268, P5800, DOI 10.1046/j.0014-2956.2001.02524.x; Emanuele JJ, 1997, BIOCHEMISTRY-US, V36, P7264, DOI 10.1021/bi970266r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eveland SS, 1997, BIOCHEMISTRY-US, V36, P6223, DOI 10.1021/bi9701078; Favini-Stabile S, 2013, ENVIRON MICROBIOL, V15, P3218, DOI 10.1111/1462-2920.12171; Frlan R, 2008, MOLECULES, V13, P11, DOI 10.3390/molecules13010011; Frlan R, 2011, ACTA CHIM SLOV, V58, P295; Frlan R, 2009, ACTA CHIM SLOV, V56, P580; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hrast M, 2014, BIOORG CHEM, V55, P2, DOI 10.1016/j.bioorg.2014.03.008; Hubbard R.E., 2010, ELS; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; IMHOFF JF, 1989, J GEN MICROBIOL, V135, P237; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotnik M, 2007, J MOL BIOL, V370, P107, DOI 10.1016/j.jmb.2007.04.048; Kouidmi I, 2014, MOL MICROBIOL, V94, P242, DOI 10.1111/mmi.12758; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liger D, 1996, MICROB DRUG RESIST, V2, P25, DOI 10.1089/mdr.1996.2.25; Longenecker KL, 2005, PROTEIN SCI, V14, P3039, DOI 10.1110/ps.051604805; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perdih A, 2007, PROTEINS, V68, P243, DOI 10.1002/prot.21374; Perdih A, 2012, COMPUT THEOR CHEM, V979, P73, DOI 10.1016/j.comptc.2011.10.018; Perdih A, 2009, BIOORG MED CHEM LETT, V19, P2668, DOI 10.1016/j.bmcl.2009.03.141; Shanmugam A, 2012, MED CHEM RES, V21, P4341, DOI 10.1007/s00044-011-9958-9; Sheng Y, 2000, J MOL BIOL, V302, P427, DOI 10.1006/jmbi.2000.3987; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simcic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052817; Simcic M, 2009, J MED CHEM, V52, P2899, DOI 10.1021/jm900117n; Sink R, 2008, CHEMMEDCHEM, V3, P1362, DOI 10.1002/cmdc.200800087; Sink Roman, 2013, Biomol Concepts, V4, P539, DOI 10.1515/bmc-2013-0024; Smith CA, 2006, J MOL BIOL, V362, P640, DOI 10.1016/j.jmb.2006.07.066; Sosic I, 2011, EUR J MED CHEM, V46, P2880, DOI 10.1016/j.ejmech.2011.04.011; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tomasic T, 2012, ACS MED CHEM LETT, V3, P626, DOI 10.1021/ml300047h; Tomasic T, 2012, J MOL MODEL, V18, P1063, DOI 10.1007/s00894-011-1139-8; Tomasic T, 2011, EUR J MED CHEM, V46, P3964, DOI 10.1016/j.ejmech.2011.05.070; Tomasic T, 2011, J MED CHEM, V54, P4600, DOI 10.1021/jm2002525; Tomasic T, 2010, CHEMMEDCHEM, V5, P286, DOI 10.1002/cmdc.200900449; Tomasic T, 2009, BIOORG MED CHEM LETT, V19, P153, DOI 10.1016/j.bmcl.2008.10.129; Turk S, 2009, BIOORGAN MED CHEM, V17, P1884, DOI 10.1016/j.bmc.2009.01.052; Vaganay S, 1996, MICROB DRUG RESIST, V2, P51, DOI 10.1089/mdr.1996.2.51; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zidar N, 2011, EUR J MED CHEM, V46, P5512, DOI 10.1016/j.ejmech.2011.09.017; Zidar N, 2010, J MED CHEM, V53, P6584, DOI 10.1021/jm100285g	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152075	10.1371/journal.pone.0152075	http://dx.doi.org/10.1371/journal.pone.0152075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031227	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800034
J	Terada, M; Seki, M; Takahashi, R; Yamada, S; Higashibata, A; Majima, HJ; Sudoh, M; Mukai, C; Ishioka, N				Terada, Masahiro; Seki, Masaya; Takahashi, Rika; Yamada, Shin; Higashibata, Akira; Majima, Hideyuki J.; Sudoh, Masamichi; Mukai, Chiaki; Ishioka, Noriaki			Effects of a Closed Space Environment on Gene Expression in Hair Follicles of Astronauts in the International Space Station	PLOS ONE			English	Article							STEM; SPACEFLIGHT; MERCURY; INCREASES; INDUCE; TISSUE; PHASE; PART; RNA	Adaptation to the space environment can sometimes pose physiological problems to International Space Station (ISS) astronauts after their return to earth. Therefore, it is important to develop healthcare technologies for astronauts. In this study, we examined the feasibility of using hair follicles, a readily obtained sample, to assess gene expression changes in response to spaceflight adaptation. In order to investigate the gene expression changes in human hair follicles during spaceflight, hair follicles of 10 astronauts were analyzed by microarray and real time qPCR analyses. We found that spaceflight alters human hair follicle gene expression. The degree of changes in gene expression was found to vary among individuals. In some astronauts, genes related to hair growth such as FGF18, ANGPTL7 and COMP were upregulated during flight, suggesting that spaceflight inhibits cell proliferation in hair follicles.	[Terada, Masahiro; Sudoh, Masamichi] Jikei Univ, Sch Med, Div Aerosp Med, Minato Ku, Tokyo, Japan; [Terada, Masahiro; Yamada, Shin; Higashibata, Akira; Sudoh, Masamichi; Mukai, Chiaki; Ishioka, Noriaki] Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan; [Terada, Masahiro] NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA; [Seki, Masaya; Takahashi, Rika] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan; [Higashibata, Akira; Majima, Hideyuki J.; Ishioka, Noriaki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Kagoshima 890, Japan; [Ishioka, Noriaki] Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 229, Japan; [Ishioka, Noriaki] SOKENDAI, Sch Phys Sci, Dept Space & Astronaut Sci, Sagamihara, Kanagawa, Japan	Jikei University; Japan Aerospace Exploration Agency (JAXA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Advanced Engineering Services Co., Ltd. (A.E.S.); Kagoshima University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Terada, M (corresponding author), Jikei Univ, Sch Med, Div Aerosp Med, Minato Ku, Tokyo, Japan.; Terada, M (corresponding author), Japan Aerosp Explorat Agcy, Tsukuba, Ibaraki, Japan.; Terada, M (corresponding author), NASA, Ames Res Ctr, Space Biosci Div, Moffett Field, CA 94035 USA.	terada.masahiro@jikei.ac.jp	Majima, Hideyuki J./K-3778-2019		Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd.	Japan Aerospace Exploration Agency (JAXA); Advanced Engineering Services Co., Ltd.	The experimental cost for this study was funded by Japan Aerospace Exploration Agency (JAXA). Advanced Engineering Services Co., Ltd. provided support in the form of salaries for authors MS (2nd author) and RT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn SY, 2012, ANN DERMATOL, V24, P26, DOI 10.5021/ad.2012.24.1.26; Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; BATZEVICH VA, 1995, SCI TOTAL ENVIRON, V164, P89, DOI 10.1016/0048-9697(95)91020-4; CHASE ES, 1981, AM J CLIN NUTR, V34, P2280, DOI 10.1093/ajcn/34.10.2280; Chuong C-M, 1998, MOL BASIC EPITHELIAL; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; de Schellenberger AA, 2011, EXP DERMATOL, V20, P361, DOI 10.1111/j.1600-0625.2010.01217.x; Dev H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-121; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; GREENLEAF JE, 1989, J APPL PHYSIOL, V67, P2191, DOI 10.1152/jappl.1989.67.6.2191; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Harada M, 1999, SCI TOTAL ENVIRON, V227, P249, DOI 10.1016/S0048-9697(99)00031-5; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Jelliffe DB, 1966, MONOGR SER WHO, V53, P3; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Kimura-Ueki M, 2012, J INVEST DERMATOL, V132, P1338, DOI 10.1038/jid.2011.490; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Lei X, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-014-0147-z; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; Mash DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001187; Mirkina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084417; Neutelings T, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.2; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Rodushkin I, 2000, SCI TOTAL ENVIRON, V250, P83, DOI 10.1016/S0048-9697(00)00369-7; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sato T, 2006, J VET MED SCI, V68, P503, DOI 10.1292/jvms.68.503; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SEKIGUCHI C, 1994, ACTA PHYSIOL SCAND, V150, P89; SPERLING LC, 1991, J AM ACAD DERMATOL, V25, P1, DOI 10.1016/0190-9622(91)70167-Z; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; SUZUKI T, 1993, ARCH ENVIRON HEALTH, V48, P221, DOI 10.1080/00039896.1993.9940363; Terada M, 2012, ACTA ASTRONAUT, V73, P23, DOI 10.1016/j.actaastro.2011.12.016; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; WIBOWO AAE, 1986, ENVIRON RES, V40, P346, DOI 10.1016/S0013-9351(86)80109-8; Wu GJ, 2008, MOL CANCER RES, V6, P1666, DOI 10.1158/1541-7786.MCR-07-2200; Xiao YR, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0102-4; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Yamamoto N, 2015, CHRONOBIOL INT, V32, P327, DOI 10.3109/07420528.2014.979940; Yasuda H., 2005, BIOMED RES TRACE ELE, V16, P39; Yasutake A, 2003, TOHOKU J EXP MED, V199, P161, DOI 10.1620/tjem.199.161; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101; Zhang WF, 2015, J VIROL, V89, P2553, DOI 10.1128/JVI.02269-14	51	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150801	10.1371/journal.pone.0150801	http://dx.doi.org/10.1371/journal.pone.0150801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029003	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500009
J	Butler, JE; Godfrey, S; Thomas, CK				Butler, Jane E.; Godfrey, Sharlene; Thomas, Christine K.			Interlimb Reflexes Induced by Electrical Stimulation of Cutaneous Nerves after Spinal Cord Injury	PLOS ONE			English	Article							HUMAN SOLEUS MUSCLE; HUMAN ARM MUSCLES; PRESYNAPTIC INHIBITION; STRETCH REFLEXES; H-REFLEX; PROPRIOSPINAL SYSTEM; AFFERENT STIMULATION; SYNAPTIC PLASTICITY; RESPONSE PATTERNS; SPASTICITY	Whether interlimb reflexes emerge only after a severe insult to the human spinal cord is controversial. Here the aim was to examine interlimb reflexes at rest in participants with chronic (>1 year) spinal cord injury (SCI, n = 17) and able-bodied control participants (n = 5). Cutaneous reflexes were evoked by delivering up to 30 trains of stimuli to either the superficial peroneal nerve on the dorsum of the foot or the radial nerve at the wrist (5 pulses, 300 Hz, approximately every 30 s). Participants were instructed to relax the test muscles prior to the delivery of the stimuli. Electromyographic activity was recorded bilaterally in proximal and distal arm and leg muscles. Superficial peroneal nerve stimulation evoked interlimb reflexes in ipsilateral and contralateral arm and contralateral leg muscles of SCI and control participants. Radial nerve stimulation evoked interlimb reflexes in the ipsilateral leg and contralateral arm muscles of control and SCI participants but only contralateral leg muscles of control participants. Interlimb reflexes evoked by superficial peroneal nerve stimulation were longer in latency and duration, and larger in magnitude in SCI participants. Interlimb reflex properties were similar for both SCI and control groups for radial nerve stimulation. Ascending interlimb reflexes tended to occur with a higher incidence in participants with SCI, while descending interlimb reflexes occurred with a higher incidence in able-bodied participants. However, the overall incidence of interlimb reflexes in SCI and neurologically intact participants was similar which suggests that the neural circuitry underlying these reflexes does not necessarily develop after central nervous system injury.	[Butler, Jane E.; Godfrey, Sharlene] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Thomas, Christine K.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Thomas, Christine K.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Butler, Jane E.] Neurosci Res Australia, Sydney, NSW, Australia; [Butler, Jane E.] Univ New S Wales, Sydney, NSW, Australia	University of Miami; University of Miami; University of Miami; Neuroscience Research Australia; University of New South Wales Sydney	Butler, JE (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.; Butler, JE (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.; Butler, JE (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	j.butler@neura.edu.au	Butler, Jane E/D-4186-2011	Butler, Jane/0000-0002-5834-8152	National Health & Medical Research Council of Australia; United States Public Health Service [NS-30226]; Miami Project to Cure Paralysis	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Miami Project to Cure Paralysis	This research was funded by: (1) the National Health & Medical Research Council of Australia (JEB), (2) United States Public Health Service grant NS-30226 (CKT) and (3) The Miami Project to Cure Paralysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Blanco S, 2009, EXP BRAIN RES, V195, P285, DOI 10.1007/s00221-009-1784-7; ASHBY P, 1974, J NEUROL NEUROSUR PS, V37, P1352, DOI 10.1136/jnnp.37.12.1352; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BROWN AG, 1987, J PHYSIOL-LONDON, V382, P331, DOI 10.1113/jphysiol.1987.sp016370; Burke D, 1988, Adv Neurol, V47, P401; BUSSEL B, 1989, BRAIN RES BULL, V22, P53, DOI 10.1016/0361-9230(89)90127-5; Butler JE, 2006, MUSCLE NERVE, V33, P637, DOI 10.1002/mus.20500; Calancie B, 1996, ELECTROMYOGR MOTOR C, V101, P304, DOI 10.1016/0924-980X(96)95194-2; CALANCIE B, 1991, EXP BRAIN RES, V85, P458; Calancie B, 2005, CLIN NEUROPHYSIOL, V116, P75, DOI 10.1016/j.clinph.2004.07.018; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Calancie B, 2002, BRAIN, V125, P1150, DOI 10.1093/brain/awf114; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; D'Amico JM, 2013, J NEUROPHYSIOL, V109, P1473, DOI 10.1152/jn.00821.2012; DELWAIDE PJ, 1977, J NEUROL NEUROSUR PS, V40, P616, DOI 10.1136/jnnp.40.6.616; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; DIMITRIJEVIC MR, 1967, BRAIN, V90, P333, DOI 10.1093/brain/90.2.333; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; GASSEL MM, 1973, J NEUROL NEUROSUR PS, V36, P282, DOI 10.1136/jnnp.36.2.282; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Hager-Ross CK, 2006, J NEUROPHYSIOL, V96, P165, DOI 10.1152/jn.01339.2005; Haridas C, 2003, J NEUROPHYSIOL, V90, P2850, DOI 10.1152/jn.00531.2003; HARRISON PJ, 1984, J PHYSIOL-LONDON, V356, P245, DOI 10.1113/jphysiol.1984.sp015462; HAYES KC, 1994, J NEUROTRAUM, V11, P433, DOI 10.1089/neu.1994.11.433; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; KEARNEY RE, 1979, BRAIN RES, V170, P214, DOI 10.1016/0006-8993(79)90958-2; KEARNEY RE, 1981, ELECTROEN CLIN NEURO, V52, P65, DOI 10.1016/0013-4694(81)90190-5; Kirkwood PA, 2002, ADV EXP MED BIOL, V508, P299; Kukulka CG, 2009, EXP BRAIN RES, V192, P167, DOI 10.1007/s00221-008-1566-7; Leis AA, 1996, NEUROLOGY, V47, P231, DOI 10.1212/WNL.47.1.231; LITTLE JW, 1985, ARCH PHYS MED REHAB, V66, P19; Little JW, 1999, ARCH PHYS MED REHAB, V80, P587, DOI 10.1016/S0003-9993(99)90204-6; LLOYD DPC, 1948, J NEUROPHYSIOL, V11, P455, DOI 10.1152/jn.1948.11.5.455; Marchand-Pauvert V, 2008, J PHYSIOL-LONDON, V586, P1247, DOI 10.1113/jphysiol.2007.145904; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McNulty PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072725; MEINCK HM, 1981, EXP BRAIN RES, V43, P78; Mendell L M, 1988, Adv Neurol, V47, P337; Morita H, 2001, BRAIN, V124, P826, DOI 10.1093/brain/124.4.826; Nakazawa K, 2006, ARCH PHYS MED REHAB, V87, P71, DOI 10.1016/j.apmr.2005.08.122; NIELSEN J, 1993, EXP BRAIN RES, V97, P173; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; Pierrot-Deseilligny E, 2002, ADV EXP MED BIOL, V508, P273; Pierrot- Deseilligny E, 1989, PROG BRAIN RES, V80, P305; Pierrot- Deseilligny E., 1989, PROG BRAIN RES, V80, P295, DOI 2699370; Pierrot-Desilligney E, 2005, PROPRIOSPINAL RELAY, P452; PIESIURSTREHLOW B, 1980, ELECTROEN CLIN NEURO, V48, P673, DOI 10.1016/0013-4694(80)90424-1; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Rank MM, 2015, J PHYSIOL-LONDON, V593, P331, DOI 10.1113/jphysiol.2014.282640; ROBYBRAMI A, 1990, EXP BRAIN RES, V81, P593, DOI 10.1007/BF02423509; ROBYBRAMI A, 1987, BRAIN, V110, P707, DOI 10.1093/brain/110.3.707; SARICA Y, 1985, BRAIN RES, V325, P299, DOI 10.1016/0006-8993(85)90327-0; Sherrington CS, 1903, J PHYSIOL-LONDON, V29, P58; Stevenson AJT, 2015, J PHYSIOL-LONDON, V593, P3657, DOI 10.1113/JP270422; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Stubbs PW, 2011, MUSCLE NERVE, V43, P845, DOI 10.1002/mus.21964; Stubbs PW, 2011, J NEUROPHYSIOL, V105, P503, DOI 10.1152/jn.00786.2010; Stubbs PW, 2009, J NEUROPHYSIOL, V102, P3596, DOI 10.1152/jn.00667.2009; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Willer J C, 1983, Adv Neurol, V39, P809; WILLER JC, 1981, PAIN, V10, P405, DOI 10.1016/0304-3959(81)90102-0; Zehr EP, 2001, EXP BRAIN RES, V140, P495; Zijdewind I, 2012, NEUROREHAB NEURAL RE, V26, P58, DOI 10.1177/1545968311417449	69	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153063	10.1371/journal.pone.0153063	http://dx.doi.org/10.1371/journal.pone.0153063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049521	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500093
J	Morel, V; Joly, D; Villatte, C; Dubray, C; Durando, X; Daulhac, L; Coudert, C; Roux, D; Pereira, B; Pickering, G				Morel, Veronique; Joly, Dominique; Villatte, Christine; Dubray, Claude; Durando, Xavier; Daulhac, Laurence; Coudert, Catherine; Roux, Delphine; Pereira, Bruno; Pickering, Gisele			Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients	PLOS ONE			English	Article							RECEPTOR ANTAGONIST MEMANTINE; PLACEBO-CONTROLLED TRIAL; PHANTOM LIMB PAIN; NEUROPATHIC PAIN; BREAST-CANCER; POSTHERPETIC NEURALGIA; COGNITIVE FUNCTION; HEALTH SURVEY; FOLLOW-UP; CHEMOTHERAPY	Background Neuropathic pain following surgical treatment for breast cancer with or without chemotherapy is a clinical burden and patients frequently report cognitive, emotional and quality of life impairment. A preclinical study recently showed that memantine administered before surgery may prevent neuropathic pain development and cognitive dysfunction. With a translational approach, a clinical trial has been carried out to evaluate whether memantine administered before and after mastectomy could prevent the development of neuropathic pain, the impairment of cognition and quality of life. Method A randomized, pilot clinical trial included 40 women undergoing mastectomy in the Oncology Department, University Hospital, Clermont-Ferrand, France. Memantine (5 to 20 mg/day; n = 20) or placebo (n = 20) was administered for four weeks starting two weeks before surgery. The primary endpoint was pain intensity measured on a (0-10) numerical rating scale at three months post-mastectomy. Results Data analyses were performed using mixed models and the tests were two-sided, with a type I error set at a = 0.05. Compared with placebo, patients receiving memantine showed at three months a significant difference in post-mastectomy pain intensity, less rescue analgesia and a better emotional state. An improvement of pain symptoms induced by cancer chemotherapy was also reported. Conclusions This study shows for the first time the beneficial effect of memantine to prevent post-mastectomy pain development and to diminish chemotherapy-induced pain symptoms. The lesser analgesic consumption and better well-being of patients for at least six months after treatment suggests that memantine could be an interesting therapeutic option to diminish the burden of breast cancer therapy.	[Morel, Veronique; Dubray, Claude; Roux, Delphine; Pickering, Gisele] CHU Clermont Ferrand, INSERM, CIC 1405, Ctr Pharmacol Clin, F-63003 Clermont Ferrand, France; [Joly, Dominique; Villatte, Christine; Durando, Xavier] Ctr Jean Perrin, Ctr Lutte Canc, 58 Rue Montalembert, F-63000 Clermont Ferrand, France; [Dubray, Claude; Daulhac, Laurence; Pickering, Gisele] Univ Auvergne, Clermont Univ, Pharmacol Fondamentale & Clin Douleur, Lab Pharmacol,Fac Med Pharm, F-63000 Clermont Ferrand, France; [Dubray, Claude; Daulhac, Laurence; Pickering, Gisele] INSERM, Neuro Dol U1107, F-63001 Clermont Ferrand, France; [Coudert, Catherine] CHU Clermont Ferrand, Pharm Hosp, Sect Rech Clin, 58 Rue Montalembert, F-63003 Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Delegat Rech Clin & Innovat Villa Annexe IFSI, 58 Rue Montalembert, F-63003 Clermont Ferrand, France	CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; CHU Clermont Ferrand	Pickering, G (corresponding author), CHU Clermont Ferrand, INSERM, CIC 1405, Ctr Pharmacol Clin, F-63003 Clermont Ferrand, France.; Pickering, G (corresponding author), Univ Auvergne, Clermont Univ, Pharmacol Fondamentale & Clin Douleur, Lab Pharmacol,Fac Med Pharm, F-63000 Clermont Ferrand, France.; Pickering, G (corresponding author), INSERM, Neuro Dol U1107, F-63001 Clermont Ferrand, France.	gisele.pickering@udamail.fr	DURANDO, Xavier/Y-3806-2019	DURANDO, Xavier/0000-0001-6035-3172; Pereira, Bruno/0000-0003-3778-7161	"APICIL" Foundation	"APICIL" Foundation	"APICIL" Foundation (a non-pharmaceutical foundation) participating of the financing of the study but had no role in the study design, data collection, data analysis, data interpretation or writing of the report. All authors provided final approval to submit the article for publication. The overall study principal investigator (GP) had full access to all data in the study and final responsibility for the decision to submit for publication.	BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; BOUREAU F, 1992, PAIN, V50, P59, DOI 10.1016/0304-3959(92)90112-O; Cavaletti G, 2014, J PERIPHER NERV SYST, V19, P66, DOI 10.1111/jns5.12073; Cimprich B, 2010, J CLIN EXP NEUROPSYC, V32, P324, DOI 10.1080/13803390903032537; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Collins S, 2010, PAIN MED, V11, P1726, DOI 10.1111/j.1526-4637.2010.00981.x; Crowe SF, 1999, AUST PSYCHOL, V34, P204, DOI 10.1080/00050069908257455; Cvrcek P, 2008, PAIN MED, V9, P253, DOI 10.1111/j.1526-4637.2007.00314.x; Debess J, 2009, ACTA ONCOL, V48, P532, DOI 10.1080/02841860802600755; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Downie FP, 2006, PSYCHO-ONCOLOGY, V15, P921, DOI 10.1002/pon.1035; Duale Christian, 2014, J Pain, V15, DOI 10.1016/j.jpain.2013.08.014; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Edge SB, 2013, J NATL COMPR CANC NE, V11, P53, DOI 10.6004/jnccn.2013.0008; Eisenberg E, 1998, EUR J PAIN-LONDON, V2, P321, DOI 10.1016/S1090-3801(98)90030-1; Golan-Vered Y, 2013, PAIN PRACT, V13, P46, DOI 10.1111/j.1533-2500.2012.00554.x; Gomez-Hernandez J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-692; Hackworth RJ, 2008, ANESTH ANALG, V107, P1377, DOI 10.1213/ane.0b013e31817f90f1; Hedayati E, 2011, ACTA ONCOL, V50, P1027, DOI 10.3109/0284186X.2011.572911; Hermelink K, 2007, CANCER, V109, P1905, DOI 10.1002/cncr.22610; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Jansen CE, 2011, SUPPORT CARE CANCER, V19, P1647, DOI 10.1007/s00520-010-0997-4; Jenkins V, 2006, BRIT J CANCER, V94, P828, DOI 10.1038/sj.bjc.6603029; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Li XY, 2014, J NEUROSCI, V34, P10675, DOI 10.1523/JNEUROSCI.5166-13.2014; Lindner OC, 2014, NEUROPSYCHOLOGY, V28, P726, DOI 10.1037/neu0000064; Lu TJ, 2011, ACTA CHIR BELG, V111, P360, DOI 10.1080/00015458.2011.11680772; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Maier C, 2003, PAIN, V103, P277, DOI 10.1016/S0304-3959(02)00456-6; Morel V, 2013, EUR J PHARMACOL, V721, P382, DOI 10.1016/j.ejphar.2013.06.020; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Nikolajsen L, 2000, ANESTH ANALG, V91, P960, DOI 10.1097/00000539-200010000-00036; PARROTT AC, 1980, PSYCHOPHARMACOLOGY, V71, P173, DOI 10.1007/BF00434408; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Pickering G, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-009689; Pickering G, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-331; Pickering G, 2014, PAIN RES MANAG, V19, pE19, DOI 10.1155/2014/507947; Pickering G, 2014, PAIN PRACT, V14, pE1, DOI 10.1111/papr.12079; Pickering G, 2011, MAGNESIUM RES, V24, P28, DOI 10.1684/mrh.2011.0282; Reitan RM, 1985, HALSTEAD REITAN NEUR; Sang CN, 2002, ANESTHESIOLOGY, V96, P1053, DOI 10.1097/00000542-200205000-00005; Terkawi AS, 2015, PAIN PHYSICIAN, V18, pE139; Terkawi AS, 2014, REGION ANESTH PAIN M, V39, P472, DOI 10.1097/AAP.0000000000000140; Thienthong Somboon, 2004, Journal of the Medical Association of Thailand, V87, P24; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van Seventer R, 2010, EUR J NEUROL, V17, P1082, DOI 10.1111/j.1468-1331.2010.02979.x; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Zielinski J, 2011, MED SCI MONITOR, V17, pCR589, DOI 10.12659/MSM.881986	55	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152741	10.1371/journal.pone.0152741	http://dx.doi.org/10.1371/journal.pone.0152741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050431	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500052
J	Campos, CF; Cangussu, SD; Duz, ALC; Cartelle, CT; Noviello, MD; Veloso, VM; Bahia, MT; Almeida-Leite, CM; Arantes, RME				Campos, Camila Franca; Cangussu, Silvia Dantas; Duz, Ana Luiza Cassin; Cartelle, Christiane Teixeira; Noviello, Maria de Lourdes; Veloso, Vanja Maria; Bahia, Maria Terezinha; Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria			Enteric Neuronal Damage, Intramuscular Denervation and Smooth Muscle Phenotype Changes as Mechanisms of Chagasic Megacolon: Evidence from a Long-Term Murine Model of Tripanosoma cruzi Infection	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN; TRYPANOSOMA-CRUZI; NITRIC-OXIDE; INTESTINAL MOTILITY; DISEASE; BENZNIDAZOLE; INTERRUPTION; POPULATIONS; STRAINS; LESIONS	We developed a novel murine model of long-term infection with Trypanosoma cruzi with the aim to elucidate the pathogenesis of megacolon and the associated adaptive and neuromuscular intestinal disorders. Our intent was to produce a chronic stage of the disease since the early treatment should avoid 100% mortality of untreated animals at acute phase. Treatment allowed animals to be kept infected and alive in order to develop the chronic phase of infection with low parasitism as in human disease. A group of Swiss mice was infected with the Y strain of T. cruzi. At the 11th day after infection, a sub-group was euthanized (acute-phase group) and another sub-group was treated with benznidazole and euthanized 15 months after infection (chronic-phase group). Whole colon samples were harvested and used for studying the histopathology of the intestinal smooth muscle and the plasticity of the enteric nerves. In the acute phase, all animals presented inflammatory lesions associated with intense and diffuse parasitism of the muscular and submucosa layers, which were enlarged when compared with the controls. The occurrence of intense degenerative inflammatory changes and increased reticular fibers suggests inflammatory-induced necrosis of muscle cells. In the chronic phase, parasitism was insignificant; however, the architecture of Auerbach plexuses was focally affected in the inflamed areas, and a significant decrease in the number of neurons and in the density of intramuscular nerve bundles was detected. Other changes observed included increased thickness of the colon wall, diffuse muscle cell hypertrophy, and increased collagen deposition, indicating early fibrosis in the damaged areas. Mast cell count significantly increased in the muscular layers. We propose a model for studying the long-term (15 months) pathogenesis of Chagasic megacolon in mice that mimics the human disease, which persists for several years and has not been fully elucidated. We hypothesize that the long-term inflammatory process mediates neuronal damage and intramuscular and intramural denervation, leading to phenotypic changes in smooth muscle cells associated with fibrosis. These long-term structural changes may represent the basic mechanism for the formation of the Chagasic megacolon.	[Campos, Camila Franca; Duz, Ana Luiza Cassin; Cartelle, Christiane Teixeira; Noviello, Maria de Lourdes; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Cangussu, Silvia Dantas] Univ Fed Ouro Preto, Dept Ciencias Biol LAFEX, Ouro Preto, MG, Brazil; [Veloso, Vanja Maria; Bahia, Maria Terezinha] Univ Fed Ouro Preto, Dept Ciencias Biol NUPEB, Ouro Preto, MG, Brazil; [Almeida-Leite, Camila Megale] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais	Arantes, RME (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	rosa@icb.ufmg	Duz, Ana Luiza Cassin/AAK-1517-2021; Arantes, Rosa ME/C-5749-2013; Cangussú, Silvia/AAX-8526-2020	Arantes, Rosa ME/0000-0003-1428-9717; Cangussú, Silvia/0000-0002-1061-6445; Duz, Ana Luiza Cassin/0000-0002-4996-5992	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [303338/2014-8, 458832/2014-6, 473013/2012-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant [2228/11]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR) [PPM-00346-14]; Programa de Apoio aos Nucleos de Excelencia-PRONEX; CAPES/UDELAR	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR); Programa de Apoio aos Nucleos de Excelencia-PRONEX; CAPES/UDELAR	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 303338/2014-8, URL: www.cnpq.br, Author: RMEA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 458832/2014-6, URL: www.cnpq.br, Author: RMEA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) grant number: 473013/2012-6, URL: www.cnpq.br, Author: RMEA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) PNDN grant number: 2228/11, URL: www.capes.gov.br, Author: RMEA; and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR) grant number: PPM-00346-14, URL: www.fapemig.br, Author: RMEA; Programa de Apoio aos Nucleos de Excelencia-PRONEX-URL: www.fapemig.br, Author: RMEA; CAPES/UDELAR-URL: www.capes.gov.br/cooperacao-internacional/uruguai/capes-udelar-projetos, author: RMEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adad SJ, 2001, VIRCHOWS ARCH, V438, P254, DOI 10.1007/s004280000319; ANDRADE SG, 1985, B WORLD HEALTH ORGAN, V63, P721; Arantes RME, 1997, CELL TISSUE RES, V290, P61, DOI 10.1007/s004410050908; Arantes RME, 2004, AM J PATHOL, V164, P1361, DOI 10.1016/S0002-9440(10)63222-1; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; BARBOSA AJA, 1985, REV I MED TROP, V27, P293, DOI 10.1590/S0036-46651985000600001; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Brener Z, 1976, Rev Inst Med Trop Sao Paulo, V18, P450; CALVERT RJ, 1989, J NUTR, V119, P1610, DOI 10.1093/jn/119.11.1610; Chagas C., 1909, TRYPANOSOMIASIS MENS, P5; CHAGAS Carlos, 1916, Memorias do Instituto Oswaldo Cruz, V8, P37; Correa-Oliveira R, 1999, MEM I OSWALDO CRUZ, V94, P253, DOI 10.1590/S0074-02761999000700042; Da Silveira ABM, 2008, PARASITOLOGY, V135, P1337, DOI 10.1017/S0031182008004770; da Silveira ABM, 2005, PARASITOLOGY, V131, P627, DOI 10.1017/S0031182005008061; De Giorgio R, 1996, Minerva Gastroenterol Dietol, V42, P83; de Oliveira GM, 2008, PARASITOL RES, V102, P747, DOI 10.1007/s00436-007-0829-8; de Souza AP, 2010, PARASITOL RES, V106, P1293, DOI 10.1007/s00436-010-1794-1; Dias J C, 1989, Rev Soc Bras Med Trop, V22, P147, DOI 10.1590/S0037-86821989000300007; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; Furness JB, 2000, GUT, V47, P60; Garcia SB, 1999, EXP PARASITOL, V93, P191, DOI 10.1006/expr.1999.4451; Gattuso JM, 1998, HISTOPATHOLOGY, V33, P34, DOI 10.1046/j.1365-2559.1998.00438.x; Gougeon PY, 2013, J NEUROSCI, V33, P3339, DOI 10.1523/JNEUROSCI.3564-12.2013; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; Guillen-Pernia B, 2001, INVEST CLIN, P42; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; HOGABOAM CM, 1995, AM J PHYSIOL-GASTR L, V268, pG673, DOI 10.1152/ajpgi.1995.268.4.G673; Khare S, 2015, ANTIMICROB AGENTS CH, V59, P6385, DOI 10.1128/AAC.00689-15; KOBERLE F, 1963, GUT, V4, P399, DOI 10.1136/gut.4.4.399; Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8; Lopes ER, 1987, BOGLIOLO PATOLOGIA, P1047; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Medeiros MD, 2010, PARASITOL RES, V107, P239, DOI 10.1007/s00436-010-1871-5; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; da Siveira ABM, 2007, HUM PATHOL, V38, P1256, DOI 10.1016/j.humpath.2007.01.020; Moreira NM, 2011, AN ACAD BRAS CIENC, V83, P545, DOI 10.1590/S0001-37652011000200014; Ny L, 2008, AM J TROP MED HYG, V79, P760; Pedrosa RC, 2001, REDOX REP, V6, P265, DOI 10.1179/135100001101536328; Petkova SB, 2001, INT J PARASITOL, V31, P499, DOI 10.1016/S0020-7519(01)00168-0; Pinheiro Simone Wanderley, 2003, Rev. Soc. Bras. Med. Trop., V36, P461, DOI 10.1590/S0037-86822003000400005; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; SHARKEY KA, 1990, NEUROSCIENCE, V38, P13, DOI 10.1016/0306-4522(90)90370-J; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; TEIXEIRA ARL, 1975, AM J PATHOL, V80, P163; Vento P, 1999, J HISTOCHEM CYTOCHEM, V47, P1405, DOI 10.1177/002215549904701107; Villela MM, 2009, CAD SAUDE PUBLICA, V25, P907, DOI 10.1590/S0102-311X2009000400022; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WHO, 2014, CHAG DIS AM TRYP; WHO, 2002, WHO TECHN REP SER, V912; World Health Organization, 2008, 62 WORLD HLTH ASS; Yamada M, 2006, NEUROSCI RES, V54, P261, DOI 10.1016/j.neures.2005.12.007; YOUNESCHENNOUFI AB, 1988, T ROY SOC TROP MED H, V82, P77, DOI 10.1016/0035-9203(88)90269-6	55	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153038	10.1371/journal.pone.0153038	http://dx.doi.org/10.1371/journal.pone.0153038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045678	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600062
J	Munoz-Esquerre, M; Lopez-Sanchez, M; Escobar, I; Huertas, D; Penin, R; Molina-Molina, M; Manresa, F; Dorca, J; Santos, S				Munoz-Esquerre, Mariana; Lopez-Sanchez, Marta; Escobar, Ignacio; Huertas, Daniel; Penin, Rosa; Molina-Molina, Maria; Manresa, Frederic; Dorca, Jordi; Santos, Salud			Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INTIMAL HYPERPLASIA; CARDIOVASCULAR-DISEASE; INTERCOSTAL ARTERY; RADIAL ARTERY; RISK-FACTORS; COPD; ATHEROSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; CORONARY	Background Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic atherosclerosis and pulmonary vascular remodelling characterized by intimal hyperplasia and luminal narrowing. We aimed to determine differences in the intimal thickening of systemic and pulmonary arteries in COPD subjects and smokers. Secondary aims include comparisons with a non-smokers group; determining the clinical variables associated with systemic and pulmonary intimal thickening, and the correlations between systemic and pulmonary remodelling changes. Methods All consecutive subjects undergoing lung resection were included and divided into 3 groups: 1) COPD, 2) smokers, and 3) non-smokers. Sections of the 5th intercostal artery and muscular pulmonary arteries were measured by histo-morphometry. Four parameters of intimal thickening were evaluated: 1) percentage of intimal area (%IA), 2) percentage of luminal narrowing, 3) intimal thickness index, and 4) intima-to-media ratio. Results In the adjusted analysis, the systemic arteries of COPD subjects showed greater intimal thickening (%IA) than those of smokers (15.6 +/- 1.5% vs. 14.2 +/- 1.6%, p = 0.038). In the pulmonary arteries, significant differences were observed for % IA between the 2 groups (37.3 +/- 2.2% vs. 29.3 +/- 2.3%, p = 0.016). Among clinical factors, metabolic syndrome, gender and COPD status were associated with the systemic intimal thickening, while only COPD status was associated with pulmonary intimal thickening. A correlation between the % IA of the systemic and pulmonary arteries was observed (Spearman's rho = 0.46, p = 0.008). Conclusions Greater intimal thickening in systemic and pulmonary arteries is observed in COPD patients than in smokers. There is a correlation between systemic and pulmonary vascular remodelling in the overall population.	[Munoz-Esquerre, Mariana; Lopez-Sanchez, Marta; Huertas, Daniel; Molina-Molina, Maria; Manresa, Frederic; Dorca, Jordi; Santos, Salud] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pulm Med, Barcelona, Spain; [Escobar, Ignacio] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Thorac Surg, Barcelona, Spain; [Penin, Rosa] Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pathol, Barcelona, Spain; [Molina-Molina, Maria; Santos, Salud] Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Santos, S (corresponding author), Univ Barcelona, Bellvitge Univ Hosp IDIBELL, Dept Pulm Med, Barcelona, Spain.; Santos, S (corresponding author), Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain.	saludsantos@bellvitgehospital.cat	Dorca, Jordi/Q-3617-2016; Munoz-Esquerre, Mariana/F-7386-2012	Dorca, Jordi/0000-0002-8137-878X; Santos, Salud/0000-0002-5835-1028; MOLINA MOLINA, MARIA/0000-0002-1852-1723	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR [081/2011]; Fundacio Catalana de Pneumologia FUCAP; Institut d'Investigacio de Bellvitge, IDIBELL	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR; Fundacio Catalana de Pneumologia FUCAP; Institut d'Investigacio de Bellvitge, IDIBELL	This study was funded by Comite de Recerca de l'Hospital Universitari de Bellvitge, no 2012, http://www.bellvitgehospital.cat/;Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR, No 081/2011, http://www.separ.es/; Fundacio Catalana de Pneumologia FUCAP No URIACH 2011, http://www.ccfundacions.cat/fundacions/fundacio-catalana- de-pneumologia-fucap; Institut d'Investigacio de Bellvitge, IDIBELL, No Predoctoral fellowship 2012, http://www.idibell.cat/. The study sponsors did not have any role in the study design, collection, analysis and interpretation of data, or in writing the report.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ARNOLD M, 1972, J THORAC CARDIOV SUR, V64, P596; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barry M, 2007, SURG RADIOL ANAT, V29, P297, DOI 10.1007/s00276-007-0214-4; Chindhi S, 2015, LUNG INDIA, V32, P137, DOI 10.4103/0970-2113.152624; Chowdhury UK, 2004, ANN THORAC SURG, V78, P1614, DOI 10.1016/j.athoracsur.2004.03.105; Cizek SM, 2007, CARDIOVASC PATHOL, V16, P344, DOI 10.1016/j.carpath.2007.05.007; COOK TA, 1972, J PATHOL, V108, P119, DOI 10.1002/path.1711080205; Dugac AV, 2015, MED HYPOTHESES, V84, P155, DOI 10.1016/j.mehy.2014.11.017; Hole DJ, 1996, BRIT MED J, V313, P711; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Irzyk K, 2015, SCAND J RHEUMATOL, V44, P385, DOI 10.3109/03009742.2015.1021710; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; JOHN LCH, 1995, ANN THORAC SURG, V59, P190, DOI 10.1016/0003-4975(94)00715-J; Lahousse L, 2013, AM J RESP CRIT CARE, V187, P58, DOI 10.1164/rccm.201206-1046OC; MAGEE F, 1988, THORAX, V43, P183, DOI 10.1136/thx.43.3.183; Matsuoka S, 2011, ACAD RADIOL, V18, P40, DOI 10.1016/j.acra.2010.08.013; Mong K, 2002, ANN THORAC SURG, V74, P2126, DOI 10.1016/S0003-4975(02)03984-X; MOORE GW, 1982, ARCH PATHOL LAB MED, V106, P378; Ruengsakulrach P, 1999, CIRCULATION, V100, P139; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; VANSON JAM, 1993, ANN THORAC SURG, V56, P1078, DOI 10.1016/0003-4975(95)90018-7; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WRIGHT JL, 1992, LUNG, V170, P109	29	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152987	10.1371/journal.pone.0152987	http://dx.doi.org/10.1371/journal.pone.0152987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046203	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600055
J	Saber, A; van der Wekken, AJ; Kok, K; Terpstra, MM; Bosman, LJ; Mastik, MF; Timens, W; Schuuring, E; Hiltermann, TJN; Groen, HJM; van den Berg, A				Saber, Ali; van der Wekken, Anthonie J.; Kok, Klaas; Terpstra, M. Martijn; Bosman, Lisette J.; Mastik, Mirjam F.; Timens, Wim; Schuuring, Ed; Hiltermann, T. Jeroen N.; Groen, Harry J. M.; van den Berg, Anke			Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing	PLOS ONE			English	Article							KINASE INHIBITORS; ALK INHIBITORS; CANCER; ALIGNMENT; MUTATION; RNA	ALK-break positive non-small cell lung cancer (NSCLC) patients initially respond to crizotinib, but resistance occurs inevitably. In this study we aimed to identify fusion genes in crizotinib resistant tumor samples. Re-biopsies of three patients were subjected to paired-end RNA sequencing to identify fusion genes using deFuse and EricScript. The IGV browser was used to determine presence of known resistance-associated mutations. Sanger sequencing was used to validate fusion genes and digital droplet PCR to validate mutations. ALK fusion genes were detected in all three patients with EML4 being the fusion partner. One patient had no additional fusion genes. Another patient had one additional fusion gene, but without a predicted open reading frame (ORF). The third patient had three additional fusion genes, of which two were derived from the same chromosomal region as the EML4-ALK. A predicted ORF was identified only in the CLIP4-VSNL1 fusion product. The fusion genes validated in the post-treatment sample were also present in the biopsy before crizotinib. ALK mutations (p.C1156Y and p.G1269A) detected in the re-biopsies of two patients, were not detected in pre-treatment biopsies. In conclusion, fusion genes identified in our study are unlikely to be involved in crizotinib resistance based on presence in pre-treatment biopsies. The detection of ALK mutations in post-treatment tumor samples of two patients underlines their role in crizotinib resistance.	[Saber, Ali; Bosman, Lisette J.; Mastik, Mirjam F.; Timens, Wim; Schuuring, Ed; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van der Wekken, Anthonie J.; Hiltermann, T. Jeroen N.; Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Kok, Klaas; Terpstra, M. Martijn] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van den Berg, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	van der Wekken, Anthonie/AAE-2328-2021; , HiltermannTJN/ABA-9144-2021; Timens, Wim/K-5570-2013; Groen, Harry/AAP-2242-2021; van den Berg, Anke/H-1718-2011	Timens, Wim/0000-0002-4146-6363; van den Berg, Anke/0000-0002-8894-2638; Saber, Ali/0000-0002-7110-6860; van der Wekken, Anthonie/0000-0001-7175-0026				Benelli M, 2012, BIOINFORMATICS, V28, P3232, DOI 10.1093/bioinformatics/bts617; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Huang DH, 2013, GENOMICS, V102, P157, DOI 10.1016/j.ygeno.2013.02.006; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HR, 2013, MOL ONCOL, V7, P1093, DOI 10.1016/j.molonc.2013.08.001; Kim S, 2013, J THORAC ONCOL, V8, P415, DOI 10.1097/JTO.0b013e318283dcc0; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117032; Lovly CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003728; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Saber A., 2015, CANC TREATMENT COMMU, V143, P23, DOI [DOI 10.1016/j.ctrc.2015.03.005, 10.1016/j.ctrc.2015.03.005]; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Savas P, 2013, J THORAC DIS, V5, pS579, DOI 10.3978/j.issn.2072-1439.2013.08.52; Shaw AT, 2016, NEW ENGL J MED, V374, P54, DOI 10.1056/NEJMoa1508887; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toyokawa G, 2015, J THORAC ONCOL, V10, pE55, DOI 10.1097/JTO.0000000000000509; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; Wilson FH, 2015, CANCER CELL, V27, P397, DOI 10.1016/j.ccell.2015.02.005; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wynes MW, 2014, J THORAC ONCOL, V9, P631, DOI 10.1097/JTO.0000000000000115	30	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153065	10.1371/journal.pone.0153065	http://dx.doi.org/10.1371/journal.pone.0153065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045755	Green Published, gold			2022-12-27	WOS:000373599600063
J	Tomaszewski, D; Gorzkowska, A				Tomaszewski, Dominik; Gorzkowska, Angelika			Is Shape of a Fresh and Dried Leaf the Same?	PLOS ONE			English	Article							PLANT-SPECIES IDENTIFICATION; ELLIPTIC FOURIER-ANALYSIS; QUANTITATIVE-EVALUATION; LEAVES; MORPHOLOGY; DESCRIPTORS; OUTLINES; IMAGES	Plants kept as dried herbarium specimens share many characteristics with their living counterparts, but there are some substantial differences between them. Due to dehydration, leaves of herbarium specimens change not only their mass and colour, but in many cases change their dimensions, too. The present study aimed to determine whether leaf shape changes during the drying process. A total of 794 pairs of fresh and dried leaves or leaflets of 22 plant taxa were studied. The shape of the blades was quantified using elliptic Fourier analysis combined with principal component analysis. In addition, area and mass of the leaves were measured. Statistical tests were applied for comparing fresh and dried leaves. The results indicate that the preservation process of pressing and drying plants for herbarium purposes causes changes in leaf shape. In general, the shape changes were directional. As the shape of fresh and dried plants is different, it is strongly recommended that shape analyses should be performed on datasets containing either of the leaf types.	[Tomaszewski, Dominik] Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland; [Gorzkowska, Angelika] Poznan Univ Life Sci, Fac Forestry, Wojska Polskiego 71c, PL-60625 Poznan, Poland	Polish Academy of Sciences; Poznan University of Life Sciences	Tomaszewski, D (corresponding author), Polish Acad Sci, Inst Dendrol, Parkowa 5, PL-62035 Kornik, Poland.	dominito@man.poznan.pl	Tomaszewski, Dominik/B-5921-2008	Tomaszewski, Dominik/0000-0001-7768-5747	Institute of Dendrology of Polish Academy of Sciences in Kornik	Institute of Dendrology of Polish Academy of Sciences in Kornik	The research was financially supported by the Institute of Dendrology of the Polish Academy of Sciences in Kornik. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebowale A, 2012, BOT J LINN SOC, V170, P542, DOI 10.1111/j.1095-8339.2012.01308.x; Agarwal G, 2006, TAXON, V55, P597, DOI 10.2307/25065637; Andrade I. M., 2008, Kew Bulletin, V63, P193, DOI 10.1007/s12225-008-9032-z; Andrade I. M., 2010, Kew Bulletin, V65, P3, DOI 10.1007/s12225-010-9188-1; Beck C.B., 2010, INTRO PLANT STRUCTUR; Belhumeur PN, 2008, LECT NOTES COMPUT SC, V5305, P116, DOI 10.1007/978-3-540-88693-8_9; Blonder B, 2012, AM J BOT, V99, P1756, DOI 10.3732/ajb.1200062; Bruno OM, 2008, INFORM SCIENCES, V178, P2722, DOI 10.1016/j.ins.2008.01.023; Casanova D, 2009, INT J IMAG SYST TECH, V19, P236, DOI 10.1002/ima.20201; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Chitwood DH, 2012, PLANT CELL, V24, P2318, DOI 10.1105/tpc.112.098798; Claude J, 2008, MORPHOMETRICS R; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Du JX, 2006, T I MEAS CONTROL, V28, P275, DOI 10.1191/0142331206tim176oa; Funk V. A., 2004, 100 USES HERBARIUM W; FURUTA N, 1995, BREEDING SCI, V45, P315; Hearn DJ, 2009, TAXON, V58, P934, DOI 10.1002/tax.583021; Hopkins W. G, 2008, INTRO PLANT PHYSL; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H, 2002, BREEDING SCI, V52, P89, DOI 10.1270/jsbbs.52.89; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; Jeong S, 2013, COMPUT GRAPH FORUM, V32, P204, DOI 10.1111/cgf.12009; Joly A, 2014, ECOL INFORM, V23, P22, DOI 10.1016/j.ecoinf.2013.07.006; Juneau KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042604; KINCAID DT, 1983, CAN J BOT, V61, P2333, DOI 10.1139/b83-256; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kumar N, 2012, LECT NOTES COMPUT SC, V7573, P502, DOI 10.1007/978-3-642-33709-3_36; Neto JC, 2006, COMPUT ELECTRON AGR, V50, P121, DOI 10.1016/j.compag.2005.09.004; Parnell J, 2013, TAXON, V62, P1259, DOI 10.12705/626.3; Pereira LAM, 2012, COMPUT ELECTRON AGR, V87, P56, DOI 10.1016/j.compag.2012.05.015; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Queenborough SA, 2014, PLANT ECOL DIVERS, V7, P383, DOI 10.1080/17550874.2013.777483; Torres MAJ, 2008, PHILIPP AGRIC SCI, V91, P18; Torrez V, 2013, AUST J BOT, V61, P350, DOI 10.1071/BT12236; Viscosi V, 2009, PLANT BIOSYST, V143, P564, DOI 10.1080/11263500902723129; Viscosi V, 2011, NORD J BOT, V29, P632, DOI 10.1111/j.1756-1051.2011.01098.x; Wang B, 2015, INFORM SCIENCES, V302, P132, DOI 10.1016/j.ins.2014.07.028; WHITE RJ, 1988, CAN J BOT, V66, P450, DOI 10.1139/b88-070; WOOLLEY JT, 1973, PLANT PHYSIOL, V51, P815, DOI 10.1104/pp.51.4.815; Yanikoglu B, 2014, MACH VISION APPL, V25, P1369, DOI 10.1007/s00138-014-0612-7	41	16	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153071	10.1371/journal.pone.0153071	http://dx.doi.org/10.1371/journal.pone.0153071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045956	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600065
J	Servan-Mori, E; Avila-Burgos, L; Nigenda, G; Lozano, R				Servan-Mori, Edson; Avila-Burgos, Leticia; Nigenda, Gustavo; Lozano, Rafael			A Performance Analysis of Public Expenditure on Maternal Health in Mexico	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COMPREHENSIVE REFORM; SYSTEM PERFORMANCE; CARE; SERVICES; INEQUALITY; COVERAGE	We explore the relationship between public expenditure, coverage of adequate ANC (including timing, frequent and content), and the maternal mortality ratio-adjusted by coverage of adequate ANC-observed in Mexico in 2012 at the State level. Additionally, we examine the inequalities and concentration of public expenditure between populations with and without Social Security. Results suggest that in the 2003-2011 period, the public expenditure gap between women with and without Social Security decreased 74%, however, the distribution is less equitable among women without Social Security, across the States. Despite high levels of coverage on each dimension of ANC explored, coverage of adequate ANC was lower among Social Security than non-Social Security women. This variability results in differences up to 1.5 times in State-adjusted maternal mortality rate at the same level of expense and maternal mortality rate, respectively. The increase in the economic resources is only a necessary condition for achieving improved health outcomes. Providing adequate health services and achieving efficient, effective and transparent use of resources in health, are critical elements for health systems performance. The attainment of universal effective coverage of maternal health and reducing maternal mortality in Mexico, requires the adjustment of policy innovations including the rules of allocation and execution of health resources. Health policies should be designed on a more holistic view promoting a balance between accessibility, effective implementation and rigorous stewardship.	[Servan-Mori, Edson; Avila-Burgos, Leticia; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Nigenda, Gustavo] State Morelos Autonomous Univ, Sch Med, Cuernavaca, Morelos, Mexico; [Lozano, Rafael] UW, Inst Hlth Metr & Evaluat, Seattle, WA USA	Instituto Nacional de Salud Publica; Institute for Health Metrics & Evaluation	Nigenda, G (corresponding author), State Morelos Autonomous Univ, Sch Med, Cuernavaca, Morelos, Mexico.	gnigenda@outlook.com	Avila-Burgos, Leticia/AAR-1815-2021; Lozano, Rafael/T-5352-2018	Lozano, Rafael/0000-0002-7356-8823; Servan-Mori, Edson/0000-0001-9820-8325	National Center for Gender Equity and Reproductive Health (CNEGSR)	National Center for Gender Equity and Reproductive Health (CNEGSR)	This work was possible with the financial support of National Center for Gender Equity and Reproductive Health (CNEGSR) during 2003-2013. The authors and founder declare that they have no competing interests. The funders did not have any role on the study design, data analysis, decision to publish, or preparation of the manuscript.	Al-Nahedh N. N. A., 1995, Eastern Mediterranean Health Journal, V1, P261; Gonzalez-Block MA, 2010, SALUD PUBLICA MEXICO, V52, P416, DOI 10.1590/S0036-36342010000500009; Atun R, 2014, LANCET, V385, P1230; Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Bravo M, 2006, SISTEMA PROTECCION S; CNPSS, 2014, SIST PROT SOC SAL IN; CONAPO, 2010, IND MARG LOC 2010; Consejo Nacional de Poblacion (CONAPO), 2015, PROYECC POBL MEX 201; Department of Making Pregnancy Safer (MPS)/WHO, 2007, STAND MAT NEON CAR D; Direccion General de Informacion en Salud (DGIS)/Secretaria de Salud (SSa), 2015, BAS DAT SUBS INF MOR; Duong DV, 2004, SOC SCI MED, V59, P2585, DOI 10.1016/j.socscimed.2004.04.007; Pinzon-Florez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120747; Frenk J, 2008, B WORLD HEALTH ORGAN, V87, P542; Frenk J, 2007, SALUD PUBLICA MEXICO, V49, pS23, DOI 10.1590/S0036-36342007000700007; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2011, SALUD PUBLICA MEXICO, V53, pS69; Goverment of Mexico, 2015, MDGS INF SYST SIODM; Government of Mexico, 2010, MILL DEV GOALS MEX 2; Government of Mexico, 2013, MILL DEV GOALS MEX 2; Grogger J, 2010, IDENTIFICACION ANALI; Heredia-Pi Ileana, 2013, Salud pública Méx, V55, pS282; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Instituto Nacional de Salud Publica (INSP), 2006, EV EXT PROGR ACC ARR; Instituto Nacional de Salud Publica (INSP), 2013, CUENT SAL REPR EQ GE; Instituto Nacional de Salud Publica (INSP), 2013, SIST PROT SOC SAL EV; Instituto Nacional de Salud Publica (INSP) Secretarta de Salud (SSa), 2008, SIST PROT SOC SAL EV; Juan Mercedes, 2013, Salud pública Méx, V55, P1; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Kolenikov S., 2004, USE DISCRETE DATA PC, P1; Lazcano-Ponce E, 2013, SALUD PUBLICA MEXICO, V55, pS214; LERMAN RI, 1985, REV ECON STAT, V67, P151, DOI 10.2307/1928447; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Lozano R., 2012, GENERO SALUD CIFRAS, V10, P11; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Magadi MA, 2003, POP STUD-J DEMOG, V57, P347, DOI 10.1080/0032472032000137853; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; McCray TM, 2004, SOC SCI MED, V59, P1843, DOI 10.1016/j.socscimed.2004.02.033; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Nigenda G, 2015, HLTH SYSTEMS REFORM; Pan American Health Organization (PAHO) World Health Organization (WHO), 2002, 26 PAN AM SAN C 54 S; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Ruiz-Rodriguez M, 2009, HEALTH POLICY, V90, P149, DOI 10.1016/j.healthpol.2008.09.006; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Secretaria de Salud (SSa), 2012, PROYECTO NORM OF MEX; Secretaria de Salud (SSa), 2006, SIST PROT SOC SAL EL; Servan-Mori E, 2015, HLTH POLICY PLANNING; Sosa-Rubi SG, 2009, J HEALTH ECON, V28, P20, DOI 10.1016/j.jhealeco.2008.08.002; Subsecretaria de Innovacion y Calidad Direccion General de Evaluacion del Desempeno (SSa), 2009, REND CUENT SAL 2008; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; WHO, 2015, GLOB HLTH EXP DAT; World Health Organisation, 2015, MDG 5 IMPR MAT HLTH; World Health Organization, 2012, WHO APPL ICD 10 DEAT	54	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152635	10.1371/journal.pone.0152635	http://dx.doi.org/10.1371/journal.pone.0152635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043819	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100020
J	Wilmington, SR; Matouschek, A				Wilmington, Shameika R.; Matouschek, Andreas			An Inducible System for Rapid Degradation of Specific Cellular Proteins Using Proteasome Adaptors	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; GENE-EXPRESSION; HALF-LIFE; SACCHAROMYCES-CEREVISIAE; STRESSED CONDITIONS; MAMMALIAN-CELLS; MONOMERIC RED; UBIQUITIN; STABILITY; DEGRON	A common way to study protein function is to deplete the protein of interest from cells and observe the response. Traditional methods involve disrupting gene expression but these techniques are only effective against newly synthesized proteins and leave previously existing and stable proteins untouched. Here, we introduce a technique that induces the rapid degradation of specific proteins in mammalian cells by shuttling the proteins to the proteasome for degradation in a ubiquitin-independent manner. We present two implementations of the system in human culture cells that can be used individually to control protein concentration. Our study presents a simple, robust, and flexible technology platform for manipulating intracellular protein levels.	[Wilmington, Shameika R.; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Wilmington, Shameika R.; Matouschek, Andreas] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	Northwestern University; University of Texas System; University of Texas Austin	Matouschek, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL USA.; Matouschek, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	matouschek@austin.utexas.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	National Institute of General Medical Sciences [T32GM08061, R01GM63004]; Bill & Melinda Gates Foundation [GCE 8 OPP1061182]; Welch Foundation [F-1817]; Cancer Prevention and Research Institute of Texas [RP140328]; National Cancer Institute (NCI) [R21CA191664]; NATIONAL CANCER INSTITUTE [R21CA196456, R21CA191664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R01GM063004] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx) (T32GM08061 SRW and R01GM63004 to AM); Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) (GCE 8 OPP1061182 to AM); the Welch Foundation (http://www.welch1.org) (F-1817 to AM); the Cancer Prevention and Research Institute of Texas (http://www.cprit.state.tx.us) (RP140328 to AM); and the National Cancer Institute (NCI) R21CA191664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bondeson D.P., 2015, NAT CHEM BIOL; Buckley DL, 2014, ANGEW CHEM INT EDIT, V53, P2312, DOI 10.1002/anie.201307761; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Chung HK, 2015, NAT CHEM BIOL, V11, P713, DOI [10.1038/nchembio.1869, 10.1038/NCHEMBIO.1869]; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Fishbain S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1194; Gurtu V, 1996, IRES BICISTRONIC EXP, P1; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hatakeyama S, 2005, CANCER RES, V65, P7874, DOI 10.1158/0008-5472.CAN-05-1581; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liberles SD, 1997, P NATL ACAD SCI USA, V94, P7825, DOI 10.1073/pnas.94.15.7825; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Marangos P, 2008, NAT CELL BIOL, V10, P445, DOI 10.1038/ncb1707; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Portnoff AD, 2014, J BIOL CHEM; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Remington SJ, 2011, PROTEIN SCI, V20, P1509, DOI 10.1002/pro.684; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schrader EK, 2010, CHEM BIOL, V17, P917, DOI 10.1016/j.chembiol.2010.09.004; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scire A, 2008, PROTEINS, V73, P839, DOI 10.1002/prot.22114; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shemiakina II, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2208; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tsien R, 1998, ANN REV BIOCH; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Xu HM, 2012, BBA-MOL CELL RES, V1823, P818, DOI 10.1016/j.bbamcr.2012.01.002	55	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152679	10.1371/journal.pone.0152679	http://dx.doi.org/10.1371/journal.pone.0152679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043013	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100025
J	Xie, XR; Qu, H; Liu, GS; Zhang, ML; Kurths, J				Xie, Xiurui; Qu, Hong; Liu, Guisong; Zhang, Malu; Kurths, Juergen			An Efficient Supervised Training Algorithm for Multilayer Spiking Neural Networks	PLOS ONE			English	Article							FUNCTIONAL ARCHITECTURE; LEARNING ALGORITHM; RECEPTIVE-FIELDS; MODEL; CLASSIFICATION; OSCILLATIONS	The spiking neural networks (SNNs) are the third generation of neural networks and perform remarkably well in cognitive tasks such as pattern recognition. The spike emitting and information processing mechanisms found in biological cognitive systems motivate the application of the hierarchical structure and temporal encoding mechanism in spiking neural networks, which have exhibited strong computational capability. However, the hierarchical structure and temporal encoding approach require neurons to process information serially in space and time respectively, which reduce the training efficiency significantly. For training the hierarchical SNNs, most existing methods are based on the traditional back-propagation algorithm, inheriting its drawbacks of the gradient diffusion and the sensitivity on parameters. To keep the powerful computation capability of the hierarchical structure and temporal encoding mechanism, but to overcome the low efficiency of the existing algorithms, a new training algorithm, the Normalized Spiking Error Back Propagation (NSEBP) is proposed in this paper. In the feedforward calculation, the output spike times are calculated by solving the quadratic function in the spike response model instead of detecting postsynaptic voltage states at all time points in traditional algorithms. Besides, in the feedback weight modification, the computational error is propagated to previous layers by the presynaptic spike jitter instead of the gradient decent rule, which realizes the layer-wised training. Furthermore, our algorithm investigates the mathematical relation between the weight variation and voltage error change, which makes the normalization in the weight modification applicable. Adopting these strategies, our algorithm outperforms the traditional SNN multi-layer algorithms in terms of learning efficiency and parameter sensitivity, that are also demonstrated by the comprehensive experimental results in this paper.	[Xie, Xiurui; Qu, Hong; Liu, Guisong; Zhang, Malu] Univ Elect Sci & Technol China, Dept Comp Sci & Engn, Chengdu 611731, Sichuan, Peoples R China; [Qu, Hong; Kurths, Juergen] Humboldt Univ, Dept Phys, D-12489 Berlin, Germany; [Qu, Hong; Kurths, Juergen] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany	University of Electronic Science & Technology of China; Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung	Qu, H (corresponding author), Univ Elect Sci & Technol China, Dept Comp Sci & Engn, Chengdu 611731, Sichuan, Peoples R China.; Qu, H (corresponding author), Humboldt Univ, Dept Phys, D-12489 Berlin, Germany.; Qu, H (corresponding author), Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany.	hongqu@uestc.edu.cn	Liu, Guisong/S-1263-2019	Liu, Guisong/0000-0003-2360-0466	National Science Foundation of China [61273308, 61573081]; China Scholarship Council [61273308, 61573081]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was partially supported by the National Science Foundation of China and the China Scholarship Council under Grants 61273308 and 61573081 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the National Science Foundation of China under Grants 61273308 and 61573081, and the China Scholarship Council.	Bache Kevin, 2013, UCI MACHINE LEARNING; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bohte Sander M., 2004, Natural Computing, V3, P195, DOI 10.1023/B:NACO.0000027755.02868.60; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; Fink CG, 2013, IEEE GLOB CONF SIG, P843, DOI 10.1109/GlobalSIP.2013.6737023; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Gerstner W, 2002, SPIKING NERUAL MODEL; Ghosh-Dastidar S, 2009, NEURAL NETWORKS, V22, P1419, DOI 10.1016/j.neunet.2009.04.003; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Hu J, 2013, NEURAL COMPUT, V25, P450, DOI 10.1162/NECO_a_00395; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Masquelier T, 2009, NEURAL COMPUT, V21, P1259, DOI 10.1162/neco.2008.06-08-804; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; McKennoch S, 2006, IEEE IJCNN, P3970; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mohemmed A, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500128; Naveros F, 2015, IEEE T NEUR NET LEAR, V26, P1567, DOI 10.1109/TNNLS.2014.2345844; O'Brien MJ, 2013, NEURAL COMPUT, V25, P123, DOI 10.1162/NECO_a_00387; Ponulak F, 2011, ACTA NEUROBIOL EXP, V71, P409; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Song WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057453; Sporea I, 2013, NEURAL COMPUT, V25, P473, DOI 10.1162/NECO_a_00396; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; THORPE SJ, 1989, CONNECTIONISM IN PERSPECTIVE, P63; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wade JJ, 2010, IEEE T NEURAL NETWOR, V21, P1817, DOI 10.1109/TNN.2010.2074212; WOLBERG WH, 1990, P NATL ACAD SCI USA, V87, P9193, DOI 10.1073/pnas.87.23.9193; Xu Y, 2013, NEURAL COMPUT, V25, P1472, DOI 10.1162/NECO_a_00450; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078318; Zhang ZM, 2015, NEUROCOMPUTING, V151, P985, DOI 10.1016/j.neucom.2014.03.086	42	11	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0150329	10.1371/journal.pone.0150329	http://dx.doi.org/10.1371/journal.pone.0150329			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044001	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100001
J	Keavy, D; Bristow, LJ; Sivarao, DV; Batchelder, M; King, D; Thangathirupathy, S; Macor, JE; Weed, MR				Keavy, Deborah; Bristow, Linda J.; Sivarao, Digavalli V.; Batchelder, Margaret; King, Dalton; Thangathirupathy, Srinivasan; Macor, John E.; Weed, Michael R.			The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; MAJOR DEPRESSION; RANDOMIZED-TRIAL; CHANNEL BLOCKER; KETAMINE; SCHIZOPHRENIA; HUMANS	The antidepressant activity of the N-methyl-D-aspartate (NMDA) receptor channel blocker, ketamine, has led to the investigation of negative allosteric modulators (NAMs) selective for the NR2B receptor subtype. The clinical development of NR2B NAMs would benefit from a translational pharmacodynamic biomarker that demonstrates brain penetration and functional inhibition of NR2B receptors in preclinical species and humans. Quantitative electro-encephalography (qEEG) is a translational measure that can be used to demonstrate pharmacodynamic effects across species. NMDA receptor channel blockers, such as ketamine and phencyclidine, increase the EEG gamma power band, which has been used as a pharmacodynamic biomarker in the development of NMDA receptor antagonists. However, detailed qEEG studies with ketamine or NR2B NAMs are lacking in nonhuman primates. The aim of the present study was to determine the effects on the qEEG power spectra of the NR2B NAMs traxoprodil (CP-101,606) and BMT-108908 in nonhuman primates, and to compare them to the NMDA receptor channel blockers, ketamine and lanicemine. Cynomolgus monkeys were surgically implanted with EEG radio-telemetry transmitters, and qEEG was measured after vehicle or drug administration. The relative power for a number of frequency bands was determined. Ketamine and lanicemine increased relative gamma power, whereas the NR2B NAMs traxoprodil and BMT-108908 had no effect. Robust decreases in beta power were elicited by ketamine, traxoprodil and BMT-108908; and these agents also produced decreases in alpha power and increases in delta power at the doses tested. These results suggest that measurement of power spectra in the beta and delta bands may represent a translational pharmacodynamic biomarker to demonstrate functional effects of NR2B NAMs. The results of these studies may help guide the selection of qEEG measures that can be incorporated into early clinical evaluation of NR2B NAMs in healthy humans.	[Keavy, Deborah; Bristow, Linda J.; Sivarao, Digavalli V.; Weed, Michael R.] Bristol Myers Squibb Co, Genetically Defined Dis & Genom, 5 Res Pkwy, Wallingford, CT 06492 USA; [Batchelder, Margaret] Bristol Myers Squibb Co, Dept Vet Sci, 5 Res Pkwy, Wallingford, CT 06492 USA; [King, Dalton; Thangathirupathy, Srinivasan; Macor, John E.] Bristol Myers Squibb Co, Discovery Chem, 5 Res Pkwy, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Weed, MR (corresponding author), Bristol Myers Squibb Co, Genetically Defined Dis & Genom, 5 Res Pkwy, Wallingford, CT 06492 USA.	michael.weed@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was funded in full by Bristol-Myers Squibb, and all authors were BMS employees during their contribution to this project. No other individuals employed or contracted by Bristol-Myers Squibb (other than the named authors) played any role in: study design, data collection and analysis, or preparation of the manuscript. Others were involved in the decision to publish, for instance, in vetting the manuscript material for disclosure of proprietary information pertaining to BMS assets other than BMT-108908. BMS is not developing BMT-108908 for clinical use. There are no additional conflicts of interest to report for the authors, other than employment at BMS.	Association WAP, 2000, AM PSYCH ASS DIAGN S; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Celesia G G, 1974, Electroencephalogr Clin Neurophysiol, V37, P354; Chilukuri Harihar, 2014, Indian J Psychol Med, V36, P71, DOI 10.4103/0253-7176.127258; CLEMENTS JA, 1982, J PHARM SCI, V71, P539, DOI 10.1002/jps.2600710516; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; GINSKI MJ, 1994, PSYCHOPHARMACOLOGY, V114, P573, DOI 10.1007/BF02244987; Goonawardena AV, 2015, NEUROPSYCHOPHARMACOL; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Nagy D, 2015, NEUROPSYCHOPHARMACOL; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; Sanacora G, 2015, NEUROPSYCHOPHARMACOL, V40, P259, DOI 10.1038/npp.2014.261; SCHUTTLER J, 1987, J PHARMACOKINET BIOP, V15, P241, DOI 10.1007/BF01066320; Sivarao DV, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00096; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Thompson L, 2016, MEDI217 ACS; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Weed MR, 2016, NEUROPSYCHOPHARMACOL, V41, P568, DOI 10.1038/npp.2015.184; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2013, BIOL PSYCHIAT, V74, P257, DOI 10.1016/j.biopsych.2012.10.019	27	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152729	10.1371/journal.pone.0152729	http://dx.doi.org/10.1371/journal.pone.0152729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035340	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200032
J	Munukka, E; Wiklund, P; Partanen, T; Valimaki, S; Laakkonen, EK; Lehti, M; Fischer-Posovzsky, P; Wabitsch, M; Cheng, SL; Huovinen, P; Pekkala, S				Munukka, Eveliina; Wiklund, Petri; Partanen, Tiina; Valimaki, Sakari; Laakkonen, Eija K.; Lehti, Maarit; Fischer-Posovzsky, Pamela; Wabitsch, Martin; Cheng, Sulin; Huovinen, Pentti; Pekkala, Satu			Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; LIVER-DISEASE; NLRP3 INFLAMMASOME; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; OBESITY; CELLS; ATHEROSCLEROSIS	While the role of both elevated levels of circulating bacterial cell wall components and adipose tissue in hepatic fat accumulation has been recognized, it has not been considered that the bacterial components-recognizing adipose tissue receptors contribute to the hepatic fat content. In this study we found that the expression of adipose tissue bacterial flagellin (FLG)-recognizing Toll-like receptor (TLR) 5 associated with liver fat content (r = 0.699, p = 0.003) and insulin sensitivity (r = -0.529, p = 0.016) in humans (n = 23). No such associations were found for lipopolysaccharides (LPS)-recognizing TLR4. To study the underlyingmolecular mechanisms of these associations, human HepG2 hepatoma cells were exposed in vitro to the conditioned culture media derived from FLG or LPS-challenged human adipocytes. The adipocyte-mediated effects were also compared to the effects of direct HepG2 exposure to FLG and LPS. We found that the media derived from FLG-treated adipocytes stimulated fat accumulation in HepG2 cells, whereas either media derived from LPS-treated adipocytes or direct FLG or LPS exposure did not. This is likely due to that FLG-treatment of adipocytes increased lipolysis and secretion of glycerol, which is known to serve a substrate for triglyceride synthesis in hepatocytes. Similarly, only FLG-media significantly decreased insulin signaling-related Akt phosphorylation, IRS1 expression and mitochondrial respiratory chain ATP5A. In conclusion, our results suggest that the FLG-induced TLR5 activation in adipocytes increases glycerol secretion fromadipocytes and decreases insulin signaling and mitochondrial functions, and increases fat accumulation in hepatocytes. These mechanisms could, at least partly, explain the adipose tissue TLR5 expression associated with liver fat content in humans.	[Munukka, Eveliina; Wiklund, Petri; Partanen, Tiina; Valimaki, Sakari; Laakkonen, Eija K.; Cheng, Sulin; Pekkala, Satu] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Munukka, Eveliina; Huovinen, Pentti; Pekkala, Satu] Univ Turku, Dept Clin Microbiol & Immunol, Turku, Finland; [Lehti, Maarit] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Fischer-Posovzsky, Pamela; Wabitsch, Martin] Univ Med Ctr Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Cheng, Sulin] Shanghai Jiao Tong Univ, Dept Phys Educ, Shanghai 200030, Peoples R China	University of Jyvaskyla; University of Turku; Ulm University; Shanghai Jiao Tong University	Pekkala, S (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.; Pekkala, S (corresponding author), Univ Turku, Dept Clin Microbiol & Immunol, Turku, Finland.	satu.p.pekkala@jyu.fi	Huovinen, Pentti/C-9121-2019; Munukka, Eveliina/GQP-6540-2022; Laakkonen, Eija/G-3345-2017; Lehti, Maarit/ABB-1812-2021; Lehti, Maarit/T-3824-2019	Huovinen, Pentti/0000-0003-0003-1539; Laakkonen, Eija/0000-0001-6655-9489; Valimaki, Sakari/0000-0002-4777-8157; Lehti, Maarit/0000-0002-9063-6541; Pekkala, Satu/0000-0003-3107-0813	Academy of Finland [ID 267719]; Finnish Diabetes Research Foundation; Finnish Culture Foundation (Central and Southwest Finland funds); Academy of Finland SKIDI-KID Project [ID 135038]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Culture Foundation (Central and Southwest Finland funds); Academy of Finland SKIDI-KID Project	This study was financially supported by The Academy of Finland postdoctoral research fellow for Dr. Satu Pekkala (Grant ID 267719), by The Finnish Diabetes Research Foundation and by the Finnish Culture Foundation (Central and Southwest Finland funds). The study of the human project was supported by Academy of Finland SKIDI-KID Project (PI: Sulin Cheng, Grant ID 135038).	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Besse-Patin Aurele, 2014, Int J Cell Biol, V2014, P519153, DOI 10.1155/2014/519153; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; Esser N, 2013, DIABETOLOGIA, V56, P2487, DOI 10.1007/s00125-013-3023-9; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Franchini M, 2010, HORM METAB RES, V42, P703, DOI 10.1055/s-0030-1261872; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanuri G, 2014, LIVER INT; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Munukka E, 2014, J HEPATOL, V61, P132, DOI 10.1016/j.jhep.2014.02.020; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Pekkala S, 2015, OBESITY, V23, P581, DOI 10.1002/oby.20993; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Pinzone Marilia Rita, 2012, Int J Microbiol, V2012, P694629, DOI 10.1155/2012/694629; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Watanabe Y, 2013, NUTRIENTS, V5, P3757, DOI 10.3390/nu5093757; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	38	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152786	10.1371/journal.pone.0152786	http://dx.doi.org/10.1371/journal.pone.0152786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035341	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200040
J	Anandan, A; Anumalla, M; Pradhan, SK; Ali, J				Anandan, Annamalai; Anumalla, Mahender; Pradhan, Sharat Kumar; Ali, Jauhar			Population Structure, Diversity and Trait Association Analysis in Rice (Oryza sativa L.) Germplasm for Early Seedling Vigor (ESV) Using Trait Linked SSR Markers	PLOS ONE			English	Article							GENETIC DIVERSITY; COMPLEX TRAITS; IDENTIFICATION; LOCI; GERMINATION; DISSECTION; VARIETIES; GENOTYPES; SOFTWARE; EASTERN	Early seedling vigor (ESV) is the essential trait for direct seeded rice to dominate and smother the weed growth. In this regard, 629 rice genotypes were studied for their morphological and physiological responses in the field under direct seeded aerobic situation on 14th, 28th and 56th days after sowing (DAS). It was determined that the early observations taken on 14th and 28th DAS were reliable estimators to study ESV as compared to56th DAS. Further, 96 were selected from 629 genotypes by principal component (PCA) and discriminate function analyses. The selected genotypes were subjected to decipher the pattern of genetic diversity in terms of both phenotypic and genotypic by using ESV QTL linked simple sequence repeat (SSR) markers. To assess the genetic structure, model and distance based approaches were used. Genotyping of 96 rice lines using 39 polymorphic SSRs produced a total of 128 alleles with the phenotypic information content (PIC) value of 0.24. The model based population structure approach grouped the accession into two distinct populations, whereas unrooted tree grouped the genotypes into three clusters. Both model based and structure based approach had clearly distinguished the early vigor genotypes from non-early vigor genotypes. Association analysis revealed that 16 and 10 SSRs showed significant association with ESV traits by general linear model (GLM) and mixed linear model (MLM) approaches respectively. Marker alleles on chromosome 2 were associated with shoot dry weight on 28 DAS, vigor index on 14 and 28 DAS. Improvement in the rate of seedling growth will be useful for identifying rice genotypes acquiescent to direct seeded conditions through marker- assisted selection.	[Anandan, Annamalai; Anumalla, Mahender; Pradhan, Sharat Kumar] Natl Rice Res Inst, Div Crop Improvement, Cuttack, Odisha, India; [Ali, Jauhar] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; CGIAR; International Rice Research Institute (IRRI)	Ali, J (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	j.ali@irri.org	Anumalla, Mahender/AAU-9955-2021; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607				Abe A, 2012, THEOR APPL GENET, V125, P647, DOI 10.1007/s00122-012-1857-z; Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; Anandan A, 2015, FIELD CROP RES, V172, P153, DOI 10.1016/j.fcr.2014.11.007; Anandan A, 2012, FUNCT PLANT BIOL, V39, P137, DOI 10.1071/FP11184; Behera L., 2012, Australian Journal of Crop Science, V6, P1369; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cairns JE, 2009, FIELD CROP RES, V113, P207, DOI 10.1016/j.fcr.2009.05.007; Cheng XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080002; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Diwan J, 2013, RES JOUR BIOL, V1, P24; Ekta Joshi, 2013, Plant Knowledge Journal, V2, P119; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Han Longzhi, 2007, Journal of Genetics and Genomics, V34, P239, DOI 10.1016/S1673-8527(07)60025-3; Huang Zheng, 2004, Acta Genetica Sinica, V31, P596; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kannan B, SCI WORLD J, V2014; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lu XL, 2007, PLANT SCI, V172, P212, DOI 10.1016/j.plantsci.2006.08.012; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Mahender A, 2015, PLANTA, V241, P1027, DOI 10.1007/s00425-015-2273-9; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nachimuthu VV, 2015, RICE, V8, DOI 10.1186/s12284-015-0062-5; Namuco OS, 2009, FIELD CROP RES, V113, P197, DOI 10.1016/j.fcr.2009.05.008; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; PATEL M Z, 1989, Indian Journal of Genetics and Plant Breeding, V49, P113; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Salgotra RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131858; Shah SM, 2013, PAK J BOT, V45, P423; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Sow M, 2014, GENET RESOUR CROP EV, V61, P199, DOI 10.1007/s10722-013-0026-9; Wang ZF, 2010, J ZHEJIANG UNIV-SC B, V11, P958, DOI 10.1631/jzus.B1000238; Xie LX, 2014, J INTEGR PLANT BIOL, V56, P749, DOI 10.1111/jipb.12190; Yang W, 2010, ACTA AGRON SIN, V36, P754, DOI DOI 10.3724/SP.J.1006.2010.00754; Yeh FC, 1999, POPGEVE VERSION 1 31; Zhang DL, 2007, CHINESE SCI BULL, V52, P343, DOI 10.1007/s11434-007-0063-x; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang ZH, 2005, ANN BOT-LONDON, V95, P423, DOI 10.1093/aob/mci039; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	48	52	54	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152406	10.1371/journal.pone.0152406	http://dx.doi.org/10.1371/journal.pone.0152406			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031620	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800067
J	Faulks, L; Ostman, O				Faulks, Leanne; Ostman, Oerjan			Genetic Diversity and Hybridisation between Native and Introduced Salmonidae Fishes in a Swedish Alpine Lake	PLOS ONE			English	Article							CHAR SALVELINUS-ALPINUS; ARCTIC CHARR; FRESH-WATER; POPULATION-STRUCTURE; BROWN TROUT; BROOK CHARR; MICROSATELLITE VARIATION; NATURAL HYBRIDIZATION; MITOCHONDRIAL GENOME; S-FONTINALIS	Understanding the processes underlying diversification can aid in formulating appropriate conservation management plans that help maintain the evolutionary potential of taxa, particularly under human-induced activities and climate change. Here we assessed the microsatellite genetic diversity and structure of three salmonid species, two native (Arctic charr, Salvelinus alpinus and brown trout, Salmo trutta) and one introduced (brook charr, Salvelinus fontinalis), from an alpine lake in sub-arctic Sweden, Lake Ann. The genetic diversity of the three species was similar and sufficiently high from a conservation genetics perspective: corrected total heterozygosity, H'(T) = 0.54, 0.66, 0.60 and allelic richness, A(R) = 4.93, 5.53 and 5.26 for Arctic charr, brown trout and brook charr, respectively. There were indications of elevated inbreeding coefficients in brown trout (G(IS) = 0.144) and brook charr (G(IS) = 0.129) although sibling relationships were likely a confounding factor, as a high proportion of siblings were observed in all species within and among sampling locations. Overall genetic structure differed between species, Fst = 0.01, 0.02 and 0.04 in Arctic charr, brown trout and brook charr respectively, and there was differentiation at only a few specific locations. There was clear evidence of hybridisation between the native Arctic charr and the introduced brook charr, with 6% of individuals being hybrids, all of which were sampled in tributary streams. The ecological and evolutionary consequences of the observed hybridisation are priorities for further research and the conservation of the evolutionary potential of native salmonid species.	[Faulks, Leanne; Ostman, Oerjan] Uppsala Univ, Dept Ecol & Genet Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden; [Faulks, Leanne] Univ Tsukuba, Sugadaira Montane Res Ctr, Sugadaira Kogen 1278-294, Ueda, Nagano 3862204, Japan; [Ostman, Oerjan] Inst Coastal Res, Dept Aquat Resources, Skolvagen 6, S-74242 Oregrund, Sweden	Uppsala University; University of Tsukuba	Faulks, L (corresponding author), Uppsala Univ, Dept Ecol & Genet Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden.; Faulks, L (corresponding author), Univ Tsukuba, Sugadaira Montane Res Ctr, Sugadaira Kogen 1278-294, Ueda, Nagano 3862204, Japan.	leanne.k.faulks@gmail.com	Östman, Örjan/ABF-8714-2020; Faulks, Leanne/AAE-8802-2019	Östman, Örjan/0000-0002-1930-0148; 	Olsson Borghs Stiftelse; Carl Tryggers Stiftelese; Vetenskapsradet; Lake Ann advisory board	Olsson Borghs Stiftelse; Carl Tryggers Stiftelese; Vetenskapsradet(Swedish Research Council); Lake Ann advisory board	LKF received funding from OlssonBorghs Stiftelse (www.stiftelsemedel.se/olsson-borghsstiftelse) and Carl Tryggers Stiftelese (www.carltryggersstiftelse.se) and OO received funding from Vetenskapsradet (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted with the support and animal ethics permit of the local agency responsible for managing the lake, Jamtlands Lansstyrelse, Ostersund. Lake Ann advisory board also supported the study. Assistance in the lab from G. Engstrom. Assistance with sample collection from S. Hellestam, L. Bergwall, P.A. Jamting and members of the Lake Ann Protection Group.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Adams BK, 2003, J FISH BIOL, V62, P517, DOI 10.1046/j.1095-8649.2003.00032.x; Adams SB, 2001, ECOSYSTEMS, V4, P296, DOI 10.1007/s10021-001-0012-5; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Amundsen PA, 2008, ENVIRON BIOL FISH, V83, P45, DOI 10.1007/s10641-007-9262-1; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Anderson EC, 2002, GENETICS, V160, P1217; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Belmar-Lucero S, 2012, ECOL EVOL, V2, P562, DOI 10.1002/ece3.196; Bergwall L, 2010, FISK UNDERSOKNINGAR; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Bhat S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091208; Blanchfield PJ, 1997, CAN J FISH AQUAT SCI, V54, P747, DOI 10.1139/cjfas-54-4-747; Briers RA, 2013, ECOL FRESHW FISH, V22, P137, DOI 10.1111/eff.12011; Brinkmann H, 2004, J MOL EVOL, V59, P834, DOI 10.1007/s00239-004-0122-8; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Castric V, 2001, EVOLUTION, V55, P1016, DOI 10.1554/0014-3820(2001)055[1016:LSAHGD]2.0.CO;2; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; CHEVASSUS B, 1979, AQUACULTURE, V17, P113, DOI 10.1016/0044-8486(79)90047-4; Costanza R, 1998, ECOL ECON, V25, P67, DOI 10.1016/S0921-8009(98)00019-6; Coyne J.A., 2004, SPECIATION; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dierking J, 2014, EVOL APPL, V7, P1068, DOI 10.1111/eva.12166; DOWLING TE, 1992, CONSERV BIOL, V6, P355, DOI 10.1046/j.1523-1739.1992.06030355.x; Drinan TJ, 2012, ECOL FRESHW FISH, V21, P420, DOI 10.1111/j.1600-0633.2012.00561.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fitzpatrick BM, 2015, CURR ZOOL, V61, P206, DOI 10.1093/czoolo/61.1.206; Fitzpatrick BM, 2010, P NATL ACAD SCI USA, V107, P3606, DOI 10.1073/pnas.0911802107; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; GIBSON RJ, 1993, REV FISH BIOL FISHER, V3, P39, DOI 10.1007/BF00043297; Glemet H, 1998, MOL ECOL, V7, P1655, DOI 10.1046/j.1365-294x.1998.00494.x; Gomez-Uchida D, 2013, ECOL EVOL, V3, P569, DOI 10.1002/ece3.485; Gomez-Uchida D, 2009, MOL ECOL, V18, P4854, DOI 10.1111/j.1365-294X.2009.04409.x; Goudet J, 1995, FSTAT VERSION 2 9 3; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; HAMMAR J, 1991, CAN J FISH AQUAT SCI, V48, P1437, DOI 10.1139/f91-171; HAMMAR J, 1989, AMBIO, V18, P6; Hansen MM, 1997, MOL ECOL, V6, P469, DOI 10.1046/j.1365-294X.1997.t01-1-00202.x; HARPER JL, 1994, PHILOS T R SOC B, V345, P5, DOI 10.1098/rstb.1994.0081; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoagstrom CW, 2015, GLOBAL CHANGE BIOL, V21, P4, DOI 10.1111/gcb.12578; HOLCIK J, 1991, CAN J FISH AQUAT SCI, V48, P13, DOI 10.1139/f91-300; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kitano S, 2014, ICHTHYOL RES, V61, P1, DOI 10.1007/s10228-013-0362-y; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Koehn JD, 2011, MAR FRESHWATER RES, V62, P1148, DOI 10.1071/MF11139; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; McLellan R, 2014, LIVING PLANET REPORT; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meli A, 2013, J FISH BIOL, V82, P1514, DOI 10.1111/jfb.12082; Miller H, 2015, ECOL FRESHW FISH, V24, P32, DOI 10.1111/eff.12122; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Naiman RJ, 2002, ENVIRON MANAGE, V30, P455, DOI 10.1007/s00267-002-2734-3; Ostergren J, 2012, ECOL FRESHW FISH, V21, P119, DOI 10.1111/j.1600-0633.2011.00529.x; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Pilgrim BL, 2012, ECOL EVOL, V2, P885, DOI 10.1002/ece3.200; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Primmer CR, 1999, HEREDITAS, V130, P277, DOI 10.1111/j.1601-5223.1999.00277.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Schluter D, 1996, PHILOS T R SOC B, V351, P807, DOI 10.1098/rstb.1996.0075; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SNORRASON SS, 1994, BIOL J LINN SOC, V52, P1; Soule M. E., 1980, CONSERVATION BIOL EV; Stelkens RB, 2012, MOL ECOL, V21, P2896, DOI 10.1111/j.1365-294X.2012.05581.x; Swatdipong A, 2010, J FISH BIOL, V77, P2048, DOI 10.1111/j.1095-8649.2010.02784.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Westgaard JI, 2004, J FISH BIOL, V65, P1185, DOI 10.1111/j.0022-1112.2004.00524.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Wilson AJ, 2004, MOL ECOL, V13, P1129, DOI 10.1111/j.1365-294X.2004.02149.x; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x	89	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152732	10.1371/journal.pone.0152732	http://dx.doi.org/10.1371/journal.pone.0152732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032100	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800131
J	Murray, ET; Jones, R; Thomas, C; Ghosh, AK; Sattar, N; Deanfield, J; Hardy, R; Kuh, D; Hughes, AD; Whincup, P				Murray, Emily T.; Jones, Rebecca; Thomas, Claudia; Ghosh, Arjun K.; Sattar, Naveed; Deanfield, John; Hardy, Rebecca; Kuh, Diana; Hughes, Alun D.; Whincup, Peter			Life Course Socioeconomic Position: Associations with Cardiac Structure and Function at Age 60-64 Years in the 1946 British Birth Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VENTRICULAR DIASTOLIC DYSFUNCTION; OLDER MEN; EJECTION FRACTION; OF-CARDIOLOGY; FAILURE; RISK; ECHOCARDIOGRAPHY; HEALTH; POPULATION	Although it is recognized that risks of cardiovascular diseases associated with heart failure develop over the life course, no studies have reported whether life course socioeconomic inequalities exist for heart failure risk. The Medical Research Council's National Survey of Health and Development was used to investigate associations between occupational socioeconomic position during childhood, early adulthood and middle age and measures of cardiac structure [left ventricular (LV) mass index and relative wall thickness (RWT)] and function [systolic: ejection fraction (EF) and midwall fractional shortening (mFS); diastolic: left atrial (LA) volume, E/A ratio and E/e' ratio)]. Different life course models were compared with a saturated model to ascertain the nature of the relationship between socioeconomic position across the life course and each cardiac marker. Findings showed that models where socioeconomic position accumulated over multiple time points in life provided the best fit for 3 of the 7 cardiac markers: childhood and early adulthood periods for the E/A ratio and E/e' ratio, and all three life periods for LV mass index. These associations were attenuated by adjustment for adiposity, but were little affected by adjustment for other established or novel cardio-metabolic risk factors. There was no evidence of a relationship between socioeconomic position at any time point and RWT, EF, mFS or LA volume index. In conclusion, socioeconomic position across multiple points of the lifecourse, particularly earlier in life, is an important determinant of some measures of LV structure and function. BMI may be an important mediator of these associations.	[Murray, Emily T.; Jones, Rebecca; Thomas, Claudia; Whincup, Peter] St Georges Univ London, Populat Hlth Res Ctr, Div Populat Hlth Sci & Educ, London, England; [Ghosh, Arjun K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Acad Hlth Sci Ctr, London, England; [Sattar, Naveed] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Deanfield, John] UCL, Vasc Physiol Unit, Inst Cardiovasc Sci, London, England; [Ghosh, Arjun K.; Hardy, Rebecca; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Hughes, Alun D.] UCL, Inst Cardiovasc Sci, London, England; [Murray, Emily T.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Jones, Rebecca] UCL, Div Psychiat, Fac Brain Sci, London, England	St Georges University London; Imperial College London; University of Glasgow; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Murray, ET (corresponding author), St Georges Univ London, Populat Hlth Res Ctr, Div Populat Hlth Sci & Educ, London, England.; Murray, ET (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	emily.murray@ucl.ac.uk	Ghosh, Arjun/ABC-9543-2020; Hughes, Alun David/N-3781-2013; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Slimings, Claudia/AAE-6550-2019	Ghosh, Arjun/0000-0003-4992-2412; Hughes, Alun David/0000-0001-5432-5271; Kuh, Diana/0000-0001-7386-2857; Slimings, Claudia/0000-0001-7988-1186; Deanfield, John/0000-0001-8806-6052; Hardy, Rebecca/0000-0001-9949-0799; Murray, Emily/0000-0001-6297-6920; Whincup, Peter/0000-0002-5589-4107	Medical Research Council United Kingdom;  [MC_UU_12019/1];  [MC_UU_12019/2];  [U1200632239];  [G1001143]; MRC [MC_UU_12019/1, MC_UU_12019/2, G1001143] Funding Source: UKRI; Medical Research Council [MC_UU_12019/2, G1001143, MR/K006584/1, MC_UU_12019/1] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Medical Research Council United Kingdom funded this project [http://www.mrc.ac.uk/]. PW received specific funding for this project through G1001143. The National Survey of Health and Development, as well as RH and DK are supported by core funding and grant funding (U1200632239), as well as funding for the age 60-64 data collection (MC_UU_12019/1, MC_UU_12019/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Bradley BJ, 2013, J ADOLESCENT HEALTH, V52, P523, DOI 10.1016/j.jadohealth.2013.01.008; Christensen S, 2011, EUR HEART J, V32, P450, DOI 10.1093/eurheartj/ehq435; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; Falkstedt D, 2011, EUR J PUBLIC HEALTH, V21, P713, DOI 10.1093/eurpub/ckq158; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Glezeva N, 2013, HEART FAIL REV; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Heidenreich PA, 2012, CIRC-CARDIOVASC QUAL, V5, P37, DOI 10.1161/CIRCOUTCOMES.110.959122; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Lawlor D. A., 2014, LIFE COURSE APPROACH, P146; Lawlor DA, 2004, AM J PUBLIC HEALTH, V94, P1386, DOI 10.2105/AJPH.94.8.1386; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Ramsay SE, 2007, INT J EPIDEMIOL, V36, P560, DOI 10.1093/ije/dym060; Ramsay SE, 2014, EUR HEART J, V35, P442, DOI 10.1093/eurheartj/eht449; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rodevand O, 1999, INT J CARDIAC IMAG, V15, P397, DOI 10.1023/A:1006276513186; Rodriguez CJ, 2004, HYPERTENSION, V43, P775, DOI 10.1161/01.HYP.0000118055.90533.88; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vardeny O, 2013, JACC-HEART FAIL, V1, P531, DOI 10.1016/j.jchf.2013.07.006; Wahad S. R. A., 2012, INT PROCEEDING EC DE, P421; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P1870, DOI 10.1016/j.jacc.2011.06.057	37	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152691	10.1371/journal.pone.0152691	http://dx.doi.org/10.1371/journal.pone.0152691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031846	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000373121800119
J	Garcia, CP; Richardson, GAV; Dimopoulos, NA; Espinosa, DDF; Miriuka, SG; Sevlever, GE; Romorini, L; Scassa, ME				Paola Garcia, Carolina; Videla Richardson, Guillermo Agustin; Alexis Dimopoulos, Nicolas; Fernandez Espinosa, Damian Dario; Gabriel Miriuka, Santiago; Emilio Sevlever, Gustavo; Romorini, Leonardo; Elida Scassa, Maria			Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; DNA-BINDING DOMAIN; P53-DEPENDENT APOPTOSIS; RAPID APOPTOSIS; NERVOUS-SYSTEM; P53; DEATH; MITOCHONDRIA; INHIBITOR; BAX	Human embryonic stem cells (hESCs) are hypersensitive to genotoxic stress and display lower survival ability relative to their differentiated progeny. Herein, we attempted to investigate the source of this difference by comparing the DNA damage responses triggered by the topoisomerase I inhibitor camptothecin, in hESCs, human induced pluripotent stem cells (hiPSCs) and hESCs-derived neuroprogenitors (NP). We observed that upon camptothecin exposure pluripotent stem cells underwent apoptosis more swiftly and at a higher rate than differentiated cells. However, the cellular response encompassing ataxia-telangiectasia mutated kinase activation and p53 phosphorylation both on serine 15 as well as on serine 46 resulted very similar among the aforementioned cell types. Importantly, we observed that hESCs and hiPSCs express lower levels of the anti-apoptotic protein Bcl-2 than NP. To assess whether Bcl-2 abundance could account for this differential response we treated cells with ABT-263, WEHI-539 and ABT-199, small molecules that preferentially target the BH3-binding pocket of Bcl-xL and/or Bcl-2 and reduce their ability to sequester pro-apoptotic factors. We found that in the absence of stress stimuli, NP exhibited a higher sensitivity to ABT-263 and WEHI-539 than hESCs and hiPSCs. Conversely, all tested cell types appeared to be highly resistant to the Bcl-2 specific inhibitor, ABT-199. However, in all cases we determined that ABT-263 or WEHI-539 treatment exacerbated camptothecin-induced apoptosis. Importantly, similar responses were observed after siRNA-mediated down-regulation of Bcl-xL or Bcl-2. Taken together, our results suggest that Bcl-xL contrary to Bcl-2 contributes to ensure cell survival and also functions as a primary suppressor of DNA double-strand brake induced apoptosis both in pluripotent and derived NP cells. The emerging knowledge of the relative dependence of pluripotent and progenitor cells on Bcl-2 and Bcl-xL activities may help to predict cellular responses and potentially manipulate these cells for therapeutic purposes in the near future.	[Paola Garcia, Carolina; Videla Richardson, Guillermo Agustin; Alexis Dimopoulos, Nicolas; Fernandez Espinosa, Damian Dario; Gabriel Miriuka, Santiago; Emilio Sevlever, Gustavo; Romorini, Leonardo; Elida Scassa, Maria] Consejo Nacl Invest Cient & Tecn, LIAN, Fdn FLENI, Ruta 9,Km 53,B1625XAF Escobar, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Scassa, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, LIAN, Fdn FLENI, Ruta 9,Km 53,B1625XAF Escobar, RA-1033 Buenos Aires, DF, Argentina.	mescassa@fleni.org.ar	Miriuka, Santiago/ABE-9614-2020; Romorini, Leonardo/AGK-7429-2022; Miriuka, Santiago/AAM-4051-2020; Sevlever, Gustavo/Q-2219-2015	Romorini, Leonardo/0000-0002-3972-0991; Miriuka, Santiago/0000-0003-2402-3920; Sevlever, Gustavo/0000-0002-9567-7553	ANPCyT [PICT 2011-2717]; Fundacion Perez Companc	ANPCyT(ANPCyT); Fundacion Perez Companc	This work was funded by grants from ANPCyT (PICT 2011-2717) and Fundacion Perez Companc.; This work was funded by grants from ANPCyT (PICT 2011-2717) and Fundacion Perez Companc. CPG and NAD are Graduate Fellows and LR and SGM are Research Members of CONICET. GAVR is a Graduate Fellow of Instituto Nacional del Cancer.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Crowther AJ, 2013, J NEUROSCI, V33, P18098, DOI 10.1523/JNEUROSCI.2602-13.2013; Davids MS, 2013, CANCER CELL, V23, P139, DOI 10.1016/j.ccr.2013.01.018; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Doerflinger M, 2015, FEBS J, V282, P1006, DOI 10.1111/febs.13190; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Hagn F, 2010, J BIOL CHEM, V285, P3439, DOI 10.1074/jbc.M109.065391; Kapinas K, 2013, J CELL PHYSIOL, V228, P9, DOI 10.1002/jcp.24104; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Lee Y, 2007, NEUROSCIENCE, V145, P1365, DOI 10.1016/j.neuroscience.2006.07.026; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Liu JC, 2014, TRENDS CELL BIOL, V24, P268, DOI 10.1016/j.tcb.2014.03.002; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Luzzani C, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt540; Madden DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028530; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, CANCER RES, V54, P3131; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Garcia CP, 2014, STEM CELL RES, V12, P400, DOI 10.1016/j.scr.2013.12.002; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao RB, 2000, GENE DEV, V14, P981	49	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152607	10.1371/journal.pone.0152607	http://dx.doi.org/10.1371/journal.pone.0152607			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030982	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800102
J	Zhang, P; Weaver, JC; Chen, G; Beretov, J; Atsumi, T; Qi, M; Bhindi, R; Qi, JC; Madigan, MC; Giannakopoulos, B; Krilis, SA				Zhang, Peng; Weaver, James C.; Chen, Gang; Beretov, Julia; Atsumi, Tatsuya; Qi, Miao; Bhindi, Ravinay; Qi, Jian C.; Madigan, Michele C.; Giannakopoulos, Bill; Krilis, Steven A.			The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANTIPHOSPHOLIPID SYNDROME; BETA(2)-GLYCOPROTEIN I; ISCHEMIA/REPERFUSION INJURY; PHOSPHOLIPID-BINDING; ENDOTHELIAL-CELLS; MURINE MODEL; ANTIBODIES; MICE; COMPLEMENT	Reperfusion after a period of ischemia results in reperfusion injury (IRI) which involves activation of the inflammatory cascade. In cardiac IRI, IgM natural antibodies (NAb) play a prominent role through binding to altered neoepitopes expressed on damaged cells. Beta 2 Glycoprotein I (beta 2GPI) is a plasma protein that binds to neoepitopes on damaged cells including anionic phospholipids through its highly conserved Domain V. Domain I of beta 2GPI binds circulating IgM NAbs and may provide a link between the innate immune system, IgM NAb binding and cardiac IRI. This study was undertaken to investigate the role of beta 2GPI and its Domain V in cardiac IRI using wild-type (WT), Rag-1(-/-) and beta 2GPI deficient mice. Compared with control, treatment with Domain V prior to cardiac IRI prevented binding of endogenous beta 2GPI to post-ischemic myocardium and resulted in smaller myocardial infarction size in both WT and beta 2GPI deficient mice. Domain V treatment in WT mice also resulted in less neutrophil infiltration, less apoptosis and improved ejection fraction at 24 h. Rag-1-/- antibody deficient mice reconstituted with IgM NAbs confirmed that Domain V prevented IgM NAb induced cardiac IRI. Domain V remained equally effective when delivered at the time of reperfusion which has therapeutic clinical relevance. Based upon this study Domain V may function as a universal inhibitor of IgM NAb binding in the setting of cardiac IRI, which offers promise as a new therapeutic strategy in the treatment of cardiac IRI.	[Zhang, Peng; Weaver, James C.; Chen, Gang; Qi, Miao; Qi, Jian C.; Giannakopoulos, Bill; Krilis, Steven A.] St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Zhang, Peng; Weaver, James C.; Chen, Gang; Qi, Miao; Qi, Jian C.; Giannakopoulos, Bill; Krilis, Steven A.] Univ New S Wales, Dept Med, Sydney, NSW, Australia; [Zhang, Peng] Tianjin Med Univ, Gen Hosp, Dept Cardiothorac Surg, Tianjin, Peoples R China; [Weaver, James C.] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Beretov, Julia] SEALS St George Hosp, Anat Pathol, Sydney, NSW, Australia; [Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Bhindi, Ravinay] Royal N Shore Hosp, Dept Cardiol, Sydney, NSW, Australia; [Madigan, Michele C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Madigan, Michele C.] Sydney Eye Hosp, Sydney, NSW, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Giannakopoulos, Bill] St George Hosp, Dept Rheumatol, Sydney, NSW, Australia	St George Hospital; University of New South Wales Sydney; Tianjin Medical University; St George Hospital; St George Hospital; Hokkaido University; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney; St George Hospital	Krilis, SA (corresponding author), St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia.; Krilis, SA (corresponding author), Univ New S Wales, Dept Med, Sydney, NSW, Australia.	s.krilis@unsw.edu.au		Beretov, Julia/0000-0001-5582-0020	St George and Sutherland Medical Research Foundation; Japan Society for the Promotion of Science [S-15107]	St George and Sutherland Medical Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the St George and Sutherland Medical Research Foundation - do not use numbers - S Krilis (www.stgeorgemrf.com.au/) and the Japan Society for the Promotion of Science S-15107 - S Krilis (www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the St George and Sutherland Medical Research Foundation; and funding from the Japan Society for the Promotion of Science to SAK.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Agar C, 2011, THROMB HAEMOSTASIS, V106, P1069, DOI 10.1160/TH11-05-0333; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Del Papa N, 1998, J IMMUNOL, V160, P5572; Dumont EAWJ, 2000, CIRCULATION, V102, P1564, DOI 10.1161/01.CIR.102.13.1564; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Elvington A, 2012, J IMMUNOL, V188, P1460, DOI 10.4049/jimmunol.1102132; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Fleming SD, 2004, J IMMUNOL, V173, P7055, DOI 10.4049/jimmunol.173.11.7055; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Fleming SD, 2010, J IMMUNOL, V185, P6168, DOI 10.4049/jimmunol.1002520; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Gandhi C, 2012, BLOOD, V120, P5224, DOI 10.1182/blood-2012-06-440255; Giannakopoulos B, 2014, ARTHRITIS RHEUMATOL, V66, P2270, DOI 10.1002/art.38646; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; HUNT J, 1994, J IMMUNOL, V152, P653; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Jones SP, 2015, CIRC RES, V116, P572, DOI 10.1161/CIRCRESAHA.116.305462; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; LEFER DJ, 1993, CIRCULATION, V88, P1779, DOI 10.1161/01.CIR.88.4.1779; Libby P, 2013, SEMIN IMMUNOPATHOL, V35, P553, DOI 10.1007/s00281-013-0387-3; MA XL, 1991, J CLIN INVEST, V88, P1237, DOI 10.1172/JCI115427; Maulik N, 1998, AM J PHYSIOL-HEART C, V274, pH242, DOI 10.1152/ajpheart.1998.274.1.H242; MILLER TD, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.3.334; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Niessen HWM, 2000, J CLIN PATHOL, V53, P863, DOI 10.1136/jcp.53.11.863; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pope MR, 2012, J IMMUNOL, V189, P5047, DOI 10.4049/jimmunol.1200290; Reddel SW, 2000, J AUTOIMMUN, V15, P91, DOI 10.1006/jaut.2000.0427; Schwartz Longacre L, 2011, CIRCULATION, V124, P1172, DOI 10.1161/CIRCULATIONAHA.111.032698; Sheng YH, 2001, J BIOL CHEM, V276, P13817, DOI 10.1074/jbc.M010990200; Shishido SN, 2012, CLIN IMMUNOL, V144, P142, DOI 10.1016/j.clim.2012.06.002; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Van Os GMA, 2011, J THROMB HAEMOST, V9, P2447, DOI 10.1111/j.1538-7836.2011.04532.x; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2006, J MOL CELL CARDIOL, V41, P62, DOI 10.1016/j.yjmcc.2006.02.006	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152681	10.1371/journal.pone.0152681	http://dx.doi.org/10.1371/journal.pone.0152681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031114	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800113
J	Fant, C; Schlosser, CA; Gao, X; Strzepek, K; Reilly, J				Fant, Charles; Schlosser, C. Adam; Gao, Xiang; Strzepek, Kenneth; Reilly, John			Projections of Water Stress Based on an Ensemble of Socioeconomic Growth and Climate Change Scenarios: A Case Study in Asia	PLOS ONE			English	Article							RESOURCES; DATASET	The sustainability of future water resources is of paramount importance and is affected by many factors, including population, wealth and climate. Inherent in current methods to estimate these factors in the future is the uncertainty of their prediction. In this study, we integrate a large ensemble of scenarios-internally consistent across economics, emissions, climate, and population-to develop a risk portfolio of water stress over a large portion of Asia that includes China, India, and Mainland Southeast Asia in a future with unconstrained emissions. We isolate the effects of socioeconomic growth from the effects of climate change in order to identify the primary drivers of stress on water resources. We find that water needs related to socioeconomic changes, which are currently small, are likely to increase considerably in the future, often overshadowing the effect of climate change on levels of water stress. As a result, there is a high risk of severe water stress in densely populated watersheds by 2050, compared to recent history. There is strong evidence to suggest that, in the absence of autonomous adaptation or societal response, a much larger portion of the region's population will live in water-stressed regions in the near future. Tools and studies such as these can effectively investigate large-scale system sensitivities and can be useful in engaging and informing decision makers.	[Fant, Charles; Schlosser, C. Adam; Gao, Xiang; Strzepek, Kenneth; Reilly, John] MIT, Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fant, C (corresponding author), MIT, Joint Program Sci & Policy Global Change, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chasfant@mit.edu			U.S. Department of Energy, Office of Science [DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64597, DE-FG02-06ER64320]; U.S. Environmental Protection Agency [XA-83344601-0, XA-83240101, XA-83042801-0, PI-83412601-0, RD-83096001, RD-83427901-0]; U.S. National Science Foundation [SES-0825915, EFRI-0835414, ATM-0120468, BCS-0410344, ATM-0329759, DMS-0426845]; U.S. National Aeronautics and Space Administration [NNX07AI49G, NNX08AY59A, NNX06AC30A, NNX09AK26G, NNX08AL73G, NNX09AI26G, NNG04GJ80G, NNG04GP30G, NNA06CN09A]; U.S. National Oceanic and Atmospheric Administration [DG1330-05-CN-1308, NA070AR4310050, NA16GP2290]; U.S. Federal Aviation Administration [06-C-NE-MIT]; Electric Power Research Institute [EP-P32616/C15124]	U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Federal Aviation Administration; Electric Power Research Institute	The Joint Program on the Science and Policy of Global Change, and therefore all authors, is funded by the U.S. Department of Energy, Office of Science under grants DE-FG02-94ER61937, DE-FG02-93ER61677, DE-FG02-08ER64597, and DE-FG02-06ER64320; the U.S. Environmental Protection Agency under grants XA-83344601-0, XA-83240101, XA-83042801-0, PI-83412601-0, RD-83096001, and RD-83427901-0; the U.S. National Science Foundation under grants SES-0825915, EFRI-0835414, ATM-0120468, BCS-0410344, ATM-0329759, and DMS-0426845; the U.S. National Aeronautics and Space Administration under grants NNX07AI49G, NNX08AY59A, NNX06AC30A, NNX09AK26G, NNX08AL73G, NNX09AI26G, NNG04GJ80G, NNG04GP30G, and NNA06CN09A; the U.S. National Oceanic and Atmospheric Administration under grants DG1330-05-CN-1308, NA070AR4310050, and NA16GP2290; the U.S. Federal Aviation Administration under grant 06-C-NE-MIT; the Electric Power Research Institute under grant EP-P32616/C15124; and a consortium of 40 industrial and foundation sponsors (for the complete list see http://globalchange.mit.edu/sponsors/all). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2010, HYDROLOGIC SCI J DES, V52; Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; [Anonymous], 2008, INT MODEL POLICY ANA; Arndt C, CLIMATIC CH IN PRESS; Arnell NW, 2011, GLOBAL ENVIRON CHANG, V21, P592, DOI 10.1016/j.gloenvcha.2011.01.015; Blanc E, 2014, EARTHS FUTURE, V2, P197, DOI 10.1002/2013EF000214; Fant C, 2012, 214 MIT JPSPGC; FAO, FAO STAT YB 2013 WOR; Forest CE, 2008, TELLUS A, V60, P911, DOI 10.1111/j.1600-0870.2008.00346.x; Georgakakos A., 2014, CLIMATE CHANGE IMPAC, P69, DOI [10.7930/J0G44N6T, DOI 10.7930/J0G44N6T]; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Huffman GJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040000; Jimenez Cisneros BE, CLIMATE CHANGE 201 A; Kumar KR, 2006, CURR SCI INDIA, V90, P334; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Oleson KW, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000563; Paltsev S, 2004, 125 MIT JPSPGC; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Ramirez-Villegas J, 2010, DECISION POLICY ANAL; Revanga C, 2005, ACCOUNT ENV WATER RE; Schlosser CA, 2013, J CLIMATE, V26, P3394, DOI 10.1175/JCLI-D-11-00730.1; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Shen YJ, 2008, HYDROLOG SCI J, V53, P11, DOI 10.1623/hysj.53.1.11; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Siebert S, 2013, UPDATE DIGITAL GLOBA, P1; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Sokolov A. P., 2005, JOINT PROGRAM REPORT, P40; Strzepek K, 2009, WATER PAPERS WORLD B; Strzepek K, 2013, J ADV MODEL EARTH SY, V5, P638, DOI 10.1002/jame.20044; Tchakaloff V., 1957, B SCI MATH, V81, P123; Thenkabail P.S., 2008, GLOBAL IRRIGATED ARE; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Webster MD, 2008, 165 MIT JPSPGC; Webster M, 2012, CLIMATIC CHANGE, V112, P569, DOI 10.1007/s10584-011-0260-0; WILLMOTT CJ, 1992, PROF GEOGR, V44, P84, DOI 10.1111/j.0033-0124.1992.00084.x; World Commission on Dams (WCOD), 2000, DAMS DEV NEW FRAM DE; Xiong W, 2009, GLOBAL ENVIRON CHANG, V19, P34, DOI 10.1016/j.gloenvcha.2008.10.006	39	30	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150633	10.1371/journal.pone.0150633	http://dx.doi.org/10.1371/journal.pone.0150633			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028871	Green Published, gold, Green Submitted			2022-12-27	WOS:000373116500008
J	Land, WM; Liu, BY; Cordova, A; Fang, M; Huang, YF; Yao, WX				Land, William M.; Liu, Binya; Cordova, Alberto; Fang, Ming; Huang, Yufei; Yao, Wan X.			Effects of Physical Practice and Imagery Practice on Bilateral Transfer in Learning a Sequential Tapping Task	PLOS ONE			English	Article							MENTAL PRACTICE; INTERMANUAL TRANSFER; MUSCLE-CONTRACTIONS; INTERLIMB TRANSFER; PERFORMANCE; INCREASES; STRENGTH; FORCE	Recent research on bilateral transfer suggests that imagery training can facilitate the transfer of motor skill from a trained limb to that of an untrained limb above and beyond that of physical practice. To further explore this effect, the present study examined the influence of practice duration and task difficulty on the extent to which imagery training and physical training influences bilateral transfer of a sequential key pressing task. In experiment 1, participants trained on the key pressing task using their non-dominant arm under one of three conditions (physical practice, imagery practice, and no practice). In a subsequent bilateral transfer test, participants performed the sequential task using their untrained dominant arm in either an original order or mirror-ordered sequence. In experiment 2, the same procedures were followed as in experiment 1 except that participants trained with their dominant arm and performed the bilateral transfer task with their non-dominant arm. Results indicated that with extended practice beyond what has been employed in previous studies, physical practice is more effective at facilitating bilateral transfer compared to training with imagery. Interestingly, significant bilateral transfer was only observed for transfer from the non-dominant to the dominant arm with no differences observed between performing the task in an original or mirror ordered sequence. Overall, these findings suggest that imagery training may benefit bilateral transfer primarily at the initial stages of learning, but with extended training, physical practice leads to larger influences on transfer.	[Land, William M.; Liu, Binya; Cordova, Alberto; Yao, Wan X.] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA; [Huang, Yufei] Univ Texas San Antonio, Dept Elect & Comp Engn, San Antonio, TX USA; [Fang, Ming] Yangzhou Univ, Coll Phys Educ, Yangzhou 225009, Jiangsu, Peoples R China	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Yangzhou University	Yao, WX (corresponding author), Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA.	wanxiang.yao@utsa.edu	Huang, Yufei/AAU-2891-2021	Land, William/0000-0003-3244-1348				Amemiya K, 2010, BRAIN RES, V1343, P93, DOI 10.1016/j.brainres.2010.04.048; Arora S, 2011, ANN SURG, V253, P265, DOI 10.1097/SLA.0b013e318207a789; Ausenda CD, 2011, EUR J PHYS REHAB MED, V47, P417; Davis WW, 1898, STUD YALE PSYCHOL LA, V6, P18; Davis WW, 1900, STUDIES YALE PSYCHOL, V8, P64; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fitts PM., 1967, HUM PERFORM; Frank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095175; Gentile AM., 1972, QUEST, V17, P3, DOI [10.1080/00336297.1972.10519717, DOI 10.1080/00336297.1972.10519717]; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; HICKS RE, 1974, AM J PSYCHOL, V87, P667, DOI 10.2307/1421973; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HIRD JS, 1991, J SPORT EXERCISE PSY, V13, P281, DOI 10.1123/jsep.13.3.281; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Lange K, 2006, EXP BRAIN RES, V168, P547, DOI 10.1007/s00221-005-0117-8; Lange RK, 2004, EXP BRAIN RES, V159, P161, DOI 10.1007/s00221-004-1942-x; LOGAN GD, 1988, HUM FACTORS, V30, P583, DOI 10.1177/001872088803000504; Lohse KR, 2010, J IMAGERY RES SPORT, V5, P1; PARLOW SE, 1990, BRAIN LANG, V39, P319, DOI 10.1016/0093-934X(90)90017-B; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; SALTZMAN E, 1979, J MATH PSYCHOL, V20, P91, DOI 10.1016/0022-2496(79)90020-8; Teixeira LA, 2000, BRAIN COGNITION, V44, P455, DOI 10.1006/brcg.1999.1205; van Mier HI, 2006, NEUROPSYCHOLOGIA, V44, P939, DOI 10.1016/j.neuropsychologia.2005.08.010; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wohldmann EL, 2008, J EXP PSYCHOL LEARN, V34, P823, DOI 10.1037/0278-7393.34.4.823; Yao WX, 2014, PERCEPT MOTOR SKILL, V118, P400, DOI 10.2466/23.25.PMS.118k19w1; Yao WX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00561; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114	29	13	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152228	10.1371/journal.pone.0152228	http://dx.doi.org/10.1371/journal.pone.0152228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050168	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500031
J	Morden, E; Technau, KG; Giddy, J; Maxwell, N; Keiser, O; Davies, MA				Morden, Erna; Technau, Karl-Guenter; Giddy, Janet; Maxwell, Nicola; Keiser, Olivia; Davies, Mary-Ann			Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TO-CHILD TRANSMISSION; INFECTED MOTHERS; MORTALITY; BORN; WOMEN; MORBIDITY; CESSATION; SEVERITY; OUTCOMES	Background HIV-exposed uninfected (HEU) infants are a growing population in sub-Saharan Africa especially with the increasing coverage of more effective prevention of mother-to-child transmission (PMTCT) antiretroviral therapy regimens. This study describes the characteristics of South African HEU infants, investigates factors impacting birth weight and assesses their growth within the first 28 weeks of life. Methods This is a retrospective cohort based on routine clinical data from two South African PMTCT programmes. Data were collected between 2007 and 2013. Linear regression assessed factors affecting birth weight-for-age z-scores (WAZ) while growth (longitudinal WAZ) was assessed using mixed effects models. Results We assessed the growth of 2621 HEU infants (median birth WAZ was -0.65 (IQR -1.46; 0.0) and 51% were male). The feeding modalities practised were as follows: 0.5% exclusive breastfeeding, 7.9% breastfeeding with unknown exclusivity, 0.08% mixed breastfeeding and 89.2% formula feeding. Mothers with CD4 <200 cells/mu l delivered infants with a lower birth WAZ (adjusted beta-0.253 [95% CI -0.043; -0.072], p = 0.006) compared to mothers with aCD4 >= 500 cells/mu l. Similarly, mothers who did not receive antiretroviral drugs delivered infants with a lower birth WAZ (adjusted beta-0.39 [95% CI -0.67; -0.11], p = 0.007) compared to mothers who received antenatal antiretrovirals. Infants with a birth weight <2 500g (beta 0.070 [95% CI 0.061; 0.078], p < 0.0001) experienced faster growth within the first 28 weeks of life compared to infants with a birth weight >= 2 500g. Infants with any breastfeeding exposure experienced slower longitudinal growth compared to formula fed infants (adjusted beta -0.012 [95% CI 0.021; -0.003], p = 0.011). Conclusion Less severe maternal disease and the use of antiretrovirals positively impacts birth weight in this cohort of South African HEU infants. Formula feeding was common with breastfed infants experiencing marginally slower longitudinal growth.	[Morden, Erna; Maxwell, Nicola; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Technau, Karl-Guenter] Rahima Moosa Mother & Child Hosp, Johannesburg, South Africa; [Technau, Karl-Guenter] Univ Witwatersrand, Johannesburg, South Africa; [Giddy, Janet] McCord Hosp, Durban, South Africa; [Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Cape Town; University of Witwatersrand; University of Bern	Morden, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	erna.morden@alumni.uct.ac.za		Technau, Karl-Gunter/0000-0001-7367-7512	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development) [5U01AI069924]; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH (National Institute of Health) NIAID (National Institute of Allergy and Infectious Diseases) Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development) Grant number 5U01AI069924 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. All children and their caregivers at participating sites. Staff at participating sites. Staff at the Universities of Cape Town and Bern.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; [Anonymous], 2013, 2012 NAT ANT SENT HI; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Fowler MG, 2015, C RETR OPP INF FEBR, P93; Goga A, 2012, EVALUATION EFFECTIVE; Goga AE, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-4; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Kuhn L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006059; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047337; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; McGrath CJ, 2012, J NUTR, V142, P757, DOI 10.3945/jn.111.148874; Muhangi L, 2013, PUBLIC HEALTH NUTR, V16, P1548, DOI 10.1017/S1368980013000499; Natchu UCM, 2012, AM J CLIN NUTR, V96, P1071, DOI 10.3945/ajcn.111.024356; National Department of Health, 2011, S AFR J CLIN NUTR, V24, P214; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Patel D, 2010, AIDS, V24, P437, DOI 10.1097/QAD.0b013e3283345f91; Ramokolo V, 2014, J NUTR, V144, P42, DOI 10.3945/jn.113.178616; South Africa National Department of Health, 2008, POL GUID IMPL PMTCT; South Africa National Department of Health, 2010, CLIN GUID PMTCT PREV; South African National Department of Health, 2008, INF YOUNG CHILD FEED; Taha T, 2010, PEDIATR INFECT DIS J, V29, P514, DOI 10.1097/INF.0b013e3181cda531; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151762	10.1371/journal.pone.0151762	http://dx.doi.org/10.1371/journal.pone.0151762			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049853	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500011
J	Chiu, HW; Hua, KF				Chiu, Huan-Wen; Hua, Kuo-Feng			Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat	PLOS ONE			English	Article							INFLAMMATORY MEDIATOR EXPRESSION; DEPRIVATION-INDUCED APOPTOSIS; NF-KAPPA-B; DEHYDROEBURICOIC ACID; SUBMERGED CULTURE; CAMPHORATA PROTECTS; LIPID-PEROXIDATION; HEPATIC-FIBROSIS; OXIDATIVE STRESS; FRUITING BODIES	Antrodia cinnamomea (A. cinnamomea) is an indigenous medical fungus in Taiwan and has multiple biological functions, including hepatoprotective and immune-modulatory effects. Currently, the commercially available A. cinnamomea are mainly liquid- and solid-state fermented A. cinnamomea. However, the hepatoprotective effect of solid-state fermented A. cinnamomea has never been reported. Here we evaluate the ability of air-dried, ground and non-extracted wheat-based solid-state fermented A. cinnamomea (WFAC) to protect against carbon tetrachloride (CCl4)-induced hepatic injury in vivo. The results showed that oral administration of WFAC dose dependently (180, 540 and 1080 mg/kg) ameliorated the increase in plasma aspartate aminotransferase and alanine aminotransferase levels caused by chronic repeated CCl4 intoxication in rats. WFAC significantly reduced the CCl4-induced increase in hepatic lipid peroxidation levels and hydroxyproline contents, as well as reducing the spleen weight and water content of the liver. WFAC also restored the hepatic soluble protein synthesis and plasma albumin concentration in CCl4-intoxicated rats, but it did not affect the activities of superoxide dismutase, catalase, or glutathione peroxidase. In addition, a hepatic morphological analysis showed that the hepatic fibrosis and necrosis induced by CCl4 were significantly ameliorated by WFAC. Furthermore, the body weights of control rats and WFAC-administered rats were not significantly different, and no adverse effects were observed in WFAC-administered rats. These results indicate that WFAC is a nontoxic hepatoprotective agent against chronic CCl4-induced hepatic injury.	[Chiu, Huan-Wen; Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Hua, Kuo-Feng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan	National Ilan University; National Defense Medical Center; Tri-Service General Hospital	Hua, KF (corresponding author), Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan.; Hua, KF (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan.	kuofenghua@gmail.com			Ministry of Science and Technology, Taiwan [102-2628-B-197-001-MY3, 103-2923-B-197-001-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/). Grant number: 102-2628-B-197-001-MY3 (KFH); 103-2923-B-197-001-MY3 (KFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ao ZH, 2009, J ETHNOPHARMACOL, V121, P194, DOI 10.1016/j.jep.2008.10.039; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CAMPS J, 1992, CLIN SCI, V83, P695, DOI 10.1042/cs0830695; Chen CC, 2006, J NAT PROD, V69, P689, DOI 10.1021/np0581263; Chen XW, 2013, INT IMMUNOPHARMACOL, V17, P543, DOI 10.1016/j.intimp.2013.08.006; Chen YC, 2011, ACTA PHARMACOL SIN, V32, P904, DOI 10.1038/aps.2011.36; Deng JS, 2013, J AGR FOOD CHEM, V61, P5064, DOI 10.1021/jf303820k; Dhiman RK, 2005, DIGEST DIS SCI, V50, P1807, DOI 10.1007/s10620-005-2942-9; Du YC, 2012, PHYTOMEDICINE, V19, P788, DOI 10.1016/j.phymed.2012.03.014; Garbuzenko DV, 2015, WORLD J GASTROENTERO, V21, P6117, DOI 10.3748/wjg.v21.i20.6117; Geethangili M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep108; Geng Y, 2016, HEPATOL RES, V46, pE15, DOI 10.1111/hepr.12516; HALL PD, 1994, J GASTROEN HEPATOL, V9, P250, DOI 10.1111/j.1440-1746.1994.tb01719.x; Han HF, 2006, CHEM PHARM BULL, V54, P496, DOI 10.1248/cpb.54.496; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Hsieh YC, 2011, J AGR FOOD CHEM, V59, P10943, DOI 10.1021/jf202771d; Huang CH, 2010, J AGR FOOD CHEM, V58, P3859, DOI 10.1021/jf100530c; Huang GJ, 2014, J AGR FOOD CHEM, V62, P5321, DOI 10.1021/jf405113g; Huang GJ, 2013, FOOD CHEM, V141, P3020, DOI 10.1016/j.foodchem.2013.03.061; Huang YL, 2015, J AGR FOOD CHEM, V63, P4561, DOI 10.1021/jf5059304; Jacobs BP, 2002, AM J MED, V113, P506, DOI 10.1016/S0002-9343(02)01244-5; Kumar KJS, 2011, J ETHNOPHARMACOL, V136, P168, DOI 10.1016/j.jep.2011.04.030; Kuo YH, 2015, J AGR FOOD CHEM, V63, P10140, DOI 10.1021/acs.jafc.5b04400; Kuo YH, 2015, J AGR FOOD CHEM, V63, P2479, DOI 10.1021/acs.jafc.5b00073; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Lee WT, 2015, FOOD CHEM TOXICOL, V78, P33, DOI 10.1016/j.fct.2015.01.012; LETTERON P, 1990, BIOCHEM PHARMACOL, V39, P2027, DOI 10.1016/0006-2952(90)90625-U; Liaw CC, 2013, J NAT PROD, V76, P489, DOI 10.1021/np300443p; LIEN HM, 2011, EVID-BASED COMPL ALT, P1, DOI DOI 10.1093/ECAM/NEP020; Lien HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105286; Liu DZ, 2007, BIOSCI BIOTECH BIOCH, V71, P23, DOI 10.1271/bbb.60268; Liu KJ, 2010, IMMUNOLOGY, V129, P351, DOI 10.1111/j.1365-2567.2009.03175.x; Liu Yen-Wenn, 2012, J Tradit Complement Med, V2, P284; Lu MK, 2008, J AGR FOOD CHEM, V56, P865, DOI 10.1021/jf072828b; Lu MK, 2006, LIFE SCI, V79, P252, DOI 10.1016/j.lfs.2005.12.042; Lu ZM, 2007, J ETHNOPHARMACOL, V110, P160, DOI 10.1016/j.jep.2006.09.029; Lu ZM, 2011, NAT PROD RES, V25, P684, DOI 10.1080/14786410802525487; Luper S, 1998, Altern Med Rev, V3, P410; MCCAY PB, 1984, J BIOL CHEM, V259, P2135; Meng LM, 2012, NUTRITION, V28, P942, DOI 10.1016/j.nut.2012.01.006; Muir AJ, 2015, CLIN THER; Muriel P, 2005, BASIC CLIN PHARMACOL, V96, P375, DOI 10.1111/j.1742-7843.2005.pto_06.x; Palmes D, 2004, BIOMATERIALS, V25, P1601, DOI 10.1016/S0142-9612(03)00508-8; Park DK, 2013, J MED FOOD, V16, P681, DOI 10.1089/jmf.2012.2605; Park DK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/914524; PAULOVA J, 1990, VET MED-CZECH, V35, P629; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Song TY, 2003, J AGR FOOD CHEM, V51, P1571, DOI 10.1021/jf0209701; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Toyoki Y, 1998, HEPATO-GASTROENTEROL, V45, P2261; Tsai PY, 2012, ARTHRITIS RHEUM-US, V64, P232, DOI 10.1002/art.33328; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Tsai TC, 2015, J ETHNOPHARMACOL, V159, P113, DOI 10.1016/j.jep.2014.11.015; Vani MG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/296082; Wang LC, 2013, APPL MICROBIOL BIOT, V97, P9955, DOI 10.1007/s00253-013-5214-1; Wang SC, 2014, J AGR FOOD CHEM, V62, P5625, DOI 10.1021/jf4056924; Wu MT, 2011, J AGR FOOD CHEM, V59, P4248, DOI 10.1021/jf104561h; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; XIA EN, 1995, J NUTR, V125, P195; Yang PY, 2013, AM J CHINESE MED, V41, P1169, DOI 10.1142/S0192415X13500791; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Yeh CT, 2013, CARCINOGENESIS, V34, P2918, DOI 10.1093/carcin/bgt255; Yeh CT, 2009, CANCER LETT, V285, P73, DOI 10.1016/j.canlet.2009.05.002; Yue PYK, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-21	65	35	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153087	10.1371/journal.pone.0153087	http://dx.doi.org/10.1371/journal.pone.0153087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046059	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600067
J	Smallwood, J; Karapanagiotidis, T; Ruby, F; Medea, B; de Caso, I; Konishi, M; Wang, HT; Hallam, G; Margulies, DS; Jefferies, E				Smallwood, Jonathan; Karapanagiotidis, Theodoros; Ruby, Florence; Medea, Barbara; de Caso, Irene; Konishi, Mahiko; Wang, Hao-Ting; Hallam, Glyn; Margulies, Daniel S.; Jefferies, Elizabeth			Representing Representation: Integration between the Temporal Lobe and the Posterior Cingulate Influences the Content and Form of Spontaneous Thought	PLOS ONE			English	Article							DEFAULT MODE; EPISODIC MEMORY; WANDERING MINDS; BRAIN; NETWORK; ROBUST; CONNECTIVITY; OPTIMIZATION; REGISTRATION; ORGANIZATION	When not engaged in the moment, we often spontaneously represent people, places and events that are not present in the environment. Although this capacity has been linked to the default mode network (DMN), it remains unclear how interactions between the nodes of this network give rise to particular mental experiences during spontaneous thought. One hypothesis is that the core of the DMN integrates information from medial and lateral temporal lobe memory systems, which represent different aspects of knowledge. Individual differences in the connectivity between temporal lobe regions and the default mode network core would then predict differences in the content and form of people's spontaneous thoughts. This study tested this hypothesis by examining the relationship between seed-based functional connectivity and the contents of spontaneous thought recorded in a laboratory study several days later. Variations in connectivity from both medial and lateral temporal lobe regions was associated with different patterns of spontaneous thought and these effects converged on an overlapping region in the posterior cingulate cortex. We propose that the posterior core of the DMN acts as a representational hub that integrates information represented in medial and lateral temporal lobe and this process is important in determining the content and form of spontaneous thought.	[Smallwood, Jonathan; Karapanagiotidis, Theodoros; Ruby, Florence; Medea, Barbara; de Caso, Irene; Konishi, Mahiko; Wang, Hao-Ting; Hallam, Glyn; Jefferies, Elizabeth] Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Medea, Barbara] Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Margulies, Daniel S.] Max Planck Inst Human & Cognit Brain Sci, Neuroanat & Connect Grp, Leipzig, Germany	University of York - UK; Sapienza University Rome; Max Planck Society	Smallwood, J (corresponding author), Univ York, Dept Psychol, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	jonny.smallwood@york.ac.uk	Konishi, Mahiko/AAF-5628-2019; Smallwood, Jonathan/ABE-8365-2020; Jefferies, Elizabeth/A-7981-2011; Margulies, Daniel/L-4719-2016	Konishi, Mahiko/0000-0001-8212-9964; Margulies, Daniel/0000-0002-8880-9204; Wang, Hao-Ting/0000-0003-4078-2038; Jefferies, Elizabeth/0000-0002-3826-4330; Karapanagiotidis, Theodoros/0000-0002-0813-1019; Smallwood, Jonathan/0000-0002-7298-2459; Hallam, Glyn Paul/0000-0002-8956-9054	Templeton Science of Prospection Award; BBSRC [BB/J006963/1]; European Research Council [SEMBIND - 283530]; Welcome Trust [103817/Z/14/Z]; John Templeton Foundation; Biotechnology and Biological Sciences Research Council [BB/J006963/1] Funding Source: researchfish	Templeton Science of Prospection Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Welcome Trust(Wellcome Trust); John Templeton Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Templeton Science of Prospection Award to the first author. EJ was supported by grants from BBSRC (BB/J006963/1) and the European Research Council (SEMBIND - 283530). DMS and JS also received upport from the Welcome Trust 103817/Z/14/Z. This publication was made possible through the support of a grant from the John Templeton Foundation, "Prospective Psychology Stage 2: A Research Competition" to Martin Seligman. The opinions expressed in this publication are those of the author(s) and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Allen M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00743; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Andrews-Hanna JR, 2014, ANN NEW YORK ACAD SC; Baird B, 2015, J COGNITIVE NEUROSCI; Baird B, 2014, DECOUPLED MIND MIND; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Baker DH, 2015, NEUROIMAGE, V119, P229, DOI 10.1016/j.neuroimage.2015.06.053; Barron E., 2011, PSYCHOL SCI; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bzdok D, 2015, NEUROIMAGE, V106, P55, DOI 10.1016/j.neuroimage.2014.11.009; Bzdok D, 2013, NEUROIMAGE, V81, P381, DOI 10.1016/j.neuroimage.2013.05.046; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Engert V, 2014, BIOL PSYCHOL, V103, P283, DOI 10.1016/j.biopsycho.2014.10.004; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Gorgolewski KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097176; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Iijima Yudai, 2012, Shinrigaku Kenkyu, V83, P232; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kucyi A, 2014, NEUROIMAGE, V100, P471, DOI 10.1016/j.neuroimage.2014.06.044; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pagnoni G, 2012, J NEUROSCI, V32, P5242, DOI 10.1523/JNEUROSCI.4135-11.2012; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ruby FJM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00962; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Seli P, 2013, FRONTIERS PSYCHOL, V4; Smallwood J., 2013, FRONTIERS HUMAN NEUR, V7; Smallwood J., 2013, PSYCHOL B; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Smallwood J, 2013, PSYCHOL BULL, V139, P542, DOI 10.1037/a0031019; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2015, HUMAN BRAIN MAPPING; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Tusche A, 2014, NEUROIMAGE, V97, P107, DOI 10.1016/j.neuroimage.2014.03.076; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	65	87	87	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152272	10.1371/journal.pone.0152272	http://dx.doi.org/10.1371/journal.pone.0152272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045292	gold, Green Published, Green Accepted			2022-12-27	WOS:000373599600013
J	Zhang, Y; Liang, JL; Lin, Q; Hu, ZH				Zhang, Yan; Liang, Jiali; Lin, Qiang; Hu, Zhenghui			Exploiting Complexity Information for Brain Activation Detection	PLOS ONE			English	Article							APPROXIMATE ENTROPY ANALYSIS; SAMPLE ENTROPY; FMRI DATA; DATA SETS; SIGNALS; SYSTEM; IRREGULARITY; VARIABILITY; APEN	We present a complexity-based approach for the analysis of fMRI time series, in which sample entropy (SampEn) is introduced as a quantification of the voxel complexity. Under this hypothesis the voxel complexity could be modulated in pertinent cognitive tasks, and it changes through experimental paradigms. We calculate the complexity of sequential fMRI data for each voxel in two distinct experimental paradigms and use a nonparametric statistical strategy, the Wilcoxon signed rank test, to evaluate the difference in complexity between them. The results are compared with the well known general linear model based Statistical Parametric Mapping package (SPM12), where a decided difference has been observed. This is because SampEn method detects brain complexity changes in two experiments of different conditions and the data-driven method SampEn evaluates just the complexity of specific sequential fMRI data. Also, the larger and smaller SampEn values correspond to different meanings, and the neutral-blank design produces higher predictability than threat-neutral. Complexity information can be considered as a complementary method to the existing fMRI analysis strategies, and it may help improving the understanding of human brain functions from a different perspective.	[Zhang, Yan; Liang, Jiali] China Jiliang Univ, Coll Opt & Elect Technol, Hangzhou 310018, Peoples R China; [Lin, Qiang; Hu, Zhenghui] Zhejiang Univ Technol, Coll Sci, Ctr Opt & Optoelect Res, Hangzhou 310023, Zhejiang, Peoples R China	China Jiliang University; Zhejiang University of Technology	Hu, ZH (corresponding author), Zhejiang Univ Technol, Coll Sci, Ctr Opt & Optoelect Res, Hangzhou 310023, Zhejiang, Peoples R China.	zhenghui@zjut.edu.cn			National Basic Research Program of China [2013CB329501]; National High Technology Research and Development Program of China [2012AA011600]; National Natural Science Foundation of China [81271645]; Public Projects of Science Technology Department of Zhejiang Province [2013C33162, 2015C31102]; Zhejiang Provincial Natural Science Foundation of China [LY 12H18004]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Projects of Science Technology Department of Zhejiang Province; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work is supported in part by the National Basic Research Program of China under Grant 2013CB329501, in part by the National High Technology Research and Development Program of China under Grant 2012AA011600, in part by the National Natural Science Foundation of China under Grant 81271645, in part by the Public Projects of Science Technology Department of Zhejiang Province under Grant 2013C33162, in part by the Zhejiang Provincial Natural Science Foundation of China under Grant LY 12H18004, and in part by the Public Projects of Science Technology Department of Zhejiang Province under Grant 2015C31102.	Alcaraz R, 2010, COMPUT METH PROG BIO, V99, P124, DOI 10.1016/j.cmpb.2010.02.009; Beckmann CF, 2000, NEUROIMAGE, V11, pS643; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chen WT, 2009, MED ENG PHYS, V31, P61, DOI 10.1016/j.medengphy.2008.04.005; Chuang KH, 1999, IEEE T MED IMAGING, V18, P1117, DOI 10.1109/42.819322; De Maziere PA, 2007, J MAGN RESON, V185, P138, DOI 10.1016/j.jmr.2006.12.001; Duann JR, 2002, NEUROIMAGE, V15, P823, DOI 10.1006/nimg.2001.1049; Gupta L, 2014, NEUROIMAGE-CLIN, V5, P266, DOI 10.1016/j.nicl.2014.06.013; HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446; Hollander M., 1973, NONPARAMETRIC STAT M; Hu X, 2008, MED ENG PHYS, V30, P631, DOI 10.1016/j.medengphy.2007.07.002; Hu ZH, 2006, REGULARITY COMPLEXIT, V3, P15; Kherif F, 2002, NEUROIMAGE, V16, P1068, DOI 10.1006/nimg.2002.1094; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Muhei-aldin O, 2014, J NEUROSCI METH, V227, P75, DOI 10.1016/j.jneumeth.2014.02.003; Noble B., 1988, APPL LINEAR ALGEBRA; PINCUS SM, 1992, COMMUN STAT THEORY, V21, P3061, DOI 10.1080/03610929208830963; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1992, AM J PHYSIOL, V262, pE741, DOI 10.1152/ajpendo.1992.262.5.E741; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rukhin AL, 2000, J APPL PROBAB, V37, P88, DOI 10.1017/S0021900200015278; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Sokunbi MO, 2015, MED ENG PHYS, V37, P1082, DOI 10.1016/j.medengphy.2015.09.001; Sokunbi MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095146; Sokunbi MO, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00069; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Sun FT, 2005, NEUROIMAGE, V28, P227, DOI 10.1016/j.neuroimage.2005.05.043; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Xie HB, 2010, ANN BIOMED ENG, V38, P1483, DOI 10.1007/s10439-010-9933-5; Xiong GL, 2010, J ZHEJIANG UNIV-SC A, V11, P270, DOI 10.1631/jzus.A0900360; Yao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02853; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zhang J, 2008, NEUROIMAGE, V41, P1242, DOI 10.1016/j.neuroimage.2008.03.034; Zou Liang, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P451, DOI 10.3881/j.issn.1000-503X.2013.04.018	36	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152418	10.1371/journal.pone.0152418	http://dx.doi.org/10.1371/journal.pone.0152418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045838	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600019
J	Cecil, JD; O'Brien-Simpson, NM; Lenzo, JC; Holden, JA; Chen, YY; Singleton, W; Gause, KT; Yan, Y; Caruso, F; Reynolds, EC				Cecil, Jessica D.; O'Brien-Simpson, Neil M.; Lenzo, Jason C.; Holden, James A.; Chen, Yu-Yen; Singleton, William; Gause, Katelyn T.; Yan, Yan; Caruso, Frank; Reynolds, Eric C.			Differential Responses of Pattern Recognition Receptors to Outer Membrane Vesicles of Three Periodontal Pathogens	PLOS ONE			English	Article							PROTEINASE-ADHESIN COMPLEXES; PORPHYROMONAS-GINGIVALIS; TREPONEMA-DENTICOLA; BACTEROIDES-GINGIVALIS; SOLUBLE PEPTIDOGLYCAN; EPITHELIAL-CELLS; VIRULENCE; BACTERIA; DNA; RELEASE	Highly purified outer membrane vesicles (OMVs) of the periodontal pathogens, Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia were produced using tangential flow ultrafiltration, ultracentrifugation and Optiprep density gradient separation. Cryo-TEM and light scattering showed OMVs to be single lipid-bilayers with modal diameters of 75 to 158 nm. Enumeration of OMVs by nanoparticle flow-cytometry at the same stage of late exponential culture indicated that P. gingivalis was the most prolific OMV producer. P. gingivalis OMVs induced strong TLR2 and TLR4-specific responses and moderate responses in TLR7, TLR8, TLR9, NOD1 and NOD2 expressing-HEK-Blue cells. Responses to T. forsythia OMVs were less than those of P. gingivalis and T. denticola OMVs induced only weak responses. Compositional analyses of OMVs from the three pathogens demonstrated differences in protein, fatty acids, lipopolysaccharide, peptidoglycan fragments and nucleic acids. Periodontal pathogen OMVs induced differential pattern recognition receptor responses that have implications for their role in chronic periodontitis.	[Cecil, Jessica D.; O'Brien-Simpson, Neil M.; Lenzo, Jason C.; Holden, James A.; Chen, Yu-Yen; Singleton, William; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia; [Gause, Katelyn T.; Yan, Yan; Caruso, Frank] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu.au	Yan, Yan/A-3720-2009; Caruso, Frank/A-9587-2011; O'Brien-Simpson, Neil/B-2901-2009	Yan, Yan/0000-0003-2938-4063; Caruso, Frank/0000-0002-0197-497X; O'Brien-Simpson, Neil/0000-0001-8462-5603; Lenzo, Jason/0000-0002-0564-9250	Australian Government, Department of Industry, Innovation and Science	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by the Australian Government, Department of Industry, Innovation and Science.	Asai Y, 2003, INFECT IMMUN, V71, P717, DOI 10.1128/IAI.71.2.717-725.2003; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chi B, 2003, RES MICROBIOL, V154, P637, DOI 10.1016/j.resmic.2003.08.001; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Draghi JA, 2006, MICROBIOL-SGM, V152, P2683, DOI 10.1099/mic.0.29013-0; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Friedrich V, 2015, MOL ORAL MICROBIOL, V30, P451, DOI 10.1111/omi.12104; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; GMUR R, 1989, J PERIODONTAL RES, V24, P113, DOI 10.1111/j.1600-0765.1989.tb00865.x; GRAHAM J, 1994, ANAL BIOCHEM, V220, P367, DOI 10.1006/abio.1994.1351; Graunaite I., 2012, J ORAL MAXILLOFAC RE, V2, pE1, DOI DOI 10.5037/jomr.2011.2401; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Ho MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123448; Imayoshi R, 2011, ORAL DIS, V17, P83, DOI 10.1111/j.1601-0825.2010.01708.x; Jain S, 2013, INFECT IMMUN, V81, P1277, DOI 10.1128/IAI.01036-12; Jervoe-Storm PM, 2007, J PERIODONTOL, V78, P909, DOI 10.1902/jop.2007.060218; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Kim PD, 2015, INFECT IMMUN, V83, P2992, DOI 10.1128/IAI.00424-15; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nonnenmacher C, 2003, INFECT IMMUN, V71, P850, DOI 10.1128/IAI.71.2.850-856.2003; Nussbaum G, 2009, INFECT IMMUN, V77, P3939, DOI 10.1128/IAI.00488-09; O'Brien-Simpson NM, 2009, INFECT IMMUN, V77, P1246, DOI 10.1128/IAI.01038-08; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Orth R, 2010, J MICROBIOL METH, V80, P123, DOI 10.1016/j.mimet.2009.11.006; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Posch G, 2013, CLIN VACCINE IMMUNOL, V20, P945, DOI 10.1128/CVI.00139-13; Prates TP, 2014, J DENT RES, V93, P1155, DOI 10.1177/0022034514551770; Qi MS, 2003, MICROB PATHOGENESIS, V35, P259, DOI 10.1016/j.micpath.2003.07.002; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; ROSEN G, 1995, INFECT IMMUN, V63, P3973, DOI 10.1128/IAI.63.10.3973-3979.1995; ROSENTHAL RS, 1979, INFECT IMMUN, V24, P869, DOI 10.1128/IAI.24.3.869-878.1979; ROSENTHAL RS, 1987, INFECT IMMUN, V55, P2117, DOI 10.1128/IAI.55.9.2117-2120.1987; Ruby J, 2007, INFECT IMMUN, V75, P5763, DOI 10.1128/IAI.01117-07; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Srisatjaluk R, 1999, MICROB PATHOGENESIS, V27, P81, DOI 10.1006/mpat.1999.0287; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Tan KH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003955; TSAI CC, 1995, J PERIODONTOL, V66, P852, DOI 10.1902/jop.1995.66.10.852; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Wieser A, 2014, INT J MED MICROBIOL, V304, P1032, DOI 10.1016/j.ijmm.2014.07.012; Woodhams KL, 2013, INFECT IMMUN, V81, P3490, DOI 10.1128/IAI.00279-13; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197; Yoshimura A, 1997, J PERIODONTAL RES, V32, P279, DOI 10.1111/j.1600-0765.1997.tb00535.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727	73	48	51	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151967	10.1371/journal.pone.0151967	http://dx.doi.org/10.1371/journal.pone.0151967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035339	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200008
J	Liang, ZX; Yuan, RY; Chen, L; Zhu, XL; Dou, YX				Liang, Zhongxiang; Yuan, Ruyi; Chen, Lei; Zhu, Xueliang; Dou, Yongxi			Molecular Evolution and Characterization of Hemagglutinin (H) in Peste des Petits Ruminants Virus	PLOS ONE			English	Article							AMINO-ACID SITES; NEURAMINIDASE PROTEIN; PHYLOGENETIC ANALYSIS; RINDERPEST VIRUS; IMMUNE; SELECTION; GLYCOPROTEIN; SEQUENCE; EPIDEMIOLOGY; INTERFACE	Peste des Petits Ruminants (PPR) is an acute, highly contagious, and febrile viral disease that affects both domestic and wild small ruminants. The disease has become a major obstacle to the development of sustainable Agriculture. Hemagglutinin (H), the envelope glycoprotein of Peste des Petits Ruminants Virus (PPRV), plays a crucial role in regulating viral adsorption and entry, thus determining pathogenicity, and release of newly produced viral particles. In order to accurately understand the epidemic of the disease and the interactions between the virus and host, we launch the work. Here, we examined H gene from all four lineages of the PPRV to investigate evolutionary and epidemiologic dynamics of PPRV by the Bayesian method. In addition, we predicted positive selection sites due to selective pressures. Finally, we studied the interaction between H protein and SLAM receptor based on homology model of the complex. Phylogenetic analysis suggested that H gene can also be used to investigate evolutionary and epidemiologic dynamics of PPRV. Positive selection analysis identified four positive selection sites in H gene, in which only one common site (aa246) was detected by two methods, suggesting strong operation structural and/or functional constraint of changes on the H protein. This target site may be of interest for future mutagenesis studies. The results of homology modeling showed PPRVHv-shSLAM binding interface and MVH-maSLAM binding interface were consistent, wherein the groove in the B4 blade and B5 of the head domain of PPRVHv bound to the AGFCC' beta-sheets of the membrane-distal ectodomain of shSLAM. The binding regions could provide insight on the nature of the protein for epitope vaccine design, novel drug discovery, and rational drug design against PPRV.	[Liang, Zhongxiang; Yuan, Ruyi; Chen, Lei; Zhu, Xueliang; Dou, Yongxi] CAAS, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Key Lab Epizoot Dis, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Dou, YX (corresponding author), CAAS, Lanzhou Vet Res Inst, Minist Agr, State Key Lab Vet Etiol Biol,Key Lab Epizoot Dis, Lanzhou, Gansu, Peoples R China.	douyongxi@caas.cn			Special Fund for Agro-scientific Research in the Public Interest [201303059]; earmarked fund for China Agriculture Research System [CARS-40-10]	Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System	This work was financially sponsored by Special Fund for Agro-scientific Research in the Public Interest (201303059) and supported by the earmarked fund for China Agriculture Research System (CARS-40-10).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adombi CM, 2011, J VIROL METHODS, V173, P306, DOI 10.1016/j.jviromet.2011.02.024; Anandakrishnan R, 2015, BIOPHYS J, V108, P1153, DOI 10.1016/j.bpj.2014.12.047; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Carugo O, 2013, AMINO ACIDS, V44, P781, DOI 10.1007/s00726-012-1402-z; Colf LA, 2007, NAT STRUCT MOL BIOL, V14, P1227, DOI 10.1038/nsmb1342; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Couacy-Hymann E, 2002, J VIROL METHODS, V100, P17, DOI 10.1016/S0166-0934(01)00386-X; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammouchi M, 2012, VET MICROBIOL, V160, P240, DOI 10.1016/j.vetmic.2012.04.043; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00247; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Khamehchian S, 2007, CAN J MICROBIOL, V53, P720, DOI 10.1139/W07-035; Kimura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11648; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Kwiatek O, 2007, J COMP PATHOL, V136, P111, DOI 10.1016/j.jcpa.2006.12.002; Langedijk JPM, 1997, J VIROL, V71, P6155, DOI 10.1128/JVI.71.8.6155-6167.1997; Lu Guangwen, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P1; Ma GJ, 2013, STAT METHODS MED RES; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mizuta K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-533; Munir M, 2012, EMERG INFECT DIS, V18, P193, DOI 10.3201/eid1801.111304; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Parida S, 2015, VET MICROBIOLOGY; Pawar RM, 2008, ACTA VIROL, V52, P231; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00; Renukaradhya GJ, 2002, VIRUS RES, V90, P171, DOI 10.1016/S0168-1702(02)00151-X; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Seth S, 2001, VIRUS RES, V75, P169, DOI 10.1016/S0168-1702(01)00238-6; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sinnathamby G, 2001, VACCINE, V19, P4816, DOI 10.1016/S0264-410X(01)00210-9; Sinnathamby G, 2004, VIRAL IMMUNOL, V17, P401, DOI 10.1089/vim.2004.17.401; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Woelk CH, 2001, J GEN VIROL, V82, P2463, DOI 10.1099/0022-1317-82-10-2463; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152587	10.1371/journal.pone.0152587	http://dx.doi.org/10.1371/journal.pone.0152587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035347	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200024
J	Gonzalez, JV; Barboza, AG; Vazquez, FJ; Gandara, E				Gonzalez, Joaquin V.; Barboza, Andres G.; Vazquez, Fernando J.; Gandara, Esteban			Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							FACTOR-V-LEIDEN; THROMBOPHILIC RISK-FACTORS; VENOUS THROMBOSIS; GENE POLYMORPHISMS; SINUS THROMBOSIS; DISTINCT ROLES; THROMBOEMBOLISM; HYPERHOMOCYSTEINEMIA; ASSOCIATION; COAGULATION	Objectives To compare the prevalence of prothrombin G20210A in patients with objectively confirmed cerebral vein or cortical vein thrombosis against healthy controls, and evaluate geographical variations. Design Systematic review and meta-analysis of case control studies. Methods We conducted a systematic review of electronic databases including MEDLINE and EMBASE. The main outcome was the prevalence of prothrombin G20210A in patients with objectively confirmed cerebral vein or cortical vein thrombosis; we also analyzed individual country variations in the prevalence. The random-effects model OR was used as the primary outcome measure. Results In total 19 studies evaluated 868 cases of cerebral venous thrombosis and 3981 controls. Prothrombin G20210A was found in 103/868 of the patients with cerebral venous thrombosis and 105/3999 of the healthy controls [random effects pooled OR 5.838, 95% CI 3.96 to 8.58; I(2)17.9%]. The prevalence of prothrombin G20210A was significantly elevated in Italian studies (OR 9.69), in Brazilian studies (OR 7.02), and in German studies (OR 3.77), but not in Iranian studies (OR 0.98). Conclusion Prothrombin G20210A is significantly associated with cerebral venous thrombosis when compared to healthy controls, although this association is highly dependent on the country of origin.	[Gonzalez, Joaquin V.] Univ Nacl Cuyo, Univ Hosp, RA-5500 Mendoza, Argentina; [Barboza, Andres G.] Hosp Cent Mendoza, Div Neurol & Neurointens Care, Mendoza, Argentina; [Barboza, Andres G.] Univ Aconcagua, Fac Ciencias Med, Mendoza, Argentina; [Vazquez, Fernando J.] Hosp Italiano Buenos Aires, Dept Internal Med, Buenos Aires, DF, Argentina; [Vazquez, Fernando J.] Hosp Italiano Buenos Aires, Dept Internal Med, Internal Med Res Unit, Buenos Aires, DF, Argentina; [Gandara, Esteban] Univ Ottawa, Dept Med, Ottawa Hosp, Thrombosis Program,Div Hematol, Ottawa, ON, Canada; [Gandara, Esteban] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Gandara, Esteban] Univ Ottawa, Ottawa Hosp, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada	University Nacional Cuyo Mendoza; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Gandara, E (corresponding author), Univ Ottawa, Dept Med, Ottawa Hosp, Thrombosis Program,Div Hematol, Ottawa, ON, Canada.; Gandara, E (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; Gandara, E (corresponding author), Univ Ottawa, Ottawa Hosp, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	gandara.esteban@gmail.com		Vazquez, Fernando/0000-0003-1480-5101; Gandara, Esteban/0000-0003-0313-9174				Arruda VR, 1997, THROMB HAEMOSTASIS, V78, P1430; Ashjazadeh N, 2012, NEUROL ASIA, V17, P199; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Ben Salem-Berrabah O, 2012, J CLIN NEUROSCI, V19, P1326, DOI 10.1016/j.jocn.2011.11.029; Bombeli T, 2002, AM J HEMATOL, V70, P126, DOI 10.1002/ajh.10103; Boncoraglio G, 2004, EUR J NEUROL, V11, P405, DOI 10.1111/j.1468-1331.2004.00802.x; Colaizzo D, 2007, J MED GENET, V44, P412, DOI 10.1136/jmg.2006.048371; Dentali F, 2006, BLOOD, V107, P2766, DOI 10.1182/blood-2005-09-3578; Dindagur N, 2006, J NEUROL SCI, V249, P25, DOI 10.1016/j.jns.2006.05.061; Egger M., 2001, SYSTEMATIC REV HLTH, DOI [10.1002/9780470693926, DOI 10.1002/9780470693926]; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Gadelha T, 2005, CEREBROVASC DIS, V19, P49, DOI 10.1159/000081911; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hillier CEM, 1998, QJM-MON J ASSOC PHYS, V91, P677, DOI 10.1093/qjmed/91.10.677; Koopman K, 2009, THROMB RES, V124, P185, DOI 10.1016/j.thromres.2008.12.032; Lauw MN, 2013, SEMIN THROMB HEMOST, V39, P913, DOI 10.1055/s-0033-1357504; Le Cam-Duchez V, 2005, BLOOD COAGUL FIBRIN, P16; Lichy C, 2006, J NEUROL, V253, P316, DOI 10.1007/s00415-005-0988-4; Madonna P, 2000, STROKE, V31, P1787, DOI 10.1161/01.STR.31.7.1785-c; Margaglione M, 2001, HAEMATOLOGICA, V86, P634; Margaglione M, 2011, THROMB HAEMOSTASIS, V105, P221, DOI 10.1160/TH10-08-0510; Martinelli I, 2003, BLOOD, V102, P1363, DOI 10.1182/blood-2003-02-0443; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Martinelli I, 2014, NAT REV CARDIOL, V11, P140, DOI 10.1038/nrcardio.2013.211; Martinelli I, 2010, CIRCULATION, V121, P2740, DOI 10.1161/CIRCULATIONAHA.109.927046; Nagaraja D, 2008, J NEUROL SCI, V272, P43, DOI 10.1016/j.jns.2008.03.021; Nagaraja D, 2007, J CLIN NEUROSCI, V14, P635, DOI 10.1016/j.jocn.2006.05.001; Rahimi Z, 2010, CLIN APPL THROMB-HEM, V16, P430, DOI 10.1177/1076029609335519; Reuner KH, 1998, STROKE, V29, P1765, DOI 10.1161/01.STR.29.9.1765; Ringelstein M, 2012, J NEUROL, V259, P2287, DOI 10.1007/s00415-012-6477-7; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Rodrigues CA, 2004, J THROMB HAEMOST, V2, P1211, DOI 10.1111/j.1538-7836.2004.00785.x; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Tang L, 2015, THROMB HAEMOSTASIS, V114, P901, DOI 10.1160/TH15-04-0330; Tufano A, 2014, BLOOD TRANSFUS-ITALY, V12, pS337, DOI 10.2450/2013.0196-12; Ventura P, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000075784; Voetsch B, 2000, THROMB HAEMOSTASIS, V83, P229; Zakai NA, 2011, J THROMB HAEMOST, V9, P1877, DOI 10.1111/j.1538-7836.2011.04443.x	41	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151607	10.1371/journal.pone.0151607	http://dx.doi.org/10.1371/journal.pone.0151607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031503	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800016
J	Makhoba, XH; Burger, A; Coertzen, D; Zininga, T; Birkholtz, LM; Shonhai, A				Makhoba, Xolani Henry; Burger, Adelle; Coertzen, Dina; Zininga, Tawanda; Birkholtz, Lyn-Marie; Shonhai, Addmore			Use of a Chimeric Hsp70 to Enhance the Quality of Recombinant Plasmodium falciparum S-Adenosylmethionine Decarboxylase Protein Produced in Escherichia coli	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; HETEROLOGOUS EXPRESSION; MOLECULAR CHAPERONES; SUBSTRATE-BINDING; TRIGGER FACTOR; IN-VITRO; DNAK; GENE; MECHANISM; SUPPRESS	S-adenosylmethionine decarboxylase (PfAdoMetDC) from Plasmodium falciparum is a prospective antimalarial drug target. The production of recombinant PfAdoMetDC for biochemical validation as a drug target is important. The production of PfAdoMetDC in Escherichia coli has been reported to result in unsatisfactory yields and poor quality product. The co-expression of recombinant proteins with molecular chaperones has been proposed as one way to improve the production of the former in E. coli. E. coli heat shock proteins DnaK, GroEL-GroES and DnaJ have previously been used to enhance production of some recombinant proteins. However, the outcomes were inconsistent. An Hsp70 chimeric protein, KPf, which is made up of the ATPase domain of E. coli DnaK and the substrate binding domain of P. falciparum Hsp70 (PfHsp70) has been previously shown to exhibit chaperone function when it was expressed in E. coli cells whose resident Hsp70 (DnaK) function was impaired. We proposed that because of its domain constitution, KPf would most likely be recognised by E. coli Hsp70 co-chaperones. Furthermore, because it possesses a substrate binding domain of plasmodial origin, KPf would be primed to recognise recombinant PfAdoMetDC expressed in E. coli. First, using site-directed mutagenesis, followed by complementation assays, we established that KPf with a mutation in the hydrophobic residue located in its substrate binding cavity was functionally compromised. We further co-expressed PfAdoMetDC with KPf, PfHsp70 and DnaK in E. coli cells either in the absence or presence of over-expressed GroEL-GroES chaperonin. The folded and functional status of the produced PfAdoMetDC was assessed using limited proteolysis and enzyme assays. PfAdoMetDC co-expressed with KPf and PfHsp70 exhibited improved activity compared to protein co-expressed with over-expressed DnaK. Our findings suggest that chimeric KPf may be an ideal Hsp70 co-expression partner for the production of recombinant plasmodial proteins in E. coli.	[Makhoba, Xolani Henry] Univ Zululand, Dept Biochem & Microbiol, Kwa Dlangezwa, South Africa; [Burger, Adelle; Zininga, Tawanda; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa; [Coertzen, Dina; Birkholtz, Lyn-Marie] Univ Pretoria, Ctr Sustainable Malaria Control, Dept Biochem, ZA-0002 Pretoria, South Africa	University of Zululand; University of Venda; University of Pretoria	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa.	adshon@gmail.com	Birkholtz, Lyn-Marie/AAF-8481-2019; Coertzen, Dina/ABG-8897-2020; Shonhai, Addmore/AAS-4506-2021; Zininga, Tawanda/AAY-1428-2021; Zininga, Tawanda/Q-4131-2019	Birkholtz, Lyn-Marie/0000-0001-5888-2905; Coertzen, Dina/0000-0002-8408-244X; Zininga, Tawanda/0000-0001-8689-0152; Makhoba, Xolani Henry/0000-0002-7238-4619	National Research Foundation [75464]; Alexander von Humboldt Foundation of Germany; National Research Foundation (South Africa); University of Zululand Research Committee; NRF	National Research Foundation; Alexander von Humboldt Foundation of Germany(Alexander von Humboldt Foundation); National Research Foundation (South Africa)(National Research Foundation - South Africa); University of Zululand Research Committee; NRF	The authors wish to acknowledge the National Research Foundation for an equipment grant (UID, 75464) awarded to AS. AS is a recipient of a Georg Foster research fellowship awarded by the Alexander von Humboldt Foundation of Germany. XHM is a recipient of a National Research Foundation (South Africa) scarce skills scholarship and also received a grant from the University of Zululand Research Committee. AB is a recipient of a postdoctoral fellowship awarded by the NRF.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Birkholtz LM, 2004, BIOCHEM J, V377, P439, DOI 10.1042/BJ20030614; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Buchberger A, 1999, J BIOL CHEM, V274, P38017, DOI 10.1074/jbc.274.53.38017; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Bukau B, 2006, CELL, V4; Burger Adelle, 2014, Journal of Parasitology Research, P172582, DOI 10.1155/2014/172582; Cabrera R, 2002, ARCH BIOCHEM BIOPHYS, V406, P289, DOI 10.1016/S0003-9861(02)00435-6; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; GEORGOPOULOS CP, 1979, MOL GEN GENET, V172, P143, DOI 10.1007/BF00268275; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Han KG, 1999, PROTEIN EXPRES PURIF, V16, P103, DOI 10.1006/prep.1999.1061; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kolaj O, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-9; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Luthuli SD, 2013, IUBMB LIFE, V65, P454, DOI 10.1002/iub.1146; Makumire S, 2014, TOXICOL LETT, DOI [10.1016/j.toxilet.2014.02.027, DOI 10.1016/J.TOXILET.2014.02.027]; Martinez-Alonso M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-64; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; Muller S, 2001, TRENDS PARASITOL, V17, P242, DOI 10.1016/S1471-4922(01)01908-0; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Ratelade J, 2009, APPL ENVIRON MICROB, V75, P3803, DOI 10.1128/AEM.00255-09; Rudiger S, 2000, J MOL BIOL, V304, P245, DOI 10.1006/jmbi.2000.4193; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P16749, DOI 10.1021/bi981738k; Stephens LL, 2011, PROTEIN EXPRES PURIF, V77, P159, DOI 10.1016/j.pep.2011.01.005; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Wells GA, 2006, J MOL GRAPH MODEL, V24, P307, DOI 10.1016/j.jmgm.2005.09.011; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	53	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152626	10.1371/journal.pone.0152626	http://dx.doi.org/10.1371/journal.pone.0152626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031344	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800105
J	Mookerjee, SA; Nicholls, DG; Brand, MD				Mookerjee, Shona A.; Nicholls, David G.; Brand, Martin D.			Determining Maximum Glycolytic Capacity Using Extracellular Flux Measurements	PLOS ONE			English	Article							OXIDATIVE STRESS; RESPIRATION; BIOENERGETICS	Measurements of glycolytic rate and maximum glycolytic capacity using extracellular flux analysis can give crucial information about cell status and phenotype during normal operation, development of pathology, differentiation, and malignant transformation. They are also of great use when assessing the effects of chemical or drug treatments. Here, we experimentally define maximum glycolytic capacity, demonstrate how it differs from glycolytic rate, and provide a protocol for determining the basal glycolytic rate and maximum glycolytic capacity in cells using extracellular flux measurements. The results illustrate the power of extracellular flux analysis to describe the energetics of adherent cells in culture in a fully quantitative way.	[Mookerjee, Shona A.; Brand, Martin D.] Touro Univ, Calif Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA; [Mookerjee, Shona A.; Nicholls, David G.; Brand, Martin D.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA	Touro University California; Buck Institute for Research on Aging	Mookerjee, SA (corresponding author), Touro Univ, Calif Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA.; Mookerjee, SA (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	shona.mookerjee@tu.edu	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153				Affourtit C, 2009, METHOD ENZYMOL, V457, P405, DOI 10.1016/S0076-6879(09)05023-X; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Epstein T, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-7; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Garrett R.H., 2012, BIOCHEMISTRY; IBSEN KH, 1961, CANCER RES, V21, P829; Issaq SH, 2014, CELL CYCLE, V13, P1152, DOI 10.4161/cc.28010; Kumagai S, 2008, BIOCHEM BIOPH RES CO, V365, P362, DOI 10.1016/j.bbrc.2007.10.199; Malinarich F, 2015, J IMMUNOL, V194, P5174, DOI 10.4049/jimmunol.1303316; Mookerjee SA, 2015, JOVE-J VIS EXP, DOI 10.3791/53464; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; NOBES CD, 1990, J BIOL CHEM, V265, P12903; Papkovsky Dmitri B, 2015, Methods Mol Biol, V1265, P333, DOI 10.1007/978-1-4939-2288-8_23; Pelletier M, 2014, METHOD ENZYMOL, V542, P125, DOI 10.1016/B978-0-12-416618-9.00007-8; Pfiffer Vanessa, 2015, Methods Mol Biol, V1264, P279, DOI 10.1007/978-1-4939-2257-4_25; Phillips D, 2010, J MOL CELL CARDIOL, V48, P582, DOI 10.1016/j.yjmcc.2009.10.033; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; Winer LSP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109916	28	78	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152016	10.1371/journal.pone.0152016	http://dx.doi.org/10.1371/journal.pone.0152016			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031845	Green Published, gold			2022-12-27	WOS:000373121800029
J	Nelson, RE; Jones, M; Leecaster, M; Samore, MH; Ray, W; Huttner, A; Huttner, B; Khader, K; Stevens, VW; Gerding, D; Schweizer, ML; Rubin, MA				Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Huttner, Angela; Huttner, Benedikt; Khader, Karim; Stevens, Vanessa W.; Gerding, Dale; Schweizer, Marin L.; Rubin, Michael A.			An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMBINED ANDROGEN BLOCKADE; HEALTH-CARE-SYSTEM; COST-EFFECTIVENESS; UNITED-STATES; GOWN-USE; HOSPITALS; SURVEILLANCE; VANCOMYCIN; ENTEROCOCCUS	Background A number of strategies exist to reduce Clostridium difficile (C. difficile) transmission. We conducted an economic evaluation of "bundling" these strategies together. Methods We constructed an agent-based computer simulation of nosocomial C. difficile transmission and infection in a hospital setting. This model included the following components: interactions between patients and health care workers; room contamination via C. difficile shedding; C. difficile hand carriage and removal via hand hygiene; patient acquisition of C. difficile via contact with contaminated rooms or health care workers; and patient antimicrobial use. Six interventions were introduced alone and "bundled" together: (a) aggressive C. difficile testing; (b) empiric isolation and treatment of symptomatic patients; (c) improved adherence to hand hygiene and (d) contact precautions; (e) improved use of soap and water for hand hygiene; and (f) improved environmental cleaning. Our analysis compared these interventions using values representing 3 different scenarios: (1) base-case (BASE) values that reflect typical hospital practice, (2) intervention (INT) values that represent implementation of hospital-wide efforts to reduce C. diff transmission, and (3) optimal (OPT) values representing the highest expected results from strong adherence to the interventions. Cost parameters for each intervention were obtained from published literature. We performed our analyses assuming low, normal, and high C. difficile importation prevalence and transmissibility of C. difficile. Results INT levels of the "bundled" intervention were cost-effective at a willingness-to-pay threshold of $100,000/quality-adjusted life-year in all importation prevalence and transmissibility scenarios. OPT levels of intervention were cost-effective for normal and high importation prevalence and transmissibility scenarios. When analyzed separately, hand hygiene compliance, environmental decontamination, and empiric isolation and treatment were the interventions that had the greatest impact on both cost and effectiveness. Conclusions A combination of available interventions to prevent CDI is likely to be cost-effective but the cost-effectiveness varies for different levels of intensity of the interventions depending on epidemiological conditions such as C. difficile importation prevalence and transmissibility.	[Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Khader, Karim; Stevens, Vanessa W.; Rubin, Michael A.] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Nelson, Richard E.; Jones, Makoto; Leecaster, Molly; Samore, Matthew H.; Ray, William; Khader, Karim; Rubin, Michael A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Huttner, Angela; Huttner, Benedikt] Geneva Hosp, Infect Control Program, Geneva, Switzerland; [Stevens, Vanessa W.] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Gerding, Dale] Edward Hines Jr VA Hosp, Hines, IL USA; [Schweizer, Marin L.] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Schweizer, Marin L.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Geneva; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Nelson, RE (corresponding author), Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA.	richard.nelson@utah.edu	Huttner, Benedikt/M-5616-2014; Huttner, Angela/AAM-1197-2020	Huttner, Benedikt/0000-0002-1749-9464; Huttner, Angela/0000-0002-8380-368X; Stevens, Vanessa/0000-0001-8933-5453; Schweizer, Marin/0000-0002-3604-0093	GOJO Industries, Inc.; VA Health Services Research and Development Service [REA 08-264, VA HSR CDA 10-030-2, VA CDA 11-210]; U.S. Centers for Disease Control and Prevention (VA Epicenter) [CDC 07FED706506]; Veterans Affairs [IK2HX001165] Funding Source: NIH RePORTER	GOJO Industries, Inc.; VA Health Services Research and Development Service(US Department of Veterans Affairs); U.S. Centers for Disease Control and Prevention (VA Epicenter); Veterans Affairs(US Department of Veterans Affairs)	This material is the result of work supported with resources and the use of facilities at the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah. This study was supported with funding from GOJO Industries, Inc. (http://www.gojo.com/), the VA Health Services Research and Development Service (REA 08-264, VA HSR CDA 10-030-2, and VA CDA 11-210), and the U.S. Centers for Disease Control and Prevention (VA Epicenter, CDC 07FED706506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TRENDS IN INPATIENT; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Briggs A, 2006, DECISION MODELLING F; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Burckhardt F, 2008, EMERG INFECT DIS, V14, P691, DOI 10.3201/eid1404.071023; Burger T, 2006, AM J INFECT CONTROL, V34, P458, DOI 10.1016/j.ajic.2005.08.010; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Curry SR, 2011, J CLIN MICROBIOL, V49, P3788, DOI 10.1128/JCM.00679-11; Doan L, 2012, J HOSP INFECT, V82, P114, DOI 10.1016/j.jhin.2012.06.014; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Duggan JM, 2008, INFECT CONT HOSP EP, V29, P534, DOI 10.1086/588164; Eckstein BC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-61; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Farbman L, 2013, CLIN MICROBIOL INFEC, V19, pE582, DOI 10.1111/1469-0691.12280; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; Gase KA, 2013, INFECT CONT HOSP EP, V34, P284, DOI 10.1086/669509; Golan Y, 2006, CLIN INFECT DIS, V42, P370, DOI 10.1086/498906; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Hacek DM, 2010, AM J INFECT CONTROL, V38, P350, DOI 10.1016/j.ajic.2009.11.003; Haley VB, 2014, INFECT CONT HOSP EP, V35, P1, DOI 10.1086/674389; Hayes JL, 2007, ANZ J SURG, V77, P782, DOI 10.1111/j.1445-2197.2007.04226.x; Hsu J, 2010, AM J GASTROENTEROL, V105, P2327, DOI 10.1038/ajg.2010.254; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kundrapu S, 2012, CLIN INFECT DIS, V55, P1527, DOI 10.1093/cid/cis707; Larson EL, 2001, CRIT CARE MED, V29, P944, DOI 10.1097/00003246-200105000-00007; Lee BY, 2010, VACCINE, V28, P5245, DOI 10.1016/j.vaccine.2010.05.062; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Penson DF, 2005, J UROLOGY, V174, P547, DOI 10.1097/01.ju.0000165569.48372.4c; Perez J, 2005, AM J INFECT CONTROL, V33, P320, DOI 10.1016/j.ajic.2005.04.240; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Puzniak LA, 2004, INFECT CONT HOSP EP, V25, P418, DOI 10.1086/502416; Ramsey S, 2005, UROLOGY, V66, P835, DOI 10.1016/j.urology.2005.04.028; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Robotham JV, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5694; Rupp ME, 2008, INFECT CONT HOSP EP, V29, P8, DOI 10.1086/524333; Saint S, 2009, AM J INFECT CONTROL, V37, P306, DOI 10.1016/j.ajic.2008.08.004; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Schneider K, 2014, CLIN INFECT DIS; Schweizer ML, 2014, US COSTS AND OUTCOME; Shaughnessy MK, 2011, INFECT CONT HOSP EP, V32, P201, DOI 10.1086/658669; Speight S, 2011, J HOSP INFECT, V79, P18, DOI 10.1016/j.jhin.2011.05.016; Stranges PM, 2013, VALUE HEALTH, V16, P297, DOI 10.1016/j.jval.2012.11.004; Zilberberg MD, 2011, INFECT CONT HOSP EP, V32, P649, DOI 10.1086/660360; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	59	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152248	10.1371/journal.pone.0152248	http://dx.doi.org/10.1371/journal.pone.0152248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031464	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800045
J	Plotz, RD; Grecian, WJ; Kerley, GIH; Linklater, WL				Plotz, Roan D.; Grecian, W. James; Kerley, Graham I. H.; Linklater, Wayne L.			Standardising Home Range Studies for Improved Management of the Critically Endangered Black Rhinoceros	PLOS ONE			English	Article							DICEROS-BICORNIS; SAMPLING REGIME; NATIONAL-PARK; HABITAT USE; CONSERVATION; RESERVE; MOVEMENTS; BEHAVIOR; SPACE; SIZE	Comparisons of recent estimations of home range sizes for the critically endangered black rhinoceros in Hluhluwe-iMfolozi Park (HiP), South Africa, with historical estimates led reports of a substantial (54%) increase, attributed to over-stocking and habitat deterioration that has far-reaching implications for rhino conservation. Other reports, however, suggest the increase is more likely an artefact caused by applying various home range estimators to non-standardised datasets. We collected 1939 locations of 25 black rhino over six years (2004-2009) to estimate annual home ranges and evaluate the hypothesis that they have increased in size. A minimum of 30 and 25 locations were required for accurate 95% MCP estimation of home range of adult rhinos, during the dry and wet seasons respectively. Forty and 55 locations were required for adult female and male annual MCP home ranges, respectively, and 30 locations were necessary for estimating 90% bivariate kernel home ranges accurately. Average annual 95% bivariate kernel home ranges were 20.4 +/- 1.2 km(2), 53 +/- 1.9% larger than 95% MCP ranges (9.8 km(2) +/- 0.9). When home range techniques used during the late-1960s in HiP were applied to our dataset, estimates were similar, indicating that ranges have not changed substantially in 50 years. Inaccurate, non-standardised, home range estimates and their comparison have the potential to mislead black rhino population management. We recommend that more care be taken to collect adequate numbers of rhino locations within standardized time periods (i.e., season or year) and that the comparison of home ranges estimated using dissimilar procedures be avoided. Home range studies of black rhino have been data deficient and procedurally inconsistent. Standardisation of methods is required.	[Plotz, Roan D.; Linklater, Wayne L.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand; [Grecian, W. James] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Plotz, Roan D.; Kerley, Graham I. H.; Linklater, Wayne L.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Plotz, Roan D.] Australian Bur Meteorol, Climate & Oceans Support Program Pacific, Melbourne, Vic, Australia	Victoria University Wellington; University of Glasgow; Nelson Mandela University; Bureau of Meteorology - Australia	Plotz, RD (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand.; Plotz, RD (corresponding author), Australian Bur Meteorol, Climate & Oceans Support Program Pacific, Melbourne, Vic, Australia.	r.plotz@bom.gov.au	Kimanzi, Johnstone/AAD-2750-2019; Plotz, Roan/I-3878-2019; Grecian, James/A-7689-2012	Plotz, Roan/0000-0001-7192-9931; Grecian, James/0000-0002-6428-719X; Linklater, Wayne/0000-0003-2627-693X	Australian Geographic Society; Rufford Small Grants for Nature Conservation; U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act [98210-6-G102, 98218-8-G690]; Victoria University of Wellington Summer Scholarship Scheme Grant	Australian Geographic Society; Rufford Small Grants for Nature Conservation; U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act; Victoria University of Wellington Summer Scholarship Scheme Grant	This research was made possible through funding grants awarded to RDP and WLL from the Australian Geographic Society (http://www.australiangeographic.com.au/society/sponsored-projects), Rufford Small Grants for Nature Conservation (http://www.rufford.org), U.S. Fish & Wildlife Service administered Rhinoceros and Tiger Conservation Act of 1994 (grant agreement numbers 98210-6-G102, 98218-8-G690; http://www.fws.gov/international/wildlife-without-borders/rhino-and-tiger-conservation-fund.html). RDP was also awarded a Victoria University of Wellington Summer Scholarship Scheme Grant (http://www.victoria.ac.nz/students/money/scholarships/summer-scholarships) that helped with analysing data and developing the manuscript. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock K, 2009, STATUS MANAGEMENT BL; Adcock K., 2001, ANNOUNCING RMG CARRY, P99; Adcock K, 2001, RMG BLACK R IN PRESS, P1; Adcock K., 1996, STATUS MANAGEMENT BL; Alibhai SK, 2001, ORYX, V35, P284, DOI 10.1017/S0030605300032014; Anderson F., 1971, Journal Sth Afr Willdl Mgmt Ass, V1, P26; Balfour D, 2001, P SADC RHIN MAN GROU, P35; Balfour D. A., 2002, African Journal of Range & Forage Science, V19, P45, DOI 10.2989/10220110209485773; Berkeley EV, 2010, S AFR J WILDL RES, V40, P53, DOI 10.3957/056.040.0102; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Brookes PM, 1983, HLUHLUWE UMFOLOZI RE, P51; Buckle AP, 1997, CROP PROT, V16, P467, DOI 10.1016/S0261-2194(97)00010-0; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Clinning G., 2009, BLACK RHINO HLUHLUWE; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Emslie R., 2001, P SADC RHIN MAN GROU, P86; Emslie R, 2012, DICEROS BICORNIS IUC; Emslie R.H., 1999, THESIS U STELLENBOSC; Emslie RH, 2009, GUIDELINES SITU REIN; ESRI Inc, 2010, ESRI ARCMAP REL 10; Fanayo L, 2006, KZN BLACK RHINO STAT; Garnier JN, 2001, MOL ECOL, V10, P2031, DOI 10.1046/j.0962-1083.2001.01338.x; Gottert T, 2010, MAMMALIA, V74, P35, DOI 10.1515/MAMM.2010.012; Gula R, 2013, EUR J WILDLIFE RES, V59, P713, DOI 10.1007/s10344-013-0726-7; Harless ML, 2010, HERPETOL CONSERV BIO, V5, P374; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hitchins P. M., 1969, Lammergeyer, VNo. 10, P81; Hitchins PM, 1971, P S BIOT CSIR PRET S, P79; Hooge PN, 1997, ANIMAL EXTENSION ARC; JENNRICH RI, 1969, J THEOR BIOL, V22, P227, DOI 10.1016/0022-5193(69)90002-2; JEWELL P. A., 1966, SYMP ZOOL SOC LONDON, V18, P85; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lent PC, 2003, S AFR J WILDL RES, V33, P109; Lewin-Koh NJ, 2011, MAPTOOLS TOOLS READI; Lewis Timothy L., 1999, Chelonian Conservation and Biology, V3, P430; Linklater WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030664; Linklater WL, 2010, S AFR J WILDL RES, V40, P58, DOI 10.3957/056.040.0107; Linklater WL, 2010, ORYX, V44, P16, DOI 10.1017/S0030605309990986; Linklater WL, 2000, NEW ZEAL J ECOL, V24, P139; Loutit BD, 1984, QUAGGA, V7, P4; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Morgan S, 2009, BIOL CONSERV, V142, P384, DOI 10.1016/j.biocon.2008.10.033; Nams V., 2006, LOCATE 3 SOFTWARE VE; Odendaal-Holmes K, 2014, S AFR J WILDL RES, V44, P148, DOI 10.3957/056.044.0208; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Plotz RD, 2014, THESIS VICTORIA U WE; Plotz RD, 2009, AFR ZOOL, V44, P283, DOI 10.3377/004.044.0216; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid C, 2007, ORYX, V41, P247, DOI 10.1017/S0030605307001780; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shrader Adrian M., 2001, Pachyderm, V30, P81; Slotow R, 2010, ORYX, V44, P18, DOI 10.1017/S0030605309991025; Tatman SC, 2000, AFR J ECOL, V38, P163, DOI 10.1046/j.1365-2028.2000.00235.x; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Walters Michele, 2004, BMC Ecology, V4, P3, DOI 10.1186/1472-6785-4-3; White G. C., 1990, ANAL RADIO TRACKING; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3	63	15	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150571	10.1371/journal.pone.0150571	http://dx.doi.org/10.1371/journal.pone.0150571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028728	Green Published, Green Accepted, gold			2022-12-27	WOS:000373116500007
J	Doucette, A; Jiang, XH; Fryzek, J; Coalson, J; McLaurin, K; Ambrose, CS				Doucette, Abigail; Jiang, Xiaohui; Fryzek, Jon; Coalson, Jenna; McLaurin, Kimmie; Ambrose, Christopher S.			Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012	PLOS ONE			English	Article							DOWN-SYNDROME; PALIVIZUMAB PROPHYLAXIS; YOUNG-CHILDREN; PREVENTION; INFECTION; DISEASE; OUTCOMES; BURDEN; EPIDEMIOLOGY; EXPERIENCE	Background Respiratory syncytial virus (RSV) causes significant pediatric morbidity and is the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US infants from 2000. 2009; however, rates in infants at high risk for RSV have not been described. This study examined RSV and unspecified bronchiolitis (UB) hospitalization rates from 1997. 2012 among US high-risk infants. Methods The Kids' Inpatient Database (KID) infant annual RSV (ICD-9 079.6, 466.11, 480.1) and UB (ICD-9 466.19, 466.1) hospitalization rates were estimated using weighted counts. Denominators were based on birth hospitalizations with conditions associated with high-risk for RSV: chronic perinatal respiratory disease (chronic lung disease [CLD]); congenital airway anomalies (CAA); congenital heart disease (CHD); Down syndrome (DS); and other genetic, metabolic, musculoskeletal, and immunodeficiency conditions. Preterm infants could not be identified. Hospitalizations were characterized by mechanical ventilation, inpatient mortality, length of stay, and total cost (2015$). Poisson and linear regression were used to test statistical significance of trends. Results RSV and UB hospitalization rates were substantially elevated for infants with higher-risk CHD, CLD, CAA and DS without CHD compared with all infants. RSV rates declined by 47.0% in CLD and 49.7% in higher-risk CHD infants; no other declines in high-risk groups were observed. UB rates increased in all high-risk groups except for a 22.5% decrease among higher-risk CHD. Among high-risk infants, mechanical ventilation increased through 2012 to 20.4% and 13.5% of RSV and UB hospitalizations; geometric mean cost increased to $31,742 and $25,962, respectively, and RSV mortality declined to 0.9%. Conclusions Among high-risk infants between 1997 and 2012, RSV hospitalization rates declined among CLD and higher-risk CHD infants, coincident with widespread RSV immunoprophylaxis use in these populations. UB hospitalization rates increased in all high-risk groups except higher-risk CHD, suggesting improvement in the health status of higher-risk CHD infants, potentially due to enhanced surgical interventions. Mechanical ventilation use and RSV and UB hospitalization costs increased while RSV mortality declined.	[Doucette, Abigail; Jiang, Xiaohui; Fryzek, Jon; Coalson, Jenna] Epidstat, Ann Arbor, MI USA; [McLaurin, Kimmie; Ambrose, Christopher S.] AstraZeneca, Gaithersburg, MD USA	AstraZeneca	Ambrose, CS (corresponding author), AstraZeneca, Gaithersburg, MD USA.	AmbroseC@MedImmune.com	Coalson, Jenna/AAD-6653-2020	Coalson, Jenna/0000-0002-8591-5642; Ambrose, Christopher/0000-0003-4175-7336	AstraZeneca; Epidstat	AstraZeneca(AstraZeneca); Epidstat	This research was funded by AstraZeneca. Employees of AstraZeneca (KM, CSA) were involved in the study design, decision to publish, and preparation of the manuscript. The funder provided support in the form of salaries for authors (KM, CSA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AstraZeneca provided Epidstat with research support for this study. Employees of Epidstat were involved in the study design (JF), data analysis (AD, XJ, JC), and preparation of the manuscript (AD, XJ, JF, JC). Epidstat provided support in the form of salaries for authors (AD, XJ, JF, JC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Editorial assistance was provided by Complete Healthcare Communications, LLC (Chadds Ford, PA, USA) and funded by AstraZeneca.	Abramson JS, 2003, PEDIATRICS, V112, P1442; Arnold SR, 1999, PEDIATR INFECT DIS J, V18, P866, DOI 10.1097/00006454-199910000-00006; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Centers for Disease Control and Prevention, RSV INFECTION AND IN; Checchia PA, 2011, PEDIATR CRIT CARE ME, V12, P580, DOI 10.1097/PCC.0b013e3182070990; Cohen SA, 2008, PEDIATR CARDIOL, V29, P382, DOI 10.1007/s00246-007-9039-5; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; Erikssen G, 2015, CIRCULATION, V131, P337, DOI 10.1161/CIRCULATIONAHA.114.012033; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Frogel M, 2008, J PERINATOL, V28, P511, DOI 10.1038/jp.2008.28; Groothuis Jessie R, 2011, Clin Epidemiol, V3, P245, DOI 10.2147/CLEP.S17189; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Iwane MK, 2013, J INFECT DIS, V208, pS165, DOI 10.1093/infdis/jit484; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Makari D, 2015, CLIN PEDIATR, V54, P594, DOI 10.1177/0009922814546040; Mitchell I, 2006, PEDIATR PULM, V41, P1167, DOI 10.1002/ppul.20507; Mori M, 2014, J INFECT CHEMOTHER, V20, P455, DOI 10.1016/j.jiac.2014.05.001; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Parnes C, 2003, PEDIATR PULM, V35, P484, DOI 10.1002/ppul.10288; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Romero JR, 2003, PEDIATR INFECT DIS J, V22, pS46, DOI 10.1097/00006454-200302001-00007; Sample NNI, AGENCY HEALTHCARE RE; Simoes EAF, 2002, RESP RES, V3, DOI 10.1186/rr187; Sorrentino M, 2000, PEDIATR INFECT DIS J, V19, P1068, DOI 10.1097/00006454-200011000-00007; Stagliano DR, 2015, J PEDIATR-US, V166, P703, DOI 10.1016/j.jpeds.2014.11.058; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Wonder C, NATALITY 2003 2006; Wonder C, 2007, NATALITY 2007 2013; Wonder C., NATALITY 1995 2002; Yi H, 2014, PEDIATRICS, V133, P1031, DOI 10.1542/peds.2013-3916; Zachariah P, 2012, J PEDIATR-US, V160, P827, DOI 10.1016/j.jpeds.2011.11.004; Zachariah P, 2011, PEDIATR INFECT DIS J, V30, P442, DOI 10.1097/INF.0b013e318201813b	39	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152208	10.1371/journal.pone.0152208	http://dx.doi.org/10.1371/journal.pone.0152208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050095	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500030
J	Edwards, HH; Martin, J; Deutsch, CJ; Muller, RG; Koslovsky, SM; Smith, AJ; Barlas, ME				Edwards, Holly H.; Martin, Julien; Deutsch, Charles J.; Muller, Robert G.; Koslovsky, Stacie M.; Smith, Alexander J.; Barlas, Margaret E.			Influence of Manatees' Diving on Their Risk of Collision with Watercraft	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; FLORIDA MANATEES; AERIAL SURVEYS; ABUNDANCE; PROBABILITY; FRAMEWORK; WINBUGS; MAMMALS	Watercraft pose a threat to endangered Florida manatees (Trichechus manatus latirostris). Mortality from watercraft collisions has adversely impacted the manatee population's growth rate, therefore reducing this threat is an important management goal. To assess factors that contribute to the risk of watercraft strikes to manatees, we studied the diving behavior of nine manatees carrying GPS tags and time-depth recorders in Tampa Bay, Florida, during winters 2002-2006. We applied a Bayesian formulation of generalized linear mixed models to depth data to model the probability (P-t) that manatees would be no deeper than 1.25 m from the water's surface as a function of behavioral and habitat covariates. Manatees above this threshold were considered to be within striking depth of a watercraft. Seventy-eight percent of depth records (individual range 62-86%) were within striking depth (mean = 1.09 m, max = 16.20 m), illustrating how vulnerable manatees are to strikes. In some circumstances manatees made consecutive dives to the bottom while traveling, even in areas >14 m, possibly to conserve energy. This is the first documentation of potential cost-efficient diving behavior in manatees. Manatees were at higher risk of being within striking depth in shallow water (<0.91 m), over seagrass, at night, and while stationary or moving slowly; they were less likely to be within striking depth when <= 50 m from a charted waterway. In shallow water the probability of a manatee being within striking depth was 0.96 (CI = 0.93-0.98) and decreased as water depth increased. The probability was greater over seagrass (P-t = 0.96, CI = 0.93-0.98) than over other substrates (P-t = 0.73, CI = 0.58-0.84). Quantitative approaches to assessing risk can improve the effectiveness of manatee conservation measures by helping identify areas for protection.	[Edwards, Holly H.; Muller, Robert G.; Koslovsky, Stacie M.; Smith, Alexander J.; Barlas, Margaret E.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, 100 Eighth Ave SE, St Petersburg, FL 33710 USA; [Martin, Julien] US Geol Survey, Southeast Ecol Sci Ctr, 7920 NW 71st St, Gainesville, FL 32653 USA; [Deutsch, Charles J.] Florida Fish & Wildlife Conservat Commiss, Wildlife Res Lab, Fish & Wildlife Res Inst, 1105 SW Williston Rd, Gainesville, FL 32610 USA; [Smith, Alexander J.] Ramboll ENVIRON Int Corp, 10150 Highland Manor Dr, Tampa, FL 33610 USA	Florida Fish & Wildlife Conservation Commission; United States Department of the Interior; United States Geological Survey; Florida Fish & Wildlife Conservation Commission	Edwards, HH (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, 100 Eighth Ave SE, St Petersburg, FL 33710 USA.	holly.edwards@myfwc.com		Martin, Julien/0000-0002-7375-129X; Barlas, Margaret/0000-0002-2378-4296	Wildlife Foundation of Florida (Conserve Wildlife Tag Fund); U.S. Fish and Wildlife Service; Pinellas County Environmental Fund; Tampa Port Authority; FWC's Save the Manatee Trust Fund; National Sea Grant College Program of the USA; Department of Commerce's National Oceanic and Atmospheric Administration (NOAA) [NA 14OAR4170108]	Wildlife Foundation of Florida (Conserve Wildlife Tag Fund); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Pinellas County Environmental Fund; Tampa Port Authority; FWC's Save the Manatee Trust Fund; National Sea Grant College Program of the USA; Department of Commerce's National Oceanic and Atmospheric Administration (NOAA)	This work was funded by the Wildlife Foundation of Florida (Conserve Wildlife Tag Fund), U.S. Fish and Wildlife Service, the Pinellas County Environmental Fund, Tampa Port Authority, and FWC's Save the Manatee Trust Fund. Support was also provided by the National Sea Grant College Program of the USA. Department of Commerce's National Oceanic and Atmospheric Administration (NOAA) Grant No. NA 14OAR4170108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauduin S, 2013, BIOL CONSERV, V159, P127, DOI 10.1016/j.biocon.2012.10.031; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Calleson CS, 2014, ENDANGER SPECIES RES, V26, P127, DOI 10.3354/esr00638; Carlson P, 2011, SEAGRASS RECOVERY TA; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Deutsch Charles J., 2012, P23; Deutsch CJ, 2006, CWT040512 WILDL FDN; Edwards HH, 2007, J WILDLIFE MANAGE, V71, P2052, DOI 10.2193/2005-645; Fonnesbeck CJ, 2009, ENVIRON ECOL STAT SE, V3, P563, DOI 10.1007/978-0-387-78151-8_24; FWC (Florida Fish and Wildlife Conservation Commission), 2007, FLOR MAN MAN PLAN TR; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Hess KW, 2001, 11 NOAA NOS CS; IRVINE AB, 1983, BIOL CONSERV, V25, P315; Kery M., 2010, INTRO WINBUGS ECOLOG; Laist DW, 2005, COAST MANAGE, V33, P279, DOI 10.1080/08920750590952018; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marsh H., 2011, ECOLOGY CONSERVATION; Martin J, 2016, METHODS ECOL EVOL, V7, P42, DOI 10.1111/2041-210X.12447; Martin J, 2015, BIOL CONSERV, V186, P44, DOI 10.1016/j.biocon.2015.02.029; Parks SE, 2012, BIOL LETTERS, V8, P57, DOI 10.1098/rsbl.2011.0578; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Runge MC, 2007, 2007108634 US GEOL S; Rycyk A, 2013, THESIS FLORIDA STATE; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sidman C, 2004, TP130 U FLOR SEA GRA; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tampa Bay Estuary Program, 2006, 0606 TP TAMP BAY EST; van der Hoop JM, 2012, ECOL APPL, V22, P2021, DOI 10.1890/11-1841.1; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Williams TM, 2001, AM ZOOL, V41, P166, DOI 10.1668/0003-1569(2001)041[0166:ISBMAS]2.0.CO;2; Worthy GAJ, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P791, DOI 10.1201/9781420041637.ch36	35	13	14	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151450	10.1371/journal.pone.0151450	http://dx.doi.org/10.1371/journal.pone.0151450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049326	Green Published, gold			2022-12-27	WOS:000373603500007
J	Geng, J; Qian, J; Cheng, H; Ji, FH; Liu, H				Geng, Jun; Qian, Ju; Cheng, Hao; Ji, Fuhai; Liu, Hong			The Influence of Perioperative Dexmedetomidine on Patients Undergoing Cardiac Surgery: A Meta-Analysis	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; BYPASS GRAFT-SURGERY; ATRIAL-FIBRILLATION; SYMPTOMATIC TACHYDYSRHYTHMIAS; NONCARDIAC SURGERY; SEDATION; DELIRIUM; PROPOFOL; INFUSION; PREDICTOR	Background The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. We conducted a meta-analysis comparing the postoperative complications in patients undergoing cardiac surgery with dexmedetomidine versus other perioperative medications to determine the influence of perioperative dexmedetomidine on cardiac surgery patients. Methods Randomized or quasi-randomized controlled trials comparing outcomes in patients who underwent cardiac surgery with dexmedetomidine, another medication, or a placebo were retrieved from EMBASE, PubMed, the Cochrane Library, and Science Citation Index. Results A total of 1702 patients in 14 studies met the selection criteria among 1,535 studies that fit the research strategy. Compared to other medications, dexmedetomidine has combined risk ratios of 0.28 (95% confidence interval [CI] 0.15, 0.55, P = 0.0002) for ventricular tachycardia, 0.35 (95% CI 0.20, 0.62, P = 0.0004) for postoperative delirium, 0.76 (95% CI 0.55, 1.06, P = 0.11) for atrial fibrillation, 1.08 (95% CI 0.74, 1.57, P = 0.69) for hypotension, and 2.23 (95% CI 1.36, 3.67, P = 0.001) for bradycardia. In addition, dexmedetomidine may reduce the length of intensive care unit (ICU) and hospital stay. Conclusions This meta-analysis revealed that the perioperative use of dexmedetomidine in patients undergoing cardiac surgery can reduce the risk of postoperative ventricular tachycardia and delirium, but may increase the risk of bradycardia. The estimates showed a decreased risk of atrial fibrillation, shorter length of ICU stay and hospitalization, and increased risk of hypotension with dexmedetomidine.	[Geng, Jun; Qian, Ju; Cheng, Hao; Ji, Fuhai] Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Jiangsu, Peoples R China; [Cheng, Hao; Liu, Hong] Univ Calif Davis Hlth Syst, Dept Anesthesiol & Pain Med, Sacramento, CA USA	Soochow University - China; University of California System; University of California Davis	Cheng, H (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Anesthesiol, Suzhou, Jiangsu, Peoples R China.; Cheng, H (corresponding author), Univ Calif Davis Hlth Syst, Dept Anesthesiol & Pain Med, Sacramento, CA USA.	chenghaojs@163.com		Liu, Hong/0000-0003-3611-7131	National Natural Science Foundation of China [81471835, 81471889]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China, No. 81471835 and No. 81471889 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Aziz N, 2011, INT J CLIN PHARM-NET, V33, P150, DOI 10.1007/s11096-011-9480-7; Ai D, 2015, J CARDIOTHOR VASC AN, V29, P396, DOI 10.1053/j.jvca.2014.05.013; AMAR D, 1995, CHEST, V108, P349, DOI 10.1378/chest.108.2.349; Amar D, 1996, ANN THORAC SURG, V61, P1506, DOI 10.1016/0003-4975(96)00111-7; Asmussen S, 2013, BURNS, V39, P625, DOI 10.1016/j.burns.2013.01.008; Balkanay OO, 2015, INTERACT CARDIOV TH, V20, P209, DOI 10.1093/icvts/ivu367; Biccard BM, 2008, ANAESTHESIA, V63, P4, DOI 10.1111/j.1365-2044.2007.05306.x; Corbett SM, 2005, CRIT CARE MED, V33, P940, DOI 10.1097/01.CCM.0000162565.18193.E5; Coriat P, 2001, ANESTH ANALG, V92, P1081; Cui J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/358396; Dasta JF, 2004, ANN PHARMACOTHER, V38, P1130, DOI 10.1345/aph.1D615; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Hall JE, 2000, ANESTH ANALG, V90, P699, DOI 10.1097/00000539-200003000-00035; Harpole DH, 1996, ANN THORAC SURG, V61, P977, DOI 10.1016/0003-4975(95)01174-9; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoy SM, 2011, DRUGS, V71, P1481, DOI 10.2165/11207190-000000000-00000; Ickeringill M, 2004, ANAESTH INTENS CARE, V32, P741, DOI 10.1177/0310057X0403200602; Ingersoll-Weng E, 2004, ANESTHESIOLOGY, V100, P738, DOI 10.1097/00000542-200403000-00040; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jalonen J, 1997, ANESTHESIOLOGY, V86, P331; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Kamibayashi T, 2000, ANESTHESIOLOGY, V93, P1345, DOI 10.1097/00000542-200011000-00030; Karaman Y, 2015, J ANESTH, V29, P522, DOI 10.1007/s00540-015-1975-2; Khalil MA, 2013, SEMIN CARDIOTHORAC V, V17, P66, DOI 10.1177/1089253212463969; Leino K, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-9; Lin YY, 2012, CRIT CARE, V16, DOI 10.1186/cc11646; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Mangano DT, 1999, ANESTHESIOLOGY, V91, P1521, DOI 10.1097/00000542-199911000-00046; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Maze M, 2001, CRIT CARE CLIN, V17, P881, DOI 10.1016/S0749-0704(05)70185-8; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Park Jae Bum, 2014, Korean J Thorac Cardiovasc Surg, V47, P249, DOI 10.5090/kjtcs.2014.47.3.249; Patel VJ, 2014, PEDIATR ANESTH, V24, P446, DOI 10.1111/pan.12368; Polanczyk CA, 1998, ANN INTERN MED, V129, P279, DOI 10.7326/0003-4819-129-4-199808150-00003; Polderman KH, 2005, CRIT CARE, V9, P335, DOI 10.1186/cc3755; Ren JJ, 2013, EXP THER MED, V6, P497, DOI 10.3892/etm.2013.1183; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; Sichrovsky TC, 2008, ANESTH ANALG, V106, P1784, DOI 10.1213/ane.0b013e318172fafc; Sun L, 2014, ACTA ANAESTH SCAND, V58, P642, DOI 10.1111/aas.12292; Szumita PM, 2007, AM J HEALTH-SYST PH, V64, P37, DOI 10.2146/ajhp050508; Tachibana K, 2012, PEDIATR ANESTH, V22, P713, DOI 10.1111/j.1460-9592.2012.03810.x; TALKE P, 1995, ANESTHESIOLOGY, V82, P620, DOI 10.1097/00000542-199503000-00003; TAYLOR GJ, 1987, AM J CARDIOL, V60, P905, DOI 10.1016/0002-9149(87)91045-9; Tosun Z, 2013, J CARDIOTHOR VASC AN, V27, P710, DOI 10.1053/j.jvca.2012.12.013; Videira RLR, 2004, ANESTHESIOLOGY, V101, P1479; Wang ZX, 2014, BRIT J ANAESTH, V112, P1055, DOI 10.1093/bja/aeu132; Wijeysundera DN, 2003, AM J MED, V114, P742, DOI 10.1016/S0002-9343(03)00165-7	52	36	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152829	10.1371/journal.pone.0152829	http://dx.doi.org/10.1371/journal.pone.0152829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049318	Green Published, gold			2022-12-27	WOS:000373603500058
J	Luter, HM; Duckworth, AR; Wolff, CW; Evans-Illidge, E; Whalan, S				Luter, Heidi M.; Duckworth, Alan R.; Wolff, Carsten W.; Evans-Illidge, Elizabeth; Whalan, Steve			Recruitment Variability of Coral Reef Sessile Communities of the Far North Great Barrier Reef	PLOS ONE			English	Article							BENTHIC ASSEMBLAGES; SPATIAL VARIABILITY; SETTLEMENT CUES; TORRES STRAIT; LIZARD ISLAND; PATTERNS; SCALES; ECOLOGY; INVERTEBRATES; POPULATIONS	One of the key components in assessing marine sessile organism demography is determining recruitment patterns to benthic habitats. An analysis of serially deployed recruitment tiles across depth (6 and 12 m), seasons (summer and winter) and space (meters to kilometres) was used to quantify recruitment assemblage structure (abundance and percent cover) of corals, sponges, ascidians, algae and other sessile organisms from the northern sector of the Great Barrier Reef (GBR). Polychaetes were most abundant on recruitment titles, reaching almost 50% of total recruitment, yet covered <5% of each tile. In contrast, mean abundances of sponges, ascidians, algae, and bryozoans combined was generally less than 20% of total recruitment, with percentage cover ranging between 15-30% per tile. Coral recruitment was very low, with <1 recruit per tile identified. A hierarchal analysis of variation over a range of spatial and temporal scales showed significant spatio-temporal variation in recruitment patterns, but the highest variability occurred at the lowest spatial scale examined (1 m -among tiles). Temporal variability in recruitment of both numbers of taxa and percentage cover was also evident across both summer and winter. Recruitment across depth varied for some taxonomic groups like algae, sponges and ascidians, with greatest differences in summer. This study presents some of the first data on benthic recruitment within the northern GBR and provides a greater understanding of population ecology for coral reefs.	[Luter, Heidi M.] NAMRA, Darwin, NT, Australia; [Luter, Heidi M.] Australian Inst Marine Sci, Arafura Timor Res Facil, Darwin, NT, Australia; [Luter, Heidi M.; Duckworth, Alan R.; Wolff, Carsten W.; Evans-Illidge, Elizabeth] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Whalan, Steve] Cent Caribbean Marine Inst, Little Cayman, Cayman Islands, Cayman Islands; [Whalan, Steve] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia	Australian Institute of Marine Science; Australian Institute of Marine Science; Southern Cross University	Luter, HM (corresponding author), NAMRA, Darwin, NT, Australia.; Luter, HM (corresponding author), Australian Inst Marine Sci, Arafura Timor Res Facil, Darwin, NT, Australia.; Luter, HM (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	h.luter@aims.gov.au	Evans-Illidge, Libby/AAK-1521-2021; Duckworth, Alan/F-3290-2017; Luter, Heidi M/E-9519-2016	Duckworth, Alan/0000-0002-5451-7633; Luter, Heidi M/0000-0001-7810-7076; Whalan, Steve/0000-0001-6786-8945	Marine and Tropical Sciences Research Facility [1.3.2]	Marine and Tropical Sciences Research Facility	This study was funded by the Marine and Tropical Sciences Research Facility, Project 1.3.2: Ecological role and potential economic value of sponges to the Torres Strait.	Abdul Wahab MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098181; Abdul Wahab MA, 2011, CORAL REEFS, V30, P451, DOI 10.1007/s00338-011-0727-5; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Bauman AG, 2014, MAR ECOL PROG SER, V499, P115, DOI 10.3354/meps10662; Bell JJ, 2014, CONSERV GENET RESOUR, V6, P105, DOI 10.1007/s12686-013-0015-5; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Colvard NB, 2011, J EXP MAR BIOL ECOL, V397, P153, DOI 10.1016/j.jembe.2010.11.015; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Doropoulos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128535; Duckworth AR, 2008, CONT SHELF RES, V28, P2168, DOI 10.1016/j.csr.2008.03.024; Duckworth AR, 2007, AQUACULTURE, V271, P188, DOI 10.1016/j.aquaculture.2007.06.037; Duckworth AR, 2016, MAR FRESHWATER RES, V67, P246, DOI 10.1071/MF14308; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; Edmunds PJ, 2015, MAR FRESHWATER RES, V66, P609, DOI 10.1071/MF14139; Edmunds PJ, 2010, MAR ECOL PROG SER, V414, P75, DOI 10.3354/meps08728; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Haywood MDE, 2008, CONT SHELF RES, V28, P2304, DOI 10.1016/j.csr.2008.03.039; Holloway MG, 2002, ECOL APPL, V12, P1803, DOI 10.2307/3099939; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUTCHINGS PA, 1981, B MAR SCI, V31, P410; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Lasker HR, 2015, PEERJ, V3, DOI 10.7717/peerj.1019; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MAIDA M, 1995, B MAR SCI, V56, P303; Martin R, 2014, P13AC00436; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; MULLINEAUX LS, 1990, LIMNOL OCEANOGR, V35, P409, DOI 10.4319/lo.1990.35.2.0409; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; O'Leary JK, 2011, CORAL REEFS, V30, P1013, DOI 10.1007/s00338-011-0789-4; OSMAN RW, 1977, ECOL MONOGR, V47, P37, DOI 10.2307/1942223; Palumbi SR, 2003, ECOL APPL, V13, pS146; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Ribas J, 2015, ZOOTAXA, V4019, P7, DOI 10.11646/zootaxa.4019.1.4; Shanks AL, 2003, ECOL APPL, V13, pS159; Smale DA, 2013, MAR ECOL PROG SER, V482, P29, DOI 10.3354/meps10273; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; TODD CD, 1986, J EXP MAR BIOL ECOL, V99, P199, DOI 10.1016/0022-0981(86)90224-8; Tuya F, 2004, MAR ECOL PROG SER, V278, P157, DOI 10.3354/meps278157; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Wahl M, 2001, J EXP MAR BIOL ECOL, V258, P101, DOI 10.1016/S0022-0981(00)00348-8; Watson DI, 2004, MAR BIOL, V145, P201, DOI 10.1007/s00227-003-1291-5; Welsh JQ, 2012, CORAL REEFS, V31, P991, DOI 10.1007/s00338-012-0922-z; Whalan S, 2008, MAR ECOL PROG SER, V368, P145, DOI 10.3354/meps07573; Whalan S, 2008, AQUAT BIOL, V3, P111, DOI 10.3354/ab00066; Whalan S, 2005, MAR BIOL, V146, P425, DOI 10.1007/s00227-004-1466-8; Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; Whalan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030386; WILKINSON CR, 1989, CORAL REEFS, V8, P127, DOI 10.1007/BF00338268	66	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153184	10.1371/journal.pone.0153184	http://dx.doi.org/10.1371/journal.pone.0153184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049650	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500111
J	Tran, BX; Nguyen, LH; Nguyen, LP; Nguyen, CT; Phan, HTT; Latkin, CA				Bach Xuan Tran; Long Hoang Nguyen; Lan Phuong Nguyen; Cuong Tat Nguyen; Huong Thi Thu Phan; Latkin, Carl A.			Methadone Maintenance Treatment Promotes Referral and Uptake of HIV Testing and Counselling Services amongst Drug Users and Their Partners	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; QUALITY-OF-LIFE; PEER EDUCATION; INJECT DRUGS; PREVENTION; ATTITUDES; HIV/AIDS; ADULTS; WOMEN; DETERMINANTS	Background Methadone maintenance treatment (MMT) reduces HIV risk behaviors and improves access to HIV-related services among drug users. In this study, we assessed the uptake and willingness of MMT patients to refer HIV testing and counseling (HTC) service to their sexual partners and relatives. Methods Health status, HIV-related risk behaviors, and HTC uptake and referrals of 1,016 MMT patients in Hanoi and Nam Dinh were investigated. Willingness to pay (WTP) for HTC was elicited using a contingent valuation technique. Interval and logistic regression models were employed to determine associated factors. Results Most of the patients (94.2%) had received HTC, 6.6 times on average. The proportion of respondents willing to refer their partners, their relatives and to be voluntary peer educators was 45.7%, 35.3%, and 33.3%, respectively. Attending MMT integrated with HTC was a facilitative factor for HTC uptake, greater WTP, and volunteering as peer educators. Older age, higher education and income, and HIV positive status were positively related to willingness to refer partners or relatives, while having health problems (mobility, usual care, pain/discomfort) was associated with lower likelihood of referring others or being a volunteer. Over 90% patients were willing to pay an average of US $17.9 for HTC service. Conclusion The results highlighted the potential role of MMT patients as referrers to HTC and voluntary peer educators. Integrating HIV testing with MMT services and applying users' fee are potential strategies to mobilize resources and encourage HIV testing among MMT patients and their partners.	[Bach Xuan Tran; Long Hoang Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Lan Phuong Nguyen] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Cuong Tat Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Huong Thi Thu Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vietnam National University Hanoi; Harvard University; Harvard T.H. Chan School of Public Health; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi 100803, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	bach@jhu.edu	Nguyen, Long/E-6145-2015	Nguyen, Long/0000-0003-1658-2394				Achmad Yanni Melliandari, 2009, Acta Med Indones, V41 Suppl 1, P23; [Anonymous], 2014, HIV AIDS JUNPO 90 90; [Anonymous], 2013, ENSURING FINANCE HIV; Tran BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142644; Tran BX, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0085-7; Tran BX, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0063-0; Tran BX, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0640-z; Tran BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086267; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690; Tran BX, 2013, B WORLD HEALTH ORGAN, V91, P475, DOI 10.2471/BLT.12.115147; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051569; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, AIDS BEHAV, V16, P1988, DOI 10.1007/s10461-012-0271-5; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Becker J, 2009, PAN AFR MED J, V3, P1; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Control VAoHA, 2015, ANN REV HIV AIDS CON; Control VAoHA, 2013, VIETN HIV AIDS EST P; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Corneli A, 2008, INT J TUBERC LUNG D, V12, pS79; Cross MJ, 2000, RHEUMATOLOGY, V39, P1242, DOI 10.1093/rheumatology/39.11.1242; Day CA, 2008, AIDS CARE, V20, P116, DOI 10.1080/09540120701426524; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Group E, 2011, EQ 5D 5L US GUID BAS; Herriges JA, 1996, J ENVIRON ECON MANAG, V30, P112, DOI 10.1006/jeem.1996.0008; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Lang HC, 2010, VALUE HEALTH, V13, P743, DOI 10.1111/j.1524-4733.2010.00743.x; Lliyasu Z, 2006, J NATL MED ASSOC, V98, P1917; Nguyen LH, 2016, AIDS BEHAV, V20, P848, DOI 10.1007/s10461-015-1188-6; Luo J., 2014, ACAD MANAGEMENT P, V2014, DOI [10.5465/ambpp.2014.11518abstract, DOI 10.5465/AMBPP.2014.11518ABSTRACT, 10.5465/AMBPP.2014.11965abstract, DOI 10.5465/AMBPP.2014.11965ABSTRACT]; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mahmoud MM, 2007, J MED VIROL, V79, P469, DOI 10.1002/jmv.20850; Markwick N, 2014, J EPIDEMIOL COMMUN H, V68, P675, DOI 10.1136/jech-2013-203707; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Matovu JKB, 2005, AIDS, V19, P503, DOI 10.1097/01.aids.0000162339.43310.33; McQuoid-Mason D, 2007, SAMJ S AFR MED J, V97, P416; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Metsch L, 2015, JAIDS-J ACQ IMM DEF, V69, pS162, DOI 10.1097/QAI.0000000000000660; Minh Hoang Van, 2012, Value Health Reg Issues, V1, P36, DOI 10.1016/j.vhri.2012.03.012; Narbro K, 2000, INT J TECHNOL ASSESS, V16, P50, DOI 10.1017/S0266462300016159; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; Nguyen TTH, 2011, AIDS EDUC PREV, V23, P30, DOI 10.1521/aeap.2011.23.3_supp.30; Nguyen TA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-37; Obermeyer CM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001329; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Rome A, 2010, SCAND J PUBLIC HEALT, V38, P151, DOI 10.1177/1403494809357099; Rosenberger RS, 2012, J FOREST ECON, V18, P271, DOI 10.1016/j.jfe.2012.06.003; Salam MA, 2006, ENVIRON MONIT ASSESS, V118, P165, DOI 10.1007/s10661-006-1488-4; SAXON AJ, 1991, J ACQ IMMUN DEF SYND, V4, P938; Seewald R, 2013, AM J DRUG ALCOHOL AB, V39, P247, DOI 10.3109/00952990.2013.798662; Sergeyev B, 1999, J DRUG ISSUES, V29, P777, DOI 10.1177/002204269902900403; Son VH, 2015, VIETN NAT AIDS C 201; Tang CH, 2007, HEALTH POLICY, V82, P251, DOI 10.1016/j.healthpol.2006.09.007; The Commission on AIDS in Asia, RED AIDS AS CRAFT EF; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Tran Bach Xuan, 2013, Int J Drug Policy, V24, pe105, DOI 10.1016/j.drugpo.2013.07.007; UNAIDS, 2014, VIETN NAT AIDS SPEND; Uzochukwu B, 2011, HEALTH POLICY, V99, P277, DOI 10.1016/j.healthpol.2010.11.007; van Dyk A C, 2003, Curationis, V26, P4; Nguyen VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126659; Wang M, 2015, SUBST USE MISUSE, V50, P15, DOI 10.3109/10826084.2014.957768; Ward J, 1994, Drug Alcohol Rev, V13, P327, DOI 10.1080/09595239400185431; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2015, CONSOLIDATED GUIDELI; Wimbush J, 1996, J SUBST ABUSE, V8, P263, DOI 10.1016/S0899-3289(96)90304-1; World Health Organization, 2012, SERV DEL APPR HIV TE; Xia YH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-899; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906	75	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152804	10.1371/journal.pone.0152804	http://dx.doi.org/10.1371/journal.pone.0152804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046029	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600036
J	Kang, E; Yousefi, M; Gruenheid, S				Kang, Eugene; Yousefi, Mitra; Gruenheid, Samantha			R-Spondins Are Expressed by the Intestinal Stroma and are Differentially Regulated during Citrobacter rodentium- and DSS-Induced Colitis in Mice	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; STRUCTURAL BASIS; STEM-CELLS; R-SPONDIN2; CATENIN; LGR5; IDENTIFICATION; RECOGNITION; TRANSCRIPTS; MAINTENANCE	The R-spondin family of proteins has recently been described as secreted enhancers of beta-catenin activation through the canonical Wnt signaling pathway. We previously reported that Rspo2 is a major determinant of susceptibility to Citrobacter rodentium-mediated colitis in mice and recent genome-wide association studies have revealed RSPO3 as a candidate Crohn's disease-specific inflammatory bowel disease susceptibility gene in humans. However, there is little information on the endogenous expression and cellular source of R-spondins in the colon at steady state and during intestinal inflammation. RNA sequencing and qRT-PCR were used to assess the expression of R-spondins at steady state and in two mouse models of colonic inflammation. The cellular source of R-spondins was assessed in specific colonic cell populations isolated by cell sorting. Data mining from publicly available datasets was used to assess the expression of R-spondins in the human colon. At steady state, colonic expression of R-spondins was found to be exclusive to non-epithelial CD45(-) lamina propria cells, and Rspo3/RSPO3 was the most highly expressed R-spondin in both mouse and human colon. R-spondin expression was found to be highly dynamic and differentially regulated during C. rodentium infection and dextran sodium sulfate (DSS) colitis, with notably high levels of Rspo3 expression during DSS colitis, and high levels of Rspo2 expression during C. rodentium infection, specifically in susceptible mice. Our data are consistent with the hypothesis that in the colon, R-spondins are expressed by subepithelial stromal cells, and that Rspo3/RSPO3 is the family member most implicated in colonic homeostasis. The differential regulation of the R-spondins in different models of intestinal inflammation indicate they respond to specific pathogenic and inflammatory signals that differ in the two models and provides further evidence that this family of proteins plays a key role in linking intestinal inflammation and homeostasis.	[Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; McGill Univ, Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University	Gruenheid, S (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	samantha.gruenheid@mcgill.ca		Gruenheid, Samantha/0000-0002-0908-6715	Canadian Institutes of Health Research grant [MOP 133580]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	Funding for this work came from Canadian Institutes of Health Research grant # MOP 133580, http://cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Aoki R, 2016, CELL MOL GASTROENTER, V2, P175, DOI 10.1016/j.jcmgh.2015.12.004; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; Diez E, 2011, GENES IMMUN, V12, P280, DOI 10.1038/gene.2010.76; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Nam JS, 2007, DEV BIOL, V311, P124, DOI 10.1016/j.ydbio.2007.08.023; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinmura K, 2014, MOL BIOL REP, V41, P5375, DOI 10.1007/s11033-014-3409-x; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Teatero SA, 2011, GUT MICROBES, V2, P173, DOI 10.4161/gmic.2.3.16297; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Yamada W, 2009, BIOCHEM BIOPH RES CO, V381, P453, DOI 10.1016/j.bbrc.2009.02.066; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	40	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152859	10.1371/journal.pone.0152859	http://dx.doi.org/10.1371/journal.pone.0152859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046199	Green Published, gold			2022-12-27	WOS:000373599600040
J	Kasai, S; Arakawa, N; Okubo, A; Shigeeda, W; Yasuhira, S; Masuda, T; Akasaka, T; Shibazaki, M; Maesawa, C				Kasai, Shuya; Arakawa, Nobuyuki; Okubo, Ayaka; Shigeeda, Wataru; Yasuhira, Shinji; Masuda, Tomoyuki; Akasaka, Toshihide; Shibazaki, Masahiko; Maesawa, Chihaya			NAD(P)H: Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG	PLOS ONE			English	Article							PHASE-II TRIAL; NRF2; COMBINATION; RESISTANCE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; 17-DEMETHOXYGELDANAMYCIN; HEAT-SHOCK-PROTEIN-90; 17-ALLYLAMINO; GELDANAMYCIN; ACTIVATION	The KEAP1-NRF2 pathway regulates cellular redox homeostasis by transcriptional induction of genes associated with antioxidant synthesis and detoxification in response to oxidative stress. Previously, we reported that KEAP1 mutation elicits constitutive NRF2 activation and resistance to cisplatin (CDDP) and dacarbazine (DTIC) in human melanomas. The present study was conducted to clarify whether an HSP90 inhibitor, 17-AAG, efficiently eliminates melanoma with KEAP1 mutation, as the NRF2 target gene, NQO1, is a key enzyme in 17-AAG bioactivation. In melanoma and non-small cell lung carcinoma cell lines with or without KEAP1 mutations, NQO1 expression and 17-AAG sensitivity are inversely correlated. NQO1 is highly expressed in normal melanocytes and in several melanoma cell lines despite the presence of wild-type KEAP1, and the NQO1 expression is dependent on NRF2 activation. Because either CDDP or DTIC produces reactive oxygen species that activate NRF2, we determined whether these agents would sensitize NQO1-low melanoma cells to 17-AAG. Synergistic cytotoxicity of the 17-AAG and CDDP combination was detected in four out of five NQO1-low cell lines, but not in the cell line with KEAP1 mutation. These data indicate that 17-AAG could be a potential chemotherapeutic agent for melanoma with KEAP1 mutation or NQO1 expression.	[Kasai, Shuya; Arakawa, Nobuyuki; Okubo, Ayaka; Shigeeda, Wataru; Yasuhira, Shinji; Shibazaki, Masahiko; Maesawa, Chihaya] Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Morioka, Iwate, Japan; [Akasaka, Toshihide] Iwate Med Univ, Dept Dermatol, Morioka, Iwate, Japan; [Masuda, Tomoyuki] Iwate Med Univ, Sch Med, Dept Pathol, Morioka, Iwate, Japan; [Kasai, Shuya] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 980, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Tohoku University	Shibazaki, M (corresponding author), Iwate Med Univ, Inst Biomed Sci, Dept Tumor Biol, Morioka, Iwate, Japan.	mashiba@iwate-med.ac.jp	Kasai, Shuya/AAL-2157-2021	Kasai, Shuya/0000-0001-7171-4885; Yasuhira, Shinji/0000-0003-0041-3545	JSPS KAKENHI [24790391]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant Number# 24790391 (https://kaken.nii.ac.jp/d/p/26860243.ja.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babchia N, 2008, INVEST OPHTH VIS SCI, V49, P2348, DOI 10.1167/iovs.07-1305; Bagatell R, 2005, INT J CANCER, V113, P179, DOI 10.1002/ijc.20611; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cheng YB, 2010, ONCOL REP, V23, P973, DOI 10.3892/or_00000722; Choi TY, 2010, J INVEST DERMATOL, V130, P784, DOI 10.1038/jid.2009.280; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Faingold D, 2008, CLIN CANCER RES, V14, P847, DOI 10.1158/1078-0432.CCR-07-0926; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guo WC, 2006, MOL PHARMACOL, V70, P1194, DOI 10.1124/mol.106.025643; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miura S, 2014, J INVEST DERMATOL, V134, P553, DOI 10.1038/jid.2013.343; Nakamura Y, 2010, J DERMATOL SCI, V60, P187, DOI 10.1016/j.jdermsci.2010.09.009; Nemekaite-Ceniene A, 2005, ARCH BIOCHEM BIOPHYS, V441, P182, DOI 10.1016/j.abb.2005.07.002; Ohba S, 2010, J NEUROSURG, V112, P33, DOI 10.3171/2009.3.JNS081146; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Rotblat B, 2012, ONCOTARGET, V3, P1272; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Vaishampayan UN, 2010, CLIN CANCER RES, V16, P3795, DOI 10.1158/1078-0432.CCR-10-0503; Vasilevskaya IA, 2003, CANCER RES, V63, P3241; Woods D, 2013, CANCER BIOL THER, V14, P379, DOI 10.4161/cbt.23761	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153181	10.1371/journal.pone.0153181	http://dx.doi.org/10.1371/journal.pone.0153181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045471	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600075
J	Xu, L; Qiu, LL; Chang, GB; Guo, QX; Liu, XP; Bi, YL; Zhang, Y; Wang, HZ; Li, ZT; Guo, XM; Wan, F; Zhang, Y; Xu, Q; Chen, GH				Xu, Lu; Qiu, Lingling; Chang, Guobin; Guo, Qixin; Liu, Xiangping; Bi, Yulin; Zhang, Yu; Wang, Hongzhi; Li, Zhiteng; Guo, Xiaoming; Wan, Fang; Zhang, Yang; Xu, Qi; Chen, Guohong			Discovery of piRNAs Pathway Associated with Early-Stage Spermatogenesis in Chicken	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; PRIMORDIAL GERM-CELLS; MOUSE TESTES; DIFFERENTIATION; SPERMIOGENESIS; REPERTOIRE	Piwi-interacting RNAs (piRNAs) play a key role in spermatogenesis. Here, we describe the piRNAs profiling of primordial germ cells (PGCs), spermatogonial stem cells (SSCs), and the spermatogonium (Sp) during early-stage spermatogenesis in chicken. We obtained 31,361,989 reads from PGCs, 31,757,666 reads from SSCs, and 46,448,327 reads from Sp cells. The length distribution of piRNAs in the three samples showed peaks at 33 nt. The resulting genes were subsequently annotated against the Gene Ontology (GO) database. Five genes (RPL7A, HSPA8, Pum1, CPXM2, and PRKCA) were found to be involved in cellular processes. Interactive pathway analysis (IPA) further revealed three important pathways in early-stage spermatogenesis including the FGF, Wnt, and EGF receptor signaling pathways. The gene Pum1 was found to promote germline stem cell proliferation, but it also plays a role in spermatogenesis. In conclusion, we revealed characteristics of piRNAs during early spermatogonial development in chicken and provided the basis for future research.	[Xu, Lu; Qiu, Lingling; Chang, Guobin; Guo, Qixin; Bi, Yulin; Zhang, Yu; Li, Zhiteng; Guo, Xiaoming; Wan, Fang; Zhang, Yang; Xu, Qi; Chen, Guohong] Yangzhou Univ, Coll Anim Sci Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Xiangping; Wang, Hongzhi] Chinese Acad Agr Sci, Poultry Inst, Yangzhou 225003, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB; Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci Technol, Yangzhou 225009, Jiangsu, Peoples R China.	passioncgb@163.com; ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022		National Natural Science Foundation of China [31372297]; International Agricultural Cooperation and Exchange Programme of China; Six talent peaks project in Jiangsu Province [2015-NY-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Agricultural Cooperation and Exchange Programme of China; Six talent peaks project in Jiangsu Province	This research was supported by the National Natural Science Foundation of China (31372297), International Agricultural Cooperation and Exchange Programme of China and the Six talent peaks project in Jiangsu Province (2015-NY-019). The authors would like to thank Guobing Chang for his help with the experimental design, and Wei Lu, Lichen Ren, Lingling Qiu and Qixin Guo for their help with sample preparation. The authors also wish to thank Guobin Chang for his help with manuscript preparation.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Caires K, 2010, J ENDOCRINOL, V205, P133, DOI 10.1677/JOE-09-0275; Chang GB, 2015, ANIM REPROD SCI, V162, P95, DOI 10.1016/j.anireprosci.2015.09.016; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051724; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; Gebert D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124860; Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Hirakata S, 2015, BIOCH BIOPHYS ACTA; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Li BC, 2010, MOL REPROD DEV, V77, P795, DOI 10.1002/mrd.21224; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lim SL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005620; Liu G, 2012, PLOS ONE, V7; Mozdziak PE, 2005, POULTRY SCI, V84, P594, DOI 10.1093/ps/84.4.594; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Park TS, 2013, J REPROD DEVELOP, V59, P252, DOI 10.1262/jrd.2012-183; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Pramod RK, 2014, J ASSIST REPROD GEN, V31, P993, DOI 10.1007/s10815-014-0277-1; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Senti KA, 2015, GENE DEV, V29, P1747, DOI 10.1101/gad.267252.115; Song H. -W., 2012, SPERMATOGENESIS, V2, P238, DOI [10.4161/spmg.22069, DOI 10.4161/SPMG.22069]; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Yu F, 2010, MOL REPROD DEV, V77, P340, DOI 10.1002/mrd.21147; Zhang CW, 2015, BIOCHEM BIOPH RES CO, V462, P8, DOI 10.1016/j.bbrc.2015.04.019; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401	30	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0151780	10.1371/journal.pone.0151780	http://dx.doi.org/10.1371/journal.pone.0151780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045806	Green Published, gold			2022-12-27	WOS:000373599600004
J	Ahirwar, R; Vellarikkal, SK; Sett, A; Sivasubbu, S; Scaria, V; Bora, U; Borthakur, BB; Kataki, AC; Sharma, JD; Nahar, P				Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sett, Arghya; Sivasubbu, Sridhar; Scaria, Vinod; Bora, Utpal; Borthakur, Bibhuti Bhusan; Kataki, Amal Chandra; Sharma, Jagannath Dev; Nahar, Pradip			Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; IN-VITRO; MONOCLONAL-ANTIBODIES; CONCANAVALIN-A; IMAGE-ANALYSIS; SELECTION; ENZYME; ASSAY; MULTICENTER; ENDOCRINE	An increase in the expression of estrogen receptors (ER) and the expanded population of ER-positive cells are two common phenotypes of breast cancer. Detection of the aberrantly expressed ER alpha in breast cancer is carried out using ER alpha-antibodies and radiolabelled ligands to make decisions about cancer treatment and targeted therapy. Capitalizing on the beneficial advantages of aptamer over the conventional antibody or radiolabelled ligand, we have identified a DNA aptamer that selectively binds and facilitates the detection of ERa in human breast cancer tissue sections. The aptamer is identified using the high throughput sequencing assisted SELEX screening. Biophysical characterization confirms the binding and formation of a thermodynamically stable complex between the identified DNA aptamer (ERaptD4) and ER alpha (Ka = 1.55 +/- 0.298x10(8) M-1; Delta H = 4.32x10(4)+/- 801.1 cal/mol; Delta S = -108 cal/mol/deg). Interestingly, the specificity measurements suggest that the ERaptD4 internalizes into ER alpha-positive breast cancer cells in a target-selective manner and localizes specifically in the nuclear region. To harness these characteristics of ERaptD4 for detection of ER alpha expression in breast cancer samples, we performed the aptamer-assisted histochemical analysis of ER alpha in tissue samples from breast cancer patients. The results were validated by performing the immunohistochemistry on same samples with an ER alpha-antibody. We found that the two methods agree strongly in assay output (kappa value = 0.930, pvalue <0.05 for strong ER alpha positive and the ER alpha negative samples; kappa value = 0.823, pvalue <0.05 for the weak/moderate ER+ve samples, n = 20). Further, the aptamer stain the ER alpha-positive cells in breast tissues without cross-reacting to ER alpha-deficient fibroblasts, adipocytes, or the inflammatory cells. Our results demonstrate a significant consistency in the aptamer-assisted detection of ER alpha in strong ER alpha positive, moderate ER alpha positive and ER alpha negative breast cancer tissues. We anticipate that the ERaptD4 aptamer targeting ER alpha may potentially be used for an efficient grading of ER alpha expression in cancer tissues.	[Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Nahar, Pradip] CSIR Inst Genom & Integrat Biol, Dept Syst & Chem Biol, Delhi, India; [Ahirwar, Rajesh; Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Nahar, Pradip] CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res, Delhi, India; [Sett, Arghya; Bora, Utpal] Indian Inst Technol, Dept Biosci & Bioengn, Gauhati, India; [Borthakur, Bibhuti Bhusan; Kataki, Amal Chandra; Sharma, Jagannath Dev] Dr Bhubaneswar Barooah Canc Inst, Gauhati, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Tata Memorial Centre (TMC); Dr. Bhubaneswar Borooah Cancer Institute	Nahar, P (corresponding author), CSIR Inst Genom & Integrat Biol, Dept Syst & Chem Biol, Delhi, India.; Nahar, P (corresponding author), CSIR Inst Genom & Integrat Biol, Acad Sci & Innovat Res, Delhi, India.	pnahar@igib.res.in	Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Scaria, Vinod/AAS-3151-2021; SETT, ARGHYA/Q-1857-2017; Ahirwar, Rajesh/AAY-1586-2021	Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Ahirwar, Rajesh/0000-0002-3406-7436; Scaria, Vinod/0000-0001-7644-7181; BORTHAKUR, BIBHUTI BHUSAN/0000-0002-8577-6590; SETT, ARGHYA/0000-0002-8356-5140	CARDIOMED task project of Council of Scientific and Industrial Research, Government of India [BSC0122]; Council of Scientific and Industrial Research, India	CARDIOMED task project of Council of Scientific and Industrial Research, Government of India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by the CARDIOMED task project of Council of Scientific and Industrial Research, Government of India, Project No. BSC0122 (http://www.csirhrdg.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.A. thanks the Council of Scientific and Industrial Research, India for the award of research fellowship. Authors thank Smita Nahar for help in ITC, Vaibhav Jain for flow cytometry and Bijay Ranjan Pattnaik for his help in immunofluorescence experiments (all from CSIR-IGIB).	Ahirwar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21285; Ahirwar R, 2016, ANAL BIOANAL CHEM, V408, P327, DOI 10.1007/s00216-015-9090-7; Ahirwar R, 2015, J CHROMATOGR B, V997, P105, DOI 10.1016/j.jchromb.2015.06.003; Ahirwar R, 2015, J AGR FOOD CHEM, V63, P4104, DOI 10.1021/acs.jafc.5b00784; Ahirwar R, 2014, ANALYST, V139, P2186, DOI 10.1039/c3an02402d; Hirata BKB, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/513158; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bora U, 2002, J IMMUNOL METHODS, V268, P171, DOI 10.1016/S0022-1759(02)00212-0; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Dhingra K, 1999, INVEST NEW DRUG, V17, P285, DOI 10.1023/A:1006348907994; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; FABRIS G, 1987, J STEROID BIOCHEM, V27, P171, DOI 10.1016/0022-4731(87)90307-4; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Goussard J, 1998, CANCER LETT, V132, P61, DOI 10.1016/S0304-3835(98)00168-2; GOUSSARD J, 1986, CANCER RES, V46, P4282; He X, 2015, NUCLEIC ACID THER, V25, P152, DOI 10.1089/nat.2014.0521; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Kupakuwana GV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019395; Lacroix M, 2001, BREAST CANCER RES TR, V67, P263, DOI 10.1023/A:1017946810277; LECLERCQ G, 1986, CANCER RES, V46, P4233; LIPPMAN ME, 1980, CANCER, V46, P2829, DOI 10.1002/1097-0142(19801215)46:12+<2829::AID-CNCR2820461419>3.0.CO;2-M; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Marx V, 2013, NAT METHODS, V10, P829, DOI 10.1038/nmeth.2607; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; NICHOLSON RI, 1986, CANCER RES, V46, P4299; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; REMMELE W, 1993, PATHOL RES PRACT, V189, P862; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; SHAFIE S, 1979, J LAB CLIN MED, V94, P784; Society AC, 2015, CANC FACTS FIG 2015; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Viale G, 2012, ANN ONCOL, V23, P207, DOI 10.1093/annonc/mds326; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Xu DY, 2014, NUCLEIC ACID THER, V24, P226, DOI 10.1089/nat.2013.0474	47	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153001	10.1371/journal.pone.0153001	http://dx.doi.org/10.1371/journal.pone.0153001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043307	Green Published, gold			2022-12-27	WOS:000373592100061
J	Alves, AV; Argandona, EJS; Linzmeier, AM; Cardoso, CAL; Macedo, MLR				Alves, Ariana Vieira; Sanjinez Argandona, Eliana Janet; Linzmeier, Adelita Maria; Lima Cardoso, Claudia Andrea; Rodrigues Macedo, Maria Ligia			Chemical Composition and Food Potential of Pachymerus nucleorum Larvae Parasitizing Acrocomia aculeata Kernels	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ANTIOXIDANT CAPACITY	Insect consumption as food is culturally practiced in various regions of the world. In Brazil, there are more than 130 species of edible insects registered, from nine orders, among which stands out the Coleoptera. The larva of the beetle Pachymerus nucleorum Fabricius, 1792, grows into the bocaiuva fruit (Acrocomia aculeata (Jacq.) Lodd. Ex Mart., 1845), which has proven nutritional quality. The aim of this work was to evaluate the nutritional potential of P. nucleorum larvae compared to bocaiuva kernels for human consumption. Proteins were the second largest portion of the larvae nutritional composition (33.13%), with percentage higher than the bocaiuva kernels (14.21%). The larval lipid content (37.87%) was also high, very close to the kernels (44.96%). The fraction corresponding to fatty acids in the oil extracted from the larvae was 40.17% for the saturated and 46.52% for the unsaturated. The antioxidant activity value was 24.3 uM trolox/g of oil extracted from larvae. The larvae tryptic activity was 0.032 +/- 0.006 nmol BAPNA/min. Both the larvae and the bocaiuva kernel presented absence of anti-nutritional factors. These results favor the use of P. nucleorum larvae as food, which are a great protein and lipid sources with considerable concentrations of unsaturated fatty acids compared to the bocaiuva kernel.	[Alves, Ariana Vieira; Sanjinez Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil; [Linzmeier, Adelita Maria] Fed Univ Fronteira Sul, Realeza, Parana, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Rodrigues Macedo, Maria Ligia] Univ Fed Mato Grosso do Sul, Dept Nat Sci, Lab Prot Purificat & Biol Funct, Campo Grande, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Fronteira Sul; Universidade Estadual de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Alves, AV (corresponding author), Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dourados, MS, Brazil.	arianavieiralves@gmail.com	Linzmeier, Adelita/A-9239-2013; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012; Cardoso, Claudia Andrea Lima/AAK-5578-2020	Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Macedo, Maria Ligia/0000-0001-6969-6307; Linzmeier, Adelita Maria/0000-0002-2979-8728	Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by a Masters scholarship (Benefitted: AVA) from Fundacao de Apoio ao Desenvolvimento ao Ensino, Ciencia a Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) [http://fundect.ledes.net/]. Financial support for equipment (Benefitted: EJSA) was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [http://www.capes.gov.br/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, FAO Food Nutr Pap, V91, P1; [Anonymous], 2011, TACO TAB BRAS COMP A; [Anonymous], 1999, GRAPHPAD PRISM VERSI; [Anonymous], 2003, OFFICIAL METHODS ANA, P17; AOAC Association of Official Analytical Chemists, 2005, OFFICIAL METHODS ANA, P18; Aranceta J, 2012, BRIT J NUTR, V107, pS8, DOI 10.1017/S0007114512001444; Atwater WO, 1896, FARMERS B, V28; BLIGH E. G., CANADIAN J BIOCH PHY, V37, P911; Costa Neto Eraldo M., 2006, Boletin de la SEA, V38, P423; Dessimoni-Pinto N. A. V., 2010, Alimentos e Nutricao, V21, P79; Drin G, 2014, ANNU REV BIOCHEM, V83, P51, DOI 10.1146/annurev-biochem-060713-035307; Dutra-De-Oliveira JED, 2008, CIENCIAS NUTR APREND; Estevan AO, 2010, S BRAS JAP; FAO, 2010, FOR INS FOOD HUM BIT; FAO, 2013, STATE HUNGER BUILDIN; Ingram J, 2011, FOOD SECUR, V3, P417, DOI 10.1007/s12571-011-0149-9; Innocenti A, 2014, J BASIC APPL SCI, V10, P96; Jongema Y, 2012, LIST EDIBLE INSECTS; Karasov WH., 1997, HDB COMP PHYSL, P409, DOI 10.1002/cphy.cp130107; Lescano CH, 2014, J MED FOOD, V00, P1; Ramos MIL, 2008, CIENCIA TECNOL ALIME, V28, P90, DOI 10.1590/S0101-20612008000500015; Longvah T, 2011, FOOD CHEM, V128, P400, DOI 10.1016/j.foodchem.2011.03.041; Luan YB, 2013, FOOD SECUR, V5, P393, DOI 10.1007/s12571-013-0260-1; Marineli RD, 2012, FOOD RES INT, V49, P487, DOI 10.1016/j.foodres.2012.07.022; Mitsuhashi J., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P115; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Prinz WA, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3825; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Ramos-Elorduy J, 2006, INTERCIENCIA, V31, P512; Ramos-Elorduy Julieta, 2009, Entomological Research, V39, P271, DOI 10.1111/j.1748-5967.2009.00238.x; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Sanjinez-Argandona EJ, 2011, REV BRAS FRUTIC, V33, P1023, DOI 10.1590/S0100-29452011000300040; Shockley M, 2013, MASS PRODUCTION BENE, P764; STATSOFT, 2008, STAT DAT AN SOFTW SY; Willhelm F. F., 2014, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V39, P179, DOI 10.4322/nutrire.2014.016; Zuo RT, 2013, BRIT J NUTR, V110, P1220, DOI 10.1017/S0007114513000378	38	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152125	10.1371/journal.pone.0152125	http://dx.doi.org/10.1371/journal.pone.0152125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031500	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800036
J	Liu, JJ; Li, G; Zhang, Y				Liu, Jianjun; Li, Guang; Zhang, Yue			Numerical Simulation of CO2 Flooding of Coalbed Methane Considering the Fluid-Solid Coupling Effect	PLOS ONE			English	Article							BASIN; SEQUESTRATION; PERMEABILITY	CO2 flooding of coalbed methane (CO2-ECBM) not only stores CO2 underground and reduces greenhouse gas emissions but also enhances the gas production ratio. This coupled process involves multi-phase fluid flow and coal-rock deformation, as well as processes such as competitive gas adsorption and diffusion from the coal matrix into fractures. A dual-porosity medium that consists of a matrix and fractures was built to simulate the flooding process, and a mathematical model was used to consider the competitive adsorption, diffusion and seepage processes and the interaction between flow and deformation. Due to the effects of the initial pressure and the differences in pressure variation during the production process, permeability changes caused by matrix shrinkage were spatially variable in the reservoir. The maximum value of permeability appeared near the production well, and the degree of rebound decreased with increasing distance from the production well.	[Liu, Jianjun; Li, Guang] Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Peoples R China; [Liu, Jianjun; Li, Guang] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Zhang, Yue] Jidong Oilfield Co, PetroChina, Tangshan, Hebei, Peoples R China	Southwest Petroleum University; Southwest Petroleum University; China National Petroleum Corporation	Li, G (corresponding author), Southwest Petr Univ, Sch Geosci & Technol, Chengdu, Peoples R China.; Li, G (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	li_1616@163.com	Liu, Jianjun/K-8732-2015	Liu, Jianjun/0000-0003-4935-219X	National Natural Science Foundation of China [51174170]; National Science and Technology Support Program Project [2012BAC26B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program Project	The research is financially supported by National Natural Science Foundation of China (Grant No. 51174170) and the National Science and Technology Support Program Project (Grant No. 2012BAC26B05). Jianjun Liu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research is financially supported by National Natural Science Foundation of China (Grant No. 51174170) and the National Science and Technology Support Program Project (Grant No. 2012BAC26B05).	An H, 2015, INT J COAL GEOL, V152, P15, DOI 10.1016/j.coal.2015.09.013; Dutta P, 2012, INT J GREENH GAS CON, V9, P103, DOI 10.1016/j.ijggc.2012.03.004; Enever J., 1997, RELATIONSHIP PERMEAB; Gray I., 1987, SPE RESERVOIR ENG, V2, P28, DOI DOI 10.2118/12514-PA; Hol S, 2014, INT J COAL GEOL, V128, P119, DOI 10.1016/j.coal.2014.04.010; Karacan CO, 2003, ENERG FUEL, V17, P1595, DOI 10.1021/ef0301349; Kumar H, 2014, FUEL, V135, P509, DOI 10.1016/j.fuel.2014.07.002; Li DY, 2010, FUEL, V89, P569, DOI 10.1016/j.fuel.2009.06.008; Massarotto P, 2010, INT J COAL GEOL, V82, P269, DOI 10.1016/j.coal.2009.11.002; Mavor MJ, 1998, SPE RESERV EVAL ENG, V1, P201, DOI 10.2118/39105-PA; Mazumder S, 2008, INT J COAL GEOL, V74, P123, DOI 10.1016/j.coal.2007.11.001; Merkel A, 2015, INT J COAL GEOL, V150, P181, DOI 10.1016/j.coal.2015.09.006; Palmer I., 1998, SPE RESERV EVAL ENG, V1, P539, DOI [DOI 10.2118/52607-PA, 10.2118/52607-pa]; Ronny P, 2011, ENERGY PROCEDIA, V4, P2157, DOI [10.1016/j.egypro.2011.02.101, DOI 10.1016/J.EGYPRO.2011.02.101]; Sayyafzadeh M, 2015, J NAT GAS SCI ENG, V27, P1205, DOI 10.1016/j.jngse.2015.09.071; Syed A, 2011, ENRGY PROCED, V4, P2137, DOI 10.1016/j.egypro.2011.02.098; Tang G.Q., 2005, SPE 95947 ANN TECH C, DOI [10.2118/95947-MS, DOI 10.2118/95947-MS]; Zhou FD, 2013, INT J GREENH GAS CON, V19, P26, DOI 10.1016/j.ijggc.2013.08.011	18	4	4	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152066	10.1371/journal.pone.0152066	http://dx.doi.org/10.1371/journal.pone.0152066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031096	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800033
J	Sondo, P; Derra, K; Nakanabo, SD; Tarnagda, Z; Kazienga, A; Zampa, O; Valea, I; Sorgho, H; Owusu-Dabo, E; Ouedraogo, JB; Guiguemde, TR; Tinto, H				Sondo, Paul; Derra, Karim; Nakanabo, Seydou Diallo; Tarnagda, Zekiba; Kazienga, Adama; Zampa, Odile; Valea, Innocent; Sorgho, Hermann; Owusu-Dabo, Ellis; Ouedraogo, Jean-Bosco; Guiguemde, Tinga Robert; Tinto, Halidou			Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE TRANSPORTER; IN-VIVO SELECTION; UNCOMPLICATED FALCIPARUM-MALARIA; DIHYDROARTEMISININ-PIPERAQUINE; POLYMORPHISMS; GENE; ASSOCIATION; SENSITIVITY; PARASITES; PROFILE	The adoption of Artemisinin based combination therapies (ACT) constitutes a basic strategy for malaria control in sub-Saharan Africa. Moreover, since cases of ACT resistance have been reported in South-East Asia, the need to understand P. falciparum resistance mechanism to ACT has become a global research goal. The selective pressure of ACT and the possibility that some specific Pfcrt and Pfmdr1 alleles are associated with treatment failures was assessed in a clinical trial comparing ASAQ to AL in Nanoro. Dried blood spots collected on Day 0 and on the day of recurrent parasitaemia during the 28-day follow-up were analyzed using the restriction fragments length polymorphism (PCR-RFLP) method to detect single nucleotide polymorphisms (SNPs) in Pfcrt (codon76) and Pfmdr1 (codons 86, 184, 1034, 1042, and 1246) genes. Multivariate analysis of the relationship between the presence of Pfcrt and Pfmdr1 alleles and treatment outcome was performed. AL and ASAQ exerted opposite trends in selecting Pfcrt K76T and Pfmdr1-N86Y alleles, raising the potential beneficial effect of using diverse ACT at the same time as first line treatments to reduce the selective pressure by each treatment regimen. No clear association between the presence of Pfcrt and Pfmdr1 alleles carried at baseline and treatment failure was observed.	[Sondo, Paul; Derra, Karim; Nakanabo, Seydou Diallo; Tarnagda, Zekiba; Kazienga, Adama; Valea, Innocent; Sorgho, Hermann; Ouedraogo, Jean-Bosco; Tinto, Halidou] IRSS, CRUN, Nanoro, Burkina Faso; [Nakanabo, Seydou Diallo; Zampa, Odile; Valea, Innocent; Guiguemde, Tinga Robert; Tinto, Halidou] Ctr Muraz Bobo Dioulasso, Bobo Dioulasso, Burkina Faso; [Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med KCCR, Kumasi, Ghana	Centre Muraz; Kumasi Center for Collaborative Research	Sondo, P (corresponding author), IRSS, CRUN, Nanoro, Burkina Faso.	paulsondo@yahoo.fr	Derra, Karim/AAC-1323-2022; Valea, Innocent/ABE-6694-2020; Kazienga, Adama/HGB-6079-2022	Derra, Karim/0000-0002-2090-9698; Sondo, Paul/0000-0003-4161-3367; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Valea, Innocent/0000-0002-3085-0490; Tinto, Halidou/0000-0002-0472-3586; Kazienga, Adama/0000-0002-6093-9648	Sanofi Aventis; WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases); Institute of Tropical Medicine, Belgium (FA3 - DGCD program)	Sanofi Aventis(Sanofi-Aventis); WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases); Institute of Tropical Medicine, Belgium (FA3 - DGCD program)	Sanofi Aventis and WHO-TDR (World Health Organisation Special Programme for Research and Training in Tropical Diseases) provided financial support for study samples collection. The Institute of Tropical Medicine, Belgium (FA3 - DGCD program) provided financial support for laboratory work.	[Anonymous], 2001, ANT DRUG COMB THER; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Baraka V, 2015, ANTIMICROB AGENTS CH, V59, P734, DOI 10.1128/AAC.03647-14; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Dahlstrom S, 2009, J INFECT DIS, V200, P1456, DOI 10.1086/606009; Derra K, 2012, INT J EPIDEMIOL, V41, P1293, DOI 10.1093/ije/dys159; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2001, J INFECT DIS, V183, P1417, DOI 10.1086/319865; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Ministry of health of Burkina Faso/DSN, 2013, PLAN ACT 2014 DISTR; Ministry of health of Burkina Faso/PNLP, 2006, NAT GUID MAL CAS MAN; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Sondo P, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.101.6437; Sondo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0843-8; Tinto H, 2005, AM J TROP MED HYG, V73, P171, DOI 10.4269/ajtmh.2005.73.171; Tinto H, 2008, TROP MED INT HEALTH, V13, P238, DOI 10.1111/j.1365-3156.2007.01995.x; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-207; Tinto H, 2014, TROP MED INT HEALTH, V19, P469, DOI 10.1111/tmi.12274; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6	30	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151565	10.1371/journal.pone.0151565	http://dx.doi.org/10.1371/journal.pone.0151565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031231	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800014
J	Chen, Y; Liu, Q; Su, QQ; Sun, YX; Peng, XW; He, XY; Zhang, LB				Chen, Yi; Liu, Qi; Su, Qianqian; Sun, Yunxiao; Peng, Xingwen; He, Xiangyang; Zhang, Libiao			'Compromise' in Echolocation Calls between Different Colonies of the Intermediate Leaf-Nosed Bat (Hipposideros larvatus)	PLOS ONE			English	Article							SOCIAL CALLS; BROWN BATS; EPTESICUS-FUSCUS; COMMUNICATION; CHIROPTERA; BEHAVIOR; VARIABILITY; FREQUENCIES; DIVERGENCE	Each animal population has its own acoustic signature which facilitates identification, communication and reproduction. The sonar signals of bats can convey social information, such as species identity and contextual information. The goal of this study was to determine whether bats adjust their echolocation call structures to mutually recognize and communicate when they encounter the bats from different colonies. We used the intermediate leafnosed bats (Hipposideros larvatus) as a case study to investigate the variations of echolocation calls when bats from one colony were introduced singly into the home cage of a new colony or two bats from different colonies were cohabitated together for one month. Our experiments showed that the single bat individual altered its peak frequency of echolocation calls to approach the call of new colony members and two bats from different colonies adjusted their call frequencies toward each other to a similar frequency after being chronically cohabitated. These results indicate that the 'compromise' in echolocation calls might be used to ensure effective mutual communication among bats.	[Chen, Yi; Liu, Qi; Su, Qianqian; Sun, Yunxiao; Peng, Xingwen; He, Xiangyang; Zhang, Libiao] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Chen, Yi; Zhang, Libiao] Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Chen, Yi; Zhang, Libiao] Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zhang, LB (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.; Zhang, LB (corresponding author), Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.; Zhang, LB (corresponding author), Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China.	zhanglb@gdei.gd.cn		Chen, Yi/0000-0001-9989-2165	Science & Technology Planning Project of Guangdong [2015A020209093, 2013B050800024]; Guangdong Province [2012B091100260]; Chinese Academy of Sciences [2012B091100260]; Funds for Environment Construction & Capacity Building of GDAS' Research Platform [2016GDASPT-0215]	Science & Technology Planning Project of Guangdong; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Funds for Environment Construction & Capacity Building of GDAS' Research Platform	Funding was provided by Science & Technology Planning Project of Guangdong (2015A020209093, 2013B050800024), The Project of Comprehensive Strategic Cooperation between Guangdong Province and Chinese Academy of Sciences (2012B091100260), and Funds for Environment Construction & Capacity Building of GDAS' Research Platform (2016GDASPT-0215).	Altringham JD, 1985, BATS BIOL BEHAV, P79; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P61; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Bates P., 1998, BIODIVERS CONSERV, V7, P1383, DOI [10.1023/A:1017113501563, DOI 10.1023/A:1017113501563]; Becker P.H., 1982, P213; BELWOOD JJ, 1984, CAN J ZOOL, V62, P2113, DOI 10.1139/z84-306; Berger-Tal O, 2008, J ZOOL, V274, P59, DOI 10.1111/j.1469-7998.2007.00357.x; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Bradshaw John W. S., 1995, P115; Broders HG, 2004, J MAMMAL, V85, P273, DOI 10.1644/BWG-102; Busnel R-G, 1967, ANIMAL SONAR SYSTEMS, VII, P939; Chen Y, 2015, BEHAVIOUR, V152, P1083, DOI 10.1163/1568539X-00003269; Corcoran AJ, 2014, SCIENCE, V346, P745, DOI 10.1126/science.1259512; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; FENTON MB, 1994, ANIM BEHAV, V47, P757, DOI 10.1006/anbe.1994.1108; Gillam Erin H, 2007, Proc Biol Sci, V274, P651, DOI 10.1098/rspb.2006.0047; GOULD E, 1971, Communications in Behavioral Biology Part A Original Articles, V5, P263; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Griffin DR, 1958, LISTENING DARK; HILL JH, 1978, J ANTHROPOL RES, V34, P1; Hiryu S, 2006, J COMP PHYSIOL A, V192, P807, DOI 10.1007/s00359-006-0118-5; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kastein HB, 2013, ANIM COGN, V16, P945, DOI 10.1007/s10071-013-0628-9; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; MASTERS WM, 1991, J ACOUST SOC AM, V89, P1402, DOI 10.1121/1.400660; Melendez KV, 2010, J ACOUST SOC AM, V128, P919, DOI 10.1121/1.3455835; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Vaughan Nancy, 1997, Bioacoustics, V7, P189; Wright GS, 2014, CURR BIOL, V24, P885, DOI 10.1016/j.cub.2014.02.058; Wund MA, 2006, AM MIDL NAT, V156, P99, DOI 10.1674/0003-0031(2006)156[99:VITECO]2.0.CO;2; ZBINDEN K, 1989, REV SUISSE ZOOL, V96, P335, DOI 10.5962/bhl.part.117768	43	3	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151382	10.1371/journal.pone.0151382	http://dx.doi.org/10.1371/journal.pone.0151382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029005	Green Submitted, gold, Green Published			2022-12-27	WOS:000373116500025
J	Carlitz, EHD; Miller, R; Kirschbaum, C; Gao, W; Hanni, DC; van Schaik, CP				Carlitz, Esther H. D.; Miller, Robert; Kirschbaum, Clemens; Gao, Wei; Haenni, Daniel C.; van Schaik, Carel P.			Measuring Hair Cortisol Concentrations to Assess the Effect of Anthropogenic Impacts on Wild Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							FECAL GLUCOCORTICOID METABOLITES; PHYSIOLOGICAL STRESS; HORMONE CHALLENGE; HOWLER MONKEYS; FOREST; TOURISM; HABITUATION; RESPONSES; ANXIETY; VALIDATION	Non-human primates face major environmental changes due to increased human impacts all over the world. Although some species are able to survive in certain landscapes with anthropogenic impact, their long-term viability and fitness may be decreased due to chronic stress. Here we assessed long-term stress levels through cortisol analysis in chimpanzee hair obtained from sleeping nests in northwestern Uganda, in order to estimate welfare in the context of ecotourism, forest fragmentation with human-wildlife conflicts, and illegal logging with hunting activity (albeit not of primates), compared with a control without human contact or conflict. Concerning methodological issues, season [F(2,129) = 37.4, p < 0.0001, r(2) = 0.18] and the age of nests [F(2,178) = 20.3, p < 0.0001, r(2) = 0.11] significantly predicted hair cortisol concentrations (HCC). With regard to effects of anthropogenic impacts, our results neither showed elevation of HCC due to ecotourism, nor due to illegal logging compared to their control groups. We did, however, find significantly increased HCC in the fragment group compared to chimpanzees living in a nearby intact forest [F(1,88) = 5.0, p = 0.03, r(2) = 0.20]. In conclusion, our results suggest that hair cortisol analysis is a powerful tool that can help understanding the impact of anthropogenic disturbances on chimpanzee well-being and could be applied to other great ape species.	[Carlitz, Esther H. D.; Haenni, Daniel C.; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Carlitz, Esther H. D.; Miller, Robert; Kirschbaum, Clemens; Gao, Wei] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Carlitz, Esther H. D.; Haenni, Daniel C.] Jane Goodall Inst Switzerland, Zurich, Switzerland	University of Zurich; Technische Universitat Dresden	Carlitz, EHD (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.; Carlitz, EHD (corresponding author), Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany.; Carlitz, EHD (corresponding author), Jane Goodall Inst Switzerland, Zurich, Switzerland.	ecarlitz@janegoodall.ch	Miller, Robert/G-4473-2016; Miller, Robert/AAV-1829-2020; Kirschbaum, Clemens/AAB-1752-2020	Miller, Robert/0000-0002-8665-5248; Miller, Robert/0000-0002-8665-5248; 	Jane Goodall Institute Switzerland	Jane Goodall Institute Switzerland	Travel and research expenses in Uganda were funded by the Jane Goodall Institute Switzerland.	Aguilar-Melo AR, 2013, AM J PRIMATOL, V75, P1108, DOI 10.1002/ajp.22172; Arck PC, 2001, HUM REPROD, V16, P1505, DOI 10.1093/humrep/16.7.1505; Aronsen GP, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov006; Balestri M, 2013, STRESS HABITAT FRAGM; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Bertolani P, 2008, FOLIA PRIMATOL, V79, P162, DOI 10.1159/000111720; Boesch C, 2000, CHIMPANZEES TAI FORE; Carlitz EHD, 2015, GEN COMP ENDOCRINOL; Carlitz EHD, CORRES KEEPER REPORT; Carlitz EHD, 2014, GEN COMP ENDOCR, V195, P151, DOI 10.1016/j.ygcen.2013.11.002; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Cocks L, 2007, INT J PRIMATOL, V28, P421, DOI 10.1007/s10764-007-9116-x; Cooke SJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P1, DOI 10.1086/671165; COURTOIS M, 1995, BRIT J DERMATOL, V132, P86, DOI 10.1111/j.1365-2133.1995.tb08630.x; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Desmond J.S., 2014, PRIMATE TOURISM, P199, DOI DOI 10.1017/CBO9781139087407; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Gao W, 2010, CLIN BIOCHEM, V43, P677, DOI 10.1016/j.clinbiochem.2010.01.014; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hamel AF, 2011, CLIN CHIM ACTA, V412, P382, DOI 10.1016/j.cca.2010.10.019; Hill CM, 2010, AM J PRIMATOL, V72, P919, DOI 10.1002/ajp.20845; Hockings KJ, 2015, TRENDS ECOL EVOL, V30, P215, DOI 10.1016/j.tree.2015.02.002; Hockings Kimberley J., 2013, Primate Conservation, V26, P57; Hockings KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033391; Hockings KJ, 2012, ANIM BEHAV, V83, P801, DOI 10.1016/j.anbehav.2012.01.002; Hockings KJ, 2009, INTERACT STUD, V10, P183, DOI 10.1075/is.10.2.05hoc; Humle T, 2004, INT J PRIMATOL, V25, P551, DOI 10.1023/B:IJOP.0000023575.93644.f4; Hvenegaard GT, 2014, PRIMATE TOURISM TOOL, P259; Jaimez NA, 2012, ANIM CONSERV, V15, P242, DOI 10.1111/j.1469-1795.2011.00508.x; Johns BG, 1996, BIOL CONSERV, V78, P257, DOI 10.1016/S0006-3207(96)00044-4; Kerbiriou C, 2009, J APPL ECOL, V46, P657, DOI 10.1111/j.1365-2664.2009.01646.x; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Kulp J, 2015, PRIMATES, P1; Li JF, 2012, CLIN CHIM ACTA, V413, P434, DOI 10.1016/j.cca.2011.10.024; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Marechal L, 2011, BIOL CONSERV, V144, P2188, DOI 10.1016/j.biocon.2011.05.010; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Mastromonaco GF, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou055; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Miller R, 2013, PSYCHONEUROENDOCRINO, V38, P941, DOI 10.1016/j.psyneuen.2012.09.013; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; Muehlenbein M, 2014, PRIMATE TOURISM TOOL, P278, DOI DOI 10.1017/CBO9781139087407.021; Muehlenbein MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033357; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Newton-Fisher NE, 1999, AFR J ECOL, V37, P344, DOI 10.1046/j.1365-2028.1999.00186.x; R Core Team, 2013, R LANG ENV STAT COMP; Rangel-Negrin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112329; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shutt K, 2014, BIOL CONSERV, V172, P72, DOI 10.1016/j.biocon.2014.02.014; Shutt K, 2012, GEN COMP ENDOCR, V179, P167, DOI 10.1016/j.ygcen.2012.08.008; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Steudte S, 2011, PSYCHIAT RES, V186, P310, DOI 10.1016/j.psychres.2010.09.002; Terwissen CV, 2013, GEN COMP ENDOCR, V194, P162, DOI 10.1016/j.ygcen.2013.09.010; Vanlangendonck N., 2015, J PRIMATOL, V4, P2; VANLAWIC.J, 1973, AM J PSYCHIAT, V130, P1; vanLawick-Goodall J., 1968, ANIM BEHAV MONOGR 3, V1; Williamson E. A., 2014, PRIMATE TOURISM TOOL, P292; Yamanashi Y, 2013, GEN COMP ENDOCR, V194, P55, DOI 10.1016/j.ygcen.2013.08.013	73	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151870	10.1371/journal.pone.0151870	http://dx.doi.org/10.1371/journal.pone.0151870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050418	Green Accepted, Green Published, gold			2022-12-27	WOS:000373603500017
J	Glei, DA; Goldman, N; Risques, RA; Rehkopf, DH; Dow, WH; Rosero-Bixby, L; Weinstein, M				Glei, Dana A.; Goldman, Noreen; Risques, Rosa Ana; Rehkopf, David H.; Dow, William H.; Rosero-Bixby, Luis; Weinstein, Maxine			Predicting Survival from Telomere Length versus Conventional Predictors: A Multinational Population-Based Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; OLDEST-OLD; ELDERLY-MEN; MORTALITY; ASSOCIATION; HEALTH; BIOMARKER; DEMENTIA; CELLS; IDENTIFICATION	Telomere length has generated substantial interest as a potential predictor of aging-related diseases and mortality. Some studies have reported significant associations, but few have tested its ability to discriminate between decedents and survivors compared with a broad range of well-established predictors that include both biomarkers and commonly collected self-reported data. Our aim here was to quantify the prognostic value of leukocyte telomere length relative to age, sex, and 19 other variables for predicting five-year mortality among older persons in three countries. We used data from nationally representative surveys in Costa Rica (N = 923, aged 61+), Taiwan (N = 976, aged 54+), and the U. S. (N = 2672, aged 60+). Our study used a prospective cohort design with all-cause mortality during five years post-exam as the outcome. We fit Cox hazards models separately by country, and assessed the discriminatory ability of each predictor. Age was, by far, the single best predictor of all-cause mortality, whereas leukocyte telomere length was only somewhat better than random chance in terms of discriminating between decedents and survivors. After adjustment for age and sex, telomere length ranked between 15th and 17th (out of 20), and its incremental contribution was small; nine self-reported variables (e.g., mobility, global self-assessed health status, limitations with activities of daily living, smoking status), a cognitive assessment, and three biological markers (C-reactive protein, serum creatinine, and glycosylated hemoglobin) were more powerful predictors of mortality in all three countries. Results were similar for cause-specific models (i.e., mortality from cardiovascular disease, cancer, and all other causes combined). Leukocyte telomere length had a statistically discernible, but weak, association with mortality, but it did not predict survival as well as age or many other self-reported variables. Although telomere length may eventually help scientists understand aging, more powerful and more easily obtained tools are available for predicting survival.	[Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC USA; [Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Risques, Rosa Ana] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Rehkopf, David H.] Stanford Univ, Div Gen Med Disciplines, Sch Med, Stanford, CA 94305 USA; [Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Rosero-Bixby, Luis] Univ Costa Rica, Ctr Ctr Amer Poblac, San Jose, Costa Rica	Georgetown University; Princeton University; University of Washington; University of Washington Seattle; Stanford University; University of California System; University of California Berkeley; Universidad Costa Rica	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC USA.	dag77@georgetown.edu		Rehkopf, David/0000-0002-7597-6513; Goldman, Noreen/0000-0003-2865-9491; Dow, William/0000-0002-4080-1668; Rosero-Bixby, Luis/0000-0002-3063-3111	National Institute on Aging [R01AG16790, R01AG16661, K01AG047280, R01AG031716, P30AG012839]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD047879]; Wellcome Trust [072406/Z/03/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG047280, R01AG016661, R01AG031716, P30AG012839, R01AG016790] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (www.nia.nih.gov), grant numbers R01AG16790 (Princeton University, NG as PI), R01AG16661 (Georgetown University, MW as PI), K01AG047280 (Stanford University, DHR as PI), R01AG031716 (University of California, Berkeley, WHD as PI), P30AG012839 (University of California, Berkeley, WHD as PI); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) grant number P2CHD047879; and the Wellcome Trust (www.wellcome.ac.uk), grant number 072406/Z/03/Z (Universidad de Costa Rica, LR-B. as PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, WAIS R MANUAL; Arai Y, EBIOMEDICIN IN PRESS; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Astrup AS, 2010, DIABETOLOGIA, V53, P45, DOI 10.1007/s00125-009-1542-1; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bendix L, 2014, J GERONTOL A-BIOL, V69, P231, DOI 10.1093/gerona/glt153; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang M, 2012, SOCIAL ENV BIOMARKER; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Curtin LR, 2012, NATL HLTH NUTR EXAMI; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Deelen J, 2014, INT J EPIDEMIOL; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glei DA, 2015, J GERONTOL A-BIOL, V70, P1490, DOI 10.1093/gerona/glu191; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Long JS, 2004, MED CARE, V42, P19, DOI 10.1097/01.mlr.0000102293.37107.c5; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Martin-Ruiz CM, 2014, INT J EPIDEMIOL; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Needham BL, 2015, EPIDEMIOLOGY, V26, P528, DOI 10.1097/EDE.0000000000000299; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rehkopf DH, 2013, EXP GERONTOL, V48, P1266, DOI 10.1016/j.exger.2013.08.005; Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074; Rosero-Bixby L, 2010, CRELES COSTA RICAN L; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Strandberg TE, 2011, J GERONTOL A-BIOL, V66, P815, DOI 10.1093/gerona/glr064; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Tulsky D, 1997, WAIS 3 WMS 3 TECHNIC; Wechsler D, 1997, ADMINISTRATION SCORI; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966; Zekry D, 2012, J NUTR HEALTH AGING, V16, P225, DOI 10.1007/s12603-011-0138-x; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	60	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152486	10.1371/journal.pone.0152486	http://dx.doi.org/10.1371/journal.pone.0152486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049651	Green Published, gold			2022-12-27	WOS:000373603500043
J	Liu, T; Liu, SF; Zheng, MS; Chen, Q; Ni, JR				Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren			Performance Assessment of Full-Scale Wastewater Treatment Plants Based on Seasonal Variability of Microbial Communities via High-Throughput Sequencing	PLOS ONE			English	Article							POLYPHOSPHATE-ACCUMULATING ORGANISMS; ACTIVATED-SLUDGE; BACTERIAL COMMUNITY; RELATIVE ABUNDANCE; DIVERSITY; AMMONIA; TEMPERATURE; DYNAMICS; PATTERNS; SYSTEMS	Microbial communities of activated sludge (AS) play a key role in the performance of wastewater treatment processes. However, seasonal variability of microbial population in varying AS-based processes has been poorly correlated with operation of full-scale wastewater treatment systems (WWTSs). In this paper, significant seasonal variability of AS microbial communities in eight WWTSs located in the city of Guangzhou were revealed in terms of 16S rRNA-based Miseq sequencing. Furthermore, variation redundancy analysis (RDA) demonstrated that the microbial community compositions closely correlated with WWTS operation parameters such as temperature, BOD, NH4+-N and TN. Consequently, support vector regression models which reasonably predicted effluent BOD, SS and TN in WWTSs were established based on microbial community compositions. This work provided an alternative tool for rapid assessment on performance of full-scale wastewater treatment plants.	[Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren] Peking Univ, Dept Environm Engn, Beijing 100871, Peoples R China; [Liu, Tang; Liu, Shufeng; Zheng, Maosheng; Chen, Qian; Ni, Jinren] Minist Educ, Key Lab Water & Sediment Sci, Beijing 100871, Peoples R China	Peking University	Ni, JR (corresponding author), Peking Univ, Dept Environm Engn, Beijing 100871, Peoples R China.; Ni, JR (corresponding author), Minist Educ, Key Lab Water & Sediment Sci, Beijing 100871, Peoples R China.	nijinren@iee.pku.edu.cn	Liu, Shufeng/GXA-1430-2022		Guangzhou Scientific and Technologic Project for Water Service [GZSK-FW-1201]; National Natural Science Foundation of China [51208007]	Guangzhou Scientific and Technologic Project for Water Service; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Guangzhou Scientific and Technologic Project for Water Service (Grant No. GZSK-FW-1201) and National Natural Science Foundation of China (Grant No. 51208007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Antony R, 2012, MICROBIOL RES, V167, P372, DOI 10.1016/j.micres.2012.03.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Community T, 2007, COMMUNITY ECOL PACKA, P631; Crocetti GR, 2000, APPL ENVIRON MICROB, V66, P1175, DOI 10.1128/AEM.66.3.1175-1182.2000; Dugan P, 2006, GENUS ZOOGLOEA PROKA, P960; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; [郭红光 Guo Hongguang], 2015, [中国科学院大学学报, Journal of University of Chinese Academy of Sciences], V32, P1; Hai RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090175; He SM, 2011, MICROB BIOTECHNOL, V4, P603, DOI 10.1111/j.1751-7915.2011.00248.x; Hong YST, 2003, WATER RES, V37, P1608, DOI 10.1016/S0043-1354(02)00494-3; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Huang MZ, 2010, BIORESOURCE TECHNOL, V101, P1642, DOI 10.1016/j.biortech.2009.08.111; Ju F, 2015, ISME J, V9, P683, DOI 10.1038/ismej.2014.162; Ju F, 2014, ENVIRON MICROBIOL, V16, P2421, DOI 10.1111/1462-2920.12355; Kim DJ, 2006, BIORESOURCE TECHNOL, V97, P459, DOI 10.1016/j.biortech.2005.03.032; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Kong YH, 2005, APPL ENVIRON MICROB, V71, P4076, DOI 10.1128/AEM.71.7.4076-4085.2005; Liu Y, 2005, BIORESOURCE TECHNOL, V96, P1205, DOI 10.1016/j.biortech.2004.11.003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; Monteiro M, 2014, J MICROBIOL, V52, P537, DOI 10.1007/s12275-014-4114-0; Nadarajah N, 2007, WATER RES, V41, P2563, DOI 10.1016/j.watres.2007.02.002; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Ren SJ, 2004, ENVIRON INT, V30, P1151, DOI 10.1016/j.envint.2004.06.003; ROSSELLOMORA RA, 1995, APPL ENVIRON MICROB, V61, P702; Seshan H, 2014, WATER RES, V53, P282, DOI 10.1016/j.watres.2014.01.015; Singh KK, 2008, J HYDROL ENG, V13, P146, DOI 10.1061/(ASCE)1084-0699(2008)13:3(146); Slater FR, 2010, WATER RES, V44, P4908, DOI 10.1016/j.watres.2010.07.028; Tan TW, 2008, CHEMOSPHERE, V70, P387, DOI 10.1016/j.chemosphere.2007.07.003; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	45	38	42	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152998	10.1371/journal.pone.0152998	http://dx.doi.org/10.1371/journal.pone.0152998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049964	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500080
J	Moore, AA; Neale, MC; Silberg, JL; Verhulst, B				Moore, Ashlee A.; Neale, Michael C.; Silberg, Judy L.; Verhulst, Brad			Substance Use and Depression Symptomatology: Measurement Invariance of the Beck Depression Inventory (BDI-II) among Non-Users and Frequent-Users of Alcohol, Nicotine and Cannabis	PLOS ONE			English	Article							PSYCHOMETRIC EVALUATION; MAJOR DEPRESSION; SELF-MEDICATION; USE DISORDERS; DRUG-ABUSE; COMORBIDITY; VALIDITY; AGE; HETEROGENEITY; MOOD	Depression is a highly heterogeneous condition, and identifying how symptoms present in various groups may greatly increase our understanding of its etiology. Importantly, Major Depressive Disorder is strongly linked with Substance Use Disorders, which may ameliorate or exacerbate specific depression symptoms. It is therefore quite plausible that depression may present with different symptom profiles depending on an individual's substance use status. Given these observations, it is important to examine the underlying construct of depression in groups of substance users compared to non-users. In this study we use a non-clinical sample to examine the measurement structure of the Beck Depression Inventory (BDI-II) in non-users and frequent-users of various substances. Specifically, measurement invariance was examined across those who do vs. do not use alcohol, nicotine, and cannabis. Results indicate strict factorial invariance across non-users and frequent-users of alcohol and cannabis, and metric invariance across non-users and frequent-users of nicotine. This implies that the factor structure of the BDI-II is similar across all substance use groups	[Moore, Ashlee A.] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA; [Moore, Ashlee A.; Neale, Michael C.; Silberg, Judy L.; Verhulst, Brad] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Neale, Michael C.; Silberg, Judy L.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Neale, Michael C.; Verhulst, Brad] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moore, AA (corresponding author), Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA.; Moore, AA (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA.	mooreaa2@vcu.edu	Moore, Ashlee A./AFX-7065-2022; Neale, Michael/AAD-5056-2020	Moore, Ashlee A./0000-0002-6577-3050; 	National Institutes of Health's National Center for Advancing Translational Sciences [TR000058]; National Institutes of Health's National Institute on Drug Abuse [DA018673, DA026119]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA018673, R25DA026119, R01DA018673] Funding Source: NIH RePORTER	National Institutes of Health's National Center for Advancing Translational Sciences; National Institutes of Health's National Institute on Drug Abuse; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health's National Center for Advancing Translational Sciences (www.ncats.nih.gov; AAM & JLS, grant number TR000058) and the National Institutes of Health's National Institute on Drug Abuse (www.nida.nih.gov; MCN & BV, grant numbers DA018673 and DA026119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggen SH, 2011, TWIN RES HUM GENET, V14, P524, DOI 10.1375/twin.14.6.524; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Apesoa-Varano EC, 2015, SOC SCI MED, V124, P1, DOI 10.1016/j.socscimed.2014.10.054; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; BROWN J, 1992, BRIT J ADDICT, V87, P1013; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chen LS, 2000, J AFFECT DISORDERS, V59, P1, DOI 10.1016/S0165-0327(99)00132-9; Davis LL, 2005, COMPR PSYCHIAT, V46, P81, DOI 10.1016/j.comppsych.2004.07.025; Del Boca FK, 2000, ADDICTION, V95, pS347; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Dum M, 2008, ADDICT BEHAV, V33, P381, DOI 10.1016/j.addbeh.2007.09.017; GALLO JJ, 1994, J GERONTOL, V49, pP251, DOI 10.1093/geronj/49.6.P251; Ghaemi SN, 2011, ACTA PSYCHIAT SCAND, V124, P497, DOI 10.1111/j.1600-0447.2011.01746.x; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Husain MM, 2005, AM J GERIAT PSYCHIAT, V13, P852, DOI 10.1176/appi.ajgp.13.10.852; Johnson ME, 2006, ASSESSMENT, V13, P168, DOI 10.1177/1073191106286951; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Little R. J. A., 1987, STAT ANAL MISSING DA; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Mehta PD, 2004, PSYCHOL METHODS, V9, P301, DOI 10.1037/1082-989X.9.3.301; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; Muthen L.K., 2012, MPLUS USERS GUIDE ST, DOI DOI 10.1111/J.1532-5415.2004.52225.X; Neale MC, 2015, PSYCHOMETRI IN PRESS; R Core Team, 2021, R LANGUAGE ENV STAT; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rice SM, INT J SOC P IN PRESS; Seignourel PJ, 2008, DRUG ALCOHOL DEPEN, V93, P271, DOI 10.1016/j.drugalcdep.2007.10.016; Skule C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088321; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Wilkowska-Chmielewska J, 2013, J AFFECT DISORDERS, V150, P142, DOI 10.1016/j.jad.2012.12.012; Basurto FZ, 2009, PSICOTHEMA, V21, P213	39	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152118	10.1371/journal.pone.0152118	http://dx.doi.org/10.1371/journal.pone.0152118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046165	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600009
J	Skibinska, I; Tomaszewski, M; Andrusiewicz, M; Urbaniak, P; Czarnecka-Klos, R; Shadi, M; Kotwicki, T; Kotwicka, M				Skibinska, Izabela; Tomaszewski, Marek; Andrusiewicz, Miroslaw; Urbaniak, Paulina; Czarnecka-Klos, Roza; Shadi, Milud; Kotwicki, Tomasz; Kotwicka, Malgorzata			Expression of Estrogen Receptor Coactivator Proline-, Glutamic Acid- and Leucine-Rich Protein 1 within Paraspinal Muscles in Adolescents with Idiopathic Scoliosis	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; COREGULATOR PELP1; PATHWAY; GROWTH; ALPHA; SPINE; BETA	Purpose The aim of this study was to detect and assess the estrogen receptor (ESR) coactivator PELP1 expression within human paraspinal skeletal muscles in patients suffering from idiopathic scoliosis. Methods During surgical correction of scoliosis the muscle biopsies harvested in 29 females. Presence of PELP1, ESR1 and ESR2 genes transcripts was studied using RT-qPCR technique while immunohistochemistry and western blot methods were used to detect the PEPL1 protein presence. Results PELP1 expression in deep paraspinal muscles revealed higher than in superficial back muscles (p = 0.005). Positive immunohistochemical staining for PELP1 was observed in the nuclei of the paraspinal muscle cells. Western blot revealed PELP1 protein in all samples. No significant difference in PELP1 expression between the convex and the concave scoliosis side (p > 0.05) was found. In deep paraspinal back muscles, a significant correlation between the PELP1 expression level on the concave side and the Cobb angle (r = 0.4; p < 0.05) was noted as well as between the PELP1 and ESR1 expression level (r = 0.7; p < 0.05) while no correlation between PELP1 and ESR2 expression level was found. Conclusion To our knowledge, three techniques for the first time demonstrated the presence of the PELP1 in paraspinal muscles of patients with idiopathic scoliosis. The PELP1 potential regulatory impact on back muscle function is to be further investigated.	[Skibinska, Izabela; Andrusiewicz, Miroslaw; Urbaniak, Paulina; Czarnecka-Klos, Roza; Kotwicka, Malgorzata] Univ Med Sci, Fac Hlth Sci, Dept Cell Biol, Poznan, Poland; [Tomaszewski, Marek; Shadi, Milud; Kotwicki, Tomasz] Univ Med Sci, Fac Med 1, Spine Disorders & Pediat Orthoped Dept, Poznan, Poland		Kotwicka, M (corresponding author), Univ Med Sci, Fac Hlth Sci, Dept Cell Biol, Poznan, Poland.	mkotwic@ump.edu.pl	Andrusiewicz, Mirosław/ABG-4949-2021; Andrusiewicz, Mirosław/N-3449-2017	Andrusiewicz, Mirosław/0000-0002-8781-3447; Andrusiewicz, Mirosław/0000-0002-8781-3447; Skibinska, Izabela/0000-0002-7684-028X	Ministry of Science and Higher Education [502-01-04410519-06466]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by the Ministry of Science and Higher Education statute investigation No 502-01-04410519-06466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dasgupta S, 2014, ANNU REV MED, V65, P279, DOI 10.1146/annurev-med-051812-145316; Duparc J, 1991, ORTHOPEDIATRIE SELEC; Esposito T, 2009, J STEROID BIOCHEM, V116, P56, DOI 10.1016/j.jsbmb.2009.04.010; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; Guo X, 2006, SPINE, V31, pE437, DOI 10.1097/01.brs.0000222048.47010.bf; Hussey KM, 2014, MOL CELL BIOL, V34, P2437, DOI 10.1128/MCB.01315-13; Inoue Masatoshi, 2002, Stud Health Technol Inform, V91, P90; Janusz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076806; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kotwicki T, 2014, SPINE, V39, pE1599, DOI 10.1097/BRS.0000000000000643; Leboeuf D, 2009, TRENDS ENDOCRIN MET, V20, P147, DOI 10.1016/j.tem.2008.12.004; Lenke LG, 2003, SPINE, V28, pS199, DOI 10.1097/01.BRS.0000092216.16155.33; Letellier K, 2008, J PINEAL RES, V45, P383, DOI 10.1111/j.1600-079X.2008.00603.x; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Nagpal JK, 2008, MOL CANCER RES, V6, P851, DOI 10.1158/1541-7786.MCR-07-2030; Pollanen E, 2015, AGING CELL, V14, P236, DOI 10.1111/acel.12309; Pollanen E, 2011, AGING CELL, V10, P650, DOI 10.1111/j.1474-9726.2011.00701.x; Raczkowski JW, 2007, NEUROENDOCRINOL LETT, V28, P302; SAARTOK T, 1984, CLIN ORTHOP RELAT R, P197; Sarwark J, 2007, J BONE JOINT SURG AM, V89A, P8, DOI 10.2106/JBJS.F.00314; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Steensberg A, 2007, FASEB J, V21, P2683, DOI 10.1096/fj.06-7477com; Vadlamudi RK, 2004, J CLIN ENDOCR METAB, V89, P6130, DOI 10.1210/jc.2004-0909; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Wiik A, 2005, ACTA PHYSIOL SCAND, V184, P105, DOI 10.1111/j.1365-201X.2005.01433.x; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Yan Y, 2013, PROTEIN CELL, V4, P620, DOI 10.1007/s13238-013-3030-0	28	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152286	10.1371/journal.pone.0152286	http://dx.doi.org/10.1371/journal.pone.0152286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045366	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600014
J	Lawlor-Savage, L; Goghari, VM				Lawlor-Savage, Linette; Goghari, Vina M.			Dual N-Back Working Memory Training in Healthy Adults: A Randomized Comparison to Processing Speed Training	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FLUID INTELLIGENCE; COMPLEX SPAN; AGE; CAPACITY; ISSUES; GAINS; TESTS; TASKS	Enhancing cognitive ability is an attractive concept, particularly for middle-aged adults interested in maintaining cognitive functioning and preventing age-related declines. Computerized working memory training has been investigated as a safe method of cognitive enhancement in younger and older adults, although few studies have considered the potential impact of working memory training on middle-aged adults. This study investigated dual n-back working memory training in healthy adults aged 30-60. Fifty-seven adults completed measures of working memory, processing speed, and fluid intelligence before and after a 5-week web-based dual n-back or active control (processing speed) training program. Results: Repeated measures multivariate analysis of variance failed to identify improvements across the three cognitive composites, working memory, processing speed, and fluid intelligence, after training. Follow-up Bayesian analyses supported null findings for training effects for each individual composite. Findings suggest that dual n-back working memory training may not benefit working memory or fluid intelligence in healthy adults. Further investigation is necessary to clarify if other forms of working memory training may be beneficial, and what factors impact training-related benefits, should they occur, in this population.	[Lawlor-Savage, Linette; Goghari, Vina M.] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Goghari, Vina M.] Univ Calgary, Dept Psychiat, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Lawlor-Savage, L; Goghari, VM (corresponding author), Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Goghari, VM (corresponding author), Univ Calgary, Dept Psychiat, Hotchkiss Brain Inst, Calgary, AB, Canada.	savagel@ucalgary.ca; vina.m.goghari@ucalgary.ca			Alberta Innovates - Health Solutions; Canadian Psychological Association Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council [402452-2011]; Natural Sciences and Engineering Research Council	Alberta Innovates - Health Solutions; Canadian Psychological Association Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Alberta Innovates - Health Solutions (www.aihealthsolutions.ca), Canadian Psychological Association Foundation (www.cpa.ca/cpafoundation) and Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) student scholarships to LLS, and Natural Sciences and Engineering Research Council (www.nserc-crsng.gc.ca) grant to VMG (402452-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amanda Fernandez, Carina Chiu, Emiko Muraki, Rachel Mackay, Anna Goupal, Madyson Huck, and Walaa Katoue for their assistance. We thank all individuals who have reviewed earlier versions of this manuscript and have thereby contributed to its improvement.This work was supported in part by Alberta Innovates-Health Solutions, Canadian Psychological Association Foundation, Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council. We thank our research participants for their time, effort, and mental energy, and Lumos Labs Inc. for the training programs. We thank Aaron Lucko,	Au J, 2015, THERE IS NO CONVINCI; Au J, 2015, PSYCHON B REV, V22, P366, DOI 10.3758/s13423-014-0699-x; Borella E, 2010, PSYCHOL AGING, V25, P767, DOI 10.1037/a0020683; Burgess GC, 2011, J EXP PSYCHOL GEN, V140, P674, DOI 10.1037/a0024695; Canivez GL, 2009, SCHOOL PSYCHOL QUART, V24, P252, DOI 10.1037/a0018030; Cattell R. B., 1959, HDB CULTURE FAIR INT; Chooi WT, 2012, INTELLIGENCE, V40, P531, DOI 10.1016/j.intell.2012.07.004; Colom R, 2003, J BIOSOC SCI, V35, P33, DOI 10.1017/S0021932003000336; Colom R, 2013, INTELLIGENCE, V41, P712, DOI 10.1016/j.intell.2013.09.002; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; Dougherty MR, 2016, PSYCHON B REV, V23, P306, DOI 10.3758/s13423-015-0865-9; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez A, 2011, GENERATIONS, V35, P63; Freitas C, 2011, FRONT AGING NEUROSCI, V3, DOI [10.3389/fnagi.2011.00005, 10.3389/fnagi.2011.00006]; Gottfredson L. S., 1997, INTELLIGENCE, V24, P24, DOI DOI 10.1016/S0160-2896(97)90014-3; Gottfredson L, 2009, CAN PSYCHOL, V50, P183, DOI 10.1037/a0016641; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Jaeggi SM, 2009, AGING NEUROPSYCHOL C, V16, P80, DOI 10.1080/13825580802233426; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jausovec N, 2012, BRAIN COGNITION, V79, P96, DOI 10.1016/j.bandc.2012.02.007; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Lilford R, 2002, BRIT J SURG, V89, P129; Lilienthal L, 2013, PSYCHON B REV, V20, P135, DOI 10.3758/s13423-012-0335-6; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Love J., 2015, JASP VERSION 07; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Melby-Lervag M, 2016, PSYCHON B REV, V23, P324, DOI 10.3758/s13423-015-0862-z; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Peng HM, 2012, J ADULT DEV, V19, P150, DOI 10.1007/s10804-012-9142-6; Raven J. C., 1975, ADV PROGR MATRICES S; Redick TS, 2015, INTELLIGENCE, V50, P14, DOI 10.1016/j.intell.2015.01.014; Redick TS, 2013, PSYCHON B REV, V20, P1102, DOI 10.3758/s13423-013-0453-9; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rudebeck SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050431; Sahakian BJ, 2011, J PSYCHOPHARMACOL, V25, P197, DOI 10.1177/0269881109106926; Salminen T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00166; Scanlon M., 2011, MENSA RES J, V42, P13, DOI DOI 10.1371/JOURNAL.PONE.0134467; Schmiedek F, 2009, J EXP PSYCHOL LEARN, V35, P1089, DOI 10.1037/a0015730; Schweizer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024372; Seidler RD, 2010, 201001 MCASTL U MICH; Shah P., 1999, MODELS WORKING MEMOR, P442, DOI DOI 10.1017/CBO9781139174909.016; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Stepankova H, 2014, DEV PSYCHOL, V50, P1049, DOI 10.1037/a0034913; Stephenson CL, 2013, INTELLIGENCE, V41, P341, DOI 10.1016/j.intell.2013.05.006; Thompson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063614; Tranter LJ, 2008, AGING NEUROPSYCHOL C, V15, P184, DOI 10.1080/13825580701322163; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Wechsler D, 2011, WECHSLER ABBREVIATED; Wechsler D., 2012, WAIS 4 KASIKIRJA; WILLIAMS EJ, 1949, AUST J SCI RES SER A, V2, P149, DOI 10.1071/CH9490149	60	36	37	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151817	10.1371/journal.pone.0151817	http://dx.doi.org/10.1371/journal.pone.0151817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043141	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100004
J	Qi, CX; Jia, XP; Lu, LL; Ma, P; Wei, M				Qi, Chunxia; Jia, Xiaopeng; Lu, Lingling; Ma, Ping; Wei, Min			HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation	PLOS ONE			English	Article							CCR5-DELTA-32 MUTATION; HIV-1 INFECTION; RESISTANCE; CD4; INDIVIDUALS; CORECEPTOR; RETROVIRUS	C-C chemokine receptor 5 (CCR5) is a receptor for chemokines and a co-receptor for HIV-1 entry into the target CD4(+) cells. CCR5 delta 32 deletion is a loss-of-function mutation, resistant to HIV-1 infection. We tried to induce the CCR5 delta 32 mutation harnessing the genome editing technique, CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR and CRISPR associated protein 9, Cas9) in the commonly used cell line human embryonic kidney HEK 293T cells. Surprisingly, we found that HEK293T cells are heterozygous for CCR5 delta 32 mutation, in contrast to the wild type CCR5 cells, human acute T cell leukemia cell line Jurkat and human breast adenocarcinoma cell line MDA-MB-231 cells. This finding indicates that at least one human cell line is heterozygous for the CCR5 delta 32 mutation. We also found that in PCR amplification, wild type CCR5 DNA and mutant delta 32 DNA can form mismatched heteroduplex and move slowly in gel electrophoresis.	[Qi, Chunxia; Jia, Xiaopeng; Lu, Lingling; Wei, Min] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ma, Ping] Tianjin Second Peoples Hosp, Dept Infect Dis, Tianjin, Peoples R China	Nankai University	Wei, M (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	weimin@nankai.edu.cn			Nankai University Starting Fund [ZB15006101]; National Natural Science Foundation of China [81571991]	Nankai University Starting Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by Nankai University Starting Fund (ZB15006101) to M. W. and National Natural Science Foundation of China (81571991 to M. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2015, CURR OPIN VIROL, V14, P24, DOI 10.1016/j.coviro.2015.06.007; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Biloglav Z, 2009, CROAT MED J, V50, P34, DOI 10.3325/cmj.2009.50.34; Buell KG, 2016, AIDS CARE, V28, P242, DOI 10.1080/09540121.2015.1074653; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Heigele A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0213-1; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; Lewin SR, 2013, LANCET, V381, P2057, DOI 10.1016/S0140-6736(13)61180-0; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lopalco L, 2010, VIRUSES-BASEL, V2, P574, DOI 10.3390/v2020574; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wainberg MA, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-31; Walli R, 1998, J ACQ IMMUN DEF SYND, V18, P229, DOI 10.1097/00042560-199807010-00005; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115987; Woollard SM, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S90580; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zawicki P, 2008, INFECT GENET EVOL, V8, P146, DOI 10.1016/j.meegid.2007.11.003; Zhou Chi, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P485, DOI 10.3760/cma.j.issn.1003-9406.2012.04.024	28	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152975	10.1371/journal.pone.0152975	http://dx.doi.org/10.1371/journal.pone.0152975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042825	gold, Green Published			2022-12-27	WOS:000373592100057
J	Oppenheimer, BW; Berger, KI; Ali, S; Segal, LN; Donnino, R; Katz, S; Parikh, M; Goldring, RM				Oppenheimer, Beno W.; Berger, Kenneth I.; Ali, Saleem; Segal, Leopoldo N.; Donnino, Robert; Katz, Stuart; Parikh, Manish; Goldring, Roberta M.			Pulmonary Vascular Congestion: A Mechanism for Distal Lung Unit Dysfunction in Obesity	PLOS ONE			English	Article							MEMBRANE DIFFUSING-CAPACITY; CAPILLARY BLOOD-VOLUME; CHRONIC HEART-FAILURE; MORBIDLY OBESE; RESPIRATORY RESISTANCE; CIRCULATORY CONGESTION; BARIATRIC SURGERY; CARBON MONOXIDE; AIRWAY FUNCTION; WEIGHT-LOSS	Rationale Obesity is characterized by increased systemic and pulmonary blood volumes (pulmonary vascular congestion). Concomitant abnormal alveolar membrane diffusion suggests subclinical interstitial edema. In this setting, functional abnormalities should encompass the entire distal lung including the airways. Objectives We hypothesize that in obesity: 1) pulmonary vascular congestion will affect the distal lung unit with concordant alveolar membrane and distal airway abnormalities; and 2) the degree of pulmonary congestion and membrane dysfunction will relate to the cardiac response. Methods 54 non-smoking obese subjects underwent spirometry, impulse oscillometry (IOS), diffusion capacity (D-LCO) with partition into membrane diffusion (D-M) and capillary blood volume (V-C), and cardiac MRI (n = 24). Alveolar-capillary membrane efficiency was assessed by calculation of D-M/V-C. Measurements and Main Results Mean age was 45 +/- 12 years; mean BMI was 44.8 +/- 7 kg/m(2). Vital capacity was 88 +/- 13% predicted with reduction in functional residual capacity (58 +/- 12% predicted). Despite normal D-LCO (98 +/- 18% predicted), V-C was elevated (135 +/- 31% predicted) while D-M averaged 94 +/- 22% predicted. D-M/V-C varied from 0.4 to 1.4 with high values reflecting recruitment of alveolar membrane and low values indicating alveolar membrane dysfunction. The most abnormal IOS (R-5 and X-5) occurred in subjects with lowest D-M/V-C (r(2) = 0.31, p<0.001; r(2) = 0.34, p<0.001). Cardiac output and index (cardiac output / body surface area) were directly related to D-M/V-C (r(2) = 0.41, p<0.001; r(2) = 0.19, p = 0.03). Subjects with lower D-M/V-C demonstrated a cardiac output that remained in the normal range despite presence of obesity. Conclusions Global dysfunction of the distal lung (alveolar membrane and distal airway) is associated with pulmonary vascular congestion and failure to achieve the high output state of obesity. Pulmonary vascular congestion and consequent fluid transudation and/or alterations in the structure of the alveolar capillary membrane may be considered often unrecognized causes of airway dysfunction in obesity.	[Oppenheimer, Beno W.; Berger, Kenneth I.; Ali, Saleem; Segal, Leopoldo N.; Goldring, Roberta M.] NYU, Sch Med, Andre Cournand Pulm Physiol Lab, Div Pulm Crit Care & Sleep,Bellevue Hosp, New York, NY USA; [Parikh, Manish] NYU, Dept Surg, Sch Med, Bellevue Hosp,Bariatr Ctr, New York, NY 10016 USA; [Donnino, Robert; Katz, Stuart] NYU, Leon H Charney Div Cardiol, Sch Med, New York, NY USA	Bellevue Hospital Center; New York University; Bellevue Hospital Center; New York University; New York University	Oppenheimer, BW (corresponding author), NYU, Sch Med, Andre Cournand Pulm Physiol Lab, Div Pulm Crit Care & Sleep,Bellevue Hosp, New York, NY USA.	beno.oppenheimer@nyumc.org		Berger, Kenneth/0000-0003-4879-6071; Stuart, Katz/0000-0003-2340-2021; Parikh, Manish/0000-0002-8612-5407; Segal, Leopoldo/0000-0003-3559-9431; goldring, roberta/0000-0003-3319-4932	Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health [7002001]	Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health	This work was supported by the Empire Clinical Research Investigator Program (ECRIP), NY State Department of Health, Grant #7002001 (Investigators: MP and BWO), http://www.health.ny.gov/professionals/doctors/graduate_medical_education/ecrip/regulation.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan A, 2014, AM J RESP CRIT CARE, V189, P1494, DOI 10.1164/rccm.201401-0178OC; ALEXANDE.JK, 1965, J CHRON DIS, V18, P895, DOI 10.1016/0021-9681(65)90136-0; Alexander JK, 1998, HEART AND LUNG IN OBESITY, P133; ALEXANDER JK, 1967, GERIATRICS, V22, P101; Alpert MA, 1997, AM J CARDIOL, V80, P736, DOI 10.1016/S0002-9149(97)00505-5; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Brown NJ, 2010, RESP PHYSIOL NEUROBI, V172, P162, DOI 10.1016/j.resp.2010.05.013; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chapman DG, 2014, RESPIROLOGY, V19, P1170, DOI 10.1111/resp.12368; Cotes JE, 1993, LUNG FUNCTION ASSESS, V5 th; DEDIVITIIS O, 1981, CIRCULATION, V64, P477, DOI 10.1161/01.CIR.64.3.477; DINAKARA P, 1970, AM REV RESPIR DIS, V102, P965; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; FORSTER RE, 1957, PHYSIOL REV, V37, P391, DOI 10.1152/physrev.1957.37.4.391; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Guazzi M, 2003, CHEST, V124, P1090, DOI 10.1378/chest.124.3.1090; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Guazzi M, 1997, CIRCULATION, V95, P1930; Hsia CCW, 2002, CHEST, V122, P1774, DOI 10.1378/chest.122.5.1774; JOHNSON RL, 1965, J CLIN INVEST, V44, P789, DOI 10.1172/JCI105191; KALTMAN AJ, 1976, AM J MED, V60, P645, DOI 10.1016/0002-9343(76)90499-X; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; King GG, 2005, EUR RESPIR J, V25, P896, DOI 10.1183/09031936.05.00104504; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Kohlhaufl M, 2001, J AEROSOL MED, V14, P1, DOI 10.1089/08942680152007855; KRUMHOLZ RA, 1966, AM REV RESPIR DIS, V94, P195; LANDSER FJ, 1982, CHEST, V81, P586, DOI 10.1378/chest.81.5.586; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; MCNEILL RS, 1958, CLIN SCI, V17, P465; Mercer R.R., 2015, COMP BIOL NORMAL LUN, P93; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; Oostveen E, 2013, EUR RESPIR J, V42, P1513, DOI 10.1183/09031936.00126212; Oppenheimer BW, 2007, CHEST, V132, P1275, DOI 10.1378/chest.07-0913; Oppenheimer BW, 2006, OBESITY, V14, P1172, DOI 10.1038/oby.2006.134; Oppenheimer BW, 2006, RESP MED, V100, P1247, DOI 10.1016/j.rmed.2005.10.015; Oppenheimer BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088015; Oppenheimer BW, 2012, SURG OBES RELAT DIS, V8, P582, DOI 10.1016/j.soard.2011.08.004; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Shiota S, 2005, RESPIROLOGY, V10, P310, DOI 10.1111/j.1440-1843.2005.00703.x; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P925, DOI 10.1016/j.jaci.2005.01.064; Sideleva O, PULMONARY PHARM THER, V26, P455; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Tamhane RM, 2001, CHEST, V120, P1850, DOI 10.1378/chest.120.6.1850; Wagner P.D., 2015, COMP BIOL NORMAL LUN, P143; Zavorsky G. S., 2014, PHYSL REP, V2; Zavorsky GS, 2008, OBES SURG, V18, P256, DOI 10.1007/s11695-007-9294-9; Zavorsky GS, 2008, OBES SURG, V18, P1587, DOI 10.1007/s11695-008-9527-6; ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470	54	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152769	10.1371/journal.pone.0152769	http://dx.doi.org/10.1371/journal.pone.0152769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035663	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200035
J	Bi, XW; Wang, L; Zhang, WW; Sun, P; Yan, SM; Liu, PP; Li, ZM; Jiang, WQ				Bi, Xi-wen; Wang, Liang; Zhang, Wen-wen; Sun, Peng; Yan, Shu-mei; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi			High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma	PLOS ONE			English	Article							INTERNATIONAL PROGNOSTIC INDEX; NASAL-TYPE; BREAST-CANCER; T-CELL; VENOUS THROMBOEMBOLISM; DISEASE PROGRESSION; COLORECTAL-CANCER; RADIATION-THERAPY; HODGKINS-DISEASE; L-ASPARAGINASE	Pretreatment plasma D-dimer levels have been reported to predict survival in several types of malignancies. The aim of this study was to evaluate the prognostic value of D-dimer levels in patients with newly diagnosed natural killer/T-cell lymphoma (NKTCL). The cut-off value of D-dimer to predict survival was set as 1.2 mu g/mL based on the receiver operating curve analysis. Patients with a D-dimer level >= 1.2 mu g/mL had significantly more adverse clinical features, including poor performance status, advanced stage diseases, B symptoms, elevated serum lactic dehydrogenase levels, involvement of regional lymph nodes, more extranodal diseases, and higher International Prognostic Index and natural killer/Tcell lymphoma prognostic index scores. A D-dimer level >= 1.2 mu g/mL was significantly associated with inferior 3-year overall survival (OS, 13.0 vs. 68.5%, P < 0.001). In the multivariate analysis, a D-dimer level >= 1.2 mu g/mL remained an independent predictor for worse OS (HR: 3.13, 95% CI: 1.47-6.68, P = 0.003) after adjusting for other confounding prognostic factors. Among patients with Ann Arbor stage I-II diseases, those with a D-dimer level >= 1.2 mu g/mL had a significantly worse survival than those with a D-dimer level < 1.2 mu g/mL (3 year-OS: 76.2 vs. 22.2%, P < 0.001). Survival of early-stage patients with a high D-dimer level was similar to that of the advanced-stage patients. In conclusion, pretreatment plasma D-dimer level may serve as a simple but effective predictor of prognosis in patients with NKTCL.	[Bi, Xi-wen; Sun, Peng; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Liang] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Wen-wen] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yan, Shu-mei] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Xi-wen; Wang, Liang; Zhang, Wen-wen; Sun, Peng; Yan, Shu-mei; Liu, Pan-pan; Li, Zhi-ming; Jiang, Wen-qi] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China	Jiang, WQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.; Jiang, WQ (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	wenqi_jiang@163.com	jiang, wen/GYI-9662-2022		National-Eleventh Five Technology Major Project [2008ZX09312-002, 2012ZX09301]	National-Eleventh Five Technology Major Project	This study was funded by the National-Eleventh Five Technology Major Project (No. 2008ZX09312-002 to WQJ, 2012ZX09301 to WQJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia G, 2009, BLOOD COAGUL FIBRIN, V20, P170, DOI 10.1097/MBC.0b013e32831bc2de; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Batschauer APB, 2010, ANN ONCOL, V21, P1267, DOI 10.1093/annonc/mdp474; Bi XW, 2015, ANN HEMATOL, V94, P1515, DOI 10.1007/s00277-015-2390-3; Bi XW, 2015, ANN HEMATOL, V94, P1525, DOI 10.1007/s00277-015-2395-y; Bi XW, 2015, ANN HEMATOL, V94, P1175, DOI 10.1007/s00277-015-2336-9; Bi XW, 2013, INT J RADIAT ONCOL, V87, P1086, DOI 10.1016/j.ijrobp.2013.08.040; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Blackwell K, 2004, CANCER-AM CANCER SOC, V101, P77, DOI 10.1002/cncr.20336; Blackwell K, 2000, J CLIN ONCOL, V18, P600, DOI 10.1200/JCO.2000.18.3.600; Buller HR, 2007, J THROMB HAEMOST, V5, P246, DOI 10.1111/j.1538-7836.2007.02497.x; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan JC, 2008, WHO CLASSIFICATION T, P285; CHAN JKC, 2001, WHO CLASSIFICATION T, P204; Chim CS, 2004, BLOOD, V103, P216, DOI 10.1182/blood-2003-05-1401; Chuang HC, 2007, CANCER SCI, V98, P1281, DOI 10.1111/j.1349-7006.2007.00549.x; Dirix LY, 2002, BRIT J CANCER, V86, P389, DOI 10.1038/sj.bjc.6600069; Fukumoto K, 2015, SURG TODAY, V45, P63, DOI 10.1007/s00595-014-0894-4; Go SI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000951; Jaccard A, 2011, BLOOD, V117, P1834, DOI 10.1182/blood-2010-09-307454; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kim BS, 2009, ANN ONCOL, V20, P121, DOI 10.1093/annonc/mdn551; Kim TM, 2005, BLOOD, V106, P3785, DOI 10.1182/blood-2005-05-2056; Kwong YL, 2012, BLOOD, V120, P2973, DOI 10.1182/blood-2012-05-431460; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Li YX, 2006, J CLIN ONCOL, V24, P181, DOI 10.1200/JCO.2005.03.2573; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Oya M, 2001, JPN J CLIN ONCOL, V31, P388, DOI 10.1093/jjco/hye075; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Wang BY, 2008, AM J HEMATOL, V83, P795, DOI 10.1002/ajh.21256; Wang H, 2015, ONCOTARGETS THER, V8, P2589, DOI 10.2147/OTT.S91077; Wang L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0860-4; Wang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0723-4; Wang L, 2013, CANCER-AM CANCER SOC, V119, P348, DOI 10.1002/cncr.27752; Yamaguchi M, 2011, J CLIN ONCOL, V29, P4410, DOI 10.1200/JCO.2011.35.6287; Yamamoto M, 2012, ONCOLOGY-BASEL, V83, P10, DOI 10.1159/000338329; Zhang PP, 2013, EJSO-EUR J SURG ONC, V39, P951, DOI 10.1016/j.ejso.2013.06.008	39	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152842	10.1371/journal.pone.0152842	http://dx.doi.org/10.1371/journal.pone.0152842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032016	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800150
J	Lathlean, JA; Seuront, L; McQuaid, CD; Ng, TPT; Zardi, GI; Nicastro, KR				Lathlean, Justin A.; Seuront, Laurent; McQuaid, Christopher D.; Ng, Terence P. T.; Zardi, Gerardo I.; Nicastro, Katy R.			Cheating the Locals: Invasive Mussels Steal and Benefit from the Cooling Effect of Indigenous Mussels	PLOS ONE			English	Article							BEHAVIORAL THERMOREGULATION; TEMPERATURE VARIABILITY; PERNA-PERNA; PATTERNS; EXPOSURE; SURVIVAL; HISTORY; COAST; COLD	The indigenous South African mussel Perna perna gapes during periods of aerial exposure to maintain aerobic respiration. This behaviour has no effect on the body temperatures of isolated individuals, but when surrounded by conspecifics, beneficial cooling effects of gaping emerge. It is uncertain, however, whether the presence of the invasive mussel Mytilus galloprovincialis limits the ability of P. perna for collective thermoregulation. We investigated whether varying densities of P. perna and M. galloprovincialis influences the thermal properties of both natural and artificial mussel beds during periods of emersion. Using infrared thermography, body temperatures of P. perna within mixed artificial beds were shown to increase faster and reach higher temperatures than individuals in conspecific beds, indicating that the presence of M. galloprovincialis limits the group cooling effects of gaping. In contrast, body temperatures of M. galloprovincialis within mixed artificial mussel beds increased slower and exhibited lower temperatures than for individuals in beds comprised entirely of M. galloprovincialis. Interestingly, differences in bed temperatures and heating rates were largely dependent on the size of mussels, with beds comprised of larger individuals experiencing less thermal stress irrespective of species composition. The small-scale patterns of thermal stress detected within manipulated beds were not observed within naturally occurring mixed mussel beds. We propose that small-scale differences in topography, size-structure, mussel bed size and the presence of organisms encrusting the mussel shells mask the effects of gaping behaviour within natural mussel beds. Nevertheless, the results from our manipulative experiment indicate that the invasive species M. galloprovincialis steals thermal properties as well as resources from the indigenous mussel P. perna. This may have significant implications for predicting how the co-existence of these two species may change as global temperatures continue to rise.	[Lathlean, Justin A.; McQuaid, Christopher D.; Zardi, Gerardo I.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Seuront, Laurent] CNRS, UMR 8187, LOG, 28 Ave Foch,BP 80, F-62930 Wimereux, France; [Ng, Terence P. T.] Univ Hong Kong, Swire Inst Marine Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Ng, Terence P. T.] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Nicastro, Katy R.] Univ Algarve, CCMAR Ctr Ciencias Mar, CIMAR Lab Associado, Campus Gambelas, P-8005139 Faro, Portugal	Rhodes University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); University of Hong Kong; University of Hong Kong; Universidade do Algarve	Lathlean, JA (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	jlathlean@gmail.com	Nicastro, Katy/AAY-3692-2021; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy R/ABI-1531-2020; Zardi, Gerardo/M-4026-2013	McQuaid, Christopher/0000-0002-3473-8308; Nicastro, Katy R/0000-0002-7071-141X; Seuront, Laurent/0000-0002-0051-5202; Zardi, Gerardo/0000-0001-8798-5794	NRF Postdoctoral Fellowship; Rhodes University Research Council Grant; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Australian Research Council's Discovery Project [DP0988554]; Fundacao para a Ciencia e a Tecnologia (FCT) [IF/01413/201 IF/01413/2014/CP1217/CT0004]; NERC [NE/L003074/1] Funding Source: UKRI; Natural Environment Research Council [NE/L003074/1] Funding Source: researchfish	NRF Postdoctoral Fellowship; Rhodes University Research Council Grant; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Australian Research Council's Discovery Project(Australian Research Council); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a NRF Postdoctoral Fellowship to JAL, a Rhodes University Research Council Grant and was further supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, an Australian Research Council's Discovery Project (project number DP0988554), and by Fundacao para a Ciencia e a Tecnologia (FCT; IF/01413/201 IF/01413/2014/CP1217/CT0004).	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bauwens D, 1996, ECOLOGY, V77, P1818, DOI 10.2307/2265786; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Branch GM, 2004, J EXP MAR BIOL ECOL, V300, P189, DOI 10.1016/j.jembe.2003.12.007; Caddy-Retalic S, 2011, MOLLUSCAN RES, V31, P106; Chapperon C, 2012, J THERM BIOL, V37, P640, DOI 10.1016/j.jtherbio.2012.08.001; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Hayford HA, 2015, MAR ECOL PROG SER, V518, P165, DOI 10.3354/meps11053; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Helmuth B, 2011, J EXP MAR BIOL ECOL, V400, P191, DOI 10.1016/j.jembe.2011.02.004; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; Jackson AC, 2011, J EXP MAR BIOL ECOL, V400, P314, DOI 10.1016/j.jembe.2011.02.012; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kearney Michael, 2001, Herpetological Review, V32, P11; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lathlean J, 2014, MAR ECOL PROG SER, V514, P263, DOI 10.3354/meps10995; Lathlean JA, 2015, MAR FRESHWATER RES, V66, P86, DOI 10.1071/MF13287; Lathlean JA, 2013, MAR ECOL PROG SER, V475, P155, DOI 10.3354/meps10105; Lathlean JA, 2012, LIMNOL OCEANOGR, V57, P1279, DOI 10.4319/lo.2012.57.5.1279; Lathlean JA, 2011, MAR ECOL PROG SER, V439, P83, DOI 10.3354/meps09317; Marshall DJ, 2012, J EXP MAR BIOL ECOL, V430, P25, DOI 10.1016/j.jembe.2012.06.011; McQuaid CD, 1988, NATO ASI ADV SCI I A, P212; McQuaid CD, 2015, OCEANOGR MAR BIOL, V53, P127; Navas CA, 1996, OECOLOGIA, V108, P617, DOI 10.1007/BF00329034; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; Pincebourde S, 2013, J EXP BIOL, V216, P2183, DOI 10.1242/jeb.083881; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Reiserer RS, 2008, J ZOOL, V274, P277, DOI 10.1111/j.1469-7998.2007.00383.x; Seabra R, 2011, J EXP MAR BIOL ECOL, V400, P200, DOI 10.1016/j.jembe.2011.02.010; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y	35	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152556	10.1371/journal.pone.0152556	http://dx.doi.org/10.1371/journal.pone.0152556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030975	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800092
J	Nyamweya, C; Desjardins, C; Sigurdsson, S; Tomasson, T; Taabu-Munyaho, A; Sitoki, L; Stefansson, G				Nyamweya, Chrispine; Desjardins, Christopher; Sigurdsson, Sven; Tomasson, Tumi; Taabu-Munyaho, Anthony; Sitoki, Lewis; Stefansson, Gunnar			Simulation of Lake Victoria Circulation Patterns Using the Regional Ocean Modeling System (ROMS)	PLOS ONE			English	Article							EAST-AFRICA; STRATIFICATION; CLIMATE; BASIN	Lake Victoria provides important ecosystem services including transport, water for domestic and industrial uses and fisheries to about 33 million inhabitants in three East African countries. The lake plays an important role in modulating regional climate. Its thermodynamics and hydrodynamics are also influenced by prevailing climatic and weather conditions on diel, seasonal and annual scales. However, information on water temperature and circulation in the lake is limited in space and time. We use a Regional Oceanographic Model System (ROMS) to simulate these processes from 1st January 2000 to 31st December 2014. The model is based on real bathymetry, river runoff and atmospheric forcing data using the bulk flux algorithm. Simulations show that the water column exhibits annual cycles of thermo-stratification (September-May) and mixing (June-August). Surface water currents take different patterns ranging from a lake-wide northward flow to gyres that vary in size and number. An under flow exists that leads to the formation of upwelling and downwelling regions. Current velocities are highest at the center of the lake and on the western inshore waters indicating enhanced water circulation in those areas. However, there is little exchange of water between the major gulfs (especially Nyanza) and the open lake, a factor that could be responsible for the different water quality reported in those regions. Findings of the present study enhance understanding of the physical processes (temperature and currents) that have an effect on diel, seasonal, and annual variations in stratification, vertical mixing, inshore-offshore exchanges and fluxes of nutrients that ultimately influence the biotic distribution and trophic structure. For instance information on areas/timing of upwelling and vertical mixing obtained from this study will help predict locations/seasons of high primary production and ultimately fisheries productivity in Lake Victoria.	[Nyamweya, Chrispine] Kenya Marine & Fisheries Res Inst, Kisumu, Kenya; [Nyamweya, Chrispine; Desjardins, Christopher; Sigurdsson, Sven; Stefansson, Gunnar] Univ Iceland, Fac Phys Sci, Sch Engn & Nat Sci, Reykjavik, Iceland; [Tomasson, Tumi] United Nations Univ, Fisheries Training Programme, Marine Res Inst, Reykjavik, Iceland; [Taabu-Munyaho, Anthony] Natl Fisheries Res Inst, Jinja, Uganda; [Sitoki, Lewis] Tech Univ Kenya, Nairobi, Kenya	University of Iceland; Marine & Freshwater Research Institute (MFRI); Technical University of Kenya	Nyamweya, C (corresponding author), Kenya Marine & Fisheries Res Inst, Kisumu, Kenya.; Nyamweya, C (corresponding author), Univ Iceland, Fac Phys Sci, Sch Engn & Nat Sci, Reykjavik, Iceland.	sanychris@yahoo.com	Stefansson, Gunnar/AAV-9432-2020; Nyamweya, Chrispine Sangara/I-5429-2019; Stefansson, Gunnar/A-2209-2008	Stefansson, Gunnar/0000-0002-2693-9142; Nyamweya, Chrispine Sangara/0000-0002-7135-7379; Stefansson, Gunnar/0000-0002-2693-9142; Desjardins, Christopher/0000-0002-8234-9665	United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship	United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship	This work was supported by the United Nations University - Fisheries Training Program (UNU-FTP) PhD scholarship to CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyah RO, 2009, INT J CLIMATOL, V29, P971, DOI 10.1002/joc.1795; Crul RCM, 1995, LIMNOLOGY AND HYDROL; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; KENDALL RL, 1969, ECOL MONOGR, V39, P121, DOI 10.2307/1950740; MacIntyre S, 2014, LIMNOL OCEANOGR, V59, P1805, DOI 10.4319/lo.2014.59.6.1805; Ochumba PBO, 1996, LIMNOLOGY CLIMATOLOG, P55; Okely P, 2010, LIMNOL OCEANOGR, V55, P1865, DOI 10.4319/lo.2010.55.5.1865; Rocha C, 2013, J COASTAL RES, P117, DOI 10.2112/SI65-021a.1; Sitoki L, 2010, INT REV HYDROBIOL, V95, P209, DOI 10.1002/iroh.201011226; Song Y, 2004, INT J CLIMATOL, V24, P57, DOI 10.1002/joc.983; Sun X, 2014, MODEL; Swenson S, 2009, J HYDROL, V370, P163, DOI 10.1016/j.jhydrol.2009.03.008; Taabu-Munyaho A, 2013, J GREAT LAKES RES, V39, P466, DOI 10.1016/j.jglr.2013.06.009; TALLING J. F., 1965, INT REV GESAMTEN HYDROBIOL, V50, P1, DOI 10.1002/iroh.19650500102; TALLING J. F., 1966, INT REV GESAMTEN HYDROBIOL, V51, P545, DOI 10.1002/iroh.19660510402; Talling JF, 1969, INT VEREINIGUNG THEO, V17, P998; Tate E, 2004, HYDROLOG SCI J, V49, P563, DOI 10.1623/hysj.49.4.563.54422; Taylor JR, 2008, J PHYS OCEANOGR, V38, P2535, DOI 10.1175/2008JPO3942.1; TEMPLE P H, 1969, Biological Journal of the Linnean Society, V1, P363, DOI 10.1111/j.1095-8312.1969.tb00126.x; Warner JC, 2005, OCEAN MODEL, V8, P81, DOI 10.1016/j.ocemod.2003.12.003	20	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151272	10.1371/journal.pone.0151272	http://dx.doi.org/10.1371/journal.pone.0151272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030983	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800012
J	Smayda, KE; Van Engen, KJ; Maddox, WT; Chandrasekaran, B				Smayda, Kirsten E.; Van Engen, Kristin J.; Maddox, W. Todd; Chandrasekaran, Bharath			Audio-Visual and Meaningful Semantic Context Enhancements in Older and Younger Adults	PLOS ONE			English	Article							SPEECH RECOGNITION; VISUAL ENHANCEMENT; PERCEPTION; NOISE; HEARING	Speech perception is critical to everyday life. Oftentimes noise can degrade a speech signal; however, because of the cues available to the listener, such as visual and semantic cues, noise rarely prevents conversations from continuing. The interaction of visual and semantic cues in aiding speech perception has been studied in young adults, but the extent to which these two cues interact for older adults has not been studied. To investigate the effect of visual and semantic cues on speech perception in older and younger adults, we recruited forty-five young adults (ages 18-35) and thirty-three older adults (ages 60-90) to participate in a speech perception task. Participants were presented with semantically meaningful and anomalous sentences in audio-only and audio-visual conditions. We hypothesized that young adults would outperform older adults across SNRs, modalities, and semantic contexts. In addition, we hypothesized that both young and older adults would receive a greater benefit from a semantically meaningful context in the audio-visual relative to audio-only modality. We predicted that young adults would receive greater visual benefit in semantically meaningful contexts relative to anomalous contexts. However, we predicted that older adults could receive a greater visual benefit in either semantically meaningful or anomalous contexts. Results suggested that in the most supportive context, that is, semantically meaningful sentences presented in the audiovisual modality, older adults performed similarly to young adults. In addition, both groups received the same amount of visual and meaningful benefit. Lastly, across groups, a semantically meaningful context provided more benefit in the audio-visual modality relative to the audio-only modality, and the presence of visual cues provided more benefit in semantically meaningful contexts relative to anomalous contexts. These results suggest that older adults can perceive speech as well as younger adults when both semantic and visual cues are available to the listener.	[Smayda, Kirsten E.; Maddox, W. Todd; Chandrasekaran, Bharath] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Van Engen, Kristin J.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO USA; [Chandrasekaran, Bharath] Univ Texas Austin, Commun Sci & Disorders Dept, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Texas System; University of Texas Austin	Smayda, KE (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	ksmayda@utexas.edu		Van Engen, Kristin/0000-0001-9069-5464; Chandrasekaran, Bharath/0000-0002-3673-9435	National Institute of Drug Abuse from the National Institutes of Health [DA032457]; National Institute on Deafness and Other Communication Disorders from the National Institutes of Health [R01DC013315]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032457] Funding Source: NIH RePORTER	National Institute of Drug Abuse from the National Institutes of Health; National Institute on Deafness and Other Communication Disorders from the National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute of Drug Abuse Grant No. DA032457 from the National Institutes of Health awarded to WTM, and National Institute on Deafness and Other Communication Disorders Grant No. R01DC013315 from the National Institutes of Health awarded to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2014, NEUROPSYCHOLOGIA, V62, P286, DOI 10.1016/j.neuropsychologia.2014.07.034; Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2012, LME4 LINEAR MIXED EF; Boersma P, 2021, PRAAT DOING PHONETIC; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Delis DC., 2000, CALIFORNIA VERBAL LE; Dubno JR, 2000, J ACOUST SOC AM, V107, P538, DOI 10.1121/1.428322; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gilbert RC, 2014, J ACOUST SOC AM, V135, P389, DOI 10.1121/1.4838975; Heaton R.K., 1993, WISCONSIN CARD SORTI; Helfer K S, 1998, J Am Acad Audiol, V9, P234; Helfer KS, 1997, J SPEECH LANG HEAR R, V40, P432, DOI 10.1044/jslhr.4002.432; Helfer KS, 2007, AGING SPEECH ON SPEE; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Nye PW, 1974, SR3738 HASK LAB; Rogers CS, 2012, PSYCHOL AGING, V27, P33, DOI 10.1037/a0026231; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schneider Bruce A., 2001, Seminars in Hearing, V22, P227, DOI 10.1055/s-2001-15628; SCHNEIDER PF, 1995, J ACOUST SOC AM, V97, P593; Smiljanic R, 2013, J SPEECH LANG HEAR R, V56, P1085, DOI 10.1044/1092-4388(2012/12-0097); Sommers MS, 2005, EAR HEARING, V26, P263, DOI 10.1097/00003446-200506000-00003; Stevenson RA, 2015, NEUROBIOL AGING, V36, P283, DOI 10.1016/j.neurobiolaging.2014.08.003; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sumby W.H., 1954, JASA EXPRESS; Van Engen KJ, 2014, J SPEECH LANG HEAR R, V57, P1908, DOI 10.1044/JSLHR-H-13-0076; Venables WN., 2002, MODERN APPL STAT S 4; WALDEN BE, 1993, J SPEECH HEAR RES, V36, P431, DOI 10.1044/jshr.3602.431; Wechsler D., 1997, WECHSLER ADULT INTEL	32	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152773	10.1371/journal.pone.0152773	http://dx.doi.org/10.1371/journal.pone.0152773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031343	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800135
J	Fleming, J; Farquhar, M; Brayne, C; Barclay, S				Fleming, Jane; Farquhar, Morag; Brayne, Carol; Barclay, Stephen		Cambridge City Over-75s Cohort	Death and the Oldest Old: Attitudes and Preferences for End-of-Life Care - Qualitative Research within a Population-Based Cohort Study	PLOS ONE			English	Article							SUSTAINING TREATMENT PREFERENCES; FAMILY CARERS; PEOPLE; PLACE; DEMENTIA; ADULTS; VIEWS; TRANSITIONS; HOMES; COMMUNICATION	Introduction Increasing longevity means more people will be dying in very old age, but little is known about the preferences of the 'oldest old' regarding their care at the end of life. Aims To understand very old people's preferences regarding care towards the end of life and attitudes towards dying, to inform policy and practice. Methods Qualitative data collection for n = 42 population-based cohort study participants aged 95101 (88% women, 42% in long-term-care): topic-guided interviews with n = 33 participants and n = 39 proxy informants, most with both (n = 30: 4 jointly + separate interviews for 26 dyads). Results Death was a part of life: these very old people mainly live day-to-day. Most were ready to die, reflecting their concerns regarding quality of life, being a nuisance, having nothing to live for and having lived long enough. Contrasting views were rare exceptions but voiced firmly. Most were not worried about death itself, but concerned more about the dying process and impacts on those left behind; a peaceful and pain-free death was a common ideal. Attitudes ranged from not wanting to think about death, through accepting its inevitable approach to longing for its release. Preferring to be made comfortable rather than have life-saving treatment if seriously ill, and wishing to avoid hospital, were commonly expressed views. There was little or no future planning, some consciously choosing not to. Uncertainty hampered end-of-life planning even when death was expected soon. Some stressed circumstances, such as severe dependency and others' likely decision-making roles, would influence choices. Carers found these issues harder to raise but felt they would know their older relatives' preferences, usually palliative care, although we found two discrepant views. Conclusions This study's rare data show >= 95-year-olds are willing to discuss dying and end-of-life care but seldom do. Formal documentation of wishes is extremely rare and may not be welcome. Although being "ready to die" and preferring a palliative approach predominated, these preferences cannot be assumed.	[Fleming, Jane; Brayne, Carol; Barclay, Stephen] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Fleming, Jane; Farquhar, Morag; Brayne, Carol; Barclay, Stephen; Cambridge City Over-75s Cohort] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Fleming, Jane; Farquhar, Morag; Barclay, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Fleming, J (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England.; Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.; Fleming, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England.	jane.fleming@phpc.cam.ac.uk	Fleming, Jane/L-5300-2015; Brayne, Carol/AAA-4285-2020; Dening, Tom/E-1335-2013; Romero-Ortuno, Roman/AAP-9221-2020; Farquhar, Morag/C-5666-2015	Fleming, Jane/0000-0002-8127-2061; Brayne, Carol/0000-0001-5307-663X; Dening, Tom/0000-0003-3387-4241; Romero-Ortuno, Roman/0000-0002-3882-7447; Buck, Jackie/0000-0002-3598-2329; Farquhar, Morag/0000-0001-7991-7679	Abbeyfield Society; BUPA Foundation under Health and Care of Older People grant; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Abbeyfield Society; BUPA Foundation under Health and Care of Older People grant; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank all the past CC75C sponsors for financial support spanning two decades (see http://www.cc75c.group.cam.ac.uk/pages/grant/default.htm for full list of project grants), particularly the Abbeyfield Society for current funding and the BUPA Foundation for support under their Health and Care of Older People grant. CC75C was a member study of the National Institute for Health Research funded Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for Cambridgeshire and Peterborough. All researchers were independent from funders. No funder sponsor played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaltonen M, 2014, J AM MED DIR ASSOC, V15, P643, DOI 10.1016/j.jamda.2014.04.018; Abba K, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-40; Barclay S, 2008, BRIT J GEN PRACT, V58, P229, DOI 10.3399/bjgp08X279724; Barclay S, 2014, BRIT J GEN PRACT, V64, pE576, DOI 10.3399/bjgp14X681397; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Bravell ME, 2010, PALLIAT SUPPORT CARE, V8, P335, DOI 10.1017/S1478951510000131; BruceJones P, 1996, J MED ETHICS, V22, P154, DOI 10.1136/jme.22.3.154; Carrese JA, 2002, BRIT MED J, V325, P125, DOI 10.1136/bmj.325.7356.125; Caswell G, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0032-0; Chan HYL, 2007, J CLIN NURS, V16, P2158, DOI 10.1111/j.1365-2702.2006.01891.x; Clarke A, 2010, J PAIN SYMPTOM MANAG, V40, P857, DOI 10.1016/j.jpainsymman.2010.02.027; Davidson S, 2013, END LIFE EVIDENCE RE; Davies E, 2004, BETTER PALLIATIVE CA; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Department of Health, 2008, END OF LIF CAR STRAT; Dickinson C, 2013, INT PSYCHOGERIATR, V25, P2011, DOI 10.1017/S1041610213001531; Ditto PH, 2006, MED DECIS MAKING, V26, P313, DOI 10.1177/0272989X06290494; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Dowling-Castronovo A, 2002, GERONTOLOGIST, V42, P82, DOI 10.1093/geront/42.suppl_3.54; Downey L, 2013, J PAIN SYMPTOM MANAG, V46, P9, DOI 10.1016/j.jpainsymman.2012.07.002; Engelberg RA, 2005, J PAIN SYMPTOM MANAG, V30, P498, DOI 10.1016/j.jpainsymman.2005.06.006; Evans CJ, 2014, BMJ SUPPORT PALLIAT, V4, P111; Fleming J, 2007, INT J EPIDEMIOL, V36, P40, DOI 10.1093/ije/dyl293; Fleming J, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483959; Garavan R, 2009, J AM GERIATR SOC, V57, P750, DOI 10.1111/j.1532-5415.2009.02197.x; Goodman C, 2013, INT J NURS STUD, V50, P1639, DOI 10.1016/j.ijnurstu.2013.06.008; Gott M, 2004, PALLIATIVE MED, V18, P460, DOI 10.1191/0269216304pm889oa; Gott M, 2013, HLTH SERV DELIV RES, V1; Gott M, 2011, BMJ-BRIT MED J, P342; Gouvernement du Quebec, 2014, ACT RESP END LIF CAR; Hallberg IR, 2004, AGING CLIN EXP RES, V16, P87; Hanratty B, 2012, J PAIN SYMPTOM MANAG, V44, P74, DOI 10.1016/j.jpainsymman.2011.08.006; Hunt KJ, 2014, J PALLIAT MED, V17, P176, DOI 10.1089/jpm.2013.0385; Janssen DJA, 2013, J PAIN SYMPTOM MANAG, V46, P826, DOI 10.1016/j.jpainsymman.2013.01.007; Kayser-Jones Jeanie, 2002, Gerontologist, V42 Spec No 3, P11; Klinkenberg M, 2004, SOC SCI MED, V59, P2467, DOI 10.1016/j.socscimed.2004.04.006; Lakasing Edin, 2014, Br J Community Nurs, V19, P130; Leeson G.W, 2014, INT J POPULATION RES, P1, DOI [10.1155/2014/521523, DOI 10.1155/2014/521523]; Lloyd-Williams M, 2007, J PAIN SYMPTOM MANAG, V34, P60, DOI 10.1016/j.jpainsymman.2006.09.028; Mathie E, 2012, PALLIATIVE MED, V26, P734, DOI 10.1177/0269216311412233; Morris ZS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-89; Nahm ES, 2001, NURS ETHICS, V8, P533; National Palliative and End of Life Care Partnership, 2015, AMB PALL END LIF CAR; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Oliver D., 2014, MAKING OUR HLTH CARE; Pasman HRW, 2013, J AM GERIATR SOC, V61, P1722, DOI 10.1111/jgs.12450; Perrels AJ, 2014, PALLIATIVE MED, V28, P220, DOI 10.1177/0269216313510341; Petkova H., 2012, UNDERSTANDING PLACE; Piers RD, 2013, PATIENT EDUC COUNS, V90, P323, DOI 10.1016/j.pec.2011.07.008; Rao R, 1997, Int Psychogeriatr, V9, P213, DOI 10.1017/S1041610297004365; Ritchie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081; Seymour J, 2004, SOC SCI MED, V59, P57, DOI 10.1016/j.socscimed.2003.10.005; Seymour J., 2005, END OF LIFE CARE PRO; Seymour JE, 2011, PALLIATIVE MED, V25, P125, DOI 10.1177/0269216310387964; Sharp T, 2013, BRIT J GEN PRACT, V63, pE657, DOI 10.3399/bjgp13X673667; Tanner D., 2012, UNDERSTANDING IMPROV; Towsley GL, 2015, J PALLIATIVE MED, V18; van Eechoud IJ, 2014, J PAIN SYMPTOM MANAG, V47, P876, DOI 10.1016/j.jpainsymman.2013.06.007; van Wijngaarden E, 2015, SOC SCI MED, V138, P257, DOI 10.1016/j.socscimed.2015.05.015	60	55	58	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0150686	10.1371/journal.pone.0150686	http://dx.doi.org/10.1371/journal.pone.0150686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045734	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600003
J	Jaggernath, M; Naicker, R; Madurai, S; Brockman, MA; Ndung'u, T; Gelderblom, HC				Jaggernath, Manjeetha; Naicker, Rumallen; Madurai, Savathree; Brockman, Mark A.; Ndung'u, Thumbi; Gelderblom, Huub C.			Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site M-Hgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South Africa	PLOS ONE			English	Article							VENOUS HEMOGLOBIN; SYSTEM; PERFORMANCE; HEMATOLOGY; AGREEMENT; ANEMIA; ADULTS; TESTS; HIV; RNA	In South Africa, various point-of-care hemoglobin meters are used. However, the regulatory framework for approval, implementation and oversight of use of point-of-care hemoglobin meters is suboptimal. We assessed the diagnostic accuracy of the HemoCue Hb 301, STAT-Site M-Hgb and URIT-12 point-of-care hemoglobin meters, compared to a central laboratory based reference assay, in a central laboratory and a community based clinic in Durban, South Africa. Differences in performance of the point-of-care assays, compared to the reference assay, were more pronounced in the community based clinic. Results were reasonable for the HemoCue Hb 301, but poor for the STAT-Site M-Hgb and the URIT-12. Poor test performance of point-of-care hemoglobin meters, and inadequate evaluations and oversight in South Africa, leads to suboptimal clinical care and clinical research, and increased costs. There is a need for proper evaluation and quality assurance of point-of-care tests, the results of which should be made widely available to key stakeholders.	[Jaggernath, Manjeetha; Ndung'u, Thumbi; Gelderblom, Huub C.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Naicker, Rumallen; Madurai, Savathree] Global Clin & Viral Lab, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Gelderblom, Huub C.] IAVI, New York, NY USA; [Brockman, Mark A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Brockman, Mark A.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Brockman, Mark A.; Ndung'u, Thumbi] MIT & Harvard, Ragon Inst MGH, Charlestown, MA USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; International AIDS Vaccine Initiative; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Max Planck Society	Gelderblom, HC (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.; Gelderblom, HC (corresponding author), IAVI, New York, NY USA.	huubcgelderblom@gmail.com	Brockman, Mark/D-1669-2016	Brockman, Mark/0000-0001-6432-1426; Ndung'u, Thumbi/0000-0003-2962-3992	Canada-sub-Saharan HIV/AIDS Network (CANSSA); Global Health Research Initiative (GHRI); CIHR; Canadian International Development Agency (CIDA); International Development Research Centre (IDRC); Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; Howard Hughes Medical Institute	Canada-sub-Saharan HIV/AIDS Network (CANSSA); Global Health Research Initiative (GHRI); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian International Development Agency (CIDA); International Development Research Centre (IDRC); Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was funded by the Canada-sub-Saharan HIV/AIDS Network (CANSSA) through funding provided by the Global Health Research Initiative (GHRI), itself a collaborative research funding partnership of the CIHR, the Canadian International Development Agency (CIDA), and the International Development Research Centre (IDRC). Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Canada-sub-Saharan HIV/AIDS Network (CANSSA) through funding provided by the Global Health Research Initiative (GHRI), itself a collaborative research funding partnership of the CIHR, the Canadian International Development Agency (CIDA), and the International Development Research Centre (IDRC). The funders had no role in study design, data collection and analysis, decision to publish,	Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cable RG, 2012, TRANSFUSION, V52, P1031, DOI 10.1111/j.1537-2995.2011.03389.x; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Gelderblom HC, 2006, ANTIVIR THER, V11, P95; Gelderblom HC, 2007, J CLIN VIROL, V39, P326, DOI 10.1016/j.jcv.2007.05.004; Ghys T, 2009, INT J LAB HEMATOL, V31, P560, DOI 10.1111/j.1751-553X.2008.01081.x; Gomez-Simon A, 2007, TRANSFUS APHER SCI, V36, P235, DOI 10.1016/j.transci.2007.01.010; Hurly DS, 2014, SEX TRANSM INFECT, V90, P179, DOI 10.1136/sextrans-2013-051246; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Muenchhoff M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103983; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; Patel AJ, 2013, VOX SANG, V104, P317, DOI 10.1111/vox.12006; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Piwowar-Manning Estelle M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P170, DOI 10.1177/1545109710368151; Qin Xue, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P2196; Teruya SL, 2009, J AM GERIATR SOC, V57, P2362, DOI 10.1111/j.1532-5415.2009.02582.x; van Hensbroek MB, 2011, BRIT J HAEMATOL, V154, P690, DOI 10.1111/j.1365-2141.2011.08761.x; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73	25	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152184	10.1371/journal.pone.0152184	http://dx.doi.org/10.1371/journal.pone.0152184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046200	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600010
J	Phelps-Polirer, K; Abt, MA; Smith, D; Yeh, ES				Phelps-Polirer, Kendall; Abt, Melissa A.; Smith, Danzell; Yeh, Elizabeth S.			Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer	PLOS ONE			English	Article							CELL-SURVIVAL; TRASTUZUMAB RESISTANCE; SIGNALING AXIS; KINASE; JUN; INHIBITION; ACTIVATION; P53; PHOSPHORYLATION; EXPRESSION	Strategies for successful primary treatment of HER2-positive breast cancer include use of the HER2 inhibitors trastuzumab or lapatinib in combination with standard chemotherapy. While successful, many patients develop resistance to these HER2 inhibitors indicating an unmet need. Consequently, current research efforts are geared toward understanding mechanisms of resistance and the signaling modalities that regulate these mechanisms. We have undertaken a study to examine whether signaling molecules downstream of epidermal growth factor receptor, which often act as compensatory signaling outlets to circumvent HER2 inhibition, can be co-targeted to overcome resistance. We identified JNK signaling as a potential area of intervention and now show that inhibiting JNK using the pan-JNK inhibitor, SP600125, is effective in the HER2-positive, resistant JIMT-1 xenograft mammary tumor model. We also investigate potential combination strategies to bolster the effects of JNK inhibition and find that co-targeting of JNK and the protein kinase HUNK can prohibit tumor growth of resistant HER2-positive mammary tumors in vivo.	[Phelps-Polirer, Kendall] Clemson Univ, Dept Hlth Sci, Columbia, SC USA; [Abt, Melissa A.; Yeh, Elizabeth S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Smith, Danzell] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Clemson University; Medical University of South Carolina; Medical University of South Carolina	Yeh, ES (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	yeh@musc.edu			NCI [R01- CA187305-01A1]; Concern Foundation; American Cancer Society Institutional Research Grant [IRG-97-219-14]; Department of Defense grant at MUSC [W81XWH-11-2-0229]; NIGMS [GM072643]; NATIONAL CANCER INSTITUTE [R01CA187305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Concern Foundation; American Cancer Society Institutional Research Grant(American Cancer Society); Department of Defense grant at MUSC; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Yeh Lab is supported by R01- CA187305-01A1 from the NCI (to E.S.Y), a grant from the Concern Foundation (to E.S.Y), as well as previous pilot funds from an American Cancer Society Institutional Research Grant (IRG-97-219-14) awarded to the Hollings Cancer Center at MUSC and from a Department of Defense grant (W81XWH-11-2-0229) at MUSC. Danzell Smith is supported in part by GM072643 from the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research in the Yeh Lab is supported by R01- CA187305-01A1 from the NCI (to E.S.Y), a grant from the Concern Foundation (to E.S.Y), as well as previous pilot funds from an American Cancer Society Institutional Research Grant (IRG-97-219-14) awarded to the Hollings Cancer Center at MUSC and from a Department of Defense grant (W81XWH-11-2-0229) at MUSC. Danzell Smith is supported in part by GM072643 from the NIGMS.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Bull SB, 2004, J CLIN ONCOL, V22, P86, DOI 10.1200/JCO.2004.09.128; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cufi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02469; Formisano L, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3650; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Han JS, 2010, ANTICANCER RES, V30, P3407; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; Kim JW, 2016, J CANCER RES CLIN, V142, P157, DOI 10.1007/s00432-015-2012-4; Klapper LN, 2000, CANCER RES, V60, P3384; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Li YL, 2014, TOXICOL APPL PHARM, V274, P319, DOI 10.1016/j.taap.2013.11.018; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nakopoulou LL, 1996, J PATHOL, V179, P31, DOI 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O; Nasrazadani Azadeh, 2011, Genes Cancer, V2, P31, DOI 10.1177/1947601911400901; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Tanner M, 2004, MOL CANCER THER, V3, P1585; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Yamashita H, 2004, BREAST CANCER RES, V6, pR24, DOI 10.1186/bcr738; Yeh ES, 2015, BREAST CANCER RES TR, V149, P91, DOI 10.1007/s10549-014-3227-9; Yeh ES, 2013, P NATL ACAD SCI USA, V110, P6103, DOI 10.1073/pnas.1217415110; Yeh ES, 2011, J CLIN INVEST, V121, P866, DOI 10.1172/JCI42928; Young CD, 2015, MOL CELL PROTEOMICS, V14, P1959, DOI 10.1074/mcp.M115.049783; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153025	10.1371/journal.pone.0153025	http://dx.doi.org/10.1371/journal.pone.0153025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045589	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600061
J	de Brito, SR; da Silva, AD; Cruz, AG; Monteiro, MD; Vijaykumar, NL; da Silva, MS; Costa, JCWA; Frances, CRL				de Brito, Silvana Rossy; da Silva, Aleksandra do Socorro; Cruz, Adejard Gaia; Monteiro, Maurilio de Abreu; Vijaykumar, Nandamudi Lankalapalli; da Silva, Marcelino Silva; Weyl Albuquerque Costa, Joao Crisostomo; Lisboa Frances, Carlos Renato			Concentration of Access to Information and Communication Technologies in the Municipalities of the Brazilian Legal Amazon	PLOS ONE			English	Article							DIGITAL DIVIDE; ICT; NETWORKS	This study fills demand for data on access and use of information and communication technologies (ICT) in the Brazilian legal Amazon, a region of localities with identical economic, political, and social problems. We use the 2010 Brazilian Demographic Census to compile data on urban and rural households (i) with computers and Internet access, (ii) with mobile phones, and (iii) with fixed phones. To compare the concentration of access to ICT in the municipalities of the Brazilian Amazon with other regions of Brazil, we use a concentration index to quantify the concentration of households in the following classes: with computers and Internet access, with mobile phones, with fixed phones, and no access. These data are analyzed along with municipal indicators on income, education, electricity, and population size. The results show that for urban households, the average concentration in the municipalities of the Amazon for computers and Internet access and for fixed phones is lower than in other regions of the country; meanwhile, that for no access and mobile phones is higher than in any other region. For rural households, the average concentration in the municipalities of the Amazon for computers and Internet access, mobile phones, and fixed phones is lower than in any other region of the country; meanwhile, that for no access is higher than in any other region. In addition, the study shows that education and income are determinants of inequality in accessing ICT in Brazilian municipalities and that the existence of electricity in rural households is directly associated with the ownership of ICT resources.	[de Brito, Silvana Rossy; da Silva, Aleksandra do Socorro] Fed Rural Univ Amazon, Cybersp Inst, Belem, Para, Brazil; [Cruz, Adejard Gaia] Fed Univ Para, Inst Appl Social Sci, BR-66059 Belem, Para, Brazil; [Monteiro, Maurilio de Abreu] Fed Univ Para, Amazon Higher Studies Nucleus, BR-66059 Belem, Para, Brazil; [Vijaykumar, Nandamudi Lankalapalli] Natl Inst Space Res, Special Technol Ctr, Sao Paulo, Brazil; [da Silva, Marcelino Silva; Weyl Albuquerque Costa, Joao Crisostomo; Lisboa Frances, Carlos Renato] Fed Univ Para, Inst Technol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Federal do Para	de Brito, SR (corresponding author), Fed Rural Univ Amazon, Cybersp Inst, Belem, Para, Brazil.	silvana.rossy@ufra.edu.br	Frances, Carlos Renato Lisboa/D-9783-2019; da Silva, Marcelino Silva/AAN-5214-2020; costa, Joao weyl/O-5146-2018; Monteiro, Maurilio/ABE-9570-2020	Frances, Carlos Renato Lisboa/0000-0003-0305-7662; da Silva, Marcelino Silva/0000-0001-7504-7434; costa, Joao weyl/0000-0003-4482-6886; Monteiro, Maurilio/0000-0002-0494-1751	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [0645-14-1]	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SRB received financial support (scholarship) from CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, 0645-14-1, www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Andrade AD, 2012, INFORM TECHNOL DEV, V18, P281, DOI 10.1080/02681102.2011.643204; Ashraf M, 2009, INFORM SYST FRONT, V11, P155, DOI 10.1007/s10796-008-9133-0; Ayanso A, 2014, INFORM TECHNOL DEV, V20, P60, DOI 10.1080/02681102.2013.797378; Babic J, TEL CONTEL 2015 13 I, P1, DOI [10.1109/ConTEL.2015.7231204, DOI 10.1109/CONTEL.2015.7231204]; Basu S., 2004, INT REV LAW COMPUTER, V18, P109, DOI [DOI 10.1080/13600860410001674779, 10.1080/13600860410001674779]; Bolzan LM, 2013, QUALIT S REV ELETRON, V14, P1; Chen Z, 2001, DATA MINING UNCERTAI; CNNIC I, 2015, 35 STAT REP INT DEV; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Crocco Marco Aurélio, 2006, Nova econ., V16, P211, DOI 10.1590/S0103-63512006000200001; Diniz E, 2012, ELECTRON COMMER R A, V11, P484, DOI 10.1016/j.elerap.2011.07.006; Dobrota M, 2015, TELECOMMUN POLICY, V39, P406, DOI 10.1016/j.telpol.2015.03.003; Luna-Reyes LF, 2012, GOV INFORM Q, V29, P324, DOI 10.1016/j.giq.2012.03.001; Hage E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-19; Heeks R, 2008, COMPUTER, V41, P26, DOI 10.1109/MC.2008.192; Instituto de Pesquisa Economica Aplicada, 2013, IND DES HUM MUN BRAS, P96; International Telecommunication Union, 2014, MAN MEAS ICT ACC US; International Telecommunications Union, 2014, MEAS INF SOC REP 201; Kennedy C., 2014, J DEV COMMUN STUD, V3, P24; Khan GF, 2011, SCIENTOMETRICS, V87, P267, DOI 10.1007/s11192-010-0322-5; Korb K.B., 2004, COM SCI DAT; Liu C, 2012, GOV INFORM Q, V29, P85, DOI 10.1016/j.giq.2011.06.002; Lucas H, 2008, SOC SCI MED, V66, P2122, DOI 10.1016/j.socscimed.2008.01.033; Martin SP, 2007, SOC PROBL, V54, P1, DOI 10.1525/sp.2007.54.1.1; Mutula SM, 2006, INT J INFORM MANAGE, V26, P212, DOI 10.1016/j.ijinfomgt.2006.02.004; National Household Sample Survey, 2013, NAT HOUS SAMPL SURV; NERI M. C., 2012, MAPA INCLUSAO DIGITA; Novo-Corti I, 2015, COMPUT HUM BEHAV, V51, P1216, DOI 10.1016/j.chb.2014.12.040; Pick JB, 2015, SOCIO-ECON PLAN SCI, V49, P16, DOI 10.1016/j.seps.2014.09.001; Ribeiro Luiz césar de Queiroz, 2013, Anál. Social, P288; Sassi S, 2013, TELECOMMUN POLICY, V37, P252, DOI 10.1016/j.telpol.2012.12.004; Schmitz H, 1999, WORLD DEV, V27, P12; United Nations, MILL DEV GOALS REP 2; United Nations, 2012, AHRC20L13 UN; United Nations Development Project, 2001, HUM DEV REP 2001 MAK; Wouters J, 2015, WORLD BANK LEGAL REV, P592	37	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152655	10.1371/journal.pone.0152655	http://dx.doi.org/10.1371/journal.pone.0152655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035577	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200026
J	Oravecz, Z; Muth, C; Vandekerckhove, J				Oravecz, Zita; Muth, Chelsea; Vandekerckhove, Joachim			Do People Agree on What Makes One Feel Loved? A Cognitive Psychometric Approach to the Consensus on Felt Love	PLOS ONE			English	Article							ROMANTIC LOVE; DECISION-MAKING; MODEL	This pragmatic study examines love as a mode of communication. Our focus is on the receiver side: what makes an individual feel loved and how felt love is defined through daily interactions. Our aim is to explore everyday life scenarios in which people might experience love, and to consider people's converging and diverging judgments about which scenarios indicate felt love. We apply a cognitive psychometric approach to quantify a receiver's ability to detect, understand, and know that they are loved. Through crowd-sourcing, we surveyed lay participants about whether various scenarios were indicators of felt love. We thus quantify these responses to make inference about consensus judgments of felt love, measure individual levels of agreement with consensus, and assess individual response styles. More specifically, we (1) derive consensus judgments on felt love; (2) describe its characteristics in qualitative and quantitative terms, (3) explore individual differences in both (a) participant agreement with consensus, and (b) participant judgment when uncertain about shared knowledge, and (4) test whether individual differences can be meaningfully linked to explanatory variables. Results indicate that people converge towards a shared cognitive model of felt love. Conversely, respondents showed heterogeneity in knowledge of consensus, and in dealing with uncertainty. We found that, when facing uncertainty, female respondents and people in relationships more frequently judge scenarios as indicators of felt love. Moreover, respondents from smaller households tend to know more about consensus judgments of felt love, while respondents from larger households are more willing to guess when unsure of consensus.	[Oravecz, Zita; Muth, Chelsea] Penn State Univ, Human Dev & Family Studies, State Coll, PA USA; [Vandekerckhove, Joachim] Univ Calif Irvine, Cognit Sci, Irvine, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of California System; University of California Irvine	Oravecz, Z (corresponding author), Penn State Univ, Human Dev & Family Studies, State Coll, PA USA.	zita@psu.edu	Oravecz, Zita/AAF-3840-2020	Oravecz, Zita/0000-0002-9070-3329; Vandekerckhove, Joachim/0000-0003-2600-5937	John Templeton Foundation [48192]	John Templeton Foundation	ZO and JV were supported by grant #48192 from the John Templeton Foundation (http://templeton.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo B. P., 2011, SOCIAL COGNITIVE AFF; Agrawal Kalin, 2012, Social Computing, Behavioral-Cultural Modeling and Prediction. Proceedings of the 5th International Conference, SBP 2012, P53, DOI 10.1007/978-3-642-29047-3_7; Anders R, 2012, J MATH PSYCHOL, V56, P452, DOI 10.1016/j.jmp.2013.01.004; [Anonymous], 2006, NEW PSYCHOL LOVE; Aron A, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P595, DOI 10.1017/CBO9780511606632.033; Batchelder WH, 2012, J MATH PSYCHOL, V56, P316, DOI 10.1016/j.jmp.2012.06.002; Batchelder WH, 1997, J MATH SOCIOL, V22, P29, DOI 10.1080/0022250X.1997.9990193; Batchelder WH, 2007, CSCA LECT AMST NETH; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Buss David, 2006, NEW PSYCHOL LOVE, P65; Fehr B, 2006, NEW PSYCHOL LOVE, P225; Fisher H., 2006, NEW PSYCHOL LOVE, P87; Fraley R., 2000, REV GEN PSYCHOL, V4, P132, DOI [DOI 10.1037/1089-2680.4.2.132, 10.1037/1089-2680.4.2.132, DOI 10.1037/0022-3514.52.3.511]; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gonzaga GC, 2006, EMOTION, V6, P163, DOI 10.1037/1528-3542.6.2.163; Hatfield E, 2012, J SOC PERS RELAT, V29, P143, DOI 10.1177/0265407511431055; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Kern M, 2014, J POSITIVE PSYCHOL; Lopez FG, 2003, ASSESSMENT ADULT ATT; Mikulincer M, 2010, FAM THER COUNSEL; Mikulincer M, 2009, J PERS SOC PSYCHOL, V97, P615, DOI 10.1037/a0015649; Mondak JJ, 2001, AM J POLIT SCI, V45, P224, DOI 10.2307/2669369; Oravecz Z, 2015, PSYCHOMETRIKA, V80, P341, DOI 10.1007/s11336-013-9379-4; Oravecz Z, 2015, AM J PSYCHOL, V128, P61, DOI 10.5406/amerjpsyc.128.1.0061; Oravecz Z, 2014, SOCIOL METHODOL, V44, P185, DOI 10.1177/0081175014529767; Oravecz Z, 2014, FIELD METHOD, V26, P207, DOI 10.1177/1525822X13520280; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Romney A. K., 1999, MIT ENCY COGNITIVE S, P208; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; van der Maas HLJ, 2011, PSYCHOL REV, V118, P339, DOI 10.1037/a0022749; Vandekerckhove J, 2014, J MATH PSYCHOL, V60, P58, DOI 10.1016/j.jmp.2014.06.004; Waubert de Puiseau B, 2012, J EXP PSYCHOL-APPL, V18, P390, DOI 10.1037/a0029801; Weller SC, 2012, SOC SCI MED, V75, P1088, DOI 10.1016/j.socscimed.2012.05.003	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152803	10.1371/journal.pone.0152803	http://dx.doi.org/10.1371/journal.pone.0152803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035569	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200042
J	Arend, I; Weiss, PH; Timpert, DC; Fink, GR; Henik, A				Arend, Isabel; Weiss, Peter H.; Timpert, David C.; Fink, Gereon R.; Henik, Avishai			Spatial Coding as a Function of Handedness and Responding Hand: Theoretical and Methodological Implications	PLOS ONE			English	Article							S-R COMPATIBILITY; 2-FINGER CHOICE REACTIONS; HUNTINGTONS-DISEASE; IRRELEVANT CUE; ATTENTION; STIMULUS; INFORMATION; ASYMMETRIES; CORTEX; CODES	The Simon effect shows that choice reactions are faster if the location of the stimulus and the response correspond, even when stimulus location is task-irrelevant. The Simon effect raises the question of what factors influence spatial coding. Until now, the effects of handedness, responding hand, and visual field were addressed in separate studies that used bimanual and unimanual tasks, providing inconclusive results. Here we aimed to close this empirical gap by looking at the effects of these variables in the same study. We used a unimanual version of a Simon task with four groups of participants: left-handed and right-handed, responding with the dominant or nondominant hand. Our results show that the Simon effect is substantially reduced in the field of the responding hand for all groups of participants, except for left-handed individuals responding with the left-hand. These findings highlight the importance of attention mechanisms in stimulus-response coding. They reflect that stimulus-response interference is influenced by hierarchical activation of response units. At a practical level, these findings call for a number of methodological considerations (e.g., handedness, responding hand, and visual field) when using stimulus-response conflict to address spatial coding and cognitive control functions in neurological populations.	[Arend, Isabel; Henik, Avishai] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Arend, Isabel; Henik, Avishai] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Weiss, Peter H.; Timpert, David C.] Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Weiss, Peter H.; Timpert, David C.; Fink, Gereon R.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany	Ben Gurion University; Ben Gurion University; Helmholtz Association; Research Center Julich; University of Cologne	Arend, I (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.; Arend, I (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	arend.psy@gmail.com	HENIK, AVISHAI/F-1176-2012; Fink, Gereon R./AFW-9377-2022; Weiss, Peter H./H-8983-2013; Fink, Gereon R./E-1616-2012	Fink, Gereon R./0000-0002-8230-1856; Weiss, Peter H./0000-0002-5230-9080; Fink, Gereon R./0000-0002-8230-1856; Henik, Avishai/0000-0002-5665-6004	German-Israel Foundation [1110-93.4/2010]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	This research was funded by the German-Israel Foundation (grant# 1110-93.4/2010) awarded to AH and PHW.	Adam JJ, 2005, VIS COGN, V12, P1444, DOI 10.1080/13506280444000779; Adam JJ, 2003, COGNITIVE PSYCHOL, V46, P302, DOI 10.1016/S0010-0285(02)00516-9; Bobath B., 1990, ADULT HEMIPLEGIA EVA; Buckingham G, 2011, CORTEX, V47, P432, DOI 10.1016/j.cortex.2009.11.003; COHEN A, 1995, NEUROPSYCHOLOGY, V9, P165, DOI 10.1037/0894-4105.9.2.165; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Danziger S, 2004, COGN AFFECT BEHAV NE, V4, P89, DOI 10.3758/CABN.4.1.89; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Floel A, 2005, BEHAV BRAIN RES, V158, P269, DOI 10.1016/j.bbr.2004.09.016; Galfano G, 2008, ACTA PSYCHOL, V127, P186, DOI 10.1016/j.actpsy.2007.04.004; GEORGIOU N, 1995, BRAIN, V118, P1305, DOI 10.1093/brain/118.5.1305; Georgiou-Karistianis N, 2007, NEUROPSYCHOLOGIA, V45, P1791, DOI 10.1016/j.neuropsychologia.2006.12.023; GOODALE MA, 1990, VISION ACTION CONTRO, P14; HEISTER G, 1986, PERCEPT PSYCHOPHYS, V40, P271, DOI 10.3758/BF03211507; HEISTER G, 1987, PERCEPT PSYCHOPHYS, V42, P195, DOI 10.3758/BF03210508; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Ivanoff J, 2000, PSYCHOL RES-PSYCH FO, V64, P117, DOI 10.1007/s004260000033; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; NICOLETTI R, 1989, J EXP PSYCHOL HUMAN, V15, P164, DOI 10.1037/0096-1523.15.1.164; NICOLETTI R, 1994, PSYCHOL RES-PSYCH FO, V56, P144, DOI 10.1007/BF00419701; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rafal R, 1996, NEUROPSYCHOLOGIA, V34, P1197, DOI 10.1016/0028-3932(96)00045-0; RIGGIO L, 1986, ACTA PSYCHOL, V62, P89, DOI 10.1016/0001-6918(86)90006-5; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rubichi S, 1997, J EXP PSYCHOL HUMAN, V23, P1353, DOI 10.1037/0096-1523.23.5.1353; Rubichi S, 2006, PERCEPT PSYCHOPHYS, V68, P1059, DOI 10.3758/BF03193709; Schneider W., 2002, E PRIME USERS GUIDE; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Spironelli C, 2009, EXP PSYCHOL, V56, P274, DOI 10.1027/1618-3169.56.4.274; Stoffer TH, 1997, ADV PSYCHOL, V118, P181; Tagliabue M, 2007, BEHAV RES METHODS, V39, P50, DOI 10.3758/BF03192843; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; UMILTA C, 1987, PSYCHOL RES-PSYCH FO, V49, P81, DOI 10.1007/BF00308672; UMILTA C, 1985, ATTENTION PERFORM, V11, P457; WALLACE RJ, 1971, J EXP PSYCHOL, V88, P354, DOI 10.1037/h0030892	44	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151979	10.1371/journal.pone.0151979	http://dx.doi.org/10.1371/journal.pone.0151979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031523	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800026
J	Cao, G; Gonzalez, J; Muller, A; Ottaviano, G; Ambrosio, G; Toblli, JE; Milei, J				Cao, Gabriel; Gonzalez, Julian; Mueller, Angelica; Ottaviano, Graciela; Ambrosio, Giuseppe; Toblli, Jorge E.; Milei, Jose			Beneficial Effect of Moderate Exercise in Kidney of Rat after Chronic Consumption of Cola Drinks	PLOS ONE			English	Article							OXIDATIVE STRESS; MECHANISMS; DISEASE; RISK; TRIGLYCERIDES; ANTIOXIDANTS; NEPHROPATHY; DYSFUNCTION; PROGRESSION; ASSOCIATION	Aim The purpose of this study was to investigate the effect of moderate intensity exercise on kidney in an animal model of high consumption of cola soft drinks. Methods Forty-eight Wistar Kyoto rats (age: 16 weeks; weight: 350-400 g) were assigned to the following groups: WR (water runners) drank water and submitted to aerobic exercise; CR (cola runners) drank cola and submitted to aerobic exercise; WS (water sedentary) and CS (cola sedentary), not exercised groups. The aerobic exercise was performed for 5 days per week throughout the study (24 weeks) and the exercise intensity was gradually increased during the first 8 weeks until it reached 20 meters / minute for 30 minutes. Body weight, lipid profile, glycemia, plasma creatinine levels, atherogenic index of plasma (AIP) and systolic blood pressure (SBP) were determined. After 6 months all rats were sacrificed. A kidney histopathological score was obtained using a semiquantitative scale. Glomerular size and glomerulosclerosis were estimated by point-counting. The oxidative stress and proinflammatory status were explored by immunohistochemistry. A one way analysis of variance (ANOVA) with Tukey-Kramer post-hoc test or the Kruskal-Wallis test with Dunn's post-hoc test was used for statistics. A value of p < 0.05 was considered significant. Results At 6 months, an increased consumption of cola soft drink was shown in CS and CR compared with water consumers (p<0.0001). Chronic cola consumption was associated with increased plasma triglycerides, AIP, heart rate, histopathological score, glomerulosclerosis, oxidative stress and pro-inflammatory status. On the other hand, moderate exercise prevented these findings. No difference was observed in the body weight, SBP, glycemia, cholesterol and plasma creatinine levels across experimental groups. Conclusions This study warns about the consequences of chronic consumption of cola drinks on lipid metabolism, especially regarding renal health. Additionally, these findings emphasize the protective role of exercise training on renal damage.	[Cao, Gabriel; Gonzalez, Julian; Mueller, Angelica; Ottaviano, Graciela; Toblli, Jorge E.; Milei, Jose] ININCA UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini, Buenos Aires, DF, Argentina; [Ambrosio, Giuseppe] Univ Perugia, Sch Med, Div Cardiol, I-06100 Perugia, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Perugia	Cao, G (corresponding author), ININCA UBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini, Buenos Aires, DF, Argentina.	gabrielcao@fibertel.com.ar	Ambrosio, Giuseppe/C-6596-2013	Ambrosio, Giuseppe/0000-0002-9677-980X	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina [PIP 6549]; Universidad de Buenos Aires, Argentina [UBACYT M052]; University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia - Division of Cardiology; CONICET [PIP 6549]; University of Buenos Aires, Argentina [UBACYT M052]; Institute S. Paolo, Turin, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires); University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia - Division of Cardiology; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Argentina(University of Buenos Aires); Institute S. Paolo, Turin, Italy	This work was funded by PIP 6549, http://www.conicet.gov.ar/, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina, to JM; UBACYT M052, http://www.uba.ar/, Universidad de Buenos Aires, Argentina, to JM; and Framework Agreement between the University of Buenos Aires - Instituto de Investigaciones Cardiologicas and the University of Perugia - Division of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study received financial support from PIP 6549, CONICET and UBACYT M052, University of Buenos Aires, Argentina, and from Institute S. Paolo, Turin, Italy. This work has been performed under a Framework Agreement between the University of Buenos Aires-Instituto de Investigaciones Cardiologicas- and the University of Perugia-Division of Cardiology.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Canadian Council on Animal Care, 1993, GUIDE CARE USE EXPT; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; Dauchy RT, 2010, COMPARATIVE MED, V60, P348; de Lemos ET, 2009, NUTRITION, V25, P330, DOI 10.1016/j.nut.2008.08.014; de Lemos ET, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/253061; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Fraser TB, 2001, CLIN EXP PHARMACOL P, V28, P831, DOI 10.1046/j.1440-1681.2001.03531.x; Gad SC, 2014, BIOMARKERS IN TOXICOLOGY, P7, DOI 10.1016/B978-0-12-404630-6.00002-6; Godoy JR, 2011, FREE RADICAL BIO MED, V51, P552, DOI 10.1016/j.freeradbiomed.2011.04.036; Hadjadj S, 2004, DIABETES METAB, V30, P43, DOI 10.1016/S1262-3636(07)70088-5; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Hill GS, 2003, KIDNEY INT, V63, P1027, DOI 10.1046/j.1523-1755.2003.00831.x; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Hussain MM, 2015, J LIPID RES, V56, P761, DOI 10.1194/jlr.R051573; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kaplan A., 1995, TERPRETATION TECHNIQ, P220; KAYSER K, 1994, PATHOL RES PRACT, V190, P1031, DOI 10.1016/S0344-0338(11)80898-8; KIMURA K, 1991, HYPERTENSION, V18, P101, DOI 10.1161/01.HYP.18.1.101; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Lachance D, 2009, CIRC-HEART FAIL, V2, P437, DOI 10.1161/CIRCHEARTFAILURE.108.845487; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lehnen AM, 2013, AUTON NEUROSCI-BASIC, V176, P64, DOI 10.1016/j.autneu.2013.02.011; Madrigal-Matute J, 2015, FREE RADICAL BIO MED, V86, P352, DOI 10.1016/j.freeradbiomed.2015.06.001; Malik VS, 2006, AM J CLIN NUTR, V84, P274; McCullough PA, 2004, AM HEART J, V148, P243, DOI 10.1016/j.ahj.2004.03.042; Mei WJ, 2015, NEPHROLOGY, V20, P832, DOI 10.1111/nep.12515; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Mizuno M, 2011, AM J PHYSIOL-REG I, V300, pR969, DOI 10.1152/ajpregu.00768.2010; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nseir W, 2010, WORLD J GASTROENTERO, V16, P2579, DOI 10.3748/wjg.v16.i21.2579; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Pagtalunan ME, 2000, KIDNEY INT, V57, P2644, DOI 10.1046/j.1523-1755.2000.00125.x; Pal GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078072; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Roshan VD, 2011, INT J TOXICOL, V30, P190, DOI 10.1177/1091581810392809; Rovin BH, 1998, AM J KIDNEY DIS, V31, P1065, DOI 10.1053/ajkd.1998.v31.pm9631856; Samuelsson O, 1998, J AM SOC NEPHROL, V9, P1482; Seely JC, 2002, TOXICOL PATHOL, V30, P681, DOI 10.1080/01926230290166779; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Soleimani M, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/392708; Teixeira-Lemos E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-12; Tsuruya K, 2014, ATHEROSCLEROSIS, V233, P260, DOI 10.1016/j.atherosclerosis.2013.12.037; Tucker PS, 2015, FREE RADICAL BIO MED, V89, P466, DOI 10.1016/j.freeradbiomed.2015.07.162; Tucker PS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/156584; Tucker PS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/806358; Yu F, 2013, NEUROREPORT, V24, P342, DOI 10.1097/WNR.0b013e3283606c5e	54	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152461	10.1371/journal.pone.0152461	http://dx.doi.org/10.1371/journal.pone.0152461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031710	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800078
J	Pashaei, T; Ponnet, K; Moeeni, M; Khazaee-pool, M; Majlessi, F				Pashaei, Tahereh; Ponnet, Koen; Moeeni, Maryam; Khazaee-pool, Maryam; Majlessi, Fereshteh			Daughters at Risk of Female Genital Mutilation: Examining the Determinants of Mothers' Intentions to Allow Their Daughters to Undergo Female Genital Mutilation	PLOS ONE			English	Article							PERCEIVED BEHAVIORAL-CONTROL; PLANNED BEHAVIOR; HEALTH; CONTINUE; EFFICACY; STRESS; WOMEN	Female genital mutilation (FGM) is still a common practice in many countries in Africa and the Middle East. Understanding the determinants of FGM can lead to more active interventions to prevent this harmful practice. The goal of this study is to explore factors associated with FGM behavior among Iranian mothers and their daughters. Based on Ajzen's theory of planned behavior, we examined the predictive value of attitudes, subjective norms, perceived behavioral control and several socio-demographic variables in relation to mothers' intentions to mutilate their daughters. A paper-and-pencil survey was conducted among 300 mothers (mean age = 33.20, SD = 9.09) who had at least one daughter and who lived in Ravansar, a county in Kermanshah Province in Iran. Structural equation modeling was used to investigate the relationships among the study variables. Our results indicate that attitude is the strongest predictor of mothers' intentions to allow their daughters to undergo FGM, followed by subjective norms. Compared to younger mothers, older mothers have more positive attitudes toward FGM, perceive themselves as having more control over their behavior and demonstrate a greater intention to allow their daughter to undergo FGM. Furthermore, we found that less educated mothers and mothers living in rural areas had more positive attitudes toward FGM and feel more social pressure to allow FGM. The model accounts for 93 percent of the variance in the mothers' intentions to allow their daughters to undergo FGM. Intervention programs that want to decrease FGM might focus primarily on converting mothers' neutral or positive feelings toward FGM into negative attitudes and on alleviating the perceived social pressure to mutilate one's daughter. Based on our findings, we provide recommendations about how to curtail mothers' intentions to allow their daughters to undergo FGM.	[Pashaei, Tahereh] Kurdistan Univ Med Sci, Sch Hlth, Dept Publ Hlth, Sanandaj, Iran; [Ponnet, Koen] Univ Antwerp, Dept Commun Studies, Sint Jacobsstr 2, B-2000 Antwerp, Belgium; [Ponnet, Koen] Odisee, Higher Inst Family Sci, Huart Hamoirlaan 136, B-1030 Brussels, Belgium; [Ponnet, Koen] Univ Antwerp, Fac Law, Venusstr 23, B-2000 Antwerp, Belgium; [Moeeni, Maryam] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Khazaee-pool, Maryam] Zanjan Univ Med Sci, Sch Hlth, Dept Hlth Educ & Promot, Zanjan, Iran; [Majlessi, Fereshteh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Educ & Promot, Tehran, Iran	Kurdistan University of Medical Sciences; University of Antwerp; University of Antwerp; Isfahan University Medical Science; Tehran University of Medical Sciences	Majlessi, F (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Educ & Promot, Tehran, Iran.	dr_f_majlessi@yahoo.com	Khazaee-Pool, Maryam/G-7193-2016; Moeeni, Maryam/K-3589-2016; Pashaei, Tahereh/Q-1873-2016; Moeeni, Maryam/I-1344-2018; Ponnet, Koen/K-9389-2017	Khazaee-Pool, Maryam/0000-0002-2587-3460; Moeeni, Maryam/0000-0002-4525-6574; Ponnet, Koen/0000-0002-6911-7632; Pashaei, Tahereh/0000-0001-7845-289X	Tehran University of Medical Sciences, Iran [15179]	Tehran University of Medical Sciences, Iran(Tehran University of Medical Sciences)	Funding for this study was provided by Tehran University of Medical Sciences, Iran [Grant number 15179].	Abd el-Tawab N., 2000, CRITICAL ANAL INTERV; Abolfotouh SM, 2015, INT J WOMENS HEALTH, V7, P259, DOI 10.2147/IJWH.S78664; Afifi M, 2009, ARCH IRAN MED, V12, P154; Ahanonu EL, 2014, HEALTH EDUC RES, V29, P683, DOI 10.1093/her/cyt118; Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; AJZEN I, 1986, J EXP SOC PSYCHOL, V22, P453, DOI 10.1016/0022-1031(86)90045-4; Ajzen I., 2011, CONSTRUCTING THEORY; Andro A, 2014, SOC SCI MED, V106, P177, DOI 10.1016/j.socscimed.2014.02.003; [Anonymous], 2005, CHANG HARMF SOC CONV; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bekalu MA, 2014, HEALTH PROMOT INT, V29, P739, DOI 10.1093/heapro/dat030; Berg RC, 2012, STUD FAMILY PLANN, V43, P135, DOI 10.1111/j.1728-4465.2012.00311.x; Berhane Y, 2001, SOC SCI MED, V53, P1525, DOI 10.1016/S0277-9536(00)00441-X; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Chalmers B, 2000, BIRTH-ISS PERINAT C, V27, P227, DOI 10.1046/j.1523-536x.2000.00227.x; Cook RJ, 2002, INT J GYNECOL OBSTET, V79, P281, DOI 10.1016/S0020-7292(02)00277-1; Dalal Koustuv, 2010, J Inj Violence Res, V2, P41, DOI 10.5249/jivr.v2i1.33; El-Defrawi MH, 2001, J SEX MARITAL THER, V27, P465, DOI 10.1080/713846810; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Gruenbaum E., 2001, FEMALE CIRCUMCISION, DOI DOI 10.9783/9780812292510; Heirman W, 2013, CYBERPSYCH BEH SOC N, V16, P81, DOI 10.1089/cyber.2012.0041; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iran SCo, 2011, IR POP HOUS CENS; Jones SD, 2004, EUR J OBSTET GYN R B, V116, P144, DOI 10.1016/j.ejogrb.2004.06.013; Karimi F, 2011, TRAGEDY BODY VIOLENC; Kline R. B., 2005, PRINCIPALS PRACTICE; Kluge EH, 2009, J OBSTET GYNAECOLOGY, V17, P71; Little CM, 2002, J CULTURAL DIVERSITY, V10, P30; Mandara MU, 2004, INT J GYNECOL OBSTET, V84, P291, DOI 10.1016/j.ijgo.2003.06.001; Masho SW, 2009, INT J GYNECOL OBSTET, V107, P232, DOI 10.1016/j.ijgo.2009.07.022; McEachan RRC, 2011, HEALTH PSYCHOL REV, V5, P97, DOI 10.1080/17437199.2010.521684; Mohammed GF, 2014, J SEX MED, V11, P2756, DOI 10.1111/jsm.12655; Muthen L. K., 2010, MPLUS USERS GUIDE VE; Oduro Ar, 2006, Ghana Med J, V40, P87; PASHAEI T, 2012, J WOMENS HLTH CARE, V1, P1, DOI DOI 10.4172/2167-0420.1000108; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Ponnet K, 2014, J YOUTH ADOLESCENCE, V43, P1752, DOI 10.1007/s10964-014-0159-y; Ponnet K, 2013, FAM PROCESS, V52, P312, DOI 10.1111/famp.12001; Riebl SK, 2015, EAT BEHAV, V18, P160, DOI 10.1016/j.eatbeh.2015.05.016; Rymer J., 2003, CURR OBS GYNECOL, V13, P185, DOI DOI 10.1016/S0957-5847(03)00004-0; Shell-Duncan B, 2007, AFR J REPROD HEALTH, V10, P57; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; Sipsma HL, 2012, B WORLD HEALTH ORGAN, V90, P120, DOI 10.2471/BLT.11.090886; Sundby J, 2006, LANCET S, V362, ps26; Tag-Eldin MA, 2008, B WORLD HEALTH ORGAN, V86, P269, DOI 10.2471/BLT.07.042093; Taheri K, 2000, ESSAYS ARCHAEOLOGY G; Tamire M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1120; Taylor S. E, 2006, HEALTH PSYCHOL; UNICEF, 2013, FEM GEN MUT CUTT STA, P1; UNICEF, 2010, DYN SOC CHANG AB FEM; UNICEF, 2010, LEV TRENDS CHILD MOR; WHO, 2018, FEM GEN MUT; Yasin BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-809	55	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151630	10.1371/journal.pone.0151630	http://dx.doi.org/10.1371/journal.pone.0151630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031613	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800017
J	Simons, RD; Page, HM; Zaleski, S; Miller, R; Dugan, JE; Schroeder, DM; Doheny, B				Simons, Rachel D.; Page, Henry M.; Zaleski, Susan; Miller, Robert; Dugan, Jenifer E.; Schroeder, Donna M.; Doheny, Brandon			The Effects of Anthropogenic Structures on Habitat Connectivity and the Potential Spread of Non-Native Invertebrate Species in the Offshore Environment	PLOS ONE			English	Article							BRYOZOAN WATERSIPORA-SUBTORQUATA; SOUTHERN CALIFORNIA BIGHT; DISTANCE SEED DISPERSAL; GULF-OF-MEXICO; LARVAL TRANSPORT; POPULATION CONNECTIVITY; BENTHIC INVERTEBRATES; MARINE ORGANISMS; OIL PLATFORMS; DURATION	Offshore structures provide habitat that could facilitate species range expansions and the introduction of non-native species into new geographic areas. Surveys of assemblages of seven offshore oil and gas platforms in the Santa Barbara Channel revealed a change in distribution of the non-native sessile invertebrate Watersipora subtorquata, a bryozoan with a planktonic larval duration (PLD) of 24 hours or less, from one platform in 2001 to four platforms in 2013. We use a three-dimensional biophysical model to assess whether larval dispersal via currents from harbors to platforms and among platforms is a plausible mechanism to explain the change in distribution of Watersipora and to predict potential spread to other platforms in the future. Hull fouling is another possible mechanism to explain the change in distribution of Watersipora. We find that larval dispersal via currents could account for the increase in distribution of Watersipora from one to four platforms and that Watersipora is unlikely to spread from these four platforms to additional platforms through larval dispersal. Our results also suggest that larvae with PLDs of 24 hours or less released from offshore platforms can attain much greater dispersal distances than larvae with PLDs of 24 hours or less released from nearshore habitat. We hypothesize that the enhanced dispersal distance of larvae released from offshore platforms is driven by a combination of the offshore hydrodynamic environment, larval behavior, and larval release above the seafloor.	[Simons, Rachel D.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Page, Henry M.; Miller, Robert; Dugan, Jenifer E.; Doheny, Brandon] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Zaleski, Susan; Schroeder, Donna M.] Bur Ocean Energy Management, Pacific Reg, Camarillo, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Simons, RD (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	simons@eri.ucsb.edu		Miller, Robert/0000-0002-8350-3759	U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C. [M13AC00007]; SZ DMS; Division Of Ocean Sciences [1232779] Funding Source: National Science Foundation	U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C.; SZ DMS; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Study collaboration and funding was provided by the U.S. Department of Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington D.C. under Co-Op Agreement # M13AC00007. Authors who received funding: HMP JED RDS. Funders: SZ DMS. The funders participated in the field work and proofed the paper.	Adams TP, 2014, J APPL ECOL, V51, P330, DOI 10.1111/1365-2664.12207; Anderson CM, 2007, APPL ENVIRON MICROB, V73, P303, DOI 10.1128/AEM.00604-06; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Cohen AN, 2005, BIOL INVASIONS, V7, P995, DOI 10.1007/s10530-004-3121-1; Cohen AN, 2011, THE EXOTICS GUIDE NO; Continental Shelf Associates, 2005, SURV INV ALG COMM OF; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Coyer J, 1999, GUIDE METHODS UNDERW; Davidson IC, 2010, AQUAT BIOL, V11, P179, DOI 10.3354/ab00302; Dong CM, 2007, CONT SHELF RES, V27, P1233, DOI 10.1016/j.csr.2007.01.016; Dong CM, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006578; Dong CM, 2009, PROG OCEANOGR, V82, P168, DOI 10.1016/j.pocean.2009.07.005; Floerl O, 2005, BIOL INVASIONS, V7, P589, DOI 10.1007/s10530-004-0952-8; Foss S., 2008, SUBMITTED TO THE CAL; Gallaway BJ, 1981, 10BS8227 FWS; Gawarkiewicz G, 2007, OCEANOGRAPHY, V20, P40, DOI 10.5670/oceanog.2007.28; Harms S, 1998, J GEOPHYS RES-OCEANS, V103, P3041, DOI 10.1029/97JC02393; Hellberg ME, 2002, B MAR SCI, V70, P273; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Mackie JA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00871; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; Mineur F, 2012, OCEANOGR MAR BIOL, V50, P189; Mitarai S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005166; Needles LA, 2013, BIOL INVASIONS, V15, P1231, DOI 10.1007/s10530-012-0362-2; Ng TYT, 2003, MAR ECOL PROG SER, V257, P77, DOI 10.3354/meps257077; Ohlmann JC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044436; Page H. M., 2010, BIOFOULING, P252, DOI [10.1002/9781444315462, DOI 10.1002/9781444315462]; Page HM, 2008, ICES J MAR SCI, V65, P851, DOI 10.1093/icesjms/fsn060; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; Pergl J, 2011, DIVERS DISTRIB, V17, P725, DOI 10.1111/j.1472-4642.2011.00771.x; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Ruiz GM, 1997, AM ZOOL, V37, P621; RYLAND JS, 1960, J EXP BIOL, V37, P783; Sammarco PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030144; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sams MA, 2015, MAR ECOL PROG SER, V531, P179, DOI 10.3354/meps11339; Santschi CA, 2012, SPATIAL PATTERNS REC; Sellheim K, 2010, MAR ECOL PROG SER, V398, P69, DOI 10.3354/meps08341; Shanks AL, 2009, BIOL BULL-US, V216, P373; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sheehy DJ, 2010, ECOL ENG, V36, P1, DOI 10.1016/j.ecoleng.2009.09.012; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simons RD, 2015, DEEP-SEA RES PT I, V100, P34, DOI 10.1016/j.dsr.2015.02.002; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Verling E, 2005, P ROY SOC B-BIOL SCI, V272, P2659, DOI 10.1098/rspb.2005.2001; Vieira LM, 2014, ZOOTAXA, V3857, P151, DOI 10.11646/zootaxa.3857.2.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Wendt DE, 1998, BIOL BULL-US, V195, P126, DOI 10.2307/1542820; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; WOOLLACOTT RM, 1989, MAR BIOL, V102, P57, DOI 10.1007/BF00391323	61	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152261	10.1371/journal.pone.0152261	http://dx.doi.org/10.1371/journal.pone.0152261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031827	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800048
J	Prado, NDR; Pereira, SS; da Silva, MP; Morais, MSS; Kayano, AM; Moreira-Dill, LS; Luiz, MB; Zanchi, FB; Fuly, AL; Huacca, MEF; Fernandes, CF; Calderon, LA; Zuliani, JP; da Silva, LHP; Soares, AM; Stabeli, RG; Fernandes, CFC				Prado, Nidiane D. R.; Pereira, Soraya S.; da Silva, Michele P.; Morais, Michelle S. S.; Kayano, Anderson M.; Moreira-Dill, Leandro S.; Luiz, Marcos B.; Zanchi, Fernando B.; Fuly, Andre L.; Huacca, Maribel E. F.; Fernandes, Cleberson F.; Calderon, Leonardo A.; Zuliani, Juliana P.; Pereira da Silva, Luiz H.; Soares, Andreimar M.; Stabeli, Rodrigo G.; Fernandes, Carla F. C.			Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A(2) by Specific Camelid Single-Domain Antibody Fragments	PLOS ONE			English	Article							CROSS-NEUTRALIZATION; SNAKE; METALLOPROTEINASE; IDENTIFICATION; NANOBODIES; ANTIVENOM; ALIGNMENT; PROTEINS; SEQUENCE; ASPER	Antivenoms, produced using animal hyperimmune plasma, remains the standard therapy for snakebites. Although effective against systemic damages, conventional antivenoms have limited efficacy against local tissue damage. Additionally, the hypersensitivity reactions, often elicited by antivenoms, the high costs for animal maintenance, the difficulty of producing homogeneous lots, and the instability of biological products instigate the search for innovative products for antivenom therapy. In this study, camelid antibody fragments (VHH) with specificity to Bothropstoxin I and II (BthTX-I and BthTX-II), two myotoxic phospholipases from Bothrops jararacussu venom, were selected from an immune VHH phage display library. After biopanning, 28 and 6 clones recognized BthTX-I and BthTX-II by ELISA, respectively. Complementarity determining regions (CDRs) and immunoglobulin frameworks (FRs) of 13 VHH-deduced amino acid sequences were identified, as well as the camelid hallmark amino acid substitutions in FR2. Three VHH clones (KF498607, KF498608, and KC329718) were capable of recognizing BthTX-I by Western blot and showed affinity constants in the nanomolar range against both toxins. VHHs inhibited the BthTX-II phospholipase A(2) activity, and when tested for cross-reactivity, presented specificity to the Bothrops genus in ELISA. Furthermore, two clones (KC329718 and KF498607) neutralized the myotoxic effects induced by B. jararacussu venom, BthTX-I, BthTX-II, and by a myotoxin from Bothrops brazili venom (MTX-I) in mice. Molecular docking revealed that VHH CDRs are expected to bind the C-terminal of both toxins, essential for myotoxic activity, and to epitopes in the BthTX-II enzymatic cleft. Identified VHHs could be a biotechnological tool to improve the treatment for snake envenomation, an important and neglected world public health problem.	[Prado, Nidiane D. R.; Pereira, Soraya S.; da Silva, Michele P.; Morais, Michelle S. S.; Kayano, Anderson M.; Moreira-Dill, Leandro S.; Luiz, Marcos B.; Zanchi, Fernando B.; Calderon, Leonardo A.; Zuliani, Juliana P.; Pereira da Silva, Luiz H.; Soares, Andreimar M.; Stabeli, Rodrigo G.; Fernandes, Carla F. C.] Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil; [Fuly, Andre L.] Univ Fed Fluminense, Rio De Janeiro, RJ, Brazil; [Huacca, Maribel E. F.; Calderon, Leonardo A.; Zuliani, Juliana P.; Stabeli, Rodrigo G.] Univ Fed Rondonia, UNIR, Porto Velho, RO, Brazil; [Fernandes, Cleberson F.] EMBRAPA, Empresa Brasileira Pesquisa Agr, Porto Velho, RO, Brazil; [Fernandes, Carla F. C.] CEPEM, Ctr Pesquisa Med Trop, Porto Velho, RO, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade Federal de Rondonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Fernandes, CFC (corresponding author), Fiocruz Rondonia, Fundacao Oswaldo Cruz, Porto Velho, RO, Brazil.; Fernandes, CFC (corresponding author), CEPEM, Ctr Pesquisa Med Trop, Porto Velho, RO, Brazil.	carlaceledonio@fiocruz.br	Soares, Andrei/ABG-3545-2020; Zuliani, JP/P-3633-2019; Zanchi, Fernando Berton/R-2291-2019; Zuliani, Juliana P/G-2329-2015; Soares, Andreimar/AAE-4657-2021; Pereira, Soraya Santos/ABA-2753-2020; de A Calderon, Leonardo/K-8515-2012; Fuly, Andre/U-1538-2019; Soares, Andreimar M/K-5556-2014; S. Moreira-Dill, Leandro/D-5024-2015; Fernandes, Cleberson/C-9973-2013; Stabeli, Rodrigo Guerino/G-1721-2017	Zuliani, JP/0000-0001-9221-7749; Zanchi, Fernando Berton/0000-0003-3386-0069; Pereira, Soraya Santos/0000-0003-2116-7670; de A Calderon, Leonardo/0000-0003-2669-092X; Fuly, Andre/0000-0002-5265-5258; S. Moreira-Dill, Leandro/0000-0003-2977-0001; Funes Huacca, Maribel Elizabeth/0000-0002-3878-0722; Soares, Andreimar/0000-0003-1032-2188; Fernandes, Cleberson/0000-0001-5269-1139; Stabeli, Rodrigo Guerino/0000-0002-0476-920X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477760/2012-0, 459046/2014-4]; CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT); Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT); Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO)(Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa do Estado de Rondonia (FAPERO)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) -www.cnpq.br/RGS-Grant Number: 477760/2012-0, CFCF-Grant Number: 459046/2014-4, CFCF-Programa Primeiros Projetos Secretaria de Estado de Planejamento de> Rondonia-SEPLAN/CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Rede de Biodiversidade e Biotecnologia da Amazonia Legal (BIONORTE/CNPq/MCT) and Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas e a Pesquisa de Rondonia (FAPERO). Nidiane D. R. Prado, student of Postgraduate Program in Experimental Biology, was supported by a fellowship of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarenga LM, 2014, TOXINS, V6, P2541, DOI 10.3390/toxins6082541; Andersson K, 1999, ANAL CHEM, V71, P2475, DOI 10.1021/ac981271j; Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0; Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Cardoso D. F., 2009, ANIMAIS PECONHENTOS, P419; Cardoso DF, 2000, SCAND J IMMUNOL, V51, P337; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Chotwiwatthanakun C, 2001, TOXICON, V39, P1487, DOI 10.1016/S0041-0101(01)00108-8; Cintra-Francischinelli M, 2010, P NATL ACAD SCI USA, V107, P14140, DOI 10.1073/pnas.1009128107; Dart RC, 2005, CLIN PRACTICE EMERGE, P1624; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Fernandes CAH, 2014, BBA-PROTEINS PROTEOM, V1844, P2265, DOI 10.1016/j.bbapap.2014.09.015; Fernandes CAH, 2010, J STRUCT BIOL, V171, P31, DOI 10.1016/j.jsb.2010.03.019; Fernandes I, 2010, TOXICON, V56, P1059, DOI 10.1016/j.toxicon.2010.07.014; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guimaraes CLS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981923; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; Gutierrez JM, 2003, CLIN PHARMACOKINET, V42, P721, DOI 10.2165/00003088-200342080-00002; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Hansson E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002009; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Helma J, 2015, J CELL BIOL, V209, P633, DOI 10.1083/jcb.201409074; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; JANSSEN M, 1990, TOXICON, V28, P975, DOI 10.1016/0041-0101(90)90026-4; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kashima S, 2004, BIOCHIMIE, V86, P211, DOI 10.1016/j.biochi.2004.02.002; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kornhauser R, 2013, BASIC CLIN PHARMACOL, V112, P138, DOI 10.1111/j.1742-7843.2012.00925.x; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; LOMONTE B, 1992, TOXICON, V30, P239, DOI 10.1016/0041-0101(92)90866-4; Mora-Obando D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109846; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Otten EJ, 2013, ROSENS EMERGENCY MED, P794; Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413; Pereira SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108067; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; Rodrigues RS, 2007, TOXICON, V50, P153, DOI 10.1016/j.toxicon.2007.03.005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Tan CH, 2015, TOXINS, V7, P572, DOI 10.3390/toxins7020572; Thanongsaksrikul J, 2010, J BIOL CHEM, V285, P9657, DOI 10.1074/jbc.M109.073163; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; (WHO), 2015, SNAK ANT	56	35	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151363	10.1371/journal.pone.0151363	http://dx.doi.org/10.1371/journal.pone.0151363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028872	Green Submitted, Green Published, gold			2022-12-27	WOS:000373116500024
J	Galetti, M; Rodarte, RR; Neves, CL; Moreira, M; Costa-Pereira, R				Galetti, Mauro; Rodarte, Raisa Reis; Neves, Carolina Lima; Moreira, Marcelo; Costa-Pereira, Raul			Trophic Niche Differentiation in Rodents and Marsupials Revealed by Stable Isotopes	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; SMALL MAMMALS; RAIN-FOREST; SYMPATRIC OPOSSUMS; FOOD-HABITS; BODY-SIZE; DIET; COMPETITION; MICROHABITAT; NITROGEN	Tropical rainforests support the greatest diversity of small mammals in the world, yet we have little understanding about the mechanisms that promote the coexistence of species. Diet partitioning can favor coexistence by lessening competition, and interspecific differences in body size and habitat use are usually proposed to be associated with trophic divergence. However, the use of classic dietary methods (e.g. stomach contents) is challenging in small mammals, particularly in community-level studies, thus we used stable isotopes (delta C-13 and delta N-15) to infer about trophic niche. We investigated i) how trophic niche is partitioned among rodent and marsupial species in three Atlantic forest sites and ii) if interspecific body size and locomotor habit inequalities can constitute mechanisms underlying the isotopic niche partitioning. We found that rodents occupied a broad isotopic niche space with species distributed in different trophic levels and relying on diverse basal carbon sources (C3 and C4 plants). Surprisingly, on the other hand, marsupials showed a narrow isotopic niche, both in delta C-13 and delta N-15 dimensions, which is partially overlapped with rodents, contradicting their description as omnivores and generalists proposed classic dietary studies. Although body mass differences did not explained the divergence in isotopic values among species, groups of species with different locomotor habit presented clear differences in the position of the isotopic niche space, indicating that the use of different forest strata can favor trophic niche partitioning in small mammals communities. We suggest that anthropogenic impacts, such as habitat modification (logging, harvesting), can simplify the vertical structure of ecosystems and collapse the diversity of basal resources, which might affect negatively small mammals communities in Atlantic forests.	[Galetti, Mauro; Rodarte, Raisa Reis; Neves, Carolina Lima] Univ Estadual Paulista UNESP, Dept Ecol, CP 199, BR-13506900 Sao Paulo, Brazil; [Rodarte, Raisa Reis] Casa Floresta Assessoria Ambiental Ltda, BR-13415030 Sao Paulo, Brazil; [Moreira, Marcelo] Univ Sao Paulo, CENA, BR-13416903 Sao Paulo, Brazil; [Costa-Pereira, Raul] Univ Estadual Paulista UNESP, Programa Posgrad Ecol & Biodiversidade, CP 199, BR-13506900 Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Galetti, M (corresponding author), Univ Estadual Paulista UNESP, Dept Ecol, CP 199, BR-13506900 Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Costa-Pereira, Raul/A-5527-2018; Galetti, Mauro/M-8751-2013; Moreira, Marcelo Z/D-4622-2013	Costa-Pereira, Raul/0000-0003-2370-5866; Galetti, Mauro/0000-0002-8187-8696; Moreira, Marcelo Z/0000-0001-6769-5570	BIOTA/FAPESP [2007/03392-6, 2014/01986-0]; CNPq	BIOTA/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank BIOTA/FAPESP 2007/03392-6 and 2014/01986-0 for financial support. Fieldwork was carried out with help from R. Souza, P. Barros, F. Labecca, P. Tokumoto, M. Gotardi, S. Tomasin, D. Flores, C. Mendes and S. Nazareth. The authors are grateful to R. Duda for the identification of marsu-pials from genus Monodelphis. R. R. Rodarte received a CNPq fellowship, M. Galetti is supported by a research grant from CNPq and R. Costa-Pereira is grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/20924-5). Collecting permits was provided by Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis (IBAMA #14428-2, IBAMA #31941-1). The authors thank Fundacao Florestal for allowing them to work in the protected areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; [Anonymous], 2012, OCCASIONAL PAPERS CO; AUGUST PV, 1983, ECOLOGY, V64, P1495, DOI 10.2307/1937504; Baltensperger AP, 2015, CANADIAN J ZOOLOGY; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Bloch CP, 2011, ECOGRAPHY, V34, P460, DOI 10.1111/j.1600-0587.2010.06270.x; Bonner J.T., 2011, WHY SIZE MATTERS BAC; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Brocardo CR, 2012, BIOTA NEOTROP, V12, P198, DOI 10.1590/S1676-06032012000400021; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Caceres NC, 2002, MAMMALIA, V66, P331, DOI 10.1515/mamm.2002.66.3.331; Carvalho FMV, 2005, MAMM BIOL, V70, P366, DOI 10.1016/j.mambio.2005.08.003; Charles-Dominique P., 1983, Special Publication American Society of Mammalogists, P395; CHARLESDOMINIQUE P, 1981, TERRE VIE-REV ECOL A, V35, P341; Chase J.M., 2009, ECOLOGICAL NICHES LI; Dammhahn M, 2013, BIOTROPICA, V45, P111, DOI 10.1111/j.1744-7429.2012.00893.x; Di-Nizo CB, 2014, COMP CYTOGENET, V8, P11, DOI 10.3897/CompCytogen.v8i1.6430; Fry B, 2007, STABLE ISOTOPE ECOLO; Galetti M, 2015, BIOTROPICA, V47, P521, DOI 10.1111/btp.12246; Galetti M, 2015, BIOL CONSERV, V190, P2, DOI 10.1016/j.biocon.2015.04.032; GRAIPEL ME, 2003, MASTOZOOL NEOTROP, V10, P255; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Hespenheide H., 1975, ECOLOGY EVOLUTION CO; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Hyodo F, 2010, J TROP ECOL, V26, P205, DOI 10.1017/S0266467409990502; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kawanishi K, 2012, RAFFLES B ZOOL, V60, P233; Kluge M., 2012, CRASSULACEAN ACID ME; Leite YLR, 1996, J TROP ECOL, V12, P435, DOI 10.1017/S0266467400009640; Lira PK, 2012, J APPL ECOL, V49, P1325, DOI 10.1111/j.1365-2664.2012.02214.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Martins EG, 2006, J ZOOL, V269, P21, DOI 10.1111/j.1469-7998.2006.00052.x; Martins EG, 2004, MAMM BIOL, V69, P58, DOI 10.1078/1616-5047-116; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; Mendel SM, 2003, ACTA THERIOL, V48, P289, DOI 10.1007/BF03194169; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Paglia AP, 2012, LISTA ANOTADA MAMFER; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Parnell A., 2015, R PACKAGE SIAR; PASCHOAL M, 1995, BIOTROPICA, V27, P268, DOI 10.2307/2389006; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Pinotti BT, 2011, STUD NEOTROP FAUNA E, V46, P1, DOI 10.1080/01650521.2010.535250; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rocha-Mendes F, 2015, BIOTA NEOTROP, V15, DOI 10.1590/1676-06032014000814; Santori RT, 2012, ALIMENTACAO NUTR ADA, P385; Sare DTJ, 2005, CAN J ZOOL, V83, P717, DOI 10.1139/Z05-064; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHOENER TW, 1974, AM NAT, V108, P332, DOI 10.1086/282911; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; TIESZEN LL, 1989, AFR J ECOL, V27, P219, DOI 10.1111/j.1365-2028.1989.tb01015.x; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vieira EM, 2005, MAMM BIOL, V70, P359, DOI 10.1016/j.mambio.2005.08.002; Vieira EM, 2003, MAMMALIA, V67, P533; Vieira EM, 2003, J TROP ECOL, V19, P501, DOI 10.1017/S0266467403003559; Vieira EM, 2012, USO ESPACO VERTICAL, P347; Vieira MV, 2003, STUD NEOTROP FAUNA E, V38, P7, DOI 10.1076/snfe.38.1.7.14034; Winemiller KO, 2015, ECOL LETT, V18, P737, DOI 10.1111/ele.12462; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x	67	42	45	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152494	10.1371/journal.pone.0152494	http://dx.doi.org/10.1371/journal.pone.0152494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049763	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500044
J	Rademaker, M; Meijaard, E; Semiadi, G; Blokland, S; Neilson, EW; Rode-Margono, EJ				Rademaker, Mark; Meijaard, Erik; Semiadi, Gono; Blokland, Simen; Neilson, Eric W.; Rode-Margono, Eva Johanna			First Ecological Study of the Bawean Warty Pig (Sus blouchi), One of the Rarest Pigs on Earth	PLOS ONE			English	Article							SOUTH-EAST; HABITAT USE; ANIMAL DENSITY; CAMERA TRAPS; WILD; ABUNDANCE; SCROFA; FOREST; POPULATIONS; VERRUCOSUS	The Bawean warty pig (Sus blouchi) is an endemic pig species confined to the 192 km(2) large island of Bawean in the Java Sea, Indonesia. Due to a lack of quantitative ecological research, understanding of natural history and conservation requirements have so far been based solely on anecdotal information from interviews with local people and study of captive and museum specimens. In this study we provide the first assessment of population and habitat preferences for S. blouchi by using camera trapping. From the 4th of November 2014 to January 8th 2015, we placed camera traps at 100 locations in the forested protected areas on Bawean. In 690.31 camera days (16567.45 hours) we captured 92 independent videos showing S. blouchi. Variation in S. blouchi trapping rates with cumulative trap effort stabilized after 500 camera days. An important outcome is that, in contrast to the suggestion of previous assessments, only S. blouchi was detected and no S. scrofa was found, which excludes hybridization threats. We fitted a Random Encounter Model, which does not require the identification of individual animals, to our camera-trapping data and estimated 172-377 individuals to be present on the island. Activity patterns and habitat data indicate that S. blouchi is mainly nocturnal and prefers community forests and areas near forest borders. Next to this, we found a positive relationship between S. blouchi occupancy, distance to nearest border, litter depth and tree density in the highest ranking occupancy models. Although these relationships proved non-significant based on model averaging, their presence in the top ranking models suggests that these covariables do play a role in predicting S. blouchi occurrence on Bawean. The estimated amount of sites occupied reached 58%. Based on our results, especially the estimation of the population size and area of occupancy, we determine that the species is Endangered according to the IUCN/SSC Red List criteria.	[Rademaker, Mark; Blokland, Simen] VHL Univ Appl Sci, Dept Anim Management, Leeuwarden, Netherlands; [Rademaker, Mark; Blokland, Simen] Bawean Endem Conservat Initiat, Jakarta, Indonesia; [Rademaker, Mark; Meijaard, Erik; Semiadi, Gono; Rode-Margono, Eva Johanna] IUCN SSC Wild Pig Specialist Grp, Jakarta, Indonesia; [Meijaard, Erik] Univ Queensland, ARC Ctr Excellence Environm Decis CEED, Brisbane, Qld 4072, Australia; [Semiadi, Gono] Indonesian Inst Sci, Div Zool, Biol Res Ctr, Cibinong, Indonesia; [Neilson, Eric W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Rode-Margono, Eva Johanna] Chester Zoo, North England Zool Soc, Chester, Cheshire, England	University of Queensland; Indonesian Institute of Sciences; University of Alberta	Rademaker, M (corresponding author), VHL Univ Appl Sci, Dept Anim Management, Leeuwarden, Netherlands.; Rademaker, M (corresponding author), Bawean Endem Conservat Initiat, Jakarta, Indonesia.; Rademaker, M (corresponding author), IUCN SSC Wild Pig Specialist Grp, Jakarta, Indonesia.	markrademaker02@gmail.com	Semiadi, Gono/G-4330-2018; Semiadi, Gono/D-3404-2015; Meijaard, Erik/A-2687-2016	Semiadi, Gono/0000-0002-9351-9746; Semiadi, Gono/0000-0002-9351-9746; Meijaard, Erik/0000-0001-8685-3685; Rademaker, Mark/0000-0001-9210-1164	Peoples Trust for Endangered Species; Die Zoologische Gesellsaft fur Arten-und Populationschutz; Los Angeles Zoo and Botanical Gardens; Stiftung Artenschutz	Peoples Trust for Endangered Species; Die Zoologische Gesellsaft fur Arten-und Populationschutz; Los Angeles Zoo and Botanical Gardens; Stiftung Artenschutz	This work was funded with the generous contribution of the Peoples Trust for Endangered Species (http://www.ptes.org/), Die Zoologische Gesellsaft fur Arten-und Populationschutz (http://www.zgap.de), the Los Angeles Zoo and Botanical Gardens (http://www.lazoo.org) and Stiftung Artenschutz (http://www.stiftung-artenschutz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengsen AJ, 2011, J WILDLIFE MANAGE, V75, P1222, DOI 10.1002/jwmg.132; Blouch R.A., 1978, P49; BLOUCH RA, 1988, BIOL CONSERV, V43, P295, DOI 10.1016/0006-3207(88)90122-X; Blouch RA., 1983, JAVAN WARTY PIG DIST; Bowkett AE, 2008, AFR J ECOL, V46, P479, DOI 10.1111/j.1365-2028.2007.00881.x; Bracke MBM, 2011, APPL ANIM BEHAV SCI, V132, P1, DOI 10.1016/j.applanim.2011.01.002; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Cucchi T, 2009, INT J OSTEOARCHAEOL, V19, P508, DOI 10.1002/oa.974; D'Huart Jean-Pierre, 1993, P84; de Bruyn M, 2014, SYST BIOL, V63, P879, DOI 10.1093/sysbio/syu047; De Indische Courant. Bawean, 1935, INDISCHE COUR 4 1029; ESRI, 2013, CREAT FISHN DAT MAN; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Frantz L, 2015, ANN REV ANIM BIOSC, V4; Genov Peter V., 1996, P214; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Groves C, 2011, UNGULATE TAXONOMY; Groves C.P., 1981, ANCESTORS PIGS TAXON; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hamada JI, 2002, J METEOROL SOC JPN, V80, P285, DOI 10.2151/jmsj.80.285; Hancock PA, 2005, ECOL MODEL, V181, P123, DOI 10.1016/j.ecolmodel.2004.06.026; Hernowo J.B., 2008, MED KONSERV, V13, P90; Hill D., 2005, HDB BIODIVERSITY MET, DOI DOI 10.1017/CBO9780511542084; Horning B, 1999, ARTGEMASSE SCHWEINEH; Ickes K, 2001, BIOTROPICA, V33, P682, DOI 10.1111/j.1744-7429.2001.tb00225.x; IUCN, 2013, IUCN REDL THREAT SPE; Kays R, 2009, C LOCAL COMPUT NETW, P811, DOI 10.1109/LCN.2009.5355046; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Lucchini V, 2005, J ZOOL, V266, P25, DOI 10.1017/S0952836905006588; MacDonald Alastair A., 1993, P155; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKinnon J., 1997, PROTECTED AREAS SYST; Massei G, 1997, J ZOOL, V242, P394; Mazerolle MJ., 2004, THESIS U LAVAL; MCGLONE JJ, 1999, S OUTD PIG PROD BRAZ; Meijaard E, 2003, J BIOGEOGR, V30, P1245, DOI 10.1046/j.1365-2699.2003.00890.x; Meijaard E., 2011, HDB MAMMALS WORLD HO, V2, P248; Meijaard Erik, 2014, Suiform Soundings, V12, P4; Meijaard Erik, 2014, Suiform Soundings, V12, P18; Meijaard Erik, 2006, Suiform Soundings, V6, P22; National Research Council Canada, ADV OPT SUN ANGL; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nijman V, 2006, BIRD CONSERV INT, V16, P131, DOI 10.1017/S0959270906000219; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Brien Timothy G., 1996, Oryx, V30, P150, DOI 10.1017/S0030605300021530; Oliver WL., 1993, PIGS PECCARIES HIPPO; Passon C, 2012, 9 INT S WILD BOAR OT; Pauwels W, 1980, THESIS U BASEL SWITZ; Pfeffer P., 1959, Mammalia Paris, V23, P277, DOI 10.1515/mamm.1959.23.3.277; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero F, 2013, J MAMMAL, V94, P792, DOI 10.1644/12-MAMM-A-235.1; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2014, METHODS ECOL EVOL, V5, P1170, DOI 10.1111/2041-210X.12278; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; Rowcliffe JM, 2011, METHODS ECOL EVOL, V2, P464, DOI 10.1111/j.2041-210X.2011.00094.x; Semiadi G, 2006, ORYX, V40, P50, DOI 10.1017/S003060530600007X; Semiadi G., 2013, STATUS BABI KUTIL SU; Semiadi G, 2008, IUCN 2013 IUCN RED L; Semiadi G, 2004, SURVEY JAVAN WARTY P; Semiadi Gono, 2009, Biodiversitas, V10, P124; SEYDACK AHW, 1992, OECOLOGIA, V90, P102, DOI 10.1007/BF00317815; Smit Sibbinga GL, 1947, TYDSCHRIFT KONINKLYK, V2, P572; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Thomas L., 2009, DISTANCE 6 0 RELEASE; Veth PJ, 1903, JAVA GEOGRAFISCH ETH; Yong D.L., 2010, Nature in Singapore, V3, P227	69	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151732	10.1371/journal.pone.0151732	http://dx.doi.org/10.1371/journal.pone.0151732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049756	gold, Green Published			2022-12-27	WOS:000373603500010
J	Van der Borght, L; Schevernels, H; Burle, B; Notebaert, W				Van der Borght, Liesbet; Schevernels, Hanne; Burle, Boris; Notebaert, Wim			Errors Disrupt Subsequent Early Attentional Processes	PLOS ONE			English	Article							CORTEX; TASK; ADJUSTMENTS; COMPONENTS; AWARENESS; RESPONSES; BLINK; WAVE	It has been demonstrated that target detection is impaired following an error in an unrelated flanker task. These findings support the idea that the occurrence or processing of unexpected error-like events interfere with subsequent information processing. In the present study, we investigated the effect of errors on early visual ERP components. We therefore combined a flanker task and a visual discrimination task. Additionally, the intertrial interval between both tasks was manipulated in order to investigate the duration of these negative after-effects. The results of the visual discrimination task indicated that the amplitude of the N1 component, which is related to endogenous attention, was significantly decreased following an error, irrespective of the intertrial interval. Additionally, P3 amplitude was attenuated after an erroneous trial, but only in the long-interval condition. These results indicate that low-level attentional processes are impaired after errors.	[Van der Borght, Liesbet; Schevernels, Hanne; Notebaert, Wim] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Burle, Boris] Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR7291, Marseille, France	Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Notebaert, W (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	wim.notebaert@ugent.be		BURLE, Boris/0000-0001-8179-9034	FWO-Vlaanderen (FWO) [3G076911]; Ghent University Multidisciplinary Research Platform; European Research Council under the European Community's Seventh Framework Program (FP) [241077]	FWO-Vlaanderen (FWO)(FWO); Ghent University Multidisciplinary Research Platform; European Research Council under the European Community's Seventh Framework Program (FP)	The work of LVDB and WN is supported by FWO-Vlaanderen (FWO grant 3G076911, http://www.fwo.be/). The work of HS is supported by the Ghent University Multidisciplinary Research Platform "The integrative neuroscience of behavioral control" (http://www.ugent.be/neuroscience/en/about). The work of BB is supported by a European Research Council under the European Community's Seventh Framework Program (FP/2007-2013 Grant Agreement no. 241077, https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, NEUROSCI LETT, V372, P161, DOI 10.1016/j.neulet.2004.09.036; Babiloni F, 2001, CLIN NEUROPHYSIOL, V112, P724, DOI 10.1016/S1388-2457(01)00494-1; Bombeke K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burle B, 2015, INT J PSYCHOPHYSIOL, V97, P210, DOI 10.1016/j.ijpsycho.2015.05.004; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Houtman F, 2013, COGNITION, V128, P228, DOI 10.1016/j.cognition.2013.04.003; Houtman F, 2012, J COGN PSYCHOL, V24, P278, DOI 10.1080/20445911.2011.617301; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Most SB, 2011, PSYCHOL SCI, V22, P300, DOI 10.1177/0956797610397665; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Ries S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058197; Segalowitz SJ, 2010, PSYCHOPHYSIOLOGY, V47, P260, DOI 10.1111/j.1469-8986.2009.00942.x; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Steinborn MB, 2012, Q J EXP PSYCHOL, V65, P624, DOI 10.1080/17470218.2012.660962; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Van der Borght L, 2016, BIOL PSYCHOL, V115, P78, DOI 10.1016/j.biopsycho.2016.01.013; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wang L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00187, 10.3389/fpsyg.2012.00438]; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635	34	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151843	10.1371/journal.pone.0151843	http://dx.doi.org/10.1371/journal.pone.0151843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050303	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500015
J	Wallace, ZP; Kennedy, PL; Squires, JR; Oakleaf, RJ; Olson, LE; Dugger, KM				Wallace, Zachary P.; Kennedy, Patricia L.; Squires, John R.; Oakleaf, Robert J.; Olson, Lucretia E.; Dugger, Katie M.			Re-Occupancy of Breeding Territories by Ferruginous Hawks in Wyoming: Relationships to Environmental and Anthropogenic Factors	PLOS ONE			English	Article							ENERGY DEVELOPMENT; SPOTTED OWLS; HABITAT USE; POPULATIONS; SELECTION; RAPTORS; CONSERVATION; DISTURBANCE; DYNAMICS; AVIFAUNA	Grassland and shrubland birds are declining globally due in part to anthropogenic habitat modification. Because population performance of these species is also influenced by non-anthropogenic factors, it is important to incorporate all relevant ecological drivers into demographic models. We used design-based sampling and occupancy models to test relationships of environmental factors that influence raptor demographics with re-occupancy of breeding territories by ferruginous hawks (Buteo regalis) across Wyoming, USA, 2011-2013. We also tested correlations of territory re-occupancy with oil and gas infrastructure-a leading cause of habitat modification throughout the range of this species of conservation concern. Probability of re-occupancy was not related to any covariates we investigated in 2011, had a strong negative relationship with cover of sagebrush (Artemisia spp.) in 2012, was slightly higher for territories with artificial platforms than other nest substrates in 2013, and had a positive relationship with abundance of ground squirrels (Urocitellus spp.) that was strong in 2012 and weak in 2013. Associations with roads were weak and varied by year, road-type, and scale: in 2012, re-occupancy probability had a weak positive correlation with density of roads not associated with oil and gas fields at the territory-scale; however, in 2013 re-occupancy had a very weak negative correlation with density of oil and gas field roads near nest sites (<= 500 m). Although our results indicate re-occupancy of breeding territories by ferruginous hawks was compatible with densities of anthropogenic infrastructure in our study area, the lack of relationships between oil and gas well density and territory re-occupancy may have occurred because pre-treatment data were unavailable. We used probabilistic sampling at a broad spatial extent, methods to account for imperfect detection, and conducted extensive prey sampling; nonetheless, future research using before-after-control-impact designs is needed to fully assess impacts of oil and gas development on ferruginous hawks.	[Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, Union, OR USA; [Squires, John R.; Olson, Lucretia E.] US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA; [Oakleaf, Robert J.] Wyoming Game & Fish Dept, Lander, WY USA; [Dugger, Katie M.] Oregon State Univ, Dept Fisheries & Wildlife, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA; [Wallace, Zachary P.] Eagle Environm Inc, Taos, NM USA	Oregon State University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; United States Department of the Interior; United States Geological Survey	Wallace, ZP (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.; Wallace, ZP (corresponding author), Oregon State Univ, Eastern Oregon Agr & Nat Resource Program, Union, OR USA.; Wallace, ZP (corresponding author), Eagle Environm Inc, Taos, NM USA.	zach@eagleenvironmental.net		Olson, Lucretia/0000-0002-5703-3351	U.S. Forest Service Rocky Mountain Research Station; Wyoming Game and Fish Department; Bureau of Land Management; Wyoming Wildlife Heritage Foundation; Wyoming Governor's Office; PacifiCorp; Pathfinder Renewable Wind Energy; Oregon State University Department of Fisheries and Wildlife; Eastern Oregon Agriculture & Natural Resource Program	U.S. Forest Service Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); Wyoming Game and Fish Department; Bureau of Land Management; Wyoming Wildlife Heritage Foundation; Wyoming Governor's Office; PacifiCorp; Pathfinder Renewable Wind Energy; Oregon State University Department of Fisheries and Wildlife; Eastern Oregon Agriculture & Natural Resource Program	The U.S. Forest Service Rocky Mountain Research Station, Wyoming Game and Fish Department, and Bureau of Land Management provided funding and assisted with study design and data collection. Additional funding was provided by the Wyoming Wildlife Heritage Foundation, Wyoming Governor's Office, PacifiCorp, and Pathfinder Renewable Wind Energy, none of whom were involved in research design, collection and analysis of data, decision to publish, or preparation of the manuscript.; We thank the U.S. Forest Service Rocky Mountain Research Station, Wyoming Game and Fish Department, Oregon State University Department of Fisheries and Wildlife, and Eastern Oregon Agriculture & Natural Resource Program for providing field and administrative support. We thank Ricardo Mata-Gonzalez for advice on study design; pilots Bobby Laird, Dave Stinson, Neil Cadwell, and Ken Overfield; field technicians Justin Broderick, Raymond Buchheit, Justin Caraway, Joseph Ceradini, David Chrismon, Nick Dobric, Andrew Greenawalt, Tia Hunter, Allyson Larned, Rod Lawrence, Jon Lipke, Peter Mahoney, Ryan Mong, Brennan Price, Mary Raikes, Sam Sellers, Edward Whitehead, Matthew Wilson, and Robert Wiltzen; and all private land owners who granted access for field work. Review by David Weins and two anonymous referees greatly improved the manuscript. The use of trade names or products does not constitute endorsement by the U.S. Government.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ayers LW, 1999, J WILDLIFE MANAGE, V63, P85, DOI 10.2307/3802489; Bechard M. J., 1995, BIRDS N AM; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Coates PS, 2014, CONDOR, V116, P341, DOI 10.1650/CONDOR-13-126.1; Collier BA, 2012, DIVERS DISTRIB, V18, P158, DOI 10.1111/j.1472-4642.2011.00831.x; Committee on the Status of Endangered Wildlife in Canada (COSEWIC), 2008, COSEWIC ASS UPD STAT; Copeland Holly E., 2011, P7; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Dreitz VJ, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00519-070106; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; ESRI, 2011, ARCGIS DESKT REL 10; FGDC Cadastral Subcommittee PLSS Work Group, 2011, STAND PLSS DAT SET C; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; GILMER DS, 1983, J WILDLIFE MANAGE, V47, P146, DOI 10.2307/3808061; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Harmata AR, 2001, J FIELD ORNITHOL, V72, P389, DOI 10.1648/0273-8570-72.3.389; Harmata AR, 1991, IMPACTS OIL GAS DEV; Hennenlan C, 2007, J WILDLIFE MANAGE, V71, P526, DOI 10.2193/2006-013; Hethcoat MG, 2015, BIOL CONSERV, V184, P327, DOI 10.1016/j.biocon.2015.02.009; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; JANES SW, 1994, CONDOR, V96, P52, DOI 10.2307/1369063; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Keeley WH, 2011, J WILDLIFE MANAGE, V75, P1034, DOI 10.1002/jwmg.140; Keinath D. A., 2010, RANGE MODELED DISTRI; KENNEDY P L, 1980, Wildlife Society Bulletin, V8, P129; Kennedy PL, 2014, CONDOR, V116, P435, DOI 10.1650/CONDOR-12-174.1; KEOUGH H.L., 2006, THESIS UTAH STATE U; Keough HL, 2012, J RAPTOR RES, V46, P378, DOI 10.3356/JRR-12-07.1; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knight D.H., 2014, MOUNTAINS PLAINS ECO; Kotliar NB, 2007, ECOL APPL, V17, P491, DOI 10.1890/06-0253; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lohmus A, 2003, ECOGRAPHY, V26, P545, DOI 10.1034/j.1600-0587.1999.03575.x; LOKEMOEN JT, 1976, CONDOR, V78, P464, DOI 10.2307/1367095; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MACLAREN PA, 1988, GREAT BASIN NAT, V48, P548; Martinez-Abrain A, 2010, BASIC APPL ECOL, V11, P312, DOI 10.1016/j.baae.2009.12.011; MILLSAP B A, 1988, Journal of Raptor Research, V22, P8; Naugle DE, 2011, STUD AVIAN BIOL, P489; Neal M. C., 2010, ARTIFICIAL NEST STRU; Newton I, 2010, POPULATION ECOLOGY R; Newton I., 1998, POPULATION LIMITATIO; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Oakleaf RJ, 2014, WYOMING GAME FISH DE; OLENDORFF R.R., 1993, STATUS BIOL MANAGEME; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Ramsey F.L., 2002, STAT SLEUTH; RESTANI M, 1991, CONDOR, V93, P1007, DOI 10.2307/3247736; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Roth SD, 1998, T KANSAS ACAD SCI, V92, P132; SCHMUTZ JK, 1987, J RANGE MANAGE, V40, P438, DOI 10.2307/3899606; SCHMUTZ JK, 1984, J WILDLIFE MANAGE, V48, P1009, DOI 10.2307/3801458; SCHMUTZ JK, 1989, CAN J ZOOL, V67, P2596, DOI 10.1139/z89-366; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; Schmutz JK, 2008, J WILDLIFE MANAGE, V72, P1352, DOI 10.2193/2007-231; SCHUECK LS, 1995, J WILDLIFE MANAGE, V59, P674, DOI 10.2307/3801943; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SMITH DG, 1981, CONDOR, V83, P52, DOI 10.2307/1367602; Smith J. P., 2010, ASSESSMENT EFFECTS O; STEENHOF K, 1985, OECOLOGIA, V66, P6, DOI 10.1007/BF00378546; Steenhof Karen, 2007, P181; Stewart BP, 2013, J WILDLIFE MANAGE, V77, P957, DOI 10.1002/jwmg.535; Tigner James R., 1996, P137, DOI 10.1016/B978-012100130-8/50017-1; U.S. Fish and Wildlife Service, 1992, FED REGISTER, V57, P37507; U.S. Geological Survey, 2010, LANDFIRE LANDFIRE 1; VAN HORN R. C., 1993, THESIS MONTANA STATE; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WAKELEY JS, 1978, CONDOR, V80, P316, DOI 10.2307/1368042; Wallace ZP, 2016, J WILDLIFE MANAGE, V80, P78, DOI 10.1002/jwmg.1000; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zelenak JR, 1997, CAN J ZOOL, V75, P1035, DOI 10.1139/z97-124	81	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152977	10.1371/journal.pone.0152977	http://dx.doi.org/10.1371/journal.pone.0152977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049324	Green Published, gold			2022-12-27	WOS:000373603500075
J	Kaido, M; Toda, I; Oobayashi, T; Kawashima, M; Katada, Y; Tsubota, K				Kaido, Minako; Toda, Ikuko; Oobayashi, Tomoo; Kawashima, Motoko; Katada, Yusaku; Tsubota, Kazuo			Reducing Short-Wavelength Blue Light in Dry Eye Patients with Unstable Tear Film Improves Performance on Tests of Visual Acuity	PLOS ONE			English	Article							BREAK-UP TIME; SYSTEM	Purpose To investigate whether suppression of blue light can improve visual function in patients with short tear break up time (BUT) dry eye (DE). Methods Twenty-two patients with short BUT DE (10 men, 12 women; mean age, 32.4 +/- 6.4 years; age range, 23-43 years) and 18 healthy controls (10 men, 8 women; mean age, 30.1 +/- 7.4 years; age range, 20-49 years) underwent functional visual acuity (VA) examinations with and without wearing eyeglasses with 50% blue light blocked lenses. The functional VA parameters were starting VA, functional VA, and visual maintenance ratio. Results The baseline mean values (logarithm of the minimum angle of resolution, logMAR) of functional VA and the visual maintenance ratio were significantly worse in the DE patients than in the controls (P < 0.05), while no significant difference was observed in the baseline starting VA (P > 0.05). The DE patients had significant improvement in mean functional VA and visual maintenance ratio while wearing the glasses (P < 0.05), while there were no significant changes with and without the glasses in the control group (P > 0.05), Conclusions Protecting the eyes from short-wavelength blue light may help to ameliorate visual impairment associated with tear instability in patients with DE. This finding represents a new concept, which is that the blue light exposure might be harmful to visual function in patients with short BUT DE.	[Kaido, Minako; Kawashima, Motoko; Katada, Yusaku; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Tokyo, Japan; [Kaido, Minako] Wada Eye Clin, Tateyama, Chiba, Japan; [Toda, Ikuko; Oobayashi, Tomoo] Minamiaoyama Eye Clin, Minato Ku, Tokyo, Japan	Keio University	Kaido, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi, Tokyo, Japan.; Kaido, M (corresponding author), Wada Eye Clin, Tateyama, Chiba, Japan.	fwiw1193@mb.infoweb.ne.jp			Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan; Kowa Co., Ltd. Japan; JINS Co., Ltd, Tokyo; Department of Ophthalmology of Keio University School of Medicine	Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan; Kowa Co., Ltd. Japan; JINS Co., Ltd, Tokyo; Department of Ophthalmology of Keio University School of Medicine	This study was supported by a grant from the Medical School Faculty and Alumni Grants of Keio University Medical School, Tokyo, Japan. Keio University School of Medicine also provided support in the form of salaries for authors M. Kawashima, YK, and KT. Wada Eye Clinic provided support in the form of salaries for author M. Kaito. Minamiaoyama Eye Clinic provided support in the form of salaries for authors IT and TO. Kowa Co., Ltd. Japan and JINS Co., Ltd, Tokyo, Japan provided a monetary grant for research unrelated to the current study to the Department of Ophthalmology of Keio University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaras A, 1997, ERGONOMICS, V40, P1255, DOI 10.1080/001401397187496; Abib AH, 1998, OCCUP ERGON, V1, P285; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; [Anonymous], 2002, S009E CIE; [Anonymous], 2005, 62471 IEC; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Holzman DC, 2010, ENVIRON HEALTH PERSP, V118, pA22, DOI 10.1289/ehp.118-a22; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2015, BRIT J OPHTHALMOL, V99, P1488, DOI 10.1136/bjophthalmol-2015-306640; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Kitchel E, 2000, J VISUAL IMPAIR BLIN, V94, P399, DOI 10.1177/0145482X0009400606; Kobashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082427; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; LERMAN S, 1988, NEW ENGL J MED, V319, P1475, DOI 10.1056/NEJM198812013192208; LIU IY, 1989, AM J PUBLIC HEALTH, V79, P765, DOI 10.2105/AJPH.79.6.765; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Shimazaki S., 2006, J EYE, V24, P181; Taylor H R, 1990, Trans Am Ophthalmol Soc, V88, P163; Thorud HMS, 2012, OPTOMETRY VISION SCI, V89, pE452, DOI 10.1097/OPX.0b013e31824c1801; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Yokoi N, 2015, AM J OPHTHALMOL, V159, P748, DOI 10.1016/j.ajo.2014.12.019	27	30	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152936	10.1371/journal.pone.0152936	http://dx.doi.org/10.1371/journal.pone.0152936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045760	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600048
J	Yuan, C; Wang, J; Ying, M				Yuan, Chuang; Wang, Jing; Ying, Michael			Predictive Value of Carotid Distensibility Coefficient for Cardiovascular Diseases and All-Cause Mortality: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; ARTERIAL STIFFNESS; CLINICAL-APPLICATIONS; TASK-FORCE; PULSE-WAVE; RISK; EVENTS; STROKE; RECOMMENDATIONS	Aims The aim of the present study is to determine the pooled predictive value of carotid distensibility coefficient (DC) for cardiovascular (CV) diseases and all-cause mortality. Background Arterial stiffness is associated with future CV events. Aortic pulse wave velocity is a commonly used predictor for CV diseases and all-cause mortality; however, its assessment requires specific devices and is not always applicable in all patients. In addition to the aortic artery, the carotid artery is also susceptible to atherosclerosis, and is highly accessible because of the surficial property. Thus, carotid DC, which indicates the intrinsic local stiffness of the carotid artery and may be determined using ultrasound and magnetic resonance imaging, is of interest for the prediction. However, the role of carotid DC in the prediction of CV diseases and all-cause mortality has not been thoroughly characterized, and the pooled predictive value of carotid DC remains unclear. Methods A meta-analysis, which included 11 longitudinal studies with 20361 subjects, was performed. Results Carotid DC significantly predicted future total CV events, CV mortality and all-cause mortality. The pooled risk ratios (RRs) of CV events, CV mortality and all-cause mortality were 1.19 (1.06-1.35, 95% CI, 9 studies with 18993 subjects), 1.09 (1.01-1.18, 95% CI, 2 studies with 2550 subjects) and 1.65 (1.15-2.37, 95% CI, 6 studies with 3619 subjects), respectively, for the subjects who had the lowest quartile of DC compared with their counterparts who had higher quartiles. For CV events, CV mortality and all-cause mortality, a decrease in DC of 1 SD increased the risk by 13%, 6% and 41% respectively, whereas a decrease in DC of 1 unit increased the risk by 3%, 1% and 6% respectively. Conclusions Carotid DC is a significant predictor of future CV diseases and all- cause mortality, which may facilitate the identification of high-risk patients for the early diagnosis and prompt treatment of CV diseases.	[Yuan, Chuang] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Wang, Jing; Ying, Michael] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China; [Wang, Jing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Neurosurg Neurooncol, Guangzhou 510275, Guangdong, Peoples R China	Hong Kong Polytechnic University; State Key Lab Oncology South China; Sun Yat Sen University	Yuan, C (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.; Ying, M (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	aeolus.yc@connect.polyu.hk; htmying@polyu.edu.hk	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Ying, Michael/0000-0001-5979-6072				Barenbrock M, 2002, J HYPERTENS, V20, P79, DOI 10.1097/00004872-200201000-00012; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570; Bramwell JC, 1922, LANCET, V1, P891; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dijk JM, 2005, EUR HEART J, V26, P1213, DOI 10.1093/eurheartj/ehi254; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Haluska BA, 2010, ATHEROSCLEROSIS, V209, P474, DOI 10.1016/j.atherosclerosis.2009.10.018; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Karras A, 2012, HYPERTENSION, V60, P1451, DOI 10.1161/HYPERTENSIONAHA.112.197210; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leone N, 2008, ARTERIOSCL THROM VAS, V28, P1392, DOI 10.1161/ATVBAHA.108.164582; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MASAWA N, 1994, STROKE, V25, P122, DOI 10.1161/01.STR.25.1.122; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Paini A, 2006, HYPERTENSION, V47, P371, DOI 10.1161/01.HYP.0000202052.25238.68; Safar ME, 2000, J HYPERTENS, V18, P1527, DOI 10.1097/00004872-200018110-00001; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stork S, 2004, CIRCULATION, V110, P344, DOI 10.1161/01.CIR.0000134966.10793.C9; Sung SH, 2014, PULSE, V2, P18, DOI 10.1159/000367645; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888; van Sloten TT, 2014, J AM COLL CARDIOL, V63, P1739, DOI 10.1016/j.jacc.2013.12.041; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Yang EY, 2012, STROKE, V43, P103, DOI 10.1161/STROKEAHA.111.626200; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	33	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152799	10.1371/journal.pone.0152799	http://dx.doi.org/10.1371/journal.pone.0152799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045958	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600035
J	Zeng, QC; Dong, YH; An, SS				Zeng, Quanchao; Dong, Yanghong; An, Shaoshan			Bacterial Community Responses to Soils along a Latitudinal and Vegetation Gradient on the Loess Plateau, China	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ORGANIC-CARBON; DIVERSITY; FOREST; CONVERSION; NITROGEN; BOREAL; LITTER; ALTERS	Soil bacterial communities play an important role in nutrient recycling and storage in terrestrial ecosystems. Loess soils are one of the most important soil resources for maintaining the stability of vegetation ecosystems and are mainly distributed in northwest China. Estimating the distributions and affecting factors of soil bacterial communities associated with various types of vegetation will inform our understanding of the effect of vegetation restoration and climate change on these processes. In this study, we collected soil samples from 15 sites from north to south on the Loess Plateau of China that represent different ecosystem types and analyzed the distributions of soil bacterial communities by high-throughput 454 pyrosequencing. The results showed that the 142444 sequences were grouped into 36816 operational taxonomic units (OTUs) based on 97% similarity. The results of the analysis showed that the dominant taxonomic phyla observed in all samples were Actinobacteria, Proteobacteria, Chloroflexi, Acidobacteria and Planctomycetes. Actinobacteria and Proteobacteria were the two most abundant groups in all samples. The relative abundance of Actinobacteria increased from 14.73% to 40.22% as the ecosystem changed from forest to sandy, while the relative abundance of Proteobacteria decreased from 35.35% to 21.40%. Actinobacteria and Proteobacteria had significant correlations with mean annual precipitation (MAP), pH, and soil moisture and nutrients. MAP was significantly correlated with soil chemical and physical properties. The relative abundance of Actinobacteria, Proteobacteria and Planctomycetes correlated significantly with MAP, suggesting that MAP was a key factor that affected the soil bacterial community composition. However, along with the MAP gradient, Chloroflexi, Bacteroidetes and Cyanobacteria had narrow ranges that did not significantly vary with the soil and environmental factors. Overall, we conclude that the edaphic properties and/or vegetation types are driving bacterial community composition. MAP was a key factor that affects the composition of the soil bacteria on the Loess Plateau of China.	[Zeng, Quanchao; Dong, Yanghong; An, Shaoshan] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [An, Shaoshan] Northwest A&F Univ, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	An, SS (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.; An, SS (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Shaanxi, Peoples R China.	shan@ms.iswc.ac.cn		quanchao, zeng/0000-0003-1272-0227	National Natural Sciences Foundation of China [41171226, 41101254]; Program for New Century Excellent Talents in University [NCET-12-0479]; Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base [KZCX2-XB3-13]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base	This study was supported by the National Natural Sciences Foundation of China (41171226, 41101254), the Program for New Century Excellent Talents in University (NCET-12-0479) and the Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Ecorestructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base (KZCX2-XB3-13). All the funding were Shaoshan An's and he conceived and designed the experiments.; This study was supported by the National Natural Sciences Foundation of China (41171226, 41101254), the Program for New Century Excellent Talents in University (NCET-12-0479) and the Demonstration of Key Technologies for Soil and Water Conservation and Restoring and Eco-restructing for Damaged Regional Ecosystem of the Shanxi-Shaanxi-Inner Mongolia energy source base (KZCX2-XB3-13).	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Aneja MK, 2004, J MICROBIOL METH, V59, P223, DOI 10.1016/j.mimet.2004.07.005; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Chan OC, 2008, FEMS MICROBIOL ECOL, V64, P449, DOI 10.1111/j.1574-6941.2008.00488.x; Chan OC, 2006, FEMS MICROBIOL ECOL, V58, P247, DOI 10.1111/j.1574-6941.2006.00156.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeForest JL, 2012, BIOGEOCHEMISTRY, V109, P189, DOI 10.1007/s10533-011-9619-6; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; FIERER N, 2008, ACCESSING UNCULTIVAT, P95; Fuchslueger L, 2014, NEW PHYTOL, V201, P916, DOI 10.1111/nph.12569; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hart SC, 2005, FOREST ECOL MANAG, V220, P166, DOI 10.1016/j.foreco.2005.08.012; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hillebrand H, 2001, ECOGRAPHY, V24, P251, DOI 10.1034/j.1600-0587.2001.240302.x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Levin S., 1995, PROBLEM PATTERN SCAL; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Long T, 2009, MICROB ECOL, V58, P262, DOI 10.1007/s00248-009-9510-3; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; OConnell D, 1975, TECHNICAL B MINISTRY; Pankratov TA, 2011, ENVIRON MICROBIOL, V13, P1800, DOI 10.1111/j.1462-2920.2011.02491.x; Papatheodorou EM, 2004, PEDOBIOLOGIA, V48, P329, DOI 10.1016/j.pedobi.2004.04.002; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Russo SE, 2012, SOIL BIOL BIOCHEM, V55, P48, DOI 10.1016/j.soilbio.2012.05.021; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Stegen JC, 2013, ISME J, V7, P2069, DOI 10.1038/ismej.2013.93; Terhonen E, 2011, SILVA FENN, V45, P301, DOI 10.14214/sf.104; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wang QK, 2014, SOIL BIOL BIOCHEM, V71, P13, DOI 10.1016/j.soilbio.2014.01.004; Wu XD, 2012, PERMAFROST PERIGLAC, V23, P162, DOI 10.1002/ppp.1740; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106; Zhang XF, 2014, RES MICROBIOL, V165, P128, DOI 10.1016/j.resmic.2014.01.002; Zhang XY, 2007, PEDOSPHERE, V17, P19, DOI 10.1016/S1002-0160(07)60003-4	52	59	76	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152894	10.1371/journal.pone.0152894	http://dx.doi.org/10.1371/journal.pone.0152894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045518	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600045
J	Lai, CH; Lai, YJJ; Chou, FP; Chang, HHD; Tseng, CC; Johnson, MD; Wang, JK; Lin, CY				Lai, Chih-Hsin; Lai, Ying-Jung J.; Chou, Feng-Pai; Chang, Hsiang-Hua D.; Tseng, Chun-Che; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE; ZYMOGEN ACTIVATION; EPITHELIAL-CELLS; HUMAN TISSUES; INHIBITOR; EXPRESSION; LOCALIZATION; PURIFICATION	Significant proteolysis may occur during milk synthesis and secretion, as evidenced by the presence of protease-protease inhibitor complex containing the activated form of the type 2 transmembrane serine protease matriptase and the transmembrane Kunitz-type serine protease inhibitor HAI-1. In order to identify other proteolysis events that may occur during lactation, human milk was analyzed for species containing HAI-1 and HAI-2 which is closely related to HAI-1. In addition to the previously demonstrated matriptase-HAI-1 complex, HAI-1 was also detected in complex with prostasin, a glycosylphosphatidylinositol (GPI)-anchored serine protease. HAI-2 was also detected in complexes, the majority of which appear to be part of higher-order complexes, which do not bind to ionic exchange columns or immunoaffinity columns, suggesting that HAI-2 and its target proteases may be incorporated into special protein structures during lactation. The small proportion HAI-2 species that could be purified contain matriptase or prostasin. Human mammary epithelial cells are the likely cellular sources for these HAI-1 and HAI-2 complexes with matriptase and prostasin given that these protease-inhibitor complexes with the exception of prostasin-HAI-2 complex were detected in milk-derived mammary epithelial cells. The presence of these protease-inhibitor complexes in human milk provides in vivo evidence that the proteolytic activity of matriptase and prostasin are significantly elevated at least during lactation, and possibly contribute to the process of lactation, and that they are under tight control by HAI-1 and HAI-2.	[Lai, Chih-Hsin] Taipei City Hosp, Renai Branch, Dept Dent, Taipei, Taiwan; [Lai, Chih-Hsin; Wang, Jehng-Kang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Ying-Jung J.; Chou, Feng-Pai; Chang, Hsiang-Hua D.; Tseng, Chun-Che; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan	Taipei City Hospital; National Defense Medical Center; Georgetown University; National Defense Medical Center	Wang, JK (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA.; Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	jkwang@ndmctsgh.edu.tw; lincy@georgetown.edu	Feng-Pai, Chou/AGS-4250-2022; Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) Grant [RO1 CA 123223]; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-016-022]; Department of Defense, Taiwan [103-M018, MAB-104-026]; Department of Health [10401-62-065]; Taipei City Government, Taiwan; Taipei City Hospital [TPCH-104-030]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Grant; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Department of Defense, Taiwan(United States Department of Defense); Department of Health; Taipei City Government, Taiwan; Taipei City Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant RO1 CA 123223 (to MDJ and CYL), Grant (MOST 103-2320-B-016-022) from the Ministry of Science and Technology, Taiwan, (to JKW), Grant (103-M018 and MAB-104-026) from the Department of Defense, Taiwan (to JKW), Grant (10401-62-065) from the Department of Health, Taipei City Government, Taiwan (to CHL), and grant (TPCH-104-030) from Taipei City Hospital (to CHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Chang HHD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120489; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Holt C, 2013, J DAIRY SCI, V96, P6127, DOI 10.3168/jds.2013-6831; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Lai YJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132163; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009	28	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152904	10.1371/journal.pone.0152904	http://dx.doi.org/10.1371/journal.pone.0152904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043831	Green Submitted, gold, Green Published			2022-12-27	WOS:000373592100042
J	Lorenz, T; Beer, C; Putz, J; Heinitz, K				Lorenz, Timo; Beer, Clemens; Puetz, Jan; Heinitz, Kathrin			Measuring Psychological Capital: Construction and Validation of the Compound PsyCap Scale (CPC-12)	PLOS ONE			English	Article							SELF-EFFICACY; PROACTIVE PERSONALITY; POSITIVE EMOTIONS; WORK ENGAGEMENT; SOCIAL SUPPORT; MEDIATING ROLE; PERFORMANCE; OPTIMISM; JOB; RESILIENCE	With the Psychological Capital Questionnaire (PCQ) being the standard measure to assess psychological capital (PsyCap) in the context of organizations, this paper aims to broaden this domain-specific approach by introducing a measure with universal claim. Two studies were conducted to create and validate a German self-report scale (CPC-12) measuring PsyCap. We performed confirmatory factor analyses and correlations with other positive psychological constructs on the data of two German samples (N-1 = 321; N-2 = 202). The twelve-item CPC-12 exhibits the anticipated factorial structure with a very good model fit and associations to other constructs concur with previous findings with other measures of PsyCap.	[Lorenz, Timo; Beer, Clemens; Puetz, Jan; Heinitz, Kathrin] Free Univ Berlin, Dept Work & Org Psychol, Berlin, Germany	Free University of Berlin	Lorenz, T (corresponding author), Free Univ Berlin, Dept Work & Org Psychol, Berlin, Germany.	timo.lorenz@fu-berlin.de	Lorenz, Timo/AAC-2249-2022	Lorenz, Timo/0000-0002-3830-489X				[Anonymous], 2004, INT WORKSH RES WELL; [Anonymous], 2014, R LANG ENV STAT COMP; Arthaud-Day ML, 2005, SOC INDIC RES, V74, P445, DOI 10.1007/s11205-004-8209-6; Avey James B., 2008, Leadership & Organization Development Journal, V29, P110, DOI 10.1108/01437730810852470; Avey J.B., 2006, J LEADERSH ORG STUD, V13, P42, DOI [DOI 10.1177/10717919070130020401, 10.1177/10717919070130020401]; Avey JB, 2011, HUM RESOUR DEV Q, V22, P127, DOI 10.1002/hrdq.20070; Avey JB, 2010, J OCCUP HEALTH PSYCH, V15, P17, DOI 10.1037/a0016998; Avey JB, 2009, HUM RESOUR MANAGE-US, V48, P677, DOI 10.1002/hrm.20294; Bakker AB, 2006, SUCCESFACTOREN BIJ V; Bakker AB, 2008, WORK STRESS, V22, P187, DOI 10.1080/02678370802393649; Balducci C, 2010, EUR J PSYCHOL ASSESS, V26, P143, DOI 10.1027/1015-5759/a000020; Baron RA, 2016, J MANAGE, V42, P742, DOI 10.1177/0149206313495411; Baumeister R. F., 1991, MEANINGS LIFE; Becker G. S., 1987, HUMAN CAPITAL THEORE, DOI DOI 10.7208/CHICAGO/9780226041223.001.0001; Bourdieu P., 2011, CULTURAL THEORY ANTH, P81; BRANDSTADTER J, 1994, Z ENTWICKL PADAGOGIS, V26, P2; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Cartwright S., 2006, Human Resources Management Review, V16, P199, DOI 10.1016/j.hrmr.2006.03.012; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Costa PT, 2007, REVISED NEO PERSONAL; Coutu DL, 2002, HARVARD BUS REV, V80, P46; CRANT JM, 1995, J APPL PSYCHOL, V80, P532, DOI 10.1037/0021-9010.80.4.532; Culbertson SS, 2010, J OCCUP HEALTH PSYCH, V15, P421, DOI 10.1037/a0020720; Cunningham CJL, 2008, J OCCUP HEALTH PSYCH, V13, P271, DOI 10.1037/1076-8998.13.3.271; Dawkins S, 2013, J OCCUP ORGAN PSYCH, V86, P348, DOI 10.1111/joop.12007; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Enders C. K., 2010, APPL MISSING DATA AN; Enders CK, 2013, CHILD DEV PERSPECT, V7, P27, DOI 10.1111/cdep.12008; Finney SJ, 2013, QUANT METH EDUC BEHA, P439; Ford MT, 2007, J APPL PSYCHOL, V92, P57, DOI 10.1037/0021-9010.92.1.57; Gerlitz J.Y., 2005, DIW RES NOTES, V4; Glaesmer H, 2008, Z GESUNDH, V16, P26, DOI 10.1026/0943-8149.16.1.26; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gottschall AC, 2012, MULTIVAR BEHAV RES, V47, P1, DOI 10.1080/00273171.2012.640589; Grosjean P., 2014, PASTECS PACKAGE ANAL; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Herzberg PY, 2006, PSYCHOL ASSESSMENT, V18, P433, DOI 10.1037/1040-3590.18.4.433; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jerusalem M, 1999, SKALEN ERFASSUNG LEH, P13; Judge T.A., 2008, SCI SUBJECTIVE WELL, P393; JUDGE TA, 1993, J APPL PSYCHOL, V78, P939, DOI 10.1037/0021-9010.78.6.939; JUDGE TA, 1994, J APPL PSYCHOL, V79, P767, DOI 10.1037/0021-9010.79.5.767; Jundt D., 2001, ANN M MIDW PSYCH ASS; Karademas EC, 2006, PERS INDIV DIFFER, V40, P1281, DOI 10.1016/j.paid.2005.10.019; Kliem S, 2015, J CLIN EPIDEMIOL, V68, P551, DOI 10.1016/j.jclinepi.2014.11.003; Larson M., 2006, J LEADERSH ORG STUD, V13, P45, DOI [10.1177/10717919070130020601, DOI 10.1177/10717919070130020601, 10.1177/10717919070130010701, DOI 10.1177/10717919070130010701]; Leppert K, 2008, KLIN DIAGNOSTIK EVAL, V2008, P226; Little L., 2007, POSITIVE ORG BEHAV A, P191, DOI DOI 10.4135/9781446212752.N14; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Luthans F, 2006, J ORGAN BEHAV, V27, P387, DOI 10.1002/job.373; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F, 2002, ACAD MANAGE EXEC, V16, P57, DOI 10.5465/AME.2002.6640181; Luthans F., 2005, MANAGE ORGAN REV, V1, P247, DOI DOI 10.1111/J.1740-8784.2005.00011.X; Luthans F., 2015, PSYCHOL CAPITAL; Luthans F., 2006, PSYCHOL CAPITAL DEV; Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618; Luthans F, 2008, J ORGAN BEHAV, V29, P219, DOI 10.1002/job.507; Luthans F, 2007, PERS PSYCHOL, V60, P541, DOI 10.1111/j.1744-6570.2007.00083.x; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Masten A. S., 2002, HDB POSITIVE PSYCHOL, P74, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0012; McCullough ME, 2002, J PERS SOC PSYCHOL, V82, P112, DOI 10.1037//0022-3514.82.1.112; Moosbrugger H., 2007, TESTTHEORIE FRAGEBOG; Newman A, 2014, J ORGAN BEHAV, V35, pS120, DOI 10.1002/job.1916; Ozbay Fatih, 2008, Curr Psychiatry Rep, V10, P304, DOI 10.1007/s11920-008-0049-7; Parker SK, 1998, J APPL PSYCHOL, V83, P835, DOI 10.1037/0021-9010.83.6.835; Pavot W., 2008, SCI SUBJECTIVE WELL, P124; Rash JA, 2011, APPL PSYCHOL-HLTH WE, V3, P350, DOI 10.1111/j.1758-0854.2011.01058.x; Scheier M. F., 2001, OPTIMISM PESSIMISM I, V1, P189, DOI DOI 10.1037/10385-009; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Schmitz G.S., 1999, Z F R EMPIRISCHE P D, V13, P3; Schumacher J., 2003, DIAGNOSTISCHE VERFAH, P305; Schyns B., 2002, EUROPEAN J WORK ORG, V11, P219, DOI [10.1080/13594320244000148, DOI 10.1080/13594320244000148]; Seligman MEP, 2004, PHILOS T ROY SOC B, V359, P1379, DOI 10.1098/rstb.2004.1513; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Snyder CR, 1996, J PERS SOC PSYCHOL, V70, P321, DOI 10.1037/0022-3514.70.2.321; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Steger MF, 2012, J CAREER ASSESSMENT, V20, P322, DOI 10.1177/1069072711436160; Symister P, 2003, HEALTH PSYCHOL, V22, P123, DOI 10.1037/0278-6133.22.2.123; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Wagnild GM., 1993, J NURSING MEASUREMEN, V1, P165; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Xanthopoulou D, 2009, J VOCAT BEHAV, V74, P235, DOI 10.1016/j.jvb.2008.11.003; Xanthopoulou Despoina, 2007, INT J STRESS MANAG, V14, P121, DOI [DOI 10.1037/1072-5245.14.2.121, 10.1037/1072-5245.14.2.121]	87	61	62	12	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152892	10.1371/journal.pone.0152892	http://dx.doi.org/10.1371/journal.pone.0152892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035437	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200049
J	Wu, W; Chen, GM; Fan, BX; Liu, JY				Wu, Wei; Chen, Guiming; Fan, Boxuan; Liu, Jianyou			Effect of Groove Surface Texture on Tribological Characteristics and Energy Consumption under High Temperature Friction	PLOS ONE			English	Article							RECIPROCATING AUTOMOTIVE COMPONENTS; PERFORMANCE; STEEL; DRY; BEHAVIOR; LUBRICATION; WATER; WEAR; TOOL	Energy consumption and tribological properties could be improved by proper design of surface texture in friction. However, some literature focused on investigating their performance under high temperature. In the study, different groove surface textures were fabricated on steels by a laser machine, and their tribological behaviors were experimentally studied with the employment of the friction and wear tester under distinct high temperature and other working conditions. The friction coefficient was recorded, and wear performance were characterized by double light interference microscope, scanning electron microscope (SEM) and x-ray energy dispersive spectrometry (EDS). Then, the performances of energy consumptions were carefully estimated. Results showed that friction coefficient, wear, and energy consumption could almost all be reduced by most textures under high temperature conditions, but to a different extent which depends on the experimental conditions and texture parameters. The main improvement mechanisms were analyzed, such as the hardness change, wear debris storage, thermal stress release and friction induced temperature reduction by the textures. Finally, a scattergram of the relatively reduced ratio of the energy consumption was drawn for different surface textures under four distinctive experimental conditions to illustrate the comprehensive energy consumption improving ability of textures, which was of benefit for the application of texture design.	[Wu, Wei; Chen, Guiming; Liu, Jianyou] Xian Res Inst Hitech, Xian, Peoples R China; [Fan, Boxuan] CASC, Acad 4, Xian, Peoples R China	China Aerospace Science & Technology Corporation (CASC)	Wu, W (corresponding author), Xian Res Inst Hitech, Xian, Peoples R China.	foterlk@163.com			Science and Technology Innovation Fund [2014kct-03]	Science and Technology Innovation Fund	Support was provided by the Science and Technology Innovation Fund (2014kct-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archard JF, 1958, WEAR, V2, P438, DOI DOI 10.1016/0043-1648(59)90159-0; Blatter A, 1999, WEAR, V232, P226, DOI 10.1016/S0043-1648(99)00150-7; Borghi A, 2008, WEAR, V265, P1046, DOI 10.1016/j.wear.2008.02.011; Chang WL, 2011, WEAR, V271, P2433, DOI 10.1016/j.wear.2010.12.026; Deng JX, 2013, SURF COAT TECH, V222, P135, DOI 10.1016/j.surfcoat.2013.02.015; Etsion I, 1999, TRIBOL T, V42, P511, DOI 10.1080/10402009908982248; Etsion I, 2013, FRICTION, V1, P195, DOI 10.1007/s40544-013-0018-y; Flatters IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032770; Ibatan T, 2015, SURF COAT TECH, V272, P102, DOI 10.1016/j.surfcoat.2015.04.017; Kawasegi N, 2009, PRECIS ENG, V33, P248, DOI 10.1016/j.precisioneng.2008.07.005; Kligerman Y, 2005, J TRIBOL-T ASME, V127, P632, DOI 10.1115/1.1866171; Klocker A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079085; Li G, 2015, J FUNCTION MAT, V44, P2033; Ma HY, 2010, MANUFACTURE INFORM E, V39, P30; Min J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137566; Mufti RA, 2009, P I MECH ENG J-J ENG, V223, P629, DOI 10.1243/13506501JET487; NAKADA M, 1994, TRIBOL INT, V27, P3, DOI 10.1016/0301-679X(94)90056-6; Pettersson U, 2003, TRIBOL INT, V36, P857, DOI 10.1016/S0301-679X(03)00104-X; Qiu Y, 2011, TRIBOL INT, V44, P635, DOI 10.1016/j.triboint.2011.01.003; Qu JQ, 2011, TECHNOLOGY HIGHWAY T, V3, P80; Ronen A, 2001, TRIBOL T, V44, P359, DOI 10.1080/10402000108982468; Ryk G, 2002, TRIBOL T, V45, P444, DOI 10.1080/10402000208982572; Sinanoglu C, 2005, J MATER PROCESS TECH, V168, P344, DOI 10.1016/j.jmatprotec.2005.02.252; Sugihara T, 2012, PRECIS ENG, V36, P229, DOI 10.1016/j.precisioneng.2011.10.002; Tala-Ighil N, 2015, TRIBOL INT, V90, P228, DOI 10.1016/j.triboint.2015.02.032; TIAN XF, 1993, J TRIBOL-T ASME, V115, P411, DOI 10.1115/1.2921652; Tong X, 2013, APPL SURF SCI, V271, P373, DOI 10.1016/j.apsusc.2013.01.209; UETZ H, 1978, WEAR, V49, P253, DOI 10.1016/0043-1648(78)90091-1; Wang XL, 2006, APPL SURF SCI, V253, P1282, DOI 10.1016/j.apsusc.2006.01.076; Wang XL, 2001, TRIBOL INT, V34, P703, DOI 10.1016/S0301-679X(01)00063-9; Wu Z, 2012, WEAR, V292, P135, DOI 10.1016/j.wear.2012.05.021; Xie J, 2013, INT J MACH TOOL MANU, V73, P25, DOI 10.1016/j.ijmachtools.2013.05.006; Xing YQ, 2013, MATER DESIGN, V52, P234, DOI 10.1016/j.matdes.2013.05.077; Yu XQ, 2002, J MATER PROCESS TECH, V129, P463, DOI 10.1016/S0924-0136(02)00611-8; Zhang ZH, 2007, THESIS JILIN U JILIN; Zhang ZH, 2010, J BIONIC ENG, V7, P390, DOI 10.1016/S1672-6529(10)60271-5; Zhou H, 2006, SURF COAT TECH, V200, P6758, DOI 10.1016/j.surfcoat.2005.10.019	37	14	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152100	10.1371/journal.pone.0152100	http://dx.doi.org/10.1371/journal.pone.0152100			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035658	gold, Green Submitted, Green Published			2022-12-27	WOS:000373201200011
J	De Gresve, J; Van Meerbeeck, J; Vansteenkiste, JF; Decoster, L; Meert, AP; Vuylsteke, P; Focan, C; Canon, JL; Humblet, Y; Berchem, G; Colinet, B; Galdermans, D; Bosquee, L; Vermeij, J; Dewaele, A; Geers, C; Schallier, D; Teugels, E				De Gresve, Jacques; Van Meerbeeck, Jan; Vansteenkiste, Johan F.; Decoster, Lore; Meert, Anne-Pascale; Vuylsteke, Peter; Focan, Christian; Canon, Jean-Luc; Humblet, Yves; Berchem, Guy; Colinet, Benoit; Galdermans, Danny; Bosquee, Lionel; Vermeij, Joanna; Dewaele, Alex; Geers, Caroline; Schallier, Denis; Teugels, Erik			Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; OPEN-LABEL; PLUS GEMCITABINE; GEFITINIB; SURVIVAL; CHEMOTHERAPY; RESISTANCE; ADENOCARCINOMA; PACLITAXEL; AFATINIB	Introduction Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibition is the preferred first-line treatment of advanced adenocarcinoma of the lung that harbors EGFR activating tyrosine kinase domain mutations. Most data available pertain to Asian populations in which such mutations are more prevalent. We report on the long-term results of first-line treatment with erlotinib in Caucasian patients with advanced adenocarcinoma of the lung that have a somatic EGFR mutation in their tumor. Methods Multicenter academic prospective phase II study with erlotinib in patients with an activating EGFR tyrosine kinase (TK) domain somatic mutation (any exon encoding the kinase domain) in the tumor and no prior treatment for their advanced disease. Results Phenotypic preselecting of 229 patients led to a high EGFR mutation detection rate of 24% of which 46 patients were included in the phase II study. With a progression free survival (PFS) of 81% at three months the study met its primary endpoint for presumed superiority over chemotherapy. With an overall median PFS of 11 months and a median overall survival (OS) of 23 months, the results compare favorably with results obtained in randomized studies using TKI in first line in EGFR mutation positive adenocarcinoma of the lung. Conclusion The present study reinforces the use of EGFR tyrosine kinase inhibition (TKI) as a first line treatment of choice for advanced adenocarcinoma of the lung carrying an activating EGFR mutation. The mutation rate in preselected Caucasian patients is higher than previously reported. Issues relevant for clinical practice are discussed.	[De Gresve, Jacques; Decoster, Lore; Dewaele, Alex; Geers, Caroline; Schallier, Denis; Teugels, Erik] Univ Ziekenhuis Brussel, Ctr Oncol, Dept Med Oncol, Brussels, Belgium; [Van Meerbeeck, Jan] Univ Hosp, Dept Thorac Oncol, Ghent, Belgium; [Vansteenkiste, Johan F.] Katholieke Univ Leuven, Univ Hosp, Dept Pneumol, Leuven, Belgium; [Meert, Anne-Pascale] Inst Jules Bordet, Dept Pneumol, B-1000 Brussels, Belgium; [Vuylsteke, Peter] Clin & Maternite St Elisabeth, Dept Med Oncol, Namur, Belgium; [Focan, Christian] CHC Clin St Joseph, Dept Med Oncol, Liege, Belgium; [Canon, Jean-Luc; Colinet, Benoit] Grand Hop Charleroi, Dept Med Oncol, Charleroi, Belgium; [Humblet, Yves] Catholic Univ Louvain, Ctr Canc, Dept Med Oncol, B-1200 Brussels, Belgium; [Berchem, Guy] Ctr Hosp Luxembourg, Dept Med Oncol, Luxembourg, Luxembourg; [Galdermans, Danny] ZNA Middelheim Hosp, Dept Med Oncol, Antwerp, Belgium; [Bosquee, Lionel] CHU Sart Tilman, Dept Resp Med, B-4000 Liege, Belgium; [Vermeij, Joanna] ZNA Jan Palfijn, Dept Med Oncol, Merksem, Belgium; [Van Meerbeeck, Jan] Univ Antwerp Hosp, Dept Thorac Oncol, Edegem, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; KU Leuven; Institut Jules Bordet; Grand Hopital De Charleroi; Universite Catholique Louvain; Luxembourg Hospital Center; ZNA Middelheim Hospital; University of Liege; University of Antwerp	De Gresve, J (corresponding author), Univ Ziekenhuis Brussel, Ctr Oncol, Dept Med Oncol, Brussels, Belgium.	jacques.degreve@uzbrussel.be	Vuylsteke, peter/GXW-1169-2022; Berchem, Guy/C-9364-2014; van Meerbeeck, Jan/ABA-5109-2020; De Greve, Jacques/J-4939-2012; Vansteenkiste, Johan F/B-8191-2014	Berchem, Guy/0000-0003-0157-2257; De Greve, Jacques/0000-0002-2389-0742; Vansteenkiste, Johan F/0000-0002-6721-2775; van Meerbeeck, Jan/0000-0001-7872-8622; Geers, Caroline/0000-0002-9389-8803; Decoster, Lore/0000-0001-7563-0179; Vuylsteke, Peter/0000-0001-6401-3722; Teugels, Erik/0000-0002-7828-4555	Stichting Tegen Kanker STK; Wetenschappelijk Fonds Willy Gepts UZ Brussel; Cancer plan 19 Grant [29-039]; Roche Belgium	Stichting Tegen Kanker STK; Wetenschappelijk Fonds Willy Gepts UZ Brussel; Cancer plan 19 Grant; Roche Belgium(Roche Holding)	This work was supported by the following sources of funding: Stichting Tegen Kanker STK (JDG); Wetenschappelijk Fonds Willy Gepts UZ Brussel (JDG); Cancer plan 19 Grant 29-039 (JDG); and Roche Belgium (JDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunn PA, 2002, J CLIN ONCOL, V20, P3565, DOI 10.1200/JCO.2002.20.17.3565; Cortot AB, 2014, EUR RESPIR REV, V23, P356, DOI 10.1183/09059180.00004614; Ding D, 2014, ONCOTARGETS THER, V7, P387, DOI 10.2147/OTT.S58870; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Janne PA, 2006, CLIN CANCER RES, V12, p4416S, DOI 10.1158/1078-0432.CCR-06-0555; Karachaliou N, 2015, JAMA ONCOL, V1, P149, DOI 10.1001/jamaoncol.2014.257; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Oizumi S, 2012, ONCOLOGIST, V17, P863, DOI 10.1634/theoncologist.2011-0426; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shahi RB, 2015, APPL IMMUNOHISTO M M, V23, P163, DOI 10.1097/PDM.0000000000000035; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Smit EF, 2003, J CLIN ONCOL, V21, P3909, DOI 10.1200/JCO.2003.03.195; Takeda M, 2010, J THORAC ONCOL, V5, P399, DOI 10.1097/JTO.0b013e3181cee47e; Tateishi K, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0450-2; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Wu JY, 2008, CLIN CANCER RES, V14, P4877, DOI 10.1158/1078-0432.CCR-07-5123; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yasuda H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007205; Yasuda H, 2012, LANCET ONCOL, V13, pE23, DOI 10.1016/S1470-2045(11)70129-2; Zhou C, 2015, ANN ONCOL, V26, P1877, DOI 10.1093/annonc/mdv276; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0147599	10.1371/journal.pone.0147599	http://dx.doi.org/10.1371/journal.pone.0147599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032107	Green Published, gold			2022-12-27	WOS:000373121800001
J	Sedova, L; Pravenec, M; Krenova, D; Kazdova, L; Zidek, V; Krupkova, M; Liska, F; Kren, V; Seda, O				Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Kazdova, Ludmila; Zidek, Vyclav; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej			Isolation of a Genomic Region Affecting Most Components of Metabolic Syndrome in a Chromosome-16 Congenic Rat Model	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BLOOD-PRESSURE; GENETIC-DETERMINANTS; GLUCOSE-TOLERANCE; HYPERTENSIVE-RAT; STRAINS; REVEALS; IDENTIFICATION; MECHANISMS; PHENOTYPES	Metabolic syndrome is a highly prevalent human disease with substantial genomic and environmental components. Previous studies indicate the presence of significant genetic determinants of several features of metabolic syndrome on rat chromosome 16 (RNO16) and the syntenic regions of human genome. We derived the SHR. BN16 congenic strain by introgression of a limited RNO16 region from the Brown Norway congenic strain (BN-Lx) into the genomic background of the spontaneously hypertensive rat (SHR) strain. We compared the morphometric, metabolic, and hemodynamic profiles of adult male SHR and SHR. BN16 rats. We also compared in silico the DNA sequences for the differential segment in the BN-Lx and SHR parental strains. SHR. BN16 congenic rats had significantly lower weight, decreased concentrations of total triglycerides and cholesterol, and improved glucose tolerance compared with SHR rats. The concentrations of insulin, free fatty acids, and adiponectin were comparable between the two strains. SHR. BN16 rats had significantly lower systolic (18-28 mmHg difference) and diastolic (10-15 mmHg difference) blood pressure throughout the experiment (repeated-measures ANOVA, P < 0.001). The differential segment spans approximately 22 Mb of the telomeric part of the short arm of RNO16. The in silico analyses revealed over 1200 DNA variants between the BN-Lx and SHR genomes in the SHR. BN16 differential segment, 44 of which lead to missense mutations, and only eight of which (in Asb14, Il17rd, Itih1, Syt15, Ercc6, RGD1564958, Tmem161a, and Gatad2a genes) are predicted to be damaging to the protein product. Furthermore, a number of genes within the RNO16 differential segment associated with metabolic syndrome components in human studies showed polymorphisms between SHR and BN-Lx (including Lpl, Nrg3, Pbx4, Cilp2, and Stab1). Our novel congenic rat model demonstrates that a limited genomic region on RNO16 in the SHR significantly affects many of the features of metabolic syndrome.	[Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Sedova, Lucie; Pravenec, Michal; Krenova, Drahomira; Krupkova, Michaela; Liska, Frantisek; Kren, Vladimir; Seda, Ondrej] Gen Teaching Hosp, Prague, Czech Republic; [Sedova, Lucie; Seda, Ondrej] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Pravenec, Michal; Zidek, Vyclav; Kren, Vladimir] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Kazdova, Ludmila] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM)	Seda, O (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Seda, O (corresponding author), Gen Teaching Hosp, Prague, Czech Republic.; Seda, O (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	oseda@lf1.cuni.cz	Liska, Frantisek/N-9192-2017; Pravenec, Michal/B-1666-2012; Krupkova, Michaela/L-2373-2017; Seda, Ondrej/A-2058-2008; Sedova, Lucie/D-1089-2017	Liska, Frantisek/0000-0002-9588-806X; Pravenec, Michal/0000-0001-9197-5871; Krupkova, Michaela/0000-0002-9371-2511; Seda, Ondrej/0000-0001-8498-5895; Sedova, Lucie/0000-0003-3783-2946	Ministry of Education, Youth and Sports of the Czech Republic [LK11217, LL1204]; Charles University in Prague [PRVOUK-P25/LF1/2, UNCE 204022]; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" [CZ.1.05/1.1.0/02.0109]; European Regional Development Fund; Czech Science Foundation [301/12/0696]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University"; European Regional Development Fund(European Commission); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Project LK11217 and LL1204 (within ERC CZ program) from the Ministry of Education, Youth and Sports of the Czech Republic; Charles University in Prague [PRVOUK-P25/LF1/2, UNCE 204022] and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.0/02.0109), from the European Regional Development Fund. MP was supported by grants 301/12/0696 from Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aneas I, 2009, PHYSIOL GENOMICS, V37, P52, DOI 10.1152/physiolgenomics.90299.2008; Baguhl R, 2009, OBESITY, V17, P1215, DOI 10.1038/oby.2008.658; Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Bonne ACM, 2002, ARTERIOSCL THROM VAS, V22, P2072, DOI 10.1161/01.ATV.0000040225.16592.CE; Bureau A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00248; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Fukuda M, 2003, BIOCHEM BIOPH RES CO, V306, P64, DOI 10.1016/S0006-291X(03)00911-2; Gesualdi NM, 2006, FREE RADICAL RES, V40, P467, DOI 10.1080/10715760600570547; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hoffman MJ, 2013, HYPERTENSION, V62, P557, DOI 10.1161/HYPERTENSIONAHA.113.01708; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P819, DOI 10.1152/physiolgenomics.00175.2011; Langley SR, 2013, CARDIOVASC RES, V97, P653, DOI 10.1093/cvr/cvs329; Mashimo T, 2007, PHYSIOL GENOMICS, V30, P95, DOI 10.1152/physiolgenomics.00211.2006; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Moujahidine M, 2004, HYPERTENS RES, V27, P203, DOI 10.1291/hypres.27.203; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 2010, METHODS MOL BIOL, V597, P415, DOI 10.1007/978-1-60327-389-3_28; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; SCHORK NJ, 1995, GENOME RES, V5, P164, DOI 10.1101/gr.5.2.164; Seda O, 2002, FOLIA BIOL-PRAGUE, V48, P81; Seda O, 2008, HYPERTENSION, V51, P1156, DOI 10.1161/HYPERTENSIONAHA.107.105247; Seda O, 2006, PHYSIOL GENOMICS, V27, P95, DOI 10.1152/physiolgenomics.00039.2006; Sedova L, 2012, HEREDITY, V109, P63, DOI 10.1038/hdy.2012.14; Sedova L, 2007, AM J PHYSIOL-ENDOC M, V292, pE1318, DOI 10.1152/ajpendo.00526.2006; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiura K, 1999, MAMM GENOME, V10, P1126, DOI 10.1007/s003359901177; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Ueno T, 2003, PHYSIOL RES, V52, P689; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Wang JK, 2015, CIRC-CARDIOVASC GENE, V8, P316, DOI 10.1161/CIRCGENETICS.114.000520; Ways JA, 2007, PHYSIOL GENOMICS, V29, P91, DOI 10.1152/physiolgenomics.00027.2006; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	38	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152708	10.1371/journal.pone.0152708	http://dx.doi.org/10.1371/journal.pone.0152708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031336	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800125
J	Singer, RH; Stoutenberg, M; Gellman, MD; Archer, E; Davis, SM; Gotman, N; Marquez, DX; Buelna, C; Deng, Y; Hosgood, HD; Zambrana, RE				Singer, Richard H.; Stoutenberg, Mark; Gellman, Marc D.; Archer, Edward; Davis, Sonia M.; Gotman, Nathan; Marquez, David X.; Buelna, Christina; Deng, Yu; Hosgood, H. Dean; Zambrana, Ruth E.			Occupational Physical Activity and Body Mass Index: Results from the Hispanic Community Health Study/Study of Latinos	PLOS ONE			English	Article							CANADIAN ADULTS; UNITED-STATES; SOCIAL-CLASS; US ADULTS; OBESITY; OVERWEIGHT; PREVALENCE; TIME; ASSOCIATIONS; TRENDS	Purpose To examine the associations between overweight/obesity and occupation among Hispanics/Latinos, the largest minority population in the U.S. Methods This study included 7,409 employed individuals in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a prospective study of Hispanic/Latino individuals aged 18-74 in four communities in the U.S. We independently examined the relationships between BMI, Occupational Activity (OA), and Total Hours Worked, quantified via self-reported hours worked per week and occupation-assigned Metabolic Equivalents (METs). Results More than three quarters of the participants were either overweight (39.3%) or obese (37.8%). Individuals with a primary occupation and those employed in a secondary occupation worked an average of 36.8 and 14.6 hrs/wk, respectively. The overall adjusted odds for being obese compared to normal weight were 3.2% (AOR = 1.03, 95% CI 1.01, 1.05) and 14.4% (AOR = 1.14 95% Cl 1.07, 1.23) greater for each 10 MET.hrs/wk unit of increased OA, and each 10-hrs/wk unit of Total Hours Worked, respectively. Conclusion This study presents the first findings on the association between OA with overweight/obesity among Hispanic/Latino individuals in the U.S. Increasing OA and Total Hours Worked per week were independently associated with increasing odds of overweight/obesity suggesting that the workplace is only one part of the overall energy expenditure dynamic. Our findings point to the need to emphasize engaging employed individuals in greater levels of PA outside of the work environment to impact overweight/obesity.	[Singer, Richard H.; Stoutenberg, Mark] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Singer, Richard H.] Nova SE Univ, Coll Dent Med, Ft Lauderdale, FL 33314 USA; [Gellman, Marc D.] Univ Miami, Dept Psychol, Miami, FL USA; [Archer, Edward] Univ Alabama Birmingham, Nutr Obes Res Ctr, Off Energet, Birmingham, AL USA; [Davis, Sonia M.; Gotman, Nathan; Deng, Yu] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Marquez, David X.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Buelna, Christina] San Diego State Univ, Grad Sch Publ Hlth, Inst Behav & Community Hlth, San Diego, CA 92182 USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Zambrana, Ruth E.] Univ Maryland, Dept Womens Studies, Consortium Race Gender & Ethn, College Pk, MD 20742 USA	University of Miami; Nova Southeastern University; University of Miami; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; California State University System; San Diego State University; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland College Park	Singer, RH (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.; Singer, RH (corresponding author), Nova SE Univ, Coll Dent Med, Ft Lauderdale, FL 33314 USA.	rsinger@med.miami.edu	Archer, Edward/J-9567-2017; Singer, D.M.D., M.S., Ph.D., Richard/AAE-8195-2022; Zambrana, Ruth Enid/ABD-5509-2020	Archer, Edward/0000-0002-9339-6918; Singer, D.M.D., M.S., Ph.D., Richard/0000-0002-1754-7438; Thomas, Sonia/0000-0003-1362-5627	NCATS NIH HHS [KL2 TR000461] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000461] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ali SM, 2006, EUR J PUBLIC HEALTH, V16, P324, DOI 10.1093/eurpub/cki187; Allman-Farinelli MA, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-14; Archer E, 2013, MAYO CLIN PROC, V88, P1398, DOI 10.1016/j.mayocp.2013.08.019; Archer E, 2013, MAYO CLIN PROC, V88, P1368, DOI 10.1016/j.mayocp.2013.09.009; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056620; Barberio A, 2011, CAN J PUBLIC HEALTH, V102, P169, DOI 10.1007/BF03404888; Bonauto DK, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130219; Caban-Martinez AJ, 2007, PREV MED, V44, P432, DOI 10.1016/j.ypmed.2006.12.017; Centers for Disease Control and Prevention, 2010, 1988 2008 NO LEISURE; Centers for Disease Control and Prevention (CDC), 2009, DIFFERENCES IN PREVA; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Finkelstein EA, 2003, HLTH AFF MILLWOOD S; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Ham S. A., 2004, Morbidity and Mortality Weekly Report, V53, P82; Hasselbalch AL, 2010, INT J OBESITY, V34, P892, DOI 10.1038/ijo.2010.1; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Imai K, 2008, OBESITY, V16, P402, DOI 10.1038/oby.2007.70; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Jang TW, 2013, J OCCUP HEALTH, V55, P359, DOI 10.1539/joh.13-0043-OA; Jitnarin N, 2010, NUTRIENTS, V2, P60, DOI [10.3390/nu20100060, 10.3390/nu2010060]; Kaleta Dorota, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P9, DOI 10.2478/v10001-007-0009-1; King GA, 2001, INT J OBESITY, V25, P606, DOI 10.1038/sj.ijo.0801583; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; McLaren L, 2009, OBESITY, V17, P290, DOI 10.1038/oby.2008.539; National Cancer Institute U.S. NIH, 2013, USUAL DIETARY INTAKE; National Cancer Institute U.S. NIH, 2014, METABOLIC EQUIVALENT; National Heart Lung and Blood Institute, 2012, AIM FOR A HEALTHY WE; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panasiuk L, 2008, ANN AGR ENV MED, V15, P149; Patterson E., 2010, GUIDELINES FOR DATA; Physical Activity Guidelines Advisory Committee, 2008, PHYSICAL ACTIVITY GU; Proper KI, 2010, INT ARCH OCC ENV HEA, V83, P61, DOI 10.1007/s00420-009-0438-1; Martin AR, 2008, APPETITE, V51, P266, DOI 10.1016/j.appet.2008.02.021; Schoeller DA, 2013, AM J CLIN NUTR, V97, P1413, DOI 10.3945/ajcn.113.062125; Shao Q, 2011, NUTR RES PRACT, V5, P253, DOI 10.4162/nrp.2011.5.3.253; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Steeves JA, 2012, INT J OBESITY, V36, P100, DOI 10.1038/ijo.2011.50; Thomas DM, 2009, MATH BIOSCI ENG, V6, P873, DOI 10.3934/mbe.2009.6.873; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Trivedi T, 2015, RURAL REMOTE HEALTH, V15; Tudor-Locke C, 2011, J PHYS ACT HEALTH, V8, P581, DOI 10.1123/jpah.8.4.581; U.S. Bureau of Labor Statistics, 2014, LABOR FORCE STATISTI; US Department of Health and Human Services, 2014, HLTH PEOPL 2020; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	52	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152339	10.1371/journal.pone.0152339	http://dx.doi.org/10.1371/journal.pone.0152339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031996	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800060
J	Tedde, V; Rosini, R; Galeotti, CL				Tedde, Vittorio; Rosini, Roberto; Galeotti, Cesira L.			Zn2+ Uptake in Streptococcus pyogenes: Characterization of adcA and lmb Null Mutants	PLOS ONE			English	Article							HISTIDINE TRIAD PROTEIN; LAMININ-BINDING PROTEIN; ZINC HOMEOSTASIS; METAL HOMEOSTASIS; ACQUISITION; TRANSPORTERS; INTERFACE; VIRULENCE; ADHESION; AFFINITY	An effective regulation of metal ion homeostasis is essential for the growth of microorganisms in any environment and in pathogenic bacteria is strongly associated with their ability to invade and colonise their hosts. To gain a better insight into zinc acquisition in Group A Streptococcus (GAS) we characterized null deletion mutants of the adcA and lmb genes of Streptococcus pyogenes strain MGAS5005 encoding the orthologues of AdcA and AdcAII, the two surface lipoproteins with partly redundant roles in zinc homeostasis in Streptococcus pneumoniae. Null adcA and lmb mutants were analysed for their capability to grow in zinc-depleted conditions and were found to be more susceptible to zinc starvation, a phenotype that could be rescued by the addition of Zn2+ ions to the growth medium. Expression of AdcA, Lmb and HtpA, the polyhistidine triad protein encoded by the gene adjacent to lmb, during growth under conditions of limited zinc availability was examined by Western blot analysis in wild type and null mutant strains. In the wild type strain, AdcA was always present with little variation in expression levels between conditions of excess or limited zinc availability. In contrast, Lmb and HtpA were expressed at detectable levels only during growth in the presence of low zinc concentrations or in the null adcA mutant, when expression of lmb is required to compensate for the lack of adcA expression. In the latter case, Lmb and HtpA were overexpressed by several fold, thus indicating that also in GAS AdcA is a zinc-specific importer and, although it shares this function with Lmb, the two substrate-binding proteins do not show fully overlapping roles in zinc homeostasis.	[Tedde, Vittorio; Rosini, Roberto; Galeotti, Cesira L.] GlaxoSmithKline Vaccines Srl, Res Ctr, Siena, Italy; [Galeotti, Cesira L.] Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy; [Tedde, Vittorio] Porto Conte Ric, Alghero, SS, Italy	GlaxoSmithKline; University of Siena; Porto Conte Ricerche	Galeotti, CL (corresponding author), GlaxoSmithKline Vaccines Srl, Res Ctr, Siena, Italy.; Galeotti, CL (corresponding author), Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy.	cesira.galeotti@gmail.com		Tedde, Vittorio/0000-0001-8025-0437	GSK Vaccines S.r.l.	GSK Vaccines S.r.l.	This study was funded by GSK Vaccines S.r.l. The authors confirm that the GSK Vaccines S.r.l funder provided support in the form of salaries for authors VT RR CLG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Carroll RK, 2011, EPIDEMICS-NETH, V3, P159, DOI 10.1016/j.epidem.2011.07.001; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Elsner A, 2002, INFECT IMMUN, V70, P4859, DOI 10.1128/IAI.70.9.4859-4869.2002; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Galeotti CL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015206; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kimoto H, 2003, BIOSCI BIOTECH BIOCH, V67, P2203, DOI 10.1271/bbb.67.2203; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; LAKSHMIDEVI G, 1990, APPL ENVIRON MICROB, V56, P934, DOI 10.1128/AEM.56.4.934-942.1990; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Lo Sapio M, 2012, J BIOTECHNOL, V157, P279, DOI 10.1016/j.jbiotec.2011.11.011; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Loisel E, 2011, BIOCHEMISTRY-US, V50, P3551, DOI 10.1021/bi200012f; Ong CLY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10799; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Plumptre CD, 2014, INFECT IMMUN, V82, P4315, DOI 10.1128/IAI.02155-14; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Shao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060116; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Terao Y, 2002, INFECT IMMUN, V70, P993; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	39	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152835	10.1371/journal.pone.0152835	http://dx.doi.org/10.1371/journal.pone.0152835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031880	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800149
J	Zheng, GA; Li, YX; Takayama, T; Nishida, T; Sudo, M; Haruta, H; Fukamachi, D; Okubo, K; Higuchi, Y; Hiro, T; Saito, S; Hirayama, A				Zheng, Guian; Li, Yuxin; Takayama, Tadateru; Nishida, Toshihiko; Sudo, Mitsumasa; Haruta, Hironori; Fukamachi, Daisuke; Okubo, Kimie; Higuchi, Yoshiharu; Hiro, Takafumi; Saito, Satoshi; Hirayama, Atsushi			The Spatial Distribution of Plaque Vulnerabilities in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ACUTE CORONARY SYNDROMES; INTRAVASCULAR ULTRASOUND ASSESSMENT; OCCLUDED CULPRIT ARTERIES; THIN-CAP FIBROATHEROMA; LONG-TERM MORTALITY; ST-ELEVATION; TASK-FORCE; RUPTURE; LESION	Objective Although the plaque characteristics have been recognized in patients with acute myocardial infarction (AMI), the plaque spatial distribution is not well clarified. Using color-mapping intravascular ultrasound (iMAP-IVUS), we examined culprit lesions to clarify plaque morphology, composition and spatial distribution of the sites of potential vulnerability. Methods Sixty-eight culprit lesions in 64 consecutive AMI patients who underwent angiography and IVUS examinations before intervention were analyzed. Plaque morphology and composition were quantified with iMAP-IVUS. The spatial distribution of the sites of potential vulnerability was assessed with longitudinal reconstruction of the consecutive IVUS images. The plaque characteristics were also compared between ruptured and non-ruptured lesions, and between totally occlusive (TO) and non-TO lesions. Results The sites with maximum necrotic area (maxNA), maximum plaque burden (maxPB) and most severely narrowed (minimal luminal area, MLA) were recognized vulnerability. In the majority of cases, maxNA sites were proximal to the maxPB sites, and MLA sites were distal to the maxNA and maxPB sites. Ruptures usually occurred close to maxNA sites and proximal to maxPB and MLA sites. The average distance from the site of rupture to the maxNA site was 0.33 +/- 4.04 mm. Ruptured lesions showed significant vessel remodeling, greater plaque volume, and greater lipidic volume compared to those of non-ruptured lesions. Both the length and plaque burden (PB) of TO lesions were greater than those of non-TO lesions. Conclusions Instead of overlapping on maxPB sites, most maxNA sites are proximal to the maxPB sites and are the sites most likely to rupture. Plaque morphology and composition play critical roles in plaque rupture and coronary occlusion.	[Zheng, Guian; Li, Yuxin; Takayama, Tadateru; Hiro, Takafumi; Saito, Satoshi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Adv Cardiovasc Imaging, Tokyo 1738610, Japan; [Zheng, Guian] Fujian Med Univ, Zhangzhou Hosp, Dept Cardiol, Zhangzhou 363000, Fujian, Peoples R China; [Takayama, Tadateru; Nishida, Toshihiko; Sudo, Mitsumasa; Haruta, Hironori; Fukamachi, Daisuke; Okubo, Kimie; Higuchi, Yoshiharu; Hiro, Takafumi; Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1738610, Japan	Nihon University; Fujian Medical University; Nihon University	Li, YX (corresponding author), Nihon Univ, Sch Med, Dept Adv Cardiovasc Imaging, Tokyo 1738610, Japan.	li.yuxin@nihon-u.ac.jp	Li, yuxin/GSD-1668-2022; Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022					Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Bahrmann P, 2011, CLIN RES CARDIOL, V100, P457, DOI 10.1007/s00392-010-0269-9; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; de Graaf MA, 2013, HEART VESSELS, V28, P166, DOI 10.1007/s00380-012-0236-7; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fishbein MC, 2010, CARDIOVASC PATHOL, V19, P6, DOI 10.1016/j.carpath.2008.08.004; Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7; Heo JH, 2014, CATHETER CARDIO INTE, V83, pE233, DOI 10.1002/ccd.23335; Kaple RK, 2009, ULTRASOUND MED BIOL, V35, P550, DOI 10.1016/j.ultrasmedbio.2008.09.024; Kim MC, 2012, INT HEART J, V53, P160, DOI 10.1536/ihj.53.160; Kim SW, 2012, AM J CARDIOL, V109, P794, DOI 10.1016/j.amjcard.2011.10.042; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Kusama I, 2012, HEART VESSELS, V27, P541, DOI 10.1007/s00380-011-0184-7; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Legutko J, 2013, AM J CARDIOL, V112, P1854, DOI 10.1016/j.amjcard.2013.08.011; Li ZY, 2008, J AM COLL CARDIOL, V52, P499, DOI 10.1016/j.jacc.2008.04.040; Li ZY, 2006, STROKE, V37, P1195, DOI 10.1161/01.STR.0000217331.61083.3b; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Ouldzein H, 2012, ANN CARDIOL ANGEIOL, V61, P20, DOI 10.1016/j.ancard.2011.07.011; Piccolo R, 2014, AM J CARDIOL, V114, P1145, DOI 10.1016/j.amjcard.2014.07.030; Plutzky J, 1999, AM J CARDIOL, V84, p15J; Pride YB, 2010, JACC-CARDIOVASC INTE, V3, P806, DOI 10.1016/j.jcin.2010.05.012; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shin DI, 2014, J INTERV CARDIOL, V27, P12, DOI 10.1111/joic.12078; Shin ES, 2011, EUROINTERVENTION, V6, P1017, DOI 10.4244/EIJV6I8A175; Speelman L, 2011, J BIOMECH, V44, P2376, DOI 10.1016/j.jbiomech.2011.07.004; Takumi T, 2007, J AM COLL CARDIOL, V50, P2197, DOI 10.1016/j.jacc.2007.07.079; Tanaka A, 2008, CIRC J, V72, P1276, DOI 10.1253/circj.72.1276; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Tian JW, 2014, J AM COLL CARDIOL, V63, P2209, DOI 10.1016/j.jacc.2014.01.061; Topaz O, 2001, AM J CARDIOL, V87, P849, DOI 10.1016/S0002-9149(00)01525-3; Toutouzas K, 2012, EUROINTERVENTION, V8, P477, DOI 10.4244/EIJV8I4A75; Toutouzas K, 2011, AM HEART J, V161, P1192, DOI 10.1016/j.ahj.2011.03.005; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; van Leeuwen MAH, 2013, INT J CARDIOL, V167, P2082, DOI 10.1016/j.ijcard.2012.05.064; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; von Birgelen C, 2001, J AM COLL CARDIOL, V37, P1864, DOI 10.1016/S0735-1097(01)01234-7; Wang TY, 2009, AM HEART J, V157, P716, DOI 10.1016/j.ahj.2009.01.004; Wykrzykowska JJ, 2012, JACC-CARDIOVASC IMAG, V5, pS10, DOI 10.1016/j.jcmg.2012.01.006; Xie Y, 2014, JACC-CARDIOVASC IMAG, V7, P397, DOI 10.1016/j.jcmg.2013.10.010; Yamada R, 2013, J CARDIOL, V61, P149, DOI 10.1016/j.jjcc.2012.10.008	48	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152825	10.1371/journal.pone.0152825	http://dx.doi.org/10.1371/journal.pone.0152825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031514	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800146
J	Li, L; Xu, JY; Xiao, WD; Ge, B				Li, Le; Xu, Junyi; Xiao, Weidong; Ge, Bin			Behavior Based Social Dimensions Extraction for Multi-Label Classification	PLOS ONE			English	Article								Classification based on social dimensions is commonly used to handle the multi-label classification task in heterogeneous networks. However, traditional methods, which mostly rely on the community detection algorithms to extract the latent social dimensions, produce unsatisfactory performance when community detection algorithms fail. In this paper, we propose a novel behavior based social dimensions extraction method to improve the classification performance in multi-label heterogeneous networks. In our method, nodes' behavior features, instead of community memberships, are used to extract social dimensions. By introducing Latent Dirichlet Allocation (LDA) to model the network generation process, nodes' connection behaviors with different communities can be extracted accurately, which are applied as latent social dimensions for classification. Experiments on various public datasets reveal that the proposed method can obtain satisfactory classification results in comparison to other state-of-the-art methods on smaller social dimensions.	[Li, Le; Xu, Junyi; Xiao, Weidong; Ge, Bin] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Xu, JY (corresponding author), Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China.	xujunyi0923@163.com			National Natural Science Foundation of China [71331008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 71331008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gallagher B., 2008, P 14 ACM SIGKDD INT, P256, DOI DOI 10.1145/1401890.1401925; Heinrich G., 2005, PARAMETER ESTIMATION; Henderson K, P 2009 ACM S APPL CO, P1456; Kong X, P 21 ACM INT C INF K, P1567; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lin F, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P192, DOI 10.1109/ASONAM.2010.19; Macskassy S.A., 2003, SIMPLE RELATIONAL CL; Macskassy S. A., 2005, INT C INT AN; Macskassy SA, 2007, J MACH LEARN RES, V8, P935; Neville J., 2005, P 11 ACM SIGKDD INT, P449, DOI DOI 10.1145/1081870.1081922; Neville J, P 4 INT WORKSH MULT, P49; Neville J., 2003, P 2 INT WORKSH MULT, P77; Perozzi Bryan, 2014, P 20 ACM SIGKDD INT, P701; Steyvers M, 2007, HDB LATENT SEMANTIC; Tang L., 2009, P 18 ACM C INFORM KN, P1107; Tang L, 2011, DATA MIN KNOWL DISC, V23, P447, DOI 10.1007/s10618-010-0210-x; Tang L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P817; Taskar B., 2001, P INT JOINT C ART IN, V17, P870; TASKAR B., 2002, P 18 C UNC ART INT, P485; Xu Z, KDD 2008 WORKSH SOC; Zhang H, INTELLIGENCE SECURIT, P200; Zhang QM, 2010, INT J MOD PHYS C, V21, P813, DOI 10.1142/S012918311001549X	27	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152857	10.1371/journal.pone.0152857	http://dx.doi.org/10.1371/journal.pone.0152857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049849	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500062
J	Wen, J; Yan, M; Liu, Y; Li, J; Xie, YM; Lu, YF; Kamata, M; Chen, ISY				Wen, Jing; Yan, Ming; Liu, Yang; Li, Jie; Xie, Yiming; Lu, Yunfeng; Kamata, Masakazu; Chen, Irvin S. Y.			Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; PROTON SPONGE; RICIN; INFECTION; IMMUNOTOXINS; PERSISTENCE; CHAIN; COMBINATION; RESERVOIRS	Anti-retroviral drugs suppress HIV-1 plasma viremia to undetectable levels; however, latent HIV-1 persists in reservoirs within HIV-1-infected patients. The silent provirus can be activated through the use of drugs, including protein kinase C activators and histone deacetylase inhibitors. This "shock" approach is then followed by "kill" of the producing cells either through direct HIV-1-induced cell death or natural immune mechanisms. However, these mechanisms are relatively slow and effectiveness is unclear. Here, we develop an approach to specifically target and kill cells that are activated early in the process of virus production. We utilize a novel nanocapsule technology whereby the ricin A chain is encapsulated in an inactive form within a polymer shell. Specificity for release of the ricin A toxin is conferred by peptide crosslinkers that are sensitive to cleavage by HIV-1 protease. By using well-established latent infection models, J-Lat and U1 cells, we demonstrate that only within an HIV-1-producing cell expressing functional HIV-1 protease will the nanocapsule release its ricin A cargo, shutting down viral and cellular protein synthesis, and ultimately leading to rapid death of the producer cell. Thus, we provide proof of principle for a novel technology to kill HIV-1-producing cells without effects on non-target cells.	[Wen, Jing; Yan, Ming; Xie, Yiming; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kamata, Masakazu] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Liu, Yang; Li, Jie; Lu, Yunfeng] Univ Calif Los Angeles, Dept Biomol & Chem Engn, Los Angeles, CA USA; [Lu, Yunfeng] Univ Calif Los Angeles, CNSI, Los Angeles, CA USA; [Chen, Irvin S. Y.] UCLA AIDS Inst, Los Angeles, CA USA; [Yan, Ming] Calimmune Inc, Pasadena, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Kamata, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.; Chen, ISY (corresponding author), UCLA AIDS Inst, Los Angeles, CA USA.	masa3k@ucla.edu; syuchen@mednet.ucla.edu	Liu, Yang/AAY-7115-2020; Wen, Jing/F-1949-2019; KAMATA, MASAKAZU/E-7550-2017; Li, Jie/I-5695-2015	Liu, Yang/0000-0001-5752-5180; Wen, Jing/0000-0002-6127-6276; Li, Jie/0000-0003-0189-2787; Kamata, Masakazu/0000-0003-0323-3742	U.S. National Institutes of Health (NIH) R21 grant [AI114433]; NIH [AI028697]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114433, P30AI028697] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) R21 grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) R21 grant (AI114433 to ISYC). p24 ELISA was performed in the CFAR Virology core laboratory supported by NIH grant (AI028697). MACSQuant Flow Cytometer and a part of Fortessa Cytometry system were supported by James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Behr JP, 1997, CHIMIA, V51, P34; Berger EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000803; BLAKEY DC, 1986, CANC DRUG DEL, V3, P189, DOI 10.1089/cdd.1986.3.189; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; CUSHLEY W, 1984, TOXICON, V22, P265, DOI 10.1016/0041-0101(84)90027-8; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; DAVEY RT, 1994, J INFECT DIS, V170, P1180, DOI 10.1093/infdis/170.5.1180; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; El-Nikhely N, 2007, PROTEIN J, V26, P481, DOI 10.1007/s10930-007-9088-x; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Gu Z, 2009, NANO LETT, V9, P4533, DOI 10.1021/nl902935b; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; JIMENEZ A, 1985, ANNU REV MICROBIOL, V39, P649, DOI 10.1146/annurev.mi.39.100185.003245; Johansson S, 2006, AIDS, V20, P1911, DOI 10.1097/01.aids.0000247111.58961.60; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kennedy PE, 2006, J LEUKOCYTE BIOL, V80, P1175, DOI 10.1189/jlb.0306139; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Liang M, 2010, J GENE MED, V12, P255, DOI 10.1002/jgm.1440; Liu CY, 2015, ADV MATER, V27, P292, DOI 10.1002/adma.201403387; Martins LJ, 2015, AIDS RES HUM RETROVI; Nagata S, 2001, Tanpakushitsu Kakusan Koso, V46, P540; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Olesen R, 2015, J VIROL; OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028; Pache L, 2015, CELL HOST MICROBE, V18, P345, DOI 10.1016/j.chom.2015.08.009; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Pincus SH, 1996, ANTIVIR RES, V33, P1, DOI 10.1016/S0166-3542(96)00995-3; RAMACHANDRAN RV, 1994, J INFECT DIS, V170, P1009, DOI 10.1093/infdis/170.4.1009; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Sigal A, 2012, CELL HOST MICROBE, V12, P132, DOI 10.1016/j.chom.2012.07.005; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Thrush GR, 1996, ANNU REV IMMUNOL, V14, P49, DOI 10.1146/annurev.immunol.14.1.49; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; UCKUN FM, 1989, BLOOD, V74, P2445; VALLERA DA, 1983, SCIENCE, V222, P512, DOI 10.1126/science.6353579; VANOOSTERHOUT YVJM, 1992, CANCER RES, V52, P5921; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; WELLNER RB, 1995, J TOXICOL-TOXIN REV, V14, P483, DOI 10.3109/15569549509016439; Wen J, 2011, ADV MATER, V23, P4549, DOI 10.1002/adma.201101771; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yan M, 2006, J AM CHEM SOC, V128, P11008, DOI 10.1021/ja064126t; Yan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127986; Yan M, 2012, J AM CHEM SOC, V134, P13542, DOI 10.1021/ja304649a; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Zhang P, 2015, P NATL ACAD SCI USA, V112, P12046, DOI 10.1073/pnas.1512465112	73	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151572	10.1371/journal.pone.0151572	http://dx.doi.org/10.1371/journal.pone.0151572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049645	Green Published, gold			2022-12-27	WOS:000373603500009
J	Rutjens, BT; Heine, SJ				Rutjens, Bastiaan T.; Heine, Steven J.			The Immoral Landscape? Scientists Are Associated with Violations of Morality	PLOS ONE			English	Article							MECHANICAL TURK; SCIENCE; DISTRUST; RELIGION; BELIEFS	Do people think that scientists are bad people? Although surveys find that science is a highly respected profession, a growing discourse has emerged regarding how science is often judged negatively. We report ten studies (N = 2328) that investigated morality judgments of scientists and compared those with judgments of various control groups, including atheists. A persistent intuitive association between scientists and disturbing immoral conduct emerged for violations of the binding moral foundations, particularly when this pertained to violations of purity. However, there was no association in the context of the individualizing moral foundations related to fairness and care. Other evidence found that scientists were perceived as similar to others in their concerns with the individualizing moral foundations of fairness and care, yet as departing for all of the binding foundations of loyalty, authority, and purity. Furthermore, participants stereotyped scientists particularly as robot-like and lacking emotions, as well as valuing knowledge over morality and being potentially dangerous. The observed intuitive immorality associations are partially due to these explicit stereotypes but do not correlate with any perceived atheism. We conclude that scientists are perceived not as inherently immoral, but as capable of immoral conduct.	[Rutjens, Bastiaan T.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Heine, Steven J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of Amsterdam; University of British Columbia	Rutjens, BT (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	b.t.rutjens@uva.nl			AXA Research Grant; AXA Research Fund (ARF) Fellowship grant	AXA Research Grant(AXA Research Fund); AXA Research Fund (ARF) Fellowship grant(AXA Research Fund)	This research was funded by an AXA Research Grant awarded to BT Rutjens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The writing of this paper was supported by an AXA Research Fund (ARF) Fellowship grant to B.T. Rutjens. The authors wish to thank Romy van der Lee for her valuable input.	Baumard N, 2013, TRENDS COGN SCI, V17, P272, DOI 10.1016/j.tics.2013.04.003; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Blancke S, 2011, SCI ED, V21, P1167; Brossard D, 2009, PUBLIC UNDERST SCI, V18, P546, DOI 10.1177/0963662507087304; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Clobert M, 2015, ARCH PSYCHOL RELIG, V37, P185, DOI 10.1163/15736121-12341302; Dawkins R., 2006, GOD DELUSION; De Waal F., 2013, BONOBO ATHEIST SEARC; Dennett DC, 2006, BREAKING THE SPELL; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Farias M, 2013, OXFORD HDB ATHEISM, P468; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13593, DOI 10.1073/pnas.1317505111; Frayling C, 2005, MAD BAD AND DANGEROU; Gervais WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092302; Gervais WM, 2011, J PERS SOC PSYCHOL, V101, P1189, DOI 10.1037/a0025882; Gleick PH, 2010, SCIENCE, V328, P689, DOI 10.1126/science.328.5979.689; Graham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050092; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray John, 2004, HERESIES PROGR OTHER; Gross N, 2007, WORKING PAPER; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt J, 2000, MORAL DUMBFOUN UNPUB; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Harris S, 2010, MORAL LANDSCAPE SCI; Kelemen D, 2013, J EXP PSYCHOL GEN, V142, P1074, DOI 10.1037/a0030399; Levelt WJM, 2012, FLAWED SCI FRAUDULEN; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Ma-Kellams C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057989; McKay R, 2014, PSYCHOL B; Mooijman M, 2014, COGNITION EMOTION, P1; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norenzayan A, 2014, BEHAVIOUR, V151, P365, DOI 10.1163/1568539X-00003139; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Osborne J, 2003, INT J SCI EDUC, V25, P1049, DOI 10.1080/0950069032000032199; Pew Research Center, 2015, ATT BEL SCI TECHN TO; Pew Research Global Attitudes Project, 2014, VIEWS REL MOR; Pittinsky TL, 2015, SCIENCE, V348, P511, DOI 10.1126/science.348.6234.511-a; Preston J, 2009, J EXP SOC PSYCHOL, V45, P238, DOI 10.1016/j.jesp.2008.07.013; Reay D, 2014, NATURE NEWS BLO 0608; Rutjens BT, 2016, INT J PSYCHOL RELIG, V26, P1, DOI 10.1080/10508619.2014.990345; Rutjens BT, 2013, CURR DIR PSYCHOL SCI, V22, P250, DOI 10.1177/0963721412469810; Schiermeier Q, 2012, ARSENIC LOVING BACTE; Shariff AF, 2016, PERS SOC PSYCHOL REV, V20, P27, DOI 10.1177/1088868314568811; Shermer M, 2015, THE MORAL ARC; The Harris Poll, 2014, DOCT MIL OFF FIR SCI; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293	49	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152798	10.1371/journal.pone.0152798	http://dx.doi.org/10.1371/journal.pone.0152798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045849	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600034
J	Senarathna, SMDKG; Page-Sharp, M; Crowe, A				Senarathna, S. M. D. K. Ganga; Page-Sharp, Madhu; Crowe, Andrew			The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation	PLOS ONE			English	Article							NEW-GUINEAN CHILDREN; IN-VITRO; METHYLENE-BLUE; CELL-CULTURE; CACO-2; ARTEMISININ; ARTESUNATE; AMODIAQUINE; PHARMACOKINETICS; COMBINATION	The combination of passive drug permeability, affinity for uptake and efflux transporters as well as gastrointestinal metabolism defines net drug absorption. Efflux mechanisms are often overlooked when examining the absorption phase of drug bioavailability. Knowing the affinity of antimalarials for efflux transporters such as P-glycoprotein (P-gp) may assist in the determination of drug absorption and pharmacokinetic drug interactions during oral absorption in drug combination therapies. Concurrent administration of P-gp inhibitors and P-gp substrate drugs may also result in alterations in the bioavailability of some antimalarials. In-vitro Caco-2 cell monolayers were used here as a model for potential drug absorption related problems and P-gp mediated transport of drugs. Artemisone had the highest permeability at around 50 x 10(-6) cm/sec, followed by amodiaquine around 20 x 10(-6) cm/sec; both mefloquine and artesunate were around 10 x 10(-6) cm/sec. Methylene blue was between 2 and 6 x 10(-6) cm/sec depending on the direction of transport. This 3 fold difference was able to be halved by use of P-gp inhibition. MRP inhibition also assisted the consolidation of the methylene blue transport. Mefloquine was shown to be a P-gp inhibitor affecting our P-gp substrate, Rhodamine 123, although none of the other drugs impacted upon rhodamine123 transport rates. In conclusion, mefloquine is a P-gp inhibitor and methylene blue is a partial substrate; methylene blue may have increased absorption if co-administered with such Pgp inhibitors. An upregulation of P-gp was observed when artemisone and dihydroartemisinin were co-incubated with mefloquine and amodiaquine.	[Senarathna, S. M. D. K. Ganga; Page-Sharp, Madhu; Crowe, Andrew] Curtin Univ, Sch Pharm, Perth, WA 6102, Australia; [Senarathna, S. M. D. K. Ganga; Crowe, Andrew] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia	Curtin University; Curtin University	Crowe, A (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6102, Australia.; Crowe, A (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.	a.p.crowe@curtin.edu.au			Curtin Strategic International Research Scholarship	Curtin Strategic International Research Scholarship	This project was funded internally from PhD funds awarded to the school to maintain the PhD student's project. S M D K Ganga Senarathna was a recipient of Curtin Strategic International Research Scholarship.; We are thankful to the supervisory support of Dr. Kevin Batty, School of Pharmacy, Curtin University. S MD K Ganga Senarathna was a recipient of Curtin Strategic International Research Scholarship.	ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Augustijns P, 1996, J PHARM SCI, V85, P577, DOI 10.1021/js960001i; Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7; Bailey CA, 1996, ADV DRUG DELIVER REV, V22, P85, DOI 10.1016/S0169-409X(96)00416-4; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Batty KT, 1996, J PHARM PHARMACOL, V48, P22, DOI 10.1111/j.2042-7158.1996.tb05870.x; BOUDREAU EF, 1982, LANCET, V2, P1335; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; Creek DJ, 2013, J INFECT DIS, V207, P1646, DOI 10.1093/infdis/jit078; Crivori P, 2006, MOL PHARMACEUT, V3, P33, DOI 10.1021/mp050071a; Crowe A, 2004, DRUG DEV IND PHARM, V30, P449, DOI 10.1081/DDC-120037471; Crowe A, 1998, PHARMACEUT RES, V15, P1666, DOI 10.1023/A:1011940108365; Crowe A, 2006, J DRUG TARGET, V14, P291, DOI 10.1080/10611860600720814; Crowe A, 2012, TOXICOL APPL PHARM, V260, P294, DOI 10.1016/j.taap.2012.03.008; Davis TME, 2007, ANTIMICROB AGENTS CH, V51, P1099, DOI 10.1128/AAC.01253-06; Debrus B, 2011, J CHROMATOGR A, V1218, P5205, DOI 10.1016/j.chroma.2011.05.102; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; European Medicines Agency, 2014, ASS REP METH CHLOR P; Gasasira AF., 2010, THESIS UC BERKELEY; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; GUSTAFSSON LL, 1983, BRIT J CLIN PHARMACO, V15, P471, DOI 10.1111/j.1365-2125.1983.tb01532.x; Hayeshi R, 2006, EUR J PHARM SCI, V29, P70, DOI 10.1016/j.ejps.2006.05.009; Haynes RK, 2006, ANGEW CHEM, V118, P2136, DOI DOI 10.1002/ange.200503071; Hosoya K, 1996, PHARMACEUT RES, V13, P885, DOI 10.1023/A:1016005212640; Impert O, 2003, DALTON T, P348, DOI 10.1039/b205786g; KARBWANG J, 1994, B WORLD HEALTH ORGAN, V72, P83; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Lan LB, 1996, CANCER CHEMOTH PHARM, V38, P181, DOI 10.1007/s002800050468; Lennernas H, 1996, INT J PHARM, V127, P103, DOI 10.1016/0378-5173(95)04204-0; Lin JH, 2003, ADV DRUG DELIVER REV, V55, P53, DOI 10.1016/S0169-409X(02)00171-0; Manning L, 2011, ANTIMICROB AGENTS CH, V55, P5027, DOI 10.1128/AAC.00375-11; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nair A, 2012, J PHARM SCI-US, V101, P4390, DOI 10.1002/jps.23312; Nontprasert A, 1998, AM J TROP MED HYG, V59, P519, DOI 10.4269/ajtmh.1998.59.519; Oga EF, 2012, AM J TROP MED HYG, V87, P64, DOI 10.4269/ajtmh.2012.11-0817; Osterberg T, 2000, EUR J PHARM SCI, V10, P295, DOI 10.1016/S0928-0987(00)00077-4; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Peters W, 1975, HDB ANIMAL MODELS IN; Pham YT, 2000, BBA-GEN SUBJECTS, V1524, P212, DOI 10.1016/S0304-4165(00)00160-4; PUSSARD E, 1986, J CHROMATOGR, V374, P111, DOI 10.1016/S0378-4347(00)83258-2; Reungpatthanaphong P, 2002, BIOL PHARM BULL, V25, P1555, DOI 10.1248/bpb.25.1555; Riffkin CD, 1996, BIOCHEM PHARMACOL, V52, P1545, DOI 10.1016/S0006-2952(96)00556-4; Salman S, 2012, ANTIMICROB AGENTS CH, V56, P3288, DOI 10.1128/AAC.06232-11; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Scholtz JC, 2010, THESIS N W U POTCHEF; Senarathna SMDKG, 2015, PHARMAZIE, V70, P798, DOI 10.1691/ph.2015.5106; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; WHO, 2010, GUID TREATM MAL, V2nd; WILS P, 1994, CELL BIOL TOXICOL, V10, P393, DOI 10.1007/BF00755788; WINSTANLEY P, 1987, BRIT J CLIN PHARMACO, V23, P1	57	21	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152677	10.1371/journal.pone.0152677	http://dx.doi.org/10.1371/journal.pone.0152677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045516	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600030
J	Trost, B; Kusalik, A; Napper, S				Trost, Brett; Kusalik, Anthony; Napper, Scott			Computational Analysis of the Predicted Evolutionary Conservation of Human Phosphorylation Sites	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; DATABASE; KINASES; INFORMATION; RESOURCES; HOMOLOGY; COMPLEX; KINOME; GENOME; MOUSE	Protein kinase-mediated phosphorylation is among the most important post-translational modifications. However, few phosphorylation sites have been experimentally identified for most species, making it difficult to determine the degree to which phosphorylation sites are conserved. The goal of this study was to use computational methods to characterize the conservation of human phosphorylation sites in a wide variety of eukaryotes. Using experimentally-determined human sites as input, homologous phosphorylation sites were predicted in all 432 eukaryotes for which complete proteomes were available. For each pair of species, we calculated phosphorylation site conservation as the number of phosphorylation sites found in both species divided by the number found in at least one of the two species. A clustering of the species based on this conservation measure was concordant with phylogenies based on traditional genomic measures. For a subset of the 432 species, phosphorylation site conservation was compared to conservation of both protein kinases and proteins in general. Protein kinases exhibited the highest degree of conservation, while general proteins were less conserved and phosphorylation sites were least conserved. Although preliminary, these data tentatively suggest that variation in phosphorylation sites may play a larger role in explaining phenotypic differences among organisms than differences in the complements of protein kinases or general proteins.	[Trost, Brett; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada; [Trost, Brett; Napper, Scott] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Napper, Scott] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Trost, B (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK S7N 0W0, Canada.; Trost, B (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	brett.trost@usask.ca	Trost, Brett/K-4127-2016	Trost, Brett/0000-0003-4863-7273	Genome Canada	Genome Canada(Genome Canada)	Funding was provided by Genome Canada (http://www.genomecanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by Genome Canada.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dou YC, 2014, AMINO ACIDS, V46, P1459, DOI 10.1007/s00726-014-1711-5; Freschi L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004062; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Malik R, 2008, BIOINFORMATICS, V24, P1426, DOI 10.1093/bioinformatics/btn197; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Nakedi KC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00237; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Trost B, 2015, BRIEF BIOINFORM, V16, P820, DOI 10.1093/bib/bbu040; Trost B, 2013, BIOINFORMATICS, V29, P1693, DOI 10.1093/bioinformatics/btt265; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Zhao BY, 2012, PROTEOMICS, V12, P3299, DOI 10.1002/pmic.201200189	34	7	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152809	10.1371/journal.pone.0152809	http://dx.doi.org/10.1371/journal.pone.0152809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046079	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600037
J	Villegas, L; Otero, L; Sterling, TR; Huaman, MA; Van der Stuyft, P; Gotuzzo, E; Seas, C				Villegas, Leonela; Otero, Larissa; Sterling, Timothy R.; Huaman, Moises A.; Van der Stuyft, Patrick; Gotuzzo, Eduardo; Seas, Carlos			Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru	PLOS ONE			English	Article							MONORESISTANT TUBERCULOSIS; DRUG-RESISTANCE; UNITED-STATES	Background Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-resistance, associated risk factors, and the association of mono-resistance on treatment outcomes. Methods A prospective, observational cohort study enrolled adults with a first episode of smear-positive pulmonary TB from 34 health facilities in a northern district of Lima, Peru, from March 2010 through December 2011. Participants were interviewed and a sputum sample was cultured on Lowenstein-Jensen (LJ) media. Drug susceptibility testing was performed using the proportion method. Medication regimens were documented for each patient. Our primary outcomes were treatment outcome at the end of treatment. The secondary outcome included recurrent episodes among cured patients within two years after completion of the treatment. Results Of 1292 patients enrolled, 1039 (80%) were culture-positive. From this subpopulation, isoniazid mono-resistance was present in 85 (8%) patients and rifampicin mono-resistance was present in 24 (2%) patients. In the multivariate logistic regression model, isoniazid mono-resistance was associated with illicit drug use (adjusted odds ratio (aOR) = 2.10; 95% confidence interval (CI): 1.1-4.1), and rifampicin mono-resistance was associated with HIV infection (aOR = 9.43; 95% CI: 1.9-47.8). Isoniazid mono-resistant patients had a higherrisk of poor treatment outcomes including treatment failure (2/85, 2%, p-value<0.01) and death (4/85, 5%, p<0.02). Rifampicin mono-resistant patients had a higher risk of death (2/24,8%, p<0.01). Conclusion A high prevalence of isoniazid and rifampicin mono-resistance was found among TB patients in our low HIV burden setting which were similar to regions with high HIV burden. Patients with isoniazid and rifampicin mono-resistance had an increased risk of poor treatment outcomes.	[Villegas, Leonela; Sterling, Timothy R.; Huaman, Moises A.] Vanderbilt Univ, Sch Med, A2209 Med Ctr North, Nashville, TN 37212 USA; [Otero, Larissa; Gotuzzo, Eduardo; Seas, Carlos] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Unit Gen Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium; [Villegas, Leonela] Vanderbilt Univ, Sch Med, Div Infect Dis, A2209 Med Ctr North, Nashville, TN 37212 USA	Vanderbilt University; Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM); Ghent University; Vanderbilt University	Villegas, L (corresponding author), Vanderbilt Univ, Sch Med, A2209 Med Ctr North, Nashville, TN 37212 USA.; Villegas, L (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, A2209 Med Ctr North, Nashville, TN 37212 USA.	Leonela.a.villegas@vanderbilt.edu		Seas, Carlos/0000-0001-7067-9141; Huaman, Moises/0000-0002-6839-5809; Villegas, Leonela/0000-0003-1937-7353; Otero, Larissa/0000-0002-8348-4340	Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru; FOGARTY INTERNATIONAL CENTER [R25TW009343] Funding Source: NIH RePORTER	Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Belgian Cooperation (www.dg-d.be) through a project of institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium (FA3) and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PERU, V53, P1854; Arentz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076533; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Clark CM, 2005, INT J TUBERC LUNG D, V9, P964; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Hoopes AJ, 2008, ARCH INTERN MED, V168, P1984, DOI 10.1001/archinte.168.18.1984; Instituto Nacional de Estadistica e Informatica, 2014, POBL LIM METR 2014; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; LoBue PA, 2005, INT J TUBERC LUNG D, V9, P501; MENZIES D, 2009, PLOS MED, V6, P1, DOI DOI 10.1371/journal.pmed.0060001; Meyssonnier V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-18; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Mulenga C, 2010, TUBERC RES TREAT, V2010; Organization WH, 2014, 4 WHO; Otero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026276; Sandgren A, 2012, EUR J MICROBIOL IMMU, V2, P292, DOI 10.1556/EuJMI.2.2012.4.8; Sandman L, 1999, AM J RESP CRIT CARE, V159, P468, DOI 10.1164/ajrccm.159.2.9805097; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; Villa-Rosas C L-LR, SALUD PUBLICA MEX, V57, P177; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316	27	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152933	10.1371/journal.pone.0152933	http://dx.doi.org/10.1371/journal.pone.0152933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045684	Green Published, gold			2022-12-27	WOS:000373599600047
J	Groves, NJ; Bradford, D; Sullivan, RKP; Conn, KA; Aljelaify, RF; McGrath, JJ; Burne, THJ				Groves, Natalie J.; Bradford, DanaKai; Sullivan, Robert K. P.; Conn, Kyna-Anne; Aljelaify, Rasha Fahad; McGrath, John J.; Burne, Thomas H. J.			Behavioural Effects of Adult Vitamin D Deficiency in BALB/c Mice Are not Associated with Proliferation or Survival of Neurons in the Adult Hippocampus	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; COGNITIVE DECLINE; FORCED SWIM; NEUROGENESIS; DEPRESSION; ANTIDEPRESSANT; EXERCISE; SYSTEM; FLUOXETINE; STATE	Epidemiological studies have shown that up to one third of adults have insufficient levels of vitamin D and there is an association between low vitamin D concentrations and adverse brain outcomes, such as depression. Vitamin D has been shown to be involved in processes associated with neurogenesis during development. Therefore, the aim of this study was to test the hypothesis that adult vitamin D (AVD) deficiency in BALB/c mice was associated with (a) adult hippocampal neurogenesis at baseline, b) following 6 weeks of voluntary wheel running and (c) a depressive-like phenotype on the forced swim test (FST), which may be linked to alterations in hippocampal neurogenesis. We assessed proliferation and survival of adult born hippocampal neurons by counting the number of cells positive for Ki67 and doublecortin (DCX), and incorporation of 5-Bromo-2'-Deoxyuridine (BrdU) within newly born mature neurons using immunohistochemistry. There were no significant effects of diet on number of Ki67(+), DCX+ or BrdU(+) cells in the dentate gyrus. All mice showed significantly increased number of Ki67+ cells and BrdU incorporation, and decreased immobility time in the FST, after voluntary wheel running. A significant correlation was found in control mice between immobility time in the FST and level of hippocampal neurogenesis, however, no such correlation was found for AVD-deficient mice. We conclude that AVD deficiency was not associated with impaired proliferation or survival of adult born neurons in BALB/c mice and that the impact on rodent behaviour may not be due to altered neurogenesis per se, but to altered function of new hippocampal neurons or processes independent of adult neurogenesis.	[Groves, Natalie J.; Bradford, DanaKai; Sullivan, Robert K. P.; Conn, Kyna-Anne; Aljelaify, Rasha Fahad; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [McGrath, John J.] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia; [Bradford, DanaKai] CSIRO, Queensland Ctr Adv Technol, Pullenvale, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burne, THJ (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.; Burne, THJ (corresponding author), Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia.	t.burne@uq.edu.au	Burne, Thomas H/C-5656-2009; Groves, Natalie/S-4541-2016; Sullivan, Robert KP/A-8639-2012; Bradford, DanaKai/B-7561-2017; McGrath, John Joseph/G-5493-2010	Burne, Thomas H/0000-0003-3502-9789; Groves, Natalie/0000-0003-3769-8185; Sullivan, Robert KP/0000-0003-3414-2448; Bradford, DanaKai/0000-0002-2939-3018; McGrath, John Joseph/0000-0002-4792-6068; Aljelaify, Rasha/0000-0003-1923-1936; Conn, Kyna-Anne/0000-0003-2244-7885	National Health and Medical Research Council of Australia [APP1070081]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by the National Health and Medical Research Council of Australia, Grant number APP1070081. The funders had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; Cui XY, 2007, INT J DEV NEUROSCI, V25, P227, DOI 10.1016/j.ijdevneu.2007.03.006; Cui XY, 2013, AM J CLIN NUTR, V97, P907, DOI 10.3945/ajcn.113.061176; Cunha MP, 2013, MED SCI SPORT EXER, V45, P851, DOI 10.1249/MSS.0b013e31827b23e6; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Groves NJ, 2013, BEHAV BRAIN RES, V241, P120, DOI 10.1016/j.bbr.2012.12.001; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Karolewicz B, 2001, EUR J PHARMACOL, V415, P197, DOI 10.1016/S0014-2999(01)00830-5; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Ko P, 2004, DEV BRAIN RES, V153, P61, DOI 10.1016/j.devbrainres.2004.07.013; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Mozaffari-Khosravi H, 2013, J CLIN PSYCHOPHARM, V33, P378, DOI 10.1097/JCP.0b013e31828f619a; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Torres-Lista V, 2014, BEHAV PROCESS, V106, P118, DOI 10.1016/j.beproc.2014.05.001; Tyler CR, 2014, NEUROTOXICOLOGY, V44, P98, DOI 10.1016/j.neuro.2014.06.006; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Ylikomi T, 2002, VITAM HORM, V64, P357, DOI 10.1016/S0083-6729(02)64010-5; Zhu Y, 2012, HIPPOCAMPUS, V22, P421, DOI 10.1002/hipo.20908	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152328	10.1371/journal.pone.0152328	http://dx.doi.org/10.1371/journal.pone.0152328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043014	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100014
J	Hiemenz, MC; Kadauke, S; Lieberman, DB; Roth, DB; Zhao, JH; Watt, CD; Daber, RD; Morrissette, JJD				Hiemenz, Matthew C.; Kadauke, Stephan; Lieberman, David B.; Roth, David B.; Zhao, Jianhua; Watt, Christopher D.; Daber, Robert D.; Morrissette, Jennifer J. D.			Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; KRAS MUTATIONS; RARE MUTATIONS; VALIDATION; PARALLEL; RESISTANCE; SURVIVAL; PCR	Next-generation sequencing (NGS) is a powerful platform for identifying cancer mutations. Routine clinical adoption of NGS requires optimized quality control metrics to ensure accurate results. To assess the robustness of our clinical NGS pipeline, we analyzed the results of 304 solid tumor and hematologic malignancy specimens tested simultaneously by NGS and one or more targeted single-gene tests (EGFR, KRAS, BRAF, NPM1, FLT3, and JAK2). For samples that passed our validated tumor percentage and DNA quality and quantity thresholds, there was perfect concordance between NGS and targeted single-gene tests with the exception of two FLT3 internal tandem duplications that fell below the stringent preestablished reporting threshold but were readily detected by manual inspection. In addition, NGS identified clinically significant mutations not covered by single-gene tests. These findings confirm NGS as a reliable platform for routine clinical use when appropriate quality control metrics, such as tumor percentage and DNA quality cutoffs, are in place. Based on our findings, we suggest a simple workflow that should facilitate adoption of clinical oncologic NGS services at other institutions.	[Hiemenz, Matthew C.; Lieberman, David B.; Roth, David B.; Zhao, Jianhua; Watt, Christopher D.; Daber, Robert D.; Morrissette, Jennifer J. D.] Hosp Univ Penn, Dept Pathol & Lab Med, Ctr Personalized Diagnost, 3400 Spruce St, Philadelphia, PA 19104 USA; [Kadauke, Stephan] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA USA; [Hiemenz, Matthew C.; Daber, Robert D.] BioReference Labs, Elmwood Pk, NJ USA; [Kadauke, Stephan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Morrissette, JJD (corresponding author), Hosp Univ Penn, Dept Pathol & Lab Med, Ctr Personalized Diagnost, 3400 Spruce St, Philadelphia, PA 19104 USA.	Jennifer.Morrissette@uphs.upenn.edu	Kadauke, Stephan/V-6197-2019	Kadauke, Stephan/0000-0003-2996-8034				Aisner DL, 2013, DIAGN CYTOPATHOL, V41, P316, DOI 10.1002/dc.21851; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aziz N, 2015, ARCH PATHOL LAB MED, V139, P481, DOI 10.5858/arpa.2014-0250-CP; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Daber R, 2013, CANCER GENET-NY, V206, P441, DOI 10.1016/j.cancergen.2013.11.005; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Frank R, 2014, ENDOCR PATHOL, V25, P236, DOI 10.1007/s12022-013-9289-0; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Gowin K, 2013, EXPERT OPIN INV DRUG, V22, P1603, DOI 10.1517/13543784.2013.832199; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; Mesa RA, 2012, NAT REV DRUG DISCOV, V11, P103, DOI 10.1038/nrd3652; Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Spencer DH, 2013, J MOL DIAGN, V15, P81, DOI 10.1016/j.jmoldx.2012.08.001; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; West H, 2009, J THORAC ONCOL, V4, pS1029, DOI 10.1097/JTO.0b013e3181b27170; Wilson MA, 2014, CANCER GENET-NY, V207, P272, DOI 10.1016/j.cancergen.2014.06.022	44	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152851	10.1371/journal.pone.0152851	http://dx.doi.org/10.1371/journal.pone.0152851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043212	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100038
J	Musa, SM; Adam, I; Lutfi, MF				Musa, Shaza M.; Adam, Ishag; Lutfi, Mohamed F.			Heart Rate Variability and Autonomic Modulations in Preeclampsia	PLOS ONE			English	Article							LOW-FREQUENCY POWER; PLASMA NORADRENALINE; SYMPATHETIC TONE; NORMAL-PREGNANCY; SUDANESE WOMEN; BLOOD-PRESSURE; HYPERTENSION; ADRENALINE; DISEASE; MECHANISMS	Background Although the exact pathophysiology of preeclampsia is not well understood, autonomic nervous system imbalance is suggested as one of the main factors. Aims To investigate heart rate variability (HRV) and autonomic modulations in Sudanese pregnant women with preeclampsia. Subjects and Methods A case-control study (60 women in each arm) was conducted at Omdurman Maternity Hospital-Sudan, during the period from June to August, 2014. Cases were women presented with preeclampsia and healthy pregnant women were the controls. Studied groups were matched for important determinants of HRV. Natural logarithm (Ln) of total power (TP), high frequency (HF), low frequency (LF) and very low frequency (VLF) were used to determine HRV. Normalized low and high frequencies (LF Norm and HF Norm) were used to evaluate sympathetic and parasympathetic autonomic modulations respectively. Results Patients with preeclampsia achieved significantly higher LF Norm [49.80 (16.25) vs. 44.55 (19.15), P = 0.044] and LnLF/HF [0.04 (0.68) vs. -0.28 (0.91), P = 0.023] readings, but lower HF Norm [49.08 (15.29) vs. 55.87 (19.56), P = 0.012], compared with healthy pregnant women. Although all other HRV measurements were higher in the patients with preeclampsia compared with the controls, only LnVLF [4.50 (1.19) vs. 4.01 (1.06), P = 0.017] and LnLF [4.01 (1.58) vs. 3.49 (1.23), P = 0.040] reached statistical significance. Conclusion The study adds further evidence for the dominant cardiac sympathetic modulations on patients with preeclampsia, probably secondary to parasympathetic withdrawal in this group. However, the higher LnVLF and LnLF readings achieved by preeclamptic women compared with the controls are unexpected in the view that augmented sympathetic modulations usually depresses all HRV parameters including these two measures.	[Musa, Shaza M.; Lutfi, Mohamed F.] Al Neelain Univ, Fac Med & Hlth Sci, Khartoum, Sudan; [Adam, Ishag] Univ Khartoum, Fac Med, Khartoum, Sudan	University of Khartoum	Lutfi, MF (corresponding author), Al Neelain Univ, Fac Med & Hlth Sci, Khartoum, Sudan.	mohamedfaisallutfi@gmail.com	MA, M LUTFI/GQH-0830-2022					Abdullahi H, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-29; Alonso A, 2015, ANN NEUROL, V77, P877, DOI 10.1002/ana.24393; [Anonymous], 1996, CIRCULATION, V93, P65; Bakheit KH, 2009, HYPERTENS PREGNANCY, V28, P224, DOI 10.1080/10641950802601245; Bueno AA, 2012, J OBSTET GYNAECOL, V32, P241, DOI 10.3109/01443615.2011.641622; D'Silva LA, 2014, PHYSIOL MEAS, V35, P15, DOI 10.1088/0967-3334/35/1/15; DAVEY DA, 1981, BRIT J OBSTET GYNAEC, V88, P611, DOI 10.1111/j.1471-0528.1981.tb01217.x; Elhaj ET, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00087; Elhassan EM, 2009, TROP DOCT, V39, P238, DOI 10.1258/td.2009.090005; Eneroth E, 1998, GYNECOL OBSTET INVES, V45, P170, DOI 10.1159/000009949; Engel T, 2015, INFLAMM BOWEL DIS, V21, P2320, DOI 10.1097/MIB.0000000000000508; Flood P, 2015, AM J PERINAT, V32, P1050, DOI 10.1055/s-0035-1548542; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Greenwood JP, 2001, CIRCULATION, V104, P2200, DOI 10.1161/hc4301.098253; Hadase M, 2004, CIRC J, V68, P343, DOI 10.1253/circj.68.343; Lakhno IV, 2015, NEW ARMEN MED J, V9, P58; Lamarca B, 2012, Minerva Ginecol, V64, P309; Lewinsky RM, 1998, OBSTET GYNECOL, V91, P935, DOI 10.1016/S0029-7844(98)00105-7; Lotufo PA, 2012, EPILEPSIA, V53, P272, DOI 10.1111/j.1528-1167.2011.03361.x; Lutfi M. F., 2011, INT J PHARM BIO RES, V2, P127; Lutfi MF, 2011, SUDAN MED J, V47, P14; Lutfi MF, 2012, LUNG INDIA, V29, P254, DOI 10.4103/0970-2113.99111; Lutfi MF, 2011, SUDAN J MED SCI, V6, P43; Lutfi MF, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0118-8; Lutfi MF, 2011, INT J HEALTH SCI-IJH, V5, P146; Matsuo H, 2007, CLIN EXP OBSTET GYN, V34, P73; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Murphy MSQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138664; NATRAJAN PG, 1982, BRIT J OBSTET GYNAEC, V89, P1041, DOI 10.1111/j.1471-0528.1982.tb04661.x; PEDERSEN EB, 1982, ACTA ENDOCRINOL-COP, V99, P594, DOI 10.1530/acta.0.0990594; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Rang S, 2004, J HYPERTENS, V22, P369, DOI 10.1097/00004872-200402000-00022; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sacha J, 2008, INT J CARDIOL, V128, P444, DOI 10.1016/j.ijcard.2007.06.047; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Tejera E, 2012, HYPERTENS PREGNANCY, V31, P91, DOI 10.3109/10641955.2010.544801; TUNBRIDGE RDG, 1981, BRIT J OBSTET GYNAEC, V88, P105, DOI 10.1111/j.1471-0528.1981.tb00950.x; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269; Zhang J, 2007, J MANIP PHYSIOL THER, V30, P374, DOI 10.1016/j.jmpt.2007.04.001; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152704	10.1371/journal.pone.0152704	http://dx.doi.org/10.1371/journal.pone.0152704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043306	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100028
J	Peng, Y; Wang, J; Zhang, M; Niu, PP; Yang, MY; Yang, YL; Zhao, Y				Peng, Ya; Wang, Jun; Zhang, Miao; Niu, Panpan; Yang, Mengya; Yang, Yilin; Zhao, Ying			Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; MACROPHAGE-LIKE CELLS; CHOLESTEROL; VULNERABILITY; FORMALDEHYDE; PROGRESSION	Given that the elevated serum semicarbazide-sensitive amine oxidase (SSAO) activity is associated with the severity of carotid atherosclerosis in clinic, the current study aims to investigate whether SSAO inactivation by semicarbazide is beneficial for established atherosclerotic lesions in LDLr knockout mice on a high-fat/high-cholesterol Western-type diet or after dietary lipid lowering. Despite no impact on plasma total cholesterol levels, the infiltration of circulating monocytes into peripheral tissues, and the size of atherosclerotic lesions, abrogation of SSAO activity resulted in the stabilization of established lesions as evidenced by the increased collagen contents under both conditions. Moreover, SSAO inactivation decreased Ly6C(high) monocytosis and lesion macrophage contents in hypercholesterolemic mice, while no effect was observed in mice after normalization of hypercholesterolemia by dietary lipid lowering. Strikingly, abrogation of SSAO activity significantly increased not only the absolute numbers of smooth muscle cells (SMCs), but also the percent of SMCs with a synthetic phenotype in established lesions of mice regardless of plasma cholesterol levels. Overall, our data indicate that SSAO inactivation in vivo stabilizes the established plaques mainly via inducing the switch of SMCs from a contractile to a synthetic phenotype. Targeting SSAO activity thus may represent a potential treatment for patients with atherosclerosis.	[Peng, Ya; Niu, Panpan; Yang, Mengya; Yang, Yilin] Soochow Univ, Peoples Hosp Changzhou 1, Dept Neurosurg, Changzhou 213003, Peoples R China; [Wang, Jun] Soochow Univ, Inst Biol, Suzhou 215123, Peoples R China; [Wang, Jun] Soochow Univ, Inst Med Sci, Suzhou 215123, Peoples R China; [Zhang, Miao; Zhao, Ying] Soochow Univ, Dept Pathophysiol, Suzhou 215123, Peoples R China; [Yang, Yilin] Soochow Univ, Peoples Hosp Changzhou 1, Modern Med Res Ctr, Changzhou 213003, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Yang, YL (corresponding author), Soochow Univ, Peoples Hosp Changzhou 1, Dept Neurosurg, Changzhou 213003, Peoples R China.; Zhao, Y (corresponding author), Soochow Univ, Dept Pathophysiol, Suzhou 215123, Peoples R China.; Yang, YL (corresponding author), Soochow Univ, Peoples Hosp Changzhou 1, Modern Med Res Ctr, Changzhou 213003, Peoples R China.	yilinyang.czfph@gmail.com; yzhao@suda.edu.cn	Zhao, Ying/C-3916-2011; Wang, Jun/B-2414-2009; Wang, Jun/AGJ-1311-2022; Zhao, Ying/AAS-7970-2021	Wang, Jun/0000-0002-4458-3741; Wang, Jun/0000-0002-4458-3741; , Miao/0000-0002-5656-2227	National Natural Science Foundation of China [31400768/81470564, 31200672/31370871, 31071046]; Jiangsu Natural Science Foundation [BK20130339]; Jiangsu Provincial Special Program of Medical Science [BL2012004/BL2014051, BL2014035]; Changzhou Applied Basic Science Project [CJ20140059]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Special Program of Medical Science; Changzhou Applied Basic Science Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from National Natural Science Foundation of China (31400768/81470564 (YZ); 31200672/31370871 (JW); 31071046 (YY), Jiangsu Natural Science Foundation (BK20130339 (YZ)), Jiangsu Provincial Special Program of Medical Science (BL2012004/BL2014051 (YZ); BL2014035 (YY)), Changzhou Applied Basic Science Project (CJ20140059 (YP), and a project (JW and YZ) funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Ballantyne CM, 2008, CIRCULATION, V117, P2458, DOI 10.1161/CIRCULATIONAHA.108.773747; Bots ML, 2009, J INTERN MED, V265, P698, DOI 10.1111/j.1365-2796.2009.02073.x; Bour S, 2009, AM J PATHOL, V174, P1075, DOI 10.2353/ajpath.2009.080612; Chaabane C, 2014, CURR OPIN LIPIDOL, V25, P374, DOI 10.1097/MOL.0000000000000113; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.065; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; El Hadri K, 2002, ARTERIOSCL THROM VAS, V22, P89, DOI 10.1161/hq0102.101550; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gray K, 2015, CIRC RES, V116, P816, DOI 10.1161/CIRCRESAHA.116.304921; Karadi I, 2002, CLIN CHIM ACTA, V323, P139, DOI 10.1016/S0009-8981(02)00189-4; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Li HY, 2009, CLIN CHIM ACTA, V403, P97, DOI 10.1016/j.cca.2009.01.027; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lutgens E, 2003, ARTERIOSCL THROM VAS, V23, P2123, DOI 10.1161/01.ATV.0000097783.01596.E2; Mercader J, 2011, J OBES, V2011, DOI 10.1155/2011/475786; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Sung HJ, 2005, ANN BIOMED ENG, V33, P1546, DOI 10.1007/s10439-005-7545-2; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Yu PH, 1998, ATHEROSCLEROSIS, V140, P357, DOI 10.1016/S0021-9150(98)00142-7; Yu PH, 1996, ATHEROSCLEROSIS, V120, P189, DOI 10.1016/0021-9150(95)05701-3; Zhao Y, 2011, AM J PATHOL, V179, P1522, DOI 10.1016/j.ajpath.2011.05.020	26	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152758	10.1371/journal.pone.0152758	http://dx.doi.org/10.1371/journal.pone.0152758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043821	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100031
J	Perez, GM; Cox, V; Ellman, T; Moore, A; Patten, G; Shroufi, A; Stinson, K; Van Cutsem, G; Ibeto, M				Perez, Guillermo Martinez; Cox, Vivian; Ellman, Tom; Moore, Ann; Patten, Gabriela; Shroufi, Amir; Stinson, Kathryn; Van Cutsem, Gilles; Ibeto, Maryrene			'I Know that I Do Have HIV but Nobody Saw Me': Oral HIV Self-Testing in an Informal Settlement in South Africa	PLOS ONE			English	Article							HEALTH; PART	Reaching universal HIV-status awareness is crucial to ensure all HIV-infected patients access antiretroviral treatment (ART) and achieve virological suppression. Opportunities for HIV testing could be enhanced by offering self-testing in populations that fear stigma and discrimination when accessing conventional HIV Counselling and Testing (HCT) in health care facilities. This qualitative research aims to examine the feasibility and acceptability of unsupervised oral self-testing for home use in an informal settlement of South Africa. Eleven in-depth interviews, two couple interviews, and two focus group discussions were conducted with seven healthcare workers and thirteen community members. Thematic analysis was done concurrently with data collection. Acceptability to offer home self-testing was demonstrated in this research. Home self-testing might help this population overcome barriers to accepting HCT; this was particularly expressed in the male and youth groups. Nevertheless, pilot interventions must provide evidence of potential harm related to home self-testing, intensify efforts to offer quality counselling, and ensure linkage to HIV/ART-care following a positive self-test result.	[Perez, Guillermo Martinez; Shroufi, Amir; Van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Cox, Vivian; Moore, Ann; Patten, Gabriela; Stinson, Kathryn; Ibeto, Maryrene] Med Sans Frontieres Khayelitsha, Cape Town, South Africa; [Ellman, Tom] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Stinson, Kathryn] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	University of Cape Town	Perez, GM (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	gmartinezgabas@gmail.com	Patten, Gabriela/J-3461-2019; Van Cutsem, Gilles/ABB-1171-2021; Martínez-Pérez, Guillermo Z./AAA-7994-2019	Patten, Gabriela/0000-0003-2511-1367; Van Cutsem, Gilles/0000-0002-8972-4480; Martinez-Perez, Guillermo Z./0000-0001-6756-9515	Medecins Sans Frontieres project in Khayelitsha, South Africa	Medecins Sans Frontieres project in Khayelitsha, South Africa	This study has not received any grant. This study has been entirely funded as operational research by Medecins Sans Frontieres project in Khayelitsha, South Africa. All authors are workers in MSF Khayelitsha project, and, as such, had played a role in study design, decision to publish, or preparation of the manuscript. The first author, GMP, is not member of Khayelitsha project, and, as social scientist, has conducted data collection and analysis. Thus, the funders didn't play a role in these stages.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown AN, 2014, AIDS BEHAV, V18, pS445, DOI 10.1007/s10461-014-0831-y; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Charmaz K, 2007, SAGE HDB GROUNDED TH, DOI DOI 10.4135/9781848607941; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Cox V, 2013, 7 IAS C HIV PATH TRE; Doherty IA, 2015, SEX TRANSM IN PRESS; Gardner J, 2012, S AFR J BIOETH LAW, V5, P15; Gonsalves GS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122244; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Institute for Security Studies, 2012, SA CRIM STAT; Koo K, 2013, AIDS CARE, V25, P43, DOI 10.1080/09540121.2012.687822; Makhunga-Ramfolo M, 2011, SO AFRICAN J HIV MED, V12; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Mkwamba A, 2015, 8 IAS C HIV PATH TRE; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; National Department of Health, 2015, NAT HIV COUNS TEST P NAT HIV COUNS TEST P; National Department of Health, 2010, HCT POL GUID MARCH 2; O'Regan C, 2014, SAFER KHAYELITSHA; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Richter M, 2010, SAMJ S AFR MED J, V100, P636, DOI 10.7196/SAMJ.4198; Scott PA, 2014, AIDS BEHAV, V18, pS438, DOI 10.1007/s10461-014-0833-9; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa (Stats SA), 2012, CENS 2011; Stoddart M.C., 2004, GRAD J SOC SCI, V1, P303; Strode AE, 2013, S AFR J HIV MED, V14, P151, DOI [10.7196/SAJHIVMED.987, 10.7196/sajhivmed.987]; Technologies OraSure, 2012, FIN ADV COMM BRIEF M; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Van Dyk AC., 2013, J ASSOC NURSE AIDS C, V24, P45; Van Rooyen H, 2014, J INT AIDS SOC, V18, P19445; Wood BR, 2014, HIV AIDS-RES PALLIAT, V6, P117, DOI 10.2147/HIV.S49083; World Health Organization, 2013, LEG ETH GEND HUM RIG; Young SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103790	37	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152653	10.1371/journal.pone.0152653	http://dx.doi.org/10.1371/journal.pone.0152653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27044006	Green Published, gold			2022-12-27	WOS:000373592100022
J	Rasheed, S; Siddique, AK; Sharmin, T; Hasan, AMR; Hanifi, SMA; Iqbal, M; Bhuiya, A				Rasheed, Sabrina; Siddique, A. K.; Sharmin, Tamanna; Hasan, A. M. R.; Hanifi, S. M. A.; Iqbal, M.; Bhuiya, Abbas			Salt Intake and Health Risk in Climate Change Vulnerable Coastal Bangladesh: What Role Do Beliefs and Practices Play?	PLOS ONE			English	Article							RANDOMIZED-TRIALS; DRINKING-WATER; BLOOD-PRESSURE; IODIZED SALT; SODIUM; REDUCTION; DISEASE; METAANALYSIS; CONSUMPTION; PREVENTION	Background High salt consumption is an important risk factor of elevated blood pressure. In Bangladesh about 20 million people are at high risk of hypertension due to climate change induced saline intrusion in water. The objective of this study is to assess beliefs, perceptions, and practices associated with salt consumption in coastal Bangladesh. Methods The study was conducted in Chakaria, Bangladesh between April-June 2011. It was a cross sectional mixed method study. For the qualitative study 6 focus group discussions, 8 key informant interviews, 60 free listing exercises, 20 ranking exercises and 10 observations were conducted. 400 adults were randomly selected for quantitative survey. For analysis we used SPSS for quantitative data, and Anthropac and Nvivo for qualitative data. Results Salt was described as an essential component of food with strong cultural and religious roots. People described both health benefits and risks related to salt intake. The overall risk perception regarding excessive salt consumption was low and respondents believed that the cooking process can render the salt harmless. Respondents were aware that salt is added in many foods even if they do not taste salty but did not recognize that salt can occur naturally in both foods and water. Conclusions In the study community people had low awareness of the risks associated with excess salt consumption and salt reduction strategies were not high in their agenda. The easy access to and low cost of salt as well as unrecognised presence of salt in drinking water has created an environment conducive to excess salt consumption. It is important to design general messages related to salt reduction and test tailored strategies especially for those at high risk of hypertension.	[Rasheed, Sabrina; Siddique, A. K.; Sharmin, Tamanna; Hasan, A. M. R.; Hanifi, S. M. A.; Iqbal, M.; Bhuiya, Abbas] Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, Dhaka 1212, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Rasheed, S (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Equ & Hlth Syst, Dhaka 1212, Bangladesh.	sabrina1@icddrb.org	rasheed, sabrina/A-4145-2010	Hasan, A M Rumayan/0000-0001-7800-5432; rasheed, sabrina/0000-0002-7444-200X	UnitedHealth group through Oxford Health Alliance of Johns Hopkins University; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	UnitedHealth group through Oxford Health Alliance of Johns Hopkins University; Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research protocol/activity/study was funded by UnitedHealth group through Oxford Health Alliance Vision 2020 of Johns Hopkins University. icddr, b acknowledges with gratitude the commitment of UnitedHealth group to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, BMJ, V297, P319; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bangladesh Bureau of Statistics (BBS), 2011, POP CENS 2011; Brewer D., 2002, FIELD METHOD, V14, P108, DOI 10.1177/1525822X02014001007; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Brown LK, 1985, ETHNIC REGIONAL FOOD; CUTLER JA, 1991, HYPERTENSION, V17, pI27, DOI 10.1161/01.HYP.17.1_Suppl.I27; Ezekowitz JA, 2003, AM FAM PHYSICIAN, V68, P2379; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Flack John M, 2003, J Clin Hypertens (Greenwich), V5, P5, DOI 10.1111/j.1524-6175.2003.02152.x; FREIS ED, 1976, CIRCULATION, V53, P589, DOI 10.1161/01.CIR.53.4.589; Frohlich ED, 2007, HYPERTENSION, V50, P161, DOI 10.1161/HYPERTENSIONAHA.107.088328; Glanz K., 2008, HLTH BEHAV HLTH ED T; Hanifi MA, 2012, INT J EPIDEMIOL, V41, P667, DOI 10.1093/ije/dys089; Hassan A., 2006, IMPACT SEA LEVEL RIS; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Hoeft KS, 2015, APPETITE, V87, P1, DOI 10.1016/j.appet.2014.11.031; HUNT LM, 1989, SOC SCI MED, V28, P945, DOI 10.1016/0277-9536(89)90324-9; JAMES WPT, 1987, LANCET, V1, P426; Kenten C, 2013, APPETITE, V70, P104, DOI 10.1016/j.appet.2013.06.095; Khan A, 2008, LANCET, V371, P385, DOI 10.1016/S0140-6736(08)60197-X; Khan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108715; Khan AE, 2011, ENVIRON HEALTH PERSP, V119, P1328, DOI 10.1289/ehp.1002804; Kurlansky Mark, 2003, SALT A WORLD HIST; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Malherbe M., 2003, J FAMILY ECOLOGY CON, V31; Marshall S, 2007, BRIT FOOD J, V109, P233, DOI 10.1108/00070700710732556; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Mitchell M, 2013, FOOD QUAL PREFER, V28, P356, DOI 10.1016/j.foodqual.2012.11.002; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Neale R. J., 1993, HLTH ED J, V52, P68; NIPORT M, 2015, ICF INT BANGLADESH D; Organization WH, 2016, GLOBAL STATUS REPORT; Quandt S, 1999, MODERN NUTR HLTH DIS, P1783; Rahman AA, 2003, GROUND WATER RESOURC; Rasheed S, 2001, J HEALTH POPUL NUTR, V19, P66; Rasheed S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-584; Roberson MHB, 1992, QUALITATIVE HLTH RES, V2, P7; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Sarmugam R, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-25; Sen TK, 2010, J HEALTH POPUL NUTR, V28, P369; Serajuddin A. M., 1978, J ECON SOC HIST ORIE, VXXI, P304, DOI DOI 10.2307/3632201; Smith SL, 2006, SOC SCI MED, V62, P189, DOI 10.1016/j.socscimed.2005.05.009; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tobin BD, 2012, MEAT SCI, V91, P460, DOI 10.1016/j.meatsci.2012.02.032; Unger CC, 2014, ARCH DIS CHILD, V99, P273, DOI 10.1136/archdischild-2013-304765; Varagic J, 2008, AM J PHYSIOL-HEART C, V294, pH853, DOI 10.1152/ajpheart.00737.2007; WHO, 2012, GUID SOD INT AD CHIL; World Health Organization, 2011, NONCOMMUNICABLE DIS; Yusuf HKM, 2008, ASIA PAC J CLIN NUTR, V17, P620	51	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152783	10.1371/journal.pone.0152783	http://dx.doi.org/10.1371/journal.pone.0152783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044049	Green Published, gold			2022-12-27	WOS:000373592100034
J	Lu, Q; Schnitzler, GR; Ueda, K; Iyer, LK; Diomede, OI; Andrade, T; Karas, RH				Lu, Qing; Schnitzler, Gavin R.; Ueda, Kazutaka; Iyer, Lakshmanan K.; Diomede, Olga I.; Andrade, Tiffany; Karas, Richard H.			ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; RECEPTOR-ALPHA; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; IN-VITRO; MICE; BETA; INFLAMMATION; NUCLEAR	Estrogen promotes the proliferation and migration of vascular endothelial cells (ECs), which likely underlies its ability to accelerate re-endothelialization and reduce adverse remodeling after vascular injury. In previous studies, we have shown that the protective effects of E2 (the active endogenous form of estrogen) in vascular injury require the estrogen receptor alpha (ER alpha). ER alpha transduces the effects of estrogen via a classical DNA binding, "genomic" signaling pathway and via a more recently-described "rapid" signaling pathway that is mediated by a subset of ER alpha localized to the cell membrane. However, which of these pathways mediates the effects of estrogen on endothelial cells is poorly understood. Here we identify a triple point mutant version of ER alpha (KRR ER alpha) that is specifically defective in rapid signaling, but is competent to regulate transcription through the "genomic" pathway. We find that in ECs expressing wild type ER alpha, E2 regulates many genes involved in cell migration and proliferation, promotes EC migration and proliferation, and also blocks the adhesion of monocytes to ECs. ECs expressing KRR mutant ER alpha, however, lack all of these responses. These observations establish KRR ER alpha as a novel tool that could greatly facilitate future studies into the vascular and non-vascular functions of ER alpha rapid signaling. Further, they support that rapid signaling through ER alpha is essential for many of the transcriptional and physiological responses of ECs to E2, and that ER alpha rapid signaling in ECs, in vivo, may be critical for the vasculoprotective and anti-inflammatory effects of estrogen.	[Lu, Qing; Schnitzler, Gavin R.; Ueda, Kazutaka; Iyer, Lakshmanan K.; Diomede, Olga I.; Andrade, Tiffany; Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	Tufts Medical Center	Schnitzler, GR; Karas, RH (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.	gschnitzler@tuftsmedicalcenter.org; rkaras@tuftsmedicalcenter.org		ueda, kazutaka/0000-0002-0509-1840	NIH [R01-HL061298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061298] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K20174] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by an NIH grant to RHK, number R01-HL061298. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Bhalla RC, 1997, AM J PHYSIOL-HEART C, V272, pH1996, DOI 10.1152/ajpheart.1997.272.4.H1996; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bobik A, 2012, CIRCULATION, V126, P1941, DOI 10.1161/CIRCULATIONAHA.112.138958; Brouchet L, 2001, CIRCULATION, V103, P423; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; COLLINS P, 1995, CIRCULATION, V92, P24, DOI 10.1161/01.CIR.92.1.24; Di Giorgio E, 2013, MOL CELL BIOL, V33, P4473, DOI 10.1128/MCB.01050-13; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gao H, 2006, INFLAMM RES, V55, P349, DOI 10.1007/s00011-006-5194-z; Gordon FK, 2014, MOL ENDOCRINOL, V28, P1337, DOI 10.1210/me.2013-1395; Hodgin JB, 2001, J CLIN INVEST, V107, P333, DOI 10.1172/JCI11320; Jiang HM, 2004, J BIOL CHEM, V279, P55905, DOI 10.1074/jbc.M406094200; Karas RH, 1999, P NATL ACAD SCI USA, V96, P15133, DOI 10.1073/pnas.96.26.15133; Karas RH, 1998, J CLIN INVEST, V101, P2851, DOI 10.1172/JCI1416; Kulkarni J, 2013, INT J ENDOCRINOL MET, V11, P129, DOI 10.5812/ijem.6615; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; MacRitchie AN, 1997, CIRC RES, V81, P355, DOI 10.1161/01.RES.81.3.355; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; Matter CM, 2006, STROKE, V37, P2625, DOI 10.1161/01.STR.0000241068.50156.82; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mendelsohn ME, 2007, NEW ENGL J MED, V356, P2639, DOI 10.1056/NEJMe078072; Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009; Miller AP, 2004, CIRCULATION, V110, P1664, DOI 10.1161/01.CIR.0000142050.19488.C7; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Nuedling S, 1999, CARDIOVASC RES, V43, P666, DOI 10.1016/S0008-6363(99)00093-0; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Pedram A, 2014, DEV CELL, V29, P482, DOI 10.1016/j.devcel.2014.04.016; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Rauch C, 2005, AM J PHYSIOL-CELL PH, V288, pC593, DOI 10.1152/ajpcell.00346.2004; REIS SE, 1994, CIRCULATION, V89, P52, DOI 10.1161/01.CIR.89.1.52; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Saxena A, 2013, MOL IMAGING BIOL, V15, P282, DOI 10.1007/s11307-012-0599-2; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Shifren JL, 2010, OBSTET GYNECOL, V115, P839, DOI 10.1097/AOG.0b013e3181d41191; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Studd John, 2010, Menopause Int, V16, P44, DOI 10.1258/mi.2010.010001; Ueda K, 2013, ARTERIOSCL THROM VAS, V33, P1837, DOI 10.1161/ATVBAHA.112.300752; Utian WH, 2010, MENOPAUSE, V17, P242, DOI 10.1097/gme.0b013e3181d0f6b9; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Xing DQ, 2004, CIRCULATION, V109, P234, DOI 10.1161/01.CIR.0000105700.95607.49; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhang LL, 2011, CARDIOVASC RES, V92, P484, DOI 10.1093/cvr/cvr238; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	62	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152807	10.1371/journal.pone.0152807	http://dx.doi.org/10.1371/journal.pone.0152807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035664	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200043
J	Reins, RY; Hanlon, SD; Magadi, S; McDermott, AM				Reins, Rose Y.; Hanlon, Samuel D.; Magadi, Sri; McDermott, Alison M.			Effects of Topically Applied Vitamin D during Corneal Wound Healing	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN CATHELICIDIN LL-37; DELTA-T-CELLS; PSEUDOMONAS-AERUGINOSA; EPITHELIAL-CELLS; OCULAR SURFACE; IN-VITRO; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; MULTIFUNCTIONAL PEPTIDE; HOST-DEFENSE	Vitamin D is an important regulator of immune function and largely acts to dampen chronic inflammatory events in a variety of tissues. There is also accumulating evidence that vitamin D acts to enhance initial inflammation, beneficial during both infection and wound healing, and then promotes resolution and prevention of chronic, damaging inflammation. The current study examines the effect of topical vitamin D in a mouse of model of corneal epithelial wound healing, where acute inflammation is necessary for efficient wound closure. At 12 and 18 hours post-wounding, vitamin D treatment significantly delayed wound closure by similar to 17% and increased infiltration of neutrophils into the central cornea. Basal epithelial cell division, corneal nerve density, and levels of VEGF, TGF beta, IL-1 beta, and TNF alpha were unchanged. However, vitamin D increased the production of the anti-microbial peptide CRAMP 12 hours after wounding. These data suggest a possible role for vitamin D in modulating corneal wound healing and have important implications for therapeutic use of vitamin D at the ocular surface.	[Reins, Rose Y.; Hanlon, Samuel D.; Magadi, Sri; McDermott, Alison M.] Univ Houston, Coll Optometry, Houston, TX USA	University of Houston System; University of Houston	McDermott, AM (corresponding author), Univ Houston, Coll Optometry, Houston, TX USA.	amcdermott@central.uh.edu			National Institutes of Health [EY13175, EY07551, T3207024]; NATIONAL EYE INSTITUTE [R01EY013175, P30EY007551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors received funding from the following grants to support this work: National Institutes of Health EY13175 (AMM), National Institutes of Health Grant EY07551 (UHCO Core Grant), and National Institutes of Health Grant T3207024 (RYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Biggs David S C, 2010, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1219s52; Byeseda SE, 2009, AM J PATHOL, V175, P571, DOI 10.2353/ajpath.2009.090112; Cantorna MT, 2015, NUTRIENTS, V7, P3011, DOI 10.3390/nu7043011; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Dekaris I, 1999, J IMMUNOL, V162, P4235; DeLuca H F, 1986, Adv Exp Med Biol, V196, P361; Elizondo RA, 2014, INVEST OPHTH VIS SCI, V55, P5245, DOI 10.1167/iovs.13-13553; Gao N, 2011, AM J PATHOL, V179, P2243, DOI 10.1016/j.ajpath.2011.07.050; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; He JC, 2010, EXP EYE RES, V91, P513, DOI 10.1016/j.exer.2010.07.007; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Hong JW, 2001, INVEST OPHTH VIS SCI, V42, P2795; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Huang LC, 2006, INVEST OPHTH VIS SCI, V47, P2369, DOI 10.1167/iovs.05-1649; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Jung MK, 2015, LIFE SCI, V128, P39, DOI 10.1016/j.lfs.2015.02.018; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Kubilus JK, 2010, INVEST OPHTH VIS SCI, V51, P782, DOI 10.1167/iovs.09-3942; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, AM J PATHOL, V169, P1590, DOI 10.2353/ajpath.2006.060415; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Q, 2012, AM J PATHOL, V181, P452, DOI 10.1016/j.ajpath.2012.04.010; MARFURT CF, 1993, J COMP NEUROL, V336, P517, DOI 10.1002/cne.903360405; McDermott Alison M, 2004, Ocul Surf, V2, P229; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Murphy CJ, 2001, INVEST OPHTH VIS SCI, V42, P2252; Reins RY, 2015, EXP EYE RES, V134, P101, DOI 10.1016/j.exer.2015.02.019; Ren ZG, 2012, DIABETES RES CLIN PR, V98, P474, DOI 10.1016/j.diabres.2012.09.028; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Sel S, 2016, GRAEF ARCH CLIN EXP, V254, P717, DOI 10.1007/s00417-016-3267-4; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Steinstraesser L, 2008, MOL MED, V14, P528, DOI 10.2119/2008-00002.Steinstraesser; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Suzuki T, 2000, CURR EYE RES, V20, P127, DOI 10.1076/0271-3683(200002)20:2;1-D;FT127; Terai K, 2011, INVEST OPHTH VIS SCI, V52, P8208, DOI 10.1167/iovs.11-8017; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weeres MA, 2014, J IMMUNOL, V193, P3456, DOI 10.4049/jimmunol.1400698; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P340, DOI 10.1046/j.1440-1711.80.4august.1.x; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P323, DOI 10.1046/j.1440-1711.2002.01094.x; Yildirim B, 2014, POSTGRAD MED, V126, P104, DOI 10.3810/pgm.2014.01.2730; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024	63	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152889	10.1371/journal.pone.0152889	http://dx.doi.org/10.1371/journal.pone.0152889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035345	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000373201200048
J	Ene, RD; Marinca, V; Marinca, B				Ene, Remus-Daniel; Marinca, Vasile; Marinca, Bogdan			Analytic Approximate Solutions to the Boundary Layer Flow Equation over a Stretching Wall with Partial Slip at the Boundary	PLOS ONE			English	Article							STAGNATION-POINT FLOW; HOMOTOPY PERTURBATION METHOD; NAVIER-STOKES EQUATIONS; HEAT-TRANSFER; ELECTRICAL MACHINE; VISCOELASTIC FLUID; POROUS CHANNEL; ROTATING-DISK; MASS-TRANSFER; SHEET	Analytic approximate solutions using Optimal Homotopy Perturbation Method (OHPM) are given for steady boundary layer flow over a nonlinearly stretching wall in presence of partial slip at the boundary. The governing equations are reduced to nonlinear ordinary differential equation by means of similarity transformations. Some examples are considered and the effects of different parameters are shown. OHPM is a very efficient procedure, ensuring a very rapid convergence of the solutions after only two iterations.	[Ene, Remus-Daniel] Univ Politehn Timisoara, Dept Math, Timisoara, Romania; [Marinca, Vasile] Univ Politehn Timisoara, Dept Mech & Vibrat, Timisoara, Romania; [Marinca, Vasile] Romania Acad, Ctr Adv & Fundamental Tech Res, Dept Electromech & Vibrat, Timisoara 300223, Romania; [Marinca, Bogdan] Univ Politehn Timisoara, Dept Appl Elect, Timisoara, Romania	Polytechnic University of Timisoara; Polytechnic University of Timisoara; Romanian Academy of Sciences; Polytechnic University of Timisoara	Ene, RD (corresponding author), Univ Politehn Timisoara, Dept Math, Timisoara, Romania.	remus.ene@upt.ro	Marinca, Bogdan Valentin/ABG-9480-2020; MARINCA, VASILE/AAA-1750-2021	Marinca, Bogdan Valentin/0000-0003-2340-1280; MARINCA, VASILE/0000-0002-0947-1322				Adomian G, 1998, J MATH ANAL APPL, V135, P507; Ariel PD, 2008, ZAMM-Z ANGEW MATH ME, V88, P320, DOI 10.1002/zamm.200700041; Boutros YZ, 2006, MECCANICA, V41, P681, DOI 10.1007/s11012-006-9014-x; Butt AS, 2015, J TAIWAN INST CHEM E, V48, P8, DOI 10.1016/j.jtice.2014.10.021; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Ene RD, 2014, MATER PLAST, V51, P194; Fang TG, 2011, INT J NONLIN MECH, V46, P1116, DOI 10.1016/j.ijnonlinmec.2011.04.014; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hassan H, 2014, INT J NUMER METHOD H, V24, P419, DOI 10.1108/HFF-08-2011-0158; He JH, 1999, INT J NONLINEAR MECH, V34, P699, DOI 10.1016/S0020-7462(98)00048-1; He JH, 2000, INT J NONLINEAR MECH, V35, P37, DOI 10.1016/S0020-7462(98)00085-7; Herisanu N, 2012, Z NATURFORSCH A, V67, P509, DOI 10.5560/ZNA.2012-0047; Ishak A, 2008, MECCANICA, V43, P411, DOI 10.1007/s11012-007-9103-5; Mahapatra TR, 2007, MECCANICA, V42, P263, DOI 10.1007/s11012-006-9040-8; Marinca V, 2011, COMPUT MATH APPL, V61, P2019, DOI 10.1016/j.camwa.2010.08.056; Marinca V., 2011, NONLINEAR DYNAMICAL; Marinca V, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/139314; Mehmood A, 2010, J TAIWAN INST CHEM E, V41, P29, DOI 10.1016/j.jtice.2009.03.011; Mehmood A, 2006, INT COMMUN HEAT MASS, V33, P1243, DOI 10.1016/j.icheatmasstransfer.2006.08.001; Misra JC, 2008, COMPUT FLUIDS, V37, P1, DOI 10.1016/j.compfluid.2006.09.005; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Munawar S, 2012, COMPUT MATH APPL, V64, P1575, DOI 10.1016/j.camwa.2012.01.003; Pal D, 2009, MECCANICA, V44, P145, DOI 10.1007/s11012-008-9155-1; Parsa AB, 2013, COMPUT BIOL MED, V43, P1142, DOI 10.1016/j.compbiomed.2013.05.019; Rashidi MM, 2012, ENG COMPUTATION, V29, P562, DOI 10.1108/02644401211246283; Rashidi MM, 2009, MOD PHYS LETT B, V23, P3147, DOI 10.1142/S0217984909021193; SAKIADIS BC, 1961, AICHE J, V7, P221, DOI 10.1002/aic.690070211; Turkyilmazoglu M, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/05/055004; Turkyilmazoglu M, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/01/015301; Turkyilmazoglu M, 2011, MATH COMPUT MODEL, V53, P1929, DOI 10.1016/j.mcm.2011.01.022; Turkyilmazoglu M, 2010, INT J MECH SCI, V52, P1735, DOI 10.1016/j.ijmecsci.2010.09.007; Van Gorder RA, 2010, ARCH APPL MECH, V80, P1329, DOI 10.1007/s00419-009-0370-6; Yao SS, 2011, COMMUN NONLINEAR SCI, V16, P752, DOI 10.1016/j.cnsns.2010.05.028	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0149334	10.1371/journal.pone.0149334	http://dx.doi.org/10.1371/journal.pone.0149334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031232	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800004
J	Kato, Y; Ogasawara, S; Oki, H; Goichberg, P; Honma, R; Fujii, Y; Kaneko, MK				Kato, Yukinari; Ogasawara, Satoshi; Oki, Hiroharu; Goichberg, Polina; Honma, Ryusuke; Fujii, Yuki; Kaneko, Mika K.			LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MEMBRANE-PROTEIN; RECEPTOR CLEC-2; MARKER; EXPRESSION; AGGRUS; AGGRUS/PODOPLANIN; RECOGNIZES; BINDING; TUMORS	Podoplanin (PDPN), also known as Aggrus, possesses three tandem repeat of platelet aggregation-stimulating (PLAG) domains in its N-terminus. Among the PLAG domains, sialylated O-glycan on Thr52 of PLAG3 is essential for the binding to C-type lectin-like receptor-2 (CLEC-2) and the platelet-aggregating activity of human PDPN (hPDPN). Although various anti-hPDPN monoclonal antibodies (mAbs) have been generated, no specific mAb has been reported to target the epitope containing glycosylated Thr52. We recently established CasMab technology to develop mAbs against glycosylated membrane proteins. Herein, we report the development of a novel anti-glycopeptide mAb (GpMab), LpMab-12. LpMab-12 detected endogenous hPDPN by flow cytometry. Immunohistochemical analyses also showed that hPDPN-expressing lymphatic endothelial and cancer cells were clearly labeled by LpMab-12. The minimal epitope of LpMab-12 was identified as Asp49-Pro53 of hPDPN. Furthermore, LpMab-12 reacted with the synthetic glycopeptide of hPDPN, corresponding to 38-54 amino acids (hpp3854: (38)-EGGVAMPGAEDDVVTPG-(54)), which carries alpha 2-6 sialylated N-acetyl-D-galactosamine (GalNAc) on Thr52. LpMab-12 did not recognize non-sialylated GalNAc-attached glycopeptide, indicating that sialylated GalNAc on Thr52 is necessary for the binding of LpMab-12 to hPDPN. Thus, LpMab-12 could serve as a new diagnostic tool for determining whether hPDPN possesses the sialylation on Thr52, a site-specific post-translational modification critical for the hPDPN association with CLEC-2.	[Kato, Yukinari; Ogasawara, Satoshi; Oki, Hiroharu; Honma, Ryusuke; Fujii, Yuki; Kaneko, Mika K.] Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Goichberg, Polina] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesia, 75 Francis St, Boston, MA 02115 USA	Tohoku University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kato, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	yukinari-k@bea.hi-ho.ne.jp		Kato, Yukinari/0000-0001-5385-8201; K. Kaneko, Mika/0000-0002-4158-9208	Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED; Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI [25462242, 26440019]; Takeda Science Foundation; American Heart Association	Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association)	This work was supported in part by the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Y.K.); by the Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from Japan Agency for Medical Research and development, AMED (Y.K.); by the Basic Science and Platform Technology Program for Innovative Biological Medicine from AMED (Y.K.); by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number Grant Number 25462242 (Y.K.) and 26440019 (M.K.K.); by Takeda Science Foundation (S.O.); and by the Grant-in-Aid from the American Heart Association (P.G.).	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Honma R, 2016, CRITICAL EPITOPE ANT; Honma Ryusuke, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P41, DOI 10.1089/mab.2015.0066; Kaji C, 2012, ACTA HISTOCHEM CYTOC, V45, P227, DOI 10.1267/ahc.12008; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kaneko Mika K., 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P310, DOI 10.1089/mab.2015.0022; Kaneko Mika K., 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P154, DOI 10.1089/mab.2014.0091; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2004, ONCOGENE, V23, P8552, DOI 10.1038/sj.onc.1207869; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2016, MONOCLON ANTIB IMMUN; Kato Y, 2014, BRAIN TUMOR PATHOL, V31, P23, DOI [10.1007/s10014-014-0202-4, 10.1007/s10014-012-0127-8]; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; Kato Y, 2015, ONCOTARGET, V6, P36003, DOI 10.18632/oncotarget.5339; Kato Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05924; Kato Y, 2010, NUCL MED BIOL, V37, P785, DOI 10.1016/j.nucmedbio.2010.03.010; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Mishima K, 2006, ACTA NEUROPATHOL, V111, P563, DOI 10.1007/s00401-006-0033-4; Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009; Ogasawara S, 2016, ESTABLISHMENT MOUSE; Ogasawara S, 2008, HYBRIDOMA, V27, P259, DOI 10.1089/hyb.2008.0017; Ogasawara Satoshi, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P318, DOI 10.1089/mab.2015.0018; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P396, DOI 10.1089/mab.2015.0041; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P174, DOI 10.1089/mab.2014.0090; Oki Hiroharu, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P44, DOI 10.1089/mab.2014.0087; RISHI AK, 1995, DEV BIOL, V167, P294, DOI 10.1006/dbio.1995.1024; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Sekiguchi T., 2015, ONCOTARGET; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200	39	11	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152912	10.1371/journal.pone.0152912	http://dx.doi.org/10.1371/journal.pone.0152912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031228	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800154
J	Martin, CM; Parthsarathy, V; Hasib, A; Ng, MT; McClean, S; Flatt, PR; Gault, VA; Irwin, N				Martin, Christine M.; Parthsarathy, Vadivel; Hasib, Annie; Ng, Ming T.; McClean, Stephen; Flatt, Peter R.; Gault, Victor A.; Irwin, Nigel			Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin	PLOS ONE			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; DIABETES-MELLITUS; GLUCOSE; SECRETION; MICE; DEGRADATION; GIP; RESISTANCE; HUMANS	Xenin is a peptide that is co-secreted with the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP), from intestinal K-cells in response to feeding. Studies demonstrate that xenin has appetite suppressive effects and modulates glucose-induced insulin secretion. The present study was undertaken to determine the bioactivity and antidiabetic properties of two C-terminal fragment xenin peptides, namely xenin 18-25 and xenin 18-25 Gln. In BRIN-BD11 cells, both xenin fragment peptides concentration-dependently stimulated insulin secretion, with similar efficacy as the parent peptide. Neither fragment peptide had any effect on acute feeding behaviour at elevated doses of 500 nmol/kg bw. When administered together with glucose to normal mice at 25 nmol/kg bw, the overall insulin secretory effect was significantly enhanced in both xenin 18-25 and xenin 18-25 Gln treated mice, with better moderation of blood glucose levels. Twice daily administration of xenin 18-25 or xenin 18-25 Gln for 21 days in high fat fed mice did not affect energy intake, body weight, circulating blood glucose or body fat stores. However, circulating plasma insulin concentrations had a tendency to be elevated, particularly in xenin 18-25 Gln mice. Both treatment regimens significantly improved insulin sensitivity by the end of the treatment period. In addition, sustained treatment with xenin 18-25 Gln significantly reduced the overall glycaemic excursion and augmented the insulinotropic response to an exogenous glucose challenge on day 21. In harmony with this, GIP-mediated glucose-lowering and insulin-releasing effects were substantially improved by twice daily xenin 18-25 Gln treatment. Overall, these data provide evidence that C-terminal octapeptide fragments of xenin, such as xenin 18-25 Gln, have potential therapeutic utility for type 2 diabetes.	[Martin, Christine M.; Parthsarathy, Vadivel; Hasib, Annie; Ng, Ming T.; McClean, Stephen; Flatt, Peter R.; Gault, Victor A.; Irwin, Nigel] Univ Ulster, Biomed Sci Res Inst, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Irwin, N (corresponding author), Univ Ulster, Biomed Sci Res Inst, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland.	n.irwin@ulster.ac.uk	Irwin, Nigel/H-9696-2019	Irwin, Nigel/0000-0003-4855-964X; Flatt, Peter/0000-0001-8548-7943; HASIB, ANNIE/0000-0002-5388-6461; /0000-0002-1610-9663; Parthsarathy, Vadivel/0000-0002-2037-7804; McClean, Stephen/0000-0001-9718-6689	Department of Education and Learning, Northern Ireland; European Foundation; European Regional Development Fund/Invest Northern Ireland (ERDF/INI)	Department of Education and Learning, Northern Ireland; European Foundation(European Science Foundation (ESF)); European Regional Development Fund/Invest Northern Ireland (ERDF/INI)	Studies were supported by the Department of Education and Learning, Northern Ireland, the European Foundation for the Study of Diabetes and a research grant from the European Regional Development Fund/Invest Northern Ireland (ERDF/INI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhury S, 2014, AM J PHYSIOL-GASTR L, V306, pG301, DOI 10.1152/ajpgi.00383.2013; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; FLATT PR, 1981, HORM METAB RES, V13, P556, DOI 10.1055/s-2007-1019334; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gault VA, 2015, ACTA DIABETOL, V52, P461, DOI 10.1007/s00592-014-0681-0; Hamscher G, 1996, PEPTIDES, V17, P889; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Kim ER, 2010, NEUROSCI LETT, V481, P59, DOI 10.1016/j.neulet.2010.06.055; Kim ER, 2014, BEHAV BRAIN RES, V261, P60, DOI 10.1016/j.bbr.2013.12.005; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Martin CMA, 2014, J ENDOCRINOL, V221, P193, DOI 10.1530/JOE-13-0617; Martin CMA, 2012, BIOCHEM PHARMACOL, V84, P312, DOI 10.1016/j.bcp.2012.04.015; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Nandar W, 2008, GEN COMP ENDOCR, V157, P58, DOI 10.1016/j.ygcen.2008.03.012; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Novakovic ZM, 2013, PEPTIDES, V43, P167, DOI 10.1016/j.peptides.2013.02.023; Park JW, 2015, CURR PHARM DESIGN, V21, P3097, DOI 10.2174/1381612821666150531163944; Parthsarathy V, 2016, BIOCH BIOPH IN PRESS; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Schiavo-Cardozo D, 2013, CLIN ENDOCRINOL, V79, P807, DOI 10.1111/cen.12114; Silvestre RA, 2003, REGUL PEPTIDES, V115, P25, DOI 10.1016/S0167-0115(03)00147-2; Taylor AI, 2010, J ENDOCRINOL, V207, P87, DOI 10.1677/JOE-10-0085; Tewari N, 2015, INT J OBESITY, V39, P1575, DOI 10.1038/ijo.2015.100; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; Wice BM, 2012, DIABETES, V61, P1793, DOI 10.2337/db11-1451; Wice BM, 2010, J BIOL CHEM, V285, P19842, DOI 10.1074/jbc.M110.129304	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152818	10.1371/journal.pone.0152818	http://dx.doi.org/10.1371/journal.pone.0152818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032106	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800141
J	Pava, MJ; Makriyannis, A; Lovinger, DM				Pava, Matthew J.; Makriyannis, Alexandros; Lovinger, David M.			Endocannabinoid Signaling Regulates Sleep Stability	PLOS ONE			English	Article							PENTOBARBITAL-INDUCED SLEEP; C-FOS EXPRESSION; TOLERANCE DEVELOPMENT; LATERAL HYPOTHALAMUS; EXTRACELLULAR LEVELS; RECEPTOR ANTAGONIST; MODULATES SLEEP; CROSS-TOLERANCE; CB1 RECEPTORS; WAKE CYCLE	The hypnogenic properties of cannabis have been recognized for centuries, but endogenous cannabinoid (endocannabinoid) regulation of vigilance states is poorly characterized. We report findings from a series of experiments in mice measuring sleep with polysomnography after various systemic pharmacological manipulations of the endocannabinoid system. Rapid, unbiased scoring of vigilance states was achieved using an automated algorithm that we devised and validated. Increasing endocannabinoid tone with a selective inhibitor of monoacyglycerol lipase (JZL184) or fatty acid amide hydrolase (AM3506) produced a transient increase in non-rapid eye movement (NREM) sleep due to an augmentation of the length of NREM bouts (NREM stability). Similarly, direct activation of type 1 cannabinoid (CB1) receptors with CP47,497 increased NREM stability, but both CP47,497 and JZL184 had a secondary effect that reduced NREM sleep time and stability. This secondary response to these drugs was similar to the early effect of CB1 blockade with the antagonist/inverse agonist AM281, which fragmented NREM sleep. The magnitude of the effects produced by JZL184 and AM281 were dependent on the time of day this drug was administered. While activation of CB1 resulted in only a slight reduction in gamma power, CB1 blockade had dramatic effects on broadband power in the EEG, particularly at low frequencies. However, CB1 blockade did not significantly reduce the rebound in NREM sleep following total sleep deprivation. These results support the hypothesis that endocannabinoid signaling through CB1 is necessary for NREM stability but it is not necessary for sleep homeostasis.	[Pava, Matthew J.; Lovinger, David M.] NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, Div Intramural Biol & Clin Res,NIH, Rockville, MD 20852 USA; [Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Northeastern University; Northeastern University; Northeastern University	Lovinger, DM (corresponding author), NIAAA, Sect Synapt Pharmacol, Lab Integrat Neurosci, Div Intramural Biol & Clin Res,NIH, Rockville, MD 20852 USA.	lovindav@mail.nih.gov	Makriyannis, Alexandros/GRF-1518-2022	Makriyannis, Alexandros/0000-0003-3272-3687	United States National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research [ZIA AA000416]; National Institute on Drug Abuse Grant [DA003801]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA003801, R01DA003801] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research; National Institute on Drug Abuse Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the United States National Institutes of Health. DML and MJP received support from the National Institute on Alcohol Abuse and Alcoholism's Division of Intramural Clinical and Biological Research, award number ZIA AA000416 (http://www.niaaa.nih.gov/). AM received support from National Institute on Drug Abuse Grant DA003801 (http://www.drugabuse.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bastianini S, 2014, J NEUROSCI METH, V235, P277, DOI 10.1016/j.jneumeth.2014.07.018; Baud MO, 2015, SLEEP, V38, P567, DOI 10.5665/sleep.4572; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bradbury J B, 1899, Br Med J, V2, P134; BUONAMICI M, 1982, NEUROPHARMACOLOGY, V21, P825, DOI 10.1016/0028-3908(82)90071-5; Ceccarini J, 2015, ADDICT BIOL, V20, P357, DOI 10.1111/adb.12116; Clendinning J, 1843, Med Chir Trans, V26, P188; COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201; Cortes-Briones J, 2015, NEUROPSYCHOPHARMACOL, V40, P2124, DOI 10.1038/npp.2015.53; Davis CJ, 2011, J CLIN SLEEP MED, V7, pS16, DOI 10.5664/JCSM.1346; DIJK DJ, 1990, SLEEP, V13, P430, DOI 10.1093/sleep/13.5.430; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Rueda-Orozco PE, 2010, NEUROSCI LETT, V473, P158, DOI 10.1016/j.neulet.2010.02.044; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; FEINBERG I, 1976, CLIN PHARMACOL THER, V19, P782; Fernandez-Mendoza J, 2015, J SLEEP RES, V24, P390, DOI 10.1111/jsr.12285; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; FUJIMORI M, 1973, PHYSIOL BEHAV, V11, P291, DOI 10.1016/0031-9384(73)90003-6; Garzon J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-11; Gates P, 2016, SUBST ABUS, V37, P255, DOI 10.1080/08897077.2015.1023484; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Goonawardena AV, 2015, BEHAV PHARMACOL, V26, P289, DOI 10.1097/FBP.0000000000000108; Goonawardena Anushka V, 2011, Sleep Disord, V2011, P178469, DOI 10.1155/2011/178469; Gunduz-Cinar O, 2013, MOL PSYCHIATR, V18, P813, DOI 10.1038/mp.2012.72; Hajos M, 2008, BIOL PSYCHIAT, V63, P1075, DOI 10.1016/j.biopsych.2007.12.005; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; He JY, 2015, J MOL NEUROSCI, V55, P644, DOI 10.1007/s12031-014-0403-7; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jacobson LH, 2011, N-S ARCH PHARMACOL, V384, P565, DOI 10.1007/s00210-011-0686-y; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim D, 2015, SLEEP, V38, P85, DOI 10.5665/sleep.4330; Kim T, 2015, NEUROSCIENCE, V303, P211, DOI 10.1016/j.neuroscience.2015.06.037; Kucewicz MT, 2011, J NEUROSCI, V31, P15560, DOI 10.1523/JNEUROSCI.2970-11.2011; Liedhegner ES, 2014, J NEUROCHEM, V128, P491, DOI 10.1111/jnc.12495; Lin Shih-Chieh, 2008, P145; MACKIE K, 1993, MOL PHARMACOL, V44, P498; Mang Geraldine Morgane, 2012, Curr Protoc Mouse Biol, V2, P55, DOI 10.1002/9780470942390.mo110126; Martinez-Vargas M, 2013, INT J MOL SCI, V14, P23341, DOI 10.3390/ijms141223341; MELVIN LS, 1993, MOL PHARMACOL, V44, P1008; Mendelson WB, 1999, NEUROREPORT, V10, P3237, DOI 10.1097/00001756-199910190-00021; MORETON JE, 1973, NEUROPHARMACOLOGY, V12, P897, DOI 10.1016/0028-3908(73)90042-7; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 2001, NEUROREPORT, V12, P2131, DOI 10.1097/00001756-200107200-00018; Murillo-Rodriguez E, 1998, BRAIN RES, V812, P270, DOI 10.1016/S0006-8993(98)00969-X; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Murillo-Rodriguez E, 2013, PHYSIOL BEHAV, V109, P88, DOI 10.1016/j.physbeh.2012.11.007; Murillo-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020766; Nathan PJ, 2011, CNS NEUROSCI THER, V17, P490, DOI 10.1111/j.1755-5949.2010.00172.x; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; OShaughnessy WB, 1843, PROV MED J RETROSPEC, V5, P363, DOI DOI 10.1136/BMJ.S1-5.123.363; Pava MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088672; Perez-Morales M, 2013, PHARMACOL BIOCHEM BE, V108, P1, DOI 10.1016/j.pbb.2013.04.006; Perez-Morales M, 2012, NEUROREPORT, V23, P814, DOI 10.1097/WNR.0b013e328357615a; Ringgold KM, 2013, J NEUROSCI METH, V219, P104, DOI 10.1016/j.jneumeth.2013.07.008; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Russo E, 2005, MIL DRUG TH, P1; RYAN LJ, 1984, BRAIN RES BULL, V13, P549, DOI 10.1016/0361-9230(84)90037-6; Sales-Carbonell C, 2013, P NATL ACAD SCI USA, V110, P719, DOI 10.1073/pnas.1217144110; Sanford AE, 2008, BRAIN RES, V1222, P141, DOI 10.1016/j.brainres.2008.05.048; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Sim LJ, 1996, J NEUROSCI, V16, P8057; Srinivasan BV, 2010, GPUML GRAPHICAL PROC; Steinberg BA, 2007, AM J CARDIOL, V100, p27P, DOI [10.1016/j.amjcard.2007.10.011, 10.1016/.j.amjcard.2007.10.011]; Sunagawa GA, 2013, GENES CELLS, V18, P502, DOI 10.1111/gtc.12053; TURKANIS SA, 1982, NEUROPHARMACOLOGY, V21, P7, DOI 10.1016/0028-3908(82)90204-0; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; WALLACH MB, 1973, EUR J PHARMACOL, V24, P172, DOI 10.1016/0014-2999(73)90068-X; Wallich G C, 1883, Br Med J, V1, P1224; WATANABE K, 1982, EUR J PHARMACOL, V77, P53, DOI 10.1016/0014-2999(82)90535-0; WATANABE K, 1987, J PHARM PHARMACOL, V39, P945, DOI 10.1111/j.2042-7158.1987.tb03136.x; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Yasuo S, 2010, CELL TISSUE RES, V340, P127, DOI 10.1007/s00441-010-0930-7; ZARCONE VP, 1973, PSYCHIAT MED, V4, P201, DOI 10.2190/BA5B-1LVX-0LQ5-XV02; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	86	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152473	10.1371/journal.pone.0152473	http://dx.doi.org/10.1371/journal.pone.0152473			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031992	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800080
J	van Dijk, LV; Steenbakkers, RJHM; ten Haken, B; van der Laan, HP; van 't Veld, AA; Langendijk, JA; Korevaar, EW				van Dijk, Lisanne V.; Steenbakkers, Roel J. H. M.; ten Haken, Bennie; van der Laan, Hans Paul; van 't Veld, Aart A.; Langendijk, Johannes A.; Korevaar, Erik W.			Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients	PLOS ONE			English	Article							SET-UP ERRORS; RANGE UNCERTAINTIES; TREATMENT PLANS; RADIOTHERAPY; OPTIMIZATION; MARGINS; PROBABILITY; SENSITIVITY; ACCOUNT; IMPACT	Purpose To compare the clinical benefit of robust optimized Intensity Modulated Proton Therapy (minimax IMPT) with current photon Intensity Modulated Radiation Therapy (IMRT) and PTV-based IMPT for head and neck cancer (HNC) patients. The clinical benefit is quantified in terms of both Normal Tissue Complication Probability (NTCP) and target coverage in the case of setup and range errors. Methods and Materials For 10 HNC patients, PTV-based IMRT (7 fields), minimax and PTV-based IMPT (2, 3, 4, 5 and 7 fields) plans were tested on robustness. Robust optimized plans differed from PTV-based plans in that they target the CTV and penalize possible error scenarios, instead of using the static isotropic CTV-PTV margin. Perturbed dose distributions of all plans were acquired by simulating in total 8060 setup (+/- 3.5 mm) and range error (+/- 3%) combinations. NTCP models for xerostomia and dysphagia were used to predict the clinical benefit of IMPT versus IMRT. Results The robustness criterion was met in the IMRT and minimax IMPT plans in all error scenarios, but this was only the case in 1 of 40 PTV-based IMPT plans. Seven (out of 10) patients had relatively large NTCP reductions in minimax IMPT plans compared to IMRT. For these patients, xerostomia and dysphagia NTCP values were reduced by 17.0% (95% CI; 13.0-21.1) and 8.1% (95% CI; 4.9-11.2) on average with minimax IMPT. Increasing the number of fields did not contribute to plan robustness, but improved organ sparing. Conclusions The estimated clinical benefit in terms of NTCP of robust optimized (minimax) IMPT is greater than that of IMRT and PTV-based IMPT in HNC patients. Furthermore, the target coverage of minimax IMPT plans in the presence of errors was comparable to IMRT plans.	[van Dijk, Lisanne V.; Steenbakkers, Roel J. H. M.; van der Laan, Hans Paul; van 't Veld, Aart A.; Langendijk, Johannes A.; Korevaar, Erik W.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [van Dijk, Lisanne V.; ten Haken, Bennie] Univ Twente, Inst Biomed Technol & Tech Med MIRA, POB 217, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Twente	van Dijk, LV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands.; van Dijk, LV (corresponding author), Univ Twente, Inst Biomed Technol & Tech Med MIRA, POB 217, NL-7500 AE Enschede, Netherlands.	l.v.van.dijk@umcg.nl	van Dijk, Lisanne/AAA-2199-2021; Haken, Bennie ten/AAI-9083-2020; Korevaar, Erik/N-2912-2013	Langendijk, Johannes A./0000-0003-1083-372X				Albertini F, 2011, PHYS MED BIOL, V56, P4399, DOI 10.1088/0031-9155/56/14/011; [Anonymous], 1993, 50 ICRU; [Anonymous], 2010, 83 ICRU; Christianen MEMC, 2012, RADIOTHER ONCOL, V105, P107, DOI 10.1016/j.radonc.2011.08.009; Cochran DM, 2008, INT J RADIAT ONCOL, V70, P1336, DOI 10.1016/j.ijrobp.2007.08.027; Dionisi F, 2013, INT J CLIN ONCOL, V18, P418, DOI 10.1007/s10147-012-0395-7; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; Engelsman M, 2005, MED PHYS, V32, P3549, DOI 10.1118/1.2126187; Fontanarosa D, 2013, RADIOTHER ONCOL, V109, P430, DOI 10.1016/j.radonc.2013.07.012; Fredriksson A, 2014, MED PHYS, V41, P48, DOI 10.1118/1.4883837; Fredriksson A, 2011, MED PHYS, V38, P1672, DOI 10.1118/1.3556559; Hansen DC, 2015, ACTA ONCOL, P1; Harding R, 2014, MED PHYS, V41, DOI 10.1118/1.4897571; Hopfgartner J, 2013, ACTA ONCOL, V52, P570, DOI 10.3109/0284186X.2012.744874; Houweling AC, 2010, INT J RADIAT ONCOL, V76, P1259, DOI 10.1016/j.ijrobp.2009.07.1685; Jakobi A, 2015, INT J RADIAT ONCOL, V92, P1165, DOI 10.1016/j.ijrobp.2015.04.031; Kraan AC, 2013, INT J RADIAT ONCOL, V87, P888, DOI 10.1016/j.ijrobp.2013.09.014; Langendijk JA, 2008, J CLIN ONCOL, V26, P3770, DOI 10.1200/JCO.2007.14.6647; Langendijk JA, 2013, RADIOTHER ONCOL, V107, P267, DOI 10.1016/j.radonc.2013.05.007; Lomax A, 1999, PHYS MED BIOL, V44, P185, DOI 10.1088/0031-9155/44/1/014; Lomax AJ, 2008, PHYS MED BIOL, V53, P1027, DOI 10.1088/0031-9155/53/4/014; Moyers MF, 2010, MED DOSIM, V35, P179, DOI 10.1016/j.meddos.2009.05.004; Park Peter C, 2012, Int J Radiat Oncol Biol Phys, V82, pe329, DOI 10.1016/j.ijrobp.2011.05.011; Pflugfelder D, 2008, PHYS MED BIOL, V53, P1689, DOI 10.1088/0031-9155/53/6/013; Rischin D, 2002, J CLIN ONCOL, V20, P1845, DOI 10.1200/JCO.2002.07.011; Simone CB, 2011, RADIOTHER ONCOL, V101, P376, DOI 10.1016/j.radonc.2011.05.028; Stuschke M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-145; Unkelbach J, 2007, PHYS MED BIOL, V52, P2755, DOI 10.1088/0031-9155/52/10/009; Unkelbach J, 2009, MED PHYS, V36, P149, DOI 10.1118/1.3021139; van de Water TA, 2011, INT J RADIAT ONCOL, V79, P1216, DOI 10.1016/j.ijrobp.2010.05.012; van de Water TA, 2011, ONCOLOGIST, V16, P366, DOI 10.1634/theoncologist.2010-0171; van der Laan HP, 2012, RADIOTHER ONCOL, V103, P76, DOI 10.1016/j.radonc.2011.11.001; van Herk M, 2000, INT J RADIAT ONCOL, V47, P1121, DOI 10.1016/S0360-3016(00)00518-6; Widesott L, 2008, INT J RADIAT ONCOL, V72, P589, DOI 10.1016/j.ijrobp.2008.05.065	34	40	41	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152477	10.1371/journal.pone.0152477	http://dx.doi.org/10.1371/journal.pone.0152477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030987	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800082
J	Zhou, B; Zhang, L; Ullah, A; Jin, X; Yang, XY; Zhang, XL				Zhou, Bin; Zhang, Lin; Ullah, Abid; Jin, Xin; Yang, Xiyan; Zhang, Xianlong			Identification of Multiple Stress Responsive Genes by Sequencing a Normalized cDNA Library from Sea-Land Cotton (Gossypium barbadense L.)	PLOS ONE			English	Article							ABIOTIC STRESS; ABSCISIC-ACID; PROTEIN-KINASES; TRANSCRIPTION FACTORS; VERTICILLIUM-DAHLIAE; SALT-STRESS; FUNCTIONAL-CHARACTERIZATION; SIGNALING PATHWAYS; OXIDATIVE STRESS; CHILLING STRESS	Background Plants often face multiple stresses including drought, extreme temperature, salinity, nutrition deficiency and biotic stresses during growth and development. All the stresses result in a series of physiological and metabolic reactions and then generate reversible inhibition of metabolism and growth and can cause seriously irreversible damage, even death. At each stage of cotton growth, environmental stress conditions pose devastating threats to plant growth and development, especially yield and quality. Due to the complex stress conditions and unclear molecular mechanisms of stress response, there is an urgent need to explore the mechanisms of cotton response against abiotic stresses. Methodology and Principal Findings A normalized cDNA library was constructed using Gossypium barbadense Hai-7124 treated with different stress conditions (heat, cold, salt, drought, potassium and phosphorus deficit and Verticillium dahliae infection). Random sequencing of this library generated 6,047 high-quality expressed sequence tags (ESTs). The ESTs were clustered and assembled into 3,135 uniESTs, composed of 2,497 contigs and 638 singletons. The blastx results demonstrated 2,746 unigenes showing significant similarity to known genes, 74 uniESTs displaying significant similarity to genes of predicted proteins, and 315 uniESTs remain uncharacterized. Functional classification unveiled the abundance of uniESTs in binding, catalytic activity, and structural molecule activity. Annotations of the uniESTs by the plant transcription factor database (PlantTFDB) and Plant Stress Protein Database (PSPDB) disclosed that transcription factors and stress-related genes were enriched in the current library. The expression of some transcription factors and specific stress-related genes were verified by RT-PCR under various stress conditions. Conclusions/Significance Annotation results showed that a huge number of genes respond to stress in our study, such as MYB-related, C2H2, FAR1, bHLH, bZIP, MADS, and mTERF. These results will improve our knowledge of stress tolerance in cotton. In addition, they are also helpful in discovering candidate genes related to stress tolerance. The publicly available ESTs from G. barbadense are a valuable genomic resource that will facilitate further molecular study and breeding of stress-tolerant cotton.	[Zhou, Bin; Zhang, Lin; Ullah, Abid; Jin, Xin; Yang, Xiyan; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University	Yang, XY (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.	yxy@mail.hzau.edu.cn	Ullah, Abid/AAD-1241-2020	Ullah, Abid/0000-0003-2389-3916	National Natural Science Foundation of China [31371675]; Fundamental Research Funds for the Central Universities [2014PY028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported through funding from the National Natural Science Foundation of China (31371675) (XY) http://www.nsfc.gov.cn/ and the Fundamental Research Funds for the Central Universities (2014PY028)(XY). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; Chaudhary B, 2008, EVOL DEV, V10, P567, DOI 10.1111/j.1525-142X.2008.00272.x; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Gai YP, 2008, J AGRON CROP SCI, V194, P278, DOI 10.1111/j.1439-037X.2008.00311.x; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Jiang ZQ, 2010, J GENET GENOMICS, V37, P219, DOI 10.1016/S1673-8527(09)60040-0; KEBEDE H, 2015, INT J PLANT GENOMICS, DOI [10.1155/2015/892716, DOI 10.1155/2015/892716]; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kumar SA, 2014, PLANT MOL BIOL REP, V32, P940, DOI 10.1007/s11105-014-0698-0; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu WW, 2014, NEW PHYTOL, V201, P1192, DOI 10.1111/nph.12607; Loka DA, 2014, S AFR J BOT, V93, P131, DOI 10.1016/j.sajb.2014.03.019; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mehrotra R, 2014, J PLANT PHYSIOL, V171, P486, DOI 10.1016/j.jplph.2013.12.007; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nam SH, 2009, BIOINFORMATICS, V25, P1846, DOI 10.1093/bioinformatics/btp293; Nobili A, 2016, CONSTR BUILD MATER, V105, P465, DOI 10.1016/j.conbuildmat.2015.12.173; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Parkinson J, 2003, BIOINFORMATICS, V19, P390, DOI 10.1093/bioinformatics/btf870; Pastori GM, 2002, PLANT PHYSIOL, V129, P460, DOI 10.1104/pp.011021; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; SHANNON MC, 1977, AGRON J, V69, P619, DOI 10.2134/agronj1977.00021962006900040024x; Shi GY, 2015, PLANT CELL REP, V34, P1005, DOI 10.1007/s00299-015-1761-5; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tian MM, 2015, PLANT J, V82, P81, DOI 10.1111/tpj.12797; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Wang H, 2016, CHINESE GEOGR SCI, V26, P35, DOI 10.1007/s11769-015-0762-1; Wei XZ, 2009, PROG NAT SCI-MATER, V19, P173, DOI 10.1016/j.pnsc.2008.06.016; White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128; Wu CA, 2004, PLANT CELL PHYSIOL, V45, P600, DOI 10.1093/pcp/pch071; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Xu L, 2014, J EXP BOT, V65, P6679, DOI 10.1093/jxb/eru393; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zhang F, 2015, PLANT MOL BIOL, V87, P47, DOI 10.1007/s11103-014-0260-3; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120; Zhang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-637; Zhao J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-110; Zhu LongFu, 2005, Acta Agronomica Sinica, V31, P1657	86	25	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152927	10.1371/journal.pone.0152927	http://dx.doi.org/10.1371/journal.pone.0152927			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031331	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800155
J	Chomicki, G; Renner, SS				Chomicki, Guillaume; Renner, Susanne S.			Evolutionary Relationships and Biogeography of the Ant-Epiphytic Genus Squamellaria (Rubiaceae: Psychotrieae) and Their Taxonomic Implications	PLOS ONE			English	Article							TUBEROUS EPIPHYTES; REVISION; MODEL; PHYLOGENETICS; REVEAL; PLANTS	Ecological research on ant/plant symbioses in Fiji, combined with molecular phylogenetics, has brought to light four new species of Squamellaria in the subtribe Hydnophytinae of the Rubiaceae tribe Psychotrieae and revealed that four other species, previously in Hydnophytum, need to be transferred to Squamellaria. The diagnoses of the new species are based on morphological and DNA traits, with further insights from microCT scanning of flowers and leaf delta C-13 ratios (associated with Crassulacean acid metabolism). Our field and phylogenetic work results in a new circumscription of the genus Squamellaria, which now contains 12 species (to which we also provide a taxonomic key), not 3 as in the last revision. A clock-dated phylogeny and a model-testing biogeographic framework were used to infer the broader geographic history of rubiaceous ant plants in the Pacific, specifically the successive expansion of Squamellaria to Vanuatu, the Solomon Islands, and Fiji. The colonization of Vanuatu may have occurred from Fiji, when these islands were still in the same insular arc, while the colonization of the Solomon islands may have occurred after the separation of this island from the Fiji/Vanuatu arc. Some of these ant-housing epiphytes must have dispersed with their specialized ants, for instance attached to floating timber. Others acquired new ant symbionts on different islands.	[Chomicki, Guillaume; Renner, Susanne S.] Univ Munich LMU, Systemat Bot & Mycol, Menzinger Str 67, D-80638 Munich, Germany	University of Munich	Chomicki, G (corresponding author), Univ Munich LMU, Systemat Bot & Mycol, Menzinger Str 67, D-80638 Munich, Germany.	guillaume.chomicki@gmail.com		Chomicki, Guillaume/0000-0003-4547-6195	German Research Foundation (DFG) [RE 603/20]; Society of Systematic Biologists; American Association of Plant Taxonomy; Stavros Niarchos Foundation; French Fonds Pacifique; Total Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Society of Systematic Biologists; American Association of Plant Taxonomy; Stavros Niarchos Foundation; French Fonds Pacifique; Total Foundation(Total SA)	This work was supported by a grant from the German Research Foundation (DFG), RE 603/20, and grants from the Society of Systematic Biologists and the American Association of Plant Taxonomy to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jeremy Aroles for help in the field; Two anonymous reviewers for comments on the manuscript; Bruno Corbara and Derrick Rowe for photographs; Alivereti Naikatini and Marika Tuiwawa from the University of South Pacific and the herbarium SUVA for technical support and advice; Gudrun Kadereit, University of Mainz, for the isotope-ratio mass spectrometry analyses carried out at the University of Mainz; Matthew Jebb and Sylvain Razafimandimbison for taxonomic advice, and Yannick Staedler for providing the microCT scanning images in Fig 3. Yasumin S. Lermer from the Botanical Institute in Munich drew two plates (S. huxleyana and S. grayi), and Rosemary Wise from Oxford drew the S. vanuatensis plate. Curators at Dublin (DUB), Kew (K), Leiden (L), Munich (M and MSB), Oxford (FHO), Paris (P), Sydney (NSW), and SUVA provided access to relevant collections. Material from Vanuatu was collected during "SANTO 2006", an international expedition organized by the Paris Natural History Museum, Pro-Natura International, and the Institut de Recherche pour le Developpement, and sponsored by the Stavros Niarchos Foundation, the French Fonds Pacifique and the Total Foundation. The expedition operated under a permit granted to Prof. P. Bouchet by the Environment Unit of the Government of Vanuatu. This work was supported by a grant from the German Research Foundation (DFG), RE 603/20, and grants from the Society of Systematic Biologists and the American Association of Plant Taxonomy to GC.	[Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker JG, 1884, J LINN SOC LOND BOT, V20, P358; Barosi F., 2010, GEOSTORIE, V18, P7; Barrabe L, 2014, MOL PHYLOGENET EVOL, V71, P15, DOI 10.1016/j.ympev.2013.10.020; Beccari O, 1884, MALESIA GENOA, VII; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chomicki G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2200; Chomicki G, 2015, NEW PHYTOL, V207, P411, DOI 10.1111/nph.13271; Chomicki G, 2015, NEW PHYTOL, V205, P526, DOI 10.1111/nph.13163; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ewart FT, 1988, CICADAS FIJI SAMOA T; Gray A, 1858, P AM ACAD ARTS SCI, V4, P31; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Heim DR, 1988, 1896 SMITHS, P411; Horne J., 1881, YEAR FIJI INQUIRY BO; HUXLEY CR, 1978, NEW PHYTOL, V80, P231, DOI 10.1111/j.1469-8137.1978.tb02285.x; HUXLEY CR, 1993, BLUMEA, V37, P271; HUXLEY CR, 1991, BLUMEA, V36, P1; HUXLEY CR, 1991, BLUMEA, V36, P21; HUXLEY CR, 1991, BLUMEA, V36, P43; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; JANZEN D H, 1974, Biotropica, V6, P237, DOI 10.2307/2989668; JEBB M, 1991, ANT - PLANT INTERACTIONS, P374; JEBB MHP, 1991, BLUMEA, V36, P53; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Lin H-L, 2012, PACIFIC ASIA INQUIRY, V3, P41; Maddison WP, 2009, MESQUITE MODULAR SYS; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; Miehe H, 1991, BIOL ZBL, V31, P73; Rambaut A, 2012, FIGTREE V 1 4 0; Razafimandimbison SG, 2014, AM J BOT, V101, P1102, DOI 10.3732/ajb.1400076; RODDA P, 1994, SOPAC TECHNICAL B, V8, P131; RODDA P., 1984, CENOZOIC TECTONIC DE, V6, P87; Smith AC, 1967, CONTRIB US NATL HERB, V37, P67; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taylor GK, 2000, J GEOPHYS RES-SOL EA, V105, P5771, DOI 10.1029/1999JB900305; Treub MM, 1888, ANN JARDIN BOT BUITE, V7, P191; Treub MM, 1883, ANN JARD BOT BUITENZ, V3, P129; Wagner Warren L., 2001, Allertonia, V8, P329	41	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151317	10.1371/journal.pone.0151317	http://dx.doi.org/10.1371/journal.pone.0151317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028599	Green Published, gold, Green Submitted			2022-12-27	WOS:000373116500022
J	Brandtneris, VW; Brandt, ME; Glynn, PW; Gyory, J; Smith, TB				Brandtneris, Viktor W.; Brandt, Marilyn E.; Glynn, Peter W.; Gyory, Joanna; Smith, Tyler B.			Seasonal Variability in Calorimetric Energy Content of Two Caribbean Mesophotic Corals	PLOS ONE			English	Article							REEF CORAL; SCLERACTINIAN CORALS; MONTASTRAEA-CAVERNOSA; ENVIRONMENTAL-STRESS; PORITES-ASTREOIDES; BLEACHED CORALS; MORTALITY RISK; CLIMATE-CHANGE; RED-SEA; TEMPERATURE	Energetic responses of zooxanthellate reef corals along depth gradients have relevance to the refugia potential of mesophotic coral ecosystems (MCEs). Previous observations suggested that MCEs in the Caribbean are thermally buffered during the warmest parts of the year and occur within or just below the chlorophyll maximum, suggesting abundant trophic resources. However, it is not known if mesophotic corals can maintain constant energy needs throughout the year with changing environmental and biological conditions. The energetic content of tissues from the stony coral species Orbicella faveolata and Agaricia lamarcki was measured on the southern insular shelf of St. Thomas, US Virgin Islands (USVI), using micro-bomb calorimetry. Three sites for each species, at depths of 6m, 25m, 38m and 63m, were selected to capture energetic differences across the major vertical range extent of both species in the USVI-and sampled over five periods from April 2013 to April 2014. Mesophotic colonies of O. faveolata exhibited a significant reduction in energetic content during the month of September 2013 compared to mid-depth and shallow colonies (p = 0.032), whereas A. lamarcki experienced similar energetic variability, but with a significant reduction in energy content that occurred in July 2013 for colonies at sites deeper than 25m (p = 0.014). The results of calorimetric analyses indicate that O. faveolata may be at risk during late summer stress events, possibly due to the timing of reproductive activities. The low-point of A. lamarcki energy content, which may also coincide with reproduction, occurs prior to seasonal stress events, indicating contrasting, species-specific responses to environmental variability on MCEs.	[Brandtneris, Viktor W.; Brandt, Marilyn E.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Glynn, Peter W.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Gyory, Joanna] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	University of the Virgin Islands; University of Miami; Tulane University	Brandtneris, VW (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	vwbrandt@gmail.com			Black Coral Penalty Fund (US Justice Departments); Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation) [0814417]; Lana Vento Charitable Trust	Black Coral Penalty Fund (US Justice Departments); Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation); Lana Vento Charitable Trust	Funding was provided by the Black Coral Penalty Fund (US Justice Departments), the Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation #0814417) and the Lana Vento Charitable Trust. No funding agency participated in the design or interpretation of the research.	Alamaru A, 2009, GEOCHIM COSMOCHIM AC, V73, P5333, DOI 10.1016/j.gca.2009.06.018; Allemand D, CORAL REFS ECOSYSTEM, P119; Anlauf H, 2011, J EXP MAR BIOL ECOL, V397, P13, DOI 10.1016/j.jembe.2010.11.009; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BAKER PA, 1975, PHYS EARTH PLANET IN, V10, P135, DOI 10.1016/0031-9201(75)90031-X; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140297; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crandall JB, 2016, J EXP MAR BIOL ECOL, V474, P133, DOI 10.1016/j.jembe.2015.10.010; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Edmunds PJ, 2001, MAR BIOL, V139, P981; Gleason DF, 2006, MAR BIOL, V148, P503, DOI 10.1007/s00227-005-0098-y; Glynn PW, 2011, B MAR SCI, V87, P767, DOI 10.5343/bms.2010.1025; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GOLLEY FB, 1961, ECOLOGY, V42, P581, DOI 10.2307/1932247; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2011, SCIENCE, V334, P1494, DOI 10.1126/science.334.6062.1494-b; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2000, LIMNOL OCEANOGR, V45, P76, DOI 10.4319/lo.2000.45.1.0076; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; NOAA, 2006, TROP OC COR BLEACH I; PAINE RT, 1966, LIMNOL OCEANOGR, V11, P126, DOI 10.4319/lo.1966.11.1.0126; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Pratchett MS, 2015, OCEANOGR MAR BIOL, V53, P215; Putnam HM, 2008, BIOL BULL-US, V215, P135, DOI 10.2307/25470694; RICHMOND RH, 1987, B MAR SCI, V41, P594; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Richmond RH, 1981, P 4 INT COR REEF S M; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Smith TB, 2014, US VIRGIN ISLANDS TE; Smith TB, 2016, GLOBAL CHANGE BIOL, V22, P2756, DOI 10.1111/gcb.13175; STEINER SCC, 1995, B MAR SCI, V56, P899; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; Szmant AM, 1997, MAR BIOL, V129, P561, DOI 10.1007/s002270050197; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Thomas CJ, 2015, DIVERS DISTRIB, V21, P1254, DOI 10.1111/ddi.12360; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; van Moorsel GWNM, 1982, P 4 INT COR REEF S M; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Ziegler M, 2014, CORAL REEFS, V33, P1115, DOI 10.1007/s00338-014-1192-8	56	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151953	10.1371/journal.pone.0151953	http://dx.doi.org/10.1371/journal.pone.0151953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050430	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500018
J	Iguchi-Manaka, A; Okumura, G; Kojima, H; Cho, Y; Hirochika, R; Bando, H; Sato, T; Yoshikawa, H; Hara, H; Shibuya, A; Shibuya, K				Iguchi-Manaka, Akiko; Okumura, Genki; Kojima, Hiroshi; Cho, Yukiko; Hirochika, Rei; Bando, Hiroko; Sato, Toyomi; Yoshikawa, Hiroyuki; Hara, Hisato; Shibuya, Akira; Shibuya, Kazuko			Increased Soluble CD155 in the Serum of Cancer Patients	PLOS ONE			English	Article							POLIOVIRUS RECEPTOR CD155; NK CELL RECOGNITION; DNAM-1 CD226; ADHESION MOLECULE; FAMILY LIGANDS; POOR-PROGNOSIS; NECTIN-2 CD112; CUTTING EDGE; PVR CD155; EXPRESSION	Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many human tumors significantly upregulate the expression of CD155; DNAM-1 on CTL and NK cells may be involved in tumor immunity. However, unlike those in mice, human tissues also express soluble isoforms of CD155 (sCD155) that lack the transmembrane region. Here, we show that sCD155 levels were significantly higher in the sera of 262 patients with lung, gastrointestinal, breast, and gynecologic cancers than in sera from healthy donors. In addition, the sCD155 levels were significantly higher in patients with early stage (stages 1 and 2) gastric cancer than in healthy donors, and were significantly higher in patients with advanced stage (stages 3 and 4) disease than in patients in those with early stage disease and healthy donors. Moreover, the sCD155 levels were significantly decreased after surgical resection of cancers. Thus, sCD155 level in serum may be potentially useful as a biomarker for cancer development and progression.	[Iguchi-Manaka, Akiko; Bando, Hiroko; Hara, Hisato] Univ Tsukuba, Fac Med, Dept Breast & Endocrine Surg, Tsukuba, Ibaraki, Japan; [Iguchi-Manaka, Akiko; Okumura, Genki; Hirochika, Rei; Shibuya, Akira; Shibuya, Kazuko] Univ Tsukuba, Fac Med, Immunol, Tsukuba, Ibaraki, Japan; [Kojima, Hiroshi] Univ Tsukuba Hosp, Ibaraki Clin Educ & Training Ctr, Tsukuba, Ibaraki, Japan; [Kojima, Hiroshi; Cho, Yukiko] Ibaraki Cent Hosp, Dept Clin Oncol, Kasama, Ibaraki, Japan; [Sato, Toyomi; Yoshikawa, Hiroyuki] Univ Tsukuba, Obstet & Gynecol, Fac Med, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, CREST, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo, Japan; [Yoshikawa, Hiroyuki] Ibaraki Cent Hosp, Kasama, Ibaraki 3091793, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Shibuya, K (corresponding author), Univ Tsukuba, Fac Med, Immunol, Tsukuba, Ibaraki, Japan.	kazukos@md.tsukuba.ac.jp		Iguchi, Akiko/0000-0002-0338-130X	Ministry of Education, Culture, Sports, Science and Technology of Japan [26861038, 24249021, 25114701]; Grants-in-Aid for Scientific Research [15K15659, 25293091, 16K14629] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 26861038, 24249021 and 25114701 to AI-M, AS, and KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baury W, 2003, BIOCHEM BIOPH RES CO, V309, P175, DOI 10.1016/S0006-291X(03)01560-2; Bevelacqua V, 2012, ONCOTARGET, V3, P879; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Iwasaki A, 2002, J INFECT DIS, V186, P585, DOI 10.1086/342682; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Midis GP, 1996, CANCER RES, V56, P3870; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2005, BIOCHEM BIOPH RES CO, V329, P996, DOI 10.1016/j.bbrc.2005.02.067; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Ugurel S, 2001, CLIN CANCER RES, V7, P1282; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	38	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152982	10.1371/journal.pone.0152982	http://dx.doi.org/10.1371/journal.pone.0152982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049654	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500077
J	Liu, J; Yan, HF; Ge, XJ				Liu, Juan; Yan, Hai-Fei; Ge, Xue-Jun			The Use of DNA Barcoding on Recently Diverged Species in the Genus Gentiana (Gentianaceae) in China	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; NUCLEOTIDE-SEQUENCES; PHYLOGENY; PLANTS; ITS2; IDENTIFICATION; BIOGEOGRAPHY; EVOLUTION; CRUCIATA; LOCI	DNA barcoding of plants poses particular challenges, especially in differentiating, recently diverged taxa. The genus Gentiana (Gentianaceae) is a species-rich plant group which rapidly radiated in the Himalaya-Hengduan Mountains in China. In this study, we tested the core plant barcode (rbcL + matK) and three promising complementary barcodes (trnH-psbA, ITSand ITS2) in 30 Gentiana species across 6 sections using three methods (the genetic distance-based method, Best CloseMatch and tree-based method). rbcL had the highest PCR efficiency and sequencing success (100%), while the lowest sequence recoverability was from ITS (68.35%). The presence of indels and inversions in trnH-psbA in Gentiana led to difficulties in sequence alignment. When using a single region for analysis, ITS exhibited the highest discriminatory power (60%-74.42%). Of the combinations, matK + ITS provided the highest discrimination success (71.43%-88.24%) and is recommended as the DNA barcode for the genus Gentiana. DNA barcoding proved effective in assigning most species to sections, though it performed poorly in some closely related species in sect. Cruciata because of hybridization events. Our analysis suggests that the status of G. pseudosquarrosa needs to be studied further. The utility of DNA barcoding was also verified in authenticating 'Qin-Jiao' Gentiana medicinal plants (G. macrophylla, G. crassicaulis, G. straminea, and G. dahurica), which can help ensure safe and correct usage of these well-known Chinese traditional medicinal herbs.	[Liu, Juan] Jiangxi Agr Univ, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Peoples R China; [Yan, Hai-Fei; Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China	Jiangxi Agricultural University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Ge, XJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475; Liu, Juan/0000-0002-6912-1068	National Key Basic Research Program of China (973 Program) [2014CB954100]; Ministry of Science and Technology of the People's Republic of China (MOST) [2011FY120200]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China)	This work was funded by National Key Basic Research Program of China (973 Program) (Grant No. 2014CB954100) [http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm]; the Ministry of Science and Technology of the People's Republic of China (MOST Grant No. 2011FY120200) [http://www.most.gov.cn/eng/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Codes G, 2000, SEQUENCHER VERSION 4; Costion C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026841; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho T.N., 2001, WORLDWIDE MONOGRAPH; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li Xiao-Juan, 2007, Acta Botanica Yunnanica, V29, P91; Liu J, 2015, DIVERS DISTRIB, V21, P188, DOI 10.1111/ddi.12276; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Mahadani P, 2013, PHARMACOGN MAG, V9, P255, DOI 10.4103/0973-1296.113284; Mankga LT, 2013, ZOOKEYS, P215, DOI 10.3897/zookeys.365.5730; Miller AM, 2010, P GAT COM ENV WORKSH; Mishiba K, 2009, BREEDING SCI, V59, P119, DOI 10.1270/jsbbs.59.119; Nalawade SM, 2003, BOT BULL ACAD SINICA, V44, P79; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Pang XH, 2013, J NAT MED-TOKYO, V67, P571, DOI 10.1007/s11418-012-0715-2; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Rambaut A, 2007, SE AL VERSION2 0A11; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Techen N, 2014, CURR OPIN BIOTECH, V25, P103, DOI 10.1016/j.copbio.2013.09.010; Wang YM, 2013, J ETHNOPHARMACOL, V147, P341, DOI 10.1016/j.jep.2013.03.016; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wong KL, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-16; Wu LH, 2012, BIOCHEM SYST ECOL, V43, P152, DOI 10.1016/j.bse.2012.03.008; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xin Tian-yi, 2012, Yaoxue Xuebao, V47, P1098; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yan LJ, 2015, MOL ECOLOGY RESOURCE, V10; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Yuan YM, 1996, AM J BOT, V83, P641, DOI 10.2307/2445924; Yuan YM, 1997, BOT J LINN SOC, V123, P25, DOI 10.1006/bojl.1996.0071; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zhang XL, 2006, ACTA PHYTOTAXON SIN, V44, P627, DOI 10.1360/aps06059; Zhang XL, 2009, TAXON, V58, P862, DOI 10.1002/tax.583014; Zheng P, 2011, BIOCHEM SYST ECOL, V39, P704, DOI 10.1016/j.bse.2011.06.002	64	24	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153008	10.1371/journal.pone.0153008	http://dx.doi.org/10.1371/journal.pone.0153008			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050315	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500083
J	Martinez-Levasseur, LM; Furgal, CM; Hammill, MO; Burness, G				Martinez-Levasseur, Laura M.; Furgal, Chris M.; Hammill, Mike O.; Burness, Gary			Towards a Better Understanding of the Effects of UV on Atlantic Walruses, Odobenus rosmarus rosmarus: A Study Combining Histological Data with Local Ecological Knowledge	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; TRADITIONAL KNOWLEDGE; CLIMATE-CHANGE; FRESH-WATER; RESISTANCE; ERYTHEMA	Walruses, Odobenus rosmarus, play a key role in the Arctic ecosystem, including northern Indigenous communities, which are reliant upon walruses for aspects of their diet and culture. However, walruses face varied environmental threats including rising sea-water temperatures and decreasing ice cover. An underappreciated threat may be the large amount of solar ultraviolet radiation (UV) that continues to reach the Arctic as a result of ozone loss. UV has been shown to negatively affect whales. Like whales, walrus skin is unprotected by fur, but in contrast, walruses spend long periods of time hauled-out on land. In this study, we combined the results of histological analyses of skin sections from five Atlantic walruses, Odobenus rosmarus rosmarus, collected in Nunavik (Northern Quebec, Canada) with qualitative data obtained through the interviews of 33 local walrus hunters and Inuit Elders. Histological analyses allowed us to explore UV-induced cellular lesions and interviews with experienced walrus hunters and Elders helped us to study the incidences and temporal changes of UV-induced gross lesions in walruses. At the microscopic scale, we detected a range of skin abnormalities consistent with UV damage. However, currently such UV effects do not seem to be widely observed at the whole-animal level (i.e., absence of skin blistering, erythema, eye cataract) by individuals interviewed. Although walruses may experience skin damage under normal everyday UV exposure, the long-term data from local walrus hunters and Inuit Elders did not report a relation between the increased sun radiation secondary to ozone loss and walrus health.	[Martinez-Levasseur, Laura M.; Burness, Gary] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Martinez-Levasseur, Laura M.; Furgal, Chris M.] Trent Univ, Dept Indigenous Studies, Peterborough, ON K9J 7B8, Canada; [Furgal, Chris M.] Trent Univ, Environm Resource Studies & Sci, Peterborough, ON K9J 7B8, Canada; [Hammill, Mike O.] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada	Trent University; Trent University; Trent University; Fisheries & Oceans Canada	Martinez-Levasseur, LM; Burness, G (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.; Martinez-Levasseur, LM (corresponding author), Trent Univ, Dept Indigenous Studies, Peterborough, ON K9J 7B8, Canada.	lmmartinezlevasseur@gmail.com; garyburness@trentu.ca	Burness, Gary/ABB-4937-2020	Martinez-Levasseur, Laura M./0000-0001-8909-5250	Nunavik Marine Region Wildlife Board; Department of Fisheries and Oceans Canada; Foreign Affairs and International Trade Canada; Trent University NSERC Internal Grant; Symons Trust Fund for Canadian Studies; Canadian Foundation for Innovation; Ontario Innovation Trust	Nunavik Marine Region Wildlife Board; Department of Fisheries and Oceans Canada; Foreign Affairs and International Trade Canada; Trent University NSERC Internal Grant; Symons Trust Fund for Canadian Studies; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	This project was supported by the Nunavik Marine Region Wildlife Board, Department of Fisheries and Oceans Canada, Foreign Affairs and International Trade Canada, Trent University NSERC Internal Grant, Symons Trust Fund for Canadian Studies and the Canadian Foundation for Innovation and Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F, 2007, COAST MANAGE, V35, P143, DOI 10.1080/08920750600970487; Blaustein AR, 2003, DIVERS DISTRIB, V9, P123, DOI 10.1046/j.1472-4642.2003.00015.x; Born EW, 2001, POLAR BIOL, V24, P713; Cockell CS, 2001, PHOTOCHEM PHOTOBIOL, V74, P570, DOI 10.1562/0031-8655(2001)074<0570:EOAFST>2.0.CO;2; Colitz CMH, 2010, JAVMA-J AM VET MED A, V237, P429, DOI 10.2460/javma.237.4.429; Creswell J.W., 2003, RES DESIGN QUALQUAN, DOI DOI 10.2307/1523157; Dahms HU, 2010, AQUAT TOXICOL, V97, P3, DOI 10.1016/j.aquatox.2009.12.002; Anadon JD, 2009, CONSERV BIOL, V23, P617, DOI 10.1111/j.1523-1739.2008.01145.x; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; De Fabo Edward C, 2005, Int J Circumpolar Health, V64, P509; Fay F., 1982, N AM FAUNA, P279; Furgal C, 2012, SYNTHESIS CRITICAL R; Gago-Ferrero P, 2013, ENVIRON SCI TECHNOL, V47, P5619, DOI 10.1021/es400675y; Garlich-Miller J., 2011, FIELD REPORT WALRUS; Gilchrist G, 2005, ECOL SOC, V10; Goertz C., 2012, PROCEEDINGS OF THE A; GOETTSCH W, 1994, TOXICOL LETT, V72, P359, DOI 10.1016/0378-4274(94)90049-3; Goettsch W, 1996, PHOTOCHEM PHOTOBIOL, V64, P581, DOI 10.1111/j.1751-1097.1996.tb03108.x; Golden AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098036; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Huntington H, 2006, CHANGING ARCTIC INDI, P61; Huntington HP, 2013, DEEP-SEA RES PT II, V94, P312, DOI 10.1016/j.dsr2.2013.03.016; Huntington HP, 2011, NATURE, V478, P182, DOI 10.1038/478182a; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; Huntington HP, 2004, ENVIRON CONSERV, V31, P177, DOI 10.1017/S0376892904001559; Ishii Y, 1997, HISTOL HISTOPATHOL, V12, P383; Krupnik I, 2007, DEEP-SEA RES PT II, V54, P2946, DOI 10.1016/j.dsr2.2007.08.011; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Mallory ML, 2003, ARCTIC, V56, P293; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; Martinez-Levasseur LM, 2011, P ROY SOC B-BIOL SCI, V278, P1581, DOI 10.1098/rspb.2010.1903; Nakaseko H, 2003, BRIT J DERMATOL, V148, P122, DOI 10.1046/j.1365-2133.2003.04898.x; Nickels S., 2006, UNIKKAAQATIGIIT PUTT; NOAA, 2014, NORTHERN PINNIPEDS U; Noaa U.S. Fish and Wildlife Service, 2012, UPDAT UNUSUAL MORTAL, P2; Norval M, 2011, PHOTOCH PHOTOBIO SCI, V10, P199, DOI 10.1039/c0pp90044c; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Orellana C, 2002, LANCET ONCOL, V3, P132, DOI 10.1016/S1470-2045(02)00670-8; Ortonne JP, 1990, BRIT J DERMATOL, V122, P1365; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reist JD, 2006, AMBIO, V35, P402, DOI 10.1579/0044-7447(2006)35[402:EOCCAU]2.0.CO;2; SAYRE RM, 1981, J AM ACAD DERMATOL, V5, P439, DOI 10.1016/S0190-9622(81)70106-3; Seidman I., 2006, INTERVIEWING QUALITA; Service CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101595; Sheehan JM, 2002, PHOTOCH PHOTOBIO SCI, V1, P365, DOI 10.1039/b108291d; SPEARMAN RI, 1972, J ANAT, V113, P373; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; Thornton TF, 2012, ECOL SOC, V17, DOI 10.5751/ES-04714-170308; Tobias T. N., 2009, LIVING PROOF ESSENTI; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turco KR, 1991, THESIS U ALASKA FAIR; Turvey ST, 2013, BIOL CONSERV, V157, P352, DOI 10.1016/j.biocon.2012.07.016; WMO (World Meteorological Organization), 2011, 52 WMO GLOB OZ RES M, P438	58	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152122	10.1371/journal.pone.0152122	http://dx.doi.org/10.1371/journal.pone.0152122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049757	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500027
J	Milner, A; Niedhammer, I; Chastang, JF; Spittal, MJ; LaMontagne, AD				Milner, A.; Niedhammer, I.; Chastang, J. -F.; Spittal, M. J.; LaMontagne, A. D.			Validity of a Job-Exposure Matrix for Psychosocial Job Stressors: Results from the Household Income and Labour Dynamics in Australia Survey	PLOS ONE			English	Article							FRENCH SUMER SURVEY; WORK-ENVIRONMENT; MENTAL-HEALTH; CARDIOVASCULAR MORTALITY; HILDA SURVEY; RISK; DEPRESSION; INEQUALITIES; DISORDERS; QUALITY	Introduction A Job Exposure Matrix (JEM) for psychosocial job stressors allows assessment of these exposures at a population level. JEMs are particularly useful in situations when information on psychosocial job stressors were not collected individually and can help eliminate the biases that may be present in individual self-report accounts. This research paper describes the development of a JEM in the Australian context. Methods The Household Income Labour Dynamics in Australia (HILDA) survey was used to construct a JEM for job control, job demands and complexity, job insecurity, and fairness of pay. Population median values of these variables for all employed people (n = 20,428) were used to define individual exposures across the period 2001 to 2012. The JEM was calculated for the Australian and New Zealand Standard Classification of Occupations (ANZSCO) at the four-digit level, which represents 358 occupations. Both continuous and binary exposures to job stressors were calculated at the 4-digit level. We assessed concordance between the JEM-assigned and individually-reported exposures using the Kappa statistic, sensitivity and specificity assessments. We conducted regression analysis using mental health as an outcome measure. Results Kappa statistics indicate good agreement between individually-reported and JEM-assigned dichotomous measures for job demands and control, and moderate agreement for job insecurity and fairness of pay. Job control, job demands and security had the highest sensitivity, while specificity was relatively high for the four exposures. Regression analysis shows that most individually reported and JEM measures were significantly associated with mental health, and individually-reported exposures produced much stronger effects on mental health than the JEM-assigned exposures. Discussion These JEM-based estimates of stressors exposure provide a conservative proxy for individual-level data, and can be applied to a range of health and organisational outcomes.	[Milner, A.; LaMontagne, A. D.] Deakin Univ, Work Hlth & Wellbeing Unit, Populat Hlth Strateg Res Ctr, Sch Hlth & Social Dev, Melbourne, Vic, Australia; [Milner, A.; LaMontagne, A. D.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Equ, Melbourne, Vic, Australia; [Niedhammer, I.; Chastang, J. -F.] Pierre Louis Inst Epidemiol & Publ Hlth, INSERM, UMR S 1136, Dept Social Epidemiol, Paris, France; [Niedhammer, I.; Chastang, J. -F.] Univ Paris 06, Sorbonne Univ, UMR S 1136, Pierre Louis Inst Epidemiol & Publ Hlth,Dept Soci, Paris, France; [Spittal, M. J.] Univ Melbourne, Ctr Mental Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Deakin University; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Melbourne	Milner, A; LaMontagne, AD (corresponding author), Deakin Univ, Work Hlth & Wellbeing Unit, Populat Hlth Strateg Res Ctr, Sch Hlth & Social Dev, Melbourne, Vic, Australia.; Milner, A; LaMontagne, AD (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Equ, Melbourne, Vic, Australia.	Allison.milner@deakin.edu.au	LaMontagne, Anthony Daniel/AAX-3285-2021; NIEDHAMMER, Isabelle/J-9421-2015	LaMontagne, Anthony Daniel/0000-0002-5811-5906; NIEDHAMMER, Isabelle/0000-0002-8042-8925; Milner, Allison/0000-0003-4657-0503; Spittal, Matthew/0000-0002-2841-1536	American Foundation for Suicide Prevention, a Society for Mental Health Fellowship; Deakin University; Victorian Health Promotion Foundation Melbourne, Victoria (Australia) [15732]; Australian Government Department of Social Services DSS	American Foundation for Suicide Prevention, a Society for Mental Health Fellowship; Deakin University; Victorian Health Promotion Foundation Melbourne, Victoria (Australia); Australian Government Department of Social Services DSS(Australian Government)	AM was funded by the American Foundation for Suicide Prevention, a Society for Mental Health Fellowship and Deakin University. This study also received centre grant funding (#15732) from the Victorian Health Promotion Foundation Melbourne, Victoria (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This paper uses unit record data from the Household, Income and Labour Dynamics in Australia HILDA Survey. The HILDA Project was initiated and is funded by the Australian Government Department of Social Services DSS and is managed by the Melbourne Institute of Applied Economic and Social Research Melbourne Institute. The findings and views reported in this paper, however, are those of the authors and should not be attributed to either DSS or the Melbourne Institute. The data used in this paper was extracted using the Add-On Package PanelWhiz for Stata. PanelWhiz (http://www.PanelWhiz.eu) was written by Dr. John P. Haisken-DeNew (john@PanelWhiz.eu).	ABS, 2009, AUSTR NZ STAND CLASS; Amick B. C., 2002, PSYCHOSOM MED, V64, P370; [Anonymous], 2012, HILDA PROJECT TECHNI; Baumert J, 2014, J PSYCHIATR RES, V57, P90, DOI 10.1016/j.jpsychires.2014.06.007; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Butterworth P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-44; Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030; Butterworth P, 2011, AUST NZ J PUBL HEAL, V35, P564, DOI 10.1111/j.1753-6405.2011.00771.x; Cohidon C, 2012, J OCCUP ENVIRON MED, V54, P184, DOI 10.1097/JOM.0b013e31823fdf3b; Danelia M, 2005, Georgian Med News, P56; FERMANIAN J, 1984, REV EPIDEMIOL SANTE, V32, P408; Fishta A, 2015, INT ARCH OCC ENV HEA, V88, P997, DOI 10.1007/s00420-015-1019-0; Johnson JV, 1996, AM J PUBLIC HEALTH, V86, P324, DOI 10.2105/AJPH.86.3.324; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kopp M, 2006, J EPIDEMIOL COMMUN H, V60, P782, DOI 10.1136/jech.2005.042960; LaMontagne AD, 2013, OCCUP ENVIRON MED, V70, P639, DOI 10.1136/oemed-2012-101171; LaMontagne AD, 2010, ADV MENT HEALTH, V9, P17, DOI 10.5172/jamh.9.1.17; Landsbergis P. A, 2000, WORKPLACE CARDIOVASC, P163; Leach L., 2010, AUST SOC POLICY, V9, P67; Milner A, 2015, AM J EPIDEMIOL, V181, P781, DOI 10.1093/aje/kwu355; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Niedhammer I, 2008, INT ARCH OCC ENV HEA, V82, P87, DOI 10.1007/s00420-008-0311-7; Niedhammer I, 2008, OCCUP MED-OXFORD, V58, P15, DOI 10.1093/occmed/kqm115; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Rugulies R, 2006, AM J EPIDEMIOL, V163, P877, DOI 10.1093/aje/kwj119; Rugulies R, 2013, EUR J PUBLIC HEALTH, V23, P415, DOI 10.1093/eurpub/cks071; Sabbath EL, 2015, SOC SCI MED, V146, P111, DOI 10.1016/j.socscimed.2015.10.024; Seidler A, 2004, OCCUP ENVIRON MED, V61, P962, DOI 10.1136/oem.2003.012153; Smith TW, 2002, J CONSULT CLIN PSYCH, V70, P548, DOI 10.1037//0022-006X.70.3.548; Solovieva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108987; Stansfeld SA, 1999, OCCUP ENVIRON MED, V56, P302, DOI 10.1136/oem.56.5.302; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Watson N, 2011, HILDA PROJECT TECHNI, V1; Wieclaw J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-280; Wilkins R., 2013, FAMILIES INCOMES JOB, V8	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152980	10.1371/journal.pone.0152980	http://dx.doi.org/10.1371/journal.pone.0152980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049527	Green Published, gold			2022-12-27	WOS:000373603500076
J	Shuster, Y; Steiner-Mordoch, S; Cudkowicz, NA; Schuldiner, S				Shuster, Yonatan; Steiner-Mordoch, Sonia; Cudkowicz, Noemie Alon; Schuldiner, Shimon			A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics	PLOS ONE			English	Article							ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE; EFFLUX PUMPS; FLUOROQUINOLONE RESISTANCE; TOPOISOMERASE MUTATIONS; MOLECULAR-MECHANISMS; CHROMOSOMAL GENES; EXPRESSION; STRESS; INHIBITION	Awareness of the problem of antimicrobial resistance (AMR) has escalated and drug-resistant infections are named among the most urgent problems facing clinicians today. Our experiments here identify a transporter interactome and portray its essential function in acquisition of antimicrobial resistance. By exposing E. coli cells to consecutive increasing concentrations of the fluoroquinolone norfloxacin we generated in the laboratory highly resistant strains that carry multiple mutations, most of them identical to those identified in clinical isolates. With this experimental paradigm, we show that the MDTs function in a coordinated mode to provide an essential first-line defense mechanism, preventing the drug reaching lethal concentrations, until a number of stable efficient alterations occur that allow survival. Single-component efflux transporters remove the toxic compounds from the cytoplasm to the periplasmic space where TolC-dependent transporters expel them from the cell. We postulate a close interaction between the two types of transporters to prevent rapid leak of the hydrophobic substrates back into the cell. The findings change the prevalent concept that in Gram-negative bacteria a single multidrug transporter, AcrAB-TolC type, is responsible for the resistance. The concept of a functional interactome, the process of identification of its members, the elucidation of the nature of the interactions and its role in cell physiology will change the existing paradigms in the field. We anticipate that our work will have an impact on the present strategy searching for inhibitors of AcrAB-TolC as adjuvants of existing antibiotics and provide novel targets for this urgent undertaking.	[Shuster, Yonatan; Steiner-Mordoch, Sonia; Cudkowicz, Noemie Alon; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	Israel Science Foundation [97/12]; Rosetrees Trust [A1004]; Rosetrees Trust [M497] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Rosetrees Trust(Rosetrees Trust)	This work was funded by Israel Science Foundation 97/12 to SS (http://www.isf.org.il/#/) and Rosetrees Trust A1004 to SS (http://www.rosetreestrust.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Blair JMA, 2015, P NATL ACAD SCI USA, V112, P3511, DOI 10.1073/pnas.1419939112; Blair JMA, 2015, J ANTIMICROB CHEMOTH, V70, P424, DOI 10.1093/jac/dku380; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Du DJ, 2015, CURR OPIN STRUC BIOL, V33, P76, DOI 10.1016/j.sbi.2015.07.015; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Inokuchi H, 2013, J BIOL CHEM, V288, P32952, DOI 10.1074/jbc.M113.507772; Jellen-Ritter AS, 2001, ANTIMICROB AGENTS CH, V45, P1467, DOI 10.1128/AAC.45.5.1467-1472.2001; Johnson JR, 2015, ANTIMICROB AGENTS CH, V59, P4471, DOI 10.1128/AAC.00673-15; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Lomovskaya O, 1999, ANTIMICROB AGENTS CH, V43, P1340, DOI 10.1128/AAC.43.6.1340; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Markham PN, 1996, ANTIMICROB AGENTS CH, V40, P2673, DOI 10.1128/AAC.40.11.2673; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2008, J ANTIBIOT, V61, P120, DOI 10.1038/ja.2008.120; Oethinger M, 2000, ANTIMICROB AGENTS CH, V44, P10, DOI 10.1128/AAC.44.1.10-13.2000; Pruteanu M, 2009, RES MICROBIOL, V160, P677, DOI 10.1016/j.resmic.2009.08.012; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sand O, 2003, MICROBIOL-SGM, V149, P2107, DOI 10.1099/mic.0.26363-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Zayed AAF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.4	42	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152917	10.1371/journal.pone.0152917	http://dx.doi.org/10.1371/journal.pone.0152917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050393	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500067
J	Adapala, NS; Kim, HKW				Adapala, Naga Suresh; Kim, Harry K. W.			Comprehensive Genome-Wide Transcriptomic Analysis of Immature Articular Cartilage following Ischemic Osteonecrosis of the Femoral Head in Piglets	PLOS ONE			English	Article							CALVE-PERTHES DISEASE; LARGE GENE LISTS; EPIPHYSEAL CARTILAGE; GROWTH-PLATE; IN-VITRO; EXPRESSION; NECROSIS; CHONDROCYTES; INFLAMMATION; HYPOXIA	Objective Ischemic osteonecrosis of the femoral head (ONFH) in piglets results in an ischemic injury to the immature articular cartilage. The molecular changes in the articular cartilage in response to ONFH have not been investigated using a transcriptomic approach. The purpose of this study was to perform a genome-wide transcriptomic analysis to identify genes that are upregulated in the immature articular cartilage following ONFH. Methods ONFH was induced in the right femoral head of 6-week old piglets. The unoperated femoral head was used as the normal control. At 24 hours (acute ischemic-hypoxic injury), 2 weeks (avascular necrosis in the femoral head) and 4 weeks (early repair) after surgery (n = 4 piglets/time point), RNA was isolated from the articular cartilage of the femoral head. A microarray analysis was performed using Affymetrix Porcine GeneChip Array. An enrichment analysis and functional clustering of the genes upregulated due to ONFH were performed using DAVID and STRING software, respectively. The increased expression of selected genes was confirmed by a real-time qRTPCR analysis. Results Induction of ONFH resulted in the upregulation of 383 genes at 24 hours, 122 genes at 2 weeks and 124 genes at 4 weeks compared to the normal controls. At 24 hours, the genes involved in oxidoreductive, cell-survival, and angiogenic responses were significantly enriched among the upregulated genes. These genes were involved in HIF-1, PI3K-Akt, and MAPK signaling pathways. At 2 weeks, secretory and signaling proteins involved in angiogenic and inflammatory responses, PI3K-Akt and matrix-remodeling pathways were significantly enriched. At 4 weeks, genes that represent inflammatory cytokines and chemokine signaling pathways were significantly enriched. Several index genes (genes that are upregulated at more than one time point following ONFH and are known to be important in various biological processes) including HIF-1A, VEGFA, IL-6, IL6R, IL-8, CCL2, FGF2, TGFB2, MMP1, MMP3, ITGA5, FN and Col6A1 were upregulated in the immature articular cartilage following ONFH. A qRTPCR analysis of selected genes confirmed the upregulated expression observed in the microarray analysis. Conclusion Immature articular cartilage responds to ONFH by the upregulation of genes involved in hypoxic stress response, angiogenesis, matrix remodeling and inflammation. This study provides novel insights into the multi-faceted role of immature articular cartilage, with inflammation as a key component, following ONFH in piglets.	[Adapala, Naga Suresh; Kim, Harry K. W.] Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA; [Adapala, Naga Suresh; Kim, Harry K. W.] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, HKW (corresponding author), Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA.; Kim, HKW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA.	Harry.Kim@tsrh.org	Kim, Harry/AAE-1892-2020; Kim, Harry/AAF-7176-2020	Kim, Harry/0000-0002-0330-4777; 	Texas Scottish Rite Hospital for Children	Texas Scottish Rite Hospital for Children	This study was supported by an intramural grant from the Texas Scottish Rite Hospital for Children, awarded to HKWK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARLSON CS, 1991, J ORTHOP RES, V9, P317, DOI 10.1002/jor.1100090303; Maranho DAC, 2013, J BONE JOINT SURG AM, V95A, P256, DOI 10.2106/JBJS.K.01039; CATTERALL A, 1982, J BONE JOINT SURG BR, V64, P269, DOI 10.1302/0301-620X.64B3.6807991; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; GUERNE PA, 1990, J IMMUNOL, V144, P499; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JENSEN OM, 1976, J BONE JOINT SURG BR, V58, P332, DOI 10.1302/0301-620X.58B3.956251; Kamiya N, 2015, J BONE MINER RES, V30, P1009, DOI 10.1002/jbmr.2435; Kamiya N, 2013, BONE, V53, P239, DOI 10.1016/j.bone.2012.11.023; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; Kim HKW, 2009, BONE, V45, P280, DOI 10.1016/j.bone.2009.03.665; Kim HKW, 2009, J BONE JOINT SURG AM, V91A, P1149, DOI 10.2106/JBJS.H.00654; Kim HKW, 2004, J BONE MINER RES, V19, P2041, DOI 10.1359/JBMR.040911; Kim HKW, 2004, J BONE JOINT SURG AM, V86A, P129, DOI 10.2106/00004623-200401000-00019; Kim HKW, 2001, J BONE JOINT SURG AM, V83A, P688, DOI 10.2106/00004623-200105000-00007; Kim HKW, 2002, J BONE JOINT SURG AM, V84A, P1329, DOI 10.2106/00004623-200208000-00007; Knight DM, 2008, J PEDIATR ORTHOP B, V17, P73, DOI 10.1097/BPB.0b013e3282f1dd18; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; MCANDREW MP, 1984, J BONE JOINT SURG AM, V66A, P860, DOI 10.2106/00004623-198466060-00006; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Pringle D, 2004, J ORTHOPAED RES, V22, P122, DOI 10.1016/S0736-0266(03)00135-9; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Schlichting N, 2014, MOL PHARMACEUT, V11, P2092, DOI 10.1021/mp5000554; STULBERG SD, 1981, J BONE JOINT SURG AM, V63, P1095, DOI 10.2106/00004623-198163070-00006; Szllarczyk D, 2015, NUCLEIC ACIDS RES, pD447, DOI [10.1093/nar/gku1003, DOI 10.1093/NAR/GKU1003]; Zhang C., 2010, SYNTHESIS LECT COMPU, V2, P1, DOI DOI 10.1038/SREP00650; Zhang C, 2011, BONE, V48, P507, DOI 10.1016/j.bone.2010.10.006	37	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153174	10.1371/journal.pone.0153174	http://dx.doi.org/10.1371/journal.pone.0153174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045355	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600074
J	Kikutake, C; Yahara, K				Kikutake, Chie; Yahara, Koji			Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis	PLOS ONE			English	Article							CANCER-CELLS; HISTONE DEACETYLASES; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; EXPRESSION; GENE; METHYLATION; BREAST; GROWTH	Epigenetic mechanisms such as DNA methylation or histone modifications are essential for the regulation of gene expression and development of tissues. Alteration of epigenetic modifications can be used as an epigenetic biomarker for diagnosis and as promising targets for epigenetic therapy. A recent study explored cancer-cell specific epigenetic biomarkers by examining different types of epigenetic modifications simultaneously. However, it was based on microarrays and reported biomarkers that were also present in normal cells at a low frequency. Here, we first analyzed multi-omics data (including ChIP-Seq data of six types of histone modifications: H3K27ac, H3K4me1, H3K9me3, H3K36me3, H3K27me3, and H3K4me3) obtained from 26 lung adenocarcinoma cell lines and a normal cell line. We identified six genes with both H3K27ac and H3K4me3 histone modifications in their promoter regions, which were not present in the normal cell line, but present in >= 85% (22 out of 26) and <= 96% (25 out of 26) of the lung adenocarcinoma cell lines. Of these genes, NUP210 (encoding a main component of the nuclear pore complex) was the only gene in which the two modifications were not detected in another normal cell line. RNA-Seq analysis revealed that NUP210 was aberrantly overexpressed among the 26 lung adenocarcinoma cell lines, although the frequency of NUP210 overexpression was lower (19.3%) in 57 lung adenocarcinoma tissue samples studied and stored in another database. This study provides a basis to discover epigenetic biomarkers highly specific to a certain cancer, based on multi-omics data at the cell population level.	[Kikutake, Chie] Kurume Univ, Sch Med, Div Biostat, Fukuoka, Japan; [Yahara, Koji] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan; [Yahara, Koji] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales	Kurume University; Kurume University; Swansea University	Yahara, K (corresponding author), Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan.; Yahara, K (corresponding author), Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales.	koji_yahara@med.kurume-u.ac.jp						Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Akhtar MM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-145; Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Blank MBaV, 2015, CANC RES; Brown R, 2014, NAT REV CANCER, V14, P747, DOI 10.1038/nrc3819; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; de las Heras JI, 2013, SEMIN CANCER BIOL, V23, P125, DOI 10.1016/j.semcancer.2012.01.008; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Findeis-Hosey JJ, 2011, HUM PATHOL, V42, P303, DOI 10.1016/j.humpath.2010.06.003; Forde PM, 2014, CLIN CANCER RES, V20, P2244, DOI 10.1158/1078-0432.CCR-13-2088; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Gomez-Cavazos JS, 2015, J CELL BIOL, V208, P671, DOI 10.1083/jcb.201410047; Gu BN, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-39; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Jilg CA, 2014, ONCOTARGET, V5, P12646, DOI 10.18632/oncotarget.2653; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lederer M, 2014, SEMIN CANCER BIOL, V29, P3, DOI 10.1016/j.semcancer.2014.07.006; Liang G, 2002, CANCER RES, V62, P961; Liu FN, 2009, INT J CANCER, V125, P2511, DOI 10.1002/ijc.24588; Luo YX, 2011, INT J CLIN PRACT, V65, P1313, DOI 10.1111/j.1742-1241.2011.02800.x; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Miller GJ, 2003, CANCER RES, V63, P5879; Nagashio R, 2011, INT J CANCER, V129, P1170, DOI 10.1002/ijc.26061; Nakabayashi K, 2004, J MED GENET, V41, P601, DOI 10.1136/jmg.2003.014142; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Natarajan TG, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-13; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Salbaum JM, 2000, GENOMICS, V64, P15, DOI 10.1006/geno.2000.6114; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shortridge-Baggett L M, 1996, J N Y State Nurses Assoc, V27, P9; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Takeshima H, 2015, CARCINOGENESIS, V36, P192, DOI 10.1093/carcin/bgu238; Vieira FQ, 2015, ONCOTARGET, V6, P13644, DOI 10.18632/oncotarget.3767; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; WOZNIAK RW, 1992, J CELL BIOL, V119, P1441, DOI 10.1083/jcb.119.6.1441; Yang H, 2013, CAN J GASTROENTEROL, V27, P467, DOI 10.1155/2013/258030; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	53	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152918	10.1371/journal.pone.0152918	http://dx.doi.org/10.1371/journal.pone.0152918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042856	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100046
J	Kahana, SY; Jenkins, RA; Bruce, D; Fernandez, MI; Hightow-Weidman, LB; Bauermeister, JA				Kahana, Shoshana Y.; Jenkins, Richard A.; Bruce, Douglas; Fernandez, Maria I.; Hightow-Weidman, Lisa B.; Bauermeister, Jose A.		Adolescent Med Trials Network HIV	Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV	PLOS ONE			English	Article							RESIDENTIAL SEGREGATION; UNITED-STATES; RACIAL DISPARITIES; HEALTH; ADHERENCE; PEOPLE; YOUTH; RISK; NONADHERENCE; HIV/AIDS	Background The authors examined associations between structural characteristics and HIV disease management among a geographically diverse sample of behaviorally and perinatally HIV-infected adolescents and young adults in the United States. Methods The sample included 1891 adolescents and young adults living with HIV (27.8% perinatally infected; 72.2% behaviorally infected) who were linked to care through 20 Adolescent Medicine Trials Network for HIV/AIDS Interventions Units. All completed audio computer-assisted self-interview surveys. Chart abstraction or blood draw provided viral load data. Geographic-level variables were extracted from the United States Census Bureau (e.g., socioeconomic disadvantage, percent of Black and Latino households, percent rural) and Esri Crime (e.g., global crime index) databases as Zip Code Tabulation Areas. AIDSVu data (e.g., prevalence of HIV among youth) were extracted at the county-level. Using HLM v.7, the authors conducted means-as-outcomes random effects multi-level models to examine the association between structural-level and individual-level factors and (1) being on antiretroviral therapy (ART) currently; (2) being on ART for at least 6 months; (3) missed HIV care appointments (not having missed any vs. having missed one or more appointments) over the past 12 months; and (4) viral suppression (defined by the corresponding assay cutoff for the lower limit of viral load at each participating site which denoted nondetectability vs. detectability). Results Frequencies for the 4 primary outcomes were as follows: current ART use (n = 1120, 59.23%); ART use for >= 6 months (n = 861, 45.53%); at least one missed HIV care appointment (n = 936, 49.50); and viral suppression (n = 577, 30.51%). After adjusting for individual-level factors, youth living in more disadvantaged areas (defined by a composite score derived from 2010 Census indicators including percent poverty, percent receiving public assistance, percent of female, single-headed households, percent unemployment, and percent of people with less than a high school degree) were less likely to report current ART use (OR: 0.85, 95% CI: 0.72-1.00, p = .05). Among current ART users, living in more disadvantaged areas was associated with greater likelihood of having used ART for >= 6 months. Participants living in counties with greater HIV prevalence among 13-24 year olds were more likely to report current ART use (OR: 1.32, 95% CI: 1.05-1.65, p = .02), >= 6 months ART use (OR: 1.32, 95% CI: 1.05-1.65, p = .02), and to be virally suppressed (OR: 1.50, 95% CI: 1.20-1.87, p = .001); however, youth in these areas were also more likely to report missed medical appointments (OR: 1.32, 95% CI: 1.07-1.63, p = .008). Conclusions The findings underscore the multi-level and structural factors associated with ART use, missed HIV care appointments, and viral suppression for adolescents and young adults in the United States. Consideration of these factors is strongly recommended in future intervention, clinical practice, and policy research that seek to understand the contextual influences on individuals' health behaviors.	[Kahana, Shoshana Y.; Jenkins, Richard A.] NIDA, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD 20892 USA; [Bruce, Douglas] Depaul Univ, Dept Hlth Sci, Chicago, IL 60604 USA; [Fernandez, Maria I.] Nova SE Univ, Dept Prevent Med, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Fernandez, Maria I.] Nova SE Univ, Dept Publ Hlth Program, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Hightow-Weidman, Lisa B.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Bauermeister, Jose A.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); DePaul University; Nova Southeastern University; Nova Southeastern University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Kahana, SY (corresponding author), NIDA, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD 20892 USA.	kahanas@mail.nih.gov	Bauermeister, Jose/X-8960-2018	Bauermeister, Jose/0000-0002-9276-2306; Bruce, Douglas/0000-0002-2137-7099	Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from National Institutes of Health through National Institute of Child Health and Human Development [U01 HD 040533, U01 HD 040474]; National Institutes on Drug Abuse and Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040533, U01HD040474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069415] Funding Source: NIH RePORTER	Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from National Institutes of Health through National Institute of Child Health and Human Development; National Institutes on Drug Abuse and Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from the National Institutes of Health [U01 HD 040533 and U01 HD 040474] through the National Institute of Child Health and Human Development, with supplemental funding from the National Institutes on Drug Abuse and Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2003, AM J PUBLIC HEALTH, V93, P215, DOI 10.2105/AJPH.93.2.215; Ali R, 2002, ADDICTION, V97, P1183; Allison PD, 2009, FIXED EFFECT REGRESS; Bauermeister JA, 2015, AIDS BEHAV; Bauermeister JA, BEHAV MED IN PRESS; Bauermeister JA, 2011, J URBAN HEALTH, V88, P66, DOI 10.1007/s11524-010-9506-9; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Bowleg L, 2014, AIDS BEHAV, V18, P2207, DOI 10.1007/s10461-014-0803-2; Bruce D, 2015, DRUG ALCOHOL DEPEN, V151, P173, DOI 10.1016/j.drugalcdep.2015.03.017; Bundock H, 2011, AIDS PATIENT CARE ST, V25, P465, DOI 10.1089/apc.2010.0279; Charania MR, 2011, AIDS BEHAV, V15, P1283, DOI 10.1007/s10461-010-9812-y; Cooper HLF, 2016, INT J DRUG POLICY, V27, P43, DOI 10.1016/j.drugpo.2015.07.015; Davies G, 2006, AIDS CARE, V18, P895, DOI 10.1080/09540120500329556; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Eberhart MG, 2015, JAIDS-J ACQ IMM DEF, V69, pS37, DOI 10.1097/QAI.0000000000000587; Fair CD, 2010, PSYCHOL HEALTH MED, V15, P515, DOI 10.1080/13548506.2010.493944; Friedman SR, 2005, J URBAN HEALTH, V82, P434, DOI 10.1093/jurban/jti088; Gaston GB, 2013, AIDS BEHAV, V17, P31, DOI 10.1007/s10461-012-0323-x; Glaeser E.L., 2010, AGGLOMERATION EC, P1, DOI DOI 10.7208/CHICAGO/9780226297927.001.0001; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Hartzell JD, 2007, JAIDS-J ACQ IMM DEF, V44, P411, DOI 10.1097/QAI.0b013e31802f83a6; Health Resources and Services Administration (HRSA), 2013, CREAT JAIL LINK PROG; Heslin KC, 2005, J GEN INTERN MED, V20, P283, DOI 10.1111/j.1525-1497.2005.40109.x; Hosek Sybil G, 2005, Psychol Health Med, V10, P166; Johns MM, 2010, AIDS EDUC PREV, V22, P509, DOI 10.1521/aeap.2010.22.6.509; Kahana SY, 2015, JAIDS-J ACQ IMM DEF, V68, P169, DOI 10.1097/QAI.0000000000000408; Kahn JG, 2002, PUBLIC HEALTH REP, V117, P252, DOI 10.1016/S0033-3549(04)50159-0; Kalichman SC, 2014, J COMMUN HEALTH, V39, P1133, DOI 10.1007/s10900-014-9868-0; Kim SH, 2015, AIDS PATIENT CARE ST, V29, P354, DOI 10.1089/apc.2014.0335; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Latkin CA, 2013, AM PSYCHOL, V68, P210, DOI 10.1037/a0032704; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Mavedzenge SN, 2013, EFFECTIVENESS HIV PR; Mellins CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18593; Mellins CA, 2011, AIDS PATIENT CARE ST, V25, P413, DOI 10.1089/apc.2011.0025; Millett G, 2013, INT C HIV TREATM PRE; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Philbin MM, 2014, AIDS CARE, V26, P12, DOI 10.1080/09540121.2013.808730; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raymond HF, 2014, AIDS BEHAV, V18, P346, DOI 10.1007/s10461-013-0508-y; Ribaudo HJ, 2013, CLIN INFECT DIS, V57, P1607, DOI 10.1093/cid/cit595; Riley ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035207; Saha S, 2013, J GEN INTERN MED, V28, P622, DOI 10.1007/s11606-012-2298-8; Schackman BR, 2007, JAIDS-J ACQ IMM DEF, V46, P547, DOI 10.1097/QAI.0b013e31815ac499; Shacham E, 2013, HIV MED, V14, P624, DOI 10.1111/hiv.12067; Sheppard S, 2014, WILLIAMS COLL EC DEP, P1; Spector SA, 2000, J INFECT DIS, V182, P1769, DOI 10.1086/317621; Sprague C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-28; Trepka MJ, 2013, AM J PUBLIC HEALTH, V103, P717, DOI 10.2105/AJPH.2012.300930; US Department of Health and Human Services, PROF BLACK AFR AM; White K, 2012, HEALTH SERV RES, V47, P1278, DOI 10.1111/j.1475-6773.2012.01410.x; Whitmore Suzanne K., 2012, Morbidity and Mortality Weekly Report, V61, P971; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Wolitski RJ, 2010, AIDS BEHAV, V14, P493, DOI 10.1007/s10461-009-9643-x; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P1064, DOI 10.2105/AJPH.90.7.1064	60	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0151106	10.1371/journal.pone.0151106	http://dx.doi.org/10.1371/journal.pone.0151106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035905	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200006
J	Cai, SX; Yang, H; Zeng, KW; Zhang, J; Zhong, N; Wang, YZ; Ye, J; Tu, PF; Liu, ZH				Cai, Shuxian; Yang, Heng; Zeng, Kewu; Zhang, Jing; Zhong, Ni; Wang, Yingzi; Ye, Jing; Tu, Pengfei; Liu, Zhonghua			EGCG Inhibited Lipofuscin Formation Based on Intercepting Amyloidogenic beta-Sheet-Rich Structure Conversion	PLOS ONE			English	Article							PROTEINS; PATHWAY; BINDING; P62; AGGREGATION; ACTIVATION; OLIGOMERS; DISEASES; FIBRILS; DAMAGE	Background Lipofuscin (LF) is formed during lipid peroxidation and sugar glycosylation by carbonylamino crosslinks with biomacrolecules, and accumulates slowly within postmitotic cells. The environmental pollution, modern dietary culture and lifestyle changes have been found to be the major sources of reactive carbonyl compounds in vivo. Irreversible carbonyl-amino crosslinks induced by carbonyl stress are essentially toxiferous for aging-related functional losses in modern society. Results show that (-)-epigallocatechin gallate (EGCG), the main polyphenol in green tea, can neutralize the carbonyl-amino cross-linking reaction and inhibit LF formation, but the underlying mechanism is unknown. Methods and Results We explored the mechanism of the neutralization process from protein, cell, and animal levels using spectrofluorometry, infrared spectroscopy, conformation antibodies, and electron microscopy. LF demonstrated an amyloidogenic beta-sheet-rich with antiparallel structure, which accelerated the carbonyl-amino crosslinks formation and disrupted proteolysis in both PC12 cells and D-galactose (D-gal)-induced brain aging mice models. Additionally, EGCG effectively inhibited the formation of the amyloidogenic beta-sheet-rich structure of LF, and prevented its conversion into toxic and on-pathway aggregation intermediates, thereby cutting off the carbonyl-amino crosslinks. Conclusions Our study indicated that the amyloidogenic beta-sheet structure of LF may be the core driving force for carbonyl-amino crosslinks further formation, which mediates the formation of amyloid fibrils from native state of biomacrolecules. That EGCG exhibits anti-amyloidogenic beta-sheet-rich structure properties to prevent the LF formation represents a novel strategy to impede the development of degenerative processes caused by ageing or stress-induced premature senescence in modern environments.	[Cai, Shuxian; Zeng, Kewu; Ye, Jing; Tu, Pengfei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Yang, Heng; Zhang, Jing; Zhong, Ni; Wang, Yingzi; Liu, Zhonghua] Hunan Agr Univ, Coinnovat Ctr Utilizat Bot Funct Ingredients, Changsha 410128, Hunan, Peoples R China	Peking University; Hunan Agricultural University	Tu, PF (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Liu, ZH (corresponding author), Hunan Agr Univ, Coinnovat Ctr Utilizat Bot Funct Ingredients, Changsha 410128, Hunan, Peoples R China.	pengfeitu@bjmu.edu.cn; larkin-liu@163.com	Tu, Peng Fei/E-2089-2018; Ke-wu, Zeng/U-6930-2019		National Natural Science Foundation of China [31471590, 31100501, 81172944]; China Postdoctoral Science Foundation [2014M560024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Natural Science Foundation of China (Nos. 31471590, 31100501 and 81172944), the China Postdoctoral Science Foundation (No. 2014M560024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Burcham PC, 1996, BIOCHEM BIOPH RES CO, V220, P996, DOI 10.1006/bbrc.1996.0521; Cai SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075687; Cai SX, 2011, J MED PLANTS RES, V5, P5470; Cai ShuXian, 2010, Journal of Tea Science, V30, P1; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Davis CM, 2014, BIOCHEMISTRY-US, V53, P5476, DOI 10.1021/bi500556h; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Di Domizio J, 2012, J BIOL CHEM, V287, P736, DOI 10.1074/jbc.M111.238477; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; Goh BC, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12027-8; Hohn A, 2014, FREE RADICAL BIO MED, V71, P70, DOI 10.1016/j.freeradbiomed.2014.02.028; Hohn A, 2011, FREE RADICAL BIO MED, V50, P585, DOI 10.1016/j.freeradbiomed.2010.12.011; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; KIKUGAWA K, 1980, CHEM PHARM BULL, V28, P3323; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Peyroux J, 2006, PATHOL BIOL, V54, P405, DOI 10.1016/j.patbio.2006.07.006; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Wu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050483; Yin DZ, 2016, CURR TOP MED CHEM, V16, P503, DOI 10.2174/1568026615666150813142854; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zeng KW, 2014, CANCER LETT, V353, P220, DOI 10.1016/j.canlet.2014.07.022	39	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152064	10.1371/journal.pone.0152064	http://dx.doi.org/10.1371/journal.pone.0152064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030967	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800032
J	Elisia, I; Nakamura, H; Lam, V; Hofs, E; Cederberg, R; Cait, J; Hughes, MR; Lee, L; Jia, W; Adomat, HH; Guns, ES; McNagny, KM; Samudio, I; Krystal, G				Elisia, Ingrid; Nakamura, Hisae; Lam, Vivian; Hofs, Elyse; Cederberg, Rachel; Cait, Jessica; Hughes, Michael R.; Lee, Leora; Jia, William; Adomat, Hans H.; Guns, Emma S.; McNagny, Kelly M.; Samudio, Ismael; Krystal, Gerald			DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE DMSO; GENE-EXPRESSION; K/BXN MOUSE; DIMETHYLSULFOXIDE; MODEL; ABSORPTION; METABOLISM; EXCRETION; MELANOMA; GROWTH	Dimethyl sulfoxide (DMSO) is currently used as an alternative treatment for various inflammatory conditions as well as for cancer. Despite its widespread use, there is a paucity of data regarding its safety and efficacy as well as its mechanism of action in human cells. Herein, we demonstrate that DMSO has ex-vivo anti-inflammatory activity using Escherichia coli-(E. coli) and herpes simplex virus-1 (HSV-1)-stimulated whole human blood. Specifically, we found that between 0.5%-2%, DMSO significantly suppressed the expression of many pro-inflammatory cytokines/chemokines and prostaglandin E-2 (PGE(2)). However, a significant reduction in monocyte viability was also observed at 2% DMSO, suggesting a narrow window of efficacy. Anti-inflammatory concentrations of DMSO suppressed E. coli-induced ERK1/2, p38, JNK and Akt phosphorylation, suggesting DMSO acts on these signaling pathways to suppress inflammatory cytokine/chemokine production. Although DMSO induces the differentiation of B16/F10 melanoma cells in vitro, topical administration of DMSO to mice subcutaneously implanted with B16 melanoma cells was ineffective at reducing tumor growth, DMSO was also found to block mouse macrophages from polarizing to either an M1- or an M2-phenotype, which may contribute to its inability to slow tumor growth. Topical administration of DMSO, however, significantly mitigated K/BxN serum-induced arthritis in mice, and this was associated with reduced levels of pro-inflammatory cytokines in the joints and white blood cell levels in the blood. Thus, while we cannot confirm the efficacy of DMSO as an anti-cancer agent, the use of DMSO in arthritis warrants further investigation to ascertain its therapeutic potential.	[Elisia, Ingrid; Nakamura, Hisae; Lam, Vivian; Hofs, Elyse; Cederberg, Rachel; Lee, Leora; Samudio, Ismael; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Cait, Jessica; Hughes, Michael R.; McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Adomat, Hans H.; Guns, Emma S.] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	gkrystal@bccrc.ca	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015; JIA, WILLIAM/AAE-4322-2020; Samudio, Ismael/D-3581-2013	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Krystal, Gerald/0000-0002-1961-6281; Samudio, Ismael/0000-0001-8676-1035	Lotte and John Hecht Memorial Foundation [3693]	Lotte and John Hecht Memorial Foundation	This work was funded by the Lotte and John Hecht Memorial Foundation to GK, Hecht Grant ID #3693 (http://www.hecht.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Ahn H, 2014, IMMUNOBIOLOGY, V219, P315, DOI 10.1016/j.imbio.2013.11.003; Aita K, 2005, EXP MOL PATHOL, V79, P265, DOI 10.1016/j.yexmp.2005.07.001; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; [Anonymous], 1966, JAMA-J AM MED ASSOC, V195, pA33, DOI [10.1001/jama.1966.03100010017005, DOI 10.1001/JAMA.1966.03100010017005]; ANTONY VB, 1983, INFLAMMATION, V7, P377, DOI 10.1007/BF00916302; Becker K, 2014, PHYTOMEDICINE, V21, P164, DOI 10.1016/j.phymed.2013.08.008; Blanchet MR, 2010, J IMMUNOL, V184, P1292, DOI 10.4049/jimmunol.0900808; Capriotti Kara, 2012, J Clin Aesthet Dermatol, V5, P24; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cox Media Group, 2014, CAM CANC CAR SHUT DO; Da Violante G, 2002, BIOL PHARM BULL, V25, P1600, DOI 10.1248/bpb.25.1600; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Deng R, 2014, J BREAST CANCER, V17, P25, DOI 10.4048/jbc.2014.17.1.25; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Ehrlich G E, 1965, Pa Med, V68, P51; GOROG P, 1968, CURR THER RES CLIN E, V10, P486; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Hollebeeck S, 2011, TOXICOL LETT, V206, P268, DOI 10.1016/j.toxlet.2011.08.010; HOSOI J, 1985, CANCER RES, V45, P1474; HUCKER HB, 1967, J PHARMACOL EXP THER, V155, P309; JACOB SW, 1964, CURR THER RES CLIN E, V6, P134; JIMENEZ RAH, 1982, J LAB CLIN MED, V100, P489; JONES RJ, 1982, JAMA-J AM MED ASSOC, V248, P1369; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; KOLB KH, 1967, ANN NY ACAD SCI, V141, P85, DOI 10.1111/j.1749-6632.1967.tb34869.x; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; LAYMAN DL, 1985, LIFE SCI, V37, P2431, DOI 10.1016/0024-3205(85)90111-0; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MATSUMOT.J, 1967, ANN NY ACAD SCI, V141, P560, DOI 10.1111/j.1749-6632.1967.tb34925.x; Monach Paul, 2007, V136, P269; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Muir M., 1996, ALTERN COMPLEMENT TH, V2, P230, DOI [10.1089/act.1996.2.230, DOI 10.1089/ACT.1996.2.230]; MYRER JW, 1986, AM J SPORT MED, V14, P165, DOI 10.1177/036354658601400214; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Nigrovic PA, 2015, METHODS MOL BIOL, V1220, P423, DOI 10.1007/978-1-4939-1568-2_26; NORDENBERG J, 1986, EXP CELL RES, V162, P77, DOI 10.1016/0014-4827(86)90427-1; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Pegg David E, 2007, Methods Mol Biol, V368, P39; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; PREZIOSI P, 1966, CURR THER RES CLIN E, V8, P261; REED K W, 1985, Journal of Parenteral Science and Technology, V39, P64; ROSENBAUM EDWARD E., 1964, NW MED, V63, P227; ROSENBAUM EE, 1965, J AMER MED ASSOC, V192, P309, DOI 10.1001/jama.1965.03080170037009; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; SIRACKY J, 1985, NEOPLASMA, V32, P685; STEINBER.A, 1967, ANN NY ACAD SCI, V141, P532, DOI 10.1111/j.1749-6632.1967.tb34922.x; Stolevik SB, 2011, TOXICOL IN VITRO, V25, P555, DOI 10.1016/j.tiv.2010.11.021; SULZBERG.MB, 1967, ANN NY ACAD SCI, V141, P437, DOI 10.1111/j.1749-6632.1967.tb34908.x; TEIGLAND.MB, 1967, ANN NY ACAD SCI, V141, P471, DOI 10.1111/j.1749-6632.1967.tb34913.x; TRICE JM, 1985, SEMIN ARTHRITIS RHEU, V15, P45, DOI 10.1016/0049-0172(85)90009-5; U.S. Food and Drug Administration, 2009, 187 FAK CANC CUR CON; Weisser Shelley B, 2013, Methods Mol Biol, V946, P225, DOI 10.1007/978-1-62703-128-8_14; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	57	47	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152538	10.1371/journal.pone.0152538	http://dx.doi.org/10.1371/journal.pone.0152538			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031833	gold, Green Published			2022-12-27	WOS:000373121800089
J	Lian, YF; Yuan, J; Cui, Q; Feng, QS; Xu, M; Bei, JX; Zeng, YX; Feng, L				Lian, Yi-Fan; Yuan, Jing; Cui, Qian; Feng, Qi-Sheng; Xu, Miao; Bei, Jin-Xin; Zeng, Yi-Xin; Feng, Lin			Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma	PLOS ONE			English	Article							TARGETING APOPTOSIS PATHWAYS; CUL3-BASED E3 LIGASE; PROTEINS; STRESS; CANCER; ACTIVATION; EPIDEMIOLOGY; INDUCTION; ADAPTER; FAMILY	Kelch proteins are implicated in the pathogenesis of many human diseases, including cancer. Nasopharyngeal carcinoma (NPC) is a rare malignancy in most countries, but prevalent in southern China and certain areas of Southeast Asia. In this study, we identified Kelch Domain Containing 4 (KLHDC4), an orphan member of the kelch repeat superfamily, as a prognosis marker for NPC. We examined the expression of KLHDC4 in 168 NPC cases by immunohistochemical staining and found a substantially higher level of KLHDC4 in NPC biopsies compared to adjacent normal nasopharyngeal mucosa. KLHDC4 expression was significantly related to the T classification (P <0.05), N classification (P <0.05) and total staging (P <0.01) in NPC, and patients with higher KLHDC4 expression had poorer overall (P <0.01) and metastasis-free survival (P <0.05) rates. Knockout (KO) of KLHDC4 via CRISPR/Cas9-mediated gene editing in NPC cell line dramatically inhibited cell proliferation, colony formation in soft agar and tumor formation in nude mice. In addition, cell migration and invasion were also impaired by KLHDC4 depletion as revealed by wound healing and Transwell assay. Mechanically, loss of KLHDC4 markedly induced spontaneous apoptosis in NPC cells, as evidenced by increased levels of cleaved caspase-3 and cleaved PARP. Consistently, KLHDC4 knockout cell-derived xenografts also showed elevated cleaved caspase-3 and PARP but reduced Ki-67 staining. In conclusion, our results suggest that KLHDC4 promotes NPC oncogenesis by suppressing cellular apoptosis. Thus, KLHDC4 may serve as a prognosis biomarker and a potential therapeutic target for NPC.	[Lian, Yi-Fan; Yuan, Jing; Cui, Qian; Feng, Qi-Sheng; Xu, Miao; Bei, Jin-Xin; Zeng, Yi-Xin; Feng, Lin] Sun Yat Sen Univ, Dept Expt Res, State Key Lab Oncol South China, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Yi-Xin] Beijing Hosp, Beijing, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Beijing Hospital	Zeng, YX; Feng, L (corresponding author), Sun Yat Sen Univ, Dept Expt Res, State Key Lab Oncol South China, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China.; Zeng, YX (corresponding author), Beijing Hosp, Beijing, Peoples R China.	zengyx@sysucc.org.cn; fengl@sysucc.org.cn	Bei, Jin-Xin/AAO-1259-2020	Feng, Lin/0000-0001-6461-5838; Yuan, Jing/0000-0002-8231-5414	National Nature Science Foundation of China [81572781]; Specialized Research Fund for the Doctoral Program of Higher Education [20110171120099]; National Basic Research Program of China (973 Program) [2013CB910303]; National High Technology Research and Development Program of China (863 Program) [2012AA02A206, 2012AA02A501]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National Nature Science Foundation of China (grant number: 81572781) (http://isisn.nsfc.gov.cn), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20110171120099) (http://www.moe.gov.cn), the National Basic Research Program of China (973 Program: 2013CB910303) (http://www.most.gov.cn) and the National High Technology Research and Development Program of China (863 Program: 2012AA02A206 and 2012AA02A501) (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2004, CURR CANCER DRUG TAR, V4, P569, DOI 10.2174/1568009043332763; Gettemans Jan, 2003, Sci STKE, V2003, pPE27, DOI 10.1126/stke.2003.191.pe27; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gorokhova S, 2007, HUM MOL GENET, V16, P2394, DOI 10.1093/hmg/ddm167; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu ZY, 2008, INT J CANCER, V123, P2418, DOI 10.1002/ijc.23752; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Huang W, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0564-4; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Li HL, 2001, CELL RES, V11, P311, DOI 10.1038/sj.cr.7290101; Lin ML, 2007, ANTICANCER RES, V27, P3313; Lin ML, 2010, CANCER LETT, V291, P46, DOI 10.1016/j.canlet.2009.09.016; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Ma J, 2001, J CLIN ONCOL, V19, P1350, DOI 10.1200/JCO.2001.19.5.1350; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sun GG, 2014, TUMOR BIOL, V35, P3185, DOI 10.1007/s13277-013-1416-5; Wang TJC, 2012, J RADIOL ONCOL, V1, P129, DOI 10.1007/s13566-012-0020-4; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; ZHANG SH, 1983, INT J CANCER, V31, P587, DOI 10.1002/ijc.2910310509	30	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152820	10.1371/journal.pone.0152820	http://dx.doi.org/10.1371/journal.pone.0152820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030985	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800142
J	Lin, F; Liu, JH; Zeng, B; Pan, XJ; Su, XL				Lin, Feng; Liu, Jianhui; Zeng, Bo; Pan, Xiaojiao; Su, Xiaolei			Submergence Tolerance and Germination Dynamics of Roegneria nutans Seeds in Water-Level Fluctuation Zones with Different Water Rhythms in the Three Gorges Reservoir	PLOS ONE			English	Article							WETLAND VEGETATION; RIPARIAN; CHINA; DRAWDOWN; RESTORATION; RESPONSES; ECOLOGY; RIVER; DAM; ESTABLISHMENT	The Three Gorges Dam features two water-level fluctuation zones (WLFZs): the preupland drawdown zone (PU-DZ) and the preriparian drawdown zone (PR-DZ). To investigate the vegetation potential of Roegneria nutans in WLFZs, we compared the submergence tolerance and germination dynamics in the natural riparian zone (NRZ), PU-DZ and PR-DZ. We found that the NRZ seeds maintained an 81.3% intactness rate and >91% germination rate. The final seed germination rate and germination dynamics were consistent with those of the controls. Meanwhile, the PU-DZ seeds submerged at 5 m, 10 m, 15 m, and 20 m exhibited intactness rates of 70.5%, 79.95%, 40.75%, and 39.87%, respectively, and >75% germination. Furthermore, the PR-DZ seeds exhibited intactness rates of 22.44%, 61.13%, 81.87%, and 15.36% at 5 m, 10 m, 15 m, and 17 m, respectively, and 80% germination. The germination rates of the intact seeds submerged > 10 m were > 80%. Finally, the intact seeds germinated quickly in all WLFZs. The high proportion of intact seeds, rapid germination capacity, and high germination rate permit R. nutans seeds to adapt to the complicated water rhythms of the PU-DZ and PR-DZ and indicate the potential for their use in vegetation restoration and recovery. Thus, perennial seeds can be used for vegetation restoration in the WLFZs of large reservoirs and in other regions with water rhythms similar to the Three Gorges Reservoir.	[Lin, Feng; Liu, Jianhui; Zeng, Bo; Pan, Xiaojiao; Su, Xiaolei] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Res Gorg, Sch Life Sci, Key Lab Ecoenvironm Gorges Reservoir Reg 3,Minist, Chongqing 400715, Peoples R China	Southwest University - China	Zeng, B (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Res Gorg, Sch Life Sci, Key Lab Ecoenvironm Gorges Reservoir Reg 3,Minist, Chongqing 400715, Peoples R China.	bzeng@swu.edu.cn	Liu, Jianhui/X-6679-2019		National Natural Science Foundation of China [31370443, 31070474]; Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China [5000002013BB5200001, 5000002013BB5200002]; Research Grant for Disciplines Conferring Doctorate in China [20100182110022]; Fundamental Research Funds for the Central Universities [XDJK2013A003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China; Research Grant for Disciplines Conferring Doctorate in China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was financed by the National Natural Science Foundation of China (31370443, 31070474), the Ministry of Finance & State Council Executive Office of Three Gorges Project Construction Committee of China (5000002013BB5200001, 5000002013BB5200002), the Research Grant for Disciplines Conferring Doctorate in China (20100182110022), and the Fundamental Research Funds for the Central Universities (XDJK2013A003).	Baskin CC, 2004, ACTA OECOL, V26, P9, DOI 10.1016/j.actao.2004.03.001; Baskin CC, 2002, WETLANDS, V22, P661, DOI 10.1672/0277-5212(2002)022[0661:EOFATO]2.0.CO;2; Baskin CC, 1996, AQUAT BOT, V54, P51, DOI 10.1016/0304-3770(96)01028-5; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Cornaglia PS, 2009, AUSTRAL ECOL, V34, P343, DOI 10.1111/j.1442-9993.2009.01935.x; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; Holzel N, 2004, PLANT ECOL, V174, P279, DOI 10.1023/B:VEGE.0000049108.04955.e2; Ismail AM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls019; Jiao F, 2011, CATENA, V86, P110, DOI 10.1016/j.catena.2011.03.001; Lu Zhi-Jun, 2010, Wuhan Zhiwuxue Yanjiu, V28, P303, DOI 10.3724/SP.J.1142.2010.30303; Luo Fang-Li, 2007, Zhiwu Shengtai Xuebao, V31, P910; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Martin DW, 2001, J RANGE MANAGE, V54, P284, DOI 10.2307/4003249; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Odland A, 2002, PLANT ECOL, V162, P185, DOI 10.1023/A:1020388910724; Peng CR, 2014, ECOL ENG, V71, P574, DOI 10.1016/j.ecoleng.2014.07.078; Shafroth PB, 2005, ENVIRON MANAGE, V35, P231, DOI 10.1007/s00267-004-0099-5; Shen Jian-Hong, 2011, Chinese Journal of Plant Ecology, V35, P237, DOI 10.3724/SP.J.1258.2011.00237; Su XL, 2012, ECOL ENG, V44, P123, DOI 10.1016/j.ecoleng.2012.03.001; [汤显强 Tang Xianqiang], 2012, [长江科学院院报, Journal of Yangtze River Scientific Research Institute], V29, P13; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vidal DB, 2014, J FORESTRY RES, V25, P903, DOI 10.1007/s11676-014-0537-z; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; [王建超 WANG Jianchao], 2011, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V20, P603; Wang Q, 2014, POL J ECOL, V62, P25, DOI 10.3161/104.062.0104; [韦红波 Wei Hongbo], 2002, [植物生态学报, Acta Phytoecologica Sinica], V26, P489; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Yang F, 2015, AQUAT ECOSYST HEALTH, V18, P240, DOI 10.1080/14634988.2015.1040332; [袁慎鸿 Yuan Shenhong], 2014, [生态学报, Acta Ecologica Sinica], V34, P6481; Zhang H, 2008, RESOUR ENV YANGTZE B, V3, P374, DOI DOI 10.3969/J.ISSN.1004-8227.2008.03.009; Zhong ZC, 2009, ILLUSTRATED SPECIES	35	6	7	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151318	10.1371/journal.pone.0151318	http://dx.doi.org/10.1371/journal.pone.0151318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031104	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800013
J	Longo, G; Ioannidu, CA; d'Abusco, AS; Superti, F; Misiano, C; Zanoni, R; Politi, L; Mazzola, L; Iosi, F; Mura, F; Scandurra, R				Longo, Giovanni; Ioannidu, Caterina Alexandra; d'Abusco, Anna Scotto; Superti, Fabiana; Misiano, Carlo; Zanoni, Robertino; Politi, Laura; Mazzola, Luca; Iosi, Francesca; Mura, Francesco; Scandurra, Roberto			Improving Osteoblast Response In Vitro by a Nanostructured Thin Film with Titanium Carbide and Titanium Oxides Clustered around Graphitic Carbon	PLOS ONE			English	Article							SURFACE FREE-ENERGY; CELL-ADHESION; EXTRACELLULAR-MATRIX; INTEGRIN; MODULATION; PROLIFERATION; WETTABILITY; EXPRESSION; ROUGHNESS; ALLOYS	Introduction Recently, we introduced a new deposition method, based on Ion Plating Plasma Assisted technology, to coat titanium implants with a thin but hard nanostructured layer composed of titanium carbide and titanium oxides, clustered around graphitic carbon. The nanostructured layer has a double effect: protects the bulk titanium against the harsh conditions of biological tissues and in the same time has a stimulating action on osteoblasts. Results The aim of this work is to describe the biological effects of this layer on osteoblasts cultured in vitro. We demonstrate that the nanostructured layer causes an overexpression of many early genes correlated to proteins involved in bone turnover and an increase in the number of surface receptors for alpha 3 beta 1 integrin, talin, paxillin. Analyses at single-cell level, by scanning electron microscopy, atomic force microscopy, and single cell force spectroscopy, show how the proliferation, adhesion and spreading of cells cultured on coated titanium samples are higher than on uncoated titanium ones. Finally, the chemistry of the layer induces a better formation of blood clots and a higher number of adhered platelets, compared to the uncoated cases, and these are useful features to improve the speed of implant osseointegration. Conclusion In summary, the nanostructured TiC film, due to its physical and chemical properties, can be used to protect the implants and to improve their acceptance by the bone.	[Longo, Giovanni] CNR, Ist Struttura Mat, Via Fosso del Cavaliere 100, I-00133 Rome, Italy; [Longo, Giovanni] Ecole Polytech Fed Lausanne, SB IPSB LPMV, BSP 409 Cubotron UNIL, CH-1015 Lausanne, Switzerland; [Ioannidu, Caterina Alexandra; d'Abusco, Anna Scotto; Politi, Laura; Mazzola, Luca; Scandurra, Roberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Superti, Fabiana; Iosi, Francesca] Ist Super Sanita, Dipartimento Tecnol & Salute, Viale Regina Elena 299, I-00161 Rome, Italy; [Misiano, Carlo] Romana Film Sottili, Rome, Italy; [Zanoni, Robertino; Mura, Francesco] Univ Roma La Sapienza, Dipartimento Chim, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Struttura della Materia (ISM-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Longo, G (corresponding author), CNR, Ist Struttura Mat, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.; Longo, G (corresponding author), Ecole Polytech Fed Lausanne, SB IPSB LPMV, BSP 409 Cubotron UNIL, CH-1015 Lausanne, Switzerland.	longo@ism.cnr.it	Zanoni, Robertino/A-1742-2008; IOSI, FRANCESCA/F-2106-2015; Longo, G./K-8923-2016; Scotto d'Abusco, Anna/E-9978-2011; Mura, Francesco/AAD-5114-2020; Superti, Fabiana/F-2100-2015; Zanoni, Robertino/N-7001-2019	Zanoni, Robertino/0000-0003-2419-309X; IOSI, FRANCESCA/0000-0002-5929-6833; Longo, G./0000-0003-2434-2155; Mura, Francesco/0000-0001-8490-9438; Superti, Fabiana/0000-0003-4909-7598; Zanoni, Robertino/0000-0003-2419-309X; scotto d'abusco, anna/0000-0002-3323-6015	Italian Department of Health [GR-2009-1305007]	Italian Department of Health	This work has been supported by the Italian Department of Health through the grant n. GR-2009-1305007.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; Anselme K, 2014, SCANNING, V36, P11, DOI 10.1002/sca.21067; Anselme K, 2011, OSTEOPOROSIS INT, V22, P2037, DOI 10.1007/s00198-011-1618-x; Ashby MF., 1980, ENG MAT INTRO THEIR; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Brama M, 2007, BIOMATERIALS, V28, P595, DOI 10.1016/j.biomaterials.2006.08.018; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4; Farrugia BL, 2014, BIOMATERIALS, V35, P1462, DOI 10.1016/j.biomaterials.2013.10.068; Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Marquez-Ramirez SG, 2012, TOXICOLOGY, V302, P146, DOI 10.1016/j.tox.2012.09.005; GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KANDASAMY K, 1980, J PHYS C SOLID STATE, V13, P689, DOI 10.1088/0022-3719/13/4/024; Kasas S, 2013, MICROSC RES TECHNIQ, V76, P357, DOI 10.1002/jemt.22174; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Lawrence WT, 1998, CLIN PLAST SURG, V25, P321; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Longo G, 2010, SURF COAT TECH, V204, P2605, DOI 10.1016/j.surfcoat.2010.02.007; Mazzola L, 2011, J NANOSCI NANOTECHNO, V11, P8754, DOI 10.1166/jnn.2011.3508; Mazzola L, 2012, MEASUREMENT, V45, P317, DOI 10.1016/j.measurement.2011.11.016; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Mohanty M, 1996, BIO-MED MATER ENG, V6, P165; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6; Pesakova V, 2007, J MATER SCI-MATER M, V18, P465, DOI 10.1007/s10856-007-2006-0; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Rama KA, 2011, TRENDS BIOMATER ARTI, V25, P112, DOI DOI 10.1007/S11056-007-9051-X; Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003; SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311; Saldana L, 2010, ACTA BIOMATER, V6, P1649, DOI 10.1016/j.actbio.2009.10.033; Santiago-Medina P, 2015, INT J DENT, V2015, P9; SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006; Wu WH, 2008, BIOCHEM BIOPH RES CO, V373, P315, DOI 10.1016/j.bbrc.2008.06.035; Yang GH, 2015, NANOSCALE, V7, P14217, DOI 10.1039/c5nr03398e; YOUNG WC, 1985, J CELL SCI, V73, P19; Zanoni R, 2015, MAT SCI ENG C-MATER, V46, P409, DOI 10.1016/j.msec.2014.10.073; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320	57	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152566	10.1371/journal.pone.0152566	http://dx.doi.org/10.1371/journal.pone.0152566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031101	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800093
J	Nagy, A; Cernikova, L; Vitaskova, E; Krivda, V; Dan, A; Dirbakova, Z; Jirincova, H; Prochazka, B; Sedlak, K; Havlickova, M				Nagy, Alexander; Cernikova, Lenka; Vitaskova, Eliska; Krivda, Vlastimil; Dan, Adam; Dirbakova, Zuzana; Jirincova, Helena; Prochazka, Bohumir; Sedlak, Kamil; Havlickova, Martina			MeltMan: Optimization, Evaluation, and Universal Application of a qPCR System Integrating the TaqMan qPCR and Melting Analysis into a Single Assay	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SYBR-GREEN-I; AFRICAN-SWINE-FEVER; RT-PCR; CURVE ANALYSIS; BURKHOLDERIA-MALLEI; DYE CONCENTRATION; RAPID DETECTION; VIRUS	In the present work, we optimised and evaluated a qPCR system integrating 6-FAM (6-carboxyfluorescein)-labelled TaqMan probes and melting analysis using the SYTO 82 (S82) DNA binding dye in a single reaction. We investigated the influence of the S82 on various TaqMan and melting analysis parameters and defined its optimal concentration. In the next step, the method was evaluated in 36 different TaqMan assays with a total of 729 paired reactions using various DNA and RNA templates, including field specimens. In addition, the melting profiles of interest were correlated with the electrophoretic patterns. We proved that the S82 is fully compatible with the FAM-TaqMan system. Further, the advantages of this approach in routine diagnostic TaqMan qPCR were illustrated with practical examples. These included solving problems with flat or other atypical amplification curves or even false negativity as a result of probe binding failure. Our data clearly show that the integration of the TaqMan qPCR and melting analysis into a single assay provides an additional control option as well as the opportunity to perform more complex analyses, get more data from the reactions, and obtain analysis results with higher confidence.	[Nagy, Alexander; Cernikova, Lenka; Vitaskova, Eliska; Krivda, Vlastimil] State Vet Inst Prague, Lab Mol Methods, Prague, Czech Republic; [Dan, Adam] Natl Food Chain Safety Off, Vet Diagnost Directorate, Mol Biol Lab, Budapest, Hungary; [Dirbakova, Zuzana] State Vet Inst Zvolen, Dept Virol, Zvolen, Slovakia; [Nagy, Alexander; Jirincova, Helena; Havlickova, Martina] Natl Inst Publ Hlth, Natl Reference Lab Influenza, Prague, Czech Republic; [Prochazka, Bohumir] Natl Inst Publ Hlth, Dept Informat & Biostat, Prague, Czech Republic; [Krivda, Vlastimil; Sedlak, Kamil] State Vet Inst Prague, Dept Virol & Serol, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic; National Institute of Public Health (SZU) - Czech Republic	Nagy, A (corresponding author), State Vet Inst Prague, Lab Mol Methods, Prague, Czech Republic.; Nagy, A (corresponding author), Natl Inst Publ Hlth, Natl Reference Lab Influenza, Prague, Czech Republic.	alexandernagy17@hotmail.com	Dán, Ádám/G-6018-2012; Jirincova, Helena/GRJ-0968-2022	Dán, Ádám/0000-0001-7849-7721; 	Ministry of Health, Czech Republic-conceptual development of research organization (NIPH) [IN 75010330]	Ministry of Health, Czech Republic-conceptual development of research organization (NIPH)	Funding for this work was provided by the Ministry of Health, Czech Republic-conceptual development of research organization (NIPH, IN 75010330).	Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Achazi K, 2011, J VIROL METHODS, V171, P34, DOI 10.1016/j.jviromet.2010.09.026; Armstrong PM, 2012, VECTOR-BORNE ZOONOT, V12, P872, DOI 10.1089/vbz.2012.1008; Avian Influenza EU Reference Laboratory Animal and Plant Health Agency UK, 2007, H7 EUR REAL TIM PCRS; Balasuriya UBR, 2002, J VIROL METHODS, V101, P21, DOI 10.1016/S0166-0934(01)00416-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Callison SA, 2006, J VIROL METHODS, V138, P60, DOI 10.1016/j.jviromet.2006.07.018; Cattoli G, 2009, J CLIN MICROBIOL, V47, P3791, DOI 10.1128/JCM.00895-09; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Colborn JM, 2008, AM J TROP MED HYG, V79, P887, DOI 10.4269/ajtmh.2008.79.887; Decaro N, 2008, J VIROL METHODS, V147, P67, DOI 10.1016/j.jviromet.2007.08.006; Diallo IS, 2007, VET MICROBIOL, V123, P93, DOI 10.1016/j.vetmic.2007.02.004; Dorak M.T., 2007, REAL TIME PCR, P1, DOI [10.4324/9780203967317, DOI 10.4324/9780203967317]; Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; European Union Reference Laboratory for Animal Proteins in Feedingstuffs, 2013, DET HORS DNA US REAL; Evans JJ, 2007, J FORENSIC SCI, V52, P93, DOI 10.1111/j.1556-4029.2006.00305.x; Everett KDE, 1999, J CLIN MICROBIOL, V37, P575, DOI 10.1128/JCM.37.3.575-580.1999; Fernandez-Pinero J, 2013, TRANSBOUND EMERG DIS, V60, P48, DOI 10.1111/j.1865-1682.2012.01317.x; Garson JA, 2012, J VIROL METHODS, V186, P157, DOI 10.1016/j.jviromet.2012.07.027; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Hakhverdyan M, 2005, J VIROL METHODS, V123, P195, DOI 10.1016/j.jviromet.2004.09.016; Hinshaw JV, 2004, LC GC N AM, V22, P252; Hole K, 2010, J VET DIAGN INVEST, V22, P428, DOI 10.1177/104063871002200315; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hupfer C, 2007, EUR FOOD RES TECHNOL, V225, P329, DOI 10.1007/s00217-006-0418-6; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; Koppel R, 2011, EUR FOOD RES TECHNOL, V232, P151, DOI 10.1007/s00217-010-1371-y; Koppel R, 2009, EUR FOOD RES TECHNOL, V230, P125, DOI 10.1007/s00217-009-1154-5; Lee DH, 2005, J CLIN MICROBIOL, V43, P5111, DOI 10.1128/JCM.43.10.5111-5116.2005; Letellier C, 2003, J VIROL METHODS, V114, P21, DOI 10.1016/j.jviromet.2003.08.004; Lind K, 2006, BIOTECHNIQUES, V40, P315, DOI 10.2144/000112101; Liu Y, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00096; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Mehndiratta M, 2008, BIOTECHNIQUES, V45, P625, DOI 10.2144/000112994; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Molecular Probes, 2001, MOL PROBES SYTO ORAN; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Nagy A, 2010, ARCH VIROL, V155, P665, DOI 10.1007/s00705-010-0636-x; Nitsche A, 2006, CLIN CHEM, V52, P316, DOI 10.1373/clinchem.2005.060335; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004; Qiagen, 2010, REAL TIME PCR BROCHU, V07, P1; Reid SM, 2004, J VIROL METHODS, V116, P169, DOI 10.1016/j.jviromet.2003.11.007; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Thibault FM, 2004, J CLIN MICROBIOL, V42, P5871, DOI 10.1128/JCM.42.12.5871-5874.2004; Tomaso H, 2006, CLIN CHEM, V52, P307, DOI 10.1373/clinchem.2005.059196; Traul DL, 2007, J VET DIAGN INVEST, V19, P405, DOI 10.1177/104063870701900412; Van Poucke M, 2012, BIOTECHNIQUES, V52, P81, DOI 10.2144/000113808; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; WHO Collaborating Centre for influenza at CDC Atlanta USA, 2009, CDC PROT REAL TIM RT; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	60	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151204	10.1371/journal.pone.0151204	http://dx.doi.org/10.1371/journal.pone.0151204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031831	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800009
J	ter Beek, J; Krause, N; Adelroth, P				ter Beek, Josy; Krause, Nils; Adelroth, Pia			Investigating the Proton Donor in the NO Reductase from Paracoccus denitrificans	PLOS ONE			English	Article							NITRIC-OXIDE REDUCTASE; CYTOCHROME-C-OXIDASE; THERMUS-THERMOPHILUS; STRUCTURAL BASIS; N2O GENERATION; PATHWAY; MECHANISM; PROTEINS; RESIDUES; ENZYME	Variant nomenclature: the variants were made in the NorB subunit if not indicated by the superscript(c), which are variants in the NorC subunit (e.g. E122A = exchange of Glu-122 in NorB for an Ala, E71(c)D; exchange of Glu-71 in NorC for an Asp). Bacterial NO reductases (NORs) are integral membrane proteins from the heme-copper oxidase superfamily. Most heme-copper oxidases are proton-pumping enzymes that reduce O-2 as the last step in the respiratory chain. With electrons from cytochrome c, NO reductase (cNOR) from Paracoccus (P.) denitrificans reduces NO to N2O via the following reaction: 2NO+2e(-)+2H(+) -> N2O+H2O. Although this reaction is as exergonic as O-2-reduction, cNOR does not contribute to the electrochemical gradient over the membrane. This means that cNOR does not pump protons and that the protons needed for the reaction are taken from the periplasmic side of the membrane (since the electrons are donated from this side). We previously showed that the P. denitrificans cNOR uses a single defined proton pathway with residues Glu-58 and Lys-54 from the NorC subunit at the entrance. Here we further strengthened the evidence in support of this pathway. Our further aim was to define the continuation of the pathway and the immediate proton donor for the active site. To this end, we investigated the region around the calcium-binding site and both propionates of heme b(3) by site directed mutagenesis. Changing single amino acids in these areas often had severe effects on cNOR function, with many variants having a perturbed active site, making detailed analysis of proton transfer properties difficult. Our data does however indicate that the calcium ligation sphere and the region around the heme b(3) propionates are important for proton transfer and presumably contain the proton donor. The possible evolutionary link between the area for the immediate donor in cNOR and the proton loading site (PLS) for pumped protons in oxygen-reducing heme-copper oxidases is discussed.	[ter Beek, Josy; Krause, Nils; Adelroth, Pia] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [ter Beek, Josy] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Krause, Nils] Free Univ Berlin, Dept Expt Phys, Berlin, Germany	Stockholm University; Umea University; Free University of Berlin	Adelroth, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	pia.adelroth@dbb.su.se	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Vetenskapsradet; Stockholm University	Vetenskapsradet(Swedish Research Council); Stockholm University	This work was supported y Vetenskapsradet, http://www.vr.se. JB was supported by a post-doctoral grant from Stockholm University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Beekter J, 2013, J BIOL CHEM, DOI [10.1074/jbc.M113.497347, DOI 10.1074/JBC.M113.497347]; Blomberg MRA, 2012, BIOCHEMISTRY-US, V51, P5173, DOI 10.1021/bi300496e; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Chang HY, 2012, P NATL ACAD SCI USA, V109, P5259, DOI 10.1073/pnas.1107345109; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hendriks JHM, 2001, BIOCHEMISTRY-US, V40, P13361, DOI 10.1021/bi011428t; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Koutny M, 1999, BIOCHEM BIOPH RES CO, V262, P562, DOI 10.1006/bbrc.1999.1245; Lachmann P, 2010, J BIOL CHEM, V285, P25531, DOI 10.1074/jbc.M110.123984; Matsumoto Y, 2012, NAT STRUCT MOL BIOL, V19, P238, DOI 10.1038/nsmb.2213; Pisliakov AV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002674; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Schurig-Briccio LA, 2013, P NATL ACAD SCI USA, V110, P12613, DOI 10.1073/pnas.1301731110; Shiro Y, 2012, PHILOS T R SOC B, V367, P1195, DOI 10.1098/rstb.2011.0310; Silverman DN, 2000, BBA-BIOENERGETICS, V1458, P88, DOI 10.1016/S0005-2728(00)00061-X; Terasaka E, 2014, BBA-BIOENERGETICS, V1837, P1019, DOI 10.1016/j.bbabio.2014.02.017; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; Wraight CA, 2006, BBA-BIOENERGETICS, V1757, P886, DOI 10.1016/j.bbabio.2006.06.017	29	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152745	10.1371/journal.pone.0152745	http://dx.doi.org/10.1371/journal.pone.0152745			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030968	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800132
J	Zewde, N; Gorham, RD; Dorado, A; Morikis, D				Zewde, Nehemiah; Gorham, Ronald D., Jr.; Dorado, Angel; Morikis, Dimitrios			Quantitative Modeling of the Alternative Pathway of the Complement System	PLOS ONE			English	Article							MEMBRANE ATTACK COMPLEX; DECAY-ACCELERATING FACTOR; BINDING-SITE; MOLECULAR-ORGANIZATION; POSITIVE REGULATOR; PROPERDIN BINDS; RECEPTOR CR-1; C3 CONVERTASE; 3RD COMPONENT; T-CELLS	The complement system is an integral part of innate immunity that detects and eliminates invading pathogens through a cascade of reactions. The destructive effects of the complement activation on host cells are inhibited through versatile regulators that are present in plasma and bound to membranes. Impairment in the capacity of these regulators to function in the proper manner results in autoimmune diseases. To better understand the delicate balance between complement activation and regulation, we have developed a comprehensive quantitative model of the alternative pathway. Our model incorporates a system of ordinary differential equations that describes the dynamics of the four steps of the alternative pathway under physiological conditions: (i) initiation (fluid phase), (ii) amplification (surfaces), (iii) termination (pathogen), and (iv) regulation (host cell and fluid phase). We have examined complement activation and regulation on different surfaces, using the cellular dimensions of a characteristic bacterium (E. coli) and host cell (human erythrocyte). In addition, we have incorporated neutrophil-secreted properdin into the model highlighting the cross talk of neutrophils with the alternative pathway in coordinating innate immunity. Our study yields a series of time-dependent response data for all alternative pathway proteins, fragments, and complexes. We demonstrate the robustness of alternative pathway on the surface of pathogens in which complement components were able to saturate the entire region in about 54 minutes, while occupying less than one percent on host cells at the same time period. Our model reveals that tight regulation of complement starts in fluid phase in which propagation of the alternative pathway was inhibited through the dismantlement of fluid phase convertases. Our model also depicts the intricate role that properdin released from neutrophils plays in initiating and propagating the alternative pathway during bacterial infection.	[Zewde, Nehemiah; Gorham, Ronald D., Jr.; Morikis, Dimitrios] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Dorado, Angel] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Morikis, D (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	dmorikis@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665; Gorham, Ronald/0000-0002-0261-6699				Agarwal S, 2010, J IMMUNOL, V185, P507, DOI 10.4049/jimmunol.0903598; AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; BOTTO M, 1992, J IMMUNOL, V149, P1348; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Brodbeck WG, 2000, J IMMUNOL, V165, P3999, DOI 10.4049/jimmunol.165.7.3999; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; Charles A Janeway J, 2001, COMPLEMENT SYSTEM IN; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choi J, 1998, J HYDROL, V209, P297, DOI 10.1016/S0022-1694(98)00093-6; COCHRANE CG, 1968, J EXP MED, V127, P371, DOI 10.1084/jem.127.2.371; COOPER NR, 1970, J EXP MED, V132, P775, DOI 10.1084/jem.132.4.775; Cortes C, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00412; Cortes C, 2011, INFECT IMMUN, V79, P724, DOI 10.1128/IAI.00980-10; DASILVA WD, 1967, J EXP MED, V126, P1027, DOI 10.1084/jem.126.6.1027; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ember JA, 1997, IMMUNOPHARMACOLOGY, V38, P3, DOI 10.1016/S0162-3109(97)00088-X; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Ferreira VP, 2010, IMMUNOBIOLOGY, V215, P932, DOI 10.1016/j.imbio.2010.02.002; Fishelson Z, 2001, MOL IMMUNOL, V38, P207, DOI 10.1016/S0161-5890(01)00055-4; FODOR WL, 1995, J IMMUNOL, V155, P4135; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Gizeli E, 2003, BIOMOLECULAR SENSORS; Greer JP, 2009, WINTROBES CLIN HEMAT; Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Hirayama H, 1996, BIOSYSTEMS, V39, P173, DOI 10.1016/0303-2647(96)01617-6; HOGASEN AKM, 1995, J IMMUNOL, V154, P4734; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; HOURCADE D, 1989, PROGRESS IN IMMUNOLOGY, VOL 7, P171; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hugli T, CURR TOP MICROBIOL I, V153, P181; HUNSICKE.LG, 1973, J IMMUNOL, V110, P128; Jozsi M, 2002, J IMMUNOL, V168, P2782, DOI 10.4049/jimmunol.168.6.2782; Kavanagh D, 2013, SEMIN NEPHROL, V33, P508, DOI 10.1016/j.semnephrol.2013.08.003; KELLOGG JA, 1984, J CLIN MICROBIOL, V20, P618, DOI 10.1128/JCM.20.4.618-623.1984; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LAW SK, 1979, J IMMUNOL, V123, P1388; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Liddington R, 2005, NATURE, V437, P484, DOI 10.1038/437484a; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; MEDICUS RG, 1976, J EXP MED, V144, P1076, DOI 10.1084/jem.144.4.1076; MEDOF ME, 1982, J EXP MED, V156, P1739, DOI 10.1084/jem.156.6.1739; MONAHAN JB, 1981, J BIOL CHEM, V256, P3258; MORGAN BP, 1994, SPRINGER SEMIN IMMUN, V15, P369, DOI 10.1007/BF01837366; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Nataf S, 1999, J IMMUNOL, V162, P4018; NELSON RA, 1958, J EXP MED, V108, P515, DOI 10.1084/jem.108.4.515; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Ottonello L, 1999, J IMMUNOL, V162, P6510; PANGBURN MK, 1989, J IMMUNOL, V142, P202; PANGBURN MK, 1983, BIOCHEMISTRY-US, V22, P178, DOI 10.1021/bi00270a026; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; PODACK ER, 1982, J EXP MED, V156, P268, DOI 10.1084/jem.156.1.268; PORTEU F, 1988, J BIOL CHEM, V263, P5091; PREISSNER KT, 1985, J IMMUNOL, V135, P445; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Ross D, 1982, CR COFACTOR ACTIVITY; Saggu G, 2013, J IMMUNOL, V190, P6457, DOI 10.4049/jimmunol.1300610; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schrier R. W., 2008, MANUAL OF NEPHROLOGY; SCHWAEBLE W, 1993, J IMMUNOL, V151, P2521; SEYA T, 1995, MICROBIOL IMMUNOL, V39, P295, DOI 10.1111/j.1348-0421.1995.tb02205.x; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; STEWART JL, 1987, J IMMUNOL, V139, P1960; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Wirthmueller U, 1997, J IMMUNOL, V158, P4444; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	95	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152337	10.1371/journal.pone.0152337	http://dx.doi.org/10.1371/journal.pone.0152337			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031863	Green Published, gold			2022-12-27	WOS:000373121800059
J	Wang, Y; Sun, JT; Ma, C; Gao, WJ; Song, BF; Xue, H; Chen, WL; Chen, X; Zhang, Y; Shao, QQ; Wang, QJ; Zhao, L; Liu, J; Wang, XW; Wang, HY; Zhang, Y; Yang, MX; Qu, X				Wang, Yang; Sun, Jintang; Ma, Chao; Gao, Wenjuan; Song, Bingfeng; Xue, Hao; Chen, Weiliang; Chen, Xi; Zhang, Yun; Shao, Qianqian; Wang, Qingjie; Zhao, Lei; Liu, Jia; Wang, Xiuwen; Wang, Huayang; Zhang, Yun; Yang, Meixiang; Qu, Xun			Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; COLORECTAL-CANCER; PROGNOSTIC-SIGNIFICANCE; T-CELLS; HEPATOCELLULAR-CARCINOMA; TIM-3 EXPRESSION; DENDRITIC CELLS; DOWN-REGULATION; BREAST-CANCER; LUNG-CANCER	Galectin-9 is a widely expressed protein that is involved in immune regulation and tumor-pathogenesis and serves as a marker of a poor prognosis in various types of cancers. However, the clinical impact and the precise mechanism by which this protein contributes to colon tumor progression are unclear. In the present study, we detected the expression of galectin-9 and CD56 cells using immunohistochemistry. Spearman's rank correlation was used to clarify the association between galectin-9 expression and natural killer (NK) cell infiltration. The influence of galectin-9 on NK-92 cell migration was evaluated in vitro using transwell chemotaxis assays. The role of rh-galectin-9 in F-actin polarization in NK-92 cells was investigated using laser scanning confocal microscopy. We showed that galectin-9 was expressed in 101 (78.91%) colon tumor tissues and that was expressed at lower levels in these tissues than in para-tumor tissues. Low levels of galectin-9 expression were positively correlated with a poor histological grade and lymph node metastasis (P<0.05). A Kaplan-Meier method and Cox proportional hazards regression analysis showed that overall survival was longer in patients with high galectin-9 expression in an 8-year follow-up (P<0.05). Spearman's rank correlation indicated that there was a linear correlation between galectin-9 expression and CD56(+) NK cell infiltration (R-2 = 0.658; P<0.0001). Galectin-9 stimulated migration in human NK-92 cells by affecting F-actin polarization through the Rho/ROCK1 signaling pathway. These results suggest that galectin-9 expression potentially represents a novel mechanism for tumors to escape immune surveillance in colon tumors.	[Wang, Yang; Sun, Jintang; Ma, Chao; Gao, Wenjuan; Song, Bingfeng; Xue, Hao; Chen, Weiliang; Chen, Xi; Zhang, Yun; Shao, Qianqian; Wang, Qingjie; Zhao, Lei; Liu, Jia; Wang, Huayang; Yang, Meixiang; Qu, Xun] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan, Shandong, Peoples R China; [Wang, Xiuwen] Shandong Univ, Qilu Hosp, Dept Chemotherapy, Jinan, Shandong, Peoples R China; [Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Sun, JT; Qu, X (corresponding author), Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan, Shandong, Peoples R China.	sunjintang003@163.com; quxun@sdu.edu.cn	Xue, Hao/GXV-4717-2022	Wang, Qing-jie/0000-0002-4845-3696	National Natural Science Foundation of China [31470885, 31270971, 81072406, 31300752, 81300510, 30901326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Xun Qu (No. 31470885; 31270971; 81072406); National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Jintang Sun (No. 31300752); National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Qianqian Shao (No. 81300510); and National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to Meixiang Yang (No. 30901326).	ALLAVENA P, 1994, BLOOD, V84, P2261; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Chircop M, 2014, SMALL GTPASES, V5, P5, DOI DOI 10.4161/SGTP.29770.CLEVELAND; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; de Kivit S, 2015, CLIN IMMUNOL, V156, P28, DOI 10.1016/j.clim.2014.10.009; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; Fainaru O, 2010, FASEB J, V24, P1411, DOI 10.1096/fj.09-147025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Golden-Mason L, 2013, J VIROL, V87, P4835, DOI 10.1128/JVI.01085-12; Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heusschen R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105460; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Jost S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-74; Kadowaki T, 2012, CLIN IMMUNOL, V142, P296, DOI 10.1016/j.clim.2011.11.006; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Koelzer VH, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-81; Laghi L, 2009, LANCET ONCOL, V10, P877, DOI 10.1016/S1470-2045(09)70186-X; Li J, 2013, ONCOL REP, V29, P895, DOI 10.3892/or.2012.2217; Li YH, 2016, CELL MOL IMMUNOL, V13, P73, DOI 10.1038/cmi.2014.126; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Ling A, 2014, BRIT J CANCER, V110, P2551, DOI 10.1038/bjc.2014.161; Lipkowitz MS, 2002, GLYCOCONJUGATE J, V19, P491, DOI 10.1023/B:GLYC.0000014078.65610.2f; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Markman JL, 2015, J GASTROINTEST ONCOL, V6, P208, DOI 10.3978/j.issn.2078-6891.2014.077; Meggyes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092371; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Spitzenberger F, 2001, BIOCHIMIE, V83, P851, DOI 10.1016/S0300-9084(01)01335-9; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Sun JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147186; TARTTER PI, 1987, ARCH SURG-CHICAGO, V122, P1264; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Yamamoto H, 2008, J BIOCHEM, V143, P311, DOI 10.1093/jb/mvm223; Yamauchi A, 2006, BREAST J, V12, pS196, DOI 10.1111/j.1075-122X.2006.00334.x; Yang JX, 2014, INT J ONCOL, V45, P1313, DOI 10.3892/ijo.2014.2494; Zhang ZY, 2012, ASIAN PAC J CANCER P, V13, P2503, DOI 10.7314/APJCP.2012.13.6.2503	50	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152599	10.1371/journal.pone.0152599	http://dx.doi.org/10.1371/journal.pone.0152599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028892	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500056
J	Jiang, J; Li, W; Liang, BH; Xie, RQ; Chen, BB; Huang, H; Li, YR; He, YH; Lv, JJ; He, WM; Chen, LN				Jiang, Jing; Li, Wan; Liang, Binhua; Xie, Ruiqiang; Chen, Binbin; Huang, Hao; Li, Yiran; He, Yuehan; Lv, Junjie; He, Weiming; Chen, Lina			A Novel Prioritization Method in Identifying Recurrent Venous Thromboembolism-Related Genes	PLOS ONE			English	Article							PROTEIN INTERACTION NETWORK; CANDIDATE DISEASE GENES; DIFFERENTIAL EXPRESSION; TISSUE FACTOR; D-DIMER; RISK; ASSOCIATION; POLYMORPHISMS; COAGULATION; WARFARIN	Identifying the genes involved in venous thromboembolism (VTE) recurrence is important not only for understanding the pathogenesis but also for discovering the therapeutic targets. We proposed a novel prioritization method called Function-Interaction-Pearson (FIP) by creating gene-disease similarity scores to prioritize candidate genes underling VTE. The scores were calculated by integrating and optimizing three types of resources including gene expression, gene ontology and protein-protein interaction. As a result, 124 out of top 200 prioritized candidate genes had been confirmed in literature, among which there were 34 antithrombotic drug targets. Compared with two well-known gene prioritization tools Endeavour and ToppNet, FIP was shown to have better performance. The approach provides a valuable alternative for drug targets discovery and disease therapy.	[Jiang, Jing; Li, Wan; Xie, Ruiqiang; Chen, Binbin; Huang, Hao; Li, Yiran; He, Yuehan; Lv, Junjie; Chen, Lina] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Hei Longjiang P, Peoples R China; [Liang, Binhua] Publ Hlth Agcy Canada, Natl Microbol Lab, Winnipeg, MB, Canada; [He, Weiming] Harbin Inst Technol, Inst Optoelect, Harbin 150006, Hei Longjiang P, Peoples R China	Harbin Medical University; Public Health Agency of Canada; Harbin Institute of Technology	Chen, LN (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Hei Longjiang P, Peoples R China.; He, WM (corresponding author), Harbin Inst Technol, Inst Optoelect, Harbin 150006, Hei Longjiang P, Peoples R China.	hewm@hit.edu.cn; chenlina@ems.hrbmu.edu.cn	Liang, Binhua/ABN-9806-2022	Li, Wan/0000-0002-9797-0315; liang, binhua/0000-0002-1108-6407; Chen, Lina/0000-0002-4576-6814	National Natural Science Foundation of China [61272388, 31301040]; Natural Science Foundation of Heilongjiang Province [F201237]; Science & Technology Research Project of the Heilongjiang Ministry of Education [12541476]; Health Department Funds of Heilongjiang Province China [2012-810]; Master Innovation Funds of Heilongjiang Province [YJSCX2014-18HYD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Science & Technology Research Project of the Heilongjiang Ministry of Education; Health Department Funds of Heilongjiang Province China; Master Innovation Funds of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (Grant No. 61272388 and 31301040); the Natural Science Foundation of Heilongjiang Province (Grant No. F201237); the Science & Technology Research Project of the Heilongjiang Ministry of Education (Grant No. 12541476); the Health Department Funds of Heilongjiang Province China (Grant No. 2012-810); and the Master Innovation Funds of Heilongjiang Province (Grant No. YJSCX2014-18HYD).	Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12832; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brown KV, 2009, J TRAUMA, V66, pS145, DOI 10.1097/TA.0b013e31819cdd82; Cai J, 2014, AM HEALTH DRUG BENEF, V7, P444; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Che J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/576349; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chew TW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1200-6; D'Asti E, 2014, J THROMB HAEMOST, V12, P1838, DOI 10.1111/jth.12715; Dahabreh Issa J, 2013, TESTING CYP2C19 VARI; Dever SM, 2014, AIDS, V28, P19, DOI 10.1097/QAD.0000000000000113; Foong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139656; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gardiner EE, 2014, ADV EXP MED BIOL, V844, P263, DOI 10.1007/978-1-4939-2095-2_13; Gigante B, 2009, THROMB HAEMOSTASIS, V101, P943, DOI 10.1160/TH08-09-0612; Goncalves JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049634; Hamidi S, 2015, ASIAN SPINE J, V9, P232, DOI 10.4184/asj.2015.9.2.232; Han JY, 2015, J CONTROL RELEASE, V210, P39, DOI 10.1016/j.jconrel.2015.05.006; Heeb MJ, 2008, EXPERT REV HEMATOL, V1, P9, DOI 10.1586/17474086.1.1.9; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsegge I, 2013, PHYSIOL GENOMICS, V45, P400, DOI 10.1152/physiolgenomics.00172.2012; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S3; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2015, J MOL BIOL; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khan K, 2011, INVEST OPHTH VIS SCI, V52, P4294, DOI 10.1167/iovs.10-6776; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kooiman J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122520; Koupenova M, 2015, J THROMB HAEMOST, V13, P268, DOI 10.1111/jth.12806; Kyrle PA, 2007, THROMB HAEMOSTASIS, V97, P880, DOI 10.1160/TH07-02-0115; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lewis DA, 2015, THROMB RES, V135, P659, DOI 10.1016/j.thromres.2015.02.003; Lewis DA, 2011, THROMB RES, V128, P536, DOI 10.1016/j.thromres.2011.06.003; Li DY, 1999, ARTERIOSCL THROM VAS, V19, P378, DOI 10.1161/01.ATV.19.2.378; Li SF, 2014, ATHEROSCLEROSIS, V237, P514, DOI 10.1016/j.atherosclerosis.2014.09.033; Liebner DA, 2014, BIOINFORMATICS, V30, P682, DOI 10.1093/bioinformatics/btt566; Lippi G, 2015, SEMIN THROMB HEMOST, V41, P255, DOI 10.1055/s-0035-1546466; Liu HX, 2014, J ATHEROSCLER THROMB, V21, P1075, DOI 10.5551/jat.22772; Livnat T, 2011, BLOOD COAGUL FIBRIN, V22, P673, DOI 10.1097/MBC.0b013e32834ad785; Loren CP, 2015, THROMB RES, V135, P155, DOI 10.1016/j.thromres.2014.11.009; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Luo JW, 2015, J BIOMED INFORM, V53, P229, DOI 10.1016/j.jbi.2014.11.004; Magger O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002690; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MARCUS AJ, 1993, FASEB J, V7, P516, DOI 10.1096/fasebj.7.6.8472890; Menzies RI, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00305; Longo CM, 2014, REV CLIN ESP, V214, P164; Misumida N, 2015, CARDIOVASC REVASC ME; Moll S, 2008, ARTERIOSCL THROM VAS, V28, P367, DOI 10.1161/ATVBAHA.108.163097; Mollard J M, 1985, Phlebologie, V38, P293; Mughini-Gras L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087933; Myers DD, 2015, PHLEBOLOGY, V30, P7, DOI 10.1177/0268355515569424; Nitsch D, 2011, NUCLEIC ACIDS RES, V39, pW334, DOI 10.1093/nar/gkr289; O'Brien MA, 2012, INT REV NEUROBIOL, V104, P91, DOI 10.1016/B978-0-12-398323-7.00005-7; Oellrich A, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau017; Oliver KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102079; Pabinger I, 2009, ARTERIOSCL THROM VAS, V29, P332, DOI 10.1161/ATVBAHA.108.182188; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Petrillo A, 2015, EUR RADIOL, V25, P1935, DOI 10.1007/s00330-014-3581-3; Rao BS, 2014, ANN INDIAN ACAD NEUR, V17, P48, DOI 10.4103/0972-2327.128551; Raps M, 2012, J THROMB HAEMOST, V10, P992, DOI 10.1111/j.1538-7836.2012.04720.x; Rubio-Terres C, 2015, APPL HEALTH ECON HEA, V13, P233, DOI 10.1007/s40258-015-0153-x; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Shin M, 2011, BIOCHIP J, V5, P27, DOI 10.1007/s13206-011-5105-4; Smith NL, 2012, J THROMB HAEMOST, V10, P719, DOI 10.1111/j.1538-7836.2012.04665.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taniya T, 2012, GENOMICS, V99, P1, DOI 10.1016/j.ygeno.2011.10.002; Tatebe S, 2015, CIRC J, V79, P1215, DOI 10.1253/circj.CJ-15-0367; Tatsumi K, 2015, J ATHEROSCLER THROMB; Thushara RM, 2015, CRIT REV ONCOL HEMAT, V93, P149, DOI 10.1016/j.critrevonc.2014.11.002; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tregouet DA, 2012, J THROMB HAEMOST, V10, P1693, DOI 10.1111/j.1538-7836.2012.04807.x; Vafaee F, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-22; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Vlieg AV, 2014, CIRC-CARDIOVASC GENE, V7, P806, DOI 10.1161/CIRCGENETICS.114.000682; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wang YB, 2013, INT J CARDIOL, V168, P163, DOI 10.1016/j.ijcard.2012.09.100; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Wypasek E, 2013, ADV CLIN EXP MED, V22, P459; Xiao Y, 2011, GENOMICS, V98, P64, DOI 10.1016/j.ygeno.2011.04.001; Xie C, 2014, PHARMACOGENET GENOM, V24, P204, DOI 10.1097/FPC.0000000000000035; Zhang F, 2015, BONE, V71, P36, DOI 10.1016/j.bone.2014.09.025; Zhang SW, 2014, MOL BIOSYST, V10, P1400, DOI 10.1039/c3mb70588a; Zheng G, 2006, AM J HUM GENET, V78, P350, DOI 10.1086/500054	98	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153006	10.1371/journal.pone.0153006	http://dx.doi.org/10.1371/journal.pone.0153006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050193	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500082
J	Branche, AR; Walsh, EE; Jadhav, N; Karmally, R; Baran, A; Peterson, DR; Falsey, AR				Branche, Angela R.; Walsh, Edward E.; Jadhav, Nagesh; Karmally, Rachel; Baran, Andrea; Peterson, Derick R.; Falsey, Ann R.			Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TRACT INFECTIONS; CHEST RADIOGRAPHS; SYNCYTIAL VIRUS; RAPID DIAGNOSIS; PROCALCITONIN; BACTERIAL; SEPSIS; ADULTS; CARE	Rationale Lower respiratory tract illness (LRTI) frequently causes adult hospitalization and antibiotic overuse. Procalcitonin (PCT) treatment algorithms have been used successfully in Europe to safely reduce antibiotic use for LRTI but have not been adopted in the United States. We recently performed a feasibility study for a randomized clinical trial (RCT) of PCT and viral testing to guide therapy for non-pneumonic LRTI. Objective The primary objective of the current study was to understand factors influencing PCT algorithm adherence during the RCT and evaluate factors influencing provider antibiotic prescribing practices for LRTI. Study Design From October 2013-April 2014, 300 patients hospitalized at a community teaching hospital with non-pneumonic LRTI were randomized to standard or PCT-guided care with viral PCR testing. Algorithm adherence data was collected and multivariate stepwise logistic regression of clinical variables used to model algorithm compliance. 134 providers were surveyed anonymously before and after the trial to assess knowledge of biomarkers and viral testing and antibiotic prescribing practices. Results Diagnosis of pneumonia on admission was the only variable significantly associated with non-adherence [7%(adherence) vs. 26% (nonadherence), p = 0.01]. Surveys confirmed possible infiltrate on chest radiograph as important for provider decisions, as were severity of illness, positive sputum culture, abnormal CBC and fever. However, age, patient expectations and medical-legal concerns were also at least somewhat important to prescribing practices. Physician agreement with the importance of viral and PCT testing increased from 42% to 64% (p = 0.007) and 49% to 74% (p = 0.001), respectively, after the study. Conclusions Optimal algorithm adherence will be important for definitive PCT intervention trials in the US to determine if PCT guided algorithms result in better outcomes than reliance on traditional clinical variables. Factors influencing treatment decisions such as patient age, presence of fever, patient expectations and medical legal concerns may be amenable to education to improve PCT algorithm compliance for LRTI.	[Branche, Angela R.; Walsh, Edward E.; Falsey, Ann R.] Univ Rochester, Dept Med, Rochester, NY USA; [Walsh, Edward E.; Jadhav, Nagesh; Karmally, Rachel; Falsey, Ann R.] Rochester Gen Hosp, Dept Med, Rochester, NY 14621 USA; [Baran, Andrea; Peterson, Derick R.] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA	University of Rochester; Rochester General Hospital; University of Rochester	Branche, AR (corresponding author), Univ Rochester, Dept Med, Rochester, NY USA.	angela_branche@urmc.rochester.edu	Peterson, Derick/W-5240-2019	Peterson, Derick/0000-0001-8603-660X; Baran, Andrea/0000-0002-7975-8919; JADHAV, NAGESH/0000-0001-8993-3947	RGH KIDD Fund; National Institutes of Health, NIAID [HHSN27220120005C]	RGH KIDD Fund; National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the RGH KIDD Fund and National Institutes of Health, NIAID; Contract # HHSN27220120005C. BioFire, Inc, Salt Lake City, UT provided the FilmArray Respiratory Panel Instrument to conduct the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Bartlett JG, 2011, CLIN INFECT DIS, V52, pS296, DOI 10.1093/cid/cir045; Basi SK, 2004, AM J MED, V117, P305, DOI 10.1016/j.amjmed.2004.03.029; Boersma WG, 2006, RESP MED, V100, P926, DOI 10.1016/j.rmed.2005.06.018; Branche AR, 2015, J INFECT DIS, V212, P1692, DOI 10.1093/infdis/jiv252; Chandra A, 2010, AM J EMERG MED, V28, P862, DOI 10.1016/j.ajem.2009.04.014; Chapin KC, 1999, MANUAL CLIN MICROBIO, P1677; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; Dusemund F, 2013, EUR J CLIN MICROBIOL, V32, P51, DOI 10.1007/s10096-012-1713-8; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Gilbert DN., 2011, CLIN INFECT DIS, V52, pS362; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kruger S, 2008, EUR RESPIR J, V31, P349, DOI 10.1183/09031936.00054507; Leroy S, 2005, PEDIATRICS, V115, pE706, DOI 10.1542/peds.2004-1631; Lidman C, 2002, SCAND J INFECT DIS, V34, P873, DOI 10.1080/0036554021000026967; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Muller B, 2007, BMC INFECT DIS, P7; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; Oosterheert JJ, 2005, CLIN INFECT DIS, V41, P1438, DOI 10.1086/497134; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Ruiz-Alvarez M J, 2009, J Intensive Care Med, V24, P63, DOI 10.1177/0885066608327095; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P1177, DOI 10.1086/656596; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Walsh EE, 2013, J HOSP MED, V8, P61, DOI 10.1002/jhm.1984; Welker JA, 2008, ARCH INTERN MED, V168, P351, DOI 10.1001/archinternmed.2007.84; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yang S, 2005, J CLIN MICROBIOL, V43, P3221, DOI 10.1128/JCM.43.7.3221-3226.2005; Yardley L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-134; Zimmerman RK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0806-2	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152986	10.1371/journal.pone.0152986	http://dx.doi.org/10.1371/journal.pone.0152986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043012	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100058
J	Kunz, M; Hennig, J; Karmann, AJ; Lautenbacher, S				Kunz, Miriam; Hennig, Juergen; Karmann, Anna J.; Lautenbacher, Stefan			Relationship of 5-HTTLPR Polymorphism with Various Factors of Pain Processing: Subjective Experience, Motor Responsiveness and Catastrophizing	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; HEALTHY-INDIVIDUALS; REGULATORY REGION; ASSOCIATIONS; DEPRESSION; MODULATION; METAANALYSIS; RESPONSES; ANXIETY; SCALE	Although serotonin is known to play an important role in pain processing, the relationship between the polymorphism in 5-HTTLPR and pain processing is not well understood. To examine the relationship more comprehensively, various factors of pain processing having putative associations with 5-HT functioning were studied, namely the subjective pain experience (pain threshold, rating of experimental pain), catastrophizing about pain (Pain Catastrophizing Scale = PCS) and motor responsiveness (facial expression of pain). In 60 female and 67 male participants, heat pain stimuli were applied by a contact thermode to assess pain thresholds, supra-threshold ratings and a composite score of pain-relevant facial responses. Participants also completed the PCS and were grouped based on their 5-HTTLPR genotype (bi-allelic evaluation) into a group with s-allele carriers (ss, sl) and a second group without (ll). S-allele carriers proved to have lower pain thresholds and higher PCS scores. These two positive findings were unrelated to each other. No other difference between genotype groups became significant. In all analyses, "age" and "gender" were controlled for. In s-allele carriers the subjective pain experience and the tendency to catastrophize about pain was enhanced, suggesting that the s-allele might be a risk factor for the development and maintenance of pain. This risk factor seems to act via two independent routes, namely via the sensory processes of subjective pain experiences and via the booster effects of pain catastrophizing.	[Kunz, Miriam] Univ Groningen, Univ Med Ctr Groningen, Geriatr Sect, Dept Gen Practice, NL-9713 AV Groningen, Netherlands; [Kunz, Miriam; Karmann, Anna J.; Lautenbacher, Stefan] Univ Bamberg, Dept Psychol, Physiol Psychol, Bamberg, Germany; [Hennig, Juergen] Univ Giessen, Dept Psychol, Personal Psychol & Individual Differences, D-35390 Giessen, Germany	University of Groningen; Otto Friedrich University Bamberg; Justus Liebig University Giessen	Kunz, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Geriatr Sect, Dept Gen Practice, NL-9713 AV Groningen, Netherlands.; Kunz, M (corresponding author), Univ Bamberg, Dept Psychol, Physiol Psychol, Bamberg, Germany.	m.kunz@umcg.nl	Kunz, Miriam/P-8160-2016	Kunz, Miriam/0000-0002-0740-6738; , Stefan/0000-0002-2829-347X	Deutsche Forschungsgemeinschaft (DFG) [Ku2294/6]; FNK grant of the University of Bamberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FNK grant of the University of Bamberg	The study was supported by a research grant from the Deutsche Forschungsgemeinschaft (DFG, Ku2294/6) and by a FNK grant of the University of Bamberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial or other relationships that might lead to a conflict of interest.	Alexander N, 2009, PSYCHONEUROENDOCRINO, V34, P1294, DOI 10.1016/j.psyneuen.2009.03.017; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Ekman P., 2002, FACIAL ACTION CODING; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Hooten WM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-78; Horjales-Araujo E, 2013, PAIN, V154, P1469, DOI 10.1016/j.pain.2013.05.011; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Karmann AJ, 2015, BIOL PSYCHOL, V104, P82, DOI 10.1016/j.biopsycho.2014.11.016; Kesic M, 2015, EUR J PAIN, V19, P508, DOI 10.1002/ejp.574; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Kunz M, 2007, PAIN, V133, P221, DOI 10.1016/j.pain.2007.09.007; Kunz M, 2011, J NEUROSCI, V31, P8730, DOI 10.1523/JNEUROSCI.0217-11.2011; Landro NI, 2015, NEUROSCI LETT, V584, P109, DOI 10.1016/j.neulet.2014.10.006; Lerman SF, 2015, PSYCHOSOM MED, V77, P333, DOI 10.1097/PSY.0000000000000158; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lindstedt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017752; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Millan MJ, 1995, SEMIN NEUROSCI, V7, P409, DOI 10.1016/1044-5765(95)90005-5; Offenbaecher M, 1999, ARTHRITIS RHEUM-US, V42, P2482, DOI 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B; Palit S, 2011, BIOL PSYCHOL, V86, P360, DOI 10.1016/j.biopsycho.2011.01.008; Park JW, 2004, HEADACHE, V44, P1005, DOI 10.1111/j.1526-4610.2004.04194.x; Potvin S, 2010, EUR J PAIN, V14, P742, DOI 10.1016/j.ejpain.2009.12.004; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Schaldemose EL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-76; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Treister R, 2011, J PAIN, V12, P875, DOI 10.1016/j.jpain.2011.02.348; Trost Z, 2015, PAIN, V156, P514, DOI 10.1097/01.j.pain.0000460326.02891.fc; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0	31	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153089	10.1371/journal.pone.0153089	http://dx.doi.org/10.1371/journal.pone.0153089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043930	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100065
J	Pak, K; Lee, SH; Lee, JG; Seok, JW; Kim, IJ				Pak, Kyoungjune; Lee, Seung Hun; Lee, Jeong Gyu; Seok, Ju Won; Kim, In Joo			Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults	PLOS ONE			English	Article							INCIDENT CARDIOVASCULAR-DISEASE; SUBCUTANEOUS ADIPOSE-TISSUE; OBESITY; ASSOCIATION; AREA; QUALITY; CANCER; FDG	We aimed to evaluate the associations of visceral adiposity with cardiometabolic risk factors in normal subjects with integrated F-18-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). A total of 58 normal subjects who underwent F-18-FDG PET/CT scan for cancer screening were included in this study. Volume and average Hounsfield unit (HU) of visceral adipose tissue (VAT) was measured from CT components of integrated PET/CT. Standardized uptake values (SUVmax) of liver, spleen, lumbar spine and ascending aorta (AA) were measured from PET components of integrated PET/CT. Body mass index (coefficient 78.25, p = 0.0259), glucose (37.62, p<0.0001), insulin (348.90, p = 0.0011), logarithmic transformation of homeostatic model assessment indexinsulin resistance (-2118.37, p = 0.0007), and VAT HU (-134.99, p<0.0001) were independently associated with VAT volume. Glucose (0.1187, p = 0.0098) and VAT volume (-0.004, p<0.0001) were found to be associated with VAT HU. Both VAT volume and VAT HU of whole abdominal cavity is significantly associated with cardiometabolic risk factors.	[Pak, Kyoungjune; Kim, In Joo] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea; [Pak, Kyoungjune; Lee, Seung Hun; Lee, Jeong Gyu; Kim, In Joo] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Lee, Seung Hun; Lee, Jeong Gyu] Pusan Natl Univ Hosp, Dept Family Med, Busan, South Korea; [Seok, Ju Won] Chung Ang Univ, Coll Med, Dept Nucl Med, Seoul 156756, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Chung Ang University; Chung Ang University Hospital	Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea.; Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	pnuhnm@gmail.com	Pak, Kyoungjune/CAE-5230-2022; Pak, Kyoungjune/F-3004-2013	Pak, Kyoungjune/0000-0001-5051-1894; 	Pusan National University Hospital	Pusan National University Hospital(Pusan National University)	This work was supported by clinical research grant from Pusan National University Hospital in 2014.	Abbasi SA, 2015, NUTR METAB CARDIOVAS, V25, P667, DOI 10.1016/j.numecd.2015.03.016; Alvey NJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000788; [Anonymous], 2013, PREV KCFDCA; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Greenfield JR, 2002, OBES RES, V10, P260, DOI 10.1038/oby.2002.35; Han JH, 2008, DIABETIC MED, V25, P106, DOI 10.1111/j.1464-5491.2007.02317.x; Haraguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111990; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Joshy G, 2014, INT J OBESITY, V38, P848, DOI 10.1038/ijo.2013.192; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Kim D, 2016, CLIN GASTROENTEROL H, V14, P132, DOI 10.1016/j.cgh.2015.07.024; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; Murphy RA, 2014, AM J CLIN NUTR, V99, P1059, DOI 10.3945/ajcn.113.080796; Nakamura K, 2011, ONCOL REP, V26, P65, DOI 10.3892/or.2011.1259; Rosenquist KJ, 2015, J CLIN ENDOCR METAB, V100, P227, DOI 10.1210/jc.2013-4296; Rosenquist KJ, 2013, JACC-CARDIOVASC IMAG, V6, P762, DOI 10.1016/j.jcmg.2012.11.021; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; Shah Ravi V, 2014, JACC Cardiovasc Imaging, V7, P1221, DOI 10.1016/j.jcmg.2014.07.017; Shen W, 2007, INT J OBESITY, V31, P763, DOI 10.1038/sj.ijo.0803474; Tahara N, 2015, J CLIN ENDOCR METAB, V100, pE739, DOI 10.1210/jc.2014-3896; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wronska A, 2012, ACTA PHYSIOL, V205, P194, DOI 10.1111/j.1748-1716.2012.02409.x; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153031	10.1371/journal.pone.0153031	http://dx.doi.org/10.1371/journal.pone.0153031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043708	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100063
J	Hansen, RW; Wang, XL; Golab, A; Bornert, O; Oswald, C; Wagner, R; Martinez, KL				Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Bornert, Olivier; Oswald, Christine; Wagner, Renaud; Martinez, Karen Laurence			Functional Stability of the Human Kappa Opioid Receptor Reconstituted in Nanodiscs Revealed by a Time-Resolved Scintillation Proximity Assay	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NANOSCALE LIPID-BILAYERS; PLASMON RESONANCE SPECTROSCOPY; MEMBRANE-PROTEINS; DRUG DISCOVERY; PHOSPHOLIPID-BILAYER; MONOMERIC RHODOPSIN; LIGAND-BINDING; TRANSDUCIN; DETERGENT	Long-term functional stability of isolated membrane proteins is crucial for many in vitro applications used to elucidate molecular mechanisms, and used for drug screening platforms in modern pharmaceutical industry. Compared to soluble proteins, the understanding at the molecular level of membrane proteins remains a challenge. This is partly due to the difficulty to isolate and simultaneously maintain their structural and functional stability, because of their hydrophobic nature. Here we show, how scintillation proximity assay can be used to analyze time-resolved high-affinity ligand binding to membrane proteins solubilized in various environments. The assay was used to establish conditions that preserved the biological function of isolated human kappa opioid receptor. In detergent solution the receptor lost high-affinity ligand binding to a radiolabelled ligand within minutes at room temperature. After reconstitution in Nanodiscs made of phospholipid bilayer the half-life of high-affinity ligand binding to the majority of receptors increased 70-fold compared to detergent solubilized receptors-a level of stability that is appropriate for further downstream applications. Time-resolved scintillation proximity assay has the potential to screen numerous conditions in parallel to obtain high levels of stable and active membrane proteins, which are intrinsically unstable in detergent solution, and with minimum material consumption.	[Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Martinez, Karen Laurence] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Hansen, Randi Westh; Wang, Xiaole; Golab, Agnieszka; Martinez, Karen Laurence] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Bornert, Olivier; Wagner, Renaud] Univ Strasbourg, CNRS, UMR7242, Lab Excellence MEDALIS,Inst Rech ESBS,Biotechnol, Illkirch Graffenstaden, France; [Oswald, Christine] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Oswald, Christine] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen; Heptares Therapeutics Ltd.	Martinez, KL (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.; Martinez, KL (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.	martinez@nano.ku.dk	martinez, karen L/J-5933-2013; Martinez, Karen/W-3709-2019	martinez, karen L/0000-0003-0932-8080; Martinez, Karen/0000-0003-0932-8080; Hansen, Randi Westh/0000-0001-5547-683X; Wagner, Renaud/0000-0002-4249-9853	Lundbeck Foundation Center for Biomembranes in Nanomedicine	Lundbeck Foundation Center for Biomembranes in Nanomedicine	UNIK Synthetic Biology founded by the Danish Ministry of Science and the Lundbeck Foundation Center for Biomembranes in Nanomedicine supported this work.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Andrews SP, 2014, CHEMMEDCHEM, V9, P256, DOI 10.1002/cmdc.201300382; Aristotelous T, 2013, ACS MED CHEM LETT, V4, P1005, DOI 10.1021/ml400312j; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bjorneras J, 2013, BIOCHEMISTRY-US, V52, P4157, DOI 10.1021/bi4004205; Borch J, 2008, ANAL CHEM, V80, P6245, DOI 10.1021/ac8000644; BOSWORTH N, 1989, NATURE, V341, P167, DOI 10.1038/341167a0; Bradford CS, 2005, J MOL ENDOCRINOL, V34, P809, DOI 10.1677/jme.1.01711; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen D, 2012, ACS CHEM BIOL, V7, P2064, DOI 10.1021/cb300436c; Christopher JA, 2013, J MED CHEM, V56, P3446, DOI 10.1021/jm400140q; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Cooke RM, 2013, BIOCHEM SOC T, V41, P185, DOI 10.1042/BST20120240; D'Antona AM, 2014, BIOCHEMISTRY-US, V53, P127, DOI 10.1021/bi4012995; Das A, 2009, ANAL CHEM, V81, P3754, DOI 10.1021/ac802612z; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Fang Y, 2012, EXPERT OPIN DRUG DIS, V7, P969, DOI 10.1517/17460441.2012.715631; Fiez-Vandal C, 2012, BIOPHYS CHEM, V165, P56, DOI 10.1016/j.bpc.2012.03.005; Fox DA, 2014, J AM CHEM SOC, V136, P9938, DOI 10.1021/ja503093y; Glickman JF, 2008, ASSAY DRUG DEV TECHN, V6, P433, DOI 10.1089/adt.2008.135; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Howell SC, 2010, BIOCHEMISTRY-US, V49, P9572, DOI 10.1021/bi101334j; Jamshad Mohammed, 2015, Biosci Rep, V35, DOI 10.1042/BSR20140171; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Lindert S, 2014, BIOCHEM BIOPH RES CO, V445, P724, DOI 10.1016/j.bbrc.2014.01.179; Locatelli-Hoops S, 2013, BIOMED SPECTROSC IMA, V2, P155, DOI 10.3233/BSI-130045; Magnin T, 2009, PROTEIN EXPRES PURIF, V64, P1, DOI 10.1016/j.pep.2008.09.007; Marty MT, 2013, ANAL BIOANAL CHEM, V405, P4009, DOI 10.1007/s00216-013-6790-8; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; McEwen DP, 2001, ANAL BIOCHEM, V291, P109, DOI 10.1006/abio.2001.5011; Mitra N, 2013, ACS CHEM BIOL, V8, P617, DOI 10.1021/cb300466n; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; Patching SG, 2014, BBA-BIOMEMBRANES, V1838, P43, DOI 10.1016/j.bbamem.2013.04.028; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rich RL, 2011, ANAL BIOCHEM, V409, P267, DOI 10.1016/j.ab.2010.10.008; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shepherd CA, 2014, PROG BIOPHYS MOL BIO, V116, P113, DOI 10.1016/j.pbiomolbio.2014.09.008; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu W, 2000, BIOCHEMISTRY-US, V39, P13904, DOI 10.1021/bi001099p; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yoshiura C, 2010, J AM CHEM SOC, V132, P6768, DOI 10.1021/ja100830f; Zoonens M, 2014, J MEMBRANE BIOL, V247, P759, DOI 10.1007/s00232-014-9666-8	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0150658	10.1371/journal.pone.0150658	http://dx.doi.org/10.1371/journal.pone.0150658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035823	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200005
J	Lee, EJ; Choi, YJ; Kim, TW; Hwang, JM				Lee, Eun Ji; Choi, Yun Jeong; Kim, Tae-Woo; Hwang, Jeong-Min			Comparison of the Deep Optic Nerve Head Structure between Normal-Tension Glaucoma and Nonarteritic Anterior Ischemic Optic Neuropathy	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; LAMINA-CRIBROSA DISPLACEMENT; FIBER LAYER THICKNESS; COHERENCE TOMOGRAPHY; BIOMECHANICAL STRUCTURE; 3-D HISTOMORPHOMETRY; PRESSURE; TRABECULECTOMY; MORPHOLOGY; GEOMETRY	Purpose To compare the deep optic nerve head (ONH) structure between normal-tension glaucoma (NTG) and nonarteritic anterior ischemic optic neuropathy (NAION) and also in healthy subjects as a control using enhanced depth imaging (EDI) spectral-domain optical coherence tomography (SD-OCT). Methods This prospective cross-sectional study included 21 NAION patients who had been diagnosed as NAION at least 6 months prior to study entry, and 42 NTG patients and 42 healthy controls who were matched with NAION patients in terms of age, intraocular pressure (IOP), and optic disc area. The retinal nerve fiber layer (RNFL) thickness in the affected sector was also matched between NAION and NTG patients. The ONH was imaged using SD-OCT with the EDI technique. The anterior lamina cribrosa surface depth (LCD) and average prelaminar tissue (PT) thickness were measured in a sector of interest in each eye and compared among the three groups. Results In the sector-matched comparison, LCD was largest in NTG patients, followed by NAION patients, while PT was thinner in NTG patients than in NAION patients (all P < 0.001). NAION patients had a comparable LCD and a thinner PT relative to normal controls (P = 0.170 and < 0.001, respectively). Conclusion The deep ONH configuration is strikingly different between NTG and NAION. The differing features provide comparative insight into the pathophysiology of the two diseases, and may be useful for differential diagnosis.	[Lee, Eun Ji; Choi, Yun Jeong; Kim, Tae-Woo; Hwang, Jeong-Min] Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU)	Kim, TW (corresponding author), Seoul Natl Univ, Dept Ophthalmol, Coll Med, Bundang Hosp, Songnam, South Korea.	twkim7@snu.ac.kr		Kim, Tae-Woo/0000-0002-5180-0978	National Research Foundation of Korea - Korean Government [2013R1A1A1A05004781]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was funded by National Research Foundation of Korea Grant funded by the Korean Government (2013R1A1A1A05004781). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Chan CKM, 2009, BRIT J OPHTHALMOL, V93, P731, DOI 10.1136/bjo.2008.143297; Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Danesh-Meyer HV, 2001, OPHTHALMOLOGY, V108, P593, DOI 10.1016/S0161-6420(00)00602-3; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037499; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Lee DS, 2015, INVEST OPHTH VIS SCI, V56, P2833, DOI 10.1167/iovs.14-15869; Lee EJ, 2013, INVEST OPHTH VIS SCI, V54, P5392, DOI 10.1167/iovs.13-12205; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Sigal IA, 2009, INVEST OPHTH VIS SCI, V50, P2785, DOI 10.1167/iovs.08-3095; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P85, DOI 10.1007/s10237-008-0120-7; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Suh MH, 2011, AM J OPHTHALMOL, V151, P277, DOI 10.1016/j.ajo.2010.08.033; Takahashi H, 2006, AM J OPHTHALMOL, V142, P88, DOI 10.1016/j.ajo.2006.02.016; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P5068, DOI 10.1167/iovs.07-0790; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349	28	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0150242	10.1371/journal.pone.0150242	http://dx.doi.org/10.1371/journal.pone.0150242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035660	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200003
J	Disanto, G; Benkert, P; Lorscheider, J; Mueller, S; Vehoff, J; Zecca, C; Ramseier, S; Achtnichts, L; Findling, O; Nedeltchev, K; Radue, EW; Sprenger, T; Stippich, C; Derfuss, T; Louvion, JF; Kamm, CP; Mattle, HP; Lotter, C; Du Pasquier, R; Schluep, M; Pot, C; Lalive, PH; Yaldizli, O; Gobbi, C; Kappos, L; Kuhle, J				Disanto, Giulio; Benkert, Pascal; Lorscheider, Johannes; Mueller, Stefanie; Vehoff, Jochen; Zecca, Chiara; Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen; Radue, Ernst-Wilhelm; Sprenger, Till; Stippich, Christoph; Derfuss, Tobias; Louvion, Jean-Francois; Kamm, Christian P.; Mattle, Heinrich P.; Lotter, Christoph; Du Pasquier, Renaud; Schluep, Myriam; Pot, Caroline; Lalive, Patrice H.; Yaldizli, Oezuer; Gobbi, Claudio; Kappos, Ludwig; Kuhle, Jens		SMSC Sci Board	The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options	PLOS ONE			English	Article							PRIMARY PROGRESSIVE MS; DIAGNOSTIC-CRITERIA; DOUBLE-BLIND; IMMUNOLOGY; MECHANISMS; THERAPY; RISK	The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drugs (DMDs) in multiple sclerosis (MS) are unclear. We aimed at building a prospective cohort of MS patients with standardized collection of demographic, clinical, MRI data and body fluids that can be used to develop prognostic indicators and biomarkers of disease evolution and therapeutic response. The Swiss MS Cohort (SMSC) is a prospective observational study performed across seven Swiss MS centers including patients with MS, clinically isolated syndrome (CIS), radiologically isolated syndrome or neuromyelitis optica. Neurological and radiological assessments and biological samples are collected every 6-12 months. We recruited 872 patients (clinically isolated syndrome [CIS] 5.5%, relapsing-remitting MS [RRMS] 85.8%, primary progressive MS [PPMS] 3.5%, secondary progressive MS [SPMS] 5.2%) between June 2012 and July 2015. We performed 2,286 visits (median follow-up 398 days) and collected 2,274 serum, plasma and blood samples, 152 cerebrospinal fluid samples and 1,276 brain MRI scans. 158 relapses occurred and expanded disability status scale (EDSS) scores increased in PPMS, SPMS and RRMS patients experiencing relapses. Most RRMS patients were treated with fingolimod (33.4%), natalizumab (24.5%) or injectable DMDs (13.6%). The SMSC will provide relevant information regarding DMDs efficacy and safety and will serve as a comprehensive infrastructure available for nested research projects.	[Disanto, Giulio; Zecca, Chiara; Gobbi, Claudio] Reg Hosp Lugano EOC, Dept Neurol, Lugano, Switzerland; [Benkert, Pascal] Univ Basel Hosp, Clin Trial Unit, Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland; [Lorscheider, Johannes; Sprenger, Till; Derfuss, Tobias; Yaldizli, Oezuer; Kappos, Ludwig; Kuhle, Jens] Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland; [Mueller, Stefanie; Vehoff, Jochen] Cantonal Hosp St Gallen, Dept Neurol, St Gallen, Switzerland; [Ramseier, Simon; Achtnichts, Lutz; Findling, Oliver; Nedeltchev, Krassen] Cantonal Hosp Aarau, Dept Neurol, Aarau, Switzerland; [Radue, Ernst-Wilhelm; Sprenger, Till] Univ Basel, Med Image Anal Ctr, Basel, Switzerland; [Stippich, Christoph] Univ Basel Hosp, Dept Radiol, Neuroradiol, CH-4031 Basel, Switzerland; [Louvion, Jean-Francois] RodanoTech, Geneva, Switzerland; [Kamm, Christian P.; Mattle, Heinrich P.] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Kamm, Christian P.; Mattle, Heinrich P.] Univ Bern, Bern, Switzerland; [Lotter, Christoph] Swiss Multiple Sclerosis Soc, Zurich, Switzerland; [Du Pasquier, Renaud; Schluep, Myriam] Univ Hosp Lausanne CHUV, Dept Neurol, Lausanne, Switzerland; [Pot, Caroline; Lalive, Patrice H.] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital St. Gallen; Kantonsspital Aarau AG (KSA); University of Basel; University of Basel; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Med, Neurol, CH-4031 Basel, Switzerland.; Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Biomed, Neurol, CH-4031 Basel, Switzerland.; Kappos, L; Kuhle, J (corresponding author), Univ Basel Hosp, Dept Clin Res, Neurol, CH-4031 Basel, Switzerland.	ludwig.kappos@usb.ch; jens.kuhle@usb.ch	Zecca, Chiara/L-3406-2013; Yaldizli, Özgür/AAN-3351-2021; Findling, Oliver/AAE-3815-2019; Benkert, Pascal/C-3895-2009; Lorscheider, Johannes/AAU-2509-2020; Haller, Sven/AAY-2564-2020; Pot, Caroline/O-8590-2016; Du Pasquier, Renaud/O-8588-2016; Kuhle, Jens/AGE-3474-2022; Yaldizli, Özgür/AAV-1423-2020; Yaldizli, Özgür/AAP-5585-2021; Lalive, Patrice/AAM-5861-2020	Haller, Sven/0000-0001-7433-0203; Pot, Caroline/0000-0002-1146-3129; Du Pasquier, Renaud/0000-0002-2786-3434; Yaldizli, Özgür/0000-0002-0800-4845; Chan, Andrew/0000-0003-3434-7283; Gobbi, Claudio/0000-0002-7554-0664; Zecca, Chiara/0000-0002-9990-3431; Derfuss, Tobias/0000-0001-8656-4250; Lorscheider, Johannes/0000-0003-1100-2506; Sprenger, Till/0000-0002-5390-819X; lovblad, karl-olof/0000-0003-2768-9779; Granziera, Cristina/0000-0002-4917-8761	Swiss MS Society; Biogen; Genzyme GmbH; Hoffmann-La Roche Ltd; Novartis Pharma Switzerland; Teva Pharma AG	Swiss MS Society; Biogen(Biogen); Genzyme GmbH(Sanofi-AventisGenzyme Corporation); Hoffmann-La Roche Ltd(Hoffmann-La Roche); Novartis Pharma Switzerland; Teva Pharma AG(Teva Pharmaceutical Industries)	This study received funding from the Swiss MS Society and also by grants from Biogen, Genzyme GmbH, Hoffmann-La Roche Ltd, Novartis Pharma Switzerland, and Teva Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rodano Tech provided support in the form of salaries for authors [JFL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen O, 2012, ACTA NEUROL SCAND, V126, P13, DOI 10.1111/ane.12023; Armstrong K, 2012, J CLIN ONCOL, V30, P4208, DOI 10.1200/JCO.2012.42.2659; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bronnum-Hansen H, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810390729; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; Derfuss T, 2013, SEMIN NEUROL, V33, P26, DOI 10.1055/s-0033-1343793; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Granberg T, 2013, MULT SCLER J, V19, P271, DOI 10.1177/1352458512451943; Hartung HP, 2015, MULT SCLER J, V21, P22, DOI 10.1177/1352458514549398; Havrdova E, 2013, EXPERT OPIN PHARMACO, V14, P2145, DOI 10.1517/14656566.2013.826190; Jurynczyk M, 2015, J NEUROL NEUROSUR PS, V86, P20, DOI 10.1136/jnnp-2014-308984; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kuhlmann T, 2013, MULT SCLER J, V19, P268, DOI 10.1177/1352458513476563; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2013, MULT SCLER J, V19, P266, DOI 10.1177/1352458512474091; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Maercker A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13751; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d; Scalfari A, 2014, J NEUROL NEUROSUR PS, V85, P67, DOI 10.1136/jnnp-2012-304333; Steinman L, 2014, ANNU REV IMMUNOL, V32, P257, DOI 10.1146/annurev-immunol-032713-120227; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002	34	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152347	10.1371/journal.pone.0152347	http://dx.doi.org/10.1371/journal.pone.0152347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032105	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800061
J	Foley, RC; Kidd, BN; Hane, JK; Anderson, JP; Singh, KB				Foley, Rhonda C.; Kidd, Brendan N.; Hane, James K.; Anderson, Jonathan P.; Singh, Karam B.			Reactive Oxygen Species Play a Role in the Infection of the Necrotrophic Fungi, Rhizoctonia solani in Wheat	PLOS ONE			English	Article							OXALATE OXIDASE GENE; SCLEROTINIA-SCLEROTIORUM; BOTRYTIS-CINEREA; NADPH OXIDASES; BRASSICA-NAPUS; GERMIN GENE; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; NONHOST RESISTANCE	Rhizoctonia solani is a nectrotrophic fungal pathogen that causes billions of dollars of damage to agriculture worldwide and infects a broad host range including wheat, rice, potato and legumes. In this study we identify wheat genes that are differentially expressed in response to the R. solani isolate, AG8, using microarray technology. A significant number of wheat genes identified in this screen were involved in reactive oxygen species (ROS) production and redox regulation. Levels of ROS species were increased in wheat root tissue following R. solani infection as determined by Nitro Blue Tetrazolium (NBT), 3,3'-diaminobenzidine (DAB) and titanium sulphate measurements. Pathogen/ROS related genes from R. solani were also tested for expression patterns upon wheat infection. TmpL, a R. solani gene homologous to a gene associated with ROS regulation in Alternaria brassicicola, and OAH, a R. solani gene homologous to oxaloacetate acetylhydrolase which has been shown to produce oxalic acid in Sclerotinia sclerotiorum, were highly induced in R. solani when infecting wheat. We speculate that the interplay between the wheat and R. solani ROS generating proteins may be important for determining the outcome of the wheat/R. solani interaction.	[Foley, Rhonda C.; Kidd, Brendan N.; Hane, James K.; Anderson, Jonathan P.; Singh, Karam B.] CSIRO Agr, Ctr Environm & Life Sci, Floreat, WA, Australia; [Anderson, Jonathan P.; Singh, Karam B.] Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia; [Hane, James K.] Curtin Univ, Dept Environm & Agr, Bentley Campus, Perth, WA 6845, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Curtin University	Singh, KB (corresponding author), CSIRO Agr, Ctr Environm & Life Sci, Floreat, WA, Australia.; Singh, KB (corresponding author), Univ Western Australia, UWA Inst Agr, Crawley, WA, Australia.	Karam.Singh@csiro.au	Anderson, Jonathan P/A-7244-2008; Hane, James/A-7062-2011; Kidd, Brendan N/D-9801-2017; Singh, Karam B/C-3235-2012; Kidd, Brendan N/J-9672-2014; Foley, Rhonda C/G-6716-2012	Anderson, Jonathan P/0000-0002-4783-5393; Hane, James/0000-0002-7651-0977; Singh, Karam B/0000-0002-2777-7448; Kidd, Brendan N/0000-0003-1770-1404; 	GRDC [UWA00145]; CSIRO	GRDC; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by GRDC (UWA00145), www.grdc.com.au, and CSIRO, www.csiro.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDER P, 1976, ARCH MICROBIOL, V109, P1, DOI 10.1007/BF00425105; [Anonymous], 2002, PLANT VARIETIES J, V15, P53; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Bailey A, 2000, J BIOL CHEM, V275, P14242, DOI 10.1074/jbc.275.19.14242; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Beracochea VC, 2015, PLANT CELL REP, V34, P1717, DOI 10.1007/s00299-015-1819-4; Berna A, 1999, PLANT MOL BIOL, V39, P539, DOI 10.1023/A:1006123432157; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Burhenne K, 2003, J BIOL CHEM, V278, P13919, DOI 10.1074/jbc.M213041200; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Chamoun R, 2015, MOL GENET GENOMICS, V290, P877, DOI 10.1007/s00438-014-0962-x; Daudi A., 2012, BIOPROTOCOL, V2, pe263, DOI DOI 10.1016/j.envexpbot.2012.08.003; Dobon A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004800; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P359, DOI 10.1016/0048-4059(83)90020-6; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Foley RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056814; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gkarmiri K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1758-z; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Hurkman WJ, 1996, PLANT PHYSIOL, V111, P735, DOI 10.1104/pp.111.3.735; Kamara S, 2008, AQUAT SCI, V70, P204, DOI 10.1007/s00027-008-8048-7; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Kim KH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000653; LANE BG, 1993, J BIOL CHEM, V268, P12239; Larroque M, 2013, J EXP BOT, V64, P3615, DOI 10.1093/jxb/ert195; Lehmann S, 2015, PHYTOCHEMISTRY, V112, P54, DOI 10.1016/j.phytochem.2014.08.027; Li XH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00463; Liang XF, 2015, MOL PLANT PATHOL, V16, P559, DOI 10.1111/mpp.12211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACNISH GC, 1993, AUST J AGR RES, V44, P1175, DOI 10.1071/AR9931175; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Molla KA, 2013, MOL PLANT PATHOL, V14, P910, DOI 10.1111/mpp.12055; Nagarajkumara M, 2005, MICROBIOL RES, V160, P291, DOI 10.1016/j.micres.2005.02.002; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Novakova M, 2014, PLANT PHYSIOL BIOCH, V80, P308, DOI 10.1016/j.plaphy.2014.04.019; Nozaki M, 2013, BIOSCI BIOTECH BIOCH, V77, P1323, DOI 10.1271/bbb.130092; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Okubara PA, 2014, PLANT SCI, V228, P61, DOI 10.1016/j.plantsci.2014.02.001; Oliveira MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01162; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Pietrowska E, 2015, PROTOPLASMA, V252, P307, DOI 10.1007/s00709-014-0680-6; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; Rioux R, 2011, CURR GENET, V57, P391, DOI 10.1007/s00294-011-0353-3; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez-Vallet A, 2010, PLANT J, V63, P115, DOI 10.1111/j.1365-313X.2010.04224.x; Sarkar TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107348; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Serrano-Carreon L, 2004, BIOTECHNOL LETT, V26, P1403, DOI 10.1023/B:BILE.0000045640.71840.b5; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shu CW, 2015, FUNCT INTEGR GENOMIC, V15, P449, DOI 10.1007/s10142-015-0435-2; Snell FD, 1949, COLORIMETRIC METHODS; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Toyomasu T, 2009, BIOSCI BIOTECH BIOCH, V73, P772, DOI 10.1271/bbb.80781; Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Wang XJ, 2010, PHYSIOL PLANTARUM, V139, P27, DOI 10.1111/j.1399-3054.2009.01338.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Xu LS, 2013, MOL PLANT MICROBE IN, V26, P431, DOI 10.1094/MPMI-07-12-0177-R; Yang SL, 2012, MOL PLANT PATHOL, V13, P900, DOI 10.1111/j.1364-3703.2012.00799.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang G, 2010, AGR SCI CHINA, V9, P549, DOI 10.1016/S1671-2927(09)60128-0; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078348, 10.1371/journal.pone.0082079]; Zhang ZY, 2012, NEW PHYTOL, V196, P1155, DOI 10.1111/j.1469-8137.2012.04353.x; Zhao J, 2015, J EXP BOT, V66, P1721, DOI 10.1093/jxb/eru540; Zhou FS, 1998, PLANT PHYSIOL, V117, P33, DOI 10.1104/pp.117.1.33	77	45	49	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152548	10.1371/journal.pone.0152548	http://dx.doi.org/10.1371/journal.pone.0152548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031952	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800090
J	Gutierrez, Y; Santos, HP; Serrao, JE; Oliveira, EE				Gutierrez, Yeisson; Santos, Helen P.; Serrao, Jose Eduardo; Oliveira, Eugenio E.			Deltamethrin-Mediated Toxicity and Cytomorphological Changes in the Midgut and Nervous System of the Mayfly Callibaetis radiatus	PLOS ONE			English	Article							PARTICLE-ASSOCIATED FENVALERATE; CERAEOCHRYSA-CLAVERI NAVAS; PYRETHROID INSECTICIDE; DAPHNIA-MAGNA; STREAM MACROINVERTEBRATES; NEUROPTERA CHRYSOPIDAE; SPODOPTERA-LITURA; MOSQUITO-CONTROL; CLOEON-DIPTERUM; ION CHANNELS	Immature instars of mayflies are important constituents of the food web in aquatic ecosystems (especially in Neotropical regions) and they are among the most susceptible arthropods to pyrethroid insecticides. These insecticides have been recognized as important stressors of freshwater ecosystems, but their cellular effects in aquatic insects have been neglected. Here, we assessed the susceptibility to deltamethrin (a typical type II pyrethroid) as well as the deltamethrin-mediated cytomorphological changes in the central nervous system and midgut of the mayfly Callibaetis radiatus. While the deltamethrin LC50 for 24h of exposure was of 0.60 (0.46-0.78) mu g of a.i/L, the survival of C. radiatus was significantly reduced in deltamethrin concentrations >= 0.25 mu g a.i/L at 96h of exposure. Sub-lethal deltamethrin exposure severely affected the cytomorphology of C. radiatus midgut (e.g., muscle layer retraction, cytoplasm vacuolation, nucleus and striated border disorganization) and also induced slight cytomorphological changes in the brain (e.g., presence of pyknotic nuclei) and in the thoracic ganglia (e.g., vacuolation of neurons and presence of pyknotic nuclei) of these insects. However, DNA damage was absent in all of these organs, suggesting that the sublethal cellular stress induced by deltamethrin might disrupt physiological processes (e.g., metabolism or electrical signal transmission) rather than cause cell death (e.g., apoptosis) in C. radiatus. Thus, our findings indicated that deltamethrin actions at cellular levels represent a clear indication of sublethal effects on the C. radiatus survival abilities.	[Gutierrez, Yeisson; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil; [Santos, Helen P.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, BR-36570000 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570000 Vicosa, MG, Brazil.	eugenio@ufv.br	de Oliveira, Eugênio Eduardo/F-4045-2016; Santos, Helen C P/AAD-3479-2019; de Oliveira, Eugenio Eduardo/ABE-8935-2021	de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Gutierrez Lopez, Yeisson/0000-0002-0166-2933; Pinto Santos, Helen Cristina/0000-0003-2234-5280	Minas Gerais State Foundation for Research Aid (FAPEMIG); CAPES Foundation; Arthur Bernardes Foundation (FUNARBE); National Council of Scientific and Technological Development (CNPq)	Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Arthur Bernardes Foundation (FUNARBE); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants to all co-authors from the Minas Gerais State Foundation for Research Aid (FAPEMIG) and the CAPES Foundation; grants from Arthur Bernardes Foundation (FUNARBE) to EEO and from National Council of Scientific and Technological Development (CNPq) for YG (PEC-PG).	Alves SN, 2010, MICRON, V41, P592, DOI 10.1016/j.micron.2010.04.004; Amweg EL, 2006, ENVIRON SCI TECHNOL, V40, P1700, DOI 10.1021/es051407c; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; Beketov MA, 2005, ENVIRON TOXICOL CHEM, V24, P1281, DOI 10.1897/04-256R1.1; Beketov MA, 2004, RUSS J ECOL+, V35, P200, DOI 10.1023/B:RUSE.0000025972.29638.46; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Bengoa M, 2014, J AM MOSQUITO CONTR, V30, P42, DOI 10.2987/13-6378.1; Bereswill R, 2013, ENVIRON TOXICOL CHEM, V32, P1254, DOI 10.1002/etc.2170; Burr SA, 2004, TOXICOL SCI, V77, P341, DOI 10.1093/toxsci/kfh027; Buss DF, 2007, ENVIRON MONIT ASSESS, V130, P365, DOI 10.1007/s10661-006-9403-6; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Clark JM, 2012, TOP CURR CHEM, V314, P49, DOI 10.1007/128_2011_268; Costa MS, 2012, NEOTROP ENTOMOL, V41, P311, DOI 10.1007/s13744-012-0050-z; Cristofoletti PT, 2001, J INSECT PHYSIOL, V47, P143, DOI 10.1016/S0022-1910(00)00098-6; Cruz PV, 2014, J NAT HIST, V48, P591, DOI 10.1080/00222933.2013.791883; Csoknya M, 1977, Acta Biol Szeged, V23, P89; Darlington C. D., 1960, HANDLING CHROMOSOMES; DOMINGUEZ E, 2006, EPHEMEROPTERA S AM; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Feo ML, 2010, J HYDROL, V393, P156, DOI 10.1016/j.jhydrol.2010.08.012; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Fu KY, 2014, PESTIC BIOCHEM PHYS, V114, P16, DOI 10.1016/j.pestbp.2014.07.009; Harker JE, 1999, J ZOOL, V248, P243; Huang J-H, 2015, INSECT BIOCH MOL BIO; KING DG, 1987, MAR POLLUT BULL, V18, P40, DOI 10.1016/0025-326X(87)90657-6; Konus M, 2013, COMP BIOCHEM PHYS D, V8, P152, DOI 10.1016/j.cbd.2013.04.001; Lawler SP, 2008, PEST MANAG SCI, V64, P843, DOI 10.1002/ps.1575; Levy SM, 2004, BRAZILIAN J BIOL; Li FC, 2016, CHEMOSPHERE, V146, P478, DOI 10.1016/j.chemosphere.2015.12.032; Licht O, 2004, ECOTOX ENVIRON SAFE, V58, P246, DOI 10.1016/j.ecoenv.2003.08.021; Mohr S, 2012, AQUAT TOXICOL, V110, P25, DOI 10.1016/j.aquatox.2011.11.016; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; Narahashi T, 1988, NEUROTOX, V88, P563; Norum U, 2010, AQUAT TOXICOL, V98, P328, DOI 10.1016/j.aquatox.2010.03.004; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pawlisz AV, 1998, ENVIRON TOXIC WATER, V13, P175, DOI 10.1002/(SICI)1098-2256(1998)13:3<175::AID-TOX1>3.3.CO;2-F; Pearse A.G.E., 1985, HISTOCHEMISTRY THEOR, Vfourth; Pinto LZ, 2003, INT J DEV BIOL, V47, P385; Rasmussen JJ, 2012, PESTICIDE EFFECTS ST; Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003; Reichenberger S, 2007, SCI TOTAL ENVIRON, V384, P1, DOI 10.1016/j.scitotenv.2007.04.046; Rharrabe K, 2007, PESTIC BIOCHEM PHYS, V89, P137, DOI 10.1016/j.pestbp.2007.05.002; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Roma GC, 2014, ACTA TROP, V136, P19, DOI 10.1016/j.actatropica.2014.04.004; Roma GC, 2013, VET PARASITOL, V196, P482, DOI 10.1016/j.vetpar.2013.02.025; Rossi CD, 2013, MICROSC RES TECHNIQ, V76, P552, DOI 10.1002/jemt.22199; Rozilawati H, 2005, Trop Biomed, V22, P143; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; SAS Institute, 2008, SAS STAT US GUID; Schulz R, 2001, ARCH ENVIRON CON TOX, V40, P481, DOI 10.1007/s002440010200; Schulz R, 2001, CHEMOSPHERE, V45, P543, DOI 10.1016/S0045-6535(00)00601-9; Schulz R, 2001, ENVIRON TOXICOL CHEM, V20, P185, DOI [10.1897/1551-5028(2001)020&lt;0185:TOAPAS&gt;2.0.CO;2, 10.1002/etc.5620200121]; Scudeler EL, 2014, NEOTROP ENTOMOL, V43, P154, DOI 10.1007/s13744-013-0191-8; Scudeler EL, 2013, MICRON, V44, P125, DOI 10.1016/j.micron.2012.05.009; SERRAO JE, 1995, ENTOMOL GEN, V19, P261; Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Toumi H, 2013, SCI TOTAL ENVIRON, V458, P47, DOI 10.1016/j.scitotenv.2013.03.085; Unkiewicz-Winiarczyk A, 2012, B ENVIRON CONTAM TOX, V89, P960, DOI 10.1007/s00128-012-0814-5; Van den Brink PJ, 2015, ENV TOXICOLOGY CHEM; Vishwanathreddy H, 2014, TOXICON, V78, P47, DOI 10.1016/j.toxicon.2013.11.012; Volland JM, 2012, MICROSC RES TECHNIQ, V75, P425, DOI 10.1002/jemt.21073; Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001; Weston DP, 2006, ENVIRON SCI TECHNOL, V40, P5817, DOI 10.1021/es0601540; Wheelock CE, 2005, AQUAT TOXICOL, V74, P47, DOI 10.1016/j.aquatox.2005.04.007; Xu ZB, 2015, INSECT SCI, V22, P503, DOI 10.1111/1744-7917.12142; Zagariya AM, 2012, EXP CELL RES, V318, P861, DOI 10.1016/j.yexcr.2012.02.001	69	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152383	10.1371/journal.pone.0152383	http://dx.doi.org/10.1371/journal.pone.0152383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031238	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800064
J	Little, MP; Hendry, JH; Puskin, JS				Little, Mark P.; Hendry, Jolyon H.; Puskin, Jerome S.			Lack of Correlation between Stem-Cell Proliferation and Radiation-or Smoking-Associated Cancer Risk	PLOS ONE			English	Article							COLON-CANCER; RELATIVE RISK; CARCINOGENESIS; MODEL; INSTABILITY; MORTALITY; LUNG; MUTATIONS; ARMITAGE; EXPOSURE	Background A recent paper by Tomasetti and Vogelstein (Science 2015 347 78-81) suggested that the variation in natural cancer risk was largely explained by the total number of stem-cell divisions, and that most cancers arose by chance. They proposed an extra-risk score as way of distinguishing the effects of the stochastic, replicative component of cancer risk from other causative factors, specifically those due to the external environment and inherited mutations. Objectives We tested the hypothesis raised by Tomasetti and Vogelstein by assessing the degree of correlation of stem cell divisions and their extra-risk score with radiation-and tobacco-associated cancer risk. Methods We fitted a variety of linear and log-linear models to data on stem cell divisions per year and cumulative stem cell divisions over lifetime and natural cancer risk, some taken from the paper of Tomasetti and Vogelstein, augmented using current US lifetime cancer risk data, and also radiation-and tobacco-associated cancer risk. Results The data assembled by Tomasetti and Vogelstein, as augmented here, are inconsistent with the power-of-age relationship commonly observed for cancer incidence and the predictions of a multistage carcinogenesis model, if one makes the strong assumption of homogeneity of numbers of driver mutations across cancer sites. Analysis of the extra-risk score and various other measures (number of stem cell divisions per year, cumulative number of stem cell divisions over life) considered by Tomasetti and Vogelstein suggests that these are poorly predictive of currently available estimates of radiation- or smoking-associated cancer risk-for only one out of 37 measures or logarithmic transformations thereof is there a statistically significant correlation (p<0.05) with radiation-or smoking-associated risk. Conclusions The data used by Tomasetti and Vogelstein are in conflict with predictions of a multistage model of carcinogenesis, under the assumption of homogeneity of numbers of driver mutations across most cancer sites. Their hypothesis that if the extra-risk score for a tissue type is high then one would expect that environmental factors would play a relatively more important role in that cancer's risk is in conflict with the lack of correlation between the extra-risk score and other stem-cell proliferation indices and radiation-or smoking-related cancer risk.	[Little, Mark P.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Rockville, MD USA; [Hendry, Jolyon H.] Christie Hosp, Christie Med Phys & Engn, Manchester, Lancs, England; [Hendry, Jolyon H.] Univ Manchester, Manchester, Lancs, England; [Puskin, Jerome S.] US EPA, Radiat Protect Div, Washington, DC 20460 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Christie NHS Foundation Trust; Christie Hospital; University of Manchester; United States Environmental Protection Agency	Little, MP (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Rockville, MD USA.	mark.little@nih.gov	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics	Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics	The work of MPL was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Annex A, 2008, UNSCEAR 2006 REP, P13; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Armstrong B, 2012, RADIATION VOLUME 100, P1; BROWN CC, 1983, ENVIRON HEALTH PERSP, V50, P293, DOI 10.2307/3429561; Committee on Health Risks of Exposure to Radon (BEIR VI), 1999, HLTH EFF EXP RAD; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; DAY NE, 1980, JNCI-J NATL CANCER I, V64, P977; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; DOLL R, 1971, J R STAT SOC SER A-G, V134, P133, DOI 10.2307/2343871; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; International Commission on Radiological Protection, 2015, ANN ICRP, V44, P1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P147, DOI 10.1007/s00411-012-0442-9; LITTLE MP, 1992, RADIAT RES, V132, P207, DOI 10.2307/3578528; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; MAZUMDAR S, 1989, RISK ANAL, V9, P551, DOI 10.1111/j.1539-6924.1989.tb01266.x; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; O'Callaghan M, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6212; Otsuka K, 2013, RADIAT RES, V179, P637, DOI 10.1667/RR3253.1; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Peto R, 1977, ORIGINS HUMAN CANC C, P1403; Potter JD, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6507; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PUSKIN JS, 1988, HEALTH PHYS, V54, P635, DOI 10.1097/00004032-198806000-00004; Rao CR, 2002, LINEAR STAT INFERENC; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; THOMAS DC, 1990, ENVIRON HEALTH PERSP, V87, P163, DOI 10.2307/3431021; Tomasetti C, 2015, ARXIV150105035V3STAT, P1; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; US. Surgeon General, 2004, THE HEALTH CONSEQUEN; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	38	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150335	10.1371/journal.pone.0150335	http://dx.doi.org/10.1371/journal.pone.0150335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031507	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800006
J	Matta, J; Morales, L; Ortiz, C; Adams, D; Vargas, W; Casbas, P; Dutil, J; Echenique, M; Suarez, E				Matta, Jaime; Morales, Luisa; Ortiz, Carmen; Adams, Damian; Vargas, Wanda; Casbas, Patricia; Dutil, Julie; Echenique, Miguel; Suarez, Erick			Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer	PLOS ONE			English	Article							CELL REACTIVATION ASSAY; ENDOCRINE RESISTANCE; PROGESTERONE-RECEPTOR; EXCISION-REPAIR; THERAPEUTIC TARGET; AMERICAN SOCIETY; SKIN-CANCER; CHEMOTHERAPY; MECHANISMS; DAMAGE	Estrogen-receptor-positive (ER+) tumors employ complex signaling that engages in crosstalk with multiple pathways through genomic and non-genomic regulation. A greater understanding of these pathways is important for developing improved biomarkers that can better determine treatment choices, risk of recurrence and cancer progression. Deficiencies in DNA repair capacity (DRC) is a hallmark of breast cancer (BC); therefore, in this work we tested whether ER signaling influences DRC. We analyzed the association between ER positivity (% receptor activation) and DRC in 270 BC patients, then further stratified our analysis by HER2 receptor status. Our results show that among HER2 negative, the likelihood of having low DRC values among ER-women is 1.92 (95% CI: 1.03, 3.57) times the likelihood of having low DRC values among ER+ women, even adjusting for different potential confounders (p<0.05); however, a contrary pattern was observed among HER2 positives women. In conclusion, there is an association between DRC levels and ER status, and this association is modified by HER2 receptor status. Adding a DNA repair capacity test to hormone receptor testing may provide new information on defective DNA repair phenotypes, which could better stratify BC patients who have ER+ tumors. ER+/HER2-tumors are heterogeneous, incompletely defined, and clinically challenging to treat; the addition of a DRC test could better characterize and classify these patients as well as help clinicians select optimal therapies, which could improve outcomes and reduce recurrences.	[Matta, Jaime; Ortiz, Carmen; Adams, Damian; Vargas, Wanda] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Pharmacol & Toxicol, Ponce, PR USA; [Matta, Jaime; Ortiz, Carmen; Adams, Damian; Vargas, Wanda; Casbas, Patricia; Dutil, Julie] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Canc Biol, Ponce, PR USA; [Morales, Luisa] Ponce Hlth Sci Univ, Publ Hlth Program, Ponce, PR USA; [Casbas, Patricia; Dutil, Julie] Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Biochem, Ponce, PR USA; [Echenique, Miguel] Auxilio Mutuo Hosp, San Juan, PR 00919 USA; [Suarez, Erick] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, Med Sci Campus, San Juan, PR 00936 USA	Ponce Health Sciences University; Ponce Health Sciences University; Ponce Health Sciences University; Ponce Health Sciences University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Matta, J (corresponding author), Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Pharmacol & Toxicol, Ponce, PR USA.; Matta, J (corresponding author), Ponce Hlth Sci Univ, Sch Med, Ponce Res Inst, Dept Basic Sci,Div Canc Biol, Ponce, PR USA.	jmatta@psm.edu		Ortiz-Sanchez, Carmen/0000-0003-3567-7866	NCI Center; NIH-MBRS Program grant [S06 GM008239-20, 9SC1CA182846-04]; PSM-MCC Partnership grant [5U54CA163071-04]; MBRS-RISE [GM082406]; NATIONAL CANCER INSTITUTE [U54CA163068, U54CA163071, SC1CA182846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008239, R25GM082406] Funding Source: NIH RePORTER	NCI Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-MBRS Program grant; PSM-MCC Partnership grant; MBRS-RISE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the NCI Center to Reduce Health Disparities and NIH-MBRS Program grant # S06 GM008239-20 and 9SC1CA182846-04 to Ponce School of Medicine through Dr. J. Matta and PSM-MCC Partnership grant # 5U54CA163071-04. Carmen Ortiz was supported by MBRS-RISE GM082406 [NIH-NIGMS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2014, CANCER MANAG RES, V6, P77, DOI 10.2147/CMAR.S50497; Abdel-Fatah TMA, 2014, ANTIOXID REDOX SIGN, V21, P2262, DOI 10.1089/ars.2014.6077; Alli E, 2012, DNA REPAIR, V11, P522, DOI 10.1016/j.dnarep.2012.02.003; American Cancer Society, 2013, BREAST CANC FACTS FI; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; ATHAS WF, 1991, CANCER RES, V51, P5786; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bonastre J, 2014, J CLIN ONCOL, V32, P3513, DOI 10.1200/JCO.2013.54.9931; Caldoe CE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00106; Chen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095185; Cheng L, 1998, CANCER EPIDEM BIOMAR, V7, P465; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Curtis CD, 2009, MOL ENDOCRINOL, V23, P1346, DOI 10.1210/me.2009-0093; D'Errico M, 1999, CANCER EPIDEM BIOMAR, V8, P553; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gnant M, 2012, EXPERT REV ANTICANC, V12, P1579, DOI [10.1586/ERA.12.138, 10.1586/era.12.138]; Good P, 2006, RESAMPLING METHODS A; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hilakivi-Clarke L, 2000, CANCER RES, V60, P4993; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hu JJ, 2004, CANCER RES, V64, P1197, DOI 10.1158/0008-5472.CAN-03-2670; Huynh KT, 2012, EXPERT REV MOL DIAGN, V12, P371, DOI [10.1586/erm.12.26, 10.1586/ERM.12.26]; Issa-Nummer Y, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27926; Jemal A, 2012, BREAST CANCER RES TR, V135, P867, DOI 10.1007/s10549-012-2214-2; Jerusalem G, 2014, BREAST CANCER-TARGET, V6, P43, DOI 10.2147/BCTT.S38679; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Kelley MR, 2012, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, P1, DOI 10.1016/B978-0-12-384999-1.10001-0; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Latimer JJ, 2010, P NATL ACAD SCI USA, V107, P21725, DOI 10.1073/pnas.0914772107; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Lips EH, 2012, BREAST CANCER RES TR, V131, P827, DOI 10.1007/s10549-011-1488-0; Magnani L, 2012, EPIGENOMICS-UK, V4, P675, DOI [10.2217/EPI.12.64, 10.2217/epi.12.64]; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Matta J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-490; Matta JL, 2003, J AM ACAD DERMATOL, V49, P433, DOI 10.1067/S0190-9622(03)00918-6; Medunjanin S, 2010, MOL BIOL CELL, V21, P1620, DOI 10.1091/mbc.E09-08-0724; Mendez P, 2011, DNA REPAIR, V10, P603, DOI 10.1016/j.dnarep.2011.04.001; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Morales L, 2013, J EPIDEMIOL GLOB HEA, V3, P205, DOI 10.1016/j.jegh.2013.08.003; Murray DM, 2004, CANC DRUG DISC DEV, P211; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Partridge AH, 2014, J CLIN ONCOL, V32, P3307, DOI 10.1200/JCO.2014.56.7479; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Qiao YW, 2002, MUTAT RES-FUND MOL M, V509, P165, DOI 10.1016/S0027-5107(02)00219-1; Raha P, 2011, EPIGENOMICS-UK, V3, P451, DOI [10.2217/epi.11.72, 10.2217/EPI.11.72]; Rahal OM, 2011, ENDOCRINOLOGY, V152, P3409, DOI 10.1210/en.2011-1085; Ramos JM, 2004, CANCER-AM CANCER SOC, V100, P1352, DOI 10.1002/cncr.20135; Robertson NM, 2014, WIRES RNA, V5, P823, DOI 10.1002/wrna.1248; Rosa FE, 2008, HUM PATHOL, V39, P720, DOI 10.1016/j.humpath.2007.09.019; Ross DD, 2010, METHODS MOL BIOL, V596, P251, DOI 10.1007/978-1-60761-416-6_12; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Stone A, 2013, MOL CANCER THER, V12, P1874, DOI 10.1158/1535-7163.MCT-13-0012; Sullivan I, 2014, CANCER LETT, V353, P160, DOI 10.1016/j.canlet.2014.07.023; Sutherland RL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2878; Tobin LA, 2012, MOL CANCER RES, V10, P96, DOI 10.1158/1541-7786.MCR-11-0255; Trimarchi Michael P, 2011, Chin J Cancer, V30, P749, DOI 10.5732/cjc.011.10128; Van Belle V, 2010, J CLIN ONCOL, V28, P4129, DOI 10.1200/JCO.2009.26.4200; Vergne Yeidyly, 2013, Integr Med (Encinitas), V12, P38; Wajed SA, 2001, ANN SURG, V234, P10, DOI 10.1097/00000658-200107000-00003; Wang DY, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3017; Wang L, 2007, CARCINOGENESIS, V28, P1430, DOI 10.1093/carcin/bgm029; Wei QY, 1996, CANCER RES, V56, P4103; WEI QY, 1993, P NATL ACAD SCI USA, V90, P1614, DOI 10.1073/pnas.90.4.1614; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zhang MH, 2014, BIOMED REP, V2, P41, DOI 10.3892/br.2013.187	74	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152422	10.1371/journal.pone.0152422	http://dx.doi.org/10.1371/journal.pone.0152422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032101	Green Published, gold			2022-12-27	WOS:000373121800071
J	Pfiffner, PB; Pinyol, I; Natter, MD; Mandl, KD				Pfiffner, Pascal B.; Pinyol, Isaac; Natter, Marc D.; Mandl, Kenneth D.			C3-PRO: Connecting ResearchKit to the Health System Using i2b2 and FHIR	PLOS ONE			English	Article								A renewed interest by consumer information technology giants in the healthcare domain is focused on transforming smartphones into personal health data storage devices. With the introduction of the open source ResearchKit, Apple provides a framework for researchers to inform and consent research subjects, and to readily collect personal health data and patient reported outcomes (PRO) from distributed populations. However, being research backend agnostic, ResearchKit does not provide data transmission facilities, leaving research apps disconnected from the health system. Personal health data and PROs are of the most value when presented in context along with health system data. Our aim was to build a toolchain that allows easy and secure integration of personal health and PRO data into an open source platform widely adopted across 140 academic medical centers. We present C3-PRO: the Consent, Contact, and Community framework for Patient Reported Outcomes. This open source toolchain connects, in a standards-compliant fashion, any ResearchKit app to the widely-used clinical research infrastructure Informatics for Integrating Biology and the Bedside (i2b2). C3-PRO leverages the emerging health data standard Fast Healthcare Interoperability Resources (FHIR).	[Pfiffner, Pascal B.; Pinyol, Isaac; Natter, Marc D.; Mandl, Kenneth D.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Pfiffner, Pascal B.] Univ Zurich Hosp, Res Ctr Med Informat, CH-8091 Zurich, Switzerland; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA USA; [Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Zurich; University Zurich Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pfiffner, PB (corresponding author), Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.; Pfiffner, PB (corresponding author), Univ Zurich Hosp, Res Ctr Med Informat, CH-8091 Zurich, Switzerland.	pascal.pfiffner@childrens.harvard.edu		Pfiffner, Pascal Bruno/0000-0003-4808-3602	National Institutes of Health: National Institute of General Medical Sciences [R01GM104303]; National Library of Medicine [5R01LM011185-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104303] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011185] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health: National Institute of General Medical Sciences (R01GM104303; https://www.nigms.nih.gov/; IP MDN KDM) and National Library of Medicine (5R01LM011185-03, https://www.nlm.nih.gov; IP MDN KDM).	Butt G, 2008, J ADV NURS, V62, P712, DOI 10.1111/j.1365-2648.2008.04641.x; Ducharme J., 2015, BOSTON MAGAZINE, V10, P5; Friend SH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1206; Internet Engineering Task Force (IETF), 2012, OAUTH 2 0 AUTH FRAM; Mandel J. C., 2016, JAMIA; Mandl KD, 2015, CELL SYST, V1, P8, DOI 10.1016/j.cels.2015.05.001; Mandl KD, 2014, J AM MED INFORM ASSN, V21, P615, DOI 10.1136/amiajnl-2014-002727; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; NIST, 2001, FIPS PUBL, V197; Pfiffner PB, 2014, SWIFT SMART, P6; Pogue D., 2015, SCI AM, V6, P1; Rivest RL, 1983, CRYPTOGRAPHIC COMMUN, V9, P20	12	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152722	10.1371/journal.pone.0152722	http://dx.doi.org/10.1371/journal.pone.0152722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031856	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800129
J	Sapkota, S; Conner, JA; Hanna, WW; Simon, B; Fengler, K; Deschamps, S; Cigan, M; Ozias-Akins, P				Sapkota, Sirjan; Conner, Joann A.; Hanna, Wayne W.; Simon, Bindu; Fengler, Kevin; Deschamps, Stephane; Cigan, Mark; Ozias-Akins, Peggy			In Silico and Fluorescence In Situ Hybridization Mapping Reveals Collinearity between the Pennisetum squamulatum Apomixis Carrier-Chromosome and Chromosome 2 of Sorghum and Foxtail Millet	PLOS ONE			English	Article							GENOMIC REGION; CENCHRUS-CILIARIS; PEARL-MILLET; APOMICTIC GRASSES; APOSPORY; PASPALUM; SEQUENCE; LOCUS; RECOMBINATION; CONSTRUCTION	Apomixis, or clonal propagation through seed, is a trait identified within multiple species of the grass family (Poaceae). The genetic locus controlling apomixis in Pennisetum squamulatum (syn Cenchrus squamulatus) and Cenchrus ciliaris (syn Pennisetum ciliare, buffelgrass) is the apospory-specific genomic region (ASGR). Previously, the ASGR was shown to be highly conserved but inverted in marker order between P. squamulatum and C. ciliaris based on fluorescence in situ hybridization (FISH) and varied in both karyotype and position of the ASGR on the ASGR-carrier chromosome among other apomictic Cenchrus/Pennisetum species. Using in silico transcript mapping and verification of physical positions of some of the transcripts via FISH, we discovered that the ASGR-carrier chromosome from P. squamulatum is collinear with chromosome 2 of foxtail millet and sorghum outside of the ASGR. The in silico ordering of the ASGR-carrier chromosome markers, previously unmapped in P. squamulatum, allowed for the identification of a backcross line with structural changes to the P. squamulatum ASGR-carrier chromosome derived from gamma irradiated pollen.	[Sapkota, Sirjan; Conner, Joann A.; Simon, Bindu; Ozias-Akins, Peggy] Univ Georgia, Dept Hort, Tifton Campus, Tifton, GA 31793 USA; [Hanna, Wayne W.] Univ Georgia, Dept Crop & Soil Sci, Tifton Campus, Tifton, GA 31793 USA; [Fengler, Kevin; Cigan, Mark] DuPont Pioneer, Johnston, IA 50131 USA; [Deschamps, Stephane] DuPont Expt Stn, Wilmington, DE 19803 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; DuPont; Pioneer Hi-Bred International, Inc.; DuPont	Conner, JA (corresponding author), Univ Georgia, Dept Hort, Tifton Campus, Tifton, GA 31793 USA.	jconner@uga.edu	Conner, Joann/AAF-1852-2020; Deschamps, Stephane/R-3806-2019	Sapkota, Sirjan/0000-0002-5718-3544; Conner, Joann/0000-0003-3825-0147	Peggy Ozias-Akins/UGA; Pioneer Hi-Bred	Peggy Ozias-Akins/UGA; Pioneer Hi-Bred	This study was partially funded by a Sponsored Research Agreement between Peggy Ozias-Akins/UGA and Pioneer Hi-Bred. Pioneer Hi-Bred provided financial support for research materials, in kind support, and had intellectual input into the design, analysis and interpretation of the results.	Akiyama Y, 2004, PLANT PHYSIOL, V134, P1733, DOI 10.1104/pp.103.033969; Akiyama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-289; Andres R. J., 2013, Journal of Cotton Science, V17, P149; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Conner JA, 2008, PLANT PHYSIOL, V147, P1396, DOI 10.1104/pp.108.119081; Conner JA, 2013, PLANTA, V238, P51, DOI 10.1007/s00425-013-1873-5; Devos KM, 2000, THEOR APPL GENET, V100, P190, DOI 10.1007/s001220050026; Fukui Kiichi, 1996, P1; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Goel S, 2006, GENETICS, V173, P389, DOI 10.1534/genetics.105.054429; HANNA WW, 1992, J HERED, V83, P386, DOI 10.1093/oxfordjournals.jhered.a111236; Hojsgaard DH, 2011, THEOR APPL GENET, V123, P959, DOI 10.1007/s00122-011-1639-z; INGHAM LD, 1993, MOL GEN GENET, V238, P350, DOI 10.1007/BF00291993; Jessup RW, 2002, CROP SCI, V42, P1688, DOI 10.2135/cropsci2002.1688; Johri, 1984, EMBRYOLOGY ANGIOSPER, P475, DOI DOI 10.1007/978-3-642-69302-1_10; Kirov I, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-21; Ozias-Akins P, 1998, P NATL ACAD SCI USA, V95, P5127, DOI 10.1073/pnas.95.9.5127; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Podio M, 2012, GENET MOL BIOL, V35, P827, DOI 10.1590/S1415-47572012005000070; Pupilli F, 2004, MOL GENET GENOMICS, V270, P539, DOI 10.1007/s00438-003-0949-5; Pupilli F, 2001, MOL BREEDING, V8, P53, DOI 10.1023/A:1011966922301; Roche D, 2002, THEOR APPL GENET, V104, P804, DOI 10.1007/s00122-001-0795-y; Roche D, 1999, PLANT J, V19, P203, DOI 10.1046/j.1365-313X.1999.00514.x; Singh M, 2010, CROP SCI, V50, P892, DOI 10.2135/cropsci2009.05.0263; Wang XY, 2015, MOL PLANT, V8, P885, DOI 10.1016/j.molp.2015.04.004; YOUNG BA, 1979, CAN J BOT, V57, P1668, DOI 10.1139/b79-204; Zeng YJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-206; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	31	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152411	10.1371/journal.pone.0152411	http://dx.doi.org/10.1371/journal.pone.0152411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031857	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800069
J	Spadafora, D; Kozhukhar, N; Alexeyev, MF				Spadafora, Domenico; Kozhukhar, Natalia; Alexeyev, Mikhail F.			Presequence-Independent Mitochondrial Import of DNA Ligase Facilitates Establishment of Cell Lines with Reduced mtDNA Copy Number	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEPLETION; DEGRADATION; DYSFUNCTION; PROGRESSION; PROTEIN; CANCER	Due to the essential role played by mitochondrial DNA (mtDNA) in cellular physiology and bioenergetics, methods for establishing cell lines with altered mtDNA content are of considerable interest. Here, we report evidence for the existence in mammalian cells of a novel, low-efficiency, presequence-independent pathway for mitochondrial protein import, which facilitates mitochondrial uptake of such proteins as Chlorella virus ligase (ChVlig) and Escherichia coli LigA. Mouse cells engineered to depend on this pathway for mitochondrial import of the LigA protein for mtDNA maintenance had severely (up to >90%) reduced mtDNA content. These observations were used to establish a method for the generation of mouse cell lines with reduced mtDNA copy number by, first, transducing them with a retrovirus encoding LigA, and then inactivating in these transductants endogenous Lig3 with CRISPR-Cas9. Interestingly, mtDNA depletion to an average level of one copy per cell proceeds faster in cells engineered to maintain mtDNA at low copy number. This makes a low-mtDNA copy number phenotype resulting from dependence on mitochondrial import of DNA ligase through presequence-independent pathway potentially useful for rapidly shifting mtDNA heteroplasmy through partial mtDNA depletion.	[Spadafora, Domenico] Univ S Alabama, Dept Pharmacol, 307 Univ Blvd, Mobile, AL 36688 USA; [Kozhukhar, Natalia; Alexeyev, Mikhail F.] Univ S Alabama, Dept Physiol & Cell Biol, 307 Univ Blvd, Mobile, AL 36688 USA; [Alexeyev, Mikhail F.] Univ S Alabama, Ctr Lung Biol, 307 Univ Blvd, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama	Alexeyev, MF (corresponding author), Univ S Alabama, Dept Physiol & Cell Biol, 307 Univ Blvd, Mobile, AL 36688 USA.; Alexeyev, MF (corresponding author), Univ S Alabama, Ctr Lung Biol, 307 Univ Blvd, Mobile, AL 36688 USA.	malexeye@southalabama.edu			National Institutes of Health [HL66299, OD010944]; DoD award [PR150220]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health HL66299 and OD010944, DoD award PR150220. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barthelemy C, 2001, ANN NEUROL, V49, P607, DOI 10.1002/ana.1002.abs; Blackstone NW, 2015, CELL CALCIUM, V57, P133, DOI 10.1016/j.ceca.2014.11.006; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cha MY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.122; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Elkholi R, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-16; Fayzulin RZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv140; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Hsu CC, 2013, WORLD J GASTROENTERO, V19, P8880, DOI 10.3748/wjg.v19.i47.8880; Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950; Li HZ, 2014, FRONT BIOSCI-LANDMRK, V19, P777, DOI 10.2741/4244; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Mansouri A, 1999, GASTROENTEROLOGY, V117, P181, DOI 10.1016/S0016-5085(99)70566-4; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Nakano Y, 2011, PEDIATR INT, V53, P240, DOI 10.1111/j.1442-200X.2010.03183.x; Nogueira C, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-34; OLIVERA BM, 1967, P NATL ACAD SCI USA, V57, P1700, DOI 10.1073/pnas.57.6.1700; Osterwalder M, 2010, NAT METHODS, V7, P893, DOI 10.1038/nmeth.1521; Sambrook J., 2001, MOL CLONING LAB MANU; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016; Shokolenko IN, 2013, J BIOL CHEM, V288, P26594, DOI 10.1074/jbc.M113.472977; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; van Leeuwen N, 2014, AGE, V36, P1463, DOI 10.1007/s11357-014-9629-0; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang DD, 2012, ACM T KNOWL DISCOV D, V6, DOI 10.1145/2362383.2362386; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	36	4	5	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152705	10.1371/journal.pone.0152705	http://dx.doi.org/10.1371/journal.pone.0152705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031233	Green Published, gold			2022-12-27	WOS:000373121800124
J	Torssander, J; Ahlbom, A; Modig, K				Torssander, Jenny; Ahlbom, Anders; Modig, Karin			Four Decades of Educational Inequalities in Hospitalization and Mortality among Older Swedes	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; EUROPEAN COUNTRIES; LIFE EXPECTANCY; HEALTH; NORWAY	Background The inverse association between education and mortality has grown stronger the last decades in many countries. During the same period, gains in life expectancy have been concentrated to older ages; still, old-age mortality is seldom the focus of attention when analyzing trends in the education-mortality gradient. It is further unknown if increased educational inequalities in mortality are preceded by increased inequalities in morbidity of which hospitalization may be a proxy. Methods Using administrative population registers from 1971 and onwards, education-specific annual changes in the risk of death and hospital admission were estimated with complimentary log-log models. These risk changes were supplemented by estimations of the ages at which 25, 50, and 75% of the population had been hospitalized or died (after age 60). Results The mortality decline among older people increasingly benefitted the well-educated over the less well-educated. This inequality increase was larger for the younger old, and among men. Educational inequalities in the age of a first hospital admission generally followed the development of growing gaps, but at a slower pace than mortality and inequalities did not increase among the oldest individuals. Conclusions Education continues to be a significant predictor of health and longevity into old age. That the increase in educational inequalities is greater for mortality than for hospital admissions (our proxy of overall morbidity) may reflect that well-educated individuals gradually have obtained more possibilities or resources to survive a disease than less well-educated individuals have the last four decades.	[Torssander, Jenny] Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden; [Ahlbom, Anders; Modig, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Stockholm University; Karolinska Institutet	Torssander, J (corresponding author), Stockholm Univ, Swedish Inst Social Res, S-10691 Stockholm, Sweden.	jenny.torssander@sofi.su.se	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867	Swedish Research Council for Health, Working Life and Welfare [20140445, 2014-0231]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Funding was received from the Swedish Research Council for Health, Working Life and Welfare (http://forte.se/en/), Grant numbers 20140445 (JT) and 2014-0231 (AA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Bronnum-Hansen H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-994; Bygren LO., 2001, J PUBLIC HLTH POLICY; Cutler DM, 2011, J HEALTH ECON, V30, P1174, DOI 10.1016/j.jhealeco.2011.06.009; Fors S., 2007, EUROPEAN J PUBLIC HL, V18, P138; Fritzell J, 2007, HLTH INEQUALITIES WE; Glied S., 2003, HLTH INEQUALITY ED M; Karampampa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099034; Karampampa K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003447; Kinge JM, 2015, AGE AGEING, V44, P1040, DOI 10.1093/ageing/afv128; Kunst AE, 2005, INT J EPIDEMIOL, V34, P295, DOI 10.1093/ije/dyh342; Lagergren M, 2016, SCAND J PUBLIC HEALT, V44, P55, DOI 10.1177/1403494815605195; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Majer IM, 2011, J EPIDEMIOL COMMUN H, V65, P972, DOI 10.1136/jech.2010.111492; Meinow Bettina, 2006, Eur J Ageing, V3, P98, DOI 10.1007/s10433-006-0027-z; Montez JK, 2013, J HEALTH SOC BEHAV, V54, P165, DOI [10.1177/0022146513491066, 10.1177/0022146513481230]; National Board of Health and Welfare, 2009, FOLKH 2009; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ostergren O, 2015, SCAND J PUBLIC HEALT, V43, P563, DOI 10.1177/1403494815585401; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	22	3	3	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152369	10.1371/journal.pone.0152369	http://dx.doi.org/10.1371/journal.pone.0152369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031107	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800063
J	Zhang, QS; Zhang, XQ; Wang, SB; Tan, C; Zhou, GF; Li, CD				Zhang, Qisen; Zhang, Xiaoqi; Wang, Songbo; Tan, Cong; Zhou, Gaofeng; Li, Chengdao			Involvement of Alternative Splicing in Barley Seed Germination	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; LANDSCAPE; STRESS; ABI3; RNA; TRANSCRIPTION; VIVIPAROUS-1; METABOLISM; COMPLEXITY	Seed germination activates many new biological processes including DNA, membrane and mitochondrial repairs and requires active protein synthesis and sufficient energy supply. Alternative splicing (AS) regulates many cellular processes including cell differentiation and environmental adaptations. However, limited information is available on the regulation of seed germination at post-transcriptional levels. We have conducted RNA-sequencing experiments to dissect AS events in barley seed germination. We identified between 552 and 669 common AS transcripts in germinating barley embryos from four barley varieties (Hordeum vulgare L. Bass, Baudin, Harrington and Stirling). Alternative 3' splicing (34%-45%), intron retention (32%-34%) and alternative 5' splicing (16%-21%) were three major AS events in germinating embryos. The AS transcripts were predominantly mapped onto ribosome, RNA transport machineries, spliceosome, plant hormone signal transduction, glycolysis, sugar and carbon metabolism pathways. Transcripts of these genes were also very abundant in the early stage of seed germination. Correlation analysis of gene expression showed that AS hormone responsive transcripts could also be co-expressed with genes responsible for protein biosynthesis and sugar metabolisms. Our RNA-sequencing data revealed that AS could play important roles in barley seed germination.	[Zhang, Qisen] Australian Export Grains Innovat Ctr, 3 Baron Hay Court, S Perth, WA 6155, Australia; [Zhang, Xiaoqi; Tan, Cong; Zhou, Gaofeng; Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, 90 South St, Murdoch, WA 6150, Australia; [Wang, Songbo] BGI Shenzhen, Beishan Ind Zone, Shenzhen 518083, Peoples R China; [Li, Chengdao] Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6155, Australia	Murdoch University; Beijing Genomics Institute (BGI); Government of Western Australia; Department of Agriculture & Food - Western Australia	Li, CD (corresponding author), Murdoch Univ, Western Barley Genet Alliance, 90 South St, Murdoch, WA 6150, Australia.; Li, CD (corresponding author), Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6155, Australia.	c.li@murdoch.edu.au		tan, cong/0000-0003-0158-4442	Australian Grain Research and Development Corporation; AEGIC research funding	Australian Grain Research and Development Corporation(Grains R&D Corp); AEGIC research funding	This research was funded by Australian Grain Research and Development Corporation to CL and AEGIC research funding to QZ.	Aghamirzaie Delasa, 2013, Biology (Basel), V2, P1311, DOI 10.3390/biology2041311; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; Bournay AS, 1996, NUCLEIC ACIDS RES, V24, P2347, DOI 10.1093/nar/24.12.2347; Brummell DA, 2011, J EXP BOT, V62, P3519, DOI 10.1093/jxb/err043; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; Chang CY, 2014, PLANT PHYSIOL, V165, P826, DOI 10.1104/pp.113.230540; Crowe J.H., 1992, WATER LIFE, P87, DOI DOI 10.1007/978-3-642-76682-4_7; Eckardt NA, 2013, PLANT CELL, V25, P3639, DOI 10.1105/tpc.113.251013; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Huang Songbo, 2011, Frontiers in Genetics, V2, P46, DOI 10.3389/fgene.2011.00046; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WF, 2013, PLANT PHYSIOL, V162, P1750, DOI 10.1104/pp.113.217778; Liu JJ, 2013, PLANT PHYSIOL, V162, P512, DOI 10.1104/pp.112.205864; Liu XD, 2013, P NATL ACAD SCI USA, V110, P15485, DOI 10.1073/pnas.1304651110; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; Min XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1914-5; Pease J, 2012, NAT METH, V9; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rohde A, 1998, J EXP BOT, V49, P1059, DOI 10.1093/jexbot/49.323.1059; SANDOVAL JA, 1995, PLANT PHYSIOL, V109, P269, DOI 10.1104/pp.109.1.269; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Sugliani M, 2010, PLANT CELL, V22, P1936, DOI 10.1105/tpc.110.074674; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wu HP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r10; Zhang QS, 2016, J PLANT PHYSIOL, V191, P127, DOI 10.1016/j.jplph.2015.12.007	44	42	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152824	10.1371/journal.pone.0152824	http://dx.doi.org/10.1371/journal.pone.0152824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031341	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800145
J	Hoffmann, M; Kruger, N; Zmora, P; Wrensch, F; Herrler, G; Pohlmann, S				Hoffmann, Markus; Krueger, Nadine; Zmora, Pawel; Wrensch, Florian; Herrler, Georg; Poehlmann, Stefan			The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; VESICULAR STOMATITIS-VIRUS; A-VIRUSES; PROTEOLYTIC CLEAVAGE; ENDOSOMAL PROTEOLYSIS; ENVELOPE PROTEINS; SERINE PROTEASES; FUSION PROTEIN; B VIRUSES; NEURAMINIDASE	New World bats have recently been discovered to harbor influenza A virus (FLUAV)-related viruses, termed bat-associated influenza A-like viruses (batFLUAV). The internal proteins of batFLUAV are functional in mammalian cells. In contrast, no biological functionality could be demonstrated for the surface proteins, hemagglutinin (HA)-like (HAL) and neuraminidase (NA)-like (NAL), and these proteins need to be replaced by their human counterparts to allow spread of batFLUAV in human cells. Here, we employed rhabdoviral vectors to study the role of HAL and NAL in viral entry. Vectors pseudotyped with batFLUAV-HAL and -NAL were able to enter bat cells but not cells from other mammalian species. Host cell entry was mediated by HAL and was dependent on prior proteolytic activation of HAL and endosomal low pH. In contrast, sialic acids were dispensable for HAL-driven entry. Finally, the type II transmembrane serine protease TMPRSS2 was able to activate HAL for cell entry indicating that batFLUAV can utilize human proteases for HAL activation. Collectively, these results identify viral and cellular factors governing host cell entry driven by batFLUAV surface proteins. They suggest that the absence of a functional receptor precludes entry of batFLUAV into human cells while other prerequisites for entry, HAL activation and protonation, are met in target cells of human origin.	[Hoffmann, Markus; Zmora, Pawel; Wrensch, Florian; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Krueger, Nadine; Herrler, Georg] Univ Vet Med Hannover, Inst Virol, Hannover, Germany	Deutsches Primatenzentrum (DPZ); University of Veterinary Medicine Hannover, Foundation	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Pöhlmann, Stefan/H-2395-2011; Krüger, Nadine/V-2282-2019; Hoffmann, Markus/J-7836-2018; Zmora, Pawel/V-3843-2019	Pöhlmann, Stefan/0000-0001-6086-9136; Krüger, Nadine/0000-0002-4413-8699; Hoffmann, Markus/0000-0003-4603-7696; Zmora, Pawel/0000-0002-2012-7223; Wrensch, Florian/0000-0002-7258-5453	Deutsche Forschungsgemeinschaft (DFG) [PO 716/6-1, GSC 226/1, GSC 226/2]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant PO 716/6-1, Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences, Deutsche Forschungsgemeinschaft (DFG) grants GSC 226/1 and GSC 226/2 (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; CARROLL SM, 1981, J BIOL CHEM, V256, P8357; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cheng ZS, 2015, J INFECT DIS, V212, P1214, DOI 10.1093/infdis/jiv246; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Diederich S, 2005, J BIOL CHEM, V280, P29899, DOI 10.1074/jbc.M504598200; Diederich S, 2012, J VIROL, V86, P3736, DOI 10.1128/JVI.06628-11; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Garcia-Sastre A, 2012, P NATL ACAD SCI USA, V109, P18635, DOI 10.1073/pnas.1215857109; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12; Jung C, 2008, BIOTECHNOL BIOENG, V99, P1016, DOI 10.1002/bit.21622; Juozapaitis M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5448; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; KLENK HD, 1977, J GEN VIROL, V36, P151, DOI 10.1099/0022-1317-36-1-151; Kruger N, 2015, J VIROL, V89, P4539, DOI 10.1128/JVI.03693-14; Kruger N, 2013, J VIROL, V87, P13889, DOI 10.1128/JVI.02458-13; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; LAZAROWITZ SG, 1973, VIROLOGY, V56, P172, DOI 10.1016/0042-6822(73)90296-1; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Maruyama J, 2016, VIROLOGY, V488, P43, DOI 10.1016/j.virol.2015.11.002; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Okumura Y, 2010, J VIROL, V84, P5089, DOI 10.1128/JVI.02605-09; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Poole DS, 2014, J VIROL, V88, P12572, DOI 10.1128/JVI.01857-14; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Roberts NA, 2001, PROG DRUG RES, V56, P195; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Steffen I, 2016, CURR GENE THER, V16, P47, DOI 10.2174/1566523216666160119093948; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; SUZUKI Y, 1989, J VIROL, V63, P4298, DOI 10.1128/JVI.63.10.4298-4302.1989; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tefsen B, 2014, J VIROL, V88, P1935, DOI 10.1128/JVI.03270-13; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Turkington HL, 2015, J VIROL, V89, P10696, DOI 10.1128/JVI.01430-15; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010; Zhou B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004420; Zhu XY, 2013, P NATL ACAD SCI USA, V110, P1458, DOI 10.1073/pnas.1218509110; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109; Zimmer G, 2014, J GEN VIROL, V95, P1634, DOI 10.1099/vir.0.065201-0; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	68	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152134	10.1371/journal.pone.0152134	http://dx.doi.org/10.1371/journal.pone.0152134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028521	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500037
J	Cubillos, S; Krieg, N; Norgauer, J				Cubillos, Susana; Krieg, Nadine; Norgauer, Johannes			Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; BONE-RESORPTION; 1,25-DIHYDROXYVITAMIN D-3; CATHEPSIN-K; IN-VITRO; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; OSTEOCLASTS; EXPRESSION; DIFFERENTIATION	Background Psoriasis, a chronic skin disease with or without joint inflammation, has increased circulating proinflammatory cytokine levels. Vitamin D is involved in calcium homeostasis, bone formation, osteoclastogenesis and osteoclast activity, as well as regulation of immune response. We aimed to study osteoclast differentiation and cytokine secretion of peripheral blood mononuclear cells (PBMCs) from patients with psoriasis vulgaris and psoriatic arthritis, in response to 1,25(OH)(2)D-3. Methods Serum levels of bone turnover markers were measured by ELISA in patients with psoriasis vulgaris and psoriatic arthritis, and healthy controls. PBMCs were isolated and cultured with or without RANKL/M-CSF and 1,25(OH)(2)D-3. Osteoclast differentiation and cytokine secretion were assessed. Results Psoriatic arthritis patients had lower osteocalcin, as well as higher C-telopeptide of type I collagen and cathepsin K serum levels compared with psoriasis vulgaris patients and controls. RANKL/M-CSF-stimulated PBMCs from psoriatic arthritis patients produced higher proinflammatory cytokine levels and had a differential secretion profile in response to 1,25 (OH)(2)D-3, compared with psoriasis vulgaris and control PBMCs. Conclusions Our data confirmed altered bone turnover in psoriatic arthritis patients, and demonstrated increased osteoclastogenic potential and proinflammatory cytokine secretion capacity of these PBMCs compared with psoriasis vulgaris and controls. 1,25(OH)(2)D-3 abrogated these effects.	[Cubillos, Susana; Krieg, Nadine; Norgauer, Johannes] Jena Univ Hosp, Dept Dermatol, Jena, Thuringen, Germany	Friedrich Schiller University of Jena	Cubillos, S (corresponding author), Jena Univ Hosp, Dept Dermatol, Jena, Thuringen, Germany.	s_cubillos@yahoo.com						ADAMS JS, 1990, J BONE MINER RES, V5, P1265; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bose F, 2014, CLIN EXP DERMATOL, V39, P385, DOI 10.1111/ced.12251; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Choe YB, 2012, BRIT J DERMATOL, V167, P762, DOI 10.1111/j.1365-2133.2012.11038.x; Chulalongkorn University (Sponsor), EFF VIT D3 TREATM CH; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Dalbeth N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3123; DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215; Ekman AK, 2013, ACTA DERM-VENEREOL, V93, P525, DOI 10.2340/00015555-1545; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Finamor DC, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24808; FRIEDMAN J, 1965, SCIENCE, V150, P1465, DOI 10.1126/science.150.3702.1465; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Gaal J, 2009, ACTA DERM-VENEREOL, V89, P140, DOI 10.2340/00015555-0555; Garnero P, 2003, J BONE MINER RES, V18, P859, DOI 10.1359/jbmr.2003.18.5.859; Gisondi P, 2012, BRIT J DERMATOL, V166, P505, DOI 10.1111/j.1365-2133.2011.10699.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grassi F, 2011, J CELL PHYSIOL, V226, P982, DOI 10.1002/jcp.22411; Grazio S, 2015, AM J MED SCI, V349, P46, DOI 10.1097/MAJ.0000000000000340; Gu JH, 2015, J STEROID BIOCHEM, V152, P25, DOI 10.1016/j.jsbmb.2015.04.003; Hao L, 2015, FEBS LETT, V589, P1331, DOI 10.1016/j.febslet.2015.04.008; Hata TR, 2014, J EUR ACAD DERMATOL, V28, P781, DOI 10.1111/jdv.12176; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Heine G, 2008, EUR J IMMUNOL, V38, P2210, DOI 10.1002/eji.200838216; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; HOLTROP ME, 1981, ENDOCRINOLOGY, V108, P2293, DOI 10.1210/endo-108-6-2293; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; HUCKINS D, 1990, ARTHRITIS RHEUM, V33, P1723, DOI 10.1002/art.1780331117; Ikic M, 2014, INT ORTHOP, V38, P183, DOI 10.1007/s00264-013-2121-0; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Kogawa M, 2010, J STEROID BIOCHEM, V121, P277, DOI 10.1016/j.jsbmb.2010.03.048; Kogawa M, 2010, ENDOCRINOLOGY, V151, P4613, DOI 10.1210/en.2010-0334; Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046; Lari R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2616; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Lim HW, 2015, J AM ACAD DERMATOL, V72, P1078, DOI 10.1016/j.jaad.2015.03.017; MAGARO M, 1989, CLIN RHEUMATOL, V8, P494, DOI 10.1007/BF02032102; Suarez-Varela MM, 2014, INT J ENV RES PUB HE, V11, P12108, DOI 10.3390/ijerph111212108; MULLER K, 1991, IMMUNOL LETT, V28, P115, DOI 10.1016/0165-2478(91)90108-M; Nakajima H, 2011, ARCH DERMATOL RES, V303, P451, DOI 10.1007/s00403-011-1159-3; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; OKeefe RJ, 1997, LAB INVEST, V76, P457; Pappalardo A, 2015, BONE, V71, P180, DOI 10.1016/j.bone.2014.10.019; Pontificia Universidad Catolica de Chile (Sponsor), EFF VIT D SUPPL MET; RAHIMI P, 1995, ENDOCRINOLOGY, V136, P2752, DOI 10.1210/en.136.6.2752; RAISZ LG, 1972, SCIENCE, V175, P768, DOI 10.1126/science.175.4023.768; Raychaudhuri S, 2014, INDIAN J DERMATOL, V59, P116, DOI 10.4103/0019-5154.127668; REICHEL H, 1987, J BIOL CHEM, V262, P10931; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Rothe L, 1998, ENDOCRINOLOGY, V139, P4353, DOI 10.1210/en.139.10.4353; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Scragg R., 2015, J STEROID BIOCH MOL; Shinki T, 1999, P NATL ACAD SCI USA, V96, P8253, DOI 10.1073/pnas.96.14.8253; Soleymani T, 2015, INT J DERMATOL, V54, P383, DOI 10.1111/ijd.12790; Szentpetery A, 2013, J RHEUMATOL, V40, P653, DOI 10.3899/jrheum.120397; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; TAKAMOTO S, 1986, CALCIFIED TISSUE INT, V39, P360, DOI 10.1007/BF02555172; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Touma Z, 2011, ARTHRIT CARE RES, V63, P1440, DOI 10.1002/acr.20530; Wallach S, 1999, BONE, V25, P509, DOI 10.1016/S8756-3282(99)00200-8; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	70	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153094	10.1371/journal.pone.0153094	http://dx.doi.org/10.1371/journal.pone.0153094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050092	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500098
J	Hatasa, Y; Chikazawa, M; Furuhashi, M; Nakashima, F; Shibata, T; Kondo, T; Akagawa, M; Hamagami, H; Tanaka, H; Tachibana, H; Uchida, K				Hatasa, Yukinori; Chikazawa, Miho; Furuhashi, Mai; Nakashima, Fumie; Shibata, Takahiro; Kondo, Tatsuhiko; Akagawa, Mitsugu; Hamagami, Hiroki; Tanaka, Hiroshi; Tachibana, Hirofumi; Uchida, Koji			Oxidative Deamination of Serum Albumins by (-)-Epigallocatechin-3-O-Gallate: A Potential Mechanism for the Formation of Innate Antigens by Antioxidants	PLOS ONE			English	Article							METAL-CATALYZED OXIDATION; NATURAL ANTIBODIES; PROTEIN OXIDATION; GREEN TEA; PRODUCTS; IDENTIFICATION; SEMIALDEHYDES; DERIVATIVES; RESIDUES; ACROLEIN	(-)-Epigallocatechin-3-O-gallate (EGCG), the most abundant polyphenol in green tea, mediates the oxidative modification of proteins, generating protein carbonyls. However, the underlying molecular mechanism remains unclear. Here we analyzed the EGCG-derived intermediates generated upon incubation with the human serum albumin (HSA) and established that EGCG selectively oxidized the lysine residues via its oxidative deamination activity. In addition, we characterized the EGCG-oxidized proteins and discovered that the EGCG could be an endogenous source of the electrically-transformed proteins that could be recognized by the natural antibodies. When HSA was incubated with EGCG in the phosphate-buffered saline (pH 7.4) at 37 degrees C, the protein carbonylation was associated with the formation of EGCG-derived products, such as the protein-bound EGCG, oxidized EGCG, and aminated EGCG. The aminated EGCG was also detected in the sera from the mice treated with EGCG in vivo. EGCG selectively oxidized lysine residues at the EGCG-binding domains in HSA to generate an oxidatively deaminated product, aminoadipic semialdehyde. In addition, EGCG treatment results in the increased negative charge of the protein due to the oxidative deamination of the lysine residues. More strikingly, the formation of protein carbonyls by EGCG markedly increased its cross-reactivity with the natural IgM antibodies. These findings suggest that many of the beneficial effects of EGCG may be partly attributed to its oxidative deamination activity, generating the oxidized proteins as a target of natural antibodies.	[Hatasa, Yukinori; Chikazawa, Miho; Furuhashi, Mai; Nakashima, Fumie; Shibata, Takahiro; Kondo, Tatsuhiko; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Takahiro] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Dept Biol Chem, Sakai, Osaka 591, Japan; [Hamagami, Hiroki; Tanaka, Hiroshi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 152, Japan; [Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Nagoya University; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tokyo Institute of Technology; Kyushu University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [26252018, 26111011]; grant from JST PRESTO program; Grants-in-Aid for Scientific Research [15H02448] Funding Source: KAKEN	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; grant from JST PRESTO program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (A) (No. 26252018) (K.U.) and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" (No. 26111011) (K.U.) of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; a grant from the JST PRESTO program (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagawa M, 2005, J AGR FOOD CHEM, V53, P8019, DOI 10.1021/jf050843f; Akagawa M, 2001, EUR J BIOCHEM, V268, P1953, DOI 10.1046/j.1432-1327.2001.02068.x; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; AMICI A, 1989, J BIOL CHEM, V264, P3341; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; CASE DA, 2002, AMBER 7 COMPUTER PRO; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; Furuhata A, 2002, J BIOL CHEM, V277, P27919, DOI 10.1074/jbc.M202794200; Gibbons TE, 2014, BEHAV BRAIN RES, V272, P131, DOI 10.1016/j.bbr.2014.05.049; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600; Ishii T, 2010, BIOORGAN MED CHEM, V18, P4892, DOI 10.1016/j.bmc.2010.06.021; Kumano-Kuramochi M, 2012, BIOCHEM J, V442, P171, DOI 10.1042/BJ20111029; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Sancataldo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084552; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 2014, FREE RADICAL BIO MED, V72, P156, DOI 10.1016/j.freeradbiomed.2014.03.016; Uchida K, 2013, REDOX BIOL, V1, P94, DOI 10.1016/j.redox.2012.12.005; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o	36	19	19	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153002	10.1371/journal.pone.0153002	http://dx.doi.org/10.1371/journal.pone.0153002			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046229	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600056
J	He, X; Garza, D; Nigam, SK; Chang, G				He, Xiao; Garza, Denisse; Nigam, Sanjay K.; Chang, Geoffrey			Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2	PLOS ONE			English	Article							ANION TRANSPORTERS; SECRETION; SYSTEMS; FAMILY; OAT1	Organic cation transporter 1 (OCT1, SLC22A1), like many solute carrier 22 (SLC22) family members, is important for the disposition of clinically important drugs, metabolites and signaling molecules. Several studies suggest that SLC22 family (eg. organic anion transporters or OATs and OCTs) bind and possibly transport prostaglandins with relatively high affinity (submicromolar). The affinities of OCT1 and OATs toward PGE2 and PGF2a reported in these cell-based transport studies are considerably greater than for xenobiotics and natural metabolite substrates-in many cases over 100-fold higher. This raises the possibility that prostaglandins are key endogenous substrates and/or that they act on the transporter in a manner different from other substrates such as xenobiotics and lower affinity metabolites. To further investigate OCT1-prostaglandin interactions, we designed biophysical studies using purified bovine OCT1 (Bos taurus, btOCT1/SLC22A1) with PGE2 analogs, in fluorescently labeled and label-free formats. Using fluorescence polarization (FP), we detected a binding of btOCT1 to the PGE2-Rhodamine conjugate at submicromolar affinity, consistent with affinity data for PGE2 from cells over-expressing the related human OCT1. Using purified native btOCT1 as analyte and biotinylated PGE2 analog as ligand, our data from surface plasmon resonance (SPR) revealed that btOCT1 specifically interacts to PGE2 with K-D values in the hundred nanomolar range. BtOCT1 also demonstrated a slow association (k(a)) in the range of 10(3) M(-1)s(-1) and an even slower dissociation rate (k(d)) in the range of 10(-4) s(-1) for PGE2, suggesting the possibility of a different mode of binding compared to other structurally unrelated transported substrates of low-affinity (eg. drugs, metabolites). Our results complement in vitro transport studies and provide direct evidence that OCT1-which is normally expressed in liver and other tissues-interacts with prostaglandin analogs. While it is not entirely clear from the published literature whether OCTs function as major prostaglandin transporters, the tight binding of the naturally occurring PGE2, as well as the slow dissociation rate, could conceivably affect the transport of lower affinity substrates such as drugs and metabolites by SLC22 transporters. More research is necessary to establish the extent to which individual SLC22 family members actually function as PG transporters in vitro and in vivo and to investigate whether PGs can, independent of being directly transported, alter the ability of SLC22 transporters to handle drugs and other substrates.	[He, Xiao; Garza, Denisse; Chang, Geoffrey] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; [Chang, Geoffrey] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Chang, G (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Chang, G (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	g1chang@ucsd.edu			National Institutes of Health [GM104098, GM94610, DK58251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058251, R01DK058251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094610, R01GM104098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM104098, GM94610, and DK58251 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Ciarimboli G, 2008, XENOBIOTICA, V38, P936, DOI [10.1080/00498250701882482, 10.1080/00498250701882482 ]; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; Decouture B, 2015, BLOOD, V126, P1823, DOI 10.1182/blood-2015-02-631044; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gose T, 2016, PROSTAG OTH LIPID M, V122, P10, DOI 10.1016/j.prostaglandins.2015.12.003; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Kimura H, 2002, J PHARMACOL EXP THER, V301, P293, DOI 10.1124/jpet.301.1.293; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Lee SC, 2014, WILEY SER DRUG DISC, P473; Levanon NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51937; Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225; Morrissey KM, 2012, CLIN PHARMACOL THER, V92, P545, DOI 10.1038/clpt.2012.44; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Raucy JL, 2010, CURR DRUG METAB, V11, P806; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Rios A, 2012, PROSTAG OTH LIPID M, V98, P86, DOI 10.1016/j.prostaglandins.2011.11.004; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Sinha C, 2015, CELL SIGNAL, V27, P1345, DOI 10.1016/j.cellsig.2015.03.022; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu ZC, METHODS MOL BIOL, V10332013, P157; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308	33	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152969	10.1371/journal.pone.0152969	http://dx.doi.org/10.1371/journal.pone.0152969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046168	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600054
J	Bernard, V; Bouilly, J; Kramer, P; Carre, N; Schlumberger, M; Visser, JA; Young, J; Binart, N				Bernard, Valerie; Bouilly, Justine; Kramer, Piet; Carre, Nadege; Schlumberger, Martin; Visser, Jenny A.; Young, Jacques; Binart, Nadine			The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; ANTI-MULLERIAN HORMONE; RENAL-CELL CARCINOMA; MALE GYNECOMASTIA; SOLID TUMORS; IMATINIB; THERAPY; RECEPTOR; CANCER; MICE	The aim of the study was to evaluate ovarian toxicity of tyrosine kinase inhibitor (TKI) sunitinib, since only scarce data are available on gonadal function after this treatment. Six-weekold female mice received orally, once daily, vehicle or sunitinib (50 mg/kg/d) during 5 weeks. Fertility parameters were analyzed from ovulation to litter assessment. Sunitinib exposure significantly reduced (i) corpora lutea number per ovary (1.1 +/- 0.38 in sunitinib group versus 4 +/- 0.79 in control group, p<0.01) and (ii) serum Anti Mullerian hormone (AMH) levels in sunitinib treated mice (12.01 +/- 1.16) compared to control mice (14.33 +/- 0.87 ng/ml, p<0.05). However, primordial and growing follicles numbers per ovary were not different in both groups. After treatment withdrawal, female mice in both groups were able to obtain litters. These data could be helpful to counsel clinicians and patients, when fertility preservation methods are discussed, before TKI treatment in girls and young women.	[Bernard, Valerie; Bouilly, Justine; Carre, Nadege; Young, Jacques; Binart, Nadine] Univ Paris Saclay, Univ Paris 11, Inserm U1185, F-94276 Le Kremlin Bicetre, France; [Kramer, Piet; Visser, Jenny A.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Schlumberger, Martin] Univ Paris 11, Inst Gustave Roussy, Dept Med Nucl & Oncol Endocrinienne, F-94800 Villejuif, France; [Young, Jacques] Univ Paris 11, AP HP, Fac Med Paris Sud, Serv Endocrinol & Malad Reprod, F-94276 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Binart, N (corresponding author), Univ Paris Saclay, Univ Paris 11, Inserm U1185, F-94276 Le Kremlin Bicetre, France.	nadine.binart@inserm.fr	Young, Jacques/N-5251-2019; Binart, Nadine/F-2949-2013; Visser, Jenny A./F-8156-2011; Young, Jacques/T-2976-2018	Young, Jacques/0000-0001-9286-5631; Binart, Nadine/0000-0002-5606-3866; Young, Jacques/0000-0001-9286-5631	Inserm; Societe francaise d'Endocrinologie	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe francaise d'Endocrinologie	This work was supported by Inserm, Societe francaise d'Endocrinologie (VB).	Ault P, 2006, J CLIN ONCOL, V24, P1204, DOI 10.1200/JCO.2005.04.6557; Baker SD, 2013, CLIN CANCER RES, V19, P5758, DOI 10.1158/1078-0432.CCR-13-1323; Ballardini P, 2009, CLIN DRUG INVEST, V29, P487, DOI 10.2165/00044011-200929070-00007; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P2741, DOI 10.1210/jc.2010-2771; Broutin S, 2011, CLIN CANCER RES, V17, P2044, DOI 10.1158/1078-0432.CCR-10-2041; Caocci G, 2008, LEUKEMIA, V22, P2127, DOI 10.1038/leu.2008.106; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Chowdhury T, 2013, J PEDIAT HEMATOL ONC, V35, pE1, DOI 10.1097/MPH.0b013e318266bf34; Christopoulos C, 2008, NEW ENGL J MED, V358, P1079, DOI 10.1056/NEJMc0707841; DuBois SG, 2011, CLIN CANCER RES, V17, P5113, DOI 10.1158/1078-0432.CCR-11-0237; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Gambacorti-Passerini C, 2003, LANCET, V361, P1954, DOI 10.1016/S0140-6736(03)13554-4; Hoffman-La Roche Limited, 2015, AVASTIN MONOGRAPH; Hutt KJ, 2006, MOL HUM REPROD, V12, P61, DOI 10.1093/molehr/gal010; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Kim H, 2005, J KOREAN MED SCI, V20, P512, DOI 10.3346/jkms.2005.20.3.512; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Le Tourneau C, 2008, CANCER TREAT REV, V34, P37, DOI 10.1016/j.ctrv.2007.09.003; Lodish MB, 2013, J CLIN ENDOCR METAB, V98, P1333, DOI 10.1210/jc.2012-4085; Lodish MB, 2010, ENDOCR-RELAT CANCER, V17, pR233, DOI 10.1677/ERC-10-0082; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Malozowski S, 2008, NEW ENGL J MED, V358, P2648, DOI 10.1056/NEJMc080707; Mariani S, 2008, LANCET, V372, P111, DOI 10.1016/S0140-6736(08)61023-5; Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nilsson EE, 2006, REPRODUCTION, V131, P1007, DOI 10.1530/rep.1.00978; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Sirotkin AV, 2011, J CELL PHYSIOL, V226, P2222, DOI 10.1002/jcp.22588; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Zimmermann RC, 2003, J CLIN INVEST, V112, P659, DOI 10.1172/JCI200318740	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152872	10.1371/journal.pone.0152872	http://dx.doi.org/10.1371/journal.pone.0152872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035144	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200047
J	Cai, AD; Xu, H; Shao, XF; Zhu, P; Zhang, WJ; Xu, MG; Murphy, DV				Cai, Andong; Xu, Hu; Shao, Xingfang; Zhu, Ping; Zhang, Wenju; Xu, Minggang; Murphy, Daniel V.			Carbon and Nitrogen Mineralization in Relation to Soil Particle-Size Fractions after 32 Years of Chemical and Manure Application in a Continuous Maize Cropping System	PLOS ONE			English	Article							ORGANIC-MATTER; MICROBIAL BIOMASS; N-MINERALIZATION; FERTILIZER; AGGREGATE; CLAY; PARTICULATE; STABILIZATION; RESPIRATION; SATURATION	Long-term manure application is recognized as an efficient management practice to enhance soil organic carbon (SOC) accumulation and nitrogen (N) mineralization capacity. A field study was established in 1979 to understand the impact of long-term manure and/or chemical fertilizer application on soil fertility in a continuous maize cropping system. Soil samples were collected from field plots in 2012 from 9 fertilization treatments (M0CK, M0N, M0NPK, M30CK, M30N, M30NPK, M60CK, M60N, and M60NPK) where M-0, M-30, and M-60 refer to manure applied at rates of 0, 30, and 60 t ha(-1) yr(-1), respectively; CK indicates no fertilizer; N and NPK refer to chemical fertilizer in the forms of either N or N plus phosphorus (P) and potassium (K). Soils were separated into three particle-size fractions (2000-250, 250-53, and < 53 mu m) by dry-and wet-sieving. A laboratory incubation study of these separated particle-size fractions was used to evaluate the effect of long-term manure, in combination with/without chemical fertilization application, on the accumulation and mineralization of SOC and total N in each fraction. Results showed that long-term manure application significantly increased SOC and total N content and enhanced C and N mineralization in the three particle-size fractions. The content of SOC and total N followed the order 2000-250 mu m > 250-53 mu m > 53 mu m fraction, whereas the amount of C and N mineralization followed the reverse order. In the < 53 mu m fraction, the M60NPK treatment significantly increased the amount of C and N mineralized (7.0 and 10.1 times, respectively) compared to the M0CK treatment. Long-term manure application, especially when combined with chemical fertilizers, resulted in increased soil microbial biomass C and N, and a decreased microbial metabolic quotient. Consequently, long-term manure fertilization was beneficial to both soil C and N turnover and microbial activity, and had significant effect on the microbial metabolic quotient.	[Cai, Andong; Shao, Xingfang; Zhang, Wenju; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China; [Xu, Hu] Guizhou Univ, Coll Agr, Guiyang 550025, Peoples R China; [Zhu, Ping] Jilin Acad Agr Sci, Gongzhuling 136100, Peoples R China; [Murphy, Daniel V.] Univ Western Australia, Inst Agr, Sch Geog & Environm Sci, Soil Biol & Mol Ecol Grp, Crawley, WA 6009, Australia	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Guizhou University; Jilin Academy of Agricultural Sciences; University of Western Australia	Zhang, WJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100081, Peoples R China.	zhangwenju01@caas.cn	Cai, Andong/J-8441-2019	Cai, Andong/0000-0001-6853-7558; Murphy, Daniel/0000-0002-4686-9276	12th National Technology R&D Program of the Ministry of Science and Technology [2014BAD14B02]; National Special Research Fund for Non-Profit Sector (Agriculture) [201203030, 201303126]; Australian Research Council Future Fellowship Scheme [FT110100246]; Chinese High-End Foreign Experts Visiting Professorship	12th National Technology R&D Program of the Ministry of Science and Technology; National Special Research Fund for Non-Profit Sector (Agriculture); Australian Research Council Future Fellowship Scheme(Australian Research Council); Chinese High-End Foreign Experts Visiting Professorship	This work received Financial support from the 12th National Technology R&D Program of the Ministry of Science and Technology (2014BAD14B02) the National Special Research Fund for Non-Profit Sector (Agriculture) (201203030, 201303126), the Australian Research Council Future Fellowship Scheme (FT110100246) and a Chinese High-End Foreign Experts Visiting Professorship is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2001, SOIL BIOL BIOCHEM, V33, P613, DOI 10.1016/S0038-0717(00)00203-0; Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Aoyama M, 1999, CAN J SOIL SCI, V79, P295, DOI 10.4141/S98-049; Ashman MR, 2003, SOIL BIOL BIOCHEM, V35, P435, DOI 10.1016/S0038-0717(02)00295-X; Besnard E, 1996, EUR J SOIL SCI, V47, P495, DOI 10.1111/j.1365-2389.1996.tb01849.x; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Chen Y, 2010, J SOIL SEDIMENT, V10, P1018, DOI 10.1007/s11368-009-0123-8; COLLINS HP, 1992, SOIL SCI SOC AM J, V56, P783, DOI 10.2136/sssaj1992.03615995005600030018x; Ding XL, 2012, SOIL TILL RES, V122, P36, DOI 10.1016/j.still.2012.02.002; Du ZL, 2014, J INTEGR AGR, V13, P2276, DOI 10.1016/S2095-3119(14)60823-6; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1090, DOI 10.2136/sssaj1997.03615995006100040015x; GUPTA VVSR, 1988, SOIL BIOL BIOCHEM, V20, P777, DOI 10.1016/0038-0717(88)90082-X; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; HASSINK J, 1993, GEODERMA, V57, P105, DOI 10.1016/0016-7061(93)90150-J; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Hernandez-Hernandez RM, 2002, SOIL BIOL BIOCHEM, V34, P1563, DOI 10.1016/S0038-0717(02)00125-6; Huang S, 2010, GEODERMA, V154, P364, DOI 10.1016/j.geoderma.2009.11.009; Jiang GY, 2014, GLOBAL BIOGEOCHEM CY, V28, P319, DOI 10.1002/2013GB004746; John B, 2005, GEODERMA, V128, P63, DOI 10.1016/j.geoderma.2004.12.013; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Kamaa M, 2011, BIOL FERT SOILS, V47, P315, DOI 10.1007/s00374-011-0539-3; Kleber M, 2004, EUR J SOIL SCI, V55, P381, DOI 10.1111/j.1365-2389.2004.00610.x; Liang B, 2012, PLANT SOIL, V353, P249, DOI 10.1007/s11104-011-1028-z; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Maillard E, 2014, GLOBAL CHANGE BIOL, V20, P666, DOI 10.1111/gcb.12438; Mendes IC, 1999, SOIL SCI SOC AM J, V63, P873, DOI 10.2136/sssaj1999.634873x; Meng QF, 2014, J SOIL SEDIMENT, V14, P1041, DOI 10.1007/s11368-014-0859-7; Mikha MM, 2004, SOIL SCI SOC AM J, V68, P809, DOI 10.2136/sssaj2004.0809; Pagliai M, 2004, SOIL TILL RES, V79, P131, DOI 10.1016/j.still.2004.07.002; Parfitt RL, 2001, AUST J SOIL RES, V39, P361, DOI 10.1071/SR00028; Pascual JA, 1997, BIOL FERT SOILS, V24, P429, DOI 10.1007/s003740050268; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; PUGET P, 1995, EUR J SOIL SCI, V46, P449, DOI 10.1111/j.1365-2389.1995.tb01341.x; SEECH AG, 1988, SOIL SCI SOC AM J, V52, P1616, DOI 10.2136/sssaj1988.03615995005200060019x; Six J, 2000, SOIL BIOL BIOCHEM, V32, P2099, DOI 10.1016/S0038-0717(00)00179-6; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; Steinweg JM, 2008, BIOL FERT SOILS, V45, P1, DOI 10.1007/s00374-008-0305-3; Suzuki C, 2009, SOIL SCI PLANT NUTR, V55, P80, DOI 10.1111/j.1747-0765.2008.00344.x; Triberti L, 2008, EUR J AGRON, V29, P13, DOI 10.1016/j.eja.2008.01.009; Wattel-Koekkoek EJW, 2003, EUR J SOIL SCI, V54, P269, DOI 10.1046/j.1365-2389.2003.00512.x; Whalen JK, 2002, SOIL SCI SOC AM J, V66, P1637, DOI 10.2136/sssaj2002.1637; Wu J., 2006, SOIL MICROBIAL BIOMA, V12, P54; Yu HY, 2012, BIOL FERT SOILS, V48, P325, DOI 10.1007/s00374-011-0629-2; Zhu P, 2007, J PLANT NUTR SOIL SC, V170, P219, DOI 10.1002/jpln.200620635	47	36	38	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152521	10.1371/journal.pone.0152521	http://dx.doi.org/10.1371/journal.pone.0152521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031697	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800088
J	Comert, M; Zill, JM; Christalle, E; Dirmaier, J; Harter, M; Scholl, I				Coemert, Musa; Zill, Joerdis Maria; Christalle, Eva; Dirmaier, Joerg; Haerter, Martin; Scholl, Isabelle			Assessing Communication Skills of Medical Students in Objective Structured Clinical Examinations (OSCE) - A Systematic Review of Rating Scales	PLOS ONE			English	Review							METHODOLOGICAL QUALITY; SUMMATIVE ASSESSMENT; COMPETENCE; CHECKLISTS; INSTRUMENT; EPSCALE	Background Teaching and assessment of communication skills have become essential in medical education. The Objective Structured Clinical Examination (OSCE) has been found as an appropriate means to assess communication skills within medical education. Studies have demonstrated the importance of a valid assessment of medical students' communication skills. Yet, the validity of the performance scores depends fundamentally on the quality of the rating scales used in an OSCE. Thus, this systematic review aimed at providing an overview of existing rating scales, describing their underlying definition of communication skills, determining the methodological quality of psychometric studies and the quality of psychometric properties of the identified rating scales. Methods We conducted a systematic review to identify psychometrically tested rating scales, which have been applied in OSCE settings to assess communication skills of medical students. Our search strategy comprised three databases (EMBASE, PsycINFO, and PubMed), reference tracking and consultation of experts. We included studies that reported psychometric properties of communication skills assessment rating scales used in OSCEs by examiners only. The methodological quality of included studies was assessed using the COnsensus based Standards for the selection of health status Measurement INstruments (COSMIN) checklist. The quality of psychometric properties was evaluated using the quality criteria of Terwee and colleagues. Results Data of twelve studies reporting on eight rating scales on communication skills assessment in OSCEs were included. Five of eight rating scales were explicitly developed based on a specific definition of communication skills. The methodological quality of studies was mainly poor. The psychometric quality of the eight rating scales was mainly intermediate. Discussion Our results reveal that future psychometric evaluation studies focusing on improving the methodological quality are needed in order to yield psychometrically sound results of the OSCEs assessing communication skills. This is especially important given that most OSCE rating scales are used for summative assessment, and thus have an impact on medical students' academic success.	[Coemert, Musa; Zill, Joerdis Maria; Christalle, Eva; Dirmaier, Joerg; Haerter, Martin; Scholl, Isabelle] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Scholl, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	i.scholl@uke.de	Scholl, Isabelle/AAN-9450-2020	Scholl, Isabelle/0000-0002-7639-0880; Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Education and Research [01GX1043]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was funded by the German Federal Ministry of Education and Research (grant number 01GX1043), www.bmbf.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAMC, 1998, 1 AAMC; ACGME (Accreditation Council for Graduate Medical Education), 2007, COMM PROGR REQ; American Board of Medical Specialties (ABMS), 2014, STAT ABMS PROGR MAIN; Baig LA, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-22; Bergus GR, 2007, MED EDUC, V41, P661, DOI 10.1111/j.1365-2923.2007.02786.x; Bergus GR, 2009, MED EDUC, V43, P688, DOI 10.1111/j.1365-2923.2009.03396.x; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Crossley J, 2002, MED EDUC, V36, P972, DOI 10.1046/j.1365-2923.2002.01320.x; De Haes JCJM, 2005, MED TEACH, V27, P583, DOI 10.1080/01421590500061378; Deveugele M, 2005, PATIENT EDUC COUNS, V58, P265, DOI 10.1016/j.pec.2005.06.004; Duffy FD, 2004, ACAD MED, V79, P495, DOI 10.1097/00001888-200406000-00002; Edgcumbe DP, 2012, PATIENT EDUC COUNS, V87, P120, DOI 10.1016/j.pec.2011.07.011; EPDAD, 2016, GUID PSYCH COUNS UND; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Fischbeck S, 2011, PSYCHOTHER PSYCH MED, V61, P465, DOI 10.1055/s-0031-1291277; Gormley Gerry, 2011, Ulster Med J, V80, P127; Harasym P, 2008, ADV HEALTH SCI EDUC, V13, P617, DOI 10.1007/s10459-007-9068-0; HARDEN RM, 1979, MED EDUC, V13, P41; Hausberg MC, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-16; Hodges B, 2003, MED EDUC, V37, P1012, DOI 10.1046/j.1365-2923.2003.01674.x; Humphris GM, 2001, ADV HEALTH SCI EDUC, V6, P69, DOI 10.1023/A:1009879220949; Huntley CD, 2012, MED EDUC, V46, P267, DOI 10.1111/j.1365-2923.2011.04162.x; Joyce Barbara L, 2010, J Grad Med Educ, V2, P165, DOI 10.4300/JGME-D-10-00024.1; Kiessling C, 2008, GMS Z MED AUSBILD, V25; Kurtz S, 2003, ACAD MED, V78, P802, DOI 10.1097/00001888-200308000-00011; Kurtz S., 1998, TEACHING LEARNING CO; Lang F, 2004, FAM MED, V36, P189; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mortsiefer A, 2014, PATIENT EDUC COUNS, V95, P348, DOI 10.1016/j.pec.2014.02.009; Muller E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106844; Newble D, 2004, MED EDUC, V38, P199, DOI 10.1111/j.1365-2923.2004.01755.x; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Scheffer S, 2008, ADV HEALTH SCI EDUC, V13, P583, DOI 10.1007/s10459-007-9074-2; Schirmer JM, 2005, FAM MED, V37, P184; Silverman J, 2011, PATIENT EDUC COUNS, V82, P89, DOI 10.1016/j.pec.2010.02.022; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thistlethwaite Jill E, 2002, Educ Health (Abingdon), V15, P170, DOI 10.1080/13576280210133099; Tijssen M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-117; Van Nuland M, 2012, PATIENT EDUC COUNS, V88, P106, DOI 10.1016/j.pec.2011.12.015; von Fragstein M, 2008, MED EDUC, V42, P1100, DOI 10.1111/j.1365-2923.2008.03137.x; WFME, 2015, BAS MED ED WFME GLOB; Zill JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112637	46	82	85	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152717	10.1371/journal.pone.0152717	http://dx.doi.org/10.1371/journal.pone.0152717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031506	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800126
J	Hosseini, SM; Moulavi, F; Tanhaie-Vash, N; Asgari, V; Ghanaei, HR; Abedi-Dorche, M; Jafarzadeh, N; Gourabi, H; Shahverdi, AH; Dizaj, AV; Shirazi, A; Nasr-Esfahani, MH				Hosseini, Sayyed-Morteza; Moulavi, Fariba; Tanhaie-Vash, Nima; Asgari, Vajihe; Ghanaei, Hamid-Reza; Abedi-Dorche, Maryam; Jafarzadeh, Naser; Gourabi, Hossein; Shahverdi, Abdol-Hossein; Dizaj, Ahmad Vosough; Shirazi, Abolfazl; Nasr-Esfahani, Mohammad-Hossein			The Principal Forces of Oocyte Polarity Are Evolutionary Conserved but May Not Affect the Contribution of the First Two Blastomeres to the Blastocyst Development in Mammals	PLOS ONE			English	Article							NORMAL MOUSE DEVELOPMENT; ANIMAL-VEGETAL AXIS; 2-CELL STAGE; POSTIMPLANTATION DEVELOPMENT; NUCLEAR TRANSFER; CLEAVAGE PLANE; NORMAL NUMBER; CELL FATE; IN-VITRO; EMBRYO	Oocyte polarity and embryonic patterning are well-established features of development in lower species. Whether a similar form of pre-patterning exists in mammals is currently under hot debate in mice. This study investigated this issue for the first time in ovine as a large mammal model. Microsurgical trisection of unfertilized MII-oocytes revealed that cortical cytoplasm around spindle (S) contained significant amounts of total maternal mRNAs and proteins compared to matched cytoplast hemispheres that were located either near (NS) or far (FS) -to-spindle. RT-qPCR provided striking examples of maternal mRNA localized to subcellular substructures S (NPM2, GMNN, H19, PCAF, DNMT3A, DNMT1, and STELLA), NS (SOX2, NANOG, POU5F1, and TET1), and FS (GCN) of MII oocyte. Immunoblotting revealed that specific maternal proteins DNMT3A and NANOG were asymmetrically enriched in MII-spindle-half of the oocytes. Topological analysis of sperm entry point (SEP) revealed that sperm preferentially entered via the MII-spindle-half of the oocytes. Even though, the topological position of first cleavage plane with regard to SEP was quite stochastic. Spatial comparison of lipid content revealed symmetrical distribution of lipids between 2-cell blastomeres. Lineage tracing using Dil, a fluorescent dye, revealed that while the progeny of leading blastomere of 2-cell embryos contributed to more cells in the developed blastocysts compared to lagging counterpart, the contributions of leading and lagging blastomeres to the embryonic-abembryonic parts of the developed blastocysts were almost unbiased. And finally, separated sister blastomeres of 2-cell embryos had an overall similar probability to arrest at any stage before the blastocyst (2-cell, 4-cell, 8-cell, and morula) or to achieve the blastocyst stage. It was concluded that the localization of maternal mRNAs and proteins at the spindle are evolutionarily conserved between mammals unfertilized ovine oocyte could be considered polar with respect to the spatial regionalization of maternal transcripts and proteins. Even though, the principal forces of this definitive oocyte polarity may not persist during embryonic cleavages.	[Hosseini, Sayyed-Morteza; Moulavi, Fariba; Tanhaie-Vash, Nima; Asgari, Vajihe; Ghanaei, Hamid-Reza; Abedi-Dorche, Maryam; Nasr-Esfahani, Mohammad-Hossein] ACECR, Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Esfahan, Iran; [Jafarzadeh, Naser] Tarbiat Modares Univ, Dept Med Phys, Tehran, Iran; [Gourabi, Hossein] ACECR, Royan Inst Reprod Biomed, Dept Genet, Reprod Biomed Res Ctr, POB 19395-4644, Tehran, Iran; [Shahverdi, Abdol-Hossein] ACECR, Royan Inst Reprod Med, Dept Embryol, Reprod Biomed Res Ctr, Tehran, Iran; [Dizaj, Ahmad Vosough] ACECR, Royan Inst Reprod Biomed, Dept Reprod Imaging, Reprod Biomed Res Ctr, Tehran, Iran; [Shirazi, Abolfazl] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Shirazi, Abolfazl] Shahrekord Univ, Res Inst Anim Embryo Technol, Shahrekord, Iran	Academic Center for Education, Culture & Research (ACECR); Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Shahrekord University	Nasr-Esfahani, MH (corresponding author), ACECR, Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, Esfahan, Iran.; Shirazi, A (corresponding author), ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran.; Shirazi, A (corresponding author), Shahrekord Univ, Res Inst Anim Embryo Technol, Shahrekord, Iran.	shiraziabbas@yahoo.com; mh.nasr-esfahani@royaninstitute.org	Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; asgari, vajihe/AAC-8528-2022; Husseini, Sayyed/AAK-8341-2021; , Nasr-Esfahani/AAR-2434-2021	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; asgari, vajihe/0000-0002-0264-4198; Shahverdi, Abdolhossein/0000-0002-9615-4586; Tanhaeivash, Nima/0000-0002-2044-443X	Royan Institute [IRAN253658]	Royan Institute	This work was supported by IRAN253658, Royan Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Alarcon VB, 2008, MOL REPROD DEV, V75, P1143, DOI 10.1002/mrd.20856; Antczak M, 1997, MOL HUM REPROD, V3, P1067, DOI 10.1093/molehr/3.12.1067; Au PCK, 2010, MOL REPROD DEV, V77, P373, DOI 10.1002/mrd.21158; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; Ciemerych MA, 2000, DEVELOPMENT, V127, P3467; DUCIBELLA T, 1975, DEV BIOL, V47, P45, DOI 10.1016/0012-1606(75)90262-6; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; Edwards RG, 1997, MOL HUM REPROD, V3, P863, DOI 10.1093/molehr/3.10.863; Fulka J, 1998, HUM REPROD, V13, P3303, DOI 10.1093/humrep/13.12.3303; Gajda B, 2009, REPROD BIOL, V9, P97; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 1999, BIOESSAYS, V21, P271, DOI 10.1002/(SICI)1521-1878(199904)21:4<271::AID-BIES2>3.0.CO;2-C; Genicot G, 2005, THERIOGENOLOGY, V63, P1181, DOI 10.1016/j.theriogenology.2004.06.006; Hardarson T, 2000, HUM REPROD, V15, P1372, DOI 10.1093/humrep/15.6.1372; Held E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102921; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Hiiragi T, 2006, INT J DEV BIOL, V50, P581, DOI 10.1387/ijdb.062181th; Hosseini SM, 2015, THERIOGENOLOGY, V83, P366, DOI 10.1016/j.theriogenology.2014.09.031; Hosseini SM, 2013, IN VITRO CELL DEV-AN, V49, P569, DOI 10.1007/s11626-013-9630-4; Hosseini SM, 2008, INT J FERTIL STERIL, V2, P66; JACKLE H, 1980, DEV BIOL, V75, P492, DOI 10.1016/0012-1606(80)90182-7; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1975, NATURE, V257, P321, DOI 10.1038/257321a0; Katayama M, 2010, BIOL REPROD, V82, P1237, DOI 10.1095/biolreprod.109.082982; Khatib H, 2012, LIVESTOCK EPIGENETICS, P1, DOI 10.1002/9781119949930; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Kim K, 2012, ANIM REPROD SCI, V130, P91, DOI 10.1016/j.anireprosci.2011.12.011; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee E, 2014, HUM REPROD; Liu ZC, 2012, DEV BIOL, V368, P304, DOI 10.1016/j.ydbio.2012.05.027; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Marlow F.L., 2010, MATERNAL CONTROL DEV; McMillen IC, 2001, ANZCCART NEWS, V14; Mitalipov SM, 2002, BIOL REPROD, V66, P1449, DOI 10.1095/biolreprod66.5.1449; MOEN TL, 1977, DEV BIOL, V58, P1, DOI 10.1016/0012-1606(77)90070-7; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Motosugi N, 2006, PLOS BIOL, V4, P799, DOI 10.1371/journal.pbio.0040135; Moulavi F, 2013, REPRODUCTION, V145, P345, DOI 10.1530/REP-12-0318; Nicholas JS, 1942, J EXP ZOOL, V90, P441, DOI 10.1002/jez.1400900307; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; PAPAIOANNOU VE, 1995, DEV DYNAM, V203, P393, DOI 10.1002/aja.1002030402; Park SK, 2009, J VET MED SCI, V71, P569, DOI 10.1292/jvms.71.569; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Reinzi L, 2003, HUM REPROD, V18, P1289, DOI 10.1093/humrep/deg274; Roberts RM, 2011, BIOL REPROD, V84, P487, DOI 10.1095/biolreprod.110.086884; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurmann A, 2006, REPRODUCTION, V132, P839, DOI 10.1530/REP-06-0054; Sirard MA, 2012, REPROD DOMEST ANIM, V47, P148, DOI 10.1111/j.1439-0531.2012.02069.x; Taei A, 2013, HUM REPROD, V28, P2661, DOI 10.1093/humrep/det309; Tagawa M, 2008, THERIOGENOLOGY, V69, P574, DOI 10.1016/j.theriogenology.2007.11.003; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; TSUNODA Y, 1983, J REPROD FERTIL, V69, P315, DOI 10.1530/jrf.0.0690315; Van der Westerlaken LAJ, 1999, HUM REPROD, V14, P2565, DOI 10.1093/humrep/14.10.2565; VanSoom A, 1997, MOL REPROD DEV, V47, P47, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;47::AID-MRD7&gt;3.0.CO;2-Q; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Waksmundzka M, 2006, BIOL REPROD, V75, P582, DOI 10.1095/biolreprod.106.053165; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; WILLADSEN SM, 1980, J REPROD FERTIL, V59, P357, DOI 10.1530/jrf.0.0590357; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	71	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0148382	10.1371/journal.pone.0148382	http://dx.doi.org/10.1371/journal.pone.0148382			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030988	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800002
J	Huang, W; Li, Q; Amiry-Moghaddam, M; Hokama, M; Sardi, SH; Nagao, M; Warman, ML; Olsen, BR				Huang, Wei; Li, Qing; Amiry-Moghaddam, Mahmood; Hokama, Madoka; Sardi, Sylvia H.; Nagao, Masashi; Warman, Matthew L.; Olsen, Bjorn R.			Critical Endothelial Regulation by LRP5 during Retinal Vascular Development	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; CRE-RECOMBINASE; TRANSGENIC MICE; LINEAGE ANALYSIS; NORRIE DISEASE; BONE MASS; IN-VIVO; ANGIOGENESIS; CELLS	Vascular abnormalities in the eye are the leading cause of many forms of inherited and acquired human blindness. Loss-of-function mutations in the Wnt-binding co-receptor LRP5 leads to aberrant ocular vascularization and loss of vision in genetic disorders such as osteoporosis-pseudoglioma syndrome. The canonical Wnt-beta-catenin pathway is known to regulate retinal vascular development. However, it is unclear what precise role LPR5 plays in this process. Here, we show that loss of LRP5 function in mice causes retinal hypovascularization during development as well as retinal neovascularization in adulthood with disorganized and leaky vessels. Using a highly specific Flk1-CreBreier line for vascular endothelial cells, together with several genetic models, we demonstrate that loss of endothelium-derived LRP5 recapitulates the retinal vascular defects in Lrp5(-/-) mice. In addition, restoring LRP5 function only in endothelial cells in Lrp5(-/-) mice rescues their retinal vascular abnormalities. Furthermore, we show that retinal vascularization is regulated by LRP5 in a dosage dependent manner and does not depend on LRP6. Our study provides the first direct evidence that endothelium-derived LRP5 is both necessary and sufficient to mediate its critical role in the development and maintenance of retinal vasculature.	[Huang, Wei; Sardi, Sylvia H.; Nagao, Masashi; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA; [Huang, Wei; Sardi, Sylvia H.; Nagao, Masashi; Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Li, Qing] GE Global Res Ctr, Translat Sci Lab, Diagnost Imaging & Biomed Technol, Niskayuna, NY USA; [Amiry-Moghaddam, Mahmood] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Hokama, Madoka] Okayama Univ, Sch Med, Okayama 700, Japan; [Warman, Matthew L.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; General Electric; University of Oslo; Okayama University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Olsen, BR (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.; Olsen, BR (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA.	bjorn_olsen@hms.harvard.edu		Amiry-Moghaddam, Mahmood/0000-0003-1071-1247	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR36819, AR36820]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR036819, R37AR036820, R01AR036820, R01AR036819, R37AR036819] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases [http://nih.gov/,http://www.niams.nih.gov/] grant numbers AR36819 and AR36820 to BO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Grammas P, 2003, MICROVASC RES, V65, P18, DOI 10.1016/S0026-2862(02)00016-X; Hackett SF, 2002, J CELL PHYSIOL, V192, P182, DOI 10.1002/jcp.10128; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Licht AH, 2004, DEV DYNAM, V229, P312, DOI 10.1002/dvdy.10416; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nikopoulos K, 2010, HUM MUTAT, V31, P656, DOI 10.1002/humu.21250; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI DOI 10.1016/J.0PHTHA.2013.05.025; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654; Tokunaga CC, 2013, INVEST OPHTH VIS SCI, V54, P222, DOI 10.1167/iovs.12-10127; TOOMES C, 2004, MUTATIONS LRP5 FZD4, V74, P721; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1; Xia C, 2010, LRP5 IS REQUIRED VAS, V5, DOI [10.1371/journal.pone.0011676, DOI 10.1371/JOURNAL.PONE.0011676]; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	42	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152833	10.1371/journal.pone.0152833	http://dx.doi.org/10.1371/journal.pone.0152833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031698	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800148
J	Plewan, T; Wascher, E; Falkenstein, M; Hoffmann, S				Plewan, Thorsten; Wascher, Edmund; Falkenstein, Michael; Hoffmann, Sven			Classifying Response Correctness across Different Task Sets: A Machine Learning Approach	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; BRAIN ACTIVITY; FUNCTIONAL-SIGNIFICANCE; PREFRONTAL CORTEX; COGNITIVE CONTROL; ERROR NEGATIVITY; ERP COMPONENTS; PERFORMANCE; POTENTIALS; ATTENTION	Erroneous behavior usually elicits a distinct pattern in neural waveforms. In particular, inspection of the concurrent recorded electroencephalograms (EEG) typically reveals a negative potential at fronto-central electrodes shortly following a response error (Ne or ERN) as well as an error-awareness-related positivity (Pe). Seemingly, the brain signal contains information about the occurrence of an error. Assuming a general error evaluation system, the question arises whether this information can be utilized in order to classify behavioral performance within or even across different cognitive tasks. In the present study, a machine learning approach was employed to investigate the outlined issue. Ne as well as Pe were extracted from the single-trial EEG signals of participants conducting a flanker and a mental rotation task and subjected to a machine learning classification scheme (via a support vector machine, SVM). Overall, individual performance in the flanker task was classified more accurately, with accuracy rates of above 85%. Most importantly, it was even feasible to classify responses across both tasks. In particular, an SVM trained on the flanker task could identify erroneous behavior with almost 70% accuracy in the EEG data recorded during the rotation task, and vice versa. Summed up, we replicate that the response-related EEG signal can be used to identify erroneous behavior within a particular task. Going beyond this, it was possible to classify response types across functionally different tasks. Therefore, the outlined methodological approach appears promising with respect to future applications.	[Plewan, Thorsten; Wascher, Edmund; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Dept Ergon, Dortmund, Germany; [Hoffmann, Sven] German Sport Univ Cologne, Inst Psychol, Dept Performance Psychol, Cologne, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); German Sport University Cologne	Plewan, T (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dept Ergon, Dortmund, Germany.; Hoffmann, S (corresponding author), German Sport Univ Cologne, Inst Psychol, Dept Performance Psychol, Cologne, Germany.	plewan@ifado.de; s.hoffmann@dshs-koeln.de	Wascher, Edmund/B-8457-2019; Plewan, Thorsten/Y-2564-2019; Wascher, Edmund/N-6848-2019; Falkenstein, Michael/ABA-7497-2020	Wascher, Edmund/0000-0003-3616-9767; Plewan, Thorsten/0000-0001-5510-1181; Hoffmann, Sven/0000-0002-4521-8332				Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Bode S, 2013, NEUROIMAGE, V65, P456, DOI 10.1016/j.neuroimage.2012.09.064; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christ S, 2000, BIOL PSYCHOL, V51, P129, DOI 10.1016/S0301-0511(99)00034-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eichele H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00065; Endrass T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00178; Endrass T, 2012, PSYCHOPHYSIOLOGY, V49, P733, DOI 10.1111/j.1469-8986.2012.01365.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 1995, EEG CL N SU, P261; Golland P, 2005, LECT NOTES COMPUT SC, V3559, P501, DOI 10.1007/11503415_34; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hoffmann S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00050; Hoffmann S, 2014, BRAIN STRUCT FUNCT, V219, P595, DOI 10.1007/s00429-013-0521-y; Hoffmann S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00171; Hoffmann S, 2012, INT J PSYCHOPHYSIOL, V83, P208, DOI 10.1016/j.ijpsycho.2011.11.015; Hoffmann S, 2012, NEUROSCI LETT, V506, P225, DOI 10.1016/j.neulet.2011.11.011; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1996, ADV NEUR IN, V8, P145; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Masaki H, 2001, NEUROREPORT, V12, P1851, DOI 10.1097/00001756-200107030-00018; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2009, J NEUROSCI, V29, P8604, DOI 10.1523/JNEUROSCI.5967-08.2009; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Palmer JA, 2007, LECT NOTES COMPUT SC, V4666, P97; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00097; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Ullsperger M, 2004, NAT NEUROSCI, V7, P1173, DOI 10.1038/nn1104-1173; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Ventouras EM, 2011, COMPUT BIOL MED, V41, P98, DOI 10.1016/j.compbiomed.2010.12.004; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wascher E, 1999, J COGNITIVE NEUROSCI, V11, P214, DOI 10.1162/089892999563346; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x	61	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152864	10.1371/journal.pone.0152864	http://dx.doi.org/10.1371/journal.pone.0152864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27032108	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800151
J	Riccadonna, S; Jurman, G; Visintainer, R; Filosi, M; Furlanello, C				Riccadonna, Samantha; Jurman, Giuseppe; Visintainer, Roberto; Filosi, Michele; Furlanello, Cesare			DTW-MIC Coexpression Networks from Time-Course Data	PLOS ONE			English	Article							MAXIMAL INFORMATION COEFFICIENT; GENE REGULATORY NETWORKS; MUTUAL INFORMATION; SERIES DATA; INFERENCE; EXPRESSION; ALGORITHM; RECONSTRUCTION; DREAM; CLASSIFICATION	When modeling coexpression networks from high-throughput time course data, Pearson Correlation Coefficient (PCC) is one of the most effective and popular similarity functions. However, its reliability is limited since it cannot capture non-linear interactions and time shifts. Here we propose to overcome these two issues by employing a novel similarity function, Dynamic Time Warping Maximal Information Coefficient (DTW-MIC), combining a measure taking care of functional interactions of signals (MIC) and a measure identifying time lag (DTW). By using the Hamming-Ipsen-Mikhailov (HIM) metric to quantify network differences, the effectiveness of the DTW-MIC approach is demonstrated on a set of four synthetic and one transcriptomic datasets, also in comparison to TimeDelay ARACNE and Transfer Entropy.	[Riccadonna, Samantha] Fdn Bruno Kessler, Trento, Italy; [Jurman, Giuseppe; Visintainer, Roberto; Filosi, Michele; Furlanello, Cesare] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy	Fondazione Bruno Kessler; Fondazione Edmund Mach	Jurman, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	jurman@fbk.eu	Riccadonna, Samantha/H-7247-2019; Jurman, Giuseppe/GRS-8221-2022	Riccadonna, Samantha/0000-0002-9737-8274; Visintainer, Roberto/0000-0003-1289-6871; Filosi, Michele/0000-0002-3872-347X; Jurman, Giuseppe/0000-0002-2705-5728				Aach J, 2001, BIOINFORMATICS, V17, P495, DOI 10.1093/bioinformatics/17.6.495; Akhand MAH, 2015, INT J BIOSCI BIOCHEM, V5, P296; Akhand MAH, 2015, P INT C EL ENG INF C, P1; Albanese D, 2013, BIOINFORMATICS, V29, P407, DOI 10.1093/bioinformatics/bts707; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; [Anonymous], 2014, R LANG ENV STAT COMP; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baralla A, 2009, ANN NY ACAD SCI, V1158, P246, DOI 10.1111/j.1749-6632.2008.04099.x; Batista GEAPA, 2014, DATA MIN KNOWL DISC, V28, P634, DOI 10.1007/s10618-013-0312-3; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Buza K, 2011, LECT NOTES ARTIF INT, V6679, P253, DOI 10.1007/978-3-642-21222-2_31; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chu S, 2002, SIAM PROC S, P195; Clark M., 2013, COMP CORRELATION MEA; Comte J, 2016, BIOGEOSCIENCES, V13, P175, DOI 10.5194/bg-13-175-2016; Das J, 2012, BIOINFORMATICS, V28, P1873, DOI 10.1093/bioinformatics/bts283; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Dempsey K, 2011, P 44 HAW INT C SYST, P1; Ding AA, 2015, COPULA CORRELATION A; Ding H, 2008, PROC VLDB ENDOW, V1, P1542; Dougherty ER, 2011, BRIEF BIOINFORM, V12, P245, DOI 10.1093/bib/bbq078; Eiler A, 2014, ENVIRON MICROBIOL, V16, P2682, DOI 10.1111/1462-2920.12301; ElBakry Ola, 2010, 2010 8th IEEE International NEWCAS Conference (NEWCAS 2010), P141, DOI 10.1109/NEWCAS.2010.5603729; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Erdem O, 2014, PHYSICA A, V414, P274, DOI 10.1016/j.physa.2014.07.054; Esling P, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379788; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Filosi M, 2014, RENETTE A WEB SERVIC; Filosi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089815; Fu TC, 2011, ENG APPL ARTIF INTEL, V24, P164, DOI 10.1016/j.engappai.2010.09.007; Furlanello C, 2006, IEEE T SIGNAL PROCES, V54, P2436, DOI 10.1109/TSP.2006.873715; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Gobbi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128115; Gorfine M, 2011, SCIENCE; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Gusfield D., 1997, ALGORITHMS STRINGS T; Hill SM, 2016, NAT METH; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Hsu CL, 2015, NAT SCI REP, V5; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Jain N, 2015, NEW ESTIMATE MUTUAL; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jeong YS, 2011, PATTERN RECOGN, V44, P2231, DOI 10.1016/j.patcog.2010.09.022; Jurman G., 2015, IEEE INT C DAT SCI A, P1, DOI [10.1109/DSAA.2015.7344816, DOI 10.1109/DSAA.2015.7344816]; Jurman G, 2011, FRONT ARTIF INTEL AP, V226, P227, DOI 10.3233/978-1-60750-692-8-227; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Keogh E. J., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P285, DOI 10.1145/347090.347153; Keogh E. J., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P239; Keogh EamonnJ., 2001, 1 SIAM INT C DATA MI, DOI [10.1137/1.9781611972719.1, DOI 10.1137/1.9781611972719.1]; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; Kinney JB, 2014, P NATL ACAD SCI USA, V111, pE3364, DOI 10.1073/pnas.1410317111; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050411; Kurt Z, 2014, BIOINFORMATICS, V30, P2142, DOI 10.1093/bioinformatics/btu182; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lavi O, 2012, J COMPUT BIOL, V19, P694, DOI 10.1089/cmb.2012.0065; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li HL, 2014, INT J ROTATING MACH, V2014, DOI 10.1155/2014/209084; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/856325; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; Lim N, 2013, BIOINFORMATICS, V29, P1416, DOI 10.1093/bioinformatics/btt167; Liseron-Monfils C, 2015, CURR PLANT BIOL, V3-4, P30, DOI 10.1016/j.cpb.2015.11.001; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS, V12, P457, DOI 10.1093/bfgp/elt003; Luedtke A, 2013, THE GENERALIZED MEAN; Ma C, 2014, PLANT CELL, V26, P520, DOI 10.1105/tpc.113.121913; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mendoza MR, 2013, P AAAI 2013, P1678; Mendoza MR., 2014, EXPLORING ENSEMBLE L; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Nguyen H. V., 2014, ICML, P775; Oates CJ, 2012, ANN APPL STAT, V6, P1209, DOI 10.1214/11-AOAS532; Omony J, 2014, ANN RES REV BIOL, V4, P577, DOI DOI 10.9734/ARRB/2014/5718; Opgen-Rhein R., 2006, REVSTAT-STAT J, V4, P53; Opgen-Rhein R., 2006, P 4 INT WORKSH COMP, P73; Pernice V, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00072; Petereit J, 2015, IEEE INT C BIOINFORM, P234, DOI 10.1109/BIBM.2015.7359686; Petitjean F, 2014, IEEE DATA MINING, P470, DOI 10.1109/ICDM.2014.27; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; Posnett D., 2012, 2012 9th IEEE Working Conference on Mining Software Repositories (MSR 2012), P22, DOI 10.1109/MSR.2012.6224295; PRICE DJD, 1965, SCIENCE, V149, P510; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rakthanmanon T, 2013, ACM T KNOWL DISCOV D, V7, DOI 10.1145/2500489; Rakthanmanon Thanawin, 2012, KDD, V2012, P262, DOI 10.1145/2339530.2339576; Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rau Christoph D., 2013, Frontiers in Genetics, V4, P28, DOI 10.3389/fgene.2013.00028; Reshef DN, 2014, P NATL ACAD SCI USA, V111, pE3362, DOI 10.1073/pnas.1408920111; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Reshef DN, 2015, AN EMPIRICAL STUDY O; Reshef YA, 2015, MEASURING DEPENDENCE; Ristevski B, 2013, NONLINEAR ANAL-MODEL, V18, P444, DOI 10.15388/NA.18.4.13972; Rodriguez-Ramos T, 2015, GLOBAL ECOL BIOGEOGR, V24, P527, DOI 10.1111/geb.12274; Rotival M, 2014, BRIEF FUNCT GENOMICS, V13, P66, DOI 10.1093/bfgp/elt030; Roy S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S10; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Salvador S., 2004, KDD WORKSH MIN TEMP, P70; Santos SD, 2014, BRIEF BIOINFORM, V15, P906, DOI 10.1093/bib/bbt051; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shaffter T, 2012, GENENETWEAVER USER M; Siegenthaler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090481; Simon N., 2014, SCIENCE         1216; Simon N, 2012, NAT BIOTECHNOL, V30, P334, DOI 10.1038/nbt.2182; Slawek J., 2014, INFERRING GENE REGUL; Song L., 2013, NOVEL MACHINE LEAMIN; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Song WM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004574; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tan Q, 2015, J DATA MINING GENOMI, V7, P183; Tian Y, 2011, P 2 ACM C BIOINF COM, P254, DOI [DOI 10.1145/2147805.2147833, 10.1145/2147805.2147833]; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Tun K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-24; Ud-Dean SMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103812; Vargha A, 2013, QUAL QUANT, V47, P3391, DOI 10.1007/s11135-012-9727-y; Verleyen W, 2015, BIOINFORMATICS, V31, P745, DOI 10.1093/bioinformatics/btu715; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Wang SL, 2015, INT J DATA MIN BIOIN, V13, P158, DOI 10.1504/IJDMB.2015.071548; Wang XY, 2013, DATA MIN KNOWL DISC, V26, P275, DOI 10.1007/s10618-012-0250-5; Wang YXR, 2014, J THEOR BIOL, V362, P53, DOI 10.1016/j.jtbi.2014.03.040; Wang Y, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0473-8; Yule GU, 1926, J R STAT SOC, V89, P1, DOI 10.2307/2341482; Zhang B, 2014, CIRC-CARDIOVASC GENE, V7, P536, DOI 10.1161/CIRCGENETICS.113.000123; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042; Zhang YH, 2013, NEUROCOMPUTING, V117, P186, DOI 10.1016/j.neucom.2013.02.015; Zhang ZQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825136; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	143	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152648	10.1371/journal.pone.0152648	http://dx.doi.org/10.1371/journal.pone.0152648			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031641	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800107
J	Roth, A; Glaesener, S; Schutz, K; Meyer-Bahlburg, A				Roth, Alena; Glaesener, Stephanie; Schuetz, Katharina; Meyer-Bahlburg, Almut			Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax (R) 23	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; MARGINAL-ZONE; PERIPHERAL-BLOOD; ANTIBODY-RESPONSE; PNEUMOCOCCAL POLYSACCHARIDES; CAPSULAR POLYSACCHARIDES; IMMUNOGLOBULIN-A; REGION GENES; IGM; DISEASE	Protective immunity against T cell independent (TI) antigens such as Streptococcus pneumoniae is characterized by antibody production of B cells induced by the combined activation of T cell independent type 1 and type 2 antigens in the absence of direct T cell help. In mice, the main players in TI immune responses have been well defined as marginal zone (MZ) B cells and B-1 cells. However, the existence of human equivalents to these B cell subsets and the nature of the human B cell compartment involved in the immune reaction remain elusive. We therefore analyzed the effect of a TI antigen on the B cell compartment through immunization of healthy individuals with the pneumococcal polysaccharide (PnPS)-based vaccine Pneumovax (R) 23, and subsequent characterization of B cell subpopulations. Our data demonstrates a transient decrease of transitional and naive B cells, with a concomitant increase of IgA(+) but not IgM(+) or IgG(+) memory B cells and a predominant generation of PnPS-specific IgA(+) producing plasma cells. No alterations could be detected in T cells, or proposed human B-1 and MZ B cell equivalents. Consistent with the idea of a TI immune response, anti-genspecific memory responses could not be observed. Finally, BAFF, which is supposed to drive class switching to IgA, was unexpectedly found to be decreased in serum in response to Pneumovax (R) 23. Our results demonstrate that a characteristic TI response induced by Pneumovax (R) 23 is associated with distinct phenotypical and functional changes within the B cell compartment. Those modulations occur in the absence of any modulations of T cells and without the development of a specific memory response.	[Roth, Alena; Glaesener, Stephanie; Schuetz, Katharina; Meyer-Bahlburg, Almut] Hannover Med Sch, Pediat Pneumol Allergy & Neonatol, Hannover, Germany	Hannover Medical School	Meyer-Bahlburg, A (corresponding author), Hannover Med Sch, Pediat Pneumol Allergy & Neonatol, Hannover, Germany.	Meyer-Bahlburg.Almut@mh-hannover.de			German Research Foundation (DFG) [ME2709/2-3]; German Center for lung research (DZL); German Center for Infection Research (DZIF, project AA2.1)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for lung research (DZL); German Center for Infection Research (DZIF, project AA2.1)	This work was supported by the German Research Foundation (DFG ME2709/2-3) and the German Center for lung research (DZL, project AA2.1) to AMB and a student stipend to AR by the German Center for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Calzas C, 2015, INFECT IMMUN, V83, P441, DOI 10.1128/IAI.02427-14; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cavaliere FM, 2013, J CLIN IMMUNOL, V33, P838, DOI 10.1007/s10875-012-9856-z; Chovancova Z, 2011, VACCINE, V29, P4142, DOI 10.1016/j.vaccine.2011.03.087; Covens K, 2013, BLOOD, V122, P3693, DOI 10.1182/blood-2013-09-528091; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; De Vos J, 2006, IMMUNOL REV, V210, P86, DOI 10.1111/j.0105-2896.2006.00362.x; Descatoire M, 2011, J EXP MED, V208, P2563, DOI 10.1084/jem.20112232; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hong R, 2010, J CLIN IMMUNOL, V30, P435, DOI 10.1007/s10875-010-9371-z; Iwajomo OH, 2015, J INFECTION, V70, P616, DOI 10.1016/j.jinf.2014.10.011; Johnson S, 1996, INFECT IMMUN, V64, P4339, DOI 10.1128/IAI.64.10.4339-4344.1996; Jolles S, 2013, J ALLER CL IMM-PRACT, V1, P545, DOI 10.1016/j.jaip.2013.09.015; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Khaskhely N, 2012, J IMMUNOL, V188, P2455, DOI 10.4049/jimmunol.1102809; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Leggat DJ, 2013, J INFECT DIS, V208, P101, DOI 10.1093/infdis/jit139; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LUE C, 1988, J IMMUNOL, V140, P3793; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Melegaro A, 2006, J INFECTION, V52, P37, DOI 10.1016/j.jinf.2005.02.008; Moens L, 2008, J IMMUNOL, V181, P5306, DOI 10.4049/jimmunol.181.8.5306; Moens L, 2015, INFECT IMMUN, V83, P2889, DOI 10.1128/IAI.00068-15; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Neumann B, 2015, J LEUKOCYTE BIOL, V97, P19, DOI 10.1189/jlb.1HI0514-243R; Perez-Andres M, 2011, J EXP MED, V208, P2565, DOI 10.1084/jem.20112203; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Quach TD, 2016, J IMMUNOL, V196, P1060, DOI 10.4049/jimmunol.1501843; Quinti I, 2011, J CLIN IMMUNOL, V31, P315, DOI 10.1007/s10875-011-9511-0; Rothstein TL, 2015, ANN NY ACAD SCI, V1362, P143, DOI 10.1111/nyas.12790; Roy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082121; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schutz K, 2013, J CLIN IMMUNOL, V33, P288, DOI 10.1007/s10875-012-9792-y; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; TARKOWSKI A, 1990, J IMMUNOL, V144, P3770; Tierens A, 1999, BLOOD, V93, P226, DOI 10.1182/blood.V93.1.226.401a30_226_234; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Verbinnen B, 2012, J ALLERGY CLIN IMMUN, V130, P272, DOI 10.1016/j.jaci.2012.04.040; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152215	10.1371/journal.pone.0152215	http://dx.doi.org/10.1371/journal.pone.0152215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031098	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800043
J	Strandberg, AY; Hoti, FJ; Strandberg, TE; Christopher, S; Haukka, J; Korhonen, P				Strandberg, Arto Y.; Hoti, Fabian J.; Strandberg, Timo E.; Christopher, Solomon; Haukka, Jari; Korhonen, Pasi			All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine	PLOS ONE			English	Article							ACTING INSULIN; CARDIOVASCULAR EVENTS; PROPENSITY SCORE; GLYCEMIC CONTROL; CANCER-RISK; HYPOGLYCEMIA; INTERMEDIATE; ASSOCIATION; OUTCOMES; ANALOGS	Background Insulin therapy in type 2 diabetes may increase mortality and cancer incidence, but the impact of different types of basal insulins on these endpoints is unclear. Compared to the traditional NPH insulin, the newer, longer-acting insulin analogues detemir and glargine have shown benefits in randomized controlled trials. Whether these advantages translate into lower mortality among users in real life is unknown. Objective To estimate the differences in all-cause and cause-specific mortality rates between new users of basal insulins in a population-based study in Finland. Methods 23 751 individuals aged >= 40 with type 2 diabetes, who initiated basal insulin therapy in 2006-2009 were identified from national registers, with comprehensive data for mortality, causes of death, and background variables. Propensity score matching was performed on characteristics. Follow-up time was up to 4 years (median 1.7 years). Results 2078 deaths incurred. With NPH as reference, the adjusted HRs for all-cause mortality were 0.39 (95% CI, 0.30-0.50) for detemir, and 0.55 (95% CI, 0.44-0.69) for glargine. As compared to glargine, the HR was 0.71 (95% CI, 0.54-0.93) among detemir users. Compared to NPH, the mortality risk for both cardiovascular causes as well as cancer were also significantly lower for glargine, and especially for detemir in adjusted analysis. Furthermore, the results were robust in various sensitivity analyses. Conclusion In real clinical practice, mortality was substantially higher among users of NPH insulin as compared to insulins detemir or glargine. Considering the large number of patients who require insulin therapy, this difference in risk may have major clinical and public health implications. Due to limitations of the observational study design, further investigation using an interventional study design is warranted.	[Strandberg, Arto Y.; Strandberg, Timo E.] Univ Helsinki, Clinicum, Helsinki, Finland; [Strandberg, Arto Y.] Aava Med Ctr, Kerava, Finland; [Hoti, Fabian J.; Christopher, Solomon; Haukka, Jari; Korhonen, Pasi] EPID Res, Espoo, Finland; [Strandberg, Timo E.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Strandberg, Timo E.] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu	Strandberg, AY (corresponding author), Univ Helsinki, Clinicum, Helsinki, Finland.; Strandberg, AY (corresponding author), Aava Med Ctr, Kerava, Finland.	arto.strandberg@aava.fi	Haukka, Jari/G-1484-2014	Haukka, Jari/0000-0003-1450-6208; Hoti, Fabian/0000-0002-7464-3549; strandberg, timo/0000-0001-6299-925X	Novo Nordisk Pharma; Gustaf V; Queen Victoria Frimurarestiftelse; EPID Research	Novo Nordisk Pharma(Novo Nordisk); Gustaf V; Queen Victoria Frimurarestiftelse; EPID Research	Retrieval of national register data by EPID Research was financially supported by Novo Nordisk Pharma. AYS's research is supported by the Gustaf V and Queen Victoria Frimurarestiftelse. FH, SC, JH and PK are employed by EPID Research and received funding in the form of salaries. The specific roles of these authors are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; Colmers IN, 2012, DIABETES METAB, V38, P485, DOI 10.1016/j.diabet.2012.08.011; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Dejgaard A, 2009, DIABETOLOGIA, V52, P2507, DOI 10.1007/s00125-009-1568-4; Fagot JP, 2013, DIABETES CARE, V36, P294, DOI 10.2337/dc12-0506; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Goldman-Levine JD, 2005, ANN PHARMACOTHER, V39, P502, DOI 10.1345/aph.1E334; Gordon J, 2010, INT J CLIN PRACT, V64, P1609, DOI 10.1111/j.1742-1241.2010.02520.x; Haukka J, 2013, PHARMACOEPIDEM DR S, V22, P1326, DOI 10.1002/pds.3534; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Karlstad O, 2013, CURR DRUG SAF, V8, P333, DOI 10.2174/15680266113136660067; Khunti K, 2015, DIABETES CARE, V38, P316, DOI 10.2337/dc14-0920; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Luo J, 2015, JAMA INTERN MED, V175, P1681, DOI 10.1001/jamainternmed.2015.4338; Meneghini LF, 2007, DIABETES OBES METAB, V9, P418, DOI 10.1111/j.1463-1326.2006.00674.x; Mikkola TS, 2015, MENOPAUSE, V22, P976, DOI 10.1097/GME.0000000000000450; Monami M, 2008, DIABETES RES CLIN PR, V81, P184, DOI 10.1016/j.diabres.2008.04.007; National institute for Health and Clinical Excellence (NICE), TYP 2 DIAB NEW AG; Price HI, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006341; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rossetti Paolo, 2008, Archives of Physiology and Biochemistry, V114, P3, DOI [10.1080/13813450801900777, 10.1080/13813450801900777 ]; Roumie CL, 2014, JAMA-J AM MED ASSOC, V311, P2288, DOI 10.1001/jama.2014.4312; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Tricco AC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5459; Tylee T, 2015, JAMA-J AM MED ASSOC, V314, P665, DOI 10.1001/jama.2015.7032; Yang XL, 2012, WORLD J DIABETES, V3, P60, DOI 10.4239/wjd.v3.i4.60; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	35	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151910	10.1371/journal.pone.0151910	http://dx.doi.org/10.1371/journal.pone.0151910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031113	gold, Green Published			2022-12-27	WOS:000373121800023
J	Castro-Gomes, T; Corrotte, M; Tam, C; Andrews, NW				Castro-Gomes, Thiago; Corrotte, Matthias; Tam, Christina; Andrews, Norma W.			Plasma Membrane Repair Is Regulated Extracellularly by Proteases Released from Lysosomes	PLOS ONE			English	Article							HUMAN ACID SPHINGOMYELINASE; ACTIVITY-BASED PROBES; CATHEPSIN-D; MUSCULAR-DYSTROPHY; CYSTEINE CATHEPSINS; EXOCYTOSIS; DYSFERLIN; CELLS; ENDOCYTOSIS; PROTEINS	Eukaryotic cells rapidly repair wounds on their plasma membrane. Resealing is Ca(2+-)dependent, and involves exocytosis of lysosomes followed by massive endocytosis. Extracellular activity of the lysosomal enzyme acid sphingomyelinase was previously shown to promote endocytosis and wound removal. However, whether lysosomal proteases released during cell injury participate in resealing is unknown. Here we show that lysosomal proteases regulate plasma membrane repair. Extracellular proteolysis is detected shortly after cell wounding, and inhibition of this process blocks repair. Conversely, surface protein degradation facilitates plasma membrane resealing. The abundant lysosomal cysteine proteases cathepsin B and L, known to proteolytically remodel the extracellular matrix, are rapidly released upon cell injury and are required for efficient plasma membrane repair. In contrast, inhibition of aspartyl proteases or RNAi-mediated silencing of the lysosomal aspartyl protease cathepsin D enhances resealing, an effect associated with the accumulation of active acid sphingomyelinase on the cell surface. Thus, secreted lysosomal cysteine proteases may promote repair by facilitating membrane access of lysosomal acid sphingomyelinase, which promotes wound removal and is subsequently downregulated extracellularly by a process involving cathepsin D.	[Castro-Gomes, Thiago; Corrotte, Matthias; Tam, Christina; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Tam, Christina] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	andrewsn@umd.edu		Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [GM064625]; Conselho Nacional de Pesquisas, Brazil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Pesquisas, Brazil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by at the National Institutes of Health grant GM064625 and a fellowship from the Conselho Nacional de Pesquisas, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Atanassoff AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089743; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brocklehurst K, 2013, CELL TISSUE RES, V351, P237, DOI 10.1007/s00441-013-1557-2; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Defour A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.272; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Draeger A, 2014, BIOCHIMIE, V107, P66, DOI 10.1016/j.biochi.2014.08.008; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Fernandes MC, 2011, J EXP MED, V208, P909, DOI 10.1084/jem.20102518; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2000, ADV EXP MED BIOL, V477, P305; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Lek A, 2013, J NEUROSCI, V33, P5085, DOI 10.1523/JNEUROSCI.3560-12.2013; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; POLGAR L, 1987, J BIOL CHEM, V262, P14448; Potez S, 2011, J BIOL CHEM, V286, P17982, DOI 10.1074/jbc.M110.187625; Qiu HW, 2003, J BIOL CHEM, V278, P32744, DOI 10.1074/jbc.M303022200; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Redpath GMI, 2014, MOL BIOL CELL, V25, P3037, DOI 10.1091/mbc.E14-04-0947; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Roy D, 2004, SCIENCE, V304, P1515, DOI 10.1126/science.1098371; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schuchman EH, 2009, INT J CLIN PHARM TH, V47, pS48; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Swaggart KA, 2014, P NATL ACAD SCI USA, V111, P6004, DOI 10.1073/pnas.1324242111; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Tam C, 2013, JOVE-J VIS EXP, DOI 10.3791/50531; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TURK B, 1994, BIOCHEMISTRY-US, V33, P14800, DOI 10.1021/bi00253a019; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; XIE XY, 1991, J NEUROSCI, V11, P3257; Xu M, 2012, MOL BIOL CELL, V23, P1546, DOI 10.1091/mbc.E11-09-0821; Zebrakovska I, 2011, BBA-MOL CELL BIOL L, V1811, P1097, DOI 10.1016/j.bbalip.2011.09.005; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	70	49	50	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152583	10.1371/journal.pone.0152583	http://dx.doi.org/10.1371/journal.pone.0152583			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028538	gold, Green Published			2022-12-27	WOS:000373116500053
J	Hasne, MP; Soysa, R; Ullman, B				Hasne, Marie-Pierre; Soysa, Radika; Ullman, Buddy			The Trypanosoma cruzi Diamine Transporter Is Essential for Robust Infection of Mammalian Cells	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; CHAGAS-DISEASE; ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; BRUCEI-BRUCEI; TRYPANOTHIONE; GENE; PUTRESCINE; SPERMIDINE; DIFLUOROMETHYLORNITHINE	Trypanosoma cruzi is incapable of synthesizing putrescine or cadaverine de novo, and, therefore, salvage of polyamines from the host milieu is an obligatory nutritional function for the parasite. A high-affinity diamine transporter (TcPOT1) from T. cruzi has been identified previously that recognizes both putrescine and cadaverine as ligands. In order to assess the functional role of TcPOT1 in intact parasites, a Delta tcpot1 null mutant was constructed by targeted gene replacement and characterized. The Delta tcpot1 mutant lacked high-affinity putrescine-cadaverine transport capability but retained the capacity to transport diamines via a non-saturable, low-affinity mechanism. Transport of spermidine and arginine was not impacted by the Delta tcpot1 lesion. The Delta tcpot1 cell line exhibited a significant but not total defect in its ability to subsist in Vero cells, although initial infection rates were not affected by the lesion. These findings reveal that TcPOT1 is the sole high-affinity diamine permease in T. cruzi, that genetic obliteration of TcPOT1 impairs the ability of the parasite to maintain a robust infection in mammalian cells, and that a secondary low-affinity uptake mechanism for this key parasite nutrient is operative but insufficient for optimal infection.	[Hasne, Marie-Pierre; Soysa, Radika; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Soysa, Radika] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Hasne, MP (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	hasnem@ohsu.edu			National Institute of Allergy and Infectious Disease [AI041622]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041622, R01AI041622] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease, Grant AI041622 (https://www.niaid.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algranati ID, 2010, AMINO ACIDS, V38, P645, DOI 10.1007/s00726-009-0425-6; Apt W, 2010, DRUG DES DEV THER, V4, P243, DOI 10.2147/DDDT.S8338; Ariyanayagam MR, 1997, MOL BIOCHEM PARASIT, V84, P111, DOI 10.1016/S0166-6851(96)02788-0; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; Bacchi CJ, 2009, ANTIMICROB AGENTS CH, V53, P3269, DOI 10.1128/AAC.00076-09; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; BYERS TL, 1991, BIOCHEM J, V274, P527, DOI 10.1042/bj2740527; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; Carrillo C, 2006, BIOCHEM BIOPH RES CO, V344, P936, DOI 10.1016/j.bbrc.2006.03.215; CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x; DANZIN C, 1990, BIOCHEM PHARMACOL, V40, P1499, DOI 10.1016/0006-2952(90)90446-R; Camara MD, 2013, FOLIA PARASIT, V60, P406, DOI 10.14411/fp.2013.042; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; EBONG S, 1993, COMP BIOCHEM PHYS C, V106, P483, DOI 10.1016/0742-8413(93)90167-J; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Hirth B, 2009, BIOORG MED CHEM LETT, V19, P2916, DOI 10.1016/j.bmcl.2009.04.096; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; HUNTER KJ, 1994, EUR J BIOCHEM, V226, P1019, DOI 10.1111/j.1432-1033.1994.t01-1-01019.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; KELLY JM, 1995, PARASITOL TODAY, V11, P447, DOI 10.1016/0169-4758(95)80057-3; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; LeQuesne SA, 1996, BIOCHEM J, V316, P481; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; MARTON LJ, 1973, CLIN CHEM, V19, P923; NOGUEIRA N, 1975, J EXP MED, V142, P224, DOI 10.1084/jem.142.1.224; Pegg A E, 1980, Adv Enzyme Regul, V19, P427; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; PEGG AE, 1987, BIOCHEM J, V241, P305, DOI 10.1042/bj2410305; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Persson K, 1998, BIOCHEM J, V333, P527, DOI 10.1042/bj3330527; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TEIXEIRA ARL, 1989, AM J TROP MED HYG, V40, P165, DOI 10.4269/ajtmh.1989.40.165; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152715	10.1371/journal.pone.0152715	http://dx.doi.org/10.1371/journal.pone.0152715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050410	Green Published, gold			2022-12-27	WOS:000373603500050
J	Ihlow, F; Vamberger, M; Flecks, M; Hartmann, T; Cota, M; Makchai, S; Meewattana, P; Dawson, JE; Kheng, L; Rodder, D; Fritz, U				Ihlow, Flora; Vamberger, Melita; Flecks, Morris; Hartmann, Timo; Cota, Michael; Makchai, Sunchai; Meewattana, Pratheep; Dawson, Jeffrey E.; Kheng, Long; Roedder, Dennis; Fritz, Uwe			Integrative Taxonomy of Southeast Asian Snail-Eating Turtles (Geoemydidae: Malayemys) Reveals a New Species and Mitochondrial Introgression	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; HERMANNS TORTOISE; TESTUDO-HERMANNI; SEA LEVELS; RIVER; PHYLOGEOGRAPHY; GENETICS	Based on an integrative taxonomic approach, we examine the differentiation of Southeast Asian snail-eating turtles using information from 1863 bp of mitochondrial DNA, 12 microsatellite loci, morphology and a correlative species distribution model. Our analyses reveal three genetically distinct groups with limited mitochondrial introgression in one group. All three groups exhibit distinct nuclear gene pools and distinct morphology. Two of these groups correspond to the previously recognized species Malayemys macrocephala (Chao Phraya Basin) and M. subtrijuga (Lower Mekong Basin). The third and genetically most divergent group from the Khorat Basin represents a previously unrecognized species, which is described herein. Although Malayemys are extensively traded and used for religious release, only few studied turtles appear to be translocated by humans. Historic fluctuations in potential distributions were assessed using species distribution models (SDMs). The Last Glacial Maximum (LGM) projection of the predictive SDMs suggests two distinct glacial distribution ranges, implying that the divergence of M. macrocephala and M. subtrijuga occurred in allopatry and was triggered by Pleistocene climate fluctuations. Only the projection derived from the global circulation model MIROC reveals a distinct third glacial distribution range for the newly discovered Malayemys species.	[Ihlow, Flora; Flecks, Morris; Hartmann, Timo; Roedder, Dennis] Zool Forschungsmuseum Alexander Koenig, Herpetol Sect, Bonn, Germany; [Vamberger, Melita; Fritz, Uwe] Senckenberg Dresden, Museum Zool, Dresden, Germany; [Cota, Michael; Makchai, Sunchai] Thailand Nat Hist Museum, Natl Sci Museum, Khlong Luang, Pathum Thani, Thailand; [Cota, Michael; Meewattana, Pratheep] Phranakhon Rajabhat Univ, Bangkok, Thailand; [Dawson, Jeffrey E.] St Louis Zoo, Charles H Hoessle Herpetarium, St Louis, MO USA; [Kheng, Long] Minist Environm, Gen Dept Adm Nat Conservat & Protect, Chamkar Mon, Phnom Penh, Cambodia	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Senckenberg Gesellschaft fur Naturforschung (SGN); Phranakhon Rajabhat University	Ihlow, F (corresponding author), Zool Forschungsmuseum Alexander Koenig, Herpetol Sect, Bonn, Germany.	F.Ihlow@ZFMK.de	Fritz, Uwe/AAC-4029-2019; Rödder, Dennis/AAT-8644-2021	Fritz, Uwe/0000-0002-6740-7214; Rödder, Dennis/0000-0002-6108-1639; Vamberger, Melita/0000-0002-1404-2469; Ihlow, Flora/0000-0002-0460-4210	Alexander Koenig Gesellschaft; British Chelonia Group; German Academic Exchange Service; Schildkroten-Interessengemeinschaft Schweiz; International Turtle Association	Alexander Koenig Gesellschaft; British Chelonia Group; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Schildkroten-Interessengemeinschaft Schweiz; International Turtle Association	FI's research was partly funded by the Alexander Koenig Gesellschaft (https://www.zfmk.de/de/akg), the British Chelonia Group (http://www.britishcheloniagroup.org.uk/), the German Academic Exchange Service (https://www.daad.de/en/), the Schildkroten-Interessengemeinschaft Schweiz (http://www.sigs.ch/), and the International Turtle Association (http://www.isv.or.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adamson EAS, 2009, J FISH BIOL, V75, P1371, DOI 10.1111/j.1095-8649.2009.02369.x; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barth D, 2004, ZOOL SCR, V33, P213, DOI 10.1111/j.0300-3256.2004.00150.x; Blonder B, 2014, HYPERVOLUME HIGH DIM; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Brophy Timothy R., 2004, Hamadryad, V29, P63; Brophy Timothy R., 2005, Bulletin of the Chicago Herpetological Society, V40, P21; Brophy TR, 2002, THESIS G MASON U; Ceballos CP, 2013, EVOL BIOL, V40, P194, DOI 10.1007/s11692-012-9199-y; Ciofi C, 2009, MOL ECOL RESOUR, V9, P189, DOI 10.1111/j.1755-0998.2008.02205.x; Claude J, 2011, ANN PALEONTOL, V97, P113, DOI 10.1016/j.annpal.2011.08.002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne J.A., 2004, SPECIATION; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ernst C. H., 1989, TURTLES WORLD; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fontaine H, 1978, P 3 REG C GEOL MIN R, P541; Forlani A, 2005, MOL ECOL NOTES, V5, P228, DOI 10.1111/j.1471-8286.2005.00890.x; Fritz U, 2008, ZOOL SCR, V37, P367, DOI 10.1111/j.1463-6409.2008.00332.x; Fritz Uwe, 2007, Vertebrate Zoology, V57, P149; Fritz U, 2006, ZOOL SCR, V35, P531, DOI 10.1111/j.1463-6409.2006.00242.x; Fritz U, 2014, VERTEBR ZOOL, V64, P229; Fritz U, 2014, ZOOTAXA, V3795, P501, DOI 10.11646/zootaxa.3795.5.1; Fritz U, 2012, J ZOOL SYST EVOL RES, V50, P125, DOI 10.1111/j.1439-0469.2011.00647.x; Fritz U, 2010, ORG DIVERS EVOL, V10, P227, DOI 10.1007/s13127-010-0007-1; Gibbons JW, 1990, HERPETOL MONOGR, V4, P29; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Glaubrecht M, 2004, BIOL J LINN SOC, V82, P275, DOI 10.1111/j.1095-8312.2004.00361.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham MR, 2012, ZOOL MIDDLE EAST, V55, P95, DOI 10.1080/09397140.2012.10648924; Halamkova L, 2013, BIOL J LINN SOC, V108, P396, DOI 10.1111/j.1095-8312.2012.02015.x; Hall Robert, 1998, P99; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASUMI H, 2004, 1 U TOK CTR CLIM SYS; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurwood DA, 2008, ECOL FRESHW FISH, V17, P273, DOI 10.1111/j.1600-0633.2007.00278.x; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Iverson JB, 1992, REVISED CHECKLIST DI; KIERS HAL, 1991, PSYCHOMETRIKA, V56, P197, DOI 10.1007/BF02294458; Kindler C, 2016, BIOL J LINN SOC, V117, P305, DOI 10.1111/bij.12647; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lindeman PV, 2008, HERPETOLOGICA, V64, P32, DOI 10.1655/07-025.1; Lukoschek V, 2011, ECOL EVOL, V1, P330, DOI 10.1002/ece3.29; Mantziou G, 2005, MOL ECOL NOTES, V5, P727, DOI 10.1111/j.1471-8286.2005.01046.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mertens R, 1961, ZOOL JB ABT SYST OEK, V83, P323; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perez M, 2006, MOL ECOL NOTES, V6, P1096, DOI 10.1111/j.1471-8286.2006.01445.x; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Petzold A, 2014, ZOOTAXA, V3795, P523, DOI 10.11646/zootaxa.3795.5.2; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Praschag P, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2233.1.3; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Roques S, 2004, CAN J ZOOL, V82, P153, DOI 10.1139/Z03-228; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; Spinks PQ, 2012, MOL PHYLOGENET EVOL, V63, P656, DOI 10.1016/j.ympev.2012.02.014; Spinks PQ, 2012, ZOOL J LINN SOC-LOND, V164, P811, DOI 10.1111/j.1096-3642.2011.00788.x; Spinks Phillip Q., 2009, Zootaxa, V2018, P56; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Stuart BL, 2004, MOL PHYLOGENET EVOL, V31, P164, DOI 10.1016/S1055-7903(03)00258-6; Stuckas H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057116; Stuckas H, 2011, J ZOOL SYST EVOL RES, V49, P335, DOI 10.1111/j.1439-0469.2011.00632.x; Suzuki D, 2015, CURR HERPETOL, V34, P112, DOI 10.5358/hsj.34.112; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teynie Alexandre, 2004, Hamadryad, V29, P33; Underwood EB, 2013, HERPETOLOGICA, V69, P397; Vamberger M, 2015, ZOOL SCR, V44, P233, DOI 10.1111/zsc.12102; Vamberger M, 2011, AMPHIBIA-REPTILIA, V32, P9, DOI 10.1163/017353710X541869; VANDIJK PP, 2014, CHELONIAN RES MONOGR, V5, P329, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3	88	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153108	10.1371/journal.pone.0153108	http://dx.doi.org/10.1371/journal.pone.0153108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050302	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500100
J	Paul, P; Dhandapani, V; Rameneni, JJ; Li, X; Sivanandhan, G; Choi, SR; Pang, W; Im, S; Lim, YP				Paul, Parameswari; Dhandapani, Vignesh; Rameneni, Jana Jeevan; Li, Xiaonan; Sivanandhan, Ganesan; Choi, Su Ryun; Pang, Wenxing; Im, Subin; Lim, Yong Pyo			Genome-Wide Analysis and Characterization of Aux/IAA Family Genes in Brassica rapa	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; AUXIN; RESPONSES	Auxins are the key players in plant growth development involving leaf formation, phototropism, root, fruit and embryo development. Auxin/Indole-3-Acetic Acid (Aux/IAA) are early auxin response genes noted as transcriptional repressors in plant auxin signaling. However, many studies focus on Aux/ARF gene families and much less is known about the Aux/IAA gene family in Brassica rapa (B. rapa). Here we performed a comprehensive genome-wide analysis and identified 55 Aux/IAA genes in B. rapa using four conserved motifs of Aux/IAA family (PF02309). Chromosomal mapping of the B. rapa Aux/IAA (BrIAA) genes facilitated understanding cluster rearrangement of the crucifer building blocks in the genome. Phylogenetic analysis of BrIAA with Arabidopsis thaliana, Oryza sativa and Zea mays identified 51 sister pairs including 15 same species (BrIAA-BrIAA) and 36 cross species (BrIAA-AtIAA) IAA genes. Among the 55 BrIAA genes, expression of 43 and 45 genes were verified using Gene-bank B. rapa ESTs and in home developed microarray data from mature leaves of Chiifu and RcBr lines. Despite their huge morphological difference, tissue specific expression analysis of BrIAA genes between the parental lines Chiifu and RcBr showed that the genes followed a similar pattern of expression during leaf development and a different pattern during bud, flower and siliqua development stages. The response of the BrIAA genes to abiotic and auxin stress at different time intervals revealed their involvement in stress response. Single Nucleotide Polymorphisms between IAA genes of reference genome Chiifu and RcBr were focused and identified. Our study examines the scope of conservation and divergence of Aux/IAA genes and their structures in B. rapa. Analyzing the expression and structural variation between two parental lines will significantly contribute to functional genomics of Brassica crops and we belive our study would provide a foundation in understanding the Aux/IAA genes in B. rapa.	[Paul, Parameswari; Dhandapani, Vignesh; Rameneni, Jana Jeevan; Li, Xiaonan; Sivanandhan, Ganesan; Choi, Su Ryun; Pang, Wenxing; Im, Subin; Lim, Yong Pyo] Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Daejeon 305764, South Korea	Chungnam National University	Lim, YP (corresponding author), Chungnam Natl Univ, Dept Hort, Mol Genet & Genom Lab, Daejeon 305764, South Korea.	yplim@cnu.ac.kr	Dhandapani, Vignesh/X-6677-2019; Pang, Wenxing/GLR-9367-2022; Paul, Parameswari/AAB-5707-2019; 최, 수련/AHE-1934-2022; Sivanandhan, Ganeshan/H-8864-2015	Dhandapani, Vignesh/0000-0002-5745-2409; Sivanandhan, Ganeshan/0000-0001-7917-2371	Golden Seed Project [213002-04-4-SBI30]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This research was supported by the Golden Seed Project (No. 213002-04-4-SBI30), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; AINLEY WM, 1988, J BIOL CHEM, V263, P10658; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Cakir B, 2013, ACTA PHYSIOL PLANT, V35, P365, DOI 10.1007/s11738-012-1079-7; Dhandapani V, 2012, GENES GENOM, V34, P671, DOI 10.1007/s13258-012-0015-y; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Lee SC, 2008, MOL CELLS, V26, P595; Li SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00119; Muto H, 2007, PLANT SIGNAL BEHAV, V2, P390, DOI 10.4161/psb.2.5.4264; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y	27	19	25	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151522	10.1371/journal.pone.0151522	http://dx.doi.org/10.1371/journal.pone.0151522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049520	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500008
J	Leehr, EJ; Schag, K; Brinkmann, A; Ehlis, AC; Fallgatter, AJ; Zipfel, S; Giel, KE; Dresler, T				Leehr, Elisabeth J.; Schag, Kathrin; Brinkmann, Amelie; Ehlis, Ann-Christine; Fallgatter, Andreas J.; Zipfel, Stephan; Giel, Katrin E.; Dresler, Thomas			Alleged Approach-Avoidance Conflict for Food Stimuli in Binge Eating Disorder	PLOS ONE			English	Article							FACIAL REACTIONS; ELECTROMYOGRAPHIC ACTIVITY; APPROACH BIAS; RESPONSES; CUES; EXPOSURE; OBESITY; PEOPLE; REWARD	Objective Food stimuli are omnipresent and naturally primary reinforcing stimuli. One explanation for the intake of high amounts of food in binge eating disorder (BED) is a deviant valuation process. Valuation of food stimuli is supposed to influence approach or avoidance behaviour towards food. Focusing on self-reported and indirect (facial electromyography) valuation process, motivational aspects in the processing of food stimuli were investigated. Methods We compared an overweight sample with BED (BED+) with an overweight sample without BED (BED-) and with normal weight controls (NWC) regarding their self-reported and indirect (via facial electromyography) valuation of food versus non-food stimuli. Results Regarding the self-reported valuation, the BED+ sample showed a significantly stronger food-bias compared to the BED-sample, as food stimuli were rated as significantly more positive than the non-food stimuli in the BED+ sample. This self-reported valuation pattern could not be displayed in the indirect valuation. Food stimuli evoked negative indirect valuation in all groups. The BED+ sample showed the plainest approach-avoidance conflict marked by a diverging self-reported (positive) and indirect (negative) valuation of food stimuli. Conclusions BED+ showed a deviant self-reported valuation of food as compared to BED-. The valuation process of the BED+ sample seems to be characterized by a motivational ambivalence. This ambivalence should be subject of further studies and may be of potential use for therapeutic interventions.	[Leehr, Elisabeth J.; Schag, Kathrin; Brinkmann, Amelie; Zipfel, Stephan; Giel, Katrin E.] Univ Hosp Tuebingen, Dept Psychosomat Med & Psychotherapy, Internal Med 6, Tubingen, Germany; [Ehlis, Ann-Christine; Fallgatter, Andreas J.; Dresler, Thomas] Univ Hosp Tuebingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Fallgatter, Andreas J.; Dresler, Thomas] Univ Tubingen, LEAD Grad Sch, Tubingen, Germany; [Giel, Katrin E.] Univ Heidelberg Hosp, Ctr Psychosocial Med, Dept Med & Psychosomat, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg	Leehr, EJ (corresponding author), Univ Hosp Tuebingen, Dept Psychosomat Med & Psychotherapy, Internal Med 6, Tubingen, Germany.	elisabeth.leehr@med.uni-tuebingen.de		Ehlis, Ann-Christine/0000-0002-8142-9743; Zipfel, Stephan/0000-0003-1659-4440	"Studienstiftung des deutschen Volkes"; Ministry of Science Baden-Wuerttemberg; European Social Fund; Athene programme; project of the Excellence Initiative of the German federal and state governments [GSC1028]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen; project of the Excellence Initiative of the German federal and state governments; LEAD graduate school	"Studienstiftung des deutschen Volkes"; Ministry of Science Baden-Wuerttemberg; European Social Fund(European Social Fund (ESF)); Athene programme; project of the Excellence Initiative of the German federal and state governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen; project of the Excellence Initiative of the German federal and state governments; LEAD graduate school	EJL receives a grant by the "Studienstiftung des deutschen Volkes" (https://www.studienstiftung.de/). There is no grant number. KEG receives a grant by the Ministry of Science Baden-Wuerttemberg and the European Social Fund and is partly supported by the Athene programme, a project of the Excellence Initiative of the German federal and state governments. TD was partly supported by the LEAD graduate school [GSC1028], a project of the Excellence Initiative of the German federal and state governments. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2013, OBESITY, V21, P367, DOI 10.1002/oby.20068; Becker D, 2015, APPETITE, V85, P58, DOI 10.1016/j.appet.2014.11.017; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Brockmeyer T, 2015, APPETITE, V95, P197, DOI 10.1016/j.appet.2015.07.013; Brockmeyer T, 2015, EUR EAT DISORD REV, V23, P352, DOI 10.1002/erv.2382; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Dalbert C., 1992, Z F R DIFFERENTIELLE, V13, P207; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 1997, J PSYCHOPHYSIOL, V11, P115; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Friederich HC, 2006, PSYCHOL MED, V36, P1327, DOI 10.1017/S0033291706008129; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Geliebter A, 2006, APPETITE, V46, P31, DOI 10.1016/j.appet.2005.09.002; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, 2011, INT J EAT DISORDER, V44, P105, DOI 10.1002/eat.20785; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; GRAND S, 1968, J EXP PSYCHOL, V77, P31, DOI 10.1037/h0025759; Hautzinger M., 2006, BECK DEPRESSIONSINVE; Hawk LW, 2004, APPETITE, V43, P285, DOI 10.1016/j.appet.2004.06.008; Hege M.A., 2014, INT J OBES LOND; Hilbert A, 2004, DIAGNOSTICA, V50, P98, DOI 10.1026/0012-1924.50.2.98; Karhunen LJ, 2000, PSYCHIAT RES-NEUROIM, V99, P29, DOI 10.1016/S0925-4927(00)00053-6; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Meule A, 2012, APPETITE, V58, P88, DOI 10.1016/j.appet.2011.09.010; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schag K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076542; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; Soussignan R, 2015, BIOL PSYCHOL, V104, P173, DOI 10.1016/j.biopsycho.2014.12.006; Svaldi J, 2014, INT J EAT DISORD; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Treasure J, 2012, EUR EAT DISORD REV, V20, pe42, DOI 10.1002/erv.1090; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Weygandt M, 2012, HUM BRAIN MAPP, V33, P2135, DOI 10.1002/hbm.21345; Wittchen H., 1997, SKID 1 SKID 2 STRUKT	45	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152271	10.1371/journal.pone.0152271	http://dx.doi.org/10.1371/journal.pone.0152271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045169	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600012
J	Wilson, DP				Wilson, David P.			Protruding Features of Viral Capsids Are Clustered on Icosahedral Great Circles	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; STRUCTURAL TRANSITIONS; CRYSTAL-STRUCTURE; VIRUS; PROTEIN; PARTICLE; REVEALS	Spherical viruses are remarkably well characterized by the Triangulation (T) number developed by Casper and Klug. The T-number specifies how many viral capsid proteins are required to cover the virus, as well as how they are further subdivided into pentamer and hexamer subunits. The T-number however does not constrain the orientations of these proteins within the subunits or dictate where the proteins should place their protruding features. These protrusions often take the form of loops, spires and helices, and are significant because they aid in stability of the capsid as well as recognition by the host organism. Until now there has be no overall understanding of the placement of protrusions for spherical viruses, other than they have icosahedral symmetry. We constructed a set of gauge points based upon the work affine extensions of Keef and Twarock, which have fixed relative angular locations with which to measure the locations of these features. This work adds a new element to our understanding of the geometric arrangement of spherical viral capsid proteins; chiefly that the locations of protruding features are not found stochastically distributed in an icosahedral manner across the viral surface, but instead these features are found only in specific locations along the 15 icosahedral great circles. We have found that this result holds true as the T number and viral capsids size increases, suggesting an underlying geometric constraint on their locations. This is in spite of the fact that the constraints on the pentamers and hexamer orientations change as a function of T-number, as you need to accommodate more hexamers in the same solid angle between pentamers. The existence of this angular constraint of viral capsids suggests that there is a fitness or energetic benefit to the virus placing its protrusions in this manner. This discovery may have profound impacts on identifying and eliminating viral pathogens, understanding evolutionary constraints as well as bioengineering for capsid drug delivery systems. This result also suggests that in addition to biochemical attachment restrictions, there are additional geometric constraints that should be adhered to when modifying protein capsids.	[Wilson, David P.] Albion Coll, Dept Phys, 611 E Porter St, Albion, MI 49224 USA	Albion College	Wilson, DP (corresponding author), Albion Coll, Dept Phys, 611 E Porter St, Albion, MI 49224 USA.	davewilson13@gmail.com						Bourne CR, 2006, J VIROL, V80, P11055, DOI 10.1128/JVI.00933-06; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Caspar DLD, 1962, S QUANTITATIVE BIOL, V27, DOI [10.1101/SQB.1962.027.001.005, DOI 10.1101/SQB.1962.027.001.005]; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Gipson P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5278; GOLMOHAMMADI R, 1993, J MOL BIOL, V234, P620, DOI 10.1006/jmbi.1993.1616; Hubert H, 1998, NATURE, V391, P376, DOI 10.1038/34885; Janner A, 2013, ACTA CRYSTALLOGR A, V69, P151, DOI 10.1107/S0108767312047162; Keef T, 2009, J MATH BIOL, V59, P287, DOI 10.1007/s00285-008-0228-5; Keef T, 2013, ACTA CRYSTALLOGR A, V69, P140, DOI 10.1107/S0108767312047150; Larson SB, 1998, J MOL BIOL, V277, P37, DOI 10.1006/jmbi.1997.1570; Liepold LO, 2005, PHYS BIOL, V2, pS166, DOI 10.1088/1478-3975/2/4/S11; Liu HJ, 2003, J STRUCT BIOL, V142, P356, DOI 10.1016/S1047-8477(03)00028-5; Luque D, 2010, J VIROL, V84, P7256, DOI 10.1128/JVI.00432-10; May ER, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.188101; Munshi S, 1996, J MOL BIOL, V261, P1, DOI 10.1006/jmbi.1996.0437; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; OLSON AJ, 1983, J MOL BIOL, V171, P61, DOI 10.1016/S0022-2836(83)80314-3; Perotti La, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.058101; Raupp C, 2012, J VIROL, V86, P9396, DOI 10.1128/JVI.00209-12; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; SALLBERG M, 1991, J MED VIROL, V33, P248, DOI 10.1002/jmv.1890330407; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Speir JA, 2012, CRYSTAL STRUCT UNPUB; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Szolajska E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046075; Tama F, 2002, J MOL BIOL, V318, P733, DOI 10.1016/S0022-2836(02)00135-3; Tang L, 2001, NAT STRUCT BIOL, V8, P77, DOI 10.1038/83089; Tars K, 1997, J MOL BIOL, V271, P759, DOI 10.1006/jmbi.1997.1214; Venkataraman S, 2008, STRUCTURE, V16, P1555, DOI 10.1016/j.str.2008.07.013; Wardman JP, 2012, THESIS U; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152319	10.1371/journal.pone.0152319	http://dx.doi.org/10.1371/journal.pone.0152319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045511	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600015
J	Cauquil, L; Hue, T; Hurlin, JC; Mitchell, G; Searle, K; Skuce, P; Zadoks, R				Cauquil, Laura; Huee, Thomas; Hurlin, Jean-Claude; Mitchell, Gillian; Searle, Kate; Skuce, Philip; Zadoks, Ruth			Prevalence and Sequence-Based Identity of Rumen Fluke in Cattle and Deer in New Caledonia	PLOS ONE			English	Article							CALICOPHORON-DAUBNEYI; PARAMPHISTOMOSIS; BOVINE; INTENSITY; ABATTOIR; DNA	An abattoir survey was performed in the French Melanesian archipelago of New Caledonia to determine the prevalence of paramphistomes in cattle and deer and to generate material for molecular typing at species and subspecies level. Prevalence in adult cattle was high at animal level (70% of 387 adult cattle) and batch level (81%). Prevalence was lower in calves at both levels (33% of 484 calves, 51% at batch level). Animals from 2 of 7 deer farms were positive for rumen fluke, with animal-level prevalence of 41.4%(29/70) and 47.1%(33/70), respectively. Using ITS-2 sequencing, 3 species of paramphistomes were identified, i.e. Calicophoron calicophorum, Fischoederius elongatus and Orthocoelium streptocoelium. All three species were detected in cattle as well as deer, suggesting the possibility of rumen fluke transmission between the two host species. Based on heterogeneity in ITS-2 sequences, the C. calicophorum population comprises two clades, both of which occur in cattle as well as deer. The results suggest two distinct routes of rumen fluke introduction into this area. This approach has wider applicability for investigations of the origin of rumen fluke infections and for the possibility of parasite transmission at the livestock-wildlife interface.	[Cauquil, Laura; Huee, Thomas; Hurlin, Jean-Claude] Inst Agron Neocaledonien Connaissance & Ameliorat, Lab Parasitol, BP 73, Paita 98890, Nouvelle Caledo, New Caledonia; [Mitchell, Gillian; Skuce, Philip; Zadoks, Ruth] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Searle, Kate] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland; [Zadoks, Ruth] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G61 1QH, Lanark, Scotland	Moredun Research Institute; UK Centre for Ecology & Hydrology (UKCEH); University of Glasgow	Skuce, P (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.	philip.skuce@moredun.ac.uk	; Searle, Kate/F-4922-2011	Zadoks, Ruth/0000-0002-1164-8000; Searle, Kate/0000-0003-4624-9023	Biotechnological and Biological Sciences Research Council Industrial Partnership Award [BBSRC-IPA BB/K015591/1]; Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); BBSRC [BB/K015230/1, BB/K015346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015346/1, BB/K015230/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Biotechnological and Biological Sciences Research Council Industrial Partnership Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors would like to acknowledge financial support from the Biotechnological and Biological Sciences Research Council Industrial Partnership Award (BBSRC-IPA BB/K015591/1; KS) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS; GM, PJS and RNZ).; The authors would like to thank the agents of the Office de Commercialisation et d'Entreposage Frigorifique for permission to sample at the abattoir. We would also like to acknowledge financial support from the Biotechnological and Biological Sciences Research Council Industrial Partnership Award (BBSRC-IPA BB/K015591/1; KS) and the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS; GM, PJS and RNZ).	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bunza MDA., 2008, NIGERIAN J BASIC APP, V16, P287; Ferreras MC, 2014, VET PARASITOL, V199, P268, DOI 10.1016/j.vetpar.2013.10.019; Desvals M, 1993, SCI TECH REV OFFICE, V12, P171; Dube S, 2010, ZIMB J SCI TECH, V5, P12; EDUARDO S L, 1980, Systematic Parasitology, V1, P203, DOI 10.1007/BF00009846; Euzeby J, 2008, GRAND DICT ILLUSTRE; Franc A., 1953, MEMOIRES MUSEUM NATL, V13, P1; Gonzalez-Warleta M, 2013, VET PARASITOL, V191, P252, DOI 10.1016/j.vetpar.2012.09.006; Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014; HORAK IVAN GERARD, 1967, ONDERSTE POORT J VET RES, V34, P451; Itagaki T, 2003, J VET MED SCI, V65, P931, DOI 10.1292/jvms.65.931; KELLY J D, 1973, Tropical Animal Health and Production, V5, P192, DOI 10.1007/BF02251389; Loock N., 2003, THESIS ECOLE NATL VE; Malrait K, 2015, VET PARASITOL, V207, P134, DOI 10.1016/j.vetpar.2014.10.033; Martinez-Ibeas AM, 2013, VET PARASITOL, V195, P57, DOI 10.1016/j.vetpar.2012.12.048; Mason C, 2012, VET REC, V170, DOI 10.1136/vr.e2368; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; Millar M, 2012, VET REC, V171, DOI 10.1136/vr.e7738; O'Toole A, 2014, PARASITOL RES, V113, P4097, DOI 10.1007/s00436-014-4078-3; Prasitirat P., 1997, PARASITOL HUNG, V29-30, P27; Rangel-Ruiz LJ, 2003, VET PARASITOL, V116, P217, DOI 10.1016/j.vetpar.2003.07.002; Raza MA, 2009, PAK VET J, V29, P214; Rinaldi L, 2005, VET PARASITOL, V131, P247, DOI 10.1016/j.vetpar.2005.04.035; ROBERTS F. H. S., 1939, JOUR COMP PATH AND THERAP, V52, P160, DOI 10.1016/S0368-1742(39)80015-7; ROLFE PF, 1987, AUST VET J, V64, P328, DOI 10.1111/j.1751-0813.1987.tb06060.x; ROLFE PF, 1991, INT J PARASITOL, V21, P813, DOI 10.1016/0020-7519(91)90150-6; Serrano M., 1984, THESIS U PHILIPPINES; Shylla JA, 2011, PARASITOL RES, V108, P1027, DOI 10.1007/s00436-010-2148-8; Sintayehu Melaku, 2012, Global Veterinaria, V8, P315; Spence SA, 1996, AUST VET J, V74, P456, DOI 10.1111/j.1751-0813.1996.tb07569.x; Sripalwit P, 2007, EXP PARASITOL, V115, P98, DOI 10.1016/j.exppara.2006.05.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MA, VET PARASITOLOGY, P53; Titi A, 2014, PARASITE, V21, DOI 10.1051/parasite/2014041; Toolan DP, 2015, VET PARASITOL, V212, P168, DOI 10.1016/j.vetpar.2015.07.040; Vaidyanathan S. N., 1941, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V11, P243; Zintl A, 2014, VET PARASITOL, V204, P199, DOI 10.1016/j.vetpar.2014.05.024	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152603	10.1371/journal.pone.0152603	http://dx.doi.org/10.1371/journal.pone.0152603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043709	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000373592100019
J	Kwon, J; Jeong, SM; Choi, I; Kim, NH				Kwon, Jeongwoo; Jeong, Sung-min; Choi, Inchul; Kim, Nam-Hyung			ADAM10 Is Involved in Cell Junction Assembly in Early Porcine Embryo Development	PLOS ONE			English	Article							BRAIN MYELIN MEMBRANES; MOLECULE-LIKE PROTEIN; E-CADHERIN; ADENOVIRUS RECEPTOR; TIGHT JUNCTIONS; TRANSENDOTHELIAL MIGRATION; CRYSTAL-STRUCTURES; BETA-CATENIN; ADHESION; ARCHITECTURE	ADAM10 (A Disintegrin and Metalloprotease domain-containing protein 10) is a cell surface protein with a unique structure possessing both potential adhesion and protease domains. However, the role of ADAM10 in preimplantation stage embryos is not clear. In this study, we examined the expression patterns and functional roles of ADAM10 in porcine parthenotes during preimplantation development. The transcription level of ADAM10 dramatically increased from the morula stage onward. Immunostaining revealed that ADAM10 was present in both the nucleus and cytoplasm in early cleavage stage embryos, and localized to the apical region of the outer cells in morula and blastocyst embryos. Knockdown (KD) of ADAM10 using double strand RNA did not alter preimplantation embryo development until morula stage, but resulted in significantly reduced development to blastocyst stage. Moreover, the KD blastocyst showed a decrease in gene expression of adherens and tight junction (AJ/TJ), and an increase in trophectoderm TJ permeability by disrupting TJ assembly. Treatment with an ADAM10 specific chemical inhibitor, GI254023X, at the morula stage also inhibited blastocyst development and led to disruption of TJ assembly. An in situ proximity ligation assay demonstrated direct interaction of ADAM10 with coxsackie virus and adenovirus receptor (CXADR), supporting the involvement of ADAM10 in TJ assembly. In conclusion, our findings strongly suggest that ADADM10 is important for blastocyst formation rather than compaction, particularly for TJ assembly and stabilization in preimplantation porcine parthenogenetic development.	[Kwon, Jeongwoo; Jeong, Sung-min; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungcheongbuk, South Korea; [Choi, Inchul] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim & Dairy Sci, Daejeon 34134, South Korea	Chungbuk National University; Chungnam National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungcheongbuk, South Korea.; Choi, I (corresponding author), Chungnam Natl Univ, Coll Agr & Life Sci, Dept Anim & Dairy Sci, Daejeon 34134, South Korea.	icchoi@cnu.ac.kr; nhkim@chungbuk.ac.kr	Choi, Inchul/AAF-6264-2021	Choi, Inchul/0000-0001-5011-2658	Next-Generation BioGreen21 Program (CABX) [PJ011213, PJ011126]; Rural Development Administration (RDA); Republic of Korea	Next-Generation BioGreen21 Program (CABX); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Republic of Korea	Next-Generation BioGreen21 Program (CABX, Project No. PJ011213 to IC, and PJ011126 to NHK), Rural Development Administration (RDA), Republic of Korea http://www.rda.go.kr/foreign/eng/.	Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; CHANTRY A, 1990, BIOCHEM J, V268, P245, DOI 10.1042/bj2680245; CHANTRY A, 1989, J BIOL CHEM, V264, P21603; Choi Inchul, 2012, Development, V139, P4623, DOI 10.1242/dev.086645; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Ebsen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102899; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fernandez-Borja M, 2010, CARDIOVASC RES, V86, P202, DOI 10.1093/cvr/cvq003; Garrido-Urbani S, 2014, CELL TISSUE RES, V355, P701, DOI 10.1007/s00441-014-1820-1; Gibb DR, 2010, J EXP MED, V207, P623, DOI 10.1084/jem.20091990; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Houri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073296; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kleino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121301; Krivega M, 2014, REPRODUCTION, V148, P531, DOI 10.1530/REP-14-0253; Kwon JW, 2016, REPRODUCTION, V151, P297, DOI 10.1530/REP-15-0397; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10; Morton PE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02889; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	41	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152921	10.1371/journal.pone.0152921	http://dx.doi.org/10.1371/journal.pone.0152921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043020	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100047
J	Almeida-Paes, R; Figueiredo-Carvalho, MHG; Brito-Santos, F; Almeida-Silva, F; Oliveira, MME; Zancope-Oliveira, RM				Almeida-Paes, Rodrigo; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Almeida-Silva, Fernando; Evangelista Oliveira, Manoel Marques; Zancope-Oliveira, Rosely Maria			Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine	PLOS ONE			English	Article							INHIBITORY CONCENTRATION INDEX; IN-VITRO; CRYPTOCOCCUS-NEOFORMANS; PARACOCCIDIOIDES-BRASILIENSIS; CUTANEOUS SPOROTRICHOSIS; PENICILLIUM-MARNEFFEI; SUSCEPTIBILITY; MELANIZATION; INFECTION; ITRACONAZOLE	Terbinafine is a recommended therapeutic alternative for patients with sporotrichosis who cannot use itraconazole due to drug interactions or side effects. Melanins are involved in resistance to antifungal drugs and Sporothrix species produce three different types of melanin. Therefore, in this study we evaluated whether Sporothrix melanins impact the efficacy of antifungal drugs. Minimal inhibitory concentrations (MIC) and minimal fungicidal concentrations (MFC) of two Sporothrix brasiliensis and four Sporothrix schenckii strains grown in the presence of the melanin precursors L-DOPA and L-tyrosine were similar to the MIC determined by the CLSI standard protocol for S. schenckii susceptibility to amphotericin B, ketoconazole, itraconazole or terbinafine. When MICs were determined in the presence of inhibitors to three pathways of melanin synthesis, we observed, in four strains, an increase in terbinafine susceptibility in the presence of tricyclazole, a DHN-melanin inhibitor. In addition, one S. schenckii strain grown in the presence of L-DOPA had a higher MFC value when compared to the control. Growth curves in presence of 2xMIC concentrations of terbinafine showed that pyomelanin and, to a lesser extent, eumelanin were able to protect the fungi against the fungicidal effect of this antifungal drug. Our results suggest that melanin protects the major pathogenic species of the Sporothrix complex from the effects of terbinafine and that the development of new antifungal drugs targeting melanin synthesis may improve sporotrichosis therapies.	[Almeida-Paes, Rodrigo; Galdino Figueiredo-Carvalho, Maria Helena; Brito-Santos, Fabio; Almeida-Silva, Fernando; Evangelista Oliveira, Manoel Marques; Zancope-Oliveira, Rosely Maria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Micol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Almeida-Paes, R (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Micol, Rio De Janeiro, Brazil.	rodrigo.paes@ini.fiocruz.br	Almeida-Paes, R/J-2976-2015; Oliveira, Manoel M E/P-8685-2014; Almeida-Paes, Rodrigo/Q-4933-2019	Oliveira, Manoel M E/0000-0001-7670-9225; Figueiredo-Carvalho, Maria Helena/0000-0002-1719-832X	Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz [407693/2012-2]; Conselho Nacional de desenvolvimento Cientifico e Tecnologico [304976/2013-0, 449184/2014-5]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/103.157/2011]	Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Programa institucional de inducao a cioncia, tecnologia e inovacao em saude PAPES VI - CNPq/Fiocruz (grant number 407693/2012-2), Conselho Nacional de desenvolvimento Cientifico e Tecnologico (grant numbers 304976/2013-0 to RMZ-O, and 449184/2014-5 to RA-P), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (grant number E-26/103.157/2011 to RMZ-O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Paes R, 2012, MELANIN BIOSYNTHESIS, P77; Almeida-Paes R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/212308; Almeida-Paes R, 2012, APPL ENVIRON MICROB, V78, P8623, DOI 10.1128/AEM.02414-12; Almeida-Paes R, 2009, MICROBES INFECT, V11, P554, DOI 10.1016/j.micinf.2009.03.002; Baltazar LM, 2015, ANTIMICROB AGENTS CH, V59, P4003, DOI 10.1128/AAC.04917-14; Teixeira PAC, 2010, MED MYCOL, V48, P687, DOI 10.3109/13693780903453287; Chakrabarti A, 2015, MED MYCOL, V53, P3, DOI 10.1093/mmy/myu062; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; da Silva MB, 2006, MICROBES INFECT, V8, P197, DOI 10.1016/j.micinf.2005.06.018; Barros MBD, 2011, CLIN MICROBIOL REV, V24, P633, DOI 10.1128/CMR.00007-11; Barros MBD, 2011, CLIN INFECT DIS, V52, pE200, DOI 10.1093/cid/cir245; Dias NM, 2011, EMERG INFECT DIS, V17, P1975, DOI 10.3201/eid1710.110737; Francesconi G, 2009, J EUR ACAD DERMATOL, V23, P1273, DOI 10.1111/j.1468-3083.2009.03306.x; Francesconi G, 2011, MYCOPATHOLOGIA, V171, P349, DOI 10.1007/s11046-010-9380-8; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Ikeda R, 2003, MICROBIOL IMMUNOL, V47, P271, DOI 10.1111/j.1348-0421.2003.tb03395.x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Marcos-Zambrano LJ, 2013, ANTIMICROB AGENTS CH, V57, P5767, DOI 10.1128/AAC.01032-13; Kaewmalakul J, 2014, ANTON LEEUW INT J G, V106, P1011, DOI 10.1007/s10482-014-0270-9; Kauffman CA, 2007, CLIN INFECT DIS, V45, P1255, DOI 10.1086/522765; Koehling HL, 2015, J CLIN MICROBIOL, V53, P255, DOI 10.1128/JCM.02830-14; Lovero G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150218; Macedo PM, 2015, J EUR ACAD DERMATOL, V29, P719, DOI 10.1111/jdv.12667; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; Morrison AS, 2013, MED MYCOL CASE REP, V2, P88, DOI 10.1016/j.mmcr.2013.03.002; Nosanchuk JD, 2007, FUNGAL GENET BIOL, V44, P517, DOI 10.1016/j.fgb.2006.09.006; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pereira SA, 2010, VET REC, V166, P290, DOI [10.1136/vr.b4752, 10.1136/vr.166.10.290]; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; Freitas DFS, 2010, CLIN INFECT DIS, V50, DOI 10.1086/649891; Song Y, 2013, J EUR ACAD DERMATOL, V27, P313, DOI 10.1111/j.1468-3083.2011.04389.x; Sun JF, 2011, MYCOPATHOLOGIA, V172, P373, DOI 10.1007/s11046-011-9439-1; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Tamura T, 2014, MICROBIOL IMMUNOL, V58, P1, DOI 10.1111/1348-0421.12109; Uran ME, 2011, CLIN VACCINE IMMUNOL, V18, P1680, DOI 10.1128/CVI.05099-11; van de Sande WWJ, 2007, MICROBES INFECT, V9, P1114, DOI 10.1016/j.micinf.2007.05.015; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; Yamada K, 2011, REV INST MED TROP SP, V53, P89, DOI 10.1590/S0036-46652011000200006; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0	44	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152796	10.1371/journal.pone.0152796	http://dx.doi.org/10.1371/journal.pone.0152796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031728	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800138
J	Okerberg, ES; Hainley, A; Brown, H; Aban, A; Alemayehu, S; Shih, A; Wu, J; Patricelli, MP; Kozarich, JW; Nomanbhoy, T; Rosenblum, JS				Okerberg, Eric S.; Hainley, Anna; Brown, Heidi; Aban, Arwin; Alemayehu, Senait; Shih, Ann; Wu, Jane; Patricelli, Matthew P.; Kozarich, John W.; Nomanbhoy, Tyzoon; Rosenblum, Jonathan S.			Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1 alpha by Chemical Proteomics	PLOS ONE			English	Article							SUPPRESSOR; INHIBITOR; RESISTANCE; LKB1	We describe the identification of a novel, tumor-specific missense mutation in the active site of casein kinase 1 alpha (CSNK1A1) using activity-based proteomics. Matched normal and tumor colon samples were analyzed using an ATP acyl phosphate probe in a kinase-targeted LC-MS2 platform. An anomaly in the active-site peptide from CSNK1A1 was observed in a tumor sample that was consistent with an altered catalytic aspartic acid. Expression and analysis of the suspected mutant verified the presence of asparagine in the probe-labeled, active-site peptide for CSNK1A1. Genomic sequencing of the colon tumor samples confirmed the presence of amissensemutation in the catalytic aspartic acid of CSNK1A1 (GAC -> AAC). To our knowledge, the D163N mutation in CSNK1A1 is a newly defined mutation to the conserved, catalytic aspartic acid of a protein kinase and the first missense mutation identified using activity-based proteomics. The tumorigenic potential of this mutation remains to be determined.	[Okerberg, Eric S.; Hainley, Anna; Brown, Heidi; Aban, Arwin; Alemayehu, Senait; Shih, Ann; Wu, Jane; Kozarich, John W.; Nomanbhoy, Tyzoon; Rosenblum, Jonathan S.] ActivX Biosci Inc, La Jolla, CA USA; [Patricelli, Matthew P.] Wellspring Biosci LLC, La Jolla, CA USA	Kyorin Pharmaceutical Co Ltd	Rosenblum, JS (corresponding author), ActivX Biosci Inc, La Jolla, CA USA.	jonr@activx.com			ActivX Biosciences	ActivX Biosciences	At the time the research was performed, all authors were employed by ActivX Biosciences. Accordingly, ActivX Biosciences paid their salaries, paid for supplies and had a role in every aspect of the research.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Arnato KR, 2014, J CLIN INVEST, V124, P2037, DOI 10.1172/JCI72522; Barouch-Bentov R, 2011, EXPERT OPIN INV DRUG, V20, P153, DOI 10.1517/13543784.2011.546344; BOJESEN G, 1987, J AM CHEM SOC, V109, P5557, DOI 10.1021/ja00252a060; Brognard J, 2001, CANCER RES, V71, P3152; Chamrad I, 2013, J PROTEOME RES, V12, P4005, DOI 10.1021/pr400309p; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Dietel M, 2015, CANCER GENE THER, V22, P417, DOI 10.1038/cgt.2015.39; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Jessani N, 2007, CHEM BIOL, P403; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Martens L, 2013, PROTEOM CLIN APPL, V7, P388, DOI 10.1002/prca.201300020; Nordin BE, 2015, BIOCHEMISTRY-US, V54, P3024, DOI 10.1021/acs.biochem.5b00148; Okerberg ES, 2014, J AM CHEM SOC, V136, P4664, DOI 10.1021/ja4129907; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Xiao YS, 2014, MOL CELL PROTEOMICS, V13, P1065, DOI 10.1074/mcp.M113.036905; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zhang MC, 2004, CLIN PROTEOM, V1, P301	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152934	10.1371/journal.pone.0152934	http://dx.doi.org/10.1371/journal.pone.0152934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031502	Green Published, gold			2022-12-27	WOS:000373121800156
J	Pfortmueller, CA; Drexel, C; Krahenmann-Muller, S; Leichtle, AB; Fiedler, GM; Lindner, G; Exadaktylos, AK				Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Leichtle, Alexander Benedikt; Fiedler, Georg Martin; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos			S-100 B Concentrations Are a Predictor of Decreased Survival in Patients with Major Trauma, Independently of Head Injury	PLOS ONE			English	Article							SERUM S100B LEVELS; BRAIN-DEATH; PROTEIN; SEVERITY; MARKER	Background Major trauma remains one of the principle causes of disability and death throughout the world. There is currently no satisfactory risk assessment to predict mortality in patients with major trauma. The aim of our study is to examine whether S-100 B protein concentrations correlate with injury severity and survival in patients with major trauma, with special emphasis on patients without head injury. Methods Our retrospective data analysis comprised adult patients admitted to our emergency department between 1.12. 2008 and 31.12 2010 with a suspected major trauma. S-100 B concentrations were routinely assessed in major trauma patients. Results A total of 27.7%(378) of all patients had major trauma. The median ISS was 24.6 (SD 8.4); 16.6% (63/378) of the patients died. S-100 B concentrations correlated overall with the ISS (p<0.0001). Patients who died had significantly higher S-100 B concentrations than survivors (8.2 mu g/l versus 2.2 mu g/l, p<0.0001). Polytraumatised patients with and without head trauma did not differ significantly with respect to S-100 B concentration (3.2 mu g/l (SD 5.3) versus 2.9 mu g/l (SD 3.8), respectively, p = 0.63) or with respect to Injury Severity Score (24.8 (SD 8.6) versus 24.2 (SD 8.1), respectively, p = 0.56). S-100 B concentrations correlated negatively with survival (p<0.0001) in all patients and in both subgroups (p = 0.001 and p = 0.006, respectively) Conclusions S-100 concentrations on admission correlate positively with greater injury severity and decreased survival in major trauma patients, independently of the presence of a head injury. S-100 B protein levels at admission in patients with major trauma may therefore be used to assess outcome in all polytraumatised patients. These measurements should be subject to further evaluation.	[Pfortmueller, Carmen Andrea] Vienna Gen Hosp, Clin Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Pfortmueller, Carmen Andrea] Univ Vienna, Vienna, Austria; [Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos] Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen Andrea; Drexel, Christian; Kraehenmann-Mueller, Simone; Lindner, Gregor; Exadaktylos, Aristomenis Konstantinos] Univ Bern, Bern, Switzerland; [Leichtle, Alexander Benedikt; Fiedler, Georg Martin] Inselspital Bern, Univ Hosp Bern, Univ Inst Clin Chem, Ctr Lab Med, CH-3010 Bern, Switzerland; [Lindner, Gregor] Hirslandenklin Pk Zurich, Dept Emergency Med, Zurich, Switzerland	University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Vienna Gen Hosp, Clin Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.; Pfortmueller, CA (corresponding author), Univ Vienna, Vienna, Austria.; Pfortmueller, CA (corresponding author), Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland.; Pfortmueller, CA (corresponding author), Univ Bern, Bern, Switzerland.	cpfortmueller@gmail.com	Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011; Lindner, Gregor/AAR-6761-2020	Fiedler, Georg Martin/0000-0001-5689-4574; Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2012, INJURY SEVERITY SCOR; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Genarelli T, 2008, ABBREVIATED INJURY S, P1; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; Lomas JP, 2005, EMERG MED J, V22, P889, DOI 10.1136/emj.2005.031732; Mussack T, 2000, ACT NEUR S, V76, P393; Network BI, 2011, DEFINITION ABI TBI; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; Stamataki E, 2013, SHOCK, V40, P274, DOI 10.1097/SHK.0b013e3182a35de5; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Union E., INJ EUR UN SUMM INJ; Wolf H, 2014, J NEUROTRAUMA	25	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152822	10.1371/journal.pone.0152822	http://dx.doi.org/10.1371/journal.pone.0152822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031106	Green Published, gold			2022-12-27	WOS:000373121800143
J	Uysal, HK; Sohrabi, P; Habip, Z; Saribas, S; Kocazeybek, E; Seyhan, F; Caliskan, R; Bonabi, E; Yuksel, P; Birinci, I; Uysal, O; Kocazeybek, B				Uysal, Hayriye Kirkoyun; Sohrabi, Pari; Habip, Zafer; Saribas, Suat; Kocazeybek, Emre; Seyhan, Fatih; Caliskan, Reyhan; Bonabi, Esad; Yuksel, Pelin; Birinci, Ilhan; Uysal, Omer; Kocazeybek, Bekir			Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PREDICTS DISEASE PROGRESSION; ANTIRETROVIRAL THERAPY HAART; HIV-1/HIV-2 RAPID TEST; INTERFERON-GAMMA; SERUM NEOPTERIN; MICROBIAL TRANSLOCATION; PROGNOSTIC-SIGNIFICANCE; VIRAL LOAD; MARKERS	Background We aimed to evaluate the roles of the plasma immune activation biomarkers neopterin and soluble CD14 (sCD14) in the indirect assessment of the immune activation status of patients with the indeterminate HIV-1 (IHIV-1) pattern and a true HIV-1-positive infection (PCG). Methods This cross-sectional and descriptive study included eighty-eight patients with the IHIV-1 pattern, 100 patients in the PCG, and 100 people in a healthy control group (HCG). Neopterin and sCD14 levels were determined by competitive and sandwich ELISA methods, respectively. Results Mean neopterin and sCD14 levels among those with the IHIV-1 pattern were significantly lower than among the PCG (p < 0.001 and p = 0.001, respectively), but they were similiar to those in the HCG (p = 0.57 and p = 0.66, respectively. Mean neopterin and sCD14 levels among the PCG were found to be significantly higher than among those with the IHIV-1 pattern (p < 0.001 and p = 0.001, respectively) and among those in the HCG (p = 0.001, p < 0.001, respectively). Neopterin did not have adequate predictive value for identifying those in the PCG (area under the curve [AUC] = 0.534; 95% CI, 0.463-0.605; p = 0.4256); sCD14 also had poor predictive value but high specificity (100%) for identifying those in the PCG (AUC = 0.627; 95% CI, 0.556-0.694; p = 0.0036). Conclusions While low levels of these two biomarkers were detected among those with the IHIV-1 pattern, they were found in high levels among those in the PCG. These two markers obviously cannot be used as a sceening test because they have low sensitivies. Taken together, we suggest that neopterin and sCD14 may be helpful because they both have high specificity (92%-100%) as indirect non-specific markers for predicting the immune activation status of individuals, whether or not they have true positive HIV-1.	[Uysal, Hayriye Kirkoyun] Istanbul Univ, Istanbul Fac Med, Dept Med Microbiol, Istanbul, Turkey; [Sohrabi, Pari] Istanbul Publ Hlth Lab, Istanbul, Turkey; [Habip, Zafer; Saribas, Suat; Caliskan, Reyhan; Yuksel, Pelin; Kocazeybek, Bekir] Istanbul Univ, Cerrahpasa Med Fac, Dept Med Microbiol, Istanbul, Turkey; [Kocazeybek, Emre] Marmara Univ, Fac Med, Istanbul, Turkey; [Seyhan, Fatih] Istanbul Leprosy Dermatol & Venereol Hosp, Istanbul, Turkey; [Bonabi, Esad] Istanbul Aydin Univ, Hlth Serv Vocat Sch Higher Educ, Istanbul, Turkey; [Birinci, Ilhan] Turkish Red Crescent, Istanbul, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Sch Med, Deparment Biostat, Istanbul, Turkey	Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Marmara University; Istanbul Lepra Skin & Venereal Diseases Hospital; Istanbul Aydin University; Bezmialem Vakif University	Saribas, S (corresponding author), Istanbul Univ, Cerrahpasa Med Fac, Dept Med Microbiol, Istanbul, Turkey.	suatsaribas@gmail.com	habip, zafer/AAA-8496-2020; Uysal, Ömer/AAR-4220-2020; Kocazeybek, Bekir/D-8113-2018; Uysal, Hayriye Kırkoyun/A-7548-2016; Saribas, Suat/D-6440-2019	Uysal, Ömer/0000-0002-8833-697X; Saribas, Suat/0000-0002-4549-3887; Kocazeybek, Bekir S/0000-0003-1072-3846; sohrabi molla yousefi, peri/0000-0001-6346-1398	Istanbul University Research Fund [45694]	Istanbul University Research Fund(Istanbul University)	This work was supported by Istanbul University Research Fund with the project number 45694.	Amirayan-Chevillard N, 2000, CLIN DIAGN LAB IMMUN, V7, P832, DOI 10.1128/CDLI.7.5.832-834.2000; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Balakrishnan P, 2005, INDIAN J MED RES, V121, P345; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bipath P, 2015, AFR HEALTH SCI, V15, P334, DOI 10.4314/ahs.v15i2.5; Branson BM, 2010, JAIDS-J ACQ IMM DEF, V55, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chadha Sanjim, 2013, Interdiscip Perspect Infect Dis, V2013, P143648, DOI 10.1155/2013/143648; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Romero-Sanchez MC, 2012, J INFECTION, V65, P431, DOI 10.1016/j.jinf.2012.06.008; Cornett JK, 2013, CLIN INFECT DIS, V57, P712, DOI 10.1093/cid/cit281; Daniel V, 1999, IMMUNOL LETT, V69, P283, DOI 10.1016/S0165-2478(99)00105-4; DENZ H, 1990, EUR J HAEMATOL, V44, P186; Eisenhut Michael, 2013, J Biomark, V2013, P196432, DOI 10.1155/2013/196432; Eller MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018779; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; Fisenk BI, 2005, SCAND J INFECT DIS, V37, P599, DOI 10.1080/00365540510043310; Fuchs D, 1992, Eur J Med, V1, P196; FUCHS D, 1992, CRIT REV CL LAB SCI, V29, P307, DOI 10.3109/10408369209114604; FUCHS D, 1991, IMMUNOL LETT, V28, P207, DOI 10.1016/0165-2478(91)90005-U; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Hoffmann G, 2004, PTERIDINES, V15, P107; HONLINGER M, 1989, DEUT MED WOCHENSCHR, V114, P172, DOI 10.1055/s-2008-1066571; Immanuel C, 2005, INDIAN J MED RES, V121, P220; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Linley L, 2013, J CLIN VIROL, V58, pE108, DOI 10.1016/j.jcv.2013.09.021; Malloch L, 2013, J CLIN VIROL, V58, pE85, DOI 10.1016/j.jcv.2013.08.008; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mildvan D, 2005, CLIN INFECT DIS, V40, P853, DOI 10.1086/427877; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nasrullah M, 2011, J CLIN VIROL, V52, pS23, DOI 10.1016/j.jcv.2011.09.020; Nubling CM, 2006, TRANSFUSION, V46, P1886, DOI 10.1111/j.1537-2995.2006.00994.x; Plaeger S, 1999, CLIN IMMUNOL, V90, P238, DOI 10.1006/clim.1998.4646; REIBNEGGER G, 1988, HEPATOLOGY, V8, P771, DOI 10.1002/hep.1840080412; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Schroecksnadel K, 2004, PTERIDINES, V15, P75; Stein DS, 1997, J INFECT DIS, V176, P1161, DOI 10.1086/514108; Sucher R, 2010, CANCER LETT, V287, P13, DOI 10.1016/j.canlet.2009.05.008; TSOUKAS CM, 1994, CLIN MICROBIOL REV, V7, P14, DOI 10.1128/CMR.7.1.14-28.1994; WAHL LM, 1989, P NATL ACAD SCI USA, V86, P621, DOI 10.1073/pnas.86.2.621; Wirleitner B, 2005, MOL IMMUNOL, V42, P183, DOI 10.1016/j.molimm.2004.06.017	43	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152258	10.1371/journal.pone.0152258	http://dx.doi.org/10.1371/journal.pone.0152258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031691	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800047
J	Westfall, J; Yarkoni, T				Westfall, Jacob; Yarkoni, Tal			Statistically Controlling for Confounding Constructs Is Harder than You Think	PLOS ONE			English	Article							INCREMENTAL VALIDITY; INDIVIDUAL-DIFFERENCES; MULTIPLE-REGRESSION; MEASUREMENT ERROR; SOCIAL COGNITION; HEXACO MODEL; I ERROR; PERSONALITY; IMPLICIT; METAANALYSIS	Social scientists often seek to demonstrate that a construct has incremental validity over and above other related constructs. However, these claims are typically supported by measurement- level models that fail to consider the effects of measurement (un)reliability. We use intuitive examples, Monte Carlo simulations, and a novel analytical framework to demonstrate that common strategies for establishing incremental construct validity using multiple regression analysis exhibit extremely high Type I error rates under parameter regimes common in many psychological domains. Counterintuitively, we find that error rates are highest-in some cases approaching 100%-when sample sizes are large and reliability is moderate. Our findings suggest that a potentially large proportion of incremental validity claims made in the literature are spurious. We present a web application (http://jakewestfall.org/ivy/) that readers can use to explore the statistical properties of these and other incremental validity arguments. We conclude by reviewing SEM-based statistical approaches that appropriately control the Type I error rate when attempting to establish incremental validity.	[Westfall, Jacob; Yarkoni, Tal] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Westfall, J (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	jake.westfall@utexas.edu		Westfall, Jacob/0000-0001-7566-3544	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096906] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aghababaei N, 2012, PERS INDIV DIFFER, V53, P880, DOI 10.1016/j.paid.2012.07.005; Andrews B, 2002, BRIT J CLIN PSYCHOL, V41, P29, DOI 10.1348/014466502163778; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Ashton MC, 2000, EUR J PERSONALITY, V14, P359, DOI 10.1002/1099-0984(200007/08)14:4<359::AID-PER382>3.0.CO;2-Y; Ashton MC, 2004, J PERS SOC PSYCHOL, V86, P356, DOI 10.1037/0022-3514.86.2.356; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Bartels LN, 2006, Q J POLIT SCI, V1, P201, DOI 10.1561/100.00000010; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brackett MA, 2003, PERS SOC PSYCHOL B, V29, P1147, DOI 10.1177/0146167203254596; Brooks C, 1999, SOC FORCES, V77, P1339, DOI 10.2307/3005879; Brunner J, 2009, CAN J STAT, V37, P33, DOI 10.1002/cjs.10004; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chirumbolo A, 2010, PERS INDIV DIFFER, V49, P43, DOI 10.1016/j.paid.2010.03.004; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; COHEN J, 1995, AM PSYCHOL, V50, P1103, DOI 10.1037//0003-066X.50.12.1103; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Culpepper SA, 2011, PSYCHOL METHODS, V16, P166, DOI 10.1037/a0023355; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Falk EB, 2011, HEALTH PSYCHOL, V30, P177, DOI 10.1037/a0022259; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Furnham A, 2009, CURR PSYCHOL, V28, P225, DOI 10.1007/s12144-009-9064-z; Gawronski B, 2010, HANDBOOK OF IMPLICIT; Gelman A, 2007, Q J POLIT SCI, V2, P345, DOI 10.1561/100.00006026; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7, DOI DOI 10.1016/J.JRP.2014.05.003; Goldberg LR, 2008, ORI TECH REP, V45; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2009, ANAL SOC ISS PUB POL, V9, P241, DOI 10.1111/j.1530-2415.2009.01195.x; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grucza RA, 2007, J PERS ASSESS, V89, P167, DOI 10.1080/00223890701468568; Hayduk L.A., 1996, LISREL ISSUES DEBATE; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hunsley J, 2003, PSYCHOL ASSESSMENT, V15, P446, DOI 10.1037/1040-3590.15.4.446; Johnson MK, 2011, PERS INDIV DIFFER, V50, P857, DOI 10.1016/j.paid.2011.01.011; Kahneman D, 1965, Psychol Bull, V64, P326, DOI 10.1037/h0022529; Kline R. B, 2010, PRINCIPLES AND PRACT; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; McCrae RR., 1999, HDB PERSONALITY THEO, V2nd, P139, DOI DOI 10.1016/S0191-8869(97)81000-8; McMahon SD, 2004, J EXP EDUC, V73, P41, DOI 10.3200/JEXE.71.1.41-52; O'Connor MC, 2007, PERS INDIV DIFFER, V43, P971, DOI 10.1016/j.paid.2007.03.017; Payne BK, 2010, J EXP SOC PSYCHOL, V46, P367, DOI 10.1016/j.jesp.2009.11.001; Petrides KV, 2007, COGNITION EMOTION, V21, P26, DOI 10.1080/02699930601038912; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Schroeder M. L., 1992, PSYCHOL ASSESSMENT, V4, P47, DOI DOI 10.1037/1040-3590.4.1.47; SECHREST L, 1963, EDUC PSYCHOL MEAS, V23, P153, DOI 10.1177/001316446302300113; Shear BR, 2013, EDUC PSYCHOL MEAS, V73, P733, DOI 10.1177/0013164413487738; Wansbeek TJ, 2000, MEASUREMENT ERROR AN, V37; Zinbarg RE, 2010, J ABNORM PSYCHOL, V119, P307, DOI 10.1037/a0017552	52	256	256	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152719	10.1371/journal.pone.0152719	http://dx.doi.org/10.1371/journal.pone.0152719			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031707	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800128
J	Wolff, J; McCrone, P; Patel, A; Normann, C				Wolff, Jan; McCrone, Paul; Patel, Anita; Normann, Claus			Determinants of per diem Hospital Costs in Mental Health	PLOS ONE			English	Article							CLASSIFICATION; SYSTEM	Introduction An understanding of differences in hospital costs between patient groups is relevant for the efficient organisation of inpatient care. The main aim of this study was to confirm the hypothesis that eight a priori identified cost drivers influence per diem hospital costs. A second aim was to explore further variables that might influence hospital costs. Methods The study included 667 inpatient episodes consecutively discharged in 2014 at the psychiatric hospital of the Medical Centre-University of Freiburg. Fifty-one patient characteristics were analysed. Per diem costs were calculated from the hospital perspective based on a detailed documentation of resource use. Mixed-effects maximum likelihood regression and an ensemble of conditional inference trees were used to analyse data. Results The study confirmed the a priori hypothesis that not being of middle age (33-64 years), danger to self, involuntary admission, problems in the activities of daily living, the presence of delusional symptoms, the presence of affective symptoms, short length of stay and the discharging ward affect per diem hospital costs. A patient classification system for prospective per diem payment was suggested with the highest per diem hospital costs in episodes having both delusional symptoms and involuntary admissions and the lowest hospital costs in episodes having neither delusional symptoms nor somatic comorbidities. Conclusion Although reliable cost drivers were identified, idiosyncrasies of mental health care complicated the identification of clear and consistent differences in hospital costs between patient groups. Further research could greatly inform current discussions about inpatient mental health reimbursement, in particular with multicentre studies that might find algorithms to split patients in more resource-homogeneous groups.	[Wolff, Jan; McCrone, Paul; Patel, Anita] Kings Coll London, Inst Psychiat Psychol & Neurosci, Kings Hlth Econ, De Crespigny Pk, London WC2R 2LS, England; [Wolff, Jan] Univ Freiburg, Med Ctr, Dept Management & Controlling, Freiburg, Germany; [Patel, Anita] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England; [Normann, Claus] Univ Freiburg, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany	University of London; King's College London; University of Freiburg; University of London; Queen Mary University London; University of Freiburg	Wolff, J (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Kings Hlth Econ, De Crespigny Pk, London WC2R 2LS, England.; Wolff, J (corresponding author), Univ Freiburg, Med Ctr, Dept Management & Controlling, Freiburg, Germany.	jan.wolff@kcl.ac.uk	Patel, Anita/F-9832-2010	McCrone, Paul/0000-0001-7001-4502; Wolff, Jan/0000-0003-2750-0606; Patel, Anita/0000-0003-0769-1732				Barbui C, 2012, EPIDEMIOL PSYCH SCI, V21, P227, DOI 10.1017/S2045796012000200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buckingham B, 1998, DEV CASEMIX CLASSIFI, V1; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Busse R, 2011, DIAGNOSIS RELATED GR, P149; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Cording C, 1997, QUALITATSSICHERUNG P, P33; Cromwell J, 2005, PSYCHIAT INPATIENT R; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drozd EM, 2006, AM J PSYCHIAT, V163, P724, DOI 10.1176/appi.ajp.163.4.724; ESSOCK SM, 1988, ARCH GEN PSYCHIAT, V45, P1041; Fetter RB, 1980, MED CARE S, V18, P1; FRIES BE, 1990, MED CARE, V28, P311, DOI 10.1097/00005650-199004000-00003; Hirdes JP, 2002, SYSTEM CLASSIFICATIO; Hothorn T, 2004, RES REPORT SERIES WI; InEK, 2010, KALK BEH HDB KALK PS; Institut fur das Entgeltsystem im Krankenhaus, 2013, ERG ANP KALK SHANDB; JENCKS SF, 1987, MED CARE, V25, pS1; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Lave JR, 2003, HEALTH AFFAIR, V22, P97, DOI 10.1377/hlthaff.22.5.97; RUPP A, 1984, HOSP COMMUNITY PSYCH, V35, P456; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tulloch AD, 2011, ADM POLICY MENT HLTH, V38, P155, DOI 10.1007/s10488-010-0310-3; Wolff J, 2015, NERVENARZT, V86, P852, DOI 10.1007/s00115-015-4311-z; Wolff J, 2015, EPIDEMIOL PSYCH SCI, V24, P78, DOI 10.1017/S204579601300067X; Wolff J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0623-6; Wolff J, 2015, SOC PSYCH PSYCH EPID, V50, P1309, DOI 10.1007/s00127-015-1041-2; Yamauchi K, 1997, BYOUIN KANRI J JAPAN, V34, P155	29	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152669	10.1371/journal.pone.0152669	http://dx.doi.org/10.1371/journal.pone.0152669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031955	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800110
J	Duplaga, M				Duplaga, Mariusz			Searching for a Role of Nursing Personnel in Developing Landscape of Ehealth: Factors Determining Attitudes toward Key Patient Empowering Applications	PLOS ONE			English	Article							HEALTH INFORMATION; NURSES; MANAGEMENT; PARTICIPATION; INTERVENTIONS; ORGANIZATION; FRAMEWORK; DISEASES; CARE	Introduction Nurses may play an important role in the delivery of medical services based on the use of ehealth tools. Nevertheless, their taking an active role in an ehealth environment depends on their possessing the appropriate skills and mindset. The main objective of this paper was to assess nurses' opinions and to analyze the predictors of their acceptance of ehealth features relevant to patient empowerment with a strong focus on chronic care. Methods A survey was conducted among nurses from hospital centers of south-eastern Poland based on a questionnaire designed to assess their attitudes toward the ehealth domain. The predictors of the nurses' acceptance of ehealth usage within specific contexts were assessed with uni-and multivariate logistic regression. Results An analysis was performed on data from 648 questionnaires retained after a quality check. The duration of Internet use was consistently related to higher acceptance of ehealth applications and more certainty regarding the reliability of health-related information available on the Internet. Nurses from urban medical centers were more skeptical about the use of specific ehealth solutions. Conclusion Previous experience in using information technologies is the main factor influencing the acceptance of specific ehealth solutions relevant for care provided to patients suffering from chronic conditions.	[Duplaga, Mariusz] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Hlth Promot,Inst Publ Hlth, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Duplaga, M (corresponding author), Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Hlth Promot,Inst Publ Hlth, Krakow, Poland.	mmduplag@cyfronet.pl	Duplaga, Mariusz/HHZ-9721-2022	Duplaga, Mariusz/0000-0001-6963-8414	National Centre of Research and Development in Poland [13-0093-10]	National Centre of Research and Development in Poland	The study was partially supported from the resources of the project No 13-0093-10 funded by National Centre of Research and Development in Poland. The funder had no role in the study design, data collection and analysis, decision to publish, or in preparation of the manuscript. No additional external funding was received for this study. The author's effort not covered by the project mentioned above was carried out within the employment by the Jagiellonian University Medical College.	Allen A, 2000, TELEMEDICINE TODAY 2, V1, P43, DOI DOI 10.13031/2013.2695; Alpay LL, 2010, TELEMED J E-HEALTH, V16, P787, DOI 10.1089/tmj.2009.0156; Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Becker DM, 1998, ARCH INTERN MED, V158, P1533, DOI 10.1001/archinte.158.14.1533; Bond CS, 2009, STUD HEALTH TECHNOL, V146, P41, DOI 10.3233/978-1-60750-024-7-41; Booth RG, 2006, INT J NURS ED SCHOLA, V3, P1548; Bravo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0907-z; Canadian Nurses Association, 2007, TEL ROL NURS, P2; Castelli D, TELEHEALTH TECHNOLOG; Catwell L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000126; Centrum Systemow Informacyjnych w Ochronie Zdrowia (Centre of Information Systems in Healthcare), 2009, KIER INF E ZDROW POL; Chang J, 2011, INT J MED INFORM, V80, P332, DOI 10.1016/j.ijmedinf.2011.01.011; Clinton JD, 2003, SAGE ENCY SOCIAL SCI; Coye MJ, 2009, HEALTH AFFAIR, V28, P126, DOI 10.1377/hlthaff.28.1.126; Curran Mary A, 2005, J Am Acad Nurse Pract, V17, P495, DOI 10.1111/j.1745-7599.2005.00085.x; Dansky KH, 2006, EVAL PROGRAM PLANN, V29, P397, DOI 10.1016/j.evalprogplan.2006.08.009; Darbyshire P, 2004, J CLIN NURS, V13, P17, DOI 10.1046/j.1365-2702.2003.00823.x; Della Mea V, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e22; Dillon TW, 2005, CIN-COMPUT INFORM NU, V23, P139, DOI 10.1097/00024665-200505000-00009; Duplaga M, 2013, HYGIEA, V48, P553; Duplaga M, 2013, CIN-COMPUT INFORM NU, V31, P281, DOI 10.1097/NXN.0b013e31828a0d98; Edirippulige S, 2009, SER BIOMED ENG, P269, DOI 10.1007/978-3-642-01387-4_13; Elbert NJ, 2014, J MED INTERNET RES, V16, P182, DOI 10.2196/jmir.2790; European Commission Information Society and Media Directorate General, 2008, EMP BENCHM ICT US GE; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.2.e20; Forkner-Dunn J, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e8; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Ganesh J., 2004, INDIAN J MED INFORM, V1, P39; Garde S, 2005, INT J MED INFORM, V74, P899, DOI 10.1016/j.ijmedinf.2005.07.008; Gilmour JA, 2008, J ADV NURS, V61, P19, DOI 10.1111/j.1365-2648.2007.04460.x; Gilmour JA, 2012, J ADV NURS, V68, P1349, DOI 10.1111/j.1365-2648.2011.05845.x; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; Hardiker Nicholas R, 2012, Int Nurs Rev, V59, P435; Hegney D., 2007, NURSES INFORM TECHNO; Kuijpers W, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2281; Lupianez-Villanueva F, 2011, INT J MED INFORM, V80, P133, DOI 10.1016/j.ijmedinf.2010.11.001; Monteagudo JL, 2007, REPORT PRIORITY TOPI; Naczelna Rada Pielegniarek i Poloznych, 2010, WSTEPN OC ZAS KADR P; Nelson R, 2007, AM J NURS, V107, P25; Pagliari Claudia, 2005, J Med Internet Res, V7, pe9, DOI 10.2196/jmir.7.1.e9; Piotrowicz E, 2012, J TELEMED TELECARE, V18, P193, DOI 10.1258/jtt.2012.111005; Reed Kirby, 2005, J Am Acad Nurse Pract, V17, P176, DOI 10.1111/j.1745-7599.2005.0029.x; RISSEL C, 1994, HEALTH PROMOT INT, V9, P39, DOI 10.1093/heapro/9.1.39; Roberts Kathleen Johnston, 1999, Health Expect, V2, P82, DOI 10.1046/j.1369-6513.1999.00048.x; Rosen E, 2000, Telemed Today, V8, P14; Sabes-Figuera R, 2013, JRC SCI POLICY REPOR; Samoocha David, 2010, J Med Internet Res, V12, pe23, DOI 10.2196/jmir.1286; Sassen EJ, 2009, CIN-COMPUT INFORM NU, V27, P281, DOI 10.1097/NCN.0b013e3181b2162a; Seybert H., 2011, INTERNET USE HOUSEHO; Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-263; van Gemert-Pijnen JEWC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1672; van Uden-Kraan CF, 2009, PATIENT EDUC COUNS, V74, P61, DOI 10.1016/j.pec.2008.07.044; Vance B, 2015, PAPER PRESENTED AT T; World Health Organization, 1986, 1 INT C HLTH PROM OT; Yusof MM, 2008, INT J MED INFORM, V77, P386, DOI 10.1016/j.ijmedinf.2007.08.011	56	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153173	10.1371/journal.pone.0153173	http://dx.doi.org/10.1371/journal.pone.0153173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049525	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500110
J	Lopes, MW; Sapio, MR; Leal, RB; Fricker, LD				Lopes, Mark William; Sapio, Matthew R.; Leal, Rodrigo B.; Fricker, Lloyd D.			Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; AMPA RECEPTOR PHOSPHORYLATION; TIME-DEPENDENT MODULATION; PILOCARPINE MODEL; STATUS EPILEPTICUS; RAT HIPPOCAMPUS; CORTEX; ANTICONVULSANT; IDENTIFICATION; ENDOTHELIN-1	Carboxypeptidase A6 (CPA6) is an extracellular matrix metallocarboxypeptidase that modulates peptide and protein function by removal of hydrophobic C-terminal amino acids. Mutations in the human CPA6 gene that reduce enzymatic activity in the extracellular matrix are associated with febrile seizures, temporal lobe epilepsy, and juvenile myoclonic epilepsy. The characterization of these human mutations suggests a dominant mode of inheritance by haploinsufficiency through loss of function mutations, however the total number of humans with pathologic mutations in CPA6 identified to date remains small. To better understand the relationship between CPA6 and seizures we investigated the effects of morpholino knockdown of cpa6 mRNA in zebrafish (Danio rerio) larvae. Knockdown of cpa6 mRNA resulted in resistance to the effect of seizure-inducing drugs pentylenetetrazole and pilocarpine on swimming behaviors. Knockdown of cpa6 mRNA also reduced the levels of mRNAs encoding neuropeptide precursors (bdnf, npy, chga, pcsk1nl, tac1, nts, edn1), a neuropeptide processing enzyme (cpe), transcription factor (c-fos), and molecules implicated in glutamatergic signaling (grin1a and slc1a2b). Treatment of zebrafish embryos with 60 mM pilocarpine for 1 hour led to reductions in levels of many of the same mRNAs when measured 1 day after pilocarpine exposure, except for c-fos which was elevated 1 day after pilocarpine treatment. Pilocarpine treatment, like cpa6 knockdown, led to a reduced sensitivity to pentylenetetrazole when tested 1 day after pilocarpine treatment. Taken together, these results add to mounting evidence that peptidergic systems participate in the biological effects of seizure-inducing drugs, and are the first in vivo demonstration of the molecular and behavioral consequences of cpa6 insufficiency.	[Lopes, Mark William; Leal, Rodrigo B.] Univ Fed Santa Catarina, Programa Posgrad Bioquim, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Sapio, Matthew R.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Universidade Federal de Santa Catarina (UFSC); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA.; Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu	Sapio, Matthew R/J-5096-2016; Leal, Rodrigo Bainy/AAL-1938-2020; Lopes, Mark William/F-3109-2015	Sapio, Matthew R/0000-0002-8855-5419; Leal, Rodrigo/0000-0003-2536-6888; Lopes, Mark William/0000-0002-5292-8455	U. S. National Institutes of Health [R01-DA004494]; National Council for Scientific and Technological Development (CNPq) Brazil [308459/2013-0]; National Coordination for the Training and Improvement of Higher Education Personnel (CAPES) [249/14]; Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project) [1262/2012-9]; INCT-National Institute of Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Coordination for the Training and Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project); INCT-National Institute of Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U. S. National Institutes of Health grant R01-DA004494 and by the National Council for Scientific and Technological Development (CNPq) Brazil (#308459/2013-0); National Coordination for the Training and Improvement of Higher Education Personnel (CAPES; #249/14); Santa Catarina State Research Foundation (FAPESC/PRONEX Program - NENASC project; and #1262/2012-9), INCT-National Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Allen NM, 2016, EPILEPSIA, V57, pE12, DOI 10.1111/epi.13250; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2009, NEUROMETHODS, V40, P59, DOI 10.1007/978-1-60327-263-6_4; BARKAI E, 1994, J NEUROPHYSIOL, V72, P72, DOI 10.1152/jn.1994.72.1.72; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; BIAGINI G, 1995, NEUROSCI LETT, V190, P212, DOI 10.1016/0304-3940(95)11529-6; Brunson KL, 2002, INT REV NEUROBIOL, V49, P185; Campbell PD, 2014, J NEUROSCI, V34, P14717, DOI 10.1523/JNEUROSCI.2770-14.2014; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Clynen E, 2014, MOL NEUROBIOL, V50, P626, DOI 10.1007/s12035-014-8669-x; Eddins D, 2010, NEUROTOXICOL TERATOL, V32, P99, DOI 10.1016/j.ntt.2009.02.005; FERRENDELLI JA, 1989, EPILEPSIA, V30, P617, DOI 10.1111/j.1528-1157.1989.tb05482.x; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Goto EM, 2010, NEUROPEPTIDES, V44, P169, DOI 10.1016/j.npep.2009.12.007; Guipponi M, 2015, HUM MOL GENET, V24, P3082, DOI 10.1093/hmg/ddv060; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Jo SM, 2011, NEUROSCI LETT, V501, P25, DOI 10.1016/j.neulet.2011.06.032; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kovac S, 2013, NEUROPEPTIDES, V47, P467, DOI 10.1016/j.npep.2013.10.015; Kudo H, 2009, ENDOCRINOLOGY, V150, P1393, DOI 10.1210/en.2008-1301; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Lee HK, 2009, CHEMMEDCHEM, V4, P400, DOI 10.1002/cmdc.200800421; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lopes MW, 2015, NEUROCHEM INT, V87, P22, DOI 10.1016/j.neuint.2015.05.003; Lopes MW, 2013, EXP BRAIN RES, V226, P153, DOI 10.1007/s00221-013-3421-8; Lopes MW, 2012, NEUROCHEM RES, V37, P1868, DOI 10.1007/s11064-012-0797-y; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Lyons PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012967; McNamara J.O., 2012, JASPERS BASIC MECH E; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; MIRSKI MA, 1986, BRAIN RES, V399, P212, DOI 10.1016/0006-8993(86)91511-8; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Okumura A, 2006, SEIZURE-EUR J EPILEP, V15, P469, DOI 10.1016/j.seizure.2006.05.010; Patrylo PR, 1999, J NEUROPHYSIOL, V82, P478, DOI 10.1152/jn.1999.82.1.478; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; PSARROPOULOU C, 1994, EPILEPSIA, V35, P12, DOI 10.1111/j.1528-1157.1994.tb02906.x; Salzmann Annick, 2012, Epilepsy Res Treat, V2012, P863702, DOI 10.1155/2012/863702; Salzmann A, 2012, HUM MUTAT, V33, P124, DOI 10.1002/humu.21613; Sapio MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123180; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Sapio MR, 2012, J BIOL CHEM, V287, P42900, DOI 10.1074/jbc.M112.414094; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; SHANK RP, 1994, EPILEPSIA, V35, P450, DOI 10.1111/j.1528-1157.1994.tb02459.x; SHIMEKAKE Y, 1992, FEBS LETT, V309, P185, DOI 10.1016/0014-5793(92)81091-Y; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Tsenov G, 2007, EPILEPSIA, V48, P7, DOI 10.1111/j.1528-1167.2007.01282.x; Vermoesen K, 2011, EPILEPSY BEHAV, V22, P450, DOI 10.1016/j.yebeh.2011.08.016; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152905	10.1371/journal.pone.0152905	http://dx.doi.org/10.1371/journal.pone.0152905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050163	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500065
J	Sharma, S; Toledo, O; Hedden, M; Lyon, KF; Brooks, SB; David, RP; Limtong, J; Newsome, JM; Novakovic, N; Rajasekaran, S; Thapar, V; Williams, SR; Schiller, MR				Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Rajasekaran, Sanguthevar; Thapar, Vishal; Williams, Sean R.; Schiller, Martin R.			The Functional Human C-Terminome	PLOS ONE			English	Article							MINIMOTIF MINER; PROTEIN-INTERACTION; DATABASE; RESOURCE; DOMAIN; PREDICTION; SIGNATURES; DIVERSITY; LIGANDS; BINDING	All translated proteins end with a carboxylic acid commonly called the C-terminus. Many short functional sequences (minimotifs) are located on or immediately proximal to the C-terminus. However, information about the function of protein C-termini has not been consolidated into a single source. Here, we built a new "C-terminome" database and web system focused on human proteins. Approximately 3,600 C-termini in the human proteome have a minimotif with an established molecular function. To help evaluate the function of the remaining C-termini in the human proteome, we inferred minimotifs identified by experimentation in rodent cells, predicted minimotifs based upon consensus sequence matches, and predicted novel highly repetitive sequences in C-termini. Predictions can be ranked by enrichment scores or Gene Evolutionary Rate Profiling (GERP) scores, a measurement of evolutionary constraint. By searching for new anchored sequences on the last 10 amino acids of proteins in the human proteome with lengths between 3-10 residues and up to 5 degenerate positions in the consensus sequences, we have identified new consensus sequences that predict instances in the majority of human genes. All of this information is consolidated into a database that can be accessed through a C-terminome web system with search and browse functions for minimotifs and human proteins. A known consensus sequence-based predicted function is assigned to nearly half the proteins in the human proteome. Weblink: http://cterminome.bio-toolkit.com.	[Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Williams, Sean R.; Schiller, Martin R.] Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA; [Sharma, Surbhi; Toledo, Oniel; Hedden, Michael; Lyon, Kenneth F.; Brooks, Steven B.; David, Roxanne P.; Limtong, Justin; Newsome, Jacklyn M.; Novakovic, Nemanja; Williams, Sean R.; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Thapar, Vishal] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut; Harvard University; Massachusetts General Hospital	Schiller, MR (corresponding author), Univ Nevada, Nevada Inst Personalized Med, Las Vegas, NV 89154 USA.; Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823; Sharma, Surbhi/0000-0001-9288-2685; Novakovic, Nemanja/0000-0002-1681-7715	National Institutes of Health [R15 GM107983, R01 GM079689, R01 LM010101]; Graduate and Professional Students Association, University of Nevada, Las Vegas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689, R15GM107983] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate and Professional Students Association, University of Nevada, Las Vegas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institutes of Health (http://www.nih.gov) grants R15 GM107983, R01 GM079689 to MRS, and R01 LM010101 to SR. The Graduate and Professional Students Association, University of Nevada, Las Vegas also funded SS.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Attwood TK, 1997, J CHEM INF COMP SCI, V37, P417, DOI 10.1021/ci960468e; Austin RS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-191; Bahir I, 2005, NUCLEIC ACIDS RES, V33, pW277, DOI 10.1093/nar/gki371; Bahir I, 2006, PROTEINS, V63, P996, DOI 10.1002/prot.20903; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chung JJ, 2003, MOL CELL PROTEOMICS, V2, P173, DOI 10.1074/mcp.M300008-MCP200; Chung JJ, 2002, TRENDS CELL BIOL, V12, P146, DOI 10.1016/S0962-8924(01)02241-3; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Dinkel H, 2011, NUCL ACIDS RES; Ezkurdia I, 2014, HUM MOL GENET; Fernandez-Suarez XM, 2014, NUCLEIC ACIDS RES, V42, pD1, DOI 10.1093/nar/gkt1282; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FUJIKI Y, 1992, No To Hattatsu, V24, P181; Gatto GJ, 2003, GENOME RES, V13, P617, DOI 10.1101/gr.667603; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Lam HYK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-243; Lange PF, 2012, NUCLEIC ACIDS RES, V40, pD351, DOI 10.1093/nar/gkr1025; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lyon KF, 2015, NUCL ACIDS RES; McEntyre J, 2001, CAN MED ASSOC J, V164, P1317; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; Mullen RT, 1997, PLANT J, V12, P313, DOI 10.1046/j.1365-313X.1997.12020313.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Nikolaus Fortelny SY, 2014, NUCL ACIDS RES; Parthasarathi L, 2008, J CHEM INF MODEL, V48, P1943, DOI 10.1021/ci800174c; Prakash T, 2004, BIOINFORMATICS, V20, P2886, DOI 10.1093/bioinformatics/bth325; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Sargeant DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049957; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takeda J, 2010, NUCLEIC ACIDS RES, V38, pD86, DOI 10.1093/nar/gkp984; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Weatheritt RJ, 2012, NUCL ACIDS RES	54	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152731	10.1371/journal.pone.0152731	http://dx.doi.org/10.1371/journal.pone.0152731			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050421	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500051
J	Brendtke, R; Wiehl, M; Groeber, F; Schwarz, T; Walles, H; Hansmann, J				Brendtke, Rico; Wiehl, Michael; Groeber, Florian; Schwarz, Thomas; Walles, Heike; Hansmann, Jan			Feasibility Study on a Microwave-Based Sensor for Measuring Hydration Level Using Human Skin Models	PLOS ONE			English	Article							HYPERNATREMIA; PERFORMANCE; POWER	Tissue dehydration results in three major types of exsiccosis-hyper-, hypo-, or isonatraemia. All three types entail alterations of salt concentrations leading to impaired biochemical processes, and can finally cause severe morbidity. The aim of our study was to demonstrate the feasibility of a microwave-based sensor technology for the non-invasive measurement of the hydration status. Electromagnetic waves at high frequencies interact with molecules, especially water. Hence, if a sample contains free water molecules, this can be detected in a reflected microwave signal. To develop the sensor system, human three-dimensional skin equivalents were instituted as a standardized test platform mimicking reproducible exsiccosis scenarios. Therefore, skin equivalents with a specific hydration and density of matrix components were generated and microwave measurements were performed. Hydration-specific spectra allowed deriving the hydration state of the skin models. A further advantage of the skin equivalents was the characterization of the impact of distinct skin components on the measured signals to investigate mechanisms of signal generation. The results demonstrate the feasibility of a non-invasive microwave-based hydration sensor technology. The sensor bears potential to be integrated in a wearable medical device for personal health monitoring.	[Brendtke, Rico; Walles, Heike; Hansmann, Jan] Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med TERM, Roentgenring 11, D-97070 Wurzburg, Germany; [Brendtke, Rico; Wiehl, Michael] Senet Healthcare Grp GmbH & Co KG, Henkestr 91, D-91052 Erlangen, Germany; [Groeber, Florian; Schwarz, Thomas; Walles, Heike; Hansmann, Jan] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Translat Ctr Oncol Wuerzburg Regenerat Therapies, Roentgenring 11, D-97070 Wurzburg, Germany	University of Wurzburg; Fraunhofer Gesellschaft	Hansmann, J (corresponding author), Univ Hosp Wuerzburg, Chair Tissue Engn & Regenerat Med TERM, Roentgenring 11, D-97070 Wurzburg, Germany.; Hansmann, J (corresponding author), Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Translat Ctr Oncol Wuerzburg Regenerat Therapies, Roentgenring 11, D-97070 Wurzburg, Germany.	Jan.Hansmann@uni-wuerzburg.de		Walles, Heike/0000-0002-1512-7448	German Federal Ministry of Education and Research (BMBF) [16SV6259]; GmbH Co.	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); GmbH Co.	This project was supported by the German Federal Ministry of Education and Research (BMBF, funding number: 16SV6259). senetics healthcare group GmbH & Co. KG provided support in the form of salaries for authors [RB, MW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 60601 1 VDE 0750 1 2; Attas-Fox L, 2014, ORBIT, V33, P331, DOI 10.3109/01676830.2014.882362; Brendtke R, 2015, BR J HEAL INFORM MON, V2, P11; DAGGETT P, 1979, BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6172.1177; De Wever B., 2015, APPL IN VITRO TOXICO, V1, P5, DOI [10.1089/aivt.2014.0011, DOI 10.1089/AIVT.2014.0011, 10.1089/AIVT.2014.0011]; FAYAD IM, 1992, LANCET, V339, P389, DOI 10.1016/0140-6736(92)90079-I; Groeber F, 2014, PHARM RES, P1; Guiraud B, 2014, INT J COSMETIC SCI, V36, P485, DOI 10.1111/ics.12150; Hofmann M, 2013, IEEE TOPIC CONF BIOM, P46, DOI 10.1109/BioWireleSS.2013.6613670; Hofmann M., 2012, IEEE MTT S INT MICR, P1, DOI DOI 10.1109/MWSYM.2012.6259771; Hofmann M, 2013, MICROWAVE BASED NONI; Huang CY, 2014, SENSORS-BASEL, V14, P17586, DOI 10.3390/s140917586; Hung K., 2015, MOBILE HLTH, P319, DOI [DOI 10.1007/978-3-319-12817-7_15, 10.1007/978-3-319-12817-7_15]; ICRP, 2012, ICRP PUBL, V118, P40; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; JOINES WT, 1980, INT J RADIAT ONCOL, V6, P681, DOI 10.1016/0360-3016(80)90223-0; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kozier B., 2008, FUNDAMENTALS NURSING; LOVELL CR, 1987, BRIT J DERMATOL, V117, P419, DOI 10.1111/j.1365-2133.1987.tb04921.x; Marino FE, 2004, J THERM BIOL, V29, P21, DOI 10.1016/j.jtherbio.2003.08.008; Mathes SH, 2014, ADV DRUG DELIVER REV, V69, P81, DOI 10.1016/j.addr.2013.12.006; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Moritz ML, 2010, METAB BRAIN DIS, V25, P91, DOI 10.1007/s11011-010-9173-2; Oncescu V, 2013, LAB CHIP, V13, P3232, DOI 10.1039/c3lc50431j; Oppliger RA, 2002, SPORTS MED, V32, P959, DOI 10.2165/00007256-200232150-00001; Rami L, 2014, J BIOMED MATER RES A, V102, P3666, DOI 10.1002/jbm.a.35035; Rimann M, 2015, J LAB AUTOM; Sandulescu V, 2015, LECT NOTES COMPUT SC, V9107, P526, DOI 10.1007/978-3-319-18914-7_55; Sawka MN, 2001, COMP BIOCHEM PHYS A, V128, P679, DOI 10.1016/S1095-6433(01)00274-4; Schwerthoeffer U., 2014, P GERM MICR C GEMIC, P1; Semenov S, 2009, PHILOS T R SOC A, V367, P3021, DOI 10.1098/rsta.2009.0092; Solovei D, 2015, SENSORS-BASEL, V15, P1479, DOI 10.3390/s150101479; Sterns R. H., 2013, HYPONATREMIA SE 12, P221, DOI [DOI 10.1007/978-1-4614-6645-1_12, 10.1007/978-1-4614-6645-1_12]; Tucker R, 2004, PFLUG ARCH EUR J PHY, V448, P422, DOI 10.1007/s00424-004-1267-4; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Walsh NP, 2004, MED SCI SPORT EXERC, V36; Wheeler H.A., 1942, P IRE, V30, P412, DOI DOI 10.1109/JRPROC.1942.232015; WHO, 2014, WORLD WAT DEV REP WW, V1, P1	40	11	11	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153145	10.1371/journal.pone.0153145	http://dx.doi.org/10.1371/journal.pone.0153145			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046226	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600071
J	Girerd, N; Rabilloud, M; Pibarot, P; Mathieu, P; Roy, P				Girerd, Nicolas; Rabilloud, Muriel; Pibarot, Philippe; Mathieu, Patrick; Roy, Pascal			Quantification of Treatment Effect Modification on Both an Additive and Multiplicative Scale	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; ABSOLUTE EFFECT MEASURES; SURVIVAL ANALYSIS; MEDICAL JOURNALS; HEART-FAILURE; RISK; HAZARDS; TIME; REVASCULARIZATION; GUIDELINES	Background In both observational and randomized studies, associations with overall survival are by and large assessed on a multiplicative scale using the Cox model. However, clinicians and clinical researchers have an ardent interest in assessing absolute benefit associated with treatments. In older patients, some studies have reported lower relative treatment effect, which might translate into similar or even greater absolute treatment effect given their high baseline hazard for clinical events. Methods The effect of treatment and the effect modification of treatment were respectively assessed using a multiplicative and an additive hazard model in an analysis adjusted for propensity score in the context of coronary surgery. Results The multiplicative model yielded a lower relative hazard reduction with bilateral internal thoracic artery grafting in older patients (Hazard ratio for interaction/year = 1.03, 95% CI: 1.00 to 1.06, p = 0.05) whereas the additive model reported a similar absolute hazard reduction with increasing age (Delta for interaction/ year = 0.10, 95% CI: -0.27 to 0.46, p = 0.61). The number needed to treat derived from the propensity score-adjusted multiplicative model was remarkably similar at the end of the follow-up in patients aged < = 60 and in patients > 70. Conclusions The present example demonstrates that a lower treatment effect in older patients on a relative scale can conversely translate into a similar treatment effect on an additive scale due to large baseline hazard differences. Importantly, absolute risk reduction, either crude or adjusted, can be calculated from multiplicative survival models. We advocate for a wider use of the absolute scale, especially using additive hazard models, to assess treatment effect and treatment effect modification.	[Girerd, Nicolas] Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 1433, Nancy, France; [Rabilloud, Muriel; Roy, Pascal] Hosp Civils Lyon, Serv Biostat, F-69003 Lyon, France; [Rabilloud, Muriel; Roy, Pascal] Univ Lyon, F-69000 Lyon, France; [Rabilloud, Muriel; Roy, Pascal] Univ Lyon 1, F-69100 Villeurbanne, France; [Rabilloud, Muriel; Roy, Pascal] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, F-69100 Villeurbanne, France; [Pibarot, Philippe] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Mathieu, Patrick] Univ Laval, Dept Surg, Quebec City, PQ, Canada	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Laval University; Laval University	Girerd, N (corresponding author), Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 1433, Nancy, France.	nicolas_girerd@yahoo.com	GIRERD, Nicolas/D-5493-2011; Pibarot, Philippe/ABD-5300-2021	Girerd, Nicolas/0000-0002-3278-2057; Roy, Pascal/0000-0003-3837-3198				Abadi A, 2011, ASIAN PAC J CANCER P, V12, P3113; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Barratt A, 2004, CAN MED ASSOC J, V171, P353, DOI 10.1503/cmaj.1021197; Blix K, 2014, EUR J EPIDEMIOL, V29, P277, DOI 10.1007/s10654-014-9902-7; Coiro S, 2015, HEART RHYTHM, V12, pE138, DOI 10.1016/j.hrthm.2015.08.008; COUGHLIN SS, 1991, AM J EPIDEMIOL, V133, P305, DOI 10.1093/oxfordjournals.aje.a115875; Ferreira JP, 2015, AM J CARDIOL, V116, P829, DOI 10.1016/j.amjcard.2015.07.023; Gigerenzer G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4830; Giolo SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037392; Girerd N, 2015, DIABETES METAB, V41, P446, DOI 10.1016/j.diabet.2015.06.004; Girerd N, 2015, EUR HEART J, V36, P2310, DOI 10.1093/eurheartj/ehv273; Girerd N, 2014, J CLIN EPIDEMIOL, V67, P236, DOI 10.1016/j.jclinepi.2013.08.010; Girerd N, 2012, ANN THORAC SURG, V94, P1166, DOI 10.1016/j.athoracsur.2012.05.023; Gram IT, 2013, EUR J EPIDEMIOL, V28, P799, DOI 10.1007/s10654-013-9851-6; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P825, DOI 10.1007/s10654-011-9613-2; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Martinussen T, 2009, LIFETIME DATA ANAL, V15, P330, DOI 10.1007/s10985-009-9111-y; Mohammadi S, 2012, ANN THORAC SURG, V93, P1432, DOI 10.1016/j.athoracsur.2012.02.033; Mohammadi S, 2008, EUR J CARDIO-THORAC, V33, P977, DOI 10.1016/j.ejcts.2008.03.026; Nordahl H, 2013, EUR J EPIDEMIOL, V28, P149, DOI [10.1007/s10654-012-9745-z, 10.1007/s10]; Rod NH, 2012, EPIDEMIOLOGY, V23, P733, DOI 10.1097/EDE.0b013e31825fa218; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Smulders Y, 2014, NEW ENGL J MED, V371, P579, DOI 10.1056/NEJMc1406283; Spencer FA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7401; Suissa D, 2012, J CLIN EPIDEMIOL, V65, P42, DOI 10.1016/j.jclinepi.2011.04.009; Venekamp RP, 2014, J CLIN EPIDEMIOL, V67, P410, DOI 10.1016/j.jclinepi.2013.11.003; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	37	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153010	10.1371/journal.pone.0153010	http://dx.doi.org/10.1371/journal.pone.0153010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045168	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600057
J	Miller, CL; Muthupalani, S; Shen, Z; Drees, F; Ge, ZM; Feng, Y; Chen, XW; Gong, GY; Nagar, KK; Wang, TC; Gertler, FB; Fox, JG				Miller, Cassandra L.; Muthupalani, Sureshkumar; Shen, Zeli; Drees, Frauke; Ge, Zhongming; Feng, Yan; Chen, Xiaowei; Gong, Guanyu; Nagar, Karan K.; Wang, Timothy C.; Gertler, Frank B.; Fox, James G.			Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma	PLOS ONE			English	Article							HELICOBACTER-HEPATICUS INFECTION; INFLAMMATORY-BOWEL-DISEASE; PYLORI INFECTION; COLON-CANCER; GASTRIC INFLAMMATION; BACTERIAL-INFECTION; MOUSE MODELS; A/JCR MICE; COLITIS; TISSUE	During a survey of clinical rectal prolapse (RP) cases in the mouse population at MIT animal research facilities, a high incidence of RP in the lamellipodin knock-out strain, C57BL/6-Raph1tm1Fbg (Lpd(-/-)) was documented. Upon further investigation, the Lpd(-/-) colony was found to be infected with multiple endemic enterohepatic Helicobacter species (EHS). Lpd(-/-) mice, a transgenic mouse strain produced at MIT, have not previously shown a distinct immune phenotype and are not highly susceptible to other opportunistic infections. Predominantly male Lpd(-/-) mice with RP exhibited lesions consistent with invasive rectal carcinoma concomitant to clinically evident RP. Multiple inflammatory cytokines, CD11b+Gr1+myeloid-derived suppressor cell (MDSC) populations, and epithelial cells positive for a DNA damage biomarker, H2AX, were elevated in affected tissue, supporting their role in the neoplastic process. An evaluation of Lpd(-/-) mice with RP compared to EHS-infected, but clinically normal (CN) Lpd(-/-) animals indicated that all of these mice exhibit some degree of lower bowel inflammation; however, mice with prolapses had significantly higher degree of focal lesions at the colo-rectal junction. When Helicobacter spp. infections were eliminated in Lpd(-/-) mice by embryo transfer rederivation, the disease phenotype was abrogated, implicating EHS as a contributing factor in the development of rectal carcinoma. Here we describe lesions in Lpd(-/-) male mice consistent with a focal inflammation-induced neoplastic transformation and propose this strain as a mouse model of rectal carcinoma.	[Miller, Cassandra L.; Muthupalani, Sureshkumar; Shen, Zeli; Ge, Zhongming; Feng, Yan; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Drees, Frauke; Gertler, Frank B.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Xiaowei; Nagar, Karan K.; Wang, Timothy C.] Columbia Univ, Div Digest & Liver Dis, New York, NY USA; [Gong, Guanyu; Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Miller, Cassandra L.] SNBL USA Ltd, Everett, WA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Columbia University; Massachusetts Institute of Technology (MIT)	Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.; Fox, JG (corresponding author), MIT, Dept Biol Engn, Cambridge, MA 02139 USA.	jgfox@mit.edu	Muthupalani, Sureshkumar/C-7244-2015; Gong, Guanyu/ABA-1935-2021	Gong, Guanyu/0000-0002-5791-0916; Ge, Zhongming/0000-0003-0924-7563; Wang, Timothy/0000-0001-5730-3019	NIH [T32-OD010978, R01-OD011141, P30-ES002109]; Ludwig Center at MIT [U54-CA114462]; NCI Core grant [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA114462, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978, R01OD011141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at MIT; NCI Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants T32-OD010978, R01-OD011141, and P30-ES002109 (to JGF); funds from the Ludwig Center at MIT, U54-CA114462 (FBG); and NCI Core grant P30-CA14051 (Koch Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Bae YH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004838; BARTHOLD SW, 1978, VET PATHOL, V15, P223, DOI 10.1177/030098587801500209; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Carmona G, ONCOGENE IN PRESS; Chan V, 2005, HELICOBACTER, V10, P114, DOI 10.1111/j.1523-5378.2005.00298.x; Chandanos E, 2008, EUR J CANCER, V44, P2397, DOI 10.1016/j.ejca.2008.07.031; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chin EY, 2000, COMPARATIVE MED, V50, P586; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Coppolino MG, 2001, J CELL SCI, V114, P4307; Corley DA, 2009, GUT, V58, P182, DOI 10.1136/gut.2008.163360; Drazenovich NL, 2002, COMPARATIVE MED, V52, P347; EDIGER RD, 1974, LAB ANIM SCI, V24, P488; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Engle SJ, 2002, CANCER RES, V62, P6362; Erdman SE, 1997, AM J PATHOL, V151, P273; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443; Feng SL, 2005, CLIN DIAGN LAB IMMUN, V12, P531, DOI 10.1128/CDLI.12.4.531-536.2005; Foltz CJ, 1998, HELICOBACTER, V3, P69, DOI 10.1046/j.1523-5378.1998.08006.x; FORMAN D, 1993, LANCET, V341, P1359; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; FOX JG, 1991, INFECT IMMUN, V59, P1875, DOI 10.1128/IAI.59.6.1875-1880.1991; Fox JG, 1997, VET PATHOL, V34, P225, DOI 10.1177/030098589703400308; FOX JG, 1990, GASTROENTEROLOGY, V99, P352, DOI 10.1016/0016-5085(90)91016-Y; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Fox JG, 1999, INFECT IMMUN, V67, P1757; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Ge ZM, 2001, J CLIN MICROBIOL, V39, P2598, DOI 10.1128/JCM.39.7.2598-2602.2001; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Hanada K, 2014, INFECT IMMUN, V82, P4182, DOI 10.1128/IAI.02368-14; Huang FY, 2013, EUR J CANCER, V49, P2760, DOI 10.1016/j.ejca.2013.03.031; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; KARNES WE, 1991, GASTROENTEROLOGY, V101, P167, DOI 10.1016/0016-5085(91)90474-Y; Knauer O, 2008, CELL MICROBIOL, V10, P2285, DOI 10.1111/j.1462-5822.2008.01207.x; Knutson CG, 2013, P NATL ACAD SCI USA, V110, pE2332, DOI 10.1073/pnas.1222669110; Koeppel M, 2015, CELL REP, V11, P1703, DOI 10.1016/j.celrep.2015.05.030; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Law AL, 2013, J CELL BIOL, V203, P673, DOI 10.1083/jcb.201304051; Lee UJ, 2008, AM J PHYSIOL-RENAL, V295, pF545, DOI 10.1152/ajprenal.00063.2008; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Miller CL, 2014, COMPARATIVE MED, V64, P171; Mutsaers AJ, 2003, J VET INTERN MED, V17, P136, DOI 10.1892/0891-6640(2003)017&lt;0136:CTCC&gt;2.3.CO;2; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nguyen DD, 2013, INFLAMM BOWEL DIS, V19, P2041, DOI 10.1097/MIB.0b013e318295fd8f; Ohtani M, 2011, CARCINOGENESIS, V32, P1244, DOI 10.1093/carcin/bgr072; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Percy DH, 2007, PATHOLOGY LAB RODENT; Petignat P, 2007, BMJ-BRIT MED J, V335, P765, DOI 10.1136/bmj.39337.615197.80; Pinheiro EM, 2011, NAT CELL BIOL, V13, P989, DOI 10.1038/ncb2292; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Rogers Arlin B., 2009, V511, P267, DOI 10.1007/978-1-59745-447-6_11; Runck LA, 2010, CELL CYCLE, V9, P3039, DOI 10.4161/cc.9.15.12437; SHAMES B, 1995, J CLIN MICROBIOL, V33, P2968, DOI 10.1128/JCM.33.11.2968-2972.1995; Sheh A, 2011, CANCER PREV RES, V4, P1426, DOI 10.1158/1940-6207.CAPR-11-0219; Shen ZL, 2000, HELICOBACTER, V5, P121, DOI 10.1046/j.1523-5378.2000.00019.x; Shomer NH, 1998, LAB ANIM SCI, V48, P455; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Smith K, 2010, CELL HOST MICROBE, V7, P13, DOI 10.1016/j.chom.2009.12.004; Takayama H, 2001, LAB INVEST, V81, P297, DOI 10.1038/labinvest.3780238; Tasaka G, 2012, J NEUROSCI, V32, P8293, DOI 10.1523/JNEUROSCI.0799-12.2012; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; U.S. Cancer Statistics Working Group United States Cancer Statistics, 2013, 1999 2009 INC MORT W; VANZANTEN SJOV, 1994, CAN MED ASSOC J, V150, P177; Ward JM, 1996, LAB ANIM SCI, V46, P15; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Whary MT, 2001, COMPARATIVE MED, V51, P413; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zhang P, 2013, ONCOGENE, V32, P2087, DOI 10.1038/onc.2012.220; Zhu YT, 2012, EXP CELL RES, V318, P2520, DOI 10.1016/j.yexcr.2012.07.021	91	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152940	10.1371/journal.pone.0152940	http://dx.doi.org/10.1371/journal.pone.0152940			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045955	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600050
J	Cernvall, M; Hoven, E; Ljungman, L; Ljungman, G; Carlbring, P; von Essen, L				Cernvall, Martin; Hoven, Emma; Ljungman, Lisa; Ljungman, Gustaf; Carlbring, Per; von Essen, Louise			Posttraumatic Stress and Attentional Bias towards Cancer-Related Stimuli in Parents of Children Recently Diagnosed with Cancer	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; CHILDHOOD-CANCER; PTSD CHECKLIST; SYMPTOMS; INFORMATION; THREAT; DISORDERS; ANXIETY; TRAUMA	Objectives To investigate whether posttraumatic stress symptoms (PTSS) are related to attentional bias towards cancer-related stimuli among parents of children recently diagnosed with cancer. Methods Sixty-two parents completed questionnaires measuring PTSS, depression, and anxiety and the emotional Stroop task via the Internet. The emotional Stroop task included cancer-related words, cardiovascular disease-related words, and neutral words. Results Participants were split in two groups based on the median of PTSS: High-PTSS and Low-PTSS. There was a significant interaction between word-type and group and a planned contrast test of this interaction indicated that the High-PTSS group had longer response latencies on cancer-related words compared to the other word-type and group combinations. Conclusions Findings suggest that PTSS are related to attentional bias towards cancer-related stimuli among parents of children recently diagnosed with cancer. Implications of this finding for the understanding of PTSS in this population, future research, and clinical practice are discussed.	[Cernvall, Martin; Hoven, Emma; Ljungman, Lisa; von Essen, Louise] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden; [Ljungman, Gustaf] Uppsala Univ, Dept Womens & Childrens Hlth, Pediat Oncol, Uppsala, Sweden; [Carlbring, Per] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Uppsala University; Uppsala University; Stockholm University	Cernvall, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden.	martin.cernvall@pubcare.uu.se	Carlbring, Per/D-3628-2009; Carlbring, Per/R-1220-2019	Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Ljungman, Lisa/0000-0002-4512-8900; Hoven, Emma/0000-0001-9335-9714; Ljungman, Gustaf/0000-0002-4949-2494	Swedish Research Council [K2008-70X-20836-01-3, K2011-70X-20836-04-4]; Swedish Cancer Society [2010/276]; Swedish Childhood Cancer Foundation [PROJ08/010, PROJ12/028]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	This research was supported by grants from the Swedish Research Council (www.vr.se, grant numbers K2008-70X-20836-01-3, K2011-70X-20836-04-4), the Swedish Cancer Society (www.cancerfonden.se, grant number 2010/276), and the Swedish Childhood Cancer Foundation (www.barncancerfonden.se, grant numbers PROJ08/010, PROJ12/028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620; BRYANT RA, 1995, J ABNORM PSYCHOL, V104, P537, DOI 10.1037/0021-843X.104.3.537; Cernvall M, 2016, J CLIN PSYCHOL MED S, V23, P67, DOI 10.1007/s10880-015-9437-4; Cernvall M, 2015, PSYCHO-ONCOLOGY, V24, P1152, DOI 10.1002/pon.3788; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Dolgin MJ, 2007, J PEDIATR PSYCHOL, V32, P771, DOI 10.1093/jpepsy/jsm013; Dunn MJ, 2012, HEALTH PSYCHOL, V31, P176, DOI 10.1037/a0025545; Erblich J, 2003, HEALTH PSYCHOL, V22, P235, DOI 10.1037/0278-6133.22.3.235; Flory JD, 2015, DIALOGUES CLIN NEURO, V17, P141; FOA EB, 1991, J ABNORM PSYCHOL, V100, P156, DOI 10.1037/0021-843X.100.2.156; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; HALL M, 1995, J APPL SOC PSYCHOL, V25, P1215, DOI 10.1111/j.1559-1816.1995.tb02615.x; Harvey AG, 1996, COGNITIVE THER RES, V20, P613, DOI 10.1007/BF02227964; Johansson L, 2008, SCAND J PSYCHOL, V49, P69, DOI 10.1111/j.1467-9450.2007.00606.x; Karademas EC, 2008, J HEALTH PSYCHOL, V13, P28, DOI 10.1177/1359105307084309; KASPI SP, 1995, COGNITIVE THER RES, V19, P433, DOI 10.1007/BF02230410; Kazak AE, 2005, J CLIN ONCOL, V23, P7405, DOI 10.1200/JCO.2005.09.110; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Linnman C, 2006, COMPUT HUM BEHAV, V22, P448, DOI 10.1016/j.chb.2004.09.010; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C, 2011, EMOT REV, V3, P62, DOI 10.1177/1754073910380970; Mundy E, 2004, CURR OPIN PSYCHIATR, V17, P123, DOI 10.1097/00001504-200403000-00009; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Pergamin-Hight L, 2015, CLIN PSYCHOL REV, V35, P10, DOI 10.1016/j.cpr.2014.10.005; Phipps S, 2006, J PEDIATR PSYCHOL, V31, P298, DOI 10.1093/jpepsy/jsj033; Phipps S, 2005, PEDIATR BLOOD CANCER, V45, P952, DOI 10.1002/pbc.20373; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Singh J. K., 2003, Artificial breeding and reproduction management in buffaloes: compendium of the lectures delivered in the Indian Council of Agricultural Research, Summer School, Central Institute for Research on Buffaloes, Sirsa Road, Hisar, Haryana, India, 10-30 June 2003, P127; Todd J, 2014, INT J BEHAV MED, V21, P470, DOI 10.1007/s12529-013-9328-8; VRANA SR, 1995, J ANXIETY DISORD, V9, P515, DOI 10.1016/0887-6185(95)00028-M; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	45	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152778	10.1371/journal.pone.0152778	http://dx.doi.org/10.1371/journal.pone.0152778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035912	gold, Green Published, Green Submitted			2022-12-27	WOS:000373201200038
J	Hoang, DT; Hara, M; Jo, J				Danh-Tai Hoang; Hara, Manami; Jo, Junghyo			Design Principles of Pancreatic Islets: Glucose-Dependent Coordination of Hormone Pulses	PLOS ONE			English	Article							INHIBITS GLUCAGON-SECRETION; POSITIVE AUTOCRINE SIGNAL; BETA-CELL FUNCTION; ALPHA-CELLS; INSULIN-SECRETION; CA2+ OSCILLATIONS; PULSATILE INSULIN; CANINE PANCREAS; SOMATOSTATIN; RELEASE	Pancreatic islets are functional units involved in glucose homeostasis. The multicellular system comprises three main cell types; beta and a cells reciprocally decrease and increase blood glucose by producing insulin and glucagon pulses, while the role of delta cells is less clear. Although their spatial organization and the paracrine/autocrine interactions between them have been extensively studied, the functional implications of the design principles are still lacking. In this study, we formulated a mathematical model that integrates the pulsatility of hormone secretion and the interactions and organization of islet cells and examined the effects of different cellular compositions and organizations in mouse and human islets. A common feature of both species was that islet cells produced synchronous hormone pulses under low-and high-glucose conditions, while they produced asynchronous hormone pulses under normal glucose conditions. However, the synchronous coordination of insulin and glucagon pulses at low glucose was more pronounced in human islets that had more a cells. When beta cells were selectively removed to mimic diabetic conditions, the anti-synchronicity of insulin and glucagon pulses was deteriorated at high glucose, but it could be partially recovered when the re-aggregation of remaining cells was considered. Finally, the third cell type, delta cells, which introduced additional complexity in the multicellular system, prevented the excessive synchronization of hormone pulses. Our computational study suggests that controllable synchronization is a design principle of pancreatic islets.	[Danh-Tai Hoang; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang 36763, Gyeongbuk, South Korea; [Danh-Tai Hoang] Quang Binh Univ, Dept Nat Sci, Dong Hoi 510000, Quang Binh, Vietnam; [Hara, Manami] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jo, Junghyo] Pohang Univ Sci & Technol, Dept Phys, Pohang 36763, Gyeongbuk, South Korea	Asia Pacific Center for Theoretical Physics; University of Chicago; Pohang University of Science & Technology (POSTECH)	Jo, J (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang 36763, Gyeongbuk, South Korea.; Jo, J (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang 36763, Gyeongbuk, South Korea.	jojunghyo@apctp.org	Hara, Masayuki/AAH-4361-2019	Hoang, Danh-Tai/0000-0003-2640-4196	Basic Science Research Program through National Foundation of Korea - Ministry of Science, ICT & Future Planning [2013R1A1A1006655]; Max Planck Society; Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City;  [DK-020595];  [DK-072473];  [AG-042151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	Basic Science Research Program through National Foundation of Korea - Ministry of Science, ICT & Future Planning; Max Planck Society(Max Planck Society); Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by Basic Science Research Program through the National Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (No. 2013R1A1A1006655) and by the Max Planck Society, the Korea Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J. J.), and DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (M.H.).	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Almaca J, 2015, DIABETOLOGIA, V58, P2810, DOI 10.1007/s00125-015-3747-9; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; BERTRAND G, 1990, EUR J PHARMACOL, V182, P369, DOI 10.1016/0014-2999(90)90296-I; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Brereton H, 2007, ENDOCRINE, V31, P61, DOI 10.1007/s12020-007-0004-0; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; CHERRINGTON AD, 1976, J CLIN INVEST, V58, P1407, DOI 10.1172/JCI108596; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; DALEY ML, 1981, DIABETOLOGIA, V21, P238; Daunt M, 2006, ENDOCRINOLOGY, V147, P1527, DOI 10.1210/en.2005-0873; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gilon P., 2015, ISLETS LANGERHANS, V2nd, P175; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; GRAPENGIESSER E, 1991, J BIOL CHEM, V266, P12207; GUILLEMIN R, 1976, ANNU REV MED, V27, P379, DOI 10.1146/annurev.me.27.020176.002115; Gylfe E, 2014, DIABETES OBES METAB, V16, P102, DOI 10.1111/dom.12345; HANSEN BC, 1982, J CLIN ENDOCR METAB, V54, P785, DOI 10.1210/jcem-54-4-785; Hellman B, 2012, BIOCHEM BIOPH RES CO, V417, P1219, DOI 10.1016/j.bbrc.2011.12.113; Hellman B, 2009, ENDOCRINOLOGY, V150, P5334, DOI 10.1210/en.2009-0600; Hoang DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110384; HONEY RN, 1979, LIFE SCI, V24, P1747, DOI 10.1016/0024-3205(79)90062-6; Hong H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032711; Hraha TH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003819; Hraha TH, 2014, BIOPHYS J, V106, P299, DOI 10.1016/j.bpj.2013.11.026; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; JASPAN JB, 1986, AM J PHYSIOL, V251, pE215, DOI 10.1152/ajpendo.1986.251.2.E215; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Leibiger B, 2012, P NATL ACAD SCI USA, V109, P20925, DOI 10.1073/pnas.1212870110; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Li J, 2015, FASEB J, V29, P3379, DOI 10.1096/fj.14-265918; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; Louzada VHP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00658; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nittala A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000983; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PATTON GS, 1976, METABOLISM, V25, P1499, DOI 10.1016/S0026-0495(76)80177-1; Pikovsky A., 2001, SYNCHRONIZATION UNIV, V12; Press W. H., 1992, ART SCI COMPUTING; Ramracheya R, 2010, DIABETES, V59, P2198, DOI 10.2337/db09-1505; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rohrer S, 2012, J CLIN ENDOCR METAB, V97, pE791, DOI 10.1210/jc.2011-3439; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SAMOLS E, 1976, METABOLISM, V25, P1443, DOI 10.1016/S0026-0495(76)80161-8; SAMOLS E, 1965, LANCET, V2, P415; SHERMAN A, 1991, BIOPHYS J, V59, P547, DOI 10.1016/S0006-3495(91)82271-8; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tuduri E, 2008, AM J PHYSIOL-ENDOC M, V294, pE952, DOI 10.1152/ajpendo.00641.2007; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Walker JN, 2011, DIABETES OBES METAB, V13, P95, DOI 10.1111/j.1463-1326.2011.01450.x; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; WEIR GC, 1978, METABOLISM, V27, P1223, DOI 10.1016/0026-0495(78)90047-1	70	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152446	10.1371/journal.pone.0152446	http://dx.doi.org/10.1371/journal.pone.0152446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035570	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200018
J	Hsu, YH; Hsu, YL; Liu, SH; Liao, HC; Lee, PX; Lin, CH; Lo, LC; Fu, SL				Hsu, Ya-Hsin; Hsu, Yu-Ling; Liu, Sheng-Hung; Liao, Hsin-Chia; Lee, Po-Xuan; Lin, Chao-Hsiung; Lo, Lee-Chiang; Fu, Shu-Ling			Development of a Bifunctional Andrographolide-Based Chemical Probe for Pharmacological Study	PLOS ONE			English	Article							NATURAL-PRODUCTS; V-SRC; INFLAMMATION; SUPPRESSION; INHIBITION; ACTIVATION; ANALOGS; TARGETS	Andrographolide (ANDRO) is a lactone diterpenoid compound present in the medicinal plant Andrographis paniculata which is clinically applied for multiple human diseases in Asia and Europe. The pharmacological activities of andrographolide have been widely demonstrated, including anti-inflammation, anti-cancer and hepatoprotection. However, the pharmacological mechanism of andrographolide remains unclear. Therefore, further characterization on the kinetics and molecular targets of andrographolide is essential. In this study, we described the synthesis and characterization of a novel fluorescent andrographolide derivative (ANDRO-NBD). ANDRO-NBD exhibited a comparable anti-cancer spectrum to andrographolide: ANDRO-NBD was cytotoxic to various types of cancer cells and suppressed the migration activity of melanoma cells; ANDRO-NBD treatment induced the cleavage of heat shock protein 90 (Hsp90) and the downregulation of its client oncoproteins, v-Src and Bcr-abl. Notably, ANDRO-NBD showed superior inhibitory effects to andrographolide in all anticancer assays we have performed. In addition, ANDRO-NBD was further used as a fluorescent probe to investigate the uptake kinetics, cellular distribution and molecular targets of andrographolide. Our data revealed that ANDRO-NBD entered cells rapidly and its fluorescent signal could be detected in nucleus, cytoplasm, mitochondria, and lysosome. Moreover, we demonstrated that ANDRO-NBD was covalently bound to several putative target proteins of andrographolide, including NF-kappa B and hnRNPK. In summary, we developed a fluorescent andrographolide probe with comparable bioactivity to andrographolide, which serves as a powerful tool to explore the pharmacological mechanism of andrographolide.	[Hsu, Ya-Hsin; Liao, Hsin-Chia; Lee, Po-Xuan; Fu, Shu-Ling] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Hsu, Yu-Ling; Lo, Lee-Chiang] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Liu, Sheng-Hung] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Liu, Sheng-Hung; Fu, Shu-Ling] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Liu, Sheng-Hung; Fu, Shu-Ling] Acad Sinica, Taipei 115, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Fu, SL (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan.; Lo, LC (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.; Fu, SL (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan.; Fu, SL (corresponding author), Acad Sinica, Taipei 115, Taiwan.	lclo@ntu.edu.tw; slfu@ym.edu.tw		Fu, Shu-ling/0000-0003-2895-225X; LIN, CHAO-HSIUNG/0000-0001-6344-271X	Ministry of Science and Technology in Taiwan [MOST-102-2113-M-002-004-MY3, MOST 103-2320-B-010-007-MY3, MOST 104-3011-B-010-001, MOST-104-2311-B-010-005]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Funded by Ministry of Science and Technology in Taiwan (https://www.most.gov.tw/en/public); Grant number: MOST-102-2113-M-002-004-MY3, MOST 103-2320-B-010-007-MY3, MOST 104-3011-B-010-001 and MOST-104-2311-B-010-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1992, BIOCHEM PHARMACOL, V43, P301, DOI 10.1016/0006-2952(92)90292-Q; Barnes KR, 2008, BIOCONJUGATE CHEM, V19, P130, DOI 10.1021/bc7002204; Bottcher T, 2010, ANGEW CHEM INT EDIT, V49, P2680, DOI 10.1002/anie.200905352; Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D; Chao HP, 2010, PLANTA MED, V76, P1827, DOI 10.1055/s-0030-1250039; Gersch M, 2012, NAT PROD REP, V29, P659, DOI 10.1039/c2np20012k; Haldar S, 2013, J ORG CHEM, V78, P10192, DOI 10.1021/jo401559t; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Jayakumar T, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/846740; Kligler B, 2006, EXPLORE-NY, V2, P25, DOI 10.1016/j.explore.2005.08.008; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Li L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11522; Liang FP, 2008, J BIOL CHEM, V283, P5023, DOI 10.1074/jbc.M705877200; Lim JCW, 2012, CLIN EXP PHARMACOL P, V39, P300, DOI 10.1111/j.1440-1681.2011.05633.x; Liu SH, 2014, BIOCHEM PHARMACOL, V87, P229, DOI 10.1016/j.bcp.2013.10.014; Liu SH, 2010, J AGR FOOD CHEM, V58, P10831, DOI 10.1021/jf1017093; Sirion U, 2012, BIOORG MED CHEM LETT, V22, P49, DOI 10.1016/j.bmcl.2011.11.085; Varma A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep135; Wang JG, 2014, MOL CELL PROTEOMICS, V13, P876, DOI 10.1074/mcp.M113.029793; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Ye JF, 2011, BIOL PHARM BULL, V34, P1666, DOI 10.1248/bpb.34.1666; Zhou B, 2013, MINI-REV MED CHEM, V13, P298	22	8	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152770	10.1371/journal.pone.0152770	http://dx.doi.org/10.1371/journal.pone.0152770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035713	gold, Green Published, Green Submitted			2022-12-27	WOS:000373201200036
J	Cavallaro, FL; Cresswell, JA; Ronsmans, C				Cavallaro, Francesca L.; Cresswell, Jenny A.; Ronsmans, Carine			Obstetricians' Opinions of the Optimal Caesarean Rate: A Global Survey	PLOS ONE			English	Article							MATERNAL REQUEST; SECTION RATES; PERSONAL PREFERENCE; INCOME COUNTRIES; MORTALITY; DELIVERY; CHOICE; VIEWS; CARE	Background The debate surrounding the optimal caesarean rate has been ongoing for several decades, with the WHO recommending an "acceptable" rate of 5-15% since 1997, despite a weak evidence base. Global expert opinion from obstetric care providers on the optimal caesarean rate has not been documented. The objective of this study was to examine providers' opinions of the optimal caesarean rate worldwide, among all deliveries and within specific sub-groups of deliveries. Methods A global online survey of medical doctors who had performed at least one caesarean in the last five years was conducted between August 2013 and January 2014. Respondents were asked to report their opinion of the optimal caesarean rate-defined as the caesarean rate that would minimise poor maternal and perinatal outcomes-at the population level and within specific sub-groups of deliveries (including women with demographic and clinical risk factors for caesareans). Median reported optimal rates and corresponding inter-quartile ranges (IQRs) were calculated for the sample, and stratified according to national caesarean rate, institutional caesarean rate, facility level, and respondent characteristics. Results Responses were collected from 1,057 medical doctors from 96 countries. The median reported optimal caesarean rate was 20% (IQR: 15-30%) for all deliveries. Providers in private for-profit facilities and in facilities with high institutional rates reported optimal rates of 30% or above, while those in Europe, in public facilities and in facilities with low institutional rates reported rates of 15% or less. Reported optimal rates were lowest among low-risk deliveries and highest for Absolute Maternal Indications (AMIs), with wide IQRs observed for most categories other than AMIs. Conclusions Three-quarters of respondents reported an optimal caesarean rate above the WHO 15% upper threshold. There was substantial variation in responses, highlighting a lack of consensus around which women are in need of a caesarean among obstetric care providers worldwide.	[Cavallaro, Francesca L.; Cresswell, Jenny A.; Ronsmans, Carine] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Cavallaro, FL (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	francesca.cavallaro@lshtm.ac.uk		Cresswell, Jenny/0000-0002-9553-1132	United Kingdom's Economic and Social Research Council [ES/I903224/1]; Economic and Social Research Council [1013749] Funding Source: researchfish	United Kingdom's Economic and Social Research Council; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	FC was funded by a PhD studentship from the United Kingdom's Economic and Social Research Council, via grant ES/I903224/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Bagheri A, 2013, WOMEN BIRTH, V26, pE45, DOI 10.1016/j.wombi.2012.09.004; Bailit J, 2012, SEMIN PERINATOL, V36, P395, DOI 10.1053/j.semperi.2012.04.026; Benova L, 2015, TROP MED INT HEALTH, V20, P1657, DOI 10.1111/tmi.12598; Bergholt T, 2004, ACTA OBSTET GYN SCAN, V83, P262, DOI 10.1111/j.0001-6349.2004.0312.x; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; Bettes BA, 2007, OBSTET GYNECOL, V109, P57, DOI 10.1097/01.AOG.0000249608.11864.b6; CHALMERS BE, 1992, S AFR MED J, V82, P161; Chilopora Garvey, 2007, Hum Resour Health, V5, P17, DOI 10.1186/1478-4491-5-17; Cotzias CS, 2001, EUR J OBSTET GYN R B, V97, P15, DOI 10.1016/S0301-2115(00)00360-2; de Meyrick J., 2003, HEALTH EDUC, V103, P7, DOI [10.1108/09654280310459112, DOI 10.1108/09654280310459112]; Dodd JM, 2013, PLANNED ELECTIVE REP; Einarsdottir K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041436; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Gonen R, 2002, OBSTET GYNECOL, V99, P577, DOI 10.1016/S0029-7844(01)01766-5; Habiba M, 2006, BJOG-INT J OBSTET GY, V113, P647, DOI 10.1111/j.1471-0528.2006.00933.x; Hanley GE, 2010, OBSTET GYNECOL, V115, P1201, DOI 10.1097/AOG.0b013e3181dd918c; Hofmeyr G, 2011, PLANNED CAESAREAN SE; Hofmeyr G.J., 2014, COCHRANE DATABASE SY; Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3; Jonsdottir G, 2009, ACTA OBSTET GYN SCAN, V88, P621, DOI 10.1080/00016340902818196; Jurdi R, 2004, HEALTH POLICY PLANN, V19, P101, DOI 10.1093/heapol/czh012; Kruk ME, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000242; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; McGurgan P, 2001, EUR J OBSTET GYN R B, V97, P17, DOI 10.1016/S0301-2115(01)00423-7; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044; Robson SJ, 2009, BIRTH-ISS PERINAT C, V36, P208, DOI 10.1111/j.1523-536X.2009.00331.x; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Stanton C, 2013, OPINION PLAUSIBLE RA; The World Bank, COUNTR LEND GROUPS; Toh-adam R, 2012, ARCH GYNECOL OBSTET, V285, P1513, DOI 10.1007/s00404-011-2168-3; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; Unmet Obstetric Need Network, 2000, TACKL UNM NEED MAJ O; Volpe FM, 2011, REV PANAM SALUD PUBL, V29, P303, DOI 10.1590/S1020-49892011000500001; WHO, 2014, GLOB HLTH OBS WHO CO; WHO, 2015, GUID TREATM MAL; World Health Organization (WHO), ALPH LIST WHO MEMB S; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104; Zizza A, 2011, J Prev Med Hyg, V52, P161	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152779	10.1371/journal.pone.0152779	http://dx.doi.org/10.1371/journal.pone.0152779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031516	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000373121800136
J	Ohkubo, H; Kanemitsu, Y; Uemura, T; Takakuwa, O; Takemura, M; Maeno, K; Ito, Y; Oguri, T; Kazawa, N; Mikami, R; Niimi, A				Ohkubo, Hirotsugu; Kanemitsu, Yoshihiro; Uemura, Takehiro; Takakuwa, Osamu; Takemura, Masaya; Maeno, Ken; Ito, Yutaka; Oguri, Tetsuya; Kazawa, Nobutaka; Mikami, Ryuji; Niimi, Akio			Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS; PHYSIOLOGICAL TESTS; VISUAL SCORES; TOMOGRAPHY; INDEXES; DISEASE; PIRFENIDONE; SYSTEM; COPD	Background Although several computer-aided computed tomography (CT) analysis methods have been reported to objectively assess the disease severity and progression of idiopathic pulmonary fibrosis (IPF), it is unclear which method is most practical. A universal severity classification system has not yet been adopted for IPF. Objective The purpose of this study was to test the correlation between quantitative-CT indices and lung physiology variables and to determine the ability of such indices to predict disease severity in IPF. Methods A total of 27 IPF patients showing radiological UIP pattern on high-resolution (HR) CT were retrospectively enrolled. Staging of IPF was performed according to two classification systems: the Japanese and GAP (gender, age, and physiology) staging systems. CT images were assessed using a commercially available CT imaging analysis workstation, and the whole-lung mean CT value (MCT), the normally attenuated lung volume as defined from -950 HU to -701 Hounsfield unit (NL), the volume of the whole lung (WL), and the percentage of NL to WL (NL%), were calculated. Results CT indices (MCT, WL, and NL) closely correlated with lung physiology variables. Among them, NL strongly correlated with forced vital capacity (FVC) (r = 0.92, P < 0.0001). NL% showed a large area under the receiver operating characteristic curve for detecting patients in the moderate or advanced stages of IPF. Multivariable logistic regression analyses showed that NL% is significantly more useful than the percentages of predicted FVC and predicted diffusing capacity of the lungs for carbon monoxide (Japanese stage II/III/IV [odds ratio, 0.73; 95% confidence intervals (CI), 0.48 to 0.92; P < 0.01]; III/IV [odds ratio. 0.80; 95% CI 0.59 to 0.96; P < 0.01]; GAP stage II/III [odds ratio, 0.79; 95% CI, 0.56 to 0.97; P < 0.05]). Conclusion The measurement of NL% by threshold-based volumetric CT analysis may help improve IPF staging.	[Ohkubo, Hirotsugu; Kanemitsu, Yoshihiro; Uemura, Takehiro; Takakuwa, Osamu; Takemura, Masaya; Maeno, Ken; Ito, Yutaka; Oguri, Tetsuya; Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan; [Kazawa, Nobutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Mikami, Ryuji] Tokyo Med Univ, Dept Radiol, Tokyo 1608402, Japan	Nagoya City University; Nagoya City University; Tokyo Medical University	Ohkubo, H (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan.	hohkubo@med.nagoya-cu.ac.jp		Ohkubo, Hirotsugu/0000-0002-8538-1150				Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Colombi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130653; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Homma S, 2015, RESPIR INVESTIG, V53, P7, DOI 10.1016/j.resinv.2014.08.003; Iwano S, 2013, INTERACT CARDIOV TH, V17, P59, DOI 10.1093/icvts/ivt122; Iwasawa T, 2014, EUR J RADIOL, V83, P32, DOI 10.1016/j.ejrad.2012.02.014; Kauczor HU, 2000, AM J ROENTGENOL, V175, P1329, DOI 10.2214/ajr.175.5.1751329; Kim KG, 2005, RADIOLOGY, V237, P657, DOI 10.1148/radiol.2372041461; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kitano M, 2014, INT J CHRONIC OBSTR, V9, P1347, DOI 10.2147/COPD.S72616; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Park SO, 2011, KOREAN J RADIOL, V12, P297, DOI 10.3348/kjr.2011.12.3.297; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Zavaletta VA, 2007, ACAD RADIOL, V14, P772, DOI 10.1016/j.acra.2007.03.009	19	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152505	10.1371/journal.pone.0152505	http://dx.doi.org/10.1371/journal.pone.0152505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031615	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800087
J	Wang, K; Ren, Y; Li, HY; Zheng, K; Jiang, J; Zou, TN; Ma, BL; Li, H; Liu, QL; Ou, JH; Wang, L; Wei, W; He, JJ; Ren, GS				Wang, Ke; Ren, Yu; Li, Hongyuan; Zheng, Ke; Jiang, Jun; Zou, Tianning; Ma, Binlin; Li, Hui; Liu, Qilun; Ou, Jianghua; Wang, Ling; Wei, Wei; He, Jianjun; Ren, Guosheng			Comparison of Clinicopathological Features and Treatments between Young (<= 40 Years) and Older (> 40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR GENE; AGE; PROGNOSIS; DIAGNOSIS; WOMEN; STAGE; EXPRESSION; PATTERNS; THERAPY	The incidence of young cases of breast cancer is higher in China compared to the western world. We aimed to explore differences in risk factors, clinicopathological features and treatment modes of young female breast cancer compared to older patients in West China. We collected clinical information from 12,209 female breast cancer patients in West China, including risk factors, clinicopathological features and treatment modes, from January 2010 to December 2012. Chi-square tests and the multivariate logistic regression analysis were applied for statistical analysis. There were 2,682 young (<= 40 years) cases and 9,527 older cases at the time of breast cancer diagnosis. Young patients had a greater tumor diameter at diagnosis, and a higher probability of axillary lymph node and distant metastasis (P < 0.05). The progesterone receptor positive expression rate, estrogen receptor/progesterone receptor double positive expression rate, and human epidermal growth factor receptor 2 (HER2) negative expression rate was higher in young patients compared to older patients (P < 0.05). For young patients, the age at menarche was earlier, they had lower marriage rates, fewer pregnancies and births, and a lower breastfeeding rate (P < 0.05). A higher proportion of young patients underwent advanced operations, neoadjuvant and adjuvant chemotherapy, radiotherapy, and endocrine therapy compared to older patients (P < 0.05). We found significant differences in the clinicopathological features, risk factors and treatment modes between young (<= 40 years) and older (>40 years) female breast cancer patients in West China. As some of these results differ from those found in the western female population, it is likely that the mechanism of tumorigenesis of young female breast cancer patients in West China may differ from that in western developed countries. Further investigation into the regional differences in breast cancer tumorigenesis is warranted.	[Wang, Ke; Ren, Yu; He, Jianjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian 710049, Shaanxi Provinc, Peoples R China; [Li, Hongyuan; Zheng, Ke; Ren, Guosheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Jiang, Jun] Third Mil Med Univ, Dept Breast Dis Ctr, Chongqing, Peoples R China; [Zou, Tianning] Yunnan Tumor Hosp, Breast Canc Res Ctr, Kunming, Yunnan Province, Peoples R China; [Ma, Binlin] Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Breast & Neck Surg, Urumqi, Xinjiang Provin, Peoples R China; [Li, Hui] Sichuan Prov Tumor Hosp, Dept Breast Surg, Chengdu, Sichuan Provinc, Peoples R China; [Liu, Qilun] Ningxia Med Univ, Dept Surg Oncol, Affiliated Hosp, Yinchuan, Ningxia Provinc, Peoples R China; [Ou, Jianghua] Xinjiang Med Univ, Dept Breast Surg, Affiliated Tumor Hosp, Urumqi, Xinjiang Provin, Peoples R China; [Wang, Ling] Fourth Mil Med Univ, Xijing Hosp, Dept Vasc & Endocrine Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Wei, Wei] Guangxi Med Univ, Canc Hosp, Dept Breast Surg, Nanning, Guangxi Provinc, Peoples R China	Xi'an Jiaotong University; Chongqing Medical University; Army Medical University; Xinjiang Medical University; Ningxia Medical University; Xinjiang Medical University; Air Force Military Medical University; Guangxi Medical University	He, JJ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Breast Surg, Xian 710049, Shaanxi Provinc, Peoples R China.; Ren, GS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China.	chinahjj@163.com; renguosheng0726@163.com						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; American Cancer Society, 2013, BREAST CANC FACTS FI; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; [Anonymous], 2011, BREAST CANC FACTS FI; [Anonymous], 1981, HIST TYP BREAST TUM; Assi HA, 2013, J THORAC DIS, V5, pS2, DOI 10.3978/j.issn.2072-1439.2013.05.24; Christinat A, 2013, J THORAC DIS, V5, pS36, DOI 10.3978/j.issn.2072-1439.2013.05.25; Elkum N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-222; Fleming I, 1997, AM JOINT COMMITTEE C; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Greene FL, 2002, AM JOINT COMMITTEE C; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Johnson RH, 2015, ONCOTARGET, V6, P13688, DOI 10.18632/oncotarget.4051; Keegan THM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3156; Kheirelseid EAH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-383; Kim IK, 2011, J BREAST CANCER, V14, P314, DOI 10.4048/jbc.2011.14.4.314; Ko SS, 2008, J SURG ONCOL, V98, P318, DOI 10.1002/jso.21110; Lee HB, 2014, J BREAST CANCER, V17, P301, DOI 10.4048/jbc.2014.17.4.301; Lee MK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/325715; Li J, 2008, J COMMUN NETW-S KOR, V10, P10, DOI 10.1109/JCN.2008.6388323; Lin CH, 2014, ONCOLOGIST, V19, P583, DOI 10.1634/theoncologist.2014-0047; Menard S, 2000, LANCET, V356, P1113, DOI 10.1016/S0140-6736(05)74556-6; Morrison DH, 2012, BRIT J CANCER, V107, P1; Morrow M, 2001, J CLIN ONCOL, V19, P2254, DOI 10.1200/JCO.2001.19.8.2254; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Partridge AH, 2012, ONCOLOGIST, V17, P775, DOI 10.1634/theoncologist.2011-0469; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Pourzand A, 2011, BREAST CANCER-BASIC, V5, P87, DOI 10.4137/BCBCR.S7199; Pronzato P, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/534256; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Reyna C, 2014, J MULTIDISCIP HEALTH, V7, P419, DOI 10.2147/JMDH.S49994; Rudat V, 2012, J ONCOL, V2012, DOI DOI 10.1155/2012/370385; Schultz JR, 2003, MOL CELL ENDOCRINOL, V201, P165, DOI 10.1016/S0303-7207(02)00415-X; Shoker BS, 1999, J PATHOL, V188, P237; Tavassoli FA, 2003, WHO CLASSIFICATION T; Vostakolaei FA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/517976; Wang K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-225; Yu KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011035; Zeng H, 2014, J THORAC DIS, V6, P466, DOI DOI 10.3978/J.ISSN.2072-1439.2014.03.03; Zhang QL, 2015, INT J CLIN EXP MED, V8, P5869; Zhou P, 2004, CANCER-AM CANCER SOC, V101, P1264, DOI 10.1002/cncr.20523	44	27	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152312	10.1371/journal.pone.0152312	http://dx.doi.org/10.1371/journal.pone.0152312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031236	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800054
J	Nair, SC; Welsing, PMJ; Choi, IYK; Roth, J; Holzinger, D; Bijlsma, JWJ; van Laar, JM; Gerlag, DM; Lafeber, FPJG; Tak, PP				Nair, S. C.; Welsing, P. M. J.; Choi, I. Y. K.; Roth, J.; Holzinger, D.; Bijlsma, J. W. J.; van Laar, J. M.; Gerlag, D. M.; Lafeber, F. P. J. G.; Tak, P. P.			A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; TNF-ALPHA THERAPY; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; DOUBLE-BLIND; PHASE-III; INFLIXIMAB; RITUXIMAB; PLACEBO	Objectives Measurement of MRP8/14 serum levels has shown potential in predicting clinical response to different biological agents in rheumatoid arthritis (RA). We aimed to develop a treatment algorithm based on a prediction score using MRP8/14 measurements and clinical parameters predictive for response to different biological agents. Methods Baseline serum levels of MRP8/14 were measured in 170 patients starting treatment with infliximab, adalimumab or rituximab. We used logistic regression analysis to develop a predictive score for clinical response at 16 weeks. MRP8/14 levels along with clinical variables at baseline were investigated. We also investigated how the predictive effect of MRP8/14 was modified by drug type. A treatment algorithm was developed based on categorizing the expected response per drug type as high, intermediate or low for each patient and optimal treatment was defined. Finally, we present the utility of using this treatment algorithm in clinical practice. Results The probability of response increased with higher baseline MRP8/14 complex levels (OR = 1.39), differentially between the TNF-blockers and rituximab (OR of interaction term = 0.78), and also increased with higher DAS28 at baseline (OR = 1.28). Rheumatoid factor positivity, functional disability (a higher HAQ), and previous use of a TNF-inhibitor decreased the probability of response. Based on the treatment algorithm 80 patients would have been recommended for anti-TNF treatment, 8 for rituximab, 13 for another biological treatment (other than TNFi or rituximab) and for 69 no recommendation was made. The predicted response rates matched the observed response in the cohort well. On group level the predicted response based on the algorithm resulted in a modest 10% higher response rate in our cohort with much higher differences in response probability in individual patients treated contrary to treatment recommendation. Conclusions Prediction of response using MRP8/14 levels along with clinical predictors has potential in personalizing treatment for RA patients starting biological anti-rheumatic treatment, and might increase cost-effectiveness.	[Nair, S. C.; Welsing, P. M. J.; Bijlsma, J. W. J.; van Laar, J. M.; Lafeber, F. P. J. G.] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Choi, I. Y. K.; Gerlag, D. M.; Tak, P. P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Roth, J.] Univ Hosp Muenster, Inst Immunol, Munster, Germany; [Holzinger, D.] Univ Childrens Hosp Muenster, Dept Pediat Rheumatol & Immunol, Munster, Germany; [Gerlag, D. M.] GSK, Clin Unit Cambridge, Cambridge, England; [Tak, P. P.] GSK Res Dev, Stevenage, Herts, England; [Tak, P. P.] Univ Cambridge, Cambridge, England; [Tak, P. P.] Univ Ghent, B-9000 Ghent, Belgium	Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Munster; University of Munster; GlaxoSmithKline; GlaxoSmithKline; University of Cambridge; Ghent University	Nair, SC (corresponding author), Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	sandyn26@gmail.com		Holzinger, Dirk/0000-0002-8062-8820	Center for Translational Molecular Medicine [04I-202]; Innovative Medicines Initiative project BTCure [115142-1]; EU FP7 grant EUTRAIN; EU FP7 grant MIAMI; Interdisciplinary Centre of Clinical Research at the University of Muenster [IZKF CRA04]; ReumaFonds [LLP-9] Funding Source: researchfish	Center for Translational Molecular Medicine; Innovative Medicines Initiative project BTCure; EU FP7 grant EUTRAIN; EU FP7 grant MIAMI; Interdisciplinary Centre of Clinical Research at the University of Muenster; ReumaFonds	This research was supported by the Center for Translational Molecular Medicine (project TRACER, grant 04I-202), the Innovative Medicines Initiative project BTCure (grant agreement number 115142-1), EU FP7 grants EUTRAIN and MIAMI and the Interdisciplinary Centre of Clinical Research at the University of Muenster (IZKF CRA04).	Alessandri C, 2004, ANN RHEUM DIS, V63, P1218, DOI 10.1136/ard.2003.014647; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Choi IY, 2015, ANN RHEUM DIS, V74, P499, DOI 10.1136/annrheumdis-2013-203923; Choi IY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106253; Coulthard LR, 2011, ANN RHEUM DIS, V70, P98, DOI 10.1136/ard.2010.133249; Daien CI, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/386148; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Fabris M, 2012, AUTOIMMUN REV, V11, P315, DOI 10.1016/j.autrev.2010.06.012; Foell D, 2010, JAMA-J AM MED ASSOC, V303, P1266, DOI 10.1001/jama.2010.375; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Holzinger D, 2012, ANN RHEUM DIS, V71, P974, DOI 10.1136/annrheumdis-2011-200598; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Isaacs JD, 2013, ANN RHEUM DIS, V72, P329, DOI 10.1136/annrheumdis-2011-201117; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; Kleinert S, 2012, RHEUMATOL INT, V32, P2759, DOI 10.1007/s00296-011-2033-5; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Moreland LW, 1999, ANN INTERN MED, V130, P478, DOI 10.7326/0003-4819-130-6-199903160-00004; Quartuccio L, 2009, RHEUMATOLOGY, V48, P1557, DOI 10.1093/rheumatology/kep314; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Tak PP, 2012, RHEUMATOLOGY, V51, P600, DOI 10.1093/rheumatology/ker300; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van Gestel AM, 1999, J RHEUMATOL, V26, P705; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Wittkowski H, 2011, ANN RHEUM DIS, V70, P2075, DOI 10.1136/ard.2011.152496	38	14	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152362	10.1371/journal.pone.0152362	http://dx.doi.org/10.1371/journal.pone.0152362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029006	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500041
J	Chen, PL; Mancini, M; Sonis, ST; Fernandez-Martinez, J; Liu, J; Cohen, EEW; Toback, FG				Chen, Peili; Mancini, Maria; Sonis, Stephen T.; Fernandez-Martinez, Juan; Liu, Jing; Cohen, Ezra E. W.; Toback, F. Gary			A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; 1 INDUCES SENESCENCE; NUDE-MOUSE MODEL; TIGHT JUNCTIONS; EPITHELIAL-CELLS; GASTRIC-CANCER; ECONOMIC OUTCOMES; APOPTOSIS; BARRIER; PROTEIN	We have characterized a novel 21 amino acid-peptide derived from Antrum Mucosal Protein (AMP)-18 that mediates growth promotion of cultured normal epithelial cells and mitigates radiation-induced oral mucositis in animal models, while suppressing in vitro function of cancer cells. The objective of this study was to evaluate these dual potential therapeutic effects of AMP peptide in a clinically relevant animal model of head and neck cancer (HNC) by simultaneously assessing its effect on tumor growth and radiation-induced oral mucositis in an orthotopic model of HNC. Bioluminescent SCC-25 HNC cells were injected into the anterior tongue and tumors that formed were then subjected to focal radiation treatment. Tumor size was assessed using an in vivo imaging system, and the extent of oral mucositis was compared between animals treated with AMP peptide or vehicle (controls). Synergism between AMP peptide and radiation therapy was suggested by the finding that tumors in the AMP peptide/radiation therapy cohort demonstrated inhibited growth vs. radiation therapy-only treated tumors, while AMP peptide-treatment delayed the onset and reduced the severity of radiation therapy-induced oral mucositis. A differential effect on apoptosis appears to be one mechanism by which AMP-18 can stimulate growth and repair of injured mucosal epithelial cells while inhibiting proliferation of HNC cells. RNA microarray analysis identified pathways that are differentially targeted by AMP-18 in HNC vs. nontransformed cells. These observations confirm the notion that normal cells and tumor cells may respond differently to common biological stimuli, and that leveraging this finding in the case of AMP-18 may provide a clinically relevant opportunity.	[Chen, Peili; Liu, Jing; Cohen, Ezra E. W.; Toback, F. Gary] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Mancini, Maria; Sonis, Stephen T.; Fernandez-Martinez, Juan] Biomodels LLC, Watertown, MA 02472 USA; [Sonis, Stephen T.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Fernandez-Martinez, Juan] Univ Oviedo, Dept Math, Asturias, Spain; [Liu, Jing] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Cohen, Ezra E. W.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Chicago; Harvard University; Brigham & Women's Hospital; University of Oviedo; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Chen, PL; Toback, FG (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	pchen@medicine.bsd.uchicago.edu; gtoback@medicine.bsd.uchicago.edu	Fernandez-Martinez, Juan Luis/M-1446-2017	Fernandez-Martinez, Juan Luis/0000-0002-4758-2832	National Cancer Institute [CA 176032]; NATIONAL CANCER INSTITUTE [R21CA176032] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (www.cancer.gov): CA 176032 to FGT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomodels, LLC. provided support in the form of salaries for authors MM, STS and JFM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Bell S, 2012, MOL ORAL MICROBIOL, V27, P160, DOI 10.1111/j.2041-1014.2012.640.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen PL, 2015, INFLAMM BOWEL DIS, V21, P2393, DOI 10.1097/MIB.0000000000000499; Chen PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125490; Chen PL, 2012, INFLAMM BOWEL DIS, V18, P1749, DOI 10.1002/ibd.22886; Chen PL, 2011, ORAL ONCOL, V47, P831, DOI 10.1016/j.oraloncology.2011.06.012; Cohen EEW, 2013, ORAL ONCOL, V49, P1025, DOI 10.1016/j.oraloncology.2013.07.009; Elting LS, 2003, CANCER, V98, P1531, DOI 10.1002/cncr.11671; Fang LY, 2010, J ORAL PATHOL MED, V39, P342, DOI 10.1111/j.1600-0714.2009.00836.x; Hawkes WC, 2012, J CELL BIOCHEM, V113, P61, DOI 10.1002/jcb.23328; Knox JJ, 2000, DRUG AGING, V17, P257, DOI 10.2165/00002512-200017040-00002; Lee TK, 2007, CANCER RES, V67, P8800, DOI 10.1158/0008-5472.CAN-07-0801; Li SH, 2015, SURGERY, V157, P570, DOI 10.1016/j.surg.2014.10.014; Li Z, 2013, EUR REV MED PHARMACO, V17, P2166; Liu ZY, 2012, HEAD NECK-J SCI SPEC, V34, P1789, DOI 10.1002/hed.22013; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Lyng G, 2013, PATHOBIOLOGY CANC RE, P75; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Maggioni D, 2013, INT J ONCOL, V43, P1675, DOI 10.3892/ijo.2013.2072; Martin TE, 2003, AM J PHYSIOL-GASTR L, V285, pG332, DOI 10.1152/ajpgi.00453.2002; McCarthy KM, 1996, J CELL SCI, V109, P2287; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Myers JN, 2002, CLIN CANCER RES, V8, P293; Oien KA, 2004, J PATHOL, V203, P789, DOI 10.1002/path.1583; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rippa E, 2011, J CELL PHYSIOL, V226, P2571, DOI 10.1002/jcp.22601; Saligan LN, 2014, CANCER INFORM, V13, P141, DOI 10.4137/CIN.S19745; Schlienger S, 2014, MOL BIOL CELL, V25, P17, DOI 10.1091/mbc.E13-06-0335; Seto K, 2013, ONCOL REP, V29, P2147, DOI 10.3892/or.2013.2387; Shrivastava R., 2013, J CANC RES TREATMENT, V1, P4, DOI [10.12691/jcrt-1-1-2, DOI 10.12691/JCRT-1-1-2]; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Sonis ST, 2013, ORAL DIS, V19, P721, DOI 10.1111/odi.12146; Sonis ST, 2001, J CLIN ONCOL, V19, P2201, DOI 10.1200/JCO.2001.19.8.2201; Sonis ST, 2002, ONCOLOGY-NY, V16, P680; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Sonis ST, 2009, CORE EVID, V4, P199; Toback FG, 2003, AM J PHYSIOL-GASTR L, V285, pG344, DOI 10.1152/ajpgi.00455.2002; Uchida K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-353; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; WEICHSELBAUM R, 1984, BRIT J CANCER, V49, P595, DOI 10.1038/bjc.1984.94; WEICHSELBAUM RR, 1985, P NATL ACAD SCI USA, V82, P4732, DOI 10.1073/pnas.82.14.4732; Winck FV, 2014, J PROTEOMICS, V96, P67, DOI 10.1016/j.jprot.2013.10.039; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu XY, 2012, INT J RADIAT ONCOL, V83, pE409, DOI 10.1016/j.ijrobp.2012.01.006; Xing R, 2011, GUT; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Yoon JH, 2011, J CANC RES CLIN ONCO; Yoon JH, 2014, J GASTRIC CANCER, V14, P147, DOI 10.5230/jgc.2014.14.3.147; Yoon JH, 2014, ONCOTARGET, V5, P11695, DOI 10.18632/oncotarget.2586; Zuo T, 2015, NUTR CANCER, V67, P364, DOI 10.1080/01635581.2015.989369	54	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152995	10.1371/journal.pone.0152995	http://dx.doi.org/10.1371/journal.pone.0152995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049860	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500079
J	Ezzine-de-Blas, D; Dutilly, C; Lara-Pulido, JA; Le Velly, G; Guevara-Sangines, A				Ezzine-de-Blas, Driss; Dutilly, Celine; Lara-Pulido, Jose-Alberto; Le Velly, Gwenole; Guevara-Sangines, Alejando			Payments for Environmental Services in a Policymix: Spatial and Temporal Articulation in Mexico	PLOS ONE			English	Article							ECOSYSTEM SERVICES; HYDROLOGICAL SERVICES; ADAPTIVE MANAGEMENT; NATIONAL PAYMENTS; CONSERVATION; PROGRAM; SYSTEMS	Government based Payments for Ecosystem Services (PES) have been criticized for not maximizing environmental effectiveness through appropriate targeting, while instead prioritizing social side-objectives. In Mexico, existing literature on how the Payments for Ecosystem Services-Hydrological program (PSA-H) has targeted deforestation and forest degradation shows that both the process of identifying the eligible areas and the choice of the selection criteria for enrolling forest parcels have been under the influence of competing agendas. In the present paper we study the influence of the PSA-H multi-level governance on the environmental effectiveness of the program-the degree to which forest at high risk of deforestation is enrolled-building from a "policyscape" framework. In particular, we combine governance analysis with two distinct applications of the policyscape framework: First, at national level we assess the functional overlap between the PSA-H and other environmental and rural programs with regard to the risk of deforestation. Second, at regional level in the states of Chiapas and Yucatan, we describe the changing policy agenda and the role of technical intermediaries in defining the temporal spatialization of the PSA-H eligible and enrolled areas with regard to key socio-economic criteria. We find that, although at national level the PSA-H program has been described as coping with both social and environmental indicators thanks to successful adaptive management, our analysis show that PSA-H is mainly found in communities where deforestation risk is low and in combination with other environmental programs (protected areas and forest management programs). Such inertia is reinforced at regional level as a result of the eligible areas' characteristics and the behaviour of technical intermediaries, which seek to minimise transaction costs and sources of uncertainty. Our project-specific analysis shows the importance of integrating the governance of a program in the policyscape framework as a way to better systematize complex interactions at different spatial and institutional scales between policies and landscape characteristics.	[Ezzine-de-Blas, Driss; Dutilly, Celine] CIRAD Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Lara-Pulido, Jose-Alberto; Guevara-Sangines, Alejando] Univ Iberoamer Dist Fed, Mexico City, DF, Mexico; [Le Velly, Gwenole] Auvergne Univ, CERDI, Clermont Ferrand, France	CIRAD; Universite Clermont Auvergne (UCA)	Ezzine-de-Blas, D (corresponding author), CIRAD Ctr Cooperat Int Rech Agron Dev, Montpellier, France.	ezzine@cirad.fr	Lara-Pulido, José Alberto/A-1840-2018	Lara-Pulido, Jose Alberto/0000-0003-1484-8451	PESMIX research program of the French Research Agency [ANR 2010-Systerra 008.01]	PESMIX research program of the French Research Agency	This study was funded by the PESMIX research program (Payments for environmental services: new panacea or auxiliary for environmental management?) of the French Research Agency (ANR 2010-Systerra 008.01), http://www.agence-nationale-recherche.fr/.	Alix-Garcia JM, 2015, AM ECON J-ECON POLIC, V7, P1, DOI 10.1257/pol.20130139; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Bioasesores, 2011, EST REG FOR UN MAN F; Calderon-Hinojosa F, 2007, COMMUNICATION; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Goulder LH, 2008, REV ENV ECON POLICY, V2, P152, DOI 10.1093/reep/ren005; Huber-Stearns HR, 2013, ECOSYST SERV, V6, P104, DOI 10.1016/j.ecoser.2013.09.006; Le Velly G, 2015, ETUDES ET DOCUMENTS; McAfee K, 2010, ANN ASSOC AM GEOGR, V100, P579, DOI 10.1080/00045601003794833; Mermet L., 2011, STRATEGIC ENV MANAGE; Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247; Munoz-Pina C, 2011, REV ESPANOLA ESTUDIO, V228, P7; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Primmer E, 2011, GUIDELINES IN PRESS; Santos R., 2014, COMP ASSESSMENT POLI, V1; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Schomers S, 2015, LAND USE POLICY, V42, P58, DOI 10.1016/j.landusepol.2014.06.025; Shapiro-Garza E, 2013, GEOFORUM, V46, P5, DOI 10.1016/j.geoforum.2012.11.018; SIMON HA, 1978, AM ECON REV, V68, P1; Sims KRE, 2014, CONSERV BIOL, V28, P1151, DOI 10.1111/cobi.12318; Tinbergen J., 1956, EC POLICY PRINCIPLES; Vazquez-Gomez J, 2009, UMAFOR 0704 CHIAPAS; Westgate MJ, 2013, BIOL CONSERV, V158, P128, DOI 10.1016/j.biocon.2012.08.016	24	19	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152514	10.1371/journal.pone.0152514	http://dx.doi.org/10.1371/journal.pone.0152514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27049963	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500046
J	Zhang, YC; Xu, ZF; Wu, Q; Peng, M; Liu, YC; Liu, X; Shi, L; Shen, GM; Pan, Y; He, L				Zhang, Yichao; Xu, Zhifeng; Wu, Qiong; Peng, Miao; Liu, Yanchao; Liu, Xing; Shi, Li; Shen, Guangmao; Pan, Yu; He, Lin			Identification of Differentially Expressed microRNAs between the Fenpropathrin Resistant and Susceptible Strains in Tetranychus cinnabarinus	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; 2-SPOTTED SPIDER-MITE; PYRETHROID RESISTANCE; DEVELOPMENTAL-STAGES; ACARI TETRANYCHIDAE; SODIUM-CHANNEL; DNA-SEQUENCES; CULEX-PIPIENS; GENES; URTICAE	The carmine spider mite (Tetranychus cinnabarinus) is one of the most serious pests on crops and its control mainly depends on chemical acaricides. The excessive and improper acaricides use has resulted in mite resistance to many acaricides, including fenpropathrin. Previous studies have indicated fenpropathrin resistance is a complex development process involving many genes, but information on resistance mechanism of post-transcription regulation is rare. Using Illumina sequencing, several categories of sRNAs were identified from susceptible (TS) and fenpropathrin-resistant strains (TR) of T. cinnabarinus, including 75 known microRNAs (miRNAs) and 64 novel miRNAs, whose target genes containing 78592 miRNA-target pairs were predicted by 6 algorithms. Also, 12 significantly differently expressed miRNAs were identified between the TS and TR libraries and RT-qPCR validation also performed a well consistency with sequencing. The targets of significantly differentially expressed miRNAs included 7 glutathione S-transferase, 7 cytochrome P450 and 16 carboxyl/choline esterase genes, their function in fenpropathrin resistance were further analyzed. The present study provides the firstly large-scale characterization of miRNAs in T. cinnabarinus and the comparison between TS and TR strains gives a clue on how miRNA involves in fenpropathrin resistance.	[Zhang, Yichao; Xu, Zhifeng; Wu, Qiong; Peng, Miao; Liu, Yanchao; Liu, Xing; Shi, Li; Shen, Guangmao; He, Lin] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Pan, Yu] Southwest Univ, Coll Hort & Landscape Agr, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	He, L (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.; Pan, Y (corresponding author), Southwest Univ, Coll Hort & Landscape Agr, Chongqing, Peoples R China.	ipying@163.com; helinok@vip.tom.com			National Nature Sciences Foundation [31272059, 31470115]; Special Fund for Agro-scientific Research in the Public Interest [201203038]; Fundamental Research Funds for the Central Universities [XDJK2016A005]	National Nature Sciences Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was funded in part by the National Nature Sciences Foundation (31272059, 31470115), the Special Fund for Agro-scientific Research in the Public Interest (201203038), and the Fundamental Research Funds for the Central Universities (XDJK2016A005).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Auger P, 2013, ACAROLOGIA, V53, P383; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIDGES CC, 1966, PSYCHOL REP, V18, P851, DOI 10.2466/pr0.1966.18.3.851; Capinera JL., 2001, HDB VEGETABLE PESTS; Chawla G, 2012, DEVELOPMENT, V139, P1788, DOI 10.1242/dev.077743; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Devaney E, 2010, TRENDS PARASITOL, V26, P428, DOI 10.1016/j.pt.2010.05.003; Enright AJ, 2004, GENOME BIOL, V5; Estabrook RW, 2003, DRUG METAB DISPOS, V31, P1461, DOI 10.1124/dmd.31.12.1461; Feng YN, 2011, PEST MANAG SCI, V67, P904, DOI 10.1002/ps.2129; Feng YN, 2011, PESTIC BIOCHEM PHYS, V100, P70, DOI 10.1016/j.pestbp.2011.02.007; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guo Fengying, 1998, Systematic and Applied Acarology, V3, P3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2009, PESTIC BIOCHEM PHYS, V93, P47, DOI 10.1016/j.pestbp.2008.11.001; Hong S, 2014, INSECT BIOCHEM MOLEC, V55, P39, DOI 10.1016/j.ibmb.2014.10.007; Jia F, 2011, CHINESE AGR SCI B, V24; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KUANG H-Y, 1990, Acta Entomologica Sinica, V33, P109; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V97, P93, DOI 10.1016/j.pestbp.2009.07.009; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei ZT, 2015, PARASITOL RES, V114, P699, DOI 10.1007/s00436-014-4236-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2009, ANN ENTOMOL SOC AM, V102, P674, DOI 10.1603/008.102.0412; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu B, 2014, INSECT MOL BIOL, V23, P216, DOI 10.1111/imb.12075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rong X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1122; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; Shen GM, 2014, INT J MOL SCI, V15, P22626, DOI 10.3390/ijms151222626; Shi L, 2015, PESTIC BIOCHEM PHYS, V119, P33, DOI 10.1016/j.pestbp.2015.02.009; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Solomon KR, 2001, ENVIRON TOXICOL CHEM, V20, P652, DOI [10.1897/1551-5028(2001)020&lt;0652:PRAOCP&gt;2.0.CO;2, 10.1002/etc.5620200326]; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Thadani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S20; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Vickers KC, 2015, TRENDS BIOCHEM SCI, V40, P4, DOI 10.1016/j.tibs.2014.10.009; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094779; Yang Shun-Yi, 2013, Acta Entomologica Sinica, V56, P1152; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Young M. D., 2012, GOSEQ GENE ONTOLOGY; Yu AM, 2009, EXPERT OPIN DRUG MET, V5, P1513, DOI 10.1517/17425250903307448; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang XF, 2014, INSECT BIOCHEM MOLEC, V47, P12, DOI 10.1016/j.ibmb.2014.01.008; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhao Lian-Feng, 2015, Acta Entomologica Sinica, V58, P90, DOI 10.16380/j.kcxb.2015.01.012; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	68	8	9	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152924	10.1371/journal.pone.0152924	http://dx.doi.org/10.1371/journal.pone.0152924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050424	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500068
J	Zhu, HD; Bhagatwala, J; Huang, Y; Pollock, NK; Parikh, S; Raed, A; Gutin, B; Harshfield, GA; Dong, YB				Zhu, Haidong; Bhagatwala, Jigar; Huang, Ying; Pollock, Norman K.; Parikh, Samip; Raed, Anas; Gutin, Bernard; Harshfield, Gregory A.; Dong, Yanbin			Race/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; D-RECEPTOR; 25-HYDROXYVITAMIN D; PHYSICAL-ACTIVITY; ADOLESCENTS; EXPRESSION; PATTERNS; EXPOSURE; FITNESS; TARGET	Objectives Understanding of the influence of vitamin D deficiency on epigenome will provide novel insights into the chronic disease risk. We tested our hypotheses that 1) vitamin D deficiency is associated with global hypomethylation and this association may be race/ethnicity dependent; and 2) vitamin D supplementation will increase global DNA methylation level. Methods A two-stage design, cross-sectional observation followed by a 16 week randomized, double-blinded, placebo-controlled trial (RCT) of vitamin D3 supplementation, was undertaken. Global DNA methylation level (percentage of 5-methylcytosine, %5-mC) was quantified using leukocyte DNA with the MethylFlash (TM) Methylated DNA Quantification kit (Epigentek). Global methylation data was obtained from 454 Caucasians and African Americans (42%) in the observation cohort and 58 African Americans with vitamin D deficiency in the dose responsive RCT. Results In the cross-sectional study, African Americans had lower % 5-mC than Caucasians (P = 0.04). A significant interaction was detected between plasma 25(OH) D and race on % 5-mC (P = 0.05), as a positive association was observed between plasma 25(OH) D and % 5-mC in African Americans (beta = 0.20, p<0.01), but not in Caucasians (beta = 0.03, p = 0.62). In the 16-week RCT, a dose-response benefit of vitamin D3 supplementation was observed for % 5-mC, as indicated by a significant linear upward trend (-0.01 +/- 0.01%, placebo; 0.11 +/- 0.01%, similar to 600 IU/day; 0.30 +/- 0.01%, similar to 2,000 IU/day; and 0.65 +/- 0.01%, similar to 4,000 IU/day group; P-trend = 0.04). Conclusions Vitamin D deficiency is associated with global hypomethylation in African Americans. Vitamin D3 supplementation increases global DNA methylation in a dose-response manner in African Americans with vitamin D deficiency.	[Zhu, Haidong; Bhagatwala, Jigar; Huang, Ying; Pollock, Norman K.; Parikh, Samip; Raed, Anas; Gutin, Bernard; Harshfield, Gregory A.; Dong, Yanbin] Georgia Regents Univ, Med Coll Georgia, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA; [Bhagatwala, Jigar; Parikh, Samip; Raed, Anas] Georgia Regents Univ, Med Coll Georgia, Internal Med, Dept Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhu, HD (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pediat, Georgia Prevent Inst, Augusta, GA USA.	hzhu@gru.edu	Parikh, Samip/AAI-6909-2020	Pollock, Norman/0000-0002-5465-2018	American Heart Association [14GRANT20480211]; NIH [P01 HL69999, HL64157]; Diabetes and Obesity Discovery Institute, Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131674] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Obesity Discovery Institute, Georgia Regents University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by American Heart Association Grant-in-Aid 14GRANT20480211 to Dong Y. Zhu H, Harshfield GA and Dong Y are also supported by NIH P01 HL69999. The participants of the LACHY study were previously recruited by NIH funded study (HL64157). The Vitamin D clinical trial was supported by The Diabetes and Obesity Discovery Institute, Georgia Regents University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhagatwala Jigar, 2015, BMC Obes, V2, P27, DOI 10.1186/s40608-015-0056-2; Bremmer F, 2012, ANTICANCER RES, V32, P341; Doig CL, 2013, CARCINOGENESIS, V34, P248, DOI 10.1093/carcin/bgs331; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Hubner U, 2013, CLIN CHEM LAB MED, V51, P649, DOI 10.1515/cclm-2012-0624; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Mozhui K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118466; Nair-Shalliker V, 2014, MUTAT RES-FUND MOL M, V765, P6, DOI 10.1016/j.mrfmmm.2014.04.001; Singh PK, 2013, J STEROID BIOCHEM, V136, P258, DOI 10.1016/j.jsbmb.2012.10.002; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Valencia RAC, 2014, J STEROID BIOCHEM, V141, P144, DOI 10.1016/j.jsbmb.2014.01.018; Wallace AM, 2010, STEROIDS, V75, P477, DOI 10.1016/j.steroids.2010.02.012; Zhang XH, 2006, CURR CANCER DRUG TAR, V6, P229, DOI 10.2174/156800906776842939; Zhu HD, 2013, J PEDIATR-US, V162, P1004, DOI 10.1016/j.jpeds.2012.10.059	22	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152849	10.1371/journal.pone.0152849	http://dx.doi.org/10.1371/journal.pone.0152849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049643	Green Published, gold			2022-12-27	WOS:000373603500060
J	Li, JL; Sunde, RA				Li, Jin-Long; Sunde, Roger A.			Selenoprotein Transcript Level and Enzyme Activity as Biomarkers for Selenium Status and Selenium Requirements of Chickens (Gallus gallus)	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; THIOREDOXIN REDUCTASE-ACTIVITY; GENE-EXPRESSION PROFILES; DIETARY SELENIUM; DEPENDENT PARAMETERS; DEFICIENCY; LIVER; SUPPLEMENTATION; METHIONINE	The NRC selenium (Se) requirement for broiler chicks is 0.15 mu g Se/g diet, based primarily on weight gain and feed intake studies reported in 1986. To determine Se requirements in today's rapidly growing broiler chick, day-old male chicks were fed Se-deficient basal diets supplemented with graded levels of Se (0, 0.025, 0.05, 0.075, 0.1, 0.2, 0.3, 0.5, 0.75, and 1.0 mu g Se/g) as Na2SeO3 (5/treatment). Diets contained 15X the vitamin E requirement, and there were no gross signs of Se-deficiency. At 29 d, Se-deficient chicks weighed 62% of Se-supplemented chicks; 0.025 mu g Se/g reversed this effect, indicating a minimum Se requirement of 0.025 mu g Se/g diet for growth for male broiler chicks. Enzyme activities in Se-deficient chicks for plasma GPX3, liver and gizzard GPX1, and liver and gizzard GPX4 decreased dramatically to 3, 2, 5, 10 and 5%, respectively, of Se-adequate levels, with minimum Se requirements of 0.10-0.13 mu g Se/g, and with defined plateaus above these levels. Pancreas GPX1 and GPX4 activities, however, lacked defined plateaus, with breakpoints at 0.3 mu g Se/g. qPCR measurement of all 24 chicken selenoprotein transcripts, plus SEPHS1, found that SEPP1 in liver, GPX3 in gizzard, and SEPP1, GPX3 and SELK in pancreas were expressed at levels comparable to housekeeping transcripts. Only 33%, 25% and 50% of selenoprotein transcripts were down-regulated significantly by Se deficiency in liver, gizzard and pancreas, respectively. No transcripts could be used as biomarkers for supernutritional Se status. For export selenoproteins SEPP1 and GPX3, tissue distribution, high expression and Se-regulation clearly indicate unique Se metabolism, which may underlie tissues targeted by Se deficiency. Based on enzyme activities in liver, gizzard, and plasma, the minimum Se requirement in today's broiler chick is 0.15 mu g Se/g diet; pancreas data indicate that the Se requirement should be raised to 0.2 mu g Se/g diet to provide a margin of safety.	[Li, Jin-Long] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China; [Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	Northeast Agricultural University - China; University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu	Li, Jin-Long/S-4288-2016	Li, Jin-Long/0000-0002-5133-9165	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch projects [233618, 1004389]; Northeast Agricultural University Program for New Century Excellent Talents in University [NECT-1207-02]; New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-009]; Wisconsin Alumni Foundation Selenium Nutrition Research Fund [12046295]	National Institute of Food and Agriculture, United States Department of Agriculture, Hatch projects; Northeast Agricultural University Program for New Century Excellent Talents in University; New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Wisconsin Alumni Foundation Selenium Nutrition Research Fund	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 233618 and 1004389, by Northeast Agricultural University (www.neau.edu.cn) Program for New Century Excellent Talents in University (No. NECT-1207-02) and New Century Excellent Talents in Heilongjiang Provincial University (No. 1252-NCET-009), and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate TJ, 2014, J APPL POULTRY RES, V23, P567, DOI 10.3382/japr.2014-00980; ATTAIX D, 1989, J NUTR, V119, P463, DOI 10.1093/jn/119.3.463; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Brennan KM, 2011, ANIM REPROD SCI, V125, P180, DOI 10.1016/j.anireprosci.2011.02.027; Brennan KM, 2012, BIOL TRACE ELEM RES, V145, P330, DOI 10.1007/s12011-011-9205-8; BUNK MJ, 1981, P SOC EXP BIOL MED, V167, P87, DOI 10.3181/00379727-167-41130; Burk RF, 2011, AM J PHYSIOL-GASTR L, V301, pG32, DOI 10.1152/ajpgi.00064.2011; GRIES CL, 1972, J NUTR, V102, P1287, DOI 10.1093/jn/102.10.1287; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Huang JQ, 2015, FREE RADICAL BIO MED, V83, P129, DOI 10.1016/j.freeradbiomed.2015.01.033; Huang JQ, 2011, J NUTR, V141, P1605, DOI 10.3945/jn.111.145722; Institute of Medicine (US) Panel on Micronutrients, 2000, DIET REF INT VIT C V, P284, DOI [10.17226/9810, DOI 10.17226/9810]; JENSEN LS, 1986, BIOL TRACE ELEM RES, V10, P11, DOI 10.1007/BF02795314; Khoso PA, 2015, CELL STRESS CHAPERON; Khoso PA, 2015, BIOL TRACE ELEM RES, V167, P48, DOI 10.1007/s12011-015-0282-y; KNIGHT SAB, 1988, J NUTR, V118, P853, DOI 10.1093/jn/118.7.853; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; LEI XG, 1995, J NUTR, V125, P1438; Liang Y, 2014, BIOL TRACE ELEM RES, V160, P41, DOI 10.1007/s12011-014-0024-6; Liu CP, 2014, BIOL TRACE ELEM RES, V159, P192, DOI 10.1007/s12011-014-0005-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; National Research Council, 1994, NUTR REQ POULTR; OMAYE ST, 1974, J NUTR, V104, P747, DOI 10.1093/jn/104.6.747; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; SUNDE RA, 1981, J NUTR, V111, P76, DOI 10.1093/jn/111.1.76; Sunde RA, 2005, J NUTR, V135, P2144, DOI 10.1093/jn/135.9.2144; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2010, EXP BIOL MED, V235, P1046, DOI 10.1258/ebm.2010.010111; Sunde RA, 2010, J NUTR BIOCHEM, V21, P665, DOI 10.1016/j.jnutbio.2009.11.012; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Taylor RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151665; THOMPSON JN, 1969, J NUTR, V97, P335, DOI 10.1093/jn/97.3.335; THOMPSON JN, 1970, J NUTR, V100, P797, DOI 10.1093/jn/100.7.797; Thompson KM, 1998, J NUTR, V128, P1289, DOI 10.1093/jn/128.8.1289; THOMPSON KM, 1995, J NUTR, V125, P864; WASCHULEWSKI IH, 1988, BRIT J NUTR, V60, P57, DOI 10.1079/BJN19880076; Weiss SL, 1996, J NUTR, V126, P2260, DOI 10.1093/jn/126.9.2260; Weiss SL, 1997, J NUTR BIOCHEM, V8, P85, DOI 10.1016/S0955-2863(96)00178-7; Xia YM, 2010, AM J CLIN NUTR, V92, P525, DOI 10.3945/ajcn.2010.29642; Xu JX, 2016, BIOL TRACE ELEM RES, V170, P438, DOI 10.1007/s12011-015-0470-9; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yao HD, 2013, J NUTR, V143, P613, DOI 10.3945/jn.112.172395; Yao HD, 2014, BIOL TRACE ELEM RES, V161, P318, DOI 10.1007/s12011-014-0125-2; Zhao X, 2014, BIOL TRACE ELEM RES, V161, P341, DOI 10.1007/s12011-014-0139-9; Zoidis E, 2010, COMP BIOCHEM PHYS B, V155, P294, DOI 10.1016/j.cbpb.2009.11.017	55	37	39	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152392	10.1371/journal.pone.0152392	http://dx.doi.org/10.1371/journal.pone.0152392			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045754	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600018
J	Zhang, LM; Cen, L; Qu, SG; Wei, L; Mo, MS; Feng, JM; Sun, CC; Xiao, YS; Luo, Q; Li, SM; Yang, XL; Xu, PY				Zhang, Limin; Cen, Luan; Qu, Shaogang; Wei, Lei; Mo, Mingshu; Feng, Junmin; Sun, Congcong; Xiao, Yousheng; Luo, Qin; Li, Shaomin; Yang, Xinling; Xu, Pingyi			Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; SIGNALING PATHWAY; DICKKOPF-1 CONTRIBUTES; INDUCED CYTOTOXICITY; PARKINSONS-DISEASE; DOWN-REGULATION; MOUSE MODEL; ACTIVATION; EXPRESSION; APOPTOSIS	Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic (DA) neurons in the substantial nigra pars compacta. Increasing evidence showed that Wnt/beta-catenin pathway and the orphan nuclear receptor Nurr1 play crucial roles in the survival and functional maintenance of DA neurons in the midbrain and GSK-3 beta antagonists LiCl and SB216763 were used to activate Wnt/beta-catenin pathway experimentally. However, the detail mechanism underlying the neuroprotection against apoptosis on DA neuron is still unclear and the interaction between Wnt/beta-catenin and Nurr1 remains undisclosed. In this study, using cell biological assay we investigated the function of Wnt/beta-catenin and its crosstalk with Nurr1 on the course of PC12 cell degeneration in vitro. Our data showed that PC12 cell viability was inhibited by rotenone, but attenuated by GSK-3 beta antagonists LiCl or SB216763. The activity of Wnt/beta-catenin pathway was deregulated on exposure of rotenone in a concentration-dependent manner. After the interference of beta-catenin with siRNA, LiCl or SB216763 failed to protect PC12 cells from apoptosis by the rotenone toxicity. Our data confirmed that Wnt/beta-catenin signaling activated by LiCl or SB216763 enhanced Nurr1 expression to 2.75 +/- 0.55 and 4.06 +/- 0.41 folds respectively compared with control detected by real-time PCR and the interaction of beta-catenin with Nurr1 was identified by co-immunoprecipitate analysis. In conclusion, the data suggested that Wnt/beta-catenin and Nurr1 are crucial factors in the survival of DA neurons, and the activation of Wnt/beta-catenin pathway exerts protective effects on DA neurons partly by mean of a co-active pattern with Nurr1. This finding may shed a light on the potential treatment of Parkinson disease.	[Zhang, Limin; Cen, Luan; Wei, Lei; Mo, Mingshu; Xiao, Yousheng; Xu, Pingyi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Limin] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan Province, Peoples R China; [Qu, Shaogang; Feng, Junmin] Southern Med Univ, Affiliated Hosp 5, Dept Blood Transfus, Guangzhou 510900, Guangdong, Peoples R China; [Wei, Lei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China; [Sun, Congcong] Shandong Univ, Qilu Affiliated Hosp, Dept Neurol, Jinan 250001, Shandong, Peoples R China; [Luo, Qin; Yang, Xinling] Xinjiang Med Univ, Affiliated Hosp 3, Dept Neurol, Urumqi 830011, Peoples R China; [Li, Shaomin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Xu, Pingyi] Guangzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Zhengzhou University; Southern Medical University - China; Sun Yat Sen University; Shandong University; Xinjiang Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangzhou Medical University	Xu, PY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.; Yang, XL (corresponding author), Xinjiang Med Univ, Affiliated Hosp 3, Dept Neurol, Urumqi 830011, Peoples R China.; Li, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Xu, PY (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.	shaomin_li@hms.harvard.edu; pingyixu@sina.com	Yang, xinling/HHC-1621-2022; Mo, Mingshu/S-1388-2019		State Key Development Program for Basic Research of China [2011CB510000]; National Natural Science Foundation of China [81271428, 81471292, U1503222, 81430021]; Science Foundation of Guangdong of China [2015A030311021]; technology project of Guangzhou [20151260]; assisting research project of science and technology for Xinjiang [201591160]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong of China; technology project of Guangzhou; assisting research project of science and technology for Xinjiang	This work was supported by research grants from the State Key Development Program for Basic Research of China (2011CB510000), the National Natural Science Foundation of China (81271428, 81471292, U1503222 and 81430021) the Science Foundation of Guangdong of China (2015A030311021), a grant supported by technology project of Guangzhou (20151260) and a grant supported by assisting research project of science and technology for Xinjiang (201591160).	Ahmadi FA, 2003, J NEUROCHEM, V87, P914, DOI 10.1046/j.1471-4159.2003.02068.x; Arenas E, 2005, ANN NY ACAD SCI, V1049, P51, DOI 10.1196/annals.1334.007; Backman C, 1999, BRAIN RES, V851, P125, DOI 10.1016/S0006-8993(99)02149-6; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Dun YY, 2013, NEUROPHARMACOLOGY, V67, P168, DOI 10.1016/j.neuropharm.2012.10.031; Dun YY, 2012, NEUROSCI LETT, V525, P83, DOI 10.1016/j.neulet.2012.07.030; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gelinas S, 2002, J NEUROSCI RES, V70, P90, DOI 10.1002/jnr.10315; Gollamudi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036191; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jiang JK, 2014, J NEUROSCI RES, V92, P783, DOI 10.1002/jnr.23352; Joksimovic M, 2014, J MOL CELL BIOL, V6, P27, DOI 10.1093/jmcb/mjt043; Kadota T, 1996, J HISTOCHEM CYTOCHEM, V44, P989, DOI 10.1177/44.9.8773564; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; L'Episcopo F, 2014, STEM CELLS, V32, P2147, DOI 10.1002/stem.1708; L'Episcopo F, 2014, J MOL CELL BIOL, V6, P13, DOI 10.1093/jmcb/mjt053; L'Episcopo F, 2012, J NEUROSCI, V32, P2062, DOI 10.1523/JNEUROSCI.5259-11.2012; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Li DW, 2014, INT J MOL MED, V34, P1358, DOI 10.3892/ijmm.2014.1904; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Morale MC, 2004, FASEB J, V18, P164, DOI 10.1096/fj.03-0501fje; Nilsen J, 1998, MENOPAUSE, V5, P211; Priyadarsini RV, 2012, ORAL ONCOL, V48, P33, DOI 10.1016/j.oraloncology.2011.08.008; Radad K, 2006, NEUROCHEM INT, V49, P379, DOI 10.1016/j.neuint.2006.02.003; Rajalin AM, 2011, ARCH BIOCHEM BIOPHYS, V509, P44, DOI 10.1016/j.abb.2011.02.018; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Watabe M, 2004, J PHARMACOL EXP THER, V311, P948, DOI 10.1124/jpet.104.071381; Wei L, 2013, J MOL NEUROSCI, V49, P105, DOI 10.1007/s12031-012-9900-8; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Wurst W, 2014, J MOL CELL BIOL, V6, P34, DOI 10.1093/jmcb/mjt046; Xu GF, 2013, NEUROTOXICOLOGY, V37, P63, DOI 10.1016/j.neuro.2013.04.005; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	29	29	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152931	10.1371/journal.pone.0152931	http://dx.doi.org/10.1371/journal.pone.0152931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045591	gold, Green Published			2022-12-27	WOS:000373599600046
J	Zhou, MJ; Wang, R; Tian, J; Ye, N; Mai, SM				Zhou, Mengjie; Wang, Rui; Tian, Jing; Ye, Ning; Mai, Shumin			A Map-Based Service Supporting Different Types of Geographic Knowledge for the Public	PLOS ONE			English	Article							SCIENCE; SYSTEM; ATLAS	The internet enables the rapid and easy creation, storage, and transfer of knowledge; however, services that transfer geographic knowledge and facilitate the public understanding of geographic knowledge are still underdeveloped to date. Existing online maps (or atlases) can support limited types of geographic knowledge. In this study, we propose a framework for map-based services to represent and transfer different types of geographic knowledge to the public. A map-based service provides tools to ensure the effective transfer of geographic knowledge. We discuss the types of geographic knowledge that should be represented and transferred to the public, and we propose guidelines and a method to represent various types of knowledge through a map-based service. To facilitate the effective transfer of geographic knowledge, tools such as auxiliary background knowledge and auxiliary map-reading tools are provided through interactions with maps. An experiment conducted to illustrate our idea and to evaluate the usefulness of the map-based service is described; the results demonstrate that the map-based service is useful for transferring different types of geographic knowledge.	[Zhou, Mengjie; Wang, Rui; Tian, Jing; Ye, Ning; Mai, Shumin] Wuhan Univ, Sch Resource & Environm Sci, 129 LuoYu Rd, Wuhan 430072, Peoples R China; [Tian, Jing] Wuhan Univ, Minist Educ, Key Lab Geog Informat Syst, 129 Luoyu Rd, Wuhan 430079, Peoples R China; [Tian, Jing] Wuhan Univ, Key Lab Digital Mapping & Land Informat Applicat, Natl Adm Surveying Mapping & Geoinformat, 129 Luoyu Rd, Wuhan 430079, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Tian, J (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, 129 LuoYu Rd, Wuhan 430072, Peoples R China.; Tian, J (corresponding author), Wuhan Univ, Minist Educ, Key Lab Geog Informat Syst, 129 Luoyu Rd, Wuhan 430079, Peoples R China.; Tian, J (corresponding author), Wuhan Univ, Key Lab Digital Mapping & Land Informat Applicat, Natl Adm Surveying Mapping & Geoinformat, 129 Luoyu Rd, Wuhan 430079, Peoples R China.	tianjing_sres@whu.edu.cn		Ye, Ning/0000-0002-6603-9157	National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1103409]; Special Program for Basic Science of China [2013FY112800]	National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Special Program for Basic Science of China	This study was supported by National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (J1103409; www.nsfc.gov.cn/) and Special Program for Basic Science of China (No. 2013FY112800; www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961; [Anonymous], 1983, SEMIOLOGY GRAPHICS D; BOARD C, 1977, T I BRIT GEOGR, V2, P19, DOI 10.2307/622191; Burkhard RA, 2005, LECT NOTES COMPUT SC, V3426, P238; D'Ambros Marco, 2011, International Journal on Software Tools for Technology Transfer, V13, P181, DOI 10.1007/s10009-010-0171-9; Dent B.D., 2008, CARTOGRAPHY THEMATIC; Eppler M, 2004, WISSENS KOMMUNIKATIO, P241; Favier TT, 2014, COMPUT EDUC, V76, P225, DOI 10.1016/j.compedu.2014.04.004; Gorman M.E., 2002, J TECHNOL TRANSFER, V27, P219, DOI DOI 10.1023/A:1015672119590; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; Huang SL, 2009, COMPUT EDUC, V53, P701, DOI 10.1016/j.compedu.2009.04.011; Kobben B, 2013, CARTOGR J, V50, P225, DOI 10.1179/1743277413Y.0000000056; KPMG Management Consulting, 1998, KNOWL MAN RES REP; Kraak Menno-Jan, 2004, J GEOGRAPHICAL SYSTE, V6, P83, DOI DOI 10.1007/S10109-004-0127-2; Kramers RE, 2008, CARTOGR J, V45, P98, DOI 10.1179/174327708X305094; Lechthaler M., 2010, LECT NOTES GEOINFORM, P384; Lienert C, 2009, CARTOGR GEOGR INF SC, V36, P45, DOI 10.1559/152304009787340188; MacEachren A.M., 1995, HOW MAPS WORK; Nolan Norton Institute, 1998, PUTT KNOW ORG VAL; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Pike WA, 2009, INFORM VISUAL, V8, P263, DOI 10.1057/ivs.2009.22; Pucher A, 2008, CARTOGR J, V45, P108, DOI 10.1179/174327708X305102; Roth RE, 2011, THESIS U PARK PA; Roth RE, 2013, IEEE T VIS COMPUT GR, V19, P2356, DOI 10.1109/TVCG.2013.130; Stafford N, 2010, NATURE, V467, pS19, DOI 10.1038/467S19a; von Krogh G, 1998, CALIF MANAGE REV, V40, P133, DOI 10.2307/41165947; Youn C, 2008, COMPUT GEOSCI-UK, V34, P1936, DOI 10.1016/j.cageo.2008.02.028	27	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152881	10.1371/journal.pone.0152881	http://dx.doi.org/10.1371/journal.pone.0152881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27045314	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600043
J	Lo, FE; Lu, PJ; Tsai, MK; Lee, JH; Wen, C; Wen, CP; Wai, JPM; Tsao, CK; Chiang, PH; Lyu, SY; Ma, KL; Chi, YC; Li, CS; Liu, CC; Wu, XF				Lo, Feng En; Lu, Po Jung; Tsai, Min Kuang; Lee, June Han; Wen, Christopher; Wen, Chi Pang; Wai, Jackson Pui Man; Tsao, Chwen Keng; Chiang, Po Huang; Lyu, Shu Yu; Ma, Ko Lu; Chi, Ying-Chen; Li, Chu-Shiu; Liu, Chwen-Chi; Wu, Xifeng			The Role of Physical Activity in Harm Reduction among Betel Quid Chewers from a Prospective Cohort of 419,378 Individuals	PLOS ONE			English	Article							ARECA NUT; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ORAL-CANCER; ASSOCIATION; EXERCISE; MORTALITY; SMOKING; ADULTS; RISK	Objective To assess the benefits of regular exercise in reducing harms associated with betel quid (BQ) chewing. Methods The study cohort, 419,378 individuals, participated in a medical screening program between 1994 and 2008, with 38,324 male and 1,495 female chewers, who consumed 5-15 quids of BQ a day. Physical activity of each individual, based on "MET-hour/week", was classified as "inactive" or "active", where activity started from a daily 15 minutes/day or more of brisk walking (>= 3.75 MET-hour/week). Hazard ratios for mortality and remaining years in life expectancy were calculated. Results Nearly one fifth (18.7%) of men, but only 0.7% of women were chewers. Chewers had a 10-fold increase in oral cancer risk; and a 2-3-fold increase in mortality from lung, esophagus and liver cancer, cardiovascular disease, and diabetes, with doubling of all-cause mortality. More than half of chewers were physically inactive (59%). Physical activity was beneficial for chewers, with a reduction of all-cause mortality by 19%. Inactive chewers had their lifespan shortened by 6.3 years, compared to non-chewers, but being active, chewers improved their health by gaining 2.5 years. The improvement, however, fell short of offsetting the harms from chewing. Conclusions Chewers had serious health consequences, but being physically active, chewers could mitigate some of these adverse effects, and extend life expectancy by 2.5 years and reduce mortality by one fifth. Encouraging exercise, in addition to quitting chewing, remains the best advice for 1.5 million chewers in Taiwan.	[Lo, Feng En] Asia Univ, Dept Leisure & Recreat Management, Taichung, Taiwan; [Lu, Po Jung; Tsai, Min Kuang; Lee, June Han; Wen, Chi Pang; Chiang, Po Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Wen, Christopher] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Wen, Chi Pang] China Med Univ Hosp, Taichung, Taiwan; [Wai, Jackson Pui Man] Natl Taiwan Sport Univ, Inst Sport Sci, Taoyuan, Taiwan; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan; [Lyu, Shu Yu] Taipei Med Univ, Dept Publ Hlth, Taipei, Taiwan; [Ma, Ko Lu] Taoyuan Innovat Inst Technol, Taoyuan, Taiwan; [Chi, Ying-Chen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Li, Chu-Shiu] Natl Kaohsiung First Univ Sci & Technol, Dept Risk Management & Insurance, Kaohsiung, Taiwan; [Li, Chu-Shiu] Asia Univ, Dept Int Business, Taichung, Taiwan; [Liu, Chwen-Chi] Feng Chia Univ, Dept Risk Management & Insurance, Taichung 40724, Taiwan; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Asia University Taiwan; National Health Research Institutes - Taiwan; University of California System; University of California Irvine; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Medical University; Taipei City Hospital; National Kaohsiung University of Science & Technology; Asia University Taiwan; Feng Chia University; University of Texas System; UTMD Anderson Cancer Center	Wen, CP (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.; Wen, CP (corresponding author), China Med Univ Hosp, Taichung, Taiwan.	cwengood@nhri.org.tw	li, chu/GPS-7224-2022	Lee, Chun Han/0000-0003-3348-6003				Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Chen CL, 1999, CARCINOGENESIS, V20, P2331, DOI 10.1093/carcin/20.12.2331; Chen THH, 2006, AM J CLIN NUTR, V83, P688, DOI 10.1093/ajcn.83.3.688; Cheng TJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001229; Chiang CL, 1984, LIFE TABLE ITS APPL; Directorate-General of Budget, 2009, ACC STAT; Fiore MC, 2008, TREATING TOBACCO USE; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Hsu YH, 2011, NEPHROLOGY, V16, P751, DOI 10.1111/j.1440-1797.2011.01489.x; International Agency of Research on Cancer, 2004, IARC MON EV CARC RIS; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; Kruk J, 2013, ASIAN PAC J CANCER P, V14, P3993, DOI 10.7314/APJCP.2013.14.7.3993; Lan TY, 2007, AM J EPIDEMIOL, V165, P677, DOI 10.1093/aje/kwk056; Lin WY, 2008, AM J CLIN NUTR, V87, P1204, DOI 10.1093/ajcn/87.5.1204; Ni LF, 2013, PUBLIC HEALTH NURS, V30, P18, DOI 10.1111/j.1525-1446.2012.01039.x; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Roberts V, 2012, PSYCHOPHARMACOLOGY, V222, P1, DOI 10.1007/s00213-012-2731-z; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tseng Chin-Hsiao, 2010, BMC Res Notes, V3, P228, DOI 10.1186/1756-0500-3-228; Tung TH, 2004, DIABETOLOGIA, V47, P1776, DOI 10.1007/s00125-004-1532-2; US Department of Health and Human Services, PHYS ACT GUID ADV CO; Wai JPM, 2008, ASIA PAC J CLIN NUTR, V17, P297; Warnakulasuriya S, 2015, ADDICTION, V110, P1533, DOI 10.1111/add.13006; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Wen CP, 2005, TOB CONTROL, V14, pI16, DOI 10.1136/tc.2004.008003; Wen CP, 2005, TOB CONTROL, V14, pI4, DOI 10.1136/tc.2004.008516; Wen CP, 2013, ORAL CANC SYMPTOMS M; Wen CP, 2007, TAIWAN J PUBLIC HEAL, V26, P386; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2008, WHO REP GLOB TOB EP; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070679; Yen AMF, 2008, AM J CLIN NUTR, V87, P70, DOI 10.1093/ajcn/87.1.70; Yen AMF, 2006, AM J CLIN NUTR, V83, P1153, DOI 10.1093/ajcn/83.5.1153	35	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152246	10.1371/journal.pone.0152246	http://dx.doi.org/10.1371/journal.pone.0152246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044010	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100011
J	Minard, LV; Deal, H; Harrison, ME; Toombs, K; Neville, H; Meade, A				Minard, Laura V.; Deal, Heidi; Harrison, Megan E.; Toombs, Kent; Neville, Heather; Meade, Andrea			Pharmacists' Perceptions of the Barriers and Facilitators to the Implementation of Clinical Pharmacy Key Performance Indicators	PLOS ONE			English	Article							BEHAVIOR-CHANGE; CARE; SERVICES; HOSPITALS; KNOWLEDGE; ATTITUDES; QUALITY	Background In hospitals around the world, there has been no consensus regarding which clinical activities a pharmacist should focus on until recently. In 2011, a Canadian clinical pharmacy key performance indicator (cpKPI) collaborative was formed. The goal of the collaborative was to advance pharmacy practice in order to improve patient outcomes and enhance the quality of care provided to patients by hospital pharmacists. Following a literature review, which indicated that pharmacists can improve patient outcomes by carrying out specific activities, and an evidence-informed consensus process, a final set of eight cpKPIs were established. Canadian hospitals leading the cpKPI initiative are currently in the early stages of implementing these indicators. Objective To explore pharmacists' perceptions of the barriers and facilitators to the implementation of cpKPIs. Methods Clinical pharmacists employed by the Nova Scotia Health Authority were invited to participate in focus groups. Focus group discussions were audio-recorded and transcribed, and data was analyzed using thematic analysis. Findings Three focus groups, including 26 pharmacists, were conducted in February 2015. Three major themes were identified. Resisting the change was comprised of documentation challenges, increased workload, practice environment constraints, and competing priorities. Embracing cpKPIs was composed of seeing the benefit, demonstrating value, and existing supports. Navigating the unknown was made up of quality versus quantity battle, and insights into the future. Conclusions Although pharmacists were challenged by documentation and other changes associated with the implementation of cpKPIs, they demonstrated significant support for cpKPIs and were able to see benefits of the implementation. Pharmacists came up with suggestions for overcoming resistance associated with the implementation of cpKPIs and provided insights into the future of pharmacy practice. The identification of barriers and facilitators to cpKPI implementation will be used to inform the implementation process on a local and national level.	[Minard, Laura V.; Toombs, Kent; Neville, Heather; Meade, Andrea] Nova Scotia Hlth Author, QEII Hlth Sci Ctr, Dept Pharm, Halifax, NS, Canada; [Deal, Heidi; Harrison, Megan E.] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada	Queen Elizabeth II Health Sciences Centre; Dalhousie University	Minard, LV (corresponding author), Nova Scotia Hlth Author, QEII Hlth Sci Ctr, Dept Pharm, Halifax, NS, Canada.	LauraV.Minard@nshealth.ca	Neville, Heather/AAX-7258-2020	Neville, Heather/0000-0002-1566-6206				Awad A, 2006, J PHARM PHARM SCI, V9, P149; Barbour RS., 2010, SAGE HDB QUALITATIVE, P327; Bassett BR, 2009, ENCY CASE STUDY RES, V1, P503; Bond CA, 2007, PHARMACOTHERAPY, V27, P481, DOI 10.1592/phco.27.4.481; Boyle TA, 2014, RES SOC ADMIN PHARM, V10, P387, DOI 10.1016/j.sapharm.2013.06.002; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fernandes O, 2015, ANN PHARMACOTHER, V49, P656, DOI 10.1177/1060028015577445; Gagnon MP, 2014, J AM MED INFORM ASSN, V21, P535, DOI 10.1136/amiajnl-2013-002203; Gillespie U, 2009, ARCH INTERN MED, V169, P894, DOI 10.1001/archinternmed.2009.71; Glesne C., 2006, BECOMING QUALITATIVE, V3rd ed.; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Halsall D, 2012, RES SOC ADMIN PHARM, V8, P360, DOI 10.1016/j.sapharm.2011.09.001; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Krueger R., 1998, DEV QUESTIONS FOCUS; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Krueger RA, 1998, ANAL REPORTING FOCUS; LANKSHEAR AJ, 1993, J ADV NURS, V18, P1986, DOI 10.1046/j.1365-2648.1993.18121986.x; Makowsky Mark J, 2009, Med Care, V47, P642, DOI 10.1097/MLR.0b013e3181926032; McCann L, 2011, INT J CLIN PHARM-NET, V33, P824, DOI 10.1007/s11096-011-9545-7; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mohamed SSE, 2015, INT J PHARM PRACT, V23, P266, DOI 10.1111/ijpp.12156; Morgan D.L., 1998, PLANNING FOCUS GROUP; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Morse J. M., 1995, QUALITATIVE RES METH; Murphy AL, 2005, ANN PHARMACOTHER, V39, P655, DOI 10.1345/aph.1E286; Ng J, 2010, J PHARM HEALTH SERV, V1, P75, DOI 10.1111/j.1759-8893.2010.00001.x; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Ortlipp M, 2008, QUAL REP, V13, P695; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Valiquette JR, 2015, CAN J PUBLIC HEALTH, V106, pE89, DOI 10.17269/cjph.106.4880; Warholak TL, 2011, RES SOC ADMIN PHARM, V7, P438, DOI 10.1016/j.sapharm.2010.08.002	35	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152903	10.1371/journal.pone.0152903	http://dx.doi.org/10.1371/journal.pone.0152903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043716	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100041
J	Thapa, N; Aryal, KK; Puri, R; Shrestha, S; Shrestha, S; Thapa, P; Mehata, S; Thapa, P; Banjara, MR; Stray-Pedersen, B				Thapa, Narbada; Aryal, Krishna Kumar; Puri, Rupendra; Shrestha, Saraswoti; Shrestha, Sheela; Thapa, Pukar; Mehata, Suresh; Thapa, Pushpa; Banjara, Megha Raj; Stray-Pedersen, Babill			Alcohol Consumption Practices among Married Women of Reproductive Age in Nepal: A Population Based Household Survey	PLOS ONE			English	Article							LUND AREA WHILA; DRINKING PROBLEMS; PATTERNS; HEALTH; PREGNANCY; PREDICTORS; ABSTINENCE; DISORDERS; BIRTH; RISK	Background Alcohol chemically known as ethanol, causes several health, economic and social consequences across the world. Literatures suggest potential harm of alcohol drinking by pregnant women especially to the fetus and the mother. Despite anumber of significant public health problems related to alcohol consumption, this area has been ignored in Nepal and information at the national level is limited. Thus this study aimed at finding the prevalence of alcohol consumption among married women of reproductive age. Methods A nationally representative household survey was carried out from April to August 2013 by taking 16 districts across all 15 eco administrative regions. From the selected districts, 86 village development committees and 14 municipalities were selected as primary sampling units using probability proportionate to size, followed by random selection of 3 wards from each primary sampling unit. Finally, 30 households within each ward were selected using systematic random sampling, and one married women of reproductive age from each household. A total of 9000 married women of reproductive age were interviewed using a semi-structured questionnaire, on alcohol consumption practices including environmental factors and socio demographic characteristics and were included in the analysis. Results National prevalence of alcohol consumption ever among married women of reproductive age was 24.7% (95% CI: 21.7-28.0), last 12 months 17.9%(95% CI: 15.3-20.7) and last 30 days (current drinking) 11.8% (95% CI: 9.8-14.1). There was substantial variation among the districts ranging from 2% to 60%. Multivariable analysis suggests women with no education or within formal education, dalit and janajatis ethnicity, whose husbands drink alcohol, who brew alcohol at home and women from mountains were significantly at higher risk of consuming alcohol. Among the women who drank alcohol in last 12 months, a substantial proportion of them drank home brewed alcoholic beverages (95.9%, 95% CI: 94.3-97.4). Conclusion Alcohol consumption was common practice among married women of reproductive age in Nepal with variation among the subgroups of population. Thus, further investigation and behavior change communication interventions to reduce alcohol consumption especially among the women with higher risk of drinking is essential.	[Thapa, Narbada] Nepalese Army Inst Hlth Sci, Kathmandu, Nepal; [Aryal, Krishna Kumar; Puri, Rupendra; Stray-Pedersen, Babill] Univ Oslo, Inst Clin Med, Oslo, Norway; [Aryal, Krishna Kumar; Thapa, Pushpa] Govt Nepal, NHRC, Kathmandu, Nepal; [Puri, Rupendra] Govt Nepal, Minist Hlth & Populat, Dept Ayurveda, Dist Ayurveda Hlth Ctr, Kathmandu, Nepal; [Shrestha, Saraswoti] Initiat Res Educ & Community Health Nepal InREACH, Kathmandu, Nepal; [Shrestha, Sheela] Govt Nepal, Minist Hlth & Populat, Natl Hlth Educ Informat & Commun Ctr, Kathmandu, Nepal; [Thapa, Pukar] Kathmandu Med Coll, Kathmandu, Nepal; [Mehata, Suresh] Ipas Nepal, Kathmandu, Nepal; [Banjara, Megha Raj] Tribhuvan Univ, Cent Dept Microbiol, Kathmandu, Nepal; [Stray-Pedersen, Babill] Oslo Univ Hosp, Div Women & Children, Rikshosp, Oslo, Norway	University of Oslo; Tribhuvan University; University of Oslo; National Hospital Norway	Thapa, N (corresponding author), Nepalese Army Inst Hlth Sci, Kathmandu, Nepal.	narbada_thapa@hotmail.com	Thapa, Narbada/H-3231-2019	thapa, narbada/0000-0001-9527-4343	Letten Foundation; Letten Foundation, Norway	Letten Foundation; Letten Foundation, Norway	This work was supported by Letten Foundation, http://www.lettenfoundation.com/. The team received the grant only for baseline survey to collect basic information regarding alcohol consumption among reproductive age women in Nepal. The main objective this project was to assist the Ph.D. students to generate ideas for their individual research as well as the sub group of main data from current study to be utilized for their thesis work too. This study was solely a work of team effort including 3 Ph.D. students, supervisors, and the research scholars. The funding contributed to conceive the study at the very initial stage, research skill development, supervision, training events, and the logistics. The contribution of funding limit up to data collection and report preparation.; We express our gratitude to Letten Foundation, Norway for financial and technical support throughout the study. We appreciate Mr Gagan Gurung, Dr Binod Karki, Mr Mohan Poudel, Dr Bimita Mahat Thapa, Mr Bharat Thapa, Mr Bharat Rawat, Mr Binod Dulal and Dr Puja Thapa for their contribution in various stages of this study. We acknowledge Ms Kari Skinningsrud for copyediting this manuscript. We would like to acknowledge Ethical Review Board of the NHRC for providing ethical clearance for this study and District (Public) Health Offices of the study districts and Ministry of Health and Population for granting permission and support for the study. We are thankful to the field supervisors, enumerators and data entry operators for their contribution in the study. We sincerely acknowledge the study participants of this study for their valuable participation.	AMARO H, 1990, AM J PUBLIC HEALTH, V80, P575, DOI 10.2105/AJPH.80.5.575; Aryal K K, 2015, J Nepal Health Res Counc, V13, P1; Aryal KK., 2014, NONCOMMUNICABLE DIS; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; BENEGAL V, 2005, WOMEN ALCOHOL INDIA, P89; Bhandari GP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-23; Breslow RA, 2007, BREASTFEED MED, V2, P152, DOI 10.1089/bfm.2007.0012; CBS, 2012, NAT POP HOUS CENS 20; Cederfjall J, 2004, EUR ADDICT RES, V10, P15, DOI 10.1159/000073722; CELENTANO DD, 1984, J STUD ALCOHOL, V45, P355, DOI 10.15288/jsa.1984.45.355; Dhital R, 2001, ALCOHOL DRUG USE NEP; Ganry O, 2001, PUBLIC HEALTH, V115, P186; Geels LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-207; GENACIS, 2012, GEND ALC CULT INT ST; Karki KB, 2008, WHO STEPS SURVEILLAN; Lee JY, 2013, PUBLIC HEALTH, V127, P473, DOI 10.1016/j.puhe.2013.02.009; Mamman LS, 2002, SUBST USE MISUSE, V37, P579, DOI 10.1081/JA-120004274; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; Martinez P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-160; May PA, 2011, ALCOHOL RES HEALTH, V34, P15; Mehata S., 2013, NEPAL HOUSEHOLD SURV; Mini GK, 2007, INDIAN J COMM MED, V32, P150; Moos RH, 2004, ADDICTION, V99, P829, DOI 10.1111/j.1360-0443.2004.00760.x; Mullally A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-27; Niraul S, 2014, HLTH RENAISSANCE, V11, P205, DOI [10.3126/hren.v11i3.9633, DOI 10.3126/HREN.V11I3.9633]; O'Leary CM, 2010, PEDIATRICS, V126, pE843, DOI 10.1542/peds.2010-0256; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rosenberg Lynn, 2002, Ethnicity & Disease, V12, P548; Rundberg J, 2008, NORD J PSYCHIAT, V62, P186, DOI 10.1080/08039480801959216; Schneider M, 2012, ADDICTION, V107, P1369, DOI 10.1111/j.1360-0443.2012.03824.x; SHRESTHA NM, 1992, BRIT J ADDICT, V87, P1241; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Subady BN, 2013, DRUG ALCOHOL REV, V32, P435, DOI 10.1111/dar.12015; Thapa N, 2015, J Nepal Health Res Counc, V13, P59; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WILSNACK RW, 1984, AM J PUBLIC HEALTH, V74, P1231, DOI 10.2105/AJPH.74.11.1231; World Health Organization, 2014, STEPS INSTR SUPP MAT	38	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152535	10.1371/journal.pone.0152535	http://dx.doi.org/10.1371/journal.pone.0152535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035722	Green Published, gold			2022-12-27	WOS:000373201200020
J	Beltrami-Moreira, M; Vromman, A; Sukhova, GK; Folco, EJ; Libby, P				Beltrami-Moreira, Marina; Vromman, Amelie; Sukhova, Galina K.; Folco, Eduardo J.; Libby, Peter			Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ATHEROSCLEROTIC PLAQUES; INTERLEUKIN-1-BETA INHIBITION; MATRIX METALLOPROTEINASES; COLLAGEN ACCUMULATION; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; HEART-FAILURE; INFLAMMATION; ANAKINRA	Aims Mice deficient in IL-1 receptor 1 (hence unresponsive to both IL-1 isoforms a and beta) have impaired expansive arterial remodeling due to diminished expression of matrix-degrading enzymes, especially MMP-3. Emergence of IL-1 as a target in cardiovascular disease prompted the investigation of the redundancy of IL-1 alpha and IL-1 beta in the induction of MMP-3 and other matrix-remodeling enzymes in human cells. Methods and Results Human primary vascular smooth muscle cells (VSMCs) and carotid endarterectomy specimens were stimulated with equimolar concentrations of IL-1 alpha or IL-1 beta and analyzed protease expression by immunoblot and ELISA. Either IL-1 alpha or IL-1 beta increased the expression of pro-MMP-3 in VSMCs, facilitated VSMC migration through Matrigel, and induced MMP-3 production in specimens from atheromatous plaques. VSMCs also secreted MMP-1 and Cathepsin S (CatS) upon stimulation with IL-1 alpha or IL-1 beta. IL-1 isoforms similarly increased MMP-1 and MMP-9 expression in carotid endarterectomy specimens. We examined the expression of MMP-3 and IL-1 isoforms by immunostaining of carotid atheromata, calculated the% positive areas, and tested associations by linear regression. MMP-3 colocalized with IL-1 isoforms in atheromata. MMP-3+ area in plaques positively associated with IL-1 alpha+ (R2 = 0.61, P < 0.001) and with IL-1 beta + areas (R2 = 0.68, P < 0.001). MMP-3+ area within atheroma also associated with CD68+ area, but not with a-smooth muscle actin area. Conclusions Either IL-1 alpha or IL-1 beta can induce the expression of enzymes implicated in remodeling of the arterial extracellular matrix, and facilitate human VSMC migration in vitro. Human atheromata contain both IL-1 isoforms in association with immunoreactive MMP-3. This redundancy of IL-1 isoforms suggests that selective blocking of one IL-1 isoform should not impair expansive arterial remodeling, a finding with important clinical implications for therapeutic targeting of IL-1 in atherosclerosis.	[Beltrami-Moreira, Marina; Vromman, Amelie; Sukhova, Galina K.; Folco, Eduardo J.; Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Beltrami Moreira, Marina/ADG-6570-2022; Libby, Peter/AAY-6404-2021; Beltrami Moreira, Marina/AGW-5591-2022	Libby, Peter/0000-0002-1502-502X; Beltrami Moreira, Marina/0000-0001-7449-9789	Novartis; Heart, Lung, and Blood Institute [HL080472]; Lemann Foundation; CNPq (National Council for Scientific and Technologic Development), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080472] Funding Source: NIH RePORTER	Novartis(Novartis); Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Lemann Foundation; CNPq (National Council for Scientific and Technologic Development), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A sponsored research agreement from Novartis contributed to the support of this project. Dr. Libby's laboratory received funding from the Heart, Lung, and Blood Institute (HL080472). MBM received support from the Lemann Foundation and CNPq (National Council for Scientific and Technologic Development), Brazil. Dr. Libby is an unpaid consultant and involved in clinical trials sponsored by Novartis. Novartis had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbate A, 2013, AM J CARDIOL, V111, P1394, DOI 10.1016/j.amjcard.2013.01.287; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; CLINTON SK, 1991, AM J PATHOL, V138, P1005; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Glagov S., 1987, NEW ENGL J MED, V316, P371; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Ikonomidis I, 2008, CIRCULATION, V117, P2662, DOI 10.1161/CIRCULATIONAHA.107.731877; Ikonomidis I, 2014, CIRC-CARDIOVASC IMAG, V7, P619, DOI 10.1161/CIRCIMAGING.113.001193; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, P167, DOI DOI 10.1007/0-387-22440-8_8; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; LOPPNOW H, 1992, EXP CELL RES, V198, P283, DOI 10.1016/0014-4827(92)90381-H; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Rader DJ, 2012, J CLIN INVEST, V122, P27, DOI 10.1172/JCI61163; Rajavashisth TB, 1999, J BIOL CHEM, V274, P11924, DOI 10.1074/jbc.274.17.11924; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Schoenhagen P, 2002, AM J CARDIOL, V89, P1354, DOI 10.1016/S0002-9149(02)02346-9; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Van Tassell BW, 2014, AM J CARDIOL, V113, P321, DOI 10.1016/j.amjcard.2013.08.047	31	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152474	10.1371/journal.pone.0152474	http://dx.doi.org/10.1371/journal.pone.0152474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032103	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800081
J	Hou, K; Zhu, ZY; Wang, Y; Zhang, CH; Yu, SY; Zhu, Q; Yan, B				Hou, Kun; Zhu, Zhenya; Wang, Yong; Zhang, Chunhui; Yu, Shiyong; Zhu, Qi; Yan, Bo			Overexpression and Biological Function of Ubiquitin-Specific Protease 42 in Gastric Cancer	PLOS ONE			English	Article							MOLECULAR BIOMARKER; POOR-PROGNOSIS; PROGRESSION; INVASION; EXPRESSION; PROTEINS; HAUSP	Ubiquitin-specific protease 42 (USP42) is a member of deubiquitinating enzymes (DUBs). The alterations of DUBs are implicated in the pathogenesis of a wide variety of tumors. However, there are few studies on the expression and biological function of USP42 in gastric cancer (GC). Here, the expression levels of USP42 were significantly higher in GC tissues than in non-tumorous tissues. USP42 expression was significantly correlated with tumor size, TNM stage, lymph node metastasis and overall survival of patients with GC. Moreover, USP42 silencing in two GC cell lines, AGS and MKN-45, notably inhibited cell proliferation, but stimulated G1 phase arrest. The proteins promoting cell cycle progression (Cyclin D1, Cyclin E1 and PCNA) were down-regulated in USP42-suppressed cells. Moreover, inhibition of USP42 in GC cells impaired cell invasion via affecting the expression of matrix metalloproteinases (MMPs) and epithelial-mesenchymal transition (EMT) regulators. In conclusion, USP42 overexpression could be a potential prognostic marker for GC, regulate the survival and invasive properties of GC, and may represent a novel therapeutic molecular target for this tumor.	[Hou, Kun; Zhu, Zhenya; Zhang, Chunhui; Yu, Shiyong; Zhu, Qi; Yan, Bo] Shanghai Pudong Dist Peoples Hosp, Dept Gen Surg, Shanghai 201299, Peoples R China; [Wang, Yong] Punan Hosp, Dept Gen Surg, Shanghai 200125, Peoples R China		Yan, B (corresponding author), Shanghai Pudong Dist Peoples Hosp, Dept Gen Surg, Shanghai 201299, Peoples R China.	yanboyanbod@sina.com			Scientific Research Project of Shanghai Municipal Commission of Health and Family Planning [20124321]	Scientific Research Project of Shanghai Municipal Commission of Health and Family Planning	This study was supported by Scientific Research Project of Shanghai Municipal Commission of Health and Family Planning (20124321).	Bhattacharya S, 2014, FEBS J, V281, P3061, DOI 10.1111/febs.12843; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Ding FB, 2015, INT J MOL SCI, V16, P307, DOI 10.3390/ijms16010307; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Guo J, 2015, ONCOL REP, V33, P3124, DOI 10.3892/or.2015.3902; He Y, 2015, TRANSL RES, V165, P407, DOI 10.1016/j.trsl.2014.09.005; Hock AK, 2014, J BIOL CHEM, V289, P34862, DOI 10.1074/jbc.M114.589267; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Liang JX, 2014, ONCOL REP, V32, P2726, DOI 10.3892/or.2014.3508; Liang J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0899-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matsumura S, 2005, J CANCER RES CLIN, V131, P19, DOI 10.1007/s00432-004-0621-4; Monig SP, 2001, HISTOPATHOLOGY, V39, P597, DOI 10.1046/j.1365-2559.2001.01306.x; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Organization WH. International Agency for Research on Cancer, 2014, WORLD CANC REPORT 20; Paulsson K, 2006, LEUKEMIA, V20, P224, DOI 10.1038/sj.leu.2404076; Qu Q, 2015, TUMOR BIOL, V36, P5415, DOI 10.1007/s13277-015-3207-7; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Yang M, 2014, TUMOR BIOL, V35, P929, DOI 10.1007/s13277-013-1121-4; Zeng Z, 2014, TUMOR BIOL, V35, P3845, DOI 10.1007/s13277-013-1509-1; Zhang ZQ, 2012, J CANCER RES CLIN, V138, P1231, DOI 10.1007/s00432-012-1193-3	28	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152997	10.1371/journal.pone.0152997	http://dx.doi.org/10.1371/journal.pone.0152997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030989	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800162
J	van Dijk, CN; van Witteloostuijn, M; Vasic, N; Avrutin, S; Blom, E				van Dijk, Chantal N.; van Witteloostuijn, Merel; Vasic, Nada; Avrutin, Sergey; Blom, Elma			The Influence of Texting Language on Grammar and Executive Functions in Primary School Children	PLOS ONE			English	Article							WORKING-MEMORY; MEDIA MULTITASKING; 2ND-LANGUAGE ACQUISITION; SENTENCE REPETITION; BILINGUAL-CHILDREN; MESSAGE LANGUAGE; LITERACY SKILLS; READING-ABILITY; SHORT-TERM; ABBREVIATIONS	When sending text messages on their mobile phone to friends, children often use a special type of register, which is called textese. This register allows the omission of words and the use of textisms: instances of non-standard written language such as 4ever (forever). Previous studies have shown that textese has a positive effect on children's literacy abilities. In addition, it is possible that children's grammar system is affected by textese as well, as grammar rules are often transgressed in this register. Therefore, the main aim of this study was to investigate whether the use of textese influences children's grammar performance, and whether this effect is specific to grammar or language in general. Additionally, studies have not yet investigated the influence of textese on children's cognitive abilities. Consequently, the secondary aim of this study was to find out whether textese affects children's executive functions. To investigate this, 55 children between 10 and 13 years old were tested on a receptive vocabulary and grammar performance (sentence repetition) task and various tasks measuring executive functioning. In addition, text messages were elicited and the number of omissions and textisms in children's messages were calculated. Regression analyses showed that omissions were a significant predictor of children's grammar performance after various other variables were controlled for: the more words children omitted in their text messages, the better their performance on the grammar task. Although textisms correlated (marginally) significantly with vocabulary, grammar and selective attention scores and omissions marginally significantly with vocabulary scores, no other significant effects were obtained for measures of textese in the regression analyses: neither for the language outcomes, nor for the executive function tasks. Hence, our results show that textese is positively related to children's grammar performance. On the other hand, use of textese does not affect-positively nor negatively-children's executive functions.	[van Dijk, Chantal N.; Vasic, Nada; Blom, Elma] Univ Utrecht, Dept Special Educ Cognit & Motor Disabil, Utrecht, Netherlands; [van Witteloostuijn, Merel] Univ Amsterdam, Dept Linguist, Amsterdam, Netherlands; [Avrutin, Sergey] Univ Utrecht, Utrecht Inst Linguist, Dept Language Literature & Commun, Utrecht, Netherlands	Utrecht University; University of Amsterdam; Utrecht University	Blom, E (corresponding author), Univ Utrecht, Dept Special Educ Cognit & Motor Disabil, Utrecht, Netherlands.	W.B.T.Blom@uu.nl	van Dijk, Chantal/AAU-6665-2021		Dynamics of Youth (DoY)-one of the strategic themes of Utrecht University [SM.YI.2013.11.GM]	Dynamics of Youth (DoY)-one of the strategic themes of Utrecht University	This project was funded through Dynamics of Youth (DoY)-one of the strategic themes of Utrecht University-by a Seed Money grant (grant number SM.YI.2013.11.GM) to EB and SA, http://www.uu.nl/en/research/dynamics-of-youth/research/first-call-seed-money-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; AKMAJIAN A, 1984, NAT LANG LINGUIST TH, V2, P1; Alloway T.P., 2007, AUTOMATED WORKING ME; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Avrutin S., 1999, DEV SYNTAX DISCOURSE; Baumgartner SE, 2014, J EARLY ADOLESCENCE, V34, P1120, DOI 10.1177/0272431614523133; Bernicot J, 2014, J COMPUT ASSIST LEAR, V30, P559, DOI 10.1111/jcal.12064; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2012, COGNITION, V122, P67, DOI 10.1016/j.cognition.2011.08.003; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bishop D. V. M., 2003, TEST FOR RECEPTION O; Blom E, 2014, J EXP CHILD PSYCHOL, V128, P105, DOI 10.1016/j.jecp.2014.06.007; Bowey JA, 1996, J EXP CHILD PSYCHOL, V63, P44, DOI 10.1006/jecp.1996.0042; Bushnell C, 2011, AUST J EDUC DEV PSYC, V11, P27; Carrington V., 2005, CAMB J EDUC, V35, P161, DOI DOI 10.1080/03057640500146799; Cingel DP, 2012, NEW MEDIA SOC, V14, P1304, DOI 10.1177/1461444812442927; CIPIELEWSKI J, 1992, J EXP CHILD PSYCHOL, V54, P74, DOI 10.1016/0022-0965(92)90018-2; CLAY MM, 1971, MONOGR SOC RES CHILD, V36, P1, DOI 10.2307/1165821; Coe JEL, 2011, J COMPUT ASSIST LEAR, V27, P4, DOI 10.1111/j.1365-2729.2010.00404.x; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Craig D., 2003, INSTANT MESSAGING LA, P116; Crystal D, 2010, SCHOLAR COMMUN, V1, P229; de Abreu PMJE, 2012, PSYCHOL SCI, V23, P1364, DOI 10.1177/0956797612443836; de Abreu PMJE, 2012, J EDUC PSYCHOL, V104, P974, DOI 10.1037/a0028390; De Lange J, 2009, LINGUA, V119, P1523, DOI 10.1016/j.lingua.2008.04.005; Drouin M, 2009, J LIT RES, V41, P46, DOI 10.1080/10862960802695131; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Dunn L.M., 2007, PEABODY PICTURE VOCA; Durkin K, 2011, J COMPUT ASSIST LEAR, V27, P49, DOI 10.1111/j.1365-2729.2010.00397.x; Ensminger ME, 2003, MON PARENT, P13; GENESEE F, 1976, LANG LEARN, V26, P267, DOI 10.1111/j.1467-1770.1976.tb00277.x; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Haegeman Liliane, 1997, ENGL LANG LINGUIST, V1, P233, DOI DOI 10.1017/S1360674300000526; Haegeman Liliane., 2001, LANG ACQUIS, V9.4, P329, DOI DOI 10.1207/S15327817LA0904_03; Haegeman Liliane, 1999, ENGL LANG LINGUIST, V3, P117, DOI DOI 10.1017/S1360674399000155; Hermans D., 1998, BILING-LANG COGN, V1, P213, DOI [10.1017/S1366728998000364, DOI 10.1017/S1366728998000364]; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hsu JL, 2013, RES DEV DISABIL, V34, P423, DOI 10.1016/j.ridd.2012.08.026; Iluz-Cohen P, 2013, BILING-LANG COGN, V16, P884, DOI 10.1017/S1366728912000788; Kemp N, 2011, J COMPUT ASSIST LEAR, V27, P18, DOI 10.1111/j.1365-2729.2010.00400.x; Kemp N, 2014, READ WRIT, V27, P1585, DOI 10.1007/s11145-014-9508-1; Kidd E, 2007, LANG COGNITIVE PROC, V22, P860, DOI 10.1080/01690960601155284; Klem M, 2015, DEVELOPMENTAL SCI, V18, P146, DOI 10.1111/desc.12202; Kort W., 2008, CELF4NL PEARS ASS IN; Lasser I, 2002, LINGUISTICS, V40, P767, DOI 10.1515/ling.2002.030; Lyytinen H, 2004, ANN DYSLEXIA, V54, P184, DOI 10.1007/s11881-004-0010-3; Manly T, 1999, TEST EVERYDAY ATTENT; Morales J, 2013, J EXP CHILD PSYCHOL, V114, P187, DOI 10.1016/j.jecp.2012.09.002; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Paradis J, 2011, LINGUIST APPROACH BI, V1, P213, DOI 10.1075/lab.1.3.01par; Pea R, 2012, DEV PSYCHOL, V48, P327, DOI 10.1037/a0027030; Plester B, 2011, J COMPUT ASSIST LEAR, V27, P37, DOI 10.1111/j.1365-2729.2010.00402.x; Plester B., 2008, LITERACY, V42, P137, DOI [10.1111/j.1741-4369.2008.00489.x, 10.1111/j.17414369.2008.00489.x, DOI 10.1111/J.1741-4369.2008.00489.X]; Plester B, 2009, BRIT J DEV PSYCHOL, V27, P145, DOI 10.1348/026151008X320507; Poarch GJ, 2012, J EXP CHILD PSYCHOL, V113, P535, DOI 10.1016/j.jecp.2012.06.013; Polisenska K, 2015, INT J LANG COMM DIS, V50, P106, DOI 10.1111/1460-6984.12126; Potter MC, 1998, J MEM LANG, V38, P265, DOI 10.1006/jmla.1997.2546; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schlichting L., 2005, PEADOBY PICTURE VOCA; Schneider W., 2012, PSYCHOL SOFTWARE TOO; Slobin D, 1967, ELICITED IMITATION R, P10; Snowling M., 2000, DYSLEXIA; Stowell T., 1999, WORDS LOST SYNTAX FO; Thurlow C., 2006, J COMPUT-MEDIAT COMM, V11, P667, DOI [DOI 10.1111/J.1083-6101.2006.00031.X, 10.111141083-6101.2006.00031.x]; van der Schuur WA, 2015, COMPUT HUM BEHAV, V53, P204, DOI 10.1016/j.chb.2015.06.035; Verheijen L, 2013, ENGL STUD, V94, P582, DOI 10.1080/0013838X.2013.795737; Wechsler D., 2008, WECHSLER NONVERBAL S; Wood C, 2011, J COMPUT ASSIST LEAR, V27, P28, DOI 10.1111/j.1365-2729.2010.00398.x; Wood C, 2014, BRIT J DEV PSYCHOL, V32, P415, DOI 10.1111/bjdp.12049; Wood C, 2014, COMPUT EDUC, V70, P281, DOI 10.1016/j.compedu.2013.09.003; Wood C, 2011, BRIT J PSYCHOL, V102, P431, DOI 10.1111/j.2044-8295.2010.02002.x	73	7	7	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152409	10.1371/journal.pone.0152409	http://dx.doi.org/10.1371/journal.pone.0152409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031708	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800068
J	Gaffney, LP; Franks, B; Weary, DM; von Keyserlingk, MAG				Gaffney, Leigh P.; Franks, Becca; Weary, Daniel M.; von Keyserlingk, Marina A. G.			Coho Salmon (Oncorhynchus kisutch) Prefer and Are Less Aggressive in Darker Environments	PLOS ONE			English	Article							VISUAL PIGMENT COMPOSITION; ATLANTIC SALMON; STOCKING DENSITY; COLOR-VISION; FISH; GOLDFISH; WELFARE; GROWTH; LIGHT; ENRICHMENT	Fish are capable of excellent vision and can be profoundly influenced by the visual properties of their environment. Ambient colours have been found to affect growth, survival, aggression and reproduction, but the effect of background darkness (i.e., the darkness vs. lightness of the background) on preference and aggression has not been evaluated systematically. One-hundred Coho salmon (Oncorhynchus kisutch), a species that is increasing in popularity in aquaculture, were randomly assigned to 10 tanks. Using a Latin-square design, every tank was bisected to allow fish in each tank to choose between all the following colour choices (8 choices in total): black vs. white, light grey, dark grey, and a mixed dark grey/black pattern, as well as industry-standard blue vs. white, light grey, dark grey, and black. Fish showed a strong preference for black backgrounds over all other options (p < 0.01). Across tests, preference strength increased with background darkness (p < 0.0001). Moreover, having darker backgrounds in the environment resulted in less aggressive behaviour throughout the tank (p < 0.0001). These results provide the first evidence that darker tanks are preferred by and decrease aggression in salmonids, which points to the welfare benefits of housing farmed salmon in enclosures containing dark backgrounds.	[Gaffney, Leigh P.; Franks, Becca; Weary, Daniel M.; von Keyserlingk, Marina A. G.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, 2357 Main Mall, Vancouver, BC V6T 1Z6, Canada	University of British Columbia	von Keyserlingk, MAG (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, 2357 Main Mall, Vancouver, BC V6T 1Z6, Canada.	nina@mail.ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Weary, Daniel M/A-8868-2010	von Keyserlingk, Marina/0000-0002-1427-3152; Weary, Daniel M/0000-0002-0917-3982	Killiam Postdoctoral Scholarship	Killiam Postdoctoral Scholarship	This work was funded through the generous donations to the UBC Animal Welfare Program. B.F. is supported through a Killiam Postdoctoral Scholarship.	ABBOTT JC, 1985, CAN J FISH AQUAT SCI, V42, P1702, DOI 10.1139/f85-213; [Anonymous], 2014, R LANG ENV STAT COMP; Ashley PJ, 2007, APPL ANIM BEHAV SCI, V104, P199, DOI 10.1016/j.applanim.2006.09.001; Batzina A, 2012, AQUACULTURE, V370, P54, DOI 10.1016/j.aquaculture.2012.10.005; Braithwaite VA, 2005, P ROY SOC B-BIOL SCI, V272, P1107, DOI 10.1098/rspb.2005.3062; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Braithwaite VA, 1998, SPATIAL REPRESENTATION IN ANIMALS, P86; BROOM D, 1998, REPORT AQUAVISION 98, P89; Chandroo KP, 2004, FISH FISH, V5, P281, DOI 10.1111/j.1467-2679.2004.00163.x; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Cott H.B., 1940, ADAPTIVE COLORATION; Davis NJ, 1999, ANIM WELFARE, V8, P193; DAWKINS M, 1977, ANIM BEHAV, V25, P1034, DOI 10.1016/0003-3472(77)90054-9; Duncan I. J. H., 1978, Applied Animal Ethology, P197, DOI 10.1016/0304-3762(78)90086-X; Dunlop R, 2005, J PAIN, V6, P561, DOI 10.1016/j.jpain.2005.02.010; Ellis T, 2002, J FISH BIOL, V61, P493, DOI [10.1006/jfbi.2002.2057, 10.1111/j.1095-8649.2002.tb00893.x]; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ O; Fraser D., 1997, Animal welfare., P159; Fraser D., 2008, UNDERSTANDING ANIMAL; FRASER NHC, 1993, P ROY SOC B-BIOL SCI, V252, P135, DOI 10.1098/rspb.1993.0057; FUJIMOTO M, 1991, PHYSIOL BEHAV, V50, P185, DOI 10.1016/0031-9384(91)90519-T; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Godin, 1997, BEHAV ECOLOGY TELEOS; Hoglund E, 2002, J EXP BIOL, V205, P2535; Hyvarinen P, 2013, CAN J FISH AQUAT SCI, V70, P1386, DOI 10.1139/cjfas-2013-0147; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; KEENLEYSIDE MHA, 1962, J FISH RES BOARD CAN, V19, P625, DOI 10.1139/f62-042; KEENLEYSIDE MILES H. A., 1962, BEHAVIOUR, V19, P139, DOI 10.1163/156853961X00231; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Kjernsmo K, 2012, P ROY SOC B-BIOL SCI, V279, P4192, DOI 10.1098/rspb.2012.1547; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Laland KN, 2003, FISH FISH, V4, P199, DOI 10.1046/j.1467-2979.2003.00124.x; LEVINE JS, 1982, SCI AM, V246, P140, DOI 10.1038/scientificamerican0282-140; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Marchesan M, 2005, FISH RES, V73, P171, DOI 10.1016/j.fishres.2004.12.009; McLean E., 2008, Ribarstvo, V66, P43; Naas K, 1996, AQUACULT ENG, V15, P291, DOI 10.1016/0144-8609(95)00019-4; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Phillips PA, 2000, APPL ANIM BEHAV SCI, V67, P59, DOI 10.1016/S0168-1591(99)00104-5; Portavella M, 2004, NEUROSCI LETT, V362, P75, DOI 10.1016/j.neulet.2004.01.083; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; Portavella M, 2003, PHYSIOL BEHAV, V80, P49, DOI 10.1016/S0031-9384(03)00208-7; Rabe-Hesketh S., 2008, MULTILEVEL LONDGITUD; Rodriguez F., 1994, ANIM LEARN BEHAV, V10, P108; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Sandercock F. K., 1991, PACIFIC SALMON LIFE, P397; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHNEIDER R, 1980, CAN J FISH AQUAT SCI, V37, P1505, DOI 10.1139/f80-195; Shapovalov L., 1954, Fishery Bulletin Sacramento, VNo. 98, P1; Smith A., 1978, COMPUT GRAPH-UK, V12, P12; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2, P354; Southgate P, 2001, IN PRACTICE, V23, P277, DOI 10.1136/inpract.23.5.277; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; STEIGER A, 1979, SCHWEIZ ARCH TIERH, V121, P109; STRADMEYER L, 1987, Aquaculture and Fisheries Management, V18, P33, DOI 10.1111/j.1365-2109.1987.tb00123.x; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; Temple SE, 2008, J EXP BIOL, V211, P2134, DOI 10.1242/jeb.009365; Thorarensen H, 2011, AQUACULTURE, V312, P1, DOI 10.1016/j.aquaculture.2010.11.043; Tucker CB, 2003, J DAIRY SCI, V86, P521, DOI 10.3168/jds.S0022-0302(03)73630-3; Turnbull J, 2005, AQUACULTURE, V243, P121, DOI 10.1016/j.aquaculture.2004.09.022; Turnbull JF, 1998, AQUACULTURE, V159, P345, DOI 10.1016/S0044-8486(97)00233-0; Ullmann JFP, 2011, AQUACULTURE, V322, P235, DOI 10.1016/j.aquaculture.2011.10.005; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Volpato GL, 2007, DIS AQUAT ORGAN, V75, P165, DOI 10.3354/dao075165; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; WIDOWSKI TM, 1992, CAN J ANIM SCI, V72, P203, DOI 10.4141/cjas92-027	75	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151325	10.1371/journal.pone.0151325	http://dx.doi.org/10.1371/journal.pone.0151325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028731	gold, Green Published, Green Submitted			2022-12-27	WOS:000373116500023
J	Choo, HY; Li, Y; Cao, F; Sato, H				Choo, Hao Yu; Li, Yao; Cao, Feng; Sato, Hirotaka			Electrical Stimulation of Coleopteran Muscle for Initiating Flight	PLOS ONE			English	Article							INSECT; AERODYNAMICS	Some researchers have long been interested in reconstructing natural insects into steerable robots or vehicles. However, until recently, these so-called cyborg insects, biobots, or living machines existed only in science fiction. Owing to recent advances in nano/micro manufacturing, data processing, and anatomical and physiological biology, we can now stimulate living insects to induce user-desired motor actions and behaviors. To improve the practicality and applicability of airborne cyborg insects, a reliable and controllable flight initiation protocol is required. This study demonstrates an electrical stimulation protocol that initiates flight in a beetle (Mecynorrhina torquata, Coleoptera). A reliable stimulation protocol was determined by analyzing a pair of dorsal longitudinal muscles (DLMs), flight muscles that oscillate the wings. DLM stimulation has achieved with a high success rate (> 90%), rapid response time (< 1.0 s), and small variation (< 0.33 s; indicating little habituation). Notably, the stimulation of DLMs caused no crucial damage to the free flight ability. In contrast, stimulation of optic lobes, which was earlier demonstrated as a successful flight initiation protocol, destabilized the beetle in flight. Thus, DLM stimulation is a promising secure protocol for inducing flight in cyborg insects or biobots.	[Choo, Hao Yu; Li, Yao; Cao, Feng; Sato, Hirotaka] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sato, H (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	hirosato@ntu.edu.sg	Sato, Hirotaka/D-5203-2014	Sato, Hirotaka/0000-0003-4634-1639	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant	Nanyang Assistant Professorship (NAP); Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF); A*STAR-JST (The Japan Science and Technology Agency) joint grant	This work has been supported by Nanyang Assistant Professorship (NAP), Agency for Science, Technology and Research (A*STAR) Public Sector Research Funding (PSF), and A*STAR-JST (The Japan Science and Technology Agency) joint grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozkurt A, 2014, BIOBOTIC INSECT SWAR; Bozkurt A, 2009, IEEE T BIO-MED ENG, V56, P2304, DOI 10.1109/TBME.2009.2022551; Cao F, 2015, IEEE INT CONF ROBOT, P4576, DOI 10.1109/ICRA.2015.7139833; Cao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105389; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; DOWDY AK, 1994, J ECON ENTOMOL, V87, P1714, DOI 10.1093/jee/87.6.1714; Dyhr JP, 2013, J EXP BIOL, V216, P1523, DOI 10.1242/jeb.077644; Ellington CP, 1999, J EXP BIOL, V202, P3439; Fedorenko D N, 2009, EVOLUTION BEETLE HIN; Ferdinandus, 2015, 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P2228, DOI 10.1109/TRANSDUCERS.2015.7181404; Ferdinandus, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116655; Haas F, 2001, ZOOL-ANAL COMPLEX SY, V104, P123, DOI 10.1078/0944-2006-00017; Haas F, 2000, SOLID MECH APPL, V80, P137; Heide G, 1996, J EXP BIOL, V199, P1711; Hinterwirth AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052725; Latif T, 2012, ENG MED BIOL SOC EMB; Maharbiz MM, 2010, SCI AM, V303, P94, DOI 10.1038/scientificamerican1210-94; Roeder K.D., 1998, NERVE CELLS INSECT B; Sanchez CJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1363; Sato H, 2015, CURR BIOL, V25, P798, DOI 10.1016/j.cub.2015.01.051; Sato H, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.024.2009; Shoji K, 2012, BIOMED MICRODEVICES, V14, P1063, DOI 10.1007/s10544-012-9706-z; Truong TV, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036021; Truong TV, 2012, J BIONIC ENG, V9, P304, DOI 10.1016/S1672-6529(11)60127-3; Verderber A, 2014, JOVE-J VIS EXP, DOI 10.3791/50901; Visvanathan K, SOL STAT SENS ACT MI, P126; Vo Doan TT, 2015, MICR EL MECH SYST ME; WeiselEichler A, 1996, J COMP PHYSIOL A, V179, P103, DOI 10.1007/BF00193438; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; Wootton R, 2000, NATURE, V403, P144, DOI 10.1038/35003074	31	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151808	10.1371/journal.pone.0151808	http://dx.doi.org/10.1371/journal.pone.0151808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050093	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500013
J	Puthiyedth, N; Riveros, C; Berretta, R; Moscato, P				Puthiyedth, Nisha; Riveros, Carlos; Berretta, Regina; Moscato, Pablo			Identification of Differentially Expressed Genes through Integrated Study of Alzheimer's Disease Affected Brain Regions	PLOS ONE			English	Article							LONG NONCODING RNAS; UBIQUITIN-PROTEASOME SYSTEM; PENTOSE-PHOSPHATE PATHWAY; FIBROBLAST-GROWTH-FACTOR; ENTORHINAL CORTEX; TRANSMEMBRANE SEMAPHORIN; REDUCED EXPRESSION; LIPID-METABOLISM; GABRG2 MUTATION; NERVOUS-SYSTEM	Background Alzheimer's disease (AD) is the most common form of dementia in older adults that damages the brain and results in impaired memory, thinking and behaviour. The identification of differentially expressed genes and related pathways among affected brain regions can provide more information on the mechanisms of AD. In the past decade, several studies have reported many genes that are associated with AD. This wealth of information has become difficult to follow and interpret as most of the results are conflicting. In that case, it is worth doing an integrated study of multiple datasets that helps to increase the total number of samples and the statistical power in detecting biomarkers. In this study, we present an integrated analysis of five different brain region datasets and introduce new genes that warrant further investigation. Methods The aim of our study is to apply a novel combinatorial optimisation based meta-analysis approach to identify differentially expressed genes that are associated to AD across brain regions. In this study, microarray gene expression data from 161 samples (74 non-demented controls, 87 AD) from the Entorhinal Cortex (EC), Hippocampus (HIP), Middle temporal gyrus (MTG), Posterior cingulate cortex (PC), Superior frontal gyrus (SFG) and visual cortex (VCX) brain regions were integrated and analysed using our method. The results are then compared to two popular meta-analysis methods, RankProd and GeneMeta, and to what can be obtained by analysing the individual datasets. Results We find genes related with AD that are consistent with existing studies, and new candidate genes not previously related with AD. Our study confirms the up-regualtion of INFAR2 and PTMA along with the down regulation of GPHN, RAB2A, PSMD14 and FGF. Novel genes PSMB2, WNK1, RPL15, SEMA4C, RWDD2A and LARGE are found to be differentially expressed across all brain regions. Further investigation on these genes may provide new insights into the development of AD. In addition, we identified the presence of 23 non-coding features, including four miRNA precursors (miR-7, miR570, miR-1229 and miR-6821), dysregulated across the brain regions. Furthermore, we compared our results with two popular meta-analysis methods RankProd and GeneMeta to validate our findings and performed a sensitivity analysis by removing one dataset at a time to assess the robustness of our results. These new findings may provide new insights into the disease mechanisms and thus make a significant contribution in the near future towards understanding, prevention and cure of AD.	[Puthiyedth, Nisha; Berretta, Regina; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia; [Puthiyedth, Nisha; Berretta, Regina; Moscato, Pablo] Univ Newcastle, Sch Elect Engn & Comp Sci, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Riveros, Carlos] Hunter Med Res Inst, Clin Res Design, Informat Technol & Stat Suport Unit, New Lambton Hts, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Moscato, P (corresponding author), Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia.; Moscato, P (corresponding author), Univ Newcastle, Sch Elect Engn & Comp Sci, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au		Berretta, Regina/0000-0002-4420-3446; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Future Fellowship [FT120100060]; Australian Research Council Discovery Project [DP120102576]; Hunter Medical Research Institute Research Grant [HMRI 13-27]	Australian Research Council (ARC) Future Fellowship(Australian Research Council); Australian Research Council Discovery Project(Australian Research Council); Hunter Medical Research Institute Research Grant	PM is supported by Australian Research Council (ARC) Future Fellowship FT120100060 (http://arc.gov.au/). This project partially funded by Australian Research Council Discovery Project DP120102576 (http://arc.gov.au/) and Hunter Medical Research Institute Research Grant HMRI 13-27 (http://hmri.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J ALZHEIMERS DIS, V14, P313; Antoniou D, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00155; Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; Berretta Regina, 2008, V453, P363, DOI 10.1007/978-1-60327-429-6_19; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boisgueheneuc F., 2006, BRAIN, V129, p[12, 3315], DOI DOI 10.1093/BRAIN/AWL244; Bradbury R, 2007, TOPICS MED CHEM; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; Cotta C, 2004, LECT NOTES COMPUT SC, V3005, P21; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Ding BQ, 2014, AM J ALZHEIMERS DIS, V29, P526, DOI 10.1177/1533317514523487; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; El Fiky A, 2005, J CELL PHYSIOL, V204, P567, DOI 10.1002/jcp.20305; Fatemi SH, 2009, CEREBELLUM, V8, P64, DOI 10.1007/s12311-008-0075-3; Faust M, 2015, HDB NEUROPSYCHOLOGY, V2; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fernandez-Enright F, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.121; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Fiandaca MS, 2014, ALZHEIMERS DEMENT, V10, pS196, DOI 10.1016/j.jalz.2014.04.015; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Fragkouli A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00182; Fransen E, 2005, NEURAL NETWORKS, V18, P1141, DOI 10.1016/j.neunet.2005.08.004; Friston K.J., 2004, HUMAN BRAIN FUNCTION; Fu W, 2014, BIOGERONTOLOGY, V15, P579, DOI 10.1007/s10522-014-9525-0; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Gueli MC, 2013, NEUROL SCI, V34, P1575, DOI 10.1007/s10072-013-1289-9; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Hales CM, 2013, J NEUROPATH EXP NEUR, V72, P1009, DOI 10.1097/01.jnen.0000435847.59828.db; Henderson ST, 2004, MED HYPOTHESES, V62, P689, DOI 10.1016/j.mehy.2003.11.028; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hossini AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1262-5; Hu J, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.60; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Iwakiri M, 2005, ACTA NEUROPATHOL, V109, P467, DOI 10.1007/s00401-005-0985-9; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kelley JM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-1; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kleiber ML, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-6; Ko JA, 2005, FEBS LETT, V579, P2236, DOI 10.1016/j.febslet.2005.03.022; Kong W, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-5; Kowalski JR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892749; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee M, 2011, J BIOL CHEM, V286, P41230, DOI 10.1074/jbc.M111.270470; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0093-y; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Liang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040498; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Luo C, 2012, J CLIN NEUROSCI, V19, P920, DOI 10.1016/j.jocn.2011.11.001; Lusa L, GENEMETA METAANALYSI; Lyall DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080513; Maass A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6547; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Manning EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097608; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Minces VH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00016; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Moscato P, 2007, BIOSYSTEMS, V88, P56, DOI 10.1016/j.biosystems.2006.04.005; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mulligan R, 2003, CLIN MANAGEMENT EARL; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Newington Jordan T, 2013, J Neurodegener Dis, V2013, P234572, DOI 10.1155/2013/234572; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; Paolinelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070233; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Pecorelli Alessandra, 2013, Mediators Inflamm, V2013, P137629, DOI 10.1155/2013/137629; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Persengiev S, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00032; Pich EM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt276; Puthiyedth N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127702; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Ristic G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00072; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; Sanchez D, 2015, EXP GERONTOL, V67, P19, DOI 10.1016/j.exger.2015.04.003; Saxena U, 2009, EXPERT OPIN THER TAR, V13, P331, DOI [10.1517/14728220902738720 , 10.1517/14728220902738720]; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Scheubert L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-266; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seneff S, 2011, EUR J INTERN MED, V22, P134, DOI 10.1016/j.ejim.2010.12.017; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Spulber G, 2013, J INTERN MED, V273, P396, DOI 10.1111/joim.12028; Stallings JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1058; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Szafranskil K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00087; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Taniguchi M, 2012, J ALZHEIMERS ASS, V8, P119, DOI [10.1016/j.jalz.2012.05.311, DOI 10.1016/J.JALZ.2012.05.311]; Tian MN, 2012, J NEUROSCI, V32, P5937, DOI 10.1523/JNEUROSCI.5332-11.2012; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Vasconcelos LD, 2014, CLINICS, V69, P28, DOI 10.6061/clinics/2014(01)05; Vlassenko AG, 2012, BBA-MOL BASIS DIS, V1822, P370, DOI 10.1016/j.bbadis.2011.11.005; Wang J, 2008, GENES BRAIN BEHAV, V7, P78, DOI 10.1111/j.1601-183X.2007.00328.x; Wang LJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S2-S15; Wilcock Donna M, 2012, Curr Gerontol Geriatr Res, V2012, P170276, DOI 10.1155/2012/170276; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu HT, 2009, J MOL NEUROSCI, V39, P27, DOI 10.1007/s12031-009-9177-8; Xiao F, 2011, NEUROSCI BULL, V27, P143, DOI 10.1007/s12264-011-1028-2; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Yamagata H, 2004, BIOCHEM BIOPH RES CO, V321, P320, DOI 10.1016/j.bbrc.2004.06.142; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Young KWH, 2005, J GERONTOL A-BIOL, V60, P1039, DOI 10.1093/gerona/60.8.1039; Zai CC, 2014, NEUROPSYCHOBIOLOGY, V69, P154, DOI 10.1159/000358839; Zai G, 2005, AM J MED GENET B, V134B, P25, DOI 10.1002/ajmg.30452; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zeitschel U, 2002, J NEUROCHEM, V83, P371, DOI 10.1046/j.1471-4159.2002.01127.x; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	162	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152342	10.1371/journal.pone.0152342	http://dx.doi.org/10.1371/journal.pone.0152342			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050411	gold, Green Submitted, Green Published			2022-12-27	WOS:000373603500033
J	Sohani, ZN; Anand, SS; Robiou-du-Pont, S; Morrison, KM; McDonald, SD; Atkinson, SA; Teo, KK; Meyre, D				Sohani, Zahra N.; Anand, Sonia S.; Robiou-du-Pont, Sebastien; Morrison, Katherine M.; McDonald, Sarah D.; Atkinson, Stephanie A.; Teo, Koon K.; Meyre, David			Risk Alleles in/near ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2 Elevate Plasma Glucose Levels at Birth and in Early Childhood: Results from the FAMILY Study	PLOS ONE			English	Article							FASTING GLUCOSE; ASSOCIATION ANALYSIS; INSULIN-RESISTANCE; GLYCEMIC TRAITS; GENETIC-LOCI; PREVALENCE; CHILDREN; OBESITY; ADOLESCENTS; TOLERANCE	Background Metabolic abnormalities that lead to type 2 diabetes mellitus begin in early childhood. Objectives We investigate whether common genetic variants identified in adults have an effect on glucose in early life. Methods 610 newborns, 463 mothers, and 366 fathers were included in the present study. Plasma glucose and anthropometric characteristics were collected at birth, 3, and 5 years. After quality assessment, 37 SNPs, which have demonstrated an association with fasting plasma glucose at the genome-wide threshold in adults, were studied. Quantitative trait disequilibrium tests and mixed-effects regressions were conducted to estimate an effect of the SNPs on glucose. Results Risk alleles for 6 loci increased glucose levels from birth to 5 years of age (ADCY5, ADRA2A, CDKAL1, CDKN2A/B, GRB10, and TCF7L2, 4.85x10(-3) <= P <= 4.60x10(-2)). Together, these 6 SNPs increase glucose by 0.05 mmol/L for each risk allele in a genotype score (P = 6.33x10(-5)). None of the associations described in the present study have been reported previously in early childhood. Conclusion Our data support the notion that a subset of loci contributing to plasma glucose variation in adults has an effect at birth and in early life.	[Sohani, Zahra N.; Anand, Sonia S.; Robiou-du-Pont, Sebastien; McDonald, Sarah D.; Teo, Koon K.; Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Anand, Sonia S.; Morrison, Katherine M.; Teo, Koon K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Morrison, Katherine M.; Atkinson, Stephanie A.] Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Morrison, Katherine M.] McMaster Univ, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Meyre, David] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Meyre, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Meyre, D (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	meyred@mcmaster.ca	Atkinson, Stephanie/AAS-4146-2021; Meyre, David/D-7315-2011; Morrison, Katherine/AAO-8046-2021	Atkinson, Stephanie/0000-0002-5680-7546; Meyre, David/0000-0003-4850-7444; Morrison, Katherine/0000-0002-1737-256X; Teo, Koon/0000-0002-3731-0956	Heart and Stroke Foundation of Canada [NA 7293]; Canadian Diabetes Association Doctoral Research Award; Ontario Graduate Scholarship; Canadian Institutes of Health Research New Investigator Salary Award; Population Health Research Institute	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Diabetes Association Doctoral Research Award; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Population Health Research Institute	This study was funded by the Heart and Stroke Foundation of Canada (grant #NA 7293 "Early genetic origins of cardiovascular risk factors"). ZNS was funded by the Canadian Diabetes Association Doctoral Research Award and the Ontario Graduate Scholarship. SSA holds the Heart and Stroke Foundation of Ontario, Michael G. DeGroote endowed Chair in Population Health and a Canada Research Chair in Ethnicity and Cardiovascular Disease. SRP was supported by the Heart and Stroke Foundation of Canada (grant #NA 7293 "Early genetic origins of cardiovascular risk factors"), DM holds a Canada Research Chair in Genetics of Obesity, and SDM was supported by a Canadian Institutes of Health Research New Investigator Salary Award. The authors also acknowledge the internal support from the Population Health Research Institute for making continuation of the study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1997, AM J HUM GENET, V60, P676; Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dimas AS, 2014, DIABETES, V63, P2158, DOI 10.2337/db13-0949; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Esmaillzadeh A, 2006, OBESITY, V14, P377, DOI 10.1038/oby.2006.50; Freathy RM, 2007, AM J HUM GENET, V80, P1150, DOI 10.1086/518517; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Katoh S, 2005, J CLIN ENDOCR METAB, V90, P2642, DOI 10.1210/jc.2004-2471; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marom R, 2010, ACTA PAEDIATR, V99, P1474, DOI 10.1111/j.1651-2227.2010.01865.x; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Whincup PH, 2005, DIABETIC MED, V22, P1275, DOI 10.1111/j.1464-5491.2005.01587.x; Wiegand S, 2004, EUR J ENDOCRINOL, V151, P199, DOI 10.1530/eje.0.1510199; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152107	10.1371/journal.pone.0152107	http://dx.doi.org/10.1371/journal.pone.0152107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049325	gold, Green Submitted, Green Published			2022-12-27	WOS:000373603500024
J	Zhang, H; Merrett, DC; Jing, ZC; Tang, JG; He, YL; Yue, HB; Yue, ZW; Yang, DYY				Zhang, Hua; Merrett, Deborah C.; Jing, Zhichun; Tang, Jigen; He, Yuling; Yue, Hongbin; Yue, Zhanwei; Yang, Dongya Y.			Osteoarchaeological Studies of Human Systemic Stress of Early Urbanization in Late Shang at Anyang, China	PLOS ONE			English	Article							LINEAR ENAMEL HYPOPLASIAS; POROTIC HYPEROSTOSIS; CRIBRA-ORBITALIA; SKELETAL AGE; PREHISTORIC POPULATIONS; HEALTH; DISEASE; TRANSITION; DEATH; BIOARCHAEOLOGY	Through the analysis of human skeletal remains and mortuary practice in Yinxu, this study investigates the impact of early urbanization on the commoners during the Late Shang dynasty (ca. 1250-1046 B.C.). A total of 347 individuals examined in this study represent non-elites who were recovered from two different burial contexts (formally buried in lineage cemeteries and randomly scattered in refuse pits). Frequencies of enamel hypoplasia (childhood stress), cribra orbitalia (childhood stress and frailty) and osteoperiostitis (adult stress) were examined to assess systemic stress exposure. Our results reveal that there was no significant difference in the frequency of enamel hypoplasia between two burial groups and between sexes, suggesting these urban commoners experienced similar stresses during childhood, but significantly elevated levels of cribra orbitalia and osteoperiostitis were observed in the refuse pit female cohort. Theoretically, urbanization would have resulted in increased population density in the urban centre, declining sanitary conditions, and increased risk of resource shortage. Biologically, children would be more vulnerable to such physiological disturbance; as a result, high percentages of enamel hypoplasia (80.9% overall) and cribra orbitalia (30.3% overall) are observed in Yin commoners. Adults continued to suffer from stress, resulting in high frequencies of osteoperiostitis (40.0% total adults); in particular, in the refuse pit females who may also reflect a compound impact of gender inequality. Our data show that the non-elite urban population in the capital city of Late Shang Dynasty had experienced extensive stress exposure due to early urbanization with further social stratification only worsening the situation, and eventually contributing to collapse of the Shang Dynasty.	[Zhang, Hua; Merrett, Deborah C.; Yang, Dongya Y.] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Jing, Zhichun] Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada; [Tang, Jigen; He, Yuling; Yue, Hongbin; Yue, Zhanwei] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Zhang, Hua; Merrett, Deborah C.; Yang, Dongya Y.] Simon Fraser Univ, Dept Archaeol, SFU JLU Joint Ctr Bioarchaeol Res, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; University of British Columbia; Chinese Academy of Social Sciences; Simon Fraser University	Zhang, H; Yang, DYY (corresponding author), Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada.; Jing, ZC (corresponding author), Univ British Columbia, Dept Anthropol, Vancouver, BC V5Z 1M9, Canada.; Zhang, H; Yang, DYY (corresponding author), Simon Fraser Univ, Dept Archaeol, SFU JLU Joint Ctr Bioarchaeol Res, Burnaby, BC V5A 1S6, Canada.	zhangh@sfu.ca; jingzh@interchange.ubc.ca; donyang@sfu.ca			Fellowship for East and Southeast Asian Archaeology and Early History from the American Council of Learned Societies; Henry Luce Foundation; Simon Fraser University; Canada's Social Sciences and Humanities Research Council Research Grant [410-2010-1601, 410-2006-2020]; Social Sciences and Humanities Research Council Partnership Development Grant [890-2012-0119]	Fellowship for East and Southeast Asian Archaeology and Early History from the American Council of Learned Societies; Henry Luce Foundation; Simon Fraser University; Canada's Social Sciences and Humanities Research Council Research Grant; Social Sciences and Humanities Research Council Partnership Development Grant	This research was supported in part by a Fellowship for East and Southeast Asian Archaeology and Early History from the American Council of Learned Societies, with funding from the Henry Luce Foundation (H. Zhang) (http://www.hluce.org); Graduate Fellowships (H. Zhang) from Simon Fraser University (https://www.sfu.ca/dean-gradstudies/awards/graduate-fellowships/graduate-fellowships.html); Canada's Social Sciences and Humanities Research Council Research Grant 410-2010-1601 (D.Y. Yang) (http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/insight_grants-subventions_savoir-eng.aspx) and Social Sciences and Humanities Research Council Partnership Development Grant 890-2012-0119 (D.Y. Yang) (http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/partnership_development_grants-subventions_partenariat_developpement-eng.aspx); Canada's Social Sciences and Humanities Research Council Research Grant 410-2006-2020 (Z.C. Jing) (http://www.sshrc-crsh.gc.ca/funding-financement/programs-programmes/insight_grantssubventions_savoir-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S., 2011, SOCIAL BIOARCHAEOLOG, P1; Amoroso A, 2014, AM J HUM BIOL, V26, P461, DOI 10.1002/ajhb.22547; Animal Campbell R., 2015, ANIMALS INEQUALITY A; [Anonymous], [No title captured]; Armelagos GJ, 2005, SOC SCI MED, V61, P755, DOI 10.1016/j.socscimed.2004.08.066; Bagley R., 1999, CAMBRIDGE HIST ANCIE, DOI 10.1017/CHOL9780521470308.005; Bass WM, 1995, SPECIAL PUBLICATION, V2; Beck BR, 1998, SPORTS MED, V26, P265, DOI 10.2165/00007256-199826040-00005; Belcastro G, 2007, AM J PHYS ANTHROPOL, V132, P381, DOI 10.1002/ajpa.20530; Benus R, 2010, HOMO, V61, P178, DOI 10.1016/j.jchb.2010.04.001; Bocquet-Appel JP, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P277, DOI 10.1007/978-1-4020-6424-1_10; Brickley M, 2008, BIOARCHAEOLOGY OF METABOLIC BONE DISEASE, P1, DOI 10.1016/B978-0-12-370486-3.00001-9; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Buckley HR, 2014, INT J PALEOPATHOL, V5, P72, DOI 10.1016/j.ijpp.2014.03.001; Buikstra J.E., 1994, STANDARDS DATA COLLE; Buzon MR, 2008, AM J PHYS ANTHROPOL, V136, P93, DOI 10.1002/ajpa.20781; Campbell R, 2012, ASIAN PERSPECT, V51, P313; Campbell RB, 2011, ANTIQUITY, V85, P1279, DOI 10.1017/S0003598X00062050; Cao XY, 2010, QUATERN INT, V227, P3, DOI 10.1016/j.quaint.2010.03.019; CHANG KC, 1974, WORLD ARCHAEOL, V6, P1; Cheung C, 2015, ARCHAEOL ANTHROP SCI, P1; Clark A-L., 2014, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V26, P196, DOI 10.1007/s13219-014-0113-2; Colli CM, 2009, HOMO, V60, P343, DOI 10.1016/j.jchb.2009.04.001; Crawford GW, 2009, P NATL ACAD SCI USA, V106, P7271, DOI 10.1073/pnas.0903375106; DeWitte SN, 2014, INT J PALEOPATHOL, V7, P38, DOI 10.1016/j.ijpp.2014.06.001; DeWitte SN, 2011, AM J PHYS ANTHROPOL, V146, P609, DOI 10.1002/ajpa.21622; Facchini F, 2004, INT J OSTEOARCHAEOL, V14, P126, DOI 10.1002/oa.717; Franklyn M, 2015, WORLD J ORTHOP, V6, P577, DOI 10.5312/wjo.v6.i8.577; Goodman A., 1991, HUMAN PALEOPATHOLOGY, P280; Goodman A.H., 2002, BACKBONE HIST, V2, P11, DOI DOI 10.1017/CB09780511549953.003; GOODMAN AH, 1990, YEARB PHYS ANTHROPOL, V33, P59; GOODMAN AH, 1980, HUM BIOL, V52, P515; Gowland RL, 2015, AM J PHYS ANTHROPOL, V158, P530, DOI 10.1002/ajpa.22820; GRAUER AL, 1993, AM J PHYS ANTHROPOL, V91, P203, DOI 10.1002/ajpa.1330910206; Guo X, 2002, COLLECT PAP HIST STU, P6; He Y, 2011, SANDAI KAOGU, P279; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hirata, 1990, HUM EVOL, V5, P375, DOI DOI 10.1007/BF02437251); HOFFMAN JM, 1979, J FORENSIC SCI, V24, P461; Hu H, 2012, HUAXIA ARCHAEOL, P149; Huang M, 2010, NEW DISCUSSIONS CHIN, P1; Institute of Archaeology Chinese Academy of Social Sciences, 2007, D 77 I ARCHAEOLOGY C; Institute of Archaeology Chinese Academy of Social Sciences, 2012, KAOGU, V12, P26; Institute of Archaeology Chinese Academy of Social Sciences, 1994, ARCH EXC RES YIN RUI; Institute of Archaeology Chinese Academy of Social Sciences, 1987, EXCAVATION YINXU 195; Jing Y, 2005, J ANTHROPOL ARCHAEOL, V24, P252, DOI 10.1016/j.jaa.2005.03.001; Jing Y, 2009, ANTIQUITY, V83, P96, DOI 10.1017/S0003598X00098112; Jing Z, 2013, COMPANION CHINESE AR, P343, DOI [10.1002/9781118325698, DOI 10.1002/9781118325698.CH17]; Keenleyside A, 1998, AM J PHYS ANTHROPOL, V107, P51, DOI 10.1002/(SICI)1096-8644(199809)107:1<51::AID-AJPA5>3.3.CO;2-I; KENT S, 1986, MAN, V21, P605, DOI 10.2307/2802900; King T, 2005, AM J PHYS ANTHROPOL, V128, P547, DOI 10.1002/ajpa.20232; Klaus HD, 2014, AM J PHYS ANTHROPOL, V155, P294, DOI 10.1002/ajpa.22574; Klaus HD, 2009, AM J PHYS ANTHROPOL, V139, P204, DOI 10.1002/ajpa.20973; Klaus HD, 2009, AM J PHYS ANTHROPOL, V138, P356, DOI 10.1002/ajpa.20944; Klaus HD, INT J PALEOPATHOL; Kong D, 2007, YINDU J, V4, P48; LAMBERT PM, 1993, AM ANTIQUITY, V58, P509, DOI 10.2307/282110; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; Larsen CS, 1998, SEX GENDER PALEOPATH, P165; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Lewis ME, 2010, AM J PHYS ANTHROPOL, V142, P405, DOI 10.1002/ajpa.21239; Li Z, 2011, JIANGHAN KAOGU, V121, P89; Li Z., 2011, SANDAI KAOGU, P471; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; McDade TW, 2008, AM J PHYS ANTHROPOL, V136, P478, DOI 10.1002/ajpa.20831; McIlvaine BK, 2015, INT J OSTEOARCHAEOL, V25, P997, DOI 10.1002/oa.2383; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; MENSFORTH ROBERT P., 1978, MED ANTHROPOL, V2, P1, DOI DOI 10.1080/01459740.1978.9986939; Merrett DC, QUAT INT; Moen MH, 2009, SPORTS MED, V39, P523, DOI 10.2165/00007256-200939070-00002; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Oxenham MF, 2010, ANTHROPOL SCI, V118, P199, DOI 10.1537/ase.100302; Oxenham MF, 2006, ASIAN PERSPECT, V45, P212, DOI DOI 10.1353/ASI.2006.0025; Paine RR, 2007, HOMO, V58, P173, DOI 10.1016/j.jchb.2006.06.001; Palubeckaite Z, 2002, INT J OSTEOARCHAEOL, V12, P189, DOI 10.1002/oa.607; Parker Pearson M., 1999, ARCHAEOLOGY DEATH BU; Pechenkina EA, 2002, AM J PHYS ANTHROPOL, V117, P15, DOI 10.1002/ajpa.10014; Pechenkina EA, 2007, ANCIENT HLTH SKELETA, P255; Pechenkina EA, 2006, AM J PHYS ANTHROPOL, V131, P218, DOI 10.1002/ajpa.20432; Peck JJ, 2013, INT J PALEOPATHOL, V3, P83, DOI 10.1016/j.ijpp.2013.03.005; Redfern RC, 2015, AM J PHYS ANTHROPOL, V157, P107, DOI 10.1002/ajpa.22693; Robb J, 2014, TROUBLED TIMES VIOLE, P111; Robb J., 1994, HUMAN EVOLUTION, V9, P215, DOI DOI 10.1007/8E02437928; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Rothschild B., 2012, ADV ANTHR, V2, P157, DOI [10.4236/aa.2012.23018, DOI 10.4236/AA.2012.23018]; Sakashita R, 1997, AM J PHYS ANTHROPOL, V103, P401, DOI 10.1002/(SICI)1096-8644(199707)103:3<401::AID-AJPA9>3.0.CO;2-S; Salanitri S, 2013, AUST DENT J, V58, P133, DOI 10.1111/adj.12039; Salvadei L, 2001, AM J HUM BIOL, V13, P709, DOI 10.1002/ajhb.1115; Schell LM, 1997, AM J PHYS ANTHROPOL, V102, P67; Schultz M, 2001, YEARB PHYS ANTHROPOL, V44, P106, DOI 10.1002/ajpa.10024; Schultz M, 2012, BONE HISTOLOGY: AN ANTHROPOLOGICAL PERSPECTIVE, P253; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; SEOW W K, 1990, Journal of Pedodontics, V14, P235; Shang H, 2001, P 8 ANN M CHIN SOC V, P281; Shao XQ, 1985, HDB HUMAN BODY MEASU; Shi Y F, 1992, SCI CHINA, V12, P1300, DOI DOI 10.1360/ZB1992-22-12-1300; Skinner M, 1996, J ARCHAEOL SCI, V23, P833, DOI 10.1006/jasc.1996.0078; Skinner MF, 2014, AM J PHYS ANTHROPOL, V154, P125, DOI 10.1002/ajpa.22485; Slaus M, 2008, AM J PHYS ANTHROPOL, V136, P455, DOI 10.1002/ajpa.20829; Song Z.H., 1991, HIST RES, V4, P92; Stuart-Macadam P., 1998, SEX GENDER PALEOPATH, P45; STUARTMACADAM P, 1992, AM J PHYS ANTHROPOL, V87, P39, DOI 10.1002/ajpa.1330870105; STUARTMACADAM P, 1985, AM J PHYS ANTHROPOL, V66, P391, DOI 10.1002/ajpa.1330660407; STUARTMACADAM P, 1989, AM J PHYS ANTHROPOL, V80, P187, DOI 10.1002/ajpa.1330800206; Sun L, 2010, HUAXIA ARCHAEOL, P100; Tang J, 1998, INT S SHANG CULT ANC, P201; Tang J., 1993, KAOGU ARCHAEOL, V10, P925; Tang J, 2009, KAOGU, P70; Tang J, 2005, YINDU J, P18; Tang J, 2002, CULT RELICS CENT CHI, V6, P50; Temple DH, 2014, AM J PHYS ANTHROPOL, V155, P186, DOI 10.1002/ajpa.22602; Temple DH, 2010, AM J PHYS ANTHROPOL, V142, P112, DOI 10.1002/ajpa.21208; Temple Daniel H., 2013, BIOARCHAEOLOGY E ASI, P344; Upex B, 2012, J ZOOL, V287, P259, DOI 10.1111/j.1469-7998.2012.00912.x; Van Der Merwe AE, 2010, INT J OSTEOARCHAEOL, V20, P227, DOI 10.1002/oa.1026; Waldron T., 1994, COUNTING DEAD EPIDEM; Walker PL, 2009, AM J PHYS ANTHROPOL, V139, P109, DOI 10.1002/ajpa.21031; Wang S, 2014, S CULT RELICS, V116, P117; Wang XP, 2011, ADV MATER RES-SWITZ, V282-283, P3, DOI 10.4028/www.scientific.net/AMR.282-283.3; Wang XQ, 2007, SCI ARCHAEOL, V2, P116; Wang XR, 2008, CHIN ARCHAEOL, V8, P22; Wapler U, 2004, AM J PHYS ANTHROPOL, V123, P333, DOI 10.1002/ajpa.10321; Wei J, 2007, ARCHAEOL CULT RELICS, P44; Weston DA, 2012, BLACKW COMPANION ANT, P492; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; Wu W, 2005, HUAXIA ARCHAEOL, P60; [许清海 Xu Qinghai], 2010, [第四纪研究, Quaternary Sciences], V30, P273; Yang B, 1983, CULT RELICS CENT CHI, P30; Yang X, 1986, STUD SHANG ARCH SEL, P49; Yang X, 1998, INT S SHANG CULT ANC, P208; Ye W, 2014, J SANMENXIA POLYTECH, V13, P11; Yinxu Xiaomintun Team, 2007, KAOGU, V1, P26; Zhang J, 2009, KAOGU ARCHAEOL, V10, P86; [张全超 Zhang Quanchao], 2006, [人类学学报, Acta Anthropologica Sinica], V25, P102; [张振卿 Zhang Zhenqing], 2007, [第四纪研究, Quaternary Sciences], V27, P461; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zheng Z, 1981, KAOGU ARCHAEOL, V6, P560; Zheng Z, 1981, KAOGU ARCHAEOL, V6, P511; Zhou LM, 1998, AM J HUM BIOL, V10, P723, DOI [10.1002/(SICI)1520-6300(1998)10:6<723::AID-AJHB4>3.0.CO;2-Q, 10.1002/(SICI)1520-6300(1998)10:6&lt;723::AID-AJHB4&gt;3.0.CO;2-Q]; Zhu F, 2004, FAMILY STRUCTURE SHA; Zhu Y, 2005, YINDU J, P1	144	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0151854	10.1371/journal.pone.0151854	http://dx.doi.org/10.1371/journal.pone.0151854			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DI6IX	27050400	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500016
J	Zhang, Y; Zhang, F; Hu, P; Huang, WJ; Lu, L; Bai, RX; Sharma, M; Zhao, Y				Zhang, Yan; Zhang, Fan; Hu, Ping; Huang, Wenjie; Lu, Lu; Bai, Ruixue; Sharma, Manoj; Zhao, Yong			Exploring Health Literacy in Medical University Students of Chongqing, China: A Cross-Sectional Study	PLOS ONE			English	Article							OF-THE-LITERATURE; QUESTIONNAIRE HLQ; CHRONIC DISEASE; PUBLIC-HEALTH; KNOWLEDGE; CARE; OUTCOMES; ASSOCIATION; WEAKNESSES; MORTALITY	Health literacy is important in public health and healthcare, particularly in effective communication between patients and health professionals. Although most medical students will eventually work as health professionals after graduation, research on health literacy of medical students is scarce. This study aimed to assess the health literacy level of medical students in Chongqing, China, and its influencing factors. A cross-sectional study was conducted and 1,275 participants (250 males and 1,022 females) who majored in five different disciplines were involved. The Health Literacy Questionnaire was used as the survey tool. The junior students obtained the highest scores, whereas the freshman students had the lowest scores on each scale. The average score of males was higher than that of females except in "feeling understood and supported by healthcare providers," and the average score of students who reside in urban areas was higher than that of students in rural areas. Moreover, the average score of engineering students was higher than that of medical or health sciences students. Multiple linear regression models (R-adj(2) = 0.435, P = 0.000) showed that the grade, socioeconomic status, and parent's highest level of education were positively correlated with health literacy. In conclusion, the health literacy levels of the medical students are insufficient and need improvement.	[Zhang, Yan; Zhang, Fan; Hu, Ping; Huang, Wenjie; Lu, Lu; Bai, Ruixue; Zhao, Yong] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Zhang, Yan; Zhang, Fan; Hu, Ping; Huang, Wenjie; Lu, Lu; Bai, Ruixue; Zhao, Yong] Chongqing Med Univ, Res Ctr Med & Social Dev, Chongqing, Peoples R China; [Zhang, Yan; Zhang, Fan; Hu, Ping; Huang, Wenjie; Lu, Lu; Bai, Ruixue; Zhao, Yong] Chongqing Med Univ, Innovat Ctr Social Risk Governance Hlth, Chongqing, Peoples R China; [Sharma, Manoj] Jackson State Univ, Dept Behav & Environm Hlth, Jackson, TN USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhao, Y (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.; Zhao, Y (corresponding author), Chongqing Med Univ, Res Ctr Med & Social Dev, Chongqing, Peoples R China.; Zhao, Y (corresponding author), Chongqing Med Univ, Innovat Ctr Social Risk Governance Hlth, Chongqing, Peoples R China.	zhaoyongzb@qq.com	Sharma, Manoj/AAN-6133-2020; Zhao, Yong/Z-3231-2019	Sharma, Manoj/0000-0002-4624-2414; Zhao, Yong/0000-0001-9290-109X	Humanity and Social Science Foundation of China's Ministry of Education [15YJA860020]	Humanity and Social Science Foundation of China's Ministry of Education	The study was funded by Humanity and Social Science Foundation of China's Ministry of Education (15YJA860020). YZ (Yong Zhao) received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: http://xm.sinoss.net/indexAction!to_index.action.	Al Sayah F, 2015, CAN J DIABETES, V39, P259, DOI 10.1016/j.jcjd.2014.11.005; Animal Health Australia, 2008, AUSVETPLAN DEC MAN V; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Beauchamp A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2056-z; Cafiero M, 2013, J HEALTH COMMUN, V18, P70, DOI 10.1080/10810730.2013.825665; Coleman C, 2011, NURS OUTLOOK, V59, P70, DOI 10.1016/j.outlook.2010.12.004; Cormier CM, 2009, J NURS EDUC, V48, P237, DOI 10.9999/01484834-20090416-02; Davis T C, 1991, Fam Med, V23, P433; Davis TC, 2004, FAM MED, V36, P595; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Institute of Education Sciences National Center for Education Statistics, 2003, NAT ASS AD LIT NAAL; Jordan JE, 2011, J CLIN EPIDEMIOL, V64, P366, DOI 10.1016/j.jclinepi.2010.04.005; Jukkala A, 2009, J CONTIN EDUC NURS, V40, P298, DOI 10.3928/00220124-20090623-01; Li YH, 2015, CHINESE J HLTH ED, V31, P99; Mackert M, 2011, PATIENT EDUC COUNS, V85, pE225, DOI 10.1016/j.pec.2011.02.022; Osborne RH, PSYCHOMETRI IN PRESS; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Pawlak R, 2005, NURS ECON, V23, P173; Peterson PN, 2009, CIRCULATION, V120, pS749; Pleasant A, 2008, HEALTH PROMOT INT, V23, P152, DOI 10.1093/heapro/dan001; RATZAN SC, 2000, NATL LIB MED CURRENT; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; SIMONDS SK, 1978, HEALTH EDUC QUART, V6, P18; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Sudore RL, 2009, PATIENT EDUC COUNS, V75, P398, DOI 10.1016/j.pec.2009.02.019; Wang WN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005182; Wawrzyniak AJ, 2013, CURR HIV-AIDS REP, V10, P295, DOI 10.1007/s11904-013-0178-4; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166	33	25	26	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152547	10.1371/journal.pone.0152547	http://dx.doi.org/10.1371/journal.pone.0152547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6IX	27050169	gold, Green Published			2022-12-27	WOS:000373603500048
J	Hung, LH; Kristiyanto, D; Lee, SB; Yeung, KY				Hung, Ling-Hong; Kristiyanto, Daniel; Lee, Sung Bong; Yeung, Ka Yee			GUIdock: Using Docker Containers with a Common Graphics User Interface to Address the Reproducibility of Research	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; INFERENCE	Reproducibility is vital in science. For complex computational methods, it is often necessary, not just to recreate the code, but also the software and hardware environment to reproduce results. Virtual machines, and container software such as Docker, make it possible to reproduce the exact environment regardless of the underlying hardware and operating system. However, workflows that use Graphical User Interfaces (GUIs) remain difficult to replicate on different host systems as there is no high level graphical software layer common to all platforms. GUIdock allows for the facile distribution of a systems biology application along with its graphics environment. Complex graphics based workflows, ubiquitous in systems biology, can now be easily exported and reproduced on many different platforms. GUIdock uses Docker, an open source project that provides a container with only the absolutely necessary software dependencies and configures a common X Windows (X11) graphic interface on Linux, Macintosh and Windows platforms. As proof of concept, we present a Docker package that contains a Bioconductor application written in R and C++ called networkBMA for gene network inference. Our package also includes Cytoscape, a java-based platform with a graphical user interface for visualizing and analyzing gene networks, and the CyNetworkBMA app, a Cytoscape app that allows the use of networkBMA via the user-friendly Cytoscape interface.	[Hung, Ling-Hong; Kristiyanto, Daniel; Lee, Sung Bong; Yeung, Ka Yee] Univ Washington, Inst Technol, Tacoma, WA 98402 USA	University of Washington; University of Washington Tacoma	Yeung, KY (corresponding author), Univ Washington, Inst Technol, Tacoma, WA 98402 USA.	kayee@uw.edu	Yeung-Rhee, Ka Yee/M-1151-2019	Yeung-Rhee, Ka Yee/0000-0002-1754-7577	National Institutes of Health [U54 HL127624]; Fulbright scholarship; University of Washington; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright scholarship; University of Washington(University of Washington); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Yeung and Hung are supported by National Institutes of Health U54 HL127624. Microsoft Azure for Research Award provided computational resources for all authors. Kristiyanto gratefully acknowledges sponsorship from the Fulbright scholarship 2014-2016 and from the University of Washington in the form of full tuition waivers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], DOCK BIOINF; [Anonymous], SOCAT MULTIPURPOSE R; Aranguren ME, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0092-3; BMA, BAYES MOD AV PACK BA; Boettiger Carl, 2015, ACM SIGOPS Operating Systems Review, V49, P71; Buck S, 2015, SCIENCE, V348, P1403, DOI 10.1126/science.aac8041; Charbonnier C, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1519; Christmas R, 2005, CYTOSCAPE SOFTWARE E; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cumbo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105001; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Fronczuk M, CYNETWORKBMA CYTOSCA; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Kaiser J, 2015, SCIENCE, V348, P1411, DOI 10.1126/science.348.6242.1411; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liu LZ, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S1, 10.1186/1752-0509-8-73]; Lo K, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-101; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; MobaXterm, ENH TERM WIND X11 SE; Moreews Francois, 2015, F1000Res, V4, P1443, DOI 10.12688/f1000research.7536.1; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Ono K., VIZBI 2015 TUTORIAL; Ono Keiichiro, 2015, F1000Res, V4, P478, DOI 10.12688/f1000research.6767.1; Pico Alexander R, 2014, F1000Res, V3, P138, DOI 10.12688/f1000research.4642.1; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Urbanek S., 2003, P DSC, P2; XQuartz, VERS X WIND SYST RUN; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Yeung KY, 2014, BIG DATA ANAL TECHNO; Young WC, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-47; Zhang SQ, 2010, ARTIF INTELL MED, V48, P153, DOI 10.1016/j.artmed.2009.11.001	39	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152686	10.1371/journal.pone.0152686	http://dx.doi.org/10.1371/journal.pone.0152686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045593	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600031
J	Zhang, XH; Zhong, SL; Xu, Y; Yu, DD; Ma, TF; Chen, L; Zhao, Y; Chen, X; Yang, SJ; Wu, YQ; Tang, JH; Zhao, JH				Zhang, Xiaohui; Zhong, Shanliang; Xu, Yong; Yu, Dandan; Ma, Tengfei; Chen, Lin; Zhao, Yang; Chen, Xiu; Yang, Sujin; Wu, Yueqin; Tang, Jinhai; Zhao, Jianhua			MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3 beta/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							DRUG-RESISTANCE; DIFFERENTIATION; INHIBITION	Acquisition of resistance to docetaxel (Doc) is one of the most important problems in treatment of breast cancer patients, but the underlying mechanisms are still not fully understood. In present study, Doc-resistant MDA-MB-231 and MCF-7 breast cancer cell lines (MDA-MB-231/Doc and MCF-7/Doc) were successfully established in vitro by gradually increasing Doc concentration on the basis of parental MDA-MB-231 and MCF-7 cell lines (MDA-MB-231/S and MCF-7/S). The potential miRNAs relevant to the Doc resistance were screened by miRNA microarray. We selected 5 upregulated miRNAs (has-miR-3646, has-miR-3658, has-miR-4438, has-miR-1246, and has-miR-574-3p) from the results of microarray for RT-qPCR validation. The results showed that expression level of miR-3646 in MDA-MB-231/Doc cells was significantly higher than in MDA-MB-231/S cells. Compared to MCF-7/S cells, miR-3646 expression was up-regulated in MCF-7/Doc cells. Further studies revealed that transfection of miR-3646 mimics into MDA-MB-231/S or MCF-7/S cells remarkably increased their drug resistance, in contrast, transfection of miR-3646 inhibitors into MDA-MB-231/Doc or MCF-7/Doc cells resulted in significant reduction of the drug resistance. By the pathway enrichment analyses for miR-3646, we found that GSK-3 beta/beta-catenin signaling pathway was a significant pathway, in which GSK-3 beta was an essential member. RT-qPCR and Western blot results demonstrated that miR-3646 could regulate GSK-3 beta mRNA and protein expressions. Furthermore, a marked increase of both nuclear and cytoplasmic beta-catenin expressions (with phosphorylated-beta-catenin decrease) was observed in MDA-MB-231/Doc cells compared with MDA-MB-231/S cells, and their expression were positively related to miR-3646 and negatively correlated with GSK-3 beta. Taken together, our results suggest that miR-3646-mediated Doc resistance of breast cancer cells maybe, at least in part, through suppressing expression of GSK-3 beta and resultantly activating GSK-3 beta/beta-catenin signaling pathway.	[Zhang, Xiaohui; Zhong, Shanliang; Zhao, Yang; Wu, Yueqin; Zhao, Jianhua] Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Yong] Nanjing First Hosp, Dept Oncol, Nanjing 210006, Jiangsu, Peoples R China; [Yu, Dandan; Chen, Lin; Chen, Xiu; Yang, Sujin; Tang, Jinhai] Jiangsu Canc Hosp, Dept Gen Surg, Nanjing 210009, Jiangsu, Peoples R China; [Ma, Tengfei] Wuxi Second Hosp, Dept Clin Lab, Wuxi 214002, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhao, JH (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing 210009, Jiangsu, Peoples R China.	jhzhao2838@sina.com	zhao, yang/GXF-4424-2022		National Natural Science Foundation of China [81272470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81272470), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Aamir, 2013, ISRN Oncol, V2013, P290568, DOI 10.1155/2013/290568; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Hassan S, 2015, ANN SURG ONCOL, V22, DOI 10.1245/s10434-014-4303-4; Hsieh CH, 2013, BIOSCI BIOTECH BIOCH, V77, P2397, DOI 10.1271/bbb.130503; Hu Q, 2014, TUMOR BIOL, V35, P6327, DOI 10.1007/s13277-014-1834-z; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Kesharwani RK, 2015, APPL BIOCHEM BIOTECH, V176, P1996, DOI 10.1007/s12010-015-1696-x; Kim JS, 2014, BIOCHEM BIOPH RES CO, V446, P894, DOI 10.1016/j.bbrc.2014.03.027; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Maia ARR, 2015, ANN ONCOL, V26, P2180, DOI 10.1093/annonc/mdv293; Maia AR, 2015, ANN ONCOLOGY OFFICIA; Nagano H, 2013, INT J ONCOL, V43, P1066, DOI 10.3892/ijo.2013.2037; Rogler A, 2013, INT J CLIN EXP PATHO, V6, P1984; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sokolosky M, 2014, CELL CYCLE, V13, P820, DOI 10.4161/cc.27728; Takahashi Ru, 2015, CANCERS, V7, P598, DOI 10.3390/cancers7020598; Takahashi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02474; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Tzeng HE, 2015, ONCOTARGET, V6, P11061, DOI 10.18632/oncotarget.3568; Wang PS, 2009, J SURG RES, V153, P210, DOI 10.1016/j.jss.2008.05.032; Wang SH, 2014, MOL MED REP, V9, P973, DOI 10.3892/mmr.2014.1889; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zhong SL, 2013, GENE, V531, P8, DOI 10.1016/j.gene.2013.08.062	27	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153194	10.1371/journal.pone.0153194	http://dx.doi.org/10.1371/journal.pone.0153194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045586	Green Submitted, Green Published, gold			2022-12-27	WOS:000373599600076
J	Guillevic, O; Ferratge, S; Pascaud, J; Driancourt, C; Boyer-Di-Ponio, J; Uzan, G				Guillevic, Oriane; Ferratge, Segolene; Pascaud, Juliette; Driancourt, Catherine; Boyer-Di-Ponio, Julie; Uzan, Georges			A Novel Molecular and Functional Stemness Signature Assessing Human Cord Blood-Derived Endothelial Progenitor Cell Immaturity	PLOS ONE			English	Article							PODOCALYXIN-LIKE PROTEIN; IN-VITRO; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; LINES; ANGIOGENESIS; MOBILIZATION; DNMT3A; OCT-4	Endothelial Colony Forming Cells (ECFCs), a distinct population of Endothelial Progenitor Cells (EPCs) progeny, display phenotypic and functional characteristics of endothelial cells while retaining features of stem/progenitor cells. Cord blood-derived ECFCs (CB-ECFCs) have a high clonogenic and proliferative potentials and they can acquire different endothelial phenotypes, this requiring some plasticity. These properties provide angiogenic and vascular repair capabilities to CB-ECFCs for ischemic cell therapies. However, the degree of immaturity retained by EPCs is still confused and poorly defined. Consequently, to better characterize CB-ECFC stemness, we quantified their clonogenic potential and demonstrated that they were reprogrammed into induced pluripotent stem cells (iPSCs) more efficiently and rapidly than adult endothelial cells. Moreover, we analyzed the transcriptional profile of a broad gene panel known to be related to stem cells. We showed that, unlike mature endothelial cells, CB-ECFCs expressed genes involved in the maintenance of embryonic stem cell properties such as DNMT3B, GDF3 or SOX2. Thus, these results provide further evidence and tools to appreciate EPC-derived cell stemness. Moreover this novel stem cell transcriptional signature of ECFCs could help better characterizing and ranging EPCs according to their immaturity profile.	[Guillevic, Oriane; Ferratge, Segolene; Pascaud, Juliette; Driancourt, Catherine; Boyer-Di-Ponio, Julie; Uzan, Georges] Hop Paul Brousse, INSERM, U972, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Uzan, G (corresponding author), Hop Paul Brousse, INSERM, U972, Villejuif, France.	georges.uzan@inserm.fr	Uzan, Georges/M-8199-2018	Uzan, Georges/0000-0002-0178-5386	French National Research Agency (ANR) grant MATRIXCELL [ANR-2010-TECS-010-02]	French National Research Agency (ANR) grant MATRIXCELL(French National Research Agency (ANR))	Support from the French National Research Agency (ANR) grant MATRIXCELL (ANR-2010-TECS-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support from the French National Research Agency (ANR) grant MATRIXCELL (ANR-2010-TECS-010-02). The authors wish to thank The Cord Blood Bank of St Louis Hospital directed by Pr. Jerome Larghero for providing cord blood samples and the human cell culture platform of the Myology Institute (Universite Pierre et Marie Curie, Paris 6) for providing adult fibroblasts. We acknowledge Denis Clay for cell sorting experiments, Julie Tosca for karyotype analysis, Janine Wechsler for teratomas histological analysis, Christophe Desterke for his help with primers design. Ibrahim Casal for mice experiments. We thank also Richard Proust for helpful readings of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Barclay GR, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt114; Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Bayat H, 2013, CELL J, V14, P298; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer-Di Ponio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084179; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Challen GA, 2014, CELL STEM CELL, V15, P350, DOI 10.1016/j.stem.2014.06.018; CIVIN CI, 1984, J IMMUNOL, V133, P157; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gehling UM, 2000, BLOOD, V95, P3106; Giorgetti A, 2010, NAT PROTOC, V5, P811, DOI 10.1038/nprot.2010.16; Goldman O, 2009, STEM CELLS, V27, P1750, DOI 10.1002/stem.100; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Hara T, 1999, IMMUNITY, V11, P567, DOI 10.1016/S1074-7613(00)80132-6; Howe M, 2009, CELL PROLIFERAT, V42, P265, DOI 10.1111/j.1365-2184.2009.00593.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kershaw DB, 1997, J BIOL CHEM, V272, P15708, DOI 10.1074/jbc.272.25.15708; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Levine AJ, 2006, DEVELOPMENT, V133, P209, DOI 10.1242/dev.02192; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Thomson JA, 2000, TRENDS BIOTECHNOL, V18, P53, DOI 10.1016/S0167-7799(99)01410-9; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vanneaux V, 2010, CELL TRANSPLANT, V19, P1143, DOI 10.3727/096368910X504487; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zangrossi S, 2007, STEM CELLS, V25, P1675, DOI 10.1634/stemcells.2006-0611	52	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152993	10.1371/journal.pone.0152993	http://dx.doi.org/10.1371/journal.pone.0152993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043207	Green Published, gold			2022-12-27	WOS:000373592100060
J	Hem, S; Ly, S; Votsi, I; Vogt, F; Asgari, N; Buchy, P; Heng, S; Picardeau, M; Sok, T; Ly, S; Huy, R; Guillard, B; Cauchemez, S; Tarantola, A				Hem, Sopheak; Ly, Sowath; Votsi, Irene; Vogt, Florian; Asgari, Nima; Buchy, Philippe; Heng, Seiha; Picardeau, Mathieu; Sok, Touch; Ly, Sovann; Huy, Rekol; Guillard, Bertrand; Cauchemez, Simon; Tarantola, Arnaud			Estimating the Burden of Leptospirosis among Febrile Subjects Aged below 20 Years in Kampong Cham Communities, Cambodia, 2007-2009	PLOS ONE			English	Article							AGGLUTINATION-TEST MAT; RISK-FACTORS; IGM-ELISA; FOLLOW-UP; SRI-LANKA; DIAGNOSIS; OUTBREAK; EPIDEMIOLOGY; ANTIBODIES; INFECTION	Background Leptospirosis is an emerging but neglected public health challenge in the Asia/Pacific Region with an annual incidence estimated at 10-100 per 100,000 population. No accurate data, however, are available for at-risk rural Cambodian communities. Method We conducted anonymous, unlinked testing for IgM antibodies to Leptospira spp. on paired sera of Cambodian patients <20 years of age between 2007-2009 collected through active, community-based surveillance for febrile illnesses in a convenience sample of 27 rural and semi-rural villages in four districts of Kampong Cham province, Cambodia. Leptospirosis testing was done on paired serological samples negative for Dengue, Japanese encephalitis and Chikungunya viruses after random selection. Convalescent samples found positive while initial samples were negative were considered as proof of acute infection. We then applied a mathematical model to estimate the risk of fever caused by leptospirosis, dengue or other causes in rural Cambodia. Results A total of 630 samples are coming from a randomly selected subset of 2358 samples. IgM positive were found on the convalescent serum sample, among which 100 (15.8%) samples were IgM negative on an earlier sample. Seventeen of these 100 seroconversions were confirmed using a Microagglutination Test. We estimated the probability of having a fever due to leptospirosis at 1.03% (95% Credible Interval CI: 0.95%-1.22%) per semester. In comparison, this probability was 2.61% (95% CI: 2.55%, 2.83%) for dengue and 17.65% (95% CI: 17.49%, 18.08%) for other causes. Conclusion Our data from febrile cases aged below 20 years suggest that the burden of leptospirosis is high in rural Cambodian communities. This is especially true during the rainy season, even in the absence of identified epidemics.	[Hem, Sopheak; Ly, Sowath; Buchy, Philippe; Heng, Seiha; Guillard, Bertrand; Tarantola, Arnaud] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Votsi, Irene; Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France; [Vogt, Florian] London Sch Hyg & Trop Med, Sci Epidemiol, London WC1, England; [Asgari, Nima] WHO, Phnom Penh, Cambodia; [Picardeau, Mathieu] Inst Pasteur, Natl Reference Ctr, Paris, France; [Picardeau, Mathieu] Inst Pasteur, WHO Collaborating Ctr Leptospirosis, Paris, France; [Sok, Touch; Ly, Sovann] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia; [Huy, Rekol] Natl Ctr Entomol Parasitol & Malaria Control, Natl Dengue Control Program, Phnom Penh, Cambodia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Center Parasitology, Entomology & Malaria Control	Hem, S (corresponding author), Inst Pasteur Cambodia, Phnom Penh, Cambodia.	hsopheak@pasteur-kh.org	Tarantola, Arnaud/D-2149-2015	Tarantola, Arnaud/0000-0002-6946-7958; Vogt, Florian/0000-0003-2686-3149; BUCHY, Philippe/0000-0003-1372-3008	World Health Organization; European Union; Pediatric Vaccine Dengue Initiative project (PDVI) from the International Vaccine Institute (IVI)	World Health Organization(World Health Organization); European Union(European Commission); Pediatric Vaccine Dengue Initiative project (PDVI) from the International Vaccine Institute (IVI)	This study was supported by the World Health Organization and the European Union and Pediatric Vaccine Dengue Initiative project (PDVI) from the International Vaccine Institute (IVI). Aside from coauthor NA who helped discuss the study results and edit the article, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-332; Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892; [Anonymous], 2009, LEP01M E LEP01M05; [Anonymous], 2003, HUM LEPT GUID DIAGN; Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249; Berlioz-Arthaud A, 2010, Bull Soc Pathol Exot, V103, P111, DOI 10.1007/s13149-010-0043-2; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Binder W D, 1998, J Emerg Med, V16, P851, DOI 10.1016/S0736-4679(98)00097-3; Cachay E R, 2005, J Postgrad Med, V51, P174; Chaudhry R, 2002, EMERG INFECT DIS, V8, P1526; Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668; Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731; de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245; Dechet AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039672; Douglin CP, 1997, EMERG INFECT DIS, V3, P78, DOI 10.3201/eid0301.970114; Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471; Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002; Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241; EVERARD COR, 1989, EPIDEMIOL INFECT, V103, P143, DOI 10.1017/S0950268800030442; Fukuoka, 2013, LEPT SOC SCI M; Gamage CD, 2012, JPN J INFECT DIS, V65, P157; Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x; Gussenhoven GC, 1997, J CLIN MICROBIOL, V35, P92, DOI 10.1128/JCM.35.1.92-97.1997; Hagan JE, GLOBAL MORBIDITY MOR; Hartskeerl R A, 2006, Indian J Med Microbiol, V24, P309; Izurieta Ricardo, 2008, J Emerg Trauma Shock, V1, P21, DOI 10.4103/0974-2700.40573; Jansen A, 2007, EMERG INFECT DIS, V13, P739, DOI 10.3201/eid1305.061302; Kariv R, 2001, EMERG INFECT DIS, V7, P990, DOI 10.3201/eid0706.010611; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0; Laras K, 2002, AM J TROP MED HYG, V67, P278, DOI 10.4269/ajtmh.2002.67.278; LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212; Lau CL, 2012, AM J TROP MED HYG, V86, P309, DOI 10.4269/ajtmh.2012.11-0398; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Libraty DH, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000111; Ooteman MC, 2006, J MICROBIOL METH, V65, P247, DOI 10.1016/j.mimet.2005.07.015; Papa A, 2009, EMERG INFECT DIS, V15, P834, DOI [10.3201/eid1505080270, 10.3201/eid1505.080270]; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Postic D, 2000, DIAGNOSTIC BIOL LEPT; Rajajee Sarala, 2002, Indian Journal of Pediatrics, V69, P851, DOI 10.1007/BF02723704; Rajapakse Senaka, 2010, J Emerg Trauma Shock, V3, P213, DOI 10.4103/0974-2700.66519; Sehgal SC, 1999, EPIDEMIOL INFECT, V122, P423, DOI 10.1017/S0950268899002435; Seng Heng, 2007, Journal of the Medical Association of Thailand, V90, P546; Senior K, 2010, LANCET INFECT DIS, V10, P823, DOI 10.1016/S1473-3099(10)70268-1; SILVA MV, 1995, J TROP MED HYG, V98, P268; Smythe LD, 2009, AM J TROP MED HYG, V81, P695, DOI 10.4269/ajtmh.2009.09-0252; Spichler A, 2011, INT J INFECT DIS, V15, pE486, DOI 10.1016/j.ijid.2011.03.020; Sugunan AP, 2009, INDIAN J MED RES, V130, P67; TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377; Thai KTD, 2008, ACTA TROP, V106, P128, DOI 10.1016/j.actatropica.2008.02.005; Thai KTD, 2006, TROP MED INT HEALTH, V11, P738, DOI 10.1111/j.1365-3156.2006.01619.x; Trubo R, 2001, Lancet Infect Dis, V1, P73, DOI 10.1016/S1473-3099(01)00058-5; Van CTB, 1998, T ROY SOC TROP MED H, V92, P625, DOI 10.1016/S0035-9203(98)90787-8; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Vijayachari P, 2008, J BIOSCIENCES, V33, P557, DOI 10.1007/s12038-008-0074-z; WHO, 2009, LEPT SIT S E AS REG; Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997; Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718; Zhang CL, 2012, MICROBES INFECT, V14, P317, DOI 10.1016/j.micinf.2011.11.007	62	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0151555	10.1371/journal.pone.0151555	http://dx.doi.org/10.1371/journal.pone.0151555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043016	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100003
J	Zhu, YY; Lin, XS; Li, H; Li, YQ; Shi, XB; Zhao, F; Xu, XL; Li, CB; Zhou, GH				Zhu, Yingying; Lin, Xisha; Li, He; Li, Yingqiu; Shi, Xuebin; Zhao, Fan; Xu, Xinglian; Li, Chunbao; Zhou, Guanghong			Intake of Meat Proteins Substantially Increased the Relative Abundance of Genus Lactobacillus in Rat Feces	PLOS ONE			English	Article							COLORECTAL-CANCER RISK; GUT MICROBIOTA; DIETARY-PROTEIN; RED MEAT; HUMAN-NUTRITION; CONSUMPTION; HEALTH; IMPACT; INFLAMMATION; OBESITY	Diet has been shown to have a critical influence on gut bacteria and host health, and high levels of red meat in diet have been shown to increase colonic DNA damage and thus be harmful to gut health. However, previous studies focused more on the effects of meat than of meat proteins. In order to investigate whether intake of meat proteins affects the composition and metabolic activities of gut microbiota, feces were collected from growing rats that were fed with either meat proteins (from beef, pork or fish) or non-meat proteins (casein or soy) for 14 days. The resulting composition of gut microbiota was profiled by sequencing the V4-V5 region of the 16S ribosomal RNA genes and the short chain fatty acids (SCFAs) were analyzed using gas chromatography. The composition of gut microbiota and SCFA levels were significantly different between the five diet groups. At a recommended dose of 20% protein in the diet, meat protein-fed rats had a higher relative abundance of the beneficial genus Lactobacillus, but lower levels of SCFAs and SCFA-producing bacteria including Fusobacterium, Bacteroides and Prevotella, compared with the soy protein-fed group. Further work is needed on the regulatory pathways linking dietary protein intake to gut microbiota.	[Li, Chunbao; Zhou, Guanghong] MOE, Key Lab Meat Proc & Qual Control, Nanjing 210095, Jiangsu, Peoples R China; MOA, Key Lab Anim Prod Proc, Nanjing 210095, Jiangsu, Peoples R China; Jiang Synerget Innovat Ctr Meat Proc & Qual Contr, Nanjing 210095, Jiangsu, Peoples R China; Nanjing Agr Univ, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, CB; Zhou, GH (corresponding author), MOE, Key Lab Meat Proc & Qual Control, Nanjing 210095, Jiangsu, Peoples R China.	chunbao.li@njau.edu.cn; guanghong.zhou@hotmail.com			National Natural Science Foundation of China [31471600, 31530054]; Ministry of Education of China [20110097110024, NCET-11-0668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	The work was supported by grant of 31471600 and 31530054 (National Natural Science Foundation of China; http://www.nsfc.gov.cn/), 20110097110024 and NCET-11-0668 (Ministry of Education of China; http://www.moe.edu.cn/). Authors GZ and CL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora T, 2012, BRIT J NUTR, V108, P1382, DOI 10.1017/S0007114511006957; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bastide NM, 2015, CANCER RES, V75, P870, DOI 10.1158/0008-5472.CAN-14-2554; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; CORRING T, 1987, REPROD NUTR DEV, V27, P967, DOI 10.1051/rnd:19870801; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Day L, 2013, TRENDS FOOD SCI TECH, V32, P25, DOI 10.1016/j.tifs.2013.05.005; Pereira PMDC, 2013, MEAT SCI, V93, P586, DOI 10.1016/j.meatsci.2012.09.018; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Gilbert JA, 2011, NUTR METAB CARDIOVAS, V21, pB16, DOI 10.1016/j.numecd.2010.12.008; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mostafa S.E., 2009, APPL ENVIRON MICROB, V75, P5277; Pham NM, 2014, JPN J CLIN ONCOL, V44, P641, DOI 10.1093/jjco/hyu061; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ollberding NJ, 2012, INT J CANCER, V131, pE1125, DOI 10.1002/ijc.27546; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Qi HW, 2011, AFR J BIOTECHNOL, V10, P3704; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rist VTS, 2013, ANIMAL, V7, P1067, DOI 10.1017/S1751731113000062; Rist VTS, 2014, ANAEROBE, V25, P72, DOI 10.1016/j.anaerobe.2013.10.003; Shen Q, 2010, ANAEROBE, V16, P572, DOI 10.1016/j.anaerobe.2010.09.007; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Toden S, 2014, CANCER BIOL THER, V5, P267; Toden S, 2007, CARCINOGENESIS, V28, P2355, DOI 10.1093/carcin/bgm216; Vlieg JETV, 2011, CURR OPIN BIOTECH, V22, P211, DOI 10.1016/j.copbio.2010.12.004; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849; Zhu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15220	42	28	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152678	10.1371/journal.pone.0152678	http://dx.doi.org/10.1371/journal.pone.0152678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042829	Green Published, gold, Green Submitted			2022-12-27	WOS:000373592100024
J	Brechbuhl, C; Girard, O; Millet, GP; Schmitt, L				Brechbuhl, Cyril; Girard, Olivier; Millet, Gregoire P.; Schmitt, Laurent			On the Use of a Test to Exhaustion Specific to Tennis (TEST) with Ball Hitting by Elite Players	PLOS ONE			English	Article							INCREMENTAL EXERCISE TEST; ON-COURT ENDURANCE; 20-M SHUTTLE RUN; AEROBIC FITNESS; SPORTS-MEDICINE; SQUASH PLAYERS; OXYGEN-UPTAKE; SCIENCE; PHYSIOLOGY; DRILLS	Purpose We aimed to a) introduce a new Test to Exhaustion Specific to Tennis (TEST) and compare performance (test duration) and physiological responses to those obtained during the 20-m multistage shuttle test (MSST), and b) determine to which extent those variables correlate with performance level (tennis competitive ranking) for both test procedures. Methods Twenty-seven junior players (8 males, 19 females) members of the national teams of the French Tennis Federation completed MSST and TEST, including elements of the game (ball hitting, intermittent activity, lateral displacement), in a randomized order. Cardiorespiratory responses were compared at submaximal (respiratory compensation point) and maximal loads between the two tests. Results At the respiratory compensation point oxygen uptake (50.1 +/- 4.7 vs. 47.5 +/- 4.3 mL.min(-1).kg(-1), p = 0.02), but not minute ventilation and heart rate, was higher for TEST compared to MSST. However, load increment and physiological responses at exhaustion did not differ between the two tests. Players' ranking correlated negatively with oxygen uptake measured at submaximal and maximal loads for both TEST (r = -0.41; p = 0.01 and -0.55; p = 0.004) and MSST (r = -0.38; P = 0.05 and -0.51; p = 0.1). Conclusion Using TEST provides a tennis-specific assessment of aerobic fitness and may be used to prescribe aerobic exercise in a context more appropriate to the game than MSST. Results also indicate that VO2 values both at submaximal and maximal load reached during TEST and MSST are moderate predictors of players competitive ranking.	[Brechbuhl, Cyril] French Tennis Federat, Natl Tech Direct, Paris, France; [Brechbuhl, Cyril; Girard, Olivier; Millet, Gregoire P.; Schmitt, Laurent] Univ Lausanne, Dept Physiol, Fac Biol & Med, Inst Sport Sci ISSUL, Lausanne, Switzerland; [Schmitt, Laurent] Natl Ctr Nord Ski, Dept Res & Performance, Premanon, France; [Brechbuhl, Cyril] Stade Roland Garros, Federat Francaise Tennis, Ctr Natl Entrainement, Paris, France; [Girard, Olivier; Millet, Gregoire P.] ISSUL, Batiment Geopolis, Lausanne, Switzerland; [Schmitt, Laurent] Ctr Natl Ski Nord, Premanon, France	University of Lausanne	Brechbuhl, C (corresponding author), French Tennis Federat, Natl Tech Direct, Paris, France.; Brechbuhl, C (corresponding author), Univ Lausanne, Dept Physiol, Fac Biol & Med, Inst Sport Sci ISSUL, Lausanne, Switzerland.; Brechbuhl, C (corresponding author), Stade Roland Garros, Federat Francaise Tennis, Ctr Natl Entrainement, Paris, France.	cyril.brechbuhl@unil.ch	Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019	Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; girard, olivier/0000-0002-4797-182X				American College of Sports Medicine, 2006, ACMS GUID EX TEST PR; Baiget E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131304; Baiget E, 2014, J STRENGTH COND RES, V28, P256, DOI 10.1519/JSC.0b013e3182955dad; Balmer J, 2000, MED SCI SPORT EXER, V32, P1790, DOI 10.1097/00005768-200010000-00020; Banzer W, 2008, BRIT J SPORT MED, V42, P152, DOI 10.1136/bjsm.2007.036798; Bekraoui N, 2012, APPL PHYSIOL NUTR ME, V37, P982, DOI [10.1139/h2012-082, 10.1139/H2012-082]; Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002; BERGERON MF, 1991, INT J SPORTS MED, V12, P474, DOI 10.1055/s-2007-1024716; Buchheit M, 2012, J SPORT SCI, V30, P555, DOI 10.1080/02640414.2012.658079; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Fargeas-Gluck MA, 2012, J STRENGTH COND RES, V26, P3036, DOI 10.1519/JSC.0b013e3182472fc3; Fernald DH, 2012, J AM BOARD FAM MED, V25, P83, DOI 10.3122/jabfm.2012.01.110019; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; Fernandez-Fernandez J, 2012, J STRENGTH COND RES, V26, P53, DOI 10.1519/JSC.0b013e318220b4ff; Fernandez-Fernandez J, 2011, J SPORT SCI MED, V10, P540; Fernandez-Fernandez J, 2010, J STRENGTH COND RES, V24, P3255, DOI 10.1519/JSC.0b013e3181e8745f; Ferrauti A, 2011, J SPORT SCI, V29, P485, DOI 10.1080/02640414.2010.539247; Foster C, 2006, PHYSL ASSESSMENT HUM, P63; Gibson AS, 1998, J SPORT SCI, V16, P331, DOI 10.1080/02640419808559361; Girard O, 2006, BRIT J SPORT MED, V40, P791, DOI 10.1136/bjsm.2006.027680; Girard O, 2005, BRIT J SPORT MED, V39, P921, DOI 10.1136/bjsm.2005.018101; Girard O, 2005, MED SCI SPORT EXER, V37, P1021, DOI 10.1249/01.mss.0000171619.99391.bb; Girard O, 2008, J ELECTROMYOGR KINES, V18, P1038, DOI 10.1016/j.jelekin.2007.05.005; Guillot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143331; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kovacs MS, 2007, SPORTS MED, V37, P189, DOI 10.2165/00007256-200737030-00001; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; LEGER L, 1989, CAN J SPORT SCI, V14, P21; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Midgley AW, 2008, SPORTS MED, V38, P441, DOI 10.2165/00007256-200838060-00001; Pialoux V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122718; Pierce S J, 1999, J Sci Med Sport, V2, P356, DOI 10.1016/S1440-2440(99)80008-5; Pyne DB, 2000, EUR J APPL PHYSIOL, V82, P112, DOI 10.1007/s004210050659; Reid M, 2008, BRIT J SPORT MED, V42, P146, DOI 10.1136/bjsm.2007.036426; Reid M, 2008, J SCI MED SPORT, V11, P248, DOI 10.1016/j.jsams.2007.05.002; Smekal G, 2000, INT J SPORTS MED, V21, P242, DOI 10.1055/s-2000-310; Vallier JM, 2000, SCI SPORT, V15, P133, DOI 10.1016/S0765-1597(00)80017-9; Wasserman K, 2005, PRINCIPLES EXERCISE	40	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152389	10.1371/journal.pone.0152389	http://dx.doi.org/10.1371/journal.pone.0152389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035342	Green Published, gold			2022-12-27	WOS:000373201200016
J	Ishihara, MI; Konno, Y; Umeki, K; Ohno, Y; Kikuzawa, K				Ishihara, Masae Iwamoto; Konno, Yasuo; Umeki, Kiyoshi; Ohno, Yasuyuki; Kikuzawa, Kihachiro			A New Model for Size-Dependent Tree Growth in Forests	PLOS ONE			English	Article							METABOLIC SCALING THEORY; YIELD-DENSITY DIAGRAM; PLANT-POPULATIONS; NORTHERN JAPAN; ASYMMETRIC COMPETITION; BIOMASS; DYNAMICS; MONOCULTURES; STANDS; LIGHT	Tree growth, especially diameter growth of tree stems, is an important issue for understanding the productivity and dynamics of forest stands. Metabolic scaling theory predicted that the 2/3 power of stem diameter at a certain time is a linear function of the 2/3 power of the initial diameter and that the diameter growth rate scales to the 1/3 power of the initial diameter. We tested these predictions of the metabolic scaling theory for 11 Japanese secondary forests at various growth stages. The predictions were not supported by the data, especially in younger stands. Alternatively, we proposed a new theoretical model for stem diameter growth on the basis of six assumptions. All these assumptions were supported by the data. The model produced a nearly linear to curvilinear relationship between the 2/3 power of stem diameters at two different times. It also fitted well to the curvilinear relationship between diameter growth rate and the initial diameter. Our model fitted better than the metabolic scaling theory, suggesting the importance of asymmetric competition among trees, which has not been incorporated in the metabolic scaling theory.	[Ishihara, Masae Iwamoto] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 724, Japan; [Konno, Yasuo] Obihiro Univ Agr & Vet Med, Dept Life Sci Agr, Obihiro, Hokkaido 080, Japan; [Umeki, Kiyoshi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Ohno, Yasuyuki] Hokkaido Res Org, Forestry Res Inst, Bibai, Hokkaido, Japan; [Kikuzawa, Kihachiro] Zushioku Onoecho, Yamashina Ku, Kyoto, Kyoto, Japan	Hiroshima University; Obihiro University of Agriculture & Veterinary Medicine; Chiba University	Ishihara, MI (corresponding author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima, Hiroshima 724, Japan.	masaish.n@gmail.com	Ishihara, Masae Iwamoto/AAU-8407-2020; Ishihara, Masae Iwamoto/P-7979-2014; Umeki, Kiyoshi/AAE-5992-2019	Ishihara, Masae Iwamoto/0000-0002-8365-7766; Ishihara, Masae Iwamoto/0000-0002-8365-7766; 	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan [S-9-3]	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan	MII was supported by the Environmental Research and Technology Development Fund (S-9-3) of the Ministry of the Environment, Japan.	AIKMAN DP, 1980, ANN BOT-LONDON, V45, P419, DOI 10.1093/oxfordjournals.aob.a085840; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Cheng XP, 2014, J FOREST RES-JPN, V19, P86, DOI 10.1007/s10310-012-0377-7; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Damgaard C, 2008, J PLANT ECOL, V1, P111, DOI 10.1093/jpe/rtn008; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Falster DS, 2015, ECOLOGY, V96, P1445, DOI 10.1890/14-1889.1; HARA T, 1988, TRENDS ECOL EVOL, V3, P129, DOI 10.1016/0169-5347(88)90175-9; HARA T, 1992, ANN BOT-LONDON, V69, P509, DOI 10.1093/oxfordjournals.aob.a088380; HOZUMI K, 1968, Japanese Journal of Ecology, V18, P10; Ishihara MI, 2015, ECOL APPL, V25, P1433, DOI 10.1890/14-0175.1; Kikuzawa K, 1999, ANN BOT-LONDON, V83, P11, DOI 10.1006/anbo.1998.0782; KIKUZAWA K, 1988, ANN BOT-LONDON, V61, P727, DOI 10.1093/oxfordjournals.aob.a087611; Kikuzawa K, 1996, ANN BOT-LONDON, V77, P565, DOI 10.1006/anbo.1996.0071; KIKUZAWA K, 1982, FOREST ECOL MANAG, V4, P341, DOI 10.1016/0378-1127(82)90034-2; KIKUZAWA K, 1993, FOREST ECOL MANAG, V58, P287, DOI 10.1016/0378-1127(93)90151-C; Kikuzawa K, 2016, ADV PHOTOSYNTH RESP, V42, P399, DOI 10.1007/978-94-017-7291-4_15; KING DA, 1994, AM J BOT, V81, P948, DOI 10.2307/2445287; Kira T, 1967, JAPANESE J ECOL; Kobayashi Y, 2000, J THEOR BIOL, V205, P253, DOI 10.1006/jtbi.2000.2058; KOYAMA HIROSI, 1956, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V7, P73; KUBOTA Y, 1995, ANN BOT-LONDON, V76, P503, DOI 10.1006/anbo.1995.1126; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Niklas K.., 1994, PLANT ALLOMETRY; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Russo SE, 2007, ECOL LETT, V10, P889, DOI 10.1111/j.1461-0248.2007.01079.x; Schneider MK, 2006, J ECOL, V94, P310, DOI 10.1111/j.1365-2745.2005.01079.x; Sedmak R, 2015, IFOREST, V8, DOI 10.3832/ifor1243-007; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Umeki K, 2001, ECOL RES, V16, P435, DOI 10.1046/j.1440-1703.2001.00409.x; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; White Ethan P., 2012, P9; YOKOZAWA M, 1992, ANN BOT-LONDON, V70, P305, DOI 10.1093/oxfordjournals.aob.a088479; Zianis D, 2004, FOREST ECOL MANAG, V187, P311, DOI 10.1016/j.foreco.2003.07.007	45	7	8	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152219	10.1371/journal.pone.0152219	http://dx.doi.org/10.1371/journal.pone.0152219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035709	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200012
J	Sabow, AB; Zulkifli, I; Goh, YM; Ab Kadir, MZA; Kaka, U; Imlan, JC; Abubakar, AA; Adeyemi, KD; Sazili, AQ				Sabow, Azad Behnan; Zulkifli, Idrus; Goh, Yong Meng; Ab Kadir, Mohd Zainal Abidin; Kaka, Ubedullah; Imlan, Jurhamid Columbres; Abubakar, Ahmed Abubakar; Adeyemi, Kazeem Dauda; Sazili, Awis Qurni			Bleeding Efficiency, Microbiological Quality and Oxidative Stability of Meat from Goats Subjected to Slaughter without Stunning in Comparison with Different Methods of Pre-Slaughter Electrical Stunning	PLOS ONE			English	Article							PROTEIN OXIDATION; LIPID OXIDATION; HALAL SLAUGHTER; PROTEOLYTIC SUSCEPTIBILITY; MYOFIBRILLAR PROTEINS; RELIGIOUS SLAUGHTER; CARCASS QUALITY; SHELF-LIFE; LAMB MEAT; MUSCLE	The influence of pre-slaughter electrical stunning techniques and slaughter without stunning on bleeding efficiency and shelf life of chevon during a 14 d postmortem aging were assessed. Thirty two Boer crossbred bucks were randomly assigned to four slaughtering techniques viz slaughter without stunning (SWS), low frequency head-only electrical stunning (LFHO; 1 A for 3 s at a frequency of 50 Hz), low frequency head-to-back electrical stunning (LFHB; 1 A for 3 s at a frequency of 50 Hz) and high frequency head-to-back electrical stunning (HFHB; 1 A for 3 s at a frequency of 850 Hz). The SWS, LFHO and HFHB goats had higher (p<0.05) blood loss and lower residual hemoglobin in muscle compared to LFHB. The LFHB meat had higher (p<0.05) TBARS value than other treatments on d 7 and 14 d postmortem. Slaughtering methods had no effect on protein oxidation. Higher bacterial counts were observed in LFHB meat compared to those from SWS, LFHO and HFHB after 3 d postmortem. Results indicate that the low bleed-out in LFHB lowered the lipid oxidative stability and microbiological quality of chevon during aging.	[Sabow, Azad Behnan; Zulkifli, Idrus; Imlan, Jurhamid Columbres; Abubakar, Ahmed Abubakar; Adeyemi, Kazeem Dauda; Sazili, Awis Qurni] Univ Putra Malaysia, Dept Anim Sci, Fac Agr, Upm Serdang 43400, Selangor, Malaysia; [Zulkifli, Idrus; Goh, Yong Meng; Sazili, Awis Qurni] Univ Putra Malaysia, Inst Trop Agr, Upm Serdang 43400, Selangor, Malaysia; [Goh, Yong Meng] Univ Putra Malaysia, Dept Vet Preclin Sci, Upm Serdang 43400, Selangor, Malaysia; [Kaka, Ubedullah] Univ Putra Malaysia, Dept Vet Clin Studies, Fac Vet Med, Upm Serdang 43400, Selangor, Malaysia; [Ab Kadir, Mohd Zainal Abidin] Univ Putra Malaysia, Dept Elect & Elect Engn, Fac Engn, Upm Serdang 43400, Selangor, Malaysia; [Sazili, Awis Qurni] Univ Putra Malaysia, Halal Prod Res Inst, Upm Serdang 43400, Selangor, Malaysia; [Ab Kadir, Mohd Zainal Abidin] Univ Putra Malaysia, Ctr Electromagnet & Lighting Protect Res, Upm Serdang 43400, Selangor, Malaysia; [Sabow, Azad Behnan] Univ Salahaddin, Dept Anim Resource, Erbil, Kurdistan Regio, Iraq; [Kaka, Ubedullah] Sindh Agr Univ Tandojam, Fac Anim Husb & Vet Sci, Dept Vet Surg & Obstet, Sindh, Pakistan; [Adeyemi, Kazeem Dauda] Univ Ilorin, Dept Anim Prod, Ilorin, Nigeria	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Salahaddin University; University of Ilorin	Adeyemi, KD (corresponding author), Univ Putra Malaysia, Dept Anim Sci, Fac Agr, Upm Serdang 43400, Selangor, Malaysia.; Adeyemi, KD (corresponding author), Univ Ilorin, Dept Anim Prod, Ilorin, Nigeria.	awisqurni@gmail.com	Goh, Y.M./B-2382-2010; Kadir, Zainal/B-6629-2009; Kaka, Ubedullah/AAV-9777-2021	Goh, Y.M./0000-0003-1237-2170; Kadir, Zainal/0000-0001-7263-2953; Kaka, Ubedullah/0000-0002-6469-3542; Idrus, Zulkifli/0000-0002-2082-7430; Adeyemi, kazeem/0000-0002-6719-2081; Qurni, Awis/0000-0002-7362-0855; Abubakar Abubakar, Ahmed/0000-0002-6015-1236	Ministry of Higher Education Malaysia via Universiti Putra Malaysia Grant [GP-IBT/2013/9409300]	Ministry of Higher Education Malaysia via Universiti Putra Malaysia Grant	The authors thank the Ministry of Higher Education Malaysia for the financial support provided via the Universiti Putra Malaysia Grant (Project No. GP-IBT/2013/9409300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Addeen A., 2014, International Food Research Journal, V21, P897; Adeyemi KD, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0050-z; Adeyemi KD, 2016, CYTA-J FOOD, V14, P405, DOI 10.1080/19476337.2015.1114974; Adeyemi KD, 2016, ANIM SCI J, V87, P1421, DOI 10.1111/asj.12597; Adeyemi KD, 2015, ITALIAN J ANIM SCI; Ali ASA, 2007, ARCH GEFLUGELKD, V71, P35; Ali S. A. M., 2011, Egyptian Poultry Science Journal, V31, P727; Alvarado CZ, 2007, POULTRY SCI, V86, P156, DOI 10.1093/ps/86.1.156; Anil M, 2004, ANIM WELFARE, V13, P387; BANDMAN E, 1988, MEAT SCI, V22, P1, DOI 10.1016/0309-1740(88)90023-X; Bekhit AEA, 2013, COMPR REV FOOD SCI F, V12, P565, DOI 10.1111/1541-4337.12027; Bernevic B, 2011, INT J MASS SPECTROM, V305, P217, DOI 10.1016/j.ijms.2010.11.010; Bornez R, 2009, MEAT SCI, V83, P383, DOI 10.1016/j.meatsci.2009.06.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi YM, 2010, LIVEST SCI, V127, P183, DOI 10.1016/j.livsci.2009.09.009; Contreras CC, 2001, POULTRY SCI, V80, P501, DOI 10.1093/ps/80.4.501; Dai Y, 2014, INNOV FOOD SCI EMERG, V26, P341, DOI 10.1016/j.ifset.2014.06.009; Delles RM, 2014, MEAT SCI, V97, P181, DOI 10.1016/j.meatsci.2014.01.022; Doulgeraki AI, 2012, INT J FOOD MICROBIOL, V157, P130, DOI 10.1016/j.ijfoodmicro.2012.05.020; Estevez M, 2011, MEAT SCI, V89, P259, DOI 10.1016/j.meatsci.2011.04.025; Falowo AB, 2014, FOOD RES INT, V64, P171, DOI 10.1016/j.foodres.2014.06.022; Farouk MM, 2014, MEAT SCI, V98, P505, DOI 10.1016/j.meatsci.2014.05.021; Farouk MM, 2013, MEAT SCI, V95, P805, DOI 10.1016/j.meatsci.2013.04.028; GABIG TG, 1981, ANNU REV MED, V32, P313, DOI 10.1146/annurev.me.32.020181.001525; Gadiyaram KM, 2008, SMALL RUMINANT RES, V78, P106, DOI 10.1016/j.smallrumres.2008.05.013; Gibson TJ, 2009, NEW ZEAL VET J, V57, P77, DOI 10.1080/00480169.2009.36882; Gregory NG, 2005, MEAT SCI, V70, P481, DOI 10.1016/j.meatsci.2004.06.026; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Insausti K, 2001, MEAT SCI, V57, P273, DOI 10.1016/S0309-1740(00)00102-9; Kaka U, 2015, BIOMED RES INT; Khalid R, 2015, MEAT SCI, V110, P15, DOI 10.1016/j.meatsci.2015.06.008; KIRTON AH, 1981, MEAT SCI, V5, P347, DOI 10.1016/0309-1740(81)90033-4; Koutsoumanis KP, 2004, ENCY MEAT SCI ELSEVI, P727, DOI DOI 10.1016/B0-12-464970-X/00070-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lametsch R, 2004, MEAT SCI, V68, P515, DOI 10.1016/j.meatsci.2004.03.018; Lerner P. T., 2009, Folia Veterinaria, V53, P25; Linares MB, 2007, MEAT SCI, V76, P715, DOI 10.1016/j.meatsci.2007.02.012; Lund MN, 2011, MOL NUTR FOOD RES, V55, P83, DOI 10.1002/mnfr.201000453; Malaysian Standard M, 2009, HALAL FOOD PRODUCTIO, P1; Maqsood S, 2011, FOOD CHEM, V124, P459, DOI 10.1016/j.foodchem.2010.06.055; Marino R, 2013, MEAT SCI, V95, P281, DOI 10.1016/j.meatsci.2013.04.009; Martinaud A, 1997, J AGR FOOD CHEM, V45, P2481, DOI 10.1021/jf960977g; Morzel M, 2006, MEAT SCI, V73, P536, DOI 10.1016/j.meatsci.2006.02.005; Mouchoniere M, 1999, POULTRY SCI, V78, P485, DOI 10.1093/ps/78.3.485; Nakyinsige K, 2015, MEAT SCI, V108, P125, DOI 10.1016/j.meatsci.2015.05.029; Nakyinsige K, 2014, ASIAN AUSTRAL J ANIM, V27, P406, DOI 10.5713/ajas.2013.13437; Nakyinsige K, 2013, MEAT SCI, V95, P352, DOI 10.1016/j.meatsci.2013.04.006; Nakyinsige K, 2014, THESIS U PUTRA MALAY; Nakyinsige K, 2012, MEAT SCI, V91, P207, DOI 10.1016/j.meatsci.2012.02.015; Nieto G, 2013, MEAT SCI, V95, P177, DOI 10.1016/j.meatsci.2013.05.016; OBRIEN PJ, 1992, MOL CELL BIOCHEM, V112, P45, DOI 10.1007/BF00229642; OELLINGRATH IM, 1990, MEAT SCI, V28, P313, DOI 10.1016/0309-1740(90)90045-8; OIE, 2014, TERR AN HLTH COD VER; Ooizumi T, 2004, J AGR FOOD CHEM, V52, P4303, DOI 10.1021/jf035521v; Richards MP, 2007, J AGR FOOD CHEM, V55, P3643, DOI 10.1021/jf0628633; Rowe LJ, 2004, J ANIM SCI, V82, P785; Sabow AB, 2015, MEAT SCI, V104, P78, DOI 10.1016/j.meatsci.2015.02.004; Sabow AB, 2016, ANIM SCI J, DOI 101111/asj12496.; Sabow AB, 2015, ANIM SCI J, V86, P981, DOI 10.1111/asj.12385; Sante-Lhoutellier V, 2008, MEAT SCI, V79, P777, DOI 10.1016/j.meatsci.2007.11.011; Sun WZ, 2011, FOOD CHEM, V124, P336, DOI 10.1016/j.foodchem.2010.06.042; TAYLOR RG, 1995, J ANIM SCI, V73, P1351; Thiansilakul Y, 2012, FOOD CHEM, V134, P789, DOI 10.1016/j.foodchem.2012.02.182; Velarde A, 2003, MEAT SCI, V63, P35, DOI 10.1016/S0309-1740(02)00049-9; Vogel KD, 2011, J ANIM SCI, V89, P1412, DOI 10.2527/jas.2010-2920; Wang RR, 2009, POULTRY SCI, V88, P1078, DOI 10.3382/ps.2008-00094; Wilkins LJ, 2002, BRIT POULTRY SCI, V43, P231, DOI 10.1080/00071660120121445; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; Xue M, 2012, FOOD CHEM, V134, P106, DOI 10.1016/j.foodchem.2012.02.072; Zhang WG, 2013, CRIT REV FOOD SCI, V53, P1191, DOI 10.1080/10408398.2011.577540; Zivotofsky AZ, 2012, MEAT SCI, V90, P956, DOI 10.1016/j.meatsci.2011.11.039	71	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152661	10.1371/journal.pone.0152661	http://dx.doi.org/10.1371/journal.pone.0152661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035716	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200028
J	Taggar, JS; Coleman, T; Lewis, S; Jones, M				Taggar, Jaspal S.; Coleman, Tim; Lewis, Sarah; Jones, Matthew			Screening for Atrial Fibrillation - A Cross-Sectional Survey of Healthcare Professionals in Primary Care	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ROUTINE PRACTICE; NURSES VIEWS; AGED 65; METAANALYSIS	Introduction Screening for atrial fibrillation (AF) in primary care has been recommended; however, the views of healthcare professionals (HCPs) are not known. This study aimed to determine the opinions of HCP about the feasibility of implementing screening within a primary care setting. Methods A cross-sectional mixed methods census survey of 418 HCPs from 59 inner-city practices (Nottingham, UK) was conducted between October-December 2014. Postal and web-surveys ascertained data on existing methods, knowledge, skills, attitudes, barriers and facilitators to AF screening using Likert scale and open-ended questions. Responses, categorized according to HCP group, were summarized using proportions, adjusting for clustering by practice, with 95% C. Is and free-text responses using thematic analysis. Results At least one General Practitioner (GP) responded from 48 (81%) practices. There were 212/418 (51%) respondents; 118/229 GPs, 67/129 nurses [50 practice nurses; 17 Nurse Practitioners (NPs)], 27/60 healthcare assistants (HCAs). 39/48 (81%) practices had an ECG machine and diagnosed AF in-house. Non-GP HCPs reported having less knowledge about ECG interpretation, diagnosing and treating AF than GPs. A greater proportion of non-GP HCPs reported they would benefit from ECG training specifically for AF diagnosis than GPs [proportion (95% CI) GPs: 11.9%(6.8-20.0); HCAs: 37.0%(21.7-55.5); nurses: 44.0% (30.0-59.0); NPs 41.2%(21.9-63.7)]. Barriers included time, workload and capacity to undertake screening activities, although training to diagnose and manage AF was a required facilitator. Conclusion Inner-city general practices were found to have adequate access to resources for AF screening. There is enthusiasm by non-GP HCPs to up-skill in the diagnosis and management of AF and they may have a role in future AF screening. However, organisational barriers, such as lack of time, staff and capacity, should be overcome for AF screening to be feasibly implemented within primary care.	[Taggar, Jaspal S.; Coleman, Tim; Jones, Matthew] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Lewis, Sarah] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Taggar, JS (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	jaspal.taggar@nottingham.ac.uk		Jones, Matthew/0000-0002-4824-9724; Coleman, Tim/0000-0002-7303-4805; Taggar, Jaspal/0000-0002-5031-0977	NIHR/School for Primary Care Research GP Career Progression Fellowship [RC08E7]; Nottingham City Clinical Commissioning Group [PCT/UoN/01/RCF/12-13]; East Midlands CLAHRC	NIHR/School for Primary Care Research GP Career Progression Fellowship; Nottingham City Clinical Commissioning Group; East Midlands CLAHRC	The study was supported by an NIHR/School for Primary Care Research GP Career Progression Fellowship (RC08E7) and Research Capability Funding from Nottingham City Clinical Commissioning Group (PCT/UoN/01/RCF/12-13). Tim Coleman acknowledges support from East Midlands CLAHRC. The funding bodies had no role in the design, conduct, interpretation and writing of the report for this research. Views and Institute for Health Research (NIHR) or Nottingham City Clinical Commissioning Group (CCG).	Allaby M., 2014, SCREENING ATRIAL FIB; Atrial Fibrillation Association (AFA), 2012, AF REP ATR FIBR PREV; Barry Kristen L, 2004, Subst Abus, V25, P27, DOI 10.1300/J465v25n01_05; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Department of Health, 2010, ADV LEV NURS POS STA; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Furaker C, 2008, J NURS MANAGE, V16, P933, DOI 10.1111/j.1365-2834.2008.00872.x; Green J, 2014, QUALITATIVE METHODS; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Health Policy and Economic Research Unit, 2013, GPS VIEWS FUT GEN PR; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Hobbs FR, 2015, EUROPEAN J PREVENTIV; Majeed A, 2013, J ROY SOC MED, V106, P384, DOI 10.1177/0141076813504326; Majeed A, 2012, BRIT J GEN PRACT, V62, P625, DOI 10.3399/bjgp12X659150; Moran PS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009586.pub2; NHS Commissioning Board, 2012, PUBL HLTH ENGL NHS N; Nottingham City Clinical Commissioning Group, 2013, WORK TOG HLTH NOTT O; Public Health England, 2014, NAT GEN PRACT PROF; Robertson C, 2012, J AM ACAD NURSE PRAC, V24, P225, DOI 10.1111/j.1745-7599.2012.00719.x; Royal College of Physicians of Edinburgh, 2012, RCPE UK CONS C APPR; Shell R, 2004, J RURAL HEALTH, V20, P368, DOI 10.1111/j.1748-0361.2004.tb00051.x; Spiva L, 2012, J CONTIN EDUC NURS, V43, P81, DOI 10.3928/00220124-20111011-02; Stenner K, 2008, J ADV NURS, V63, P27, DOI 10.1111/j.1365-2648.2008.04644.x; Taggar JS, 2015, INT J CARDIOL, V184, P175, DOI 10.1016/j.ijcard.2015.02.014; Wakeford R, 2014, BMJ CLIN RES ED, P349; Whalley D, 2006, BRIT J GEN PRACT, V56, P87; Workforce and Facilities Team Health and Social Care Information Centre, 2015, GEN PERS MED SERV EN; Zhang HJ, 2013, INT EMERG NURS, V21, P247, DOI 10.1016/j.ienj.2012.11.001	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152086	10.1371/journal.pone.0152086	http://dx.doi.org/10.1371/journal.pone.0152086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035567	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000373201200010
J	Benazzi, S; Nguyen, HN; Kullmer, O; Kupczik, K				Benazzi, Stefano; Nguyen, Huynh Nhu; Kullmer, Ottmar; Kupczik, Kornelius			Dynamic Modelling of Tooth Deformation Using Occlusal Kinematics and Finite Element Analysis	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; STRESS-DISTRIBUTION; MASTICATORY PERFORMANCE; JAW MOVEMENT; HUMAN TEETH; BITE FORCE; BEHAVIOR; DENTIN; BIOMECHANICS; ENAMEL	Background Dental biomechanics based on finite element (FE) analysis is attracting enormous interest in dentistry, biology, anthropology and palaeontology. Nonetheless, several shortcomings in FE modeling exist, mainly due to unrealistic loading conditions. In this contribution we used kinematics information recorded in a virtual environment derived from occlusal contact detection between high resolution models of an upper and lower human first molar pair (M-1 and M-1, respectively) to run a non-linear dynamic FE crash colliding test. Methodology MicroCT image data of a modern human skull were segmented to reconstruct digital models of the antagonistic right M-1 and M-1 and the dental supporting structures. We used the Occlusal Fingerprint Analyser software to reconstruct the individual occlusal pathway trajectory during the power stroke of the chewing cycle, which was applied in a FE simulation to guide the M-1 3D-path for the crash colliding test. Results FE analysis results showed that the stress pattern changes considerably during the power stroke, demonstrating that knowledge about chewing kinematics in conjunction with a morphologically detailed FE model is crucial for understanding tooth form and function under physiological conditions. Conclusions/Significance Results from such advanced dynamic approaches will be applicable to evaluate and avoid mechanical failure in prosthodontics/endodontic treatments, and to test material behavior for modern tooth restoration in dentistry. This approach will also allow us to improve our knowledge in chewing-related biomechanics for functional diagnosis and therapy, and it will help paleoanthropologists to illuminate dental adaptive processes and morphological modifications in human evolution.	[Benazzi, Stefano] Univ Bologna, Dept Cultural Heritage, Ravenna, Italy; [Benazzi, Stefano] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Nguyen, Huynh Nhu] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Kullmer, Ottmar] Senckenberg Res Inst, Dept Palaeoanthropol & Messel Res, Frankfurt, Germany; [Kupczik, Kornelius] Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany	University of Bologna; Max Planck Society; Max Planck Society; Senckenberg Gesellschaft fur Naturforschung (SGN); Max Planck Society	Benazzi, S (corresponding author), Univ Bologna, Dept Cultural Heritage, Ravenna, Italy.; Benazzi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	stefano.benazzi@unibo.it	Benazzi, Stefano/AAH-3923-2020; Kupczik, Kornelius/E-9788-2011	Kupczik, Kornelius/0000-0003-1502-581X; Kullmer, Ottmar/0000-0002-5929-8070	Max Planck Society; German Science Foundation (DFG)	Max Planck Society(Max Planck Society); German Science Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the Max Planck Society and the German Science Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Vienna micro-CT Lab (University of Vienna, Austria) for micro-CT scanning of the modern human skull. We are grateful to Johannes Schoneich for help with the CT segmentation. This research was supported by the Max Planck Society and the German Science Foundation (DFG). This is publication no 84 of the DFG Research Unit 771 "Function and performance enhancement in the mammalian dentition-phylogenetic and ontogenetic impact on the masticatory apparatus".	Barak MM, 2009, J STRUCT BIOL, V168, P511, DOI 10.1016/j.jsb.2009.07.019; Benazzi S, 2015, J ANAT, V226, P180, DOI 10.1111/joa.12260; Benazzi S, 2014, CLIN ORAL INVEST, V18, P369, DOI 10.1007/s00784-013-0973-8; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069990; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062263; Benazzi S, 2012, AM J PHYS ANTHROPOL, V147, P128, DOI 10.1002/ajpa.21607; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Calderon Patrícia dos Santos, 2006, J. Appl. Oral Sci., V14, P448, DOI 10.1590/S1678-77572006000600011; Chattah NLT, 2011, J ANAT, V218, P87, DOI 10.1111/j.1469-7580.2010.01234.x; Cheng YY, 2010, DENT MATER, V26, pE211, DOI 10.1016/j.dental.2010.05.002; Commisso MS, 2015, J MECH BEHAV BIOMED, V41, P23, DOI 10.1016/j.jmbbm.2014.09.022; Daegling DJ, 2003, AM J PHYS ANTHROPOL, V122, P38, DOI 10.1002/ajpa.10225; Daegling DJ, 1998, AM J PHYS ANTHROPOL, V105, P73, DOI 10.1002/(SICI)1096-8644(199801)105:1<73::AID-AJPA7>3.3.CO;2-Y; Dejak B, 2015, DENT MATER, V31, pE77, DOI 10.1016/j.dental.2014.11.016; Duck F.A., 1990, MED PHYS, V18; Field C, 2010, J DENT BIOMECH, V2010, P1, DOI DOI 10.4061/2010/902537; Fu G, 2010, DENT TRAUMATOL, V26, P64, DOI 10.1111/j.1600-9657.2009.00829.x; Hall BK., 1992, BONE BONE GROWTH, V7; Hasegawa A, 2010, INT J BIOMATER, P1, DOI DOI 10.1155/2010/659802; Ho SP, 2007, BIOMATERIALS, V28, P5238, DOI 10.1016/j.biomaterials.2007.08.031; Holmes DC, 1996, J PROSTHET DENT, V75, P140, DOI 10.1016/S0022-3913(96)90090-6; Hughes K, 2014, P I MECH ENG G-J AER, V228, P1890, DOI 10.1177/0954410013506415; Hylander W.L., 2006, TEMPOROMANDIBULAR DI, P3; Jiang W, 2010, J PROSTHET DENT, V103, P6, DOI 10.1016/S0022-3913(09)60206-7; KO CC, 1992, J PROSTHET DENT, V68, P421, DOI 10.1016/0022-3913(92)90404-X; Kullmer O, 2013, J HUM EVOL, V64, P151, DOI 10.1016/j.jhevol.2012.10.009; Kuninori T, 2014, J ORAL REHABIL, V41, P338, DOI 10.1111/joor.12149; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Kupczik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097677; Kupczik K, 2012, BIOL J LINN SOC, V105, P456, DOI 10.1111/j.1095-8312.2011.01779.x; Li H, 2001, WEAR, V249, P980, DOI 10.1016/S0043-1648(01)00835-3; Lin TS, 2010, J MED BIOL ENG, V30, P79; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Magne P, 2007, DENT MATER, V23, P539, DOI 10.1016/j.dental.2006.03.013; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; McCormack SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102387; de Abreu RAM, 2014, ARCH ORAL BIOL, V59, P1065, DOI 10.1016/j.archoralbio.2014.05.005; Natali AN., 2003, DENT BIOMECHANICS, P1, DOI [10.1201/9780203514849, DOI 10.1201/9780203514849]; Okiyama S, 2003, J ORAL REHABIL, V30, P278, DOI 10.1046/j.1365-2842.2003.01009.x; Pacher HM, 1961, RUDOLF POCHS NACHL A, VXII; Park JC, 2015, J PERIODONTAL IMPLAN, V45, P8, DOI 10.5051/jpis.2015.45.1.8; Pascale AM, 2015, INT J COMPUT DENT, V18, P237; Pesqueira AA, 2014, J ORAL IMPLANTOL, V40, P217, DOI 10.1563/AAID-JOI-D-11-00066; Prombonas A, 2002, J PROSTHET DENT, V88, P415, DOI 10.1067/mpr.2002.128174; RUBIN C, 1983, J DENT RES, V62, P82, DOI 10.1177/00220345830620021701; Schmidt H, 2005, MODEL SIMUL MATER SC, V13, P77, DOI 10.1088/0965-0393/13/1/006; Shen LK, 2009, J DENT SCI, V4, P81, DOI 10.1016/S1991-7902(09)60012-X; Stamfelj I, 2008, ANN ANAT, V190, P129, DOI 10.1016/j.aanat.2007.10.006; Trujillo L, 2012, ENG, V4, P972; von Koenigswald W, 2013, PALAEONTOL Z, V87, P141, DOI 10.1007/s12542-012-0142-4; Vukicevic AM, 2015, J DENT, V43, P556, DOI 10.1016/j.jdent.2015.02.011; Watanabe Fumihiko, 2003, Odontology, V91, P31, DOI 10.1007/s10266-003-0029-7; WEIDMANN SM, 1967, ARCH ORAL BIOL, V12, P85, DOI 10.1016/0003-9969(67)90145-8; Zaslansky P, 2006, J STRUCT BIOL, V153, P188, DOI 10.1016/j.jsb.2005.10.010; Zaytsev D, 2014, MAT SCI ENG C-MATER, V34, P15, DOI 10.1016/j.msec.2013.10.009; Zelic K, 2015, INT ENDOD J, V48, P850, DOI 10.1111/iej.12381; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	59	39	43	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152663	10.1371/journal.pone.0152663	http://dx.doi.org/10.1371/journal.pone.0152663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031836	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800109
J	Celandroni, F; Salvetti, S; Gueye, SA; Mazzantini, D; Lupetti, A; Senesi, S; Ghelardi, E				Celandroni, Francesco; Salvetti, Sara; Gueye, Sokhna Aissatou; Mazzantini, Diletta; Lupetti, Antonella; Senesi, Sonia; Ghelardi, Emilia			Identification and Pathogenic Potential of Clinical Bacillus and Paenibacillus Isolates	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION IONIZATION-TIME; MEMBRANE-DAMAGING TOXINS; MALDI-TOF-MS; CEREUS; THURINGIENSIS; LICHENIFORMIS; BACTEREMIA; SECRETION; SUSCEPTIBILITY	The soil-related Bacillus and Paenibacillus species have increasingly been implicated in various human diseases. Nevertheless, their identification still poses problems in the clinical microbiology laboratory and, with the exception of Bacillus anthracis and Bacillus cereus, little is known on their pathogenicity for humans. In this study, we evaluated the use of matrixassisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) in the identification of clinical isolates of these genera and conducted genotypic and phenotypic analyses to highlight specific virulence properties. Seventy-five clinical isolates were subjected to biochemical and MALDI-TOF MS identification. 16S rDNA sequencing and supplemental tests were used to solve any discrepancies or failures in the identification results. MALDI-TOF MS significantly outperformed classical biochemical testing for correct species identification and no misidentification was obtained. One third of the collected strains belonged to the B. cereus species, but also Bacillus pumilus and Bacillus subtilis were isolated at high rate. Antimicrobial susceptibility testing showed that all the B. cereus, B. licheniformis, B. simplex, B. mycoides, Paenibacillus glucanolyticus and Paenibacillus lautus isolates are resistant to penicillin. The evaluation of toxin/enzyme secretion, toxinencoding genes, motility, and biofilm formation revealed that B. cereus displays the highest virulence potential. However, although generally considered nonpathogenic, most of the other species were shown to swim, swarm, produce biofilms, and secrete proteases that can have a role in bacterial virulence. In conclusion, MALDI-TOF MS appears useful for fast and accurate identification of Bacillus and Paenibacillus strains whose virulence properties make them of increasing clinical relevance.	[Celandroni, Francesco; Salvetti, Sara; Gueye, Sokhna Aissatou; Mazzantini, Diletta; Lupetti, Antonella; Ghelardi, Emilia] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Senesi, Sonia] Univ Pisa, Dept Biol, Pisa, Italy; [Ghelardi, Emilia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy; [Salvetti, Sara] S Giuseppe Hosp USL 11, Empoli, Italy	University of Pisa; University of Pisa; University of Pisa	Ghelardi, E (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.; Ghelardi, E (corresponding author), Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy.	emilia.ghelardi@med.unipi.it	Ghelardi, Emilia/ABH-6508-2020	GHELARDI, EMILIA/0000-0001-6863-1384; SALVETTI, SARA/0000-0001-7386-385X; Celandroni, Francesco/0000-0001-7920-7159				Abrishami M, 2015, J CLIN DIAGN RES, V9, pNC1, DOI 10.7860/JCDR/2015/10291.5733; AlMasoud N, 2014, ANAL CHIM ACTA, V840, P49, DOI 10.1016/j.aca.2014.06.032; Ameur MA, 2005, MED MALADIES INFECT, V35, P417, DOI 10.1016/j.medmal.2005.04.007; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Bohme K, 2011, ELECTROPHORESIS, V32, P2951, DOI 10.1002/elps.201100217; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Caamano-Antelo S, 2015, FOOD MICROBIOL, V46, P288, DOI 10.1016/j.fm.2014.08.013; Castiaux V, 2015, INT J FOOD MICROBIOL, V211, P79, DOI 10.1016/j.ijfoodmicro.2015.06.020; Celandroni F, 2000, FEMS MICROBIOL LETT, V190, P247, DOI 10.1016/S0378-1097(00)00343-8; Celandroni F, 2014, FEMS MICROBIOL LETT, V361, P95, DOI 10.1111/1574-6968.12615; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clinical and Laboratory Standards Institute, 2008, 18A MM CLIN LAB STAN; De Bellis P, 2015, INT J FOOD MICROBIOL, V197, P30, DOI 10.1016/j.ijfoodmicro.2014.12.017; Di Franco C, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-33; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Farfour E, 2012, J CLIN MICROBIOL, V50, P2702, DOI 10.1128/JCM.00368-12; Fernandez-No IC, 2013, FOOD MICROBIOL, V33, P235, DOI 10.1016/j.fm.2012.09.022; Ferrand J, 2013, J CLIN MICROBIOL, V51, P3439, DOI 10.1128/JCM.00864-13; FUNADA H, 1988, JPN J CLIN ONCOL, V18, P69, DOI 10.1093/jjco/18.1.69; Ghelardi E, 2002, FEMS MICROBIOL LETT, V208, P129, DOI [10.1016/S0378-1097(02)00450-0, 10.1111/j.1574-6968.2002.tb11072.x]; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Ghelardi E, 2007, APPL ENVIRON MICROB, V73, P4089, DOI 10.1128/AEM.02345-06; Ghelardi E, 2007, MICROBES INFECT, V9, P591, DOI 10.1016/j.micinf.2007.02.001; Ghelardi E, 2012, APPL ENVIRON MICROB, V78, P6540, DOI 10.1128/AEM.01341-12; Hotta Y, 2011, J AGR FOOD CHEM, V59, P5222, DOI 10.1021/jf2004095; HOULT B, 1991, J CLIN PATHOL, V44, P455, DOI 10.1136/jcp.44.6.455; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Idelevich EA, 2013, J MED MICROBIOL, V62, P940, DOI 10.1099/jmm.0.051987-0; Jessberger N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00560; Ki JS, 2009, J MICROBIOL METH, V77, P48, DOI 10.1016/j.mimet.2009.01.003; Kimouli M, 2012, J MED MICROBIOL, V61, P596, DOI 10.1099/jmm.0.033175-0; Kumar S, 2015, CARBOHYD POLYM, V117, P543, DOI 10.1016/j.carbpol.2014.10.017; Kuroki R, 2009, INTERNAL MED, V48, P791, DOI 10.2169/internalmedicine.48.1885; La Jeon Y, 2012, J MED MICROBIOL, V61, P1766, DOI 10.1099/jmm.0.042275-0; Luna VA, 2007, J ANTIMICROB CHEMOTH, V60, P555, DOI 10.1093/jac/dkm213; Padhi Sanghamitra, 2013, J Lab Physicians, V5, P133, DOI 10.4103/0974-2727.119872; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rieg S, 2010, EMERG INFECT DIS, V16, P487, DOI 10.3201/eid1603.091457; Rowan NJ, 2001, APPL ENVIRON MICROB, V67, P3873, DOI 10.1128/AEM.67.9.3873-3881.2001; Sahu C, 2013, INT OPHTHALMOL, V33, P611, DOI 10.1007/s10792-012-9697-z; Schafer MO, 2014, VET MICROBIOL, V170, P291, DOI 10.1016/j.vetmic.2014.02.006; Senesi S, 2010, TOXINS, V2, P1690, DOI 10.3390/toxins2071690; Senesi S, 2010, RES MICROBIOL, V161, P743, DOI 10.1016/j.resmic.2010.10.007; Starostin KV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16989; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Tourasse NJ, 2011, FOOD MICROBIOL, V28, P236, DOI 10.1016/j.fm.2010.06.014; WANDERSMAN C, 1986, J GEN MICROBIOL, V132, P899; Yim JH, 2015, J FOOD SCI, V80, pM1266, DOI 10.1111/1750-3841.12872	50	53	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152831	10.1371/journal.pone.0152831	http://dx.doi.org/10.1371/journal.pone.0152831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031639	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800147
J	Fahrenkrog, B; Martinelli, V; Nilles, N; Fruhmann, G; Chatel, G; Juge, S; Sauder, U; Di Giacomo, D; Mecucci, C; Schwaller, J				Fahrenkrog, Birthe; Martinelli, Valerie; Nilles, Nadine; Fruhmann, Gernot; Chatel, Guillaume; Juge, Sabine; Sauder, Ursula; Di Giacomo, Danika; Mecucci, Cristina; Schwaller, Juerg			Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype	PLOS ONE			English	Article							NUCLEOPORIN NUP98; PORE COMPLEX; C-TERMINUS; GENE; TRANSLOCATION; NUP98-HOXA9; LAP2-ALPHA; TRANSCRIPTION; CELLS; T(7/11)(P15,P15)	Chromosomal translocations involving the nucleoporin NUP98 have been described in several hematopoietic malignancies, in particular acute myeloid leukemia (AML). In the resulting chimeric proteins, Nup98's N-terminal region is fused to the C-terminal region of about 30 different partners, including homeodomain (HD) transcription factors. While transcriptional targets of distinct Nup98 chimeras related to immortalization are relatively well described, little is known about other potential cellular effects of these fusion proteins. By comparing the sub-nuclear localization of a large number of Nup98 fusions with HD and non-HD partners throughout the cell cycle we found that while all Nup98 chimeras were nuclear during interphase, only Nup98-HD fusion proteins exhibited a characteristic speckled appearance. During mitosis, only Nup98-HD fusions were concentrated on chromosomes. Despite the difference in localization, all tested Nup98 chimera provoked morphological alterations in the nuclear envelope (NE), in particular affecting the nuclear lamina and the lamina-associated polypeptide 2 alpha (LAP2 alpha). Importantly, such aberrations were not only observed in transiently transfected HeLa cells but also in mouse bone marrow cells immortalized by Nup98 fusions and in cells derived from leukemia patients harboring Nup98 fusions. Our findings unravel Nup98 fusion-associated NE alterations that may contribute to leukemogenesis.	[Fahrenkrog, Birthe; Martinelli, Valerie; Nilles, Nadine; Chatel, Guillaume] Univ Libre Bruxelles, Inst Mol Biol & Med, Charleroi, Belgium; [Fruhmann, Gernot; Juge, Sabine; Schwaller, Juerg] Univ Childrens Hosp Basel, Dept Biomed, Basel, Switzerland; [Sauder, Ursula] Univ Basel, Biozentrum, Microscopy Ctr, Basel, Switzerland; [Di Giacomo, Danika; Mecucci, Cristina] Univ Perugia, Hematol & Bone Marrow Transplantat Unit, I-06100 Perugia, Italy	Universite Libre de Bruxelles; University of Basel; University of Basel; University of Perugia	Fahrenkrog, B (corresponding author), Univ Libre Bruxelles, Inst Mol Biol & Med, Charleroi, Belgium.; Schwaller, J (corresponding author), Univ Childrens Hosp Basel, Dept Biomed, Basel, Switzerland.	bfahrenk@ulb.ac.be; j.schwaller@unibas.ch	Schwaller, Juerg/A-3044-2016	Schwaller, Juerg/0000-0001-8616-0096; Fahrenkrog, Birthe/0000-0003-4080-9413; Fruhmann, Gernot/0000-0002-4828-8301	Fonds de la Recherche Scientifique-FNRS [T.0237.13, 7.4595.14]; Swiss National Science Foundation [31003A 149714]; Swiss Cancer League [KFS-3019-08-2012]	Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by Fonds de la Recherche Scientifique-FNRS: grant numbers T.0237.13 and 7.4595.14; (www.frs-fnrs.be); the Swiss National Science Foundation: grant number 31003A 149714, (www.sf.ch); and the Swiss Cancer League, grant number: KFS-3019-08-2012, (www.krebsliga.ch).	Ahuja HG, 2000, CANCER RES, V60, P6227; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Becker M, 2010, CELL CYCLE, V9, P1360, DOI 10.4161/cc.9.7.11177; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Bradley CM, 2007, STRUCTURE, V15, P643, DOI 10.1016/j.str.2007.04.007; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Chou WC, 2009, LEUKEMIA, V23, P1303, DOI 10.1038/leu.2009.25; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Cross MK, 2011, MOL BIOL CELL, V22, P661, DOI 10.1091/mbc.E10-06-0478; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fahrenkrog B., 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/468306, DOI 10.1155/2014/468306]; Forrester AM, 2011, BRIT J HAEMATOL, V155, P167, DOI 10.1111/j.1365-2141.2011.08810.x; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gotic I, 2010, NUCLEUS-PHILA, V1, P397, DOI 10.4161/nucl.1.5.12394; Gotic I, 2010, STEM CELLS, V28, P480, DOI 10.1002/stem.292; Gotic I, 2010, CIRC RES, V106, P346, DOI 10.1161/CIRCRESAHA.109.205724; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Jeganathan KB, 2006, CELL CYCLE, V5, P366, DOI 10.4161/cc.5.4.2483; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; La Starza R, 2004, GENE CHROMOSOME CANC, V41, P395, DOI 10.1002/gcc.20103; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Light WH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001524; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Panarello C, 2002, GENE CHROMOSOME CANC, V35, P277, DOI 10.1002/gcc.10119; Pascual-Garcia P, 2014, CELL REP, V9, P433, DOI 10.1016/j.celrep.2014.09.002; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Qiu JJ, 2015, LEUKEMIA, V29, P1153, DOI 10.1038/leu.2014.334; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Singer S, 2012, MOL CELL, V48, P799, DOI 10.1016/j.molcel.2012.09.020; Snyers L, 2007, J BIOL CHEM, V282, P6308, DOI 10.1074/jbc.M605782200; Such E, 2011, BLOOD, V117, P242, DOI 10.1182/blood-2010-06-291658; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Taketani T, 2009, CANCER GENET CYTOGEN, V190, P108, DOI 10.1016/j.cancergencyto.2008.12.008; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Xu SL, 2010, MOL BIOL CELL, V21, P1585, DOI 10.1091/mbc.E09-07-0561; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Zhang SF, 2013, J BIOL CHEM, V288, P18104, DOI 10.1074/jbc.C113.469544	70	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152321	10.1371/journal.pone.0152321	http://dx.doi.org/10.1371/journal.pone.0152321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031510	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800056
J	Giandolini, M; Gimenez, P; Temesi, J; Arnal, PJ; Martin, V; Rupp, T; Morin, JB; Samozino, P; Millet, GY				Giandolini, Marlene; Gimenez, Philippe; Temesi, John; Arnal, Pierrick J.; Martin, Vincent; Rupp, Thomas; Morin, Jean-Benoit; Samozino, Pierre; Millet, Guillaume Y.			Effect of the Fatigue Induced by a 110-km Ultramarathon on Tibial Impact Acceleration and Lower Leg Kinematics	PLOS ONE			English	Article							SPRING-MASS BEHAVIOR; SHORTENING CYCLE EXERCISE; RUNNING MECHANICS; CARTILAGE DEGENERATION; MUSCLE CONTRIBUTIONS; MULTIJOINT MOVEMENT; STRIDE FREQUENCY; EXHAUSTIVE RUN; KNEE-JOINT; FORCE	Ultramarathon runners are exposed to a high number of impact shocks and to severe neuromuscular fatigue. Runners may manage mechanical stress and muscle fatigue by changing their running kinematics. Our purposes were to study (i) the effects of a 110-km mountain ultramarathon (MUM) on tibial shock acceleration and lower limb kinematics, and (ii) whether kinematic changes are modulated according to the severity of neuromuscular fatigue. Twenty-three runners participated in the study. Pre-and post-MUM, neuromuscular tests were performed to assess knee extensor (KE) and plantar flexor (PF) central and peripheral fatigue, and a treadmill running bouts was completed during which step frequency, peak acceleration, median frequency and impact frequency content were measured from tibial acceleration, as well as foot-to-treadmill, tibia-to-treadmill, and ankle flexion angles at initial contact, and ankle range of motion using video analysis. Large neuromuscular fatigue, including peripheral changes and deficits in voluntary activation, was observed in KE and PF. MVC decrements of similar to 35% for KE and of similar to 28% for PF were noted. Among biomechanical variables, step frequency increased by similar to 2.7% and the ankle range of motion decreased by similar to 4.1% post-MUM. Runners adopting a non rearfoot strike pre-MUM adopted a less plantarflexed foot strike pattern post-MUM while those adopting a rearfoot strike pre-MUM tended to adopt a less dorsiflexed foot strike pattern post-MUM. Positive correlations were observed between percent changes in peripheral PF fatigue and the ankle range of motion. Peripheral PF fatigue was also significantly correlated to both percent changes in step frequency and the ankle angle at contact. This study suggests that in a fatigued state, ultratrail runners use compensatory/ protective adjustments leading to a flatter foot landing and this is done in a fatigue dose-dependent manner. This strategy may aim at minimizing the overall load applied to the musculoskeletal system, including impact shock and muscle stretch.	[Giandolini, Marlene; Rupp, Thomas; Samozino, Pierre] Univ Savoie Mont Blanc, Lab Exercise Physiol EA4338, Le Bourget Du Lac, France; [Gimenez, Philippe] Univ Franche Comte, Lab Culture Sport Hlth Soc EA 4660, F-25030 Besancon, France; [Temesi, John; Millet, Guillaume Y.] Univ Calgary, Human Performance Lab, Fac Kinesiol, Calgary, AB, Canada; [Gimenez, Philippe; Arnal, Pierrick J.; Morin, Jean-Benoit; Millet, Guillaume Y.] Univ Lyon, Lab Exercise Physiol EA4338, St Etienne, France; [Arnal, Pierrick J.] IRBA, Fatigue & Vigilance Team, Bretigny Sur Orge, France; [Martin, Vincent] Univ Blaise Pascal Clermont Auvergne, Lab Adaptat Metabol Exercice Condit Physiol & Pat, Clermont Ferrand, France; [Morin, Jean-Benoit] Univ Nice Sophia Antipolis, Lab Human Motr Educ Sport & Hlth EA6312, F-06189 Nice, France	Universite de Franche-Comte; University of Calgary; UDICE-French Research Universities; Universite Cote d'Azur	Giandolini, M (corresponding author), Univ Savoie Mont Blanc, Lab Exercise Physiol EA4338, Le Bourget Du Lac, France.	marlene.giandolini@salomon.com	Samozino, Pierre/R-1927-2019; Martin, Vincent/ABF-7135-2020; Millet, Guillaume/AAO-6520-2020	Martin, Vincent/0000-0002-6681-1610; Millet, Guillaume/0000-0002-6395-0762; Temesi, John/0000-0002-5086-6350; Morin, Jean-Benoit/0000-0003-3808-6762	Rhone-Alpes Region	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	This study was funded by John Temesi's doctoral research grant from the Rhone-Alpes Region.	Abt JP, 2011, J STRENGTH COND RES, V25, P1479, DOI 10.1519/JSC.0b013e3181ddfcf8; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Avela J, 1999, J APPL PHYSIOL, V86, P1292, DOI 10.1152/jappl.1999.86.4.1292; Boyer KA, 2004, J BIOMECH, V37, P1583, DOI 10.1016/j.jbiomech.2004.01.002; Clansey AC, 2012, MED SCI SPORT EXER, V44, P1917, DOI 10.1249/MSS.0b013e318259480d; Degache F, 2016, INT J SPORT PHYSIOL, V11, P608, DOI 10.1123/ijspp.2015-0238; Degache F, 2013, J SPORT SCI, V31, P299, DOI 10.1080/02640414.2012.729136; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; Ellis RG, 2014, GAIT POSTURE, V40, P594, DOI 10.1016/j.gaitpost.2014.07.002; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Forestier N, 1998, NEUROSCI LETT, V252, P187, DOI 10.1016/S0304-3940(98)00584-9; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Giandolini M, 2013, EUR J APPL PHYSIOL, V113, P599, DOI 10.1007/s00421-012-2465-y; Girard O, 2013, INT J SPORTS MED, V34, P832, DOI 10.1055/s-0032-1329958; GOLLHOFER A, 1987, INT J SPORTS MED, V8, P71, DOI 10.1055/s-2008-1025644; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; HAMILL CL, 1984, MED SCI SPORT EXER, V16, P185; Hamill J, 2014, EUR J SPORT SCI, V14, P130, DOI 10.1080/17461391.2012.728249; Horisberger M, 2013, CLIN BIOMECH, V28, P536, DOI 10.1016/j.clinbiomech.2013.04.009; Huffenus AF, 2006, EXP BRAIN RES, V170, P438, DOI 10.1007/s00221-005-0227-3; Marqueste T, 2004, BRAIN RES, V1023, P222, DOI 10.1016/j.brainres.2004.07.027; Mercer JA, 2003, J SPORT SCI, V21, P911, DOI 10.1080/0264041031000140383; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2009, EUR J APPL PHYSIOL, V107, P731, DOI 10.1007/s00421-009-1194-3; Mizrahi J, 1997, BASIC APPL MYOL, V7, P111; Mizrahi J, 2000, HUM MOVEMENT SCI, V19, P139, DOI 10.1016/S0167-9457(00)00013-0; Morin JB, 2007, J BIOMECH, V40, P3341, DOI 10.1016/j.jbiomech.2007.05.001; Morin JB, 2011, J BIOMECH, V44, P1104, DOI 10.1016/j.jbiomech.2011.01.028; Morin JB, 2011, MED SCI SPORT EXER, V43, P829, DOI 10.1249/MSS.0b013e3181fec518; Morio C, 2012, EUR J APPL PHYSIOL, V112, P2817, DOI 10.1007/s00421-011-2242-3; NICOL C, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P10; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Rabita G, 2013, J BIOMECH, V46, P2011, DOI 10.1016/j.jbiomech.2013.06.011; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Shih Y, 2013, GAIT POSTURE, V38, P490, DOI 10.1016/j.gaitpost.2013.01.030; SHORTEN MR, 1992, INT J SPORT BIOMECH, V8, P288, DOI 10.1123/ijsb.8.4.288; Temesi J, 2015, MED SCI SPORT EXER, V47, P1372, DOI 10.1249/MSS.0000000000000540; Townshend AD, 2010, MED SCI SPORT EXER, V42, P160, DOI 10.1249/MSS.0b013e3181af21e2; Valiant G.A., 1989, BIOMECHANICS DISTANC, P225; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; Vernillo G, 2015, J SPORT SCI, V33, P1998, DOI 10.1080/02640414.2015.1022870; Voloshin AS, 1998, CLIN BIOMECH, V13, P515, DOI 10.1016/S0268-0033(98)00030-8; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; Warden SJ, 2014, J ORTHOP SPORT PHYS, V44, P749, DOI 10.2519/jospt.2014.5334	48	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151687	10.1371/journal.pone.0151687	http://dx.doi.org/10.1371/journal.pone.0151687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031830	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000373121800019
J	Grangeia, TDG; de Jorge, B; Franci, D; Santos, TM; Setubal, MSV; Schweller, M; de Carvalho, MA				Guerra Grangeia, Tiago de Araujo; de Jorge, Bruno; Franci, Daniel; Santos, Thiago Martins; Vellutini Setubal, Maria Silvia; Schweller, Marcelo; de Carvalho-Filho, Marco Antonio			Cognitive Load and Self-Determination Theories Applied to E-Learning: Impact on Students' Participation and Academic Performance	PLOS ONE			English	Article							MEDICAL-EDUCATION; VIRTUAL PATIENTS; GUIDE; PRINCIPLES; STRATEGIES; DESIGN	Background Emergency clerkships expose students to a stressful environment that require multiple tasks, which may have a direct impact on cognitive load and motivation for learning. To address this challenge, Cognitive Load Theory and Self Determination Theory provided the conceptual frameworks to the development of a Moodle-based online Emergency Medicine course, inspired by real clinical cases. Methods Three consecutive classes (2013-2015) of sixth-year medical students (n = 304) participated in the course, during a curricular and essentially practical emergency rotation. "Virtual Rounds" provided weekly virtual patients in narrative format and meaningful schemata to chief complaints, in order to simulate real rounds at Emergency Unit. Additional activities such as Extreme Decisions, Emergency Quiz and Electrocardiographic challenge offered different views of emergency care. Authors assessed student's participation and its correlation with their academic performance. A survey evaluated students' opinions. Students graduating in 2015 answered an online questionnaire to investigate cognitive load and motivation. Results Each student produced 1965 pageviews and spent 72 hours logged on. Although Clinical Emergency rotation has two months long, students accessed the online course during an average of 5.3 months. Virtual Rounds was the most accessed activity, and there was positive correlations between the number of hours logged on the platform and final grades on Emergency Medicine. Over 90% of students felt an improvement in their clinical reasoning and considered themselves better prepared for rendering Emergency care. Considering a Likert scale from 1 (minimum load) to 7 (maximum load), the scores for total cognitive load were 4.79 +/- 2.2 for Virtual Rounds and 5.56 +/- 1.96 for real medical rounds(p<0,01). Conclusions A real-world inspired online course, based on cognitive and motivational conceptual frameworks, seems to be a strong tool to engage students in learning. It may support them to manage the cognitive challenges involved in clinical care and increase theirmotivation for learning.	[Guerra Grangeia, Tiago de Araujo; Franci, Daniel; Santos, Thiago Martins; Schweller, Marcelo; de Carvalho-Filho, Marco Antonio] State Univ Campinas Unicamp, Fac Med Sci, Div Emergency Med, Dept Internal Med, Sao Paulo, Brazil; [de Jorge, Bruno; Vellutini Setubal, Maria Silvia] State Univ Campinas Unicamp, Fac Med Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	de Carvalho, MA (corresponding author), State Univ Campinas Unicamp, Fac Med Sci, Div Emergency Med, Dept Internal Med, Sao Paulo, Brazil.	macarvalhofilho@gmail.com	Santos, Thiago/ABC-7839-2021; Santos, Thiago M/B-3644-2019; Carvalho-Filho, Marco Antonio/M-4335-2013	Santos, Thiago/0000-0002-4686-3122; Carvalho-Filho, Marco Antonio/0000-0001-7008-4092; Grangeia, Tiago de Araujo Guerra/0000-0001-5584-4073; de Jorge, Bruno/0000-0001-6669-5288				Abendroth M, 2013, CLIN TEACH, V10, P51, DOI 10.1111/j.1743-498X.2012.00629.x; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; Brunken R, 2003, EDUC PSYCHOL-US, V38, P53, DOI 10.1207/S15326985EP3801_7; Chen PSD, 2010, COMPUT EDUC, V54, P1222, DOI 10.1016/j.compedu.2009.11.008; Coates WC, 2004, ACAD EMERG MED, V11, P300, DOI 10.1197/j.aem.2003.09.019; Consorti F, 2012, COMPUT EDUC, V59, P1001, DOI 10.1016/j.compedu.2012.04.017; Cook DA, 2006, ACAD MED, V81, P231, DOI 10.1097/00001888-200603000-00005; Cook DA, 2004, J GEN INTERN MED, V19, P698, DOI 10.1111/j.1525-1497.2004.30029.x; Cook DA, 2006, MED TEACH, V28, P594, DOI 10.1080/01421590601028854; Cook DA, 2010, ADV HEALTH SCI EDUC, V15, P755, DOI 10.1007/s10459-010-9231-x; Cook DA, 2009, MED EDUC, V43, P303, DOI 10.1111/j.1365-2923.2008.03286.x; Davies J, 2005, BRIT J EDUC TECHNOL, V36, P657, DOI 10.1111/j.1467-8535.2005.00542.x; de Jong T, 2010, INSTR SCI, V38, P105, DOI 10.1007/s11251-009-9110-0; Deladisma AM, 2007, AM J SURG, V193, P756, DOI 10.1016/j.amjsurg.2007.01.021; Ellaway R, 2008, MED TEACH, V30, P455, DOI [10.1080/01421590802108349, 10.1080/01421590802108331]; Ellaway RH, 2014, PERSPECT MED EDUC, V3, P266, DOI 10.1007/s40037-014-0134-z; Ende J, 1992, JGIM S2, V12, ps41; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; Farrell SE, 2009, ACAD EMERG MED, V16, P1318, DOI 10.1111/j.1553-2712.2009.00570.x; Frehywot S, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-4; Gormley GJ, 2009, MED TEACH, V31, pE6, DOI 10.1080/01421590802334317; HART S G, 1988, P139; Ituma A., 2011, ACT LEARN HIGH EDUC, V12, P57, DOI [DOI 10.1177/1469787410387722, 10.1177/1469787410387722]; Johnson CE, 2004, MED EDUC, V38, P599, DOI 10.1111/j.1365-2929.2004.01792.x; Jones R, 2001, LANCET, V357, P699, DOI 10.1016/S0140-6736(00)04134-9; Jwayyed S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-51; Kalyuga S, 2009, LEARN INSTR, V19, P402, DOI 10.1016/j.learninstruc.2009.02.003; Kemp N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01278; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; McLaughlin SA, 2005, ACAD EMERG MED, V12, P1003, DOI 10.1197/j.aem.2005.05.029; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Naismith LM, 2015, MED EDUC, V49, P805, DOI 10.1111/medu.12732; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; PAAS FGWC, 1992, J EDUC PSYCHOL, V84, P429, DOI 10.1037/0022-0663.84.4.429; Putzer GJ, 2012, PERSPECT HLTH INF MA, V9, P1; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Smith PJW, 2013, ANN SURG, V258, P838, DOI 10.1097/SLA.0000000000000211; Taylor DCM, 2013, MED TEACH, V35, pE1561, DOI 10.3109/0142159X.2013.828153; ten Cate TJ, 2011, MED TEACH, V33, P961, DOI 10.3109/0142159X.2011.595435; Tews MC, 2011, ACAD EMERG MED, V18, P1072, DOI 10.1111/j.1553-2712.2011.01168.x; van Merrienboer JJG, 2010, MED EDUC, V44, P85, DOI 10.1111/j.1365-2923.2009.03498.x; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; Wilson JI, 2012, INT J MED EDUC, V3, P115, DOI 10.5116/ijme.4fea.1918; Young JQ, 2015, PERSPECT MED EDUC, V4, P107, DOI 10.1007/s40037-015-0193-9; Young JQ, 2014, MED TEACH, V36, P371, DOI 10.3109/0142159X.2014.889290	47	21	21	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152462	10.1371/journal.pone.0152462	http://dx.doi.org/10.1371/journal.pone.0152462			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031859	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800079
J	Hisham, R; Liew, SM; Ng, CJ; Nor, KM; Osman, IF; Ho, GJ; Hamzah, N; Glasziou, P				Hisham, Ranita; Liew, Su May; Ng, Chirk Jenn; Nor, Kamaliah Mohd; Osman, Iskandar Firzada; Ho, Gah Juan; Hamzah, Nurazira; Glasziou, Paul			Rural Doctors' Views on and Experiences with Evidence-Based Medicine: The FrEEDoM Qualitative Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; HEALTH INFORMATION; CARE PHYSICIANS; BARRIERS; ATTITUDES; BEHAVIOR; BELIEFS	Background Evidence-based medicine is the integration of individual clinical expertise, best external evidence and patient values which was introduced more than two decades ago. Yet, primary care physicians in Malaysia face unique barriers in accessing scientific literature and applying it to their clinical practice. Aim This study aimed to explore the views and experiences of rural doctors' about evidence-based medicine in their daily clinical practice in a rural primary care setting. Methods Qualitative methodology was used. The interviews were conducted in June 2013 in two rural health clinics in Malaysia. The participants were recruited using purposive sampling. Four focus group discussions with 15 medical officers and three individual in-depth interviews with family medicine specialists were carried out. All interviews were conducted using a topic guide and were audio-recorded, transcribed verbatim, checked and analyzed using a thematic approach. Results Key themes identified were: (1) doctors viewed evidence-based medicine mainly as statistics, research and guidelines, (2) reactions to evidence-based medicine were largely negative, (3) doctors relied on specialists, peers, guidelines and non-evidence based internet sources for information, (4) information sources were accessed using novel methods such as mobile applications and (5) there are several barriers to evidence-based practice, including doctor-, evidence-based medicine-, patient-and system-related factors. These included inadequacies in knowledge, attitude, management support, time and access to evidence-based information sources. Participants recommended the use of online services to support evidence-based practice in the rural settings. Conclusion The level of evidence-based practice is low in the rural setting due to poor awareness, knowledge, attitude and resources. Doctors use non-evidence based sources and access them through new methods such as messaging applications. Further research is recommended to develop and evaluate interventions to overcome the identified barriers.	[Hisham, Ranita; Liew, Su May; Ng, Chirk Jenn; Ho, Gah Juan; Hamzah, Nurazira] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Nor, Kamaliah Mohd] Minist Hlth, Family Hlth Dev Div, Putrajaya, Malaysia; [Osman, Iskandar Firzada] Klin Kesihatan Jaya Gading, Kuantan, Pahang, Malaysia; [Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia	Universiti Malaya; Kementerian Kesihatan Malaysia; Bond University	Hisham, R (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.	ranita@um.edu.my	Hisham Shunmugam, Ranita/F-5073-2011; Glasziou, Paul/A-7832-2008; Noh, Kamaliah Mohamad/AAD-2694-2020; LIEW, Su May/B-8852-2010; NG, CHIRK JENN/C-1344-2010	Hisham Shunmugam, Ranita/0000-0002-3356-2291; Glasziou, Paul/0000-0001-7564-073X; Noh, Kamaliah Mohamad/0000-0001-5744-0515; LIEW, Su May/0000-0003-2865-7955; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya Research Grant [UMRG 474/12HTM]	University of Malaya Research Grant	This work was supported by the University of Malaya Research Grant, reference number: UMRG 474/12HTM (http://ippp.um.edu.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded by University of Malaya Research Grant (UMRG 474/12HTM). We thank all the healthcare professionals who participated in this study and the Ministry of Health, Malaysia for granting permission for this study to be conducted in the health clinics.	Agarwal R, 2008, NEUROL ASIA, V13, P87; Ahmad ASH, 2009, J EVAL CLIN PRACT, V15, P1125, DOI 10.1111/j.1365-2753.2009.01125.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albarrak AI, 2014, SAUDI PHARM J, V22, P207, DOI 10.1016/j.jsps.2013.05.003; Amin FA, 2006, SAUDI MED J, V27, P1394; Anderson J, 1991, J Contin Educ Nurs, V22, P29; Burdette SD, 2008, CLIN INFECT DIS, V47, P117, DOI 10.1086/588788; Calderon C, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-84; Cheers B., 1998, WELFARE BUSHED SOCIA; Cruez A, 2008, SPORT LIGHT MALAYSIA; Davies KS, 2011, INT J EVID-BASED HEA, V9, P265, DOI 10.1111/j.1744-1609.2011.00218.x; Department of Statistics Malaysia, 2010, VIT STAT MAL; Dickersin K, 2007, BRIT MED J, V6, P334; Edejer TTT, 2000, BRIT MED J, V321, P797, DOI 10.1136/bmj.321.7264.797; Emparanza JI, 2015, J EVALUATION CLIN PR; Flores G, 2000, PEDIATRICS, V105, P496, DOI 10.1542/peds.105.3.496; Gerteis M., 1993, PATIENTS EYES UNDERS; Godlee F, 2004, LANCET, V364, P295, DOI 10.1016/S0140-6736(04)16681-6; Hay MC, 2008, J EVAL CLIN PRACT, V14, P707, DOI 10.1111/j.1365-2753.2008.01009.x; Index Mundi, 2013, MAL DEM PROF 2013; Lai Nai Ming, 2010, BMC Res Notes, V3, P279, DOI 10.1186/1756-0500-3-279; Mazen F, 2010, NEWSLETTER INT SOC E; McCarthy A, 1998, Aust J Rural Health, V6, P96, DOI 10.1111/j.1440-1584.1998.tb00291.x; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; McDonald J, 2001, 6 NAT RUR HLTH C CAN; Muir GJA, 1997, EVIDENCE BASED HEALT; National Health and Medical Research Council, 1999, GUID DEV IMPL EV CLI; Parsons Jacqueline E, 2003, Aust J Rural Health, V11, P242, DOI 10.1111/j.1440-1584.2003.00527.x; Ramos K, 2003, FAM MED, V35, P257; Robert Wood Johnson Foundation, 2010, QUAL EQ US HLTH CAR, P1; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sackett DL, 1998, JAMA-J AM MED ASSOC, V280, P1336, DOI 10.1001/jama.280.15.1336; Sadeghi-Bazargani H, 2014, J EVAL CLIN PRACT, V20, P793, DOI 10.1111/jep.12222; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; Turner TJ, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-235; Weller D., 1999, EVIDENCE BASED POLIC; Young JM, 2001, J EVAL CLIN PRACT, V7, P201, DOI 10.1046/j.1365-2753.2001.00294.x; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152649	10.1371/journal.pone.0152649	http://dx.doi.org/10.1371/journal.pone.0152649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031700	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800108
J	Stoker, SD; Fles, R; Herdini, C; Rijntjes, FJF; Tjokronagoro, M; Dwidanarti, SR; Sikorska, K; Leemans, CR; Schmidt, MK; Al-Mamgani, A; Wildeman, MA; Haryana, SM; Indrasari, SR; Tan, IB				Stoker, S. D.; Fles, R.; Herdini, C.; Rijntjes, F. J. F.; Tjokronagoro, M.; Dwidanarti, S. R.; Sikorska, K.; Leemans, C. R.; Schmidt, M. K.; Al-Mamgani, A.; Wildeman, M. A.; Haryana, S. M.; Indrasari, S. R.; Tan, I. B.			The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FRACTIONATED RADIOTHERAPY; CONCURRENT CHEMOTHERAPY; CURRENT MANAGEMENT; LOCAL-CONTROL; HEAD; NECK; CANCER; INTERRUPTIONS; FAILURE	Purpose In Yogyakarta, nasopharyngeal carcinoma (NPC) shows a poor response to radiotherapy treatment. Previous study showed a prolonged overall treatment time (OTT), due to interruptions during treatment. This study explores the association between clinical outcome and OTT. Secondary, the relation between clinical outcome and disease stage, waiting time to radiation (WT) and chemotherapy schedule was explored. Methods In this retrospective cohort, 142 patients who started curative intent radiotherapy for NPC between March 2009 and May 2014, with or without chemotherapy, were included. The median follow up time was 1.9 years. Data was collected on WT, OTT, disease stage, and chemotherapy schedule. Time factors were log-transformed. Clinical outcome was defined as therapy response, loco-regional control (LRC), disease free survival (DFS) and overall survival (OS). Results The median WT was 117 days (range 12-581) and OTT was 58 days (43-142). OTT and disease stage were not associated to any of the clinical outcome parameters. The log-WT was associated to poor therapy outcome (HR 1.68; 95% ci: 1.09-2.61), LRC (HR 1.66; 95% ci: 1.15-2.39), and DFS (HR 1.4; 95% ci: 1.09-1.81). In the multivariable analysis, significant hazard risk for poor therapy response, LRC, DFS and OS were seen for patients who didn't received concurrent chemotherapy. Conclusion Not receiving concurrent chemotherapy showed the strongest risk for poor outcome. Since the choice of chemotherapy is related to a variety of factors, like the WT and patient's physical condition when radiation can start, careful interpretation is needed. Reason for not finding a relation between OTT and clinical outcome might be the low number of patients who finished radiotherapy within 7 weeks, or by a stronger detrimental effect of other factors.	[Stoker, S. D.; Fles, R.; Rijntjes, F. J. F.; Wildeman, M. A.; Tan, I. B.] Netherlands Canc Inst, Dept Head & Neck Surg & Oncol, Amsterdam, Netherlands; [Stoker, S. D.; Leemans, C. R.] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Herdini, C.; Indrasari, S. R.; Tan, I. B.] Gadjah Mada Univ, Dr Sardjito Hosp, Dept Otolaryngol Head & Neck Surg, Yogyakarta, Indonesia; [Tjokronagoro, M.; Dwidanarti, S. R.] Gadjah Mada Univ, Dr Sardjito Hosp, Dept Radiotherapy, Yogyakarta, Indonesia; [Sikorska, K.] Netherlands Canc Inst, Dept Bioinformat, Amsterdam, Netherlands; [Schmidt, M. K.] Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Schmidt, M. K.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Al-Mamgani, A.] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Wildeman, M. A.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Haryana, S. M.] Gadjah Mada Univ, Dept Histol Cell & Tumour Biol, Fac Med, Yogyakarta, Indonesia; [Tan, I. B.] Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Central General Hospital Dr. Sardjito; Gadjah Mada University; Central General Hospital Dr. Sardjito; Gadjah Mada University; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Gadjah Mada University; University of Amsterdam	Tan, IB (corresponding author), Netherlands Canc Inst, Dept Head & Neck Surg & Oncol, Amsterdam, Netherlands.; Tan, IB (corresponding author), Gadjah Mada Univ, Dr Sardjito Hosp, Dept Otolaryngol Head & Neck Surg, Yogyakarta, Indonesia.; Tan, IB (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.tan@nki.nl	Schmidt, Marjanka K/G-9058-2011	Schmidt, Marjanka K/0000-0002-2228-429X; Leemans, C. Rene/0000-0001-7887-083X	Dutch Cancer Society [KWF2012-5423]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society, KWF2012-5423 (http://www.kwf.nl/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANC; Adham M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102353; Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Blanchard P, 2015, LANCET ONCOL, V16, P645, DOI 10.1016/S1470-2045(15)70126-9; Cannon DM, 2014, HEAD NECK-J SCI SPEC, V36, P1120, DOI 10.1002/hed.23419; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Chua DTT, 2003, CANCER-AM CANCER SOC, V98, P74, DOI 10.1002/cncr.11485; Fatema CN, 2013, ANN NUCL MED, V27, P355, DOI 10.1007/s12149-013-0693-9; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2015, CANCER-AM CANCER SOC, V121, P1328, DOI 10.1002/cncr.29208; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AW, 2015, NPC 2015 YOG 7 INT N; LEE AWM, 1995, RADIOTHER ONCOL, V36, P24, DOI 10.1016/0167-8140(95)01579-6; Li PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141332; MARKS LB, 1991, INT J RADIAT ONCOL, V21, P1377, DOI 10.1016/0360-3016(91)90301-J; McCloskey SA, 2009, AM J CLIN ONCOL-CANC, V32, P587, DOI 10.1097/COC.0b013e3181967dd0; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Pan ZQ, 2012, AM J CLIN ONCOL-CANC, V35, P600, DOI 10.1097/COC.0b013e31822dfd55; Platek ME, 2012, HEAD NECK; Rades D, 2008, INT J RADIAT ONCOL, V70, P1108, DOI 10.1016/j.ijrobp.2007.07.2380; Sher DJ, 2011, INT J RADIAT ONCOL, V81, pE813, DOI 10.1016/j.ijrobp.2010.12.005; Song CH, 2008, LARYNGOSCOPE, V118, P663, DOI 10.1097/MLG.0b013e3181626cfe; Stoker SD, 2013, MC C 2013 IST; Su Sheng-fa, 2011, Zhonghua Yi Xue Za Zhi, V91, P469; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Teo PML, 2000, INT J RADIAT ONCOL, V48, P1311, DOI 10.1016/S0360-3016(00)00786-0; Wei WI, 2010, CLIN EXP OTORHINOLAR, V3, P1, DOI 10.3342/ceo.2010.3.1.1; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Yang J, 2014, ONCOL LETT, V7, P1755, DOI 10.3892/ol.2014.1990	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151899	10.1371/journal.pone.0151899	http://dx.doi.org/10.1371/journal.pone.0151899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030990	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800022
J	Wang, B; Franklin, JM; Eddings, W; Landon, J; Kesselheim, AS				Wang, Bo; Franklin, Jessica M.; Eddings, Wesley; Landon, Joan; Kesselheim, Aaron S.			Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis	PLOS ONE			English	Article							OPEN-LABEL; RISK; ADOLESCENTS; MEDICATIONS; OLANZAPINE; MONOTHERAPY; QUETIAPINE; DISORDER; COHORT	Background Following Food and Drug Administration (FDA) approval, many drugs are prescribed for non-FDA-approved ("off-label") uses. If substantial evidence supports the efficacy and safety of off-label indications, manufacturers can pursue formal FDA approval through supplemental new drug applications (sNDAs). We evaluated the effect of FDA determinations on pediatric sNDAs for antipsychotic drugs on prescribing of these products in children. Methods Retrospective, segmented time-series analysis using new prescription claims during 20032012 for three atypical antipsychotics (olanzapine, quetiapine, ziprasidone). FDA approved the sNDAs for pediatric use of olanzapine and quetiapine in December 2009, but did not approve the sNDA for pediatric use of ziprasidone. Results During the months before FDA approval of its pediatric sNDA, new prescriptions of olanzapine decreased for both children and adults. After FDA approval, the increase in prescribing trends was similar for both age groups (P = 0.47 for schizophrenia and bipolar disorder; P = 0.37 for other indications). Comparable decreases in use of quetiapine were observed between pediatrics and adults following FDA approval of its pediatric sNDA (P = 0.88; P = 0.63). Prescribing of ziprasidone decreased similarly for pediatric and adult patients after FDA non-approval of its pediatric sNDA (P = 0.61; P = 0.79). Conclusions The FDA's sNDA determinations relating to use of antipsychotics in children did not result in changes in use that favored the approved sNDAs and disfavored the unapproved sNDA. Improved communication may help translate the agency's expert judgments to clinical practice.	[Wang, Bo; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Wang, Bo; Franklin, Jessica M.; Eddings, Wesley; Landon, Joan; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Franklin, Jessica M.; Eddings, Wesley; Landon, Joan] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA.; Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Harvard Program in Therapeutic Science; Laura and John Arnold Foundation	Harvard Program in Therapeutic Science; Laura and John Arnold Foundation	Dr. Kesselheim's work is supported by the Harvard Program in Therapeutic Science and the Laura and John Arnold Foundation. The funders had no role in the conception, writing, or review of the manuscript.	Advisory meeting minutes: US Food and Drug Administration, 2009, SUMM MIN PSYCH DRUGS; Agency for Healthcare Research and Quality, 2011, OFF LAB US AT ANT UP; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Barnett MS, 2004, J CHILD ADOL PSYCHOP, V14, P471, DOI 10.1089/cap.2004.14.471; Barry CL, 2012, J MENT HEALTH POLICY, V15, P119; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Czaja AS, 2012, PHARMACOEPIDEM DR S, V21, P997, DOI 10.1002/pds.3312; Department of Health and Human Services and US Food and Drug Administration, FDA TRANSP IN IMPR T; Department of Health and Human Services and US Food and Drug Administration, FOOD DRUG ADM TRANSP; DiMasi JA, 2013, CLIN THER, V35, P808, DOI 10.1016/j.clinthera.2013.04.004; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Eli Lilly and Company, 2009, FDA APPR LILL ZYPR 2; Eng PM, 2005, PHARMACOEPIDEM DR S, V14, pS1; Findling RL, 2002, J CLIN PSYCHIAT, V63, P27; Food and Drug Administration, CLIN REV UNPUB; Frazier JA, 2001, J CHILD ADOL PSYCHOP, V11, P239, DOI 10.1089/10445460152595568; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Harris G., 2009, NY TIMES; Justice Department Press Release, 2022, JUST DEP INV LEADS S; Kemner C, 2002, J CLIN PSYCHOPHARM, V22, P455, DOI 10.1097/00004714-200210000-00003; Kesselheim AS, 2014, ANN INTERN MED, V161, P96, DOI 10.7326/M13-2381; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2318, DOI 10.1377/hlthaff.2011.0370; Lambert BL, 2006, AM J EPIDEMIOL, V164, P672, DOI 10.1093/aje/kwj289; Mack Alicia, 2003, J Manag Care Pharm, V9, P559; McIntyre RS, 2008, ARCH PEDIAT ADOL MED, V162, P929, DOI 10.1001/archpedi.162.10.929; Penfold RB, 2010, PEDIATRICS, V125, P475, DOI 10.1542/peds.2009-1288; Tarkan Laurie, 2008, NY TIMES; U.S. Department of Justice, 2010, PHARM GIANT ASTRAZEN; US Department of Justice, 2009, EL LILL COMP AGR PAY; US Food and Drug Administration, DRUG RES CHILDR; Vitiello B, 2009, EUR NEUROPSYCHOPHARM, V19, P629, DOI 10.1016/j.euroneuro.2009.04.008; Wang B, 2014, JAMA INTERN MED, V174, P1938, DOI 10.1001/jamainternmed.2014.5266; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wilson D., 2010, 520 MILLION ASTRAZEN; World Health Organization, PROM SAF MED CHILDR	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152195	10.1371/journal.pone.0152195	http://dx.doi.org/10.1371/journal.pone.0152195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032095	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800041
J	Yoon, SJ; Rahman, MS; Kwon, WS; Park, YJ; Pang, MG				Yoon, Sung-Jae; Rahman, Md Saidur; Kwon, Woo-Sung; Park, Yoo-Jin; Pang, Myung-Geol			Addition of Cryoprotectant Significantly Alters the Epididymal Sperm Proteome	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; 2 DIFFERENT EXTENDERS; BOVINE SPERMATOZOA; OXIDATIVE STRESS; BINDING-PROTEIN; SUPEROXIDE-DISMUTASE; MAMMALIAN SPERM; MALE-FERTILITY; BULL SPERM; CRYOPRESERVATION	Although cryopreservation has been developed and optimized over the past decades, it causes various stresses, including cold shock, osmotic stress, and ice crystal formation, thereby reducing fertility. During cryopreservation, addition of cryoprotective agent (CPA) is crucial for protecting spermatozoa from freezing damage. However, the intrinsic toxicity and osmotic stress induced by CPA cause damage to spermatozoa. To identify the effects of CPA addition during cryopreservation, we assessed the motility (%), motion kinematics, capacitation status, and viability of epididymal spermatozoa using computer-assisted sperm analysis and Hoechst 33258/chlortetracycline fluorescence staining. Moreover, the effects of CPA addition were also demonstrated at the proteome level using two-dimensional electrophoresis. Our results demonstrated that CPA addition significantly reduced sperm motility (%), curvilinear velocity, viability (%), and non-capacitated spermatozoa, whereas straightness and acrosome-reacted spermatozoa increased significantly (p < 0.05). Ten proteins were differentially expressed (two decreased and eight increased) (>3 fold, p < 0.05) after CPA, whereas NADH dehydrogenase flavoprotein 2, f-actin-capping protein subunit beta, superoxide dismutase 2, and outer dense fiber protein 2 were associated with several important signaling pathways (p < 0.05). The present study provides a mechanistic basis for specific cryostresses and potential markers of CPA-induced stress. Therefore, these might provide information about the development of safe biomaterials for cryopreservation and basic ground for sperm cryopreservation.	[Yoon, Sung-Jae; Rahman, Md Saidur; Kwon, Woo-Sung; Park, Yoo-Jin; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea	Chung Ang University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Rahman, Saidur/J-7855-2012; Pang, Myung-Geol/AAV-2014-2021; Rahman, Md Saidur/AAT-2972-2020; Kwon, Woo-Sung/J-6731-2019; Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Saidur/0000-0003-4583-8731; Pang, Myung-Geol/0000-0003-2019-3789; Kwon, Woo-Sung/0000-0002-0848-7189; Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF-2014R1A2A2A01002706]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (no. NRF-2014R1A2A2A01002706), http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none.	Alapati R, 2009, CRYOBIOLOGY, V59, P164, DOI 10.1016/j.cryobiol.2009.06.009; AMANN RP, 1974, J DAIRY SCI, V57, P212, DOI 10.3168/jds.S0022-0302(74)84862-9; Ardon F, 2013, REPRODUCTION, V146, P111, DOI 10.1530/REP-12-0468; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Awad MM, 2004, ANIM REPROD SCI, V84, P83, DOI 10.1016/j.anireprosci.2003.12.001; Ball BA, 2001, J ANDROL, V22, P1061; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Borini A, 2009, SEMIN REPROD MED, V27, P443, DOI 10.1055/s-0029-1241053; Braun S, 2007, ONCOGENE, V26, P532, DOI 10.1038/sj.onc.1209822; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Celeghini ECC, 2008, ANIM REPROD SCI, V104, P119, DOI 10.1016/j.anireprosci.2007.02.001; Chen J, 2011, J ANDROL, V32, P26, DOI 10.2164/jandrol.109.009662; Chen XL, 2012, J PROTEOMICS, V77, P59, DOI 10.1016/j.jprot.2012.07.004; Chiou SH, 2011, KAOHSIUNG J MED SCI, V27, P1, DOI 10.1016/j.kjms.2010.12.001; Cormier N, 1997, J ANDROL, V18, P461; Cui YG, 2008, J PROTEOME RES, V7, P3984, DOI 10.1021/pr800259t; Curry M R, 1995, Methods Mol Biol, V38, P189; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; Day JG, 2008, MOL BIOTECHNOL, V40, P202, DOI 10.1007/s12033-008-9099-7; Desai NR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-114; Dvorakova K, 2005, REPRODUCTION, V130, P61, DOI 10.1530/rep.1.00549; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Fahy GM, 2010, CRYOBIOLOGY, V60, pS45, DOI 10.1016/j.cryobiol.2009.05.005; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Finkelstein M, 2013, DEV BIOL, V381, P62, DOI 10.1016/j.ydbio.2013.06.014; Fujii J, 2003, ASIAN J ANDROL, V5, P231; Fujita A, 2000, J CELL SCI, V113, P103; Glover M, 2014, ANTIVIR RES, V111, P136, DOI 10.1016/j.antiviral.2014.09.010; Goovaerts IGF, 2006, THERIOGENOLOGY, V66, P323, DOI 10.1016/j.theriogenology.2005.11.018; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Ikeda T, 2010, CELL STRUCT FUNCT, V35, P23, DOI 10.1247/csf.09016; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kaabi M, 2003, THERIOGENOLOGY, V60, P1249, DOI 10.1016/S0093-691X(03)00139-0; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kwon WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13821; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Liu QH, 2015, FISH PHYSIOL BIOCHEM, V41, P413, DOI 10.1007/s10695-014-9993-9; Liu ZS, 1998, CRYOBIOLOGY, V37, P207, DOI 10.1006/cryo.1998.2116; Garcia BM, 2012, THERIOGENOLOGY, V77, P1280, DOI 10.1016/j.theriogenology.2011.10.033; Martins CF, 2009, ANIM REPROD SCI, V116, P50, DOI 10.1016/j.anireprosci.2008.12.018; Martins MIM, 2012, REPROD DOMEST ANIM, V47, P293, DOI 10.1111/rda.12042; Mazzilli F, 1995, Acta Eur Fertil, V26, P145; Mochida K, 2005, THERIOGENOLOGY, V64, P135, DOI 10.1016/j.theriogenology.2004.11.013; Mota AC, 2014, CRYOBIOLOGY, V69, P17, DOI 10.1016/j.cryobiol.2014.04.013; Mruk DD, 2002, CONTRACEPTION, V65, P305, DOI 10.1016/S0010-7824(01)00320-1; NAKAMURA M, 1988, BIOL REPROD, V39, P771, DOI 10.1095/biolreprod39.4.771; Oh JH, 2002, CRYOBIOLOGY, V44, P279, DOI 10.1016/S0011-2240(02)00034-2; Ohno K, 2002, CRYOBIOLOGY, V44, P142, DOI 10.1016/S0011-2240(02)00016-0; Olaciregui M, 2014, CRYOBIOLOGY, V68, P91, DOI 10.1016/j.cryobiol.2013.12.009; Oliva R, 2009, PROTEOMICS, V9, P1004, DOI 10.1002/pmic.200800588; Papa FO, 2008, ANIM REPROD SCI, V107, P293, DOI 10.1016/j.anireprosci.2008.05.003; Papa PM, 2015, ANIM REPROD SCI, V161, P58, DOI 10.1016/j.anireprosci.2015.08.004; Park YJ, 2012, J REPROD DEVELOP, V58, P461, DOI 10.1262/jrd.11-067H; Parrish JJ, 1999, THERIOGENOLOGY, V51, P461, DOI 10.1016/S0093-691X(98)00240-4; Peterson C, 1999, MOL HUM REPROD, V5, P627, DOI 10.1093/molehr/5.7.627; Rahman MS, 2014, ANDROLOGY-US, V2, P899, DOI 10.1111/j.2047-2927.2014.00273.x; Rahman MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09169; Rahman MS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/360986; Rosato MP, 2013, THERIOGENOLOGY, V79, P508, DOI 10.1016/j.theriogenology.2012.11.008; SHABANOWITZ RB, 1987, BIOL REPROD, V36, P753, DOI 10.1095/biolreprod36.3.753; Shamonki MI, 2005, SEMIN REPROD MED, V23, P266, DOI 10.1055/s-2005-872455; Songsasen N, 1998, J EXP ZOOL, V280, P189, DOI 10.1002/(SICI)1097-010X(19980201)280:2&lt;189::AID-JEZ10&gt;3.0.CO;2-H; Sorrenti G, 2014, CRYOBIOLOGY, V68, P43, DOI 10.1016/j.cryobiol.2013.11.005; Wang XL, 2015, MOL HUM REPROD, V21, P136, DOI 10.1093/molehr/gau097; Wasinger V.C., 2013, INT J PROTEOMICS, V2013, DOI [10.1155/2013/180605, DOI 10.1155/2013/180605]; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Yoon SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126232	72	58	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152690	10.1371/journal.pone.0152690	http://dx.doi.org/10.1371/journal.pone.0152690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031703	Green Published, gold			2022-12-27	WOS:000373121800118
J	Kim, CS; Choi, JS; Joo, SY; Bae, EH; Ma, SK; Lee, J; Kim, SW				Kim, Chang Seong; Choi, Joon Seok; Joo, Soo Yeon; Bae, Eun Hui; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Nicotine-Induced Apoptosis in Human Renal Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR GENES; SIGNALING PATHWAYS; CIGARETTE-SMOKING; OXIDATIVE STRESS; AMERICAN-INDIANS; KIDNEY-DISEASE; RISK-FACTORS; INJURY; PROGRESSION; DEATH	Background Nicotine is, to a large extent, responsible for smoking-mediated renal dysfunction. This study investigated nicotine's effects on renal tubular epithelial cell apoptosis in vitro and it explored the mechanisms underlying its effects. Methods Human proximal tubular epithelial (HK-2) cells were treated with nicotine. Cell viability was examined by using the WST-1 assay. Intracellular levels of reactive oxygen species (ROS) and the expression of mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappa B) proteins were determined. The messenger ribonucleic acid and the protein expression associated with the nicotine acetylcholine receptors (nAChRs) in HK-2 cells was examined, and apoptosis was detected using flow cytometry, cell cycle analysis, and immunoblot analysis. Results The HK-2 cells were endowed with nAChRs. Nicotine treatment reduced cell viability dose dependently, increased ROS levels, and increased extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK expression. Nicotine increased NF-kappa B activation, which was attenuated by N-acetyl-L-cysteine, and ERK and JNK inhibitors, but was not affected by a p38 MAPK inhibitor. Nicotine increased the Bax/Bcl-2 ratio, which was attenuated by N-acetyl-L-cysteine, the NF-kappa B inhibitor, Bay 11-7082, and hexamethonium, a non-specific nAChR blocker. Flow cytometry revealed nicotine-induced G2/M phase arrest. While nicotine treatment increased the expression of phosphorylated cdc2 and histone H3, a marker of G2/M phase arrest, hexamethonium and Bay 11-7082 pretreatment reduced their expression. Conclusions Nicotine caused apoptosis in HK-2 cells by inducing ROS generation that activated the NF-kappa B signaling pathway via the MAPK pathway and it arrested the cell cycle at the G2/M phase. Nicotine-induced apoptosis in HK-2 cells involves the nAChRs.	[Kim, Chang Seong; Choi, Joon Seok; Joo, Soo Yeon; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Joo, Soo Yeon; Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	skimw@chonnam.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2084]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084).	Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386; BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; Berger F, 1998, J NEUROSCI, V18, P6871; Bhatt K, 2008, AM J PHYSIOL-RENAL, V294, pF499, DOI 10.1152/ajprenal.00415.2007; Bleyer AJ, 2000, KIDNEY INT, V57, P2072, DOI 10.1046/j.1523-1755.2000.00056.x; Bonegio R, 2002, CURR OPIN NEPHROL HY, V11, P301, DOI 10.1097/00041552-200205000-00006; Graham A, 2002, NEUROSCIENCE, V113, P493, DOI 10.1016/S0306-4522(02)00223-3; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Jaimes EA, 2009, AM J NEPHROL, V29, P319, DOI 10.1159/000163593; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063186; Kim Seewan, 2011, Chonnam Med J, V47, P104, DOI 10.4068/cmj.2011.47.2.104; Lee KE, 2013, BIOCHEM BIOPH RES CO, V434, P527, DOI 10.1016/j.bbrc.2013.03.108; Ma Seong Kwon, 2013, Chonnam Med J, V49, P108, DOI 10.4068/cmj.2013.49.3.108; Macklin KD, 1998, J PHARMACOL EXP THER, V287, P435; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Regalado M, 2000, AM J KIDNEY DIS, V35, P687, DOI 10.1016/S0272-6386(00)70017-5; Rezonzew G, 2012, AM J PHYSIOL-RENAL, V303, pF304, DOI 10.1152/ajprenal.00661.2011; Rossing P, 2002, DIABETES CARE, V25, P859, DOI 10.2337/diacare.25.5.859; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z; STEGMAYR BG, 1990, J INTERN MED, V228, P121, DOI 10.1111/j.1365-2796.1990.tb00204.x; Takeda M, 1997, ARCH TOXICOL, V71, P612, DOI 10.1007/s002040050434; URAKAWA N, 1994, INT J LEGAL MED, V106, P232, DOI 10.1007/BF01225411; Vickers AEM, 2004, TOXICOL PATHOL, V32, P577, DOI 10.1080/01926230490508821; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zeidler R, 2007, APOPTOSIS, V12, P1927, DOI 10.1007/s10495-007-0102-8; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zhu Y, 2014, J HYPERTENS, V32, P1042, DOI 10.1097/HJH.0000000000000151	40	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152591	10.1371/journal.pone.0152591	http://dx.doi.org/10.1371/journal.pone.0152591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028622	gold, Green Submitted, Green Published			2022-12-27	WOS:000373116500054
J	Reuten, R; Nikodemus, D; Oliveira, MB; Patel, TR; Brachvogel, B; Breloy, I; Stetefeld, J; Koch, M				Reuten, Raphael; Nikodemus, Denise; Oliveira, Maria B.; Patel, Trushar R.; Brachvogel, Bent; Breloy, Isabelle; Stetefeld, Joerg; Koch, Manuel			Maltose-Binding Protein (MBP), a Secretion-Enhancing Tag for Mammalian Protein Expression Systems	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; FUSION PROTEINS; DOMAIN; CELLS; ACID	Recombinant proteins are commonly expressed in eukaryotic expression systems to ensure the formation of disulfide bridges and proper glycosylation. Although many proteins can be expressed easily, some proteins, sub-domains, and mutant protein versions can cause problems. Here, we investigated expression levels of recombinant extracellular, intracellular as well as transmembrane proteins tethered to different polypeptides in mammalian cell lines. Strikingly, fusion of proteins to the prokaryotic maltose-binding protein (MBP) generally enhanced protein production. MBP fusion proteins consistently exhibited the most robust increase in protein production in comparison to commonly used tags, e.g., the Fc, Glutathione S-transferase (GST), SlyD, and serum albumin (ser alb) tag. Moreover, proteins tethered to MBP revealed reduced numbers of dying cells upon transient transfection. In contrast to the Fc tag, MBP is a stable monomer and does not promote protein aggregation. Therefore, the MBP tag does not induce artificial dimerization of tethered proteins and provides a beneficial fusion tag for binding as well as cell adhesion studies. Using MBP we were able to secret a disease causing laminin beta 2 mutant protein (congenital nephrotic syndrome), which is normally retained in the endoplasmic reticulum. In summary, this study establishes MBP as a versatile expression tag for protein production in eukaryotic expression systems.	[Reuten, Raphael; Nikodemus, Denise; Koch, Manuel] Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany; [Reuten, Raphael; Nikodemus, Denise; Oliveira, Maria B.; Brachvogel, Bent; Breloy, Isabelle; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Patel, Trushar R.; Stetefeld, Joerg] Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB RT3 2N2, Canada; [Patel, Trushar R.] Univ Birmingham, Sch Biosci, Edgbaston B15 2TT, Middx, England; [Brachvogel, Bent] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany; [Koch, Manuel] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal	University of Cologne; University of Cologne; University of Manitoba; University of Birmingham; University of Cologne; Universidade de Lisboa	Reuten, R; Koch, M (corresponding author), Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany.; Reuten, R; Koch, M (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany.; Koch, M (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal.	rreuten@uni-koeln.de; Manuel.Koch@uni-koeln.de	Reuten, Raphael/AAA-3235-2022; Patel, Trushar R./AAB-6250-2020; Patel, Trushar R/F-2776-2011; Koch, Manuel/AAG-9914-2021; Stetefeld, Joerg/H-7630-2017	Reuten, Raphael/0000-0002-9434-4108; Patel, Trushar R./0000-0003-0627-2923; Patel, Trushar R/0000-0003-0627-2923; Koch, Manuel/0000-0002-2962-7814; Stetefeld, Joerg/0000-0003-1478-3248; Nikodemus, Denise/0000-0003-4492-817X; Brachvogel, Bent/0000-0002-3923-0554	DFG [CRC829, DFG 2304/5-3, 2304/7-1, 2304/9-1]; KOLN FORTUNE program of the Medical Faculty; Multiple Sclerosis Society of Canada; Canadian Institute of Health Research [RPA-109759]; Canadian Institutes of Health Research Postdoctoral Fellowships; Marie Sklodowska-Curie Fellowship	DFG(German Research Foundation (DFG)); KOLN FORTUNE program of the Medical Faculty; Multiple Sclerosis Society of Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Postdoctoral Fellowships(Canadian Institutes of Health Research (CIHR)); Marie Sklodowska-Curie Fellowship	This work was supported by grants from the DFG (A2, CRC829 to M.K.; B04, CRC829, DFG 2304/5-3, 2304/7-1, 2304/9-1 to B.B.) and the KOLN FORTUNE program of the Medical Faculty. Jorg Stetefeld is partially supported by the Multiple Sclerosis Society of Canada and by the Canadian Institute of Health Research (RPA-109759). Trushar R. Patel was in receipt of Canadian Institutes of Health Research Postdoctoral Fellowships and a Marie Sklodowska-Curie Fellowship.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Baldi L, 2012, METHODS MOL BIOL, V801, P13, DOI 10.1007/978-1-61779-352-3_2; Bire S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082559; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Grandin M, 2016, CANCER CELL, V29, P173, DOI 10.1016/j.ccell.2016.01.001; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048629; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Knappe TA, 2007, J MOL BIOL, V368, P1458, DOI 10.1016/j.jmb.2007.02.097; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Korf U, 2005, PROTEOMICS, V5, P3571, DOI 10.1002/pmic.200401195; Li MC, 2006, BIOTECHNOL LETT, V28, P1141, DOI 10.1007/s10529-006-9066-y; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Lo KM, 1998, PROTEIN ENG, V11, P495, DOI 10.1093/protein/11.6.495; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; Patel TR, 2012, MATRIX BIOL, V31, P135, DOI 10.1016/j.matbio.2011.11.004; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pennati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106724; Rosenbaum S, 2011, J BIOL CHEM, V286, P5708, DOI 10.1074/jbc.M110.193086; Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Wolper SA, 2014, ANAL BIOCHEM, V447, P64, DOI 10.1016/j.ab.2013.10.031	26	31	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152386	10.1371/journal.pone.0152386	http://dx.doi.org/10.1371/journal.pone.0152386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029048	Green Published, gold, Green Submitted			2022-12-27	WOS:000373116500042
J	Boulos, PK; Dalwani, MS; Tanabe, J; Mikulich-Gilbertson, SK; Banich, MT; Crowley, TJ; Sakai, JT				Boulos, Peter K.; Dalwani, Manish S.; Tanabe, Jody; Mikulich-Gilbertson, Susan K.; Banich, Marie T.; Crowley, Thomas J.; Sakai, Joseph T.			Brain Cortical Thickness Differences in Adolescent Females with Substance Use Disorders	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ANTERIOR CINGULATE CORTEX; ENVIRONMENTAL RISK-FACTORS; HUMAN ORBITOFRONTAL CORTEX; HUMAN CEREBRAL-CORTEX; GRAY-MATTER VOLUME; CONDUCT DISORDER; ALCOHOL DEPENDENCE; SEX-DIFFERENCES; SURFACE-AREA	Some youths develop multiple substance use disorders early in adolescence and have severe, persistent courses. Such youths often exhibit impulsivity, risk-taking, and problems of inhibition. However, relatively little is known about the possible brain bases of these behavioral traits, especially among females. Methods We recruited right-handed female patients, 14-19 years of age, from a university-based treatment program for youths with substance use disorders and community controls similar for age, race and zip code of residence. We obtained 43 T1-weighted structural brain images (22 patients and 21 controls) to examine group differences in cortical thickness across the entire brain as well as six a priori regions-of-interest: 1) medial orbitofrontal cortex; 2) rostral anterior cingulate cortex; and 3) middle frontal cortex, in each hemisphere. Age and IQ were entered as nuisance factors for all analyses. Results A priori region-of-interest analyses yielded no significant differences. However, whole-brain group comparisons revealed that the left pregenual rostral anterior cingulate cortex extending into the left medial orbitofrontal region (355.84 mm(2) in size), a subset of two of our a priori regions-of-interest, was significantly thinner in patients compared to controls (vertex-level threshold p = 0.005 and cluster-level family wise error corrected threshold p = 0.05). The whole-brain group differences did not survive after adjusting for depression or externalizing scores. Whole-brain within-patient analyses demonstrated a positive association between cortical thickness in the left precuneus and behavioral disinhibition scores (458.23 mm(2) in size). Conclusions Adolescent females with substance use disorders have significant differences in brain cortical thickness in regions engaged by the default mode network and that have been associated with problems of emotional dysregulation, inhibition, and behavioral control in past studies.	[Boulos, Peter K.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Crowley, Thomas J.; Sakai, Joseph T.] Univ Colorado Denver, Div Subst Dependence, Dept Psychiat, Sch Med, Aurora, CO USA; [Tanabe, Jody] Univ Colorado Denver, Dept Radiol, Sch Med, Aurora, CO USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Sakai, JT (corresponding author), Univ Colorado Denver, Div Subst Dependence, Dept Psychiat, Sch Med, Aurora, CO USA.	joseph.sakai@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	BANICH, MARIE/0000-0001-9373-9194; Sakai, Joseph/0000-0003-1600-6100	NIDA [DA009842, DA011015, DA034604, DA031761]; Kane Family Foundation; Hewit Family Foundation;  [R25DA033219]; NATIONAL INSTITUTE ON DRUG ABUSE [P60DA011015, R37DA009842, R01DA031761, R01DA034604, R25DA033219, R01DA009842] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Kane Family Foundation; Hewit Family Foundation; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIDA grants DA009842, DA011015, DA034604 and the Kane Family Foundation. Drs. Sakai, Crowley, Tanabe, and Mikulich-Gilbertson and Mr. Dalwani are also supported by NIDA grant DA031761. Dr. Sakai's lab is also supported by the Hewit Family Foundation. Peter Boulos' effort on this project was supported under R25DA033219.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], 1991, MANUAL CHILD BEHAV C; Becker JB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-14; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Chumachenko SY, 2015, AM J DRUG ALCOHOL AB, P1; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Crowley T. J., 1995, RES MONOGRAPH SERIES, V156, P49; Crowley TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132322; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dalwani M, 2011, DRUG ALCOHOL DEPEN, V118, P295, DOI 10.1016/j.drugalcdep.2011.04.006; Dalwani MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126368; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dore V, 2013, JAMA NEUROL, V70, P903, DOI 10.1001/jamaneurol.2013.1062; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247, DOI 10.2466/pr0.1978.43.3f.1247; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fein G, 2013, PSYCHIAT RES-NEUROIM, V214, P1, DOI 10.1016/j.pscychresns.2013.06.001; Field M, 2007, ADDICTION, V102, P579, DOI 10.1111/j.1360-0443.2007.01743.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Forman SD, 2004, BIOL PSYCHIAT, V55, P531, DOI 10.1016/j.biopsych.2003.09.011; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman NP, 2011, DEV PSYCHOL, V47, P1410, DOI 10.1037/a0023750; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Hardee J, 2015, COLL PROBL DRUG DEP; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2007, J ABNORM PSYCHOL, V116, P433, DOI 10.1037/0021-843X.116.3.433; Hicks BM, 2012, DRUG ALCOHOL DEPEN, V123, pS18, DOI 10.1016/j.drugalcdep.2011.12.017; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hong SB, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-11; Hopfer C, 2013, J AM ACAD CHILD PSY, V52, P511, DOI 10.1016/j.jaac.2013.02.014; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Johnston L. D., 2012, MONITORING FUTURE NA, VI; Jung P, 2003, NEUROIMAGE, V19, P913, DOI 10.1016/S1053-8119(03)00164-2; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Koester P, 2012, NEUROSCIENCE, V221, P182, DOI 10.1016/j.neuroscience.2012.06.049; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Krueger RF, 1999, J PERS, V67, P39, DOI 10.1111/1467-6494.00047; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; McGue M, 2005, AM J PSYCHIAT, V162, P1118, DOI 10.1176/appi.ajp.162.6.1118; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Pajer Kathleen, 2008, Child Adolesc Psychiatry Ment Health, V2, P28, DOI 10.1186/1753-2000-2-28; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pardoe HR, 2013, HUM BRAIN MAPP, V34, P3000, DOI 10.1002/hbm.22120; Parsons CE, 2013, SOC NEUROSCI-UK, V8, P525, DOI 10.1080/17470919.2013.842610; Pope AW, 1999, DEV PSYCHOL, V35, P335, DOI 10.1037/0012-1649.35.2.335; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Soros P, 1999, NEUROSCI LETT, V271, P89, DOI 10.1016/S0304-3940(99)00528-5; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, DAWN REP HIGHL 2011; Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Thompson LL, 2012, DRUG ALCOHOL DEPEN, V123, P84, DOI 10.1016/j.drugalcdep.2011.10.017; Thompson LL, 2006, ASSESSMENT, V13, P3, DOI 10.1177/1073191105282247; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Thurstone C, 2013, AM J ADDICTION, V22, P558, DOI 10.1111/j.1521-0391.2013.12064.x; Tyrfingsson T, 2010, ANN NY ACAD SCI, V1187, P208, DOI 10.1111/j.1749-6632.2009.05151.x; US Department of Justice, 2011, EC IMP ILL DRUG US A; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Volkow ND, 2014, NEUROPHARMACOLOGY, V76, P235, DOI 10.1016/j.neuropharm.2013.05.007; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; YOUNG SE, 1995, DRUG ALCOHOL DEPEN, V37, P149, DOI 10.1016/0376-8716(94)01069-W; Young SE, 2000, AM J MED GENET, V96, P684, DOI 10.1002/1096-8628(20001009)96:5<684::AID-AJMG16>3.3.CO;2-7; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	118	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152983	10.1371/journal.pone.0152983	http://dx.doi.org/10.1371/journal.pone.0152983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049765	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500078
J	Nilsson, L; Larsson, A; Begum, A; Iakovleva, I; Carlsson, M; Brannstrom, K; Sauer-Eriksson, AE; Olofsson, A				Nilsson, Lina; Larsson, Andreas; Begum, Afshan; Iakovleva, Irina; Carlsson, Marcus; Brannstrom, Kristoffer; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; AMYLOIDOGENESIS; POLYNEUROPATHY; METABOLISM; GLUCURONIDATION; DENATURATION; TAFAMIDIS; DISEASE; COMPLEX; DRUGS	Amyloid formation of the plasma protein transthyretin (TTR) has been linked to familial amyloid polyneuropathy and senile systemic amyloidosis. Binding of ligands within its natural hormone binding site can stabilize the tetrameric structure and impair amyloid formation. We have recently shown that the flavonoid luteolin stabilizes TTR in human plasma with a very high selectivity. Luteolin, however, is inactivated in vivo via glucuronidation for which the preferred site is the hydroxy group at position 7 on its aromatic A-ring. We have evaluated the properties of two luteolin variants in which the 7-hydroxy group has been exchanged for a chlorine (7-Cl-Lut) or a methoxy group (7-MeO-Lut). Using an in vitro model, based on human liver microsomes, we verified that these modifications increase the persistence of the drug. Crystal structure determinations show that 7-Cl-Lut binds similarly to luteolin. The larger MeO substituent cannot be accommodated within the same space as the chlorine or hydroxy group and as a result 7-MeO-Lut binds in the opposite direction with the methoxy group in position 7 facing the solvent. Both 7-Cl-Lut and 7-MeO-Lut qualify as high-affinity binders, but in contrast to luteolin, they display a highly non-specific binding to other plasma components. The binding of the two conformations and the key-interactions to TTR are discussed in detail. Taken together, these results show a proof-of-concept that the persistence of luteolin towards enzymatic modification can be increased. We reveal two alternative high-affinity binding modes of luteolin to TTR and that modification in position 7 is restricted only to small substituents if the original orientation of luteolin should be preserved. In addition, the present work provides a general and convenient method to evaluate the efficacy of TTR-stabilizing drugs under conditions similar to an in vivo environment.	[Nilsson, Lina; Iakovleva, Irina; Brannstrom, Kristoffer; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Nilsson, Lina; Larsson, Andreas; Begum, Afshan; Carlsson, Marcus; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Larsson, Andreas] Swedish Def Res Agcy, CBRN Def & Secur, SE-90621 Umea, Sweden	Umea University; Umea University; Saab Group	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.olofsson@umu.se	Brännström, Kristoffer/AAC-1204-2020	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199; BEGUM, AFSHAN/0000-0001-5047-5168	Swedish Research Council; Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; Ahlenstiftelsen; J.C. Kempes stiftelse; Hjarnfonden; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; Ahlenstiftelsen; J.C. Kempes stiftelse; Hjarnfonden; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	This work was funded by The Swedish Research Council to AESE, AO; Parkinsonfonden to AO; Insamlingsstiftelsen vid Umea Universitet to AO; Alzheimerfonden to AO; Ahlenstiftelsen to AO; J.C. Kempes stiftelse to AO, KB; Hjarnfonden to AO, KB; Magn. Bergvalls stiftelse to KB; O.E. och Edlas stiftelse to AO; Torsten Soderbergs stiftelse to AO; Vasterbottens Lans lasting (ALF-medel) to AO; Patientforeningen FAMY/AMYL to AO; and The Medical Faculty of Umea University to AO.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Berk JL, 2012, AMYLOID, V19, P37, DOI 10.3109/13506129.2012.678509; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Boersma MG, 2002, CHEM RES TOXICOL, V15, P662, DOI 10.1021/tx0101705; Buchheit D, 2011, BIOL CHEM, V392, P1089, DOI [10.1515/BC-2011-194, 10.1515/BC.2011.194]; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Cotrina EY, 2013, J MED CHEM, V56, P9110, DOI 10.1021/jm401061w; Donato MT, 2003, CLIN PHARMACOKINET, V42, P153, DOI 10.2165/00003088-200342020-00004; Dubrey S, 2015, POSTGRAD MED J, V91, P439, DOI 10.1136/postgradmedj-2014-133224; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein M, 2002, J HYPERTENS, V20, pS17; Florio P, 2015, J BIOL CHEM; Florio P, 2015, J BIOL CHEM, V290, P29769, DOI 10.1074/jbc.M115.690172; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; Grimster NP, 2013, J AM CHEM SOC, V135, P5656, DOI 10.1021/ja311729d; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; HARRELL SA, 1964, J AM CHEM SOC, V86, P4497, DOI 10.1021/ja01074a061; HOLMGREN G, 1991, CLIN GENET, V40, P242; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Iakovleva I, 2015, J MED CHEM, V58, P6507, DOI 10.1021/acs.jmedchem.5b00544; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaivosaari S, 2011, XENOBIOTICA, V41, P652, DOI 10.3109/00498254.2011.563327; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lozeron P, 2013, EUR J NEUROL, V20, P1539, DOI 10.1111/ene.12225; Maetzler W, 2012, PLOS ONE, V7, P25; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; Mangione PP, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palaninathan SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006290; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Plante-Bordeneuve V, 2014, J NEUROL, V261, P1227, DOI 10.1007/s00415-014-7373-0; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Raghu P, 2004, BBA-PROTEINS PROTEOM, V1703, P1, DOI 10.1016/j.bbapap.2004.09.023; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Taliou A, 2013, CLIN THER, V35, P592, DOI 10.1016/j.clinthera.2013.04.006; Trelle S, 2011, BMJ, V11; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Van Vranken DL, 2004, CHEM BIOL, V11, P1604, DOI 10.1016/j.chembiol.2004.11.016; Wallace JL, 2001, BEST PRACT RES CL GA, V15, P691, DOI 10.1053/bega.2001.0229; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	56	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153112	10.1371/journal.pone.0153112	http://dx.doi.org/10.1371/journal.pone.0153112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050398	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500101
J	Park, SA; Lee, JW; Herbst, RS; Koo, JS				Park, Sin-Aye; Lee, Jong Woo; Herbst, Roy S.; Koo, Ja Seok			GSK-3 alpha Is a Novel Target of CREB and CREB-GSK-3 alpha Signaling Participates in Cell Viability in Lung Cancer	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; ACUTE MYELOID-LEUKEMIA; GENOME-WIDE ANALYSIS; PANCREATIC-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; BETA-CATENIN; GSK-3-BETA; TRANSCRIPTION	Overexpression or activation of cyclic AMP-response element-binding protein (CREB) has been known to be involved in several human malignancies, including lung cancer. Genes regulated by CREB have been reported to suppress apoptosis, induce cell proliferation, inflammation, and tumor metastasis. However, the critical target genes of CREB in lung cancer have not been well understood. Here, we identified GSK-3 alpha as one of the CREB target genes which is critical for the viability of lung cancer cells. The CREB knockdown significantly reduced the expression of GSK-3 alpha and the direct binding of CREB on the promoter of GSK3A was identified. Kaplan-Meier analysis with a public database showed a prognostic significance of aberrant GSK-3 alpha expression in lung cancer. Inhibition of GSK-3 alpha suppressed cell viability, colony formation, and tumor growth. For the first time, we demonstrated that GSK-3 alpha is regulated by CREB in lung cancer and is required for the cell viability. These findings implicate CREB-GSK-3 alpha axis as a novel therapeutic target for lung cancer treatment.	[Park, Sin-Aye; Lee, Jong Woo; Herbst, Roy S.; Koo, Ja Seok] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Koo, Ja Seok] Yale Comprehens Canc Ctr, Translat Res Program, Dev Therapeut, New Haven, CT 06520 USA	Yale University; Yale University	Koo, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Comprehens Canc Ctr, 333 Cedar St, New Haven, CT 06520 USA.; Koo, JS (corresponding author), Yale Comprehens Canc Ctr, Translat Res Program, Dev Therapeut, New Haven, CT 06520 USA.	jpeter.koo@yale.edu	Koo, J Peter/AAE-6700-2019; Park, Sin-Aye/E-2303-2019	Park, Sin-Aye/0000-0003-2456-3572	National Cancer Institute [R01-CA126801]; Cancer Center Support Grant [CA-16359]; NATIONAL CANCER INSTITUTE [R01CA126801, P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Cancer Institute grant R01-CA126801 (to Ja Seok Koo) and Cancer Center Support Grant CA-16359 (to Yale Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-40; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Banerji V, 2012, J CLIN INVEST, V122, P935, DOI 10.1172/JCI46465; Bang D, 2013, CANCER DISCOV, V3, P690, DOI 10.1158/2159-8290.CD-12-0541; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Bender RA, 2001, EUR J NEUROSCI, V13, P679, DOI 10.1046/j.1460-9568.2001.01432.x; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Crans-Vargas HN, 2002, BLOOD, V99, P2617, DOI 10.1182/blood.V99.7.2617; Darrington RS, 2012, INT J CANCER, V131, pE872, DOI 10.1002/ijc.27620; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Esfandiari F, 2012, STEM CELLS DEV, V21, P3233, DOI 10.1089/scd.2011.0678; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hansen TV, 2004, NEUROREPORT, V15, P841, DOI 10.1097/00001756-200404090-00021; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Li DS, 2006, CELL RES, V16, P609, DOI 10.1038/sj.cr.7310082; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Rix LLR, 2014, ACS CHEM BIOL, V9, P353, DOI 10.1021/cb400660a; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zeng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091231; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhang YQ, 2013, EMBO MOL MED, V5, P1322, DOI 10.1002/emmm.201302507	50	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153075	10.1371/journal.pone.0153075	http://dx.doi.org/10.1371/journal.pone.0153075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049759	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500095
J	Li, L; Mo, H; Zhang, J; Zhou, YX; Peng, XH; Luo, XP				Li, Li; Mo, Hui; Zhang, Jing; Zhou, Yongxian; Peng, Xiuhong; Luo, Xiping			The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome	PLOS ONE			English	Article							CELL LUNG-CANCER; INSULIN-RESISTANCE; SIGNALING PATHWAYS; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; DOWN-REGULATION; RAT MODEL; HSP90; INHIBITOR; APOPTOSIS	Polycystic ovary syndrome (PCOS) is a heterogenetic disorder in women that is characterized by arrested follicular growth and anovulatory infertility. The altered protein expression levels in the ovarian tissues reflect the molecular defects in folliculogenesis. To identify aberrant protein expression in PCOS, we analyzed protein expression profiles in the ovarian tissues of patients with PCOS. We identified a total of 18 protein spots that were differentially expressed in PCOS compared with healthy ovarian samples. A total of 13 proteins were upregulated and 5 proteins were downregulated. The expression levels of heat shock protein 90B1 (HSP90B1) and calcium signaling activator calmodulin 1 (CALM1) were increased by at least two-fold. The expression levels of HSP90B1 and CALM1 were positively associated with ovarian cell survival and negatively associated with caspase-3 activation and apoptosis. Knock-down of HSP90B1 with siRNA attenuated ovarian cell survival and increased apoptosis. In contrast, ovarian cell survival was improved and cell apoptosis was decreased in cells over-expressing HSP90B1. These results demonstrated the pivotal role of HSP90B1 in the proliferation and survival of ovarian cells, suggesting a critical role for HSP90B1 in the pathogenesis of PCOS. We also observed a downregulation of antiinflammatory activity-related annexin A6 (ANXA6) and tropomyosin 2 (TPM2) compared with the normal controls, which could affect cell division and folliculogenesis in PCOS. This is the first study to identify novel altered gene expression in the ovarian tissues of patients with PCOS. These findings may have significant implications for future diagnostic and treatment strategies for PCOS using molecular interventions.	[Li, Li; Zhou, Yongxian; Peng, Xiuhong; Luo, Xiping] Guangdong Women & Children Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Li, Li; Mo, Hui] Macau Univ Sci & Technol, Lab Chinese Med Qual Res, Macau, Peoples R China; [Zhang, Jing] Guangzhou Family Planning Specialty Hosp, Guangzhou, Guangdong, Peoples R China	Macau University of Science & Technology	Luo, XP (corresponding author), Guangdong Women & Children Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	luoxpdr@163.com			Science and Technology Planning Project of Guangdong Province [2014A020212237]; Guangdong Natural Science Foundation [S2013010011984]; Guangdong provincial population and family planning commission [20133071]; Guangzhou Municipal Science and Technology Innovation Council [201510010290]; Traditional Chinese Medicine Bureau of Guangdong Province [2010247]	Science and Technology Planning Project of Guangdong Province; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong provincial population and family planning commission; Guangzhou Municipal Science and Technology Innovation Council; Traditional Chinese Medicine Bureau of Guangdong Province	This study has received funding from the Science and Technology Planning Project of Guangdong Province (2014A020212237), Guangdong Natural Science Foundation (S2013010011984), Guangdong provincial population and family planning commission (20133071), Guangzhou Municipal Science and Technology Innovation Council (201510010290), and Traditional Chinese Medicine Bureau of Guangdong Province (2010247).	Ambekar AS, 2015, J CLIN ENDOCR METAB, V100, P744, DOI 10.1210/jc.2014-2086; Anas AA, 2016, J PATHOL, V238, P74, DOI 10.1002/path.4637; Assinder SJ, 2010, MOL CARCINOGEN, V49, P525, DOI 10.1002/mc.20626; Audouard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017109; Beloosesky R, 2004, INT J MOL MED, V14, P207; Block MS, 2015, CYTOKINE, V73, P108, DOI 10.1016/j.cyto.2015.01.035; Cawthorn TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030992; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chehab M, 2015, ONCOTARGET, V6, P8454, DOI 10.18632/oncotarget.3502; Coskunpinar E, 2014, ANTICANCER RES, V34, P753; Daneasa A, 2014, EXP CLIN ENDOCR DIAB, V122, P154, DOI 10.1055/s-0033-1363685; Das M, 2008, J CLIN ENDOCR METAB, V93, P881, DOI 10.1210/jc.2007-1650; Denz CR, 2004, BIOCHEM BIOPH RES CO, V320, P1291, DOI 10.1016/j.bbrc.2004.06.084; Dorfman M, 2009, BIOL REPROD, V80, P264, DOI 10.1095/biolreprod.108.070904; ERICKSON GF, 1992, HUM REPROD, V7, P293, DOI 10.1093/oxfordjournals.humrep.a137638; Ernst A, 2015, CANCER LETT, V365, P211, DOI 10.1016/j.canlet.2015.05.024; Gao M, 2015, ASIAN PAC J TROP MED, V8, P305, DOI 10.1016/S1995-7645(14)60335-7; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Gong AJ, 2015, EXP BIOL MED, V240, P639, DOI 10.1177/1535370214555664; Greiner M, 2005, ENDOCRINE, V28, P319, DOI 10.1385/ENDO:28:3:319; Gupta S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/916212; Insenser M, 2013, EXPERT REV PROTEOMIC, V10, P435, DOI 10.1586/14789450.2013.837665; Ko SK, 2015, CHEM BIOL, V22, P391, DOI 10.1016/j.chembiol.2015.02.004; Lee KH, 2015, AM J RESP CELL MOL B; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; Morrison NA, 2014, J CELL BIOCHEM, V115, P303, DOI 10.1002/jcb.24663; Nollen EAA, 2002, J CELL SCI, V115, P2809; Oksjoki S, 2004, MOL HUM REPROD, V10, P7, DOI 10.1093/molehr/gah003; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Ono N, 2013, CANCER SCI, V104, P1346, DOI 10.1111/cas.12237; Park E, 2012, J OBSTET GYNAECOL RE, V38, P396, DOI 10.1111/j.1447-0756.2011.01705.x; Park SY, 2015, PHARMAZIE, V70, P193, DOI 10.1691/ph.2015.4689; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rice JW, 2009, ONCOL RES, V18, P229, DOI 10.3727/096504009X12596189659240; Salilew-Wondim D, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0151-5; Schneider R, 2014, J BIOL RHYTHM, V29, P87, DOI 10.1177/0748730414523559; Smith DL, 2015, TARGET ONCOL, V10, P235, DOI 10.1007/s11523-014-0329-6; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sun YF, 2015, ACTA BIOCH BIOPH SIN, V47, P451, DOI 10.1093/abbs/gmv034; Suzuki M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00280; Takizawa Y, 2013, BRIT J NUTR, V110, P2150, DOI 10.1017/S0007114513001670; Tao Wenjing, 2015, Genes Cancer, V6, P19; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Tukaj S, 2015, EXP DERMATOL, V24, P567, DOI 10.1111/exd.12760; Yoon SH, 2011, J BONE MINER RES, V26, P1217, DOI 10.1002/jbmr.310; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhang Liping, 2015, Oncoscience, V2, P419	47	16	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152837	10.1371/journal.pone.0152837	http://dx.doi.org/10.1371/journal.pone.0152837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046189	Green Published, gold			2022-12-27	WOS:000373599600039
J	Kamio, T; Gu, BW; Olson, TS; Zhang, YP; Mason, PJ; Bessler, M				Kamio, Takuya; Gu, Bai-wei; Olson, Timothy S.; Zhang, Yanping; Mason, Philip J.; Bessler, Monica			Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; HEMATOPOIETIC-CELLS; S19 DEFICIENCY; P53 ACTIVATION; IN-VITRO; EXPANSION; PATHWAY; GROWTH; L11; PHENOTYPE	MDM2, an E3 ubiquitin ligase, is an important negative regulator of tumor suppressor p53. In turn the Mdm2 gene is a transcriptional target of p53, forming a negative feedback loop that is important in cell cycle control. It has recently become apparent that the ubiquitination of p53 by MDM2 can be inhibited when certain ribosomal proteins, including RPL5 and RPL11, bind to MDM2. This inhibition, and the resulting increase in p53 levels has been proposed to be responsible for the red cell aplasia seen in Diamond-Blackfan anemia (DBA) and in 5q-myelodysplastic syndrome (MDS). DBA and 5q-MDS are associated with inherited (DBA) or acquired (5q-MDS) haploinsufficiency of ribosomal proteins. A mutation in Mdm2 causing a C305F amino acid substitution blocks the binding of ribosomal proteins. Mice harboring this mutation (Mdm2(C305F)), retain a normal p53 response to DNA damage, but lack the p53 response to perturbations in ribosome biogenesis. While studying the interaction between RP haploinsufficiency and the Mdm2(C305F) mutation we noticed that Mdm2(C305F) homozygous mice had altered hematopoiesis. These mice developed a mild macrocytic anemia with reticulocytosis. In the bone marrow (BM), these mice showed a significant decrease in Ter119(hi) cells compared to wild type (WT) littermates, while no decrease in the number of mature erythroid cells (Ter119(hi)CD71(low)) was found in the spleen, which showed compensated bone marrow hematopoiesis. In methylcellulose cultures, BFU-E colonies from the mutant mice were slightly reduced in number and there was a significant reduction in CFU-E colony numbers in mutant mice compared with WT controls (p < 0.01). This erythropoietic defect was abrogated by concomitant p53 deficiency (Trp53(ko/ko)). Further investigation revealed that in Mdm2C305F animals, there was a decrease in Lin(-)Sca-1(+)c-Kit(+) (LSK) cells, accompanied by significant decreases in multipotent progenitor (MPP) cells (p < 0.01). Competitive BM repopulation experiments showed that donor BM harboring the Mdm2(C305F) mutation possessed decreased repopulation capacity compared to WT BM, suggesting a functional stem cell deficit. These results suggest that there is a fine tuned balance in the interaction of ribosomal proteins with the MDM2/p53 axis which is important in normal hematopoiesis.	[Kamio, Takuya; Gu, Bai-wei; Olson, Timothy S.; Mason, Philip J.; Bessler, Monica] Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA 19104 USA; [Olson, Timothy S.; Bessler, Monica] Childrens Hosp Philadelphia, Comprehens Bone Marrow Failure Ctr, Philadelphia, PA 19104 USA; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kamio, T (corresponding author), Childrens Hosp Philadelphia, Dept Hematol, Philadelphia, PA 19104 USA.	kamiotak@gmail.com			Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan [NIH/NHLBI K08 HL 122306]; NIH [R01-CA105312]; NATIONAL CANCER INSTITUTE [R01CA105312] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL122306] Funding Source: NIH RePORTER	Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Grant of Pediatric Oncology Research Fellowship from Children's Cancer Association of Japan to TK, NIH/NHLBI K08 HL 122306 to TSO, and NIH R01-CA105312 to MB.	Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; CHINYEE I, 1991, CLIN LAB HAEMATOL, V13, P177; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Dey A, 2010, SEMIN CANCER BIOL, V20, P3, DOI 10.1016/j.semcancer.2010.02.004; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Farrar JE, 2011, BLOOD, V118, P6943, DOI 10.1182/blood-2011-08-375170; GLADER BE, 1983, NEW ENGL J MED, V309, P1486, DOI 10.1056/NEJM198312153092404; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Jaako P, 2015, LEUKEMIA, V29, P2221, DOI 10.1038/leu.2015.128; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Jin SK, 2001, J CELL SCI, V114, P4139; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; McGowan KA, 2011, BLOOD, V118, P3622, DOI 10.1182/blood-2010-11-318584; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; OKADA S, 1992, BLOOD, V80, P3044; Olney HJ, 2001, BEST PRACT RES CL HA, V14, P479, DOI 10.1053/beha.2001.0151; Olson TS, 2013, BLOOD, V121, P5238, DOI 10.1182/blood-2012-10-463414; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152263	10.1371/journal.pone.0152263	http://dx.doi.org/10.1371/journal.pone.0152263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27042854	Green Submitted, gold, Green Published			2022-12-27	WOS:000373592100013
J	Niu, L; Qiu, YY; Luo, D; Chen, X; Wang, M; Pakenham, KI; Zhang, XX; Huang, ZL; Xiao, SY				Niu, Lu; Qiu, Yangyang; Luo, Dan; Chen, Xi; Wang, Min; Pakenham, Kenneth I.; Zhang, Xixing; Huang, Zhulin; Xiao, Shuiyuan			Cross-Culture Validation of the HIV/AIDS Stress Scale: The Development of a Revised Chinese Version	PLOS ONE			English	Article							PERCEIVED STRESS; SOCIAL SUPPORT; LIFE EVENTS; HIV; INDIVIDUALS; DISTRESS; TRAUMA; WOMEN	Background Being HIV-infected is a stressful experience for many individuals. To assess HIV-related stress in the Chinese context, ameasure with satisfied psychometric properties is yet underdeveloped. This study aimed to examine the psychometric characteristics of a simplified Chinese version of the HIV/AIDS Stress Scale (SS-HIV) among people living with HIV/AIDS in central China. Method A total of 667 people living with HIV (92% were male) were recruited from March 1st 2014 to August 31th 2015 by consecutive sampling. A standard questionnaire package containing the Chinese HIV/AIDS Stress Scale (CSS-HIV), the Chinese Patient Health Questionnaire 9 (PHQ-9), and the Chinese Generalized Anxiety Disorder Scale (GAD-7) were administered to all participants, and 38 of the participants were selected randomly to be re-tested in four weeks after the initial testing. Results Our data supported that a revised 17-item CSS-HIV had adequate psychometric properties. It consisted of 3 factors: emotional stress (6 items), social stress (6 items) and instrumental stress (5 items). The overall Cronbach's a was 0.906, and the test-retest reliability coefficient was 0.832. The revised CSS-HIV was significantly correlated with the number of HIV-related symptoms, as well as scores on the PHQ-9 and GAD-7, indicating acceptable concurrent validity. Conclusion The 17-item Chinese version of the SS-HIV has potential research and clinical utility in identifying important stressors among the Chinese HIV-infected population and in understanding the effects of stress on adjustment to HIV.	[Niu, Lu; Qiu, Yangyang; Luo, Dan; Xiao, Shuiyuan] Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wang, Min] First Hosp Changsha, Changsha, Hunan, Peoples R China; [Pakenham, Kenneth I.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Zhang, Xixing; Huang, Zhulin] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China	Central South University; University of Queensland	Luo, D (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	luodan_csu_2011@126.com	Pakenham, Kenneth/A-9973-2008	Pakenham, Kenneth/0000-0002-8653-4593	National Natural Science Foundation of China [81202290]; Hunan Academy of Social Science [13WTB22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Academy of Social Science	This study was funded by the National Natural Science Foundation of China (81202290), and the Hunan Academy of Social Science (13WTB22), which are both received by DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHINA NEWS      1201; Bian C., 2009, J TONGJI U, V132, P136; Byrnes DM, 1998, PSYCHOSOM MED, V60, P714, DOI 10.1097/00006842-199811000-00009; Chinese Center for Disease Control and Prevention, 2015, 2014 NAT REP NOT INF; Chinese Center for Disease Control and Prevention, 2013, 2012 NAT REP NOT INF; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crystal S, 1998, SOC WORK HEALTH CARE, V28, P41, DOI 10.1300/J010v28n01_03; Eller LS, 2003, J NURS SCHOLARSHIP, V35, P53, DOI 10.1111/j.1547-5069.2003.00053.x; Gao LL, 2008, THESIS SUN YS U; He XY., 2010, SHANGHAI ARCH PSYCHI, V22, P200, DOI DOI 10.3969/J.ISSN.1002-0829.2010.04.002; Ho AHY, 2015, COMPR PSYCHIAT, V56, P198, DOI 10.1016/j.comppsych.2014.09.016; Hou J., 2004, STRUCTURAL EQUATION; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Kelly BC, 2009, AIDS BEHAV, V13, P792, DOI 10.1007/s10461-009-9586-2; KESSLER RC, 1991, AM J PSYCHIAT, V148, P733; Koopman C, 2000, AIDS CARE, V12, P663, DOI 10.1080/095401200750003833; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee EH, 2015, SCAND J CARING SCI, V29, P183, DOI 10.1111/scs.12131; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; LIN XY, 2004, CHINESE J APPL PSYCH, V10, P49; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Marshall MM, 2011, ADDICT BEHAV, V36, P61, DOI 10.1016/j.addbeh.2010.08.022; McNaught A, 2000, SOC SCI MED, V51, P65, DOI 10.1016/S0277-9536(99)00433-5; Meade CS, 2010, AIDS BEHAV, V14, P328, DOI 10.1007/s10461-008-9494-x; Myers HF, 2009, J BEHAV HEALTH SER R, V36, P233, DOI 10.1007/s11414-008-9134-2; National Health and Family Planning Commission of China, 2014, 2014 CHIN AIDS RESP; Ndlovu U, 2010, ARCH WOMEN MENT HLTH, V13, P215, DOI 10.1007/s00737-010-0148-4; NOTT KH, 1995, AIDS CARE, V7, P55, DOI 10.1080/09540129550126966; Pakenham KI, 2002, PSYCHOL HEALTH, V17, P203, DOI 10.1080/08870440290013680; Pakenham KI, 1996, SOC SCI MED, V42, P245, DOI 10.1016/0277-9536(95)00099-2; Pakenham KI, 2011, OXFORD HDB STRESS HL, P242; Pakenharn KI, 2007, REHABIL PSYCHOL, V52, P380, DOI 10.1037/0090-5550.52.4.380; Qiu Yangyang, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P835, DOI 10.3969/j.issn.1672-7347.2014.08.014; Qiu YY, 2015, THESIS CENTRAL S U; Qu W., 2005, CHINA J AIDS STD, V2, P91; Reif S, 2011, AIDS CARE, V23, P152, DOI 10.1080/09540121.2010.498872; Roberts JE, 2001, PERS INDIV DIFFER, V30, P241, DOI 10.1016/S0191-8869(00)00042-8; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Su XY, 2013, AIDS CARE, V25, P239, DOI 10.1080/09540121.2012.701713; Su XY, 2008, AIDS PATIENT CARE ST, V22, P989, DOI 10.1089/apc.2008.0095; The former Ministry of Health of the Republic of China, 2012, 2012 CHIN AIDS RESP; Thompson SC, 1996, AIDS CARE, V8, P5, DOI 10.1080/09540129650125957; Tseng W-S, 2003, CLIN GUIDE CULTURAL; Wu Y., 2007, CHINESE J DIS CONTRO, V4, P342; Wu YL, 2015, INT J STD AIDS, V26, P496, DOI 10.1177/0956462414544722; Yi ZY, 2014, RED NET         1201; Zhang YB, 2010, MED STAT	48	23	27	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152990	10.1371/journal.pone.0152990	http://dx.doi.org/10.1371/journal.pone.0152990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043134	Green Submitted, gold, Green Published			2022-12-27	WOS:000373592100059
J	Tabak, NM; Laba, M; Spector, S				Tabak, Nava M.; Laba, Magdeline; Spector, Sacha			Simulating the Effects of Sea Level Rise on the Resilience and Migration of Tidal Wetlands along the Hudson River	PLOS ONE			English	Article							FRESH-WATER MARSH; NEW-YORK; COASTAL WETLANDS; ESTUARY; VEGETATION; SEDIMENT; IMPACTS; BAY; OPPORTUNITIES; ACCRETION	Sea Level Rise (SLR) caused by climate change is impacting coastal wetlands around the globe. Due to their distinctive biophysical characteristics and unique plant communities, freshwater tidal wetlands are expected to exhibit a different response to SLR as compared with the better studied salt marshes. In this study we employed the Sea Level Affecting Marshes Model (SLAMM), which simulates regional- or local-scale changes in tidal wetland habitats in response to SLR, and adapted it for application in a freshwater-dominated tidal river system, the Hudson River Estuary. Using regionally-specific estimated ranges of SLR and accretion rates, we produced simulations for a spectrum of possible future wetland distributions and quantified the projected wetland resilience, migration or loss in the HRE through the end of the 21(st) century. Projections of total wetland extent and migration were more strongly determined by the rate of SLR than the rate of accretion. Surprisingly, an increase in net tidal wetland area was projected under all scenarios, with newly-formed tidal wetlands expected to comprise at least 33% of the HRE's wetland area by year 2100. Model simulations with high rates of SLR and/or low rates of accretion resulted in broad shifts in wetland composition with widespread conversion of high marsh habitat to low marsh, tidal flat or permanent inundation. Wetland expansion and resilience were not equally distributed through the estuary, with just three of 48 primary wetland areas encompassing >50% of projected new wetland by the year 2100. Our results open an avenue for improving predictive models of the response of freshwater tidal wetlands to sea level rise, and broadly inform the planning of conservation measures of this critical resource in the Hudson River Estuary.	[Tabak, Nava M.; Spector, Sacha] Scenic Hudson Inc, Dept Conservat Sci, Poughkeepsie, NY USA; [Laba, Magdeline] Cornell Univ, Sch Integrat Plant Sci, Sect Soil & Crop Sci, Ithaca, NY USA	Cornell University	Tabak, NM (corresponding author), Scenic Hudson Inc, Dept Conservat Sci, Poughkeepsie, NY USA.	ntabak@scenichudson.org			Wildlife Conservation Society Climate Adaptation Fund	Wildlife Conservation Society Climate Adaptation Fund	An early iteration of this research was supported by a grant from the Wildlife Conservation Society Climate Adaptation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank our partners in the study, conservation and restoration of the Hudson's tidal wetlands, which include staff at the NYS Department of Environmental Conservation's Hudson River Estuary Program, the Hudson River National Estuarine Research Reserve (HRNERR), the Cary Institute of Ecosystem Studies (CIES), The Nature Conservancy, and Hudsonia Ltd.; in particular Stuart Findlay (CIES) and Sarah Fernald (HRNERR) who assisted us in parameterizing the accretion models. Jonathan Clough, Marco Propato, and Amy Polaczyk of Warren Pinnacle Consulting, Inc. generously shared their expertise and time to assist us in adapting SLAMMto our study area and using accretion models. Jason Winner and James Mudd provided technical GIS support for model inputs and uncertainty analyses, respectively. We are also grateful to the academic editor and three anonymous peer reviewers who provided extremely valuable comments to improve this manuscript. An early iteration of this research was supported by a grant from the Wildlife Conservation Society Climate Adaptation Fund.	Arrigoni A, 2008, ECOSYSTEMS, V11, P790, DOI 10.1007/s10021-008-9161-0; Baldwin, 2009, TIDAL FRESHWATER WET, P71; Baldwin A. H., 2009, TIDAL FRESHWATER WET, P1; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Benoit G, 1999, ESTUARIES, V22, P167, DOI 10.2307/1352974; Biging G., 2012, IMPACTS PREDICTED SE; BOKUNIEWICZ H, 2006, HUDSON RIVER ESTUARY, P39; Cadol D, 2014, LIMNOL OCEANOGR, V59, P1065, DOI 10.4319/lo.2014.59.3.1065; Chu ML, 2014, ENVIRON MODELL SOFTW, V52, P111, DOI 10.1016/j.envsoft.2013.10.020; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Clough J., 2015, APPL SLAMM COASTAL C; Clough J, 2014, APPL SEA LEVEL AFFEC; Clough J.S., 2012, SLAMM 6 2 TECHNICAL; Cornell Institute for Resource Information Sciences, 2011, HUDS RIV EST TID WET; Craft C, 2009, FRONT ECOL ENVIRON, V7, P127, DOI 10.1890/09.WB.006; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Craft CB, 2012, GLOBAL CHANGE BIOL, V18, P3615, DOI 10.1111/gcb.12009; de Vries M.P., 2001, SALT FRONT MOVEMENT; Edinger G.J., 2002, ECOLOGICAL IN PRESS; ESRI Inc, 2013, ARCGIS DESKT; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Georgas N, 2013, HUDSON RIVER ESTUARY; Geselbracht L, 2011, CLIMATIC CHANGE, V107, P35, DOI [10.1007/s10584-011-0084-y, 10.1007/s10584-011-0084-v]; Geyer W.R., 2006, HUDSON RIVER ESTUARY, P24, DOI DOI 10.1017/CBO9780511550539.005; Glick P, 2013, J COASTAL RES, P211, DOI [10.2112/S163-017.1, 10.2112/SI63-0017.1]; Gornitz V, 2001, GLOBAL PLANET CHANGE, V32, P61, DOI 10.1016/S0921-8181(01)00150-3; Hartig EK, 2002, WETLANDS, V22, P71, DOI 10.1672/0277-5212(2002)022[0071:AACCIO]2.0.CO;2; Hassan R, 2005, ECOSYSTEMS HUMAN WEL, V1; Horton R, 2015, KNOWLEDGE BASE CLIMA, V1336, P36, DOI DOI 10.1111/NYAS.12593; Horton R, 2014, CLIMATE CHANGE NEW Y; Houghton J. T., 2001, CLIMATE CHANGE 2001; KEARNEY MS, 1988, GEOGR REV, V78, P205, DOI 10.2307/214178; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kiviat Erik, 2006, P279, DOI 10.1017/CBO9780511550539.022; Laba M, 2008, REMOTE SENS ENV; Leck M.A., 2009, TIDAL FRESHWATER WET, P145; Levinton J. S., 2005, HUDSON RIVER ESTUARY, P1; Li SS, 2015, OCEAN COAST MANAGE, V109, P1, DOI 10.1016/j.ocecoaman.2015.02.006; McIvor, 1984, ECOLOGY TIDAL FRESHW; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Miller D, 2006, AM FISH S S, V51, P29; Mitchell SB, 2015, ESTUAR COAST SHELF S, V156, P1, DOI 10.1016/j.ecss.2014.12.027; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; National Oceanic and Atmospheric Administration, TID CURR WAT LEV; Neubauer S.C., 2007, TIDAL FRESHWATER WET, P253; Neubauer SC, 2008, ESTUAR COAST SHELF S, V78, P78, DOI 10.1016/j.ecss.2007.11.011; Neubauer SC, 2013, ESTUAR COAST, V36, P491, DOI 10.1007/s12237-011-9455-x; New York Sea Level Rise Task Force, 2010, NEW YORK STAT SEA LE; New York State Department of State, 2012, SIGN COAST FISH WILD; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; ODUM WE, 1995, ESTUARIES, V18, P547, DOI 10.2307/1352375; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Park R.A., 1993, GEOCARTO INT, V8, P99, DOI DOI 10.1080/10106049309354433; Pederson DC, 2005, QUATERNARY RES, V63, P238, DOI 10.1016/j.yqres.2005.01.001; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Penhollow M.E., 2006, HUDSON RIVER ESTUARY; Perry JE, 1999, WETLANDS, V19, P90, DOI 10.1007/BF03161737; Photo Science Inc, 2012, COAST NEW YORK LIDAR; Robideau RM, 1997, SEDIMENTATION RATES; Rogers K, 2014, ESTUAR COAST, V37, P67, DOI 10.1007/s12237-013-9664-6; Rosenzweig C, 2011, ANN NY ACAD SCI, V1244; Scenic Hudson Inc, 2014, HRE SLAMM SLOP; Scenic Hudson Inc, 2014, HRE SLAMM 2007 DEM; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Sritrairat S, 2012, ESTUAR COAST SHELF S, V102, P24, DOI 10.1016/j.ecss.2012.03.003; Stevenson KA, 1985, POLGAR FELLOWSHIP RE; Strayer DL, 2012, HUDSON PRIMER: THE ECOLOGY OF AN ICONIC RIVER, P1; Tiner R.W., 2013, TIDAL WETLANDS PRIME; Tol R.S.J., 2009, ENCY OCEAN SCI, P197; Traill LW, 2011, DIVERS DISTRIB, V17, P1225, DOI 10.1111/j.1472-4642.2011.00807.x; Wall GR, 2008, ESTUAR COAST, V31, P542, DOI 10.1007/s12237-008-9050-y; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504	74	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152437	10.1371/journal.pone.0152437	http://dx.doi.org/10.1371/journal.pone.0152437			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043136	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100015
J	Chatio, S; Baiden, F; Achana, FS; Oduro, A; Akazili, J				Chatio, Samuel; Baiden, Frank; Achana, Fabian Sebastian; Oduro, Abraham; Akazili, James			Knowledge and Perceptions about Clinical Trials and the Use of Biomedical Samples: Findings from a Qualitative Study in Rural Northern Ghana	PLOS ONE			English	Article							PARTICIPATION; HEALTH; COMMUNITIES; ATTITUDES	Introduction Clinical trials conducted in sub-Saharan Africa have helped to address the prevalent health challenges. The knowledge about how communities perceive clinical trials is however only now evolving. This study was conducted among parents whose children participated in past clinical trials in northern Ghana to assess their knowledge and perceptions of clinical trials and the use of biomedical samples. Method This was a qualitative study based on eighty in-depth interviews with parents. The participants were randomly selected from among parents whose children were enrolled in a clinical trial conducted in the Kassena-Nankana districts between 2000 and 2003. The interviews were transcribed and coded into emergent themes using Nvivo 9 software. The thematic analysis framework was used to analyze the data. Results Study participants reported that clinical trials were carried out to determine the efficacy of drugs and to make sure that these drugs were suitable for human beings to use. The conduct of clinical trials was perceived to have helped to reduce the occurrence of diseases such as malaria, cerebrospinal meningitis and diarrhea. Quality of care was reported to be better in clinical trials than in the routine care. Parents indicated that participation in clinical trials positively influenced their health-seeking behavior. Apprehensions about blood draw and the use to which samples were put were expressed, with suspicion by a few participants that researchers sold blood samples. The issue of blood draw was most contentious. Conclusion Parents perception about the conduct of clinical trials in the study districts is generally positive. However, misconceptions made about the use of blood samples in this studymust be taken seriously and strategies found to improve transparency and greater community acceptability.	[Chatio, Samuel; Achana, Fabian Sebastian; Oduro, Abraham; Akazili, James] Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana; [Baiden, Frank] Ensign Coll Publ Hlth, Kpong, ER, Ghana	Navrongo Health Research Center	Chatio, S (corresponding author), Navrongo Hlth Res Ctr, POB 114, Navrongo, Ghana.	schatio@yahoo.co.uk	Baiden, Frank/Q-2018-2019; Baiden, Frank/AAF-7309-2020	Baiden, Frank/0000-0003-0141-6561; ODURO, ABRAHAM/0000-0002-4191-7419; Chatio, Samuel Tamti/0000-0001-9998-748X	European Developing Countries Clinical Trials Partnership [JCMS 2010_10300]	European Developing Countries Clinical Trials Partnership	European Developing Countries Clinical Trials Partnership. Grant number/Identifier: JCMS 2010_10300. The funders had no role in the study design, data collection, data analysis, decision to publish and preparation of the manuscript.	[Anonymous], GLOBAL HLTH; Baiden F, 2006, TROP MED INT HEALTH, V11, P532, DOI 10.1111/j.1365-3156.2006.01582.x; Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477; Binka FN, 2007, TROP MED INT HEALTH, V12, P578, DOI 10.1111/j.1365-3156.2007.01826.x; Boahen O, 2013, T R SOC TROP MED HYG; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Crowe S, 2015, BIOMED CENTRAL; Featherstone K, 2002, SOC SCI MED, V55, P709, DOI 10.1016/S0277-9536(01)00197-6; Goldberg-Freeman Clara, 2007, Prog Community Health Partnersh, V1, P231, DOI 10.1353/cpr.2007.0021; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Guest G., 2006, MANY INTERVIEWS ARE, DOI 10.1177/1525822x05279903; Moreira Edson Duarte Jr, 2006, J Pediatr Adolesc Gynecol, V19, P81, DOI 10.1016/j.jpag.2006.01.003; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newton S, 2009, T ROY SOC TROP MED H, V103, P497, DOI 10.1016/j.trstmh.2008.11.030; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Odutola AB, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.1.e5; QSR International, 1999, NVIVO QUAL DAT AN SO; Roberts TG, 2004, JAMA, V292; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Tinto H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-113; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2007, EV BUS STRENGTH HLTH	24	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152854	10.1371/journal.pone.0152854	http://dx.doi.org/10.1371/journal.pone.0152854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035916	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200046
J	Gloersen, O; Federolf, P				Gloersen, Oyvind; Federolf, Peter			Predicting Missing Marker Trajectories in Human Motion Data Using Marker Intercorrelations	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; SOFT-TISSUE ARTIFACT; CLINICAL GAIT; STEREOPHOTOGRAMMETRY	Missing information in motion capture data caused by occlusion or detachment of markers is a common problem that is difficult to avoid entirely. The aim of this study was to develop and test an algorithm for reconstruction of corrupted marker trajectories in datasets representing human gait. The reconstruction was facilitated using information of marker inter-correlations obtained from a principal component analysis, combined with a novel weighting procedure. The method was completely data-driven, and did not require any training data. We tested the algorithm on datasets with movement patterns that can be considered both well suited (healthy subject walking on a treadmill) and less suited (transitioning from walking to running and the gait of a subject with cerebral palsy) to reconstruct. Specifically, we created 50 copies of each dataset, and corrupted them with gaps in multiple markers at random temporal and spatial positions. Reconstruction errors, quantified by the average Euclidian distance between predicted and measured marker positions, was <= 3 mm for the well suited dataset, even when there were gaps in up to 70% of all time frames. For the less suited datasets, median reconstruction errors were in the range 5-6 mm. However, a few reconstructions had substantially larger errors (up to 29 mm). Our results suggest that the proposed algorithm is a viable alternative both to conventional gap-filling algorithms and state-of-the-art reconstruction algorithms developed for motion capture systems. The strengths of the proposed algorithm are that it can fill gaps anywhere in the dataset, and that the gaps can be considerably longer than when using conventional interpolation techniques. Limitations are that it does not enforce musculoskeletal constraints, and that the reconstruction accuracy declines if applied to datasets with less predictable movement patterns.	[Gloersen, Oyvind; Federolf, Peter] Univ Oslo, Dept Phys, Oslo, Norway; [Gloersen, Oyvind; Federolf, Peter] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Federolf, Peter] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Federolf, Peter] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria	University of Oslo; Norwegian School of Sport Sciences; Norwegian University of Science & Technology (NTNU); University of Innsbruck	Gloersen, O (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.; Gloersen, O (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	o.n.gloersen@fys.uio.no	Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813				Begon M, 2008, J BIOMECH, V41, P581, DOI 10.1016/j.jbiomech.2007.10.005; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Federolf P, 2014, J BIOMECH, V47, P1555, DOI 10.1016/j.jbiomech.2014.02.013; Federolf PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078689; Feng YF, 2014, INFORM SCIENCES, V277, P777, DOI 10.1016/j.ins.2014.03.013; Herda L, 2001, HUM MOVEMENT SCI, V20, P313, DOI 10.1016/S0167-9457(01)00050-1; Howarth SJ, 2010, COMPUT METHOD BIOMEC, V13, P847, DOI 10.1080/10255841003664701; Junhui H, 2014, 2014 IEEE INT C MULT; Li L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P507; Liu GD, 2006, VISUAL COMPUT, V22, P721, DOI 10.1007/s00371-006-0080-9; Liu X, 2014, SIGNAL PROCESS, V105, P350, DOI 10.1016/j.sigpro.2014.06.009; Maurer C, 2012, GAIT POSTURE, V36, P40, DOI 10.1016/j.gaitpost.2011.12.023; Richards JG, 1999, HUM MOVEMENT SCI, V18, P589, DOI 10.1016/S0167-9457(99)00023-8; Stagni R, 2005, CLIN BIOMECH, V20, P320, DOI 10.1016/j.clinbiomech.2004.11.012; Tan CH, 2015, VISUAL COMPUT, V31, P1521, DOI 10.1007/s00371-014-1031-5; Xiao J, 2011, COMPUT ANIMAT VIRT W, V22, P221, DOI 10.1002/cav.413	18	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152616	10.1371/journal.pone.0152616	http://dx.doi.org/10.1371/journal.pone.0152616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031243	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800104
J	Hu, SD; Luebberstedt, T; Zhao, GW; Lee, M				Hu, Shuaidong; Luebberstedt, Thomas; Zhao, Guangwu; Lee, Michael			QTL Mapping of Low-Temperature Germination Ability in the Maize IBM Syn4 RIL Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; ZEA-MAYS L.; COLD STRESS; RICE; GERMINABILITY; TOLERANCE; IDENTIFICATION; SELECTION; SEEDLINGS	Low temperature is the primary factor to affect maize sowing in early spring. It is, therefore, vital for maize breeding programs to improve tolerance to low temperatures at seed germination stage. However, little is known about maize QTL involved in low-temperature germination ability. 243 lines of the intermated B73xMo17 (IBM) Syn4 recombinant inbred line (RIL) population was used for QTL analysis of low-temperature germination ability. There were significant differences in germination-related traits under both conditions of low temperature (12 degrees C/16h, 18 degrees C/8h) and optimum temperature (28 degrees C/24h) between the parental lines. Only three QTL were identified for controlling optimum-temperature germination rate. Six QTL controlling low-temperature germination rate were detected on chromosome 4, 5, 6, 7 and 9, and contribution rate of single QTL explained between 3.39%similar to 11.29%. In addition, six QTL controlling low-temperature primary root length were detected in chromosome 4, 5, 6, and 9, and the contribution rate of single QTL explained between 3.96%similar to 8.41%. Four pairs of QTL were located at the same chromosome position and together controlled germination rate and primary root length under low temperature condition. The nearest markers apart from the corresponding QTL (only 0.01 cM) were umc1303 (265.1 cM) on chromosome 4, umc1 (246.4 cM) on chromosome 5, umc62 (459.1 cM) on chromosome 6, bnl14.28a (477.4 cM) on chromosome 9, respectively. A total of 3155 candidate genes were extracted from nine separate intervals based on the Maize Genetics and Genomics Database (http://www.maizegdb.org). Five candidate genes were selected for analysis as candidates putatively affecting seed germination and seedling growth at low temperature. The results provided a basis for further fine mapping, molecular marker assisted breeding and functional study of cold-tolerance at the stage of seed germination in maize.	[Hu, Shuaidong; Zhao, Guangwu] Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Linan 311300, Zhejiang, Peoples R China; [Luebberstedt, Thomas; Lee, Michael] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Zhejiang A&F University; Iowa State University	Zhao, GW (corresponding author), Zhejiang Agr & Forestry Univ, Coll Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Linan 311300, Zhejiang, Peoples R China.	gwuzhao@126.com		Lubberstedt, Thomas/0000-0002-0526-0798	Zhejiang Natural Science Foundation [LY13C130011]; National Natural Science Foundation of China [31371712]; Special Fund for Agro-scientific Research in the Public Interest of China [201303002]; Crop Germplasm Resources Protection Project of Zhejiang [2015004]; Key Project for Breeding of Agricultural New Variety of Zhejiang [2012C12902]; USDA's National Institute of Food and Agriculture [IOW04314, IOW01018]; RF Baker Center for Plant Breeding	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Crop Germplasm Resources Protection Project of Zhejiang; Key Project for Breeding of Agricultural New Variety of Zhejiang; USDA's National Institute of Food and Agriculture; RF Baker Center for Plant Breeding	This research was supported by Zhejiang Natural Science Foundation (LY13C130011), National Natural Science Foundation of China (31371712), Special Fund for Agro-scientific Research in the Public Interest of China (201303002), Crop Germplasm Resources Protection Project of Zhejiang (2015004), the Key Project for Breeding of Agricultural New Variety of Zhejiang (2012C12902). The authors would also like to thank USDA's National Institute of Food and Agriculture (project numbers: IOW04314, IOW01018), as well as the RF Baker Center for Plant Breeding and K. J. Frey Chair in Agronomy at Iowa State University for funding this work.	Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Basten C, 2005, QTL CARTOGRAPHER VER; CHURCHILL GA, 1994, GENETICS, V138, P963; Dong YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143181; Frascaroli E, 2013, THEOR APPL GENET, V126, P733, DOI 10.1007/s00122-012-2014-4; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Hund A, 2004, THEOR APPL GENET, V109, P618, DOI 10.1007/s00122-004-1665-1; Hyun DY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0298-1; Iwata N, 2010, GENOME, V53, P763, DOI [10.1139/G10-060, 10.1139/g10-060]; Ji SL, 2009, PLANT BREEDING, V128, P387, DOI 10.1111/j.1439-0523.2008.01533.x; Jiang L, 2006, FIELD CROP RES, V98, P68, DOI 10.1016/j.fcr.2005.12.015; Jompuk C, 2005, J EXP BOT, V56, P1153, DOI 10.1093/jxb/eri108; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Miura K, 2001, BREEDING SCI, V51, P293, DOI 10.1270/jsbbs.51.293; NYQUIST WE, 1991, CRIT REV PLANT SCI, V10, P235, DOI 10.1080/07352689109382313; Prigge MJ, 2001, PLANT CELL, V13, P1263, DOI 10.1105/tpc.13.6.1263; Rodriguez VM, 2008, INT J PLANT SCI, V169, P551, DOI 10.1086/528755; Rodriguez V, 2014, MOL BREEDING, V33, P363, DOI 10.1007/s11032-013-9955-4; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Teng S, 2001, CHINESE SCI BULL, V46, P1800, DOI 10.1007/BF02900554; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang WB, 2012, CAN J PLANT SCI, V92, P1381, DOI 10.4141/CJPS2011-098	24	33	39	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152795	10.1371/journal.pone.0152795	http://dx.doi.org/10.1371/journal.pone.0152795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031623	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800137
J	Yang, X; Jiang, L; Jia, YG; Hu, Y; Xu, Q; Xu, X; Huang, H				Yang, Xin; Jiang, Ling; Jia, Yigang; Hu, Yi; Xu, Qing; Xu, Xian; Huang, He			Counteraction of Trehalose on N,N-Dimethylformamide-Induced Candida rugosa Lipase Denaturation: Spectroscopic Insight and Molecular Dynamic Simulation	PLOS ONE			English	Article							INDUCED PROTEIN DENATURATION; BIODIESEL PRODUCTION; INTERNAL-FRICTION; STABILITY; BIOCATALYSIS; ACCUMULATION; SOLVENTS; WATER; PH	Candida rugosa lipase (CRL) has been widely used as a biocatalyst for non-aqueous synthesis in biotechnological applications, which, however, often suffers significant loss of activity in organic solvent. Experimental results show that trehalose could actively counteract the organic-solvent-induced protein denaturation, while the molecular mechanisms still don't unclear. Herein, CRL was used as a model enzyme to explore the effects of trehalose on the retention of enzymatic activity upon incubation in N,N-dimethylformamide (DMF). Results showed that both catalytic activity and conformation changes of CRL influenced by DMF solvent were inhibited by trehalose in a dose-dependent fashion. The simulations further indicated that the CRL protein unfolded in binary DMF solution, but retained the native state in the ternary DMF/trehalose system. Trehalose as the second osmolyte added into binary DMF solution decreased DMF-CRL hydrogen bonds efficiently, whereas increased the intermolecular hydrogen bondings between DMF and trehalose. Thus, the origin of its denaturing effects of DMF on protein is thought to be due to the preferential exclusion of trehalose as well as the intermolecular hydrogen bondings between trehalose and DMF. These findings suggest that trehalose protect the CRL protein from DMF-induced unfolding via both indirect and direct interactions.	[Yang, Xin; Hu, Yi; Xu, Qing; Xu, Xian] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China; [Jiang, Ling; Jia, Yigang] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China; [Huang, He] Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Jiang, L (corresponding author), Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China.; Huang, H (corresponding author), Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China.	jinagling@njtech.edu.cn; biotech@njtech.edu.cn			National Science Foundation; National Basic Research Program of China; National High Technology Research and Development Program of China; Natural Science Foundation of Jiangsu Province; Six Talent Peaks Project in Jiangsu Province	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Six Talent Peaks Project in Jiangsu Province	The authors are grateful for the support of the National Science Foundation, National Basic Research Program of China, the National High Technology Research and Development Program of China, the Natural Science Foundation of Jiangsu Province, and the Six Talent Peaks Project in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2011, INT J BIOL MACROMOL, V49, P652, DOI 10.1016/j.ijbiomac.2011.06.025; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Borgia A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2204; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Colombo G, 2002, J BIOTECHNOL, V96, P23, DOI 10.1016/S0168-1656(02)00034-2; De Los Rios P, 2012, NAT CHEM BIOL, V8, P226, DOI 10.1038/nchembio.791; DePaz RA, 2002, ENZYME MICROB TECH, V31, P765, DOI 10.1016/S0141-0229(02)00173-4; Eisenmenger MJ, 2009, ENZYME MICROB TECH, V45, P331, DOI 10.1016/j.enzmictec.2009.08.001; Gangadhara, 2009, J AM OIL CHEM SOC, V86, P773, DOI 10.1007/s11746-009-1408-1; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; GROCHULSKI P, 1994, BIOCHEMISTRY-US, V33, P3494, DOI 10.1021/bi00178a005; Haque I, 2006, BIOPHYS CHEM, V119, P224, DOI 10.1016/j.bpc.2005.09.016; He F, 2011, PHARM RES-DORDR, V28, P1552, DOI 10.1007/s11095-011-0388-7; Hu Y, 2013, CHINESE J CATAL, V34, P1608, DOI 10.1016/S1872-2067(12)60628-7; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jia R, 2013, ACS CATAL, V3, P1976, DOI 10.1021/cs400404f; Jiang L, 2015, GREEN CHEM, V17, P250, DOI 10.1039/c4gc01256a; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Korman TP, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-70; Lei Y, 2003, J PHYS CHEM A, V107, P1574, DOI 10.1021/jp026638+; Lerbret A, 2007, J PHYS CHEM B, V111, P9410, DOI 10.1021/jp071946z; Li XJ, 2015, IND ENG CHEM RES, V54, P8072, DOI 10.1021/acs.iecr.5b01881; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; Lousa D, 2013, PHYS CHEM CHEM PHYS, V15, P13723, DOI 10.1039/c3cp51761f; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pace C N, 1986, Methods Enzymol, V131, P266; Paul S, 2015, J PHYS CHEM B, V119, P10975, DOI 10.1021/acs.jpcb.5b01457; Pazhang M, 2006, J BIOTECHNOL, V127, P45, DOI 10.1016/j.jbiotec.2006.05.017; Reetz MT, 2010, CHEM COMMUN, V46, P8657, DOI 10.1039/c0cc02657c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Secundo F, 2004, BIOTECHNOL BIOENG, V86, P236, DOI 10.1002/bit.20034; Shu ZY, 2010, J MOL CATAL B-ENZYM, V62, P1, DOI 10.1016/j.molcatb.2009.09.003; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Stergiou PY, 2013, BIOTECHNOL ADV, V31, P1846, DOI 10.1016/j.biotechadv.2013.08.006; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Villeneuve P, 2000, J MOL CATAL B-ENZYM, V9, P113, DOI 10.1016/S1381-1177(99)00107-1; Wang PM, 2014, BIORESOURCE TECHNOL, V152, P371, DOI 10.1016/j.biortech.2013.11.033; Wensley BG, 2012, P NATL ACAD SCI USA, V109, P17795, DOI 10.1073/pnas.1201793109; Yang J, 2013, BIOCHEM ENG J, V70, P46, DOI 10.1016/j.bej.2012.09.016; Yang X, 2015, BIORESOURCES BIOPROC, V2, P1; Zhang N, 2014, BIOCHEM ENG J, V91, P231, DOI 10.1016/j.bej.2014.08.019; Zhang N, 2012, J PHYS CHEM B, V116, P7040, DOI 10.1021/jp300171h	46	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152275	10.1371/journal.pone.0152275	http://dx.doi.org/10.1371/journal.pone.0152275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031946	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800049
J	Martinez, O; Wu, E; Levine, EC; Munoz-Laboy, M; Fernandez, MI; Bass, SB; Moya, EM; Frasca, T; Chavez-Baray, S; Icard, LD; Ovejero, H; Carballo-Dieguez, A; Rhodes, SD				Martinez, Omar; Wu, Elwin; Levine, Ethan C.; Munoz-Laboy, Miguel; Fernandez, M. Isabel; Bass, Sarah Bauerle; Moya, Eva M.; Frasca, Timothy; Chavez-Baray, Silvia; Icard, Larry D.; Ovejero, Hugo; Carballo-Dieguez, Alex; Rhodes, Scott D.			Integration of Social, Cultural, and Biomedical Strategies into an Existing Couple-Based Behavioral HIV/STI Prevention Intervention: Voices of Latino Male Couples	PLOS ONE			English	Article							CLUB-DRUG-USE; NEW-YORK-CITY; HIV-PREVENTION; UNITED-STATES; QUALITATIVE DESCRIPTION; COMBINATION PREVENTION; AFRICAN-AMERICAN; SEXUAL HEALTH; HISPANIC MEN; RISK	Introduction Successful HIV prevention and treatment requires evidence-based approaches that combine biomedical strategies with behavioral interventions that are socially and culturally appropriate for the population or community being prioritized. Although there has been a push for a combination approach, how best to integrate different strategies into existing behavioral HIV prevention interventions remains unclear. The need to develop effective combination approaches is of particular importance for men who have sex with men (MSM), who face a disproportionately high risk of HIV acquisition. Materials and Methods We collaborated with Latino male couples and providers to adapt Connect 'n Unite, an evidence-based intervention for Black male couples, for Latino male couples. We conducted a series of three focus groups, each with two cohorts of couples, and one focus group with providers. A purposive stratified sample of 20 couples (N = 40, divided into two cohorts) and 10 providers provided insights into how to adapt and integrate social, cultural, and biomedical approaches in a couples-based HIV/AIDS behavioral intervention. Results The majority (N = 37) of the couple participants had no prior knowledge of the following new biomedical strategies: non-occupational post-exposure prophylaxis (nPEP); pre-exposure prophylaxis (PrEP); and HIV self-testing kits. After they were introduced to these biomedical interventions, all participants expressed a need for information and empowerment through knowledge and awareness of these interventions. In particular, participants suggested that we provide PrEP and HIV self-testing kits by the middle or end of the intervention. Providers suggested a need to address behavioral, social and structural issues, such as language barriers; and the promotion of client-centered approaches to increase access to, adaptation of, and adherence to biomedical strategies. Corroborating what couple participants suggested, providers agreed that biomedical strategies should be offered after providing information about these tools. Regarding culturally sensitive and responsive approaches, participants identified stigma and discrimination associated with HIV and sexual identity as barriers to care, language barriers and documentation status as further barriers to care, the couple-based approach as ideal to health promotion, and the need to include family topics in the intervention. Discussion We successfully adapted an evidence-based behavioral HIV prevention intervention for Latino male couples. The adapted intervention, called Conectando Latinos en Pareja, integrates social, cultural, behavioral and biomedical strategies to address the HIV epidemic among Latino MSM. The study highlights the promise regarding the feasibility of implementing a combination approach to HIV prevention in this population.	[Martinez, Omar; Munoz-Laboy, Miguel; Icard, Larry D.] Temple Univ, Coll Publ Hlth, Sch Social Work, Philadelphia, PA 19122 USA; [Wu, Elwin] Columbia Univ, Sch Social Work, New York, NY USA; [Levine, Ethan C.] Temple Univ, Coll Liberal Arts, Philadelphia, PA 19122 USA; [Fernandez, M. Isabel] Nova SE Univ, Coll Osteopath Med, Ft Lauderdale, FL 33314 USA; [Bass, Sarah Bauerle] Temple Univ, Sch Publ Hlth, Philadelphia, PA 19122 USA; [Moya, Eva M.] Univ Texas El Paso, Sch Social Work, El Paso, TX 79968 USA; [Frasca, Timothy; Carballo-Dieguez, Alex] Columbia Univ, HIV Ctr Clin & Behav Studies, New York, NY USA; [Ovejero, Hugo] Lutheran Family Hlth Ctr, New York, NY USA; [Rhodes, Scott D.] Wake Forest Univ, Med Ctr, Winston Salem, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nova Southeastern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas El Paso; Columbia University; Wake Forest University	Martinez, O (corresponding author), Temple Univ, Coll Publ Hlth, Sch Social Work, Philadelphia, PA 19122 USA.	omar.martinez@temple.edu		Chavez-Baray, Silvia M./0000-0002-6301-1378; Levine, Ethan/0000-0002-9872-2989; Bass, Sarah/0000-0003-2742-1609	center grant from the National Institute of Mental Health [P30-MH43520]; National Institute of Mental Health [T32 MH19139]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520, T32MH019139] Funding Source: NIH RePORTER	center grant from the National Institute of Mental Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University (P30-MH43520; Principal Investigator: Robert H. Remien, Ph.D.). Mr. Omar Martinez was supported by a training grant from the National Institute of Mental Health (T32 MH19139, Behavioral Sciences Research in HIV Infection; Principal Investigator: Theo Sandfort, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH.	Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Avila RM, 2013, MATERN CHILD HLTH J, V17, P415, DOI 10.1007/s10995-012-0988-9; Ayala G, 1999, SOCIAL OPPRESSION RE; Ayala GX, AM J MENS H IN PRESS; Bekker L-G, 2012, COLD SPRING HARBOR P; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Carrier Joseph, 1995, OTROS INTIMACY HOMOS; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1145; Centers for Disease Control Prevention, 2013, HIV HISP LAT, P2013; Chan R, 2012, ANN ACAD MED SINGAP, V41, P595; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Deiss RG, 2008, SEX TRANSM DIS, V35, P243, DOI 10.1097/OLQ.0b013e31815abab5; Deschamps M, 1991, HETEROSEXUAL ACTIVIT; Diaz RafaelM., 1999, CULTURE HLTH SEXUALI, V1, DOI [10.1080/136910599301021, DOI 10.1080/136910599301021]; Diaz RM, 1999, HISPANIC J BEHAV SCI, V21, P480, DOI 10.1177/0739986399214007; Dûíaz RM., 1998, LATINO GAY MEN HIV C; Fallon SJ, 2012, AIDS BEHAV, V16, P1739, DOI 10.1007/s10461-012-0258-2; Fernandez MI, 2005, SUBST USE MISUSE, V40, P1347, DOI 10.1081/JA-200066904; Fernandez MI, 2005, J URBAN HEALTH, V82, pI79, DOI 10.1093/jurban/jti027; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenwood GL, 2002, AM J PUBLIC HEALTH, V92, P1964, DOI 10.2105/AJPH.92.12.1964; Grossman CI, 2013, AM PSYCHOL, V68, P237, DOI 10.1037/a0032711; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hoebbel C, 2003, EFFECT BEHAV COUPLES; Hosek SG, 2013, J HIV-AIDS SOC SERV, V12, P333, DOI 10.1080/15381501.2013.773575; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Jarama SL, 2005, AIDS BEHAV, V9, P513, DOI 10.1007/s10461-005-9022-1; Johnson WD, 2002, J ACQ IMMUN DEF SYND, V30, pS118, DOI 10.1097/01.QAI.0000018918.84759.19; King HL, 2014, AIDS BEHAV, V18, P1722, DOI 10.1007/s10461-014-0845-5; Krueger RA, 1988, FOCUS GROUPS A PRACT; Krueger RA., 2000, FOCUS GROUPS A PRACT; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Martinez O, 2014, 9TH INTERNATIONAL CO; Martinez O, 2014, AIDS BEHAV; Martinez O, HLTH ED MON IN PRESS; Martinez O, 2015, AMERICAN JOURNAL OF; Martinez O, 2014, AIDS RES HUM RETROV, V30, pA136, DOI 10.1089/aid.2014.5272b.abstract; Martinez O, 2014, J MED INTERNET RES, V16, P168, DOI 10.2196/jmir.3311; Martinez O, 2014, AIDS EDUC PREV, V26, P68, DOI 10.1521/aeap.2014.26.1.68; Martinez O, 2012, J BISEXUALITY, V12, P283, DOI 10.1080/15299716.2012.674865; Martinez O, 2011, CULT HEALTH SEX, V13, P1073, DOI 10.1080/13691058.2011.600461; Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284; Mustanski B, 2014, AIDS BEHAV; New York State, 2014, GOVERNOR CUOMO ANNOU; North Carolina Department of Health and Human Services, 2004, RAC ETHN DIFF HLTH N, P1; Ramirez-Valles J, 2002, HEALTH EDUC RES, V17, P389, DOI 10.1093/her/17.4.389; Ramirez-Valles J., 2005, AIDS BEHAV, V27, P1; Rausch DM, 2013, JAIDS-J ACQ IMM DEF, V63, pS6, DOI 10.1097/QAI.0b013e318292153b; Rhodes SD, 2006, AIDS CARE, V18, P1018, DOI 10.1080/09540120600568731; Rhodes SD, 2006, AIDS EDUC PREV, V18, P375, DOI 10.1521/aeap.2006.18.5.375; Rhodes SD, 2013, HEALTH PROMOT PRACT, V14, P607, DOI 10.1177/1524839912462391; Rhodes SD, 2009, CULT HEALTH SEX, V11, P17, DOI 10.1080/13691050802488405; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Royster MO, 2006, MEN MASC, V8, P389, DOI 10.1177/1097184X04268798; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sandfort TGM, 2007, J SEX RES, V44, P181, DOI 10.1080/00224490701263819; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS30, DOI 10.1097/01.QAI.0000018886.51315.A9; Sharma A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-109; Shedlin MG, 2005, J NATL MED ASSOC, V97, p32S; Shoptaw S, 2008, AIDS CARE, V20, P376, DOI 10.1080/09540120701660353; Snowden LR, 2013, AM J PUBLIC HEALTH, V103, P1628, DOI 10.2105/AJPH.2013.301238; Spinner CD, 2015, INFECTION; Stallworth JM, 2009, AIDS EDUC PREV, V21, P152, DOI 10.1521/aeap.2009.21.5_supp.152; Stappenbeck CA, 2004, WOMENS INDIRECT RISK; Stockman JK, 2004, HIV PREVENTION FATIG, P432; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tjaden P, 1999, Violence Vict, V14, P413; Trost J. E., 1986, QUAL SOCIOL, V9, P54, DOI [10.1007/BF00988249, DOI 10.1007/BF00988249, 10.1007/bf00988249]; Tung WC, 2012, HOME HLTH CARE MAN P, V24, P153, DOI 10.1177/1084822311435544; Waldner-Haugrud L K, 1997, Violence Vict, V12, P173; WATERMAN CK, 1989, J SEX RES, V26, P118, DOI 10.1080/00224498909551495; Wolitski RJ, 2005, J GAY LESBIAN MENT H, V9, P9, DOI 10.1300/J236v09n03_02; Wu E, 2011, AIDS BEHAV, V15, P1745, DOI 10.1007/s10461-011-9997-8; Wu Elwin, 2010, Open AIDS J, V4, P123, DOI 10.2174/1874613601004030123	77	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152361	10.1371/journal.pone.0152361	http://dx.doi.org/10.1371/journal.pone.0152361			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9LB	27028873	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500040
J	Salamekh, S; Rong, Y; Ayan, AS; Mo, XK; Williams, TM; Mayr, NA; Grecula, JC; Chakravarti, A; Xu-Welliver, M				Salamekh, Samer; Rong, Yi; Ayan, Ahmet S.; Mo, Xiaokui; Williams, Terence M.; Mayr, Nina A.; Grecula, John C.; Chakravarti, Arnab; Xu-Welliver, Meng			Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables	PLOS ONE			English	Article							CONE-BEAM CT; TARGET VOLUMES; RADIOTHERAPY SBRT; CANCER; REGRESSION; POSITION	Purpose Analyze inter-fraction volumetric changes of lung tumors treated with stereotactic body radiation therapy (SBRT) and determine if the volume changes during treatment can be predicted and thus considered in treatment planning. Methods and Materials Kilo-voltage cone-beam CT (kV-CBCT) images obtained immediately prior to each fraction were used to monitor inter-fraction volumetric changes of 15 consecutive patients (18 lung nodules) treated with lung SBRT at our institution (45-54 Gy in 3-5 fractions) in the year of 2011-2012. Spearman's (rho) correlation and Spearman's partial correlation analysis was performed with respect to patient/tumor and treatment characteristics. Multiple hypothesis correction was performed using False Discovery Rate (FDR) and q-values were reported. Results All tumors studied experienced volume change during treatment. Tumor increased in volume by an average of 15% and regressed by an average of 11%. The overall volume increase during treatment is contained within the planning target volume (PTV) for all tumors. Larger tumors increased in volume more than smaller tumors during treatment (q = 0.0029). The volume increase on CBCT was correlated to the treatment planning gross target volume (GTV) as well as internal target volumes (ITV) (q = 0.0085 and q = 0.0039 respectively) and could be predicted for tumors with a GTV less than 22 mL. The volume increase was correlated to the integral dose (ID) in the ITV at every fraction (q = 0.0049). The peak inter-fraction volume occurred at an earlier fraction in younger patients (q = 0.0122). Conclusions We introduced a new analysis method to follow inter-fraction tumor volume changes and determined that the observed changes during lung SBRT treatment are correlated to the initial tumor volume, integral dose (ID), and patient age. Furthermore, the volume increase during treatment of tumors less than 22mL can be predicted during treatment planning. The volume increase remained significantly less than the overall PTV expansion, and radiation re-planning was therefore not required for the purpose of tumor control. The presence of the studied correlations suggests that the observed volumetric changes may reflect some underlying biologic process rather than random fluctuations.	[Salamekh, Samer; Ayan, Ahmet S.; Williams, Terence M.; Grecula, John C.; Chakravarti, Arnab; Xu-Welliver, Meng] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA; [Rong, Yi] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Mayr, Nina A.] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA	University System of Ohio; Ohio State University; University of California System; University of California Davis; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle	Xu-Welliver, M (corresponding author), Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA.	meng.welliver@osumc.edu		Salamekh, Samer/0000-0002-2315-0277	Ohio State University Comprehensive Cancer Center; NIH/NCI [1U10CA180850-01, 1R01CA188500-01]; Ohio State University College of Medicine Fellowship; NATIONAL CANCER INSTITUTE [P30CA016058, U10CA180850, R01CA188500] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University College of Medicine Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: The Ohio State University Comprehensive Cancer Center (to AC); NIH/NCI 1U10CA180850-01 and 1R01CA188500-01 (to AC); and The Ohio State University College of Medicine Fellowship (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt AD, 2015, AM J CLIN ONCOL-CANC, V38, P41, DOI 10.1097/COC.0b013e318287bd7f; Brinkman KL, 2012, J RADIOL ONCOL, V1, P311, DOI 10.1007/s13566-012-0023-1; Britton KR, 2007, INT J RADIAT ONCOL, V68, P1036, DOI 10.1016/j.ijrobp.2007.01.021; Gomez DR, 2011, J ONCOL, V2011, DOI 10.1155/2011/898391; Gunter T, 2014, J MED IMAG RADIAT ON, V58, P384, DOI 10.1111/1754-9485.12168; Haasbeek CJA, 2007, INT J RADIAT ONCOL, V67, P1370, DOI 10.1016/j.ijrobp.2006.11.018; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1024, DOI 10.1016/j.ijrobp.2005.04.046; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Matsugi K, 2009, INT J RADIAT ONCOL, V75, P543, DOI 10.1016/j.ijrobp.2008.12.091; Morin O, 2006, MED DOSIM, V31, P51, DOI 10.1016/j.meddos.2005.12.009; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Onozato Y, 2014, INT J RADIAT ONCOL, V89, P416, DOI 10.1016/j.ijrobp.2014.02.007; Rong Y, 2007, MED PHYS, V34, P2334, DOI 10.1118/1.2760362; Rong Y, 2010, MED DOSIM, V35, P195, DOI 10.1016/j.meddos.2009.06.001; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Tatekawa K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-8; Underberg RWM, 2006, INT J RADIAT ONCOL, V64, P1221, DOI 10.1016/j.ijrobp.2005.09.045; Yi BSK, 2011, TECHNOL CANCER RES T, V10, P495, DOI 10.7785/tcrt.2012.500226	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153245	10.1371/journal.pone.0153245	http://dx.doi.org/10.1371/journal.pone.0153245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049962	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500114
J	Shi, CY; He, J; Yu, J; Yu, B; Mao, XB; Zheng, P; Huang, ZQ; Chen, DW				Shi, Changyou; He, Jun; Yu, Jie; Yu, Bing; Mao, Xiangbing; Zheng, Ping; Huang, Zhiqing; Chen, Daiwen			Physicochemical Properties Analysis and Secretome of Aspergillus niger in Fermented Rapeseed Meal	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; NUTRITIONAL QUALITY; PHYTIC ACID; DIGESTIBILITY; HYDROLYSIS; PURIFICATION; PERFORMANCE; REDUCTION; CELLULOSE; PROTEINS	The nutrient digestibility and feeding value of rapeseed meal (RSM) for non-ruminant animals is poor due to the presence of anti-nutritional substances such as glucosinolate, phytic acid, crude fiber etc. In the present study, a solid state fermentation (SSF) using Aspergillus niger was carried out with the purpose of improving the nutritional quality of RSM. The chemical composition and physicochemical properties of RSM before and after fermentation were compared. To further understand possible mechanism of solid state fermentation, the composition of extracellular enzymes secreted by Aspergillus niger during fermentation was analysed using two-dimentional difference gel electrophoresis (2D-DIGE) combined with matrix assisted laser desorption ionization-time of flight-mass spectrometer (MALDI-TOF-MS). Results of the present study indicated that SSF had significant effects on chemical composition of RSM. The fermented rapeseed meal (FRSM) contained more crude protein (CP) and amino acid (AA) (except His) than unfermented RSM. Notably, the small peptide in FRSM was 2.26 time larger than that in unfermented RSM. Concentrations of anti-nutritional substrates in FRSM including neutral detergent fiber (NDF), glucosinolates, isothiocyanate, oxazolidithione, and phytic acid declined (P < 0.05) by 13.47, 43.07, 55.64, 44.68 and 86.09%, respectively, compared with unfermented RSM. A. niger fermentation disrupted the surface structure, changed macromolecular organic compounds, and reduced the protein molecular weights of RSM substrate. Total proteins of raw RSM and FRSM were separated and 51 protein spots were selected for mass spectrometry according to 2D-DIGE map. In identified proteins, there were 15 extracellular hydrolases secreted by A. niger including glucoamylase, acid protease, beta-glucanase, arabinofuranosidase, xylanase, and phytase. Some antioxidant related enzymes also were identified. These findings suggested that A. niger is able to secrete many extracellular degradation enzymes (especially lignocellulosic hydrolyzing enzymes, acid proteases and phytase) during fermentation of RSM, thus altering chemical composition and physicochemical properties of RSM.	[Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China; Sichuan Agr Univ, Anim Dis Resistance Nutr Key Lab Sichuan Prov, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China.	dwchen@sicau.edu.cn			Modern Agro-industry Technology Research System of China [CARS-36]; Science and Technology Support Program of Sichuan Province of China [2010GZ0193, 2012NZ0001, 2013NC0056]	Modern Agro-industry Technology Research System of China; Science and Technology Support Program of Sichuan Province of China	Modern Agro-industry Technology Research System of China (CARS-36), the role of this funder is the study design, data collection and analysis. Science and Technology Support Program of Sichuan Province of China (Grant no. 2010GZ0193, 2012NZ0001 and 2013NC0056), the role of this funder is decision to publish and preparation of the manuscript.	Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Association of Official Analytical Chemists, 2007, OFFICIAL METHODS ANA; BAU HM, 1994, J SCI FOOD AGR, V65, P315, DOI 10.1002/jsfa.2740650309; Berot S, 2005, J CHROMATOGR B, V818, P35, DOI 10.1016/j.jchromb.2004.08.001; Chen CC, 2010, ASIAN AUSTRAL J ANIM, V23, P598, DOI 10.5713/ajas.2010.90341; Chiang G, 2010, ASIAN AUSTRAL J ANIM, V23, P263; Choi MMF, 2004, ANAL CHIM ACTA, V516, P155, DOI 10.1016/j.aca.2004.04.010; El-Batal AI, 2001, FOOD RES INT, V34, P715, DOI 10.1016/S0963-9969(01)00093-X; ELLIS R, 1977, ANAL BIOCHEM, V77, P536, DOI 10.1016/0003-2697(77)90269-X; Faurobert M, 1997, ELECTROPHORESIS, V18, P170, DOI 10.1002/elps.1150180130; Guggenbuhl P, 2007, LIVEST SCI, V109, P261, DOI 10.1016/j.livsci.2007.01.110; Hishikawa Y, 2005, BIOMACROMOLECULES, V6, P2468, DOI 10.1021/bm050032k; HOLST DO, 1973, J ASSOC OFF ANA CHEM, V56, P1352; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Hsiao NW, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2014.02.002; Khajali F, 2012, POULTRY SCI, V91, P2564, DOI 10.3382/ps.2012-02332; Khalaf M. A., 2008, International Journal of Agriculture and Biology, V10, P185; Kiran EU, 2012, ENZYME MICROB TECH, V50, P337, DOI 10.1016/j.enzmictec.2012.03.004; LI XM, 1989, CARLSBERG RES COMMUN, V54, P241; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; Mahajan A, 1998, INT J FOOD SCI NUTR, V49, P435, DOI 10.3109/09637489809086422; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Noda I., 2004, 2 DIMENSIONAL CORREL; Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027; Oso AO, 2015, ANIM FEED SCI TECH, V210, P281, DOI 10.1016/j.anifeedsci.2015.09.015; Ovissipour M, 2009, FOOD CHEM, V115, P238, DOI 10.1016/j.foodchem.2008.12.013; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Rakariyatham N, 2002, BIODEGRADATION, V13, P395, DOI 10.1023/A:1022851129684; Rozan P, 1996, INT J FOOD SCI TECH, V31, P85, DOI 10.1111/j.1365-2621.1996.17-315.x; Rutherfurd SM, 2010, J AOAC INT, V93, P1515; SEGUEILHA L, 1992, J FERMENT BIOENG, V74, P7, DOI 10.1016/0922-338X(92)90259-W; Shi C, 2015, J ANIM SCI, V93, P2916, DOI 10.2527/jas.2014-8326; Shi CY, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0015-2; SMITS JP, 1994, J FERMENT BIOENG, V77, P579, DOI 10.1016/0922-338X(94)90135-X; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Vig AP, 2001, BIORESOURCE TECHNOL, V78, P309, DOI 10.1016/S0960-8524(01)00030-X; Wang LP, 2012, BIORESOURCE TECHNOL, V105, P88, DOI 10.1016/j.biortech.2011.11.064; Wang XS, 2012, ANN MICROBIOL, V62, P1013, DOI 10.1007/s13213-011-0341-3; WATHELET JP, 1988, FRESEN Z ANAL CHEM, V332, P689, DOI 10.1007/BF00472670; Xu FZ, 2011, ASIAN AUSTRAL J ANIM, V24, P678, DOI 10.5713/ajas.2011.10458; Zhang B, 2012, INT J FOOD MICROBIOL, V155, P113, DOI 10.1016/j.ijfoodmicro.2012.01.014	42	70	75	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153230	10.1371/journal.pone.0153230	http://dx.doi.org/10.1371/journal.pone.0153230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049858	gold, Green Submitted, Green Published			2022-12-27	WOS:000373603500113
J	Sloan, CE; Luskin, MR; Boccuti, AM; Sehgal, AR; Zhao, JH; Daber, RD; Morrissette, JJD; Luger, SM; Bagg, A; Gimotty, PA; Carroll, M				Sloan, Caroline E.; Luskin, Marlise R.; Boccuti, Anne M.; Sehgal, Alison R.; Zhao, Jianhua; Daber, Robert D.; Morrissette, Jennifer J. D.; Luger, Selina M.; Bagg, Adam; Gimotty, Phyllis A.; Carroll, Martin			A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							STUDY-GROUP ULM; AML STUDY-GROUP; PROGNOSTIC-SIGNIFICANCE; NORMAL CYTOGENETICS; EUROPEAN LEUKEMIANET; MUTATIONS; ADULTS; ASXL1; TRIAL; MLL	Background Although cytogenetics-based prognostication systems are well described in acute myeloid leukemia (AML), overall survival (OS) remains highly variable within risk groups. An integrated genetic prognostic (IGP) model using cytogenetics plus mutations in nine genes was recently proposed for patients <= 60 years to improve classification. This model has not been validated in clinical practice. Methods and Findings We retrospectively studied 197 patients with newly diagnosed de novo AML. We compared OS curves among the mutational profiles defined by the IGP model. The IGP model assigned patients with intermediate cytogenetics as having favorable, intermediate or unfavorable mutational profiles. The IGP model reassigned 50 of 137 patients with intermediate cytogenetics to favorable or unfavorable mutational profiles. Median OS was 2.8 years among 14 patients with intermediate cytogenetics and favorable mutational profiles (mutant NPM1 and mutant IDH1 or IDH2) and 1.3 years among patients with intermediate mutational profiles. Among patients with intermediate cytogenetics labeled as having unfavorable mutational profiles, median OS was 0.8 years among 24 patients with FLT3-ITD positive AML and high-risk genetic changes (trisomy 8, TET2 and/or DNMT3A) and 1.7 years among 12 patients with FLT3-ITD negative AML and high-risk mutations (TET2, ASXL1 and/or PHF6). OS for patients with intermediate cytogenetics and favorable mutational profiles was similar to OS for patients with favorable cytogenetics (p = 0.697) and different from patients with intermediate cytogenetics and intermediate mutational profiles (p = 0.028). OS among patients with FLT3-ITD positive AML and high-risk genetic changes was similar to patients with unfavorable cytogenetics (p = 0.793) and different from patients with intermediate IGP profile (p = 0.022). Patients with FLT3-ITD negative AML and high-risk mutations, defined as 'unfavorable' in the IGP model, had OS similar to patients with intermediate IGP profile (p = 0.919). Conclusions The IGP model was not completely validated in our cohort. However, mutations in six out of the nine genes can be used to characterize survival (NPMI, IDH1, IDH2, FLT3-ITD, TET2, DNMT3A) and allow for more robust prognostication in the patients who are re-categorized by the IGP model. These mutations should be incorporated into clinical testing for younger patients outside of clinical trials, in order to guide therapy.	[Sloan, Caroline E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sloan, Caroline E.; Zhao, Jianhua; Daber, Robert D.; Morrissette, Jennifer J. D.; Bagg, Adam] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Luskin, Marlise R.; Luger, Selina M.; Carroll, Martin] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boccuti, Anne M.; Gimotty, Phyllis A.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sehgal, Alison R.] Univ Pittsburgh, Sch Med, Div Hematol & Oncol, Pittsburgh, PA USA; [Carroll, Martin] Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carroll, M (corresponding author), Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Carroll, M (corresponding author), Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA.	carroll2@mail.med.upenn.edu	Bagg, Adam/R-8450-2019; Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Sloan, Caroline/0000-0003-1611-3846; Luskin, Marlise/0000-0002-5781-4529	NCI [R21CA185365]; Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016520, R21CA185365] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI grant R21CA185365 and by the Hematologic Malignancies Translational Center of Excellence of the Abramson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab, 2012, HEMATOLOGY, DOI [10.1179/102453312X13336169155411, DOI 10.1179/102453312X13336169155411]; Caligiuri MA, 1998, CANCER RES, V58, P55; Chou WC, 2011, BLOOD, V118, P3803, DOI 10.1182/blood-2011-02-339747; Damm F, 2011, J CLIN ONCOL, V29, P682, DOI 10.1200/JCO.2010.31.1118; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gaidzik VI, 2012, J CLIN ONCOL, V30, P1350, DOI 10.1200/JCO.2011.39.2886; Green CL, 2010, J CLIN ONCOL, V28, P2739, DOI 10.1200/JCO.2009.26.2501; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Luskin MR, 2014, COMMUNICATION; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Metzeler KH, 2011, BLOOD, V118, P6920, DOI 10.1182/blood-2011-08-368225; Metzeler KH, 2011, J CLIN ONCOL, V29, P1373, DOI 10.1200/JCO.2010.32.7742; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pratcorona M, 2012, HAEMATOL-HEMATOL J, V97, P388, DOI 10.3324/haematol.2011.051532; Rollig C, 2015, J CLIN ONCOL, V33, P403, DOI 10.1200/JCO.2013.54.4973; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2013, LEUKEMIA, V27, P82, DOI 10.1038/leu.2012.262; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Steven H, 2008, WHO CLASSIFICATION T; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247	29	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153016	10.1371/journal.pone.0153016	http://dx.doi.org/10.1371/journal.pone.0153016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050425	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000373603500085
J	Wang, NL; Li, LT; Wu, BB; Gong, JY; Abuduxikuer, K; Li, G; Wang, JS				Wang, Neng-Li; Li, Li-Ting; Wu, Bing-Bing; Gong, Jing-Yu; Abuduxikuer, Kuerbanjiang; Li, Gang; Wang, Jian-She			The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; GAMMA-GLUTAMYL-TRANSFERASE; CHINESE CHILDREN; CYTOMEGALOVIRUS-INFECTION; NEONATAL HEPATITIS; GENE-MUTATIONS; DISORDERS; FIC1; INFANTS; DISEASE	Background and Aims Genetic defects in ATP8B1 or ABCB11 account for the majority of cholestasis with low GGT. But the ranges for GGT in patients with ATP8B1 or ABCB11 deficiency are unclear. This study tried to unravel the features of GGT in these patients that improve diagnostic efficiency. Methods This study enrolled 207 patients with chronic cholestasis who were ordered to test for ATP8B1 and/or ABCB11 from January 2012 to December 2015. Additional 17 patients with ATPB81 or ABCB11 deficiency diagnosed between January 2004 and December 2011 were also enrolled in this study. 600 population-matched children served as controls. Clinical data were obtained by retrospectively reviewing medical records. Results A total of 26 patients were diagnosed with ATP8B1 deficiency and 30 patients were diagnosed with ABCB11 deficiency. GGT levels were similar between the two disorders at any observed month of age, but varied with age. The peak GGT value was <70U/L in the 2nd similar to 6th month of life, <60U/L in the 7th similar to 12th month and <50U/L beyond one year. GGT levels in patients with a genetic diagnosis were different from that in patients without a genetic diagnosis and controls. Larger ranges for GGT were found in patients without a genetic diagnosis. Some controls had GGT >= 70U/L in the 2nd similar to 6th month. Of the 207 patients, 39 (18.8%) obtained a genetic diagnosis. 111 patients met the ranges described above, including all the 39 patients with ATP8B1 or ABCB11 deficiency. The sensitivity was 100.0%. The rate of a positive molecular diagnosis increased to 35.1% (39/111 vs. 39/207, chi(2) = 10.363, P = 0.001). The remaining 96 patients exceeded the ranges described above and failed to receive a genetic diagnosis. These patients accounted for 43.8% of sequencing cost. Conclusions GGT levels in patients with ATP8B1 or ABCB11 deficiency varied with age. The peak GGT value was <70U/L in the 2nd similar to 6th month of life, <60U/L in the 7th similar to 12th month and <50U/L beyond one year.	[Wang, Neng-Li; Gong, Jing-Yu; Wang, Jian-She] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China; [Li, Li-Ting; Abuduxikuer, Kuerbanjiang; Wang, Jian-She] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China; [Wu, Bing-Bing; Li, Gang] Fudan Univ, Childrens Hosp, Pediat Res Inst, Mol Genet Diag Ctr,Shanghai Key Lab Birth Defects, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, JS (corresponding author), Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai 200433, Peoples R China.; Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai 200433, Peoples R China.	jshwang@shmu.edu.cn	Abuduxikuer, Kuerbanjiang/T-6521-2019; wang, Jian-She/F-1154-2011	Abuduxikuer, Kuerbanjiang/0000-0003-0298-3269; wang, jianshe/0000-0003-0823-586X; Wang, Neng-Li/0000-0001-6967-9873	National Natural Science Foundation of China [81070281, 81361128006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by the National Natural Science Foundation of China (No. 81070281 and No. 81361128006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LS, 2015, CLINICS, V70, P515, DOI 10.6061/clinics/2015(07)09; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cabrera-Abreu JC, 2002, ANN CLIN BIOCHEM, V39, P22, DOI 10.1258/0004563021901685; CHANG MH, 1987, J PEDIATR GASTR NUTR, V6, P203, DOI 10.1097/00005176-198703000-00006; Chen HL, 2002, J PEDIATR-US, V140, P119, DOI 10.1067/mpd.2002.119993; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Fang LJ, 2012, J PEDIATR GASTR NUTR, V55, P150, DOI 10.1097/MPG.0b013e31824ef36f; Herbst SM, 2015, MOL CELL PROBE, V29, P291, DOI 10.1016/j.mcp.2015.03.001; Hirschfield GM, 2013, GASTROENTEROLOGY, V144, P1357, DOI 10.1053/j.gastro.2013.03.053; Jim WT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001835; Li LT, 2015, J PEDIATR-US, V167, P1334, DOI 10.1016/j.jpeds.2015.08.037; Liu LU, 2010, SEMIN LIVER DIS, V30, P205, DOI 10.1055/s-0030-1253523; Liu LY, 2010, LIVER INT, V30, P809, DOI 10.1111/j.1478-3231.2009.02112.x; Liu LY, 2010, J PEDIATR GASTR NUTR, V50, P179, DOI 10.1097/MPG.0b013e3181c1b368; Morotti RA, 2011, SEMIN LIVER DIS, V31, P3, DOI 10.1055/s-0031-1272831; Pawlikowska L, 2010, J HEPATOL, V53, P170, DOI 10.1016/j.jhep.2010.01.034; Sambrotta M, 2014, NAT GENET, V46, P326, DOI 10.1038/ng.2918; Stormon MO, 2001, J PAEDIATR CHILD H, V37, P47, DOI 10.1046/j.1440-1754.2001.00613.x; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; van der Woerd WL, 2010, BEST PRACT RES CL GA, V24, P541, DOI 10.1016/j.bpg.2010.07.010; van Mil SWC, 2005, J MED GENET, V42, P449, DOI 10.1136/jmg.2004.026187; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; van Ooteghem NAM, 2002, J HEPATOL, V36, P439, DOI 10.1016/S0168-8278(01)00299-9; Wang JS, 2006, EUR J PEDIATR, V165, P795, DOI 10.1007/s00431-006-0175-3; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	28	9	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153114	10.1371/journal.pone.0153114	http://dx.doi.org/10.1371/journal.pone.0153114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050426	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500102
J	Afshar, Y; Sbalzarini, IF				Afshar, Yaser; Sbalzarini, Ivo F.			A Parallel Distributed-Memory Particle Method Enables Acquisition-Rate Segmentation of Large Fluorescence Microscopy Images	PLOS ONE			English	Article							REGION COMPETITION; PERCOLATION; SIMULATION; ALGORITHM; TOPOLOGY; NUMBERS	Modern fluorescence microscopy modalities, such as light-sheet microscopy, are capable of acquiring large three-dimensional images at high data rate. This creates a bottleneck in computational processing and analysis of the acquired images, as the rate of acquisition outpaces the speed of processing. Moreover, images can be so large that they do not fit the main memory of a single computer. We address both issues by developing a distributed parallel algorithm for segmentation of large fluorescence microscopy images. The method is based on the versatile Discrete Region Competition algorithm, which has previously proven useful in microscopy image segmentation. The present distributed implementation decomposes the input image into smaller sub-images that are distributed across multiple computers. Using network communication, the computers orchestrate the collectively solving of the global segmentation problem. This not only enables segmentation of large images (we test images of up to 10(10) pixels), but also accelerates segmentation to match the time scale of image acquisition. Such acquisition-rate image segmentation is a prerequisite for the smart microscopes of the future and enables online data compression and interactive experiments.	[Afshar, Yaser; Sbalzarini, Ivo F.] Tech Univ Dresden, Fac Comp Sci, Chair Sci Comp Syst Biol, D-01187 Dresden, Germany; [Afshar, Yaser; Sbalzarini, Ivo F.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Afshar, Yaser; Sbalzarini, Ivo F.] Ctr Syst Biol Dresden, MOSAIC Grp, D-01397 Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Sbalzarini, IF (corresponding author), Tech Univ Dresden, Fac Comp Sci, Chair Sci Comp Syst Biol, D-01187 Dresden, Germany.; Sbalzarini, IF (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.; Sbalzarini, IF (corresponding author), Ctr Syst Biol Dresden, MOSAIC Grp, D-01397 Dresden, Germany.	ivos@mpi-cbg.de	Sbalzarini, Ivo F/B-2789-2017; Afshar, Yaser/AAT-3905-2021	Afshar, Yaser/0000-0002-6451-3169; Sbalzarini, Ivo Fabian/0000-0003-4414-4340	Max Planck Society; German Federal Ministry of Education and Research (BMBF) [031A099]	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Max Planck Society, and by funding from the German Federal Ministry of Education and Research (BMBF) under funding code 031A099. We thank the Center for Information Services and High Performance Computing (ZIH) at TU Dresden for generous allocations of computer time.	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Aubert G., 2006, MATH PROBLEMS IMAGE; Awile O, 2013, P 3 INT C PART BAS M, pp52; Awile O, 2010, AIP CONF PROC, V1281, P1313, DOI 10.1063/1.3497957; Beare R, 2006, INSIGHT J; BERTRAND G, 1994, PATTERN RECOGN LETT, V15, P1003, DOI 10.1016/0167-8655(94)90032-9; Cardinale J, 2013, THESIS; Cardinale J, 2012, IEEE T IMAGE PROCESS, V21, P3531, DOI 10.1109/TIP.2012.2192129; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Cremers D, 2007, INT J COMPUT VISION, V72, P195, DOI 10.1007/s11263-006-8711-1; Delong A, 2012, INT J COMPUT VISION, V96, P1, DOI 10.1007/s11263-011-0437-z; Ebrahim E., 2011, THESIS; FLANIGAN M, 1995, PHYSICA A, V215, P461, DOI 10.1016/0378-4371(95)00019-4; Galizia A, 2015, J COMPUT APPL MATH, V273, P414, DOI 10.1016/j.cam.2014.05.004; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Ibanez L., 2005, ITK SOFTWARE GUIDE; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Knop F, 1998, J PARALLEL DISTR COM, V49, P182, DOI 10.1006/jpdc.1997.1420; Lamy J, 2007, COMPUT METH PROG BIO, V85, P51, DOI 10.1016/j.cmpb.2006.08.006; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Moloney NR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.037701; Montagnat J, 2001, IMAGE VISION COMPUT, V19, P1023, DOI 10.1016/S0262-8856(01)00064-6; Olmedo E, 2012, INT J COMPUTER SCI I, V9, P1; Paul G, 2013, INT J COMPUT VISION, V104, P69, DOI 10.1007/s11263-013-0615-2; PAWLEY GS, 1985, COMPUT PHYS COMMUN, V37, P251, DOI 10.1016/0010-4655(85)90160-2; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Royer LA, 2015, NAT METHODS, V12, P480, DOI 10.1038/nmeth.3372; Sbalzarini IF, 2006, J COMPUT PHYS, V215, P566, DOI 10.1016/j.jcp.2005.11.017; Sbalzarini IF, 2014, ARXIV14030240V1, P1; Scherf N, 2015, NAT BIOTECHNOL, V33, P815, DOI 10.1038/nbt.3310; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3207; Segonne F., 2005, SEGMENTATION MED IMA; Shi Y, 2008, IEEE T IMAGE PROCESS, V17, P645, DOI 10.1109/TIP.2008.920737; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Teuler JM, 2000, COMPUT PHYS COMMUN, V130, P118, DOI 10.1016/S0010-4655(00)00046-1; Tiggemann D, 2001, INT J MOD PHYS C, V12, P871, DOI 10.1142/S012918310100205X; Veltkamp RC, 2001, ADV PTRN RECOGNIT, P87; Wang KB, 2003, J INF SCI ENG, V19, P353; Xu CY, 2000, CONF REC ASILOMAR C, P483, DOI 10.1109/ACSSC.2000.911003; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152528	10.1371/journal.pone.0152528	http://dx.doi.org/10.1371/journal.pone.0152528			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046144	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600023
J	Koo, BK; Lee, JH; Kim, J; Jang, EJ; Lee, CH				Koo, Bo Kyung; Lee, Joon Ho; Kim, Jimin; Jang, Eun Jin; Lee, Chang-Hoon			Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; INCREASING PREVALENCE; METABOLIC SYNDROME; UNITED-STATES; WOMEN; INSULIN; GLYBURIDE; TRENDS; TUBERCULOSIS; METAANALYSIS	Aims/Introduction This study aimed to estimate the prevalence of gestational diabetes mellitus (GDM) and use of anti-diabetic medications for patients with GDM in Korea, using data of the period 2007-2011 from the Health Insurance Review and Assessment (HIRA) database, which includes the claims data of 97% of the Korean population. Materials and Methods We used the Healthcare Common Procedure Coding System codes provided by the HIRA to identify women with delivery in the HIRA database between 2009 and 2011. GDM was defined according to ICD-10 codes, and patients with pre-existing diabetes between January 1, 2007 and pregnancy were excluded. A Poisson regression was performed to evaluate the trends in annual prevalence rates. Results The annual numbers of deliveries in 2009-2011 were 479,160 in 2009, 449,747 in 2010, and 377,374 in 2011. The prevalence of GDM during that period was 7.5% in 2009-2011: 5.7% in 2009, 7.8% in 2010, and 9.5% in 2011. The age-stratified analysis showed that the prevalence of GDM was highest in women aged 40-44 years, at 10.6% in 2009-2011, and that the annual prevalence significantly increased even in young women aged 20-29 years during that period (P < 0.05). More than 95% of the patients with GDM did not take any antidiabetic medication. Among the anti-diabetic medications prescribed for patients with GDM, insulin was most commonly prescribed (for >98% of the patients with GDM on medication). Conclusions The prevalence of GDM in Korean women recently reached 5.7-9.5% in recent years. This represents a public health concern that warrants proper screening and medical care for GDM in women during the childbearing years.	[Koo, Bo Kyung; Lee, Chang-Hoon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Koo, Bo Kyung] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Joon Ho] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Kim, Jimin; Jang, Eun Jin; Lee, Chang-Hoon] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; National Evidence-based Healthcare Collaborating Agency (NECA)	Lee, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea.; Lee, CH (corresponding author), Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea.	kauri670@empal.com	Lee, Chang-Hoon/AAC-7650-2021; Koo, Bo Kyung/ABB-7170-2020	Koo, Bo Kyung/0000-0002-6489-2656	National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea [NA13-004]	National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea	This study was funded by the National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea. - Grant number: NA13-004 - Receiver: Chang-Hoon Lee - Website: http://www.neca.re.kr/nHTA/eng/ The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS5, DOI 10.2337/dc15-S004; [Anonymous], 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1; [Anonymous], 2014, INCR PREV GEST DIAB; Balsells M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h102; Campbell SK, 2012, MATERN CHILD HLTH J, V16, P1284, DOI 10.1007/s10995-011-0889-3; Castillo WC, 2015, JAMA PEDIATR, V169, P452, DOI 10.1001/jamapediatrics.2015.74; Castillo WC, 2014, OBSTET GYNECOL, V123, P1177, DOI 10.1097/AOG.0000000000000285; Charvat H, 2015, J DIABETES INVEST, V6, P533, DOI 10.1111/jdi.12333; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Jang HC, 2011, DIABETES METAB J, V35, P1, DOI 10.4093/dmj.2011.35.1.1; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jesmin S, 2014, DIABETES RES CLIN PR, V103, P57, DOI 10.1016/j.diabres.2013.11.024; JEWELL SE, 1995, OBSTET GYNECOL, V85, P229, DOI 10.1016/0029-7844(94)00354-G; Kang YA, 2014, INT J TUBERC LUNG D, V18, P717, DOI 10.5588/ijtld.13.0854; Kang YK, 2011, 2010 HLTH INSURANCE; Kim CH, 2015, J DIABETES INVEST, V6, P51, DOI 10.1111/jdi.12245; Kim YS, 2014, LIVE BIRTHS AGE GROU; Koo BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110650; Koo BK, 2013, DIABETES CARE, V36, pE95, DOI 10.2337/dc13-0247; Korean Diabetes Association, 2011, TREATM GUID DIAB; Korean Diabetes Association, 2007, TREATM GUID DIAB; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lamberg S, 2012, EUR J PUBLIC HEALTH, V22, P278, DOI 10.1093/eurpub/ckq193; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lauenborg J, 2005, J CLIN ENDOCR METAB, V90, P4004, DOI 10.1210/jc.2004-1713; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Lee CH, 2013, RESP MED, V107, P1222, DOI 10.1016/j.rmed.2012.12.002; Leng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121029; Mayo K, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.027; Nicholson W, 2009, OBSTET GYNECOL, V113, P193, DOI 10.1097/AOG.0b013e318190a459; Noctor E, 2015, ACTA DIABETOL, V52, P153, DOI 10.1007/s00592-014-0621-z; 변은경, 2005, Endocrinology and Metabolism, V20, P120; Sloan FA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1548, DOI 10.1001/archopht.126.11.1548; SPELLACY WN, 1978, OBSTET GYNECOL, V52, P210; Vanky E, 2012, ACTA OBSTET GYN SCAN, V91, P1460, DOI 10.1111/aogs.12015; Freire CMV, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-59; Wong VW, 2012, DIABETIC MED, V29, P366, DOI 10.1111/j.1464-5491.2011.03439.x; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	43	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153107	10.1371/journal.pone.0153107	http://dx.doi.org/10.1371/journal.pone.0153107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046149	Green Published, gold, Green Submitted			2022-12-27	WOS:000373599600068
J	Thomas, EW; Stepanek, JG; Kociolek, JP				Thomas, Evan W.; Stepanek, Joshua G.; Kociolek, J. Patrick			Historical and Current Perspectives on the Systematics of the 'Enigmatic' Diatom Genus Rhoicosphenia (Bacillariophyta), with Single and Multi-Molecular Marker and Morphological Analyses and Discussion on the Monophyly of 'Monoraphid' Diatoms	PLOS ONE			English	Article							LIFE-HISTORY; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; MULTIGENE PHYLOGENY; SEQUENCE ALIGNMENT; SIZE-REDUCTION; EVOLUTION; CLASSIFICATION; GENERA; ALGAE	This study seeks to determine the phylogenetic position of the diatom genus Rhoicosphenia. Currently, four hypotheses based on the morphology of the siliceous valve and its various ultrastructural components, sexual reproduction, and chloroplasts have been proposed. Two previous morphological studies have tentatively placed Rhoicosphenia near members of the Achnanthidiaceae and Gomphonemataceae, and no molecular studies have been completed. The position of Rhoicosphenia as sister to 'monoraphid' diatoms is problematic due to the apparent non-monophyly of that group, so hypotheses of 'monoraphid' monophyly are also tested. Using an analysis of morphological and cytological features, as well as sequences from three genes, SSU, LSU, and rbcL, recovered from several freshwater Rhoicosphenia populations that have similar morphology to Rhoicosphenia abbreviata (Agardh) Lange-Bertalot, we have analyzed the phylogenetic position of Rhoicosphenia in the context of raphid diatoms. Further, we have used topology testing to determine the statistical likelihoods of these relationships. The hypothesis that Rhoicosphenia is a member of the Achnanthidiaceae cannot be rejected, while the hypothesis that it is a member of the Gomphonemataceae can be rejected. In our analyses, members of the Achnanthidiaceae are basal to Rhoicosphenia, and Rhoicosphenia is basal to the Cymbellales, or a basal member of the Cymbellales, which includes the Gomphonemataceae. Hypothesis testing rejects the monophyly of 'monoraphid' diatoms.	[Thomas, Evan W.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Thomas, EW (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ewt@colorado.edu			University of Colorado Boulder Museum of Natural History Student Research Award; University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant; University of Colorado Boulder (UCB) Museum of Natural History	University of Colorado Boulder Museum of Natural History Student Research Award; University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant; University of Colorado Boulder (UCB) Museum of Natural History	Funded by University of Colorado Boulder Museum of Natural History Student Research Award and University of Colorado Boulder Department of Ecology & Evolutionary Biology Graduate Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; EWT would like to thank the University of Colorado Boulder (UCB) Museum of Natural History for a Student Research Award which assisted in field collections of Rhoicosphenia in California and Oregon. EWT also thanks the UCB Department of Ecology & Evolutionary Biology for a Graduate Student Research Grant to sequence Rhoicosphenia populations. The authors thank Dr. Sarah Hamsher for assistance with hypothesis testing software and valuable phylogenetic discussions.	Agardh C.A., 1830, CONSPECTUS CRITICU 1, P1; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Bory de Saint-Vincent J. B. G. M., 1824, DICT CLASSIQUE HIST, V6, DOI [10.5962/bhl.title.33901, DOI 10.5962/BHL.TITLE.33901]; Bruder K, 2008, DIATOM RES, V23, P331; Bruder K, 2008, DIATOM RES, V23, P283; Bukhtiyarova Ludmila, 1996, Diatom Research, V11, P1; Chen J-Y., 1983, ACTA PHYTOTAXONOMICA, V21, P449; Cleve P.T., 1894, KONGLIGA SVENSKA VET, V4, P1, DOI DOI 10.5962/BHL.TITLE.54740; CLEVE PT, 1895, KONGLIGA SVENSKA VET, V27, P1, DOI DOI 10.5962/BHL.TITLE.68663; CLEVE-EULER ASTRID, 1953, K SVENSKA VETENSKAPSAKAD HANDL, V4, P1; Cox EJ, 2006, SYST BIODIVERS, V4, P385, DOI 10.1017/S1477200006001940; Cox EJ, 2006, EUR J PHYCOL, V41, P67, DOI 10.1080/09670260500491543; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; de Queiroz Kevin, 2012, Bibliotheca Herpetologica, V9, P135; De Toni GB, 1891, BACILLARIAE PATAVIA, VII, P1891, DOI [10.5962/bhl.title.10544, DOI 10.5962/BHL.TITLE.10544]; Drummond A. J., 2012, GENEIOUS V5 6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar SM, 2004, J PHYCOL, V40, P772, DOI 10.1111/j.1529-8817.2004.03126.x; Ehrenberg C.G., 1831, ABH PREUSS AKAD WISS, V1831, P1; Ehrenberg CG, 1835, ABH PREUSS AKAD WISS, P150; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grunow A., 1877, MONTHLY MICROSCOPICA, V18, P165, DOI [10.1111/j.1365-2818.1877.tb00123.x, DOI 10.1111/J.1365-2818.1877.TB00123.X]; Grunow A., 1860, VERHANDLUNGEN KAISER, V10, P503; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; Hustedt F, 1959, L RABENHORSTS KRYPTO, V7, P1; Hustedt F., 1934, ABHANDLUNGEN VORTRAG, V8, P362; Jones HM, 2005, EUR J PHYCOL, V40, P61, DOI 10.1080/09670260400024675; Kermarrec L, 2011, DIATOM RES, V26, P305, DOI 10.1080/0269249X.2011.633255; Kociolek JP, 2013, EUR J PHYCOL, V48, P474, DOI 10.1080/09670262.2013.860239; KOCIOLEK JP, 1986, PHYCOLOGIA, V25, P297, DOI 10.2216/i0031-8884-25-3-297.1; KOCIOLEK JP, 1988, J PHYCOL, V24, P377, DOI 10.1111/j.1529-8817.1988.tb00187.x; KOCIOLEK JP, 1987, SYST BOT, V12, P451, DOI 10.2307/2418882; Kooistra WHCF, 2003, PROG MOLEC, V33, P59; Krammer K., 2004, SUSSWASSERFLORA MITT; Krammer K., 1997, BIBLIOTHECA DIATOMOL, V36, P382; Kulikovskiy M, 2014, PHYTOTAXA, V177, P249, DOI 10.11646/phytotaxa.177.5.1; Kutzing F.T., 1833, LINNAEA, V8, P529, DOI DOI 10.5962/BHL.TITLE.65634; Kutzing F.T., 1844, KIESELSCHALIGEN BACI, pi, DOI DOI 10.1080/037454809495289; Lange-Bertalot H, 1996, ANNOTATED DIATOM MIC, V2, DOI [10.2216/i0031-8884-36-3-255.1, DOI 10.2216/I0031-8884-36-3-255.1]; Lange-Bertalot H., 1999, ANNOTATED DIATOM MIC, V6; MANN DG, 1982, J PHYCOL, V18, P162, DOI 10.1111/j.1529-8817.1982.tb03170.x; MANN DG, 1982, J PHYCOL, V18, P264; MANN DG, 1984, J PHYCOL, V20, P544, DOI 10.1111/j.0022-3646.1984.00544.x; MANN DG, 1995, PHYCOLOGIA, V34, P74, DOI 10.2216/i0031-8884-34-1-74.1; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Medlin L.K., 1984, P 7 INT DIAT S, P255; MEDLIN LK, 1984, J PHYCOL, V20, P101, DOI 10.1111/j.0022-3646.1984.00101.x; Medlin LK, 2004, PHYCOLOGIA, V43, P245, DOI 10.2216/i0031-8884-43-3-245.1; Mereschkowsky C., 1902, SCRIPTA BOT HORTI U, V21, P1; Mereschkowsky C, 1903, BOT CENTRALBLATT S, V15, P1; Moser G., 1998, BIBLIOTHECA DIATOMOL, V38, P1; Nakov T, 2014, PHYCOLOGIA, V53, P359, DOI 10.2216/14-002.1; Patrick R., 1966, DIATOMS US EXCLUSIVE, DOI [10.2307/1351135, DOI 10.2307/1351135]; Peragallo H., 1897, MICROGRAPHIE PREPARA, V5, P9, DOI [10.5962/bhl.title.13501, DOI 10.5962/BHL.TITLE.13501]; Pfitzer E, 1871, BOT ABHANDLUNGEN GEB, V2; Richlen ML, 2005, MOL ECOL NOTES, V5, P688, DOI 10.1111/j.1471-8286.2005.01032.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Round F. E., 1998, Diatom Research, V13, P181; Round F. E., 1996, Diatom Research, V11, P345; Round F. E., 1997, Diatom Research, V12, P71; Round F. E., 1990, DIATOMS BIOL MORPHOL; Ruck EC, 2011, PROTIST, V162, P723, DOI 10.1016/j.protis.2011.02.003; Schmidt M, 1899, ATLAS DIATOMACEENKUN, DOI [10.5962/bhl.title.64254, DOI 10.5962/BHL.TITLE.64254]; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Schutt F., 1896, NATURLICHEN PFLANZEN, VI, P31, DOI DOI 10.5962/BHL.TITLE.4635; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silva P.C., 1962, PHYSL BIOCH ALGAE, P827; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SIMONSEN R, 1979, Bacillaria, V2, P9; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Smith W., 1853, SYNOPSIS BRIT DIATOM, P89, DOI DOI 10.5962/BHL.TITLE.10706; Sorhannus U, 2004, CLADISTICS, V20, P487, DOI 10.1111/j.1096-0031.2004.00034.x; Souffreau C, 2011, MOL PHYLOGENET EVOL, V61, P866, DOI 10.1016/j.ympev.2011.08.031; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stepanek JG, 2014, PROTIST, V165, P177, DOI 10.1016/j.protis.2014.02.002; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Theriot EC, 2010, PLANT ECOL EVOL, V143, P278, DOI 10.5091/plecevo.2010.418; Van Heurck H, 1896, TREATISE DIATOMACEAE, DOI [10.5962/bhl.title.2002, DOI 10.5962/BHL.TITLE.2002]	82	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152797	10.1371/journal.pone.0152797	http://dx.doi.org/10.1371/journal.pone.0152797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045763	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600033
J	Al-Janabi, B; Kruse, I; Graiff, A; Winde, V; Lenz, M; Wahl, M				Al-Janabi, Balsam; Kruse, Inken; Graiff, Angelika; Winde, Vera; Lenz, Mark; Wahl, Martin			Buffering and Amplifying Interactions among OAW (Ocean Acidification & Warming) and Nutrient Enrichment on Early Life-Stage Fucus vesiculosus L. (Phaeophyceae) and Their Carry Over Effects to Hypoxia Impact	PLOS ONE			English	Article							LONG-TERM CHANGES; BALTIC SEA; DEPTH DISTRIBUTION; GENETIC DIVERSITY; MARINE ECOSYSTEM; CLIMATE-CHANGE; GROWTH; TEMPERATURE; PHOTOSYNTHESIS; SEAWEED	Ocean acidification and warming (OAW) are occurring globally. Additionally, at a more local scale the spreading of hypoxic conditions is promoted by eutrophication and warming. In the semi-enclosed brackish Baltic Sea, occasional upwelling in late summer and autumn may expose even shallow-water communities including the macroalga Fucus vesiculosus to particularly acidified, nutrient-rich and oxygen-poor water bodies. During summer 2014 (July-September) sibling groups of early life-stage F. vesiculosus were exposed to OAW in the presence and absence of enhanced nutrient levels and, subsequently to a single upwelling event in a near-natural scenario which included all environmental fluctuations in the Kiel Fjord, southwestern Baltic Sea, Germany (54 degrees 27 'N, 10 degrees 11 'W). We strove to elucidate the single and combined impacts of these potential stressors, and how stress sensitivity varies among genetically different sibling groups. Enhanced by a circumstantial natural heat wave, warming and acidification increased mortalities and reduced growth in F. vesiculosus germlings. This impact, however, was mitigated by enhanced nutrient conditions. Survival under OAW conditions strongly varied among sibling groups hinting at a substantial adaptive potential of the natural Fucus populations in the Western Baltic. A three-day experimental upwelling caused severe mortality of Fucus germlings, which was substantially more severe in those sibling groups which previously had been exposed to OAW. Our results show that global (OAW), regional (nutrient enrichment) and local pressures (upwelling), both alone and co-occurring may have synergistic and antagonistic effects on survival and/or growth of Fucus germlings. This result emphasizes the need to consider combined stress effects.	[Al-Janabi, Balsam; Kruse, Inken; Lenz, Mark; Wahl, Martin] GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany; [Graiff, Angelika] Univ Rostock, Inst Biol Sci Appl Ecol & Phycol, D-18055 Rostock, Germany; [Winde, Vera] Leibniz Inst Balt Sea Res, Geochem & Isotope Biogeochem Grp, Dept Marine Geol, Warnemunde, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Rostock; Leibniz Institut fur Ostseeforschung Warnemunde	Al-Janabi, B (corresponding author), GEOMAR, Helmholtz Ctr Ocean Res Kiel, Benth Ecol Grp, Kiel, Germany.	baljanabi@geomar.de	Wahl, Martin/D-2038-2016	Wahl, Martin/0000-0001-8703-3857	Project BIOACID II of the German Federal Ministry of Education and Research (BMBF) [FKZ 03F0655]	Project BIOACID II of the German Federal Ministry of Education and Research (BMBF)	The research was funded by the Project BIOACID II of the German Federal Ministry of Education and Research (BMBF; FKZ 03F0655, A). They support this project, the experimental setup and all accompanied costs.	AErtebjerg G., 2003, NUTR EUTROPHICATION; Al-Janabi B, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2804-8; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Andersen GS, 2013, J PHYCOL, V49, P689, DOI 10.1111/jpy.12077; [Anonymous], 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Assis J, 2014, MOL ECOL, V23, P2797, DOI 10.1111/mec.12772; BACC II Author Team, 2015, 2 ASS CLIM CHANG BAL, DOI [10.1007/978-3-319-16006-1, DOI 10.1007/978-3-319-16006-1]; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Berger R, 2004, HYDROBIOLOGIA, V514, P243, DOI 10.1023/B:hydr.0000018222.44511.b7; Bergstrom L, 2003, EUR J PHYCOL, V38, P41, DOI 10.1080/0967026031000096236; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Burnett LE, 1997, AM ZOOL, V37, P633; Pineda MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046672; Carstensen J, 2014, AMBIO, V43, P26, DOI 10.1007/s13280-013-0474-7; Coelho Susana M., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P317, DOI 10.1023/A:1009916129009; Diaz RJ, 1996, OCEANOGRAPH LIT REV, V43, P1250; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Elken J, 2015, REG CLIM STUD, P131, DOI 10.1007/978-3-319-16006-1_7; Eriksson BK, 2003, EUR J PHYCOL, V38, P217, DOI 10.1080/0967026031000121688; Eriksson BK, 1998, EUR J PHYCOL, V33, P241, DOI 10.1080/09670269810001736743; Fernandez PA, 2015, PHOTOSYNTH RES, V124, P293, DOI 10.1007/s11120-015-0138-5; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Gordillo FJL, 2001, PLANTA, V213, P64, DOI 10.1007/s004250000468; Graiff A, 2015, J EXP MAR BIOL ECOL, V471, P8, DOI 10.1016/j.jembe.2015.05.009; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; HADER DP, 1994, ENVIRON MONIT ASSESS, V32, P259, DOI 10.1007/BF00546280; HELCOM, BALT SEA ENV P 2007; Hemmi A, 2002, ECOLOGY, V83, P1052, DOI 10.2307/3071913; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, AMBIO, V40, P179, DOI 10.1007/s13280-010-0129-x; Jueterbock A, 2013, ECOL EVOL, V3, P1356, DOI 10.1002/ece3.541; Jutterstrom S, 2014, MAR POLLUT BULL, V86, P468, DOI 10.1016/j.marpolbul.2014.06.027; KAUTSKY N, 1986, MAR ECOL PROG SER, V28, P1, DOI 10.3354/meps028001; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lehvo A, 2001, BOT MAR, V44, P345, DOI 10.1515/BOT.2001.044; Lloret J, 2011, MAR POLLUT BULL, V62, P2732, DOI 10.1016/j.marpolbul.2011.09.014; Lloret J, 2009, MAR POLLUT BULL, V58, P1827, DOI 10.1016/j.marpolbul.2009.08.001; Lotze HK, 2001, LIMNOL OCEANOGR, V46, P749, DOI 10.4319/lo.2001.46.4.0749; Maczassek K., 2014, THESIS; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Neumann T, 2010, J MARINE SYST, V81, P213, DOI 10.1016/j.jmarsys.2009.12.001; Nicastro KR, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-6; Nielsen SL, 2014, MAR BIOL, V161, P1895, DOI 10.1007/s00227-014-2471-1; Nygard CA, 2008, EUR J PHYCOL, V43, P253, DOI 10.1080/09670260802172627; Olischlager M, 2013, PHYCOL RES, V61, P180, DOI 10.1111/pre.12006; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; PECKOL P, 1995, J EXP MAR BIOL ECOL, V190, P1, DOI 10.1016/0022-0981(95)00026-N; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Queiros AM, 2015, GLOBAL CHANGE BIOL, V21, P130, DOI 10.1111/gcb.12675; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Rinne H, 2011, ESTUAR COAST SHELF S, V94, P182, DOI 10.1016/j.ecss.2011.06.010; Rohde S, 2008, EUR J PHYCOL, V43, P143, DOI 10.1080/09670260801901018; Saderne V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062689; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schmidt AL, 2011, MAR ECOL PROG SER, V437, P51, DOI 10.3354/meps09276; Serrao EA, 1996, OECOLOGIA, V107, P1, DOI 10.1007/BF00582229; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Stocker T.F., 2013, CONTRIBUTION WORKING, P1, DOI [DOI 10.1017/CBO9781107415324, 10.1017/CBO9781107415324]; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Torn K, 2006, AQUAT BOT, V84, P53, DOI 10.1016/j.aquabot.2005.07.011; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; VOGT H, 1991, MAR ECOL PROG SER, V69, P189, DOI 10.3354/meps069189; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Wahl M, 2015, LIMNOL OCEANOGR METH; Wahl M., 2015, PERSPECTIVES PHYCOLO, V2, P11, DOI [10.1127/pip/2015/0019, DOI 10.1127/PIP/2015/0019]; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9; WALLENTINUS I, 1984, MAR BIOL, V80, P215, DOI 10.1007/BF02180189; WEIGELT M, 1991, MEERESFORSCHUNG, V33, P197; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wikstrom SA, 2007, ESTUAR COAST SHELF S, V72, P168, DOI 10.1016/j.ecss.2006.10.009; Winde V, 2014, J MARINE SYST, V129, P396, DOI 10.1016/j.jmarsys.2013.08.005; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; YORDANOV I, 1986, PHOTOBIOCH PHOTOBIOP, V12, P147; Zou DH, 2005, AQUACULTURE, V250, P726, DOI 10.1016/j.aquaculture.2005.05.014; Zou DH, 2011, J PHYCOL, V47, P87, DOI 10.1111/j.1529-8817.2010.00929.x	81	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152948	10.1371/journal.pone.0152948	http://dx.doi.org/10.1371/journal.pone.0152948			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043710	Green Published, gold, Green Accepted			2022-12-27	WOS:000373592100052
J	van Apeldoorn, J; Schram, A				van Apeldoorn, Jacobien; Schram, Arthur			Indirect Reciprocity; A Field Experiment	PLOS ONE			English	Article							SOCIAL NORMS; GIFT EXCHANGE; COOPERATION; EVOLUTION; REPUTATION; PUNISHMENT; STRANGERS; HUMANS	Indirect reciprocity involves cooperative acts towards strangers, either in response to their kindness to third parties (downstream) or after receiving kindness from others oneself (upstream). It is considered to be important for the evolution of cooperative behavior amongst humans. Though it has been widely studied theoretically, the empirical evidence of indirect reciprocity has thus far been limited and based solely on behavior in laboratory experiments. We provide evidence from an online environment where members can repeatedly ask and offer services to each other, free of charge. For the purpose of this study we created several new member profiles, which differ only in terms of their serving history. We then sent out a large number of service requests to different members from all over the world. We observe that a service request is more likely to be rewarded for those with a profile history of offering the service (to third parties) in the past. This provides clear evidence of (downstream) indirect reciprocity. We find no support for upstream indirect reciprocity (in this case, rewarding the service request after having previously received the service from third parties), however. Our evidence of downstream indirect reciprocity cannot be attributed to reputational effects concerning one's trustworthiness as a service user.	[van Apeldoorn, Jacobien] Univ Amsterdam, NL-1001 NJ Amsterdam, Netherlands; [Schram, Arthur] Univ Amsterdam, Amsterdam Sch Econ, CREED, POB 15867, NL-1001 NJ Amsterdam, Netherlands; [Schram, Arthur] European Univ Inst, Robert Schumann Ctr Adv Studies, Via Roccettini 9, I-50014 San Domenico Die Fiesole, FI, Italy	University of Amsterdam; University of Amsterdam; European University Institute	Schram, A (corresponding author), Univ Amsterdam, Amsterdam Sch Econ, CREED, POB 15867, NL-1001 NJ Amsterdam, Netherlands.; Schram, A (corresponding author), European Univ Inst, Robert Schumann Ctr Adv Studies, Via Roccettini 9, I-50014 San Domenico Die Fiesole, FI, Italy.	Schram@uva.nl	Schram, Arthur/G-5045-2011	Schram, Arthur/0000-0002-1767-4998				Alexander R., 2008, ESSAYS PEDAGOGY; Andreoni J., 1993, EC J             MAY, P570; Arrow K. J., 1974, LIMITS ORG; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Bolton GE, 2005, J PUBLIC ECON, V89, P1457, DOI 10.1016/j.jpubeco.2004.03.008; Boorman S.A., 1980, GENETICS ALTRUISM; Brandts J, 2001, J PUBLIC ECON, V79, P399, DOI 10.1016/S0047-2727(99)00120-6; BROWN JS, 1982, J THEOR BIOL, V99, P319, DOI 10.1016/0022-5193(82)90008-X; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Dufwenberg Martin, 2001, HOMO OECON, V18, P19; ELLISON G, 1994, REV ECON STUD, V61, P567, DOI 10.2307/2297904; Engelmann D, 2009, GAME ECON BEHAV, V67, P399, DOI 10.1016/j.geb.2008.12.006; Falk A, 2007, ECONOMETRICA, V75, P1501, DOI 10.1111/j.1468-0262.2007.00800.x; Fehr E, 1998, J LABOR ECON, V16, P324, DOI 10.1086/209891; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FEHR E, 1993, Q J ECON, V108, P437, DOI 10.2307/2118338; Gachter S, 2002, SCAND J ECON, V104, P1, DOI 10.1111/1467-9442.00269; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; Guth Werner, 2001, HOMO OECON, V18, P241; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ohtsuki H, 2006, J THEOR BIOL, V239, P435, DOI 10.1016/j.jtbi.2005.08.008; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Sugden R, 1986, EC RIGHTS COOPERATIO; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ule A, 2009, SCIENCE, V326, P1701, DOI 10.1126/science.1178883; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	36	13	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152076	10.1371/journal.pone.0152076	http://dx.doi.org/10.1371/journal.pone.0152076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27043712	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100008
J	van Zelst, M; Hesta, M; Gray, K; Beech, K; Cools, A; Alexander, LG; Du Laing, G; Janssens, GPJ				van Zelst, Marielle; Hesta, Myriam; Gray, Kerry; Beech, Karen; Cools, An; Alexander, Lucille G.; Du Laing, Gijs; Janssens, Geert P. J.			Selenium Digestibility and Bioactivity in Dogs: What the Can Can, the Kibble Can't	PLOS ONE			English	Article							CANCER PREVENTION; GLUTATHIONE-PEROXIDASE; TISSUE SELENIUM; PROSTATE-CANCER; T-CELL; DIETARY; TRIIODOTHYRONINE; SUPPLEMENTATION; THIOREDOXIN; ANTIOXIDANT	There is a growing concern for the long-term health effects of selenium (Se) over-or underfeeding. The efficiency of utilization of dietary Se is subject to many factors. Our study in dogs evaluated the effect of diet type (canned versus kibble) and dietary protein concentration on Se digestibility and bioactivity. Canned and kibble diets are commonly used formats of dog food, widely ranging in protein concentration. Twenty-four Labrador retrievers were used and four canned and four kibble diets were selected with crude protein concentrations ranging from 10.1 to 27.5 g/MJ. Crude protein concentration had no influence on the digestibility of Se in either canned or kibble diets, but a lower Se digestibility was observed in canned compared to kibble diets. However, the biological activity of Se, as measured by whole blood glutathione peroxidase, was higher in dogs fed the canned diets than in dogs fed the kibble diets and decreased with increasing crude protein intake. These results indicate that selenium recommendations in dog foods need to take diet type into account.	[van Zelst, Marielle; Hesta, Myriam; Cools, An; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium; [Gray, Kerry; Beech, Karen; Alexander, Lucille G.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Du Laing, Gijs] Univ Ghent, Fac Biosci Engn, Dept Appl Analyt & Phys Chem, B-9000 Ghent, Belgium	Ghent University; Mars; WALTHAM Petcare Science Institute; Ghent University	Janssens, GPJ (corresponding author), Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium.	Nutrition@UGent.be	Janssens, Geert/C-2264-2008	Hesta, Myriam/0000-0001-9423-9765; Du Laing, Gijs/0000-0001-6661-1312	WALTHAM(R) Centre for Pet Nutrition	WALTHAM(R) Centre for Pet Nutrition	This study is part of a PhD project of MvZ funded by the WALTHAM (R) Centre for Pet Nutrition (grant number not applicable) (www.waltham.com). The funders, other than the named authors, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich G, 2006, ESSENT RENDER, P159; [Anonymous], 2013, RSTUDIO INT DEV ENV; Basu S., 2007, Scandinavian Journal of Food & Nutrition, V51, P48, DOI 10.1080/17482970701411642; Bierla K, 2008, ANAL BIOANAL CHEM, V390, P1789, DOI 10.1007/s00216-008-1883-5; Carlson BA, 2010, P NUTR SOC, V69, P300, DOI 10.1017/S002966511000176X; Clark LC, 1998, BRIT J UROL, V81, P730; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; DARRAS VM, 1992, COMP BIOCHEM PHYS A, V103, P131, DOI 10.1016/0300-9629(92)90252-L; de Lorgeril M, 2001, EUR J HEART FAIL, V3, P661, DOI 10.1016/S1388-9842(01)00179-9; Dumont E, 2006, ANAL BIOANAL CHEM, V385, P1304, DOI 10.1007/s00216-006-0529-8; FEDIAF, 2013, NUTR GUID COMPL COMP; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Gregus Z, 1998, BIOCHEM PHARMACOL, V56, P1391, DOI 10.1016/S0006-2952(98)00190-7; Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071; ISO, 2005, 59831 ISO; Kantrowitz LB, 2001, J AM VET MED ASSOC, V219, P765, DOI 10.2460/javma.2001.219.765; Koller G, 1984, ABBILD EMOTION OSTER; Lavu RVS, 2012, J AGR FOOD CHEM, V60, P10930, DOI 10.1021/jf302931z; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MCCONNELL KP, 1952, J BIOL CHEM, V194, P183; Myers WD, 2004, J ANIM SCI, V82, P179; National Research Council, 2006, NUTR REQ DOGS CATS; OLIVIERI O, 1995, CLIN SCI, V89, P637, DOI 10.1042/cs0890637; Payne RL, 2005, POULTRY SCI, V84, P1268, DOI 10.1093/ps/84.8.1268; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; REASBECK PG, 1985, DIGEST DIS SCI, V30, P489, DOI 10.1007/BF01318184; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schneider H A, 1936, Science, V83, P32, DOI 10.1126/science.83.2141.32-a; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Souci S. W., 2008, FOOD COMPOSITION NUT; Tinggi Ujang, 2008, Environmental Health and Preventive Medicine, V13, P102, DOI 10.1007/s12199-007-0019-4; Todd SE, 2012, J ANIM SCI, V90, P2549, DOI 10.2527/jas.2011-3911; Todd SE, 2012, J ANIM PHYSIOL AN N, V96, P148, DOI 10.1111/j.1439-0396.2011.01132.x; Todd SE, 2006, THESIS MASSEY U PALM; Toufektsian MC, 2000, TOXICOLOGY, V148, P125, DOI 10.1016/S0300-483X(00)00203-1; van Zelst M, 2015, BRIT J NUTR, V113, P1888, DOI 10.1017/S0007114515001324; WASCHULEWSKI IH, 1988, BRIT J NUTR, V60, P57, DOI 10.1079/BJN19880076; Wedekind K, 2001, FASEB J, V15, pA953; Wedekind K. J., 1997, FASEB Journal, V11, pA360; Wedekind KJ, 2004, J ANIM PHYSIOL AN N, V88, P340, DOI 10.1111/j.1439-0396.2004.00489.x; Wedekind KJ, 1998, FASEB J, V12, pA823; Wedekind KJ, 2000, COMPEND CONTIN ED VE, V22, P17; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6; YOUNG VR, 1982, AM J CLIN NUTR, V35, P1076, DOI 10.1093/ajcn/35.5.1076; Yu S, 2002, J ANIM PHYSIOL AN N, V86, P36, DOI 10.1046/j.1439-0396.2002.00338.x; Zentek J., CHANGING LANDSCAPE P	47	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152709	10.1371/journal.pone.0152709	http://dx.doi.org/10.1371/journal.pone.0152709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043433	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100029
J	Beharry, AA; Nagel, ZD; Samson, LD; Kool, ET				Beharry, Andrew A.; Nagel, Zachary D.; Samson, Leona D.; Kool, Eric T.			Fluorogenic Real-Time Reporters of DNA Repair by MGMT, a Clinical Predictor of Antitumor Drug Response	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY; HUMAN O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; PROMOTER METHYLATION; SUBSTRATE-SPECIFICITY; IN-VITRO; OLIGONUCLEOTIDE; INACTIVATION; RESISTANCE; MUTANTS	Common alkylating antitumor drugs, such as temozolomide, trigger their cytotoxicity by methylating the O6-position of guanosine in DNA. However, the therapeutic effect of these drugs is dampened by elevated levels of the DNA repair enzyme, O6-methylguanine DNA methyltransferase (MGMT), which directly reverses this alkylation. As a result, assessing MGMT levels in patient samples provides an important predictor of therapeutic response; however, current methods available to measure this protein are indirect, complex and slow. Here we describe the design and synthesis of fluorescent chemosensors that report directly on MGMT activity in a single step within minutes. The chemosensors incorporate a fluorophore and quencher pair, which become separated by the MGMT dealkylation reaction, yielding light-up responses of up to 55-fold, directly reflecting repair activity. Experiments show that the best-performing probe retains near-native activity at mid-nanomolar concentrations. A nuclease-protected probe, NR-1, was prepared and tested in tumor cell lysates, demonstrating an ability to evaluate relative levels of MGMT repair activity in twenty minutes. In addition, a probe was employed to evaluate inhibitors of MGMT, suggesting utility for discovering new inhibitors in a high-throughput manner. Probe designs such as that of NR-1 may prove valuable to clinicians in selection of patients for alkylating drug therapies and in assessing resistance that arises during treatment.	[Beharry, Andrew A.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Nagel, Zachary D.; Samson, Leona D.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nagel, Zachary D.; Samson, Leona D.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kool, ET (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	kool@stanford.edu		Kool, Eric/0000-0002-7310-2935	US National Institutes of Health [GM106067, GM110050, DP1-ES 022576]; Human Frontier Science Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES022576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110050, R01GM106067] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health (GM106067, GM110050 to ETK; DP1-ES 022576 to LDS). AAB is supported by a postdoctoral fellowship from the Human Frontier Science Program. LDS is an American Cancer Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilina G, 1998, CANCER RES, V58, P135; Bacolod MD, 2004, MOL CANCER THER, V3, P1127; Barr Fritcher EG, 2015, OPTIMIZED SET FLUORE, P1; Brandwein JM, 2014, BRIT J HAEMATOL, V167, P664, DOI 10.1111/bjh.13094; Brian T, 2007, DNA REPAIR, V6, P1161, DOI 10.1016/j.dnarep.2007.03.015; Cabrini G, 2015, INT J ONCOL, V47, P417, DOI 10.3892/ijo.2015.3026; Cancer MC, 2002, CHEMOTHERAPY INDUCED, P3070; Chen ZP, 1997, MOL PHARMACOL, V52, P815, DOI 10.1124/mol.52.5.815; Clemons M, 2005, BRIT J CANCER, V93, P1152, DOI 10.1038/sj.bjc.6602833; Damoiseaux R, 2001, CHEMBIOCHEM, V2, P285, DOI 10.1002/1439-7633(20010401)2:4<285::AID-CBIC285>3.3.CO;2-E; Encell LP, 1999, BIOCHEMISTRY-US, V38, P12097, DOI 10.1021/bi9913606; Folco EG, 2012, JOVE-J VIS EXP, DOI 10.3791/4140; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gao JM, 2004, J AM CHEM SOC, V126, P12748, DOI 10.1021/ja046910o; Gao JM, 2002, J AM CHEM SOC, V124, P11590, DOI 10.1021/ja027197a; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Ishiguro Kimiko, 2013, J Cancer Ther, V4, P919; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Kreklau EL, 2001, NUCLEIC ACIDS RES, V29, P2558, DOI 10.1093/nar/29.12.2558; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; Kuwasaki T, 2003, J ANTIMICROB CHEMOTH, V51, P813, DOI 10.1093/jac/dkg174; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Li X, 2012, ORG BIOMOL CHEM, V10, P3189, DOI 10.1039/c2ob25231g; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; Luu KX, 2002, BIOCHEMISTRY-US, V41, P8689, DOI 10.1021/bi025857i; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Meyer AS, 2003, CHEM RES TOXICOL, V16, P1405, DOI 10.1021/tx0341254; MYRNES B, 1984, CARCINOGENESIS, V5, P1061, DOI 10.1093/carcin/5.8.1061; Nagel G, 2003, ANAL BIOCHEM, V321, P38, DOI 10.1016/S0003-2697(03)00432-9; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pegg AE, 2001, J PHARMACOL EXP THER, V296, P958; Pegg AE, 1998, J BIOL CHEM, V273, P10863, DOI 10.1074/jbc.273.18.10863; Phillips WP, 1999, CANCER CHEMOTH PHARM, V44, P319, DOI 10.1007/s002800050984; Rabik CA, 2006, CANCER TREAT REV, V32, P261, DOI 10.1016/j.ctrv.2006.03.004; Robinson C, 2010, ANAL BIOCHEM, V405, P263, DOI 10.1016/j.ab.2010.06.019; Ruiz FM, 2008, J CHEM INF MODEL, V48, P844, DOI 10.1021/ci700447r; Terashima I, 1997, CHEM RES TOXICOL, V10, P1234, DOI 10.1021/tx9700580; Thon N, 2013, ONCOTARGETS THER, V6, P1363, DOI 10.2147/OTT.S50208; Tintore M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/632041; Tomaszowski K-H, 2015, MOL PHARM; Voelter V, 2008, INT J CANCER, V123, P1215, DOI 10.1002/ijc.23632; Wang C, 2016, ANGEW CHEM INT EDIT, V55, P2911, DOI 10.1002/anie.201511301; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Xu-Welliver M, 1998, CANCER RES, V58, P1936; Yu W-T, 2015, CHEM SCI; Zhang J, 2012, CURR MOL PHARMACOL, V5, P102, DOI DOI 10.2174/1874467211205010102	49	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152684	10.1371/journal.pone.0152684	http://dx.doi.org/10.1371/journal.pone.0152684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035132	Green Published, gold			2022-12-27	WOS:000373201200031
J	Teng, CJ; Huon, LK; Hu, YW; Yeh, CM; Chien, SH; Chen, SC; Liu, CJ				Teng, Chung-Jen; Huon, Leh-Kiong; Hu, Yu-Wen; Yeh, Chiu-Mei; Chien, Sheng-Hsuan; Chen, San-Chi; Liu, Chia-Jen			Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							STAGE RENAL-DISEASE; 2ND NEOPLASMS; FOLLOW-UP; CANCER; CHILDHOOD; THERAPY; CHEMOTHERAPY; CHILDREN; ADULTS; END	Background Acute lymphoblastic leukemia (ALL) is more common in children than in adults. Secondary neoplasms (SNs) in childhood ALL have been widely reported. However, only one study has demonstrated SNs in adult ALL. Because of the poorer survival of adult ALL, the incidence might be underestimated. Objective To evaluate the incidence and risk factors of secondary solid organ neoplasms among adult and child ALL patients. Methods Newly diagnosed ALL patients between 1997 and 2011 were recruited from the Taiwan National Health Insurance database. Those who had antecedent or combined malignancies were excluded. Standardized incidence ratios (SIRs) were analyzed to compare the risk of our cohort to general population in the same age, sex and calendar year. Risk factors for SN development were analyzed by Cox proportional hazards models. Effects of treatments were treated as time-dependent variables. Results The 15-year cumulative incidence of SN was 1.9% and 8.4% in 1,381 child and 2,154 adult ALL patients, respectively. The SIR was significantly increased in child ALL (SIR 6.06), but not in adult ALL (SIR 1.16). The SIRs of follow-up periods were 5.14, 2.24,.87 and .71 at >= 10 years, 5-10 years, 1-5 years and 0-1, respectively. Overall, 15 SNs developed, and CNS tumors (SIR 11.56) were the most common type. Multivariate analysis showed that age >= 20 years (hazard ratio [HR] 5.04), end-stage renal disease (HR 18.98) and cranial irradiation (HR 8.12) were independent risk factors for cancer development. Conclusions When compared with the general population, child ALL shows a increased risk of developing SNs. CNS tumors are the most common type, and cranial irradiation is an independent risk factor. With longer follow-up, the risk of SNs increases. Hence, physicians need to pay more attention on the risk of developing SNs in long-term ALL survivors with risk factors.	[Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen; Hu, Yu-Wen; Chien, Sheng-Hsuan; Chen, San-Chi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huon, Leh-Kiong] Cathay Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Huon, Leh-Kiong] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Yeh, Chiu-Mei] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chien, Sheng-Hsuan; Chen, San-Chi; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Chen, San-Chi] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Cathay General Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, SC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Chen, SC; Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	sunkist.chen37@gmail.com; chiajenliu@gmail.com	Chien, Sheng-Hsuan/HDM-2486-2022	Hu, Yu-Wen/0000-0002-7983-415X; Chen, San-Chi/0000-0002-9436-5400				Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chow EJ, 2013, PEDIATR BLOOD CANCER, V60, P110, DOI 10.1002/pbc.24198; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; de Gonzalez AB, 2010, BRIT J CANCER, V102, P220, DOI 10.1038/sj.bjc.6605435; Haddy N, 2006, EUR J CANCER, V42, P2757, DOI 10.1016/j.ejca.2006.05.034; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; Kantarjian H, 2004, CANCER-AM CANCER SOC, V101, P2788, DOI 10.1002/cncr.20668; LARSON RA, 1995, BLOOD, V85, P2025, DOI 10.1182/blood.V85.8.2025.bloodjournal8582025; Linker C, 2002, J CLIN ONCOL, V20, P2464, DOI 10.1200/JCO.2002.07.116; Liu CJ, 2014, INT J CANCER, V135, P250, DOI 10.1002/ijc.28664; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Murray L, 2014, RADIOTHER ONCOL, V110, P213, DOI 10.1016/j.radonc.2013.12.012; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Robison LL, 2011, HEMATOL-AM SOC HEMAT, P238, DOI 10.1182/asheducation-2011.1.238; Rowe JM, 2005, BLOOD, V106, P3760, DOI 10.1182/blood-2005-04-1623; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Tavernier E, 2007, CANCER-AM CANCER SOC, V110, P2747, DOI 10.1002/cncr.23097; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vandecruys E, 2012, J CANCER SURVIV, V6, P95, DOI 10.1007/s11764-011-0186-6; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152909	10.1371/journal.pone.0152909	http://dx.doi.org/10.1371/journal.pone.0152909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035574	Green Published, gold, Green Submitted			2022-12-27	WOS:000373201200050
J	Barkal, AA; Srinivasan, S; Hashimoto, T; Gifford, DK; Sherwood, RI				Barkal, Amira A.; Srinivasan, Sharanya; Hashimoto, Tatsunori; Gifford, David K.; Sherwood, Richard I.			Cas9 Functionally Opens Chromatin	PLOS ONE			English	Article							HUMAN GENOME; TARGET DNA; RNA; BINDING; CRISPR; GENES; TRANSPOSITION; TRANSCRIPTION; ENDONUCLEASE; ELEMENT	Using a nuclease-dead Cas9 mutant, we show that Cas9 reproducibly induces chromatin accessibility at previously inaccessible genomic loci. Cas9 chromatin opening is sufficient to enable adjacent binding and transcriptional activation by the settler transcription factor retinoic acid receptor at previously unbound motifs. Thus, we demonstrate a new use for Cas9 in increasing surrounding chromatin accessibility to alter local transcription factor binding.	[Barkal, Amira A.; Srinivasan, Sharanya; Sherwood, Richard I.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Barkal, Amira A.; Srinivasan, Sharanya; Sherwood, Richard I.] Harvard Univ, Sch Med, Boston, MA USA; [Barkal, Amira A.; Srinivasan, Sharanya; Hashimoto, Tatsunori; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gifford, David K.] Harvard Univ, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA; [Gifford, David K.] Harvard Univ, Sch Med, 7 Divin Ave, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University	Sherwood, RI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Sherwood, RI (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	rsherwood@partners.org	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	National Institutes of Health [5UL1DE019581, RL1DE019021, 1K01DK101684-01, 1U01HG007037, 5P01NS055923]; Harvard Stem Cell Institute's Sternlicht Director's Fund award; Human Frontier Science Program grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037, R01HG008754, R01HG008363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019581, RL1DE019021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute's Sternlicht Director's Fund award; Human Frontier Science Program grant(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from The National Institutes of Health 5UL1DE019581, RL1DE019021, 1K01DK101684-01, 1U01HG007037 and 5P01NS055923; the Harvard Stem Cell Institute's Sternlicht Director's Fund award and Human Frontier Science Program grant to R.I.S.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	21	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152683	10.1371/journal.pone.0152683	http://dx.doi.org/10.1371/journal.pone.0152683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031353	Green Submitted, gold, Green Published			2022-12-27	WOS:000373121800115
J	Cao, HY; Wang, S; Zhang, ZY; Lou, JY				Cao, Hanyu; Wang, Si; Zhang, Zhenyu; Lou, Jiangyan			Prognostic Value of Overexpressed p16(INK4a) in Vulvar Cancer: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; COLORECTAL-CANCER; P16 EXPRESSION; SURVIVAL; FEATURES; HYPERMETHYLATION; SUPPRESSOR; EXPERIENCE	Objective This study aimed to examine the prognostic value of overexpressed p16(INK4a) in vulvar cancer. Although the tumor suppressor p16(INK4a) has been shown to be of prognostic value in a wide variety of cancers and precancerous lesions, its role in the vulvar cancer is still unclear. Methods All publications in English language on the association between p16(INK4a) and clinicopathological features of vulvar cancer were searched from Pubmed, Embase, and Web of Science, and those in Chinese language were identified manually and online from the China National Knowledge Infrastructure. Strict inclusion and exclusion criteria were followed. Odds ratios(ORs) or risk ratios(RRs) with 95% confidence intervals(CIs) were pooled to assess the strength of association. Publication bias was estimated using funnel plots and the Egger's regression test. Results A total of 17 studies with 2309 patients were included. The p16(INK4a) overexpression was found to correlate significantly with the lower International Federation of Gynecology and Obstetrics stage(I+II vs III+IV; OR = 0.60,95% CI: 0.41-0.86, P = 0.006), negative lymph node metastasis(negative vs positive; OR = 0.61,95% CI: 0.39-0.95, P = 0.029), patient's age<55 (OR = 0.54,95% CI: 0.31-0.96, P = 0.034), human papillomavirus-positive status(OR = 0.01,95% CI: 0.00-0.11, P<0.001), and higher overall survival(RR = 0.53,95% CI = 0.35-0.80, P = 0.003). Conclusion The p16(INK4a) might be associated with a higher survival and indicates better prognosis of vulvar cancer.	[Cao, Hanyu] Sichuan Univ, West China Univ Hosp 2, Dept Gynecol & Obstet, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Si] Sichuan Univ, West China Univ Hosp 2, Genome Stabil Lab, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Zhenyu; Lou, Jiangyan] Sichuan Univ, Minist Educ, Key Lab Birth & Related Dis Women & Children, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Lou, JY (corresponding author), Sichuan Univ, Minist Educ, Key Lab Birth & Related Dis Women & Children, Chengdu 610064, Sichuan Provinc, Peoples R China.	Loujiangyan2@163.com						Alonso I, 2011, GYNECOL ONCOL, V122, P509, DOI 10.1016/j.ygyno.2011.05.016; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bergeron C, 2010, AM J CLIN PATHOL, V133, P395, DOI 10.1309/AJCPXSVCDZ3D5MZM; Beutner Karl R., 1997, American Journal of Medicine, V102, P9; Blecharz P, 2008, EUR J GYNAECOL ONCOL, V29, P260; BLOSS JD, 1991, HUM PATHOL, V22, P711, DOI 10.1016/0046-8177(91)90294-Y; Bu J, 2014, INT J CLIN EXP PATHO, V7, P6091; BURGER MPM, 1995, GYNECOL ONCOL, V57, P327, DOI 10.1006/gyno.1995.1151; Chan MKM, 1998, GYNECOL ONCOL, V68, P156, DOI 10.1006/gyno.1997.4914; Chen YZ, 2014, DNA CELL BIOL, V33, P729, DOI 10.1089/dna.2013.2253; CRUM CP, 1992, OBSTET GYNECOL, V79, P448, DOI 10.1097/00006250-199203000-00025; de Sanjose S, 2013, EUR J CANCER, V49, P3450, DOI 10.1016/j.ejca.2013.06.033; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dong F, 2015, AM J SURG PATHOL, V39, P1045, DOI 10.1097/PAS.0000000000000454; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Guerrero D, 2011, INT J CANCER, V128, P2853, DOI 10.1002/ijc.25629; Hao S, 2004, THESIS CHINA MED U; Harada H, 1999, CANCER RES, V59, P3783; Hellman K, 2014, BRIT J CANCER, V110, P1561, DOI 10.1038/bjc.2014.32; Honoki K, 2007, CANCER-AM CANCER SOC, V110, P1351, DOI 10.1002/cncr.22908; Horn LC, 2008, AM J SURG PATHOL, V32, P502, DOI 10.1097/PAS.0b013e31815ac420; Jiang WJ, 2014, CANCER INVEST, V32, P43, DOI 10.3109/07357907.2013.861476; Kagie MJ, 1997, GYNECOL ONCOL, V67, P178, DOI 10.1006/gyno.1997.4834; Knopp S, 2004, GYNECOL ONCOL, V95, P37, DOI 10.1016/j.ygyno.2004.07.026; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; KOSARY CL, 1994, SEMIN SURG ONCOL, V10, P31, DOI 10.1002/ssu.2980100107; KURMAN RJ, 1993, AM J SURG PATHOL, V17, P133, DOI 10.1097/00000478-199302000-00005; Lanneau GS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.014; Lavorato-Rocha AM, 2013, TUMOR BIOL, V34, P3713, DOI 10.1007/s13277-013-0955-0; Lin Jiaying, 2014, PLoS One, V9, pe106384, DOI 10.1371/journal.pone.0106384; Lou-Qian Zhang, 2013, PLoS One, V8, pe54970, DOI 10.1371/journal.pone.0054970; Ma H, 2002, THESIS QINGDAO U; Ma H.K., 2013, SMART MAT RES, V2013, P1, DOI DOI 10.1016/J.JEURCERAMS0C.2013.01.004; Maggino T, 2000, CANCER-AM CANCER SOC, V89, P116, DOI 10.1002/1097-0142(20000701)89:1<116::AID-CNCR16>3.0.CO;2-4; Malesci A, 2007, CLIN CANCER RES, V13, P3831, DOI 10.1158/1078-0432.CCR-07-0366; Missaoui N, 2014, ASIAN PAC J CANCER P, V15, P10803, DOI 10.7314/APJCP.2014.15.24.10803; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nogueira MC, 2006, PATHOL ONCOL RES, V12, P153, DOI 10.1007/BF02893362; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Riethdorf S, 2004, HUM PATHOL, V35, P1477, DOI 10.1016/j.humpath.2004.09.004; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Santos M, 2006, AM J SURG PATHOL, V30, P1347, DOI 10.1097/01.pas.0000213251.82940.bf; Scheistroen M, 2002, EUR J GYNAECOL ONCOL, V23, P93; Sideri M, 2005, J REPROD MED, V50, P807; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sznurkowski JJ, 2013, ARCH GYNECOL OBSTET, V287, P1211, DOI 10.1007/s00404-012-2683-x; Tada T, 2003, HEPATO-GASTROENTEROL, V50, P1756; Trietsch MD, 2014, GYNECOL ONCOL, V135, P149, DOI 10.1016/j.ygyno.2014.07.094; Tringler B, 2007, APPL IMMUNOHISTO M M, V15, P279, DOI 10.1097/01.pai.0000213118.81343.32; van der Avoort IAM, 2006, INT J GYNECOL PATHOL, V25, P22, DOI 10.1097/01.pgp.0000177646.38266.6a; Wei L, 2008, MATERN CHILD HLTH J, P3168; Zhao FY, 2014, INT J CLIN EXP PATHO, V7, P1012; Zheng A, 2000, SICHUAN MED J, P405; Zong L, 2012, HEPATO-GASTROENTEROL, V59, P1458, DOI 10.5754/hge11473	56	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152459	10.1371/journal.pone.0152459	http://dx.doi.org/10.1371/journal.pone.0152459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031618	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800077
J	Hu, XT; Tai, JD; Qu, ZH; Zhao, SC; Zhang, L; Li, M; Sun, XG; Jiang, YF				Hu, Xintong; Tai, Jiandong; Qu, Zhihui; Zhao, Songchen; Zhang, Li; Li, Man; Sun, Xiguang; Jiang, Yanfang			A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis	PLOS ONE			English	Article							SCHONLEIN PURPURA; TRANSPLANTATION; PATHOGENESIS; LYMPHOCYTES; HEPATITIS; TARGETS; SUBSET; KIDNEY; RISK	Background Henoch-Schoenlein purpura is the one of most common types of systemic vasculitis that involves impaired renal function and Henoch-Schoenlein purpura nephritis (HSPN). The diagnosis of this condition is largely based on immunohistologic detection of immunoglobulin A1-containing immune complex in the glomerular deposits of mesangium. Despite clinical advances, the etiopathogenesis of HSPN is still largely unknown. Methods In this study, we enrolled 25 newly diagnosed HSPN patients and 14 healthy controls. Then, fractions of B cell subtypes were determined in venous blood using flow cytometry. The serum interleukin (IL)-10 concentration was determined by enzyme-linked immunosorbent assay. Results Compared to those in healthy controls, the numbers of CD38(+)CD19(+), CD86(+)CD19(+), CD38(+)CD86(+)CD19(+), and CD95(+)CD19(+) B cells per microliter of blood were significantly higher in HSPN patients. In contrast, the numbers of CD5(+)CD19(+), IL-10(+)CD19(+), CD5(+)CD1d(+)CD19(+), and IL-10(+)CD5(+)CD1d(+)CD19(+) B cells per microliter of blood and the serum IL-10 concentration were significantly lower in HSPN patients. Following treatment, the numbers of CD38(+)CD19(+) and CD86(+)CD19(+) B cells per microliter of blood were significantly reduced in HSPN patients. However, the numbers of CD5(+)CD1d(+)CD19(+), CD5(+)CD1d(+)IL-10(+)CD19(+), and IL-10(+)CD19(+) B cells per microliter of blood and the serum IL-10 concentration were significantly increased in HSPN patients following treatment. The estimated glomerular filtration rate (eGFR) was negatively correlated with the number of CD38(+)CD19(+) B cells but positively correlated with the numbers of IL-10(+)CD19(+), CD1d(+)CD5(+)CD19(+), and IL-10(+)CD1d(+)CD5(+)CD19(+)B cells per microliter of blood and the serum IL-10 concentration. The 24-h urinary protein concentration was positively correlated with the number of CD38(+)CD19(+)B cells but negatively correlated with the numbers of IL-10(+)CD19(+), CD1d(+-)CD5(+) CD19(+), and IL-10(+)CD1d(+)CD5(+)CD19(+)B cells per microliter of blood and the serum IL-10 concentration. Conclusion Our results suggest that CD38(+)CD19(+) and CD1d(+)CD5(+)CD19(+) B cells (Bregs) contribute to the pathogenesis of HSPN.	[Hu, Xintong; Tai, Jiandong; Zhao, Songchen; Li, Man; Sun, Xiguang; Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Key Lab Zoonoses Res, Minist Educ, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Qu, Zhihui; Zhang, Li] Jilin Univ, Hosp 1, Dept Nephrol, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Sun, XG; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China.; Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Key Lab Zoonoses Res, Minist Educ, Changchun 130023, Peoples R China.; Jiang, YF (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	xi-guangsun@hotmail.com; yanfangjiang@jlu.edu.cn						Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Aybar LT, 2015, CLIN EXP IMMUNOL, V180, P178, DOI 10.1111/cei.12483; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Dumoitier N, 2015, AUTOIMMUN REV, V14, P996, DOI 10.1016/j.autrev.2015.06.008; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Fremd C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25443; Gunderson AJ, 2013, EXP CELL RES, V319, P1644, DOI 10.1016/j.yexcr.2013.03.005; Jennette JC, 2014, SEMIN IMMUNOPATHOL, V36, P327, DOI 10.1007/s00281-014-0431-y; Ji SM, 2004, CLIN TRANSPLANT, V18, P536, DOI 10.1111/j.1399-0012.2004.00206.x; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Kammertoens T, 2012, INT J CANCER, V131, P1499, DOI 10.1002/ijc.27411; Kang Y, 2014, J KOREAN MED SCI, V29, P198, DOI 10.3346/jkms.2014.29.2.198; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Liu Y, 2016, CLIN EXP PHARM PHYSL; Liu Y, 2014, INT IMMUNOPHARMACOL, V22, P98, DOI 10.1016/j.intimp.2014.06.024; Menezes SM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-18; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Moroni G, 2008, NEPHROL DIAL TRANSPL, V23, P3010, DOI 10.1093/ndt/gfn209; Narchi H, 2005, ARCH DIS CHILD, V90, P916, DOI 10.1136/adc.2005.074641; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nzula S, 2003, CANCER RES, V63, P3275; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Pillebout E, 2014, REV MED INTERNE, V35, P372, DOI 10.1016/j.revmed.2013.12.004; Pohl M, 2015, PEDIATR NEPHROL, V30, P245, DOI 10.1007/s00467-014-2815-6; Qi SQ, 2014, REPROD TOXICOL, V50, P108, DOI 10.1016/j.reprotox.2014.10.013; Ronkainen J, 2003, CLIN NEPHROL, V60, P80; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Soler MJ, 2005, TRANSPL P, V37, P3705, DOI 10.1016/j.transproceed.2005.09.172; Sun F, 2014, MUSCLE NERVE, V49, P487, DOI 10.1002/mus.23951; Unizony S, 2015, ARTHRITIS RHEUMATOL, V67, P535, DOI 10.1002/art.38916; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Wang YY, 2014, SCAND J IMMUNOL, V79, P51, DOI 10.1111/sji.12128; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Ye Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127767; Zhang N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836157; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461	45	10	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152368	10.1371/journal.pone.0152368	http://dx.doi.org/10.1371/journal.pone.0152368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030970	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800062
J	Schwarzer, C; Fischer, H; Machen, TE				Schwarzer, Christian; Fischer, Horst; Machen, Terry E.			Chemotaxis and Binding of Pseudomonas aeruginosa to Scratch-Wounded Human Cystic Fibrosis Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; CL-TRANSPORT; IDENTIFICATION; CHEMORECEPTOR; INFECTION; PROTEINS; TISSUE; CF	Confocal imaging was used to characterize interactions of Pseudomonas aeruginosa (PA, expressing GFP or labeled with Syto 11) with CF airway epithelial cells (CFBE41o-, grown as confluent monolayers with unknown polarity on coverglasses) in control conditions and following scratch wounding. Epithelia and PAO1-GFP or PAK-GFP (2 MOI) were incubated with Ringer containing typical extracellular salts, pH and glucose and propidium iodide (PI, to identify dead cells). PAO1 and PAK swam randomly over and did not bind to non-wounded CFBE41o-cells. PA migrated rapidly (began within 20 sec, maximum by 5 mins) and massively (10-80 fold increase, termed "swarming"), but transiently (random swimming after 15 mins), to wounds, particularly near cells that took up PI. Some PA remained immobilized on cells near the wound. PA swam randomly over intact CFBE41o-monolayers and wounded monolayers that had been incubated with medium for 1 hr. Expression of CFTR and altered pH of the media did not affect PA interactions with CFBE41o-wounds. In contrast, PAO1 swarming and immobilization along wounds was abolished in PAO1 (PAO1 Delta cheYZABW, no expression of chemotaxis regulatory components cheY, cheZ, cheA, cheB and cheW) and greatly reduced in PAO1 that did not express amino acid receptors pctA, B and C (PAO1 Delta pctABC) and in PAO1 incubated in Ringer containing a high concentration of mixed amino acids. Non-piliated PAK Delta pilA swarmed normally towards wounded areas but bound infrequently to CFBE41o- cells. In contrast, both swarming and binding of PA to CFBE41o- cells near wounds were prevented in non-flagellated PAK Delta fliC. Data are consistent with the idea that (i) PA use amino acid sensor-driven chemotaxis and flagella-driven swimming to swarm to CF airway epithelial cells near wounds and (ii) PA use pili to bind to epithelial cells near wounds.	[Schwarzer, Christian; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Fischer, Horst] Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	tmachen@berkeley.edu						Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; Alvarez-Ortega C, 2007, APPL ENVIRON MICROB, V73, P7793, DOI 10.1128/AEM.01898-07; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; Cao XF, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0191-9; Cho DY, 2011, INT FORUM ALLERGY RH, V1, P123, DOI 10.1002/alr.20028; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deng XF, 2013, J VIROL, V87, P4097, DOI 10.1128/JVI.03132-12; Falke JJ, 2014, CURR OPIN STRUC BIOL, V29, P85, DOI 10.1016/j.sbi.2014.10.001; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Garvis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000540; Glekas GD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413518; Hampton TH, 2012, AM J PHYSIOL-LUNG C, V303, pL509, DOI 10.1152/ajplung.00226.2011; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Huang JY, 2015, CELL HOST MICROBE, V18, P147, DOI 10.1016/j.chom.2015.07.002; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Illek B, 2010, CELL PHYSIOL BIOCHEM, V26, P983, DOI 10.1159/000324011; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; KATO J, 1992, J BACTERIOL, V174, P5149, DOI 10.1128/JB.174.15.5149-5151.1992; Kato J, 2008, J BIOSCI BIOENG, V106, P1, DOI 10.1263/jbb.106.1; KELLYWINTENBERG K, 1994, APPL ENVIRON MICROB, V60, P363, DOI 10.1128/AEM.60.1.363-367.1994; Kong M, 2013, VIRUSES-BASEL, V5, P2260, DOI 10.3390/v5092260; KURODA A, 1995, J BACTERIOL, V177, P7019, DOI 10.1128/jb.177.24.7019-7025.1995; Lacal J, 2010, J BIOL CHEM, V285, P23124, DOI 10.1074/jbc.M110.110403; Lee A, 1999, AM J PHYSIOL-LUNG C, V277, pL204, DOI 10.1152/ajplung.1999.277.1.L204; Liu XX, 2009, J BACTERIOL, V191, P2909, DOI 10.1128/JB.01708-08; Losa D, 2014, J IMMUNOL, V192, P4804, DOI 10.4049/jimmunol.1301294; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Nguyen TNT, 2012, EUR RESPIR J, V40, P1390, DOI 10.1183/09031936.00221711; Oglesby IK, 2013, J IMMUNOL, V190, P3354, DOI 10.4049/jimmunol.1202960; OHGA T, 1993, FEMS MICROBIOL LETT, V113, P63; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; Pena J, 2009, INFECT IMMUN, V77, P2857, DOI 10.1128/IAI.01355-08; Psoter KJ, 2015, ANN AM THORAC SOC, V12, P385, DOI 10.1513/AnnalsATS.201408-400OC; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Sammak PJ, 1997, J CELL SCI, V110, P465; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Schwarzer C, 2014, AM J PHYSIOL-CELL PH, V306, pC844, DOI 10.1152/ajpcell.00002.2014; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Shitashiro M, 2003, J BIOTECHNOL, V101, P11, DOI 10.1016/S0168-1656(02)00285-7; SLY LM, 1993, CAN J MICROBIOL, V39, P1079, DOI 10.1139/m93-163; Taguchi K, 1997, MICROBIOL-UK, V143, P3223, DOI 10.1099/00221287-143-10-3223; Tran CS, 2014, CELL HOST MICROBE, V15, P636, DOI 10.1016/j.chom.2014.04.007; UHLMAN DL, 1982, J GEN MICROBIOL, V128, P415; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yoshizaki K, 2010, INHAL TOXICOL, V22, P610, DOI 10.3109/08958371003621633	54	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150109	10.1371/journal.pone.0150109	http://dx.doi.org/10.1371/journal.pone.0150109			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031335	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800005
J	Toma, S; Lacquaniti, F				Toma, Simone; Lacquaniti, Francesco			Mapping Muscles Activation to Force Perception during Unloading	PLOS ONE			English	Article							PSYCHOPHYSICAL SENSITIVITY; PERCEIVED HEAVINESS; ARM-MOVEMENT; MOTOR; DISCRIMINATION; SIGNALS; WEIGHT; MOTION; MASS; REPRESENTATION	It has been largely proved that while judging a force humans mainly rely on the motor commands produced to interact with that force (i.e., sense of effort). Despite of a large bulk of previous investigations interested in understanding the contributions of the descending and ascending signals in force perception, very few attempts have been made to link a measure of neural output (i.e., EMG) to the psychophysical performance. Indeed, the amount of correlation between EMG activity and perceptual decisions can be interpreted as an estimate of the contribution of central signals involved in the sensation of force. In this study we investigated this correlation by measuring the muscular activity of eight arm muscles while participants performed a quasi-isometric force detection task. Here we showed a method to quantitatively describe muscular activity ("muscle-metric function") that was directly comparable to the description of the participants' psychophysical decisions about the stimulus force. We observed that under our experimental conditions, muscle-metric absolute thresholds and the shape of the muscle-metric curves were closely related to those provided by the psychophysics. In fact a global measure of the muscles considered was able to predict approximately 60% of the perceptual decisions total variance. Moreover the inter-subjects differences in psychophysical sensitivity showed high correlation with both participants' muscles sensitivity and participants' joint torques. Overall, our findings gave insights into both the role played by the corticospinal motor commands while performing a force detection task and the influence of the gravitational muscular torque on the estimation of vertical forces.	[Toma, Simone; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Toma, Simone; Lacquaniti, Francesco] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata	Toma, S (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy.; Toma, S (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	stoma1@asu.edu			Italian University Ministry PRIN grant [2010MEFNF7_002]; Italian Space Agency (COREA grants)	Italian University Ministry PRIN grant; Italian Space Agency (COREA grants)	This research was supported by grants from the Italian University Ministry PRIN grant 2010MEFNF7_002 and the Italian Space Agency (COREA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alaerts K, 2010, EUR J NEUROSCI, V31, P1144, DOI 10.1111/j.1460-9568.2010.07124.x; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Dalecki M, 2012, EXP BRAIN RES, V218, P41, DOI 10.1007/s00221-012-2999-6; Debats NB, 2010, EUROHAPTICS, V2, P392; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; FLANDERS M, 1994, J NEUROPHYSIOL, V71, P811, DOI 10.1152/jn.1994.71.2.811; Fontana M, 2013, SENSORS-BASEL, V13, P7618, DOI 10.3390/s130607618; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; GANDEVIA SC, 1976, BRAIN RES, V109, P399, DOI 10.1016/0006-8993(76)90542-4; GANDEVIA SC, 1977, J PHYSIOL-LONDON, V272, P673, DOI 10.1113/jphysiol.1977.sp012066; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Ghosh A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1139; Goodall S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080202; Gottlieb GL, 1997, J NEUROPHYSIOL, V78, P2985, DOI 10.1152/jn.1997.78.6.2985; GOTTLIEB GL, 1994, EXP BRAIN RES, V97, P545; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Jones LA, 2003, EXP BRAIN RES, V151, P197, DOI 10.1007/s00221-003-1434-4; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; JONES LA, 1983, EXP NEUROL, V81, P640, DOI 10.1016/0014-4886(83)90332-1; Kim HR, 2015, J NEUROSCI, V35, P2766, DOI 10.1523/JNEUROSCI.3134-14.2015; Lackner JR, 2000, TRENDS COGN SCI, V4, P279, DOI 10.1016/S1364-6613(00)01493-5; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Lenzo B, 2015, TRACKHOLD NOVEL PASS; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewandowsky S., 2011, COMPUTATIONAL MODELI; Linschoten MR, 2001, PERCEPT PSYCHOPHYS, V63, P1330, DOI 10.3758/BF03194546; Lipshits MI, 1998, LIF SCI RES SPAC P 5, P36; McCloskey D. I, 1981, COROLLARY DISCHARGE; McIntyre J, 1998, BRAIN RES REV, V28, P143, DOI 10.1016/S0165-0173(98)00034-4; Miall RC, 2000, EXP BRAIN RES, V133, P491, DOI 10.1007/s002210000433; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Pellegrini JJ, 1996, EXP BRAIN RES, V110, P80; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; Ross H. E., 2008, HUMAN HAPTIC PERCEPT, DOI [10.1007/978-3-7643-7612-3_22, DOI 10.1007/978-3-7643-7612-3_22]; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; Russo M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00024; Sakajiri T, 2013, EXP BRAIN RES, V231, P129, DOI 10.1007/s00221-013-3676-0; SANES JN, 1995, CAN J PHYSIOL PHARM, V73, P223, DOI 10.1139/y95-033; Sanes JN, 1990, ATTENTION PERFORM, VXIII, P714; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shemmell J, 2005, J NEUROPHYSIOL, V94, P3046, DOI 10.1152/jn.00670.2004; STEVENS JC, 1959, J EXP PSYCHOL, V58, P405, DOI 10.1037/h0046906; STEVENS JC, 1970, PERCEPT PSYCHOPHYS, V8, P240, DOI 10.3758/BF03210214; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Takarada Y, 2014, NEUROSCI RES, V89, P54, DOI 10.1016/j.neures.2014.09.005; Thickbroom GW, 2006, J NEUROL, V253, P1048, DOI 10.1007/s00415-006-0159-2; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Uka T, 2003, J NEUROSCI, V23, P3515; Waller A. D., 1891, BRAIN, V14, P179, DOI [10.1093/brain/14.2-3.179, DOI 10.1093/BRAIN/14.2-3.179]; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu B, 2011, IEEE T HAPTICS, V4, P221, DOI 10.1109/ToH.2011.3	59	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152552	10.1371/journal.pone.0152552	http://dx.doi.org/10.1371/journal.pone.0152552			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27032087	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800091
J	Xu, YM; Bai, XN; Zhao, AL; Zhang, W; Ba, PB; Liu, K; Jin, YJ; Wang, H; Guo, QS; Sun, H; Xu, JG; Xiong, YW				Xu, Yanmei; Bai, Xiangning; Zhao, Ailan; Zhang, Wang; Ba, Pengbin; Liu, Kai; Jin, Yujuan; Wang, Hong; Guo, Qiusheng; Sun, Hui; Xu, Jianguo; Xiong, Yanwen			Genetic Diversity of Intimin Gene of Atypical Enteropathogenic Escherichia coli Isolated from Human, Animals and Raw Meats in China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; METROPOLITAN-AREA; STRAINS; CHILDREN; DIARRHEA; IDENTIFICATION; PREVALENCE; OUTBREAK; RESISTANCE; SEROTYPES	Atypical enteropathogenic Escherichia coli (aEPEC) is considered to be an emerging enteropathogen that is more prevalent than typical EPEC in developing and developed countries. The major adherence factor, intimin, an outer membrane protein encoded by eae, plays a pivotal role in the pathogenesis of aEPEC. This study investigated the distribution and polymorphisms of intimin subtypes of 143 aEPEC strains from diarrheal patients, healthy carriers, animals, and raw meats in China. These aEPEC strains belonged to more than 71 different serotypes, which comprised 52 O serogroups and 24 H types. Sixty-eight different eae genotypes and 19 intimin subtypes were detected. Eighteen, eight, seven, and five intimin subtypes were identified from 86 diarrheal patients, 14 healthy carriers, 19 animals, and 24 raw meats strains, respectively. Intimin beta 1 was the most prevalent subtype in strains from diarrheal patients (34.88%) and animals (47.37%). There was a statistically significant difference in the distribution of eae-beta 1 between diarrheal patients and healthy carriers (P = 0.004). Intimin-theta was more predominant among raw meat strains (50%) than among diarrheal patients strains (12.79%, P = 0.0003), healthy carrier strains (7.14%, P = 0.007), or animal strains (15.79%, P = 0.020). The two predominant subtypes (eae-beta 1 and eae-theta) had considerable polymorphisms with no significant differences among the four sources. PFGE analysis revealed 119 distinct patterns and the strains were clustered into 11 groups with similarity indices ranging from 63% to 100%. These results suggest that in China, aEPEC strains from different sources are highly heterogeneous. Animals and raw meats are important sources of genetically diverse intimin-harboring aEPEC, which might serve as important transmission vehicles of these bacteria.	[Xu, Yanmei; Bai, Xiangning; Zhao, Ailan; Zhang, Wang; Ba, Pengbin; Liu, Kai; Sun, Hui; Xu, Jianguo; Xiong, Yanwen] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Jin, Yujuan] Longgang Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Wang, Hong] Zigong Ctr Dis Control & Prevent, Zigong, Sichuan Provinc, Peoples R China; [Guo, Qiusheng] Suixian Ctr Dis Control & Prevent, Shangqiu, Henan Province, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Xiong, YW (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xiongyanwen@icdc.cn			National Natural Science Foundation of China [81371762]; State Key Laboratory for Infectious Disease Prevention and Control [2015SKLID504]; National Basic Research Priorities Program of China [2015CB554201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control; National Basic Research Priorities Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (81371762) [http://www.nsfc.gov.cn/publish/portal1/], the State Key Laboratory for Infectious Disease Prevention and Control (2015SKLID504) [http://www.sklid.cn/], and the National Basic Research Priorities Program of China (2015CB554201) [http://www.most.gov.cn/eng/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maldonado NA, 2014, BIOMEDICA, V34, P433, DOI [10.1590/S0120-41572014000300013, 10.7705/biomedica.v34i3.1658]; Bardiau M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-124; Beutin L, 2003, INFECT IMMUN, V71, P3995, DOI 10.1128/IAI.71.7.3995-4002.2003; Bielaszewska M, 2008, CLIN INFECT DIS, V47, P208, DOI 10.1086/589245; Blanco JE, 2004, J CLIN MICROBIOL, V42, P311, DOI 10.1128/JCM.42.1.311-319.2004; Blanco M, 2006, J MED MICROBIOL, V55, P1165, DOI 10.1099/jmm.0.46518-0; Blanco M, 2006, INT MICROBIOL, V9, P103; Chen Y, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12188; Contreras CA, 2010, J MED MICROBIOL, V59, P25, DOI 10.1099/jmm.0.013706-0; Cookson AL, 2007, FEMS MICROBIOL LETT, V272, P163, DOI 10.1111/j.1574-6968.2007.00755.x; Creuzburg K, 2011, ENVIRON MICROBIOL, V13, P439, DOI 10.1111/j.1462-2920.2010.02349.x; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Donnenberg MS, 2013, TRENDS MICROBIOL, V21, P317, DOI 10.1016/j.tim.2013.05.003; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Franco RT, 2012, DIAGN MICR INFEC DIS, V74, P81, DOI 10.1016/j.diagmicrobio.2012.05.022; FRANKEL G, 1995, INFECT IMMUN, V63, P4323, DOI 10.1128/IAI.63.11.4323-4328.1995; Ghosh PK, 2010, J MED MICROBIOL, V59, P1156, DOI 10.1099/jmm.0.014530-0; Girard F, 2005, INFECT IMMUN, V73, P6005, DOI 10.1128/IAI.73.9.6005-6016.2005; Hao RZ, 2012, J CLIN MICROBIOL, V50, P2450, DOI 10.1128/JCM.00276-12; Hedberg CW, 1997, J INFECT DIS, V176, P1625, DOI 10.1086/517342; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2008, MICROBIOL-SGM, V154, P559, DOI 10.1099/mic.0.2007/013334-0; Iguchi A, 2015, J CLIN MICROBIOL, V53, P2427, DOI 10.1128/JCM.00321-15; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Moller-Stray J, 2012, EUROSURVEILLANCE B E, V17; Moura RA, 2009, APPL ENVIRON MICROB, V75, P7399, DOI 10.1128/AEM.00636-09; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nguyen RN, 2006, EMERG INFECT DIS, V12, P597; Ochoa TJ, 2008, T ROY SOC TROP MED H, V102, P852, DOI 10.1016/j.trstmh.2008.03.017; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Oh JY, 2012, POULTRY SCI, V91, P2438, DOI 10.3382/ps.2012-02301; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Pacheco VCR, 2014, PATHOG DIS, V70, P167, DOI 10.1111/2049-632X.12112; Park JH, 2014, FOODBORNE PATHOG DIS, V11, P775, DOI 10.1089/fpd.2014.1754; Phillips AD, 2000, J INFECT DIS, V181, P1496, DOI 10.1086/315404; Pitondo-Silva A, 2015, APMIS, V123, P128, DOI 10.1111/apm.12314; Ramachandran V, 2003, J CLIN MICROBIOL, V41, P5022, DOI 10.1128/JCM.41.11.5022-5032.2003; Scaletsky ICA, 2010, J CLIN MICROBIOL, V48, P302, DOI 10.1128/JCM.01980-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Wang LL, 2013, APPL ENVIRON MICROB, V79, P1232, DOI 10.1128/AEM.03380-12; Yang K, 2014, APPL ENVIRON MICROB, V80, P119, DOI 10.1128/AEM.02747-13; Yatsuyanagi J, 2002, J CLIN MICROBIOL, V40, P294, DOI 10.1128/JCM.40.1.294-297.2002; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001	47	9	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152571	10.1371/journal.pone.0152571	http://dx.doi.org/10.1371/journal.pone.0152571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031337	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800095
J	Yu, CC; Huang, HB; Hung, SK; Liao, HF; Lee, CC; Lin, HY; Li, SC; Ho, HC; Hung, CL; Su, YC				Yu, Chih-Chia; Huang, Hsien-bin; Hung, Shih-Kai; Liao, Hui-Fen; Lee, Ching-Chih; Lin, Hon-Yi; Li, Szu-Chin; Ho, Hsu-Chueh; Hung, Chung-Lin; Su, Yu-Chieh			AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest	PLOS ONE			English	Article							MTORC2; GROWTH; RESISTANCE	Background Oral squamous cell carcinoma (OSCC) is one of the most common malignant neoplasms in Taiwan. Activation of the mTOR signaling pathway has been linked to decreased radiation responsiveness in human oral cancer, thus it limits efficacy of radiotherapy. To address this question, we investigated the effect of AZD2014, a novel small molecular ATP-competitive inhibitor of mTORC1 and mTORC2 kinase, as a radiosensitizer in primary OSCC and OSCC-derived cell line models. Methods We isolated primary tumor cells from OSCC tissues and cell lines. AZD2014 was administered with and without ionizing radiation. The radiosensitizing effect of AZD2014 were then assessed using cell viability assays, clonogenic survival assays, and cell cycle analyses. Western blotting was used to detect protein expression. Results Combination treatment with AZD2014 and irradiation resulted in significant reduction in OSCC cell line and primary OSCC cell colony formation due to the enhanced inhibition of AKT and both mTORC1 and mTORC2 activity. Pre-treatment with AZD2014 in irradiated oral cancer cells induced tumor cell cycle arrest at the G1 and G2/M phases, which led to disruption of cyclin D1-CDK4 and cyclin B1-CDC2 complexes. Moreover, AZD2014 synergized with radiation to promote both apoptosis and autophagy by increasing caspase-3 and LC3 in primary OSCC cells. Conclusions These findings suggest that in irradiated OSCC cells, co-treatment with AZD2014, which targets mTORC1 and mTORC2 blockade, is an effective radiosensitizing strategy for oral squamous cell carcinoma.	[Yu, Chih-Chia; Huang, Hsien-bin; Li, Szu-Chin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan; [Yu, Chih-Chia; Huang, Hsien-bin; Li, Szu-Chin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan; [Yu, Chih-Chia; Li, Szu-Chin; Hung, Chung-Lin; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Hung, Shih-Kai; Lee, Ching-Chih; Lin, Hon-Yi; Ho, Hsu-Chueh; Su, Yu-Chieh] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hung, Shih-Kai; Lin, Hon-Yi] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh] Buddhist Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Liao, Hui-Fen] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chiayi University	Su, YC (corresponding author), Buddhist Dalin Tzu Chi Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan.; Su, YC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hepatoma@gmail.com		Hung, Shih-Kai/0000-0002-4945-528X	Buddhist Dalin Tzu Chi Hospital [DTCRD102(2)-I-15, DTCRD103(2)-I-02]	Buddhist Dalin Tzu Chi Hospital	This study was supported by research grants from the Buddhist Dalin Tzu Chi Hospital (DTCRD102(2)-I-15 and DTCRD103(2)-I-02). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SH, 2010, INDIAN J MED PAEDIAT, V31, P132, DOI 10.4103/0971-5851.76197; Altman JK, 2011, CLIN CANCER RES, V17, P4378, DOI 10.1158/1078-0432.CCR-10-2285; Anandharaj A, 2011, ACTA BIOCH BIOPH SIN, V43, P292, DOI 10.1093/abbs/gmr012; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Chen BW, 2015, MOL CANCER THER, V14, P1805, DOI 10.1158/1535-7163.MCT-15-0029; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gao Wei, 2012, ISRN Otolaryngol, V2012, P953089, DOI 10.5402/2012/953089; Gogineni VR, 2011, CANCER LETT, V313, P64, DOI 10.1016/j.canlet.2011.08.022; Health Do, 2010, EX YUAN RCRA; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Kahn J, 2014, NEURO-ONCOLOGY, V16, P29, DOI 10.1093/neuonc/not139; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Koo J, 2014, CANCER RES, V74, P2555, DOI 10.1158/0008-5472.CAN-13-2946; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liao H, 2015, AM J CANCER RES, V5, P125; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nassim R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065257; Peyressatre M, 2015, CANCERS, V7, P179, DOI 10.3390/cancers7010179; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Smrz D, 2011, BLOOD, V118, P6803, DOI 10.1182/blood-2011-06-359984; Wei F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-81; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Yano T, 2014, CIRC RES, V114, P1268, DOI 10.1161/CIRCRESAHA.114.303562; Yardley DA, 2013, BREAST CANCER-BASIC, V7, P7, DOI 10.4137/BCBCR.S10071; Yu CC, 2014, ANTICANCER RES, V34, P2927	30	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151942	10.1371/journal.pone.0151942	http://dx.doi.org/10.1371/journal.pone.0151942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031247	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800024
J	Lim, HJ; Weinheimer, O; Wielputz, MO; Dinkel, J; Hielscher, T; Gompelmann, D; Kauczor, HU; Heussel, CP				Lim, Hyun-ju; Weinheimer, Oliver; Wielpuetz, Mark O.; Dinkel, Julien; Hielscher, Thomas; Gompelmann, Daniela; Kauczor, Hans-Ulrich; Heussel, Claus Peter			Fully Automated Pulmonary Lobar Segmentation: Influence of Different Prototype Software Programs onto Quantitative Evaluation of Chronic Obstructive Lung Disease	PLOS ONE			English	Article							VOLUME REDUCTION SURGERY; COMPUTED-TOMOGRAPHY; EMPHYSEMA; CT; QUANTIFICATION; DENSITY; AIRWAYS	Objectives Surgical or bronchoscopic lung volume reduction (BLVR) techniques can be beneficial for heterogeneous emphysema. Post-processing software tools for lobar emphysema quantification are useful for patient and target lobe selection, treatment planning and post-interventional follow-up. We aimed to evaluate the inter-software variability of emphysema quantification using fully automated lobar segmentation prototypes. Material and Methods 66 patients with moderate to severe COPD who underwent CT for planning of BLVR were included. Emphysema quantification was performed using 2 modified versions of in-house software (without and with prototype advanced lung vessel segmentation; programs 1 [YACTA v.2.3.0.2] and 2 [YACTA v.2.4.3.1]), as well as 1 commercial program 3 [Pulmo3D VA30A_HF2] and 1 pre-commercial prototype 4 [CT COPD ISP ver7.0]). The following parameters were computed for each segmented anatomical lung lobe and the whole lung: lobar volume (LV), mean lobar density (MLD), 15th percentile of lobar density (15th), emphysema volume (EV) and emphysema index (EI). Bland-Altman analysis (limits of agreement, LoA) and linear random effects models were used for comparison between the software. Results Segmentation using programs 1, 3 and 4 was unsuccessful in 1 (1%), 7 (10%) and 5 (7%) patients, respectively. Program 2 could analyze all datasets. The 53 patients with successful segmentation by all 4 programs were included for further analysis. For LV, program 1 and 4 showed the largest mean difference of 72 ml and the widest LoA of [-356, 499 ml] (p<0.05). Program 3 and 4 showed the largest mean difference of 4% and the widest LoA of [-7, 14%] for EI (p<0.001). Conclusions Only a single software program was able to successfully analyze all scheduled data-sets. Although mean bias of LV and EV were relatively low in lobar quantification, ranges of disagreement were substantial in both of them. For longitudinal emphysema monitoring, not only scanning protocol but also quantification software needs to be kept constant.	[Lim, Hyun-ju; Weinheimer, Oliver; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich; Heussel, Claus Peter] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Lim, Hyun-ju; Weinheimer, Oliver; Wielpuetz, Mark O.; Dinkel, Julien; Heussel, Claus Peter] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Amalienstr 5, D-69126 Heidelberg, Germany; [Lim, Hyun-ju; Weinheimer, Oliver; Wielpuetz, Mark O.; Dinkel, Julien; Gompelmann, Daniela; Kauczor, Hans-Ulrich; Heussel, Claus Peter] Translat Lung Res Ctr Heidelberg TLRC, Neuenheimer Feld 430, D-69120 Heidelberg, Germany; [Lim, Hyun-ju] German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Dinkel, Julien] Univ Munich, Univ Hosp, Inst Clin Radiol, Marchioninistr 15, D-81377 Munich, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Gompelmann, Daniela] Heidelberg Univ, Thoraxklin, Dept Pneumol & Resp Crit Care Med, Amalienstr 5, D-69126 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Heussel, CP (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Heussel, CP (corresponding author), Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Amalienstr 5, D-69126 Heidelberg, Germany.; Heussel, CP (corresponding author), Translat Lung Res Ctr Heidelberg TLRC, Neuenheimer Feld 430, D-69120 Heidelberg, Germany.	heussel@uni-heidelberg.de	Kauczor, Hans-Ulrich/AAU-5955-2021; Gompelmann, Daniela/S-3536-2019; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Weinheimer, Oliver/AAN-3652-2021; Kauczor, HU/AAX-6033-2021	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Gompelmann, Daniela/0000-0002-4857-9854	Ruprecht-Karls-Universitat Heidelberg; Translational Lung Research Center Heidelberg (TLRC), section of the German Lung Research (DZL) - Federal Ministry of Education and Research (BMBF)	Ruprecht-Karls-Universitat Heidelberg; Translational Lung Research Center Heidelberg (TLRC), section of the German Lung Research (DZL) - Federal Ministry of Education and Research (BMBF)	Software development has been supported by the Translational Lung Research Center Heidelberg (TLRC), section of the German Lung Research (DZL) funded by the Federal Ministry of Education and Research (BMBF). The authors further acknowledge the financial support of the Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brown MS, 2012, EUR RADIOL, V22, P1547, DOI 10.1007/s00330-012-2393-6; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Carstensen B., 2013, METHCOMP FUNCTIONS A; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Fiorelli A, 2014, INTERACT CARDIOV TH, V19, P246, DOI 10.1093/icvts/ivu107; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gierada DS, 2000, CHEST, V117, P991, DOI 10.1378/chest.117.4.991; Goldin Jonathan G, 2009, Thorac Surg Clin, V19, P159, DOI 10.1016/j.thorsurg.2009.04.006; Goldin JG, 2009, J THORAC IMAG, V24, P163, DOI 10.1097/RTI.0b013e3181b41b53; Grabenhorst M, 2015, AM J ROENTGENOL, V204, P475, DOI 10.2214/AJR.14.13185; HARRIS EK, 1979, AM J CLIN PATHOL, V72, P374; Heussel CP, 2006, ROFO-FORTSCHR RONTG, V178, P987, DOI 10.1055/s-2006-926823; Heussel CP, 2010, EUR J RADIOL, V74, P473, DOI 10.1016/j.ejrad.2009.03.023; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Hochhegger B, 2013, J APPL CLIN MED PHYS, V14, P254, DOI 10.1120/jacmp.v14i4.4215; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kim V, 2009, J THORAC IMAG, V24, P195, DOI 10.1097/RTI.0b013e3181b41a46; Kuhnigk JM, 2005, RADIOGRAPHICS, V25, P525, DOI 10.1148/rg.252045070; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Molinari F, 2010, RADIOL MED, V115, P516, DOI 10.1007/s11547-010-0536-x; Molinari F, 2013, DIAGN INTERV RADIOL, V19, P279, DOI 10.5152/dir.2013.047; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; MURRAY GD, 1990, BRIT J SURG, V77, P384, DOI 10.1002/bjs.1800770410; Pinheiro J., 2013, R DEV CORE TEAM NLME; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Revel MP, 2008, EUR RADIOL, V18, P2723, DOI 10.1007/s00330-008-1065-z; Schonhofer B, 2015, MED KLIN-INTENSIVMED, V110, P182, DOI 10.1007/s00063-014-0373-0; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Screaton NJ, 2006, CLIN RADIOL, V61, P237, DOI 10.1016/j.crad.2005.09.009; Stratakos G, 2013, CURR DRUG TARGETS, V14, P253, DOI 10.2174/1389450111314020010; Weinheimer O, 2011, FOURTH INTERNATIONAL; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wielputz MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112898; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Zaporozhan J, 2006, J COMPUT ASSIST TOMO, V30, P460, DOI 10.1097/00004728-200605000-00018	41	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0151498	10.1371/journal.pone.0151498	http://dx.doi.org/10.1371/journal.pone.0151498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029047	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500026
J	Park, HJ; Lee, SW; Park, SH; Hong, S				Park, Hyun Jung; Lee, Sung Won; Park, Se-Ho; Hong, Seokmann			iNKT Cells Are Responsible for the Apoptotic Reduction of Basophils That Mediate Th2 Immune Responses Elicited by Papain in Mice Following gamma PGA Stimulation	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; KILLER T-CELLS; ALLERGIC AIRWAY INFLAMMATION; GLUTAMIC ACID; IFN-GAMMA; DENDRITIC CELLS; MAST-CELLS; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; BACILLUS-SUBTILIS	Recent studies have demonstrated that Bacillus subtilis-derived poly-gamma glutamic acid (gamma PGA) treatment suppresses the development of allergic diseases such as atopic dermatitis (AD). Although basophils, an innate immune cell, are known to play critical roles in allergic immune responses and repeated long-term administration of gamma PGA results in decreased splenic basophils in an AD murine model, the underlying mechanisms by which gamma PGA regulates basophil frequency remain unclear. To investigate how gamma PGA modulates basophils, we employed basophil-mediated Th2 induction in vivo model elicited by the allergen papain protease. Repeated injection of gamma PGA reduced the abundance of basophils and their production of IL4 in mice, consistent with our previous study using NC/Nga AD model mice. The depletion of basophils by a single injection of gamma PGA was dependent on the TLR4/DC/IL12 axis. CD1d-dependent V alpha 14 TCR invariant natural killer T (iNKT) cells are known to regulate a variety of immune responses, such as allergy. Because iNKT cell activation is highly sensitive to IL12 produced by DCs, we evaluated whether the effect of gamma PGA on basophils is mediated by iNKT cell activation. We found that in vivo gamma PGA treatment did not induce the reduction of basophils in iNKT cell-deficient CD1d KO mice, suggesting the critical role of iNKT cells in gamma PGA-mediated basophil depletion at the early time points. Furthermore, increased apoptotic basophil reduction triggered by iNKT cells upon gamma PGA stimulation was mainly attributed to Th1 cytokines such as IFN gamma and TNF alpha, consequently resulting in inhibition of papain-induced Th2 differentiation via diminishing basophil-derived IL4. Taken together, our results clearly demonstrate that gamma PGA-induced iNKT cell polarization toward the Th1 phenotype induces apoptotic basophil depletion, leading to the suppression of Th2 immune responses. Thus, elucidation of the crosstalk between innate immune cells will contribute to the design and development of new therapeutics for Th2-mediated immune diseases such as AD.	[Park, Hyun Jung; Lee, Sung Won; Hong, Seokmann] Sejong Univ, Inst Anticanc Med Dev, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Lee, Sung Won; Park, Se-Ho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Sejong University; Korea University	Hong, S (corresponding author), Sejong Univ, Inst Anticanc Med Dev, Dept Biosci & Biotechnol, Seoul 143747, South Korea.	shong@sejong.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2010772]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2010772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; de Bruin AM, 2010, BLOOD, V116, P2559, DOI 10.1182/blood-2009-12-261339; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; Ding SQ, 2010, HEPATOB PANCREAT DIS, V9, P645; Duthie MS, 2005, INFECT IMMUN, V73, P1890, DOI 10.1128/IAI.73.3.1890-1894.2005; Gomez MR, 2014, MUCOSAL IMMUNOL, V7, P188, DOI 10.1038/mi.2013.38; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hida S, 2005, BLOOD, V106, P2011, DOI 10.1182/blood-2005-04-1344; Hubner MP, 2011, CLIN IMMUNOL, V141, P205, DOI 10.1016/j.clim.2011.08.004; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim S, 2009, INT IMMUNOL, V21, P977, DOI 10.1093/intimm/dxp065; Kim TW, 2007, J IMMUNOL, V179, P775, DOI 10.4049/jimmunol.179.2.775; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Lee K, 2011, CLIN EXP ALLERGY, V41, P1143, DOI 10.1111/j.1365-2222.2011.03792.x; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132329; Lee SW, 2015, BIOCHEM BIOPH RES CO, V461, P86, DOI 10.1016/j.bbrc.2015.03.174; Lee SW, 2014, BIOCHEM BIOPH RES CO, V443, P413, DOI 10.1016/j.bbrc.2013.11.097; Lee SW, 2013, EXP DERMATOL, V22, P561, DOI 10.1111/exd.12198; Lee TY, 2014, J INVEST DERMATOL, V134, P704, DOI 10.1038/jid.2013.389; Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4; Lu X, 2006, CHEMBIOCHEM, V7, P1750, DOI 10.1002/cbic.200600197; Luttmann W, 2000, SCAND J IMMUNOL, V51, P54; Mann-Chandler MN, 2005, J IMMUNOL, V175, P3000, DOI 10.4049/jimmunol.175.5.3000; Matsumoto K, 2008, INT ARCH ALLERGY IMM, V146, P40, DOI 10.1159/000126060; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Moore ML, 2009, J IMMUNOL, V183, P2016, DOI 10.4049/jimmunol.0803167; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Poo H, 2010, CHEM BIODIVERS, V7, P1555, DOI 10.1002/cbdv.200900283; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Sakurai T, 2014, CLIN EXP IMMUNOL, V178, P65, DOI 10.1111/cei.12399; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Schneider E, 2004, J IMMUNOL, V172, P5262, DOI 10.4049/jimmunol.172.9.5262; Schroeder JT, 2009, J IMMUNOL, V182, P2432, DOI 10.4049/jimmunol.0801782; Schweitzer AN, 1998, J IMMUNOL, V161, P2762; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Yang YF, 2000, INT IMMUNOL, V12, P1669, DOI 10.1093/intimm/12.12.1669; Yasumi T, 2005, J IMMUNOL, V174, P1325, DOI 10.4049/jimmunol.174.3.1325; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123; Zheng XY, 2002, IMMUNOLOGY, V107, P306, DOI 10.1046/j.1365-2567.2002.01517.x	53	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152189	10.1371/journal.pone.0152189	http://dx.doi.org/10.1371/journal.pone.0152189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049954	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500029
J	Vandenplas, S; Willems, M; Witten, PE; Hansen, T; Fjelldal, PG; Huysseune, A				Vandenplas, Sam; Willems, Maxime; Witten, P. Eckhard; Hansen, Tom; Fjelldal, Per Gunnar; Huysseune, Ann			Epithelial Label-Retaining Cells Are Absent during Tooth Cycling in Salmo salar and Polypterus senegalus	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; LOWER JAW DENTITION; STEM-CELLS; ATLANTIC SALMON; DENTAL LAMINA; DERMAL SKELETON; ADULT STEM; REPLACEMENT; TEETH; SOX2	The Atlantic salmon (Salmo salar) and African bichir (Polypterus senegalus) are both actinopterygian fish species that continuously replace their teeth without the involvement of a successional dental lamina. Instead, they share the presence of a middle dental epithelium: an epithelial tier enclosed by inner and outer dental epithelium. It has been hypothesized that this tier could functionally substitute for a successional dental lamina and might be a potential niche to house epithelial stem cells involved in tooth cycling. Therefore, in this study we performed a BrdU pulse chase experiment on both species to (1) determine the localization and extent of proliferating cells in the dental epithelial layers, (2) describe cell dynamics and (3) investigate if label-retaining cells are present, suggestive for the putative presence of stem cells. Cells proliferate in the middle dental epithelium, outer dental epithelium and cervical loop at the lingual side of the dental organ to form a new tooth germ. Using long chase times, both in S. salar (eight weeks) and P. senegalus (eight weeks and twelve weeks), we could not reveal the presence of label-retaining cells in the dental organ. Immunostaining of P. senegalus dental organs for the transcription factor Sox2, often used as a stem cell marker, labelled cells in the zone of outer dental epithelium which grades into the oral epithelium (ODE transition zone) and the inner dental epithelium of a successor only. The location of Sox2 distribution does not provide evidence for epithelial stem cells in the dental organ and, more specifically, in the middle dental epithelium. Comparison of S. salar and P. senegalus reveals shared traits in tooth cycling and thus advances our understanding of the developmental mechanism that ensures lifelong replacement.	[Vandenplas, Sam; Witten, P. Eckhard; Huysseune, Ann] Univ Ghent, Evolutionary Dev Biol, B-9000 Ghent, Belgium; [Willems, Maxime] Univ Ghent, Pharmaceut Technol, B-9000 Ghent, Belgium; [Hansen, Tom; Fjelldal, Per Gunnar] Inst Marine Res, Matre Res Stn, Matredal, Norway	Ghent University; Ghent University; Institute of Marine Research - Norway	Huysseune, A (corresponding author), Univ Ghent, Evolutionary Dev Biol, B-9000 Ghent, Belgium.	Ann.Huysseune@UGent.be	Witten, Paul Eckhard/AAY-3113-2020	Witten, Paul Eckhard/0000-0002-2928-5762				Abduweli D, 2014, MICROSCOPY-JPN, V63, P141, DOI 10.1093/jmicro/dft085; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Berkovitz B.K., 2000, P186, DOI 10.1017/CBO9780511542626.013; BERKOVITZ BKB, 1977, J EXP ZOOL, V200, P65, DOI 10.1002/jez.1402000109; BERKOVITZ BKB, 1975, J EXP ZOOL, V193, P221, DOI 10.1002/jez.1401930211; BERKOVITZ BKB, 1974, ARCH ORAL BIOL, V19, P1111, DOI 10.1016/0003-9969(74)90239-8; BERKOVITZ BKB, 1978, J BIOL BUCCALE, V6, P205; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Davit-Beal T, 2007, BIOL REV, V82, P49, DOI 10.1111/j.1469-185X.2006.00003.x; Fraser GJ, 2006, EVOL DEV, V8, P446, DOI 10.1111/j.1525-142X.2006.00118.x; Fraser GJ, 2013, DEV BIOL, V377, P399, DOI 10.1016/j.ydbio.2013.02.007; Fraser GJ, 2011, J EXP ZOOL PART B, V316B, P99, DOI 10.1002/jez.b.21387; Fraser GJ, 2004, P ROY SOC B-BIOL SCI, V271, P2311, DOI 10.1098/rspb.2004.2878; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gaete M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074484; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Guzman A, 2013, BIOL OPEN, V2, P1179, DOI 10.1242/bio.20136023; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Handrigan GR, 2010, DEV BIOL, V337, P171, DOI 10.1016/j.ydbio.2009.10.020; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada Hidemitsu, 2002, Odontology, V90, P1, DOI 10.1007/s102660200000; Huysseune A, 2008, EVOL DEV, V10, P6, DOI 10.1111/j.1525-142X.2007.00209.x; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Huysseune A, 2012, J APPL ICHTHYOL, V28, P330, DOI 10.1111/j.1439-0426.2012.02002.x; Huysseune A., 1989, Progress in Zoology, V35, P456; Huysseune A, 2008, DEV GENES EVOL, V218, P427, DOI 10.1007/s00427-008-0237-9; Huysseune A, 2007, J ANAT, V211, P471, DOI 10.1111/j.1469-7580.2007.00788.x; Huysseune A, 2006, INT J DEV BIOL, V50, P637, DOI 10.1387/ijdb.052098ah; Huysseune A, 2006, J EXP ZOOL PART B, V306B, P204, DOI 10.1002/jez.b.21091; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Lau AN, 2012, MOL THER, V20, P1116, DOI 10.1038/mt.2012.37; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Moriyama K, 2010, CELL TISSUE RES, V340, P189, DOI 10.1007/s00441-010-0935-2; Reif W.E., 1984, PATTERN FORMATION PR, P603; REIF WE, 1980, J MORPHOL, V166, P275, DOI 10.1002/jmor.1051660303; REIF WE, 1982, EVOL BIOL, V15, P287; Sasagawa I, 2004, CONNECT TISSUE RES, V46, P33; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Shimada A, 2008, J IMMUNOL METHODS, V339, P11, DOI 10.1016/j.jim.2008.07.013; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Sotiropoulou PA, 2012, COLD SPRING HARB PER, V4, P1; Trapani J, 2001, COPEIA, P35, DOI 10.1643/0045-8511(2001)001[0035:PODRTI]2.0.CO;2; Tucker AS, 2014, SEMIN CELL DEV BIOL, V25, P71, DOI 10.1016/j.semcdb.2013.12.013; Tummers M., 2004, HDB STEM CELLS, V1, P265; Van der heyden C, 2001, ARCH ORAL BIOL, V46, P1051, DOI 10.1016/S0003-9969(01)00064-4; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Vandenplas S, 2012, J APPL ICHTHYOL, V28, P336, DOI 10.1111/j.1439-0426.2012.02003.x; Vandenplas S, 2016, DEV BIOL, V413, P39, DOI 10.1016/j.ydbio.2016.03.004; Vandenplas S, 2014, J EXP ZOOL PART B, V322, P281, DOI 10.1002/jez.b.22577; Vieira FA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-490; Whitear M., 1986, BIOL INTEGUMENT, P8, DOI DOI 10.1007/978-3-662-00989-5; Witten PE, 2005, ARCH ORAL BIOL, V50, P213, DOI 10.1016/j.archoralbio.2004.10.018; Zaminy A, 2012, FLOW CYTOMETRY RECEN, P261	63	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152870	10.1371/journal.pone.0152870	http://dx.doi.org/10.1371/journal.pone.0152870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049953	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000373603500063
J	Zheng, YF; Cai, JL; Hutchins, AP; Jia, L; Liu, PF; Yang, DD; Chen, SB; Ge, LH; Pei, DQ; Wei, SC				Zheng, Yunfei; Cai, Jinglei; Hutchins, Andrew Paul; Jia, Lingfei; Liu, Pengfei; Yang, Dandan; Chen, Shubin; Ge, Lihong; Pei, Duanqing; Wei, Shicheng			Remission for Loss of Odontogenic Potential in a New Micromilieu In Vitro	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NEURAL CREST; MESENCHYMAL CELLS; TISSUE INTERACTIONS; DENTAL MESENCHYME; TOOTH; DIFFERENTIATION; TEETH; BMP4; EXPRESSION	During embryonic organogenesis, the odontogenic potential resides in dental mesenchyme from the bud stage until birth. Mouse dental mesenchymal cells (mDMCs) isolated from the inductive dental mesenchyme of developing molars are frequently used in the context of tooth development and regeneration. We wondered if and how the odontogenic potential could be retained when mDMCs were cultured in vitro. In the present study, we undertook to test the odontogenic potential of cultured mDMCs and attempted to maintain the potential during culturing. We found that cultured mDMCs could retain the odontogenic potential for 24 h with a ratio of 60% for tooth formation, but mDMCs were incapable of supporting tooth formation after more than 24 h in culture. This loss of odontogenic potential was accompanied by widespread transcriptomic alteration and, specifically, the downregulation of some dental mesenchyme-specific genes, such as Pax9, Msx1, and Pdgfra. To prolong the odontogenic potential of mDMCs in vitro, we then cultured mDMCs in a serum-free medium with Knockout Serum Replacement (KSR) and growth factors (fibroblastic growth factor 2 and epidermal growth factor). In this new micromilieu, mDMCs could maintain the odontogenic potential for 48 h with tooth formation ratio of 50%. Moreover, mDMCs cultured in KSR-supplemented medium gave rise to tooth-like structures when recombined with non-dental second-arch epithelium. Among the supplements, KSR is essential for the survival and adhesion of mDMCs, and both Egf and Fgf2 induced the expression of certain dental mesenchyme-related genes. Taken together, our results demonstrated that the transcriptomic changes responded to the alteration of odontogenic potential in cultured mDMCs and a new micromilieu partly retained this potential in vitro, providing insight into the long-term maintenance of odontogenic potential in mDMCs.	[Zheng, Yunfei; Jia, Lingfei; Wei, Shicheng] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Zheng, Yunfei; Cai, Jinglei; Hutchins, Andrew Paul; Liu, Pengfei; Yang, Dandan; Chen, Shubin; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Jia, Lingfei; Wei, Shicheng] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100081, Peoples R China; [Ge, Lihong] Peking Univ, Dept Pediat Dent, Sch & Hosp Stomatol, Beijing 100081, Peoples R China	Peking University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Peking University; Peking University	Wei, SC (corresponding author), Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China.; Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China.; Wei, SC (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100081, Peoples R China.	pei_duanqing@gibh.ac.cn; sc-wei@pku.edu.cn	Ge, Li/T-3955-2018; Wei, Shicheng/F-9552-2017; zheng, yunfei/M-4172-2018; YANG, Dan/HHD-2733-2022; Hutchins, Andrew/O-5708-2018	Ge, Li/0000-0002-1824-8034; Wei, Shicheng/0000-0001-6024-9615; Hutchins, Andrew/0000-0001-7784-2255	Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences [KLRB201401]; National Natural Science Foundation of China [81371697, 81570944]	Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Peking University's 985 Grants, Open Project of Key Laboratory of Regenerative Biology, Chinese Academy of Sciences (KLRB201401), and National Natural Science Foundation of China (No. 81371697; 81570944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei M, 1998, DEVELOPMENT, V125, P4325; Benveniste P, 2014, BLOOD, V123, P1167, DOI 10.1182/blood-2013-07-505099; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Brunskill EW, 2014, DEV BIOL, V391, P133, DOI 10.1016/j.ydbio.2014.04.016; Cai Jinglei, 2013, Cell Regen, V2, P6, DOI 10.1186/2045-9769-2-6; Chai Y, 2000, DEVELOPMENT, V127, P1671; Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039; Hu X, 2014, J DENT RES, V93, P490, DOI 10.1177/0022034514523988; Huang YD, 2015, J DENT, V43, P576, DOI 10.1016/j.jdent.2015.02.008; Hutchins Andrew Paul, 2014, Cell Regen, V3, P1, DOI 10.1186/2045-9769-3-1; Imai H, 1996, DEV BIOL, V176, P151, DOI 10.1006/dbio.1996.9985; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Keller L, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00007; Keller LV, 2012, INT J DEV BIOL, V56, P737, DOI 10.1387/ijdb.120076hl; KOLLAR EJ, 1970, J EMBRYOL EXP MORPH, V24, P173; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Liu C, 2013, DEVELOPMENT, V140, P4375, DOI 10.1242/dev.097733; LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Minamino Y, 2015, STEM CELLS DEV, V24, P172, DOI 10.1089/scd.2014.0152; Morito A, 2009, ARCH HISTOL CYTOL, V72, P51, DOI 10.1679/aohc.72.51; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Otsu K, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00036; Otsu K, 2012, STEM CELLS DEV, V21, P1156, DOI 10.1089/scd.2011.0210; PARTANEN A-M, 1989, International Journal of Developmental Biology, V33, P165; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Saito K, 2013, J ENDODONT, V39, P1250, DOI 10.1016/j.joen.2013.06.017; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; SAXEN L, 1992, CIBA F SYMP, V165, P183; Seki D, 2015, STEM CELL TRANSL MED, V4, P993, DOI 10.5966/sctm.2014-0292; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shetty S, 1999, BIOCHEM J, V339, P751, DOI 10.1042/0264-6021:3390751; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Volponi AA, 2013, J DENT RES, V92, P329, DOI 10.1177/0022034513481041; Wang BM, 2010, DEV BIOL, V344, P795, DOI 10.1016/j.ydbio.2010.05.511; Wang F, 2013, IN VITRO CELL DEV-AN, V49, P626, DOI 10.1007/s11626-013-9641-1; Wu L, 2015, J CELL PHYSIOL, V230, P2588, DOI 10.1002/jcp.25061; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152893	10.1371/journal.pone.0152893	http://dx.doi.org/10.1371/journal.pone.0152893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050091	Green Published, Green Submitted, gold			2022-12-27	WOS:000373603500064
J	Bane, CE; Ivanov, I; Matafonov, A; Boyd, KL; Cheng, QF; Sherwood, ER; Tucker, EI; Smiley, ST; McCarty, OJT; Gruber, A; Gailani, D				Bane, Charles E., Jr.; Ivanov, Ivan; Matafonov, Anton; Boyd, Kelli L.; Cheng, Qiufang; Sherwood, Edward R.; Tucker, Erik I.; Smiley, Stephen T.; McCarty, Owen J. T.; Gruber, Andras; Gailani, David			Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; COAGULATION-FACTOR-XI; CECAL LIGATION; HAGEMAN-FACTOR; PLASMA PREKALLIKREIN; BLOOD-COAGULATION; SYSTEM; KALLIKREIN; RISK; COAGULOPATHY	Sepsis, a systemic inflammatory response to infection, is often accompanied by abnormalities of blood coagulation. Prior work with a mouse model of sepsis induced by cecal ligation and puncture (CLP) suggested that the protease factor XIa contributed to disseminated intravascular coagulation (DIC) and to the cytokine response during sepsis. We investigated the importance of factor XI to cytokine and coagulation responses during the first 24 hours after CLP. Compared to wild type littermates, factor XI-deficient (FXI-/-) mice had a survival advantage after CLP, with smaller increases in plasma levels of TNF-alpha and IL-10 and delayed IL-1 beta and IL-6 responses. Plasma levels of serum amyloid P, an acute phase protein, were increased in wild type mice 24 hours post-CLP, but not in FXI(-/-)mice, supporting the impression of a reduced inflammatory response in the absence of factor XI. Surprisingly, there was little evidence of DIC in mice of either genotype. Plasma levels of the contact factors factor XII and prekallikrein were reduced in WT mice after CLP, consistent with induction of contact activation. However, factor XII and PK levels were not reduced in FXI(-/-)animals, indicating factor XI deficiency blunted contact activation. Intravenous infusion of polyphosphate into WT mice also induced changes in factor XII, but had much less effect in FXI deficient mice. In vitro analysis revealed that factor XIa activates factor XII, and that this reaction is enhanced by polyanions such polyphosphate and nucleic acids. These data suggest that factor XI deficiency confers a survival advantage in the CLP sepsis model by altering the cytokine response to infection and blunting activation of the contact (kallikrein-kinin) system. The findings support the hypothesis that factor XI functions as a bidirectional interface between contact activation and thrombin generation, allowing the two processes to influence each other.	[Bane, Charles E., Jr.; Ivanov, Ivan; Matafonov, Anton; Boyd, Kelli L.; Cheng, Qiufang; Gailani, David] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Matafonov, Anton] Tomsk Polytech Univ, Dept Bioengn & Organ Chem, Tomsk, Russia; [Sherwood, Edward R.] Vanderbilt Univ, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Tucker, Erik I.; Gruber, Andras] Aronora Inc, Portland, OR USA; [Smiley, Stephen T.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McCarty, Owen J. T.; Gruber, Andras] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Vanderbilt University; Tomsk Polytechnic University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Oregon Health & Science University	Gailani, D (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	dave.gailani@vanderbilt.edu		Gruber, Andras/0000-0001-6212-2247	National Institutes of Health [HL81326, HL58837, GM116184]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101972, R01HL058837, R01HL081326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to acknowledge the support of National Institutes of Health grants HL81326 and HL58837 (DG) and GM116184 (OJM). DG is a consultant, and receives consultant's fees from several pharmaceutical companies. These fees were not used to support the work described in this manuscript. EIT and AG are employees of the company Aronora. Aronora provided support in the form of salaries for these individuals, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen Karen S, 2015, World J Crit Care Med, V4, P105, DOI 10.5492/wjccm.v4.i2.105; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; Bane CE, 2014, DRUG DISCOV TODAY, V19, P1454, DOI 10.1016/j.drudis.2014.05.018; Berthelsen LO, 2011, THROMB RES, V128, P103, DOI 10.1016/j.thromres.2010.12.002; Bjorkqvist J, 2014, THROMB HAEMOSTASIS, V112, P868, DOI 10.1160/TH14-04-0311; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; Corral J, 2005, AM J PATHOL, V166, P1089, DOI 10.1016/S0002-9440(10)62329-2; Couture R, 2014, CURR VASC PHARMACOL, V12, P223, DOI 10.2174/1570161112666140226121627; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; DELACADENA RA, 1993, BLOOD, V81, P3313; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Emsley J, 2010, BLOOD, V115, P2569, DOI 10.1182/blood-2009-09-199182; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; EWALD GA, 1995, CIRCULATION, V91, P28, DOI 10.1161/01.CIR.91.1.28; Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051; Gailani D, 2015, J THROMB HAEMOST, V13, P1383, DOI 10.1111/jth.13005; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; GALLIMORE MJ, 1978, THROMB RES, V12, P307, DOI 10.1016/0049-3848(78)90301-8; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Geng Y, 2013, J THROMB HAEMOST, V11, P1374, DOI 10.1111/jth.12275; Gould TJ, 2015, J THROMB HAEMOST, V13, pS82, DOI 10.1111/jth.12977; GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Herwald H, 2003, SCAND J INFECT DIS, V35, P604, DOI 10.1080/00365540310016268; Hoffmeister HM, 1998, J CARDIOVASC PHARM, V31, P764, DOI 10.1097/00005344-199805000-00016; Iwaki T, 2008, J THROMB HAEMOST, V6, P1993, DOI 10.1111/j.1538-7836.2008.03142.x; Kenniston JA, 2014, J BIOL CHEM, V289, P23596, DOI 10.1074/jbc.M114.569061; Key NS, 2014, HEMATOL-AM SOC HEMAT, P66, DOI 10.1182/asheducation-2014.1.66; Khan MM, 2006, ARTERIOSCL THROM VAS, V26, P2260, DOI 10.1161/01.ATV.0000240290.70852.c0; Lang JD, 2009, CRIT CARE, V13, DOI 10.1186/cc7144; Levi M, 2015, SEMIN THROMB HEMOST, V41, P9, DOI 10.1055/s-0034-1398376; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu J, 2011, NAT MED, V17, P206, DOI 10.1038/nm.2295; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Matafonov A, 2011, BLOOD, V118, P437, DOI 10.1182/blood-2010-10-312983; MCMULLEN BA, 1991, BIOCHEMISTRY-US, V30, P2056, DOI 10.1021/bi00222a008; MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Patel KN, 2010, J THROMB HAEMOST, V8, P1403, DOI 10.1111/j.1538-7836.2010.03853.x; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Pawlinski R, 2004, CRIT CARE MED, V32, pS293, DOI 10.1097/01.CCM.0000128445.95144.B8; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; PIXLEY RA, 1993, J CLIN INVEST, V91, P61, DOI 10.1172/JCI116201; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Schmaier AH, 2014, THROMB RES, V133, pS41, DOI 10.1016/j.thromres.2014.03.018; Schmidt GA, INVESTIGATIONAL INEF; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; SCOTT CF, 1985, J BIOL CHEM, V260, P856; Semeraro N, 2015, SEMIN THROMB HEMOST, V41, P650, DOI 10.1055/s-0035-1556730; Sharma Jagdish N, 2014, Prog Drug Res, V69, P1; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Suri MFK, 2010, CEREBROVASC DIS, V29, P497, DOI 10.1159/000297966; Tao WK, 2004, SHOCK, V21, P31, DOI 10.1097/01.shk.0000101673.49265.5d; THOMPSON RE, 1979, P NATL ACAD SCI USA, V76, P4862, DOI 10.1073/pnas.76.10.4862; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; THOMPSON RE, 1978, J EXP MED, V147, P488, DOI 10.1084/jem.147.2.488; TOOSSI Z, 1992, P NATL ACAD SCI USA, V89, P11969, DOI 10.1073/pnas.89.24.11969; Tucker EI, 2008, J INFECT DIS, V198, P271, DOI 10.1086/589514; Tucker EI, 2012, BLOOD, V119, P4762, DOI 10.1182/blood-2011-10-386185; van der Poll T, 2012, CURR VASC PHARMACOL, V10, P632, DOI 10.2174/157016112801784549; van Montfoort ML, 2014, HEMATOL-AM SOC HEMAT, P60, DOI 10.1182/asheducation-2014.1.60; Vilahur G, 2015, VASC PHARMACOL, V73, P38, DOI 10.1016/j.vph.2015.05.001; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; WIGGINS RC, 1977, P NATL ACAD SCI USA, V74, P4636, DOI 10.1073/pnas.74.10.4636; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Yun TH, 2009, J CELL MOL MED, V13, P4146, DOI 10.1111/j.1582-4934.2009.00884.x	74	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152968	10.1371/journal.pone.0152968	http://dx.doi.org/10.1371/journal.pone.0152968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046148	gold, Green Published, Green Submitted			2022-12-27	WOS:000373599600053
J	Nagy, E; Rodriguiz, RM; Wetsel, WC; MacIver, NJ; Hale, LP				Nagy, Eniko; Rodriguiz, Ramona M.; Wetsel, William C.; MacIver, Nancie J.; Hale, Laura P.			Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; GUT MICROBIOTA; TNF-ALPHA; CROHNS; POPULATION; VARIANTS; COLITIS; OBESITY; LEPTIN; FAT	Studies in transgenic murine models have provided insight into the complexity underlying inflammatory bowel disease (IBD), a disease hypothesized to result from an injurious immune response against intestinal microbiota. We recently developed a mouse model of IBD that phenotypically and histologically resembles human childhood-onset ulcerative colitis (UC), using mice that are genetically modified to be deficient in the cytokines TNF and IL-10 ("T/I" mice). Here we report the effects of early life onset of colon inflammation on growth and reproductive performance of T/I mice. T/I dams with colitis often failed to get pregnant or had small litters with pups that failed to thrive. Production was optimized by breeding double homozygous mutant T/I males to females homozygous mutant for TNF deficiency and heterozygous for deficiency of IL-10 ("T/I-het" dams) that were not susceptible to spontaneous colon inflammation. When born to healthy (T/I-het) dams, T/I pups initially gained weight similarly to wild type (WT) pups and to their non-colitis-susceptible T/I-het littermates. However, their growth curves diverged between 8 and 13 weeks, when most T/I mice had developed moderate to severe colitis. The observed growth failure in T/I mice occurred despite a significant increase in their food consumption and in the absence of protein loss in the stool. This was not due to TNF-induced anorexia or altered food consumption due to elevated leptin levels. Metabolic studies demonstrated increased consumption of oxygen and water and increased production of heat and CO2 in T/I mice compared to their T/I-het littermates, without differences in motor activity. Based on the clinical similarities of this early life onset model of IBD in T/I mice to human IBD, these results suggest that mechanisms previously hypothesized to explain growth failure in children with IBD require re-evaluation. The T/I mouse model may be useful for further investigation of such mechanisms and for development of therapies to prevent reproductive complications and/or growth failure in humans with IBD.	[Nagy, Eniko; Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [MacIver, Nancie J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Hale, LP (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Hale, LP (corresponding author), Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA.	laura.hale@duke.edu		MacIver, Nancie/0000-0003-3676-9391	United States National Institutes of Health [5R21CA170069]; National Multiple Sclerosis Society Grant [RG-5333]; NATIONAL CANCER INSTITUTE [R21CA170069] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant number 5R21CA170069 (to LPH) from the United States National Institutes of Health and the National Multiple Sclerosis Society Grant RG-5333 (to NJM). Some of the equipment and software was purchased through a grant (to WCW) from the North Carolina Biotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu DB, 2011, WORLD J GASTROENTERO, V17, P2696, DOI 10.3748/wjg.v17.i22.2696; Billiet T, 2014, EXPERT OPIN BIOL TH, V14, P75, DOI 10.1517/14712598.2014.858695; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Cioffi Michele, 2015, World J Gastrointest Pathophysiol, V6, P13, DOI 10.4291/wjgp.v6.i1.13; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Cormier K, 2005, JPEN-PARENTER ENTER, V29, P102, DOI 10.1177/0148607105029002102; Dalal SR, 2014, J CLIN INVEST, V124, P4190, DOI 10.1172/JCI72330; Day AS, 2012, WORLD J GASTROENTERO, V18, P5862, DOI 10.3748/wjg.v18.i41.5862; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Griffiths AM, 2004, BEST PRACT RES CL GA, V18, P509, DOI 10.1016/j.bpg.2004.01.002; Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041797; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P346, DOI 10.1002/ibd.21283; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Manosa M, 2013, SCAND J GASTROENTERO, V48, P427, DOI 10.3109/00365521.2013.772229; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Meyer SU, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0083-0; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Pawlowska Katarzyna, 2014, Dev Period Med, V18, P323; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; Sammarco R, 2017, CLIN NUTR, V36, P467, DOI 10.1016/j.clnu.2016.01.005; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sasaki M, 2010, J CLIN BIOCHEM NUTR, V47, P32, DOI 10.3164/jcbn.10-07; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Selinger CP, 2012, WORLD J GASTROENTERO, V18, P2600, DOI 10.3748/wjg.v18.i21.2600; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramaniam K, 2015, ALIMENT PHARM THER, V41, P419, DOI 10.1111/apt.13058; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Vanderford DA, 2010, EXP DERMATOL, V19, P518, DOI 10.1111/j.1600-0625.2009.01032.x; Varille V, 1996, J PEDIATR GASTR NUTR, V23, P13, DOI 10.1097/00005176-199607000-00003; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079; Wang H, 2015, REV ENDOCR METAB DIS, V16, P47, DOI 10.1007/s11154-014-9306-8; Yang Y, 2014, DIS MODEL MECH, V7, P1131, DOI 10.1242/dmm.016428	45	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152764	10.1371/journal.pone.0152764	http://dx.doi.org/10.1371/journal.pone.0152764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045690	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600032
J	Ranjbar, B; Krogh, LB; Laursen, MB; Primo, MN; Marques, SC; Dybkaer, K; Mikkelsen, JG				Ranjbar, Benyamin; Krogh, Louise Bechmann; Laursen, Maria Bach; Primo, Maria Nascimento; Marques, Sara Correia; Dybkaer, Karen; Mikkelsen, Jacob Giehm			Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; CD43 EXPRESSION; DOWN-REGULATION; GENE; CHEMOTHERAPY; CD20; RESISTANCE; CHOP; SURVIVAL; THERAPY	Diffuse large B-cell lymphoma (DLBCL) is characterized by great genetic and clinical heterogeneity which complicates prognostic prediction and influences treatment efficacy. The most common regimen, R-CHOP, consists of a combination of anthracycline- and immuno-based drugs including Rituximab. It remains elusive how and to which extent genetic variability impacts the response and potential tolerance to R-CHOP. Hence, an improved understanding of mechanisms leading to drug tolerance in B-cells is crucial, and modelling by genetic intervention directly in B-cells is fundamental in such investigations. Lentivirus-based gene vectors are widely used gene vehicles, which in B-cells are an attractive alternative to potentially toxic transfection-based methodologies. Here, we investigate the use of VSV-G-pseudotyped lentiviral vectors in B-cells for exploring the impact of microRNAs on tolerance to Rituximab. Notably, we find that robust lentiviral transduction of cancerous B-cell lines markedly and specifically enhances the resistance of transduced germinal center B-cells (GCBs) to Rituximab. Although Rituximab works partially through complement-mediated cell lysis, increased tolerance is not achieved through effects of lentiviral transduction on cell death mediated by complement. Rather, reduced levels of PARP1 and persistent high levels of CD43 in Rituximab-treated GCBs demonstrate anti-apoptotic effects of lentiviral transduction that may interfere with the outcome and interpretation of Rituximab tolerance studies. Our findings stress that caution should be exercised exploiting lentiviral vectors in studies of tolerance to therapeutics in DLBCL. Importantly, however, we demonstrate the feasibility of using the lentiviral gene delivery platform in studies addressing the impact of specific microRNAs on Rituximab responsiveness.	[Ranjbar, Benyamin; Krogh, Louise Bechmann; Primo, Maria Nascimento; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Laursen, Maria Bach; Marques, Sara Correia; Dybkaer, Karen] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark; [Marques, Sara Correia] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Mikkelsen, JG (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	giehm@biomed.au.dk	Primo, Maria/P-1780-2017	Primo, Maria/0000-0003-2808-0607; Mikkelsen, Jacob Giehm/0000-0002-1322-3209; Dybkaer, Karen/0000-0003-2488-435X	Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat; Aarhus University; The Danish Cancer Society [R124-A7623] Funding Source: researchfish	Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat; Aarhus University; The Danish Cancer Society(Danish Cancer Society)	This work was supported by Agnes og Poul Friis Fond; Aase og Ejnar Danielsens Fond; Frits, Georg og Marie Cecilie Gluds Legat; Else og Mogens Wedell-Wedellsborgs Fond; Civilingenior Frode V. Nyegaard og hustrus Fond; Arvid Nilssons Fond; Fabrikant Ejnar Willumsens Legat. All received by J.G. Mikkelsen. PhD mobility fellowship from Aarhus University received by B. Ranjbar.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bai HT, 2013, INT J HEMATOL, V97, P223, DOI 10.1007/s12185-012-1256-x; Bak RO, 2013, RNA, V19, P280, DOI 10.1261/rna.034850.112; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Baruch M, 1996, LEUKEMIA LYMPHOMA, V21, P485, DOI 10.3109/10428199609093448; Bodogai M, 2013, CANCER RES, V73, P2127, DOI 10.1158/0008-5472.CAN-12-4184; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Di Lisio L, 2012, BLOOD, V120, P1782, DOI 10.1182/blood-2012-05-402784; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Falgreen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1237-6; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Girard-Gagnepain A, 2014, BLOOD, V124, P1221, DOI 10.1182/blood-2014-02-558163; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Henry C, 2010, BLOOD, V115, P2420, DOI 10.1182/blood-2009-06-229112; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hollensen AK, 2013, RNA BIOL, V10, P406, DOI 10.4161/rna.23543; Iqbal J, 2015, BLOOD, V125, P1137, DOI 10.1182/blood-2014-04-566778; Jakobsen M, 2009, MOL THER, V17, P1743, DOI 10.1038/mt.2009.141; Jorgensen LK, 2015, DAN MED J, V62; Kadaja-Saarepuu L, 2008, ONCOGENE, V27, P1705, DOI 10.1038/sj.onc.1210802; Karaayvaz M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.193; Kneissl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079047; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Maloney DG, 2012, NEW ENGL J MED, V366, P2008, DOI 10.1056/NEJMct1114348; Marques SC, 2015, ONCOTARGET, V6, P7, DOI 10.18632/oncotarget.3057; Mehra S, 2002, GENE CHROMOSOME CANC, V33, P225, DOI 10.1002/gcc.10025; Mitrovic Z, 2013, BRIT J HAEMATOL, V162, P87, DOI 10.1111/bjh.12356; Mitrovic Z, 2009, CLIN LYMPHOMA MYELOM, V9, P133, DOI 10.3816/CLM.2009.n.033; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Nusbaum P, 2004, BIOCHEM SOC T, V32, P477, DOI 10.1042/BST0320477; Olejniczak SH, 2008, CLIN CANCER RES, V14, P1550, DOI 10.1158/1078-0432.CCR-07-1255; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Perez-Callejo D, 2015, CANCER TREAT REV, V41, P680, DOI 10.1016/j.ctrv.2015.05.007; Rasmussen TK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0660-z; Roschewski M, 2014, NAT REV CLIN ONCOL, V11, P12, DOI 10.1038/nrclinonc.2013.197; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Song GQ, 2014, CURR CANCER DRUG TAR, V14, P659, DOI 10.2174/1568009614666140818211103; Song GQ, 2014, ANN HEMATOL, V93, P1735, DOI 10.1007/s00277-014-2111-3; Takwi AA, 2014, ONCOGENE, V33, P3717, DOI 10.1038/onc.2013.330; THNG KH, 1987, INT J CANCER, V39, P89, DOI 10.1002/ijc.2910390116; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Tsai PC, 2012, CLIN CANCER RES, V18, P1039, DOI 10.1158/1078-0432.CCR-11-1429; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Vega MI, 2004, ONCOGENE, V23, P3530, DOI 10.1038/sj.onc.1207336; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0153069	10.1371/journal.pone.0153069	http://dx.doi.org/10.1371/journal.pone.0153069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045839	Green Published, gold			2022-12-27	WOS:000373599600064
J	Albrecht, MA; Waltz, JA; Cavanagh, JF; Frank, MJ; Gold, JM				Albrecht, Matthew A.; Waltz, James A.; Cavanagh, James F.; Frank, Michael J.; Gold, James M.			Reduction of Pavlovian Bias in Schizophrenia: Enhanced Effects in Clozapine-Administered Patients	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; LEARNING IMPAIRMENTS; REWARD; DOPAMINE; EEG; PERFORMANCE; THETA; FEEDBACK	The negative symptoms of schizophrenia (SZ) are associated with a pattern of reinforcement learning (RL) deficits likely related to degraded representations of reward values. However, the RL tasks used to date have required active responses to both reward and punishing stimuli. Pavlovian biases have been shown to affect performance on these tasks through invigoration of action to reward and inhibition of action to punishment, and may be partially responsible for the effects found in patients. Forty-five patients with schizophrenia and 30 demographically-matched controls completed a four-stimulus reinforcement learning task that crossed action ("Go" or "NoGo") and the valence of the optimal outcome (reward or punishment-avoidance), such that all combinations of action and outcome valence were tested. Behaviour was modelled using a six-parameter RL model and EEG was simultaneously recorded. Patients demonstrated a reduction in Pavlovian performance bias that was evident in a reduced Go bias across the full group. In a subset of patients administered clozapine, the reduction in Pavlovian bias was enhanced. The reduction in Pavlovian bias in SZ patients was accompanied by feedback processing differences at the time of the P3a component. The reduced Pavlovian bias in patients is suggested to be due to reduced fidelity in the communication between striatal regions and frontal cortex. It may also partially account for previous findings of poorer "Go-learning" in schizophrenia where "Go" responses or Pavlovian consistent responses are required for optimal performance. An attenuated P3a component dynamic in patients is consistent with a view that deficits in operant learning are due to impairments in adaptively using feedback to update representations of stimulus value.	[Albrecht, Matthew A.; Waltz, James A.; Gold, James M.] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Albrecht, Matthew A.] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia; [Albrecht, Matthew A.] Curtin Univ, Curtin Hlth Innovat Res Inst Biosci, Perth, WA 6845, Australia; [Cavanagh, James F.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Psychiat, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA	University System of Maryland; University of Maryland Baltimore; Curtin University; Curtin University; University of New Mexico; Brown University; Brown University; Brown University	Albrecht, MA (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA.; Albrecht, MA (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA 6845, Australia.; Albrecht, MA (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst Biosci, Perth, WA 6845, Australia.	malbrecht@mprc.umaryland.edu	Waltz, James/AAU-8304-2020; Albrecht, Matthew/H-5918-2019	Waltz, James/0000-0002-9236-3719; Albrecht, Matthew/0000-0002-6540-5979	National Institute of Mental Health [2R01MH080066-06A1]; National Health and Medical Research Council [APP1090716]; Department of Health Western Australia; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Health Western Australia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by 2R01MH080066-06A1 National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) to AW, MJF, and JMG; APP1090716 National Health and Medical Research Council (https://www.nhmrc.gov.au/) to MAA; and Department of Health Western Australia (http://ww2.health.wa.gov.au/) to MAA.	[Anonymous], 1992, SEMIN NEUROSCI; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2013, J NEUROSCI, V33, P8541, DOI 10.1523/JNEUROSCI.5754-12.2013; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Collins AGE, 2014, J NEUROSCI, V34, P13747, DOI 10.1523/JNEUROSCI.0989-14.2014; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Danna CL, 2010, PHARMACOL BIOCHEM BE, V96, P40, DOI 10.1016/j.pbb.2010.04.004; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Demjaha A, 2012, AM J PSYCHIAT, V169, P1203, DOI 10.1176/appi.ajp.2012.12010144; Esslinger C, 2012, SCHIZOPHR RES, V140, P114, DOI 10.1016/j.schres.2012.06.025; First MB., 1997, USERS GUIDE STRUCTUR; Fischer AG, 2013, NEURON, V79, P1243, DOI 10.1016/j.neuron.2013.07.006; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gold JM, 2008, SCHIZOPHRENIA BULL, V34, P835, DOI 10.1093/schbul/sbn068; Gold JM, 2012, ARCH GEN PSYCHIAT, V69, P129, DOI 10.1001/archgenpsychiatry.2011.1269; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; HajiHosseini A, 2012, NEUROIMAGE, V60, P1678, DOI 10.1016/j.neuroimage.2012.01.125; Helmbold K, 2015, EUR NEUROPSYCHOPHARM, V25, P846, DOI 10.1016/j.euroneuro.2015.02.007; HERSHBERGER WA, 1986, ANIM LEARN BEHAV, V14, P443, DOI 10.3758/BF03200092; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Horan WP, 2012, PSYCHOL MED, V42, P1637, DOI 10.1017/S0033291711002819; Javitt DC, 2005, MOL PSYCHIATR, V10, P276, DOI 10.1038/sj.mp.4001552; Jeong B, 2009, HUM BRAIN MAPP, V30, P4138, DOI 10.1002/hbm.20835; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Knott V, 2001, SCHIZOPHR RES, V50, P41, DOI 10.1016/S0920-9964(00)00165-1; Koch K, 2010, NEUROIMAGE, V50, P223, DOI 10.1016/j.neuroimage.2009.12.031; Kruschke J. K., 2011, DOING BAYESIAN DATA; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; LACROIX D, 1995, PROG NEURO-PSYCHOPH, V19, P861, DOI 10.1016/0278-5846(95)00116-D; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; MALOW BA, 1994, ELECTROEN CLIN NEURO, V91, P205, DOI 10.1016/0013-4694(94)90070-1; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Meltzer HY, 2015, AM J PSYCHIAT, V172, P502, DOI 10.1176/appi.ajp.2015.15030338; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris SE, 2008, SCHIZOPHR RES, V99, P274, DOI 10.1016/j.schres.2007.08.027; Morris SE, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00123; Palmer JA, 2007, LECT NOTES COMPUT SC, V4666, P97; Pernet CR, 2015, J NEUROSCI METH, V250, P85, DOI 10.1016/j.jneumeth.2014.08.003; Pfohl B., 1997, STRUCTURED INTERVIEW; Polich J, 2007, CLIN NEUROPHYSIOL, P118; Premkumar P, 2008, NEUROPSYCHOLOGIA, V46, P2002, DOI 10.1016/j.neuropsychologia.2008.01.022; Price GW, 2002, INT J PSYCHIAT CLIN, V6, P95, DOI 10.1080/136515002753724090; Quide Y, 2013, SCHIZOPHR RES, V150, P468, DOI 10.1016/j.schres.2013.08.009; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Stan Development Team, 2019, STAN C LIB PROBABILI; Strauss GP, 2014, SCHIZOPHRENIA BULL, V40, pS107, DOI 10.1093/schbul/sbt197; Strauss GP, 2011, BIOL PSYCHIAT, V69, P424, DOI 10.1016/j.biopsych.2010.10.015; Tislerova B, 2008, NEUROPSYCHOBIOLOGY, V58, P1, DOI 10.1159/000154474; Twomey DM, 2015, EUR J NEUROSCI, V42, P1636, DOI 10.1111/ejn.12936; Ullsperger M, 2014, TRENDS COGN SCI, V18, P259, DOI 10.1016/j.tics.2014.02.009; van de Vijver I, 2011, J COGNITIVE NEUROSCI, V23, P4106, DOI 10.1162/jocn_a_00110; Verleger R, 2008, CLIN NEUROPHYSIOL, V119, P968, DOI 10.1016/j.clinph.2007.11.175; Verleger R, 2014, NEUROIMAGE, V100, P271, DOI 10.1016/j.neuroimage.2014.06.036; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Weiner DM, 2004, PSYCHOPHARMACOLOGY, V177, P207, DOI 10.1007/s00213-004-1940-5; Yoon JH, 2013, BIOL PSYCHIAT, V74, P122, DOI 10.1016/j.biopsych.2012.11.018	79	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152781	10.1371/journal.pone.0152781	http://dx.doi.org/10.1371/journal.pone.0152781			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6EN	27044008	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100033
J	Rumberg, F; Bakir, MS; Taylor, WR; Haberl, H; Sarpong, A; Sharankou, I; Lebek, S; Funk, JF				Rumberg, Franziska; Bakir, Mustafa Sinan; Taylor, William R.; Haberl, Hannes; Sarpong, Akosua; Sharankou, Ilya; Lebek, Susanne; Funk, Julia F.			The Effects of Selective Dorsal Rhizotomy on Balance and Symmetry of Gait in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; ORTHOPEDIC-SURGERY; POSTURAL BALANCE; SPASTIC DIPLEGIA; FOLLOW-UP; WALKING; PATTERNS	Aim Cerebral palsy (CP) is associated with dysfunction of the upper motor neuron and results in balance problems and asymmetry during locomotion. Selective dorsal rhizotomy (SDR) is a surgical procedure that results in reduced afferent neuromotor signals from the lower extremities with the aim of improving gait. Its influence on balance and symmetry has not been assessed. The aim of this prospective cohort study was to evaluate the impact of SDR on balance and symmetry during walking. Methods 18 children (10 girls, 8 boys; age 6 years (y) 3 months (m), SD 1y 8m) with bilateral spastic CP and Gross Motor Function Classification System levels I to II underwent gait analysis before and 6 to 12 months after SDR. Results were compared to 11 typically developing children (TDC; 6 girls, 5 boys; age 6y 6m, SD 1y 11m). To analyse balance, sway velocity, radial displacement and frequency were calculated. Symmetry ratios were calculated for balance measures and spatio-temporal parameters during walking. Results Most spatio-temporal parameters of gait, as well as all parameters of balance, improved significantly after SDR. Preoperative values of symmetry did not vary considerably between CP and TDC group and significant postoperative improvement did not occur. Interpretation The reduction of afferent signalling through SDR improves gait by reducing balance problems rather than enhancing movement symmetry.	[Rumberg, Franziska; Bakir, Mustafa Sinan; Lebek, Susanne; Funk, Julia F.] Charite, Ctr Musculoskeletal Surg CMSC, Dept Orthopaed, Paediat Orthopaed Surg & Neuroorthopaed, D-13353 Berlin, Germany; [Taylor, William R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Haberl, Hannes] Univ Ulm, Dept Neurosurg, Sect Paediat Neurosurg, D-89069 Ulm, Germany; [Sarpong, Akosua] Charite, Social Paediat Ctr, D-13353 Berlin, Germany; [Sharankou, Ilya] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Funk, JF (corresponding author), Charite, Ctr Musculoskeletal Surg CMSC, Dept Orthopaed, Paediat Orthopaed Surg & Neuroorthopaed, D-13353 Berlin, Germany.	julia.funk@charite.de	Taylor, William R./F-8692-2010	Taylor, William R./0000-0003-4060-4098; Bakir, Sinan/0000-0002-2448-2150				Bakir MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069500; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BERGER W, 1984, HUM NEUROBIOL, V3, P163; BLECK EE, 1994, DEV MED CHILD NEUROL, V36, P377; Bolster EAM, 2013, DEV MED CHILD NEUROL, V55, P610, DOI 10.1111/dmcn.12148; Buckon CE, 2004, ARCH PHYS MED REHAB, V85, P457, DOI 10.1016/j.apmr.2003.05.009; Burtner PA, 1998, GAIT POSTURE, V8, P163, DOI 10.1016/S0966-6362(98)00032-0; Chan SHS, 2008, PEDIATR NEUROL, V39, P22, DOI 10.1016/j.pediatrneurol.2008.03.017; Chen J, 2007, J MOTOR BEHAV, V39, P306, DOI 10.3200/JMBR.39.4.306-316; Cole GF, 2007, ARCH DIS CHILD, V92, P781, DOI 10.1136/adc.2006.111559; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Dudley RWR, 2013, J NEUROSURG-PEDIATR, V12, P142, DOI 10.3171/2013.4.PEDS12539; Engsberg J R, 1998, Neurosurg Focus, V4, pe4; Engsberg JR, 2006, J NEUROSURG S, V105, P8; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Funk JF, 2015, RES DEV DISABIL, V37, P127, DOI 10.1016/j.ridd.2014.11.012; Funk JF, 2016, CHILD NERV SYST, V32, P819, DOI 10.1007/s00381-016-3016-3; Goble DJ, 2003, HUM MOVEMENT SCI, V22, P271, DOI 10.1016/S0167-9457(03)00047-2; Grunt S, 2010, NEUROPEDIATRICS, V41, P209, DOI 10.1055/s-0030-1267983; HANNAH RE, 1984, ARCH PHYS MED REHAB, V65, P155; HOF AL, 1996, GAIT POSTURE, V4, P222; Hsue BJ, 2009, GAIT POSTURE, V29, P471, DOI 10.1016/j.gaitpost.2008.11.008; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Josenby AL, 2012, DEV MED CHILD NEUROL, V54, P429, DOI 10.1111/j.1469-8749.2012.04258.x; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Langerak NG, 2012, GAIT POSTURE, V35, P244, DOI 10.1016/j.gaitpost.2011.09.014; Liao HF, 1997, DEV MED CHILD NEUROL, V39, P106, DOI 10.1111/j.1469-8749.1997.tb07392.x; Lundkvist A, 2006, J PEDIATR ORTHOP B, V15, P244, DOI 10.1097/01202412-200607000-00002; Lythgo N, 2011, GAIT POSTURE, V33, P29, DOI 10.1016/j.gaitpost.2010.09.017; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; Macwilliams BA, 2011, DEV MED CHILD NEUROL, V53, P717, DOI 10.1111/j.1469-8749.2011.04010.x; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; Mittal S, 2002, J NEUROSURG, V97, P315, DOI 10.3171/jns.2002.97.2.0315; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; NASHNER LM, 1983, EXP BRAIN RES, V49, P393; Nordmark E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-54; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Park TS, 2006, TECHNICAL NOTE NEURO, V21, pe7, DOI DOI 10.3171/F0C.2006.21.2.8; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Pavao SL, 2013, RES DEV DISABIL, V34, P1367, DOI 10.1016/j.ridd.2013.01.034; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; Phillips LH, 1989, NEUROSURGERY STATE A, P459; Prosser LA, 2010, GAIT POSTURE, V31, P522, DOI 10.1016/j.gaitpost.2010.03.001; Roberts A, 2015, GAIT POSTURE, V42, P16, DOI 10.1016/j.gaitpost.2015.04.004; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rose J, 2002, DEV MED CHILD NEUROL, V44, P58, DOI 10.1017/S0012162201001669; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; Sadeghi H, 2000, GAIT POSTURE, V12, P34, DOI 10.1016/S0966-6362(00)00070-9; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Sharenkov A, 2014, GAIT POSTURE, V40, P730, DOI 10.1016/j.gaitpost.2014.07.025; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Shumway-Cook A, 2003, DEV MED CHILD NEUROL, V45, P591, DOI 10.1017/S0012162203001099; Stolze H, 1998, GAIT POSTURE, V7, P125, DOI 10.1016/S0966-6362(97)00043-X; Taylor WR, 2010, GAIT POSTURE, V32, P231, DOI 10.1016/j.gaitpost.2010.05.005; Tedroff K, 2011, DEV MED CHILD NEUROL, V53, P724, DOI 10.1111/j.1469-8749.2011.03969.x; THILMANN AF, 1991, BRAIN, V114, P233; Thomas SS, 1996, J PEDIATR ORTHOPED, V16, P747, DOI 10.1097/01241398-199611000-00009; Trost JP, 2008, DEV MED CHILD NEUROL, V50, P765, DOI 10.1111/j.1469-8749.2008.03031.x; van Schie PEM, 2011, J NEUROSURG-PEDIATR, V7, P557, DOI 10.3171/2011.2.PEDS10452; Wallard L, 2014, GAIT POSTURE, V40, P43, DOI 10.1016/j.gaitpost.2014.02.009; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211	64	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152930	10.1371/journal.pone.0152930	http://dx.doi.org/10.1371/journal.pone.0152930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043310	Green Published, Green Submitted, gold			2022-12-27	WOS:000373592100050
J	Gomez, J; Salazar, I; Vargas, P				Gomez, Jaime; Salazar, Idana; Vargas, Pilar			Sources of Information as Determinants of Product and Process Innovation	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; EXTERNAL KNOWLEDGE ACQUISITION; UK MANUFACTURING FIRMS; TECHNOLOGICAL-INNOVATION; EMPIRICAL-ANALYSIS; DATA MODELS; PERFORMANCE; PERSISTENCE; COMPLEMENTARITY; COLLABORATION	In this paper we use a panel of manufacturing firms in Spain to examine the extent to which they use internal and external sources of information (customers, suppliers, competitors, consultants and universities) to generate product and process innovation. Our results show that, although internal sources are influential, external sources of information are key to achieve innovation performance. These results are in line with the open innovation literature because they show that firms that are opening up their innovation process and that use different information sources have a greater capacity to generate innovations. We also find that the importance of external sources of information varies depending on the type of innovation (product or process) considered. To generate process innovation, firms mainly rely on suppliers while, to generate product innovation, the main contribution is from customers. The potential simultaneity between product and process innovation is also taken into consideration. We find that the generation of both types of innovation is not independent.	[Gomez, Jaime; Salazar, Idana; Vargas, Pilar] Univ La Rioja, Dept Econ & Empresa, Logrono, La Rioja, Spain	Universidad de La Rioja	Vargas, P (corresponding author), Univ La Rioja, Dept Econ & Empresa, Logrono, La Rioja, Spain.	pilar.vargas@unirioja.es	Vargas, Pilar/K-2783-2014; Salazar, Idana/K-2789-2014; Gómez, Jaime/C-6929-2014	Vargas, Pilar/0000-0002-2018-7269; Salazar, Idana/0000-0001-5438-5995; Gómez, Jaime/0000-0003-0603-5725	Ministerio de Economia y Competitividad [ECO2011-22947, ECO2014-53904-R]	Ministerio de Economia y Competitividad(Spanish Government)	The authors acknowledge financial support from Ministerio de Economia y Competitividad grant ECO2011-22947 and ECO2014-53904-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2005, TECHNOVATION, V25, P245, DOI 10.1016/S0166-4972(03)00113-5; Barge-Gil A, 2013, APPL ECON LETT, V20, P1426, DOI 10.1080/13504851.2013.815307; Beneito P, 2011, PAPELES DE EC ESP, V127, P89; Beneito P, 2014, TECHNOL FORECAST SOC, V88, P290, DOI 10.1016/j.techfore.2013.10.009; Berchicci L, 2014, IND CORP CHANGE, V23, P429, DOI 10.1093/icc/dtt011; Berchicci L, 2013, RES POLICY, V42, P117, DOI 10.1016/j.respol.2012.04.017; BLUNDELL R, 1995, ECON J, V105, P333, DOI 10.2307/2235494; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; British Telecom, 2006, EMBR OP INN NEW APPR; Cappellari L, 2003, STATA J, V3, P278, DOI 10.1177/1536867X0300300305; Cassiman B, 2006, MANAGE SCI, V52, P68, DOI 10.1287/mnsc.1050.0470; Chesbrough H., 2003, OPEN INNOVATION NEW; Chesbrough H.S., 2013, MANAGING OPEN INNOVA; Chesbrough HW, 1996, HARVARD BUS REV, V74, P65; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Dahlander L, 2010, RES POLICY, V39, P699, DOI 10.1016/j.respol.2010.01.013; De Marchi V, 2012, RES POLICY, V41, P614, DOI 10.1016/j.respol.2011.10.002; Dodgson M, 2006, R&D MANAGE, V36, P333, DOI 10.1111/j.1467-9310.2006.00429.x; Gambardella A.., 2006, INNOVATIONS PRODUCTS; Gomez J, 2012, RES POLICY, V41, P1607, DOI 10.1016/j.respol.2012.04.016; Greene W. H., 2012, ECONOMETRIC ANAL, V7th; Huizingh EKRE, 2011, TECHNOVATION, V31, P2, DOI 10.1016/j.technovation.2010.10.002; Hunter J, 2010, NAT REV DRUG DISCOV, V9, P87, DOI 10.1038/nrd3099; Huston L, 2006, HARVARD BUS REV, V84, P58; JAFFE AB, 1986, AM ECON REV, V76, P984; Nieto MJ, 2010, J SMALL BUS MANAGE, V48, P44, DOI 10.1111/j.1540-627X.2009.00286.x; Keupp MM, 2009, R&D MANAGE, V39, P331, DOI 10.1111/j.1467-9310.2009.00563.x; Laursen K, 2006, STRATEGIC MANAGE J, V27, P131, DOI 10.1002/smj.507; Leiponen A, 2010, STRATEGIC MANAGE J, V31, P224, DOI 10.1002/smj.807; Lokshin B, 2008, OXFORD B ECON STAT, V70, P399, DOI 10.1111/j.1468-0084.2008.00503.x; Love J. H., 2007, IND INNOV, V14, P477, DOI [DOI 10.1080/13662710701711380, 10.1080/13662710701711380]; M??ez-Castillejo J.A., 2009, APPL EC Q, V55, P219, DOI [10.3790/aeq.55.3.219, DOI 10.3790/AEQ.55.3.219]; Martinez-Ros E., 1999, J HIGH TECHNOLOGY MA, V10, P223, DOI DOI 10.1016/S1047-8310(99)00016-4; Martinez-Ros E, 2009, EUR MANAG REV, V6, P64, DOI 10.1057/emr.2009.4; OECD, 2005, OECD SCI TECHNOLOGY; OECD Eurostat, 2005, OSLO MANUAL GUIDELIN, VThird; Owens PK, 2015, NAT REV DRUG DISCOV, V14, P17, DOI 10.1038/nrd4497; Peters B, 2009, J TECHNOL TRANSFER, V34, P226, DOI 10.1007/s10961-007-9072-9; Raymond W, 2010, REV ECON STAT, V92, P495, DOI 10.1162/REST_a_00004; Reichstein T, 2006, IND CORP CHANGE, V15, P653, DOI 10.1093/icc/dtl014; Rigby D, 2002, HARVARD BUS REV, V80, P80; Roper S, 2002, RES POLICY, V31, P1087, DOI 10.1016/S0048-7333(01)00175-5; Roper S, 2008, RES POLICY, V37, P961, DOI 10.1016/j.respol.2008.04.005; Schuhmacher A, 2013, DRUG DISCOV TODAY, V18, P1133, DOI 10.1016/j.drudis.2013.07.013; Sofka W, 2010, R&D MANAGE, V40, P310, DOI 10.1111/j.1467-9310.2010.00592.x; Stoneman P., 2002, EC TECHNOLOGICAL DIF; TEECE DJ, 1986, RES POLICY, V15, P285, DOI 10.1016/0048-7333(86)90027-2; Tether BS, 2002, RES POLICY, V31, P947, DOI 10.1016/S0048-7333(01)00172-X; Vega-Jurado J, 2008, RES POLICY, V37, P616, DOI 10.1016/j.respol.2008.01.001; VONHIPPEL E, 1986, MANAGE SCI, V32, P791, DOI 10.1287/mnsc.32.7.791; Wooldridge JM, 2005, J APPL ECONOM, V20, P39, DOI 10.1002/jae.770	51	43	44	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152743	10.1371/journal.pone.0152743	http://dx.doi.org/10.1371/journal.pone.0152743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI0QF	27035456	gold, Green Published, Green Submitted			2022-12-27	WOS:000373201200033
J	Suzukawa, M; Akashi, S; Nagai, H; Nagase, H; Nakamura, H; Matsui, H; Hebisawa, A; Ohta, K				Suzukawa, Maho; Akashi, Shunsuke; Nagai, Hideaki; Nagase, Hiroyuki; Nakamura, Hiroyuki; Matsui, Hirotoshi; Hebisawa, Akira; Ohta, Ken			Combined Analysis of IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; GRANULOMA-FORMATION; RELEASE ASSAYS; IP-10; DIAGNOSIS; THERAPY; DISEASE	The QuantiFERON (R)-TB Gold In-Tube test (QFT), an interferon-gamma release assay, is used to diagnose Mycobacterium tuberculosis, but its inaccuracy in distinguishing active tuberculosis from latent infection is a major concern. There is thus a need for an easy and accurate tool for achieving that goal in daily clinical settings. This study aimed to identify candidate cytokines for specifically differentiating active tuberculosis from latent infection. Our study population consisted of 31 active TB (tuberculosis) patients, 29 LTBI (latent tuberculosis infection) patients and 10 healthy control subjects. We assayed for 27 cytokines in QFT supernatants of both specific antigen-stimulated blood samples (TBAg) and negative-control samples (Nil). We analyzed their specificities and sensitivities by creating receiver operating characteristic (ROC) curves and measuring the area under those curves (AUCs). In TBAg-Nil supernatants, IL-10, IFN-gamma, MCP-1 and IL-1RA showed high AUCs of 0.8120, 0.7842, 0.7419 and 0.7375, respectively. Compared with each cytokine alone, combined assay for these top four cytokines showed positive rates in diagnosing active TB, and GDA analysis revealed that MCP-1 and IL-5 are potent in distinguishing active TB from LTBI, with Wilk's lambda = 0.718 (p < 0.001). Furthermore, utilizing the unique characteristic of IL-2 that its TBAg-Nil supernatant levels are higher in LTBI compared to active TB, the difference between IFN-gamma and IL-2 showed a large AUC of 0.8910. In summary, besides IFN-gamma, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT supernatants may be useful for distinguishing active TB from LTBI. Those cytokines may also help us understand the difference in pathogenesis between active TB and LTBI.	[Suzukawa, Maho; Akashi, Shunsuke; Nagai, Hideaki; Matsui, Hirotoshi; Hebisawa, Akira; Ohta, Ken] Natl Hosp Org Tokyo Natl Hosp, Tokyo, Japan; [Nagase, Hiroyuki] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 173, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa 9201192, Japan	Teikyo University; Kanazawa University	Ohta, K (corresponding author), Natl Hosp Org Tokyo Natl Hosp, Tokyo, Japan.	kenohta@tokyo-hosp.jp	Nagase, Hiroyuki/Y-4367-2019	Nagase, Hiroyuki/0000-0002-0296-5901; Suzukawa, Maho/0000-0002-2265-1950	Banyu Life Science Foundation International; Waksman Foundation of Japan, Inc.; Ministry of Health Labour and Welfare of Japan	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Waksman Foundation of Japan, Inc.(Waksman Foundation of Japan Inc.); Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This project was supported by a grant from Banyu Life Science Foundation International and a grant from the Waksman Foundation of Japan, Inc. to Maho Suzukawa, and a Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare of Japan to Hideaki Nagai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Biancotto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076091; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; CHAN LS, 1992, J INVEST DERMATOL, V99, P315, DOI 10.1111/1523-1747.ep12616653; Chang KC, 2010, THORAX, V65, P271, DOI 10.1136/thx.2009.126771; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Clifford V, 2015, J INFECTION, V71, P696, DOI 10.1016/j.jinf.2015.08.001; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; Fiske CT, 2014, INT J TUBERC LUNG D, V18, P421, DOI 10.5588/ijtld.13.0688; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Harada S, 1999, ARTHRITIS RHEUM, V42, P1508, DOI 10.1002/1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L; Hur YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079742; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Kruczak K, 2014, SCAND J INFECT DIS, V46, P649, DOI 10.3109/00365548.2014.927955; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; ROLFE MW, 1992, AM J PHYSIOL, V263, pL536, DOI 10.1152/ajplung.1992.263.5.L536; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Ruth JH, 1996, J IMMUNOL, V156, P2503; Tebruegge M, 2015, AM J RESP CRIT CARE, V192, P485, DOI 10.1164/rccm.201501-0059OC; Tonby K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09223; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Wergeland I, 2015, J INFECTION, V70, P381, DOI 10.1016/j.jinf.2014.12.019; WHO, 2014, GLOB TUB REP 2014	32	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152483	10.1371/journal.pone.0152483	http://dx.doi.org/10.1371/journal.pone.0152483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035669	gold, Green Published			2022-12-27	WOS:000373201200019
J	Chu, HY; Katz, J; Tielsch, J; Khatry, SK; Shrestha, L; LeClerq, SC; Magaret, A; Kuypers, J; Steinhoff, MC; Englund, JA				Chu, Helen Y.; Katz, Joanne; Tielsch, James; Khatry, Subarna K.; Shrestha, Laxman; LeClerq, Steven C.; Magaret, Amalia; Kuypers, Jane; Steinhoff, Mark C.; Englund, Janet A.			Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy	PLOS ONE			English	Article							INFLUENZA IMMUNIZATION; UNITED-STATES; PCR ASSAYS; ANTIBODY; MOTHERS; NEPAL; WOMEN	Background Respiratory syncytial virus (RSV) is the most important cause of viral pneumonia in children worldwide. A maternal vaccine may protect both the mother and infant from RSV illness. The epidemiology and clinical presentation of RSV in pregnant and postpartum women is not well-described. Methods Data were collected from a prospective, randomized trial of influenza immunization in pregnant women in rural southern Nepal. Women were enrolled in their second trimester of pregnancy and followed until six months postpartum. Active weekly home-based surveillance for febrile respiratory illness was performed. Mid-nasal swabs collected with episodes of respiratory illness were tested for RSV by real-time polymerase chain reaction. Results RSV was detected in 14 (0.4%) illness episodes in 3693 women over 3554 person-years of surveillance from 2011-2014. RSV incidence was 3.9/1000 person-years overall, and 11.8/1000 person-years between September and December. Seven (50%) women sought care for RSV illness; none died. Of the 7 (50%) illness episodes during pregnancy, all had live births with 2 (29%) preterm births and a median birthweight of 3060 grams. This compares to 469 (13%) preterm births and a median birthweight of 2790 grams in women without RSV during pregnancy. Of the 7 mothers with postpartum RSV infection, RSV was detected in 4 (57%) of their infants. Conclusions RSV was an uncommon cause of febrile respiratory illness in mothers during pregnancy in Nepal. These data will inform prevention and therapeutic strategies against RSV in resource-limited settings.	[Chu, Helen Y.] Univ Washington, Dept Med, Seattle, WA 98102 USA; [Katz, Joanne] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Tielsch, James] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Khatry, Subarna K.; LeClerq, Steven C.] Nepal Nutr Intervent Project Sarlahi, Sarlahi, Nepal; [Shrestha, Laxman] Tribhuvan Univ, Inst Med, Dept Pediat & Child Hlth, Kathmandu, Nepal; [Magaret, Amalia; Kuypers, Jane] Univ Washington, Dept Lab Med, Seattle, WA 98102 USA; [Magaret, Amalia] Univ Washington, Dept Biostat, Seattle, WA 98102 USA; [Steinhoff, Mark C.] Cincinnati Childrens Hosp, Global Hlth Ctr, Cincinnati, OH 45229 USA; [Englund, Janet A.] Univ Washington, Seattle Childrens Hosp, Dept Infect Dis, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Chu, HY (corresponding author), Univ Washington, Dept Med, Seattle, WA 98102 USA.	helenchu@uw.edu		Katz, Joanne/0000-0002-5997-7823	National Institutes of Health grants [K23-AI103105]; PATH; Bill & Melinda Gates Foundation Grant [50274]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103105] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PATH; Bill & Melinda Gates Foundation Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants K23-AI103105 (HYC), PATH (HYC, JAE), and the Bill & Melinda Gates Foundation Grant 50274 (all authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bridges CB, 2013, MMWR-MORBID MORTAL W, V62, P9; Broor S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000491; Chadha MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124122; Chu HY, 2013, J CLIN VIROL; Chu HY, 2014, CLIN INFECT DIS; Chu HY, 2014, J INFECT DIS; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Glenn GM, 2015, J INFECT DIS; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Kuypers J, 2006, J CLIN MICROBIOL, V44, P2382, DOI 10.1128/JCM.00216-06; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Munywoki P., 2013, J INFECT DIS; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Naorat S, 2013, J INFECT DIS, V208, pS238, DOI 10.1093/infdis/jit456; O'Shea MK, 2005, CLIN INFECT DIS, V41, P311, DOI 10.1086/431591; Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131; Schlaudecker EP, 2014, DIAGN MICR INFEC DIS, V80, P107, DOI 10.1016/j.diagmicrobio.2014.05.018; Sobanjo-Ter Meulen A, 2015, VACCINE; Suara RO, 1996, CLIN DIAGN LAB IMMUN, V3, P477, DOI 10.1128/CDLI.3.4.477-479.1996; Tielsch JM, 2007, PEDIATRICS, V119, pE330, DOI 10.1542/peds.2006-1192; Tielsch JM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0470-y; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wheeler SM, 2015, EMERG INFECT DIS, V21, P1951, DOI 10.3201/eid2111.150497; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	33	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152015	10.1371/journal.pone.0152015	http://dx.doi.org/10.1371/journal.pone.0152015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031702	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800028
J	Estomba, H; Munoa-Hoyos, I; Gianzo, M; Urizar-Arenaza, I; Casis, L; Irazusta, J; Subiran, N				Estomba, Haizea; Munoa-Hoyos, Iraia; Gianzo, Marta; Urizar-Arenaza, Itziar; Casis, Luis; Irazusta, Jon; Subiran, Nerea			Expression and Localization of Opioid Receptors in Male Germ Cells and the Implication for Mouse Spermatogenesis	PLOS ONE			English	Article							ENKEPHALIN-DEGRADING ENZYMES; SPERM MOTILITY; HUMAN SEMEN; MEIOTIC RECOMBINATION; MET-ENKEPHALIN; MALE-FERTILITY; STEM-CELLS; TESTIS; MICE; RAT	The presence of endogenous opioid peptides in different testicular cell types has been extensively characterized and provides evidence for the participation of the opioid system in the regulation of testicular function. However, the exact role of the opioid system during the spermatogenesis has remained controversial since the presence of the mu-, delta-and kappa-opioid receptors in spermatogenic cells was yet to be demonstrated. Through a combination of quantitative real-time PCR, immunofluorescence, immunohistochemistry and flow cytometry approaches, we report for the first time the presence of active mu-, deltaand kappa-opioid receptors in mouse male germ cells. They show an exposition time-dependent response to opioid agonist, hence suggesting their active involvement in spermatogenesis. Our results contribute to understanding the role of the opioid receptors in the spermatogenesis and could help to develop new strategies to employ the opioid system as a biochemical tool for the diagnosis and treatment of male infertility.	[Estomba, Haizea; Munoa-Hoyos, Iraia; Gianzo, Marta; Urizar-Arenaza, Itziar; Casis, Luis; Irazusta, Jon; Subiran, Nerea] Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain	University of Basque Country	Subiran, N (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain.	nerea.subiran@ehu.es	Subirán, Nerea/AAA-4395-2019; Irazusta, Jon/ABB-1237-2020	Subirán, Nerea/0000-0001-9202-1287; MUNOA HOYOS, IRAIA/0000-0002-5107-6991; CASIS SAENZ, LUIS/0000-0001-9968-3216; Irazusta, Jon/0000-0002-6763-8602; URIZAR ARENAZA, ITZIAR/0000-0002-6390-7887; Gianzo, Marta/0000-0003-2351-4955	Basque Government; University of the Basque Country (UPV/EHU); Merck Serono; Gangoti Barrera Foundation; Basque Government (Zabalduz)	Basque Government(Basque Government); University of the Basque Country (UPV/EHU); Merck Serono(Merck & Company); Gangoti Barrera Foundation; Basque Government (Zabalduz)(Basque Government)	This work was supported by grants from The Basque Government, University of the Basque Country (UPV/EHU) and Merck Serono. HE was supported by a fellowship from the Gangoti Barrera Foundation; MG was supported by a fellowship from Basque Government (Zabalduz); IM was supported by a fellowship from Basque Government and IU was supported by a fellowship from University of Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; This work was supported by grants from The Basque Government, University of the Basque Country (UPV/EHU) and Merck Serono. HE was supported by a fellowship from the Gangoti Barrera Foundation; MG was supported by a fellowship from Basque Government (Zabalduz); IM was supported by a fellowship from Basque Government and IU was supported by a fellowship from University of Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Agirregoitia E, 2006, J CLIN ENDOCR METAB, V91, P4969, DOI 10.1210/jc.2006-0599; Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; BADR FM, 1979, MUTAT RES, V68, P235, DOI 10.1016/0165-1218(79)90155-1; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Cicero TJ, 2002, PHARMACOL BIOCHEM BE, V72, P157, DOI 10.1016/S0091-3057(01)00751-1; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Eto K, 2013, ENDOCRINOLOGY, V154, P2891, DOI 10.1210/en.2012-1977; FABBRI A, 1985, ENDOCRINOLOGY, V117, P2544, DOI 10.1210/endo-117-6-2544; FABBRI A, 1988, ENDOCRINOLOGY, V122, P749, DOI 10.1210/endo-122-2-749; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Gaveriaux-Ruff C, 1999, OPIOID RECEPTORS GEN; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; HAYWARD NJ, 1993, EUR J NEUROSCI, V5, P961, DOI 10.1111/j.1460-9568.1993.tb00947.x; Hosoya N, 2012, EMBO REP, V13, P44, DOI 10.1038/embor.2011.221; HUANG HFS, 1991, ENDOCRINOLOGY, V128, P3152, DOI 10.1210/endo-128-6-3152; Irazusta J, 2004, J ANDROL, V25, P733; Kalejs M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-6; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kouznetsova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028255; Malendowicz LK, 2005, INT J MOL MED, V15, P841; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; OHARA BF, 1994, MOL REPROD DEV, V38, P275, DOI 10.1002/mrd.1080380308; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Soverchia L, 2006, MOL REPROD DEV, V73, P1, DOI 10.1002/mrd.20341; Subiran N, 2008, FERTIL STERIL, V89, P1571, DOI 10.1016/j.fertnstert.2007.06.056; Subiran N, 2012, FERTIL STERIL, V98, P617, DOI 10.1016/j.fertnstert.2012.05.036; Subiran N, 2011, MOL MED, V17, P846, DOI 10.2119/molmed.2010.00268; TSONG SD, 1982, ENDOCRINOLOGY, V110, P2204, DOI 10.1210/endo-110-6-2204; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	39	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152162	10.1371/journal.pone.0152162	http://dx.doi.org/10.1371/journal.pone.0152162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031701	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800038
J	Ghaghada, KB; Sato, AF; Starosolski, ZA; Berg, J; Vail, DM				Ghaghada, Ketan B.; Sato, Amy F.; Starosolski, Zbigniew A.; Berg, John; Vail, David M.			Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; CT; LIVER; COMPLEMENT; PERFORMANCE; DOXORUBICIN; ACTIVATION; METASTASES; ANIMALS; MODELS	Objectives Companion dogs with naturally occurring cancer serve as an important large animal model in translational research because they share strong similarities with human cancers. In this study, we investigated a long circulating liposomal-iodine contrast agent (Liposomal-I) for computed tomography (CT) imaging of solid tumors in companion dogs with naturally occurring cancer. Materials and Methods The institutional animal ethics committees approved the study and written informed consent was obtained from all owners. Thirteen dogs (mean age 10.1 years) with a variety of masses including primary and metastatic liver tumors, sarcomas, mammary carcinoma and lung tumors, were enrolled in the study. CT imaging was performed pre-contrast and at 15 minutes and 24 hours after intravenous administration of Liposomal-I (275 mg/kg iodine dose). Conventional contrast-enhanced CT imaging was performed in a subset of dogs, 90 minutes prior to administration of Liposomal-I. Histologic or cytologic diagnosis was obtained for each dog prior to admission into the study. Results Liposomal-I resulted in significant (p < 0.05) enhancement and uniform opacification of the vascular compartment. Non-renal, reticulo-endothelial systemic clearance of the contrast agent was demonstrated. Liposomal-I enabled visualization of primary and metastatic liver tumors. Sub-cm sized liver lesions grossly appeared as hypo-enhanced compared to the surrounding normal parenchyma with improved lesion conspicuity in the post-24 hour scan. Large liver tumors (> 1 cm) demonstrated a heterogeneous pattern of intra-tumoral signal with visibly higher signal enhancement at the post-24 hour time point. Extra-hepatic, extra-splenic tumors, including histiocytic sarcoma, anaplastic sarcoma, mammary carcinoma and lung tumors, were visualized with a heterogeneous enhancement pattern in the post-24 hour scan. Conclusions The long circulating liposomal-iodine contrast agent enabled prolonged visualization of small and large tumors in companion dogs with naturally occurring cancer. The study warrants future work to assess the sensitivity and specificity of the Liposomal-I agent in various types of naturally occurring canine tumors.	[Ghaghada, Ketan B.; Starosolski, Zbigniew A.] Texas Childrens Hosp, Singleton Dept Pediat Radiol, Houston, TX 77030 USA; [Sato, Amy F.; Berg, John] Tufts Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA; [Vail, David M.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA	Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison	Ghaghada, KB (corresponding author), Texas Childrens Hosp, Singleton Dept Pediat Radiol, Houston, TX 77030 USA.	kbghagha@texaschildrens.org			Marval Pharma Ltd.	Marval Pharma Ltd.	The study was supported by a research grant from Marval Pharma Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NG, 2014, CONTRAST MEDIA MOL I, V9, P3, DOI 10.1002/cmmi.1550; Annapragada Ananth V, 2012, Methodist Debakey Cardiovasc J, V8, P18; [Anonymous], 2011, VET COMP ONCOL; Badea CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034496; Boll H, 2013, ACAD RADIOL, V20, P1137, DOI 10.1016/j.acra.2013.06.002; Dekrafft KE, 2009, ANGEW CHEM INT EDIT, V48, P9901, DOI 10.1002/anie.200904958; Ekdawi SN, 2015, J CONTROL RELEASE, V207, P101, DOI 10.1016/j.jconrel.2015.04.006; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hansen AE, 2015, ACS NANO, V9, P6985, DOI 10.1021/acsnano.5b01324; Hong S-I, 2015, SCAND J CLIN LAB INV, P1; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Koukourakis MI, 2000, BRIT J CANCER, V83, P1281, DOI 10.1054/bjoc.2000.1459; Labori KJ, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115580877; Lairmore MD, 2014, ILAR J, V55, P1, DOI 10.1093/ilar/ilu022; Langereis S, 2013, NMR BIOMED, V26, P728, DOI 10.1002/nbm.2971; Leander P, 2001, EUR RADIOL, V11, P698, DOI 10.1007/s003300000712; Lee YJ, 2015, RADIOLOGY, V275, P97, DOI 10.1148/radiol.14140690; Li X, 2014, ADV DRUG DELIVER REV, V76, P116, DOI 10.1016/j.addr.2014.07.013; Liu YL, 2012, ACCOUNTS CHEM RES, V45, P1817, DOI 10.1021/ar300150c; Llimpe FLR, 2014, BRIT J CANCER, V111, P667, DOI 10.1038/bjc.2014.351; Maeda H, 2015, ADV DRUG DELIVER REV, V91, P3, DOI 10.1016/j.addr.2015.01.002; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Moos SI, 2013, EUR J RADIOL, V82, pE387, DOI 10.1016/j.ejrad.2013.04.029; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Phillips WT, 2009, WIRES NANOMED NANOBI, V1, P69, DOI 10.1002/wnan.3; SELTZER SE, 1995, RADIOLOGY, V194, P775, DOI 10.1148/radiology.194.3.7862978; Spinazzi A, 2000, INVEST RADIOL, V35, P1, DOI 10.1097/00004424-200001000-00001; Symon Z, 1999, CANCER, V86, P72, DOI 10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.3.CO;2-T; Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023; Szebeni J, 2004, CURR ALLERGY ASTHM R, V4, P25, DOI 10.1007/s11882-004-0038-9; Szebeni J, 2007, J LIPOSOME RES, V17, P107, DOI 10.1080/08982100701375118; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1105, P193, DOI 10.1016/0005-2736(92)90194-Q; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	38	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152718	10.1371/journal.pone.0152718	http://dx.doi.org/10.1371/journal.pone.0152718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031614	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800127
J	Greacen, T; Kersaudy-Rahib, D; Le Gall, JM; Lydie, N; Ghosn, J; Champenois, K				Greacen, Tim; Kersaudy-Rahib, Delphine; Le Gall, Jean-Marie; Lydie, Nathalie; Ghosn, Jade; Champenois, Karen			Comparing the Information and Support Needs of Different Population Groups in Preparation for 2015 Government Approval for HIV Self-testing in France	PLOS ONE			English	Article							HIGH-RISK; INFECTION; DELPHI; MEN; SEX	Context HIV self-tests are currently being introduced in France with the aim of promoting screening both for the general population and for high-risk populations. Objective The current study aimed to identify and compare the information and support needs of the different target population groups. Methods The Delphi process was used to synthesize expert opinions for each population group. Experts were chosen for their experience and expertise in the area of HIV and HIV screening for each population. Each group developed recommendations for a specific population: six high HIV prevalence populations (men who have sex with men; transgender people; substance users; migrants from sub-Saharan Africa; French West Indies; French Guiana) and two low prevalence populations (the general population; people under 25). Each group included expertise from four areas: research, screening and care, policy-making, and community groups. Results A final total of 263 recommendations were grouped into eight main themes: Communicating at both national and community levels about self-test arrival (24% of all recommendations); Providing information adapted to the different community groups' needs (23%); Providing counselling on self-test use and access to care (15%); Making self-tests available to all in terms of accessibility and cost (13%); Preparing community healthcare and screening systems for the arrival of the self-test (11%); Approving only high quality self-tests (6%); Defending self-test users' legal rights (5%); Evaluating self-test use (3%). Although a large number of recommendations were common to several groups of experts, the study highlighted a certain number of recommendations specific to each different population group, particularly with regard to information content and access both to information and to the self-tests themselves. Conclusion Results from the current study should make a significant contribution to policy decisions concerning catering for the specific access, information and support needs of different potential HIV self-test user groups in France.	[Greacen, Tim; Champenois, Karen] EPS Maison Blanche, Lab Rech, Paris, France; [Kersaudy-Rahib, Delphine; Lydie, Nathalie] INPES, St Denis, France; [Le Gall, Jean-Marie] AIDES, Pantin, France; [Ghosn, Jade] Hop Hotel Dieu, AP HP, UF Therapeut Immunoinfectiol, F-75181 Paris, France; [Ghosn, Jade] Univ Paris 05, EA7327, Fac Med Site Necker, Paris, France; [Champenois, Karen] INSERM, U1018, CESP Epidemiol VIH & IST 4, F-94275 Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Greacen, T; Champenois, K (corresponding author), EPS Maison Blanche, Lab Rech, Paris, France.; Champenois, K (corresponding author), INSERM, U1018, CESP Epidemiol VIH & IST 4, F-94275 Le Kremlin Bicetre, France.	tgreacen@ch-maison-blanche.fr; karen.champenois@inserm.fr		Rahib, Delphine/0000-0001-9187-0690	Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency) [ANRS 95012]; Laboratoire de recherche, EPS Maison Blanche	Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency); Laboratoire de recherche, EPS Maison Blanche	This research project was supported by a research grant from the Agence Nationale de Recherche sur le Sida et les hepatites virales (National AIDS and Hepatitis Research Agency; http://www.anrs.fr) (ANRS 95012). The Laboratoire de recherche, EPS Maison Blanche received the funding (TG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beltzer N, 2011, KNOWLEDGE ATTITUDES; Cazein F, 2011, B EPIDEMIOLOGIQUE HE, V43-44, P446; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; de la Fuente L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046555; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Figueroa C, 2015, AIDS BEHAV; French National AIDS Council, 2013, REC HIV SELF TESTS; French National Health Ethics Advisory Board, 2013, ETH ISS REG COMM HIV; Gordon T, 2006, TECHNOL FORECAST SOC, V73, P321, DOI 10.1016/j.techfore.2005.09.005; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greacen T, 2012, AIDS CARE        JUN, P37; Greacen T, 2012, SEX TRANSM INFECT MA, P1; Greensides DR, 2003, PUBLIC HEALTH REP, V118, P531, DOI 10.1016/S0033-3549(04)50289-3; Grispen JEJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-112; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hsu CC, 2007, PARE, V12, P1; Hung HL, 2008, EVAL PROGRAM PLANN, V31, P191, DOI 10.1016/j.evalprogplan.2008.02.005; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lert F, 2009, RISK REDUCTION MISSI; Lorente N, 2013, J SEX TRANSM DIS, V213; Martinez O, 2014, AIDS BEHAV, V18, P2485, DOI 10.1007/s10461-014-0790-3; Myers J, 2012, IDWEEK; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Phillips KA, 2003, AM J PREV MED, V24, P340, DOI 10.1016/S0749-3797(03)00019-9; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Supervie V, 2013, AIDS LOND ENGL, V2014, P1	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152567	10.1371/journal.pone.0152567	http://dx.doi.org/10.1371/journal.pone.0152567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031234	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800094
J	Jia, HQ; Wang, Y; Morris, CD; Jacques, V; Gottesfeld, JM; Rusche, JR; Thomas, EA				Jia, Haiqun; Wang, Ying; Morris, Charles D.; Jacques, Vincent; Gottesfeld, Joel M.; Rusche, James R.; Thomas, Elizabeth A.			The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MUTANT HUNTINGTIN; MOUSE MODEL; EXPRESSION; ACETYLATION; ACTIVATION; DISORDERS; PATHWAY; PROTEIN; PROFILE	An important epigenetic modification in Huntington's disease (HD) research is histone acetylation, which is regulated by histone acetyltransferase and histone deacetylase (HDAC) enzymes. HDAC inhibitors have proven effective in HD model systems, and recent work is now focused on functional dissection of the individual HDAC enzymes in these effects. Histone deacetylase 3 (HDAC3), a member of the class I subfamily of HDACs, has previously been implicated in neuronal toxicity and huntingtin-induced cell death. Hence, we tested the effects of RGFP966 ((E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide), a benzamide-type HDAC inhibitor that selectively targets HDAC3, in the N171-82Q transgenic mouse model of HD. We found that RGFP966 at doses of 10 and 25 mg/kg improves motor deficits on rotarod and in open field exploration, accompanied by neuroprotective effects on striatal volume. In light of previous studies implicating HDAC3 in immune function, we measured gene expression changes for 84 immune-related genes elicited by RGFP966 using quantitative PCR arrays. RGFP966 treatment did not cause widespread changes in cytokine/chemokine gene expression patterns, but did significantly alter the striatal expression of macrophage migration inhibitory factor (Mif), a hormone immune modulator associated with glial cell activation, in N171-82Q transgenic mice, but not WT mice. Accordingly, RGFP966-treated mice showed decreased glial fibrillary acidic protein (GFAP) immunoreactivity, a marker of astrocyte activation, in the striatum of N171-82Q transgenic mice compared to vehicle-treated mice. These findings suggest that the beneficial actions of HDAC3 inhibition could be related, in part, with lowered Mif levels and its associated downstream effects.	[Jia, Haiqun; Wang, Ying; Morris, Charles D.; Thomas, Elizabeth A.] Scripps Res Inst, Dept Cellular & Mol Neurosci, La Jolla, CA 92037 USA; [Jia, Haiqun; Wang, Ying] Calif Inst Biomed Res, La Jolla, CA USA; [Jacques, Vincent; Rusche, James R.] Repligen Corp, Waltham, MA USA; [Gottesfeld, Joel M.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Thomas, EA (corresponding author), Scripps Res Inst, Dept Cellular & Mol Neurosci, La Jolla, CA 92037 USA.	bthomas@scripps.edu		Gottesfeld, Joel/0000-0002-4643-5777	National Institutes of Health [U01NS063953]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Vincent Jacques and James R. Rusche were employees of Repligen Corporation and received funding in the form of salaries. The specific roles of these authors are articulated in the Author Contributions section. This study was also funded by National Institutes of Health grant U01NS063953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Choo QY, 2013, MOLECULES, V18, P14085, DOI 10.3390/molecules181114085; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; GROUP HSD, 1993, CELL, V72, P971; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jeong Y, 2013, J LEUKOCYTE BIOL; Jia H, 2012, 7 ANN HUNT DIS THER; Jia HQ, 2015, P NATL ACAD SCI USA, V112, pE56, DOI 10.1073/pnas.1415195112; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Li SQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0396-3; Malvaez M, 2013, P NATL ACAD SCI US; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Nishibori M, 2000, EUR J NEUROSCI, V12, P415, DOI 10.1046/j.1460-9568.2000.00914.x; Ogata A, 1998, NEUROSCI LETT, V246, P173, DOI 10.1016/S0304-3940(98)00203-1; Quinti L., 2010, PLOS CURRENTS, V2; Kalathur RKR, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-47; Rumbaugh G, 2015, NEUROPSYCHOPHARMACOL, V40, P2307, DOI 10.1038/npp.2015.93; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Tang B, 2013, BRAIN BEHAV IMMUN, V30, P168, DOI 10.1016/j.bbi.2013.01.086; Thomas EA, 2001, J NEUROCHEM, V76, P789, DOI 10.1046/j.1471-4159.2001.00027.x; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Thomas EA, 2014, PHARMACEUTICALS, V7, P634, DOI 10.3390/ph7060634	40	57	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152498	10.1371/journal.pone.0152498	http://dx.doi.org/10.1371/journal.pone.0152498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031333	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800085
J	Van de Sompel, D; Sasportas, LS; Jokerst, JV; Gambhir, SS				Van de Sompel, Dominique; Sasportas, Laura S.; Jokerst, Jesse V.; Gambhir, Sanjiv S.			Comparison of Deconvolution Filters for Photoacoustic Tomography	PLOS ONE			English	Article							IMAGE-RECONSTRUCTION; IN-VIVO; COMPUTED-TOMOGRAPHY; SYSTEM; RESOLUTION; ALGORITHM	In this work, we compare the merits of three temporal data deconvolution methods for use in the filtered backprojection algorithm for photoacoustic tomography (PAT). We evaluate the standard Fourier division technique, the Wiener deconvolution filter, and a Tikhonov L-2 norm regularized matrix inversion method. Our experiments were carried out on subjects of various appearances, namely a pencil lead, two man-made phantoms, an in vivo subcutaneous mouse tumor model, and a perfused and excised mouse brain. All subjects were scanned using an imaging system with a rotatable hemispherical bowl, into which 128 ultrasound transducer elements were embedded in a spiral pattern. We characterized the frequency response of each deconvolution method, compared the final image quality achieved by each deconvolution technique, and evaluated each method's robustness to noise. The frequency response was quantified by measuring the accuracy with which each filter recovered the ideal flat frequency spectrum of an experimentally measured impulse response. Image quality under the various scenarios was quantified by computing noise versus resolution curves for a point source phantom, as well as the full width at half maximum (FWHM) and contrast-to-noise ratio (CNR) of selected image features such as dots and linear structures in additional imaging subjects. It was found that the Tikhonov filter yielded the most accurate balance of lower and higher frequency content (as measured by comparing the spectra of deconvolved impulse response signals to the ideal flat frequency spectrum), achieved a competitive image resolution and contrast-to-noise ratio, and yielded the greatest robustness to noise. While the Wiener filter achieved a similar image resolution, it tended to underrepresent the lower frequency content of the deconvolved signals, and hence of the reconstructed images after backprojection. In addition, its robustness to noise was poorer than that of the Tikhonov filter. The performance of the Fourier filter was found to be the poorest of all three methods, based on the reconstructed images' lowest resolution (blurriest appearance), generally lowest contrast-to-noise ratio, and lowest robustness to noise. Overall, the Tikhonov filter was deemed to produce the most desirable image reconstructions.	[Van de Sompel, Dominique; Sasportas, Laura S.; Gambhir, Sanjiv S.] Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA; [Jokerst, Jesse V.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA	Stanford University; University of California System; University of California San Diego	Gambhir, SS (corresponding author), Stanford Univ, Sch Med, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu			Susan G. Komen postdoctoral fellowship; Molecular Imaging Program at Stanford (MIPS); Stanford Molecular Imaging Scholars Program SMIS [R25-T CA118681]; NIH Loan Repayment Program; National Cancer Institute CCNE [U54 CA119367]; In Vivo Cancer Molecular Imaging Center ICMIC [P50 CA114747]; Gambhir laboratory from NCI ICMIC [P50CA114747]; NCI [CCNE-T U54 U54CA151459]; Doris Duke Foundation; Canary Foundation; Ben and Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE [U54CA199075, U54CA119367, P50CA114747, U54CA151459, R25CA118681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL117048] Funding Source: NIH RePORTER	Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Molecular Imaging Program at Stanford (MIPS); Stanford Molecular Imaging Scholars Program SMIS; NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute CCNE; In Vivo Cancer Molecular Imaging Center ICMIC; Gambhir laboratory from NCI ICMIC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Canary Foundation; Ben and Catherine Ivy Foundation; Sir Peter Michael Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Van de Sompel was supported by a Susan G. Komen postdoctoral fellowship, as well as the Molecular Imaging Program at Stanford (MIPS). Dr. Jokerst is grateful for fellowship support from the Stanford Molecular Imaging Scholars Program SMIS R25-T CA118681, and acknowledges the NIH Loan Repayment Program. This work is also funded in part by the National Cancer Institute CCNE U54 CA119367 (S.S.G.) and In Vivo Cancer Molecular Imaging Center ICMIC P50 CA114747 (S.S.G.). Lastly, the authors would like to acknowledge funding for the Gambhir laboratory from NCI ICMIC P50CA114747, NCI CCNE-T U54 U54CA151459, the Doris Duke Foundation, Canary Foundation, Ben and Catherine Ivy Foundation, and the Sir Peter Michael Foundation.	Balboa RM, 2003, VISION RES, V43, P2527, DOI 10.1016/S0042-6989(03)00471-1; Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028; Brecht HP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259361; Burgholzer P, 2012, PROC SPIE, V8223, DOI 10.1117/12.908451; Burgholzer P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046706; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; Finch D, 2004, SIAM J MATH ANAL, V35, P1213, DOI 10.1137/S0036141002417814; Gamelin J, 2009, OPT EXPRESS, V17, P10489, DOI 10.1364/OE.17.010489; Gamelin J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907157; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Ghahramani S., 2000, FUNDAMENTALS PROBABI; Guo ZJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3381187; Hoelen CGA, 2000, APPL OPTICS, V39, P5872, DOI 10.1364/AO.39.005872; Hristova Y, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/5/055006; Jetzfellner T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3167280; KRUGER RA, 1995, MED PHYS, V22, P1605, DOI 10.1118/1.597429; Kruger RA, 2003, MED PHYS, V30, P856, DOI 10.1118/1.1565340; Kruger RA, 2000, RADIOLOGY, V216, P279, DOI 10.1148/radiology.216.1.r00jl30279; Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677; Ku G, 2005, APPL OPTICS, V44, P770, DOI 10.1364/AO.44.000770; Kunyansky LA, 2007, INVERSE PROBL, V23, P373, DOI 10.1088/0266-5611/23/1/021; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; MACKENZIE KV, 1981, J ACOUST SOC AM, V70, P807, DOI 10.1121/1.386920; Manohar S, 2005, PHYS MED BIOL, V50, P2543, DOI 10.1088/0031-9155/50/11/007; Paltauf G, 2002, J ACOUST SOC AM, V112, P1536, DOI 10.1121/1.1501898; Provost J, 2009, IEEE T MED IMAGING, V28, P585, DOI 10.1109/TMI.2008.2007825; Razansky D., 2011, SELECTED TOPICS QUAN, V99, P1; Rosenthal A, 2010, IEEE T MED IMAGING, V29, P1275, DOI 10.1109/TMI.2010.2044584; Tikhonov A. N., 1943, DOKL AKAD NAUK SSSR, V39, P195; Treeby BE, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/11/115003; Treeby BE, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3360308; Vaithilingam S, 2009, IEEE T ULTRASON FERR, V56, P2411, DOI [10.1109/TUFFC.2009.1329, 10.1109/TUFFc.2009.1329]; Van de Sompel D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045337; Wang K, 2012, PROC SPIE, V8223, DOI 10.1117/12.909690; Wang K, 2012, PROC SPIE, V8223, DOI 10.1117/12.909610; Wang K, 2011, IEEE T MED IMAGING, V30, P203, DOI 10.1109/TMI.2010.2072514; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2002, MED PHYS, V29, P2799, DOI 10.1118/1.1521720; Wang Y, 2004, PHYS MED BIOL, V49, P3117, DOI 10.1088/0031-9155/49/14/006; Wiener N., 1949, INTERPOLATION EXTRAP; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Xu MH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016706; Xu Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033902; Yang DW, 2007, OPT EXPRESS, V15, P15566, DOI 10.1364/OE.15.015566; Yin BZ, 2004, PHYS MED BIOL, V49, P1339, DOI 10.1088/0031-9155/49/7/019; Zhang C, 2010, IEEE PHOTONICS J, V2, P57, DOI 10.1109/JPHOT.2010.2042801; Zhang E, 2008, APPL OPTICS, V47, P561, DOI 10.1364/AO.47.000561; Zhang J, 2009, IEEE T MED IMAGING, V28, P1781, DOI 10.1109/TMI.2009.2024082	48	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152597	10.1371/journal.pone.0152597	http://dx.doi.org/10.1371/journal.pone.0152597			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031832	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800099
J	Matsuoka, S; Ishii, Y; Nakao, A; Abe, M; Ohtsuji, N; Momose, S; Jin, H; Arase, H; Sugimoto, K; Nakauchi, Y; Masutani, H; Maeda, M; Yagita, H; Komatsu, N; Hino, O				Matsuoka, Shuji; Ishii, Yasuyuki; Nakao, Atsuhito; Abe, Masaaki; Ohtsuji, Naomi; Momose, Shuji; Jin, Hui; Arase, Hisashi; Sugimoto, Koichi; Nakauchi, Yusuke; Masutani, Hiroshi; Maeda, Michiyuki; Yagita, Hideo; Komatsu, Norio; Hino, Okio			Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; T-CELLS; APOPTOSIS; RITUXIMAB; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; COMPLEMENT; INHIBITORS; DISEASE; DOMAIN	To develop a new therapeutic monoclonal Antibody (mAb) for Hodgkin lymphoma (HL), we immunized a BALB/c mouse with live HL cell lines, alternating between two HL cell lines. After hybridization, we screened the hybridoma clones by assessing direct cytotoxicity against a HL cell line not used for immunization. We developed this strategy for establishing mAb to reduce the risk of obtaining clonotypic mAb specific for single HL cell line. A newly established mouse anti-human mAb (4713) triggered cytoskeleton-dependent, but complement- and caspase-independent, cell death in HL cell lines, Burkitt lymphoma cell lines, and advanced adult T-cell leukemia cell lines. Intravenous injection of mAb 4713 in tumor-bearing SCID mice improved survival significantly. mAb 4713 was revealed to be a mouse antihuman pan-HLA class II mAb. Treatment with this mAb induced the formation of large pores on the surface of target lymphoma cells within 30 min. This finding suggests that the cell death process induced by this anti-pan HLA-class II mAb may involve the same death signals stimulated by a cytolytic anti-pan MHC class I mAb that also induces large pore formation. This multifaceted study supports the therapeutic potential of mAb 4713 for various forms of lymphoma.	[Matsuoka, Shuji; Abe, Masaaki; Ohtsuji, Naomi; Momose, Shuji; Hino, Okio] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 1138421, Japan; [Ishii, Yasuyuki] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2040022, Japan; [Nakao, Atsuhito] Yamanashi Univ, Fac Med, Dept Immunol, Kofu, Yamanashi 4093898, Japan; [Jin, Hui; Arase, Hisashi] Osaka Univ, Dept Immunochem, WPI Immunol Frontier Res Ctr, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Sugimoto, Koichi] JR Tokyo Hosp, Dept Hematol & Oncol, Tokyo 1518523, Japan; [Nakauchi, Yusuke] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Tokyo 1088639, Japan; [Masutani, Hiroshi; Maeda, Michiyuki] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068507, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Komatsu, Norio] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1138421, Japan	Juntendo University; RIKEN; University of Yamanashi; Osaka University; University of Tokyo; Kyoto University; Juntendo University; Juntendo University	Matsuoka, S (corresponding author), Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 1138421, Japan.	matsuoka@juntendo.ac.jp	; Arase, Hisashi/C-8442-2009	Masutani, Hiroshi/0000-0001-7633-2827; Nakauchi, Yusuke/0000-0002-6943-3811; Arase, Hisashi/0000-0002-1153-3166	Japan Society for the Promotion of Science [15K06880]; Grants-in-Aid for Scientific Research [25460386] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S. Matsuoka received the grant from Japan Society for the Promotion of Science (Web: https://kaken.nii.ac.jp/d/p/15K06880.en.html, grant number: 15K06880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2006, ONCOGENE, V25, P2181, DOI 10.1038/sj.onc.1209256; Altes A, 2013, LEUKEMIA LYMPHOMA, V54, P1706, DOI 10.3109/10428194.2012.752080; Brockhaus F, 1998, EXP CELL RES, V238, P33, DOI 10.1006/excr.1997.3778; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Curnock AP, 1998, CELL IMMUNOL, V187, P77, DOI 10.1006/cimm.1998.1335; Fernandez-Marrero Y, 2011, MABS-AUSTIN, V3, P528, DOI 10.4161/mabs.3.6.17770; Genestier L, 1997, BLOOD, V90, P3629, DOI 10.1182/blood.V90.9.3629; Genestier L, 1998, J BIOL CHEM, V273, P5060, DOI 10.1074/jbc.273.9.5060; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; HELSON L, 1975, CANCER RES, V35, P2594; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Ishida T, 2015, BRIT J HAEMATOL, V169, P672, DOI 10.1111/bjh.13338; Ishida T, 2011, INT J HEMATOL, V94, P443, DOI 10.1007/s12185-011-0941-5; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; MATSUOKA S, 1995, J EXP MED, V181, P2007, DOI 10.1084/jem.181.6.2007; Matsuoka S, 2003, J EXP MED, V198, P497, DOI 10.1084/jem.20021301; NAGATANI T, 1990, CANCER-AM CANCER SOC, V66, P2380, DOI 10.1002/1097-0142(19901201)66:11<2380::AID-CNCR2820661122>3.0.CO;2-H; Nagy ZA, 2002, NAT MED, V8, P801, DOI 10.1038/nm736; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; SCHAADT M, 1980, INT J CANCER, V26, P723, DOI 10.1002/ijc.2910260605; SHELTON MW, 1992, TRANSPLANTATION, V54, P278, DOI 10.1097/00007890-199208000-00017; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Skov S, 1997, J CELL BIOL, V139, P1523, DOI 10.1083/jcb.139.6.1523; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; TRUMAN JP, 1994, INT IMMUNOL, V6, P887, DOI 10.1093/intimm/6.6.887; Tsukasaki Kunihiro, 2012, Leuk Res Treatment, V2012, P101754, DOI 10.1155/2012/101754; Verma D, 2009, CANCER-AM CANCER SOC, V115, P101, DOI 10.1002/cncr.24005; Xie T, 2013, STRUCTURE, V21, P493, DOI 10.1016/j.str.2013.01.016; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhang CG, 1998, P NATL ACAD SCI USA, V95, P6290, DOI 10.1073/pnas.95.11.6290	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150496	10.1371/journal.pone.0150496	http://dx.doi.org/10.1371/journal.pone.0150496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028595	Green Published, Green Submitted, gold			2022-12-27	WOS:000373116500006
J	McDonnell, SL; Baggerly, C; French, CB; Baggerly, LL; Garland, CF; Gorham, ED; Lappe, JM; Heaney, RP				McDonnell, Sharon L.; Baggerly, Carole; French, Christine B.; Baggerly, Leo L.; Garland, Cedric F.; Gorham, Edward D.; Lappe, Joan M.; Heaney, Robert P.			Serum 25-Hydroxyvitamin D Concentrations >= 40 ng/ml Are Associated with > 65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study	PLOS ONE			English	Article							VITAMIN-D LEVELS; BREAST-CANCER; COLORECTAL-CANCER; HEALTH; PREVENTION; WOMEN; SUPPLEMENTATION; POPULATION; SUNLIGHT	Background Higher serum 25-hydroxyvitamin D [25(OH) D] concentrations have been associated with a lower risk of multiple cancer types across a range of 25(OH) D concentrations. Objectives To investigate whether the previously reported inverse association between 25(OH) D and cancer risk could be replicated, and if a 25(OH) D response region could be identified among women aged 55 years and older across a broad range of 25(OH) D concentrations. Methods Data from two cohorts representing different median 25(OH) D concentrations were pooled to afford a broader range of 25(OH) D concentrations than either cohort alone: the Lappe cohort (N = 1,169), a randomized clinical trial cohort (median 25(OH) D = 30 ng/ml) and the GrassrootsHealth cohort (N = 1,135), a prospective cohort (median 25(OH) D = 48 ng/ml). Cancer incidence over a multi-year period (median: 3.9 years) was compared according to 25(OH) D concentration. Kaplan-Meier plots were developed and the association between 25(OH) D and cancer risk was examined with multivariate Cox regression using multiple 25 (OH) D measurements and spline functions. The study included all invasive cancers excluding skin cancer. Results Age-adjusted cancer incidence across the combined cohort (N = 2,304) was 840 cases per 100,000 person-years (1,020 per 100,000 person-years in the Lappe cohort and 722 per 100,000 person-years in the GrassrootsHealth cohort). Incidence was lower at higher concentrations of 25(OH)D. Women with 25(OH) D concentrations >= 40 ng/ml had a 67% lower risk of cancer than women with concentrations <20 ng/ml (HR = 0.33, 95% CI = 0.12-0.90). Conclusions 25(OH)D concentrations >= 40 ng/ml were associated with substantial reduction in risk of all invasive cancers combined.	[McDonnell, Sharon L.; Baggerly, Carole; French, Christine B.; Baggerly, Leo L.] GrassrootsHealth, Encinitas, CA USA; [Garland, Cedric F.; Gorham, Edward D.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Lappe, Joan M.; Heaney, Robert P.] Creighton Univ, Dept Med, Omaha, NE 68178 USA	University of California System; University of California San Diego; Creighton University	McDonnell, SL (corresponding author), GrassrootsHealth, Encinitas, CA USA.	sharon@grassrootshealth.org			Department of Health and Human Services [AG14683-01A2]; Bio-Tech Pharmacal; Pure North S'Energy Foundation; Vitamin D Society; NATIONAL INSTITUTE ON AGING [R01AG014683] Funding Source: NIH RePORTER	Department of Health and Human Services; Bio-Tech Pharmacal; Pure North S'Energy Foundation; Vitamin D Society; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Lappe et al. study was funded by the Department of Health and Human Services grant AG14683-01A2. GrassrootsHealth is a nonprofit entity; this project was funded by self-sponsorship by the participants and donations from Bio-Tech Pharmacal, Pure North S'Energy Foundation and the Vitamin D Society. These funds provided the resources for the study design and data collection for the GrassrootsHealth study and the analysis and interpretations of this pooled analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Bilinski K, 2013, BREAST CANCER RES TR, V137, P599, DOI 10.1007/s10549-012-2381-1; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Brestoff JR, 2013, EPIDEMIOLOGY PRINCIP, P455; Cannell J, 2008, EXPERT OPIN PHARMACO, V9, P107, DOI 10.1517/14656566.9.1.107; Chandler PD, 2015, CANCER PREV RES, V8, P675, DOI 10.1158/1940-6207.CAPR-14-0470; Cheng TYD, 2013, AM J CLIN NUTR, V98, P1002, DOI 10.3945/ajcn.112.055905; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Food and Nutrition Board Institute of Medicine National Academy of Sciences, 2010, DIETARY REFERENCE IN; Garland CF, 2011, ANTICANCER RES, V31, P607; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Gorham ED, 2005, J STEROID BIOCHEM, V97, P179, DOI 10.1016/j.jsbmb.2005.06.018; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Holick MF, 2013, ANTI-CANCER AGENT ME, V13, P70; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; National Cancer Institute (NCI), CANC STAT; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Rejnmark L, 2009, CANCER EPIDEM BIOMAR, V18, P2655, DOI 10.1158/1055-9965.EPI-09-0531; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P321; Selvin S, 2011, STAT TOOLS EPIDEMIOL, P258; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wolpin BM, 2012, CANCER EPIDEM BIOMAR, V21, P82, DOI 10.1158/1055-9965.EPI-11-0836; Yao S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017251; Zhang LQ, 2015, CELL PHYSIOL BIOCHEM, V36, P299, DOI 10.1159/000374072	35	83	85	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152441	10.1371/journal.pone.0152441	http://dx.doi.org/10.1371/journal.pone.0152441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049526	Green Published, gold			2022-12-27	WOS:000373603500042
J	Meng, YF; Zhang, C; Yi, J; Zhou, ZJ; Fa, ZZ; Zhao, JY; Yang, YL; Fang, W; Wang, Y; Liao, WQ				Meng, Yunfang; Zhang, Chao; Yi, Jiu; Zhou, Zhaojing; Fa, Zhenzong; Zhao, Jingyu; Yang, Yali; Fang, Wei; Wang, Yan; Liao, Wan-qing			Deubiquitinase Ubp5 Is Required for the Growth and Pathogenicity of Cryptococcus gattii	PLOS ONE			English	Article							FUNGAL PATHOGEN; SACCHAROMYCES-CEREVISIAE; UBIQUITIN HOMEOSTASIS; SIGNALING PATHWAYS; CANDIDA-ALBICANS; VANCOUVER-ISLAND; NEOFORMANS; VIRULENCE; YEAST; GENE	Cryptococcus gattii is a resurgent fungal pathogen that primarily infects immunocompetent hosts. Thus, it poses an increasingly significant impact on global public health; however, the mechanisms underlying its pathogenesis remain largely unknown. We conducted a detailed characterization of the deubiquitinase Ubp5 in the biology and virulence of C. gattii using the hypervirulent strain R265, and defined its properties as either distinctive or shared with C. neoformans. Deletion of the C. gattii Ubp5 protein by site-directed disruption resulted in a severe growth defect under both normal and stressful conditions (such as high temperature, high salt, cell wall damaging agents, and antifungal agents), similar to the effects observed in C. neoformans. However, unlike C. neoformans, the C. gattii ubp5 Delta mutant displayed a slight enhancement of capsule and melanin production, indicating the evolutionary convergence and divergence of Ubp5 between these two sibling species. Attenuated virulence of the Cg-ubp5. mutant was not solely due to its reduced thermotolerance at 37 degrees C, as shown in both worm and mouse survival assays. In addition, the assessment of fungal burden in mammalian organs further indicated that Ubp5 was required for C. gattii pulmonary survival and, consequently, extrapulmonary dissemination. Taken together, our work highlights the importance of deubiquitinase Ubp5 in the virulence composite of both pathogenic cryptococcal species, and it facilitates a better understanding of C. gattii virulence mechanisms.	[Meng, Yunfang; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Yi, Jiu; Zhou, Zhaojing; Fa, Zhenzong; Yang, Yali; Fang, Wei] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Zhao, Jingyu] Shanghai Dermatol Hosp, Shanghai, Peoples R China; [Wang, Yan] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Meng, Yunfang] Shandong Univ, Shandong Prov Hosp, Dept Dermatol, Jinan 250100, Shandong, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Lang, Ming/HIK-0758-2022; Yang, Ya-Li/GYU-4320-2022; yang, yang/HGT-7999-2022		National Key Basic Research Programs of China [2013CB531601]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]	National Key Basic Research Programs of China(National Basic Research Program of China); Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Molecular Medical Mycology	This study was supported by the National Key Basic Research Programs of China (2013CB531601, WL), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400 and 14495800500, WF), the National Natural Science Foundation of China (81401651, 81471926 and 31170139, WL), and Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900, WL).	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Bahn YS, 2013, EUKARYOT CELL, V12, P1564, DOI 10.1128/EC.00218-13; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bozza WP, 2011, BIOCHEMISTRY-US, V50, P6423, DOI 10.1021/bi200529z; Brouwer Annemarie E, 2007, J Infect, V54, pe165, DOI 10.1016/j.jinf.2006.10.002; Byrnes EJ, 2011, MICROBES INFECT, V13, P895, DOI 10.1016/j.micinf.2011.05.009; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cheon KW, 2006, INT J ONCOL, V28, P1209; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Enyenihi AH, 2003, GENETICS, V163, P47; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038326; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fonseca FL, 2009, EUKARYOT CELL, V8, P1543, DOI 10.1128/EC.00142-09; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Gutteridge A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-68; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hu GG, 2006, CURR GENET, V49, P341, DOI 10.1007/s00294-005-0054-x; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Nicholson Benjamin, 2007, Future Oncol, V3, P191, DOI 10.2217/14796694.3.2.191; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; Park YD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004037; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Ramanathan Arvind, 2007, J Biol, V6, P3, DOI 10.1186/jbiol56; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Vidotto Valerio, 2004, Revista Iberoamericana de Micologia, V21, P87; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	56	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153219	10.1371/journal.pone.0153219	http://dx.doi.org/10.1371/journal.pone.0153219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049762	gold, Green Published, Green Submitted			2022-12-27	WOS:000373603500112
J	van der Graaf-van Bloois, L; Miller, WG; Yee, E; Gorkiewicz, G; Forbes, KJ; Zomer, AL; Wagenaar, JA; Duim, B				van der Graaf-van Bloois, Linda; Miller, William G.; Yee, Emma; Gorkiewicz, Gregor; Forbes, Ken J.; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta			Campylobacter fetus Subspecies Contain Conserved Type IV Secretion Systems on Multiple Genomic Islands and Plasmids	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PATHOGENICITY ISLAND; HELICOBACTER-PYLORI; SERUM-RESISTANCE; INFECTIONS; VIRULENCE; PATHOGENESIS; PROTEINS; HUMANS; CAG	The features contributing to differences in pathogenicity of the Campylobacter fetus subspecies are unknown. Putative factors involved in pathogenesis are located in genomic islands that encode a type IV secretion system (T4SS) and fic domain (filamentation induced by cyclic AMP) proteins, which may disrupt host cell processes. In the genomes of 27 C. fetus strains, three phylogenetically-different T4SS-encoding regions (T4SSs) were identified: one was located in both the chromosome and in extra-chromosomal plasmids; one was located exclusively in the chromosome; and one exclusively in extra-chromosomal plasmids. We observed that C. fetus strains can contain multiple T4SSs and that homologous T4SSs can be present both in chromosomal genomic islands (GI) and on plasmids in the C. fetus strains. The GIs of the chromosomally located T4SS differed mainly by the presence of fic genes, insertion sequence elements and phage-related or hypothetical proteins. Comparative analysis showed that T4SS sequences, inserted in the same locations, were conserved in the studied C. fetus genomes. Using phylogenetic analysis of the T4SSs, it was shown that C. fetus may have acquired the T4SS regions from other Campylobacter species by horizontal gene transfer. The identified T4SSs and fic genes were found in Cff and Cfv strains, although the presence of T4SSs and fic genes were significantly associated with Cfv strains. The T4SSs and fic genes could not be associated with S-layer serotypes or geographical origin of the strains.	[van der Graaf-van Bloois, Linda; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van der Graaf-van Bloois, Linda; Zomer, Aldert L.; Wagenaar, Jaap A.; Duim, Birgitta] WHO Collaborating Ctr Campylobacter OIE Reference, Utrecht, Netherlands; [Miller, William G.; Yee, Emma] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Gorkiewicz, Gregor] Med Univ Graz, Inst Pathol, Graz, Austria; [Forbes, Ken J.] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands	Utrecht University; United States Department of Agriculture (USDA); Medical University of Graz; University of Aberdeen; Wageningen University & Research	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.; Duim, B (corresponding author), WHO Collaborating Ctr Campylobacter OIE Reference, Utrecht, Netherlands.	B.Duim@uu.nl	Gorkiewicz, Gregor/ABF-1602-2021	Gorkiewicz, Gregor/0000-0003-1149-4782; van der Graaf-van Bloois, Linda/0000-0001-8181-3393; Zomer, Aldert/0000-0002-0758-5190				Abril C, 2010, ANTIMICROB AGENTS CH, V54, P3052, DOI 10.1128/AAC.00304-10; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; AltMorbe J, 1996, J BACTERIOL, V178, P4248, DOI 10.1128/jb.178.14.4248-4257.1996; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BLASER MJ, 1987, J INFECT DIS, V155, P696, DOI 10.1093/infdis/155.4.696; BLASER MJ, 1993, AM J MED SCI, V306, P325, DOI 10.1097/00000441-199311000-00011; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Dekeyser J, 1984, CAMPYLOBACTER INFECT, P181; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitzgerald C, 2014, INT J SYST EVOL MICR, V64, P2944, DOI 10.1099/ijs.0.057778-0; Gilbert MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101599; Gorkiewicz G, 2010, J BACTERIOL, V192, P502, DOI 10.1128/JB.00803-09; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kienesberger S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085491; Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10; Moolhuijzen PM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-86; On SLW, 2001, J APPL MICROBIOL, V90, P285, DOI 10.1046/j.1365-2672.2001.01247.x; Pearson BM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01056-13; PEI ZH, 1990, J CLIN INVEST, V85, P1036, DOI 10.1172/JCI114533; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Thompson SA, 2000, CAMPYLOBACTER, P321; Tu ZC, 2005, J CLIN MICROBIOL, V43, P3334, DOI 10.1128/JCM.43.7.3334-3340.2005; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van der Graaf-van Bloois L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01246-13; van der Graaf-van Bloois L, 2014, J CLIN MICROBIOL, V52, P4183, DOI 10.1128/JCM.01837-14; VERON M, 1973, INT J SYST BACTERIOL, V23, P122, DOI 10.1099/00207713-23-2-122; Wagenaar JA, 2014, CLIN INFECT DIS, V58, P1579, DOI 10.1093/cid/ciu085; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; WESLEY IV, 1989, AM J VET RES, V50, P807; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008	33	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152832	10.1371/journal.pone.0152832	http://dx.doi.org/10.1371/journal.pone.0152832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049518	Green Published, gold, Green Submitted			2022-12-27	WOS:000373603500059
J	Yum, HR; Park, SH; Park, HYL; Shin, SY				Yum, Hae Ri; Park, Shin Hae; Park, Hae-Young Lopilly; Shin, Sun Young			Macular Ganglion Cell Analysis Determined by Cirrus HD Optical Coherence Tomography for Early Detecting Chiasmal Compression	PLOS ONE			English	Article							NERVE-FIBER LAYER; VISUAL-FIELD SENSITIVITY; NORMAL-PRESSURE GLAUCOMA; BAND ATROPHY; PREPERIMETRIC GLAUCOMA; THICKNESS; DISK; ABILITY; SCANS; OCT	Purpose To evaluate the performance of macular ganglion cell-inner plexiform layer (mGCIPL) measurement with Cirrus high-definition (HD) optical coherence tomography (OCT) for early detection of optic chiasmal compression. Methods Forty-six eyes of 46 patients with optic chiasmal compression caused by a pituitary adenoma (PA group), 31 eyes of 31 patients with normal tension glaucoma (NTG group), and 32 eyes of 32 normal participants (control group) were enrolled. The PA group was subdivided into two subgroups, which comprised patients with temporal visual field (VF) defects (perimetric PA group, 34 eyes) and without VF defect (preperimetric PA group, 12 eyes). The mGCIPL thickness and circumpapillary retinal nerve fiber layer (cpRNFL) thickness were measured using Cirrus HD-OCT. We calculated the number of patients who had an abnormal GCA sector map, defined as at least one yellow or red sector. Results Eyes in the perimetric PA group had significantly decreased mGCIPL thickness in all sectors. Eyes in the preperimetric PA group had significantly thinner mGCIPL in the superior, superonasal, inferonasal, and inferior sectors than eyes in control group, but no changes in cpRNFL parameters were observed. The mGCIPL thickness in inferonasal area showed the greatest AUC value (0.965), followed by the superonasal area (0.958) for discriminating preperimetric PA group from the control group. A higher reduction rate of mGCIPL thickness was noted in the nasal sector compared to other sectors, which was irrespective of temporal visual field defects. The mGCIPL thickness maps showed superonasal (P = 0.003) and inferonasal thinning in the PA group (P = 0.003), while inferotemporal thinning was revealed in the NTG group (P = 0.001). Conclusions Macular GCIPL thickness parameters obtained with the Cirrus HD-OCT were useful in early detection of chiasmal compression and differentiating from NTG by characteristic nasal mGCIPL thinning.	[Yum, Hae Ri] Konyang Univ, Konyang Univ Hosp, Dept Ophthalmol, Coll Med, Daejeon, South Korea; [Park, Shin Hae; Park, Hae-Young Lopilly; Shin, Sun Young] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea	Konyang University; Konyang University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.	eyeshin@catholic.ac.kr						Ahmed IIK, 2002, J GLAUCOMA, V11, P279, DOI 10.1097/00061198-200208000-00002; Ajtony C, 2007, INVEST OPHTH VIS SCI, V48, P258, DOI 10.1167/iovs.06-0410; Asrani S, 2003, J GLAUCOMA, V12, P119, DOI 10.1097/00061198-200304000-00006; Begum VU, 2014, INVEST OPHTH VIS SCI, V55, P4768, DOI 10.1167/iovs.14-14598; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Drummond Suzannah R., 2010, International Ophthalmology, V30, P215, DOI 10.1007/s10792-009-9308-9; Greenfield D S, 1999, Semin Ophthalmol, V14, P95, DOI 10.3109/08820539909056069; Greenfield DS, 1998, OPHTHALMOLOGY, V105, P1866, DOI 10.1016/S0161-6420(98)91031-4; HITCHINGS RA, 1977, BRIT J OPHTHALMOL, V61, P107, DOI 10.1136/bjo.61.2.107; HITCHINGS RA, 1976, BRIT J OPHTHALMOL, V60, P778, DOI 10.1136/bjo.60.11.778; HOYT W. F., 1962, BULL JOHNS HOPKINS HOSP, V111, P57; HOYT WF, 1963, ARCH OPHTHALMOL-CHIC, V70, P69, DOI 10.1001/archopht.1963.00960050071013; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jacob M, 2009, AM J OPHTHALMOL, V147, P64, DOI 10.1016/j.ajo.2008.07.016; KALENAK JW, 1992, J CLIN NEURO-OPHTHAL, V12, P230; Kanamori A, 2004, OPHTHALMOLOGY, V111, P2278, DOI 10.1016/j.ophtha.2004.05.035; Kanamori A, 2013, GRAEF ARCH CLIN EXP, V251, P591, DOI 10.1007/s00417-012-2096-3; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim MJ, 2014, INVEST OPHTH VIS SCI, V55, P2079, DOI 10.1167/iovs.13-13506; Kotowski J, 2012, BRIT J OPHTHALMOL, V96, P1420, DOI 10.1136/bjophthalmol-2011-301021; Monteiro MLR, 2007, AM J OPHTHALMOL, V143, P896, DOI 10.1016/j.ajo.2006.11.054; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Monteiro MLR, 2004, BRIT J OPHTHALMOL, V88, P896, DOI 10.1136/bjo.2003.038489; Moura FC, 2007, OPHTHALMOLOGY, V114, P175, DOI 10.1016/j.ophtha.2006.06.045; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P3817, DOI 10.1167/iovs.11-9369; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; OH JY, 2008, ASIAN J OPHTHALMOL, V10, P364; Qu YZ, 2011, ACTA OPHTHALMOL, V89, pE428, DOI 10.1111/j.1755-3768.2011.02118.x; Shin HY, 2014, GRAEF ARCH CLIN EXP, V252, P1501, DOI 10.1007/s00417-014-2706-3; Stewart W, 1992, J GLAUCOMA, V1, P27, DOI DOI 10.1097/00061198-199204000-00007; Sung MS, 2014, J GLAUCOMA, V23, pE144, DOI 10.1097/IJG.0000000000000028; SWARTZ NG, 1993, SEMIN ULTRASOUND CT, V14, P206, DOI 10.1016/S0887-2171(05)80081-2; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1046; UNSOLD R, 1980, ARCH OPHTHALMOL-CHIC, V98, P1637, DOI 10.1001/archopht.1980.01020040489020; WYBAR K, 1977, P ROY SOC MED, V70, P307, DOI 10.1177/003591577707000505; Yamashita T, 2012, JPN J OPHTHALMOL, V56, P502, DOI 10.1007/s10384-012-0146-3	42	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153064	10.1371/journal.pone.0153064	http://dx.doi.org/10.1371/journal.pone.0153064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049647	Green Submitted, Green Published, gold			2022-12-27	WOS:000373603500094
J	Toren, P; Kim, S; Johnson, F; Zoubeidi, A				Toren, Paul; Kim, Soojin; Johnson, Fraser; Zoubeidi, Amina			Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; GROWTH IN-VITRO; ANDROGEN RECEPTOR; CASTRATION-RESISTANT; MOUSE MODEL; PHASE-II; PROGRESSION; PI3K/AKT/MTOR; ACTIVATION; INHIBITION	Despite recent improvements in patient outcomes using newer androgen receptor (AR) pathway inhibitors, treatment resistance in castrate resistant prostate cancer (CRPC) continues to remain a clinical problem. Co-targeting alternate resistance pathways are of significant interest to treat CRPC and delay the onset of resistance. Both the AKT and MEK signaling pathways become activated as prostate cancer develops resistance to AR-targeted therapies. This pre-clinical study explores co-targeting these pathways in AR-positive prostate cancer models. Using various in vitro models of prostate cancer disease states including androgen dependent (LNCaP), CRPC (V16D and 22RV1) and ENZ-resistant prostate cancer (MR49C and MR49F), we evaluate the relevance of targeting both AKT and MEK pathways. Our data reveal that AKT inhibition induces apoptosis and inhibits cell growth in PTEN null cell lines independently of their sensitivity to hormone therapy; however, AKT inhibition had no effect on the PTEN positive 22RV1 cell line. Interestingly, we found that MEK inhibition had greater effect on 22RV1 cells compared to LNCaP, V16D or ENZ-resistant cells MR49C and MR49F cells. In vitro, combination AKT and MEK blockade had evidence of synergy observed in some cell lines and assays, but this was not consistent across all results. In vivo, the combination of AKT and MEK inhibition resulted in more consistent tumor growth inhibition of MR49F xenografts and longer disease specific survival compared to AKT inhibitor monotherapy. As in our in vitro study, 22RV1 xenografts were more resistant to AKT inhibition while they were more sensitive to MEK inhibition. Our results suggest that targeting AKT and MEK in combination may be a valuable strategy in prostate cancer when both pathways are activated and further support the importance of characterizing the dominant oncogenic pathway in each patient's tumor in order to select optimal therapy.	[Toren, Paul; Kim, Soojin; Johnson, Fraser; Zoubeidi, Amina] Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC, Canada	University of British Columbia	Zoubeidi, A (corresponding author), Univ British Columbia, Fac Med, Dept Urol Sci, Vancouver Prostate Ctr, Vancouver, BC, Canada.	azoubeidi@prostatecentre.com		Toren, Paul/0000-0002-5762-5787	Prostate Cancer Canada; AstraZeneca; Canadian Urological Association Scholarship Foundation; Discovery Grant	Prostate Cancer Canada; AstraZeneca(AstraZeneca); Canadian Urological Association Scholarship Foundation; Discovery Grant	Funding was provided by Discovery Grant, Prostate Cancer Canada and AstraZeneca to A. Zoubeidi. PT was supported by the Canadian Urological Association Scholarship Foundation. AstraZeneca was involved in discussions regarding the study design and review of the manuscript, but the data collection and analysis and decision to publish was made by the authors. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Discovery Grant, Prostate Cancer Canada. We would like to thank Dr Barry Davies (AstraZeneca) for providing AZD5363 and selumetinib, and for helpful discussions. AZD5363 was discovered by AstraZeneca subsequent to a collaboration with Astex Therapeutics (and its collaboration with the Institute of Cancer Research and Cancer Research Technology Limited). We also thank Virginia Yago, Darrell Trendall, and Mary Bowden for their technical assistance.	Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chee KG, 2007, CLIN GENITOURIN CANC, V5, P433, DOI 10.3816/CGC.2007.n.031; Cirone P, 2014, CANCER CHEMOTH PHARM, V73, P525, DOI 10.1007/s00280-014-2376-1; Clark DE, 2005, CANCER RES, V65, P3108; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Ewald F, 2014, INVEST NEW DRUG, V32, P1144, DOI 10.1007/s10637-014-0149-7; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Georgi B, 2014, INT J ONCOL, V45, P1337, DOI 10.3892/ijo.2014.2567; Gioeli D, 2005, CLIN SCI, V108, P293, DOI 10.1042/CS20040329; Gioeli D, 1999, CANCER RES, V59, P279; HSIEH JT, 1993, CANCER RES, V53, P2852; Huggins C, 1941, CANCER RES, V1, P293; Kandil E, 2013, J SURG RES, V184, P898, DOI 10.1016/j.jss.2013.03.052; Karantanos T, 2015, EUR UROL, V67, P470, DOI 10.1016/j.eururo.2014.09.049; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lee JT, 2008, CELL CYCLE, V7, P631, DOI 10.4161/cc.7.5.5416; Liu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108780; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Loriot Y, 2012, UROL CLIN N AM, V39, P517, DOI 10.1016/j.ucl.2012.07.008; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Matsumoto H, 2013, CANCER RES, V73, P5206, DOI 10.1158/0008-5472.CAN-13-0359; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Park H, 2015, PROSTATE, V75, P1747, DOI 10.1002/pros.23057; Pitts TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113037; Posadas EM, 2005, CANCER BIOL THER, V4, P1133, DOI 10.4161/cbt.4.10.2064; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Toren P, 2015, EUR UROL, V67, P986, DOI 10.1016/j.eururo.2014.08.006; Toren PJ, 2015, MOL CANCER THER, V14, P59, DOI 10.1158/1535-7163.MCT-14-0521; Toulany M, 2013, CANC BIOL THER, V15; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Zardan A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.30; Zoubeidi A, 2010, CANCER RES, V70, P2307, DOI 10.1158/0008-5472.CAN-09-3252; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	45	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152861	10.1371/journal.pone.0152861	http://dx.doi.org/10.1371/journal.pone.0152861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27046225	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600041
J	Liu, WN; Xu, C; You, XJ; Olson, DM; Chemtob, S; Gao, L; Ni, X				Liu, Weina; Xu, Chen; You, Xingji; Olson, David M.; Chemtob, Sylvain; Gao, Lu; Ni, Xin			Hydrogen Sulfide Delays LPS-Induced Preterm Birth in Mice via Anti-Inflammatory Pathways	PLOS ONE			English	Article							MOUSE MODEL; LABOR; INFLAMMATION; PARTURITION; EXPRESSION; MYOMETRIUM; INFECTION; DELIVERY	A major cause of preterm labor in pregnant women is intra-amniotic infection, which is mediated by an inflammatory process. Hydrogen sulfide (H2S), a gaseous transmitter, has been implicated to be involved in inflammatory responses. We sought to investigate whether H2S affects infectious preterm birth using the mouse model of lipopolysaccharides (LPS)induced preterm birth. Administration of LPS at 0.4 mg/kg with two injections intraperitoneally (i.p.) on gestational day 14.5 induced preterm labor. LPS significantly increased leukocyte infiltration in uterus, stimulated the expression of pro-inflammatory cytokines interleukin 1 beta (IL-1 beta), IL-6, tumor necrosis factor a (TNF-alpha), CCL2 and CXCL15 in myometrium. Administration of NaHS (i.p.) delayed the onset of labor induced by LPS in a dose-dependent manner. NaHS prevented leukocyte infiltration into intrauterine tissues and inhibited the production of pro-inflammatory cytokines in myometrium and decreased the levels of these cytokines in maternal circulation. H2S also decreased LPS-activated extracellular signal-regulated kinase (ERK) 1/2/nuclear factor (NF)-kappa B signaling pathways in myometrium. This study provides new in vivo evidence for the roles of H2S in attenuating inflammation, and a potential novel therapeutic strategy for infection-related preterm labor.	[Liu, Weina; Xu, Chen; You, Xingji; Gao, Lu; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Pediat, Montreal, PQ, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada; [Chemtob, Sylvain] CHU St Justine Res Ctr, Dept Pharmacol, Montreal, PQ, Canada; [Liu, Weina] Chinese Peoples Liberat Army, Hosp 413, Zhoushan, Zhejiang, Peoples R China; [Xu, Chen] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	Naval Medical University; University of Alberta; University of Alberta; University of Alberta; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Fudan University	Gao, L; Ni, X (corresponding author), Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China.	lu.gao@smmu.edu.cn; nixin@smmu.edu.cn	Xingji, You/GQY-5030-2022		National Natural Science Foundation of China [81170596, 81270756, 81370734, 81471479]; Science and Technology Commission of Shanghai Municipals [15PJ1410400, 13430722900]; Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipals; Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative	This work was supported by National Natural Science Foundation of China No. 81170596 & 81270756 (to LG), No. 81370734 (to XN), and 81471479 (to XY); Science and Technology Commission of Shanghai Municipals No. 15PJ1410400 (to LG) and No. 13430722900 (to XN); and Global Alliance for the Prevention of Prematurity and Stillbirth (GAPPS): Preventing Preterm Birth Initiative (to DMO, SC & XN).	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bokstrom H, 1997, HUM REPROD, V12, P586; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Cindrova-Davies T, 2013, AM J PATHOL, V182, P1448, DOI 10.1016/j.ajpath.2013.01.001; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Filipovich Y, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.025; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Holwerda KM, 2012, PLACENTA, V33, P518, DOI 10.1016/j.placenta.2012.02.014; Holwerda KM, 2013, HYPERTENSION, V62, P653, DOI 10.1161/HYPERTENSIONAHA.113.01625; Hua W, 2013, CHINESE MED J-PEKING, V126, P1360, DOI 10.3760/cma.j.issn.0366-6999.20122557; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kakinuma C, 1997, OBSTET GYNECOL, V90, P117, DOI 10.1016/S0029-7844(97)00176-2; Kimura H, 2015, ANTIOXID REDOX SIGN, V22, P347, DOI 10.1089/ars.2014.6082; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lin Y, 2006, J REPROD IMMUNOL, V71, P87, DOI 10.1016/j.jri.2006.01.005; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Muniraj N, 2017, INT J RHEUM DIS, V20, P182, DOI 10.1111/1756-185X.12472; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Osmers R G, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P185; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Paul BD, 2012, NAT REV MOL CELL BIO, V13, DOI 10.1038/nrm3391-c2; Ray A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00052; Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shynlova O, 2013, J CELL MOL MED, V17, P90, DOI 10.1111/j.1582-4934.2012.01650.x; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Wallace JL, 2015, ANTIOXID REDOX SIGN, V22, P398, DOI 10.1089/ars.2014.5901; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang GS, 2013, AM J PATHOL, V182, P1188, DOI 10.1016/j.ajpath.2012.12.008; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599	37	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152838	10.1371/journal.pone.0152838	http://dx.doi.org/10.1371/journal.pone.0152838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035826	Green Published, Green Submitted, gold			2022-12-27	WOS:000373201200045
J	Simmons, M; Sun, PF; Putnak, R				Simmons, Monika; Sun, Peifang; Putnak, Robert			Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine	PLOS ONE			English	Article							WEST-NILE-VIRUS; IMMUNOLOGICAL-PROPERTIES; STRUCTURAL PROTEINS; MICE; ENCEPHALITIS; IMMUNIZATION; PROTECTION; NEUTRALIZATION; IMMUNOGENICITY; IDENTIFICATION	Dengue virus purified inactivated vaccines (PIV) are highly immunogenic and protective over the short term, but may be poor at inducing cell-mediated immune responses and long-term protection. The dengue nonstructural protein 3 (NS3) is considered the main target for T-cell responses during viral infection. The amino (N)-terminal protease and the carboxy (C)-terminal helicase domains of DENV-2 NS3 were expressed in E.coli and analyzed for their immune-potentiating capacity. Mice were immunized with DENV-2 PIV with and without recombinant NS3 protease or NS3 helicase proteins, and NS3 proteins alone on days 0, 14 and 28. The NS3 helicase but not the NS3 protease was effective in inducing T-cell responses quantified by IFN-gamma ELISPOT. In addition, markedly increased total IgG antibody titer against virus antigen was seen in mice immunized with the PIV/NS3 helicase combination in the ELISA, as well as increased neutralizing antibody titer measured by the plaque reduction neutralization test. These results indicate the potential immunogenic properties of the NS3 helicase protein and its use in a dengue vaccine formulation.	[Simmons, Monika; Sun, Peifang] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Putnak, Robert] Walter Reed Army Inst Res, Div Viral Dis, Silver Spring, MD USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Simmons, M (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	monika.simmons.civ@mail.mil			Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD [A1325]	Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD	This work was funded by a grant from the Military Infectious Disease Research Program (MIDRP), U.S. Army Medical Research and Materiel Command, Fort Detrick, MD, work unit number A1325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; BRAY M, 1989, J VIROL, V63, P2853, DOI 10.1128/JVI.63.6.2853-2856.1989; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; CHURDBOONCHART V, 1991, AM J TROP MED HYG, V44, P481, DOI 10.4269/ajtmh.1991.44.481; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Durbin AP, 2011, VIRUSES-BASEL, V3, P1800, DOI 10.3390/v3101800; Edelman R, 2011, EXPERT REV VACCINES, V10, P133, DOI 10.1586/ERV.10.159; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Gao M, 2006, VACCINE, V24, P5491, DOI 10.1016/j.vaccine.2006.04.004; Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Jiao XM, 2004, J GEN VIROL, V85, P1545, DOI 10.1099/vir.0.79896-0; Kaltenbock A, 2009, VACCINE, V27, P4483, DOI 10.1016/j.vaccine.2009.05.034; Kaufman B, 1989, MONOCLONAL ANTIBODIE; Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7; KURANE I, 1993, J VIROL, V67, P6285, DOI 10.1128/JVI.67.10.6285-6288.1993; Lopez L, 2006, MICROBIAL CELL FA S1, V5, pP59; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Alvarez-Rodriguez LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/956875; Morozova OV, 1999, VIRAL IMMUNOL, V12, P277, DOI 10.1089/vim.1999.12.277; Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176; Ramirez R, 2014, VIRUS GENES, V49, P185, DOI 10.1007/s11262-014-1087-3; Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Rivino L, 2012, J VIROL; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; RUSSELL PK, 1967, J IMMUNOL, V99, P291; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Simmons M, 2001, AM J TROP MED HYG, V65, P420, DOI 10.4269/ajtmh.2001.65.420; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Stephenson JR, 2005, T ROY SOC TROP MED H, V99, P643, DOI 10.1016/j.trstmh.2005.05.003; Thomas SJ, 2011, J INFECT DIS, V203, P299, DOI 10.1093/infdis/jiq060; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; Vogelzang A, 2014, J INFECT DIS, V210, P1928, DOI 10.1093/infdis/jiu347; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wuest T, 2004, VACCINE, V22, P2717, DOI 10.1016/j.vaccine.2004.01.048; ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988	48	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2016	11	4							e0152811	10.1371/journal.pone.0152811	http://dx.doi.org/10.1371/journal.pone.0152811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI0QF	27035715	gold, Green Published, Green Submitted			2022-12-27	WOS:000373201200044
J	Guo, XM; Dong, ZM; Zhang, Y; Li, YS; Liu, HW; Xia, QY; Zhao, P				Guo, Xiaomeng; Dong, Zhaoming; Zhang, Yan; Li, Youshan; Liu, Huawei; Xia, Qingyou; Zhao, Ping			Proteins in the Cocoon of Silkworm Inhibit the Growth of Beauveria bassiana	PLOS ONE			English	Article							GALLERIA-MELLONELLA LARVAE; BOMBYX-MORI; PROTEASE INHIBITORS; DOMESTICATED SILKWORM; TRYPSIN-INHIBITOR; GENE-EXPRESSION; MANDUCA-SEXTA; HEMOLYMPH; GENOME; INSECT	Silk cocoons are composed of fiber proteins (fibroins) and adhesive glue proteins (sericins), which provide a physical barrier to protect the inside pupa. Moreover, other proteins were identified in the cocoon silk, many of which are immune related proteins. In this study, we extracted proteins from the silkworm cocoon by Tris-HCl buffer (pH7.5), and found that they had a strong inhibitory activity against fungal proteases and they had higher abundance in the outer cocoon layers than in the inner cocoon layers. Moreover, we found that extracted cocoon proteins can inhibit the germination of Beauveria bassiana spores. Consistent with the distribution of protease inhibitors, we found that proteins from the outer cocoon layers showed better inhibitory effects against B. bassiana spores than proteins from the inner layers. Liquid chromatography-tandem mass spectrometry was used to reveal the extracted components in the scaffold silk, the outermost cocoon layer. A total of 129 proteins were identified, 30 of which were annotated as protease inhibitors. Protease inhibitors accounted for 89.1% in abundance among extracted proteins. These protease inhibitors have many intramolecular disulfide bonds to maintain their stable structure, and remained active after being boiled. This study added a new understanding to the antimicrobial function of the cocoon.	[Guo, Xiaomeng; Dong, Zhaoming; Zhang, Yan; Li, Youshan; Liu, Huawei; Xia, Qingyou; Zhao, Ping] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaop@swu.edu.cn	Dong, Zhaoming/AAK-1802-2021; Dong, Zhaoming/AAW-3060-2021	Dong, Zhaoming/0000-0001-5665-9953; Dong, Zhaoming/0000-0001-5665-9953	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31530071, 31472154]; China Postdoctoral Science Foundation [2015M570765]; Fundamental Research Funds for the Central Universities of China [XDJK2016C008]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2012CB114600), the National Natural Science Foundation of China (31530071 and 31472154), the China Postdoctoral Science Foundation (2015M570765) and the Fundamental Research Funds for the Central Universities of China (XDJK2016C008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charnley A.K., 1991, P267; Charnley A.K., 1984, P229; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chen FJ, 2013, J EXP BIOL, V216, P2648, DOI 10.1242/jeb.082545; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; Ezzati-Tabrizi R, 2013, CURR PROTEIN PEPT SC, V14, P698; GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9; Gandhe AS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-184; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; GOETTEL MS, 1989, J GEN MICROBIOL, V135, P2233; International Silkworm Genome Consortium, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI DOI 10.1016/J.IBMB.2008.11.004; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kludkiewicz B, 2005, PROTEIN EXPRES PURIF, V43, P94, DOI 10.1016/j.pep.2005.06.011; Korayem AM, 2007, BIOCHEM BIOPH RES CO, V352, P317, DOI 10.1016/j.bbrc.2006.11.022; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Li Y, 2012, AASRI PROC, V1, P549, DOI 10.1016/j.aasri.2012.06.086; Li YS, 2015, INSECT BIOCHEM MOLEC, V57, P11, DOI 10.1016/j.ibmb.2014.11.006; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; NAYAR JK, 1992, J PARASITOL, V78, P876, DOI 10.2307/3283321; Nirmala X, 2001, INSECT MOL BIOL, V10, P437, DOI 10.1046/j.0962-1075.2001.00282.x; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Pandiarajan J, 2011, RAPID COMMUN MASS SP, V25, P3203, DOI 10.1002/rcm.5213; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Shaik HA, 2009, J INSECT PHYSIOL, V55, P781, DOI 10.1016/j.jinsphys.2009.04.010; Singh CP, 2014, CELL MICROBIOL, V16, P1354, DOI 10.1111/cmi.12294; Slepneva IA, 2003, BIOCHEM BIOPH RES CO, V300, P188, DOI 10.1016/S0006-291X(02)02766-3; URIEL J, 1968, NATURE, V218, P578, DOI 10.1038/218578b0; Vilcinskas A, 1997, BIOCONTROL SCI TECHN, V7, P591, DOI 10.1080/09583159730640; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiong Q, 2013, MICRON, V44, P303, DOI 10.1016/j.micron.2012.08.002; YOSHIDA S, 1990, COMP BIOCHEM PHYS B, V95, P559, DOI 10.1016/0305-0491(90)90021-K; Yoshizaki L, 2007, PHYTOCHEMISTRY, V68, P2625, DOI 10.1016/j.phytochem.2007.06.003; Zdybicka-Barabas A, 2014, ARCH INSECT BIOCHEM, V87, P1, DOI 10.1002/arch.21175; Zhang Y., 2015, PLOS ONE, V10; Zhao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031168; Zhong X, 2012, INSECT BIOCHEM MOLEC, V42, P514, DOI 10.1016/j.ibmb.2012.03.009	44	18	23	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151764	10.1371/journal.pone.0151764	http://dx.doi.org/10.1371/journal.pone.0151764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032085	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800021
J	Hategekimana, C; Shoveller, J; Tuyisenge, L; Kenyon, C; Cechetto, DF; Lynd, LD				Hategekimana, Celestin; Shoveller, Jeannie; Tuyisenge, Lisine; Kenyon, Cynthia; Cechetto, David F.; Lynd, Larry D.			Correlates of Performance of Healthcare Workers in Emergency, Triage, Assessment and Treatment plus Admission Care (ETAT plus ) Course in Rwanda: Context Matters	PLOS ONE			English	Article							RESUSCITATION; PROGRAM	Background The Emergency, Triage, Assessment and Treatment plus Admission care (ETAT+) course, a comprehensive advanced pediatric life support course, was introduced in Rwanda in 2010 to facilitate the achievement of the fourth Millennium Development Goal. The impact of the course on improving healthcare workers (HCWs) knowledge and practical skills related to providing emergency care to severely ill newborns and children in Rwanda has not been studied. Objective To evaluate the impact of the ETAT+ course on HCWs knowledge and practical skills, and to identify factors associated with greater improvement in knowledge and skills. Methods We used a one group, pre-post test study using data collected during ETAT+ course implementation from 2010 to 2013. The paired t-test was used to assess the effect of ETAT+ course on knowledge improvement in participating HCWs. Mixed effects linear and logistic regression models were fitted to explore factors associated with HCWs performance in ETAT+ course knowledge and practical skills assessments, while accounting for clustering of HCWs in hospitals. Results 374 HCWs were included in the analysis. On average, knowledge scores improved by 22.8/100 (95% confidence interval (CI) 20.5, 25.1). In adjusted models, bilingual (French & English) participants had a greater improvement in knowledge 7.3 (95% CI 4.3, 10.2) and higher odds of passing the practical skills assessment (adjusted odds ratio (aOR) = 2.60; 95% CI 1.25, 5.40) than those who were solely proficient in French. Participants who attended a course outside of their health facility had higher odds of passing the skills assessment (aOR = 2.11; 95% CI 1.01, 4.44) than those who attended one within their health facility. Conclusions The current study shows a positive impact of ETAT+ course on improving participants' knowledge and skills related to managing emergency pediatric and neonatal care conditions. The findings regarding key factors influencing ETAT+ course outcomes demonstrate the importance of considering key contextual factors (e.g., language barriers) that might affect HCWs performance in this type of continuous medical education.	[Hategekimana, Celestin; Shoveller, Jeannie] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hategekimana, Celestin; Lynd, Larry D.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [Tuyisenge, Lisine] Univ Teaching Hosp Kigali, Dept Pediat, Kigali, Rwanda; [Kenyon, Cynthia] London Hlth Sci Ctr, Childrens Hosp, Div Neonatal Perinatal Med, London, ON, Canada; [Cechetto, David F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON, Canada; [Lynd, Larry D.] Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Hategekimana, C (corresponding author), Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Hategekimana, C; Lynd, LD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.; Lynd, LD (corresponding author), Providence Hlth Res Inst, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	celekimana@gmail.com; larry.lynd@ubc.ca		Lynd, Larry/0000-0002-7622-3919; Hategeka, Celestin/0000-0001-7808-4652	Maternal Newborn and Child Health in Rwanda from Foreign Affairs and International Trade Canada [S-065358]; International Health Partnership Funding Scheme; Belgian Development Agency; IntraHealth Rwanda	Maternal Newborn and Child Health in Rwanda from Foreign Affairs and International Trade Canada; International Health Partnership Funding Scheme; Belgian Development Agency; IntraHealth Rwanda	DFC received a grant (Maternal Newborn and Child Health in Rwanda, S-065358) from Foreign Affairs and International Trade Canada (http://www.international.gc.ca/international/index.aspx?lang=eng) that supported the ETAT+ course in Rwanda as well as CH to undertake a graduate training in Canada. The ETAT+ course received further funding from other institutions/agencies including: International Health Partnership Funding Scheme (http://www.thet.org/health-partnership-scheme), Belgian Development Agency (https://www.btcctb.org/en/countries/rwanda), and IntraHealth Rwanda (http://www.intrahealth.org/page/rwanda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen D, 2008, RESUSCITATION, V76, P419, DOI 10.1016/j.resuscitation.2007.08.019; [Anonymous], 2010, REPORT QUALITY HLTH; Binagwaho A, 2013, NEW ENGL J MED, V369, P2054, DOI 10.1056/NEJMsr1302176; Curran V, 2012, J CONTIN EDUC HEALTH, V32, P126, DOI 10.1002/chp.21135; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Jabbour M, 1996, ANN EMERG MED, V28, P690, DOI 10.1016/S0196-0644(96)70095-1; Mabey D, 2013, PRINCIPLES MED AFRIC; Mayhew M, 2015, INT J HLTH POLICY MA, V4; Ministry of Health of the Republic of Rwanda, 2011, HUM RES HLTH STRAT P; Ministry of Health of the Republic of Rwanda, 2014, RWAND ANN HLTH STAT; Ministry of Health of the Republic of Rwanda, BAS PED PROT 2011; Ministry of Youth and ICT of the Republic of Rwanda, 2012, RWAND ICT PROF MEAS; National Institute of Statistics of Rwanda & Ministry of Finance and Economic Planning, 2012, 4 RWAND POP HOUS CEN; National Public Radio, 2008, ENGL BEC OFF LANG RW; Ralston ME, 2013, LANCET, V381, P256, DOI 10.1016/S0140-6736(12)61191-X; Rwanda Pediatric Association, 2010, EM TRIAG ASS TREATM; Trochim W.M., 2006, RES METHODS KNOWLEDG; Tuyisenge L, 2014, ARCH DIS CHILDHOOD; Waisman Y, 2002, PEDIATR EMERG CARE, V18, P168, DOI 10.1097/00006565-200206000-00004; WHO, 1987, WHO EXP COMM ROL HOS; World Health Organization, 2013, CHART, V13, P131	21	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152882	10.1371/journal.pone.0152882	http://dx.doi.org/10.1371/journal.pone.0152882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030974	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800152
J	Kim, BJ; Kim, BR; Lee, SY; Kim, GN; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Kim, Bo-Ram; Lee, So-Young; Kim, Ga-Na; Kook, Yoon-Hoh; Kim, Bum-Joon			Molecular Taxonomic Evidence for Two Distinct Genotypes of Mycobacterium yongonense via Genome-Based Phylogenetic Analysis	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SP-NOV.; AVIUM COMPLEX; SEQUENCE-ANALYSIS; IDENTIFICATION; ABSCESSUS; PROPOSAL; ELEVATE; HSP65	Recently, we introduced a distinct Mycobacterium intracellulare INT-5 genotype, distantly related to other genotypes of M. intracellulare (INT-1 to -4). The aim of this study is to determine the exact taxonomic status of the M. intracellulare INT-5 genotype via genome-based phylogenetic analysis. To this end, genome sequences of the two INT-5 strains, MOTT-H4Y and MOTT-36Y were compared with M. intracellulare ATCC 13950(T) and Mycobacterium yongonense DSM 45126(T). Our phylogenetic analysis based on complete genome sequences, multi-locus sequence typing (MLST) of 35 target genes, and single nucleotide polymorphism (SNP) analysis indicated that the two INT-5 strains were more closely related to M. yongonense DSM 45126T than the M. intracellulare strains. These results suggest their taxonomic transfer from M. intracellulare into M. yongonense. Finally, we selected 5 target genes (argH, dnaA, deaD, hsp65, and recF) and used SNPs for the identification of M. yongonese strains from other M. avium complex (MAC) strains. The application of the SNP analysis to 14 MAC clinical isolates enabled the selective identification of 4 M. yongonense clinical isolates from the other MACs. In conclusion, our genome-based phylogenetic analysis showed that the taxonomic status of two INT-5 strains, MOTT-H4Y and MOTT-36Y should be revised into M. yongonense. Our results also suggest that M. yongonense could be divided into 2 distinct genotypes (the Type I genotype with the M. parascrofulaceum rpoB gene and the Type II genotype with the M. intracellulare rpoB gene) depending on the presence of the lateral gene transfer of rpoB from M. parascrofulaceum.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Canc Res Inst,Inst Endem Dis, Seoul, South Korea; Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Canc Res Inst,Inst Endem Dis, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [HI13C15620000]; National Research Foundation of Korea [NRF-2014R1A1A2004008]	Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	Funded by www.htdream.kr, Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No., HI13C15620000) (Bum-Joon Kim) and ernd.nrf.re.kr, National Research Foundation of Korea (Grant No., NRF-2014R1A1A2004008) (YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Bang D, 2008, INT J SYST EVOL MICR, V58, P2398, DOI 10.1099/ijs.0.65503-0; Ben Salah I, 2009, INT J SYST EVOL MICR, V59, P2803, DOI 10.1099/ijs.0.010637-0; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim Bu-Yeo, 2013, Evid Based Complement Alternat Med, V2013, P584604, DOI 10.1155/2013/584604; Kim BJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1978-2; Kim BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051846; Kim BJ, 2013, INT J SYST EVOL MICR, V63, P192, DOI 10.1099/ijs.0.037465-0; Kim BJ, 2012, J BACTERIOL, V194, P4141, DOI 10.1128/JB.00752-12; Kim BJ, 2012, J BACTERIOL, V194, P3268, DOI 10.1128/JB.00471-12; Kim BJ, 2012, J BACTERIOL, V194, P2771, DOI 10.1128/JB.00365-12; Kim BJ, 2012, J BACTERIOL, V194, P2750, DOI 10.1128/JB.00295-12; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Macheras E, 2014, RES MICROBIOL, V165, P82, DOI 10.1016/j.resmic.2013.12.003; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Murcia MI, 2006, INT J SYST EVOL MICR, V56, P2049, DOI 10.1099/ijs.0.64190-0; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pagliaro E, 2013, J FORENSIC INV, V1, P5, DOI DOI 10.1128/GEN0MEA.00006-13; Park JH, 2010, J MED MICROBIOL, V59, P1037, DOI 10.1099/jmm.0.020727-0; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tortoli E, 2004, INT J SYST EVOL MICR, V54, P1277, DOI 10.1099/ijs.0.02777-0; Tortoli E, 2013, EMERG INFECT DIS, V19, P1902, DOI 10.3201/eid1911.130911; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; van Ingen J, 2009, INT J SYST EVOL MICR, V59, P2277, DOI 10.1099/ijs.0.008854-0; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152703	10.1371/journal.pone.0152703	http://dx.doi.org/10.1371/journal.pone.0152703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031100	Green Published, gold			2022-12-27	WOS:000373121800123
J	Omar, HA; Mohamed, WR; Arab, HH; Arafa, ESA				Omar, Hany A.; Mohamed, Wafaa R.; Arab, Hany H.; Arafa, El-Shaimaa A.			Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; ACUTE-RENAL-FAILURE; FACTOR-KAPPA-B; POLYMETHOXYLATED FLAVONE; INDUCED HEPATOTOXICITY; INDUCED NEPHROTOXICITY; MOLECULAR-MECHANISMS; BREAST-CANCER; LIVER-INJURY; ACTIVATION	Despite its broad applications, cisplatin affords considerable nephro- and hepatotoxicity through triggering inflammatory and oxidative stress cascades. The aim of the current investigation was to study the possible protective effects of tangeretin on cisplatin-induced hepatotoxicity. The impact of tangeretin on cisplatin-evoked hepatic dysfunction and histopathologic changes along with oxidative stress, inflammatory and apoptotic biomarkers were investigated compared to silymarin. Tangeretin pre-treatment significantly improved liver function tests (ALT and AST), inhibited cisplatin-induced lipid profile aberrations (total cholesterol and triglycerides) and diminished histopathologic structural damage in liver tissues. Tangeretin also attenuated cisplatin-induced hepatic inflammatory events as indicated by suppression of tumor necrosis factor-alpha (TNF-alpha) and enhancement of interleukin-10 (IL-10). Meanwhile, it lowered malondialdehyde (MDA), nitric oxide (NO) and nuclear factor erythroid 2-related factor 2 (NRF-2) levels with restoration of glutathione (GSH), and glutathione peroxidase (GPx). Regarding mitogen-activated protein kinase (MAPK) pathway, tangeretin attenuated cisplatin-induced increase in phospho-p38, phospho-c-Jun Nterminal kinase (p-JNK) and phospho-extracellular signal-regulated kinase (p-ERK1/2) in liver tissues. In addition, tangeretin downregulated Bax expression with augmentation of Bcl-2 promoting liver cell survival. Our results highlight the protective effects of tangeretin against cisplatin-induced acute hepatic injury via the concerted modulation of inflammation, oxidative stress, MAPKs and apoptotic pathways.	[Omar, Hany A.; Mohamed, Wafaa R.; Arafa, El-Shaimaa A.] Beni Suef Univ, Dept Pharmacol & Toxicol, Fac Pharm, Bani Suwayf 62514, Egypt; [Omar, Hany A.] Univ Sharjah, Coll Pharm, Sharjah Inst Med Res, Sharjah 27272, U Arab Emirates; [Arab, Hany H.] Cairo Univ, Dept Biochem, Fac Pharm, Cairo 11562, Egypt; [Arafa, El-Shaimaa A.] Taif Univ, Dept Pharmacol & Toxicol, Fac Pharm, At Taif 21974, Saudi Arabia	Egyptian Knowledge Bank (EKB); Beni Suef University; University of Sharjah; Egyptian Knowledge Bank (EKB); Cairo University; Taif University	Arafa, ESA (corresponding author), Beni Suef Univ, Dept Pharmacol & Toxicol, Fac Pharm, Bani Suwayf 62514, Egypt.; Arafa, ESA (corresponding author), Taif Univ, Dept Pharmacol & Toxicol, Fac Pharm, At Taif 21974, Saudi Arabia.	elshimaa.arafa@pharm.bsu.edu.eg	Omar, Hany/B-7440-2013; Arafa, El-Shaimaa A/C-4777-2013; Arafa, Elshaimaa/Q-1316-2019; Arab, Hany/AAF-3652-2020	Omar, Hany/0000-0002-4670-8149; Arafa, El-Shaimaa A/0000-0002-9034-6624; Arafa, Elshaimaa/0000-0002-9034-6624; Arab, Hany/0000-0002-4195-6901; Mohamed, Wafaa/0000-0003-3652-6648	Deanship of Scientific Research, Taif University, Saudi Arabia [1-434-2830]	Deanship of Scientific Research, Taif University, Saudi Arabia	The current work was financially supported by grant number 1-434-2830 from the Deanship of Scientific Research, Taif University, Saudi Arabia.	Antunes LMG, 2000, PHARMACOL RES, V41, P405, DOI 10.1006/phrs.1999.0600; Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Arivazhagan L, 2014, J NUTR BIOCHEM, V25, P1140, DOI 10.1016/j.jnutbio.2014.06.007; Atessahin A, 2006, REPROD TOXICOL, V21, P42, DOI 10.1016/j.reprotox.2005.05.003; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bentli R, 2013, ARCH MED RES, V44, P521, DOI 10.1016/j.arcmed.2013.09.013; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Buege J A, 1978, Methods Enzymol, V52, P302; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018; Chou WY, 2006, ACTA PHARMACOL SIN, V27, P469, DOI 10.1111/j.1745-7254.2006.00304.x; Clichici S, 2015, J MED FOOD, V18, P290, DOI 10.1089/jmf.2013.0179; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Flora K, 1998, AM J GASTROENTEROL, V93, P139, DOI 10.1111/j.1572-0241.1998.00139.x; Francescato HDC, 2007, NEPHROL DIAL TRANSPL, V22, P2138, DOI 10.1093/ndt/gfm144; Gopi K S, 2010, Toxicol Int, V17, P64, DOI 10.4103/0971-6580.72672; Hayakawa K, 2006, AM J PHYSIOL-RENAL, V291, pF1169, DOI 10.1152/ajprenal.00513.2005; Helmy MM, 2014, EUR J PHARMACOL, V730, P133, DOI 10.1016/j.ejphar.2014.03.002; HIRANO T, 1995, BRIT J CANCER, V72, P1380, DOI 10.1038/bjc.1995.518; Hong KO, 2005, ARCH TOXICOL, V79, P231, DOI 10.1007/s00204-004-0623-7; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Iroanya OO, 2014, J CLIN DIAGN RES, V8, pHC15, DOI 10.7860/JCDR/2014/5875.4501; Iseri S, 2007, TOXICOLOGY, V230, P256, DOI 10.1016/j.tox.2006.11.073; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kurowska EA, 2004, J AGR FOOD CHEM, V52, P2879, DOI 10.1021/jf035354z; Laekeman G, 2003, J Pharm Belg, V58, P28; Lakshmi A, 2014, BIOCHIMIE, V99, P96, DOI 10.1016/j.biochi.2013.11.017; Lakshmi A, 2014, TOXICOL LETT, V229, P333, DOI 10.1016/j.toxlet.2014.06.845; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lu YK, 2006, TOXICOL SCI, V89, P515, DOI 10.1093/toxsci/kfj031; Luo JH, 2008, NEPHROL DIAL TRANSPL, V23, P2198, DOI 10.1093/ndt/gfn090; Malik S, 2015, EUR J PHARMACOL, V748, P54, DOI 10.1016/j.ejphar.2014.12.008; Mansour HH, 2006, J BIOCHEM MOL BIOL, V39, P656; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nakagawa Hayato, 2012, Patholog Res Int, V2012, P172894, DOI 10.1155/2012/172894; Naveau S, 2001, PRESSE MED, V30, P1024; Omar HA, 2009, MOL PHARMACOL, V76, P957, DOI 10.1124/mol.109.058180; Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677; Parlakpinar H, 2002, J PINEAL RES, V33, P161, DOI 10.1034/j.1600-079X.2002.02910.x; Periyasamy K, 2015, CANCER CHEMOTH PHARM, V75, P263, DOI 10.1007/s00280-014-2629-z; Pratibha R, 2006, EUR J PHARMACOL, V532, P290, DOI 10.1016/j.ejphar.2006.01.007; Pushpavalli G, 2010, FOOD CHEM TOXICOL, V48, P1654, DOI 10.1016/j.fct.2010.03.040; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramos AS, 2014, ENVIRON TOXICOL PHAR, V37, P1221, DOI 10.1016/j.etap.2014.04.005; Rehman MU, 2014, PHARMACOL REP, V66, P1050, DOI 10.1016/j.pharep.2014.06.004; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Shaw JiaJiu, 2011, J Exp Ther Oncol, V9, P129; Shi RX, 2007, MOL CANCER THER, V6, P1338, DOI 10.1158/1535-7163.MCT-06-0638; Shu ZP, 2014, INT IMMUNOPHARMACOL, V19, P275, DOI 10.1016/j.intimp.2014.01.011; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh D, 2015, J ETHNOPHARMACOL, V161, P186, DOI 10.1016/j.jep.2014.12.025; Singh RP, 2006, CURR DRUG TARGETS, V7, P345, DOI 10.2174/138945006776055004; Sohn JH, 2008, BIOL PHARM BULL, V31, P273, DOI 10.1248/bpb.31.273; Sun Y, 2014, HUM EXP TOXICOL, V33, P855, DOI 10.1177/0960327113511475; Sundaram R, 2015, J FUNCT FOODS, V16, P315, DOI 10.1016/j.jff.2015.03.024; Syed SN, 2014, AFR J TRADIT COMPLEM, V11, P102, DOI 10.4314/ajtcam.v11i3.15; Tadagavadi RK, 2010, J IMMUNOL, V185, P4904, DOI 10.4049/jimmunol.1000383; Tsuruya K, 2003, KIDNEY INT, V63, P72, DOI 10.1046/j.1523-1755.2003.00709.x; Vanhoecke BW, 2005, IN VIVO, V19, P103; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walle T, 2007, J PHARM PHARMACOL, V59, P857, DOI 10.1211/jpp.59.6.0012; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zicca A, 2002, EUR J PHARMACOL, V442, P265, DOI 10.1016/S0014-2999(02)01537-6	71	85	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151649	10.1371/journal.pone.0151649	http://dx.doi.org/10.1371/journal.pone.0151649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031695	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800018
J	Yang, WE; Ho, CC; Yang, SF; Lin, SH; Yeh, KT; Lin, CW; Chen, MK				Yang, Wei-En; Ho, Chuan-Chen; Yang, Shun-Fa; Lin, Shu-Hui; Yeh, Kun-Tu; Lin, Chiao-Wen; Chen, Mu-Kuan			Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CYSTEINE CATHEPSINS; OCCLUDING LOOP; CANCER; INHIBITION; INVASION; METASTASIS; MIGRATION	Background Cathepsin B (CTSB), a member of the cathepsin family, is a cysteine protease that is widely distributed in the lysosomes of cells in various tissues. It is overexpressed in several human cancers and may be related to tumorigenesis. The main purpose of this study was to analyze CTSB expression in oral squamous cell carcinoma (OSCC) and its correlation with patient prognosis. Methodology/Principal Findings Tissue microarrays were used to detect CTSB expression in 280 patients and to examine the association between CTSB expression and clinicopathological parameters. In addition, the metastatic effects of the CTSB knockdown on two oral cancer cell lines were investigated by transwell migration assay. Cytoplasmic CTSB expression was detected in 34.6% (97/280) of patients. CTSB expression was correlated with positive lymph node metastasis (p = 0.007) and higher tumor grade (p = 0.008) but not with tumor size and distant metastasis. In addition, multivariate analysis using a Cox proportional hazards model revealed a higher hazard ratio, demonstrating that CTSB expression was an independent unfavorable prognostic factor in buccal mucosa carcinoma patients. Furthermore, the Kaplan-Meier curve revealed that buccal mucosa OSCC patients with positive CTSB expression had significantly shorter overall survival. Moreover, treatment with the CTSB siRNA exerted an inhibitory effect on migration in OC2 and CAL27 oral cancer cells. Conclusions We conclude that CTSB expression may be useful for determining OSCC prognosis, particularly for patients with lymph node metastasis, and may function as a biomarker of the survival of OSCC patients in Taiwan.	[Yang, Wei-En; Yang, Shun-Fa; Yeh, Kun-Tu; Chen, Mu-Kuan] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Wei-En; Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Ho, Chuan-Chen] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Ho, Chuan-Chen; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung 40201, Taiwan; [Lin, Shu-Hui; Yeh, Kun-Tu] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Lin, Shu-Hui] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University	Chen, MK (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Chen, MK (corresponding author), Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung 40201, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.	cwlin@csmu.edu.tw; 53780@cch.org.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	National Science Council, Taiwan [NSC101-2314-B-371-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council, Taiwan (NSC101-2314-B-371-002-MY3). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from National Science Council, Taiwan (NSC101-2314-B-371-002-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapati K, 2014, STEM CELL RES, V12, P716, DOI 10.1016/j.scr.2014.02.008; Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Knopfova L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-15; Ko CP, 2015, TUMOR BIOL, V36, P7099, DOI 10.1007/s13277-015-3419-x; Kusunoki Takeshi, 1995, Auris Nasus Larynx, V22, P43; Lai WFT, 2004, OSTEOARTHR CARTILAGE, V12, P239, DOI 10.1016/j.joca.2003.11.005; 이혜림, 2013, Journal of Biomedical and Translational Research, V14, P1, DOI 10.12729/jbr.2013.14.1.1; Lin SH, 2014, INT J MOL SCI, V15, P2876, DOI 10.3390/ijms15022876; Lin WJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/525976; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nishikawa H, 2004, GYNECOL ONCOL, V92, P881, DOI 10.1016/j.ygyno.2003.11.017; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; SLOANE BF, 1981, SCIENCE, V212, P1151, DOI 10.1126/science.7233209; Tong B, 2014, CLIN EXP IMMUNOL, V177, P586, DOI 10.1111/cei.12357; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vigneswaran N, 2000, HUM PATHOL, V31, P931, DOI 10.1053/hupa.2000.9035; Wickramasinghe NS, 2005, ARCH BIOCHEM BIOPHYS, V436, P187, DOI 10.1016/j.abb.2005.01.023; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Wu D, 2012, HISTOL HISTOPATHOL, V27, P79, DOI 10.14670/HH-27.79; Xu ZZ, 2015, MOL MED REP, V11, P3499, DOI 10.3892/mmr.2014.3140; Yan SQ, 1998, BIOL CHEM, V379, P113; Yang SF, 2015, ONCOTARGET, V6, P2736, DOI 10.18632/oncotarget.3088; Yang X, 2010, INT J ORAL MAX SURG, V39, P174, DOI 10.1016/j.ijom.2009.11.018; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x	35	39	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152165	10.1371/journal.pone.0152165	http://dx.doi.org/10.1371/journal.pone.0152165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031837	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800039
J	Mirkovic, J; Gaskell, MG				Mirkovic, Jelena; Gaskell, M. Gareth			Does Sleep Improve Your Grammar? Preferential Consolidation of Arbitrary Components of New Linguistic Knowledge	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; COMPLEMENTARY LEARNING-SYSTEMS; MEMORY CONSOLIDATION; EPISODIC MEMORIES; TIME-COURSE; REPRESENTATION; HIPPOCAMPUS; ORGANIZATION; ACQUISITION; VOCABULARY	We examined the role of sleep-related memory consolidation processes in learning new form-meaning mappings. Specifically, we examined a Complementary Learning Systems account, which implies that sleep-related consolidation should be more beneficial for new hippocampally dependent arbitrary mappings (e.g. new vocabulary items) relative to new systematic mappings (e.g. grammatical regularities), which can be better encoded neocortically. The hypothesis was tested using a novel language with an artificial grammatical gender system. Stem-referent mappings implemented arbitrary aspects of the new language, and determiner/suffix+natural gender mappings implemented systematic aspects (e.g. tib scoiffesh + ballerina, tib mofeem + bride; ked jorool + cowboy, ked heefaff + priest). Importantly, the determiner-gender and the suffix-gender mappings varied in complexity and salience, thus providing a range of opportunities to detect beneficial effects of sleep for this type of mapping. Participants were trained on the new language using a word-picture matching task, and were tested after a 2-hour delay which included sleep or wakefulness. Participants in the sleep group outperformed participants in the wake group on tests assessing memory for the arbitrary aspects of the new mappings (individual vocabulary items), whereas we saw no evidence of a sleep benefit in any of the tests assessing memory for the systematic aspects of the new mappings: Participants in both groups extracted the salient determiner-natural gender mapping, but not the more complex suffix-natural gender mapping. The data support the predictions of the complementary systems account and highlight the importance of the arbitrariness/systematicity dimension in the consolidation process for declarative memories.	[Mirkovic, Jelena] York St John Univ, Fac Hlth & Life Sci, York YO31 7EX, N Yorkshire, England; [Mirkovic, Jelena; Gaskell, M. Gareth] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	York Saint John University; University of York - UK	Mirkovic, J (corresponding author), York St John Univ, Fac Hlth & Life Sci, York YO31 7EX, N Yorkshire, England.; Mirkovic, J; Gaskell, MG (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	jelena.mirkovic@york.ac.uk; gareth.gaskell@york.ac.uk	Gaskell, M. Gareth/B-4870-2008	Gaskell, M. Gareth/0000-0001-8325-1427	Economic and Social Research Council [ES/I032452/1]; ESRC [ES/I032452/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research presented here was supported by the Economic and Social Research Council grant ES/I032452/1 awarded to MGG and JM. The funder had no involvement in any aspect of the research.	[Anonymous], 1987, MECH LANGUAGE ACQUIS, DOI DOI 10.4324/9781315798721; Batterink LJ, 2014, NEUROPSYCHOLOGIA, V65, P169, DOI 10.1016/j.neuropsychologia.2014.10.024; Bayley PJ, 2008, HIPPOCAMPUS, V18, P575, DOI 10.1002/hipo.20417; BERKO J, 1958, WORD, V14, P150, DOI 10.1080/00437956.1958.11659661; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Cassidy KW, 2001, PSYCHON B REV, V8, P519; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Corbett G., 1991, GENDER; Coutanche MN, 2013, HIPPOCAMPUS, V23, P1189, DOI 10.1002/hipo.22157; Cumming G., 2012, UNDERSTANDING THE NE; Davis MH, 2009, PHILOS T R SOC B, V364, P3773, DOI 10.1098/rstb.2009.0111; DeKeyser RM, 2005, LANG LEARN, V55, P1, DOI 10.1111/j.0023-8333.2005.00294.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dikker S, 2010, PSYCHOL SCI, V21, P629, DOI 10.1177/0956797610367751; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Dumay N, 2007, PSYCHOL SCI, V18, P35, DOI 10.1111/j.1467-9280.2007.01845.x; Durrant SJ, 2013, CEREB CORTEX, V23, P2467, DOI 10.1093/cercor/bhs244; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Ellis NC, 2006, APPL LINGUIST, V27, P164, DOI 10.1093/applin/aml015; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; Feldman LB, 2000, J EXP PSYCHOL LEARN, V26, P1431, DOI 10.1037/0278-7393.26.6.1431; Fernald A, 2006, HDB PSYCHOLINGUISTIC; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fitneva SA, 2009, J CHILD LANG, V36, P967, DOI 10.1017/S0305000908009252; Foerde K, 2013, J NEUROSCI, V33, P5698, DOI 10.1523/JNEUROSCI.5217-12.2013; Franck J, 2016, J MEM LANG, V87, P84, DOI 10.1016/j.jml.2015.11.003; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friedrich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7004; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Gomez RL, 2015, CHILD DEV PERSPECT, V9, P183, DOI 10.1111/cdep.12130; Gomez RL, 2000, TRENDS COGN SCI, V4, P178, DOI 10.1016/S1364-6613(00)01467-4; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gonnerman LM, 2007, J EXP PSYCHOL GEN, V136, P323, DOI 10.1037/0096-3445.136.2.323; Henderson LM, 2012, DEVELOPMENTAL SCI, V15, P674, DOI 10.1111/j.1467-7687.2012.01172.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hupbach A, 2009, DEVELOPMENTAL SCI, V12, P1007, DOI 10.1111/j.1467-7687.2009.00837.x; Iber C, 2007, AASM MANUAL SCROING; KELLY MH, 1992, PSYCHOL REV, V99, P349, DOI 10.1037/0033-295X.99.2.349; Kielar A, 2010, J COGNITIVE NEUROSCI, V22, P1373, DOI 10.1162/jocn.2009.21353; Kielar A, 2008, J MEM LANG, V58, P327, DOI 10.1016/j.jml.2007.10.002; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Lahl O, 2008, J SLEEP RES, V17, P3, DOI 10.1111/j.1365-2869.2008.00622.x; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lau HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027139; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; McClelland JL, 2013, J EXP PSYCHOL GEN, V142, P1190, DOI 10.1037/a0033812; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Melinger A, 2003, LANG COGNITIVE PROC, V18, P335, DOI 10.1080/01690960244000072; Mirkovic J, 2005, LANG COGNITIVE PROC, V20, P139, DOI 10.1080/01690960444000205; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Monaghan P, 2011, J EXP PSYCHOL GEN, V140, P325, DOI 10.1037/a0022924; Nieuwenhuis ILC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065046; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Pallier C., 2002, COMPUTING DISCRIMINA; Pillon A, 1998, LANG COGNITIVE PROC, V13, P465, DOI 10.1080/016909698386465; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S., 1995, LANGUAGE INSTINCT NE; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rastle K, 2002, Q J EXP PSYCHOL-A, V55, P1339, DOI 10.1080/02724980244000099; Rastle K, 2008, LANG COGNITIVE PROC, V23, P942, DOI 10.1080/01690960802069730; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schreiner T, 2015, CEREB CORTEX, V25, P4169, DOI 10.1093/cercor/bhu139; Seidenberg MS, 1997, SCIENCE, V275, P1599, DOI 10.1126/science.275.5306.1599; Seidenberg MS, 2000, TRENDS COGN SCI, V4, P353, DOI 10.1016/S1364-6613(00)01515-1; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Sweegers CCG, 2014, CORTEX, V59, P49, DOI 10.1016/j.cortex.2014.07.006; Tamminen J, 2015, COGNITIVE PSYCHOL, V79, P1, DOI 10.1016/j.cogpsych.2015.03.003; Tamminen J, 2012, COGNITION, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; van den Bos E, 2012, J MEM LANG, V67, P507, DOI 10.1016/j.jml.2012.07.008; Vouloumanos A, 2009, DEV PSYCHOL, V45, P1611, DOI 10.1037/a0016134; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Werchan DM, 2014, CHILD DEV, V85, P429, DOI 10.1111/cdev.12149; Werchan DM, 2013, NEUROBIOL LEARN MEM, V100, P70, DOI 10.1016/j.nlm.2012.12.006; Williams SE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00184; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yu C, 2007, PSYCHOL SCI, V18, P414, DOI 10.1111/j.1467-9280.2007.01915.x; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x; Zubin DA, 1981, 17 REG M CHIC LING S	99	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152489	10.1371/journal.pone.0152489	http://dx.doi.org/10.1371/journal.pone.0152489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DI6HK	27046022	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000373599600021
J	Pereira, RC; Andersen, TL; Friedman, PA; Tumber, N; Salusky, IB; Wesseling-Perry, K				Pereira, Renata C.; Andersen, Thomas L.; Friedman, Peter A.; Tumber, Navdeep; Salusky, Isidro B.; Wesseling-Perry, Katherine			Bone Canopies in Pediatric Renal Osteodystrophy	PLOS ONE			English	Article							REMODELING COMPARTMENT CANOPIES; ADULT HUMAN BONE; PARATHYROID-HORMONE; REVERSAL-CELLS; HISTOMORPHOMETRY; RESORPTION; HYPERPARATHYROIDISM; OSTEOPOROSIS; OUTCOMES; DISEASE	Pediatric renal osteodystrophy (ROD) is characterized by changes in bone turnover, mineralization, and volume that are brought about by alterations in bone resorption and formation. The resorptive and formative surfaces on the cancellous bone are separated from the marrow cavity by canopies consisting of a layer of flat osteoblastic cells. These canopies have been suggested to play a key role in the recruitment of osteoprogenitors during the process of bone remodeling. This study was performed to address the characteristics of the canopies above bone formation and resorption sites and their association with biochemical and bone histomorphometric parameters in 106 pediatric chronic kidney disease (CKD) patients (stage 2-5) across the spectrum of ROD. Canopies in CKD patients often appeared as thickened multilayered canopies, similar to previous reports in patients with primary hyperparathyroidism. This finding contrasts with the thin appearance reported in healthy individuals with normal kidney function. Furthermore, canopies in pediatric CKD patients showed immunoreactivity to the PTH receptor (PTHR1) as well as to the receptor activator of nuclear factor kappa-B ligand (RANKL). The number of surfaces with visible canopy coverage was associated with plasma parathyroid hormone (PTH) levels, bone formation rate, and the extent of remodeling surfaces. Collectively, these data support the conclusion that canopies respond to the elevated PTH levels in CKD and that they possess the molecular machinery necessary to respond to PTH signaling.	[Pereira, Renata C.; Tumber, Navdeep; Salusky, Isidro B.; Wesseling-Perry, Katherine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Andersen, Thomas L.] Univ Southern Denmark, Inst Reg Hlth Sci, Lillebaelt Hosp, Dept Clin Cell Biol KCB,Vejle Hosp, Vejle, Denmark; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern Denmark; Lillebaelt Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wesseling-Perry, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	kwesseling@mednet.ucla.edu	Levin Andersen, Thomas/AAY-6777-2021	Levin Andersen, Thomas/0000-0002-6981-7276	US Public Health Service [DK-67563, DK-35423, DK-54171, DK-080984]; University of California's Clinical Translational Science Institute [UL1 TR-000124]; Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Norman Siegel Research Scholar Award; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK067563, K23DK080984, R01DK035423] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of California's Clinical Translational Science Institute; Children's Discovery and Innovation Institute; American Society of Nephrology Foundation's Norman Siegel Research Scholar Award; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US Public Health Service grants DK-67563, DK-35423, DK-54171 (PAF), DK-080984 and University of California's Clinical Translational Science Institute grant UL1 TR-000124, funds from the Children's Discovery and Innovation Institute, from the American Society of Nephrology Foundation's Norman Siegel Research Scholar Award, and from the Casey Lee Ball Foundation.	Abdelgawad ME, 2016, HISTOCHEM CELL BIOL; Andersen TL, 2014, AM J PATHOL, V184, P1142, DOI 10.1016/j.ajpath.2013.12.005; Andersen TL, 2013, AM J PATHOL, V183, P235, DOI 10.1016/j.ajpath.2013.03.006; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Bartosh SM, 2003, TRANSPLANTATION, V76, P1195, DOI 10.1097/01.TP.0000092524.75807.84; Bi L. X., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P43; Delaisse Jean-Marie, 2014, Bonekey Rep, V3, P561, DOI 10.1038/bonekey.2014.56; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; Groothoff JW, 2003, KIDNEY INT, V63, P266, DOI 10.1046/j.1523-1755.2003.00727.x; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Hernandez JD, 2008, CLIN J AM SOC NEPHRO, V3, pS164, DOI 10.2215/CJN.00460107; Jensen PR, 2015, BONE, V73, P16, DOI 10.1016/j.bone.2014.12.004; Jensen PR, 2012, J BONE MINER RES, V27, P770, DOI 10.1002/jbmr.1490; Kidney Disease: Improving Global Outcomes, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Uchiyama T, 1999, J BONE MINER METAB, V17, P283, DOI 10.1007/s007740050096; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352	24	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152871	10.1371/journal.pone.0152871	http://dx.doi.org/10.1371/journal.pone.0152871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045269	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000373599600042
J	Polyakov, P; Breban, R				Polyakov, Pavel; Breban, Romulus			Bayesian Monitoring of Emerging Infectious Diseases	PLOS ONE			English	Article							VACCINATION; MEASLES; VIRUS	We define data analyses to monitor a change in R, the average number of secondary cases caused by a typical infected individual. The input dataset consists of incident cases partitioned into outbreaks, each initiated from a single index case. We split the input dataset into two successive subsets, to evaluate two successive R values, according to the Bayesian paradigm. We used the Bayes factor between the model with two different R values and that with a single R value to justify that the change in R is statistically significant. We validated our approach using simulated data, generated using known R. In particular, we found that claiming two distinct R values may depend significantly on the number of outbreaks. We then reanalyzed data previously studied by Jansen et al. [Jansen et al. Science 301 (5634), 804], concerning the effective reproduction number for measles in the UK, during 1995-2002. Our analyses showed that the 1995-2002 dataset should be divided into two separate subsets for the periods 1995-1998 and 1999-2002. In contrast, Jansen et al. take this splitting point as input of their analysis. Our estimated effective reproduction numbers R are in good agreement with those found by Jansen et al. In conclusion, our methodology for detecting temporal changes in R using outbreak-size data worked satisfactorily with both simulated and real-world data. The methodology may be used for updating R in real time, as surveillance outbreak data become available.	[Polyakov, Pavel; Breban, Romulus] Inst Pasteur, Emerging Dis Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Polyakov, P (corresponding author), Inst Pasteur, Emerging Dis Epidemiol, Paris, France.	pavel.polyakov@pasteur.fr		Breban, Romulus/0000-0002-5821-8139	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases)	Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases)(French National Research Agency (ANR))	This work was funded by Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases) (https://research.pasteur.fr/en/program_project/integrative-biology-ofemerging-infectious-diseases/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof V.A.A. Jansen (Royal Holloway University of London) for the epidemiological data. We thank the reviewers for their helpful comments. P.P. is grateful for financing in the form of a postdoctoral scholarship from Agence Nationale de la Recherche (Labex Integrative Biology of Emerging Infectious Diseases).	Angelov AG, 2012, COMPUT MATH APPL, V64, P229, DOI 10.1016/j.camwa.2012.01.049; [Anonymous], 2005, BRANCHING PROCESSES; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068; Blumberg S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002993; Cotten M, 2014, MBIO, V5, DOI 10.1128/mBio.01062-13; Diekmann O., 2013, PRINCETON SERIES THE; Farrington CP, 2003, BIOSTATISTICS, V4, P621, DOI 10.1093/biostatistics/4.4.621; Farrington CP, 2003, BIOSTATISTICS, V4, P279, DOI 10.1093/biostatistics/4.2.279; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; HAIGHT FA, 1960, BIOMETRIKA, V47, P143, DOI 10.2307/2332966; Hamborsky J., 2015, EPIDEMIOLOGY PREVENT, P209; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Kaas RE, 1995, J AM STAT ASSOC, V90, P773; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; MacKay D. J. C., 2003, INFORM THEORY INFERE; Pitman J, 1998, DIMACS SER DISCRET M, V41, P163; Press W. H., 2007, NUMERICAL RECIPES AR, P487; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Robert H., 2004, INFECT DIS HUMANS, P27; World Health Organization (WHO), DIS INC PREV DIS; [No title captured]	23	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0152629	10.1371/journal.pone.0152629	http://dx.doi.org/10.1371/journal.pone.0152629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045370	gold, Green Submitted, Green Published			2022-12-27	WOS:000373599600029
J	Chang, TP; Lin, YW; Sung, PY; Chuang, HY; Chung, HY; Liao, WL				Chang, Tzu-Pu; Lin, Yueh-Wen; Sung, Pi-Yu; Chuang, Hsun-Yang; Chung, Hsien-Yang; Liao, Wen-Ling			Benign Paroxysmal Positional Vertigo after Dental Procedures: A Population-Based Case-Control Study	PLOS ONE			English	Article							COMPLICATION; OSTEOTOME; MALLET	Background Benign paroxysmal positional vertigo (BPPV), the most common type of vertigo in the general population, is thought to be caused by dislodgement of otoliths from otolithic organs into the semicircular canals. In most cases, however, the cause behind the otolith dislodgement is unknown. Dental procedures, one of the most common medical treatments, are considered to be a possible cause of BPPV, although this has yet to be proven. This study is the first nationwide population-based case-control study conducted to investigate the correlation between BPPV and dental manipulation. Methods Patients diagnosed with BPPV between January 1, 2007 and December 31, 2012 were recruited from the National Health Insurance Research Database in Taiwan. We further identified those who had undergone dental procedures within 1 month and within 3 months before the first diagnosis date of BPPV. We also identified the comorbidities of the patients with BPPV, including head trauma, osteoporosis, migraine, hypertension, diabetes, hyperlipidemia and stroke. These variables were then compared to those in age-and gender-matched controls. Results In total, 768 patients with BPPV and 1536 age-and gender-matched controls were recruited. In the BPPV group, 9.2% of the patients had undergone dental procedures within 1 month before the diagnosis of BPPV. In contrast, only 5.5% of the controls had undergone dental treatment within 1 month before the date at which they were identified (P = 0.001). After adjustments for demographic factors and comorbidities, recent exposure to dental procedures was positively associated with BPPV (adjusted odds ratio 1.77; 95% confidence interval 1.27-2.47). This association was still significant if we expanded the time period from 1 month to 3 months (adjusted odds ratio 1.77; 95% confidence interval 1.39-2.26). Conclusions Our results demonstrated a correlation between dental procedures and BPPV. The specialists who treat patients with BPPV should consider dental procedures to be a risk factor, and dentists should recognize BPPV as a possible complication of dental treatment.	[Chang, Tzu-Pu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Neurol, Neuromed Sci Ctr, Taichung, Taiwan; [Chang, Tzu-Pu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Yueh-Wen] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Sung, Pi-Yu; Liao, Wen-Ling] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Chuang, Hsun-Yang] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Res, Taichung, Taiwan; [Chung, Hsien-Yang] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Dent, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Taipei Medical University; Taipei Medical University Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital	Liao, WL (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan.	wling00921@gmail.com		liao, wen-ling/0000-0001-7429-4126				Amir I, 2010, J LARYNGOL OTOL, V124, P796, DOI 10.1017/S0022215109992441; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiarella G, 2007, Acta Otorhinolaryngol Ital, V27, P126; Chiarella G, 2008, EUR ARCH OTO-RHINO-L, V265, P119, DOI 10.1007/s00405-007-0397-7; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; GORDON N, 1954, LANCET, V1, P1216; GYO K, 1988, LARYNGOSCOPE, V98, P332; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Kansu L, 2015, J MAXILLOFAC ORAL SU, V14, pS113, DOI 10.1007/s12663-012-0356-8; NIGAM A, 1989, J LARYNGOL OTOL, V103, P203, DOI 10.1017/S0022215100108448; Penarrocha M, 2001, J ORAL MAXIL SURG, V59, P106, DOI 10.1053/joms.2001.19307; Penarrocha M, 2006, J ORAL MAXIL SURG, V64, P1324, DOI 10.1016/j.joms.2006.02.024; Saker M, 2005, J ORAL MAXIL SURG, V63, P1385, DOI 10.1016/j.joms.2005.05.296; Sammartino G, 2011, CLIN ORAL IMPLAN RES, V22, P669, DOI 10.1111/j.1600-0501.2010.01998.x; Vibert D, 2003, ANN OTO RHINOL LARYN, V112, P885, DOI 10.1177/000348940311201010; Vibert D, 2007, ANN OTO RHINOL LARYN, V116, P887, DOI 10.1177/000348940711601203; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420	18	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0153092	10.1371/journal.pone.0153092	http://dx.doi.org/10.1371/journal.pone.0153092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27044009	Green Submitted, Green Published, gold			2022-12-27	WOS:000373592100066
J	Engin, HB; Kreisberg, JF; Carter, H				Engin, H. Billur; Kreisberg, Jason F.; Carter, Hannah			Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SOMATIC MUTATIONS; GENOME; STABILITY; COMPLEXES; DRIVER; REPAIR; GENES; SITES; HEAD	Recently it has been shown that cancer mutations selectively target protein-protein interactions. We hypothesized that mutations affecting distinct protein interactions involving established cancer genes could contribute to tumor heterogeneity, and that novel mechanistic insights might be gained into tumorigenesis by investigating protein interactions under positive selection in cancer. To identify protein interactions under positive selection in cancer, we mapped over 1.2 million nonsynonymous somatic cancer mutations onto 4,896 experimentally determined protein structures and analyzed their spatial distribution. In total, 20% of mutations on the surface of known cancer genes perturbed protein-protein interactions (PPIs), and this enrichment for PPI interfaces was observed for both tumor suppressors (Odds Ratio 1.28, P-value < 10(-4)) and oncogenes (Odds Ratio 1.17, P-value < 10(-3)). To study this further, we constructed a bipartite network representing structurally resolved PPIs from all available human complexes in the Protein Data Bank (2,864 proteins, 3,072 PPIs). Analysis of frequently mutated cancer genes within this network revealed that tumor-suppressors, but not oncogenes, are significantly enriched with functional mutations in homo-oligomerization regions (Odds Ratio 3.68, P-Value < 10(-8)). We present two important examples, TP53 and beta-2-microglobulin, for which the patterns of somatic mutations at interfaces provide insights into specifically perturbed biological circuits. In patients with TP53 mutations, patient survival correlated with the specific interactions that were perturbed. Moreover, we investigated mutations at the interface of protein-nucleotide interactions and observed an unexpected number of missense mutations but not silent mutations occurring within DNA and RNA binding sites. Finally, we provide a resource of 3,072 PPI interfaces ranked according to their mutation rates. Analysis of this list highlights 282 novel candidate cancer genes that encode proteins participating in interactions that are perturbed recurrently across tumors. In summary, mutation of specific protein interactions is an important contributor to tumor heterogeneity and may have important implications for clinical outcomes.	[Engin, H. Billur; Kreisberg, Jason F.; Carter, Hannah] Univ Calif San Diego, Dept Med, Div Med Genet, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Carter, H (corresponding author), Univ Calif San Diego, Dept Med, Div Med Genet, 9500 Gilman Dr, La Jolla, CA 92093 USA.	hkcarter@ucsd.edu	Carter, Hannah/R-8425-2017	Carter, Hannah/0000-0002-1729-2463; Kreisberg, Jason/0000-0002-3616-079X	National Institutes of Health [DP5 OD017937-01, P50 GM085764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health DP5 OD017937-01 to HC and P50 GM085764 to JFK.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen KX, 2007, CLIN CANCER RES, V13, P4300, DOI 10.1158/1078-0432.CCR-07-0469; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cox DR O, 1987, ANAL SURVIVAL DATA; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; del Campo AB, 2014, INT J CANCER, V134, P102, DOI 10.1002/ijc.28338; Engin HB, 2015, BIOCOMPUT-PAC SYM, P84; Engin HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081035; Espinosa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084598; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hubbard S. J., 1993, NACCESS; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li SY, 2010, BIOCOMPUT-PAC SYM, P337; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Meyer MJ, 2013, BIOINFORMATICS, V29, P1577, DOI 10.1093/bioinformatics/btt181; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Mosca R, 2015, NAT METHODS, V12, P167, DOI 10.1038/nmeth.3289; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066273; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Porta-Pardo E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004518; Porta-Pardo E, 2014, BIOINFORMATICS, V30, P3109, DOI 10.1093/bioinformatics/btu499; RCore Team, 2020, R LANG ENV STAT COMP; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Robson S, 2006, RECENT PAT ANTI-CANC, V1, P305, DOI 10.2174/157489206778776934; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Seagle BL, 2015, GYNECOLOGIC ONCOLOGY; Shi Z, 2011, J MOL BIOL, V413, P495, DOI 10.1016/j.jmb.2011.06.046; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Vazquez M, 2015, BIOINFORMATICS; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Yang F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004147; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	57	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152929	10.1371/journal.pone.0152929	http://dx.doi.org/10.1371/journal.pone.0152929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27043210	Green Submitted, gold, Green Published			2022-12-27	WOS:000373592100049
J	Gladh, H; Folestad, EB; Muhl, L; Ehnman, M; Tannenberg, P; Lawrence, AL; Betsholtz, C; Eriksson, U				Gladh, Hanna; Folestad, Erika Bergsten; Muhl, Lars; Ehnman, Monika; Tannenberg, Philip; Lawrence, Anna-Lisa; Betsholtz, Christer; Eriksson, Ulf			Mice Lacking Platelet-Derived Growth Factor D Display a Mild Vascular Phenotype	PLOS ONE			English	Article							PROTEASE-ACTIVATED LIGAND; PDGF-D; CARDIAC DEVELOPMENT; ATHEROSCLEROSIS; EXPRESSION; DEFICIENT; ALPHA; CELLS; NOTCH; BETA	Platelet-derived growth factor D (PDGF-D) is the most recently discovered member of the PDGF family. PDGF-D signals through PDGF receptor beta, but its biological role remains largely unknown. In contrast to other members of the PDGF family of growth factors, which have been extensively investigated using different knockout approaches in mice, PDGF-D has until now not been characterized by gene inactivation in mice. Here, we present the phenotype of a constitutive Pdgfd knockout mouse model (Pdgfd(-/-)), carrying a LacZ reporter used to visualize Pdgfd promoter activity. Inactivation of the Pdgfd gene resulted in a mild phenotype in C57BL/6 mice, and the offspring was viable, fertile and generally in good health. We show that Pdgfd reporter gene activity was consistently localized to vascular structures in both postnatal and adult tissues. The expression was predominantly arterial, often localizing to vascular bifurcations. Endothelial cells appeared to be the dominating source for Pdgfd, but reporter gene activity was occasionally also found in sub-populations of mural cells. Tissue-specific analyses of vascular structures revealed that NG2-expressing pericytes of the cardiac vasculature were disorganized in Pdgfd(-/-) mice. Furthermore, Pdgfd(-/-) mice also had a slightly elevated blood pressure. In summary, the vascular expression pattern together with morphological changes in NG2-expressing cells, and the increase in blood pressure, support a function for PDGF-D in regulating systemic arterial blood pressure, and suggests a role in maintaining vascular homeostasis.	[Gladh, Hanna; Folestad, Erika Bergsten; Muhl, Lars; Ehnman, Monika; Tannenberg, Philip; Lawrence, Anna-Lisa; Betsholtz, Christer; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Tannenberg, Philip] Karolinska Univ Hosp, Div Vasc Surg, Dept Surg Sci, Stockholm, Sweden; [Betsholtz, Christer] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ehnman, Monika] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Lawrence, Anna-Lisa] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; University of Michigan System; University of Michigan	Folestad, EB; Eriksson, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden.	erika.folestad@ki.se; ulf.pe.eriksson@ki.se	Lawrence, Anna-Lisa/GNW-3815-2022; Ehnman, Monika/R-3687-2016	Ehnman, Monika/0000-0003-0468-2531	Swedish Heart and Lung Foundation [2012-0077]; Swedish Cancer Foundation [2014/630]; Swedish Research Council [2011-3861]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this work came from The Swedish Heart and Lung Foundation 2012-0077 (www.hjart-lungfonden.se), The Swedish Cancer Foundation 2014/630 (www.cancerfonden.se), and The Swedish Research Council 2011-3861 (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; [Anonymous], 2015, ASS HLTH STAT SMALL; [Anonymous], 2015, EXT ASS HLTH STAT SM; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Boron WBE., 2005, MED PHYSL, P478; Boron WBE, 2005, MED PHYSL, P236; Changsirikulchai S, 2002, J AM SOC NEPHROL, V13, p78A; Chen JZ, 2005, BIOCHEM BIOPH RES CO, V329, P976, DOI 10.1016/j.bbrc.2005.02.062; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; Ehnman M, 2009, ONCOGENE, V28, P534, DOI 10.1038/onc.2008.410; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Karvinen H, 2009, EUR J CLIN INVEST, V39, P320, DOI 10.1111/j.1365-2362.2009.02095.x; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Niessen K, 2007, AM J PHYSIOL-CELL PH, V293, pC1, DOI 10.1152/ajpcell.00415.2006; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Ray S, 2005, J BIOL CHEM, V280, P8494, DOI 10.1074/jbc.M413570200; Reglin B, 2014, J VASC RES, V51, P376, DOI 10.1159/000369460; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Tuuminen R, 2006, TRANSPLANT P, V38, P3271, DOI 10.1016/j.transproceed.2006.10.056; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Uutela M, 2004, BLOOD, V104, P3198, DOI 10.1182/blood-2004-04-1485; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Zhou PZ, 2012, CURR TOP DEV BIOL, V100, P143, DOI 10.1016/B978-0-12-387786-4.00005-1; Zhou XL, 2014, BRAZ J MED BIOL RES, V47, P1, DOI 10.1590/1414-431X20133177	37	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152276	10.1371/journal.pone.0152276	http://dx.doi.org/10.1371/journal.pone.0152276			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27032083	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800050
J	Hofmann, N; Galetskiy, D; Rauch, D; Wittmann, T; Marquardt, A; Griese, M; Zarbock, R				Hofmann, Nicole; Galetskiy, Dmitry; Rauch, Daniela; Wittmann, Thomas; Marquardt, Andreas; Griese, Matthias; Zarbock, Ralf			Analysis of the Proteolytic Processing of ABCA3: Identification of Cleavage Site and Involved Proteases	PLOS ONE			English	Article							CATHEPSIN-L; LYSOSOMAL MEMBRANE; CYSTEINE PROTEASES; TRANSPORTER ABCA3; LUNG; PROTEIN; APOPTOSIS; MUTANTS; CELLS	Rationale ABCA3 is a lipid transporter in the limiting membrane of lamellar bodies in alveolar type II cells. Mutations in the ABCA3 gene cause respiratory distress syndrome in new-borns and childhood interstitial lung disease. ABCA3 is N-terminally cleaved by an as yet unknown protease, a process believed to regulate ABCA3 activity. Methods The exact site where ABCA3 is cleaved was localized using mass spectrometry (MS). Proteases involved in ABCA3 processing were identified using small molecule inhibitors and siRNA mediated gene knockdown. Results were verified by in vitro digestion of a synthetic peptide substrate mimicking ABCA3's cleavage region, followed by MS analysis. Results We found that cleavage of ABCA3 occurs after Lys174 which is located in the proteins' first luminal loop. Inhibition of cathepsin L and, to a lesser extent, cathepsin B resulted in attenuation of ABCA3 cleavage. Both enzymes showed activity against the ABCA3 peptide in vitro with cathepsin L being more active. Conclusion We show here that, like some other proteins of the lysosomal membrane, ABCA3 is a substrate of cathepsin L. Therefore, cathepsin L may represent a potential target to therapeutically influence ABCA3 activity in ABCA3-associated lung disease.	[Hofmann, Nicole; Rauch, Daniela; Wittmann, Thomas; Griese, Matthias; Zarbock, Ralf] Univ Munich, Dr von Hauner Childrens Hosp, German Ctr Lung Res, D-80337 Munich, Germany; [Galetskiy, Dmitry; Marquardt, Andreas] Univ Konstanz, Prote Facil, D-78547 Constance, Germany	University of Munich; University of Konstanz	Zarbock, R (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, German Ctr Lung Res, D-80337 Munich, Germany.	Ralf.Zarbock@med.uni-muenchen.de	Zarbock, Ralf/K-9031-2019		Deutsche Forschungsgemeinschaft [GR 970/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to MG (GR 970/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai B, 2014, J PROTEOME RES, V13, P4526, DOI 10.1021/pr5003593; Beers MF, 2013, AM J PHYSIOL-LUNG C, V305, pL970, DOI 10.1152/ajplung.00184.2013; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bromme D, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2102s21; Buhling F, 2004, EUR RESPIR J, V23, P620, DOI 10.1183/09031936.04.00105304; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Campo I, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-43; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Engelbrecht S, 2010, FEBS LETT, V584, P4306, DOI 10.1016/j.febslet.2010.09.026; Herber-Jonat S, 2013, PEDIATR RES, V74, P384, DOI 10.1038/pr.2013.127; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaltenborn E, 2012, HUM MOL GENET, V21, P2793, DOI 10.1093/hmg/dds107; Matsumura Y, 2007, FEBS LETT, V581, P3139, DOI 10.1016/j.febslet.2007.05.078; Matsumura Y, 2006, J BIOL CHEM, V281, P34503, DOI 10.1074/jbc.M600071200; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Savalas LRT, 2011, BIOCHEM J, V439, P113, DOI 10.1042/BJ20110166; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Steenhuis P, 2012, BBA-MOL BASIS DIS, V1822, P1617, DOI 10.1016/j.bbadis.2012.05.015; Wambach JA, 2014, AM J RESP CRIT CARE, V189, P1538, DOI 10.1164/rccm.201402-0342OC; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Wenzel JJ, 2007, MED KLIN, V102, P524, DOI 10.1007/s00063-007-1066-8; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Yasuma T, 1998, J MED CHEM, V41, P4301, DOI 10.1021/jm9803065; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152594	10.1371/journal.pone.0152594	http://dx.doi.org/10.1371/journal.pone.0152594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031696	gold, Green Submitted, Green Published			2022-12-27	WOS:000373121800098
J	Pow, EHN; Chen, ZF; Kwong, DLW; Lam, OLT				Pow, Edmond H. N.; Chen, Zhuofan; Kwong, Dora L. W.; Lam, Otto L. T.			Salivary Anionic Changes after Radiotherapy for Nasopharyngeal Carcinoma: A 1-Year Prospective Study	PLOS ONE			English	Article							NECK-CANCER-PATIENTS; QUALITY-OF-LIFE; CHINESE FOLLOWING RADIOTHERAPY; RADIATION-INDUCED XEROSTOMIA; HUMAN WHOLE SALIVA; SOUTHERN CHINESE; ORAL-HEALTH; ION CHROMATOGRAPHY; DIETARY NITRATE; GLAND FUNCTION	Objectives To investigate the salivary anionic changes of patients with nasopharyngeal carcinoma (NPC) treated by radiotherapy. Material and Methods Thirty-eight patients with T1-4, N0-2, M0 NPC received conventional radiotherapy. Stimulated whole saliva was collected at baseline and 2, 6 and 12 months after radiotherapy. Salivary anions levels were measured using ion chromatography. Results A reduction in stimulated saliva flow and salivary pH was accompanied by sustained changes in anionic composition. At 2 months following radiotherapy, there was a significant increase in chloride, sulphate, lactate and formate levels while significant reductions in nitrate and thiocyanate levels were found. No further changes in these anion levels were observed at 6 and 12 months. No significant changes were found in phosphate, acetate, or propionate levels throughout the study period. Conclusions Conventional radiotherapy has a significant and prolonged impact on certain anionic species, likely contributing to increased cariogenic properties and reduced antimicrobial capacities of saliva in NPC patients post-radiotherapy.	[Pow, Edmond H. N.; Lam, Otto L. T.] Univ Hong Kong, Fac Dent, Oral Rehabil, Hong Kong, Hong Kong, Peoples R China; [Chen, Zhuofan] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral Implantol, Guangzhou 510275, Guangdong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Sun Yat Sen University; University of Hong Kong	Lam, OLT (corresponding author), Univ Hong Kong, Fac Dent, Oral Rehabil, Hong Kong, Hong Kong, Peoples R China.	ottolam@hku.hk		Chen, Zhuofan/0000-0002-1665-1073				Almstahl A, 2003, ARCH ORAL BIOL, V48, P337, DOI 10.1016/S0003-9969(02)00200-5; Bardow A, 2000, ARCH ORAL BIOL, V45, P1, DOI 10.1016/S0003-9969(99)00119-3; BENARYEH H, 1975, INT J ORAL MAXILLOF, V4, P205, DOI 10.1016/S0300-9785(75)80027-5; Chen C, 2010, ARCH ORAL BIOL, V55, P613, DOI 10.1016/j.archoralbio.2010.05.016; Chen ZF, 2004, ARCH ORAL BIOL, V49, P855, DOI 10.1016/j.archoralbio.2004.05.001; Chen ZF, 2004, ARCH ORAL BIOL, V49, P863, DOI 10.1016/j.archoralbio.2004.05.002; Chen ZF, 2015, CLIN CHIM ACTA, V438, P231, DOI 10.1016/j.cca.2014.08.027; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; COLE DEC, 1985, J CHROMATOGR, V337, P267, DOI 10.1016/0378-4347(85)80040-2; DAWES C, 1974, ARCH ORAL BIOL, V19, P887, DOI 10.1016/0003-9969(74)90051-X; DREIZEN S, 1976, CANCER, V38, P273, DOI 10.1002/1097-0142(197607)38:1<273::AID-CNCR2820380141>3.0.CO;2-8; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; EDGAR WM, 1981, J ORAL PATHOL MED, V10, P284, DOI 10.1111/j.1600-0714.1981.tb01275.x; Furness S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008934.pub2; Gasparoto TH, 2012, GERODONTOLOGY, V29, pE331, DOI 10.1111/j.1741-2358.2011.00476.x; Gupta SC, 2009, INDIAN J OTOLARYNGOL, V61, P286, DOI 10.1007/s12070-009-0084-7; Hahnel S, 2009, SUPPORT CARE CANCER, V17, P1331, DOI 10.1007/s00520-009-0671-x; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jalil Rosnah Abdul, 1994, Journal of Nihon University School of Dentistry, V36, P254; Kapil V, 2010, HEART, V96, P1703, DOI 10.1136/hrt.2009.180372; KELSAY JL, 1972, J NUTR, V102, P661, DOI 10.1093/jn/102.5.661; LASSITER MO, 1987, J DENT RES, V66, P480, DOI 10.1177/00220345870660021601; MARGOLIS HC, 1994, CRIT REV ORAL BIOL M, V5, P1; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; McMillan AS, 2004, J ORAL REHABIL, V31, P600, DOI 10.1111/j.1365-2842.2004.01383.x; NAVAZESH M, 1982, J DENT RES, V61, P1158, DOI 10.1177/00220345820610100901; Odajima T, 1998, CONNECT TISSUE RES, V38, P119, DOI 10.3109/03008209809017028; Palmer LB, 2001, AM J RESP CRIT CARE, V164, P464, DOI 10.1164/ajrccm.164.3.2008149; Park YD, 2014, ARCH ORAL BIOL, V59, P1, DOI 10.1016/j.archoralbio.2013.10.006; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Pow EHN, 2003, CLIN ORAL INVEST, V7, P230, DOI 10.1007/s00784-003-0215-6; Pow EHN, 2003, ORAL DIS, V9, P196, DOI 10.1034/j.1601-0825.2003.02924.x; Schwarz E, 1999, J DENT, V27, P21, DOI 10.1016/S0300-5712(98)00024-4; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; TENOVUO J, 1984, J ORAL PATHOL MED, V13, P573, DOI 10.1111/j.1600-0714.1984.tb01459.x; Tiwana MS, 2011, INDIAN J CANCER, V48, P289, DOI 10.4103/0019-509X.84918; TOBGI R S, 1988, Oral Microbiology and Immunology, V3, P35, DOI 10.1111/j.1399-302X.1988.tb00603.x; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Xia DS, 2003, J DENT RES, V82, P101, DOI 10.1177/154405910308200205; Xie SH, 2013, EUR J CANCER, V49, P150, DOI 10.1016/j.ejca.2012.07.004; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123137	43	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152817	10.1371/journal.pone.0152817	http://dx.doi.org/10.1371/journal.pone.0152817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031997	Green Submitted, Green Published, gold			2022-12-27	WOS:000373121800140
J	Rosenberg, YJ; Montefiori, DC; LaBranche, CC; Lewis, MG; Sack, M; Lees, JP; Jiang, XM				Rosenberg, Yvonne J.; Montefiori, David C.; LaBranche, Celia C.; Lewis, Mark G.; Sack, Markus; Lees, Jonathan P.; Jiang, Xiaoming			Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques	PLOS ONE			English	Article							ABSORPTION; POTENT	Intravascular delivery of broadly neutralizing antibodies (bnAbs) has shown promise for prevention and treatment of HIV infection. However, multiple IV administrations in geographic locations with poor accessibility to medical care have practical limitations. We have assessed the efficacy of plant-derived PGT121 delivered subcutaneously (SC) against pre- and post-intravaginal challenge using a rigorous SHIV-SF162P3 macaque protection model. SC administered PGT121 exhibited a longer serum half-life than IV administration and was more consistent than intramuscular delivery. A dose of 3.5mg/kg PGT121 prevented infection at a minimum ID50 neutralization titer of 1:295 while 5mg/kg protected five of six macaques when delivered immediately post-challenge. These results suggest the utility of plant-derived bnAbs delivered SC for HIV prevention.	[Rosenberg, Yvonne J.; Lees, Jonathan P.; Jiang, Xiaoming] PlantVax Corp, Rockville, MD 20850 USA; [Montefiori, David C.; LaBranche, Celia C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD 20850 USA; [Sack, Markus] Rhein Westfal TH Aachen, Inst Mol Biotechnol, D-52056 Aachen, Germany	Duke University; BIOQUAL Inc.; RWTH Aachen University	Rosenberg, YJ (corresponding author), PlantVax Corp, Rockville, MD 20850 USA.	yjr@plantvax.com	Sack, Markus/K-6681-2013; Sack, Markus/AAP-9252-2021	Sack, Markus/0000-0002-7380-9228; 	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621]; NIH/NIAID NHP Humoral Immunology Laboratory [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI081621] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID NHP Humoral Immunology Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YR received funding from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grant # R44AI081621, which provided support in the form of salaries for authors YR, XJ and JL but did not have additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. DCM was funded in part by NIH/NIAID NHP Humoral Immunology Laboratory Contract # HHSN27201100016C.	Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chung HK, 2008, VIRAL IMMUNOL, V21, P411, DOI 10.1089/vim.2008.0076; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30; Matucci A, 2014, INT TRENDS IMMUNITY, V2, P11; McLennan DN, 2006, PHARM RES, V23, P2060, DOI 10.1007/s11095-006-9064-8; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; R Core Team, 2013, R LANG ENV STAT COMP; Rosenberg YJ, 2012, INSECTICIDES BASIC O; Rosenberg Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120451; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shytaj IL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-71; SUPERSAXO A, 1990, PHARMACEUT RES, V7, P167, DOI 10.1023/A:1015880819328	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152760	10.1371/journal.pone.0152760	http://dx.doi.org/10.1371/journal.pone.0152760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031108	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800133
J	Rostrup, M; Edwards, JK; Abukalish, M; Ezzabi, M; Some, D; Ritter, H; Menge, T; Abdelrahman, A; Rootwelt, R; Janssens, B; Lind, K; Paasma, R; Hovda, KE				Rostrup, Morten; Edwards, Jeffrey K.; Abukalish, Mohamed; Ezzabi, Masoud; Some, David; Ritter, Helga; Menge, Tom; Abdelrahman, Ahmed; Rootwelt, Rebecca; Janssens, Bart; Lind, Kyrre; Paasma, Raido; Hovda, Knut Erik			The Methanol Poisoning Outbreaks in Libya 2013 and Kenya 2014	PLOS ONE			English	Article							DIAGNOSIS; EPIDEMIOLOGY; CHALLENGES	Background Outbreaks of methanol poisoning occur frequently on a global basis, affecting poor and vulnerable populations. Knowledge regarding methanol is limited, likely many cases and even outbreaks go unnoticed, with patients dying unnecessarily. We describe findings from the first three large outbreaks of methanol poisoning where Medecins Sans Frontieres (MSF) responded, and evaluate the benefits of a possible future collaboration between local health authorities, a Non-Governmental Organisation and international expertise. Methods Retrospective study of three major methanol outbreaks in Libya (2013) and Kenya (May and July 2014). Data were collected from MSF field personnel, local health personnel, hospital files, and media reports. Findings In Tripoli, Libya, over 1,000 patients were poisoned with a reported case fatality rate of 10% (101/1,066). In Kenya, two outbreaks resulted in approximately 341 and 126 patients, with case fatality rates of 29% (100/341) and 21% (26/126), respectively. MSF launched an emergency team with international experts, medications and equipment, however, the outbreaks were resolving by the time of arrival. Interpretation Recognition of an outbreak of methanol poisoning and diagnosis seem to be the most challenging tasks, with significant delay from time of first presentations to public health warnings being issued. In spite of the rapid response from an emergency team, the outbreaks were nearly concluded by the time of arrival. A major impact on the outcome was not seen, but large educational trainings were conducted to increase awareness and knowledge about methanol poisoning. Based on this training, MSF was able to send a local emergency team during the second outbreak, supporting that such an approach could improve outcomes. Basic training, simplified treatment protocols, point-of-care diagnostic tools, and early support when needed, are likely the most important components to impact the consequences of methanol poisoning outbreaks in these challenging contexts.	[Rostrup, Morten; Rootwelt, Rebecca] Oslo Univ Hosp, Dept Acute Med, N-0450 Oslo, Norway; [Rostrup, Morten] Med Sans Frontieres Int, Geneva, Switzerland; [Rostrup, Morten] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Edwards, Jeffrey K.; Some, David; Ritter, Helga] Med Sans Frontieres, Nairobi, Kenya; [Edwards, Jeffrey K.] Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Abukalish, Mohamed] Libyan Emergency Med Assoc, Tripoli Med Ctr, Tripoli, Libya; [Ezzabi, Masoud] Tripoli Cent Hosp, Dept Med, Tripoli, Libya; [Menge, Tom] Kenyatta Natl Hosp, Dept Pharm, Nairobi, Kenya; [Abdelrahman, Ahmed] Med Sans Frontieres, Libya Mission, Tripoli, Libya; [Janssens, Bart] Med Sans Frontieres Operat Ctr, Brussels, Belgium; [Lind, Kyrre; Hovda, Knut Erik] Med Sans Frontieres, Oslo, Norway; [Paasma, Raido] Parnu Cty Hosp, Dept Anesthesiol, Parnu, Estonia; [Paasma, Raido] Parnu Cty Hosp, ICU, Parnu, Estonia; [Hovda, Knut Erik] Oslo Univ Hosp, Dept Acute Med, Norwegian CBRNe Ctr Med, N-0450 Oslo, Norway	University of Oslo; University of Oslo; Johns Hopkins University; Kenyatta National Hospital; Doctors Without Borders; University of Oslo	Hovda, KE (corresponding author), Med Sans Frontieres, Oslo, Norway.; Hovda, KE (corresponding author), Oslo Univ Hosp, Dept Acute Med, Norwegian CBRNe Ctr Med, N-0450 Oslo, Norway.	knuterikhovda@gmail.com		Hovda, Knut Erik/0000-0001-6341-8699	MSF Kenya; Libyan missions; Oslo University Hospital	MSF Kenya; Libyan missions; Oslo University Hospital	Study expenses were supported from the regular operation budgets of the MSF Kenya and Libyan missions as well as Oslo University Hospital. Thus no specific funding was received for this work.; We want to thank Prof. Michael Eddleston, Edinburgh, Scotland for his invaluable input and critical review of the manuscript. Study expenses were supported from the regular operation budgets of the MSF Kenya and Libyan missions as well as Oslo University Hospital, but had no role in the writing of the report as such.	AbdulRahim F.A.A., 2012, SUDAN MED J, V48, P1; Ahmad K, 2000, LANCET, V356, P1911, DOI 10.1016/S0140-6736(05)73469-3; [Anonymous], 2014, ALLAFRICA       0508; [Anonymous], 2013, LIBYA HERALD    0310; [Anonymous], 2013, LIBYA HERALD    0316; [Anonymous], 2014, DAILY MAIL KENY 0507; [Anonymous], 2015, TIMES INDIA; [Anonymous], 2012, RAIDO POLAND    1228; [Anonymous], 2013, LIBYA HERALD    0318; [Anonymous], 2010, CNN INT EDITION 0727; [Anonymous], 2015, WIKITOX AN OPEN ACCE; [Anonymous], 2013, JAKARTA POST; Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Barnard E, 2014, J ROY ARMY MED CORPS, V160, P245, DOI 10.1136/jramc-2013-000117; Hassanian-Moghaddam H, 2015, J PUBLIC HEALTH-UK, V37, P354, DOI 10.1093/pubmed/fdu038; Hovda KE, 2005, J ANAL TOXICOL, V29, P586, DOI 10.1093/jat/29.6.586; Hovda KE, 2005, J INTERN MED, V258, P181, DOI 10.1111/j.1365-2796.2005.01521.x; Hovda KE, 2004, INTENS CARE MED, V30, P1842, DOI 10.1007/s00134-004-2373-7; Hovda KE, 2015, SCAND J CLIN LAB INV, V75, P610, DOI 10.3109/00365513.2015.1066847; Hunderi Odd Helge, 2004, Tidsskr Nor Laegeforen, V124, P3199; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Lapatto-Reiniluoto O, 2013, HUM EXP TOXICOL, V32, P600, DOI 10.1177/0960327112462723; Levy P, 2003, J TOXICOL-CLIN TOXIC, V41, P23, DOI 10.1081/CLT-120018267; McMartin K, 2016, BRIT J CLIN PHARMACO, V81, P505, DOI 10.1111/bcp.12824; Mowry JB, 2014, CLIN TOXICOL, V52, P1032, DOI 10.3109/15563650.2014.987397; Paasma R, 2007, CLIN TOXICOL, V45, P152, DOI 10.1080/15563650600956329; Ravichandran R, 1984, J Postgrad Med, V30, P69; World Health Organization-Global Alcohol Report, WHO GLOB ALC REP 201; Zakharov S, 2014, CLIN TOXICOL, V52, P1013, DOI 10.3109/15563650.2014.974106	29	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152676	10.1371/journal.pone.0152676	http://dx.doi.org/10.1371/journal.pone.0152676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27030969	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800112
J	van Alphen, HJM; Volkers, KM; Blankevoort, CG; Scherder, EJA; Hortobagyi, T; van Heuvelen, MJG				van Alphen, Helena J. M.; Volkers, Karin M.; Blankevoort, Christiaan G.; Scherder, Erik J. A.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.			Older Adults with Dementia Are Sedentary for Most of the Day	PLOS ONE			English	Article							MEASURING PHYSICAL-ACTIVITY; COGNITIVE IMPAIRMENT; ACCELEROMETER OUTPUT; ALZHEIMERS-DISEASE; ACTIVITY PATTERNS; CALIBRATION; EXERCISE; DECLINE	Purpose Self-reported data suggest that older adults with dementia are inactive. The purpose of the present study was to objectively assess the physical activity (PA) levels of community-dwelling and institutionalized ambulatory patients with dementia, and to compare with the PA levels of cognitive healthy older adults. Methods We used actigraphy to assess the PA levels in institutionalized (n = 83, age: 83.0 +/- 7.6, Mini-Mental-State Examination (MMSE): 15.5 +/- 6.5) and community-dwelling dementia patients (n = 37, age: 77.3 +/- 5.6, MMSE-score: 20.8 +/- 4.8), and healthy older adults (n = 26, age: 79.5 +/- 5.6, MMSE-score: 28.2 +/- 1.6). We characterized PA levels based on the raw data and classified <100 counts/min as sedentary behavior. Results Institutionalized dementia patients had the lowest daily PA levels (1.69 +/- 1.33 counts/day), spent 72.1% of the day sedentary, and were most active between 8: 00 and 9: 00 am. Institutionalized vs. community-dwelling dementia patients had 23.5% lower daily PA levels (difference M = 0.52, p =.004) and spent 9.3% longer in sedentariness (difference M = 1.47, p =.032). Community-dwelling dementia patients spent 66.0% of the day sedentary and were most active between 9: 00 to 10: 00 am with a second peak between 14: 00 to 15: 00. Community-dwelling dementia patients vs healthy older adults' daily PA levels and sedentary time were 21.6% lower and 8.9% longer, respectively (difference M = 0.61, p =.007; difference M = 1.29, p =.078). Conclusions Institutionalized and community-dwelling dementia patients are sedentary for most of the day and the little PA they perform is of lower intensity compared to their healthy peers. Their highest PA peak is when they get out of bed in the morning. In addition, it seems that institutionalized living is associated with lower PA levels in dementia patients. These are the first results that objectively characterize institutionalized as well as community-dwelling dementia patients' PA levels and confirm that dementia patients are inactive.	[van Alphen, Helena J. M.; Scherder, Erik J. A.; Hortobagyi, Tibor; van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands; [Volkers, Karin M.; Scherder, Erik J. A.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Blankevoort, Christiaan G.] Lentis, Mental Hlth Care Inst, Zuidlaren, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	van Heuvelen, MJG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands.	m.j.g.van.heuvelen@umcg.nl		van Alphen, Helena/0000-0003-4130-1187				Allan L, 2006, DEMENT GERIATR COGN, V22, P230, DOI 10.1159/000094971; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Bossers WJR, 2015, AM J GERIAT PSYCHIAT, V23, P1106, DOI 10.1016/j.jagp.2014.12.191; Burns JM, 2008, ALZ DIS ASSOC DIS, V22, P39, DOI 10.1097/WAD.0b013e31815a9ddc; Chen Kong Y, 2003, Diabetes Technol Ther, V5, P1023, DOI 10.1089/152091503322641088; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P861, DOI 10.3233/JAD-2010-091579; Erickson KI, 2013, J AM GERIATR SOC, V61, P158, DOI 10.1111/jgs.12050; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Hortobagyi T., 2014, FUTURE HLTH FITNESS, P54; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; James BD, 2012, ALZ DIS ASSOC DIS, V26, P238, DOI 10.1097/WAD.0b013e31822fc3cb; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Kozey S, 2010, J PHYS ACT HEALTH, V7, P508, DOI 10.1123/jpah.7.4.508; Lovden M, 2013, CURR OPIN PSYCHIATR, V26, P239, DOI 10.1097/YCO.0b013e32835f4135; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Reid N, 2013, INT J ENV RES PUB HE, V10, P6783, DOI 10.3390/ijerph10126783; Rikli RE, 2000, RES Q EXERCISE SPORT, V71, pS89, DOI 10.1080/02701367.2000.11082791; Routen AC, 2012, J SPORT SCI, V30, P1303, DOI 10.1080/02640414.2012.709266; Stubbs B, 2014, ARCH GERONTOL GERIAT, V59, P195, DOI 10.1016/j.archger.2014.06.006; Takeda M, 2012, PSYCHIAT CLIN NEUROS, V66, P1, DOI 10.1111/j.1440-1819.2011.02304.x; Tariot PN, 1994, ALZ DIS ASSOC DIS, V8, pS12; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; Vital TM, 2012, GERIATR GERONTOL INT, V12, P637, DOI 10.1111/j.1447-0594.2011.00830.x; Volkers KM, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-38; Watts A., 2013, CLIN GERONTOLOGIST, V36, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	43	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152457	10.1371/journal.pone.0152457	http://dx.doi.org/10.1371/journal.pone.0152457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031509	Green Published, gold, Green Submitted			2022-12-27	WOS:000373121800076
J	Vernunft, A; Ivell, R; Heng, K; Anand-Ivell, R				Vernunft, Andreas; Ivell, Richard; Heng, Kee; Anand-Ivell, Ravinder			The Male Fetal Biomarker INSL3 Reveals Substantial Hormone Exchange between Fetuses in Early Pig Gestation	PLOS ONE			English	Article							INSULIN-LIKE FACTOR-3; PEPTIDE 3 INSL3; INTRAUTERINE POSITION; TESTICULAR DESCENT; AMNIOTIC-FLUID; HEALTHY BOYS; SEX; CRYPTORCHIDISM; TESTOSTERONE; GUBERNACULUM	The peptide hormone INSL3 is uniquely produced by the fetal testis to promote the transabdominal phase of testicular descent. Because it is fetal sex specific, and is present in only very low amounts in the maternal circulation, INSL3 acts as an ideal biomarker with which to monitor the movement of fetal hormones within the pregnant uterus of a polytocous species, the pig. INSL3 production by the fetal testis begins at around GD30. At GD45 of the ca. 114 day gestation, a time at which testicular descent is promoted, INSL3 evidently moves from male to female allantoic compartments, presumably impacting also on the female fetal circulation. At later time-points (GD63, GD92) there is less inter-fetal transfer, although there still appears to be significant INSL3, presumably of male origin, in the plasma of female fetuses. This study thus provides evidence for substantial transfer of a peptide hormone between fetuses, and probably also across the placenta, emphasizing the vulnerability of the fetus to extrinsic hormonal influences within the uterus.	[Vernunft, Andreas] FBN Leibniz Inst Farm Anim Biol, D-18196 Dummerstorf, Germany; [Ivell, Richard; Heng, Kee; Anand-Ivell, Ravinder] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	Forschungsinstitut fur Nutztierbiologie (FBN); University of Nottingham	Anand-Ivell, R (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.	ravinder.anand-ivell@nottingham.ac.uk		Anand-Ivell, Ravinder/0000-0002-4976-4314; Ivell, Richard/0000-0001-6513-2109	Leibniz Institute; School of Biosciences, University of Nottingham	Leibniz Institute; School of Biosciences, University of Nottingham	This project was funded by incidental support from the Leibniz Institute for Farm Animal Biology, Dummerstorf, and by the School of Biosciences, University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support from Ms Yanzhenzi Dai (University of Nottingham) and from the technical staff in the Leibniz Institute for Farm Animal Biology, in particular Ms Katarina Poeppel, as well financial support from the same institute, and from the School of Biosciences, University of Nottingham.	ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Anand-Ivell R, 2013, HUM REPROD, V28, P3093, DOI 10.1093/humrep/det349; Anand-Ivell R, 2006, INT J ANDROL, V29, P618, DOI 10.1111/j.1365-2605.2006.00714.x; Anand-Ivell R, 2014, REPRODUCTION, V147, pR87, DOI 10.1530/REP-13-0486; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; Barthold JS, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119560; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; Bazer FW, 2011, BIOL REPROD, V85, P228, DOI 10.1095/biolreprod.111.091454; Drickamer LC, 1997, J ANIM SCI, V75, P2192; EVEN MD, 1992, J REPROD FERTIL, V96, P709, DOI 10.1530/jrf.0.0960709; GERNEKE W H, 1967, Onderstepoort Journal of Veterinary Research, V34, P219; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; GUTHRIE HD, 2005, J ANIM SCI, V83, pE79, DOI DOI 10.2527/2005.8313_; Hunter RHF, 1996, MOL REPROD DEV, V45, P392, DOI 10.1002/(SICI)1098-2795(199611)45:3<392::AID-MRD17>3.0.CO;2-0; Hutson JM, 2013, ENDOCR REV, V34, P725, DOI 10.1210/er.2012-1089; Ivell R, 2003, MOL HUM REPROD, V9, P175, DOI 10.1093/molehr/gag025; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Johansen ML, 2014, REPRODUCTION, V147, P529, DOI 10.1530/REP-13-0435; Kawate N, 2011, THERIOGENOLOGY, V76, P1632, DOI 10.1016/j.theriogenology.2011.07.011; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Magann EF, 2011, J ULTRAS MED, V30, P1573, DOI 10.7863/jum.2011.30.11.1573; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; Minagawa I, 2014, J ENDOCRINOL, V220, P247, DOI 10.1530/JOE-13-0430; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; NONNEMAN DJ, 1992, BIOL REPROD, V47, P723, DOI 10.1095/biolreprod47.5.723; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; PARFET KAR, 1990, J ANIM SCI, V68, P179; Parma P, 1999, BIOL REPROD, V61, P741, DOI 10.1095/biolreprod61.3.741; Preston Jane E, 2014, Adv Pharmacol, V71, P147, DOI 10.1016/bs.apha.2014.06.001; Retnakaran R, 2015, DIABETES CARE, V38, P844, DOI 10.2337/dc14-2551; Russe I, 1991, LEHRBUCH EMBRYOLOGIE, P1; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Satchell L, 2013, ENDOCRINOLOGY, V154, P1897, DOI 10.1210/en.2012-2232; Schneider F, 2006, REPROD FERT DEVELOP, V18, P857, DOI 10.1071/RD06027; Sembon S, 2008, ZYGOTE, V16, P327, DOI 10.1017/S0967199408004826; Soede NM, 2011, ANIM REPROD SCI, V124, P251, DOI 10.1016/j.anireprosci.2011.02.025; TOBET SA, 1982, HORM BEHAV, V16, P251, DOI 10.1016/0018-506X(82)90025-3; Vallet JL, 2013, J ANIM SCI, V91, P3030, DOI 10.2527/jas.2012-6138; VANDERHOEVEN T, 1992, J PHARMACOL EXP THER, V263, P32; VANVLISSINGEN JMF, 1988, ENDOCRINOLOGY, V123, P2868; VISSER JH, 1995, J UROLOGY, V153, P516, DOI 10.1097/00005392-199502000-00074; Waldmann KH, 2001, LEHRBUCH SCHWEINEKRA, P604; Wikstrom AM, 2006, J CLIN ENDOCR METAB, V91, P4705, DOI 10.1210/jc.2006-0669; WISE TH, 1992, J ANIM SCI, V70, P2787, DOI 10.2527/1992.7092787x; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	48	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152689	10.1371/journal.pone.0152689	http://dx.doi.org/10.1371/journal.pone.0152689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031644	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800117
J	Callister, KE; Griffioen, PA; Avitabile, SC; Haslem, A; Kelly, LT; Kenny, SA; Nimmo, DG; Farnsworth, LM; Taylor, RS; Watson, SJ; Bennett, AF; Clarke, MF				Callister, Kate E.; Griffioen, Peter A.; Avitabile, Sarah C.; Haslem, Angie; Kelly, Luke T.; Kenny, Sally A.; Nimmo, Dale G.; Farnsworth, Lisa M.; Taylor, Rick S.; Watson, Simon J.; Bennett, Andrew F.; Clarke, Michael F.			Historical Maps from Modern Images: Using Remote Sensing to Model and Map Century-Long Vegetation Change in a Fire-Prone Region	PLOS ONE			English	Article							EASTERN IBERIAN PENINSULA; NORTHWEST-TERRITORIES; LANDSCAPE-PERSPECTIVE; MALLEE ECOSYSTEMS; NEURAL-NETWORKS; TM IMAGERY; AUSTRALIA; FOREST; AGE; REGIMES	Understanding the age structure of vegetation is important for effective land management, especially in fire-prone landscapes where the effects of fire can persist for decades and centuries. In many parts of the world, such information is limited due to an inability to map disturbance histories before the availability of satellite images (similar to 1972). Here, we describe a method for creating a spatial model of the age structure of canopy species that established pre-1972. We built predictive neural network models based on remotely sensed data and ecological field survey data. These models determined the relationship between sites of known fire age and remotely sensed data. The predictive model was applied across a 104,000 km(2) study region in semi-arid Australia to create a spatial model of vegetation age structure, which is primarily the result of stand-replacing fires which occurred before 1972. An assessment of the predictive capacity of the model using independent validation data showed a significant correlation (r(s) = 0.64) between predicted and known age at test sites. Application of the model provides valuable insights into the distribution of vegetation age-classes and fire history in the study region. This is a relatively straightforward method which uses widely available data sources that can be applied in other regions to predict age-class distribution beyond the limits imposed by satellite imagery.	[Callister, Kate E.; Avitabile, Sarah C.; Haslem, Angie; Kenny, Sally A.; Farnsworth, Lisa M.; Taylor, Rick S.; Watson, Simon J.; Bennett, Andrew F.; Clarke, Michael F.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Griffioen, Peter A.; Kenny, Sally A.; Bennett, Andrew F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [Kelly, Luke T.; Nimmo, Dale G.; Bennett, Andrew F.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Kelly, Luke T.] Univ Melbourne, Sch Biosci, ARC Ctr Excellence Environm Decis, Parkville, Vic 3052, Australia; [Nimmo, Dale G.] Charles Sturt Univ, Sch Environm Sci, Inst Land Water & Soc, Albury, NSW, Australia; [Taylor, Rick S.] Anindilyakwa Land Council, Alyangula, NT, Australia	La Trobe University; Arthur Rylah Institute for Environmental Research (ARI); Deakin University; University of Melbourne; Charles Sturt University	Callister, KE (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	k.callister@latrobe.edu.au		Kelly, Luke/0000-0002-3127-3111; Callister, Kate/0000-0001-7871-0326	Parks Victoria; Department of Environment, Land, Water Planning (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage; Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Murray Mallee Partnership	Parks Victoria; Department of Environment, Land, Water Planning (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage; Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Murray Mallee Partnership	This study is part of a larger research project, the Mallee Fire and Biodiversity Project, which received funding and support from: Parks Victoria (http://parkweb.vic.gov.au), Department of Environment, Land, Water & Planning (Vic) (http://www.delwp.vic.gov.au), Mallee Catchment Management Authority (http://www.malleecma.vic.gov.au), NSW National Parks and Wildlife Service (http://www.nationalparks.nsw.gov.au), Department of Environment and Climate Change (NSW) (http://www.environment.nsw.gov.au), Lower Murray Darling Catchment Management Authority (http://murray.lls.nsw.gov.au/home), Department for Environment and Heritage (SA) (http://www.environment.sa.gov.au/Home), Land and Water Australia (http://lwa.gov.au), Natural Heritage Trust (http://www.nationaltrust.org.au/natural-heritage), Birdlife Australia (Gluepot Reserve) (http://www.birdlife.org.au), Australian Wildlife Conservancy (Scotia Sanctuary) (http://www.australianwildlife.org), Murray Mallee Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Blackmore M, 2000, BIOTROPICA, V32, P625, DOI 10.1646/0006-3606(2000)032[0625:CGFLAF]2.0.CO;2; Bowman DMJS, 2003, INT J WILDLAND FIRE, V12, P341, DOI 10.1071/WF03030; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Buddenbaum H, 2005, INT J REMOTE SENS, V26, P5453, DOI 10.1080/01431160500285076; Bureau of Meteorology, 2014, CLIM DAT ONL AUSTR; Carpenter GA, 1999, REMOTE SENS ENVIRON, V70, P326, DOI 10.1016/S0034-4257(99)00051-6; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Department for Environment and Heritage, 2009, FIR MAN PLAN BILL DI; Dye M, 2011, GEOCARTO INT, V26, P275, DOI 10.1080/10106049.2011.562308; Ecological Burning in Box-Ironbark-Phase 1. Literature review, EC BURN BOX IN PHAS; Floyd ML, 2000, ECOL APPL, V10, P1666, DOI 10.1890/1051-0761(2000)010[1666:FHAVPI]2.0.CO;2; Franklin SE, 2003, INT J REMOTE SENS, V24, P1823, DOI 10.1080/01431160210144589; Furby S, 2008, EARTH C STUD MOD SEN; Gerylo GR, 2002, CAN J REMOTE SENS, V28, P68, DOI 10.5589/m02-007; Gosper CR, 2012, AUSTRAL ECOL, V37, P164, DOI 10.1111/j.1442-9993.2011.02259.x; Greenville AC, 2009, INT J WILDLAND FIRE, V18, P631, DOI 10.1071/WF08093; Haslem A, 2012, BIOL CONSERV, V152, P212, DOI 10.1016/j.biocon.2012.04.007; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Haslem A, 2010, LANDSCAPE URBAN PLAN, V97, P296, DOI 10.1016/j.landurbplan.2010.07.002; Haydon DT, 2000, LANDSCAPE ECOL, V15, P373, DOI 10.1023/A:1008138029197; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; Hudak AT, 2004, INT J REMOTE SENS, V25, P3231, DOI 10.1080/01431160310001632666; Jakubauskas ME, 2000, GEOCARTO INT, V15, P21; Jensen JR, 1999, INT J REMOTE SENS, V20, P2805, DOI 10.1080/014311699211804; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Kayitakire F, 2006, REMOTE SENS ENVIRON, V102, P390, DOI 10.1016/j.rse.2006.02.022; Kelly LT, 2012, J APPL ECOL, V49, P412, DOI 10.1111/j.1365-2664.2012.02124.x; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Kraaij T, 2013, INT J WILDLAND FIRE, V22, P277, DOI 10.1071/WF11163; Land Conservation Council, 1987, MALL AR REV; Lans R, 1988, RED CLIFFS; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Lloret F, 2002, LANDSCAPE ECOL, V17, P745, DOI 10.1023/A:1022966930861; MILLER DM, 1995, COMPUT GEOSCI, V21, P377, DOI 10.1016/0098-3004(94)00082-6; Morgan P, 2001, INT J WILDLAND FIRE, V10, P329, DOI 10.1071/WF01032; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; NIEMANN KO, 1995, PHOTOGRAMM ENG REM S, V61, P1119; Nimmo DG, 2013, CONSERV BIOL, V27, P345, DOI 10.1111/j.1523-1739.2012.01958.x; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Noble J, 1980, RANGELAND J, V2, P104, DOI DOI 10.1071/RJ9800104; Noble J. C., 1993, Rangeland Journal, V15, P270, DOI 10.1071/RJ9930270; O'Brien TP., 1989, MEDITERRANEAN LANDSC, P181; Parsons BC, 2011, INT J WILDLAND FIRE, V20, P184, DOI 10.1071/WF09099; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JG, 2007, GLOBAL ECOL BIOGEOGR, V16, P330, DOI 10.1111/j.1466-8238.2006.00283.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Regos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094906; Rollins MG, 2004, ECOL APPL, V14, P75, DOI 10.1890/02-5145; Sandell PR, 2002, WILDLIFE RES, V29, P591, DOI 10.1071/WR00089; Scardi M, 1996, MAR ECOL PROG SER, V139, P289, DOI 10.3354/meps139289; Smith AL, 2013, J APPL ECOL, V50, P1178, DOI 10.1111/1365-2664.12119; Sokal R. R., 2012, BIOMETRY; StatSoft Inc, 2010, STATISTICA; Swetnam TW, 2003, TREE RING RECONSTRUC, P158; Taylor RS, 2013, BIOL CONSERV, V159, P248, DOI 10.1016/j.biocon.2012.12.005; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; Turner D, 2008, RANGELAND J, V30, P95, DOI 10.1071/RJ07039; Van de Water K, 2010, FOREST ECOL MANAG, V260, P384, DOI 10.1016/j.foreco.2010.04.032; Watson SJ, 2012, ECOL APPL, V22, P685, DOI 10.1890/11-0850.1; WELLINGTON AB, 1985, J ECOL, V73, P657, DOI 10.2307/2260502	62	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0150808	10.1371/journal.pone.0150808	http://dx.doi.org/10.1371/journal.pone.0150808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27029046	Green Published, gold			2022-12-27	WOS:000373116500010
J	Giardini, ME; Zippo, AG; Valente, M; Krstajic, N; Biella, GEM				Giardini, Mario E.; Zippo, Antonio G.; Valente, Maurizio; Krstajic, Nikola; Biella, Gabriele E. M.			Electrophysiological and Anatomical Correlates of Spinal Cord Optical Coherence Tomography	PLOS ONE			English	Article							IMAGE-GUIDED NAVIGATION; DORSAL-HORN NEURONS; CT ANGIOGRAPHY; SURGERY; LOCALIZATION; RESPONSES; CELLS	Despite the continuous improvement in medical imaging technology, visualizing the spinal cord poses severe problems due to structural or incidental causes, such as small access space and motion artifacts. In addition, positional guidance on the spinal cord is not commonly available during surgery, with the exception of neuronavigation techniques based on static pre-surgical data and of radiation-based methods, such as fluoroscopy. A fast, bedside, intraoperative real-time imaging, particularly necessary during the positioning of endoscopic probes or tools, is an unsolved issue. The objective of our work, performed on experimental rats, is to demonstrate potential intraoperative spinal cord imaging and probe guidance by optical coherence tomography (OCT). Concurrently, we aimed to demonstrate that the electromagnetic OCT irradiation exerted no particular effect at the neuronal and synaptic levels. OCT is a user-friendly, low-cost and endoscopy-compatible photonics-based imaging technique. In particular, by using a Fourier-domain OCT imager, operating at 850 nm wavelength and scanning transversally with respect to the spinal cord, we have been able to: 1) accurately image tissue structures in an animal model (muscle, spine bone, cerebro-spinal fluid, dura mater and spinal cord), and 2) identify the position of a recording microelectrode approaching and inserting into the cord tissue 3) check that the infrared radiation has no actual effect on the electrophysiological activity of spinal neurons. The technique, potentially extendable to full three-dimensional image reconstruction, shows prospective further application not only in endoscopic intraoperative analyses and for probe insertion guidance, but also in emergency and adverse situations (e.g. after trauma) for damage recognition, diagnosis and fast image-guided intervention.	[Giardini, Mario E.] Univ Strathclyde, Dept Biomed Engn, Wolfson Ctr, 106 Rottenrow, Glasgow G4 0NW, Lanark, Scotland; [Zippo, Antonio G.; Valente, Maurizio; Biella, Gabriele E. M.] CNR, Inst Mol Bioimaging & Physiol, Via Fratelli Cervi 93, I-20090 Milan, Italy; [Krstajic, Nikola] Univ Edinburgh, Sch Engn, CMOS Sensors Grp, Integrated Micro & Nano Syst, Kings Bldg, Edinburgh EH9 3JL, Midlothian, Scotland	University of Strathclyde; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Edinburgh	Biella, GEM (corresponding author), CNR, Inst Mol Bioimaging & Physiol, Via Fratelli Cervi 93, I-20090 Milan, Italy.	gabriele.biella@ibfm.cnr.it	Giardini, Mario/C-3552-2008; Zippo, Antonio G./O-7313-2017; Zippo, Antonio Giuliano/AAF-8781-2020	Giardini, Mario/0000-0003-4849-9683; Zippo, Antonio G./0000-0001-8421-7554; Zippo, Antonio Giuliano/0000-0001-8421-7554; Krstajic, Nikola/0000-0002-4165-8111	European Union [225464, 224014]	European Union(European Commission)	The authors acknowledge funding from the European Union Framework Programme 7 under grant agreements no. 225464 (ARAKNES-Array of Robots Augmenting the Kinematics of Endoluminal Surgery) and 224014 sub 2.16 (Photonics4Life-Fibre Optic Sensors as Guidance and Diagnostic Tools for Epiduroscopy). Part of the study was performed when MEG was employed at the University of St Andrews, UK, and significant sections of OCT software were written while NK was employed by the University of Sheffield. PON01_01297 and from the Ministero dell'Istruzione Universita'e Ricerca (MIUR).	Barker R, 2009, CHILD NERV SYST, V25, P955, DOI 10.1007/s00381-009-0904-9; Biella G, 1997, EUR J NEUROSCI, V9, P1017, DOI 10.1111/j.1460-9568.1997.tb01452.x; Boppart SA, 1998, RADIOLOGY, V208, P81, DOI 10.1148/radiology.208.1.9646796; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2009, J NEUROSCI METH, V178, P162, DOI 10.1016/j.jneumeth.2008.11.026; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jones MR, 2012, AM J NEURORADIOL, V33, P1494, DOI 10.3174/ajnr.A3016; Kim KH, 2007, OPT EXPRESS, V15, P18130, DOI 10.1364/OE.15.018130; Krstajic N, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071305; Krstajic N, 2011, OPT COMMUN, V284, P3168, DOI 10.1016/j.optcom.2011.02.073; Kuo WC, 2015, ANESTHESIOLOGY, V122, P585, DOI 10.1097/ALN.0000000000000531; Leitch JK, 2010, MAGN RESON IMAGING, V28, P1225, DOI 10.1016/j.mri.2010.03.032; Liang CP, 2011, OPT EXPRESS, V19, P26283, DOI 10.1364/OE.19.026283; Gutierrez-Chico JL, 2012, EUR HEART J-CARD IMG, V13, P370, DOI 10.1093/ehjci/jes025; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Nellensteijn J, 2010, EUR SPINE J, V19, P879, DOI 10.1007/s00586-009-1272-6; Ou P, 2007, AM J NEURORADIOL, V28, P216; PALECEK J, 1992, J NEUROPHYSIOL, V67, P1562, DOI 10.1152/jn.1992.67.6.1562; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Sammon PM, 2011, BRIT J NEUROSURG, V25, P778, DOI 10.3109/02688697.2011.584987; Sotgiu ML, 2004, SOMATOSENS MOT RES, V21, P211, DOI 10.1080/08990220400012539; Squire LR, 2012, FUNDAMENTAL NEUROSCI, P93; Stelter K, 2012, COMPUT AIDED SURG, V17, P153, DOI 10.3109/10929088.2012.668937; Stroman PW, 2008, MAGN RESON IMAGING, V26, P809, DOI 10.1016/j.mri.2008.01.038; Tjardes T, 2010, EUR SPINE J, V19, P25, DOI 10.1007/s00586-009-1091-9; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Wang XD, 2011, J CRANIOFAC SURG, V22, P1552, DOI 10.1097/SCS.0b013e31822e5d3d; Watanabe H, 2011, BIOMED OPT EXPRESS, V2, P3129, DOI 10.1364/BOE.2.003129; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Yaqoob Z, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2360525	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152539	10.1371/journal.pone.0152539	http://dx.doi.org/10.1371/journal.pone.0152539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050096	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000373603500047
J	Naha, D; Jhala, YV; Qureshi, Q; Roy, M; Sankar, K; Gopal, R				Naha, Dipanjan; Jhala, Yadvendradev V.; Qureshi, Qamar; Roy, Manjari; Sankar, Kalyansundaram; Gopal, Rajesh			Ranging, Activity and Habitat Use by Tigers in the Mangrove Forests of the Sundarban	PLOS ONE			English	Article							PANTHERA-TIGRIS-ALTAICA; RADIO-TRACKING DATA; HOME-RANGE; BANGLADESH SUNDARBANS; PREY ABUNDANCE; CONSERVATION; INDIA; MANAGEMENT; LANDSCAPE; DENSITIES	The Sundarban of India and Bangladesh (about 6000 km(2)) are the only mangrove forests inhabited by a sizeable population of tigers. The adjoining area also supports one of the highest human densities and experiences severe human-tiger conflicts. We used GPS-Satellite and VHF radio-collars on 6 (3 males and 3 female) tigers to study their ranging patterns and habitat preference. The average home range (95% Fixed Kernel) for resident females was 56.4 (SE 5.69) and for males it was 110 (SE 49) km(2). Tigers crossed an average of 5 water channels > 30 meters per day with a mean width of 54 meters, whereas channels larger than 400 meters were rarely crossed. Tigers spent over 58% of their time within Phoenix habitat but compositional analysis showed a habitat preference of the order Avicennia-Sonneratia > Phoenix > Ceriops > Barren > Water. Average daily distance moved was 4.6 km (range 0.1-23). Activity of tigers peaked between 05: 00 hours and 10: 00 hours showing some overlap with human activity. Territory boundaries were demarcated by large channels which tigers intensively patrolled. Extra caution should be taken while fishing or honey collection during early morning in Avicennia-Sonneratia and Phoenix habitat types along wide channels to reduce human-tiger conflict. Considering home-range core areas as exclusive, tiger density was estimated at 4.6 (SE range 3.6 to 6.7) tigers/100 km(2) giving a total population of 76 (SE range 59-110) tigers in the Indian Sundarban. Reluctance of tigers to cross wide water channels combined with increasing commercial boat traffic and sea level rise due to climate change pose a real threat of fragmenting the Sundarban tiger population.	[Naha, Dipanjan; Jhala, Yadvendradev V.; Roy, Manjari] Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India; [Qureshi, Qamar] Wildlife Inst India, Dept Landscape Level Planning & Management, Dehra Dun, Uttarakhand, India; [Sankar, Kalyansundaram] Wildlife Inst India, Dept Habitat Ecol, Dehra Dun, Uttarakhand, India; [Gopal, Rajesh] Global Tiger Forum, New Delhi, India	Wildlife Institute of India; Wildlife Institute of India; Wildlife Institute of India	Jhala, YV (corresponding author), Wildlife Inst India, Dept Anim Ecol & Conservat Biol, Dehra Dun, Uttarakhand, India.	yvjhala@gmail.com	Jhala, Yadvendradev/AAL-9711-2020		National Tiger Conservation Authority	National Tiger Conservation Authority	This work was supported by projecttiger.nic.in/National Tiger Conservation Authority to YVJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2011, DISTRICT POPULATION; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Barlow A. C. D., 2009, THESIS U MINNESOTA S; Barlow ACD, 2008, BIOL CONSERV, V141, P2032, DOI 10.1016/j.biocon.2008.05.018; Barlow ACD, 2011, ORYX, V45, P125, DOI 10.1017/S0030605310001456; Barlow ACD, 2010, CONSERV BIOL, V24, P1338, DOI 10.1111/j.1523-1739.2010.01496.x; Bates D., PACKAGE LME4; Bera G. K., 2010, LAGOONS GANGETIC DEL; Blanford WT., 1891, FAUNA BIRT INDIA; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Chaknabarti K., 1984, Tigerpaper (Bangkok), V11, P29; Chakrabarti K., 1992, MAN EATING TIGERS; Champion S.H.G., 1968, REVISED SURVEY FORES; Chowdhury MK, 1985, ENV ECOL, V2, P243; Chundawat Raghunandan S., 1999, P123; Dey T, 2015, TIGER ABUNDANCE BANG; Dey TK, 2004, THESIS U DHAKA; Dinerstein E, 1997, FRAMEWORK WORK IDENT; Garga DP, 1947, J BOMBAY NATURAL HIS, V47, P545; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Global Tiger Initiative Secretariat, 2012, GLOB TIG REV PROGR I; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hazra S., 2002, SCI CULT-INDIA, V68, P309; HENDRICHS H, 1975, Saeugetierkundliche Mitteilungen, V23, P161; Hooge P. M., 2000, ANIMAL MOVEMENT EXTE, P2; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jhala Y. V., 2011, STATUS TIGERS COPRED; Jhala YV, 2014, NATL TIGER CONSERVAT; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth KU, 2000, J ZOOL, V250, P255; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Khan M.M.H., 2004, THESIS U CAMBRIDGE THESIS U CAMBRIDGE; Khan MMH, 2008, BNHS, V3, P105; Kotwal P.C., 1995, Tigerpaper (Bangkok), V22, P6; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Miller CS, 2014, BIOL CONSERV, V170, P120, DOI 10.1016/j.biocon.2013.12.012; Miquelle Dale G., 1999, P71; Miquelle Dale G., 2010, P325; Mohr CO, 1996, WILDL MANAG, V30, P293; Montgomery S., 2008, SPELL TIGER MAN EATE; Powell RA, 2000, METH C CONS, P65; Reza AHMA., 2000, THESIS JAHANGIRNAGAR; Reza AHMA, 2002, BANGLADESH J LIFE SC, V14, P75; Rhinos Simson BF., 1999, OXFORD ANTHOLOGY IND, P58; Rodgers A.R., 2011, HRT HOME RANGE TOOLS; Rodgers Arthur R., 2001, P79, DOI 10.1016/B978-012497781-5/50005-0; Roy M, 2015, POPUL ECOL IN PRESS; Schaller GB., 1967, DEER TIGER; SEIDENSTICKER J, 1976, BIOTROPICA, V8, P225, DOI 10.2307/2989714; Sen N., 2003, ALGAL FLORA SUNDARBA; Sharma R.N., 2010, J CURR PHARM RES, V1, P1; Sharma Rishi Kumar, 2011, Cat News, V54, P13; Simcharoen A, 2014, ORYX, V48, P370, DOI 10.1017/S0030605312001408; Smith J.L.D., 1987, P97; Smith JLD, 1998, CONSERV BIOL, V12, P1338, DOI 10.1046/j.1523-1739.1998.97068.x; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Smith JLD, 1998, ANIM BEHAV, V37, P1; Sunquist M. E., 1981, SOCIAL ORG TIGERS PA; Tak PC, RECORDS ZOOLOGICAL S; White G. C., 1990, ANAL WILDLIFE RADIO, P383, DOI 10.1016/B978-0-08-092657-5.50008-2; Withey J. C., 2001, RADIO TRACKING ANIMA, P45; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zar H.H., 2009, BIOSTATISTICAL ANAL	75	19	19	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0152119	10.1371/journal.pone.0152119	http://dx.doi.org/10.1371/journal.pone.0152119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27049644	gold, Green Published			2022-12-27	WOS:000373603500026
J	Shi, XJ; Yu, Y; Luo, M; Zhang, ZR; Shi, SS; Feng, XL; Chen, ZL; He, J				Shi, Xuejiao; Yu, Yue; Luo, Mei; Zhang, Zhirong; Shi, Susheng; Feng, Xiaoli; Chen, Zhaoli; He, Jie			Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TET FAMILY PROTEINS; MAMMALIAN DNA; MUTATIONS; 5-METHYLCYTOSINE; CONVERSION; CANCERS; EXPRESSION	Ten-eleven translocation (TET) enzymes catalyze the oxidation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine and 5-carboxylcytosine, which result in genomic DNA demethylation. It was reported that 5-hmC levels were decreased in a variety of cancers and could be regarded as an epigenetic hallmark of cancer. In the present study, 5-hmC levels were detected by immunohistochemistry (IHC) in 173 esophageal squamous cell carcinoma (ESCC) tissues and 91 corresponding adjacent non-tumor tissues; DNA dot blot assays were used to detect the 5-hmC level in another 50 pairs of ESCC tissues and adjacent non-tumor tissues. In addition, the mRNA level of TET1, TET2 and TET3 in these 50 pairs of ESCC tissues was detected by real-time PCR. The IHC and DNA dot blot results showed that 5-hmC levels were significantly lower in ESCC tissues compared with corresponding adjacent non-tumor tissues (P = 0.029). TET2 and TET3 expression was also significantly decreased in tumor tissues compared with paired non-tumor tissues (TET2, P < 0.0001; TET3, P = 0.009), and the decrease in 5-hmC was significantly associated with the downregulation of TET2 expression (r = 0.405, P = 0.004). Moreover, the loss of 5-hmC in ESCC tissues was significantly associated with poor overall survival among patients with ESCC (P = 0.043); multivariate Cox regression analysis showed that the loss of 5-hmC in ESCC tissues was an independent unfavorable prognostic indicator for patients with ESCC (HR = 1.569, P = 0.029). In conclusion, 5-hmC levels were decreased in ESCC tissues, and the loss of 5-hmC in tumor tissues was an independent unfavorable prognostic factor for patients with ESCC.	[Shi, Xuejiao; Yu, Yue; Luo, Mei; Zhang, Zhirong; Chen, Zhaoli; He, Jie] Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China; [Shi, Susheng; Feng, Xiaoli] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Chen, ZL; He, J (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China.	chenzhaoli@126.com; prof.hejie@263.net			National Natural Science Foundation of China [81172336, 81372219, 81301851, U1302223]; National Key Basic Research Development Plan973 Plan [2014CB542006]; Beijing Natural Science Foundation [7141011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Development Plan973 Plan(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (81172336, 81372219) and the National Key Basic Research Development Plan973 Plan (2014CB542006) (JH); National Natural Science Foundation of China (81301851 and U1302223) and Beijing Natural Science Foundation (7141011) (ZLC).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cazzola M, 2010, HAEMATOL-HEMATOL J, V95, P1623, DOI 10.3324/haematol.2010.030015; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Frycz BA, 2014, BIOMED PHARMACOTHER, V68, P209, DOI 10.1016/j.biopha.2013.12.011; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Haffner MC, 2011, ONCOTARGET, V2, P627; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Konstandin N, 2011, LEUKEMIA, V25, P1649, DOI 10.1038/leu.2011.134; Kriukiene E, 2012, CHEM SOC REV, V41, P6916, DOI 10.1039/c2cs35104h; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	24	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2016	11	4							e0153100	10.1371/journal.pone.0153100	http://dx.doi.org/10.1371/journal.pone.0153100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6IX	27050164	Green Submitted, gold, Green Published			2022-12-27	WOS:000373603500099
J	Tette, EMA; Neizer, M; Nyarko, MY; Sifah, EK; Nartey, ET; Donkor, ES				Tette, Edem M. A.; Neizer, Margaret; Nyarko, Maame Yaa; Sifah, Eric K.; Nartey, Edmund T.; Donkor, Eric S.			Changing Patterns of Disease and Mortality at the Children's Hospital, Accra: Are Infections Rising?	PLOS ONE			English	Article							CARE	Background The Millennium Development Goals (MDGs) have led to reductions in child mortality worldwide. This has, invariably, led to the changes in the epidemiology of diseases associated with child mortality. Although facility based data do not capture all deaths, they provide an opportunity to confirm diagnoses and insight into these changes which are relevant for further disease control. Objective To identify changes in the disease pattern of children who died at the Princess Marie Louise Children's Hospital (PML) in Ghana from 2003-2013. Methods A cross sectional review of mortality data was carried out at PML. The age, sex, duration of admission and diagnosis of consecutive patients who died at the hospital between 2003 and 2013 were reviewed. This information was entered into an Access database and analysed using Stata 11.0 software. Results Altogether, 1314 deaths (3.6%) occurred out of a total of 37,012 admissions. The majority of the deaths, 1187 (90.3%), occurred in children under the age of 5 years. While deaths caused by malaria, malnutrition, HIV infection and diarrhoea decreased, deaths caused by pneumonia were rising. Suspected septicaemia and meningitis showed a fluctuating trend with only a modest decrease between 2012 and 2013. The ten leading causes of mortality among under-fives were malnutrition, 363 (30.6%); septicaemia, 301 (25.4%); pneumonia, 218 (18.4%); HIV infection, 183 (15.4%); malaria, 155 (13.1%); anaemia, 135 (11.4%); gastroenteritis/dehydration, 110 (9.3%); meningitis, 58 (4.9%); tuberculosis, 34 (2.9%) and hypoglycaemia, 27 (2.3%). For children aged 5-9 years, the leading causes of mortality were malaria, 42 (42.9%); HIV infection, 27 (27.6%); anaemia, 14 (14.3%); septicaemia, 12 (12.2%); meningitis, 10 (10.2%); malnutrition, 9 (9.2%); tuberculosis, 5 (5.1%); pneumonia, 4 (4.1%); encephalopathy, 3 (3.1%); typhoid fever, 3 (3.1%) and lymphoma, 3 (3.1%). In the adolescent age group, malaria, 8 (27.6%); anaemia, 6 (20.7%); HIV infection, 5 (17.2%); sickle cell disease, 3 (10.3%) and meningitis, 3 (10.3%) were most common. Conclusion There has been a decline in the under-five mortality at PML over the years; however, deaths caused by pneumonia appear to be rising. This highlights the need for better diagnostic services, wider HIV screening and clinical audits to improve outcomes in order to achieve further reductions in child mortality and maintain the gains.	[Tette, Edem M. A.] Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Legon, Ghana; [Tette, Edem M. A.; Neizer, Margaret; Nyarko, Maame Yaa; Sifah, Eric K.] Princess Marie Louis Childrens Hosp, Accra, Ghana; [Nartey, Edmund T.] Univ Ghana, Sch Med & Dent, Ctr Trop Clin Pharmacol & Therapeut, Legon, Ghana; [Nartey, Edmund T.] Univ Ghana, Sch Publ Hlth, Dept Epidemiol & Dis Control, Legon, Ghana; [Donkor, Eric S.] Univ Ghana, Dept Med Microbiol, Coll Hlth Sci, Legon, Ghana	University of Ghana; University of Ghana; University of Ghana; University of Ghana	Tette, EMA (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Legon, Ghana.; Tette, EMA (corresponding author), Princess Marie Louis Childrens Hosp, Accra, Ghana.	edemenator@googlemail.com		Donkor, Eric S./0000-0002-9368-0636	Building Stronger Universities Initiative Platform on Human Health (BSU-PHH)	Building Stronger Universities Initiative Platform on Human Health (BSU-PHH)	The study was supported by Building Stronger Universities Initiative Platform on Human Health (BSU-PHH). BSU-PHH had no role in the design, analysis or writing of this article	Adjei END, 2010, STUDY DETERMINE CLIN; Aluvaala J, 2015, ARCH DIS CHILD, V100, P42, DOI 10.1136/archdischild-2014-306423; BAMGBOYE E A, 1990, African Journal of Medicine and Medical Sciences, V19, P127; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brown MM, 2003, INDICATORS MONITORIN; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Bustreo F, 2014, WHO CALLS STRONGER; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Carrol ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006621; Commey JO, 1991, GHANA MED J, V25, P334; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Ghana National AIDS Control Programme, 2011, HIV SENT SURV REP; GHS, 2010, INT NAT GUID COMM BA; Grandin W, 2006, SAMJ S AFR MED J, V96, P964; Gyamfi S, 2009, GHANA DEMOGRAPHIC HL; Jackson AA, 2006, ARCH DIS CHILD, V91, P706, DOI 10.1136/adc.2006.095596; Julien M, 1995, J TROP PEDIATRICS, V41, P366, DOI 10.1093/tropej/41.6.366; Krug A, 2004, SAMJ S AFR MED J, V94, P202; Krug A, 2004, SAMJ S AFR MED J, V94, P198; Maurice J, 2012, LANCET, V379, P699, DOI 10.1016/S0140-6736(12)60294-3; MENGE I, 1995, E AFR MED J, V72, P165; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; OFOSU-AMAAH S., 1970, Ghana Medical Journal, V9, P12; Ohene Sally-Ann, 2011, BMC Res Notes, V4, P353, DOI 10.1186/1756-0500-4-353; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Requejo J., 2013, ACCOUNTABILITY MATER; Rogerson SR, 2004, T ROY SOC TROP MED H, V98, P544, DOI 10.1016/j.trstmh.2003.12.011; Simoes EAF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P483; Tette EMA, CHILD MORTALIT UNPUB; Whitty CJM, 2013, PRINCIPLES MED AFRIC, P182; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2010, TECHN GUID INT DIS S	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2016	11	4							e0150387	10.1371/journal.pone.0150387	http://dx.doi.org/10.1371/journal.pone.0150387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6HK	27045667	Green Published, Green Submitted, gold			2022-12-27	WOS:000373599600002
J	Cugno, G; Parreira, JR; Ferlizza, E; Hernandez-Castellano, LE; Carneiro, M; Renaut, J; Castro, N; Arguello, A; Capote, J; Campos, AMO; Almeida, AM				Cugno, Graziano; Parreira, Jose R.; Ferlizza, Enea; Hernandez-Castellano, Lorenzo E.; Carneiro, Mariana; Renaut, Jenny; Castro, Noemi; Arguello, Anastasio; Capote, Juan; Campos, Alexandre M. O.; Almeida, Andre M.			The Goat (Capra hircus) Mammary Gland Mitochondrial Proteome: A Study on the Effect of Weight Loss Using Blue-Native PAGE and Two-Dimensional Gel Electrophoresis	PLOS ONE			English	Article							AUSTRALIAN MERINO LAMBS; GENETIC-RESOURCES; ANIMAL PRODUCTION; MILK-PRODUCTION; GUINEA-BISSAU; LIVE WEIGHT; PROTEINS; COMPLEX; MUSCLE; IDENTIFICATION	Seasonal weight loss (SWL) is the most important limitation to animal production in the Tropical and Mediterranean regions, conditioning producer's incomes and the nutritional status of rural communities. It is of importance to produce strategies to oppose adverse effects of SWL. Breeds that have evolved in harsh climates have acquired tolerance to SWL through selection. Most of the factors determining such ability are related to changes in biochemical pathways as affected by SWL. In this study, a gel based proteomics strategy (BN: Blue-Native Page and 2DE: Two-dimensional gel electrophoresis) was used to characterize the mitochondrial proteome of the secretory tissue of the goat mammary gland. In addition, we have conducted an investigation of the effects of weight loss in two goat breeds with different levels of adaptation to nutritional stress: Majorera (tolerant) and Palmera (susceptible). The study used Majorera and Palmera dairy goats, divided in 4 sets, 2 for each breed: underfed group fed on wheat straw (restricted diet, so their body weight would be 15-20% reduced by the end of experiment), and a control group fed with an energy-balanced diet. At the end of the experimental period (22 days), mammary gland biopsies were obtained for all experimental groups. The proteomic analysis of the mitochondria enabled the resolution of a total of 277 proteins, and 148 (53%) were identified by MALDI-TOF/TOF mass spectrometry. Some of the proteins were identified as subunits of the glutamate dehydrogenase complex and the respiratory complexes I, II, IV, V from mitochondria, as well as numerous other proteins with functions in: metabolism, development, localization, cellular organization and biogenesis, biological regulation, response to stimulus, among others, that were mapped in both BN and 2DE gels. The comparative proteomics analysis enabled the identification of several proteins: NADH-ubiquinone oxidoreductase 75 kDa subunit and lamin B1 mitochondrial (up-regulated in the Palmera breed), Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (up-regulated in the Majorera breed) and cytochrome b-c1 complex subunit 1, mitochondrial and Chain D, Bovine F1-C8 Sub-Complex Of Atp Synthase (down-regulated in the Majorera breed) as a consequence of weight loss.	[Cugno, Graziano; Ferlizza, Enea; Carneiro, Mariana; Campos, Alexandre M. O.] Univ Porto, CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Campo Alegre 823, P-4100 Porto, Portugal; [Cugno, Graziano; Hernandez-Castellano, Lorenzo E.; Castro, Noemi; Arguello, Anastasio] Univ Las Palmas Gran Canaria, Dept Anim Sci, Arucas, Gran Canaria, Spain; [Parreira, Jose R.; Almeida, Andre M.] IBET, Oeiras, Portugal; [Parreira, Jose R.; Almeida, Andre M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Ferlizza, Enea] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Hernandez-Castellano, Lorenzo E.] Univ Bern, Vet Physiol, Vetsuisse Fac, Bern, Switzerland; [Renaut, Jenny] LIST, Belvaux, Luxembourg; [Capote, Juan] Inst Canario Invest Agr, Tenerife, Spain; [Almeida, Andre M.] CIISA, Lisbon, Portugal; [Almeida, Andre M.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi	Universidade do Porto; Universidad de Las Palmas de Gran Canaria; Universidade Nova de Lisboa; University of Bologna; University of Bern; Luxembourg Institute of Science & Technology; Universidade de Lisboa	Almeida, AM (corresponding author), IBET, Oeiras, Portugal.; Almeida, AM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.; Almeida, AM (corresponding author), CIISA, Lisbon, Portugal.	adealmeida@rossvet.edu.kn	Ferlizza, Enea/ABD-9218-2020; Almeida, Andre/I-4369-2013; Ferlizza, Enea/AAE-2655-2019; Renaut, Jenny/K-3216-2012; Castro, N./F-9621-2016; Castellano, Lorenzo E. Hernández/T-1034-2016; Campos, Alexandre/AGP-3558-2022; Castro, Noemí/T-6378-2019; Arguello, Anastasio/B-4493-2010	Almeida, Andre/0000-0002-7810-3988; Ferlizza, Enea/0000-0003-3391-0679; Renaut, Jenny/0000-0002-0450-3866; Castro, N./0000-0002-3026-2031; Castellano, Lorenzo E. Hernández/0000-0003-2729-0434; Campos, Alexandre/0000-0003-4621-885X; Arguello, Anastasio/0000-0002-4426-0678; Carneiro, Mariana/0000-0003-1981-3303; Parreira, Jose/0000-0003-3278-8122	Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal) [PTDC/CVT/116499/2010]; European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT - Foundation for Science and Technology [PEst-C/MAR/LA0015/2011]; FCT [SFRH/BPD/103683/2014, PD/BD/113474/2015]; Short Term Scientific Mission - COST action [FA1002]	Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT - Foundation for Science and Technology; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Short Term Scientific Mission - COST action	This research was supported by the research project PTDC/CVT/116499/2010 - Lactation and milk production in Goat (Capra hircus): identifying molecular markers underlying adaptation to seasonal weight loss from Fundacao para a Ciencia e Tecnologia (FCT, Lisbon, Portugal) and by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme and national funds through FCT - Foundation for Science and Technology, under the project "PEst-C/MAR/LA0015/2011". Author AM Almeida contract work is supported by the Ciencia 2007 program, A Campos work by a postdoctoral grant (SFRH/BPD/103683/2014) and J Parreira by a PhD grant (PD/BD/113474/2015) all from FCT. G Cugno was supported by a Short Term Scientific Mission financed by COST action FA1002 Proteomics in Farm Animals to whom network funding is finally acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2007, SMALL RUMINANT RES, V73, P216, DOI 10.1016/j.smallrumres.2007.02.001; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; Almeida AM, 2015, ANIMAL, V9, P1, DOI 10.1017/S1751731114002602; Almeida AM, 2010, ANIM GENET, V41, P260, DOI 10.1111/j.1365-2052.2009.01994.x; Almeida AM, 2004, SMALL RUMINANT RES, V55, P141, DOI 10.1016/j.smallrumres.2004.01.009; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Amills M, 2004, J DAIRY RES, V71, P257, DOI 10.1017/S0022029904000342; Arianmanesh M, 2011, J ENDOCRINOL, V210, P47, DOI 10.1530/JOE-10-0336; Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7; Campos A, 2010, PLANT BIOLOGY, V12, P708, DOI 10.1111/j.1438-8677.2009.00280.x; Campos A, 2013, J SCI FOOD AGR, V93, P1779, DOI 10.1002/jsfa.5977; Capote J, 2006, J DAIRY SCI, V89, P2076, DOI 10.3168/jds.S0022-0302(06)72276-7; Cardoso L. A., 2013, FAO Animal Production and Health Paper, P37; Chaudhary N, 2013, CHEM-BIOL INTERACT, V204, P125, DOI 10.1016/j.cbi.2013.05.004; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Eckersall PD, 2012, J PROTEOMICS, V75, P4187, DOI 10.1016/j.jprot.2012.05.014; Escuder A., 2006, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P95; Fan NJ, 2012, J PROTEOMICS, V75, P3977, DOI 10.1016/j.jprot.2012.05.008; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Ferreira AM, 2013, J PROTEOMICS, V94, P110, DOI 10.1016/j.jprot.2013.09.012; Fresno M. R., 1994, Archivos de Zootecnia, V43, P181; Giusti L, 2014, PROTEOM CLIN APPL, V8, P258, DOI 10.1002/prca.201300052; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Hernandez-Castellano LE, 2015, J DAIRY SCI, V98, P135, DOI 10.3168/jds.2014-8143; Hernandez-Castellano LE, 2014, CURR PROTEIN PEPT SC, V15, P64, DOI 10.2174/1389203715666140221124622; Hernandez-Castellano LE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-85; Herrera RG, 2001, J CLIMATE, V14, P3889, DOI 10.1175/1520-0442(2001)014<3889:IOTNAO>2.0.CO;2; Janjanam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102515; Lerias JR, 2015, J DAIRY RES, V82, P416, DOI 10.1017/S0022029915000412; Lerias JR, 2014, J DAIRY RES, V81, P304, DOI 10.1017/S0022029914000235; Lerias JR, 2013, TROP ANIM HEALTH PRO, V45, P1731, DOI 10.1007/s11250-013-0423-2; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Martinez-de la Puente J, 2011, VET REC, V168, P377, DOI 10.1136/vr.c6483; McDonald P, 1988, ANIMAL NUTR; MEHARD CW, 1971, CANCER RES, V31, P2148; Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135; Navarro-Rios M. J., 2011, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P205; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oliva K, 2013, J ENDOCRINOL, V218, P165, DOI 10.1530/JOE-13-0010; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Paredi G, 2013, J PROTEOMICS, V88, P58, DOI 10.1016/j.jprot.2013.01.029; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Roberts DJ, 2004, BIOCHEM PHARMACOL, V68, P799, DOI 10.1016/j.bcp.2004.05.044; Rolyan H, 2015, J NEUROSCI, V35, P12002, DOI 10.1523/JNEUROSCI.1668-15.2015; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Soares R, 2012, J PROTEOMICS, V75, P4190, DOI 10.1016/j.jprot.2012.04.009; Torres A, 2013, J DAIRY SCI, V96, P1071, DOI 10.3168/jds.2012-5435; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Ura B, 2015, ONCOL REP, V33, P2219, DOI 10.3892/or.2015.3827; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Young SG, 2014, MOL CELL BIOL, V34, P2776, DOI 10.1128/MCB.00486-14	57	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0151599	10.1371/journal.pone.0151599	http://dx.doi.org/10.1371/journal.pone.0151599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031334	Green Published, Green Submitted, gold			2022-12-27	WOS:000373121800015
J	Pratihast, AK; DeVries, B; Avitabile, V; de Bruin, S; Herold, M; Bergsma, A				Pratihast, Arun Kumar; DeVries, Ben; Avitabile, Valerio; de Bruin, Sytze; Herold, Martin; Bergsma, Aldo			Design and Implementation of an Interactive Web-Based Near Real-Time Forest Monitoring System	PLOS ONE			English	Article							VOLUNTEERED GEOGRAPHIC INFORMATION; REDD PLUS; CITIZEN SCIENCE; SOCIAL MEDIA; LANDSAT; DEFORESTATION; OPPORTUNITIES; DISTURBANCE; EMISSIONS; COVER	This paper describes an interactive web-based near real-time (NRT) forest monitoring system using four levels of geographic information services: 1) the acquisition of continuous data streams from satellite and community-based monitoring using mobile devices, 2) NRT forest disturbance detection based on satellite time-series, 3) presentation of forest disturbance data through a web-based application and social media and 4) interaction of the satellite based disturbance alerts with the end-user communities to enhance the collection of ground data. The system is developed using open source technologies and has been implemented together with local experts in the UNESCO Kafa Biosphere Reserve, Ethiopia. The results show that the system is able to provide easy access to information on forest change and considerably improves the collection and storage of ground observation by local experts. Social media leads to higher levels of user interaction and noticeably improves communication among stakeholders. Finally, an evaluation of the system confirms the usability of the system in Ethiopia. The implemented system can provide a foundation for an operational forest monitoring system at the national level for REDD+ MRV applications.	[Pratihast, Arun Kumar; DeVries, Ben; Avitabile, Valerio; de Bruin, Sytze; Herold, Martin; Bergsma, Aldo] Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, POB 47, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research	Pratihast, AK (corresponding author), Wageningen Univ, Lab Geoinformat Sci & Remote Sensing, POB 47, NL-6700 AA Wageningen, Netherlands.	arun.pratihast@wur.nl	Herold, Martin/F-8553-2012; Pratihast, Arun/AAO-8661-2020; de Bruin, Sytze/N-1183-2014; DeVries, Ben/H-5588-2019	Herold, Martin/0000-0003-0246-6886; DeVries, Ben/0000-0003-2136-3401	International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project) [05/2014-2]; Google Earth Engine Research Awards	International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project); Google Earth Engine Research Awards(Google Incorporated)	The work presented in this paper has been carried out with in the frame of the project "Forest, Carbon and Biodiversity Monitoring", implemented by the Nature and Biodiversity Conservation Union (NABU), German and Ethiopian branches, with funding from the International Climate Initiative (IKI) of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMU) (IKI-1 project number 05/2014-2). Funding for the work of Arun Kumar Pratihast was provided by the Google Earth Engine Research Awards 2015.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Aerts R, 2015, SCIENCE, V347, P139, DOI 10.1126/science.347.6218.139-b; Anderson LO, 2005, IEEE GEOSCI REMOTE S, V2, P315, DOI 10.1109/LGRS.2005.850364; Asner GP, 2001, INT J REMOTE SENS, V22, P3855, DOI 10.1080/01431160010006926; Torres AB, 2014, FORESTS, V5, P3295, DOI 10.3390/f5123295; Torres AB, 2012, FORESTS, V3, P137, DOI 10.3390/f3010137; Bellfield H, 2015, FORESTS, V6, P133, DOI 10.3390/f6010133; Biezen JV, 2015, THESIS UTRECHT U UTR; Bimber O, 2000, COMPUT GRAPH-UK, V24, P851, DOI 10.1016/S0097-8493(00)00088-1; Bocher E, 2012, LECT NOTES GEOINFORM, P247; Borner J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121544, 10.1371/journal.pone.0116846]; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Bugs G, 2010, CITIES, V27, P172, DOI 10.1016/j.cities.2009.11.008; CIFOR, 2021, CIFOR FORESTS NEWS; Connors JP, 2012, ANN ASSOC AM GEOGR, V102, P1267, DOI 10.1080/00045608.2011.627058; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; Danielsen F, 2011, CONSERV LETT, V4, P158, DOI 10.1111/j.1755-263X.2010.00159.x; Danielsen F, 2010, J APPL ECOL, V47, P1166, DOI 10.1111/j.1365-2664.2010.01874.x; Daume S, 2014, FOREST ECOL MANAG, V316, P9, DOI 10.1016/j.foreco.2013.09.004; de Bruin S, 2014, BIOSYST ENG, V120, P15, DOI 10.1016/j.biosystemseng.2013.07.009; de Sassi C, 2015, CURR OPIN ENV SUST, V14, P93, DOI 10.1016/j.cosust.2015.04.003; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Devries B, 2013, LAW, TROPICAL FORESTS AND CARBON: THE CASE OF REDD+, P151; Dickson B, 2012, CURR OPIN ENV SUST, V4, P717, DOI 10.1016/j.cosust.2012.09.017; Diga M, 2009, PUBLIC RELAT REV, V35, P440, DOI 10.1016/j.pubrev.2009.07.003; Dragicevic S., 2004, J GEOGRAPHICAL SYSTE, V6, P133, DOI [10.1007/s10109-004-0130-7, DOI 10.1007/S10109-004-0130-7]; Dresen E, 2014, LAND-BASEL, V3, P1137, DOI 10.3390/land3031137; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Eggleston H.S., 2006, GUIDELINES NATL GREE; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Getahun K, 2013, FOREST ECOL MANAG, V304, P171, DOI 10.1016/j.foreco.2013.05.001; GOFC-GOLD, 2014, SOURC METH PROC MON; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Gouveia C, 2004, J ENVIRON MANAGE, V71, P135, DOI 10.1016/j.jenvman.2004.01.009; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P3784, DOI 10.1016/j.rse.2008.05.012; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herold M, 2012, CURRENT OPINION ENV; Herold M, 2008, REALISING REDD NATL, V7, P85; Keramitsoglou I, 2004, ENVIRON MANAGE, V33, P212, DOI 10.1007/s00267-003-0092-4; Kingston R., 2000, Computers, Environment and Urban Systems, V24, P109, DOI 10.1016/S0198-9715(99)00049-6; Li WeiJiang, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P59; Li ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116781; Lynch J, 2013, NATURE, V496, P293, DOI 10.1038/496293a; Maguire D. J., 2005, Computers, Environment and Urban Systems, V29, P3, DOI 10.1016/j.compenvurbsys.2004.05.012; Moore R.T., 2011, AGU FALL M ABSTR 201; Newman G, 2011, ECOL INFORM, V6, P217, DOI 10.1016/j.ecoinf.2011.03.002; Pocas I, 2014, INT J GEOGR INF SCI, V28, P2356, DOI 10.1080/13658816.2014.924627; Pratihast AK, 2014, FORESTS, V5, P2464, DOI 10.3390/f5102464; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Pratihast AK, 2013, SENSORS-BASEL, V13, P21, DOI 10.3390/s130100021; Reiche J, 2015, REMOTE SENS-BASEL, V7, P4973, DOI 10.3390/rs70504973; Renate Steinmann AK, 2004, 24 URB DAT MAN S; Rocha R, 2019, WORK PAP; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Schmitt CB, 2010, APPL VEG SCI, V13, P291, DOI 10.1111/j.1654-109X.2009.01067.x; Shimabukuro Y., 2007, REVISTAAMBI AGUA, V1, P37, DOI DOI 10.4136/AMBI-AGUA.4; Shrestha S, 2014, FORESTS, V5, P2425, DOI 10.3390/f5102425; Skar C, 2012, NORWEGIAN INT CLIMAT; Skarlatidou A, 2011, INT J GEOGR INF SCI, V25, P1913, DOI 10.1080/13658816.2011.557379; Skutsch MM, 2014, BIODIVERS CONSERV, V23, P233, DOI 10.1007/s10531-013-0594-1; Skutsch Margaret M, 2011, Carbon Balance Manag, V6, P16, DOI 10.1186/1750-0680-6-16; Souza CM, 2009, EARTH SCI INFORM, V2, P205, DOI 10.1007/s12145-009-0035-6; Tomppo E., 2010, NATL FOREST INVENTOR, P541, DOI DOI 10.1007/978-90-481-3233-1; UNFCCC, 2013, GUID PROC TECHN ASS; United Nations Collaborative Programme on Reducing Emissions from Deforestation and Forest Degradation in Developing Countries (UN-REDD), 2009, AB REDD; Vadrevu KP, 2008, J ENVIRON PLANN MAN, V51, P817, DOI 10.1080/09640560802423657; van Oort PAJ, 2010, GEOJOURNAL, V75, P105, DOI 10.1007/s10708-009-9294-5; Verbesselt J, 2012, REMOTE SENS ENVIRON, V123, P98, DOI 10.1016/j.rse.2012.02.022; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P590, DOI 10.1016/j.cosust.2012.10.006; Werts JD, 2012, ENVIRON MANAGE, V49, P816, DOI 10.1007/s00267-012-9818-5; Wheeler D, SATELLITE BASED FORE; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Xin QC, 2013, REMOTE SENS ENVIRON, V135, P234, DOI 10.1016/j.rse.2013.04.002; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	81	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0150935	10.1371/journal.pone.0150935	http://dx.doi.org/10.1371/journal.pone.0150935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH9NC	27031694	gold, Green Published, Green Submitted			2022-12-27	WOS:000373121800008
J	Qureshi, MA; Noor, RM; Shamim, A; Shamshirband, S; Choo, KKR				Qureshi, Muhammad Ahsan; Noor, Rafidah Md; Shamim, Azra; Shamshirband, Shahaboddin; Choo, Kim-Kwang Raymond			A Lightweight Radio Propagation Model for Vehicular Communication in Road Tunnels	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; INTER-VEHICLE COMMUNICATION; WAVE PROPAGATION; LOSS PREDICTION; CHANNEL; NETWORKS; MEMORY	Radio propagation models (RPMs) are generally employed in Vehicular Ad Hoc Networks (VANETs) to predict path loss in multiple operating environments (e.g. modern road infrastructure such as flyovers, underpasses and road tunnels). For example, different RPMs have been developed to predict propagation behaviour in road tunnels. However, most existing RPMs for road tunnels are computationally complex and are based on field measurements in frequency band not suitable for VANET deployment. Furthermore, in tunnel applications, consequences of moving radio obstacles, such as large buses and delivery trucks, are generally not considered in existing RPMs. This paper proposes a computationally inexpensive RPM with minimal set of parameters to predict path loss in an acceptable range for road tunnels. The proposed RPM utilizes geometric properties of the tunnel, such as height and width along with the distance between sender and receiver, to predict the path loss. The proposed RPM also considers the additional attenuation caused by the moving radio obstacles in road tunnels, while requiring a negligible overhead in terms of computational complexity. To demonstrate the utility of our proposed RPM, we conduct a comparative summary and evaluate its performance. Specifically, an extensive data gathering campaign is carried out in order to evaluate the proposed RPM. The field measurements use the 5 GHz frequency band, which is suitable for vehicular communication. The results demonstrate that a close match exists between the predicted values and measured values of path loss. In particular, an average accuracy of 94% is found with R-2 = 0.86.	[Qureshi, Muhammad Ahsan; Noor, Rafidah Md; Shamshirband, Shahaboddin] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Shamim, Azra] COMSATS Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan; [Choo, Kim-Kwang Raymond] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia	Universiti Malaya; COMSATS University Islamabad (CUI); University of South Australia	Qureshi, MA; Noor, RM; Shamshirband, S (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	ahsanqureshi1@gmail.com; fidah@um.edu.my; shahab1396@gmail.com	S.Band, Shahab/ABI-7388-2020; S.Band, Shahab/AAD-3311-2021; Choo, Kim-Kwang Raymond/A-3634-2009; Noor, Rafidah Md/B-5445-2010	S.Band, Shahab/0000-0002-8963-731X; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Noor, Rafidah Md/0000-0001-6266-2390; Shamshirband, Shahaboddin/0000-0002-6605-498X	UM High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/FCSIT/09]	UM High Impact Research MoE Grant from the Ministry of Education Malaysia	This research is supported by UM High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/FCSIT/09 from the Ministry of Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J.B., 1995, COMMUNICATIONS MAGAZ, V33, P42; Behrisch M., 2011, P 3 INT C ADV SYST S, V42; Boban M, 2011, IEEE J SEL AREA COMM, V29, P15, DOI 10.1109/JSAC.2011.110103; Changsen Z, 2006, ANT PROP EM THEOR 20; CHAZELLE B, 1992, J ACM, V39, P1, DOI 10.1145/147508.147511; Cheng L, 2007, IEEE J SEL AREA COMM, V25, P1501, DOI 10.1109/JSAC.2007.071002; Cheng L, 2013, IEEE J SEL AREA COMM, V31, P449, DOI 10.1109/JSAC.2013.SUP.0513040; Cheng Lin, 2008, WIR COMM NETW C 2008; Deryck L., 1978, VEHICULAR TECHNOLOGY, V27, P145; Didascalou D, 2000, VEH TECHN C P 2000 V; FRIIS HT, 1946, P IRE, V34, P254, DOI 10.1109/JRPROC.1946.234568; Geiger A, 2012, IEEE T INTELL TRANSP, V13, P1008, DOI 10.1109/TITS.2012.2189882; Giordano E, 2011, P IEEE, V99, P1280, DOI 10.1109/JPROC.2011.2138110; Gokulakrishnan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143383; Hrovat A, 2010, IET MICROW ANTENNA P, V4, P571, DOI 10.1049/iet-map.2009.0159; Hrovat A, 2014, IEEE COMMUN SURV TUT, V16, P658, DOI 10.1109/SURV.2013.091213.00175; Huo Y, 2009, MICR EL 2009 PRIMEAS; Jiang D, 2008, VEH TECHN C 2008 VTC; Jiping S, 2004, COMM 2004 5 INT S MU; Kenney JB, 2011, P IEEE, V99, P1162, DOI 10.1109/JPROC.2011.2132790; Kesting A, 2010, IEEE T INTELL TRANSP, V11, P172, DOI 10.1109/TITS.2009.2037924; Lee YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130758; Lenz H, 1999, EUR PHYS J B, V7, P331, DOI 10.1007/s100510050618; Lienard M, 2009, J COMMUN, V4, P241; Masson E., 2011, EURASIP J WIREL COMM, V2011, P1; Maurer J, 2005, P 28 URSI GA; Mo YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142775; Moutairou M, 2010, ANT PROP EUCAP 2010; Qureshi M. A., 2013, FRONT INF TECHN FIT; Qureshi MA, 2015, ARAB J SCI ENG, V40, P1385, DOI 10.1007/s13369-015-1600-6; Rana MM, 2012, IEEE T MAGN, V48, P223, DOI 10.1109/TMAG.2011.2177075; Shah SAA, 2014, J ZHEJIANG U-SCI C, V15, P489, DOI 10.1631/jzus.C1300332; Sun Z, 2010, IEEE T COMMUN, V58, P1758, DOI 10.1109/TCOMM.2010.06.080353; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; van Nunen E, 2012, IEEE T INTELL TRANSP, V13, P1018, DOI 10.1109/TITS.2012.2200475; Wang S., 2010, MODERN APPL SCI, V4, P65, DOI DOI 10.5539/mas.v4n2p65; Wang Y, 2000, IEEE T ANTENN PROPAG, V48, P743, DOI 10.1109/8.855493; YAMAGUCHI Y, 1989, IEEE T ELECTROMAGN C, V31, P87, DOI 10.1109/15.19912; Yang XX, 2007, INT J INFRARED MILLI, V28, P901, DOI 10.1007/s10762-007-9268-y; Yu SW, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215500848; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Yu SW, 2014, PHYSICA A, V407, P152, DOI 10.1016/j.physa.2014.03.081; Zhang YP, 2003, IEEE T VEH TECHNOL, V52, P1308, DOI 10.1109/TVT.2003.816647; Zhang YP, 1999, MICROW OPT TECHN LET, V23, P38, DOI 10.1002/(SICI)1098-2760(19991005)23:1<38::AID-MOP11>3.0.CO;2-N	46	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152727	10.1371/journal.pone.0152727	http://dx.doi.org/10.1371/journal.pone.0152727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27031989	Green Published, Green Accepted, gold			2022-12-27	WOS:000373121800130
J	Jia, GD; Yu, XX; Fan, DX; Jia, JB				Jia, Guodong; Yu, Xinxiao; Fan, Dengxing; Jia, Jianbo			Mechanism Underlying the Spatial Pattern Formation of Dominant Tree Species in a Natural Secondary Forest	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; BIVARIATE DISTRIBUTION; POSITIVE INTERACTIONS; GROWTH; COMPETITION; ASSOCIATIONS; DIVERSITY; DYNAMICS; BEECH; POINT	Studying the spatial pattern of plant species may provide significant insights into processes and mechanisms that maintain stand stability. To better understand the dynamics of naturally regenerated secondary forests, univariate and bivariate Ripley's L(r) functions were employed to evaluate intra-/interspecific relationships of four dominant tree species (Populus davidiana, Betula platyphylla, Larix gmelinii and Acer mono) and to distinguish the underlying mechanism of spatial distribution. The results showed that the distribution of soil, water and nutrients was not fragmented but presented clear gradients. An overall aggregated distribution existed at most distances. No correlation was found between the spatial pattern of soil conditions and that of trees. Both positive and negative intra-and interspecific relationships were found between different DBH classes at various distances. Large trees did not show systematic inhibition of the saplings. By contrast, the inhibition intensified as the height differences increased between the compared pairs. Except for Larix, universal inhibition of saplings by upper layer trees occurred among other species, and this reflected the vertical competition for light. Therefore, we believe that competition for light rather than soil nutrients underlies the mechanism driving the formation of stand spatial pattern in the rocky mountainous areas examined.	[Jia, Guodong; Yu, Xinxiao; Fan, Dengxing; Jia, Jianbo] Beijing Forestry Univ, Coll Soil & Water Conservat, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Beijing, Peoples R China	Beijing Forestry University	Yu, XX (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Beijing, Peoples R China.	yuxinxiao111@163.com			Fundamental Research Funds for the Central Universities [BLX2013032, 2015ZCQ-SB-03]; National Nature Science Foundation of China [41401013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (Grant No. BLX2013032), National Nature Science Foundation of China (Grant No. 41401013) and the Fundamental Research Funds for the Central Universities (NO. 2015ZCQ-SB-03).	Aldrich PR, 2003, FOREST ECOL MANAG, V180, P475, DOI 10.1016/S0378-1127(02)00612-6; Barker MG, 1997, OECOLOGIA, V112, P453, DOI 10.1007/s004420050332; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Boyden S, 2005, FOREST ECOL MANAG, V219, P43, DOI 10.1016/j.foreco.2005.08.041; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Burslem DFRP, 2001, SCIENCE, V291, P606, DOI 10.1126/science.1055873; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CARSON PL, 1980, N DAK AGR EXP STA BU, P17; Chen Yifeng, 2000, Acta Acustica, V25, P265; Chokkalingam U., 2001, International Forestry Review, V3, P19; CHRISTENSEN NL, 1977, AM MIDL NAT, V97, P176, DOI 10.2307/2424693; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Coomes DA, 2009, J ECOL, V97, P705, DOI 10.1111/j.1365-2745.2009.01507.x; Dimov L, 2013, ANN FOREST SCI, V70, P813, DOI 10.1007/s13595-013-0322-8; Druckenbrod DL, 2005, J VEG SCI, V16, P37, DOI 10.1111/j.1654-1103.2005.tb02336.x; Fang WP, 1988, FLORA CHINA, V46, P94; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Genet A, 2014, ECOL MODEL, V288, P143, DOI 10.1016/j.ecolmodel.2014.06.002; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hao ZQ, 2007, FOREST ECOL MANAG, V252, P1, DOI 10.1016/j.foreco.2007.06.026; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Heineman KD, 2011, FOREST ECOL MANAG, V261, P1820, DOI 10.1016/j.foreco.2011.02.005; Kammesheidt L, 2002, AMBIO, V31, P243, DOI 10.1639/0044-7447(2002)031[0243:POSFMI]2.0.CO;2; Kitzberger T, 2000, ECOLOGY, V81, P1914, DOI 10.1890/0012-9658(2000)081[1914:EOCVOF]2.0.CO;2; Kuang KR, 1988, FLORA CHINA, V21, P112; Kubota Y, 2007, PLANT ECOL, V190, P143, DOI 10.1007/s11258-006-9197-1; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Li YF, 2014, FOREST ECOL MANAG, V314, P17, DOI 10.1016/j.foreco.2013.11.012; Li YF, 2012, J VEG SCI, V23, P1180, DOI 10.1111/j.1654-1103.2012.01431.x; Lu R.K, 2000, ANAL METHOD SOIL AGR; MALIK AR, 1976, AUST J BOT, V24, P265, DOI 10.1071/BT9760265; Martinez I, 2010, FOREST ECOL MANAG, V260, P456, DOI 10.1016/j.foreco.2010.04.039; Nanami S, 2011, ECOL RES, V26, P37, DOI 10.1007/s11284-010-0750-y; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Petritan IC, 2015, FOREST ECOL MANAG, V356, P184, DOI 10.1016/j.foreco.2015.07.015; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Raphael JPA, 2016, SOIL TILL RES, V155, P45, DOI 10.1016/j.still.2015.07.020; REBERTUS AJ, 1989, J ECOL, V77, P638, DOI 10.2307/2260975; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROBERTS MR, 1995, ECOL APPL, V5, P969, DOI 10.2307/2269348; Romanya J, 2005, GEODERMA, V124, P169, DOI 10.1016/j.geoderma.2004.04.011; Rozas V, 2003, FOREST ECOL MANAG, V182, P175, DOI 10.1016/S0378-1127(03)00070-7; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Szwagrzyk J, 2001, FOREST ECOL MANAG, V141, P237, DOI 10.1016/S0378-1127(00)00332-7; SZWAGRZYK J, 1993, J VEG SCI, V4, P469, DOI 10.2307/3236074; van Breugel M, 2012, PLANT ECOL, V213, P25, DOI 10.1007/s11258-011-0003-3; vanBreemen N, 1997, CAN J FOREST RES, V27, P1110, DOI 10.1139/cjfr-27-7-1110; Verzelen N, 2006, ECOL COMPLEX, V3, P209, DOI 10.1016/j.ecocom.2006.03.001; Vyse A, 2009, FOREST ECOL MANAG, V258, pS36, DOI 10.1016/j.foreco.2009.08.027; Wang Z, 1988, FLORA CHINA, V20, P11; Wehenkel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140442; WHIPPLE SA, 1980, B TORREY BOT CLUB, V107, P71, DOI 10.2307/2484854; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Yan QL, 2010, PLANT SOIL, V329, P469, DOI 10.1007/s11104-009-0172-1; Zhao HY, 2012, MT RES DEV, V32, P187, DOI 10.1659/MRD-JOURNAL-D-11-00125.1; Zheng WJ, 1988, FLORA CHINA, V7, P187	69	8	9	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2016	11	3							e0152596	10.1371/journal.pone.0152596	http://dx.doi.org/10.1371/journal.pone.0152596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9LB	27028757	Green Published, gold, Green Submitted			2022-12-27	WOS:000373116500055
J	Caini, S; Andrade, W; Badur, S; Balmaseda, A; Barakat, A; Bella, A; Bimohuen, A; Brammer, L; Bresee, J; Bruno, A; Castillo, L; Ciblak, MA; Clara, AW; Cohen, C; Cutter, J; Daouda, C; de Lozano, C; De Mora, D; Dorji, K; Emukule, GO; Fasce, RA; Feng, L; de Almeida, WAF; Guiomar, R; Heraud, JM; Holubka, O; Huang, QS; Kadjo, HA; Kiyanbekova, L; Kosasih, H; Kusznierz, G; Lara, J; Li, M; Lopez, L; Hoang, PVM; Henriques, CMP; Matute, ML; Mironenko, A; Moreno, B; Mott, JA; Njouom, R; Nurhayati; Ospanova, A; Owen, R; Pebody, R; Pennington, K; Puzelli, S; Le, MTQ; Razanajatovo, NH; Rodrigues, A; Rudi, JM; Lin, RTP; Venter, M; Vernet, MA; Wangchuk, S; Yang, J; Yu, H; Zambon, M; Schellevis, F; Paget, J				Caini, Saverio; Andrade, Winston; Badur, Selim; Balmaseda, Angel; Barakat, Amal; Bella, Antonino; Bimohuen, Abderrahman; Brammer, Lynnette; Bresee, Joseph; Bruno, Alfredo; Castillo, Leticia; Ciblak, Meral A.; Clara, Alexey W.; Cohen, Cheryl; Cutter, Jeffery; Daouda, Coulibaly; de Lozano, Celina; De Mora, Domenica; Dorji, Kunzang; Emukule, Gideon O.; Fasce, Rodrigo A.; Feng, Luzhao; Ferreira de Almeida, Walquiria Aparecida; Guiomar, Raquel; Heraud, Jean-Michel; Holubka, Olha; Huang, Q. Sue; Kadjo, Herve A.; Kiyanbekova, Lyazzat; Kosasih, Herman; Kusznierz, Gabriela; Lara, Jenny; Li, Ming; Lopez, Liza; Phuong Vu Mai Hoang; Pessanha Henriques, Claudio Maierovitch; Matute, Maria Luisa; Mironenko, Alla; Moreno, Brechla; Mott, Joshua A.; Njouom, Richard; Nurhayati; Ospanova, Akerke; Owen, Rhonda; Pebody, Richard; Pennington, Kate; Puzelli, Simona; Mai Thi Quynh Le; Razanajatovo, Norosoa Harline; Rodrigues, Ana; Rudi, Juan Manuel; Lin, Raymond Tzer Pin; Venter, Marietjie; Vernet, Marie-Astrid; Wangchuk, Sonam; Yang, Juan; Yu, Hongjie; Zambon, Maria; Schellevis, Franois; Paget, John		Global Influenza B Study	Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?	PLOS ONE			English	Article							SEASONAL INFLUENZA; SURVEILLANCE	Introduction Determining the optimal time to vaccinate is important for influenza vaccination programmes. Here, we assessed the temporal characteristics of influenza epidemics in the Northern and Southern hemispheres and in the tropics, and discuss their implications for vaccination programmes. Methods This was a retrospective analysis of surveillance data between 2000 and 2014 from the Global Influenza B Study database. The seasonal peak of influenza was defined as the week with the most reported cases (overall, A, and B) in the season. The duration of seasonal activity was assessed using the maximum proportion of influenza cases during three consecutive months and the minimum number of months with >= 80% of cases in the season. We also assessed whether co-circulation of A and B virus types affected the duration of influenza epidemics. Results 212 influenza seasons and 571,907 cases were included from 30 countries. In tropical countries, the seasonal influenza activity lasted longer and the peaks of influenza A and B coincided less frequently than in temperate countries. Temporal characteristics of influenza epidemics were heterogeneous in the tropics, with distinct seasonal epidemics observed only in some countries. Seasons with co-circulation of influenza A and B were longer than influenza A seasons, especially in the tropics. Discussion Our findings show that influenza seasonality is less well defined in the tropics than in temperate regions. This has important implications for vaccination programmes in these countries. High-quality influenza surveillance systems are needed in the tropics to enable decisions about when to vaccinate.	[Caini, Saverio; Schellevis, Franois; Paget, John] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Andrade, Winston; Fasce, Rodrigo A.] Inst Salud Publ Chile, Secc Virus Resp & Exantemat, Santiago, Chile; [Badur, Selim; Ciblak, Meral A.] Istanbul Univ, Istanbul, Turkey; [Balmaseda, Angel] Minist Hlth, Natl Influenza Ctr, Managua, Nicaragua; [Barakat, Amal; Bimohuen, Abderrahman] Minist Hlth, Inst Natl Hyg, Natl Influenza Ctr, Rabat, Morocco; [Bella, Antonino] NIH, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [Brammer, Lynnette; Bresee, Joseph] Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA USA; [Bruno, Alfredo; De Mora, Domenica] INSPI, Ctr Ref Nacl Influenza & Otros Virus Resp, Guayaquil, Ecuador; [Castillo, Leticia] Minist Hlth, Natl Influenza Ctr, Guatemala City, Guatemala; [Clara, Alexey W.] US Ctr Dis Control, Cent Amer Reg, Guatemala City, Guatemala; [Cohen, Cheryl] Natl Inst Communicable Dis, CRDM, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Cutter, Jeffery; Lin, Raymond Tzer Pin] Minist Hlth, Communicable Dis Div, Singapore, Singapore; [Daouda, Coulibaly; Kadjo, Herve A.] Pasteur Inst Cote Ivoire, Resp Viruses Unit, Abidjan, Cote Ivoire; [de Lozano, Celina] Minist Hlth, Natl Influenza Ctr, San Salvador, El Salvador; [Dorji, Kunzang; Wangchuk, Sonam] Minist Hlth, Dept Publ Hlth, Publ Hlth Lab, Thimphu, Bhutan; [Emukule, Gideon O.; Mott, Joshua A.] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Feng, Luzhao; Li, Ming; Yang, Juan; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early warning Infect Dis, Div Infect Dis, Beijing, Peoples R China; [Ferreira de Almeida, Walquiria Aparecida; Pessanha Henriques, Claudio Maierovitch] Minist Hlth, Brasilia, DF, Brazil; [Guiomar, Raquel] Natl Inst Hlth, Dept Infect Dis, Natl Influenza Ref Lab, Lisbon, Portugal; [Heraud, Jean-Michel; Razanajatovo, Norosoa Harline] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Holubka, Olha; Mironenko, Alla] Natl Acad Med Sci Ukraine, LV Gromashevsky Inst Epidemiol & Infect Dis, Kiev, Ukraine; [Huang, Q. Sue; Lopez, Liza] Inst Environm Sci & Res, Wellington, New Zealand; [Kiyanbekova, Lyazzat; Ospanova, Akerke] Astana Ctr Sanit Epidemiol Expertise, Zonal Virol Lab, Astana, Kazakhstan; [Kosasih, Herman; Nurhayati] US Naval, Med Res Unit 2, Jakarta, Indonesia; [Kusznierz, Gabriela; Rudi, Juan Manuel] Inst Nacl Enfermedades Resp Dr Emilio Coni, Santa Fe, Argentina; [Lara, Jenny] Minist Hlth, Natl Influenza Ctr, San Jose, Costa Rica; [Phuong Vu Mai Hoang; Mai Thi Quynh Le] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Matute, Maria Luisa] Minist Hlth, Natl Influenza Ctr, Tegucigalpa, Honduras; [Moreno, Brechla] IC Gorgas, Natl Influenza Ctr, Panama City, Panama; [Njouom, Richard; Vernet, Marie-Astrid] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon; [Owen, Rhonda; Pennington, Kate] Off Hlth Protect, Dept Hlth, Hlth Policy Protect Branch, Vaccine Preventable Dis Surveillance Sect, Woden, ACT, Australia; [Pebody, Richard] Publ Hlth England, Dept Resp Dis, Colindale, England; [Puzelli, Simona] Natl Inst Hlth, Natl Influenza Ctr, Rome, Italy; [Rodrigues, Ana] Natl Inst Hlth, Dept Epidemiol, Lisbon, Portugal; [Venter, Marietjie] US CDC, Global Dis Detect, Pretoria, South Africa; [Venter, Marietjie] Univ Pretoria, Zoonoses Res Ctr, Dept Med Virol, ZA-0002 Pretoria, South Africa; [Zambon, Maria] Publ Hlth England, Resp Virus Unit, Colindale, England	Netherlands Institute for Health Services Research; Istanbul University; Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Ministry of Health-Singapore; Chinese Center for Disease Control & Prevention; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine; Institute of Environmental Science & Research (ESR) - New Zealand; Naval Medical Research Center (NMRC); US Naval Medical Research Unit-2 (NAMRU-2); National Institute of Hygiene & Epidemiology (NIHE); Centre Pasteur du Cameroun; Public Health England; Istituto Superiore di Sanita (ISS); University of Pretoria; Public Health England	Caini, S (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	s.caini@nivel.nl	Rizzo, Caterina/H-4092-2012; Dorji, Kunzang/CAF-3728-2022; Bella, Antonino/AAB-9943-2019; Henriques, Claudio/AAW-8044-2021; Mironenko, Alla/AAG-9950-2019; Venter, Marietjie/P-9604-2016; Dorji, Kunzang/ABB-7631-2020; Yu, Hongjie/GZK-5351-2022; Heraud, Jean-Michel/O-1464-2013; Caini, Saverio/AAI-3788-2020; Rodrigues, Ana/GYQ-6273-2022; Mironenko, Alla/O-2870-2016; BRUNO, ALFREDO/AAW-8354-2020; Holubka, Olha/P-5164-2016; Puzelli, Simona/C-2542-2016	Rizzo, Caterina/0000-0002-5583-7508; Mironenko, Alla/0000-0002-2630-1827; Venter, Marietjie/0000-0003-2696-824X; Heraud, Jean-Michel/0000-0003-1107-0859; Caini, Saverio/0000-0002-2262-1102; Mironenko, Alla/0000-0002-2630-1827; BRUNO, ALFREDO/0000-0002-9678-4203; Pebody, Richard/0000-0002-9069-2885; Cohen, Cheryl/0000-0003-0376-2302; Holubka, Olha/0000-0001-8085-1638; Puzelli, Simona/0000-0003-4497-9719; Pechirra, Pedro/0000-0001-6352-1100; Guiomar, Raquel/0000-0002-4563-6315; Dorji, Kunzang/0000-0002-3876-9638; Rodrigues, Ana Paula/0000-0003-2264-4723; Huang, Q. Sue/0000-0002-3923-5195; Nunes, Baltazar/0000-0001-6230-7209	Sanofi Pasteur; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	Sanofi Pasteur; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Global Influenza B Study is supported by an unrestricted research grant from Sanofi Pasteur. The study sponsor had no role in the design of the study; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. The study sponsor had no access to the data in the study.	Alonso WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-982; Alonso WJ, 2015, INFLUENZA OTHER RESP, V9, P101, DOI 10.1111/irv.12308; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P201; Axelsen JB, 2014, P NATL ACAD SCI USA, V111, P9538, DOI 10.1073/pnas.1321656111; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; Castilla J, 2013, EUROSURVEILLANCE, V18, P17; Central Intelligence Agency, WORLD FACTBOOK; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Kissling E, 2013, EURO SURVEILL, V18; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Pebody RG, 2013, EUROSURVEILLANCE, V18, P25; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Richard SA, 2010, VACCINE, V28, P2693, DOI 10.1016/j.vaccine.2010.01.053; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Soebiyanto RP, 2015, GEOSPATIAL HEALTH, V10, P144, DOI 10.4081/gh.2015.372; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Steffen C, 2012, B WORLD HEALTH ORGAN, V90, P301, DOI 10.2471/BLT.11.098244; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; World Health Organization (WHO), STAT WORLDS VACC IMM; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yu HJ, 2013, INFLUENZA OTHER RESP, V7, P1350, DOI 10.1111/irv.12121	30	56	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2016	11	3							e0152310	10.1371/journal.pone.0152310	http://dx.doi.org/10.1371/journal.pone.0152310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH9NC	27135748	Green Published, gold			2022-12-27	WOS:000373121800053
J	Caini, S; Andrade, W; Badur, S; Balmaseda, A; Barakat, A; Bella, A; Bimohuen, A; Brammer, L; Bresee, J; Bruno, A; Castillo, L; Ciblak, MA; Clara, AW; Cohen, C; Daouda, C; de Lozano, C; De Mora, D; Dorji, K; Emukule, GO; Fasce, RA; Feng, L; de Almeida, WAF; Guiomar, R; Heraud, JM; Holubka, O; Huang, QS; Kadjo, HA; Kiyanbekova, L; Kosasih, H; Kusznierz, G; Lee, VJM; Lara, J; Li, M; Lopez, L; Mai, HPV; Pessanha, HCM; Matute, ML; Mironenko, A; Moreno, B; Mott, JA; Njouom, R; Nurhayati; Ospanova, A; Owen, R; Pebody, R; Pennington, K; Puzelli, S; Le, MTQ; Razanajatovo, NH; Rodrigues, A; Rudi, JM; Venter, M; Vernet, MA; Wei, AL; Wangchuk, S; Yang, J; Yu, H; Zambon, M; Schellevis, F; Paget, J				Caini, S.; Andrade, W.; Badur, S.; Balmaseda, A.; Barakat, A.; Bella, A.; Bimohuen, A.; Brammer, L.; Bresee, J.; Bruno, A.; Castillo, L.; Ciblak, M. A.; Clara, A. W.; Cohen, C.; Daouda, C.; de Lozano, C.; De Mora, D.; Dorji, K.; Emukule, G. O.; Fasce, R. A.; Feng, L.; de Almeida, W. A. Ferreira; Guiomar, R.; Heraud, J. M.; Holubka, O.; Huang, Q. S.; Kadjo, H. A.; Kiyanbekova, L.; Kosasih, H.; Kusznierz, G.; Lee, V. J. M.; Lara, J.; Li, M.; Lopez, L.; Mai, Hoang P. V.; Pessanha, Henriques C. M.; Matute, M. L.; Mironenko, A.; Moreno, B.; Mott, J. A.; Njouom, R.; Nurhayati; Ospanova, A.; Owen, R.; Pebody, R.; Pennington, K.; Puzelli, S.; Quynh Le, M. T.; Razanajatovo, N. H.; Rodrigues, A.; Rudi, J. M.; Venter, M.; Vernet, M. A.; Wei, A. L.; Wangchuk, S.; Yang, J.; Yu, H.; Zambon, M.; Schellevis, F.; Paget, J.		Global Influenza B Study	Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? (vol 11, e0152310, 2016)	PLOS ONE			English	Correction									[Lee, V. J. M.] Minist Hlth, Communicable Dis Div, Singapore, Singapore; [Wei, A. L.] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore	Ministry of Health-Singapore; Ministry of Health-Singapore			Rizzo, Caterina/H-4092-2012; Dorji, Kunzang/CAF-3728-2022; Bella, Antonino/AAB-9943-2019; Henriques, Claudio/AAW-8044-2021; Mironenko, Alla/AAG-9950-2019; Venter, Marietjie/P-9604-2016; Dorji, Kunzang/ABB-7631-2020; Yu, Hongjie/GZK-5351-2022; Heraud, Jean-Michel/O-1464-2013; Caini, Saverio/AAI-3788-2020; Rodrigues, Ana/GYQ-6273-2022; Mironenko, Alla/O-2870-2016; BRUNO, ALFREDO/AAW-8354-2020; Holubka, Olha/P-5164-2016; Puzelli, Simona/C-2542-2016	Rizzo, Caterina/0000-0002-5583-7508; Mironenko, Alla/0000-0002-2630-1827; Venter, Marietjie/0000-0003-2696-824X; Heraud, Jean-Michel/0000-0003-1107-0859; Caini, Saverio/0000-0002-2262-1102; Mironenko, Alla/0000-0002-2630-1827; BRUNO, ALFREDO/0000-0002-9678-4203; Pebody, Richard/0000-0002-9069-2885; Cohen, Cheryl/0000-0003-0376-2302; Holubka, Olha/0000-0001-8085-1638; Puzelli, Simona/0000-0003-4497-9719; Pechirra, Pedro/0000-0001-6352-1100; Guiomar, Raquel/0000-0002-4563-6315; Dorji, Kunzang/0000-0002-3876-9638; Rodrigues, Ana Paula/0000-0003-2264-4723; Huang, Q. Sue/0000-0002-3923-5195; Nunes, Baltazar/0000-0001-6230-7209	National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)		Caini S, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0155089, 10.1371/journal.pone.0152310]	1	56	56	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2016	11	5							e0155089	10.1371/journal.pone.0155089	http://dx.doi.org/10.1371/journal.pone.0155089			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL5KB	27135748	Green Published, gold			2022-12-27	WOS:000375674800057
J	Zhou, Y; Shah, SZA; Yang, LF; Zhang, ZQ; Zhou, XM; Zhao, DM				Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhang, Zhongqiu; Zhou, Xiangmei; Zhao, Deming			Virulent Mycobacterium bovis Beijing Strain Activates the NLRP7 Inflammasome in THP-1 Macrophages	PLOS ONE			English	Article							AIM2 INFLAMMASOME; TUBERCULOSIS INFECTION; LISTERIA-MONOCYTOGENES; IL-1-BETA PRODUCTION; PROTEIN; SECRETION; HUMANS; RECOGNITION; LIPOPROTEIN; PYROPTOSIS	Mycobacterium bovis is the causative agent of tuberculosis in a wide range of mammals, including humans. Macrophages are the first line of host defense. They secrete proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta), in response to mycobacterial infection, but the underlying mechanisms by which human macrophages are activated and release IL-1 beta following M. bovis infection are poorly understood. Here we show that the 'nucleotide binding and oligomerization of domain-like receptor (NLR) family pyrin domain containing 7 protein' (NLRP7) inflammasome is involved in IL-1 beta secretion and caspase-1 activation induced by M. bovis infection in THP-1 macrophages. NLRP7 inflammasome activation promotes the induction of pyroptosis as well as the expression of tumor necrosis factor alpha (TNF-alpha), Chemokine (C-C motif) ligand 3 (CCL3) and IL-1 beta mRNAs. Thus, the NLRP7 inflammasome contributes to IL-1 beta secretion and induction of pyroptosis in response to M. bovis infection in THP-1 macrophages.	[Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China; [Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Zhongqiu] Minist Agr Peoples Republ China, Vet Bur, Beijing 100125, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China.; Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zhouxm@cau.edu.cn; zhaodm@cau.edu.cn	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	MoSTRCUK international cooperation project [2013DFG32500]; National Natural Science Foundation of China [31572487]; Funding of State Key Lab of Agrobiotechnology [2012SKLAB06-14]; CAU Foreign Experts Major Projects [2012z018]; Foreign Experts Recruitment Program [GDW20151100036]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	MoSTRCUK international cooperation project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding of State Key Lab of Agrobiotechnology; CAU Foreign Experts Major Projects; Foreign Experts Recruitment Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by MoSTRCUK international cooperation project (Project No. 2013DFG32500) http://www.istcp.org.cn, National Natural Science Foundation of China (Project No. 31572487) https://isisn.nsfc.gov.cn, Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB06-14) http://cbs.cau.edu.cn, 2015 CAU Foreign Experts Major Projects (Project No: 2012z018) http://cau.edu.cn, and High-end Foreign Experts Recruitment Program (Project No: GDW20151100036) http://cepms.safea.gov.cn.	Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Baker MG, 2006, EPIDEMIOL INFECT, V134, P1068, DOI 10.1017/S0950268806005930; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bigi F, 1997, MICROBIOL-SGM, V143, P3599, DOI 10.1099/00221287-143-11-3599; Bigi F, 2000, MICROBIOL-UK, V146, P1011, DOI 10.1099/00221287-146-4-1011; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fend R, 2005, J CLIN MICROBIOL, V43, P1745, DOI 10.1128/JCM.43.4.1745-1751.2005; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lee HM, 2013, GLIA, V61, P441, DOI 10.1002/glia.22448; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segueni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126058; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	41	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152853	10.1371/journal.pone.0152853	http://dx.doi.org/10.1371/journal.pone.0152853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27583358	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100039
J	Zhou, YE; Buchowski, MS; Liu, JG; Schlundt, DG; Ukoli, FAM; Blot, WJ; Hargreaves, MK				Zhou, Yuan E.; Buchowski, Maciej S.; Liu, Jianguo; Schlundt, David G.; Ukoli, Flora A. M.; Blot, William J.; Hargreaves, Margaret K.			Plasma Lycopene Is Associated with Pizza and Pasta Consumption in Middle-Aged and Older African American and White Adults in the Southeastern USA in a Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; 3RD NATIONAL-HEALTH; ALPHA-TOCOPHEROL; DIETARY PATTERNS; UNITED-STATES; RACIAL-DIFFERENCES; NUTRIENT INTAKE; ENERGY-INTAKE; CANCER-RISK; NHANES-III	Background The role of dietary lycopene in chronic disease prevention is not well known. Methods This study examined intake of lycopene and other antioxidants from lycopene-rich foods (e.g., pizza and pasta) simultaneously with plasma levels of lycopene and other antioxidants in a representative cross-sectional sample (187 Blacks, 182 Whites, 40-79 years old) from the Southern Community Cohort Study (SCCS). The SCCS is an ongoing study conducted in populations at high risk for chronic diseases living in Southeastern United States. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and plasma levels of lycopene and other antioxidants were measured at baseline (2002-2005). The participants were classified into tertiles according to consumption of pizza and pasta food groups. Results Lycopene dietary intake and plasma lycopene concentrations were significantly higher in the highest (tertile 3) compared to tertiles 1 and 2 (both P < 0.01). Total energy intake ranged from 1964.3 +/- 117.1 kcal/day (tertile 1) to 3277.7 +/- 115.8 kcal/day (tertile 3) (P<0.0001). After adjusting for age and energy intake, total dietary fat, saturated fatty acids, trans-fatty acids, and sodium intakes were significantly higher in tertile 3 than tertiles 2 and 1 (all P < 0.01). Vitamin C intake was significantly lower in tertile 3 than tertiles 1 and 2 (P = 0.003). Except for gamma-tocopherol being higher in tertile 3 than tertiles 1 and 2 (P = 0.015), the plasma concentrations of antioxidants were lower in tertile 3 than tertiles 1 and 2 ( beta-carotene, alpha-carotene, lutein and zeaxanthin, all P<0.05). Conclusions In the SCCS population, pizza and pasta were the main sources of dietary lycopene and their intake was associated with plasma lycopene concentration. Diets with frequent pizza and pasta consumption were high in energy, saturated fatty acids, trans-fatty acids, sodium and low in other antioxidants. Future studies of lycopene as a protective dietary factor against chronic disease should consider the overall nutritional quality of lycopene-containing foods.	[Zhou, Yuan E.; Liu, Jianguo; Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Blot, William J.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ukoli, Flora A. M.] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; Meharry Medical College	Zhou, YE (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	yzhou@mmc.edu	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	NCI grant from the National Cancer Institute [R01 CA092447]; CTSA grant from the National Center for Advancing Translational Sciences [202815-502001-20]; CNPC grant from the National Cancer Institute [3 U54 CA1 S3708-03]; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases [1 P30 DK092986]; Vanderbilt-Ingram Cancer Center (US) [P30CA068485]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	NCI grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA grant from the National Center for Advancing Translational Sciences; CNPC grant from the National Cancer Institute; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt-Ingram Cancer Center (US); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grant R01 CA092447 from the National Cancer Institute, CTSA grant 202815-502001-20 from the National Center for Advancing Translational Sciences, CNPC grant 3 U54 CA1 S3708-03 from the National Cancer Institute, NIDDK grant 1 P30 DK092986 from the National Institute of Diabetes and Digestive and Kidney Diseases, and Vanderbilt-Ingram Cancer Center (US) P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron KJ, 2011, AM J CLIN NUTR, V94, P1071, DOI 10.3945/ajcn.111.013094; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bovell-Benjamin A, 2010, J HEALTH CARE POOR U, V21, P57, DOI 10.1353/hpu.0.0361; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; COATES RJ, 1991, AM J EPIDEMIOL, V134, P658, DOI 10.1093/oxfordjournals.aje.a116138; Cook A, 2000, J EPIDEMIOL COMMUN H, V54, P611, DOI 10.1136/jech.54.8.611; CRAFT NE, 1988, CLIN CHEM, V34, P44; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P; Garcia AL, 2008, BRIT J NUTR, V99, P1293, DOI 10.1017/S0007114507868486; Gerster H, 1997, J AM COLL NUTR, V16, P109; Grainger EM, 2015, BRIT J NUTR, V114, P596, DOI 10.1017/S0007114515002202; Gross M, 2003, AM J CLIN NUTR, V77, P458, DOI 10.1093/ajcn/77.2.458; GROSS MD, 1995, CLIN CHEM, V41, P943; Gutierrez OM, 2014, AM J KIDNEY DIS, V64, P204, DOI 10.1053/j.ajkd.2014.02.013; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hargreaves MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084972; HORNE DW, 1988, CLIN CHEM, V34, P2357; Institute of Medicine, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Judd SE, 2013, STROKE, V44, P3305, DOI 10.1161/STROKEAHA.113.002636; Kachan D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140023; Kiage JN, 2014, AM J CLIN NUTR, V99, P1071, DOI 10.3945/ajcn.113.075713; Locher JL, 2004, ALABAMA HERITAGE, V74, P6; Mackinnon ES, 2011, J NUTR HEALTH AGING, V15, P133, DOI 10.1007/s12603-011-0026-4; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mayne ST, 1999, J NUTR, V129, P849, DOI 10.1093/jn/129.4.849; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Obisesan TO, 2000, STROKE, V31, P19, DOI 10.1161/01.STR.31.1.19; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rao AV, 2006, ADV FOOD NUTR RES, V51, P99, DOI 10.1016/S1043-4526(06)51002-2; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccioni G, 2008, EUR REV MED PHARMACO, V12, P183; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shah M, 2010, J NUTR EDUC BEHAV, V42, P99, DOI 10.1016/j.jneb.2009.02.001; Shi J, 2000, CRIT REV FOOD SCI, V40, P1, DOI 10.1080/10408690091189275; Siega-Riz A M, 2001, J Am Med Womens Assoc (1972), V56, P44; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2010, AM J EPIDEMIOL, V171, P488, DOI 10.1093/aje/kwp402; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Soory Mena, 2012, Infectious Disorders - Drug Targets, V12, P388; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1895, DOI 10.1016/j.jada.2007.08.016; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1218, DOI 10.1016/j.jada.2007.04.008; Talegawkar SA, 2007, J NUTR, V137, P2297, DOI 10.1093/jn/137.10.2297; Testa R, 2014, CURR OPIN CLIN NUTR, V17, P338, DOI 10.1097/MCO.0000000000000066; TONUCCI LH, 1995, J AGR FOOD CHEM, V43, P579, DOI 10.1021/jf00051a005; United States Department of Agriculture (USDA) National Agricultural Library, 2016, USDA NUTR DAT LISTS; Voeks JH, 2008, STROKE, V39, P1675, DOI 10.1161/STROKEAHA.107.507053; Wei MY, 2012, J ONCOL, V2012, DOI 10.1155/2012/271063; Whelton PK, 2014, CURR OPIN LIPIDOL, V25, P75, DOI 10.1097/MOL.0000000000000033; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146	59	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161918	10.1371/journal.pone.0161918	http://dx.doi.org/10.1371/journal.pone.0161918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583358	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600074
